PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ali, S; Chopra, R; Manvati, S; Singh, YP; Kaul, N; Behura, A; Mahajan, A; Sehajpal, P; Gupta, S; Dhar, MK; Chainy, GBN; Bhanwer, AS; Sharma, S; Bamezai, RNK				Ali, Shafat; Chopra, Rupali; Manvati, Siddharth; Singh, Yoginder Pal; Kaul, Nabodita; Behura, Anita; Mahajan, Ankit; Sehajpal, Prabodh; Gupta, Subash; Dhar, Manoj K.; Chainy, Gagan B. N.; Bhanwer, Amarjit S.; Sharma, Swarkar; Bamezai, Rameshwar N. K.			Replication of Type 2 Diabetes Candidate Genes Variations in Three Geographically Unrelated Indian Population Groups	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-DEGRADING ENZYME; LARGE-SCALE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK LOCI; JAPANESE POPULATION; ADULT OBESITY; VARIANTS; MELLITUS; METAANALYSIS	Type 2 diabetes (T2D) is a syndrome of multiple metabolic disorders and is genetically heterogeneous. India comprises one of the largest global populations with highest number of reported type 2 diabetes cases. However, limited information about T2D associated loci is available for Indian populations. It is, therefore, pertinent to evaluate the previously associated candidates as well as identify novel genetic variations in Indian populations to understand the extent of genetic heterogeneity. We chose to do a cost effective high-throughput mass-array genotyping and studied the candidate gene variations associated with T2D in literature. In this case-control candidate genes association study, 91 SNPs from 55 candidate genes have been analyzed in three geographically independent population groups from India. We report the genetic variants in five candidate genes: TCF7L2, HHEX, ENPP1, IDE and FTO, are significantly associated (after Bonferroni correction, p<5.5E204) with T2D susceptibility in combined population. Interestingly, SNP rs7903146 of the TCF7L2 gene passed the genome wide significance threshold (combined P value = 2.05E208) in the studied populations. We also observed the association of rs7903146 with blood glucose (fasting and postprandial) levels, supporting the role of TCF7L2 gene in blood glucose homeostasis. Further, we noted that the moderate risk provided by the independently associated loci in combined population with Odds Ratio (OR)<1.38 increased to OR = 2.44, (95% CI = 1.67-3.59) when the risk providing genotypes of TCF7L2, HHEX, ENPP1 and FTO genes were combined, suggesting the importance of gene-gene interactions evaluation in complex disorders like T2D.	[Ali, Shafat; Chopra, Rupali; Manvati, Siddharth; Singh, Yoginder Pal; Kaul, Nabodita; Behura, Anita; Mahajan, Ankit; Sharma, Swarkar; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Chopra, Rupali; Manvati, Siddharth; Bamezai, Rameshwar N. K.] Shri Mata Vaishno Devi Univ, Katra, Jammu & Kashmir, India; [Singh, Yoginder Pal; Kaul, Nabodita; Sehajpal, Prabodh; Bhanwer, Amarjit S.] Guru Nanak Dev Univ, Amritsar, Punjab, India; [Behura, Anita; Chainy, Gagan B. N.] Utkal Univ, Dept Biotechnol, Bhubaneswar, Odisha, India; [Mahajan, Ankit; Gupta, Subash; Dhar, Manoj K.] Univ Jammu, Jammu 180004, Jammu & Kashmir, India; [Sharma, Swarkar] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Sharma, Swarkar] Shri Mata Vaishno Devi Univ, Sch Biol & Chem, Katra, Jammu & Kashmir, India	Jawaharlal Nehru University, New Delhi; Shri Mata Vaishno Devi University; Guru Nanak Dev University; Utkal University; University of Jammu; Texas Scottish Rite Hospital for Children; Shri Mata Vaishno Devi University	Sharma, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	sawerkar@hotmail.com; bamezai@hotmail.com	Chainy, Gagan B.N./G-7020-2012; ALI, SHAFAT/Q-6269-2017; Kaul, Nabodita/AAR-8832-2020; SHARMA, SWARKAR/B-8096-2008	SHARMA, SWARKAR/0000-0001-8857-5906; Bhanwer, AJS/0000-0001-5181-9268; Chainy, Gagan/0000-0002-6418-0480; Bamezai, R.N.K/0000-0002-5128-2859	Department of Biotechnology (DBT) [BT/PR/8846/MED/12/327/2007]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	Authors acknowledge the support provided by the Department of Biotechnology (DBT) through a multi-centric research project BT/PR/8846/MED/12/327/2007, sanctioned under the supervision of RNKB to ASB, PS and SG. RNKB also acknowledges the infrastructure support provided to NCAHG by UGC and DBT for its high-throughput project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhary S, 2009, DIABETES, V58, P2137, DOI 10.2337/db09-0059; Ali S, 2012, HUM GENET, V131, P703, DOI 10.1007/s00439-011-1114-6; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gamboa-Melendez MA, 2012, DIABETES; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gu HF, 2004, DIABETES, V53, P2137, DOI 10.2337/diabetes.53.8.2137; Gupta V, 2012, DIABETOLOGIA, V55, P349, DOI 10.1007/s00125-011-2355-6; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Meyre D, 2012, DIABETOLOGIA, V55, P873, DOI 10.1007/s00125-012-2478-4; Mtiraoui N, 2012, DIABETES METAB; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Rai E, 2007, HUM GENET, V122, P535, DOI 10.1007/s00439-007-0421-4; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schulze MB, 2007, DIABETOLOGIA, V50, P2405, DOI 10.1007/s00125-007-0766-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shetty P, 2012, NATURE, V485, pS14, DOI 10.1038/485S14a; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	57	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58881	10.1371/journal.pone.0058881	http://dx.doi.org/10.1371/journal.pone.0058881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527042	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562100053
J	Apicella, A; Soncini, M; Deriu, MA; Natalello, A; Bonanomi, M; Dellasega, D; Tortora, P; Regonesi, ME; Casari, CS				Apicella, Alessandra; Soncini, Monica; Deriu, Marco Agostino; Natalello, Antonino; Bonanomi, Marcella; Dellasega, David; Tortora, Paolo; Regonesi, Maria Elena; Casari, Carlo Spartaco			A Hydrophobic Gold Surface Triggers Misfolding and Aggregation of the Amyloidogenic Josephin Domain in Monomeric Form, While Leaving the Oligomers Unaffected	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; ATAXIN-3; MEMBRANE; PROTEINS; DYNAMICS; FIBRILLOGENESIS; ADSORPTION; MICROSCOPY; FIELD	Protein misfolding and aggregation in intracellular and extracellular spaces is regarded as a main marker of the presence of degenerative disorders such as amyloidoses. To elucidate the mechanisms of protein misfolding, the interaction of proteins with inorganic surfaces is of particular relevance, since surfaces displaying different wettability properties may represent model systems of the cell membrane. Here, we unveil the role of surface hydrophobicity/hydrophilicity in the misfolding of the Josephin domain (JD), a globular-shaped domain of ataxin-3, the protein responsible for the spinocerebellar ataxia type 3. By means of a combined experimental and theoretical approach based on atomic force microscopy, Fourier transform infrared spectroscopy and molecular dynamics simulations, we reveal changes in JD morphology and secondary structure elicited by the interaction with the hydrophobic gold substrate, but not by the hydrophilic mica. Our results demonstrate that the interaction with the gold surface triggers misfolding of the JD when it is in native-like configuration, while no structural modification is observed after the protein has undergone oligomerization. This raises the possibility that biological membranes would be unable to affect amyloid oligomeric structures and toxicity.	[Apicella, Alessandra; Dellasega, David; Casari, Carlo Spartaco] Politecn Milan, Dept Energy, I-20133 Milan, Italy; [Apicella, Alessandra] Politecn Milan, NEMAS Ctr NanoEngn Mat & Surfaces, I-20133 Milan, Italy; [Apicella, Alessandra] Ecole Polytech Fed Lausanne, Dept Sci & Genie Mat, Lab Technol Composites & Polymeres LTC, Lausanne, Switzerland; [Soncini, Monica] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Deriu, Marco Agostino] Politecn Torino, Dept Aerosp & Mech Engn DIMEAS, Turin, Italy; [Natalello, Antonino; Bonanomi, Marcella; Tortora, Paolo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Regonesi, Maria Elena] Univ Milano Bicocca, Dept Stat & Quantitat Methods DiSMeQ, Milan, Italy; [Casari, Carlo Spartaco] Italian Inst Technol, Ctr Nano Sci & Technol Polimi, Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Polytechnic University of Milan; Polytechnic University of Turin; University of Milano-Bicocca; University of Milano-Bicocca; Istituto Italiano di Tecnologia - IIT	Soncini, M (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy.	monica.soncini@polimi.it; mariaelena.regonesi@unimib.it	Dellasega, David/G-4371-2011; Deriu, Marco Agostino Agostino/GPW-8179-2022; Deriu, Marco Agostino/M-5161-2016; Casari, Carlo S./C-6189-2008; Natalello, Antonino/B-9659-2012; Soncini, Monica/E-9609-2018	Dellasega, David/0000-0002-7389-9307; Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Deriu, Marco Agostino/0000-0003-1918-1772; Casari, Carlo S./0000-0001-9144-6822; Natalello, Antonino/0000-0002-1489-272X; Tortora, Paolo/0000-0001-5234-601X; Soncini, Monica/0000-0001-8607-7196	Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research (PRIN); Regione Lombardia (N.E.D.D. project)	Fondazione Cariplo (N.O.B.E.L. project)(Fondazione Cariplo); Italian Ministry for Instruction, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia (N.E.D.D. project)	This work was funded by the Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research (PRIN 2007); Regione Lombardia (N.E.D.D. project). The funders had a role in the data collection and analysis and for the payment of the publication.	Ahmad S, 2010, J R SOC INTERFACE, V7, pS423, DOI 10.1098/rsif.2010.0190.focus; Apicella A, 2012, BIOCHIMIE, V94, P1026, DOI 10.1016/j.biochi.2012.01.002; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Artali R, 2008, J R SOC INTERFACE, V5, P273, DOI 10.1098/rsif.2007.1137; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Deriu MA, 2007, J MATER SCI, V42, P8864, DOI 10.1007/s10853-007-1784-6; Deriu MA, 2010, BIOPHYS J, V99, P2190, DOI 10.1016/j.bpj.2010.06.070; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Evangelisti E, 2012, J CELL SCI, V125, P2416, DOI 10.1242/jcs.098434; Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8; HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4; Heinz H, 2005, CHEM MATER, V17, P5658, DOI 10.1021/cm0509328; Heinz H, 2010, J COMPUT CHEM, V31, P1564, DOI 10.1002/jcc.21421; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iori F, 2009, J COMPUT CHEM, V30, P1465, DOI 10.1002/jcc.21165; Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863; KARPLUS M, 1995, CURR OPIN STRUC BIOL, V5, P58, DOI 10.1016/0959-440X(95)80010-X; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2011, BIOPHYS J, V100, P2033, DOI 10.1016/j.bpj.2011.02.056; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Morozova-Roche LA, 2004, BIOCHEMISTRY-US, V43, P9610, DOI 10.1021/bi0494121; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183; ODIN C, 1994, SURF SCI, V317, P321, DOI 10.1016/0039-6028(94)90288-7; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Sethuraman A, 2005, BIOPHYS J, V88, P1322, DOI 10.1529/biophysj.104.051797; Soncini M, 2007, BIOMECH MODEL MECHAN, V6, P399, DOI 10.1007/s10237-006-0060-z; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Stefani M, 2008, INT J MOL SCI, V9, P2515, DOI 10.3390/ijms9122515; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	41	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58794	10.1371/journal.pone.0058794	http://dx.doi.org/10.1371/journal.pone.0058794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527026	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100043
J	Zhou, SB; Salisbury, J; Preedy, VR; Emery, PW				Zhou, Shaobo; Salisbury, Jonathan; Preedy, Victor R.; Emery, Peter W.			Increased Collagen Synthesis Rate during Wound Healing in Muscle	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; IN-VIVO; DEGRADATION; TISSUES; PROLINE	Wound healing in muscle involves the deposition of collagen, but it is not known whether this is achieved by changes in the synthesis or the degradation of collagen. We have used a reliable flooding dose method to measure collagen synthesis rate in vivo in rat abdominal muscle following a surgical incision. Collagen synthesis rate was increased by 480% and 860% on days 2 and 7 respectively after surgery in the wounded muscle compared with an undamaged area of the same muscle. Collagen content was increased by approximately 100% at both day 2 and day 7. These results demonstrate that collagen deposition during wound healing in muscle is achieved entirely by an increase in the rate of collagen synthesis.	[Zhou, Shaobo; Preedy, Victor R.; Emery, Peter W.] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England; [Salisbury, Jonathan] Kings Coll Hosp, Dept Histopathol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Emery, PW (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England.	peter.emery@kcl.ac.uk	Salisbury, Jonathan/N-1356-2019; Zhou, Shaobo/I-1536-2019	Zhou, Shaobo/0000-0001-5214-2973; Salisbury, Jonathan/0000-0002-5889-4276	BBSRC - Biotechnology and Biological Sciences Research Council [S16409]	BBSRC - Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by BBSRC - Biotechnology and Biological Sciences Research Council Grant no S16409 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrione P, 2010, AM J PHYS MED REHAB, V89, P854, DOI 10.1097/PHM.0b013e3181f1c1c7; Bucci L. R., 1995, NUTR APPL INJURY REH; EMERY PW, 1994, BRIT J SURG, V81, P539, DOI 10.1002/bjs.1800810417; EMERY PW, 1995, CLIN SCI, V89, P383, DOI 10.1042/cs0890383; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9; Kiernan J.A, 1990, HISTOLOGICAL HISTOCH; LAURENT GJ, 1982, BIOCHEM J, V206, P535, DOI 10.1042/bj2060535; LAURENT GJ, 1982, ANAL BIOCHEM, V123, P223, DOI 10.1016/0003-2697(82)90438-9; LAURENT GJ, 1987, AM J PHYSIOL, V252, P1; MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307; MCANULTY RJ, 1987, COLLAGEN REL RES, V7, P93; McAnulty RJ, 2005, METH MOLEC MED, V117, P189; Zhou SB, 2006, ELECTROPHORESIS, V27, P1147, DOI 10.1002/elps.200500684	15	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58324	10.1371/journal.pone.0058324	http://dx.doi.org/10.1371/journal.pone.0058324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526975	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100022
J	Li, DL; Zhao, ZJ; Huang, YD; Lu, ZJ; Yao, M; Hao, YJ; Zhai, CH; Wang, YC				Li, Delong; Zhao, Zhijian; Huang, Yidan; Lu, Zhaojun; Yao, Meng; Hao, Yujuan; Zhai, Chunhua; Wang, Yuanchao			PsVPS1, a Dynamin-Related Protein, Is Involved in Cyst Germination and Soybean Infection of Phytophthora sojae	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CANDIDA-ALBICANS; FUNCTIONAL-ANALYSIS; VACUOLE BIOGENESIS; FILAMENTOUS FUNGI; USTILAGO-MAYDIS; YEAST; PATHOGEN; AVIRULENCE; SECRETION	Plant pathogens secrete effector proteins to suppress plant immunity. However, the mechanism by which oomycete pathogens deliver effector proteins during plant infection remains unknown. In this report, we characterized a Phytophthora sojae vps1 gene. This gene encodes a homolog of the Saccharomyces cerevisiae vacuolar protein sorting gene vps1 that mediates budding of clathrin-coated vesicles from the late Golgi, which are diverted from the general secretory pathway to the vacuole. PsVPS1-silenced mutants were generated using polyethylene glycol-mediated protoplast stable transformation and were viable but had reduced extracellular protein activity. The PsVPS1-silenced mutants showed impaired hyphal growth, and the shapes of the vacuoles were highly fragmented. Silencing of PsVPS1 affected cyst germination as well as the polarized growth of germinated cysts. Silenced mutants showed impaired invasion of susceptible soybean plants regardless of wounding. These results suggest that PsVPS1 is involved in vacuole morphology and cyst development. Moreover, it is essential for the virulence of P. sojae and extracellular protein secretion.	[Wang, Yuanchao] Nanjing Agr Univ, Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Jiangsu, Peoples R China; Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University	Wang, YC (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Jiangsu, Peoples R China.	wangyc@njau.edu.cn	wang, yuanchao/G-9667-2011	wang, yuanchao/0000-0001-5803-5343	National Natural Science Funds for Distinguished Young Scholar from the Chinese government [31225022]	National Natural Science Funds for Distinguished Young Scholar from the Chinese government	This work was supported by National Natural Science Funds for Distinguished Young Scholar (31225022) from the Chinese government to YCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2011, FUNGAL BIOL-UK, V115, P882, DOI 10.1016/j.funbio.2011.07.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barelle CJ, 2006, EUKARYOT CELL, V5, P359, DOI 10.1128/EC.5.2.359-367.2006; Bernardo SM, 2008, FUNGAL GENET BIOL, V45, P861, DOI 10.1016/j.fgb.2008.01.001; Birch PRJ, 2001, MOL PLANT PATHOL, V2, P257, DOI 10.1046/j.1464-6722.2001.00073.x; Bruckmann A, 2001, YEAST, V18, P343, DOI 10.1002/1097-0061(20010315)18:4&lt;343::AID-YEA675&gt;3.0.CO;2-Z; Conesa A, 2001, FUNGAL GENET BIOL, V33, P155, DOI 10.1006/fgbi.2001.1276; CONIBEAR E, 1995, CELL, V83, P513, DOI 10.1016/0092-8674(95)90088-8; Cornet M, 2005, INFECT IMMUN, V73, P7977, DOI 10.1128/IAI.73.12.7977-7987.2005; Doehlemann G, 2011, MOL MICROBIOL, V81, P751, DOI 10.1111/j.1365-2958.2011.07728.x; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Erwin D. C., 1996, Phytophthora diseases worldwide.; Franke K, 2006, MICROBIOL-SGM, V152, P3111, DOI 10.1099/mic.0.29115-0; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Gow Neil A. R., 1997, Current Topics in Medical Mycology, V8, P43; Griffin D., 1996, FUNGAL PHYSL; Guerriero G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001070; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; HERTH W, 1980, PROTOPLASMA, V105, P129, DOI 10.1007/BF01279855; Howlett BJ, 2009, PLOS PATHOG, V5; Hua CL, 2008, EUKARYOT CELL, V7, P2133, DOI 10.1128/EC.00286-08; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Lee SA, 2007, FEMS YEAST RES, V7, P973, DOI 10.1111/j.1567-1364.2007.00253.x; LIN CC, 1970, ARCH MIKROBIOL, V72, P111, DOI 10.1007/BF00409517; MACKENZIE DA, 1993, J GEN MICROBIOL, V139, P2295, DOI 10.1099/00221287-139-10-2295; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McLeod A, 2004, EUKARYOT CELL, V3, P91, DOI 10.1128/EC.3.1.91-99.2004; Mishra Ritu, 2011, Commun Integr Biol, V4, P115, DOI 10.4161/cib.4.1.14206; MOEHLE CM, 1989, J CELL BIOL, V108, P309, DOI 10.1083/jcb.108.2.309; Morris PF, 1998, PLANT PHYSIOL, V117, P1171, DOI 10.1104/pp.117.4.1171; Palmer GE, 2003, EUKARYOT CELL, V2, P411, DOI 10.1128/EC.2.3.411-421.2003; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rothlisberger S, 2009, FUNGAL GENET BIOL, V46, P927, DOI 10.1016/j.fgb.2009.07.008; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Siriputthaiwan P, 2005, J CELL SCI, V118, P323, DOI 10.1242/jcs.01616; Smaczynska-de Rooij II, 2010, J CELL SCI, V123, P3496, DOI 10.1242/jcs.070508; Steinberg G, 1998, J CELL SCI, V111, P2235; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Takegawa K, 2003, CELL STRUCT FUNCT, V28, P399, DOI 10.1247/csf.28.399; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarutani Y, 2001, GENE, V268, P23, DOI 10.1016/S0378-1119(01)00418-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wrather JA, 2006, J NEMATOL, V38, P173; Ye WW, 2011, MOL PLANT MICROBE IN, V24, P1530, DOI 10.1094/MPMI-05-11-0106; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Zhao W, 2011, FUNGAL GENET BIOL, V48, P241, DOI 10.1016/j.fgb.2010.11.006; Zuo YuHu, 2005, Acta Phytopathologica Sinica, V35, P235	58	4	4	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58623	10.1371/journal.pone.0058623	http://dx.doi.org/10.1371/journal.pone.0058623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516518	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400041
J	Prates, ET; Stankovic, I; Silveira, RL; Liberato, MV; Henrique-Silva, F; Pereira, N; Polikarpov, I; Skaf, MS				Prates, Erica T.; Stankovic, Ivana; Silveira, Rodrigo L.; Liberato, Marcelo V.; Henrique-Silva, Flavio; Pereira, Nei, Jr.; Polikarpov, Igor; Skaf, Munir S.			X-ray Structure and Molecular Dynamics Simulations of Endoglucanase 3 from Trichoderma harzianum: Structural Organization and Substrate Recognition by Endoglucanases That Lack Cellulose Binding Module	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INITIAL CONFIGURATIONS; ENZYMATIC-HYDROLYSIS; CELLOBIOHYDROLASE-I; CATALYTIC CORE; REESEI; MODEL; CEL12A; DEGRADATION; CELLULASES	Plant biomass holds a promise for the production of second-generation ethanol via enzymatic hydrolysis, but its utilization as a biofuel resource is currently limited to a large extent by the cost and low efficiency of the cellulolytic enzymes. Considerable efforts have been dedicated to elucidate the mechanisms of the enzymatic process. It is well known that most cellulases possess a catalytic core domain and a carbohydrate binding module (CBM), without which the enzymatic activity can be drastically reduced. However, Cel12A members of the glycosyl hydrolases family 12 (GHF12) do not bear a CBM and yet are able to hydrolyze amorphous cellulose quite efficiently. Here, we use X-ray crystallography and molecular dynamics simulations to unravel the molecular basis underlying the catalytic capability of endoglucanase 3 from Trichoderma harzianum (ThEG3), a member of the GHF12 enzymes that lacks a CBM. A comparative analysis with the Cellulomonas fimi CBM identifies important residues mediating interactions of EG3s with amorphous regions of the cellulose. For instance, three aromatic residues constitute a harboring wall of hydrophobic contacts with the substrate in both ThEG3 and CfCBM structures. Moreover, residues at the entrance of the active site cleft of ThEG3 are identified, which might hydrogen bond to the substrate. We advocate that the ThEG3 residues Asn152 and Glu201 interact with the substrate similarly to the corresponding CfCBM residues Asn81 and Arg75. Altogether, these results show that CBM motifs are incorporated within the ThEG3 catalytic domain and suggest that the enzymatic efficiency is associated with the length and position of the substrate chain, being higher when the substrate interact with the aromatic residues at the entrance of the cleft and the catalytic triad. Our results provide guidelines for rational protein engineering aiming to improve interactions of GHF12 enzymes with cellulosic substrates.	[Prates, Erica T.; Stankovic, Ivana; Silveira, Rodrigo L.; Skaf, Munir S.] State Univ Campinas UNICAMP, Inst Chem, Campinas, SP, Brazil; [Liberato, Marcelo V.; Polikarpov, Igor] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil; [Henrique-Silva, Flavio] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Pereira, Nei, Jr.] Univ Fed Rio de Janeiro, Ctr Tecnol, Escola Quim, Lab Desenvolvimento Bioproc LaDeBio, Rio De Janeiro, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Federal do Rio de Janeiro	Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil.	ipolikarpov@ifsc.usp.br; skaf@iqm.unicamp.br	Prates, Erica/E-3858-2016; Henrique-Silva, Flavio/A-1937-2013; Teixeira Prates, Erica/GLU-6833-2022; UNICAMP, CCES -/J-7787-2015; Liberato, Marcelo V/J-3606-2014; Polikarpov, Igor/D-2575-2012; Skaf, Munir S/B-1614-2013; Pereira, Nei/H-2471-2016; Silveira, Rodrigo L/I-3961-2014	Liberato, Marcelo V/0000-0002-7609-7844; Skaf, Munir S/0000-0001-7485-1228; Silveira, Rodrigo L/0000-0001-9515-3082; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/56255-9, 09/54035-4, 10/08680-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [490022/2009-0, 550985/2010-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants 08/56255-9, 09/54035-4 and 10/08680-2; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) via grants 490022/2009-0, 550985/2010-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Berner RA, 2003, NATURE, V426, P323, DOI 10.1038/nature02131; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cheng YS, 2011, PROTEINS, V79, P1193, DOI 10.1002/prot.22953; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Generoso WC, 2012, GENET MOL RES, V11, P1544, DOI 10.4238/2012.May.21.11; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hatcher ER, 2009, J CHEM THEORY COMPUT, V5, P1315, DOI 10.1021/ct9000608; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Kuzmanic A, 2010, BIOPHYS J, V98, P861, DOI 10.1016/j.bpj.2009.11.011; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Liberato MV, 2012, ACTA CRYSTALLOGR F, V68, P306, DOI 10.1107/S1744309112000838; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez JM, 2003, J COMPUT CHEM, V24, P819, DOI 10.1002/jcc.10216; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; MARTYNA GJ, 1994, PHYS REV E, V50, P3234, DOI 10.1103/PhysRevE.50.3234; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakazawa H, 2009, APPL MICROBIOL BIOT, V83, P649, DOI 10.1007/s00253-009-1901-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PHILLIPS GN, 1990, BIOPHYS J, V57, P381, DOI 10.1016/S0006-3495(90)82540-6; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sims R, 2008, 1 2 GENERATION BIOFU; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sulzenbacher G, 1999, BIOCHEMISTRY-US, V38, P4826, DOI 10.1021/bi982648i; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Xiao ZZ, 2001, BIOTECHNOL LETT, V23, P711, DOI 10.1023/A:1010325122851; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	58	29	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59069	10.1371/journal.pone.0059069	http://dx.doi.org/10.1371/journal.pone.0059069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516599	gold, Green Submitted, Green Published			2022-12-25	WOS:000316407400089
J	Barriga, M; Cal, R; Cabello, N; Llach, A; Vallmitjana, A; Benitez, R; Badimon, L; Cinca, J; Llorente-Cortes, V; Hove-Madsen, L				Barriga, Montserrat; Cal, Roi; Cabello, Nuria; Llach, Anna; Vallmitjana, Alexander; Benitez, Raul; Badimon, Lina; Cinca, Juan; Llorente-Cortes, Vicenta; Hove-Madsen, Leif			Low Density Lipoproteins Promote Unstable Calcium Handling Accompanied by Reduced SERCA2 and Connexin-40 Expression in Cardiomyocytes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN ATRIAL-FIBRILLATION; VENTRICULAR-FIBRILLATION; SARCOPLASMIC-RETICULUM; MYOCYTES; PROTEIN; ARRHYTHMIAS; SIMVASTATIN; RECEPTORS; JUNCTIONS	The damaging effects of high plasma levels of cholesterol in the cardiovascular system are widely known, but little attention has been paid to direct effects on cardiomyocyte function. We therefore aimed at testing the hypothesis that Low Density Lipoprotein (LDL) cholesterol affects calcium dynamics and signal propagation in cultured atrial myocytes. For this purpose, mRNA and protein expression levels were determined by real time PCR and western blot analysis, respectively, and intracellular calcium was visualized in fluo-4 loaded atrial HL-1 myocyte cultures subjected to field stimulation. At low stimulation frequencies all cultures had uniform calcium transients at all tested LDL concentrations. However, 500 mu g LDL/mL maximally reduced the calcium transient amplitude by 43% from 0.30 +/- 0.04 to 0.17 +/- 0.02 (p<0.05). Moreover, LDL-cholesterol dose-dependently increased the fraction of alternating and irregular beat-to-beat responses observed when the stimulation interval was shortened. This effect was linked to a concurrent reduction in SERCA2, RyR2, IP3RI and IP3RII mRNA levels. SERCA2 protein levels were also reduced by 43% at 200 mu g LDL/mL (p<0.05) and SR calcium loading was reduced by 38 +/- 6% (p<0.001). By contrast, HDL-cholesterol had no significant effect on SERCA expression or SR calcium loading. LDL-cholesterol also slowed the conduction velocity of the calcium signal from 3.2 +/- 0.2 mm/s without LDL to 1.7 +/- 0.1 mm/s with 500 mu g LDL/mL (p<0.05). This coincided with a reduction in Cx40 expression (by 44 +/- 3%; p<0.05 for mRNA and by 79 +/- 2%; p<0.05 for Cx40 protein at 200 mu g/ml LDL) whereas the Cx-43 expression did not significantly change. In conclusion, LDL-cholesterol destabilizes calcium handling in cultured atrial myocytes subjected to rapid pacing by reducing SERCA2 and Cx40 expression and by slowing the conduction velocity of the calcium signal.	[Barriga, Montserrat; Cal, Roi; Cabello, Nuria; Badimon, Lina; Llorente-Cortes, Vicenta; Hove-Madsen, Leif] CSIC, Inst Catala Ciencies Cardiovasc, Cardiovasc Res Ctr, Barcelona, Spain; [Barriga, Montserrat; Cal, Roi; Cabello, Nuria; Badimon, Lina; Llorente-Cortes, Vicenta; Hove-Madsen, Leif] Inst Invest Biomed St Pau, Barcelona, Spain; [Llach, Anna; Cinca, Juan] Inst Invest Biomed St Pau, Serv Cardiol, Barcelona, Spain; [Llach, Anna; Cinca, Juan] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Badimon, Lina] Ctr Invest Biomed Red Obesidad & Nutr, Barcelona, Spain; [Vallmitjana, Alexander; Benitez, Raul] Univ Politecn Cataluna, Dept Ingn Sistemas Automat & Informat Ind, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat Politecnica de Catalunya	Llorente-Cortes, V (corresponding author), CSIC, Inst Catala Ciencies Cardiovasc, Cardiovasc Res Ctr, Barcelona, Spain.	cllorente@csic-iccc.org; lhove@csic-iccc.org	BADIMON, LINA/O-4711-2014; Benítez, Raúl/AGO-5018-2022; Vallmitjana, Alexander/B-5058-2019; BADIMON, LINA/S-2950-2019; Llach Martinez, Ana/M-6691-2016	BADIMON, LINA/0000-0002-9162-2459; Benítez, Raúl/0000-0002-8782-9406; Vallmitjana, Alexander/0000-0002-7149-9385; Llach Martinez, Ana/0000-0002-7486-1079; Hove-Madsen, Leif/0000-0001-5493-3998; Llach, Anna/0000-0002-4352-2920	Spanish Ministry of Science and Innovation [SAF2011-30312, CNIC2009-08]; Spanish Ministry of Health and Consume [FIS PI11/00747]; Redes de Investigacion Cooperativa, Instituto de Salud Carlos III, red REDINSCOR [RD06-0003-0000, RD06-0003-0015];  [DPI2009-06999]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Health and Consume; Redes de Investigacion Cooperativa, Instituto de Salud Carlos III, red REDINSCOR; 	This work was supported by grants from the Spanish Ministry of Science and Innovation: SAF2011-30312 and CNIC2009-08 to Leif Hove Madsen, DPI2009-06999 to Raul Benitez and from the Spanish Ministry of Health and Consume: FIS PI11/00747 to Vicenta Llorente. Funding from Redes de Investigacion Cooperativa, Instituto de Salud Carlos III, red REDINSCOR RD06-0003-0000 and RD06-0003-0015 is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacova B, 2010, J PHYSIOL PHARMACOL, V61, P717; Castellano J, 2011, J MOL CELL CARDIOL, V50, P894, DOI 10.1016/j.yjmcc.2011.02.002; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Clunn GF, 2010, INT J CARDIOL, V139, P2, DOI 10.1016/j.ijcard.2009.05.019; de Groot JR, 2003, CARDIOVASC RES, V60, P288, DOI 10.1016/j.cardiores.2003.07.004; Draeger A, 2010, AM J PATHOL, V177, P291, DOI 10.2353/ajpath.2010.091140; Fujita S, 2008, HEART VESSELS, V23, P440, DOI 10.1007/s00380-008-1079-0; GOURDIE RG, 1993, J CELL SCI, V105, P985; Gray DF, 2000, CARDIOVASC RES, V47, P329, DOI 10.1016/S0008-6363(00)00106-1; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Lin LC, 2005, LAB INVEST, V85, P1224, DOI 10.1038/labinvest.3700324; Liu YB, 2003, CIRC RES, V92, P1145, DOI 10.1161/01.RES.0000072999.51484.92; Llach A, 2011, J PHYSIOL-LONDON, V589, P3247, DOI 10.1113/jphysiol.2010.197715; Llach A, 2011, EUR HEART J, V32, P721, DOI 10.1093/eurheartj/ehq464; Llorente-Cortes V, 2006, ARTERIOSCL THROM VAS, V26, P117, DOI 10.1161/01.ATV.0000193618.32611.8b; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Maguy A, 2009, CIRC RES, V104, P1113, DOI 10.1161/CIRCRESAHA.108.191809; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Osadchii OE, 2011, AM J PHYSIOL-HEART C, V300, pH989, DOI 10.1152/ajpheart.00816.2010; Pogwizd SM, 2000, CIRC RES, V87, P641, DOI 10.1161/01.RES.87.8.641; Seto SW, 2007, BRIT J PHARMACOL, V151, P987, DOI 10.1038/sj.bjp.0707327; van der Velden HMW, 2002, CARDIOVASC RES, V54, P270, DOI 10.1016/S0008-6363(01)00557-0; van der Velden HMW, 1998, J CARDIOVASC ELECTR, V9, P596; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; VanWagoner DR, 1997, CIRC RES, V80, P772; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yeh HI, 2003, ARTERIOSCL THROM VAS, V23, P1391, DOI 10.1161/01.ATV.0000083508.21989.15; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	32	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58128	10.1371/journal.pone.0058128	http://dx.doi.org/10.1371/journal.pone.0058128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516438	Green Published, gold			2022-12-25	WOS:000316849200035
J	Herbst, A; Johnson, CJ; Hynes, K; McKenzie, D; Aiken, JM				Herbst, Allen; Johnson, Chad J.; Hynes, Kayla; McKenzie, Debbie; Aiken, Judd M.			Mitochondrial Biogenesis Drives a Vicious Cycle of Metabolic Insufficiency and Mitochondrial DNA Deletion Mutation Accumulation in Aged Rat Skeletal Muscle Fibers	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; CREATINE-KINASE; GENE-EXPRESSION; HUMAN-CELLS; WILD-TYPE; SARCOPENIA; ALPHA; RESPIRATION; DISEASE; NUMBER	Aged muscles possess dysfunctional fibers that contain intracellular expansions of somatically derived mitochondrial DNA deletion mutations. At high abundance, these mutations disrupt the expression of mitochondrially-encoded protein subunits of the electron transport chain resulting in aerobic respiration deficient muscle fiber segments. These fiber segments atrophy and break contributing to the loss of muscle mass and function that occurs with age. By combining micro-dissection of individual muscle fibers with microarray analysis, we observed the response induced within these abnormal muscle fibers and detected an increase in many genes affecting metabolism and metabolic regulation. The transcriptional profile and subsequent protein validation suggested that a non-compensatory program of mitochondrial biogenesis was initiated. We hypothesized that this non-adaptive program of mitochondrial biogenesis was driving mtDNA deletion mutation accumulation. We tested this hypothesis by treating aged rats with beta-Guanidinopropionic acid, a compound that stimulates mitochondrial biogenesis. beta-Guanidinopropionic acid treatment increased muscle mitochondrial genome copy number and resulted in a 3.7 fold increase in the abundance of electron transport chain negative muscle fiber segments. We conclude that in electron transport system abnormal muscle fiber segments, a vicious cycle of metabolic insufficiency and non-compensatory mitochondrial biogenesis drive mtDNA deletion mutation accumulation.	[Herbst, Allen; Aiken, Judd M.] Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada; [Johnson, Chad J.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Hynes, Kayla; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada	University of Alberta; University of Wisconsin System; University of Wisconsin Madison; University of Alberta	Aiken, JM (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada.	Judd.Aiken@ualberta.ca	McKenzie, Debbie/G-4459-2015	McKenzie, Debbie/0000-0002-9291-6977; Herbst, Allen/0000-0001-6601-1245; Aiken, Judd/0000-0001-6119-4521	Senior Scholar Grant from the Ellison Medical Foundation; National Institutes of Health NIA [5R01AG030423-04]; NATIONAL INSTITUTE ON AGING [R01AG030423] Funding Source: NIH RePORTER	Senior Scholar Grant from the Ellison Medical Foundation; National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a Senior Scholar Grant from the Ellison Medical Foundation and by the National Institutes of Health NIA 5R01AG030423-04 (http://www.ellisonfoundation.org, http://www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x; Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002; Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje; EINSIEDEL LJ, 1992, J NEUROL SCI, V112, P170, DOI 10.1016/0022-510X(92)90147-D; Evans W, 1997, J NUTR, V127, pS998; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921; Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006; Mueller-Hoecker J., 1993, Virchows Archiv A Pathological Anatomy and Histopathology, V422, P7; OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rosenberg IH, 1997, J NUTR, V127, P990, DOI DOI 10.1016/J.CGER.2011.03.003; ROWLEY GL, 1971, J AM CHEM SOC, V93, P5542, DOI 10.1021/ja00750a038; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; STADHOUDERS AM, 1994, P NATL ACAD SCI USA, V91, P5089, DOI 10.1073/pnas.91.11.5089; Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015; Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230; Tien ES, 2003, CANCER RES, V63, P5767; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	43	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59006	10.1371/journal.pone.0059006	http://dx.doi.org/10.1371/journal.pone.0059006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516592	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200126
J	Mitnick, CD; Franke, MF; Rich, ML; Viru, FAA; Appleton, SC; Atwood, SS; Bayona, JN; Bonilla, CA; Chalco, K; Fraser, HSF; Furin, JJ; Guerra, D; Hurtado, RM; Joseph, K; Llaro, K; Mestanza, L; Mukherjee, JS; Munoz, M; Palacios, E; Sanchez, E; Seung, KJ; Shin, SS; Sloutsky, A; Tolman, AW; Becerra, MC				Mitnick, Carole D.; Franke, Molly F.; Rich, Michael L.; Alcantara Viru, Felix A.; Appleton, Sasha C.; Atwood, Sidney S.; Bayona, Jaime N.; Bonilla, Cesar A.; Chalco, Katiuska; Fraser, Hamish S. F.; Furin, Jennifer J.; Guerra, Dalia; Hurtado, Rocio M.; Joseph, Keith; Llaro, Karim; Mestanza, Lorena; Mukherjee, Joia S.; Munoz, Maribel; Palacios, Eda; Sanchez, Epifanio; Seung, Kwonjune J.; Shin, Sonya S.; Sloutsky, Alexander; Tolman, Arielle W.; Becerra, Mercedes C.			Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality	PLOS ONE			English	Article							MDR-TB; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; STANDARDIZED TREATMENT; THERAPY; PERU; TIME; LIMA; FLUOROQUINOLONES; METAANALYSIS	Rationale: A better understanding of the composition of optimal treatment regimens for multidrug-resistant tuberculosis (MDR-TB) is essential for expanding universal access to effective treatment and for developing new therapies for MDR-TB. Analysis of observational data may inform the definition of an optimized regimen. Objectives: This study assessed the impact of an aggressive regimen-one containing at least five likely effective drugs, including a fluoroquinolone and injectable-on treatment outcomes in a large MDR-TB patient cohort. Methods: This was a retrospective cohort study of patients treated in a national outpatient program in Peru between 1999 and 2002. We examined the association between receiving an aggressive regimen and the rate of death. Measurements and Main Results: In total, 669 patients were treated with individualized regimens for laboratory-confirmed MDR-TB. Isolates were resistant to a mean of 5.4 (SD 1.7) drugs. Cure or completion was achieved in 66.1% (442) of patients; death occurred in 20.8% (139). Patients who received an aggressive regimen were less likely to die (crude hazard ratio [HR]: 0.62; 95% CI: 0.44,0.89), compared to those who did not receive such a regimen. This association held in analyses adjusted for comorbidities and indicators of severity (adjusted HR: 0.63; 95% CI: 0.43,0.93). Conclusions: The aggressive regimen is a robust predictor of MDR-TB treatment outcome. TB policy makers and program directors should consider this standard as they design and implement regimens for patients with drug-resistant disease. Furthermore, the aggressive regimen should be considered the standard background regimen when designing randomized trials of treatment for drug-resistant TB.	[Mitnick, Carole D.; Franke, Molly F.; Mukherjee, Joia S.; Tolman, Arielle W.; Becerra, Mercedes C.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02215 USA; [Mitnick, Carole D.; Franke, Molly F.; Rich, Michael L.; Appleton, Sasha C.; Bayona, Jaime N.; Fraser, Hamish S. F.; Joseph, Keith; Mukherjee, Joia S.; Seung, Kwonjune J.; Shin, Sonya S.; Becerra, Mercedes C.] Partners Hlth, Boston, MA USA; [Mitnick, Carole D.; Rich, Michael L.; Atwood, Sidney S.; Fraser, Hamish S. F.; Joseph, Keith; Mukherjee, Joia S.; Seung, Kwonjune J.; Shin, Sonya S.; Becerra, Mercedes C.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Alcantara Viru, Felix A.; Bayona, Jaime N.; Chalco, Katiuska; Guerra, Dalia; Llaro, Karim; Mestanza, Lorena; Munoz, Maribel; Palacios, Eda] Socios Salud Sucursal Peru, Lima, Peru; [Bonilla, Cesar A.] Minist Hlth, Lima, Peru; [Furin, Jennifer J.] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA; [Hurtado, Rocio M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hurtado, Rocio M.] Global Hlth Comm, Boston, MA USA; [Sanchez, Epifanio] Hosp Nacl Sergio E Bernales, Lima, Peru; [Sloutsky, Alexander] Ctr Hlth Policy & Res, Massachusetts Supranat TB Reference Lab, Boston, MA USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Harvard University; Massachusetts General Hospital	Mitnick, CD (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02215 USA.	carole_mitnick@hms.harvard.edu	Akram, Nudrat Aisha/F-6882-2010; BONILLA-ASALDE, CÉSAR ANTONIO/AHH-6777-2022; Franke, Molly/AAK-7559-2020; AlQurainy, Fahd/GZA-7225-2022; Mitnick, Carole/GRO-1991-2022; Fraser, Hamish HS/E-3773-2013; Akram, Nudrat Aisha/I-1512-2015; Ashraf, Muhammad/I-6800-2015; Fraser, Hamish/AGP-6129-2022	Akram, Nudrat Aisha/0000-0001-9140-8252; BONILLA-ASALDE, CÉSAR ANTONIO/0000-0002-4470-1939; Franke, Molly/0000-0002-4890-5728; Mitnick, Carole/0000-0002-3455-658X; Fraser, Hamish/0000-0003-4383-2854	National Institute of Allergy and Infectious Diseases [1 K01 AI065836-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI065836] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) (1 K01 AI065836-01 to CDM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Chalco K, 2006, INT NURS REV, V53, P253, DOI 10.1111/j.1466-7657.2006.00490.x; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Devasia RA, 2009, J ANTIMICROB CHEMOTH, V63, P1173, DOI 10.1093/jac/dkp096; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Flament-Saillour M, 1999, AM J RESP CRIT CARE, V160, P587, DOI 10.1164/ajrccm.160.2.9901012; Franke MF, 2013, CLIN INFECT DIS; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Fraser HSF, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P270; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joseph P, 2011, INDIAN J MED RES, V133, P529; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leung EC, 2012, EUR RESP J; Matrat S, 2006, ANTIMICROB AGENTS CH, V50, P4170, DOI 10.1128/AAC.00944-06; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Ministerio de Salud, 2006, NORM TECN SAL CONTR; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick C, 2010, AM J RESP CRIT CARE, V182, P1337, DOI 10.1164/rccm.201007-1126ED; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pachas AMC, 2004, INT J TUBERC LUNG D, V8, P52; Palacios E, 2012, INT J TUBERC LUNG D, V16, P348, DOI 10.5588/ijtld.11.0473; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; *PARTN HLTH, 2003, PIH GUID MED MAN MUL; Partners In Health Harvard Medical School Bill & Melinda Gates Foundation, 2002, DOTS PLUS HDB GUID C; Partners In Health World Health Organization, 2010, MAN MDR TB FIELD GUI; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Rich ML, 2006, INT J TUBERC LUNG D, V10, P290; Shah NS, 2011, EMERG INFECT DIS, V17, P510, DOI 10.3201/eid1703.101363; Shin SS, 2010, AM J RESP CRIT CARE, V182, P426, DOI 10.1164/rccm.200911-1768OC; Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Sweetland A, 2002, WORLD MENTAL HLTH CA; Toczek A, 2012, INT J TUBERC LUNG DI; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; Waisman JL, 2001, MEDICINA-BUENOS AIRE, V61, P810; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2006, GUID PROGR MAN DRUG; World Health Organization, 2006, GUID MAN DRUG RES TU; World Health Organization, 2012, GLOB TUB REP P2012; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	59	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58664	10.1371/journal.pone.0058664	http://dx.doi.org/10.1371/journal.pone.0058664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516529	Green Published, gold			2022-12-25	WOS:000316849200103
J	Miyata, Y; Watanabe, S; Sagara, Y; Mitsunari, K; Matsuo, T; Ohba, K; Sakai, H				Miyata, Yasuyoshi; Watanabe, Shin-ichi; Sagara, Yuji; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki			High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-A; RENAL-CELL CARCINOMA; BINDING PROTEIN HUR; FACTOR-C; ANGIOGENESIS; RNA; LYMPHANGIOGENESIS; CYCLOOXYGENASE-2; ROLES	Introduction: Human antigen R (HuR) regulates the stability of mRNA and is associated with cell proliferation, angiogenesis, and lymphangiogenesis. However, the clinical significance and pathological role of HuR in bladder cancer remains unclear. The main objective of this investigation was to clarify the relationships between HuR expression and clinical significance and cancer cell proliferation, angiogenesis, lymphangiogenesis, and expressions of cyclooxygenase (COX)-2 and vascular endothelial growth factor (VEGF)-A, -C, and -D. Methods: All expressions were examined by immunohistochemical techniques in 122 formalin-fixed specimens of bladder cancer patients. HuR expression was evaluated separately with cytoplasmic and nuclear staining. Cell proliferation, angiogenesis and lymphangiogenesis were measured as the percentage of Ki-67-positive cell (proliferation index, PI), CD34-stained vessels (microvessel density, MVD), and D2-40-stained vessels (lymph vessel density, LVD). Relationships between each HuR expression and clinicopathological features, prognosis, and expressions of COX-2 and VEGFs were analyzed by multi-variate analyses. HuR expression was also investigated in 10 mice of N-Butyl-N-[4-hydroxybutil] nitrosamine (BBN) induced bladder cancer model. Results: In human tissues, high cytoplasmic expression was seen in 5% and 25.4% of normal and cancer cells, respectively. Nuclear HuR expression bore no significant relationship to any pathological features. However, cytoplasmic HuR expression appeared positively associated with pT stage and grade (P<0.001). In mouse tissues, similar trends were confirmed. Cytoplasmic expression correlated with PI, MVD, and LVD, as well as expression of VEGF-A and -C, but not VEGF-D. High cytoplasmic expression of HuR was a significant predictor of metastasis and cause-specific survival, and was identified as a prognostic correlative factor for metastasis (hazard ratio, 4.75; P = 0.028) in a multivariate analysis model that included pathological features. Conclusions: Cytoplasmic HuR appears to play important roles in cell proliferation, progression, and survival of bladder cancer patients. Its expression was associated with angiogenesis, lymphangiogenesis, and expressions of VEGF-A and -C.	[Miyata, Yasuyoshi; Watanabe, Shin-ichi; Sagara, Yuji; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 852, Japan	Nagasaki University	Miyata, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 852, Japan.	int.doc.miya@m3.dion.ne.jp	mitsunari, kensuke/ABI-1916-2020	Matsuo, Tomohiro/0000-0002-9508-0319	Japan Society for the Promotion of Science [22591771]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (No. 22591771). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Afonso J, 2009, HISTOPATHOLOGY, V55, P514, DOI 10.1111/j.1365-2559.2009.03425.x; Ajili F, 2012, ULTRASTRUCT IN PRESS; Atasoy U, 1998, J CELL SCI, V111, P3145; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Brennan CM, 2011, CELL MIL LIFE SCI, V58, P341; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Iwata T, 2008, UROLOGY, V71, P749, DOI 10.1016/j.urology.2007.10.063; Kadota K, 2008, EUR J CANCER, V44, P1057, DOI 10.1016/j.ejca.2008.03.012; Kim I, 2012, NUCLEIC ACIDS RES, V40, P6863, DOI 10.1093/nar/gks331; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125; Lim SJ, 2009, CANCER RES TREAT, V13, P6959; Miyata Y, 2003, CLIN CANCER RES, V9, P1741; Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284; Ronkainen H, 2011, TUMOR BIOL, V32, P481, DOI 10.1007/s13277-010-0141-6; Sagara Y, 2010, CANCER EPIDEMIOL, V34, P350, DOI 10.1016/j.canep.2010.03.001; Sakuma T, 2008, J NEURO-ONCOL, V88, P143, DOI 10.1007/s11060-008-9559-8; Shariat SF, 2003, J UROLOGY, V170, P985, DOI 10.1097/01.ju.0000080401.85145.ee; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6; Wang J, 2009, ONCOLOGY-BASEL, V76, P420, DOI 10.1159/000216837; Yuan Z, 2011, ANTICANCER RES, V31, P303	25	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59095	10.1371/journal.pone.0059095	http://dx.doi.org/10.1371/journal.pone.0059095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516604	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200133
J	Naviaux, RK; Zolkipli, Z; Wang, L; Nakayama, T; Naviaux, JC; Le, TP; Schuchbauer, MA; Rogac, M; Tang, QB; Dugan, LL; Powell, SB				Naviaux, Robert K.; Zolkipli, Zarazuela; Wang, Lin; Nakayama, Tomohiro; Naviaux, Jane C.; Le, Thuy P.; Schuchbauer, Michael A.; Rogac, Mihael; Tang, Qingbo; Dugan, Laura L.; Powell, Susan B.			Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model	PLOS ONE			English	Article							RECEPTOR; ACTIVATION; CHILDREN; PROTEIN; STRESS; BRAIN; ABNORMALITIES; MITOCHONDRIA; SUPPRESSION; CEREBELLUM	Background: Autism spectrum disorders (ASDs) are caused by both genetic and environmental factors. Mitochondria act to connect genes and environment by regulating gene-encoded metabolic networks according to changes in the chemistry of the cell and its environment. Mitochondrial ATP and other metabolites are mitokines-signaling molecules made in mitochondria-that undergo regulated release from cells to communicate cellular health and danger to neighboring cells via purinergic signaling. The role of purinergic signaling has not yet been explored in autism spectrum disorders. Objectives and Methods: We used the maternal immune activation (MIA) mouse model of gestational poly(IC) exposure and treatment with the non-selective purinergic antagonist suramin to test the role of purinergic signaling in C57BL/6J mice. Results: We found that antipurinergic therapy (APT) corrected 16 multisystem abnormalities that defined the ASD-like phenotype in this model. These included correction of the core social deficits and sensorimotor coordination abnormalities, prevention of cerebellar Purkinje cell loss, correction of the ultrastructural synaptic dysmorphology, and correction of the hypothermia, metabolic, mitochondrial, P2Y2 and P2X7 purinergic receptor expression, and ERK1/2 and CAMKII signal transduction abnormalities. Conclusions: Hyperpurinergia is a fundamental and treatable feature of the multisystem abnormalities in the poly(IC) mouse model of autism spectrum disorders. Antipurinergic therapy provides a new tool for refining current concepts of pathogenesis in autism and related spectrum disorders, and represents a fresh path forward for new drug development.	[Naviaux, Robert K.; Zolkipli, Zarazuela; Wang, Lin; Nakayama, Tomohiro; Naviaux, Jane C.; Le, Thuy P.; Rogac, Mihael] Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA; [Naviaux, Robert K.; Wang, Lin; Rogac, Mihael; Tang, Qingbo; Dugan, Laura L.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Naviaux, Robert K.; Le, Thuy P.] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA; [Zolkipli, Zarazuela; Nakayama, Tomohiro] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92103 USA; [Naviaux, Jane C.; Schuchbauer, Michael A.; Powell, Susan B.] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.	Naviaux@ucsd.edu	Nakayama, Tomohiro/GYU-0303-2022		Autism Speaks Trailblazer program; Jane Botsford-Johnson Foundation; Wright Family Foundation; UCSD Christini Foundation; Lennox Foundation; Hailey's Wish Foundation; Larry L. Hillblom Foundation; Gerber Foundation;  [MH091407]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033679] Funding Source: NIH RePORTER	Autism Speaks Trailblazer program; Jane Botsford-Johnson Foundation; Wright Family Foundation; UCSD Christini Foundation; Lennox Foundation; Hailey's Wish Foundation; Larry L. Hillblom Foundation; Gerber Foundation; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the Autism Speaks Trailblazer program, the Jane Botsford-Johnson Foundation, and the Wright Family Foundation, and MH091407, with additional support from the UCSD Christini Foundation, the Lennox Foundation, the Hailey's Wish Foundation, and the Larry L. Hillblom Foundation, and the Gerber Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bitanihirwe BKY, 2010, NEUROPSYCHOPHARMACOL, V35, P2462, DOI 10.1038/npp.2010.129; Bouma HR, 2012, J CELL PHYSIOL, V227, P1285, DOI 10.1002/jcp.22850; Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; COURCHESNE E, 1994, AM J ROENTGENOL, V162, P123, DOI 10.2214/ajr.162.1.8273650; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003; Galassetti Pietro R, 2005, Diabetes Technol Ther, V7, P115, DOI 10.1089/dia.2005.7.115; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P159, DOI 10.1111/j.1365-2982.2007.01004.x; Greco CM, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-2; Harada K, 2011, J NEUROCHEM, V116, P1138, DOI 10.1111/j.1471-4159.2011.07170.x; HASHIMOTO T, 1995, J AUTISM DEV DISORD, V25, P1, DOI 10.1007/BF02178163; Hatefi Y, 1978, Methods Enzymol, V53, P48; Heuer L, 2008, AUTISM RES, V1, P275, DOI 10.1002/aur.42; Housley GD, 2002, AUDIOL NEURO-OTOL, V7, P55, DOI 10.1159/000046865; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; James SJ, 2008, J AUTISM DEV DISORD, V38, P1966, DOI [10.1007/s10803-008-0614-2, 10.1007/s10803-008-0591-5]; Jones CK, 2012, NEUROPSYCHOPHARMACOL, V37, P16, DOI 10.1038/npp.2011.199; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Khera TK, 2010, FEBS J, V277, P2754, DOI 10.1111/j.1742-4658.2010.07692.x; Kobayashi K, 1996, CANCER, V78, P2411, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2411::AID-CNCR20>3.0.CO;2-2; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Korjamo T, 2009, J PHARM SCI-US, V98, P4469, DOI 10.1002/jps.21762; Kou Y, 2012, AM J MED GENET C, V160C, P130, DOI 10.1002/ajmg.c.31330; Leng YX, 2008, NEUROSCI LETT, V445, P195, DOI 10.1016/j.neulet.2008.09.014; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; Light AR, 2006, NEURON GLIA BIOL, V2, P125, DOI 10.1017/S1740925X05000323; Matos JE, 2007, PFLUG ARCH EUR J PHY, V454, P977, DOI 10.1007/s00424-007-0248-9; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Mulder EJ, 2004, J AM ACAD CHILD PSY, V43, P491, DOI 10.1097/00004583-200404000-00016; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; Page T, 2000, BBA-MOL BASIS DIS, V1500, P291, DOI 10.1016/S0925-4439(99)00113-1; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Pelegrin P, 2008, DRUG NEWS PERSPECT, V21, P424, DOI 10.1358/dnp.2008.21.8.1265800; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; STUMPF DA, 1981, BIOCHEM MED METAB B, V25, P234, DOI 10.1016/0006-2944(81)90080-6; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Traynor TR, 2004, LIFE SCI, V74, P2563, DOI 10.1016/j.lfs.2003.10.010; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Waring R. H., 2000, Journal of Nutritional and Environmental Medicine (Abingdon), V10, P25, DOI 10.1080/13590840050000861; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wharton DC., 1967, METHOD ENZYMOL, P245; Yang D, 2009, ENVIRON HEALTH PERSP, V117, P426, DOI 10.1289/ehp.11771; Zerbo O, 2012, J AUTISM DEV DISORD; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	60	107	111	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57380	10.1371/journal.pone.0057380	http://dx.doi.org/10.1371/journal.pone.0057380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516405	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200011
J	Rikhtegar, F; Pacheco, F; Wyss, C; Stok, KS; Ge, H; Choo, RJ; Ferrari, A; Poulikakos, D; Muller, R; Kurtcuoglu, V				Rikhtegar, Farhad; Pacheco, Fernando; Wyss, Christophe; Stok, Kathryn S.; Ge, Heng; Choo, Ryan J.; Ferrari, Aldo; Poulikakos, Dimos; Mueller, Ralph; Kurtcuoglu, Vartan			Compound Ex Vivo and In Silico Method for Hemodynamic Analysis of Stented Arteries	PLOS ONE			English	Article							WALL SHEAR-STRESS; CORONARY-ARTERY; BLOOD-FLOW; VITRO EVALUATION; IMPLANTATION; RESTENOSIS; VELOCITY; TOMOGRAPHY; GEOMETRY; BALLOON	Hemodynamic factors such as low wall shear stress have been shown to influence endothelial healing and atherogenesis in stent-free vessels. However, in stented vessels, a reliable quantitative analysis of such relations has not been possible due to the lack of a suitable method for the accurate acquisition of blood flow. The objective of this work was to develop a method for the precise reconstruction of hemodynamics and quantification of wall shear stress in stented vessels. We have developed such a method that can be applied to vessels stented in or ex vivo and processed ex vivo. Here we stented the coronary arteries of ex vivo porcine hearts, performed vascular corrosion casting, acquired the vessel geometry using micro-computed tomography and reconstructed blood flow and shear stress using computational fluid dynamics. The method yields accurate local flow information through anatomic fidelity, capturing in detail the stent geometry, arterial tissue prolapse, radial and axial arterial deformation as well as strut malapposition. This novel compound method may serve as a unique tool for spatially resolved analysis of the relationship between hemodynamic factors and vascular biology. It can further be employed to optimize stent design and stenting strategies.	[Rikhtegar, Farhad; Ferrari, Aldo; Poulikakos, Dimos; Kurtcuoglu, Vartan] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, Zurich, Switzerland; [Pacheco, Fernando] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Wyss, Christophe; Ge, Heng] Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland; [Stok, Kathryn S.; Choo, Ryan J.; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland; [Kurtcuoglu, Vartan] Univ Zurich, Inst Physiol, Interface Grp, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Imperial College London; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kurtcuoglu, V (corresponding author), Swiss Fed Inst Technol, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, Zurich, Switzerland.	vartan.kurtcuoglu@uzh.ch	Müller, Ralph/A-1198-2008; Stok, Kathryn S/A-4871-2011; Kurtcuoglu, Vartan/A-8940-2008; Stok, Kathryn/AAA-2667-2021; Ferrari, Aldo/H-5209-2012; poulikakos, dimos/O-2853-2014	Müller, Ralph/0000-0002-5811-7725; Stok, Kathryn S/0000-0002-0522-4180; Kurtcuoglu, Vartan/0000-0003-2665-0995; Stok, Kathryn/0000-0002-0522-4180; poulikakos, dimos/0000-0001-5733-6478	Swiss Federal Commission for Technology and Innovation (CTI) through the EnOp project [9921.1]	Swiss Federal Commission for Technology and Innovation (CTI) through the EnOp project	This work was partially funded by the Swiss Federal Commission for Technology and Innovation (CTI) through the EnOp project, grant 9921.1. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andermahr J, 1998, SURG RADIOL ANAT, V20, P419, DOI 10.1007/BF01653134; ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793; Benndorf G, 2009, AM J NEURORADIOL, V30, P479, DOI 10.3174/ajnr.A1396; Benndorf G, 2010, J BIOMECH, V43, P740, DOI 10.1016/j.jbiomech.2009.10.015; Berne R. M., 1986, CARDIOVASCULAR PHYSL; Castagna MT, 2001, AM HEART J, V142, P970, DOI 10.1067/mhj.2001.119613; Chiastra C, 2012, EUR J MECH B-FLUID, V35, P76, DOI 10.1016/j.euromechflu.2012.01.011; Connolley T, 2007, MED ENG PHYS, V29, P1132, DOI 10.1016/j.medengphy.2006.10.016; De Santis G, 2011, COMPUTER METHODS BIO, P1; Doriot PA, 2000, ULTRASOUND MED BIOL, V26, P221, DOI 10.1016/S0301-5629(99)00133-7; Ehara M, 2007, J AM COLL CARDIOL, V49, P951, DOI 10.1016/j.jacc.2006.10.065; Elezi S, 1998, CIRCULATION, V98, P1875, DOI 10.1161/01.CIR.98.18.1875; Fearon WF, 2003, CIRCULATION, V108, P2198, DOI 10.1161/01.CIR.0000099521.31396.9D; FINGERLE J, 1990, ARTERIOSCLEROSIS, V10, P1082, DOI 10.1161/01.ATV.10.6.1082; Foerst J, 2010, CATHETER CARDIO INTE, V76, P527, DOI 10.1002/ccd.22498; Foin N, 2011, EUROINTERVENTION, V7, P597, DOI 10.4244/EIJV7I5A96; Furber AP, 1999, AM J CARDIOL, V84, P24, DOI 10.1016/S0002-9149(99)00186-1; Garasic JM, 2000, CIRCULATION, V101, P812, DOI 10.1161/01.CIR.101.7.812; Gatehouse PD, 2005, EUR RADIOL, V15, P2172, DOI 10.1007/s00330-005-2829-3; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Gundert TJ, 2011, ANN BIOMED ENG, V39, P1423, DOI 10.1007/s10439-010-0238-5; Hikichi Y, 2009, J INTERV CARDIOL, V22, P128, DOI 10.1111/j.1540-8183.2009.00442.x; Hoffmann R, 2000, EUR HEART J, V21, P1739, DOI 10.1053/euhj.2000.2153; Hollnagel DI, 2009, NMR BIOMED, V22, P795, DOI 10.1002/nbm.1389; Hong YJ, INT J CARDI IN PRESS; Jang IK, 2001, CIRCULATION, V104, P2754, DOI 10.1161/hc4701.098069; Johnson K, 2008, J BIOMECH, V41, P595, DOI 10.1016/j.jbiomech.2007.10.010; Katritsis DG, 2012, CIRC-CARDIOVASC INTE, V5, P530, DOI 10.1161/CIRCINTERVENTIONS.112.968347; Kaufmann PA, 2005, J NUCL MED, V46, P75; Kralev S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021778; Krucker T, 2006, MICROSC RES TECHNIQ, V69, P138, DOI 10.1002/jemt.20263; LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004; LaDisa JF, 2005, J APPL PHYSIOL, V98, P947, DOI 10.1152/japplphysiol.00872.2004; LaDisa JF, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-40; LaDisa JF, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-59; Larrabide I, 2012, MED IMAGE ANAL, V16, P721, DOI 10.1016/j.media.2010.04.009; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Meyer EP, 2007, CLIN ANAT, V20, P448, DOI 10.1002/ca.20403; Morlacchi S, 2011, ANN BIOMED ENG, V39, P2615, DOI 10.1007/s10439-011-0355-9; Mortier P, 2010, ANN BIOMED ENG, V38, P88, DOI 10.1007/s10439-009-9836-5; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Murphy J, 2010, COMPUT BIOL MED, V40, P408, DOI 10.1016/j.compbiomed.2010.02.005; Murphy JB, 2010, BIORHEOLOGY, V47, P117, DOI 10.3233/BIR-2010-0568; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Napoli C, 2006, SCAND J CLIN LAB INV, V66, P407, DOI 10.1080/00365510600763319; Ohta M, 2007, J INTEL MAT SYST STR, V19, P313, DOI DOI 10.1177/1045389X07083184; Olgac U, 2009, AM J PHYSIOL-HEART C, V296, pH1969, DOI 10.1152/ajpheart.01182.2008; RIEW CK, 1971, J POLYM SCI A1, V9, P2739, DOI 10.1002/pol.1971.150090927; Rikhtegar F, 2012, ATHEROSCLEROSIS, V221, P432, DOI 10.1016/j.atherosclerosis.2012.01.018; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; van der Giessen AG, 2011, J BIOMECH, V44, P1089, DOI 10.1016/j.jbiomech.2011.01.036; Venkitachalam L, 2009, CIRC-CARDIOVASC INTE, V2, P6, DOI 10.1161/CIRCINTERVENTIONS.108.825323; Verli FD, 2007, SCANNING, V29, P128, DOI 10.1002/sca.20051; Vignon-Clementel IE, 2010, COMPUT METHOD BIOMEC, V13, P625, DOI 10.1080/10255840903413565; Wang SZ, 2011, COMPUT METHOD BIOMEC, V14, P927, DOI 10.1080/10255842.2010.502531; Wentzel JJ, 2001, CIRCULATION, V103, P1740, DOI 10.1161/01.CIR.103.13.1740; Wentzel JJ, 2000, J BIOMECH, V33, P1287, DOI 10.1016/S0021-9290(00)00066-X; Williams AR, 2010, J APPL PHYSIOL, V109, P532, DOI 10.1152/japplphysiol.00086.2010; Yajima J, 2007, QUANTIFIZIERUNG INTI; Yilmaz F, 2008, KOREA-AUST RHEOL J, V20, P197	66	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58147	10.1371/journal.pone.0058147	http://dx.doi.org/10.1371/journal.pone.0058147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516442	Green Published, Green Accepted, gold			2022-12-25	WOS:000316849200037
J	Van Acker, H; Sass, A; Bazzini, S; De Roy, K; Udine, C; Messiaen, T; Riccardi, G; Boon, N; Nelis, HJ; Mahenthiralingam, E; Coenye, T				Van Acker, Heleen; Sass, Andrea; Bazzini, Silvia; De Roy, Karen; Udine, Claudia; Messiaen, Thomas; Riccardi, Giovanna; Boon, Nico; Nelis, Hans J.; Mahenthiralingam, Eshwar; Coenye, Tom			Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; PERSISTER CELLS; CENOCEPACIA; MECHANISMS; RESISTANCE; PLASMID	The presence of persister cells has been proposed as a factor in biofilm resilience. In the present study we investigated whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. After treatment of Bcc biofilms with high concentrations of various antibiotics often a small subpopulation survived. To investigate the molecular mechanism of tolerance in this subpopulation, Burkholderia cenocepacia biofilms were treated with 1024 mu g/ml of tobramycin. Using ROS-specific staining and flow cytometry, we showed that tobramycin increased ROS production in treated sessile cells. However, approximately 0.1% of all sessile cells survived the treatment. A transcriptome analysis showed that several genes from the tricarboxylic acid cycle and genes involved in the electron transport chain were downregulated. In contrast, genes from the glyoxylate shunt were upregulated. These data indicate that protection against ROS is important for the survival of persisters. To confirm this, we determined the number of persisters in biofilms formed by catalase mutants. The persister fraction in Delta katA and Delta katB biofilms was significantly reduced, confirming the role of ROS detoxification in persister survival. Pretreatment of B. cenocepacia biofilms with itaconate, an inhibitor of isocitrate lyase (ICL), the first enzyme in the glyoxylate shunt, reduced the persister fraction approx. 10-fold when the biofilms were subsequently treated with tobramycin. In conclusion, most Bcc biofilms contain a significant fraction of persisters that survive treatment with high doses of tobramycin. The surviving persister cells downregulate the TCA cycle to avoid production of ROS and at the same time activate an alternative pathway, the glyoxylate shunt. This pathway may present a novel target for combination therapy.	[Van Acker, Heleen; Sass, Andrea; Messiaen, Thomas; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Bazzini, Silvia; Udine, Claudia; Riccardi, Giovanna] Univ Pavia, Dipartimento Biol & Biotecnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Mahenthiralingam, Eshwar] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [De Roy, Karen; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium	Ghent University; University of Pavia; Cardiff University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Tom.Coenye@UGent.be	Sass, Andrea Michaela/G-6537-2014; Mahenthiralingam, Eshwar/D-3333-2009; Coenye, Tom/A-6291-2014; De Roy, Karen/A-7624-2011; Coenye, Tom/Z-1928-2019; Boon, Nico/B-4083-2011	Sass, Andrea Michaela/0000-0001-9396-7648; Mahenthiralingam, Eshwar/0000-0001-9014-3790; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Boon, Nico/0000-0002-7734-3103; RICCARDI, Giovanna/0000-0003-3295-0070	The Research Foundation - Flanders FWO-Vlaanderen; Special Research Fund of Ghent University; Cystic Fibrosis Foundation Therapeutics Inc; Interuniversity Attraction Poles Programme	The Research Foundation - Flanders FWO-Vlaanderen(FWO); Special Research Fund of Ghent University(Ghent University); Cystic Fibrosis Foundation Therapeutics Inc; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	This work was financially supported by The Research Foundation - Flanders FWO-Vlaanderen, Special Research Fund of Ghent University, Cystic Fibrosis Foundation Therapeutics Inc and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. EM and TC acknowledge the European Cooperation in Science and Technology (COST) action BM1003 for facilitating collaborative networking that assisted with these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Miguel Valvano for providing us with B. cenocepacia C524 and the B. cenocepacia MDL1 and MDL2 mutant strains and Pam Sokol, James Zlosnik and John LiPuma for the early and late clonal pairs. TC acknowledges the support of the Special Research Fund of Ghent University and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. EM and TC acknowledge the European Cooperation in Science and Technology ( COST) action BM1003 for facilitating collaborative networking that assisted with these studies.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Caraher E, 2007, EUR J CLIN MICROBIOL, V26, P213, DOI 10.1007/s10096-007-0256-x; Cardona ST, 2006, APPL ENVIRON MICROB, V72, P2547, DOI 10.1128/AEM.72.4.2547-2555.2006; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; De Soyza A, 2004, THORAX, V59, P526, DOI 10.1136/thx.2003.010801; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; Hagins JM, 2010, MICROBIOL-SGM, V156, P1201, DOI 10.1099/mic.0.033381-0; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lefebre MD, 2005, MICROBIOL-SGM, V151, P1975, DOI 10.1099/mic.0.27704-0; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; LiPuma JJ, 2002, LANCET, V359, P2002, DOI 10.1016/S0140-6736(02)08836-0; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Singh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007344; Van Acker E, 2010, J CYST FIBROS, V9, P450, DOI 10.1016/j.jcf.2010.08.015; van Schaik EJ, 2009, INFECT IMMUN, V77, P4275, DOI 10.1128/IAI.00609-09; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	34	90	90	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58943	10.1371/journal.pone.0058943	http://dx.doi.org/10.1371/journal.pone.0058943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516582	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000316849200123
J	Wallace, SC; Hulbert, RC				Wallace, Steven C.; Hulbert, Richard C., Jr.			A New Machairodont from the Palmetto Fauna (Early Pliocene) of Florida, with Comments on the Origin of the Smilodontini (Mammalia, Carnivora, Felidae)	PLOS ONE			English	Article							LATE MIOCENE; PREDATORY BEHAVIOR; OGYGIA FELIDAE; PLEISTOCENE; SPAIN; DISPERSAL; REVISION; FATALIS; CANINE; SITE	South-central Florida's latest Hemphillian Palmetto Fauna includes two machairodontine felids, the lion-sized Machairodus coloradensis and a smaller, jaguar-sized species, initially referred to Megantereon hesperus based on a single, relatively incomplete mandible. This made the latter the oldest record of Megantereon, suggesting a New World origin of the genus. Subsequent workers variously accepted or rejected this identification and biogeographic scenario. Fortunately, new material, which preserves previously unknown characters, is now known for the smaller taxon. The most parsimonious results of a phylogenetic analysis using 37 cranio-mandibular characters from 13 taxa place it in the Smilodontini, like the original study; however, as the sister-taxon to Megantereon and Smilodon. Accordingly, we formally describe Rhizosmilodon fiteae gen. et sp. nov. Rhizosmilodon, Megantereon, and Smilodon (= Smilodontini) share synapomorphies relative to their sister-taxon Machairodontini: serrations smaller and restricted to canines; offset of P3 with P4 and p4 with m1; complete verticalization of mandibular symphysis; m1 shortened and robust with widest point anterior to notch; and extreme posterior "lean'' to p3/p4. Rhizosmilodon has small anterior and posterior accessory cusps on p4, a relatively large lower canine, and small, non-procumbent lower incisors; all more primitive states than in Megantereon and Smilodon. The former also differs from Megantereon and Smilodon gracilis by having a very small mandibular flange. Rhizosmilodon is the oldest known member of the Smilodontini, suggesting that the tribe originated in North America. Two more derived, similar-sized species evolved in parallel during the Blancan, Megantereon hesperus and Smilodon gracilis. The former is rarer, known only from the north-central and northwestern US, and presumably dispersed into the Old World. The latter is known from the eastern and southern US, and dispersed into South America.	[Wallace, Steven C.] E Tennessee State Univ, Don Sundquist Ctr Excellence Paleontol, Dept Geosci, Johnson City, TN 37614 USA; [Hulbert, Richard C., Jr.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	East Tennessee State University; State University System of Florida; University of Florida	Wallace, SC (corresponding author), E Tennessee State Univ, Don Sundquist Ctr Excellence Paleontol, Dept Geosci, Johnson City, TN 37614 USA.	wallaces@etsu.edu	Wang, Xiaoming/I-9033-2019; Hulbert Jr, Richard C./HDM-4028-2022	Hulbert, Richard/0000-0002-2242-4256	Don Sundquist Center of Excellence in Paleontology; East Tennessee State University; National Science Foundation (NSF Award) [0958985]; Directorate For Geosciences [0958985] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1203222] Funding Source: National Science Foundation	Don Sundquist Center of Excellence in Paleontology; East Tennessee State University; National Science Foundation (NSF Award)(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded in part by the Don Sundquist Center of Excellence in Paleontology (http://www.etsu.edu/cas/paleontology/default.aspx), East Tennessee State University and the National Science Foundation (NSF Award ID (-) 0958985) (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024971; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; BERTA A, 1987, Bulletin of the Florida State Museum Biological Sciences, V31, P1; BERTA A, 1983, J PALEONTOL, V57, P892; BERTA A, 1985, CONTRIB SCI, V370, P1; Biknevicius AR, 1996, J VERTEBR PALEONTOL, V16, P510, DOI 10.1080/02724634.1996.10011336; Christiansen P, 2005, J MORPHOL, V266, P369, DOI 10.1002/jmor.10384; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Churcher CS., 1984, R ONTARIO MUS LIFE S, V140, P1; Feranec Robert S., 2005, Bulletin of the Florida Museum of Natural History, V45, P369; Feranec RS, 2004, PALAEOGEOGR PALAEOCL, V206, P303, DOI 10.1016/j.palaeo.2004.01.009; GAZIN C. LEWIS, 1933, JOUR MAMMALOGY, V14, P251, DOI 10.2307/1373825; GILL T., 1872, SMITHSONIAN MISC COL, V11, P2; GONYEA W J, 1976, Paleobiology, V2, P332; Hodnett John-Paul, 2010, Paleobios, V29, P76; Kohn MJ, 2005, GEOLOGY, V33, P649, DOI 10.1130/G21476.1; Kurten B., 1990, Journal of Vertebrate Paleontology, V10, P158; Kurten B., 1963, Eiszeitalter und Gegenwart, V14, P96; MARTINEZ-NAVARRO B, 1995, J ARCHAEOL SCI, V22, P569, DOI 10.1006/jasc.1994.0054; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; McKenna MC, 1997, CLASSIFICATION MAMMA; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Merriam J. C., 1932, FELIDAE RANCHO LA BR; Morgan Gary S., 1994, Proceedings of the San Diego Society of Natural History, V29, P239; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palmqvist P, 2007, J VERTEBR PALEONTOL, V27, P160, DOI 10.1671/0272-4634(2007)27[160:AROTDO]2.0.CO;2; PIRKLE EC, 1967, ECON GEOL, V62, P237, DOI 10.2113/gsecongeo.62.2.237; Rincon AD, 2011, J VERTEBR PALEONTOL, V31, P468, DOI 10.1080/02724634.2011.550366; Salesa MJ, 2010, PALAEONTOLOGY, V53, P1369, DOI 10.1111/j.1475-4983.2010.01013.x; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; SARDELLA R., 1998, NEUES JB GEOLOGIE PA, V207, P1, DOI [10.1127/njgpa/207/1998/1, DOI 10.1127/njgpa/207/1998/1]; Scott T, 1988, FLORIDA GEOL SURV B, V59, P1; Shaw CA, 1985, CONTRIBUTIONS SCI, V359, P1; Tedford Richard H., 2004, P169; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; TURNER A, 1987, J PALEONTOL, V61, P1256, DOI 10.1017/S0022336000029632; Turner A., 1997, BIG CATS THEIR FOSSI; Van Valkenburgh B, 2002, J VERTEBR PALEONTOL, V22, P164, DOI 10.1671/0272-4634(2002)022[0164:SDSBAI]2.0.CO;2; Webb S. D., 1986, VERTEBRATES PHYLOGEN, V3, P237, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; Webb S David, 2000, P38; Webb S. David, 2008, Natural History Museum of Los Angeles County Science Series, P293; Werdelin L, 2001, ZOOL J LINN SOC-LOND, V132, P147, DOI 10.1006/zjls.2000.0260; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008	46	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56173	10.1371/journal.pone.0056173	http://dx.doi.org/10.1371/journal.pone.0056173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516394	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200003
J	Mattheij, NJA; Gilio, K; van Kruchten, R; Jobe, SM; Wieschhaus, AJ; Chishti, AH; Collins, P; Heemskerk, JWM; Cosemans, JMEM				Mattheij, Nadine J. A.; Gilio, Karen; van Kruchten, Roger; Jobe, Shawn M.; Wieschhaus, Adam J.; Chishti, Athar H.; Collins, Peter; Heemskerk, Johan W. M.; Cosemans, Judith M. E. M.			Dual Mechanism of Integrin alpha(IIb)beta(3) Closure in Procoagulant Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLSERINE EXPOSURE; THROMBUS FORMATION; CALPAIN CLEAVAGE; ACTIVATION; APOPTOSIS	Aggregation of platelets via activated integrin alpha(IIb)beta(3) is a prerequisite for thrombus formation. Phosphatidylserine-exposing platelets with a key role in the coagulation process disconnect from a thrombus by integrin inactivation via an unknown mechanism. Here we show that alpha(IIb)beta(3) inactivation in procoagulant platelets relies on a sustained high intracellular Ca2+, stimulating intracellular cleavage of the beta(3) chain, talin, and Src kinase. Inhibition of calpain activity abolished protein cleavage, but only partly suppressed alpha(IIb)beta(3) inactivation. Integrin alpha(IIb)beta(3) inactivation was unchanged in platelets from Capn1(-/-) mice, suggesting a role of the calpain-2 isoform. Scott syndrome platelets, lacking the transmembrane protein TMEM16F and having low phosphatidylserine exposure, displayed reduced alpha(IIb)beta(3) inactivation with the remaining activity fully dependent on calpain. In platelets from Ppif(-/-) mice, lacking mitochondrial permeability transition pore (mPTP) formation, agonist-induced phosphatidylserine exposure and alpha(IIb)beta(3) inactivation were reduced. Treatment of human platelets with cyclosporin A gave a similar phenotype. Together, these data point to a dual mechanism of alpha(IIb)beta(3) inactivation via calpain(-2) cleavage of integrin-associated proteins and via TMEM16F-dependent phospholipid scrambling with an assistant role of mPTP formation.	[Mattheij, Nadine J. A.; Gilio, Karen; van Kruchten, Roger; Heemskerk, Johan W. M.; Cosemans, Judith M. E. M.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Jobe, Shawn M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Wieschhaus, Adam J.] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Wieschhaus, Adam J.; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Collins, Peter] Cardiff Univ, Sch Med, Dept Haematol, Arthur Bloom Haemophilia Ctr, Cardiff CF14 4YU, S Glam, Wales	Maastricht University; Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tufts University; Cardiff University	Heemskerk, JWM (corresponding author), Maastricht Univ, Dept Biochem CARIM, POB 616, NL-6200 MD Maastricht, Netherlands.	heemskerk@maastrichtuniversity.nl	Cosemans, Judith MEM/C-8161-2016; Heemskerk, Johan/AAM-8323-2021	Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121	Cardiovascular Centre, Maastricht; Center for Translational Molecular Medicine Innovative Coagulation Diagnostics (INCOAG); Netherlands Heart Foundation [2011T6]; National Institute of Health [HL089519]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089519] Funding Source: NIH RePORTER	Cardiovascular Centre, Maastricht; Center for Translational Molecular Medicine Innovative Coagulation Diagnostics (INCOAG); Netherlands Heart Foundation(Netherlands Heart Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Cardiovascular Centre, Maastricht, the Center for Translational Molecular Medicine Innovative Coagulation Diagnostics (INCOAG), and the Netherlands Heart Foundation grant 2011T6 (to J. M. E. M. C.) and National Institute of Health grant HL089519 (to A. H. C.).	Arachiche A, 2009, ARTERIOSCL THROM VAS, V29, P1883, DOI 10.1161/ATVBAHA.109.190926; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Berny MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010415; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x; Cosemans JMEM, 2011, BLOOD, V117, P651, DOI 10.1182/blood-2010-01-262683; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Fuse I, 2001, BRIT J HAEMATOL, V112, P603, DOI 10.1046/j.1365-2141.2001.02637.x; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Kim C, J CELL BIOL, V197, P605; Kuchay SM, 2012, J THROMB HAEMOST, V10, P1120, DOI 10.1111/j.1538-7836.2012.04715.x; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Naik MU, 2012, BLOOD, V119, P3352, DOI 10.1182/blood-2011-12-397398; Nieswandt B, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2009.03370.x; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; van Kruchten R, 2013, BLOOD, V121, P1850, DOI 10.1182/blood-2012-09-454314; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Wolfs JLN, 2005, CELL MOL LIFE SCI, V62, P1514, DOI 10.1007/s00018-005-5099-y; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	42	80	82	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13325	13336		10.1074/jbc.M112.428359	http://dx.doi.org/10.1074/jbc.M112.428359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23519467	Green Published, hybrid			2022-12-25	WOS:000318850300018
J	Banas, M; Zabieglo, K; Kasetty, G; Kapinska-Mrowiecka, M; Borowczyk, J; Drukala, J; Murzyn, K; Zabel, BA; Butcher, EC; Schroeder, JM; Schmidtchen, A; Cichy, J				Banas, Magdalena; Zabieglo, Katarzyna; Kasetty, Gopinath; Kapinska-Mrowiecka, Monika; Borowczyk, Julia; Drukala, Justyna; Murzyn, Krzysztof; Zabel, Brian A.; Butcher, Eugene C.; Schroeder, Jens M.; Schmidtchen, Artur; Cichy, Joanna			Chemerin Is an Antimicrobial Agent in Human Epidermis	PLOS ONE			English	Article							ANTIBIOTIC PEPTIDE; STRATUM-CORNEUM; DENDRITIC CELLS; DISEASED SKIN; PH GRADIENT; IN-VIVO; RECRUITMENT; ACTIVATION; RECEPTOR; PROTEIN	Chemerin, a chemoattractant ligand for chemokine-like receptor 1 (CMKLR1) is predicted to share similar tertiary structure with antibacterial cathelicidins. Recombinant chemerin has antimicrobial activity. Here we show that endogenous chemerin is abundant in human epidermis, and that inhibition of bacteria growth by exudates from organ cultures of primary human skin keratinocytes is largely chemerin-dependent. Using a panel of overlapping chemerin-derived synthetic peptides, we demonstrate that the antibacterial activity of chemerin is primarily mediated by Val 66 -Pro 85, which causes direct bacterial lysis. Therefore, chemerin is an antimicrobial agent in human skin.	[Banas, Magdalena; Zabieglo, Katarzyna; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Borowczyk, Julia; Drukala, Justyna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland; [Murzyn, Krzysztof] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Computat Biophys & Bioinformat, Krakow, Poland; [Kasetty, Gopinath; Schmidtchen, Artur] Lund Univ, Div Dermatol & Venerol, Dept Clin Sci, Lund, Sweden; [Kapinska-Mrowiecka, Monika] Zeromski Hosp, Dept Dermatol, Krakow, Poland; [Zabel, Brian A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Inst Res & Educ, Palo Alto, CA USA; [Butcher, Eugene C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Schroeder, Jens M.] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany	Jagiellonian University; Jagiellonian University; Jagiellonian University; Lund University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Kiel; Schleswig Holstein University Hospital	Cichy, J (corresponding author), Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	Joanna.Cichy@uj.edu.pl	Schmidtchen, Artur/F-9507-2015; Murzyn, Krzysztof/A-4744-2014	Drukala, Justyna/0000-0001-5573-2979; Cichy, Joanna/0000-0002-0552-8344; Borowczyk, Julia/0000-0002-4638-1596	Team Award; Polish National Science Center [2011/02/A/NZ5/00337]; European Union [POIG.02.01.00-12-064/08]; National Institutes of Health (NIH); NIH [AI-079320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320] Funding Source: NIH RePORTER	Team Award; Polish National Science Center; European Union(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Team Award and Polish National Science Center grant 2011/02/A/NZ5/00337 (to JC). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08). ECB is supported by grants from the National Institutes of Health (NIH) and by an endowed chair in Experimental Pathology. BAZ is supported by NIH grant AI-079320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Allen SJ, 2007, BIOMOL NMR ASSIGM, V1, P171, DOI 10.1007/s12104-007-9047-7; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Cichy J, 2011, PROTEINASE REGULATOR, P137; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Gesell J, 1997, J BIOMOL NMR, V9, P127, DOI 10.1023/A:1018698002314; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Mak P, 2007, AM J REPROD IMMUNOL, V57, P81, DOI 10.1111/j.1600-0897.2006.00456.x; Malmsten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016400; Mani R, 2007, CHEMBIOCHEM, V8, P1877, DOI 10.1002/cbic.200700335; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Ohman H, 1998, J INVEST DERMATOL, V111, P674, DOI 10.1046/j.1523-1747.1998.00356.x; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; RADETSKY M, 1986, J CLIN MICROBIOL, V24, P600, DOI 10.1128/JCM.24.4.600-606.1986; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Skrzeczynska-Moncznik J, 2009, BIOCHEM BIOPH RES CO, V380, P323, DOI 10.1016/j.bbrc.2009.01.071; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	37	55	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58709	10.1371/journal.pone.0058709	http://dx.doi.org/10.1371/journal.pone.0058709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527010	Green Published, gold			2022-12-25	WOS:000317562600033
J	Miranda, LN; Hutchison, K; Grossman, AR; Brawley, SH				Miranda, Lilibeth N.; Hutchison, Keith; Grossman, Arthur R.; Brawley, Susan H.			Diversity and Abundance of the Bacterial Community of the Red Macroalga Porphyra umbilicalis: Did Bacterial Farmers Produce Macroalgae?	PLOS ONE			English	Article							AGARILYTICA SP NOV.; MARINE BACTERIUM; MICROBIAL DIVERSITY; ALGA; DISEASE; MORPHOGENESIS; VARIABILITY; RHODOPHYTA; BANGIALES; L.	Macroalgae harbor microbial communities whose bacterial biodiversity remains largely uncharacterized. The goals of this study were 1) to examine the composition of the bacterial community associated with Porphyra umbilicalis Kutzing from Schoodic Point, ME, 2) determine whether there are seasonal trends in species diversity but a core group of bacteria that are always present, and 3) to determine how the microbial community associated with a laboratory strain (P.um.1) established in the presence of antibiotics has changed. P. umbilicalis blades (n = 5, fall 2010; n = 5, winter 2011; n = 2, clonal P.um.1) were analyzed by pyrosequencing over two variable regions of the 16 S rDNA (V5-V6 and V8; 147,880 total reads). The bacterial taxa present were classified at an 80% confidence threshold into eight phyla (Bacteroidetes, Proteobacteria, Planctomycetes, Chloroflexi, Actinobacteria, Deinococcus-Thermus, Firmicutes, and the candidate division TM7). The Bacteroidetes comprised the majority of bacterial sequences on both field and lab blades, but the Proteobacteria (Alphaproteobacteria, Gammaproteobacteria) were also abundant. Sphingobacteria (Bacteroidetes) and Flavobacteria (Bacteroidetes) had inverse abundances on natural versus P.um.1 blades. Bacterial communities were richer and more diverse on blades sampled in fall compared to winter. Significant differences were observed between microbial communities among all three groups of blades examined. Only two OTUs were found on all 12 blades, and only one of these, belonging to the Saprospiraceae (Bacteroidetes), was abundant. Lewinella (as 66 OTUs) was found on all field blades and was the most abundant genus. Bacteria from the Bacteroidetes, Proteobacteria and Planctomycetes that are known to digest the galactan sulfates of red algal cell walls were well-represented. Some of these taxa likely provide essential morphogenetic and beneficial nutritive factors to P. umbilicalis and may have had unexpected effects upon evolution of macroalgal form as well as function.	[Miranda, Lilibeth N.; Brawley, Susan H.] Univ Maine, Sch Marine Sci, Orono, ME USA; [Hutchison, Keith] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA; [Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Carnegie Institution for Science	Miranda, LN (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore.	lilibethnmiranda@gmail.com			National Science Foundation [IOS 0929558, IOS 0929758]; National Oceanic and Atmospheric Administration [NA060AR4170108]; Division Of Integrative Organismal Systems [0741907] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by National Science Foundation IOS 0929558 to SHB and IOS 0929758 to ARG, and National Oceanic and Atmospheric Administration NA060AR4170108 to SHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegado RA, 2012, ELIFE, V1, DOI 10.7554/eLife.00013; Andersen R. A., 2005, ALGAL CULTURING TECH; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Blouin N, 2007, AQUACULTURE, V270, P77, DOI 10.1016/j.aquaculture.2007.03.002; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Brodie J, 2008, TAXON, V57, P1328, DOI 10.1002/tax.574022; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caro-Quintero A, 2011, ISME J, V5, P131, DOI 10.1038/ismej.2010.93; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Cayrou C, 2010, J ANTIMICROB CHEMOTH, V65, P2119, DOI 10.1093/jac/dkq290; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chan CX, 2012, J PHYCOL, V48, P1328, DOI 10.1111/j.1529-8817.2012.01229.x; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; DUAN D, 1995, WORLD J MICROB BIOT, V11, P351, DOI 10.1007/BF00367118; Egan S, 2001, FEMS MICROBIOL ECOL, V35, P67, DOI 10.1111/j.1574-6941.2001.tb00789.x; FRIES L, 1978, Z PFLANZENPHYSIOL, V88, P383, DOI 10.1016/S0044-328X(78)80253-0; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gantt E, 2010, RED ALGAE GENOMIC AG; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kazamia E, 2012, ENVIRON MICROBIOL, V14, P1466, DOI 10.1111/j.1462-2920.2012.02733.x; Kim Jeong-Hee, 1992, Bulletin of the Korean Fisheries Society, V25, P314; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee SD, 2007, INT J SYST EVOL MICR, V57, P2814, DOI 10.1099/ijs.0.65254-0; Lin BK, 2012, INT J SYST EVOL MICR, V62, P869, DOI 10.1099/ijs.0.027136-0; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; MacArtain P, 2007, NUTR REV, V65, P535, DOI [10.1301/nr.2007.dec.535-543, 10.1111/j.1753-4887.2007.tb00278.x]; Marshall K, 2006, MICROB ECOL, V52, P302, DOI 10.1007/s00248-006-9060-x; Matsuo Y, 2005, SCIENCE, V307, P1598, DOI 10.1126/science.1105486; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; Namba A, 2010, FISHERIES SCI, V76, P873, DOI 10.1007/s12562-010-0273-z; Nasrolahi A, 2012, FEMS MICROBIOL ECOL, V81, P583, DOI 10.1111/j.1574-6941.2012.01384.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Park CS, 2006, J APPL PHYCOL, V18, P295, DOI 10.1007/s10811-006-9031-0; PROVASOLI L, 1972, Journal of Phycology, V8, P10; PROVASOLI L, 1958, BIOL BULL, V114, P375, DOI 10.2307/1538992; PROVASOLI L, 1980, J PHYCOL, V16, P196, DOI 10.1111/j.1529-8817.1980.tb03019.x; PROVASOLI L, 1964, AM J BOT, V51, P681; R Core Team, 2012, R LANG ENV STAT COMP; Sakai T, 2003, MAR BIOTECHNOL, V5, P409, DOI 10.1007/s10126-002-0118-6; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042872; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Steinberg PD, 1997, BIODEGRADATION, V8, P211, DOI 10.1023/A:1008236901790; SUNAIRI M, 1995, J APPL BACTERIOL, V79, P225, DOI 10.1111/j.1365-2672.1995.tb00939.x; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; SUTO SHUNZO, 1954, BULL JAPANESE SOC SCI FISH, V19, P1176; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Thomas F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021475; TSUKIDATE J-I, 1971, BULL JAP SOC SCI FISH, V37, P376; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; Vairappan CS, 2010, J APPL PHYCOL, V22, P305, DOI 10.1007/s10811-009-9460-7; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinberger F, 1999, J PHYCOL, V35, P747, DOI 10.1046/j.1529-8817.1999.3540747.x; White RE, 2011, ELDRIDGE TIDE PILOT; Yamanoi H, 2008, NIPPON SUISAN GAKK, V74, P1024, DOI 10.2331/suisan.74.1024; Yamazaki A, 1998, J PHYCOL, V34, P1082, DOI 10.1046/j.1529-8817.1998.341082.x; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Yung PY, 2011, APPL ENVIRON MICROB, V77, P1512, DOI 10.1128/AEM.02038-10	75	81	82	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58269	10.1371/journal.pone.0058269	http://dx.doi.org/10.1371/journal.pone.0058269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526971	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562600016
J	Francis, RM; Nielsen, SL; Kryger, P				Francis, Roy M.; Nielsen, Steen L.; Kryger, Per			Varroa-Virus Interaction in Collapsing Honey Bee Colonies	PLOS ONE			English	Article							DEFORMED WING VIRUS; APIS-MELLIFERA L.; NOSEMA-CERANAE; DESTRUCTOR ACARI; PARALYSIS VIRUS; PREVALENCE; JACOBSONI; TRANSMISSION; INFECTIONS; PESTICIDES	Varroa mites and viruses are the currently the high-profile suspects in collapsing bee colonies. Therefore, seasonal variation in varroa load and viruses (Acute-Kashmir-Israeli complex (AKI) and Deformed Wing Virus (DWV)) were monitored in a yearlong study. We investigated the viral titres in honey bees and varroa mites from 23 colonies (15 apiaries) under three treatment conditions: Organic acids (11 colonies), pyrethroid (9 colonies) and untreated (3 colonies). Approximately 200 bees were sampled every month from April 2011 to October 2011, and April 2012. The 200 bees were split to 10 sub-samples of 20 bees and analysed separately, which allows us to determine the prevalence of virus-infected bees. The treatment efficacy was often low for both treatments. In colonies where varroa treatment reduced the mite load, colonies overwintered successfully, allowing the mites and viruses to be carried over with the bees into the next season. In general, AKI and DWV titres did not show any notable response to the treatment and steadily increased over the season from April to October. In the untreated control group, titres increased most dramatically. Viral copies were correlated to number of varroa mites. Most colonies that collapsed over the winter had significantly higher AKI and DWV titres in October compared to survivors. Only treated colonies survived the winter. We discuss our results in relation to the varroa-virus model developed by Stephen Martin.	[Francis, Roy M.; Nielsen, Steen L.; Kryger, Per] Aarhus Univ, Dept Agroecol Sci & Technol, Slagelse, Denmark	Aarhus University	Francis, RM (corresponding author), Aarhus Univ, Dept Agroecol Sci & Technol, Slagelse, Denmark.	royfrancis.mathew@agrsci.dk	Kryger, Per/C-1773-2013; Kryger, Per/H-4600-2019	Kryger, Per/0000-0001-5306-3230; Kryger, Per/0000-0001-5306-3230	Promilleafgiftsfonden	Promilleafgiftsfonden	The authors wish to thank Promilleafgiftsfonden for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL B V, 1983, EXPT APPL ACAROLOGY, V19, P607; BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Branco MR, 2006, APIDOLOGIE, V37, P452, DOI 10.1051/apido:2006010; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Carreck NL, 2010, J APICULT RES, V49, P93, DOI 10.3896/IBRA.1.49.1.13; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Cowling DW, 1999, PREV VET MED, V39, P211, DOI 10.1016/S0167-5877(98)00131-7; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Duay Pedro, 2002, Genetics and Molecular Research, V1, P227; EU, 2011, GUID PIL SURV PROJ H, P1; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Francis RM, 2012, J APIC SCI, V56, P137, DOI 10.2478/v10289-012-0014-x; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gross M, 2008, CURR BIOL, V18, pR684, DOI 10.1016/j.cub.2008.08.004; Hauck Walter W., 1991, Annals of Epidemiology, V1, P277; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; IFANTIDIS MD, 1983, J APICULT RES, V22, P200, DOI 10.1080/00218839.1983.11100588; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; LE CONTE Y, 1987, APIDOLOGIE, V18, P305, DOI 10.1051/apido:19870402; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lee KV, 2010, J ECON ENTOMOL, V103, P1039, DOI 10.1603/EC10037; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Martin S, 2001, EUROPE-REV LIT MENS, V79, P321; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin SJ, 2010, J APICULT RES, V49, P72, DOI 10.3896/IBRA.1.49.1.10; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nordstrom S, 1999, APIDOLOGIE, V30, P475, DOI 10.1051/apido:19990602; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; PIOTROWSKI F, 1982, Angewandte Parasitologie, V23, P49; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sergeant ESG, 2012, EPITOOLS EPIDEMIOLOG; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vejsnaes F, 2010, J APICULT RES, V49, P109, DOI 10.3896/IBRA.1.49.1.20; Vetharaniam I, 2012, ECOL MODEL, V224, P11, DOI 10.1016/j.ecolmodel.2011.10.016; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	57	204	213	2	277	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57540	10.1371/journal.pone.0057540	http://dx.doi.org/10.1371/journal.pone.0057540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526946	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100014
J	Im, SK; Jeong, H; Jeong, HW; Kim, KT; Hwang, D; Ikegami, M; Kong, YY				Im, Sun-Kyoung; Jeong, HyoBin; Jeong, Hyun-Woo; Kim, Kyong-Tai; Hwang, Daehee; Ikegami, Machiko; Kong, Young-Yun			Disruption of Sorting Nexin 5 Causes Respiratory Failure Associated with Undifferentiated Alveolar Epithelial Type I Cells in Mice	PLOS ONE			English	Article							MOUSE LUNG DEVELOPMENT; PULMONARY SURFACTANT; MAMMALIAN RETROMER; GENETIC-DISORDERS; EGF RECEPTOR; MIND BOMB-1; PROTEIN; NOTCH; SNX5; DIFFERENTIATION	Sorting nexin 5 (Snx5) has been posited to regulate the degradation of epidermal growth factor receptor and the retrograde trafficking of cation-independent mannose 6-phosphate receptor/insulin-like growth factor II receptor. Snx5 has also been suggested to interact with Mind bomb-1, an E3 ubiquitin ligase that regulates the activation of Notch signaling. However, the in vivo functions of Snx5 are largely unknown. Here, we report that disruption of the Snx5 gene in mice (Snx5(-/-) mice) resulted in partial perinatal lethality; 40% of Snx5(-/-) mice died shortly after birth due to cyanosis, reduced air space in the lungs, and respiratory failure. Histological analysis revealed that Snx5(-/-) mice exhibited thickened alveolar walls associated with undifferentiated alveolar epithelial type I cells. In contrast, alveolar epithelial type II cells were intact, exhibiting normal surfactant synthesis and secretion. Although the expression levels of surfactant proteins and saturated phosphatidylcholine in the lungs of Snx5(-/-) mice were comparable to those of Snx5(+/+) mice, the expression levels of T1 alpha, Aqp5, and Rage, markers for distal alveolar epithelial type I cells, were significantly decreased in Snx5(-/-) mice. These results demonstrate that Snx5 is necessary for the differentiation of alveolar epithelial type I cells, which may underlie the adaptation to air breathing at birth.	[Im, Sun-Kyoung; Jeong, Hyun-Woo; Kong, Young-Yun] Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul, South Korea; [Im, Sun-Kyoung; Kim, Kyong-Tai] POSTECH, Div Mol & Life Sci, Dept Life Sci, Pohang, South Korea; [Jeong, HyoBin; Hwang, Daehee] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Ikegami, Machiko] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Ikegami, Machiko] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Cincinnati Children's Hospital Medical Center; University of Cincinnati	Kong, YY (corresponding author), Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul, South Korea.	ykong@snu.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627; Jeong, Hyun-Woo/0000-0002-6976-6739	Basic Science Research Program through the National Research Foundation of Korea [2012-0000121]; National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea [0920310]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2011-0019269]; Global Frontier Project grant of the National Research Foundation [2011-0028413]; Ministry of Education, Science and Technology of Korea	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Global Frontier Project grant of the National Research Foundation(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (RND no. 2012-0000121), National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND no. 0920310), Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST; RND no. 2011-0019269), and Global Frontier Project grant (RND no. 2011-0028413) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cole FS, 2001, PEDIATR RES, V50, P157, DOI 10.1203/00006450-200108000-00001; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; DEMELLO DE, 1994, AM J RESP CELL MOL, V11, P230, DOI 10.1165/ajrcmb.11.2.8049084; Galambos C, 2002, AM J RESP CELL MOL, V27, P194, DOI 10.1165/ajrcmb.27.2.4703; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Glasser SW, 2006, SEMIN PERINATOL, V30, P341, DOI 10.1053/j.semperi.2006.09.001; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17302, DOI 10.1073/pnas.0508649102; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Jin N, 2009, DEVELOPMENT, V136, P3347, DOI 10.1242/dev.032979; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kumar VH, 2005, ADV CLIN CHEM, V40, P261, DOI 10.1016/S0065-2423(05)40007-4; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; MASON RJ, 1976, J LIPID RES, V17, P281; Matsui R, 1999, CELL SIGNAL, V11, P221, DOI 10.1016/S0898-6568(98)00070-9; Matzke A, 2007, MOL CELL BIOL, V27, P8797, DOI 10.1128/MCB.01355-07; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; O'Brien KB, 2010, DEVELOPMENT, V137, P2147, DOI 10.1242/dev.037150; Panaro NJ, 2000, CLIN CHEM, V46, P1851; Pei LM, 2011, NAT MED, V17, P1466, DOI 10.1038/nm.2450; Rawlins EL, 2011, DEV DYNAM, V240, P463, DOI 10.1002/dvdy.22482; Lyra PPR, 2007, CLINICS, V62, P181, DOI 10.1590/S1807-59322007000200014; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Warburton D, 1998, BIOCHEM CELL BIOL, V76, P971, DOI 10.1139/bcb-76-6-971; Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Wert SE, 2009, PEDIATR DEVEL PATHOL, V12, P253, DOI 10.2350/09-01-0586.1; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yoon MJ, 2008, MOL CELL BIOL, V28, P4794, DOI 10.1128/MCB.00436-08	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58511	10.1371/journal.pone.0058511	http://dx.doi.org/10.1371/journal.pone.0058511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526992	gold, Green Submitted, Green Published			2022-12-25	WOS:000317562100028
J	Meng, FD; Ren, YD; Suo, SQGW; Sun, XJ; Li, XL; Li, PC; Yang, W; Li, GX; Li, L; Schwegmann-Wessels, C; Herrler, G; Ren, XF				Meng, Fandan; Ren, Yudong; Suo, Siqingaowa; Sun, Xuejiao; Li, Xunliang; Li, Pengchong; Yang, Wei; Li, Guangxing; Li, Lu; Schwegmann-Wessels, Christel; Herrler, Georg; Ren, Xiaofeng			Evaluation on the Efficacy and Immunogenicity of Recombinant DNA Plasmids Expressing Spike Genes from Porcine Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus	PLOS ONE			English	Article							ANTIGENIC STRUCTURE; PROTEIN; CORONAVIRUS; VACCINATION; PROTECTION; ANTIBODIES; INFLUENZA; EPITOPES; SEQUENCE; CELLS	Porcine transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PDEV) can cause severe diarrhea in pigs. Development of effective vaccines against TGEV and PEDV is one of important prevention measures. The spike (S) protein is the surface glycoprotein of TGEV and PEDV, which can induce specific neutralization antibodies and is a candidate antigen for vaccination attempts. In this study, the open reading frames of the TGEV S1 protein and in addition of the S or S1 proteins of PEDV were inserted into the eukaryotic expression vector, pIRES, resulting in recombinant plasmids, pIRES-(TGEV-S1-PEDV-S1) and pIRES-(TGEV-S1-PEDV-S). Subsequently, 6-8 weeks old Kunming mice were inoculated with both DNA plasmids. Lymphocyte proliferation assay, virus neutralization assay, IFN-gamma assay and CTL activity assay were performed. TGEV/PEDV specific antibody responses as well as kinetic changes of T lymphocyte subgroups of the immunized mice were analyzed. The results showed that the recombinant DNA plasmids increased the proliferation of T lymphocytes and the number of CD4+ and CD8+ T lymphocyte subgroups. In addition, the DNA vaccines induced a high level of IFN-gamma in the immunized mice. The specific CTL activity in the pIRES-(TGEV-S1-PEDV-S) group became significant at 42 days post-immunization. At 35 days post-immunization, the recombinant DNA plasmids bearing full-length S genes of TGEV and PEDV stimulated higher levels of specific antibodies and neutralizing antibodies in immunized mice.	[Meng, Fandan; Ren, Yudong; Suo, Siqingaowa; Sun, Xuejiao; Li, Xunliang; Li, Pengchong; Yang, Wei; Li, Guangxing; Ren, Xiaofeng] Northeast Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Li, Lu] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Schwegmann-Wessels, Christel; Herrler, Georg] Univ Vet Med, Inst Virol, Hannover, Germany	Northeast Agricultural University - China; Northeast Agricultural University - China; University of Veterinary Medicine Hannover, Foundation	Ren, XF (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn			National Natural Science Foundation of China [31270187]; Program for New Century Excellent Talents in University of Ministry of Education of P.R. China [NCET-10-0144]; Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang; Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University [2011TD001]; Innovation Talent Project (Excellent discipline leader) of the Harbin Science and Technology Bureau [RC2012XK002003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of P.R. China(Program for New Century Excellent Talents in University (NCET)); Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang; Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University; Innovation Talent Project (Excellent discipline leader) of the Harbin Science and Technology Bureau	The authors acknowledge National Natural Science Foundation of China (31270187), The Program for New Century Excellent Talents in University of Ministry of Education of P.R. China (NCET-10-0144), Sponsored by Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang, Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University (2011TD001), Innovation Talent Project (Excellent discipline leader) of the Harbin Science and Technology Bureau (RC2012XK002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIDGEN A, 1993, J GEN VIROL, V74, P1795, DOI 10.1099/0022-1317-74-9-1795; CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1; Claerebout E, 2005, PARASITE IMMUNOL, V27, P325, DOI 10.1111/j.1365-3024.2005.00780.x; Cruz DJM, 2008, VIRUS RES, V132, P192, DOI 10.1016/j.virusres.2007.10.015; DEBOUCK P, 1982, P INT PIG VET SOC C, V7, P53; DELMAS B, 1986, J GEN VIROL, V67, P1405, DOI 10.1099/0022-1317-67-7-1405; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; DUARTE M, 1994, J GEN VIROL, V75, P1195, DOI 10.1099/0022-1317-75-5-1195; DUARTE M, 1994, VIROLOGY, V198, P466, DOI 10.1006/viro.1994.1058; GARWES DJ, 1979, VET MICROBIOL, V3, P179, DOI 10.1016/0378-1135(79)90034-8; GOODWIN R. F. W., 1958, Veterinary Record, V70, P271; Isabel C, 1990, J GEN VIROL, V71, P271; JIMENEZ G, 1986, J VIROL, V60, P131; Jimenez G, 1985, P INT PIG VET SOC C, V9, P186; JOHNSON MW, 1992, VET MED-US, V87, P382; Jung-Eun P, 2010, ARCH VIROL, V155, P595; Kweon CH, 1993, KOREAN J VET RES, V33, P249; LAUDE H, 1986, J GEN VIROL, V67, P119, DOI 10.1099/0022-1317-67-1-119; LAVIADA MD, 1990, VIRUS RES, V16, P247, DOI 10.1016/0168-1702(90)90051-C; Lekutis C, 1997, J IMMUNOL, V158, P4471; Li GX, 2012, IMMUNOL INVEST, V41, P231, DOI 10.3109/08820139.2011.614306; Liu BQ, 2009, J BIOTECHNOL, V141, P91, DOI 10.1016/j.jbiotec.2009.02.005; Liu MA, 2003, J INTERN MED, V253, P402, DOI 10.1046/j.1365-2796.2003.01140.x; Margaret AL, 2011, IMMUNOL REV, V239, P62; Meng FD, 2010, HYBRIDOMA, V29, P345, DOI 10.1089/hyb.2010.0009; MOXLEY RA, 1989, AM J VET RES, V50, P111; Niu XY, 1992, VET, V22, P22; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; ROBINSON HL, 1993, VACCINE, V11, P957, DOI 10.1016/0264-410X(93)90385-B; Sasahara J, 1958, VET SCI, V20, P1; Sestak K, 1996, AM J VET RES, V57, P664; Shuojie L, 2007, MED SCI, V27, P625; Spaan W, 1988, GEN VIROL, V69, P29; Straw BE, 2000, DIS SWINE, P181; STURMAN LS, 1985, J VIROL, V56, P904, DOI 10.1128/JVI.56.3.904-911.1985; Sui XW, 2010, ANTIVIR RES, V85, P346, DOI 10.1016/j.antiviral.2009.10.014; Sumi T, 2007, IMMUNOL LETT, V108, P62, DOI 10.1016/j.imlet.2006.10.003; Sun DB, 2007, ACTA VIROL, V51, P149; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Sun-Hwa C., 2002, MOL CELLS, V14, P295; Tsuda T, 1997, VET SOC, V31, P21; Ulmer J B, 1997, Behring Inst Mitt, P79; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Yin J.C., 2006, VET SCI CHINA, V3, P203	47	33	42	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57468	10.1371/journal.pone.0057468	http://dx.doi.org/10.1371/journal.pone.0057468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526943	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562100012
J	Chen, LQ; Qu, GB; Sun, X; Zhang, SP; Wang, L; Sang, NG; Du, YG; Liu, J; Liu, SJ				Chen, Liqun; Qu, Guangbo; Sun, Xue; Zhang, Shuping; Wang, Lei; Sang, Nan; Du, Yuguo; Liu, Jun; Liu, Sijin			Characterization of the Interaction between Cadmium and Chlorpyrifos with Integrative Techniques in Incurring Synergistic Hepatoxicity	PLOS ONE			English	Article							LIPID-PEROXIDATION; METABOLIZING ENZYMES; RAT HEPATOCYTES; METHYL MERCURY; HEAVY-METALS; HEPG2 CELLS; EXPOSURE; TOXICITY; ZINC; EXPRESSION	Mixture toxicity is an important issue for the risk assessment of environmental pollutants, for which an extensive amount of data are necessary in evaluating their potential adverse health effects. However, it is very hard to decipher the interaction between compounds due to limited techniques. Contamination of heavy metals and organophosphoric insecticides under the environmental and biological settings poses substantial health risk to humans. Although previous studies demonstrated the co-occurrence of cadmium (Cd) and chlorpyrifos (CPF) in environmental medium and food chains, their interaction and potentially synergistic toxicity remain elusive thus far. Here we integrated the approaches of thin-layer chromatography and H-1 NMR to study the interaction between Cd2+ and CPF in inducing hepatoxicity. A novel interaction was identified between Cd2+ and CPF, which might be the bonding between Cd2+ and nitrogen atom in the pyridine ring of CPF, or the chelation formation between one Cd2+ and two CPF molecules. The Cd-CPF complex was conferred with distinct biological fate and toxicological performances from its parental components. We further demonstrated that the joint hepatoxicity of Cd ion and CPF was chiefly due to the Cd-CPF complex-facilitated intracellular transport associated with oxidative stress.	[Chen, Liqun; Qu, Guangbo; Sun, Xue; Zhang, Shuping; Wang, Lei; Du, Yuguo; Liu, Jun; Liu, Sijin] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Chen, Liqun; Sang, Nan] Shanxi Univ, Coll Environm & Resource, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Shanxi University	Liu, J (corresponding author), Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	junliu@rcees.ac.cn; sjliu@rcees.ac.cn	Wang, Lei/D-7812-2019; Qu, Guangbo/R-6605-2016	Wang, Lei/0000-0001-7103-9402; Sang, Nan/0000-0002-2433-3200; Qu, Guangbo/0000-0002-5220-7009	Chinese Academy of Sciences [KZCX2-EW-404]; National Natural Science Foundation of China [21077128, 20921063, 21177151]; program of "Hundreds Talents'' of from Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program of "Hundreds Talents'' of from Chinese Academy of Sciences	This work was supported by grants from the Chinese Academy of Sciences (KZCX2-EW-404), National Natural Science Foundation of China (grant numbers: 21077128, 20921063, 21177151), and from the program of "Hundreds Talents'' of from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenard G, 2010, ENVIRON HEALTH PERSP, V118, P331, DOI 10.1289/ehp.0900975; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Babczynska A, 2002, B ENVIRON CONTAM TOX, V69, P586, DOI 10.1007/s00128-002-0101-y; Baran CP, 2004, CURR PHARM DESIGN, V10, P855, DOI 10.2174/1381612043452866; Boobis A, 2011, CRIT REV TOXICOL, V41, P369, DOI 10.3109/10408444.2010.543655; BUCIO L, 1995, TOXICOLOGY, V102, P285, DOI 10.1016/0300-483X(95)03095-W; DelRaso NJ, 2003, TOXICOL SCI, V72, P19, DOI 10.1093/toxsci/kfg009; DIETER MP, 1975, B ENVIRON CONTAM TOX, V13, P257, DOI 10.1007/BF01685332; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Ediz L, 2011, INT J MED SCI, V8, P139, DOI 10.7150/ijms.8.139; Fatta D, 2007, J HAZARD MATER, V145, P169, DOI 10.1016/j.jhazmat.2006.11.009; Goel A, 2006, TOXICOL LETT, V163, P235, DOI 10.1016/j.toxlet.2005.11.002; Goel A, 2005, CHEM-BIOL INTERACT, V156, P131, DOI 10.1016/j.cbi.2005.08.004; Goel A, 2000, BIOL TRACE ELEM RES, V74, P171, DOI 10.1385/BTER:74:2:171; Hass U, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9360; Hsieh Chia-Jung, 2011, BMC Res Notes, V4, P291, DOI 10.1186/1756-0500-4-291; Jayalakshmi K, 2005, BRAIN RES, V1046, P97, DOI 10.1016/j.brainres.2005.03.054; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P106, DOI 10.1289/ehp.9358; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011272; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Lowe ER, 2009, TOXICOL SCI, V108, P258, DOI 10.1093/toxsci/kfp034; Mansour SA, 2009, CHEMOSPHERE, V75, P601, DOI 10.1016/j.chemosphere.2009.01.058; Markovic M, 2010, ARCH ENVIRON CON TOX, V58, P341, DOI 10.1007/s00244-009-9359-y; MOHR FC, 1995, MOL PHARMACOL, V48, P512; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Padilla S, 2005, TOXICOL SCI, V88, P161, DOI 10.1093/toxsci/kfi274; Pehkonen SO, 2005, ENVIRON SCI TECHNOL, V39, P2586, DOI 10.1021/es0486869; Ragunathan N, 2010, ENVIRON HEALTH PERSP, V118, P1685, DOI 10.1289/ehp.1002334; Rai A, 2010, TOXICOL SCI, V118, P586, DOI 10.1093/toxsci/kfq266; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Rusyniak DE, 2004, SEMIN NEUROL, V24, P197, DOI 10.1055/s-2004-830907; SHAIKH ZA, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432017; Smith E, 2012, J HAZARD MATER, V199, P453, DOI 10.1016/j.jhazmat.2011.11.016; Steevens JA, 1999, TOXICOL SCI, V52, P168, DOI 10.1093/toxsci/52.2.168; Tully DB, 2000, TOXICOL APPL PHARM, V168, P79, DOI 10.1006/taap.2000.9014; Tuzmen N, 2008, CELL BIOCHEM FUNCT, V26, P119, DOI 10.1002/cbf.1411; Yang RH, 2007, ENVIRON HEALTH PERSP, V115, P1339, DOI 10.1289/ehp.10290	41	21	24	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059553	10.1371/journal.pone.0059553	http://dx.doi.org/10.1371/journal.pone.0059553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516638	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400114
J	Dane, B; Harris, R; Reed, JM				Dane, Benjamin; Harris, Rebecca; Reed, J. Michael			Female Goldeneye Ducks (Bucephala clangula) Do Not Discriminate among Male Precopulatory Display Patterns	PLOS ONE			English	Article							SEXUAL SELECTION; REPERTOIRE SIZE; EVOLUTION; SONG; COURTSHIP; PREFERENCES; PEACOCKS	Female goldeneyes remain motionless on the surface of the water while single males circle them performing a series of highly stereotyped displays. After performing between eight and 90 of these displays the male either copulates or attempts to copulate with the female. However, females allow only 58% of males to mount them, while rejecting 42%. We have examined 804 of these precopulatory sequences containing 11,841 actions in an effort to determine why females find some display sequences of males unsuitable, while others are accepted. Males have an extraordinarily varied sequence of actions, and sequence variation leading to successful and unsuccessful copulation attempts was similar. Most surprising was the tendency of males to eliminate one of the five actions, whether in successful or unsuccessful attempts. As unlikely as we think it might be as the result of natural selection, the only statistically significant difference we found between successful and unsuccessful attempts was the reduction in the frequency of expression of one or more of the behaviors in successful attempts. These observations, coupled with the large variation seen in most sequences, suggest that there is not a correct sequence, or even a correct set of actions leading to copulation. The male must, however, perform goldeneye species-specific precopulatory behavior as performed by adult males, although it apparently can be performed in a wide variety of patterns.	[Dane, Benjamin; Harris, Rebecca; Reed, J. Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University	Reed, JM (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	michael.reed@tufts.edu						AFTON AD, 1982, CAN FIELD NAT, V96, P295; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; BURGHARDT GM, 1985, FDN COMP ETHOLOGY; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Dane B., 1964, Behaviour, V22, P282, DOI 10.1163/156853964X00058; DANE BENJAMIN, 1959, BEHAVIOUR, V14, P265, DOI 10.1163/156853959X00108; Davis ES, 1997, ANIM BEHAV, V53, P1025, DOI 10.1006/anbe.1996.0355; FINLEY J, 1983, ANIM BEHAV, V31, P348, DOI 10.1016/S0003-3472(83)80053-0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Heinroth O., 1911, BEITRAGE BIOL NAMENT, P589; Johnson KP, 2000, J EVOLUTION BIOL, V13, P634; Johnson KP, 2000, ANIM BEHAV, V59, P953, DOI 10.1006/anbe.1999.1399; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; LIND HANS, 1959, DANSK ORNITHOL FOR TIDSSKR, V53, P177; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; Lorenz K., 1941, Journal fuer Ornithologie Berlin Festschrift Oskar Heinroth, P194; Lorenz KZ, 1935, J ORNITHOL, V83, P289, DOI DOI 10.1007/BF01905572; MacDougall AK, 2003, NATURWISSENSCHAFTEN, V90, P464, DOI 10.1007/s00114-003-0459-7; MCKINNEY F, 1990, AUK, V107, P188; MCKINNEY F, 1983, BEHAVIOUR, V86, P250, DOI 10.1163/156853983X00390; McKinney Frank, 1992, P214; PAYNE RB, 1977, Z TIERPSYCHOL, V45, P113; Payne RJH, 1997, ANIM BEHAV, V54, P109, DOI 10.1006/anbe.1996.0391; PETRIE M, 1994, BEHAV ECOL SOCIOBIOL, V35, P213, DOI 10.1007/s002650050090; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1984, Z TIERPSYCHOL, V66, P128; SEARCY WA, 1984, BEHAV ECOL SOCIOBIOL, V14, P281, DOI 10.1007/BF00299499; SEARCY WA, 1981, SCIENCE, V213, P926, DOI 10.1126/science.213.4510.926; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WISHART RA, 1983, CAN J ZOOL, V61, P1733, DOI 10.1139/z83-224; [No title captured]	36	0	0	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57589	10.1371/journal.pone.0057589	http://dx.doi.org/10.1371/journal.pone.0057589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516410	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400011
J	Vostatek, P; Novak, D; Rychnovsky, T; Rychnovska, S				Vostatek, Pavel; Novak, Daniel; Rychnovsky, Tomas; Rychnovska, Sarka			Diaphragm Postural Function Analysis Using Magnetic Resonance Imaging	PLOS ONE			English	Article							LOW-BACK-PAIN; OBSTRUCTIVE PULMONARY-DISEASE; DYNAMIC BREATHING MRI; MUSCLE RECRUITMENT; HEALTHY-ADULTS; LUMBAR SPINE; MOVEMENT; MOTION; MANEUVERS; PEOPLE	We present a postural analysis of diaphragm function using magnetic resonance imaging (MRI). The main aim of the study was to identify changes in diaphragm motion and shape when postural demands on the body were increased (loading applied to a distal part of the extended lower extremities against the flexion of the hips was used). Sixteen healthy subjects were compared with 17 subjects suffering from chronic low back pain and in whom structural spine disorders had been identified. Two sets of features were calculated from MRI recordings: dynamic parameters reflecting diaphragm action, and static parameters reflecting diaphragm anatomic characteristics. A statistical analysis showed that the diaphragm respiratory and postural changes were significantly slower, bigger in size and better balanced in the control group. When a load was applied to the lower limbs, the pathological subjects were mostly not able to maintain the respiratory diaphragm function, which was lowered significantly. Subjects from the control group showed more stable parameters of both respiratory and postural function. Our findings consistently affirmed worse muscle cooperation in the low back pain population subgroup. A clear relation with spinal findings and with low back pain remains undecided, but various findings in the literature were confirmed. The most important finding is the need to further address various mechanisms used by patients to compensate deep muscle insufficiency.	[Vostatek, Pavel; Novak, Daniel] Czech Tech Univ, Dept Cybernet, CR-16635 Prague, Czech Republic; [Rychnovsky, Tomas; Rychnovska, Sarka] AVETE OMNE Physiotherapy Ctr, Prague, Czech Republic	Czech Technical University Prague	Vostatek, P (corresponding author), Czech Tech Univ, Dept Cybernet, CR-16635 Prague, Czech Republic.	vostapav@fel.cvut.cz	Novak, Daniel/G-9231-2014	Novak, Daniel/0000-0001-6996-9344	CVUT [SGS.SGS10/279/OHK3/3T/13]; Ministry of Education, Youth and Sport of the Czech Republic [MSM6840770012]	CVUT; Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work has been supported by the research program CVUT SGS.SGS10/279/OHK3/3T/13 and by Ministry of Education, Youth and Sport of the Czech Republic with the grant number MSM6840770012 entitled "Transdisciplinary Research in Biomedical Engineering II''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr KP, 2005, AM J PHYS MED REHAB, V84, P473, DOI 10.1097/01.phm.0000163709.70471.42; Butler JE, 2001, J APPL PHYSIOL, V90, P147, DOI 10.1152/jappl.2001.90.1.147; Carragee E, 2006, SPINE J, P624; Cholewicki J, 2002, EUR J APPL PHYSIOL, V87, P127, DOI 10.1007/s00421-002-0598-0; Cholewicki J, 1996, CLIN BIOMECH, P1; Chu WCW, 2006, SPINE, V31, P2243, DOI 10.1097/01.brs.0000232822.74349.32; COHEN E, 1994, THORAX, V49, P885, DOI 10.1136/thx.49.9.885; Courtney R, 2009, INT J OSTEOPATH MED, V12, P78, DOI 10.1016/j.ijosm.2009.04.002; Daggfeldt K, 2003, J BIOMECH, V36, P815, DOI 10.1016/S0021-9290(03)00015-0; Etlik O, 2004, EUR J RADIOL, V51, P150, DOI 10.1016/S0720-048X(03)00210-9; Gierada DS, 1997, J THORAC IMAG, V12, P70, DOI 10.1097/00005382-199701000-00011; GIERADA DS, 1995, RADIOLOGY, V194, P879, DOI 10.1148/radiology.194.3.7862995; Grimstone SK, 2003, EXP BRAIN RES, V151, P218, DOI 10.1007/s00221-003-1433-5; HARRIS RI, 1954, J BONE JOINT SURG BR, V36, P304, DOI 10.1302/0301-620X.36B2.304; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hodges PW, 1997, J PHYSIOL-LONDON, V505, P539, DOI 10.1111/j.1469-7793.1997.539bb.x; Hodges PW, 1999, ARCH PHYS MED REHAB, V80, P1005, DOI 10.1016/S0003-9993(99)90052-7; Hodges PW, 1997, J APPL PHYSIOL, V83, P753, DOI 10.1152/jappl.1997.83.3.753; Hodges PW, 2002, EXP BRAIN RES, V144, P293, DOI 10.1007/s00221-002-1040-x; Hodges PW, 2001, EXP BRAIN RES, V141, P261, DOI 10.1007/s002210100873; Hodges PW, 1997, ERGONOMICS, P539; Hungerford B, 2003, SPINE, V28, P1593, DOI 10.1097/00007632-200307150-00022; Iwasawa T, 2002, EUR RESPIR J, V19, P225, DOI 10.1183/09031936.02.00044602; Janda V, 1996, FUNKCNI SVALOVY TEST; Janssens L, 2010, SPINE, V35, P1088, DOI 10.1097/BRS.0b013e3181bee5c3; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kapandji I, 1998, PHYSL JOINTS, VThree; Kolar P, 2009, PHYSIOL RES, V58, P383, DOI 10.33549/physiolres.931376; Kolar P, 2012, J ORTHOP SPORT PHYS, V42, P352, DOI 10.2519/jospt.2012.3830; Kondo T, 2005, TOKAI J EXPT CLIN ME, P15; Kondo T, 2000, RESPIROLOGY, P19; Kotani T, 2004, SPINE, V29, P298, DOI 10.1097/01.BRS.0000106490.82936.89; LEWIT K, 1980, J AM OSTEOPATH ASSOC, V79, P525; McGill SM, 1995, ERGONIMICS, P1772; Miyamoto K, 2002, SPINE, V27, P1749, DOI 10.1097/00007632-200208150-00012; Plathow C, 2005, J MAGN RESON IMAGING, V21, P212, DOI 10.1002/jmri.20255; Plathow C, 2005, INVEST RADIOL, V40, P173, DOI 10.1097/00004424-200503000-00007; Plathow C, 2006, EUR RADIOL, V16, P173, DOI 10.1007/s00330-005-2795-9; Plathow C, 2005, INT J RADIAT ONCOL, V62, P238, DOI 10.1016/j.ijrobp.2005.01.042; Plathow C, 2004, EUR RADIOL, V14, P1392, DOI 10.1007/s00330-004-2336-y; Roussel N, 2009, EUR SPINE J, V18, P1066, DOI 10.1007/s00586-009-1020-y; SHARP JT, 1977, AM REV RESPIR DIS, V115, P47; SKLADAL J, 1978, AGRESSOLOGIE, V19, P45; Smith MD, 2005, AUSTR J PHYSIOTHERAP, P11; Smolkov L, 2006, FYZIOTERAPIE POHYBOV; Suga K, 1999, JMRI-J MAGN RESON IM, V10, P510, DOI 10.1002/(SICI)1522-2586(199910)10:4<510::AID-JMRI3>3.0.CO;2-G; Suwatanapongched T, 2003, CHEST, V123, P2019, DOI 10.1378/chest.123.6.2019; Takazakura R, 2004, J MAGN RESON IMAGING, V19, P605, DOI 10.1002/jmri.20051; Troyer AD, 1981, THORAX, P169; Troyer AD, 1997, EUROPEAN RESP J OFFI, P708; Unal O, 2000, CLIN IMAG, V24, P347, DOI 10.1016/S0899-7071(00)00245-X	51	38	39	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e56724	10.1371/journal.pone.0056724	http://dx.doi.org/10.1371/journal.pone.0056724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516397	Green Published, gold			2022-12-25	WOS:000316407400005
J	Balko, SM; Kreer, T; Costanzo, PJ; Patten, TE; Johner, A; Kuhl, TL; Marques, CM				Balko, Suzanne M.; Kreer, Torsten; Costanzo, Philip J.; Patten, Tim E.; Johner, Albert; Kuhl, Tonya L.; Marques, Carlos M.			Polymer Brushes under High Load	PLOS ONE			English	Article							POLYELECTROLYTE BRUSHES; FORCES; SURFACES; LUBRICATION; CHAINS; SHEAR; COMPRESSION; ADSORPTION; FRICTION; LAYERS	Polymer coatings are frequently used to provide repulsive forces between surfaces in solution. After 25 years of design and study, a quantitative model to explain and predict repulsion under strong compression is still lacking. Here, we combine experiments, simulations, and theory to study polymer coatings under high loads and demonstrate a validated model for the repulsive forces, proposing that this universal behavior can be predicted from the polymer solution properties.	[Balko, Suzanne M.; Kuhl, Tonya L.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; [Balko, Suzanne M.; Kreer, Torsten] Leibniz Inst Polymerforsch Dresden EV, Dresden, Germany; [Costanzo, Philip J.; Patten, Tim E.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Johner, Albert; Marques, Carlos M.] Univ Strasbourg, CNRS, Inst Charles Sadron, Strasbourg, France	University of California System; University of California Davis; Leibniz Institut fur Polymerforschung Dresden; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kuhl, TL (corresponding author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.	tlkuhl@ucdavis.edu; marques@unistra.fr	Marques, Carlos M/B-2322-2010; Balko, Suzanne M/K-2669-2014; Costanzo, Philip/E-8879-2011	Marques, Carlos M/0000-0002-3952-0498; Balko, Suzanne M/0000-0002-9713-3349; Costanzo, Philip/0000-0001-6220-463X	United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-06ER46340]; Chateaubriand Fellowship (Paris, France); Deutsche Forschungsgemeinshaft (DFG) [DFG-KR 2854/3-1]	United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Chateaubriand Fellowship (Paris, France); Deutsche Forschungsgemeinshaft (DFG)(German Research Foundation (DFG))	The authors are grateful to O. Felix for QCM-D measurements. This research was supported primarily by the United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award DE-FG02-06ER46340 (TLK, SMB & PJC). SMB thanks the Chateaubriand Fellowship (Paris, France) for partial financial support. TK thanks the Deutsche Forschungsgemeinshaft (DFG) for financial support (DFG-KR 2854/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S, 1977, J PHYS-PARIS, V38, P977, DOI 10.1051/jphys:01977003808097700; [Anonymous], 1992, INTERMOLECULAR SURFA; [Anonymous], SIMULATION DATA LEAD; AUROY P, 1991, PHYS REV LETT, V66, P719, DOI 10.1103/PhysRevLett.66.719; CARIGNANO MA, 1993, J CHEM PHYS, V98, P5006, DOI 10.1063/1.464954; Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399; Costanzo PJ, 2005, ASSEMBLY MECH APPL N; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; ESPANOL P, 1995, PHYS REV E, V52, P1734, DOI 10.1103/PhysRevE.52.1734; Frenkel D., 2000, UNDERSTANDING MOL SI; Galuschko A, 2010, LANGMUIR, V26, P6418, DOI 10.1021/la904119c; Grest GS, 1999, ADV POLYM SCI, V138, P149; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; HADZIIOANNOU G, 1986, J AM CHEM SOC, V108, P2869, DOI 10.1021/ja00271a014; Hamley I. W., 2007, INTRO SOFT MATTER SY; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; ISRAELAC.JN, 1973, J COLLOID INTERF SCI, V44, P259, DOI 10.1016/0021-9797(73)90218-X; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; Kim JU, 2007, EUR PHYS J E, V23, P135, DOI 10.1140/epje/i2007-10188-1; Kim JU, 2009, MACROMOLECULES, V42, P3430, DOI 10.1021/ma900033p; Klein J, 1996, ANNU REV MATER SCI, V26, P581, DOI 10.1146/annurev.ms.26.080196.003053; Kreer T, 2003, LANGMUIR, V19, P7551, DOI 10.1021/la030008x; Liao WP, 2012, MACROMOLECULES, V45, P5766, DOI 10.1021/ma3009146; Malham IB, 2010, LANGMUIR, V26, P4762, DOI 10.1021/la9035387; MILNER ST, 1988, EUROPHYS LETT, V7, P695, DOI 10.1209/0295-5075/7/8/005; MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051; MILNER ST, 1994, J POLYM SCI POL PHYS, V32, P2743, DOI 10.1002/polb.1994.090321620; MILNER ST, 1989, MACROMOLECULES, V22, P853, DOI 10.1021/ma00192a057; Moore NW, 2008, LANGMUIR, V24, P1212, DOI 10.1021/la702202x; Mulder DJ, 2010, SOFT MATTER, V6, P5401, DOI 10.1039/c0sm00444h; MURAT M, 1989, PHYS REV LETT, V63, P1074, DOI 10.1103/PhysRevLett.63.1074; Odian G., 1991, PRINCIPLES POLYM, V3; Ruths M, 2000, MACROMOLECULES, V33, P3860, DOI 10.1021/ma9920994; Spirin L, 2013, ACS MACRO LETT, V2, P63, DOI 10.1021/mz300504k; Spirin L, 2011, MACROMOLECULES, V44, P9399, DOI 10.1021/ma2014029; Spirin L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.168301; Spirin L, 2010, EUR PHYS J E, V33, P307, DOI 10.1140/epje/i2010-10674-3; SWANN DA, 1984, ARTHRITIS RHEUM, V27, P552, DOI 10.1002/art.1780270511; Szleifer I, 1996, ADV CHEM PHYS, V94, P165, DOI 10.1002/9780470141533.ch3; TAUNTON HJ, 1990, MACROMOLECULES, V23, P571, DOI 10.1021/ma00204a033; TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; WATANABE H, 1993, MACROMOLECULES, V26, P6455, DOI 10.1021/ma00076a023; Zappone B, 2007, BIOPHYS J, V92, P1693, DOI 10.1529/biophysj.106.088799; Zhulina EB, 1997, J CHEM PHYS, V107, P5952, DOI 10.1063/1.474320	46	20	20	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58392	10.1371/journal.pone.0058392	http://dx.doi.org/10.1371/journal.pone.0058392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516470	gold, Green Published			2022-12-25	WOS:000316849200062
J	Green, JL; Bauer, M; Yum, KW; Li, YC; Cox, ML; Willert, K; Wahl, GM				Green, Jennifer L.; Bauer, Matthieu; Yum, Kyu Won; Li, Yao-Cheng; Cox, Miranda L.; Willert, Karl; Wahl, Geoffrey M.			Use of a Molecular Genetic Platform Technology to Produce Human Wnt Proteins Reveals Distinct Local and Distal Signaling Abilities	PLOS ONE			English	Article							ACUTE LYMPHOBLASTOID LEUKEMIA; HEMATOPOIETIC STEM-CELLS; WNT/BETA-CATENIN; PATHWAY; RECEPTORS; LGR5; TRANSFORMATION; ENDOCYTOSIS; ACTIVATION; INHIBITION	Functional and mechanistic studies of Wnt signaling have been severely hindered by the inaccessibility of bioactive proteins. To overcome this long-standing barrier, we engineered and characterized a panel of Chinese hamster ovary (CHO) cell lines with inducible transgenes encoding tagged and un-tagged human WNT1, WNT3A, WNT5A, WNT7A, WNT11, WNT16 or the soluble Wnt antagonist Fzd8CRD, all integrated into an identical genomic locus. Using a quantitative real-time bioluminescence assay, we show that cells expressing WNT1, 3A and 7A stimulate Wnt/beta-catenin reporter activity, while the other WNT expressing cell lines interfere with this activation. Additionally, in contrast to WNT3A, WNT1 only exhibits activity when cell-associated, and thus only signals to neighboring cells. The reporter assay also revealed a rapid decline of Wnt activity at 37 degrees C, indicating that Wnt activity is highly labile. These engineered cell lines will reduce the cost of making and purifying Wnt proteins and serve as a continuous, reliable and regulatable source of Wnts to research laboratories around the world.	[Green, Jennifer L.; Yum, Kyu Won; Li, Yao-Cheng; Cox, Miranda L.; Wahl, Geoffrey M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Bauer, Matthieu; Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Wahl, GM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu			Department of Defense (DoD) Breast Cancer Research Program (BCRP) [W81XWH-09-1-0326]; DOD [WH1210106]; National Cancer Institute [5P30CA014195]; Susan G. Komen Foundation; California Institute for Regenerative Medicine [RB1-01406]; CIRM training grant [TG2-01154]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Department of Defense (DoD) Breast Cancer Research Program (BCRP)(United States Department of Defense); DOD(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Department of Defense (DoD) Breast Cancer Research Program (BCRP) (Award W81XWH-09-1-0326 to J. Green), DOD WH1210106 (to G. Wahl), National Cancer Institute 5P30CA014195 (to G. Wahl), the Susan G. Komen Foundation (to G. Wahl), and the California Institute for Regenerative Medicine (to KW RB1-01406). MB is supported by a CIRM training grant awarded to University of California San Diego (UCSD) (TG2-01154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Cajanek L, 2010, J CELL BIOCHEM, V111, P1077, DOI 10.1002/jcb.22771; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Najdi R, 2012, DIFFERENTIATION; PAPKOFF J, 1989, MOL CELL BIOL, V9, P3377, DOI 10.1128/MCB.9.8.3377; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Uysal-Onganer P, 2011, ACTA PHYSL OXF; van Amerongen R, 2012, DEV BIOL; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2; Wong ET, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni145; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	44	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58395	10.1371/journal.pone.0058395	http://dx.doi.org/10.1371/journal.pone.0058395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516471	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200063
J	Ohkouchi, S; Shibata, M; Sasaki, M; Koike, M; Safig, P; Peters, C; Nagata, S; Uchiyama, Y				Ohkouchi, Susumu; Shibata, Masahiro; Sasaki, Mitsuho; Koike, Masato; Safig, Paul; Peters, Christoph; Nagata, Shigekazu; Uchiyama, Yasuo			Biogenesis and Proteolytic Processing of Lysosomal DNase II	PLOS ONE			English	Article							PORCINE SPLEEN DEOXYRIBONUCLEASE; PROGRAMMED CELL-DEATH; MOUSE EYE LENS; CATHEPSIN-D; IMMUNOAFFINITY PURIFICATION; MOLECULAR-CLONING; RAT MACROPHAGES; GENE-EXPRESSION; MAMMALIAN DNA; BODY-FLUIDS	Deoxyribonuclease II (DNase II) is a key enzyme in the phagocytic digestion of DNA from apoptotic nuclei. To understand the molecular properties of DNase II, particularly the processing, we prepared a polyclonal antibody against carboxyl-terminal sequences of mouse DNase II. In the present study, partial purification of DNase II using Con A Sepharose enabled the detection of endogenous DNase II by Western blotting. It was interesting that two forms of endogenous DNase II were detected - a 30 kDa form and a 23 kDa form. Neither of those forms carried the expected molecular weight of 45 kDa. Subcellular fractionation showed that the 23 kDa and 30 kDa proteins were localized in lysosomes. The processing of DNase II in vivo was also greatly altered in the liver of mice lacking cathepsin L. DNase II that was extracellularly secreted from cells overexpressing DNase II was detected as a pro-form, which was activated under acidic conditions. These results indicate that DNase II is processed and activated in lysosomes, while cathepsin L is involved in the processing of the enzyme.	[Ohkouchi, Susumu; Sasaki, Mitsuho; Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 113, Japan; [Shibata, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Gross Anat & Morphogenesis, Niigata, Japan; [Safig, Paul] Univ Kiel, Inst Biochem, Unit Mol Cell Biol & Transgen Res, Kiel, Germany; [Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, D-79106 Freiburg, Germany; [Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan	Juntendo University; Niigata University; University of Kiel; University of Freiburg; Kyoto University	Uchiyama, Y (corresponding author), Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 113, Japan.	y-uchi@juntendo.ac.jp	Koike, Masato/F-9584-2010; Nagata, Shigekazu/AAG-3203-2019	Koike, Masato/0000-0002-3174-5684; Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science [16GS0315, 23111004, 23110517, 23659102, 23390041]; Ministry of Education, Science, Sports and Culture, Japan (MEXT); MEXT; Grants-in-Aid for Scientific Research [24590249] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Creative Scientific Research (16GS0315), for Scientific Research on Innovative Areas (23111004 and 23110517 for YU), for Challenging Exploratory Research (23659102) and for Scientific Research (B) (23390041) from the Japan Society for the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan (MEXT), MEXT-supported Program for the Strategic Research Foundation at Private Universities (YU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KP, 1998, GENE, V215, P281, DOI 10.1016/S0378-1119(98)00280-7; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; Chou SF, 2002, BIOCHEM BIOPH RES CO, V296, P48, DOI 10.1016/S0006-291X(02)00835-5; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; DULANEY JT, 1972, J BIOL CHEM, V247, P1424; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARA K, 1988, FEBS LETT, V231, P229, DOI 10.1016/0014-5793(88)80737-3; Huang RT, 2009, FEBS J, V276, P1891, DOI 10.1111/j.1742-4658.2009.06915.x; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2008, METHOD ENZYMOL, V442, P271, DOI 10.1016/S0076-6879(08)01414-6; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; KOIZUMI T, 1995, EXP ANIM TOKYO, V44, P169, DOI 10.1538/expanim.44.169; KOMINAMI E, 1988, FEBS LETT, V231, P225, DOI 10.1016/0014-5793(88)80736-1; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; LIAO TH, 1989, BIOCHIM BIOPHYS ACTA, V1007, P15, DOI 10.1016/0167-4781(89)90124-3; LIAO TH, 1985, J BIOL CHEM, V260, P708; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; MacLea KS, 2003, BIOCHEM J, V371, P867, DOI 10.1042/BJ20021875; MacLea KS, 2002, BIOCHEM BIOPH RES CO, V292, P415, DOI 10.1006/bbrc.2002.6687; McIlroy D, 2000, GENE DEV, V14, P549; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nakajima T, 2002, BBA-GEN SUBJECTS, V1570, P160, DOI 10.1016/S0304-4165(02)00191-5; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; PARWARESCH MR, 1986, AM J PATHOL, V125, P141; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; Uchiyama Y, 2009, METHOD ENZYMOL, V453, P33, DOI 10.1016/S0076-6879(08)04003-2; Wang CC, 1998, J BIOL CHEM, V273, P17192, DOI 10.1074/jbc.273.27.17192; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; YASUDA T, 1992, BIOCHIM BIOPHYS ACTA, V1119, P185, DOI 10.1016/0167-4838(92)90390-Y; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	40	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59148	10.1371/journal.pone.0059148	http://dx.doi.org/10.1371/journal.pone.0059148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516607	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200134
J	Tiwari, S; Hudson, S; Gattone, VH; Miller, C; Chernoff, EAG; Belecky-Adams, TL				Tiwari, Sarika; Hudson, Scott; Gattone, Vincent H., II; Miller, Caroline; Chernoff, Ellen A. G.; Belecky-Adams, Teri L.			Meckelin 3 Is Necessary for Photoreceptor Outer Segment Development in Rat Meckel Syndrome	PLOS ONE			English	Article							INHERITED RETINAL DEGENERATION; LEBER CONGENITAL AMAUROSIS; POLYCYSTIC KIDNEY-DISEASE; RETINITIS-PIGMENTOSA; CELL-DEATH; GRUBER-SYNDROME; INTRAFLAGELLAR TRANSPORT; KNOCKOUT MICE; PRIMARY CILIA; MEDIATES CILIOGENESIS	Ciliopathies lead to multiorgan pathologies that include renal cysts, deafness, obesity and retinal degeneration. Retinal photoreceptors have connecting cilia joining the inner and outer segment that are responsible for transport of molecules to develop and maintain the outer segment process. The present study evaluated meckelin (MKS3) expression during outer segment genesis and determined the consequences of mutant meckelin on photoreceptor development and survival in Wistar polycystic kidney disease Wpk/Wpk rat using immunohistochemistry, analysis of cell death and electron microscopy. MKS3 was ubiquitously expressed throughout the retina at postnatal day 10 (P10) and P21. However, in the mature retina, MKS3 expression was restricted to photoreceptors and the retinal ganglion cell layer. At P10, both the wild type and homozygous Wpk mutant retina had all retinal cell types. In contrast, by P21, cells expressing rod- and cone-specific markers were fewer in number and expression of opsins appeared to be abnormally localized to the cell body. Cell death analyses were consistent with the disappearance of photoreceptor-specific markers and showed that the cells were undergoing caspase-dependent cell death. By electron microscopy, P10 photoreceptors showed rudimentary outer segments with an axoneme, but did not develop outer segment discs that were clearly present in the wild type counterpart. At p21 the mutant outer segments appeared much the same as the P10 mutant outer segments with only a short axoneme, while the wild-type controls had developed outer segments with many well-organized discs. We conclude that MKS3 is not important for formation of connecting cilium and rudimentary outer segments, but is critical for the maturation of outer segment processes.	[Tiwari, Sarika; Hudson, Scott; Chernoff, Ellen A. G.; Belecky-Adams, Teri L.] Indiana Univ Purdue Univ Indianapolis, Dept Biol, Indianapolis, IN 46202 USA; [Gattone, Vincent H., II; Miller, Caroline] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Tiwari, Sarika; Hudson, Scott; Chernoff, Ellen A. G.; Belecky-Adams, Teri L.] Indiana Univ Purdue Univ Indianapolis, Ctr Regenerat Biol & Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Belecky-Adams, TL (corresponding author), Indiana Univ Purdue Univ Indianapolis, Dept Biol, Indianapolis, IN 46202 USA.	tbadams@iupui.edu		Belecky-Adams, Teri/0000-0003-1299-8448	National Eye Institute [5RO1EY019525-02, 1R15EY020816-01]; American Health Assistance Foundation [G2008-113]; National Institutes of Health [R01DK68581]; NATIONAL EYE INSTITUTE [R15EY020816, R01EY019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068581] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Eye Institute (5RO1EY019525-02 and 1R15EY020816-01 to TBA), American Health Assistance Foundation (G2008-113 to TBA), and National Institutes of Health (R01DK68581 to VG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2012, HUM MOL GENET, V21, P1272, DOI 10.1093/hmg/ddr557; Alexiev BA, 2006, ARCH PATHOL LAB MED, V130, P1236; Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Collin GB, 2012, INVEST OPHTH VIS SCI, V53, P967, DOI 10.1167/iovs.11-8766; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; DE ROBERTIS E., 1960, JOUR GEN PHYSIOL, V43, P1; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Guo CR, 2012, EXP EYE RES, V104, P39, DOI 10.1016/j.exer.2012.08.013; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Ikeda S, 2000, HUM MOL GENET, V9, P155, DOI 10.1093/hmg/9.2.155; Jozwick C, 2006, EXP EYE RES, V83, P1074, DOI 10.1016/j.exer.2006.05.012; Keady BT, 2011, MOL BIOL CELL, V22, P921, DOI 10.1091/mbc.E10-09-0792; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; KUWABARA T, 1976, ARCH OPHTHALMOL-CHIC, V94, P1369; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Liu CD, 1999, J NEUROSCI, V19, P4778; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Lopes VS, 2010, MOL BIOL CELL, V21, P4076, DOI 10.1091/mbc.E10-08-0715; MESSER A, 1995, AM J MED GENET, V57, P361, DOI 10.1002/ajmg.1320570251; Morgan NV, 2002, HUM GENET, V111, P456, DOI 10.1007/s00439-002-0817-0; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nakanishi T, 2012, J NEUROCHEM; Nauta J, 2000, J AM SOC NEPHROL, V11, P2272, DOI 10.1681/ASN.V11122272; NILSSON SEG, 1964, J ULTRA MOL STRUCT R, V11, P581, DOI 10.1016/S0022-5320(64)80084-8; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Organisciak DT, 2003, INVEST OPHTH VIS SCI, V44, P486, DOI 10.1167/iovs.02-0708; PAGHROEHL K, 1991, CELL MOL NEUROBIOL, V11, P593, DOI 10.1007/BF00741448; Papermaster DS, 2002, INVEST OPHTH VIS SCI, V43, P1300; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Pretorius PR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000884; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Ramamurthy V, 2009, CLIN GENET, V76, P137, DOI 10.1111/j.1399-0004.2009.01240.x; Rascher K, 2004, VISION RES, V44, P2091, DOI 10.1016/j.visres.2004.03.027; Rattner A, 2006, AM J OPHTHALMOL, V141, P558, DOI 10.1016/j.ajo.2005.10.045; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANYAL S, 1986, J EMBRYOL EXP MORPH, V98, P111; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; SMITH SB, 1994, EXP EYE RES, V58, P77, DOI 10.1006/exer.1994.1196; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Szymanska K, 2012, CILIA, V1, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1186; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; Thompson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035865; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Valter K, 2009, EXP EYE RES, V89, P1003, DOI 10.1016/j.exer.2009.08.009; Warburton-Pitt SR, 2012, J CELL SCI; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Won J, 2011, HUM MOL GENET, V20, P482, DOI 10.1093/hmg/ddq494; Won JY, 2009, HUM MOL GENET, V18, P4329, DOI 10.1093/hmg/ddp385; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yamashita T, 2009, J NEUROSCI, V29, P9748, DOI 10.1523/JNEUROSCI.5854-08.2009; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P3965, DOI 10.1073/pnas.0637349100	91	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59306	10.1371/journal.pone.0059306	http://dx.doi.org/10.1371/journal.pone.0059306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516626	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200143
J	Yang, Y; Li, Y; Wang, KB; Wang, Y; Yin, WQ; Li, L				Yang, Ye; Li, Yuan; Wang, Kebo; Wang, Yu; Yin, Wenqin; Li, Lei			P38/NF-kappa B/Snail Pathway Is Involved in Caffeic Acid-Induced Inhibition of Cancer Stem Cells-Like Properties and Migratory Capacity in Malignant Human Keratinocyte	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; UP-REGULATES SNAIL; NF-KAPPA-B; E-CADHERIN; SKIN-CANCER; EXPRESSION; ACTIVATION; REPRESSION; KINASES; BREAST	Background: Skin cancer is the most common cancer throughout the world. The epithelial-mesenchymal transition (EMT) and the acquisition of cancer stem cells (CSCs)-like properties emerge as critical steps in the metastasis of human skin cancers. Caffeic acid (CaA) exerts anticarcinogenic effects. However, the effects of CaA on the migratory capability and on the CSCs-like properties of skin cancer cells, and the molecular mechanisms underlying it are not fully understood. Methods: Malignant HaCaT cells were treated by CaA. Transwell assay was performed to determine that CaA attenuated the migratory capability; Spheroid formation assay was performed to confirm that CaA decreased the CSCs-like phenotype; Treated malignant HaCaT cells were molecularly characterized by RT-PCR, Western blots, Southwestern blot, and immunoprecipitation. Results: In CaA-treated malignant human keratinocyte (malignant HaCaT cells), inhibition of the migratory capability and CSCs-like phenotype were observed. CaA up-regulated the phosphorylation of p38, and down-regulated the activation of nuclear factor kappa B (NF-kappa B)/snail signal pathway. Indeed, p38 decreased the DNA-binding activity of NF-kappa B to the promoter of snail gene, which resulted in the transcriptional inactivation of snail. Blockage of p38 attenuated the CaA-induced inhibition of migratory capability and CSCs-like phenotype in malignant HaCaT cells. Conclusions: CaA attenuates the migratory capability and CSCs-like Properties of malignant human keratinocyte, in which, p38-mediated down-regulation of NF-kappa B/snail signal pathway is involved.	[Yang, Ye; Wang, Kebo; Wang, Yu; Yin, Wenqin; Li, Lei] Nanjing Med Univ, Sch Publ Hlth, Dept Hyg Anal & Detect, Nanjing, Jiangsu, Peoples R China; [Li, Yuan; Li, Lei] Nanjing Med Univ, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Li, L (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Hyg Anal & Detect, Nanjing, Jiangsu, Peoples R China.	drleili@hotmail.com			Natural Science Foundations of China [81072338]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundations of China (81072338) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Benitah SA, 2011, NATURE, V478, P329, DOI 10.1038/478329a; Borden EC, 2007, SEMIN ONCOL, V34, P449, DOI 10.1053/j.seminoncol.2007.09.001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; Eaves CJ, 2008, NATURE, V456, P581, DOI 10.1038/456581a; HUANG MT, 1988, CANCER RES, V48, P5941; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Jung JE, 2007, CARCINOGENESIS, V28, P1780, DOI 10.1093/carcin/bgm130; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Kim HM, 2012, ANN SURG ONCOL, V19, pS539, DOI 10.1245/s10434-011-2040-5; Lencinas A, 2010, TOXICOL SCI, V116, P273, DOI 10.1093/toxsci/kfq086; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Nagasaka R, 2007, BIOCHEM BIOPH RES CO, V358, P615, DOI 10.1016/j.bbrc.2007.04.178; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; Nemoto Y, 2011, VET PATHOL, V48, P1029, DOI 10.1177/0300985810396106; Shaikh WR, 2012, J CANCER EDUC, V27, P709, DOI 10.1007/s13187-012-0378-4; Staniforth V, 2006, CARCINOGENESIS, V27, P1803, DOI 10.1093/carcin/bgl006; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Szliszka E, 2012, INT J ONCOL, V41, P818, DOI 10.3892/ijo.2012.1527; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Tokar EJ, 2010, JNCI-J NATL CANCER I, V102, P638, DOI 10.1093/jnci/djq093; Tokar EJ, 2010, ENVIRON HEALTH PERSP, V118, P108, DOI 10.1289/ehp.0901059; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang ZS, 2012, ENVIRON HEALTH PERSP, V120, P92, DOI 10.1289/ehp.1104061; Wu Y, 2012, CELL ADHES MIGR, V4, P199; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang KJ, 2011, HEPATO-GASTROENTEROL, V58, P1; Zhu LF, 2012, LAB INVEST, V92, P744, DOI 10.1038/labinvest.2012.8	36	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58915	10.1371/journal.pone.0058915	http://dx.doi.org/10.1371/journal.pone.0058915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516577	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200122
J	Badiola, N; Alcalde, V; Pujol, A; Munter, LM; Multhaup, G; Lleo, A; Coma, M; Soler-Lopez, M; Aloy, P				Badiola, Nahuai; Alcalde, Victor; Pujol, Albert; Muenter, Lisa-Marie; Multhaup, Gerd; Lleo, Alberto; Coma, Mireia; Soler-Lopez, Montserrat; Aloy, Patrick			The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; NEURONAL LOSS; A-BETA-42; OLIGOMERS; NEURODEGENERATION; FLURBIPROFEN; TANGLES	A key event in the pathogenesis of Alzheimer's disease (AD) is the accumulation of amyloid-beta (A beta) species in the brain, derived from the sequential cleavage of the amyloid precursor protein (APP) by beta- and gamma-secretases. Based on a systems biology study to repurpose drugs for AD, we explore the effect of lansoprazole, and other proton-pump inhibitors (PPIs), on Ab production in AD cellular and animal models. We found that lansoprazole enhances A beta 37, A beta 40 and A beta 42 production and lowers A beta 38 levels on amyloid cell models. Interestingly, acute lansoprazole treatment in wild type and AD transgenic mice promoted higher A beta 40 levels in brain, indicating that lansoprazole may also exacerbate Ab production in vivo. Overall, our data presents for the first time that PPIs can affect amyloid metabolism, both in vitro and in vivo.	[Badiola, Nahuai; Alcalde, Victor; Pujol, Albert; Soler-Lopez, Montserrat; Aloy, Patrick] Inst Res Biomed, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Pujol, Albert; Coma, Mireia] Anax Biotech, Barcelona, Spain; [Muenter, Lisa-Marie; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Lleo, Alberto] Hosp Santa Creu & Sant Pau, Dept Neurol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Aloy, Patrick] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Free University of Berlin; CIBERNED; Hospital of Santa Creu i Sant Pau; ICREA	Aloy, P (corresponding author), Inst Res Biomed, Joint IRB BSC Program Computat Biol, Barcelona, Spain.	patrick.aloy@irbbarcelona.org	Lleó, Alberto/K-5783-2019; Aloy, Patrick/AAB-3538-2019; Badiola, Nahuai/C-6526-2011	Badiola, Nahuai/0000-0001-9488-5628; Munter, Lisa/0000-0001-5736-1462; Aloy, Patrick/0000-0002-3557-0236; Alcalde Adell, Victor/0000-0002-7868-2983	Spanish Ministerio de Ciencia e Innovacion [PSE-010000-2009-1, BIO2010-22073]; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ICREA(ICREA)	The present work has been supported by the Spanish Ministerio de Ciencia e Innovacion (PSE-010000-2009-1; BIO2010-22073) and by the own fund of each institute, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hay SO, 2009, J NEUROCHEM, V111, P683, DOI 10.1111/j.1471-4159.2009.06355.x; ARNOLD R, 1994, ALIMENT PHARM THER, V8, P65; Bien J, 2012, J BIOL CHEM; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DaRocha-Souto B, 2011, J NEUROPATH EXP NEUR, V70, P360, DOI 10.1097/NEN.0b013e318217a118; Dias LM, 2009, CLIN DRUG INVEST, V29, P3, DOI 10.2165/1153121-S0-000000000-00000; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Geerts H, 2007, IDRUGS, V10, P121; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lai KC, 2005, AM J MED, V118, P1271, DOI 10.1016/j.amjmed.2005.04.031; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazzaroni M, 2009, DRUGS, V69, P51, DOI 10.2165/00003495-200969010-00004; Li Y, 2006, FASEB J, V20, P285, DOI 10.1096/fj.05-4986com; Lleo A, 2007, CELL MOL LIFE SCI, V64, P1403, DOI 10.1007/s00018-007-6516-1; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; LONDONG W, 1991, ALIMENT PHARM THERAP, V5, P245; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Morihara T, 2002, J NEUROCHEM, V83, P1009, DOI 10.1046/j.1471-4159.2002.01195.x; Nakagawa S, 2012, INFLAMMATION, V35, P1062, DOI 10.1007/s10753-011-9412-7; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P176, DOI 10.1016/j.bmcl.2006.09.061; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Parsons C, 2012, DRUG AGING, V29, P143, DOI 10.2165/11598560-000000000-00000; Pilotto A, 2010, SURG ONCOL, V19, P167, DOI 10.1016/j.suronc.2009.11.014; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Pospai D, 1998, GASTROEN CLIN BIOL, V22, P801; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Rojo LE, 2010, J ALZHEIMERS DIS, V19, P573, DOI 10.3233/JAD-2010-1262; SATOH H, 1989, J PHARMACOL EXP THER, V248, P806; Schulz-Geske S, 2009, WORLD J GASTROENTERO, V15, P4392, DOI 10.3748/wjg.15.4392; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheen E, 2011, DIGEST DIS SCI, V56, P931, DOI 10.1007/s10620-010-1560-3; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Spires-Jones TL, 2007, AM J PATHOL, V171, P1304, DOI 10.2353/ajpath.2007.070055; Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702; Tanigawa T, 2009, J CLIN BIOCHEM NUTR, V45, P86, DOI 10.3164/jcbn.08-267; Vonkeman HE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2207; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang-Dietrich L, 2013, J ALZHEIMERS DIS; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	54	100	104	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58837	10.1371/journal.pone.0058837	http://dx.doi.org/10.1371/journal.pone.0058837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520537	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900097
J	Fiorito, F; Irace, C; Di Pascale, A; Colonna, A; Iovane, G; Pagnini, U; Santamaria, R; De Martino, L				Fiorito, Filomena; Irace, Carlo; Di Pascale, Antonio; Colonna, Alfredo; Iovane, Giuseppe; Pagnini, Ugo; Santamaria, Rita; De Martino, Luisa			2,3,7,8-Tetrachlorodibenzo-p-Dioxin Promotes BHV-1 Infection in Mammalian Cells by Interfering with Iron Homeostasis Regulation	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; BOVINE HERPESVIRUS-1 BHV-1; ARYL-HYDROCARBON RECEPTOR; RIBONUCLEOTIDE REDUCTASE; FERRITIN BIOSYNTHESIS; INDUCED APOPTOSIS; OXIDATIVE STRESS; METABOLISM; EXPRESSION; TYPE-1	Mammalian cells require iron to satisfy metabolic needs or to accomplish specialized functions, and DNA viruses, like bovine herpesvirus 1 (BHV-1), require an iron-replete host to efficiently replicate, so that iron bioavailability is an important component of viral virulence. Cellular iron metabolism is coordinately controlled by the Iron Regulatory Proteins (IRP1 and IRP2), whose activity is affected by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a current and persistent environmental contaminant. Considering that TCDD enhances BHV-1 replication, herein we analyzed the effects of TCDD on iron metabolism during BHV-1 infection in MDBK cells, and presented evidences of a divergent modulation of IRP1 and IRP2 RNA-binding capacity. Moreover, an up-regulation of transferrin receptor 1 (TfR1) and a concomitant down-regulation of ferritin were observed. This scenario led to an expansion of the labile iron pool (LIP) and induces a significant enhance of viral titer, as confirmed by increased levels of BHV-1 infected cell protein 0 (blCP0), the major transcriptional regulatory protein of BHV-1. Taken together, our data suggest that TCDD increases the free intracellular iron availability thereby promoting the onset of BHV-1 infection and rendering bovine cells more vulnerable to the virus.	[Fiorito, Filomena; Iovane, Giuseppe; Pagnini, Ugo; De Martino, Luisa] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Naples, Italy; [Irace, Carlo; Di Pascale, Antonio; Colonna, Alfredo; Santamaria, Rita] Univ Naples Federico II, Dipartimento Farm, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Pagnini, U (corresponding author), Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Naples, Italy.	upagnini@unina.it; rsantama@unina.it	Fiorito, Filomena/O-2175-2016	Fiorito, Filomena/0000-0002-6658-7807	Polo delle Scienze e delle Tecnologie per la Vita dell'Universita di Napoli "Federico II'' [2012-4/STV-Progetto FORGIARE]; Compagnia San Paolo di Torino, Italy	Polo delle Scienze e delle Tecnologie per la Vita dell'Universita di Napoli "Federico II''; Compagnia San Paolo di Torino, Italy	Filomena Fiorito was supported by a fellowship from Polo delle Scienze e delle Tecnologie per la Vita dell'Universita di Napoli "Federico II'' (2012-4/STV-Progetto FORGIARE) co-funded by Compagnia San Paolo di Torino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Ackermann M, 2006, VET MICROBIOL, V113, P293, DOI 10.1016/j.vetmic.2005.11.043; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Burleson GR, 1996, FUND APPL TOXICOL, V29, P40, DOI 10.1006/faat.1996.0004; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; De Martino L, 2003, J CELL BIOCHEM, V89, P373, DOI 10.1002/jcb.10518; Devireddy LR, 1999, J VIROL, V73, P3778, DOI 10.1128/JVI.73.5.3778-3788.1999; Diletti G., 2003, ORGANOHALOGEN COMPOU, V64, P1; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Esposito M, 2010, CHEMOSPHERE, V79, P341, DOI 10.1016/j.chemosphere.2010.01.025; Fiorito F, 2008, J CELL BIOCHEM, V103, P221, DOI 10.1002/jcb.21398; Fiorito F, 2008, APOPTOSIS, V13, P1243, DOI 10.1007/s10495-008-0249-y; Fiorito F, 2011, TOXICOLOGY, V290, P258, DOI 10.1016/j.tox.2011.10.004; Fiorito F, 2010, J CELL BIOCHEM, V111, P333, DOI 10.1002/jcb.22700; FRAEFEL C, 1994, J VIROL, V68, P3154, DOI 10.1128/JVI.68.5.3154-3162.1994; Gollapudi S, 1996, BIOCHEM BIOPH RES CO, V226, P889, DOI 10.1006/bbrc.1996.1445; HANSON N, 1994, VIRUS RES, V34, P265, DOI 10.1016/0168-1702(94)90127-9; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; IARC Social Inequalities and Cancer, 1997, IARC MON; Irace C, 2005, J NEUROCHEM, V95, P1321, DOI 10.1111/j.1471-4159.2005.03449.x; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jones C, 2003, CLIN MICROBIOL REV, V16, P79, DOI 10.1128/CMR.16.1.79-95.2003; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Lamarche N, 1996, BIOCHEM J, V320, P129, DOI 10.1042/bj3200129; LAMBERT DM, 1973, LAB INVEST, V29, P737; Maffettone C, 2008, J CELL BIOCHEM, V104, P213, DOI 10.1002/jcb.21618; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Murayama T, 2002, BIOCHEM BIOPH RES CO, V296, P651, DOI 10.1016/S0006-291X(02)00921-X; Ohata H, 2003, MICROBIOL IMMUNOL, V47, P363, DOI 10.1111/j.1348-0421.2003.tb03408.x; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Rashed MN, 2011, J TRACE ELEM MED BIO, V25, P181, DOI 10.1016/j.jtemb.2011.07.001; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; REED L. J., 1938, AMER JOUR HYG, V27, P493; Romeo AM, 2001, J BIOL CHEM, V276, P24301, DOI 10.1074/jbc.M010806200; Santamaria R, 2004, BBA-MOL CELL RES, V1691, P151, DOI 10.1016/j.bbamcr.2004.01.004; Santamaria R, 2006, BBA-MOL CELL RES, V1763, P815, DOI 10.1016/j.bbamcr.2006.03.010; Santamaria R, 2011, BBA-MOL CELL RES, V1813, P704, DOI 10.1016/j.bbamcr.2011.02.003; Santelli F, 2006, EUR FOOD RES TECHNOL, V223, P51, DOI 10.1007/s00217-005-0112-0; Smith AG, 1998, MOL PHARMACOL, V53, P52, DOI 10.1124/mol.53.1.52; TIKOO SK, 1995, ADV VIRUS RES, V45, P191, DOI 10.1016/S0065-3527(08)60061-5; van Asbeck BS, 2001, J CLIN VIROL, V20, P141, DOI 10.1016/S1386-6532(00)00122-0; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	55	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58845	10.1371/journal.pone.0058845	http://dx.doi.org/10.1371/journal.pone.0058845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520538	gold, Green Published, Green Submitted			2022-12-25	WOS:000318679900098
J	Hartmann, A; Arroyo-Olarte, RD; Imkeller, K; Hegemann, P; Lucius, R; Gupta, N				Hartmann, Anne; Arroyo-Olarte, Ruben Dario; Imkeller, Katharina; Hegemann, Peter; Lucius, Richard; Gupta, Nishith			Optogenetic Modulation of an Adenylate Cyclase in Toxoplasma gondii Demonstrates a Requirement of the Parasite cAMP for Host-Cell Invasion and Stage Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRADYZOITE DIFFERENTIATION; MOLECULAR-MECHANISMS; GENE-EXPRESSION; TRANSCRIPTION; TACHYZOITE; DOMAINS; MALARIA; LEVEL	Successful infection and transmission of the obligate intracellular parasite Toxoplasma gondii depends on its ability to switch between fast-replicating tachyzoite (acute) and quiescent bradyzoite (chronic) stages. Induction of cAMP in the parasitized host cells has been proposed to influence parasite differentiation. It is not known whether the parasite or host cAMP is required to drive this phenomenon. Other putative roles of cAMP for the parasite biology also remain to be identified. Unequivocal research on cAMP-mediated signaling in such intertwined systems also requires a method for an efficient and spatial control of the cAMP pool in the pathogen or in the enclosing host cell. We have resolved these critical concerns by expressing a photoactivated adenylate cyclase that allows light-sensitive control of the parasite or host-cell cAMP. Using this method, we reveal multiple roles of the parasite-derived cAMP in host-cell invasion, stage-specific expression, and asexual differentiation. An optogenetic method provides many desired advantages such as: (i) rapid, transient, and efficient cAMP induction in extracellular/intracellular and acute/chronic stages; (ii) circumvention of the difficulties often faced in cultures, i. e. poor diffusion, premature degradation, steady activation, and/or pleiotropic effects of cAMP agonists and antagonists; (iii) genetically encoded enzyme expression, thus inheritable to the cell progeny; and (iv) conditional and spatiotemporal control of cAMP levels. Importantly, a successful optogenetic application in Toxoplasma also illustrates its wider utility to study cAMP-mediated signaling in other genetically amenable two-organism systems such as in symbiotic and pathogen-host models.	[Hartmann, Anne; Arroyo-Olarte, Ruben Dario; Imkeller, Katharina; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany; [Hegemann, Peter] Humboldt Univ, Dept Expt Biophys, D-10115 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Gupta, N (corresponding author), Dept Mol Parasitol, Philippstr 13, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de	Arroyo-Olarte, Ruben D/AAW-3127-2021; Arroyo-Olarte, Ruben D/AAH-8939-2020	Arroyo-Olarte, Ruben D/0000-0002-8096-2423; Gupta, Nishith/0000-0003-1452-5126	German Research Foundation [SFB618, GRK1121]	German Research Foundation(German Research Foundation (DFG))	This work was supported by Grants SFB618 and GRK1121 from the German Research Foundation (to N. G. and R. L.).	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; da Silva MDF, 2008, MOL BIOSYST, V4, P824, DOI 10.1039/b800520f; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; DUBREMETZ JF, 1985, EXP PARASITOL, V59, P24, DOI 10.1016/0014-4894(85)90053-0; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Gould MK, 2011, FEMS MICROBIOL REV, V35, P515, DOI 10.1111/j.1574-6976.2010.00262.x; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Kirkman LA, 2001, INFECT IMMUN, V69, P148, DOI 10.1128/IAI.69.1.148-153.2001; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Ono T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000008; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001	38	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13705	13717		10.1074/jbc.M113.465583	http://dx.doi.org/10.1074/jbc.M113.465583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525100	hybrid, Green Published			2022-12-25	WOS:000318850300053
J	Brum, DG; Luizon, MR; Santos, AC; Lana-Peixoto, MA; Rocha, CF; Brito, ML; de Oliveira, EML; Bichuetti, DB; Gabbai, AA; Diniz, DS; Kaimen-Maciel, DR; Comini-Frota, ER; Wiezel, CEV; Muniz, YCN; Costa, RMD; Mendes, CT; Donadi, EA; Barreira, AA; Simoes, AL				Brum, Doralina Guimaraes; Luizon, Marcelo Rizzatti; Santos, Antonio Carlos; Lana-Peixoto, Marco Aurelio; Rocha, Cristiane Franklin; Brito, Maria Lucia; Lobato de Oliveira, Enedina Maria; Bichuetti, Denis Bernardi; Gabbai, Alberto Alan; Diniz, Denise Sisterolli; Kaimen-Maciel, Damacio Ramon; Comini-Frota, Elizabeth Regina; Vieira Wiezel, Claudia E.; Netto Muniz, Yara Costa; da Silva Costa, Roberta Martins; Mendes-Junior, Celso Teixeira; Donadi, Eduardo Antonio; Barreira, Amilton Antunes; Simoes, Aguinaldo Luiz			European Ancestry Predominates in Neuromyelitis Optica and Multiple Sclerosis Patients from Brazil	PLOS ONE			English	Article								Background: Neuromyelitis optica (NMO) is considered relatively more common in non-Whites, whereas multiple sclerosis (MS) presents a high prevalence rate, particularly in Whites from Western countries populations. However, no study has used ancestry informative markers (AIMs) to estimate the genetic ancestry contribution to NMO patients. Methods: Twelve AIMs were selected based on the large allele frequency differences among European, African, and Amerindian populations, in order to investigate the genetic contribution of each ancestral group in 236 patients with MS and NMO, diagnosed using the McDonald and Wingerchuck criteria, respectively. All 128 MS patients were recruited at the Faculty of Medicine of Ribeirao Preto (MS-RP), Southeastern Brazil, as well as 108 healthy bone marrow donors considered as healthy controls. A total of 108 NMO patients were recruited from five Neurology centers from different Brazilian regions, including Ribeirao Preto (NMO-RP). Principal Findings: European ancestry contribution was higher in MS-RP than in NMO-RP (78.5% vs. 68.7%) patients. In contrast, African ancestry estimates were higher in NMO-RP than in MS-RP (20.5% vs. 12.5%) patients. Moreover, principal component analyses showed that groups of NMO patients from different Brazilian regions were clustered close to the European ancestral population. Conclusions: Our findings demonstrate that European genetic contribution predominates in NMO and MS patients from Brazil.	[Brum, Doralina Guimaraes; Santos, Antonio Carlos; Barreira, Amilton Antunes] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Sao Paulo, Brazil; [Brum, Doralina Guimaraes] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Neurol Psicol & Psiquiatria, Botucatu, SP, Brazil; [Luizon, Marcelo Rizzatti; Vieira Wiezel, Claudia E.; Simoes, Aguinaldo Luiz] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [Lana-Peixoto, Marco Aurelio; Rocha, Cristiane Franklin] Univ Fed Minas Gerais, Fac Med, Dept Oftalmol & Otorrinolaringol, Belo Horizonte, MG, Brazil; [Brito, Maria Lucia] Hosp Restauracao, Secretaria Saude Estado Pernambuco, Recife, PE, Brazil; [Lobato de Oliveira, Enedina Maria; Bichuetti, Denis Bernardi; Gabbai, Alberto Alan] Univ Fed Sao Paulo, Dept Neurol & Neurocirurgia, Sao Paulo, Brazil; [Bichuetti, Denis Bernardi] Univ Fed Goias, Fac Med, Dept Clin Med, Goiania, Go, Brazil; [Kaimen-Maciel, Damacio Ramon] Univ Estadual Londrina, Dept Clin Med, Ctr Ciencias Saude, Londrina, Parana, Brazil; [Comini-Frota, Elizabeth Regina] Univ Fed Minas Gerais, Fac Med, Dept Neurol, Belo Horizonte, MG, Brazil; [Netto Muniz, Yara Costa; Donadi, Eduardo Antonio] Univ Sao Paulo, Div Imunol Clin, Fac Med Ribeirao Preto, Dept Clin Med, Sao Paulo, Brazil; [da Silva Costa, Roberta Martins] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol & Otorrinolaringol & Cirurgia Cabec, Sao Paulo, Brazil; [Mendes-Junior, Celso Teixeira] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Goias; Universidade Estadual de Londrina; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Barreira, AA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Sao Paulo, Brazil.	aabarrei@fmrp.usp.br	Bichuetti, Denis B/F-7240-2012; donadi, eduardo A/H-7080-2013; Mendes-Junior, Celso Teixeira/B-1994-2010; Luizon, Marcelo R/G-1400-2014; Luizon, Marcelo/AAC-5910-2019; Brum, Doralina G/A-1225-2015; Lana-Peixoto, Marco Aurelio/AAD-2580-2019; Simoes, Aguinaldo L/E-7508-2011; Comini-Frota, Elizabeth R./F-8461-2012; Vieira Wiezel, Cláudia/P-7748-2017; Oliveira, Enedina M.L/B-2720-2016; Muniz, Yara Costa Netto/C-6456-2016	Bichuetti, Denis B/0000-0002-4011-3734; donadi, eduardo A/0000-0002-9457-9601; Mendes-Junior, Celso Teixeira/0000-0002-7337-1203; Luizon, Marcelo R/0000-0002-8331-3525; Luizon, Marcelo/0000-0002-8331-3525; Brum, Doralina G/0000-0002-9050-3319; Lana-Peixoto, Marco Aurelio/0000-0003-2454-681X; Comini-Frota, Elizabeth R./0000-0002-2702-0402; Vieira Wiezel, Cláudia/0000-0002-4381-0834; Oliveira, Enedina M.L/0000-0002-4939-7200; Muniz, Yara Costa Netto/0000-0001-9526-8306; Simoes, Aguinaldo Luiz/0000-0001-5950-894X; Barreira, Amilton/0000-0002-4791-223X	Coordencao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil); Fundacao de Apoio ao Ensino, Pesquisa e Assisteancia do HCFMRP-USP (FAEPA-Brazil)	Coordencao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino, Pesquisa e Assisteancia do HCFMRP-USP (FAEPA-Brazil)	This study was funded by the Coordencao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil), and Fundacao de Apoio ao Ensino, Pesquisa e Assisteancia do HCFMRP-USP (FAEPA-Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Brum DG, 2010, MULT SCLER J, V16, P21, DOI 10.1177/1352458509350741; Cabre P, 2001, NEUROLOGY, V56, P507, DOI 10.1212/WNL.56.4.507; Cabrera-Gomez JA, 2009, J NEUROL, V256, P35, DOI 10.1007/s00415-009-0009-0; Enoch Mary-Anne, 2006, J Psychopharmacol, V20, P19, DOI 10.1177/1359786806066041; Kira J, 1996, ANN NEUROL, V40, P569; KURTZKE JF, 1977, J NEUROL, V215, P1, DOI 10.1007/BF00312546; Luizon MR, 2008, AM J HUM BIOL, V20, P86, DOI 10.1002/ajhb.20681; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	14	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58925	10.1371/journal.pone.0058925	http://dx.doi.org/10.1371/journal.pone.0058925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527051	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562600045
J	Giudice, FS; Pinto, DS; Nor, JE; Squarize, CH; Castilho, RM				Giudice, Fernanda S.; Pinto, Decio S., Jr.; Noer, Jacques E.; Squarize, Cristiane H.; Castilho, Rogerio M.			Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; LINKING NUMBER CHANGE; GENE-EXPRESSION; EMERGING MECHANISMS; PANCREATIC-CANCER; TUMOR PROGRESSION; PROSTATE-CANCER; CARCINOMA-CELLS; GASTRIC-CANCER; TRICHOSTATIN-A	The genome is organized and packed into the nucleus through interactions with core histone proteins. Emerging evidence suggests that tumors are highly responsive to epigenetic alterations that induce chromatin-based events and dynamically influence tumor behavior. We examined chromatin organization in head and neck squamous cell carcinoma (HNSCC) using acetylation levels of histone 3 as a marker of chromatin compaction. Compared to control oral keratinocytes, we found that HNSCC cells are hypoacetylated and that microenvironmental cues (e. g., microvasculature endothelial cells) induce tumor acetylation. Furthermore, we found that chemical inhibition of histone deacetylases (HDAC) reduces the number of cancer stem cells (CSC) and inhibits clonogenic sphere formation. Paradoxically, inhibition of HDAC also induced epithelial-mesenchymal transition (EMT) in HNSCC cells, accumulation of BMI-1, an oncogene associated with tumor aggressiveness, and expression of the vimentin mesenchymal marker. Importantly, we observed co-expression of vimentin and acetylated histone 3 at the invasion front of human HNSCC tumor tissues. Collectively, these findings suggest that environmental cues, such as endothelial cell-secreted factors, modulate tumor plasticity by limiting the population of CSC and inducing EMT. Therefore, inhibition of HDAC may constitute a novel strategy to disrupt the population of CSC in head and neck tumors to create a homogeneous population of cancer cells with biologically defined signatures and predictable behavior.	[Giudice, Fernanda S.; Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA; [Giudice, Fernanda S.; Pinto, Decio S., Jr.] Univ Sao Paulo, Sch Dent, Dept Oral Pathol, Sao Paulo, Brazil; [Noer, Jacques E.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidade de Sao Paulo; University of Michigan System; University of Michigan	Castilho, RM (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA.	rcastilh@umich.edu	Nor, Jacques/AAJ-6139-2021; Pinto, Décio/B-6041-2011; Castilho, Rogerio M/E-4987-2010	Nor, Jacques/0000-0002-4056-0235; Pinto, Décio/0000-0001-6198-5155; Castilho, Rogerio M/0000-0001-5358-612X; Squarize, Cristiane/0000-0002-6782-3429	National Institutes of Health (NIH/NCI) [P50-CA97248]; NIH/NIDCR [R01-DE21139]; NATIONAL CANCER INSTITUTE [P50CA097248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021139] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the National Institutes of Health (NIH/NCI) P50-CA97248 (University of Michigan Head and Neck SPORE); and by grant R01-DE21139 from the NIH/NIDCR (JEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1989, P NATL ACAD SCI USA, V86, P4102, DOI 10.1073/pnas.86.11.4102; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Birchmeier C, 1996, ACTA ANAT, V156, P217; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Chen C, 2011, CANCER INVEST, V29, P548, DOI 10.3109/07357907.2011.597810; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Er O, 2009, ONKOLOGIE, V32, P605, DOI 10.1159/000232375; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Izumiya M, 2012, ANTICANCER RES, V32, P3847; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jayani RS, 2010, METHOD CELL BIOL, V98, P35, DOI 10.1016/S0091-679X(10)98002-3; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kaneko T, 2007, CANCER RES, V67, P9685, DOI 10.1158/0008-5472.CAN-07-1497; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; La Fleur L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044071; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251; Li W, 2010, J GASTROEN HEPATOL, V25, P568, DOI 10.1111/j.1440-1746.2009.06045.x; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Lydall D, 2005, DNA REPAIR, V4, P1195, DOI 10.1016/j.dnarep.2005.06.007; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qin ZK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-61; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Robey RW, 2011, MOL PHARMACEUT, V8, P2021, DOI 10.1021/mp200329f; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Salnikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046391; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song SH, 2011, DRUGS, V71, P2391, DOI 10.2165/11596690-000000000-00000; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spotswood HT, 2002, J CLIN INVEST, V110, P577, DOI 10.1172/JCI200216547; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUGITA K, 1992, CANCER RES, V52, P168; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Warner KA, 2008, NEOPLASIA, V10, P131, DOI 10.1593/neo.07815; WATT FM, 1988, J CELL SCI, P85; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; YOSHIDA M, 1987, CANCER RES, V47, P3688; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40; Zhang ZC, 2012, ORAL ONCOL, V48, P1, DOI 10.1016/j.oraloncology.2011.10.004; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7	100	97	105	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58672	10.1371/journal.pone.0058672	http://dx.doi.org/10.1371/journal.pone.0058672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527004	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600030
J	Jin, YL; Turaev, D; Weinmaier, T; Rattei, T; Makse, HA				Jin, Yuliang; Turaev, Dmitrij; Weinmaier, Thomas; Rattei, Thomas; Makse, Hernan A.			The Evolutionary Dynamics of Protein-Protein Interaction Networks Inferred from the Reconstruction of Ancient Networks	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; SMALL-WORLD; ORTHOLOGOUS GROUPS; MAP; DIVERGENCE; DUPLICATION; MODULARITY; MODULES; EGGNOG; GENES	Cellular functions are based on the complex interplay of proteins, therefore the structure and dynamics of these protein-protein interaction (PPI) networks are the key to the functional understanding of cells. In the last years, large-scale PPI networks of several model organisms were investigated. A number of theoretical models have been developed to explain both the network formation and the current structure. Favored are models based on duplication and divergence of genes, as they most closely represent the biological foundation of network evolution. However, studies are often based on simulated instead of empirical data or they cover only single organisms. Methodological improvements now allow the analysis of PPI networks of multiple organisms simultaneously as well as the direct modeling of ancestral networks. This provides the opportunity to challenge existing assumptions on network evolution. We utilized present-day PPI networks from integrated datasets of seven model organisms and developed a theoretical and bioinformatic framework for studying the evolutionary dynamics of PPI networks. A novel filtering approach using percolation analysis was developed to remove low confidence interactions based on topological constraints. We then reconstructed the ancient PPI networks of different ancestors, for which the ancestral proteomes, as well as the ancestral interactions, were inferred. Ancestral proteins were reconstructed using orthologous groups on different evolutionary levels. A stochastic approach, using the duplication-divergence model, was developed for estimating the probabilities of ancient interactions from today's PPI networks. The growth rates for nodes, edges, sizes and modularities of the networks indicate multiplicative growth and are consistent with the results from independent static analysis. Our results support the duplication-divergence model of evolution and indicate fractality and multiplicative growth as general properties of the PPI network structure and dynamics.	[Jin, Yuliang; Makse, Hernan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Jin, Yuliang; Makse, Hernan A.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Turaev, Dmitrij; Weinmaier, Thomas; Rattei, Thomas] Univ Vienna, Dept Computat Syst Biol, Vienna, Austria	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); University of Vienna	Rattei, T (corresponding author), Univ Vienna, Dept Computat Syst Biol, Vienna, Austria.	thomas.rattei@univie.ac.at; hmakse@lev.ccny.cuny.edu	Weinmaier, Thomas/K-5780-2013; Rattei, Thomas/F-1366-2011	Weinmaier, Thomas/0000-0002-9552-3220; Rattei, Thomas/0000-0002-0592-7791	National Science Foundation [NSF-0827508]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant NSF-0827508 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bizhani G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036110; Bollobas B., 1985, RANDOM GRAPHS; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Bunde A., 1996, FRACTALS DISORDERED; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Evlampiev K, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-49; Evlampiev K, 2008, P NATL ACAD SCI USA, V105, P9863, DOI 10.1073/pnas.0804119105; Fields S, 2005, FEBS J, V272, P5391, DOI 10.1111/j.1742-4658.2005.04973.x; Gallos LK, 2007, P NATL ACAD SCI USA, V104, P7746, DOI 10.1073/pnas.0700250104; Gallos LK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00454; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Galvao V, 2010, P NATL ACAD SCI USA, V107, P5750, DOI 10.1073/pnas.0914748107; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gibson TA, 2011, BIOINFORMATICS, V27, P376, DOI 10.1093/bioinformatics/btq623; Gibson TA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000252; Gibson TA, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P190; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055101; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kunin V, 2004, MOL BIOL EVOL, V21, P1171, DOI 10.1093/molbev/msh085; Lei Yang, 2008, 2008 International Conference on Neural Networks and Signal Processing, P53, DOI 10.1109/ICNNSP.2008.4590308; Li W. H, 1997, MOL EVOLUTION; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Navlakha S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001119; Ohno S., 1970, EVOLUTION GENE DUPLI; Patro R, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-25; Patthy Laszlo, 1999, PROTEIN EVOLUTION; Pinney JW, 2007, P NATL ACAD SCI USA, V104, P20449, DOI 10.1073/pnas.0706339104; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Rajagopala SV, 2009, PROTEOMICS, V9, P5296, DOI 10.1002/pmic.200900282; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rozenfeld HD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.025701; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Song CM, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/03/P03006; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Suter B, 2008, CURR OPIN BIOTECH, V19, P316, DOI 10.1016/j.copbio.2008.06.005; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodak SJ, 2009, MOL CELL PROTEOMICS, V8, P3, DOI 10.1074/mcp.R800014-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang XC, 2010, INTRODUCTION TO THZ WAVE PHOTONICS, P1, DOI 10.1007/978-1-4419-0978-7_1; Zinman GE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-134	74	38	38	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58134	10.1371/journal.pone.0058134	http://dx.doi.org/10.1371/journal.pone.0058134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526967	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600013
J	Elamin, E; Masclee, A; Juuti-Uusitalo, K; van IJzendoorn, S; Troost, F; Pieters, HJ; Dekker, J; Jonkers, D				Elamin, Elhaseen; Masclee, Ad; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Pieters, Harm-Jan; Dekker, Jan; Jonkers, Daisy			Fatty Acid Ethyl Esters Induce Intestinal Epithelial Barrier Dysfunction via a Reactive Oxygen Species-Dependent Mechanism in a Three-Dimensional Cell Culture Model	PLOS ONE			English	Article							ACETALDEHYDE-INDUCED INCREASE; KAPPA-B ACTIVATION; PARACELLULAR PERMEABILITY; NONOXIDATIVE METABOLITES; TYROSINE PHOSPHORYLATION; ETHANOL-METABOLISM; INDUCED DISRUPTION; HYDROGEN-PEROXIDE; HEAVY DRINKERS; FACTOR-ALPHA	Background & Aims: Evidence is accumulating that ethanol and its oxidative metabolite, acetaldehyde, can disrupt intestinal epithelial integrity, an important factor contributing to ethanol-induced liver injury. However, ethanol can also be metabolized non-oxidatively generating phosphatidylethanol and fatty acid ethyl esters (FAEEs). This study aims to investigate the effects of FAEEs on barrier function, and to explore the role of oxidative stress as possible mechanism. Methods: Epithelial permeability was assessed by paracellular flux of fluorescein isothiocyanate-conjugated dextran using live cell imaging. Cell integrity was evaluated by lactate dehydrogenase release. Localization and protein levels of ZO-1 and occludin were analyzed by immunofluorescence and cell-based ELISA, respectively. Intracellular oxidative stress and cellular ATP levels were measured by dichlorofluorescein and luciferase driven bioluminescence, respectively. Results: In vitro, ethyl oleate and ethyl palmitate dose dependently increased permeability associated with disruption and decreased ZO-1 and occludin protein levels, respectively, and increased intracellular oxidative stress without compromising cell viability. These effects could partially be attenuated by pretreatment with the antioxidant, resveratrol, pointing to the role of oxidative stress in the FAEEs-induced intestinal barrier dysfunction. Conclusions: These findings show that FAEEs can induce intestinal barrier dysfunction by disrupting the tight junctions, most likely via reactive oxygen species-dependent mechanism.	[Elamin, Elhaseen; Masclee, Ad; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Dekker, Jan; Jonkers, Daisy] TIFN, Wageningen, Netherlands; [Elamin, Elhaseen; Masclee, Ad; Troost, Freddy; Pieters, Harm-Jan; Jonkers, Daisy] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [van IJzendoorn, Sven] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Juuti-Uusitalo, Kati] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Dekker, Jan] Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; University of Groningen; Tampere University; Wageningen University & Research	Jonkers, D (corresponding author), TIFN, Wageningen, Netherlands.	d.jonkers@maastrichtuniversity.nl	Troost, Freddy/B-2782-2015	Juuti-Uusitalo, Kati/0000-0003-2275-5562	Top Institute Food and Nutrition Wageningen, The Netherlands	Top Institute Food and Nutrition Wageningen, The Netherlands(Netherlands Government)	This study was supported by Top Institute Food and Nutrition (http://www.tifn.nl), Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Aydin HH, 2005, FOOD CHEM TOXICOL, V43, P139, DOI 10.1016/j.fct.2004.09.003; Banan A, 2000, GUT, V46, P830, DOI 10.1136/gut.46.6.830; Banan A, 2004, AM J PHYSIOL-CELL PH, V287, pC1139, DOI 10.1152/ajpcell.00146.2004; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; Banan A, 2000, J PHARMACOL EXP THER, V294, P997; Basuroy S, 2005, AM J PHYSIOL-GASTR L, V289, pG367, DOI 10.1152/ajpgi.00464.2004; Belguendouz L, 1998, BIOCHEM PHARMACOL, V55, P811, DOI 10.1016/S0006-2952(97)00544-3; Borucki K, 2007, ALCOHOL CLIN EXP RES, V31, P423, DOI 10.1111/j.1530-0277.2006.00323.x; Borucki K, 2004, ALCOHOL CLIN EXP RES, V28, P1102, DOI 10.1097/01.ALC.0000130791.20186.4D; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Carrasco-Pozo C, 2012, CHEM-BIOL INTERACT, V195, P199, DOI 10.1016/j.cbi.2011.12.007; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Doyle KM, 1996, JAMA-J AM MED ASSOC, V276, P1152, DOI 10.1001/jama.276.14.1152; DOYLE KM, 1994, J LIPID RES, V35, P428; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; GubitosiKlug RA, 1996, J BIOL CHEM, V271, P32519, DOI 10.1074/jbc.271.51.32519; HABER PS, 1993, J LAB CLIN MED, V121, P759; Kaldas MI, 2003, J PHARM PHARMACOL, V55, P307, DOI 10.1211/002235702612; Kaphalia B.S., 2001, CELL MOL BIOL, V47, P173; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; LANGE LG, 1983, J CLIN INVEST, V72, P724, DOI 10.1172/JCI111022; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; LAPOSATA M, 1995, PROSTAG LEUKOTR ESS, V52, P87, DOI 10.1016/0952-3278(95)90003-9; Lewis K, 2009, ANN NY ACAD SCI, V1165, P327, DOI 10.1111/j.1749-6632.2009.04036.x; Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0; Liu Y, 2000, J CELL SCI, V113, P2363; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Martin AR, 2004, BIOCHEM PHARMACOL, V67, P1399, DOI 10.1016/j.bcp.2003.12.024; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Panaro MA, 2012, BRIT J NUTR, V108, P1623, DOI 10.1017/S0007114511007227; Poritz LS, 2004, J SURG RES, V116, P14, DOI 10.1016/S0022-4804(03)00311-1; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Rao RK, 1997, AM J PHYSIOL-GASTR L, V273, pG812, DOI 10.1152/ajpgi.1997.273.4.G812; Rao RK, 1998, ALCOHOL CLIN EXP RES, V22, P1724, DOI 10.1097/00000374-199811000-00015; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; Reilly ME, 2000, J NUTR, V130, P3045, DOI 10.1093/jn/130.12.3045; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Soderberg Britt L, 2003, Am J Clin Pathol, V119 Suppl, pS94; SZCZEPIORKOWSKI ZM, 1995, GASTROENTEROLOGY, V108, P515, DOI 10.1016/0016-5085(95)90081-0; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Tyulina OV, 2002, ALCOHOL ALCOHOLISM, V37, P179, DOI 10.1093/alcalc/37.2.179; Unno N, 1996, AM J PHYSIOL-GASTR L, V270, pG1010, DOI 10.1152/ajpgi.1996.270.6.G1010; Vespa A, 2003, J BIOL CHEM, V278, P11528, DOI 10.1074/jbc.M208337200; Waszkiewicz N, 2012, FOLIA HISTOCHEM CYTO, V50, P1, DOI [10.5603/FHC.2012.0001, 10.2478/18690]; Werner J, 2001, SURGERY, V129, P736, DOI 10.1067/msy.2001.113891; Wu H, 2006, TOXICOL APPL PHARM, V216, P238, DOI 10.1016/j.taap.2006.05.003	56	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58561	10.1371/journal.pone.0058561	http://dx.doi.org/10.1371/journal.pone.0058561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526996	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562100030
J	Ailes, E; Budge, P; Shankar, M; Collier, S; Brinton, W; Cronquist, A; Chen, M; Thornton, A; Beach, MJ; Brunkard, JM				Ailes, Elizabeth; Budge, Philip; Shankar, Manjunath; Collier, Sarah; Brinton, William; Cronquist, Alicia; Chen, Melissa; Thornton, Andrew; Beach, Michael J.; Brunkard, Joan M.			Economic and Health Impacts Associated with a Salmonella Typhimurium Drinking Water Outbreak-Alamosa, CO, 2008	PLOS ONE			English	Article							REACTIVE ARTHRITIS; INFECTION; MILWAUKEE; ILLNESS; LOSSES	In 2008, a large Salmonella outbreak caused by contamination of the municipal drinking water supply occurred in Alamosa, Colorado. The objectives of this assessment were to determine the full economic costs associated with the outbreak and the long-term health impacts on the community of Alamosa. We conducted a postal survey of City of Alamosa (2008 population: 8,746) households and businesses, and conducted in-depth interviews with local, state, and nongovernmental agencies, and City of Alamosa healthcare facilities and schools to assess the economic and long-term health impacts of the outbreak. Twenty-one percent of household survey respondents (n = 369/1,732) reported diarrheal illness during the outbreak. Of those, 29% (n = 108) reported experiencing potential long-term health consequences. Most households (n = 699/771, 91%) reported municipal water as their main drinking water source at home before the outbreak; afterwards, only 30% (n = 233) drank unfiltered municipal tap water. The outbreak's estimated total cost to residents and businesses of Alamosa using a Monte Carlo simulation model (10,000 iterations) was approximately $1.5 million dollars (range: $196,677-$6,002,879), and rose to $2.6 million dollars (range: $1,123,471-$7,792,973) with the inclusion of outbreak response costs to local, state and nongovernmental agencies and City of Alamosa healthcare facilities and schools. This investigation documents the significant economic and health impacts associated with waterborne disease outbreaks and highlights the potential for loss of trust in public water systems following such outbreaks.	[Ailes, Elizabeth; Collier, Sarah] Int Hlth Resources Consulting, Atlanta, GA USA; [Ailes, Elizabeth; Budge, Philip; Shankar, Manjunath; Collier, Sarah; Chen, Melissa; Thornton, Andrew; Beach, Michael J.; Brunkard, Joan M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Brinton, William] San Luis Valley Publ Hlth Emergency Preparedness, Alamosa, CO USA; [Cronquist, Alicia] Colorado Dept Publ Hlth & Environm, Dis Control & Environm Epidemiol Div, Denver, CO USA	Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment	Brunkard, JM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	jbrunkard@cdc.gov	Budge, Philip/ABE-6458-2020	Budge, Philip/0000-0002-0069-2372; Chen, Melissa/0000-0002-4569-5614; Brunkard, Joan/0000-0001-5270-2627	Environmental Protection Agency Office of Science and Technology	Environmental Protection Agency Office of Science and Technology	The Environmental Protection Agency Office of Science and Technology provided funding for this project but had no role in project design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US CENS BUR 2005 200; [Anonymous], US CENS BUR 2008 POP; Bureau of Labor Statistics, MAY 2009 METR NONM A; Buxton JA, 2002, J RHEUMATOL, V29, P2154; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; Corso PS, 2003, EMERG INFECT DIS, V9, P426, DOI 10.3201/eid0904.020417; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; Environmental Protection Agency, 1975, FED REG, P59566; Falco R., 2009, WATERBORNE SALMONELL; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; HARRINGTON W, 1989, J URBAN ECON, V25, P116, DOI 10.1016/0094-1190(89)90048-X; Link MW, 2006, AM J EPIDEMIOL, V164, P1019, DOI 10.1093/aje/kwj310; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Pontius F, 1994, J AM WATER WORKS ASS, V86, P63; Pontius FW, 1997, J AM WATER WORKS ASS, V89, P18; SAMUEL MP, 1995, J RHEUMATOL, V22, P1947; Townes JM, 2008, ANN RHEUM DIS, V67, P1689, DOI 10.1136/ard.2007.083451; Yelin E, 2007, ARTHRITIS RHEUM-US, V56, P1397, DOI 10.1002/art.22565	19	25	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e57439	10.1371/journal.pone.0057439	http://dx.doi.org/10.1371/journal.pone.0057439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526942	Green Published, gold			2022-12-25	WOS:000316411600003
J	Relan, V; Morrison, L; Parsonson, K; Clarke, BE; Duhig, EE; Windsor, MN; Matar, KS; Naidoo, R; Passmore, L; McCaul, E; Courtney, D; Yang, IA; Fong, KM; Bowman, RV				Relan, Vandana; Morrison, Leanne; Parsonson, Kylie; Clarke, Belinda E.; Duhig, Edwina E.; Windsor, Morgan N.; Matar, Kevin S.; Naidoo, Rishendran; Passmore, Linda; McCaul, Elizabeth; Courtney, Deborah; Yang, Ian A.; Fong, Kwun M.; Bowman, Rayleen V.			Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines	PLOS ONE			English	Article							COPY-NUMBER CHANGES; CHROMOSOMAL-ABNORMALITIES; ESTABLISHMENT; ASBESTOS; TISSUE; TUMORIGENICITY; EXPRESSION; DIAGNOSIS; CULTURE; MARKER	Background: Malignant mesothelioma is an aggressive tumour of serosal surfaces most commonly pleura. Characterised cell lines represent a valuable tool to study the biology of mesothelioma. The aim of this study was to develop and biologically characterise six malignant mesothelioma cell lines to evaluate their potential as models of human malignant mesothelioma. Methods: Five lines were initiated from pleural biopsies, and one from pleural effusion of patients with histologically proven malignant mesothelioma. Mesothelial origin was assessed by standard morphology, Transmission Electron Microscopy (TEM) and immunocytochemistry. Growth characteristics were assayed using population doubling times. Spectral karyotyping was performed to assess chromosomal abnormalities. Authentication of donor specific derivation was undertaken by DNA fingerprinting using a panel of SNPs. Results: Most of cell lines exhibited spindle cell shape, with some retaining stellate shapes. At passage 2 to 6 all lines stained positively for calretinin and cytokeratin 19, and demonstrated capacity for anchorage-independent growth. At passage 4 to 16, doubling times ranged from 30-72 hours, and on spectral karyotyping all lines exhibited numerical chromosomal abnormalities ranging from 41 to 113. Monosomy of chromosomes 8, 14, 22 or 17 was observed in three lines. One line displayed four different karyotypes at passage 8, but only one karyotype at passage 42, and another displayed polyploidy at passage 40 which was not present at early passages. At passages 5-17, TEM showed characteristic features of mesothelioma ultrastructure in all lines including microvilli and tight intercellular junctions. Conclusion: These six cell lines exhibit varying cell morphology, a range of doubling times, and show diverse passage-dependent structural chromosomal changes observed in malignant tumours. However they retain characteristic immunocytochemical protein expression profiles of mesothelioma during maintenance in artificial culture systems. These characteristics support their potential as in vitro model systems for studying cellular, molecular and genetic aspects of mesothelioma.	[Relan, Vandana; Parsonson, Kylie; Passmore, Linda; McCaul, Elizabeth; Courtney, Deborah; Yang, Ian A.; Fong, Kwun M.; Bowman, Rayleen V.] Univ Queensland, Sch Med, UQ Thorac Res Ctr, Brisbane, Qld, Australia; [Relan, Vandana; Morrison, Leanne; Parsonson, Kylie; Passmore, Linda; McCaul, Elizabeth; Courtney, Deborah; Yang, Ian A.; Fong, Kwun M.; Bowman, Rayleen V.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Clarke, Belinda E.; Duhig, Edwina E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia; [Windsor, Morgan N.; Matar, Kevin S.; Naidoo, Rishendran] Prince Charles Hosp, Dept Thorac Surg, Brisbane, Qld 4032, Australia	University of Queensland; Prince Charles Hospital; Prince Charles Hospital; Prince Charles Hospital	Relan, V (corresponding author), Univ Queensland, Sch Med, UQ Thorac Res Ctr, Brisbane, Qld, Australia.	v.relan@uq.edu.au	Parsonson, Kylie R/J-9466-2014; Yang, Ian A/B-9609-2008; Bowman, Rayleen V/G-4144-2013; Fong, Kwun M/G-6369-2010	Yang, Ian A/0000-0001-8338-1993; Fong, Kwun/0000-0002-6507-1403	Prince Charles Hospital Foundation; Dust Diseases Board (New South Wales, Australia); Cancer Australia; NHMRC Practitioner Fellowship; NHMRC Career Development Fellowship; UQ Early Career Researcher	Prince Charles Hospital Foundation; Dust Diseases Board (New South Wales, Australia); Cancer Australia; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); UQ Early Career Researcher	The study was supported by the following funding bodies: The Prince Charles Hospital Foundation, The Dust Diseases Board (New South Wales, Australia), Cancer Australia, NHMRC Practitioner Fellowship (KF), NHMRC Career Development Fellowship (IY) and UQ Early Career Researcher (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi C, 2007, IND HEALTH, V45, P379, DOI 10.2486/indhealth.45.379; Bjorkqvist AM, 1997, BRIT J CANCER, V75, P523, DOI 10.1038/bjc.1997.91; Bowman R, 2011, AUST PRESCR, V34, P144; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Dong Woo Kang S-HL, 2010, CANCER RES, V70, P4233; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gazdar AF, 1981, SMALL CELL LUNG CANC, P145; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hiyama J, 1998, INTERN MED, P37; Ivanov SV, 2009, BIOCHEM BIOPH RES CO, V382, P514, DOI 10.1016/j.bbrc.2009.03.042; KNUDSON A, 1995, P NATL ACAD SCI USA, V92, P10819, DOI 10.1073/pnas.92.24.10819; Krismann M, 2004, LUNG CANCER, V45, pS29, DOI 10.1016/j.lungcan.2004.04.005; Lindholm PM, 2007, CYTOGENET GENOME RES, V119, P46, DOI 10.1159/000109618; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Marchevsky AM, 2008, ARCH PATHOL LAB MED, V132, P397, DOI 10.1043/1543-2165(2008)132[397:AOITTD]2.0.CO;2; Masters JRW, 2000, BRIT J CANCER, V82, P1495; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Neragi-Miandoab Siyamek, 2009, Interact Cardiovasc Thorac Surg, V9, P42, DOI 10.1510/icvts.2008.201509; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; PELINENLUND K, 1990, CARCINOGENESIS, V11, P673, DOI 10.1093/carcin/11.4.673; Philippeaux MM, 2004, HISTOCHEM CELL BIOL, V122, P249, DOI 10.1007/s00418-004-0701-1; Pylkkanen L, 2002, ONCOL REP, V9, P955; Safe work Australia, 2009, MES AUSTR INCIDENCE; SANDBERG AA, 1983, CANCER GENET CYTOGEN, V8, P277, DOI 10.1016/0165-4608(83)90070-5; Sato G, 2008, CYTOTECHNOLOGY, V57, P111, DOI 10.1007/s10616-007-9109-9; Sato GH, 2010, IN VITRO CELL DEV-AN, V46, P590, DOI 10.1007/s11626-010-9315-1; SCHAEFFER WI, 1990, IN VITRO CELL DEV B, V26, P97; Suster S, 2005, EXPERT REV MOL DIAGN, V5, P715, DOI 10.1586/14737159.5.5.715; Suzuki H, 2010, ANTICANCER RES, V30, P4343; TIAINEN M, 1989, BRIT J CANCER, V60, P618, DOI 10.1038/bjc.1989.326; TIAINEN M, 1988, CANCER GENET CYTOGEN, V33, P251, DOI 10.1016/0165-4608(88)90035-0; Usami N, 2006, CANCER SCI, V97, P387, DOI 10.1111/j.1349-7006.2006.00184.x; Veldwijk MR, 2008, ONKOLOGIE, V31, P91, DOI 10.1159/000113504; Wenger SL, 2004, BIOSCIENCE REP, V24, P631, DOI 10.1007/s10540-005-2797-5; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Zanazzi C, 2007, GENE CHROMOSOME CANC, V46, P895, DOI 10.1002/gcc.20475	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58132	10.1371/journal.pone.0058132	http://dx.doi.org/10.1371/journal.pone.0058132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516439	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400018
J	Chagnot, C; Agus, A; Renier, S; Peyrin, F; Talon, R; Astruc, T; Desvaux, M				Chagnot, Caroline; Agus, Allison; Renier, Sandra; Peyrin, Frederic; Talon, Regine; Astruc, Thierry; Desvaux, Mickael			In Vitro Colonization of the Muscle Extracellular Matrix Components by Escherichia coli O157:H7: The Influence of Growth Medium, Temperature and pH on Initial Adhesion and Induction of Biofilm Formation by Collagens I and III	PLOS ONE			English	Article							CLOSTRIDIUM-CELLULOLYTICUM; AUTOTRANSPORTER PROTEIN; CONNECTIVE-TISSUE; SECRETION SYSTEM; BEEF; ATTACHMENT; O157-H7; BINDING; EXPRESSION; VIRULENCE	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 are responsible for repeated food-poisoning cases often caused by contaminated burgers. EHEC infection is predominantly a pediatric illness, which can lead to life-threatening diseases. Ruminants are the main natural reservoir for EHEC and food contamination almost always originates from faecal contamination. In beef meat products, primary bacterial contamination occurs at the dehiding stage of slaughtering. The extracellular matrix (ECM) is the most exposed part of the skeletal muscles in beef carcasses. Investigating the adhesion to the main muscle fibrous ECM proteins, insoluble fibronectin, collagen I, III and IV, laminin-alpha 2 and elastin, results demonstrated that the preceding growth conditions had a great influence on subsequent bacterial attachment. In the tested experimental conditions, maximal adhesion to fibril-forming collagens I or III occurred at 25 degrees C and pH 7. Once initially adhered, exposure to lower temperatures, as applied to meat during cutting and storage, or acidification, as in the course of post-mortem physiological modifications of muscle, had no effect on detachment, except at pH(u). In addition, dense biofilm formation occurred on immobilized collagen I or III and was induced in growth medium supplemented with collagen I in solution. From this first comprehensive investigation of EHEC adhesion to ECM proteins with respect to muscle biology and meat processing, new research directions for the development of innovative practices to minimize the risk of meat contamination are further discussed.	[Chagnot, Caroline; Agus, Allison; Renier, Sandra; Talon, Regine; Desvaux, Mickael] INRA, Microbiol UR454, Clermont Ferrand, France; [Chagnot, Caroline; Peyrin, Frederic; Astruc, Thierry] INRA, Qual Prod Anim UR370, Clermont Ferrand, France	INRAE; INRAE	Desvaux, M (corresponding author), INRA, Microbiol UR454, Clermont Ferrand, France.	mickael.desvaux@clermont.inra.fr	DESVAUX, Mickael/A-8333-2008; Peyrin, Francoise/G-2823-2013; TALON, Régine/A-2427-2011; TALON, Régine/AAZ-4941-2020	DESVAUX, Mickael/0000-0003-2986-6417; Peyrin, Francoise/0000-0002-1988-3435; TALON, Régine/0000-0003-3122-4376; TALON, Régine/0000-0003-3122-4376	INRA (French National Institute for Agronomical Research) in part with the MICEL project; inter-departement CEPIA/MICA (Science and Process Engineering of Agricultural Products/Microbiology and Food Chain) AIP (Action Incitative Programmee)	INRA (French National Institute for Agronomical Research) in part with the MICEL project; inter-departement CEPIA/MICA (Science and Process Engineering of Agricultural Products/Microbiology and Food Chain) AIP (Action Incitative Programmee)	This work was supported by INRA (French National Institute for Agronomical Research) in part with the MICEL project funded by the inter-departement CEPIA/MICA (Science and Process Engineering of Agricultural Products/Microbiology and Food Chain) AIP (Action Incitative Programmee) 2010-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Anand SK, 2003, INT J FOOD MICROBIOL, V85, P1, DOI 10.1016/S0168-1605(02)00482-8; Ando H, 2007, MICROBIOL-SGM, V153, P464, DOI 10.1099/mic.0.2006/000893-0; Auty M, 2005, J FOOD PROTECT, V68, P482, DOI 10.4315/0362-028X-68.3.482; Bavaro Mary F, 2012, Curr Gastroenterol Rep, V14, P317, DOI 10.1007/s11894-012-0264-6; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Bonifait L, 2008, APPL ENVIRON MICROB, V74, P4969, DOI 10.1128/AEM.00558-08; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Brady MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00226; Cabedo L, 1997, J FOOD PROTECT, V60, P102, DOI 10.4315/0362-028X-60.2.102; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chen JR, 2007, LWT-FOOD SCI TECHNOL, V40, P249, DOI 10.1016/j.lwt.2005.10.011; Chingcuanco F, 2012, MICROBIOL-SGM, V158, P2399, DOI 10.1099/mic.0.056374-0; Collington GK, 1998, GUT, V42, P200, DOI 10.1136/gut.42.2.200; Desvaux M, 2004, J MICROBIOL BIOTECHN, V14, P1200; Desvaux M, 2002, MICROB ECOL, V43, P271, DOI 10.1007/s00248-001-0043-7; Desvaux M, 2001, APPL ENVIRON MICROB, V67, P3846, DOI 10.1128/AEM.67.9.3846-3851.2001; Desvaux M, 2003, BIOFUTUR, V237, P34; Desvaux M, 2006, FEMS MICROBIOL LETT, V264, P22, DOI 10.1111/j.1574-6968.2006.00425.x; Desvaux M, 2006, BIOTECHNOL PROGR, V22, P1229, DOI 10.1021/bp060016e; Duffy G, 2006, MEAT SCI, V74, P76, DOI 10.1016/j.meatsci.2006.04.011; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Farfan MJ, 2011, INFECT IMMUN, V79, P3744, DOI 10.1128/IAI.05317-11; Frank J F, 2001, Adv Food Nutr Res, V43, P319, DOI 10.1016/S1043-4526(01)43008-7; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fratamico PM, 1996, J FOOD PROTECT, V59, P453, DOI 10.4315/0362-028X-59.5.453; Gobert AP, 2007, J IMMUNOL, V178, P8168, DOI 10.4049/jimmunol.178.12.8168; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Guedon E, 2000, BIOTECHNOL BIOENG, V67, P327, DOI 10.1002/(SICI)1097-0290(20000205)67:3<327::AID-BIT9>3.3.CO;2-L; GUINEE PAM, 1977, INFECT IMMUN, V15, P676; Hasman H, 1999, J BACTERIOL, V181, P4834, DOI 10.1128/JB.181.16.4834-4841.1999; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Henderson IR, 2004, DRUG DISCOV TODAY, V9, P241; Hennequin C, 2007, RES MICROBIOL, V158, P339, DOI 10.1016/j.resmic.2007.02.005; Hermos CR, 2011, J CLIN MICROBIOL, V49, P955, DOI 10.1128/JCM.02119-10; Hirakawa H, 2009, MICROBIOL-SGM, V155, P541, DOI 10.1099/mic.0.020420-0; House B, 2009, MICROBIOL-SGM, V155, P2907, DOI 10.1099/mic.0.025171-0; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Karch H, 2009, BERL MUNCH TIERARZTL, V122, P417, DOI 10.2376/0005-9366-122-417; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; LEEDLE JAZ, 1980, APPL ENVIRON MICROB, V39, P709, DOI 10.1128/AEM.39.4.709-719.1980; Li J, 1999, INT J FOOD MICROBIOL, V53, P185, DOI 10.1016/S0168-1605(99)00159-2; Lonergan EH, 2010, MEAT SCI, V86, P184, DOI 10.1016/j.meatsci.2010.05.004; Medina MB, 2002, BIOTECHNOL LETT, V24, P77, DOI 10.1023/A:1013871329099; Medina MB, 1998, BIOTECHNOL TECH, V12, P235, DOI 10.1023/A:1008829609813; Medina MB, 2001, INT J FOOD MICROBIOL, V69, P199, DOI 10.1016/S0168-1605(01)00497-4; Meng J, 1997, ANNU REV NUTR, V17, P255, DOI 10.1146/annurev.nutr.17.1.255; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0; Payot S, 1999, APPL MICROBIOL BIOT, V52, P670, DOI 10.1007/s002530051577; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Purslow PP, 2010, J BODYW MOV THER, V14, P411, DOI 10.1016/j.jbmt.2010.01.005; Purslow PP, 2005, MEAT SCI, V70, P435, DOI 10.1016/j.meatsci.2004.06.028; Purslow PP, 2002, COMP BIOCHEM PHYS A, V133, P947, DOI 10.1016/S1095-6433(02)00141-1; Rhoades JR, 2009, FOOD MICROBIOL, V26, P357, DOI 10.1016/j.fm.2008.10.012; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rivas L, 2006, J FOOD PROTECT, V69, P999, DOI 10.4315/0362-028X-69.5.999; Tarr PI, 2009, KIDNEY INT, V75, pS29, DOI 10.1038/ki.2008.615; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; Torres AG, 2002, MOL MICROBIOL, V45, P951, DOI 10.1046/j.1365-2958.2002.03094.x; Totsika M, 2012, APPL ENVIRON MICROB, V78, P2179, DOI 10.1128/AEM.06680-11; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Voermans NC, 2008, NEUROMUSCULAR DISORD, V18, P843, DOI 10.1016/j.nmd.2008.05.017; Wells TJ, 2008, ENVIRON MICROBIOL, V10, P589, DOI 10.1111/j.1462-2920.2007.01479.x; Wells TJ, 2009, ENVIRON MICROBIOL, V11, P1803, DOI 10.1111/j.1462-2920.2009.01905.x; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Zulfakar SS, 2012, INT J FOOD MICROBIOL, V157, P210, DOI 10.1016/j.ijfoodmicro.2012.05.007	76	21	21	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59386	10.1371/journal.pone.0059386	http://dx.doi.org/10.1371/journal.pone.0059386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516631	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200146
J	Guo, L; Wu, CJ; Zhou, HL; Wu, C; Paranhos-Baccala, G; Vernet, G; Jin, Q; Wang, JW; Hung, T				Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Paranhos-Baccala, Glaucia; Vernet, Guy; Jin, Qi; Wang, Jianwei; Hung, Tao			Identification of a Nonstructural DNA-Binding Protein (DBP) as an Antigen with Diagnostic Potential for Human Adenovirus	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMORAL IMMUNE-RESPONSES; OUTER-MEMBRANE PROTEINS; ANTIBODY DETECTION; GENE; SENSITIVITY; VECTORS; SPECIFICITY; INFECTIONS; ASSAYS	Background: Human adenoviruses (HAdVs) have been implicated as important agents in a wide range of human illnesses. To date, 58 distinct HAdV serotypes have been identified and can be grouped into six species. For the immunological diagnosis of adenoviruses, the hexon protein, a structural protein, has been used. The potential of other HAdV proteins has not been fully addressed. Methodology/Principal Findings: In this study, a nonstructural antigenic protein, the DNA binding protein (DBP) of human adenovirus 5 and 35 (Ad5, Ad35) - was identified using immunoproteomic technology. The expression of Ad5 and Ad35 DBP in insect cells could be detected by rhesus monkey serum antibodies and healthy adult human serum positive for Ad5 and Ad35. Recombinant DBPs elicited high titer antibodies in mice. Their conserved domain displayed immunological cross-reactions with heterologous DBP antibodies in Western blot assays. DBP-IgM ELISA showed higher sensitivity adenovirus IgM detection than the commercial Adenovirus IgM Human ELISA Kit. A Western blot method developed based on Ad5 DBP was highly consistent with (chi(2) = 44.9, P<0.01) the Western blot assay for the hexon protein in the detection of IgG, but proved even more sensitive. Conclusions/Significance: The HAdV nonstructural protein DBP is an antigenic protein that could serve as an alternative common antigen for adenovirus diagnosis.	[Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Jin, Qi; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, IPB,MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Jin, Qi; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, IPB,Christophe Merieux Lab, Beijing 100730, Peoples R China; [Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Jin, Qi; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China; [Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France; [Hung, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, IPB,MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zdsys@vip.sina.com; wangjw28@163.com	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559	International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China [2012ZX10004-206]	International Science and Technology Cooperation Program of China; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China (2012ZX10004-206) (http://www.nmp.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; ALTER HJ, 1992, HEPATOLOGY, V15, P350, DOI 10.1002/hep.1840150228; Ayalew S, 2010, PROTEOMICS, V10, P2151, DOI 10.1002/pmic.200900557; BAHRAOUI E, 1990, AIDS RES HUM RETROV, V6, P1087, DOI 10.1089/aid.1990.6.1087; BARRERA JM, 1991, ANN INTERN MED, V115, P596, DOI 10.7326/0003-4819-115-8-596; Bauer U, 2005, J CLIN MICROBIOL, V43, P4426, DOI 10.1128/JCM.43.9.4426-4433.2005; Bell C, 2012, J PROTEOME RES, V11, P119, DOI 10.1021/pr2007939; Caravokyri C, 1996, VIRUS GENES, V12, P65, DOI 10.1007/BF00370002; CLEGHON V, 1989, J VIROL, V63, P2289, DOI 10.1128/JVI.63.5.2289-2299.1989; Colin C, 2001, J VIRAL HEPATITIS, V8, P87, DOI 10.1046/j.1365-2893.2001.00280.x; Curreem SOT, 2012, PROTEIN CELL, V3, P346, DOI 10.1007/s13238-012-2034-5; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; El-Gogo S, 2008, J GENE MED, V10, P177, DOI 10.1002/jgm.1144; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; Harfst E, 1999, VIRUS GENES, V18, P97, DOI 10.1023/A:1008009630695; Harvey BG, 1999, J VIROL, V73, P6729, DOI 10.1128/JVI.73.8.6729-6742.1999; Jian-Umpunkul P, 2012, J VIROL METHODS, V185, P24, DOI 10.1016/j.jviromet.2012.05.021; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kamili S., 2012, Clinical Infectious Diseases, V55, P43, DOI 10.1093/cid/cis368; Liao YH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-172; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Lu GL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-62; NICOLAS JC, 1983, VIROLOGY, V126, P228, DOI 10.1016/0042-6822(83)90474-9; Sankar SG, 2012, CLIN MICROBIOL INFEC, V18, pE8, DOI 10.1111/j.1469-0691.2011.03694.x; Shenk T. E., 2001, Fundamental virology, P1053; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TSERNOGLOU D, 1985, FEBS LETT, V188, P248, DOI 10.1016/0014-5793(85)80381-1; Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09; Wold WSM, 2007, FIELDS VIROLOGY, V1, P2396; Wu CJ, 2011, J VIROL METHODS, V177, P55, DOI 10.1016/j.jviromet.2011.06.016; Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014; Zhu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013915; ZIJDERVELD DC, 1994, J VIROL, V68, P8288, DOI 10.1128/JVI.68.12.8288-8295.1994	36	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56708	10.1371/journal.pone.0056708	http://dx.doi.org/10.1371/journal.pone.0056708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516396	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200005
J	Ketuly, KA; Hadi, AHA; Golbabapour, S; Hajrezaie, M; Hassandarvish, P; Ali, HM; Majid, NA; Abdulla, MA				Ketuly, Kamal A.; Hadi, A. Hamid A.; Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Ali, Hapipah Mohd; Majid, Nazia Abdul; Abdulla, Mahmood A.			Acute Toxicity and Gastroprotection Studies with a Newly Synthesized Steroid	PLOS ONE			English	Article							GASTRIC-MUCOSAL INJURY; ANTIULCEROGENIC ACTIVITY; LEAF EXTRACT; LESIONS; ULCER; DIPROPIONATE; PANTOPRAZOLE; ANTIOXIDANT; OMEPRAZOLE; APOPTOSIS	Background: Synthetic steroids, such as 9 alpha-bromobeclomethasonedipropionate, have shown gastroprotective activity. For example, the potent glucocorticoid steroid, beclomethasone dipropionate, has been used for treatment of bowel ulcerations. The purpose of the present study was to evaluate the effect of a synthetic steroid, (20S)-22-acetoxymethyl-6 beta-methoxy-3 alpha,5-dihydro-3'H-cyclopropa[3 alpha,5]-5 alpha-pregnane (AMDCP), on ethanol-induced gastric mucosa injuries in rats. Methodology/Principal Finding: Rats were divided into 8 groups. The negative control and ethanol control groups were administered Tween 20 (10%v/v) orally. The reference control group, 20 mg/kg omeprazole (10% Tween 20, 5 mL/kg), was administrated orally. The experimental groups received 1, 5, 10, 15 or 20 mg/kg of the AMDCP compound (10% Tween 20, 5 mL/kg). After 60 min, Tween 20 and absolute ethanol was given orally (5 mL/kg) to the negative control group and to the rest of the groups, and the rats were sacrificed an hour later. The acidity of gastric content, gastric wall mucus and areas of mucosal lesions were assessed. In addition, histology and immunohistochemistry of the gastric wall were assessed. Prostaglandin E2 (PGE(2)) and malondialdehyde (MDA) content were also measured. The ethanol control group exhibited severe mucosal lesion compared with the experimental groups with fewer mucosal lesions along with a reduction of edema and leukocyte infiltration. Immunohistochemical staining of Hsp70 and Bax proteins showed over-expression and under-expression, respectively, in the experimental groups. The experimental groups also exhibited high levels of PGE(2) as well as a reduced amount of MDA. AMDCP decreased the acidity and lipid peroxidation and increased the levels of antioxidant enzymes. Conclusion/Significance: The current investigation evaluated the gastroprotective effects of AMDCP on ethanol-induced gastric mucosal lesions in rats. This study also suggests that AMDCP might be useful as a gastroprotective agent.	[Ketuly, Kamal A.; Hadi, A. Hamid A.; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Abdulla, Mahmood A.] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Golbabapour, Shahram; Hajrezaie, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	Hassandarvish, Pouya/K-8112-2012; MAJID, NAZIA ABDUL/B-9215-2010	Hassandarvish, Pouya/0000-0003-0364-5587; MAJID, NAZIA ABDUL/0000-0002-6817-8046	University of Malaya HIR-MOHE [HIR-MOHE] [F000009-21001]; UMRG [RG035/10, RG0373/11]	University of Malaya HIR-MOHE [HIR-MOHE]; UMRG	This study was funded by the University of Malaya HIR-MOHE [HIR-MOHE (F000009-21001)] and UMRG grants (RG035/10 BIO and RG0373/11 HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Al-Attar A. M., 2011, Research Journal of Medicinal Plant, V5, P477, DOI 10.3923/rjmp.2011.477.490; AlRashdi AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786426; Bandyopadhyay Debashis, 2001, Current Molecular Medicine (Hilversum), V1, P501, DOI 10.2174/1566524013363483; Bandyopadhyay Debashis, 2002, Indian Journal of Experimental Biology, V40, P693; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Blandizzi C, 2000, FUNDAM CLIN PHARM, V14, P89, DOI 10.1111/j.1472-8206.2000.tb00396.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski T, 2005, WORLD J GASTROENTERO, V11, P6450, DOI 10.3748/wjg.v11.i41.6450; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Demir Suleyman, 2003, Turk J Gastroenterol, V14, P39; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Huang JQ, 2001, BEST PRACT RES CL GA, V15, P355, DOI 10.1053/bega.2001.0184; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Jelski W, 2009, DIGEST DIS SCI, V54, P725, DOI 10.1007/s10620-008-0422-8; Ketuly KA, 1997, ACTA CRYSTALLOGR C, V53, P981, DOI 10.1107/S0108270197003570; Ketuly KA, 2011, J MED PLANTS RES, V5, P514; Ketuly KA, 2009, ACTA CRYSTALLOGR E, V65, pO1822, DOI 10.1107/S1600536809025987; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P211; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Liang P, 1997, J CELL SCI, V110, P1431; Mahmood AA, 2010, J MED PLANTS RES, V4, P685; Mahmood AA, 2011, J MED PLANTS RES, V5, P2562; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; MARHUENDA E, 1993, PHYTOTHER RES, V7, P13, DOI 10.1002/ptr.2650070105; MILLER TA, 1985, AM J PHYSIOL, V249, pG137, DOI 10.1152/ajpgi.1985.249.1.G137; MORON F, 1983, ARCH INT PHARMACOD T, V265, P309; OECD Guideline for testing of chemicals, 2005, OECD GUID TEST CHEM; Rizzello F, 2002, ALIMENT PHARM THERAP, V16, P1109, DOI 10.1046/j.1365-2036.2002.01298.x; Sannomiya M, 2005, J ETHNOPHARMACOL, V97, P1, DOI 10.1016/j.jep.2004.09.053; Schubert ML, 2005, CURR OPIN GASTROEN, V21, P636, DOI 10.1097/01.mog.0000181713.89281.14; Silen W, 1981, World J Surg, V5, P165; Takeuchi K., 2002, GASTROINTESTINAL MUC, P227; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Targosz A, 2012, INFLAMM RES, V61, P955, DOI 10.1007/s00011-012-0487-x; Toma W, 2002, BIOL PHARM BULL, V25, P1151, DOI 10.1248/bpb.25.1151; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Yildirim A, 2007, J PHYSIOL PHARMACOL, V58, P105; Zhao W, 2009, ACTA BIOCH BIOPH SIN, V41, P301, DOI 10.1093/abbs/gmp014	42	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59296	10.1371/journal.pone.0059296	http://dx.doi.org/10.1371/journal.pone.0059296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516624	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200141
J	Musetti, C; Krapcho, AP; Palumbo, M; Sissi, C				Musetti, Caterina; Krapcho, A. Paul; Palumbo, Manlio; Sissi, Claudia			Effect of G-Quadruplex Polymorphism on the Recognition of Telomeric DNA by a Metal Complex	PLOS ONE			English	Article							CONFORMATIONAL SWITCH; BINDING; CALORIMETRY; ENERGETICS; LIGANDS; TARGETS; DESIGN; CANCER	The physiological role(s) played by G-quadruplexes renders these 'non-canonical' DNA secondary structures interesting new targets for therapeutic intervention. In particular, the search for ligands for selective recognition and stabilization of G-quadruplex arrangements has led to a number of novel targeted agents. An interesting approach is represented by the use of metal-complexes, their binding to DNA being modulated by ligand and metal ion nature, and by complex stoichiometry. In this work we characterized thermodynamically and stereochemically the interactions of a Ni(II) bis-phenanthroline derivative with telomeric G-quadruplex sequences using calorimetric, chiroptical and NMR techniques. We employed three strictly related sequences based on the human telomeric repeat, namely Tel22, Tel26 and wtTel26, which assume distinct conformations in potassium containing solutions. We were able to monitor specific enthalpy/entropy changes according to the structural features of the target telomeric sequence and to dissect the binding process into distinct events. Interestingly, temperature effects turned out to be prominent both in terms of binding stoichiometry and Delta H/Delta S contributions, while the final G-quadruplex-metal complex architecture tended to merge for the examined sequences. These results underline the critical choice of experimental conditions and DNA sequence for practical use of thermodynamic data in the rational development of effective G-quadruplex binders.	[Musetti, Caterina; Palumbo, Manlio; Sissi, Claudia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Krapcho, A. Paul] Univ Vermont, Dept Chem, Burlington, VT 05405 USA	University of Padua; University of Vermont	Sissi, C (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	claudia.sissi@unipd.it		SISSI, CLAUDIA/0000-0002-9713-1415; Palumbo, Manlio/0000-0002-3163-1564	University of Padova [CPDA114388]; MIUR (Ministero dell'Istruzione, dell'Universita' e della Ricerca) (PRIN) [2009MFRKZ8_004]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	University of Padova; MIUR (Ministero dell'Istruzione, dell'Universita' e della Ricerca) (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors thank Dr. Giuseppe Marson for helpful discussion and Dr. Ileana Menegazzo for NMR assistance. This work was funded by University of Padova (grant # CPDA114388) and MIUR (Ministero dell'Istruzione, dell'Universita' e della Ricerca) (PRIN # 2009MFRKZ8_004) is gratefully acknowledged. The authors also thank AIRC for the Postdoctoral Fellowship "Gabriele Santoro" to C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; Bertrand H, 2007, ORG BIOMOL CHEM, V5, P2555, DOI 10.1039/b708635k; Bhattacharjee AJ, 2011, BIOCHIMIE, V93, P1297, DOI 10.1016/j.biochi.2011.05.038; Bianco S, 2010, DALTON T, V39, P5833, DOI 10.1039/c0dt00038h; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Choi J, 2011, CHEM SOC REV, V40, P5893, DOI 10.1039/c1cs15153c; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Cuesta J, 2003, MINI-REV MED CHEM, V3, P11, DOI 10.2174/1389557033405502; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Davis JT, 2007, CHEM SOC REV, V36, P296, DOI 10.1039/b600282j; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Folini M, 2011, EXPERT OPIN THER TAR, V15, P579, DOI 10.1517/14728222.2011.556621; Garbett NC, 2012, EXPERT OPIN DRUG DIS, V7, P299, DOI 10.1517/17460441.2012.666235; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Grandin N, 2008, BIOCHIMIE, V90, P41, DOI 10.1016/j.biochi.2007.07.008; Gray RD, 2009, J PHYS CHEM B, V113, P2676, DOI 10.1021/jp809578f; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Jiang YL, 2010, MINI-REV MED CHEM, V10, P726, DOI 10.2174/138955710791572433; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Mazur S, 2000, J MOL BIOL, V300, P321, DOI 10.1006/jmbi.2000.3869; Monchaud D, 2008, ANGEW CHEM INT EDIT, V47, P4858, DOI 10.1002/anie.200800468; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Musetti C, 2009, DALTON T, P3657, DOI 10.1039/b904630p; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Orlotti NI, 2012, AUTOPHAGY, V8, P1185, DOI 10.4161/auto.20519; Pagano B, 2007, CURR CANCER DRUG TAR, V7, P520, DOI 10.2174/156800907781662257; Pagano B, 2009, INT J MOL SCI, V10, P2935, DOI 10.3390/ijms10072935; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Pilch DS, 2008, BIOCHIMIE, V90, P1233, DOI 10.1016/j.biochi.2008.03.011; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Rajput C, 2006, CHEM-EUR J, V12, P4611, DOI 10.1002/chem.200501349; Ralph SF, 2011, CURR TOP MED CHEM, V11, P572; Rao L, 2011, J PHYS CHEM B, V115, P13701, DOI 10.1021/jp207265s; Reed JE, 2009, DALTON T, P2558, DOI 10.1039/b820086f; Riou Jean-Francois, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P439, DOI 10.2174/1568011043352740; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zeglis BM, 2007, CHEM COMMUN, P4565, DOI 10.1039/b710949k; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	48	17	17	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58529	10.1371/journal.pone.0058529	http://dx.doi.org/10.1371/journal.pone.0058529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516498	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200079
J	Sheet, T; Supakar, S; Banerjee, R				Sheet, Tridip; Supakar, Subhrangshu; Banerjee, Raja			Conformational Preference of '(CNN)-N-alpha' Short Peptide Motif towards Recognition of Anions	PLOS ONE			English	Article							PHOSPHATE-BINDING; INORGANIC-PHOSPHATE; CRYSTAL-STRUCTURE; STRUCTURAL MOTIF; DOMINANT ROLE; ALPHA-HELIX; PROTEIN; SITES; NMR; SIMULATION	Among several 'anion binding motifs', the recently described '(CNN)-N-alpha' motif occurring in the loop regions preceding a helix, is conserved through evolution both in sequence and its conformation. To establish the significance of the conserved sequence and their intrinsic affinity for anions, a series of peptides containing the naturally occurring '(CNN)-N-alpha' motif at the N-terminus of a designed helix, have been modeled and studied in a context free system using computational techniques. Appearance of a single interacting site with negative binding free-energy for both the sulfate and phosphate ions, as evidenced in docking experiments, establishes that the '(CNN)-N-alpha' segment has an intrinsic affinity for anions. Molecular Dynamics (MD) simulation studies reveal that interaction with anion triggers a conformational switch from non-helical to helical state at the '(CNN)-N-alpha' segment, which extends the length of the anchoring-helix by one turn at the N-terminus. Computational experiments substantiate the significance of sequence/structural context and justify the conserved nature of the '(CNN)-N-alpha' sequence for anion recognition through "local'' interaction.	[Sheet, Tridip; Supakar, Subhrangshu; Banerjee, Raja] West Bengal Univ Technol, Dept Bioinformat, Kolkata, India	Maulana Abul Kalam Azad University of Technology	Banerjee, R (corresponding author), West Bengal Univ Technol, Dept Bioinformat, Kolkata, India.	ban_raja@yahoo.com		Sheet, Tridip/0000-0002-7269-5353	DBT,GOI (Department of Biotechnology, Govt. of India) [BT/PR10277/GBD/27/90/2007]; BIF-DBT,GOI (Bioinformatics Infra structural facility-Department of Biotechnology, Govt. of India) [BT/BI/25/001/2006-Vol. II]	DBT,GOI (Department of Biotechnology, Govt. of India); BIF-DBT,GOI (Bioinformatics Infra structural facility-Department of Biotechnology, Govt. of India)	Funding was provided by (a) DBT,GOI (Department of Biotechnology, Govt. of India) Sanction No. BT/PR10277/GBD/27/90/2007 dt. 25-03-2008; and (b) BIF-DBT,GOI (Bioinformatics Infra structural facility-Department of Biotechnology, Govt. of India) Sanction No. BT/BI/25/001/2006-Vol. II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev ZK, 2002, BIOCHEM J, V362, P749, DOI 10.1042/0264-6021:3620749; Aburi M., 2004, J PHYS CHEM B, V108, P7382, DOI DOI 10.1021/JP036582Z; Accelrys Software Inc, 2010, DISC STUD MOD ENV RE; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Aquist J, 1991, P NATL ACAD SCI USA, V88, P2026; Banerjee R, 2002, CHEMBIOCHEM, V3, P1263, DOI 10.1002/1439-7633(20021202)3:12<1263::AID-CBIC1263>3.0.CO;2-O; Banerjee R, 2009, PROTEINS, V76, P184, DOI 10.1002/prot.22337; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bianchi A, 2012, PROTEINS, V80, P1418, DOI 10.1002/prot.24038; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; CHAKRABARTI P, 1993, J MOL BIOL, V234, P463, DOI 10.1006/jmbi.1993.1599; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; Crisma M, 2007, J PEPT SCI, V13, P190, DOI 10.1002/psc.833; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demuth C, 2001, BIOSENS BIOELECTRON, V16, P783, DOI 10.1016/S0956-5663(01)00221-4; Denessiouk KA, 2005, J MOL BIOL, V345, P611, DOI 10.1016/j.jmb.2004.10.058; Denessiouk KA, 2003, J MOL BIOL, V333, P1025, DOI 10.1016/j.jmb.2003.09.017; Denessiouk KA, 2001, PROTEINS, V44, P282, DOI 10.1002/prot.1093; Denesyuk AI, 2003, BBA-PROTEINS PROTEOM, V1647, P234, DOI 10.1016/S1570-9639(03)00057-8; Dennington R., 2016, GAUSSVIEW; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HE JJ, 1993, PROTEIN SCI, V2, P1643, DOI 10.1002/pro.5560021010; He QY, 2000, BIOCHEM J, V350, P909, DOI 10.1042/0264-6021:3500909; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Holt PA, 2008, J MED CHEM, V51, P3878; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARLE IL, 1994, PROTEIN SCI, V3, P1547, DOI 10.1002/pro.5560030920; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Ledvina PS, 1996, P NATL ACAD SCI USA, V93, P6786, DOI 10.1073/pnas.93.13.6786; Ledvina PS, 1998, PROTEIN SCI, V7, P2550, DOI 10.1002/pro.5560071208; Liu MTW, 2000, J BIOL CHEM, V275, P1814, DOI 10.1074/jbc.275.3.1814; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Markovich D, 2001, PHYSIOL REV, V81, P1499, DOI 10.1152/physrev.2001.81.4.1499; MARTINEZLIARTE JH, 1992, BIOCHEMISTRY-US, V31, P2712, DOI 10.1021/bi00125a011; MEIERING EM, 1991, BIOCHEMISTRY-US, V30, P11348, DOI 10.1021/bi00111a022; Milner-White EJ, 2005, ORIGINS LIFE EVOL B, V35, P19, DOI 10.1007/s11084-005-4582-7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramakrishnan C, 2002, PROTEIN ENG, V15, P783, DOI 10.1093/protein/15.10.783; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Sansom MSP, 1998, J STRUCT BIOL, V121, P246, DOI 10.1006/jsbi.1997.3950; Sheet T, 2010, J STRUCT BIOL, V171, P345, DOI 10.1016/j.jsb.2010.06.003; SMITH SO, 1989, SCIENCE, V244, P961, DOI 10.1126/science.2499045; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; WIERENGA RK, 1984, J MOL BIOL, V178, P487, DOI 10.1016/0022-2836(84)90155-4; Wuthrich K, 1986, NMR PROTEINS NUCL AC	61	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57366	10.1371/journal.pone.0057366	http://dx.doi.org/10.1371/journal.pone.0057366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516403	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200009
J	Wyrebek, M; Bidochka, MJ				Wyrebek, Michael; Bidochka, Michael J.			Variability in the Insect and Plant Adhesins, Mad1 and Mad2, within the Fungal Genus Metarhizium Suggest Plant Adaptation as an Evolutionary Force	PLOS ONE			English	Article							M-FLAVOVIRIDE; ANISOPLIAE; RHIZOSPHERE; ELEMENT; TRANSCRIPTION; EXPRESSION; DESTRUXINS; ROBERTSII; VIRULENCE; PATHOGEN	Several species of the insect pathogenic fungus Metarhizium are associated with certain plant types and genome analyses suggested a bifunctional lifestyle; as an insect pathogen and as a plant symbiont. Here we wanted to explore whether there was more variation in genes devoted to plant association (Mad2) or to insect association (Mad1) overall in the genus Metarhizium. Greater divergence within the genus Metarhizium in one of these genes may provide evidence for whether host insect or plant is a driving force in adaptation and evolution in the genus Metarhizium. We compared differences in variation in the insect adhesin gene, Mad1, which enables attachment to insect cuticle, and the plant adhesin gene, Mad2, which enables attachment to plants. Overall variation for the Mad1 promoter region (7.1%), Mad1 open reading frame (6.7%), and Mad2 open reading frame (7.4%) were similar, while it was higher in the Mad2 promoter region (9.9%). Analysis of the transcriptional elements within the Mad2 promoter region revealed variable STRE, PDS, degenerative TATA box, and TATA box-like regions, while this level of variation was not found for Mad1. Sequences were also phylogenetically compared to EF-1 alpha, which is used for species identification, in 14 isolates representing 7 different species in the genus Metarhizium. Phylogenetic analysis demonstrated that the Mad2 phylogeny is more congruent with 5' EF-1 alpha than Mad1. This would suggest that Mad2 has diverged among Metarhizium lineages, contributing to clade- and species-specific variation, while it appears that Mad1 has been largely conserved. While other abiotic and biotic factors cannot be excluded in contributing to divergence, these results suggest that plant relationships, rather than insect host, have been a major driving factor in the divergence of the genus Metarhizium.	[Wyrebek, Michael; Bidochka, Michael J.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada	Brock University	Bidochka, MJ (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	bidochka@brocku.ca		Bidochka, Michael/0000-0002-2544-9977	NSERC (Natural Sciences and Engineering Research Council) of Canada	NSERC (Natural Sciences and Engineering Research Council) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The sole source of funding was NSERC (Natural Sciences and Engineering Research Council) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barelli L, 2011, FUNGAL BIOL-UK, V115, P1174, DOI 10.1016/j.funbio.2011.08.003; Berry V, 2006, IEEE ACM T COMPUT BI, V3, P289, DOI 10.1109/TCBB.2006.39; Bidochka MJ, 2001, APPL ENVIRON MICROB, V67, P1335, DOI 10.1128/AEM.67.3.1335-1342.2001; Bischoff JF, 2006, MYCOLOGIA, V98, P737, DOI 10.3852/mycologia.98.5.737; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; BOORSTEIN WR, 1990, EMBO J, V9, P2543, DOI 10.1002/j.1460-2075.1990.tb07435.x; BRIDGE PD, 1993, J GEN MICROBIOL, V139, P1163, DOI 10.1099/00221287-139-6-1163; Bridge PD, 1997, BIODIVERS CONSERV, V6, P177, DOI 10.1023/A:1018387918686; Bruck DJ, 2010, BIOCONTROL, V55, P103, DOI 10.1007/s10526-009-9236-7; Bruck DJ, 2005, BIOL CONTROL, V32, P155, DOI 10.1016/j.biocontrol.2004.09.003; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; FEGAN M, 1993, J GEN MICROBIOL, V139, P2075, DOI 10.1099/00221287-139-9-2075; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hu G, 2002, APPL ENVIRON MICROB, V68, P6383, DOI 10.1128/AEM.68.12.6383-6387.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal SCM, 1997, MYCOL RES, V101, P257, DOI 10.1017/S0953756296002560; LEAL SCM, 1994, MYCOL RES, V98, P1077, DOI 10.1016/S0953-7562(09)80436-X; LIN KJ, 1986, J INVERTEBR PATHOL, V47, P120, DOI 10.1016/0022-2011(86)90170-9; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; Nakazato L, 2006, APPL MICROBIOL BIOT, V72, P521, DOI 10.1007/s00253-005-0292-3; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nishi O, 2011, APPL ENTOMOL ZOOL, V46, P301, DOI 10.1007/s13355-011-0045-y; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; RIBA G, 1986, MYCOPATHOLOGIA, V96, P161, DOI 10.1007/BF00437383; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; Small CLN, 2004, CURR MICROBIOL, V48, P428, DOI 10.1007/s00284-003-4228-9; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; TIGANOMILANI MS, 1995, J INVERTEBR PATHOL, V65, P206, DOI 10.1006/jipa.1995.1031; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wang SB, 2011, P NATL ACAD SCI USA, V108, P20449, DOI 10.1073/pnas.1113824108; Wang SB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002097; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0	40	17	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59357	10.1371/journal.pone.0059357	http://dx.doi.org/10.1371/journal.pone.0059357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516629	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200145
J	Diomede, L; Rigacci, S; Romeo, M; Stefani, M; Salmona, M				Diomede, Luisa; Rigacci, Stefania; Romeo, Margherita; Stefani, Massimo; Salmona, Mario			Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing A beta 42 by Reducing Plaque Load and Motor Deficit	PLOS ONE			English	Article							INCLUSION-BODY MYOSITIS; AMYLOID-INDUCED TOXICITY; BILOBA EXTRACT EGB-761; VIRGIN OLIVE OIL; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; MEDITERRANEAN DIET; COGNITIVE IMPAIRMENT; MOLECULAR PATHOLOGY; MASS-SPECTROMETRY	The presence of amyloid aggregates of the 42 amino acid peptide of amyloid beta (A beta 42) in the brain is the characteristic feature of Alzheimer's disease (AD). Amyloid beta (A beta deposition is also found in muscle fibers of individuals affected by inclusion body myositis (sIBM), a rare muscular degenerative disease affecting people over 50. Both conditions are presently lacking an effective therapeutic treatment. There is increasing evidence to suggest that natural polyphenols may prevent the formation of toxic amyloid aggregates; this applies also to oleuropein aglycone (OLE), the most abundant polyphenol in extra virgin olive oil, previously shown to hinder amylin and A beta aggregation. Here we evaluated the ability of OLE to interfere with A beta proteotoxicity in vivo by using the transgenic CL2006 and CL4176 strains of Caenorhabditis elegans, simplified models of AD and of sIBM, which express human A beta in the cytoplasm of body wall muscle cells. OLE-fed CL2006 worms displayed reduced A beta plaque deposition, less abundant toxic A beta oligomers, remarkably decreased paralysis and increased lifespan with respect to untreated animals. A protective effect was also observed in CL4176 worms but only when OLE was administered before the induction of the A beta transgene expression. These effects were specific, dose-related, and not mediated by the known polyphenolic anti-oxidant activity, suggesting that, in this model organism, OLE interferes with the A beta aggregation skipping the appearance of toxic species, as already shown in vitro for A beta 42.	[Diomede, Luisa; Romeo, Margherita; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Rigacci, Stefania; Stefani, Massimo] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Rigacci, Stefania; Stefani, Massimo] Res Ctr Mol Basis Neurodegenerat CIMN, Florence, Italy; [Stefani, Massimo] Natl Inst Biostruct & Biosyst, Rome, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Florence	Diomede, L (corresponding author), Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy.	luisa.diomede@marionegri.it	salmona, mario/ABI-4066-2020; salmona, mario/AAA-7116-2020; Diomede, Luisa/P-3417-2014	salmona, mario/0000-0002-9098-9873; Diomede, Luisa/0000-0002-2258-0531; STEFANI, MASSIMO/0000-0002-4490-1922; Romeo, Margherita/0000-0002-3020-8545	Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute''; Banca Intesa San Paolo [2009-2012]; NIH Office of Research Infrastructure Program [P40 OD010440]; Cariplo Foundation [2009-2543]	Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute''(Regione Toscana); Banca Intesa San Paolo; NIH Office of Research Infrastructure Program; Cariplo Foundation(Fondazione Cariplo)	This work was partly supported by grants from the Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute 2009,'' from the Cariplo Foundation, Project n. 2009-2543 and from the Banca Intesa San Paolo, Grant 2009-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ada De Luigi for X-34 synthesis. C. elegans strains and E. coli OP50 were provided by CGC, which is funded by NIH Office of Research Infrastructure Program (P40 OD010440).	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bazoti FN, 2006, J AM SOC MASS SPECTR, V17, P568, DOI 10.1016/j.jasms.2005.11.016; Bazoti FN, 2008, J AM SOC MASS SPECTR, V19, P1078, DOI 10.1016/j.jasms.2008.03.011; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; Berr C, 2009, DEMENT GERIATR COGN, V28, P357, DOI 10.1159/000253483; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; D'Agostino C, 2011, ACTA NEUROPATHOL, V122, P627, DOI 10.1007/s00401-011-0874-3; Daccache A, 2011, NEUROCHEM INT, V58, P700, DOI 10.1016/j.neuint.2011.02.010; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Engel WK, 2006, NEUROLOGY, V66, pS20, DOI 10.1212/01.wnl.0000192260.33106.bb; Farr SA, 2012, J ALZHEIMERS DIS, V28, P81, DOI 10.3233/JAD-2011-110662; Feart C, 2010, CURR OPIN CLIN NUTR, V13, P14, DOI 10.1097/MCO.0b013e3283331fe4; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Morita M, 2009, BRAIN RES, V1295, P186, DOI 10.1016/j.brainres.2009.08.002; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Omar Syed Haris, 2010, Sci Pharm, V78, P133, DOI 10.3797/scipharm.0912-18; Papandreou MA, 2009, BEHAV BRAIN RES, V198, P352, DOI 10.1016/j.bbr.2008.11.013; Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Rigacci S, 2011, CURR ALZHEIMER RES, V8, P841, DOI 10.2174/156720511798192682; Rigacci S, 2010, J NUTR BIOCHEM, V21, P726, DOI 10.1016/j.jnutbio.2009.04.010; Scarmeas N, 2011, ANN NEUROL, V69, P257, DOI 10.1002/ana.22317; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Soler-Rivas C, 2000, J SCI FOOD AGR, V80, P1013, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1013::AID-JSFA571>3.0.CO;2-C, 10.1002/(SICI)1097-0010(20000515)80:7&lt;1013::AID-JSFA571&gt;3.0.CO;2-C]; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Zhu JTT, 2009, NEUROSCI LETT, V461, P172, DOI 10.1016/j.neulet.2009.06.010	53	98	101	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58893	10.1371/journal.pone.0058893	http://dx.doi.org/10.1371/journal.pone.0058893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520540	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900100
J	Koshiba, M; Shirakawa, Y; Mimura, K; Senoo, A; Karino, G; Nakamura, S				Koshiba, Mamiko; Shirakawa, Yuka; Mimura, Koki; Senoo, Aya; Karino, Genta; Nakamura, Shun			Familiarity Perception Call Elicited under Restricted Sensory Cues in Peer-Social Interactions of the Domestic Chick	PLOS ONE			English	Article							BIOLOGICAL MOTION; GALLUS-GALLUS; STIMULATION; RECOGNITION; BEHAVIOR; STRESS; HEN	Social cognitive mechanisms are central to understanding developmental abnormalities, such as autistic spectrum disorder. Peer relations besides parent-infant or pair-bonding interactions are pivotal social relationships that are especially well developed in humans. Cognition of familiarity forms the basis of peer socialization. Domestic chick (Gallus gallus) studies have contributed to our understanding of the developmental process in sensory-motor cognition but many processes remain unknown. In this report, we used chicks, as they are precocial birds, and we could therefore focus on peer interaction without having to consider parenting. The subject chick behavior towards familiar and unfamiliar reference peers was video-recorded, where the subject and the reference were separated by either an opaque or transparent wall. Spectrogram and behavior correlation analyses based on principal component analysis, revealed that chicks elicited an intermediate contact call and a morphologically different distress call, more frequently towards familiar versus unfamiliar chicks in acoustic only conditions. When both visual and acoustic cues were present, subject chicks exhibited approaching and floor pecking behavior, while eliciting joyful (pleasant) calls, irrespective of whether reference peers were familiar or unfamiliar. Our result showed that chicks recognized familiarity using acoustic cues and expressed cognition through modified distress calls. These finding suggests that peer affiliation may be established by acoustic recognition, independent of visual face recognition, and that eventually, both forms of recognition are integrated, with modulation of acoustic recognition.	[Koshiba, Mamiko; Shirakawa, Yuka; Mimura, Koki; Senoo, Aya; Karino, Genta; Nakamura, Shun] Tokyo Univ Agr & Technol, Tokyo, Japan; [Koshiba, Mamiko; Nakamura, Shun] NCNP, Tokyo, Japan	Tokyo University of Agriculture & Technology; National Center for Neurology & Psychiatry - Japan	Koshiba, M (corresponding author), Tokyo Univ Agr & Technol, Tokyo, Japan.	koshiba@cc.tuat.ac.jp	Nakamura, Shun/GVN-8593-2022; Koshiba, Mamiko/AAV-4841-2021		MEXT [21200017]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [22-6]; Comprehensive study on making practical guideline for developmental disorders based on the neuroscientific findings	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Comprehensive study on making practical guideline for developmental disorders based on the neuroscientific findings	This study was supported by MEXT, Grant-in-Aid for Scientific Research on Innovative Areas (21200017), Comprehensive study on making practical guideline for developmental disorders based on the neuroscientific findings, and by the Intramural Research Grant (22-6) for Neurological and Psychiatric Disorders of NCNP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RJ, 1969, ANN NY ACAD SCI, V159, P625, DOI 10.1111/j.1749-6632.1969.tb12967.x; Bolhuis JJ, 1999, BEHAV BRAIN RES, V98, P245, DOI 10.1016/S0166-4328(98)00090-4; BOLHUIS JJ, 1999, DEV ANIMAL BEHAV REA, P176; Bouchet H, 2012, J COMP PSYCHOL, V126, P45, DOI 10.1037/a0025018; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Brown J, 2010, ANIM COGN, V13, P555, DOI 10.1007/s10071-009-0306-0; COLLIAS N, 1953, BEHAVIOUR, V5, P175, DOI 10.1163/156853953X00104; Ellis JMS, 2012, BRAIN BEHAV EVOLUT, V79, P128, DOI 10.1159/000334078; Feltenstein MW, 2005, PSYCHOPHARMACOLOGY, V181, P153, DOI 10.1007/s00213-005-2227-1; Field SE, 2007, NEUROBIOL LEARN MEM, V88, P321, DOI 10.1016/j.nlm.2007.04.001; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; KENT JP, 1989, BEHAVIOUR, V108, P1, DOI 10.1163/156853989X00015; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kondo N, 2012, P ROY SOC B-BIOL SCI, V279, P1937, DOI 10.1098/rspb.2011.2419; Kondo N, 2009, JPN PSYCHOL RES, V51, P197, DOI 10.1111/j.1468-5884.2009.00399.x; Konishi M., 1963, Z TIERPSYCHOL, V20, P349, DOI DOI 10.1111/J.1439-0310.1963.TB01156.X; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Koshiba M, 2011, PROG NEURO-PSYCHOPH, V35, P1499, DOI 10.1016/j.pnpbp.2011.01.021; Lemasson A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-362; MacKay D. M., 1972, NONVERBAL COMMUNICAT, P3; Marx G, 2001, APPL ANIM BEHAV SCI, V75, P61, DOI 10.1016/S0168-1591(01)00180-0; Mascalzoni E, 2010, P NATL ACAD SCI USA, V107, P4483, DOI 10.1073/pnas.0908792107; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; MUIR D, 1979, CAN J PSYCHOL, V33, P320, DOI 10.1037/h0081729; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Salva OR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018802; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; VALLORTIGARA G, 1994, NEUROPSYCHOLOGIA, V32, P417, DOI 10.1016/0028-3932(94)90087-6; Vallortigara G., 1988, ETHOLOGY, V78, P241; Yazaki Y, 1999, J COMP PHYSIOL A, V184, P13, DOI 10.1007/s003590050302	35	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58847	10.1371/journal.pone.0058847	http://dx.doi.org/10.1371/journal.pone.0058847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520539	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900099
J	Torregrosa, A; Taylor, MD; Flint, LE; Flint, AL				Torregrosa, Alicia; Taylor, Maxwell D.; Flint, Lorraine E.; Flint, Alan L.			Present, Future, and Novel Bioclimates of the San Francisco, California Region	PLOS ONE			English	Article							CLIMATE-CHANGE; VEGETATION	Bioclimates are syntheses of climatic variables into biologically relevant categories that facilitate comparative studies of biotic responses to climate conditions. Isobioclimates, unique combinations of bioclimatic indices (continentality, ombrotype, and thermotype), were constructed for northern California coastal ranges based on the Rivas-Martinez worldwide bioclimatic classification system for the end of the 20th century climatology (1971-2000) and end of the 21st century climatology (2070-2099) using two models, Geophysical Fluid Dynamics Laboratory (GFDL) model and the Parallel Climate Model (PCM), under the medium-high A2 emission scenario. The digitally mapped results were used to 1) assess the relative redistribution of isobioclimates and their magnitude of change, 2) quantify the loss of isobioclimates into the future, 3) identify and locate novel isobioclimates projected to appear, and 4) explore compositional change in vegetation types among analog isobioclimate patches. This study used downscaled climate variables to map the isobioclimates at a fine spatial resolution -270 m grid cells. Common to both models of future climate was a large change in thermotype. Changes in ombrotype differed among the two models. The end of 20th century climatology has 83 isobioclimates covering the 63,000 km(2) study area. In both future projections 51 of those isobioclimates disappear over 40,000 km(2). The ordination of vegetation-bioclimate relationships shows very strong correlation of Rivas-Martinez indices with vegetation distribution and composition. Comparisons of vegetation composition among analog patches suggest that vegetation change will be a local rearrangement of species already in place rather than one requiring long distance dispersal. The digitally mapped results facilitate comparison with other Mediterranean regions. Major remaining challenges include predicting vegetation composition of novel isobioclimates and developing metrics to compare differences in climate space.	[Torregrosa, Alicia; Taylor, Maxwell D.] US Geol Survey, Western Geog Sci Ctr, Menlo Pk, CA 94025 USA; [Flint, Lorraine E.; Flint, Alan L.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Torregrosa, A (corresponding author), US Geol Survey, Western Geog Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	atorregrosa@usgs.gov		Torregrosa, Alicia/0000-0001-7361-2241	US Geological Survey Land Change Science Program	US Geological Survey Land Change Science Program(United States Geological Survey)	This work was supported by the US Geological Survey Land Change Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; [Anonymous], 2010, 2010 FOR RANG ASS SA; Barbour MG, 2007, TERRESTRIAL VEGETATI, Vxvii; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Boeye J, 2013, EVOL APPL, V6, P353, DOI 10.1111/eva.12004; Briles CE, 2008, PALAEOGEOGR PALAEOCL, V265, P159, DOI 10.1016/j.palaeo.2008.05.007; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; California Climate and Agricultural Network, 2021, INV CAL AGR CLIM SOL; Castri F., 1973, MEDITERRANEAN TYPE E; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; CODY ML, 1978, ANNU REV ECOL SYST, V9, P265, DOI 10.1146/annurev.es.09.110178.001405; Cress JJ, 2009, TERRESTRIAL ECOSYSTE, P1; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Eklof A, 2012, PHIL T R SOC B, VB367; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; Fischer DT, 2009, J BIOGEOGR, V36, P783, DOI 10.1111/j.1365-2699.2008.02025.x; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Franco G, 2009, CALIFORNIA ENERGY CO; Franco G, 2003, CLIMATE CHANGE RES D; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Koeppen W., 1900, GEOGR Z, V6, P593, DOI DOI 10.2307/27803939; Ku┬ppen, 1900, GEOGR Z, V6, P657, DOI DOI 10.2307/27803939; Lancaster LT, 2013, ORIGIN DIVERSIFICATI, DOI [10.1111/evo.12016, DOI 10.1111/EVO.12016]; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; Leakey ADB, 2012, ADV PHOTOSYNTH RESP, V34, P733, DOI 10.1007/978-94-007-1579-0_29; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; Nalder IA, 1998, AGR FOREST METEOROL, V92, P211, DOI 10.1016/S0168-1923(98)00102-6; Notaro M, 2012, ECOL APPL, V22, P1365, DOI 10.1890/11-1269.1; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Rivas-Martinez S., 1997, Itinera Geobotanica, V10, P5; Rivas-Martinez S., 1995, FOLIA BOTANICA MATRI, V16, P1; Rivas-Martinez S, 2003, CD SERIES PHYTOSOCIO; RIVASMARTINEZ S, 1996, GEOBOTANICA CLIMATOL; RUNDEL PW, 1982, OECOLOGIA, V55, P409, DOI 10.1007/BF00376930; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanderson M, 1999, B AM METEOROLOGICAL, V80; Sawyer J. O., 2008, MANUAL CALIFORNIA VE; Sayre R, 2009, NEW MAP STANDARDIZED, P17; Stein B., 2000, PRECIOUS HERITAGE ST; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; ter Braak, 1996, UNIMODAL MODELS RELA; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thompson RS, 1998, STRATEGY ASSESSING P; Thorne J. H., 2012, DEV APPL DOWNSCALED; Torregrosa A, 1999, THESIS SAN FRANCISCO; Vallis G. K, 2011, CLIMATE OCEANS; Van de Ven CM, 2007, EARTH INTERACT, V11, DOI 10.1175/EI205.1; Westerling AL, 2008, CLIMATIC CHANGE, V87, pS231, DOI 10.1007/s10584-007-9363-z; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wisz MS, 2012, BIOL REV CAMBRIDGE P	56	14	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58450	10.1371/journal.pone.0058450	http://dx.doi.org/10.1371/journal.pone.0058450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526985	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562600023
J	Williams, M; Villarreal, A; Bozhilov, K; Lin, S; Talbot, P				Williams, Monique; Villarreal, Amanda; Bozhilov, Krassimir; Lin, Sabrina; Talbot, Prue			Metal and Silicate Particles Including Nanoparticles Are Present in Electronic Cigarette Cartomizer Fluid and Aerosol	PLOS ONE			English	Article							TRACE-ELEMENTS; TOXICITY; TOBACCO; NICOTINE; SMOKE	Background: Electronic cigarettes (EC) deliver aerosol by heating fluid containing nicotine. Cartomizer EC combine the fluid chamber and heating element in a single unit. Because EC do not burn tobacco, they may be safer than conventional cigarettes. Their use is rapidly increasing worldwide with little prior testing of their aerosol. Objectives: We tested the hypothesis that EC aerosol contains metals derived from various components in EC. Methods: Cartomizer contents and aerosols were analyzed using light and electron microscopy, cytotoxicity testing, x-ray microanalysis, particle counting, and inductively coupled plasma optical emission spectrometry. Results: The filament, a nickel-chromium wire, was coupled to a thicker copper wire coated with silver. The silver coating was sometimes missing. Four tin solder joints attached the wires to each other and coupled the copper/silver wire to the air tube and mouthpiece. All cartomizers had evidence of use before packaging (burn spots on the fibers and electrophoretic movement of fluid in the fibers). Fibers in two cartomizers had green deposits that contained copper. Centrifugation of the fibers produced large pellets containing tin. Tin particles and tin whiskers were identified in cartridge fluid and outer fibers. Cartomizer fluid with tin particles was cytotoxic in assays using human pulmonary fibroblasts. The aerosol contained particles > 1 mu m comprised of tin, silver, iron, nickel, aluminum, and silicate and nanoparticles (<100 nm) of tin, chromium and nickel. The concentrations of nine of eleven elements in EC aerosol were higher than or equal to the corresponding concentrations in conventional cigarette smoke. Many of the elements identified in EC aerosol are known to cause respiratory distress and disease. Conclusions: The presence of metal and silicate particles in cartomizer aerosol demonstrates the need for improved quality control in EC design and manufacture and studies on how EC aerosol impacts the health of users and bystanders.	[Williams, Monique; Villarreal, Amanda; Lin, Sabrina; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bozhilov, Krassimir] Univ Calif Riverside, Cent Facil Adv Microscopy & Microanal, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021		Tobacco-Related Disease Research Program (TRDRP); MARC National Institutes of Health (NIH); TRDRP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM062756] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program (TRDRP)(University of California System); MARC National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Tobacco-Related Disease Research Program (TRDRP) to PT, a Cornelius Hopper Award to MW, a MARC National Institutes of Health (NIH) fellowship to AV, and a TRDRP Postdoctoral Fellowship to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Administration FaD Services DoHaP], 2012, HAMF POT HARMF CONST; Agency for Toxic Substances and Disease Registry (ATSDR), 2007, TOX PROF LEAD; Agency for Toxic Substances and Disease Registry ATSDR, 2010, TOX PROF BOR; Agency for Toxic Substances and Disease Registry (ATSDR), 2004, INT PROF BENZ TOL ET; [ATSDR Services DoHaH], 2008, TOX PROF MAN; ATSDR, 2004, TOX PROF STRONT; ATSDR, 2005, TOXICOLOGICAL PROFIL; ATSDR, 2004, TOX PROF COPP; [ATSDR Agency for Toxic Substances & Disease Registry CfDCaP], 2005, TOX PROF ZINC; ATSDR, 2017, TOX PROF AL; ATSDR, 2007, TOX PROF BAR BAR COM; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CHROM; ATSDR (Agency for Toxic Substances and Disease Registry), 2005, TOX PROF NICK; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Bakand S, 2012, INHAL TOXICOL, V24, P125, DOI 10.3109/08958378.2010.642021; Behar RZ, 2012, J PHARMACOL TOX MET, V66, P238, DOI 10.1016/j.vascn.2012.07.003; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bhabra G, 2009, NAT NANOTECHNOL, V4, P876, DOI [10.1038/NNANO.2009.313, 10.1038/nnano.2009.313]; Bian L, 2011, MED ONCOL, V28, pS560, DOI 10.1007/s12032-010-9655-4; Caponnetto Pasquale, 2011, J Med Case Rep, V5, P585, DOI 10.1186/1752-1947-5-585; Caponnetto P, 2012, EXPERT REV RESP MED, V6, P63, DOI [10.1586/ers.11.92, 10.1586/ERS.11.92]; Chen IL, 2013, NICOTINE TOB RES, V15, P615, DOI 10.1093/ntr/nts145; Chen Wei-hong, 2005, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V23, P366; CHIBA M, 1992, B WORLD HEALTH ORGAN, V70, P269; Etter JF, 2011, EUR RESPIR J, V38, P1219, DOI 10.1183/09031936.00066011; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Flouris AD, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c311; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Horie M., 2011, ENVIRON TOXICOL, V28, P61, DOI [10.1002/tox.20695, DOI 10.1002/TOX.20695]; Hua M, 2011, TOBACCO CONTROL; Kang GS, 2011, ENVIRON HEALTH PERSP, V119, P176, DOI 10.1289/ehp.1002508; Laugesen M., 2008, SAFETY REPORT RUYAN, P1; Lee NC, 2009, LEAD FREE SOLDERING; Liu SH, 2004, J APPL PHYS, V95, P7742, DOI 10.1063/1.1712019; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; [NJDHSS Services NJDoHS], 2007, HAZ SUBST FACT SHEET; Noel JK, 2011, TOB CONTROL, V20, P81, DOI 10.1136/tc.2010.038562; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Odum Lauren E, 2012, J Pharm Pract, V25, P611, DOI 10.1177/0897190012451909; [RTKHS Services NJDoHS], 2009, RIGHT KNOW HAZ SUBST; [RTKHS Services NJDoHS], 2010, RIGHT KNOW HAZ SUBST; [RTKHS Services NJDoHS], 2008, RIGHT KNOW HAZ SUBST; [RTKHS Services NJDoHS], 2011, RIGHT KNOW HAZ SUBST; Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103; SCHULER P, 1958, Ind Med Surg, V27, P432; Smith CJ, 1997, FOOD CHEM TOXICOL, V35, P1107, DOI 10.1016/S0278-6915(97)00063-X; SMITH RA, 1986, J NON-CRYST SOLIDS, V84, P421, DOI 10.1016/0022-3093(86)90805-7; Stohs SJ, 1997, INHAL TOXICOL, V9, P867; Takenaka S, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3454667; Terzano C, 2010, EUR REV MED PHARMACO, V14, P809; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; U.S. Food and Drug Administration, 2012, HARMF POT HARMF CONS; van Dijk WD, 2011, ANAL BIOANAL CHEM, V399, P3573, DOI 10.1007/s00216-011-4701-4; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; Westenberger B., 2009, EVALUATION E CIGARET, P1; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164; Yang W, 2008, INT J PHARMACEUT, V356, P239, DOI 10.1016/j.ijpharm.2008.02.011; Young JA, 2008, J CHEM EDUC, V85, P193; Young JA, 2004, J CHEM EDUC, V81, P1562	61	418	437	11	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57987	10.1371/journal.pone.0057987	http://dx.doi.org/10.1371/journal.pone.0057987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526962	gold, Green Published			2022-12-25	WOS:000317562600011
J	Feng, S; Chen, Y; Gao, YG				Feng, Shu; Chen, Yun; Gao, Yong-Gui			Crystal Structure of 70S Ribosome with Both Cognate tRNAs in the E and P Sites Representing an Authentic Elongation Complex	PLOS ONE			English	Article							ALLOSTERIC 3-SITE MODEL; ESCHERICHIA-COLI; MESSENGER-RNA; BACTERIAL RIBOSOME; READING FRAME; L1 STALK; ANGSTROM RESOLUTION; PROTEIN-SYNTHESIS; PEPTIDE-BOND; FUSIDIC ACID	During the translation cycle, a cognate deacylated tRNA can only move together with the codon into the E site. We here present the first structure of a cognate tRNA bound to the ribosomal E site resulting from translocation by EF-G, in which an entire L1 stalk (L1 protein and L1 rRNA) interacts with E-site tRNA (E-tRNA), representing an authentic ribosome elongation complex. Our results revealed that the Watson-Crick base pairing is formed at the first and second codon-anticodon positions in the E site in the ribosome elongation complex, whereas the codon-anticodon interaction in the third position is indirect. Analysis of the observed conformations of mRNA and E-tRNA suggests that the ribosome intrinsically has the potential to form codon-anticodon interaction in the E site, independently of the mRNA configuration. We also present a detailed description of the biologically relevant position of the entire L1 stalk and its interacting cognate E-tRNA, which provides a better understanding of the structural basis for translation elongation. Furthermore, to gain insight into translocation, we report the positioning of protein L6 contacting EF-G, as well as the conformational change of the C-terminal tail of protein S13 in the decoding center.	[Feng, Shu; Chen, Yun; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Gao, Yong-Gui] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Gao, Yong-Gui] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; MRC Laboratory Molecular Biology	Gao, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ygao@ntu.edu.sg	Gao, Yonggui/A-9473-2015; Gao, Yong Gui/A-2187-2011	Gao, Yonggui/0000-0001-7298-0835; 	Singapore National Research Foundation [NRF-RF2009-RF001-267]; Medical Research Council (UK) [U105184332]	Singapore National Research Foundation(National Research Foundation, Singapore); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Singapore National Research Foundation (NRF-RF2009-RF001-267) and the Medical Research Council (UK) grant U105184332. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blaha G, 2001, COLD SPRING HARB SYM, V66, P135, DOI 10.1101/sqb.2001.66.135; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; BODLEY JW, 1970, J BIOL CHEM, V245, P5656; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Davies C, 1998, J MOL BIOL, V279, P873, DOI 10.1006/jmbi.1998.1780; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Du X, 2003, NUCLEIC ACIDS RES, V31, P2865, DOI 10.1093/nar/gkg382; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KUHBERGER R, 1979, BIOCHEMISTRY-US, V18, P187; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Nechifor R, 2007, J MOL BIOL, V368, P1412, DOI 10.1016/j.jmb.2007.03.009; Nierhaus KH, 2006, BIOCHIMIE, V88, P1013, DOI 10.1016/j.biochi.2006.02.009; Nierhaus KH, 2012, J BIOL CHEM, V287, P27049, DOI 10.1074/jbc.L112.381848; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan DL, 2006, NAT STRUCT MOL BIOL, V13, P354, DOI 10.1038/nsmb1074; Petropoulos AD, 2012, J BIOL CHEM, V287, P11642, DOI 10.1074/jbc.C111.330068; RHEINBERGER HJ, 1981, P NATL ACAD SCI-BIOL, V78, P5310, DOI 10.1073/pnas.78.9.5310; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Trabuco LG, 2010, J MOL BIOL, V402, P741, DOI 10.1016/j.jmb.2010.07.056; Walker SE, 2008, P NATL ACAD SCI USA, V105, P9192, DOI 10.1073/pnas.0710146105; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	49	23	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58829	10.1371/journal.pone.0058829	http://dx.doi.org/10.1371/journal.pone.0058829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527033	Green Published, gold			2022-12-25	WOS:000317562100048
J	Li, B; Baylink, DJ; Deb, C; Zannetti, C; Rajaallah, F; Xing, WR; Walter, MH; Lau, KHW; Qin, XZ				Li, Bo; Baylink, David J.; Deb, Chandra; Zannetti, Claudia; Rajaallah, Fatima; Xing, Weirong; Walter, Michael H.; Lau, K. -H. William; Qin, Xuezhong			1,25-Dihydroxyvitamin D3 Suppresses TLR8 Expression and TLR8-Mediated Inflammatory Responses in Monocytes In Vitro and Experimental Autoimmune Encephalomyelitis In Vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MULTIPLE-SCLEROSIS; D-3; ACTIVATION; VITAMIN-D3; DISEASE; BRAIN; CELLS	1,25-Dihydroxyvitamin D3 (1,25(OH)(2)D-3) suppresses autoimmunity and inflammation; however, the mechanism of its action has not been fully understood. We sought in this study to determine whether the anti-immune/anti-inflammatory action of 1,25(OH)(2)D-3 is in part mediated through an interplay between 1,25(OH)(2)D-3 and toll-like receptor (TLR)7/8 signaling. 1,25(OH)(2)D-3 treatment prior to and/or following experimental autoimmune encephalomyelitis (EAE) induction effectively reduced inflammatory cytokine expression in the spinal cord and ameliorated EAE. These effects were accompanied with a reduction in expression of several TLRs with the most profound effect observed for TLR8. The expression of TLR8 adaptor protein MyD88 was also significantly reduced by 1,25(OH)(2)D-3. To determine the molecular mechanism by which 1,25(OH)(2)D-3 suppresses EAE induction of TLR8 and inflammatory cytokine expression, we evaluated whether 1,25(OH)(2)D-3 can directly inhibit TLR8 signaling and the resulting inflammatory responses in human THP-1 monocytes. 1,25(OH)(2)D-3 treatment not only significantly reduced TLR8 expression but also the expression or activity of MyD88, IRF-4, IRF-7 and NF-kB in monocytes challenged with TLR8 ligands. TLR8 promoter-luciferase reporter assays indicated that 1,25(OH)(2)D-3 decreases TLR8 mRNA level in part via inhibiting TLR8 gene transcription activity. As a result of inhibition on TLR8 signaling cascade at various stages, 1,25(OH)(2)D-3 significantly diminished the TLR8 target gene expression (TNF-alpha and IL-1 beta). In summary, our novel findings suggest that TLR8 is a new target of 1,25(OH)(2)D-3 and may mediate the anti-inflammatory action of 1,25(OH)(2)D-3. Our findings also point to a destructive role of TLR8 in EAE and shed lights on pathogenesis of multiple sclerosis.	[Li, Bo; Baylink, David J.; Deb, Chandra; Rajaallah, Fatima; Walter, Michael H.; Lau, K. -H. William; Qin, Xuezhong] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Zannetti, Claudia] Int Agcy Res Canc, F-69372 Lyon, France; [Xing, Weirong; Lau, K. -H. William; Qin, Xuezhong] Jerry L Pettis Mem Vet Affairs Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA	Loma Linda University; World Health Organization; International Agency for Research on Cancer (IARC)	Qin, XZ (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA.	xqin@llu.edu		Lau, Kin-Hing/0000-0003-1109-5052	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-11-2-0052]; GI Foundation of Loma Linda University; Department of Medicine, Loma Linda University School of Medicine	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); GI Foundation of Loma Linda University; Department of Medicine, Loma Linda University School of Medicine	This study was supported by funding from the Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) under Grant No. W81XWH-11-2-0052 (to David J. Baylink), GI Foundation of Loma Linda University (to Michael Walter) and Department of Medicine, Loma Linda University School of Medicine, (to Xuezhong Qin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becklund BR, 2009, P NATL ACAD SCI USA, V106, P5276, DOI 10.1073/pnas.0813312106; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Do JE, 2008, RHEUMATOLOGY, V47, P840, DOI 10.1093/rheumatology/ken109; Gambhir V, 2011, IMMUNOBIOLOGY, V216, P988, DOI 10.1016/j.imbio.2011.03.011; Gao Z, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/383087; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Katrych O, 2009, CNS NEUROL DISORD-DR, V8, P512, DOI 10.2174/187152709789824598; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Mayne CG, 2011, EUR J IMMUNOL, V41, P822, DOI 10.1002/eji.201040632; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Sloka S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-56; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Spach KM, 2004, PHYSIOL GENOMICS, V18, P141, DOI 10.1152/physiolgenomics.00003.2004; Trudler D, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/497987; Ulzheimer JC, 2010, BIODRUGS, V24, P249, DOI 10.2165/11537160-000000000-00000; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Wingerchuk DM, 2005, J NEUROL NEUROSUR PS, V76, P1294, DOI 10.1136/jnnp.2004.056499; Zannetti C, 2010, J BIOL CHEM, V285, P34773, DOI 10.1074/jbc.M110.133884	34	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58808	10.1371/journal.pone.0058808	http://dx.doi.org/10.1371/journal.pone.0058808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516559	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400064
J	Song, LJ; Li, XM; Jayandharan, GR; Wang, Y; Aslanidi, GV; Ling, C; Zhong, L; Gao, GP; Yoder, MC; Ling, CQ; Tan, MQ; Srivastava, A				Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Wang, Yuan; Aslanidi, George V.; Ling, Chen; Zhong, Li; Gao, Guangping; Yoder, Mervin C.; Ling, Changquan; Tan, Mengqun; Srivastava, Arun			High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; HUMAN BETA-GLOBIN; LEBERS CONGENITAL AMAUROSIS; GROWTH-FACTOR RECEPTOR; HUMAN GENE-THERAPY; HUMAN GAMMA-GLOBIN; HUMAN BONE-MARROW; 2-MEDIATED TRANSDUCTION; PROGENITOR CELLS; TRANSGENE EXPRESSION	We have observed that of the 10 AAV serotypes, AAV6 is the most efficient in transducing primary human hematopoietic stem cells (HSCs), and that the transduction efficiency can be further increased by specifically mutating single surface-exposed tyrosine (Y) residues on AAV6 capsids. In the present studies, we combined the two mutations to generate a tyrosine double-mutant (Y705+731F) AAV6 vector, with which >70% of CD34(+) cells could be transduced. With the long-term objective of developing recombinant AAV vectors for the potential gene therapy of human hemoglobinopathies, we generated the wild-type (WT) and tyrosine-mutant AAV6 vectors containing the following erythroid cell-specific promoters: beta-globin promoter (beta p) with the upstream hyper-sensitive site 2 (HS2) enhancer from the beta-globin locus control region (HS2-beta bp), and the human parvovirus B19 promoter at map unit 6 (B19p6). Transgene expression from the B19p6 was significantly higher than that from the HS2-beta p, and increased up to 30-fold and up to 20-fold, respectively, following erythropoietin (Epo)-induced differentiation of CD34(+) cells in vitro. Transgene expression from the B19p6 or the HS2-beta p was also evaluated in an immuno-deficient xenograft mouse model in vivo. Whereas low levels of expression were detected from the B19p6 in the WT AAV6 capsid, and that from the HS2-beta p in the Y705+ 731F AAV6 capsid, transgene expression from the B19p6 promoter in the Y705+ 731F AAV6 capsid was significantly higher than that from the HS2-beta p, and was detectable up to 12 weeks post-transplantation in primary recipients, and up to 6 additional weeks in secondary transplanted animals. These data demonstrate the feasibility of the use of the novel Y705+ 731F AAV6-B19p6 vectors for high-efficiency transduction of HSCs as well as expression of the b-globin gene in erythroid progenitor cells for the potential gene therapy of human hemoglobinopathies such as beta-thalassemia and sickle cell disease.	[Song, Liujiang; Tan, Mengqun] Cent S Univ, Sch Basic Med Sci, Dept Physiol, Expt Hematol Lab, Changsha, Hunan, Peoples R China; [Song, Liujiang; Tan, Mengqun] Shenzhen Inst Xiangya Biomed, Shenzhen, Peoples R China; [Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Aslanidi, George V.; Ling, Chen; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL USA; [Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Aslanidi, George V.; Ling, Chen; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL USA; [Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Aslanidi, George V.; Ling, Chen; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA; [Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India; [Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Wang, Yuan; Ling, Changquan] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Wang, Yuan; Ling, Changquan] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China; [Zhong, Li; Gao, Guangping] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Zhong, Li] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Yoder, Mervin C.] Indiana Univ Sch Med, Herman B Well Ctr Pediat Res, Indianapolis, IN USA; [Yoder, Mervin C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Srivastava, Arun] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Srivastava, Arun] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL USA	Central South University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Naval Medical University; Shanghai University of Traditional Chinese Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tan, MQ (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Physiol, Expt Hematol Lab, Changsha, Hunan, Peoples R China.	mqtan26@163.com; aruns@peds.ufl.edu	Zhong, Li/GZM-4358-2022; Ling, Changquan/J-2108-2016; Aslanidi, George/C-5680-2019	Zhong, Li/0000-0003-1611-5171; Ling, Changquan/0000-0003-3476-6445; Yoder, Mervin/0000-0003-4354-7631; Ling, Changquan/0000-0002-0037-4059; Ling, Chen/0000-0003-1527-1471; Aslanidi, George/0000-0002-2726-8627	Fanconi Anemia Research Fund, Inc.; Natural Science Foundation of China (NSFC) [30971299]; Public Health Service [R01 HL-065770, HL-076901, P01 DK-058327, R01 HL-097088]; National Institutes of Health; Department of Biotechnology, Government of India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076901, R01HL097088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	Fanconi Anemia Research Fund, Inc.; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by a grant from the Fanconi Anemia Research Fund, Inc. (to LZ), a Natural Science Foundation of China (NSFC) grant 30971299 (to MT), and Public Health Service grants R01 HL-065770, HL-076901, P01 DK-058327 (Project 1), and R01 HL-097088 from the National Institutes of Health (to AS). GRJ was supported in part by an Overseas Associate Fellowship-2006 from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN H, 1990, BIOCHEM J, V271, P785, DOI 10.1042/bj2710785; Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Aslanidi GV, 2013, PLOS ONE IN PRESS; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cheng B, 2012, GENE THER, V19, P375, DOI 10.1038/gt.2011.105; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dalkara D, 2012, GENE THER, V19, P176, DOI 10.1038/gt.2011.163; Denard J, 2012, J VIROL, V86, P6620, DOI 10.1128/JVI.00297-12; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fisher KJ, 1996, J VIROL, V70, P520, DOI 10.1128/JVI.70.1.520-532.1996; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Han ZC, 2008, HUM GENE THER, V19, P267, DOI 10.1089/hum.2007.161; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Kauss MA, 2010, HUM GENE THER, V21, P1129, DOI 10.1089/hum.2010.016; Kurpad C, 1999, J HEMATOTH STEM CELL, V8, P585, DOI 10.1089/152581699319740; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maina N, 2008, HUM GENE THER, V19, P365, DOI 10.1089/hum.2007.173; Maina N, 2008, HUM GENE THER, V19, P376, DOI 10.1089/hum.2007.143; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; MILLER JL, 1993, BLOOD, V82, P1900; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Miyachi T, 1999, BRIT J CANCER, V79, P1018, DOI 10.1038/sj.bjc.6690163; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Oh IH, 2004, EXP HEMATOL, V32, P461, DOI 10.1016/j.exphem.2004.02.001; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Pawliuk R, 1998, ANN NY ACAD SCI, V850, P151, DOI 10.1111/j.1749-6632.1998.tb10472.x; Ponnazhagan S, 1997, J VIROL, V71, P3098, DOI 10.1128/JVI.71.4.3098-3104.1997; Ponnazhagan S, 1997, J VIROL, V71, P8262, DOI 10.1128/JVI.71.11.8262-8267.1997; PONNAZHAGAN S, 1995, J VIROL, V69, P8096, DOI 10.1128/JVI.69.12.8096-8101.1995; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Qiao CP, 2010, HUM GENE THER, V21, P1343, DOI 10.1089/hum.2010.003; Schuhmann NK, 2010, EXP HEMATOL, V38, P707, DOI 10.1016/j.exphem.2010.04.016; SHADE RO, 1986, J VIROL, V58, P921, DOI 10.1128/JVI.58.3.921-936.1986; Song L, 2013, CYTOTHERAPY IN PRESS; Song SH, 2004, P NATL ACAD SCI USA, V101, P2112, DOI 10.1073/pnas.0307833100; Tan MQ, 2001, MOL THER, V3, P940, DOI 10.1006/mthe.2001.0346; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; Ussher JE, 2010, HUM GENE THER, V21, P1675, DOI 10.1089/hum.2010.087; Veldwijk MR, 2010, CYTOTHERAPY, V12, P107, DOI 10.3109/14653240903348293; WALSH CE, 1992, P NATL ACAD SCI USA, V89, P7257, DOI 10.1073/pnas.89.15.7257; Wang XS, 1995, P NATL ACAD SCI USA, V92, P12416, DOI 10.1073/pnas.92.26.12416; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Weltner J, 2012, J VIROL, V86, P4463, DOI 10.1128/JVI.06302-11; Wilber A, 2011, BLOOD, V117, P2817, DOI 10.1182/blood-2010-08-300723; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; YAKOBSON B, 1987, J VIROL, V61, P972, DOI 10.1128/JVI.61.4.972-981.1987; Zhong L, 2006, HUM GENE THER, V17, P321, DOI 10.1089/hum.2006.17.321; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhou SZ, 1996, GENE THER, V3, P223	64	25	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58757	10.1371/journal.pone.0058757	http://dx.doi.org/10.1371/journal.pone.0058757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516552	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400061
J	Zocevic, A; Vorimore, F; Vicari, N; Gasparini, J; Jacquin, L; Sachse, K; Magnino, S; Laroucau, K				Zocevic, Aleksandar; Vorimore, Fabien; Vicari, Nadia; Gasparini, Julien; Jacquin, Lisa; Sachse, Konrad; Magnino, Simone; Laroucau, Karine			A Real-Time PCR Assay for the Detection of Atypical Strains of Chlamydiaceae from Pigeons	PLOS ONE			English	Article							PSITTACI INFECTIONS; POULTRY	Recent evidence of the occurrence of atypical Chlamydiaceae strains in pigeons, different from the established Chlamydiaceae, requires the development of a specific and rapid detection tool to investigate their prevalence and significance. Here is described a new real-time PCR assay that allows specific detection of atypical Chlamydiaceae from pigeons. The assay has been used to assess the dissemination of these strains in field samples collected from Parisian pigeon populations in 2009. The results suggest a limited dissemination compared to the usually higher prevalence of Chlamydia psittaci that is the main species associated with avian chlamydiosis.	[Zocevic, Aleksandar; Vorimore, Fabien; Laroucau, Karine] Univ Paris Est, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France; [Vicari, Nadia; Magnino, Simone] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Pavia, Italy; [Gasparini, Julien; Jacquin, Lisa] UPMC, CNRS, Lab Ecol & Evolut, ENS,UMR 7625, Paris, France; [Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany	Ecole Nationale Veterinaire d'Alfort (ENVA); IZS Lombardia e Emilia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Laroucau, K (corresponding author), Univ Paris Est, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France.	karine.laroucau@anses.fr	Gasparini, Julien/J-9263-2012; Vicari, Nadia/HCH-8694-2022; Laroucau, Karine/GSO-1980-2022; Sachse, Konrad/GWC-4999-2022; Jacquin, Lisa/H-6878-2019	Laroucau, Karine/0000-0001-7605-8602; Sachse, Konrad/0000-0003-1230-1786; Jacquin, Lisa/0000-0002-0521-6113; Vicari, Nadia/0000-0001-8156-0138	Region Ile-de-France [2008-07]	Region Ile-de-France(Region Ile-de-France)	This work was supported by grants from Region Ile-de-France (post-doctoral fellowship and Sustainable Development 145 Network R2DS, No. 2008-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AA, 1997, J VET DIAGN INVEST, V9, P159, DOI 10.1177/104063879700900209; Deschuyffeleer TPG, 2012, ANN OCCUP HYG, V56, P340, DOI 10.1093/annhyg/mer102; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Gasparini J, 2011, ENVIRON MICROBIOL, V13, P3186, DOI 10.1111/j.1462-2920.2011.02575.x; Greub Gilbert, 2010, Int J Syst Evol Microbiol, V60, P2694, DOI 10.1099/ijs.0.028233-0; Herrmann B, 2000, APPL ENVIRON MICROB, V66, P3654, DOI 10.1128/AEM.66.8.3654-3656.2000; Laroucau K, 2009, INFECT GENET EVOL, V9, P1240, DOI 10.1016/j.meegid.2009.08.005; Lemus JA, 2010, PLOS ONE; Menard A, 2006, J MED MICROBIOL, V55, P471, DOI 10.1099/jmm.0.46335-0; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; Sachse K, 2012, VET MICROBIOL, V157, P476, DOI 10.1016/j.vetmic.2012.01.002; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vicari N., 2009, 1 EUR M AN CHLAM ZOO; Zocevic A, 2012, ENVIRON MICROBIOL, V14, P2212, DOI 10.1111/j.1462-2920.2012.02800.x	18	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58741	10.1371/journal.pone.0058741	http://dx.doi.org/10.1371/journal.pone.0058741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516548	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400059
J	Bolton, CC; Gatica, G; Parada, V				Contreras Bolton, Carlos; Gatica, Gustavo; Parada, Victor			Automatically Generated Algorithms for the Vertex Coloring Problem	PLOS ONE			English	Article							GENETIC ALGORITHMS; SEARCH HEURISTICS; GRAPH; OPTIMIZATION	The vertex coloring problem is a classical problem in combinatorial optimization that consists of assigning a color to each vertex of a graph such that no adjacent vertices share the same color, minimizing the number of colors used. Despite the various practical applications that exist for this problem, its NP-hardness still represents a computational challenge. Some of the best computational results obtained for this problem are consequences of hybridizing the various known heuristics. Automatically revising the space constituted by combining these techniques to find the most adequate combination has received less attention. In this paper, we propose exploring the heuristics space for the vertex coloring problem using evolutionary algorithms. We automatically generate three new algorithms by combining elementary heuristics. To evaluate the new algorithms, a computational experiment was performed that allowed comparing them numerically with existing heuristics. The obtained algorithms present an average 29.97% relative error, while four other heuristics selected from the literature present a 59.73% error, considering 29 of the more difficult instances in the DIMACS benchmark.	[Contreras Bolton, Carlos; Parada, Victor] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile; [Gatica, Gustavo] Univ Andres Bello, Escuela Informat, Santiago, Chile	Universidad de Santiago de Chile; Universidad Andres Bello	Parada, V (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	victor.parada@usach.cl	Contreras-Bolton, Carlos/D-9624-2016; Parada, Victor/AHD-6455-2022; Parada, Victor/M-5840-2014	Contreras-Bolton, Carlos/0000-0001-9549-4143; Parada, Victor/0000-0002-8649-5694; Gustavo, Gatica/0000-0002-1816-6856	Complex Engineering Systems Institute [ICM: P-05-004-F, CONICYT: FBO16]; DICYT-USACH	Complex Engineering Systems Institute; DICYT-USACH	Funding was provided by the Complex Engineering Systems Institute (ICM: P-05-004-F, CONICYT: FBO16) and DICYT-USACH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenzeller M, 2009, NUMER INSIGHT, P1, DOI 10.1201/9781420011326; Al-Omari H, 2006, J MATH STAT, V2, P739; [Anonymous], 1998, GENETIC ALGORITHMS G; [Anonymous], 2001, BOOST GRAPH LIB USER; [Anonymous], 1983, DATA STRUCTURES ALGO; Bain S, 2005, LECT NOTES COMPUT SC, V3709, P732, DOI 10.1007/11564751_54; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; Burke E, 2010, J SCHED, V13, P1, DOI 10.1007/s10951-010-0161-5; Burke EK, 2007, EUR J OPER RES, V176, P177, DOI 10.1016/j.ejor.2005.08.012; Burke EK, 2010, IEEE T EVOLUT COMPUT, V14, P942, DOI 10.1109/TEVC.2010.2041061; Culberson J.C., 1996, DIMACS SERIES DISCRE, P245; Epstein S.L., 2002, LNCS, V2470, P525; Fukunaga A, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P641; Fukunaga AS, 2008, EVOL COMPUT, V16, P31, DOI 10.1162/evco.2008.16.1.31; Garey M.R., 1979, COMPUTERS INTRACTABI; GEORGE A, 1989, SIAM REV, V31, P1, DOI 10.1137/1031001; GREFENSTETTE JJ, 1986, IEEE T SYST MAN CYB, V16, P122, DOI 10.1109/TSMC.1986.289288; HERTZ A, 1987, COMPUTING, V39, P345, DOI 10.1007/BF02239976; Johnson DS, 1996, DIMACS SERIES DISCRE, V26, P1; Koza J.R., 2003, GENETIC PROGRAMMING; Koza JR, 1992, GENETIC PROGRAMMING; LEIGHTON FT, 1979, J RES NAT BUR STAND, V84, P489, DOI 10.6028/jres.084.024; Malaguti E, 2008, INFORMS J COMPUT, V20, P302, DOI 10.1287/ijoc.1070.0245; Malaguti E, 2011, DISCRETE OPTIM, V8, P174, DOI 10.1016/j.disopt.2010.07.005; Malaguti E, 2010, INT T OPER RES, V17, P1, DOI 10.1111/j.1475-3995.2009.00696.x; Matula David W, 1972, GRAPH THEORY COMPUT, P109, DOI DOI 10.1016/B978-1-4832-3187-7.50015-5; Mendez-Diaz I, 2006, DISCRETE APPL MATH, V154, P826, DOI 10.1016/j.dam.2005.05.022; Mendez-Diaz I, 2008, DISCRETE APPL MATH, V156, P159, DOI 10.1016/j.dam.2006.07.010; Minton S, 1993, P 13 INT JOINT C ART, P922; Nareyek A, 2004, APPL OPTIM, V86, P523; Poli R., 2008, FIELD GUIDE GENETIC; Porumbel DC, 2010, COMPUT OPER RES, V37, P1822, DOI 10.1016/j.cor.2010.01.015; Rothlauf F., 2006, REPRESENTATIONS GENE; Titiloye O, 2011, LECT NOTES ARTIF INT, V6682, P553, DOI 10.1007/978-3-642-22000-5_57; Titiloye O, 2011, DISCRETE OPTIM, V8, P376, DOI 10.1016/j.disopt.2010.12.001	35	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58551	10.1371/journal.pone.0058551	http://dx.doi.org/10.1371/journal.pone.0058551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516506	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200085
J	Fidler, V; Nagelkerke, N				Fidler, Vaclav; Nagelkerke, Nico			The Mantel-Haenszel Procedure Revisited: Models and Generalizations	PLOS ONE			English	Article							BINARY DATA	Several statistical methods have been developed for adjusting the Odds Ratio of the relation between two dichotomous variables X and Y for some confounders Z. With the exception of the Mantel-Haenszel method, commonly used methods, notably binary logistic regression, are not symmetrical in X and Y. The classical Mantel-Haenszel method however only works for confounders with a limited number of discrete strata, which limits its utility, and appears to have no basis in statistical models. Here we revisit the Mantel-Haenszel method and propose an extension to continuous and vector valued Z. The idea is to replace the observed cell entries in strata of the Mantel-Haenszel procedure by subject specific classification probabilities for the four possible values of (X,Y) predicted by a suitable statistical model. For situations where X and Y can be treated symmetrically we propose and explore the multinomial logistic model. Under the homogeneity hypothesis, which states that the odds ratio does not depend on Z, the logarithm of the odds ratio estimator can be expressed as a simple linear combination of three parameters of this model. Methods for testing the homogeneity hypothesis are proposed. The relationship between this method and binary logistic regression is explored. A numerical example using survey data is presented.	[Fidler, Vaclav] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands; [Nagelkerke, Nico] United Arab Emirates Univ, Inst Publ Hlth, Al Ain, U Arab Emirates; [Nagelkerke, Nico] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Nagelkerke, Nico] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	University of Groningen; United Arab Emirates University; University of Manitoba; Erasmus University Rotterdam; Erasmus MC	Fidler, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands.	v.fidler@umcg.nl						Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Fidler V, 2013, PARTIALOR R PACKAGE; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lash T. L, 2008, MODERN EPIDEMIOLOGY, V3rd; LECESSIE S, 1994, J R STAT SOC C-APPL, V43, P95; MANTEL N, 1959, J NATL CANCER I, V22, P719; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Pike MC, 1979, EPIDEMIOL COMMUNITY, V33, P104; R Core Team, 2012, R LANG ENV STAT COMP; Robins JM, 2001, EPIDEMIOLOGY, V12, P313, DOI 10.1097/00001648-200105000-00011	11	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58327	10.1371/journal.pone.0058327	http://dx.doi.org/10.1371/journal.pone.0058327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516463	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200056
J	Georgi, JA; Sipla, JS; Forster, CA				Georgi, Justin A.; Sipla, Justin S.; Forster, Catherine A.			Turning Semicircular Canal Function on Its Head: Dinosaurs and a Novel Vestibular Analysis	PLOS ONE			English	Article							EARLY EVOLUTION; BONY LABYRINTH; BODY-SIZE; BIOMECHANICS; ALLOMETRY; SYSTEM; LENGTH; MOLE; MASS	Previous investigations have correlated vestibular function to locomotion in vertebrates by scaling semicircular duct radius of curvature to body mass. However, this method fails to discriminate bipedal from quadrupedal non-avian dinosaurs. Because they exhibit a broad range of relative head sizes, we use dinosaurs to test the hypothesis that semicircular ducts scale more closely with head size. Comparing the area enclosed by each semicircular canal to estimated body mass and to two different measures of head size, skull length and estimated head mass, reveals significant patterns that corroborate a connection between physical parameters of the head and semicircular canal morphology. Head mass more strongly correlates with anterior semicircular canal size than does body mass and statistically separates bipedal from quadrupedal taxa, with bipeds exhibiting relatively larger canals. This morphologic dichotomy likely reflects adaptations of the vestibular system to stability demands associated with terrestrial locomotion on two, versus four, feet. This new method has implications for reinterpreting previous studies and informing future studies on the connection between locomotion type and vestibular function.	[Georgi, Justin A.] Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA; [Sipla, Justin S.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Midwestern University; University of Iowa; George Washington University	Georgi, JA (corresponding author), Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA.	jgeorgi@midwestern.edu		Sipla, Justin/0000-0001-8171-8126	Jurassic Foundation	Jurassic Foundation	This study was funded by Jurassic Foundation (jurasicfoundation.org) grants to the first and second authors. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J. A., 1913, MEM AM MUS NAT HIST, V1, P101; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Butler RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2041, DOI 10.1098/rspb.2007.0367; Choiniere J, 2010, THESIS G WASHINGTON; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Christiansen Per, 1999, Historical Biology, V13, P269; Clarke AH, 2005, J VESTIBUL RES-EQUIL, V15, P65; Dashzeveg D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)498[0001:NSSDEA]2.0.CO;2; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; Eberth DA, 1993, GEOLOGICAL ASS CANAD, P84; Falster D., 2006, STANDARDISED MAJOR A; Fish FE, 2003, J EXP BIOL, V206, P667, DOI 10.1242/jeb.00144; Fish FE, 2000, PHYSIOL BIOCHEM ZOOL, V73, P683, DOI 10.1086/318108; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; foundation R, 2009, R STAT COMP SOFTW; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; GRAND TI, 1990, ANAT EMBRYOL, V182, P85; Gray AA, 1906, P R SOC LOND B-CONTA, V78, P284, DOI 10.1098/rspb.1906.0063; GRAY AA, 1907, LABYRINTH ANIMALS, V1; GRAY AA, 1908, LABYRINTH ANIMALS, V2; Green AM, 2010, EXP BRAIN RES, V200, P197, DOI 10.1007/s00221-009-2054-4; Gunz P, 2012, J ANAT, V220, P529, DOI 10.1111/j.1469-7580.2012.01493.x; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hicks JF, 2002, GEOL S AM S, P35; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; HOWLAND HC, 1973, Z MORPHOL TIERE, V75, P283, DOI 10.1007/BF00288475; Huterer M, 2002, J NEUROPHYSIOL, V88, P13, DOI 10.1152/jn.2002.88.1.13; JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019; LINDENLAUB T, 1994, ANAT RECORD, V240, P286, DOI 10.1002/ar.1092400217; Maddison WP, 2017, MESQUITE MODULAR SYS; Martin John, 1998, Oryctos, V1, P113; MathWorks, 2010, MATLAB; Mayne R, 1965, NASA SP77, P57; McVean A, 1999, COMP BIOCHEM PHYS A, V123, P173, DOI 10.1016/S1095-6433(99)00047-1; Midford P. E., 2010, PDAP PDTREE PACKAGE; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Oikawa S, 2003, FISHERIES SCI, V69, P687, DOI 10.1046/j.1444-2906.2003.00675.x; Rabbitt RD, 2004, SPR HDB AUD, P153; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Savelle JM, 1996, J ARCHAEOL SCI, V23, P705, DOI 10.1006/jasc.1996.0066; Schoonaert K, 2007, J ANAT, V210, P518, DOI 10.1111/j.1469-7580.2007.00720.x; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sereno PC, 2007, ACTA PALAEONTOL POL, V52, P275; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; Spoor F, 2003, J HUM EVOL, V44, P141, DOI 10.1016/S0047-2484(02)00166-5; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Spoor F, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P257; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Taylor MP, 2010, GEOL SOC SPEC PUBL, V343, P361, DOI 10.1144/SP343.22; TENKATE JH, 1970, J EXP BIOL, V53, P495; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Trujillo K.C., 2006, GEOLOGICAL SOC AM AB, V38, P7; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Visage Imaging, 2009, VIS IM; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Weishampel DB., 2004, DINOSAURIA; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048	60	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58517	10.1371/journal.pone.0058517	http://dx.doi.org/10.1371/journal.pone.0058517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516495	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849200076
J	Nakamura, T; Takumi, T; Takano, A; Hatanaka, F; Yamamoto, Y				Nakamura, Toru; Takumi, Toru; Takano, Atsuko; Hatanaka, Fumiyuki; Yamamoto, Yoshiharu			Characterization and Modeling of Intermittent Locomotor Dynamics in Clock Gene-Deficient Mice	PLOS ONE			English	Article							D-ASPARTATE ANTAGONIST; MICROTUS-ARVALIS; CIRCADIAN GENES; HEAVY TAILS; COMMON VOLE; RHYTHMS; LESIONS; DEPRESSION; DISORDERS; COMPONENT	The scale-invariant and intermittent dynamics of animal behavior are attracting scientific interest. Recent findings concerning the statistical laws of behavioral organization shared between healthy humans and wild-type mice (WT) and their alterations in human depression patients and circadian clock gene (Period 2; Per2) mutant mice indicate that clock genes play functional roles in intermittent, ultradian locomotor dynamics. They also claim the clinical and biological importance of the laws as objective biobehavioral measures or endophenotypes for psychiatric disorders. In this study, to elucidate the roles of breakdown of the broader circadian regulatory circuit in intermittent behavioral dynamics, we studied the statistical properties and rhythmicity of locomotor activity in Per2 mutants and mice deficient in other clock genes (Bmal1, Clock). We performed wavelet analysis to examine circadian and ultradian rhythms and estimated the cumulative distributions of resting period durations during which locomotor activity levels are continuously lower than a predefined threshold value. The wavelet analysis revealed significant amplification of ultradian rhythms in the BMAL1-deficient mice, and instability in the Per2 mutants. The resting period distributions followed a power-law form in all mice. While the distributions for the BMAL1-deficient and Clock mutant mice were almost identical to those for the WT mice, with no significant differences in their parameter (power-law scaling exponent), only the Per2 mutant mice showed consistently and significantly lower values of the scaling exponent, indicating the increased intermittency in ultradian locomotor dynamics. Furthermore, based on a stochastic priority queuing model, we explained the power-law nature of resting period distributions, as well as its alterations shared with human depressive patients and Per2 mutant mice. Our findings lead to the development of a novel mathematical model for abnormal behaviors in psychiatric disorders.	[Nakamura, Toru; Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Takumi, Toru; Hatanaka, Fumiyuki] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Takano, Atsuko] Osaka Univ, Res Ctr Child Mental Dev, Osaka, Japan	University of Tokyo; Hiroshima University; Osaka University	Yamamoto, Y (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	yamamoto@p.u-tokyo.ac.jp		Yamamoto, Yoshiharu/0000-0002-1132-0355; nakamura, toru/0000-0002-5340-6333	Ministry of Education, Culture, Sports, Science and Technology [23240094, 23700795]; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23240094, 23700795] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (A) [23240094] (to YY) and Grant-in-Aid for Young Scientists (B) [23700795] (to TN) from the Ministry of Education, Culture, Sports, Science and Technology and by Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (to TT and YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; GERKEMA MP, 1993, J BIOL RHYTHM, V8, P151, DOI 10.1177/074873049300800205; GERKEMA MP, 1990, J BIOL RHYTHM, V5, P81, DOI 10.1177/074873049000500201; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; NAKAMURA T, 2007, PHYS REV LETT, V99, DOI DOI 10.1103/PHYSREVLETT.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Sano W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043539; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; Sorribes A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002075; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58884	10.1371/journal.pone.0058884	http://dx.doi.org/10.1371/journal.pone.0058884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516567	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849200118
J	Sookoian, S; Pirola, CJ				Sookoian, Silvia; Pirola, Carlos J.			Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease	PLOS ONE			English	Article							GENE PRIORITIZATION; SUSCEPTIBILITY; MICRORNAS; VARIANT; PNPLA3; RISK; TOOL	The abnormal accumulation of fat in the liver is often related either to metabolic risk factors associated with metabolic syndrome in the absence of alcohol consumption (nonalcoholic fatty liver disease, NAFLD) or to chronic alcohol consumption (alcoholic fatty liver disease, AFLD). Clinical and histological studies suggest that NAFLD and AFLD share pathogenic mechanisms. Nevertheless, current data are still inconclusive as to whether the underlying biological process and disease pathways of NAFLD and AFLD are alike. Our primary aim was to integrate omics and physiological data to answer the question of whether NAFLD and AFLD share molecular processes that lead to disease development. We also explored the extent to which insulin resistance (IR) is a distinctive feature of NAFLD. To answer these questions, we used systems biology approaches, such as gene enrichment analysis, protein-protein interaction networks, and gene prioritization, based on multi-level data extracted by computational data mining. We observed that the leading disease pathways associated with NAFLD did not significantly differ from those of AFLD. However, systems biology revealed the importance of each molecular process behind each of the two diseases, and dissected distinctive molecular NAFLD and AFLD-signatures. Comparative co-analysis of NAFLD and AFLD clarified the participation of NAFLD, but not AFLD, in cardiovascular disease, and showed that insulin signaling is impaired in fatty liver regardless of the noxa, but the putative regulatory mechanisms associated with NAFLD seem to encompass a complex network of genes and proteins, plausible of epigenetic modifications. Gene prioritization showed a cancer-related functional map that suggests that the fatty transformation of the liver tissue is regardless of the cause, an emerging mechanism of ubiquitous oncogenic activation. In conclusion, similar underlying disease mechanisms lead to NAFLD and AFLD, but specific ones depict a particular disease signature that has a different impact on the systemic context.	[Sookoian, Silvia] Univ Buenos Aires, Natl Council Sci & Technol Res CONICET, Inst Med Res IDIM, Dept Clin & Mol Hepatol, Buenos Aires, DF, Argentina; [Pirola, Carlos J.] Univ Buenos Aires, Natl Council Sci & Technol Res CONICET, Inst Med Res IDIM, Dept Mol Genet & Biol Complex Dis, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sookoian, S (corresponding author), Univ Buenos Aires, Natl Council Sci & Technol Res CONICET, Inst Med Res IDIM, Dept Clin & Mol Hepatol, Buenos Aires, DF, Argentina.	sookoian.silvia@lanari.fmed.uba.ar; pirola.carlos@lanari.fmed.uba.ar	Pirola, Carlos Jose/H-2720-2019	Pirola, Carlos Jose/0000-0001-8234-4058	Agencia Nacional de Promocion Cienti-fica y Tecnologica [PICT 2008-1521, PICT 2010-0441]; Universidad de Buenos Aires [UBACYT CM04]	Agencia Nacional de Promocion Cienti-fica y Tecnologica(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This study was partially supported by grants PICT 2008-1521 and PICT 2010-0441 (Agencia Nacional de Promocion Cienti-fica y Tecnologica) and UBACYT CM04 (Universidad de Buenos Aires). SS and CJP belong to Consejo Nacional de Investigaciones Cienti-ficas (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Barbosa-Silva A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-435; Barbosa-Silva A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-70; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Guzman G, 2008, ARCH PATHOL LAB MED, V132, P1761, DOI 10.1043/1543-2165-132.11.1761; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Hwang ST, 2010, J GASTROEN HEPATOL, V25, P562, DOI 10.1111/j.1440-1746.2009.06117.x; Pirola CJ, 2013, GUT, V62, P1356, DOI 10.1136/gutjnl-2012-302962; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; Lefkowitch Jay H, 2005, Clin Liver Dis, V9, P37, DOI 10.1016/j.cld.2004.11.001; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pavlopoulos Georgios A, 2011, BMC Res Notes, V4, P384, DOI 10.1186/1756-0500-4-384; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Sookoian S, 2010, J HYPERTENS, V28, P1194, DOI 10.1097/HJH.0b013e328337f6d5; Sookoian S, 2010, MOL GENET METAB, V99, P80, DOI 10.1016/j.ymgme.2009.08.004; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Sorensen HT, 2003, J CLIN GASTROENTEROL, V36, P356, DOI 10.1097/00004836-200304000-00015; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Syn WK, 2009, SEMIN LIVER DIS, V29, P200, DOI 10.1055/s-0029-1214375; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Trepo E, 2011, J HEPATOL, V55, P906, DOI 10.1016/j.jhep.2011.01.028; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974	33	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58895	10.1371/journal.pone.0058895	http://dx.doi.org/10.1371/journal.pone.0058895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516571	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200119
J	Wong, CKH; Lam, CLK; Poon, JTC; Kwong, DLW				Wong, Carlos K. H.; Lam, Cindy L. K.; Poon, Jensen T. C.; Kwong, Dora L. W.			Clinical Correlates of Health Preference and Generic Health-Related Quality of Life in Patients with Colorectal Neoplasms	PLOS ONE			English	Article							CANCER PATIENTS; SURVIVORS; PREDICTORS; EQUIVALENT; RESECTION; COLON; SF-6D	Background: The aims of the study were to assess the health preference and health-related quality of life (HRQOL) in patients with colorectal neoplasms (CRN), and to determine the clinical correlates that significantly influence the HRQOL of patients. Methods: Five hundred and fifty-four CRN patients, inclusive of colorectal polyp or cancer, who attended the colorectal specialist outpatient clinic at Queen Mary Hospital in Hong Kong between October 2009 and July 2010, were included. Patients were interviewed with questionnaires on socio-demographic characteristics, and generic and health preference measures of HRQOL using the SF-12 and SF-6D Health Surveys, respectively. Clinical information on stage of disease at diagnosis, time since diagnosis, primary tumour site was extracted from electronic case record. Mean HRQOL and health preference scores of CRN patients were compared with age-sex matched controls from the Chinese general population using independent t-test. Multiple linear regression analyses were conducted to explore the associations of clinical characteristics with HRQOL measures with the adjustment of socio-demographic characteristics. Results: Cross-sectional data of 515 eligible patients responded to the whole questionnaires were included in outcome analysis. In comparison with age-sex matched normative values, CRN patients reported comparable physical-related HRQOL but better mental-related HRQOL. Amongst CRN patients, time since diagnosis was positively associated with health preference score whilst patients with rectal neoplasms had lower health preference and physical-related HRQOL scores than those with sigmoid neoplasms. Health preference and HRQOL scores were significantly lower in patients with stage IV colorectal cancer than those with other less severe stages, indicating that progressive decline from low-risk polyp to stage IV colorectal cancer was observed in HRQOL scores. Conclusion: In CRN patients, a more advanced stage of disease was associated with worse HRQOL scores. Despite potentially adverse effect of disease on physical-related HRQOL, the mental-related HRQOL of CRN patients were better than that of Chinese general population.	[Wong, Carlos K. H.; Lam, Cindy L. K.] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Poon, Jensen T. C.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwong, Dora L. W.] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Wong, CKH (corresponding author), Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China.	carlosho@hku.hk	Wong, Carlos King Ho/B-4322-2011	Wong, Carlos King Ho/0000-0002-6895-6071	Committee of Research and Conference Grants of the University of Hong Kong [200907176135]; Health and Health Service Research Fund (HHSRF) of Food and Health Bureau, Hong Kong Special Administrative Region [08090851]	Committee of Research and Conference Grants of the University of Hong Kong; Health and Health Service Research Fund (HHSRF) of Food and Health Bureau, Hong Kong Special Administrative Region	This study was financially supported by the Committee of Research and Conference Grants (Project code 200907176135) of the University of Hong Kong, and Health and Health Service Research Fund (HHSRF #08090851) of Food and Health Bureau, Hong Kong Special Administrative Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Bernhard J, 1999, ANN ONCOL, V10, P775, DOI 10.1023/A:1008311918967; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Byrne C, 2007, EJSO-EUR J SURG ONC, V33, pS95, DOI 10.1016/j.ejso.2007.10.003; CELLA DF, 1993, CANCER INVEST, V11, P327, DOI 10.3109/07357909309024860; Santos VLCD, 2006, J WOUND OSTOMY CONT, V33, P503, DOI 10.1097/00152192-200609000-00008; Fong DYT, 2010, J CLIN EPIDEMIOL, V63, P1020, DOI 10.1016/j.jclinepi.2009.11.011; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hornbrook MC, 2011, MED CARE, V49, P321, DOI 10.1097/MLR.0b013e31820194c8; Krouse RS, 2009, J CLIN ONCOL, V27, P4664, DOI 10.1200/JCO.2008.20.9502; Lam CLK, 2008, VALUE HEALTH, V11, P295, DOI 10.1111/j.1524-4733.2007.00233.x; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Lam CLK, 2010, HONG KONG PRACTITION, V32, P77; Lam ETP, 2013, J EVAL CLIN PRACT, V19, P200, DOI 10.1111/j.1365-2753.2011.01800.x; Liu LY, 2010, DIS COLON RECTUM, V53, P200, DOI 10.1007/DCR.0b013e3181bdc408; McGhee S M, 2011, Hong Kong Med J, V17 Suppl 6, P17; National Institute for Clinical Excellence, 2008, N1618 NICE; Paika V, 2010, PSYCHO-ONCOLOGY, V19, P273, DOI 10.1002/pon.1563; Ramsey SD, 2002, AM J GASTROENTEROL, V97, P1228, DOI 10.1111/j.1572-0241.2002.05694.x; Ramsey SD, 2000, CANCER-AM CANCER SOC, V88, P1294, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.3.CO;2-D; Rauch P, 2004, J CLIN ONCOL, V22, P354, DOI 10.1200/JCO.2004.03.137; Rinaldis M, 2010, BRIT J PSYCHOL, V101, P259, DOI 10.1348/000712609X448676; Ristvedt SL, 2009, BRIT J HEALTH PSYCH, V14, P701, DOI 10.1348/135910708X400462; Ross L, 2007, SUPPORT CARE CANCER, V15, P505, DOI 10.1007/s00520-006-0177-8; Sharma A, 2007, ANN SURG ONCOL, V14, P3435, DOI 10.1245/s10434-007-9554-x; Shiroiwa T, 2009, QUAL LIFE RES, V18, P1095, DOI 10.1007/s11136-009-9513-z; Simon AE, 2009, COLORECTAL DIS, V11, P19, DOI 10.1111/j.1463-1318.2008.01501.x; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Sultan S, 2004, CANCER-AM CANCER SOC, V101, P2737, DOI 10.1002/cncr.20699; Trentham-Dietz A, 2003, ONCOLOGIST, V8, P342, DOI 10.1634/theoncologist.8-4-342; Wilson TR, 2006, DIS COLON RECTUM, V49, P1692, DOI 10.1007/s10350-006-0709-9; Wong CK, 2013, J CLIN EPIDEMIOL, V66, P557, DOI 10.1016/j.jclinepi.2012.11.010; Wong CKH, 2013, QUAL LIFE RES, V22, P1415, DOI 10.1007/s11136-012-0272-x; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1186, DOI 10.1111/j.1365-2753.2011.01753.x; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1203, DOI 10.1111/j.1365-2753.2011.01776.x; Wong CKH, 2012, VALUE HEALTH, V15, P495, DOI 10.1016/j.jval.2011.12.009; Wong CKH, 2013, VALUE HEALTH, V16, P373, DOI 10.1016/j.jval.2012.12.004; Yost KJ, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-66	40	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58341	10.1371/journal.pone.0058341	http://dx.doi.org/10.1371/journal.pone.0058341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516465	Green Published, gold			2022-12-25	WOS:000316849200057
J	Zhang, B; Liu, JY				Zhang, Bing; Liu, Jin-Yuan			Mass Spectrometric Identification of In Vivo Phosphorylation Sites of Differentially Expressed Proteins in Elongating Cotton Fiber Cells	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; LARGE-SCALE; SACCHAROMYCES-CEREVISIAE; PHOSPHOPROTEOME ANALYSIS; ARABIDOPSIS-THALIANA; PROTEOMICS; DATABASE; REVEALS; LEAVES	Two-dimensional gel electrophoresis (2-DE)-based proteomics approach was applied to extensively explore the molecular basis of plant development and environmental adaptation. These proteomics analyses revealed thousands of differentially expressed proteins (DEPs) closely related to different biological processes. However, little attention has been paid to how peptide mass fingerprinting (PMF) data generated by the approach can be directly utilized for the determination of protein phosphorylation. Here, we used the software tool FindMod to predict the peptides that might carry the phosphorylation modification by examining their PMF data for mass differences between the empirical and theoretical peptides and then identified phosphorylation sites using MALDI TOF/TOF according to predicted peptide data from these DEP spots in the 2-D gels. As a result, a total of 48 phosphorylation sites of 40 DEPs were successfully identified among 235 known DEPs previously revealed in the 2-D gels of elongating cotton fiber cells. The 40 phosphorylated DEPs, including important enzymes such as enolase, transketolase and UDP-L-rhamnose synthase, are presumed to participate in the functional regulation of numerous metabolic pathways, suggesting the reverse phosphorylation of these proteins might play important roles in elongating cotton fibers. The results also indicated that some different isoforms of the identical DEP revealed in our 2-DE-based proteomics analysis could be annotated by phosphorylation events. Taken together, as the first report of large-scale identification of phosphorylation sites in elongating cotton fiber cells, our study provides not only an excellent example of directly identifying phosphorylation sites from known DEPs on 2-D gels but also provides a valuable resource for future functional studies of phosphorylated proteins in this field.	[Liu, Jin-Yuan] Tsinghua Univ, Sch Life Sci, Mol Biol Lab, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Liu, JY (corresponding author), Tsinghua Univ, Sch Life Sci, Mol Biol Lab, Beijing 100084, Peoples R China.	liujy@mail.tsinghua.edu.cn	Zhang, Bing/Z-3337-2019	Zhang, Bing/0000-0001-9774-517X	State Key Basic Research and Development Plan [2010CB126003]; National Natural Science Foundation of China [90608016]; National Transgenic Animals and Plants Research Project [2011ZX08005-003, 2011ZX08009-003]	State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Animals and Plants Research Project	This work was supported by grants from the State Key Basic Research and Development Plan (2010CB126003), the National Natural Science Foundation of China (90608016) and the National Transgenic Animals and Plants Research Project (2011ZX08005-003 and 2011ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; CLAUSER KR, 1995, P NATL ACAD SCI USA, V92, P5072, DOI 10.1073/pnas.92.11.5072; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gao JJ, 2009, NUCLEIC ACIDS RES, V37, pD960, DOI 10.1093/nar/gkn733; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Gerhardt S, 2003, PLANT PHYSIOL, V132, P1941, DOI 10.1104/pp.103.020982; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Larsen MR, 2001, ELECTROPHORESIS, V22, P566, DOI 10.1002/1522-2683(200102)22:3<566::AID-ELPS566>3.0.CO;2-T; Lemeer S, 2012, ANAL BIOANAL CHEM, V402, P249, DOI 10.1007/s00216-011-5469-2; Luo R, 2012, J PROTEOMICS, V75, P868, DOI 10.1016/j.jprot.2011.10.003; Mujer CV, 1995, PLANT CELL PHYSIOL, V36, P1459; Munoz J, 2011, METHODS MOL BIOL, V767, P297, DOI 10.1007/978-1-61779-201-4_22; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Paradela A, 2008, J PROTEOME RES, V7, P1809, DOI 10.1021/pr7006544; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Sundstrom JM, 2009, J PROTEOME RES, V8, P798, DOI 10.1021/pr8005556; Thaker VS, 1999, ACTA PHYSIOL PLANT, V21, P57, DOI 10.1007/s11738-999-0027-7; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; Tichy A, 2011, J PROTEOMICS, V74, P2786, DOI 10.1016/j.jprot.2011.07.018; Torres MP, 2005, J PROTEOME RES, V4, P1628, DOI 10.1021/pr050129d; Tress ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r162; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wilkins MR, 1999, J MOL BIOL, V289, P645, DOI 10.1006/jmbi.1999.2794; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Zhang B, 2013, PROTEOMICS, V13, P1159, DOI 10.1002/pmic.201200176; Zhou L, 2011, PLOS ONE, V6; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	35	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58758	10.1371/journal.pone.0058758	http://dx.doi.org/10.1371/journal.pone.0058758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516553	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200111
J	El-Zaatari, M; Kao, JY; Tessier, A; Bai, LC; Hayes, MM; Fontaine, C; Eaton, KA; Merchant, JL				El-Zaatari, Mohamad; Kao, John Y.; Tessier, Art; Bai, Longchuan; Hayes, Michael M.; Fontaine, Clinton; Eaton, Kathryn A.; Merchant, Juanita L.			Gli1 Deletion Prevents Helicobacter-Induced Gastric Metaplasia and Expansion of Myeloid Cell Subsets	PLOS ONE			English	Article							SONIC HEDGEHOG; KAPPA-B; TUMOR MICROENVIRONMENT; ATROPHIC GASTRITIS; SIGNALING PATHWAY; SUPPRESSOR-CELLS; IL-6 PRODUCTION; ACTIVATION; CANCER; INTERLEUKIN-1-BETA	Chronic inflammation in the stomach induces metaplasia, the pre-cancerous lesion that precedes inflammation-driven neoplastic transformation. While Hedgehog signaling contributes to the initiation of some cancers, its role in gastric transformation remains poorly defined. We found that Helicobacter-infected C57BL/6 mice develop extensive mucous cell metaplasia at 6 month but not at 2 months post-infection. Gastric metaplasia coincided with the appearance of CD45(+)MHCII(+)CD11b(+)CD11c(+) myeloid cells that were normally not present in the chronic gastritis at 2 months. The myeloid regulatory gene Schlafen-4 was identified in a microarray analysis comparing infected WT versus Gli1 null mice and was expressed in the CD11b(+)CD11c(+) myeloid population. Moreover this same population expressed IL-1 beta and TNF alpha pro-inflammatory cytokines. By 6 months, the mucous neck cell metaplasia (SPEM) expressed IL-6, phosphorylated STAT3 and the proliferative marker Ki67. Expression was not observed in Gli1 mutant mice consistent with the requirement of Gli1 to induce this pre-neoplastic phenotype. Ectopic Shh ligand expression alone was not sufficient to induce SPEM, but with Helicobacter infection synergistically increased the histologic severity observed with the inflammation. Therefore Hedgehog signaling is required, but is not sufficient to generate pre-neoplastic changes during chronic gastritis. Gli1-dependent myeloid cell differentiation plays a pivotal role in the appearance of myeloid cell subtypes ostensibly required for SPEM development. Moreover, it suggests that therapies capable of targeting this phenotypic switch might prevent progression to metaplasia, the pre-neoplastic change that develops prior to dysplasia and gastric cancer, which also occurs in other epithelial-derived neoplasias initiated by chronic inflammation.	[El-Zaatari, Mohamad; Kao, John Y.; Tessier, Art; Bai, Longchuan; Hayes, Michael M.; Merchant, Juanita L.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Fontaine, Clinton; Eaton, Kathryn A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Merchant, JL (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	merchanj@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184	Public Health Service [P01-DK62041, R01 DK087708-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK062041, R01DK087708] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Public Health Service Grants P01-DK62041 (JLM) and R01 DK087708-01 (JYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; CORREA P, 1975, LANCET, V2, P58; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Zaatari M, 2010, GASTROENTEROLOGY, V139, P2061, DOI 10.1053/j.gastro.2010.08.047; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Howlett M, 2012, GUT, V61, P1398, DOI 10.1136/gutjnl-2011-300539; Ihrig M, 2005, INFECT IMMUN, V73, P1664, DOI 10.1128/IAI.73.3.1664-1670.2005; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; KAUMA SW, 1994, ENDOCRINOLOGY, V134, P457, DOI 10.1210/en.134.1.457; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Lamb A, 2012, J CELL BIOCH; Lauth M, 2011, ADV CANCER RES, V110, P1, DOI 10.1016/B978-0-12-386469-7.00001-3; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Mohammadi M, 1996, J IMMUNOL, V156, P4729; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Obonyo M, 2011, HELICOBACTER, V16, P398, DOI 10.1111/j.1523-5378.2011.00861.x; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Schmidt PH, 1999, LAB INVEST, V79, P639; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Shiotani A, 2006, ALIMENT PHARM THER, V24, P71, DOI 10.1111/j.1365-2036.2006.00028.x; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Syu LJ, 2012, AM J PATHOL, V181, P2114, DOI 10.1016/j.ajpath.2012.08.017; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Tsukihara S, 2004, AM J REPROD IMMUNOL, V52, P218, DOI 10.1111/j.1600-0897.2004.00209.x; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van Zuylen WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015723; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Zavros Y, 2007, J BIOL CHEM, V282, P33265, DOI 10.1074/jbc.M707090200	40	53	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58935	10.1371/journal.pone.0058935	http://dx.doi.org/10.1371/journal.pone.0058935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520544	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900104
J	Kondor, D; Vattay, G				Kondor, Daniel; Vattay, Gabor			Dynamics and Structure in Cell Signaling Networks: Off-State Stability and Dynamically Positive Cycles	PLOS ONE			English	Article							TRANSDUCTION; SYSTEMS; PATHWAYS; DATABASE; MODELS	The signaling system is a fundamental part of the cell, as it regulates essential functions including growth, differentiation, protein synthesis, and apoptosis. A malfunction in this subsystem can disrupt the cell significantly, and is believed to be involved in certain diseases, with cancer being a very important example. While the information available about intracellular signaling networks is constantly growing, and the network topology is actively being analyzed, the modeling of the dynamics of such a system faces difficulties due to the vast number of parameters, which can prove hard to estimate correctly. As the functioning of the signaling system depends on the parameters in a complex way, being able to make general statements based solely on the network topology could be especially appealing. We study a general kinetic model of the signaling system, giving results for the asymptotic behavior of the system in the case of a network with only activatory interactions. We also investigate the possible generalization of our results for the case of a more general model including inhibitory interactions too. We find that feedback cycles made up entirely of activatory interactions (which we call dynamically positive) are especially important, as their properties determine whether the system has a stable signal-off state, which is desirable in many situations to avoid autoactivation due to a noisy environment. To test our results, we investigate the network topology in the Signalink database, and find that the human signaling network indeed has only significantly few dynamically positive cycles, which agrees well with our theoretical arguments.	[Kondor, Daniel; Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	Eotvos Lorand University	Kondor, D (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	kdani88@elte.hu	Vattay, Gabor/G-9638-2017; Kondor, Daniel/AAD-9871-2019; Vattay, Gabor/Q-4266-2019	Vattay, Gabor/0000-0002-0919-9429; Kondor, Daniel/0000-0003-3720-7462; 	Hungarian National Development Agency [TAMOP 4.2.1/B-09/1/KMR-2010-0003, TECH08:3dhist08]; Hungarian National Science Foundation [OTKA 7779]	Hungarian National Development Agency; Hungarian National Science Foundation	Hungarian National Development Agency (TAMOP 4.2.1/B-09/1/KMR-2010-0003 and TECH08:3dhist08) and the Hungarian National Science Foundation (OTKA 7779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Binder Bernd, 2004, Genome Inform, V15, P13; Choi C, 2004, COMP FUNCT GENOM, V5, P163, DOI 10.1002/cfg.386; Copeland NG, 2009, TRENDS GENET, V25, P455, DOI 10.1016/j.tig.2009.08.004; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; Gough NR, 2002, ANN NY ACAD SCI, V971, P585, DOI 10.1111/j.1749-6632.2002.tb04532.x; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Kartal O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008001; Korcsmaros T, 2010, BIOINFORMATICS, V26, P2042, DOI 10.1093/bioinformatics/btq310; Levitzki A, 1995, ANN NY ACAD SCI, V766, P363, DOI 10.1111/j.1749-6632.1995.tb26686.x; Meye C.D., 2000, MATRIX ANAL APPL LIN, P661; Mitkowski W, 2008, BULL POL ACAD SCI-TE, V56, P309; Sontag Eduardo D, 2007, Syst Synth Biol, V1, P59, DOI 10.1007/s11693-007-9005-9; Sprott JC, 2008, AM J PHYS, V76, P474, DOI 10.1119/1.2830540; Szabo A., 2012, NANO COMMUN NETW, V3, P57; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	19	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57653	10.1371/journal.pone.0057653	http://dx.doi.org/10.1371/journal.pone.0057653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520476	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900035
J	Voorhees, JL; Tarr, AJ; Wohleb, ES; Godbout, JP; Mo, XK; Sheridan, JF; Eubank, TD; Marsh, CB				Voorhees, Jeffrey L.; Tarr, Andrew J.; Wohleb, Eric S.; Godbout, Jonathan P.; Mo, Xiaokui; Sheridan, John F.; Eubank, Timothy D.; Marsh, Clay B.			Prolonged Restraint Stress Increases IL-6, Reduces IL-10, and Causes Persistent Depressive-Like Behavior That Is Reversed by Recombinant IL-10	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; PITUITARY-ADRENAL AXIS; FORCED SWIM TEST; MAJOR DEPRESSION; PROTEIN EXPRESSION; IMMUNE-RESPONSES; GENE-EXPRESSION; VIRUS-INFECTION; TNF-ALPHA; HPA AXIS	Altered inflammatory cytokine profiles are often observed in individuals suffering from major depression. Recent clinical work reports on elevated IL-6 and decreased IL-10 in depression. Elevated IL-6 has served as a consistent biomarker of depression and IL-10 is proposed to influence depressive behavior through its ability to counterbalance pro-inflammatory cytokine expression. Clinical and animal studies suggest a role for IL-10 in modifying depressive behavior. Murine restraint stress (RST) is regularly employed in the study of behavioral and biological symptoms associated with depressive disorders. While responses to acute RST exposure have been widely characterized, few studies have examined the ongoing and longitudinal effects of extended RST and fewer still have examined the lasting impact during the post-stress period. Consistent with clinical data, we report that a protocol of prolonged murine RST produced altered cytokine profiles similar to those observed in major depressive disorder. Parallel to these changes in circulating cytokines, IL-10 mRNA expression was diminished in the cortex and hippocampus throughout the stress period and following cessation of RST. Moreover, chronic RST promoted depressive-like behavior throughout the 28-day stress period and these depressive-like complications were maintained weeks after cessation of RST. Because of the correlation between IL-10 suppression and depressive behavior and because many successful antidepressant therapies yield increases in IL-10, we examined the effects of IL-10 treatment on RST-induced behavioral changes. Behavioral deficits induced by RST were reversed by exogenous administration of recombinant IL-10. This work provides one of the first reports describing the biological and behavioral impact following prolonged RST and, taken together, this study provides details on the correlation between responses to chronic RST and those seen in depressive disorders.	[Voorhees, Jeffrey L.; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Voorhees, Jeffrey L.; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Tarr, Andrew J.; Wohleb, Eric S.; Sheridan, John F.] Ohio State Univ, Div Oral Biol, Columbus, OH 43210 USA; [Tarr, Andrew J.; Godbout, Jonathan P.; Sheridan, John F.] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA; [Wohleb, Eric S.; Sheridan, John F.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Godbout, Jonathan P.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Godbout, Jonathan P.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eubank, TD (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Tim.Eubank@osumc.edu; Clay.Marsh@osumc.edu	Sheridan, John F/E-4081-2011; Wohleb, Eric/AAQ-6895-2021; Eubank, Tim/E-3043-2011	Eubank, Tim/0000-0002-8225-7824; Sheridan, John/0000-0002-6927-0266	National Institutes of Health (NIH) [T32 HL07946, NIH R01 HL067176, NIH R01 HL102464]; TDE; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067176, T32HL007946, R01HL102464] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TDE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) T32 HL07946, NIH R01 HL067176, NIH R01 HL102464, and startup funds from TDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Anisman H, 1998, BRAIN RES, V779, P177, DOI 10.1016/S0006-8993(97)01114-1; Bartolomucci A, 2003, BRAIN RES BULL, V62, P173, DOI 10.1016/j.brainresbull.2003.09.009; Blume J, 2011, BRAIN BEHAV IMMUN, V25, P221, DOI 10.1016/j.bbi.2010.10.008; Bluthe RM, 1999, PSYCHONEUROENDOCRINO, V24, P301, DOI 10.1016/S0306-4530(98)00077-8; Bowers SL, 2008, BRAIN BEHAV IMMUN, V22, P105, DOI 10.1016/j.bbi.2007.07.012; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Campbell T, 2001, BRAIN BEHAV IMMUN, V15, P235, DOI 10.1006/brbi.2000.0598; Carlezon WA, 2002, BIOL PSYCHIAT, V51, P882, DOI 10.1016/S0006-3223(01)01344-0; Connor TJ, 2005, J NEUROIMMUNOL, V159, P119, DOI 10.1016/j.jneuroim.2004.10.016; Curtin NM, 2009, BRAIN BEHAV IMMUN, V23, P371, DOI 10.1016/j.bbi.2008.12.010; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Delgado-Morales R, 2012, PHYSIOL BEHAV, V105, P669, DOI 10.1016/j.physbeh.2011.10.008; Dhabhar FS, 2009, J PSYCHIATR RES, V43, P962, DOI 10.1016/j.jpsychires.2009.05.010; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; El Bouhassani M, 2011, J BIOL CHEM, V286, P17227, DOI 10.1074/jbc.M111.220483; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Harris RBS, 2002, AM J PHYSIOL-REG I, V282, pR77, DOI 10.1152/ajpregu.2002.282.1.R77; Harvey D, 2006, PHYSIOL BEHAV, V87, P842, DOI 10.1016/j.physbeh.2006.03.002; HOLM S, 1979, SCAND J STAT, V6, P65; Houshyar H, 2001, J NEUROENDOCRINOL, V13, P862, DOI 10.1046/j.1365-2826.2001.00713.x; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; KEIM KL, 1977, PHARMACOL BIOCHEM BE, V6, P79, DOI 10.1016/0091-3057(77)90162-9; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; Khairova RA, 2009, INT J NEUROPSYCHOPH, V12, P561, DOI 10.1017/S1461145709009924; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042054; Klinsey SG, 2007, BRAIN BEHAV IMMUN, V21, P458, DOI 10.1016/j.bbi.2006.11.001; Koldzic-Zivanovic N, 2006, BRAIN BEHAV IMMUN, V20, P460, DOI 10.1016/j.bbi.2005.09.003; Krzyszton CP, 2008, AM J PHYSIOL-REG I, V295, pR1109, DOI 10.1152/ajpregu.90302.2008; Kubera M, 2001, J AFFECT DISORDERS, V63, P171, DOI 10.1016/S0165-0327(00)00182-8; Kubera N, 2001, J CLIN PSYCHOPHARM, V21, P199, DOI 10.1097/00004714-200104000-00012; Lamkin DM, 2012, BRAIN BEHAV IMMUN, V26, P635, DOI 10.1016/j.bbi.2012.01.013; Lanquillon S, 2000, NEUROPSYCHOPHARMACOL, V22, P370, DOI 10.1016/S0893-133X(99)00134-7; Lawson MA, 2011, BRAIN BEHAV IMMUN, V25, P1569, DOI 10.1016/j.bbi.2011.05.006; Leitch MM, 2003, NEUROPSYCHOPHARMACOL, V28, P119, DOI 10.1038/sj.npp.1300016; Lenczowski MJP, 1999, AM J PHYSIOL-REG I, V276, pR652, DOI 10.1152/ajpregu.1999.276.3.R652; Liu J, 2012, P NATL ACAD SCI USA, V109, P10018, DOI 10.1073/pnas.1200941109; Loftis JM, 2010, NEUROBIOL DIS, V37, P519, DOI 10.1016/j.nbd.2009.11.015; Lundh SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051168; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Maes M, 1999, NEUROPSYCHOPHARMACOL, V20, P370, DOI 10.1016/S0893-133X(98)00088-8; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mesquita AR, 2008, J PSYCHIATR RES, V43, P89, DOI 10.1016/j.jpsychires.2008.02.004; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Mohawk JA, 2005, J BIOL RHYTHM, V20, P245, DOI 10.1177/0748730405276323; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; O'Brien SM, 2007, J PSYCHIAT RES, V41, P326, DOI 10.1016/j.jpsychires.2006.05.013; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Raedler TJ, 2011, CURR OPIN PSYCHIATR, V24, P519, DOI 10.1097/YCO.0b013e32834b9db6; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Roque S, 2009, CARDIOVASC PSYCHIAT, V2009; Sakic B, 2001, BRAIN BEHAV IMMUN, V15, P25, DOI 10.1006/brbi.1999.0576; Sakic B, 1997, BRAIN RES BULL, V44, P155, DOI 10.1016/S0361-9230(97)00107-X; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Selye H., 1936, CAN MED ASSOC J, V34, P704; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; SHERIDAN JF, 1991, J NEUROIMMUNOL, V31, P245, DOI 10.1016/0165-5728(91)90046-A; Smith EM, 1999, J NEUROIMMUNOL, V100, P140, DOI 10.1016/S0165-5728(99)00206-4; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solomon MB, 2011, NEUROSCIENCE; Swiergiel AH, 1999, BRAIN BEHAV IMMUN, V13, P252, DOI 10.1006/brbi.1999.0565; Swiergiel AH, 2008, BEHAV BRAIN RES, V186, P32, DOI 10.1016/j.bbr.2007.07.018; Swiergiel AH, 2006, BEHAV BRAIN RES, V171, P94, DOI 10.1016/j.bbr.2006.03.024; Tu HL, 2007, CELL MOL NEUROBIOL, V27, P161, DOI 10.1007/s10571-006-9137-6; Walker TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044371; Wang JP, 1998, NEUROCHEM INT, V33, P143, DOI 10.1016/S0197-0186(98)00016-3; Wang Y, 2008, J IMMUNOL, V181, P3441, DOI 10.4049/jimmunol.181.5.3441; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; ZALCMAN S, 1994, BRAIN RES, V643, P40, DOI 10.1016/0006-8993(94)90006-X; Zalcman S, 1998, BRAIN RES, V811, P111, DOI 10.1016/S0006-8993(98)00904-4; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zhou QD, 2011, P NATL ACAD SCI USA, V108, P2867, DOI 10.1073/pnas.1019270108; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	87	154	158	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58488	10.1371/journal.pone.0058488	http://dx.doi.org/10.1371/journal.pone.0058488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520517	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900076
J	Fenichel, EP; Kuminoff, NV; Chowell, G				Fenichel, Eli P.; Kuminoff, Nicolai V.; Chowell, Gerardo			Skip the Trip: Air Travelers' Behavioral Responses to Pandemic Influenza	PLOS ONE			English	Article							INFECTIOUS-DISEASES; TRANSMISSION; SPREAD; IMPACT; STRAIN; UK	Theory suggests that human behavior has implications for disease spread. We examine the hypothesis that individuals engage in voluntary defensive behavior during an epidemic. We estimate the number of passengers missing previously purchased flights as a function of concern for swine flu or A/H1N1 influenza using 1.7 million detailed flight records, Google Trends, and the World Health Organization's FluNet data. We estimate that concern over "swine flu," as measured by Google Trends, accounted for 0.34% of missed flights during the epidemic. The Google Trends data correlates strongly with media attention, but poorly (at times negatively) with reported cases in FluNet. Passengers show no response to reported cases. Passengers skipping their purchased trips forwent at least $50 M in travel related benefits. Responding to actual cases would have cut this estimate in half. Thus, people appear to respond to an epidemic by voluntarily engaging in self-protection behavior, but this behavior may not be responsive to objective measures of risk. Clearer risk communication could substantially reduce epidemic costs. People undertaking costly risk reduction behavior, for example, forgoing nonrefundable flights, suggests they may also make less costly behavior adjustments to avoid infection. Accounting for defensive behaviors may be important for forecasting epidemics, but linking behavior with epidemics likely requires consideration of risk communication.	[Fenichel, Eli P.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Kuminoff, Nicolai V.] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA; [Chowell, Gerardo] Arizona State Univ, Sch Human Evolut, Tempe, AZ USA; [Chowell, Gerardo] Arizona State Univ, Sch Change, Tempe, AZ USA; [Chowell, Gerardo] NIH, Div Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA	Yale University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Fenichel, EP (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	eli.fenichel@yale.edu	Chowell, Gerardo/F-5038-2012	Chowell, Gerardo/0000-0003-2194-2251; Fenichel, Eli/0000-0002-7649-8250	National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health [1R01GM100471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	U.S. Airways Corporation generously provided data and background information on the airline industry. This publication was made possible by grant number 1R01GM100471-01 from the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not represent the official views of NIGMS or US Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bitar D, 2009, EUROSURVEILLANCE, V14; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Cameron A. C., 2010, MICROECONOMETRICS US; Cameron C., 2005, MICROECONOMETRICS US, P1056; Chen FH, 2009, MATH BIOSCI, V217, P125, DOI 10.1016/j.mbs.2008.11.005; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; d'Onofrio A, 2009, J THEOR BIOL, V256, P473, DOI 10.1016/j.jtbi.2008.10.005; DeHart RL, 2003, ANNU REV PUBL HEALTH, V24, P133, DOI 10.1146/annurev.publhealth.24.100901.140853; Dell'Omodarme M, 2005, STAT MED, V24, P2669, DOI 10.1002/sim.2131; Dickmann P, 2011, INFLUENZA OTHER RESP, V5, P39, DOI 10.1111/j.1750-2659.2010.00168.x; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Fenichel E. P., 2013, MODELING INTERPLAY H, P153; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Gelman A., 2007, DATA ANAL USING REGR; GEOFFARD PY, 1995, BIOMETRIKA, V82, P101; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022151; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Keogh-Brown MR, 2010, HEALTH ECON, V19, P1345, DOI 10.1002/hec.1554; Lau JTF, 2004, EPIDEMIOL INFECT, V132, P727, DOI 10.1017/S0950268804002225; Leggat PA, 2010, J TRAVEL MED, V17, P291, DOI 10.1111/j.1708-8305.2010.00445.x; Mao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024706; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Mesnard A, 2009, J PUBLIC ECON, V93, P931, DOI 10.1016/j.jpubeco.2009.05.001; Nguyen AV, 2010, EMERG INFECT DIS, V16, P1710, DOI 10.3201/eid1611.100703; Nishiura H, 2009, EUROSURVEILLANCE, V14, P1; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Stern AM, 2009, JAMA-J AM MED ASSOC, V302, P1221, DOI 10.1001/jama.2009.1367; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503; Vosen S, 2011, J FORECASTING, V30, P565, DOI 10.1002/for.1213; Wagner BG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-81	47	74	74	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58249	10.1371/journal.pone.0058249	http://dx.doi.org/10.1371/journal.pone.0058249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23526970	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562600015
J	O'Reilly-Wapstra, JM; Miller, AM; Hamilton, MG; Williams, D; Glancy-Dean, N; Potts, BM				O'Reilly-Wapstra, Julianne M.; Miller, Alison M.; Hamilton, Matthew G.; Williams, Dean; Glancy-Dean, Naomi; Potts, Brad M.			Chemical Variation in a Dominant Tree Species: Population Divergence, Selection and Genetic Stability across Environments	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; PLANT DEFENSIVE CHEMISTRY; QUANTITATIVE TRAIT LOCI; GLOBULUS SSP GLOBULUS; EUCALYPTUS-GLOBULUS; MAMMALIAN HERBIVORE; WOOD DENSITY; PULP YIELD; RESISTANCE; NITENS	Understanding among and within population genetic variation of ecologically important plant traits provides insight into the potential evolutionary processes affecting those traits. The strength and consistency of selection driving variability in traits would be affected by plasticity in differences among genotypes across environments (GxE). We investigated population divergence, selection and environmental plasticity of foliar plant secondary metabolites (PSMs) in a dominant tree species, Eucalyptus globulus. Using two common garden trials we examined variation in PSMs at multiple genetic scales; among 12 populations covering the full geographic range of the species and among up to 60 families within populations. Significant genetic variation in the expression of many PSMs resides both among and within populations of E. globulus with moderate (e. g., sideroxylonal A h(2)op = 0.24) to high (e. g., macrocarpal G h(2)op = 0.48) narrow sense heritabilities and high coefficients of additive genetic variation estimated for some compounds. A comparison of Qst and Fst estimates suggest that variability in some of these traits may be due to selection. Importantly, there was no genetic by environment interaction in the expression of any of the quantitative chemical traits despite often significant site effects. These results provide evidence that natural selection has contributed to population divergence in PSMs in E. globulus, and identifies the formylated phloroglucinol compounds (particularly sideroxylonal) and a dominant oil, 1,8-cineole, as candidates for traits whose genetic architecture has been shaped by divergent selection. Additionally, as the genetic differences in these PSMs that influence community phenotypes is stable across environments, the role of plant genotype in structuring communities is strengthened and these genotypic differences may be relatively stable under global environmental changes.	[O'Reilly-Wapstra, Julianne M.; Miller, Alison M.; Hamilton, Matthew G.; Glancy-Dean, Naomi; Potts, Brad M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Williams, Dean] Forestry Tasmania, Hobart, Tas, Australia; [O'Reilly-Wapstra, Julianne M.; Miller, Alison M.; Hamilton, Matthew G.; Potts, Brad M.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	O'Reilly-Wapstra, JM (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	joreilly@utas.edu.au	Potts, Brad M/C-6489-2013; O'Reilly-Wapstra, Julianne M/J-7275-2014; Hamilton, Matthew/C-6556-2008	Potts, Brad M/0000-0001-6244-289X; O'Reilly-Wapstra, Julianne M/0000-0003-4801-4412; Hamilton, Matthew/0000-0001-8098-8845	Australian Research Council [DP1094084, DP120102889]; UTAS Rising Stars Programme	Australian Research Council(Australian Research Council); UTAS Rising Stars Programme	This work was funded by the Australian Research Council (DP1094084, DP120102889) and the UTAS Rising Stars Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Ramirez-Valiente JA, 2011, TREE GENET GENOMES, V7, P285, DOI 10.1007/s11295-010-0331-9; Andrew RL, 2007, OECOLOGIA, V153, P891, DOI 10.1007/s00442-007-0784-1; Andrew RL, 2010, ANN BOT-LONDON, V105, P707, DOI 10.1093/aob/mcq034; [Anonymous], 2002, TANNIN CHEM; ARMBRUSTER WS, 1991, EVOLUTION, V45, P1229, DOI 10.1111/j.1558-5646.1991.tb04389.x; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; Bulinski J, 1999, FOREST ECOL MANAG, V113, P241, DOI 10.1016/S0378-1127(98)00430-7; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Silva JCE, 2009, TREE GENET GENOMES, V5, P291, DOI 10.1007/s11295-008-0174-9; Downes GM, 2010, J NEAR INFRARED SPEC, V18, P147, DOI 10.1255/jnirs.875; Dungey HS, 1997, CAN J FOREST RES, V27, P750, DOI 10.1139/cjfr-27-5-750; Dutkowski GW, 1999, AUST J BOT, V47, P237, DOI 10.1071/BT97114; Dutkowski GW, 2012, TREE GENET GENOMES, P1; Edelaar P, 2011, MOL ECOL, V20, P1805, DOI 10.1111/j.1365-294X.2011.05051.x; Falconer D. S, 1996, INTRO QUANTITATIVE G; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Freeman JS, 2008, NEW PHYTOL, V178, P846, DOI 10.1111/j.1469-8137.2008.02417.x; Freeman JS, 2001, AUST J BOT, V49, P585, DOI 10.1071/BT00094; Frei ES, 2012, J ECOL, V100, P297, DOI 10.1111/j.1365-2745.2011.01909.x; Fritz RS, 1999, ECOLOGY, V80, P382, DOI 10.1890/0012-9658(1999)080[0382:ROHPTH]2.0.CO;2; Garcia-Gonzalez F, 2012, EVOLUTION, V66, P2341, DOI 10.1111/j.1558-5646.2011.01565.x; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gilmour AR, 2009, ASREML USER GUIDE RE; GRAHAM HD, 1992, J AGR FOOD CHEM, V40, P801, DOI 10.1021/jf00017a018; GRIFFIN AR, 1988, SILVAE GENET, V37, P124; Hallsson LR, 2012, J EVOLUTION BIOL, V25, P1275, DOI 10.1111/j.1420-9101.2012.02512.x; Hamilton M. G., 2008, New Zealand Journal of Forestry Science, V38, P102; HOULE D, 1992, GENETICS, V130, P195; Humphreys JR, 2008, SILVAE GENET, V57, P262, DOI 10.1515/sg-2008-0040; Jimenez-Ambriz G, 2007, NEW PHYTOL, V173, P199, DOI 10.1111/j.1469-8137.2006.01923.x; Johnson GR, 2007, TREE GENET GENOMES, V3, P25, DOI 10.1007/s11295-006-0054-0; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Latta RG, 1998, AM NAT, V151, P283, DOI 10.1086/286119; Lopez GA, 2003, CAN J FOREST RES, V33, P2108, DOI [10.1139/x03-132, 10.1139/X03-132]; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; McKiernan AB, 2012, J CHEM ECOL, V38, P204, DOI 10.1007/s10886-012-0071-4; McKinnon GE, 2005, AUST J BOT, V53, P827, DOI 10.1071/BT04195; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Miller AM, 2009, FOREST ECOL MANAG, V259, P45, DOI 10.1016/j.foreco.2009.09.040; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; Moore BD, 2010, ECOLOGY, V91, P3165, DOI 10.1890/09-1714.1; O'Reilly-Wapstra JM, 2004, FUNCT ECOL, V18, P677, DOI 10.1111/j.0269-8463.2004.00887.x; O'Reilly-Wapstra JM, 2005, OECOLOGIA, V142, P597, DOI 10.1007/s00442-004-1769-y; O'Reilly-Wapstra JM, 2005, J CHEM ECOL, V31, P357, DOI 10.1007/s10886-005-1346-9; O'Reilly-Wapstra JM, 2007, J CHEM ECOL, V33, P1876, DOI 10.1007/s10886-007-9366-2; O'Reilly-Wapstra JM, 2012, ECOL REV, P10; O'Reilly-Wapstra JM, 2010, EVOL ECOL RES, V12, P491; Orians CM, 2010, OECOLOGIA, V163, P283, DOI 10.1007/s00442-009-1521-8; Poelman EH, 2008, TRENDS PLANT SCI, V13, P534, DOI 10.1016/j.tplants.2008.08.003; POTTS BM, 1994, AUST J BOT, V42, P471, DOI 10.1071/BT9940471; Potts BM, 2004, P IUFRO C, P4661; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; SAS Institute Inc, 2009, STATISTICS-ABINGDON, V2; Stackpole DJ, 2010, TREE GENET GENOMES, V6, P179, DOI 10.1007/s11295-009-0239-4; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Steinbauer MJ, 2010, AUSTRAL ECOL, V35, P205, DOI 10.1111/j.1442-9993.2009.02028.x; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Thompson J. N., 2005, INTERSPEC INTERACT; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; Vannette RL, 2011, GLOBAL CHANGE BIOL, V17, P1277, DOI 10.1111/j.1365-2486.2010.02316.x; VOLKER PW, 1994, SILVAE GENET, V43, P366; Wallis IR, 2011, PERSPECT PLANT ECOL, V13, P305, DOI 10.1016/j.ppees.2011.05.005; Wallis IR, 2005, PHYTOCHEM ANALYSIS, V16, P49, DOI 10.1002/pca.810; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Williams E.R., 2002, EXPT DESIGN ANAL TRE; WOODS EC, 2011, ECOLOGICAL MONOGRAPH, V0082; Yeoh SH, 2012, TREE GENET GENOMES, V8, P695, DOI 10.1007/s11295-011-0457-4	74	27	28	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58416	10.1371/journal.pone.0058416	http://dx.doi.org/10.1371/journal.pone.0058416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526981	gold, Green Published, Green Accepted			2022-12-25	WOS:000317562600020
J	Basu, A; Jaisankar, P; Kumar, GS				Basu, Anirban; Jaisankar, Parasuraman; Kumar, Gopinatha Suresh			Binding of the 9-O-N-aryl/arylalkyl Amino Carbonyl Methyl Substituted Berberine Analogs to tRNA(phe)	PLOS ONE			English	Article							PLANT ALKALOID PALMATINE; ENHANCED DNA-BINDING; ALKYL ETHER ANALOGS; TRANSFER-RNA; SMALL MOLECULES; SELF-STRUCTURE; STRANDED POLY(A); DRUG TARGET; PROTOBERBERINE; RECOGNITION	Background: Three new analogs of berberine with aryl/arylalkyl amino carbonyl methyl substituent at the 9-position of the isoquinoline chromophore along with berberrubine were studied for their binding to tRNA(phe) by wide variety of biophysical techniques like spectrophotometry, spectrofluorimetry, circular dichroism, thermal melting, viscosity and isothermal titration calorimetry. Methodology/Principal Findings: Scatchard binding isotherms revealed that the cooperative binding mode of berberine was propagated in the analogs also. Thermal melting studies showed that all the 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs stabilized the tRNA(phe) more in comparison to berberine. Circular dichroism studies showed that these analogs perturbed the structure of tRNA(phe) more in comparison to berberine. Ferrocyanide quenching studies and viscosity results proved the intercalative binding mode of these analogs into the helical organization of tRNA(phe). The binding was entropy driven for the analogs in sharp contrast to the enthalpy driven binding of berberine. The introduction of the aryl/arylalkyl amino carbonyl methyl substituent at the 9-position thus switched the enthalpy driven binding of berberine to entropy dominated binding. Salt and temperature dependent calorimetric studies established the involvement of multiple weak noncovalent interactions in the binding process. Conclusions/Significance: The results showed that 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs exhibited almost ten folds higher binding affinity to tRNA(phe) compared to berberine whereas the binding of berberrubine was dramatically reduced by about twenty fold in comparison to berberine. The spacer length of the substitution at the 9-position of the isoquinoline chromophore appears to be critical in modulating the binding affinities towards tRNA(phe).	[Basu, Anirban; Jaisankar, Parasuraman; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Div Chem, Kolkata, India; [Basu, Anirban; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Kumar, GS (corresponding author), CSIR Indian Inst Chem Biol, Div Chem, Kolkata, India.	gskumar@csiriicb.in	Kumar, Gopinatha Suresh/W-1461-2019; Jaisankar, Parasuraman/C-1553-2009; KUMAR, P. SURESH/AAT-8951-2020; Kumar, Dr Suresh/HHZ-2615-2022	Jaisankar, Parasuraman/0000-0003-0583-4920; KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553	CSIR, Government of India; UGC Senior research fellowship	CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC Senior research fellowship	This work was supported by grants from the network project GenCODE of CSIR, Government of India and UGC Senior research fellowship to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baird AW, 1997, ADV DRUG DELIVER REV, V23, P111, DOI 10.1016/S0169-409X(96)00429-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu A, 2012, RSC ADV, V2, P7714, DOI 10.1039/c2ra20841e; Basu A, 2012, BIOORGAN MED CHEM, V20, P2498, DOI 10.1016/j.bmc.2012.03.006; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; Bhadra K, 2007, BBA-GEN SUBJECTS, V1770, P1071, DOI 10.1016/j.bbagen.2007.03.001; Bhadra K, 2008, DNA CELL BIOL, V27, P675, DOI 10.1089/dna.2008.0779; Bhadra K, 2008, BBA-GEN SUBJECTS, V1780, P1054, DOI 10.1016/j.bbagen.2008.05.005; Bhowmik D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037939; Bodiwala HS, 2011, EUR J MED CHEM, V46, P1045, DOI 10.1016/j.ejmech.2011.01.016; Buchmueller KL, 2006, BIOCHEMISTRY-US, V45, P13551, DOI 10.1021/bi061245c; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; CHAIRES JB, 1982, BIOCHEMISTRY-US, V21, P3933, DOI 10.1021/bi00260a005; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Chen WH, 2005, BIOORG MED CHEM LETT, V15, P2689, DOI 10.1016/j.bmcl.2004.10.098; Cheong HK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh081; Chueh WH, 2012, FOOD CHEM, V131, P1263, DOI 10.1016/j.foodchem.2011.09.116; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023186; DEBNATH D, 1989, INDIAN J BIOCHEM BIO, V26, P201; Foloppe N, 2006, DRUG DISCOV TODAY, V11, P1019, DOI 10.1016/j.drudis.2006.09.001; Fulle S, 2010, J MOL RECOGNIT, V23, P220, DOI 10.1002/jmr.1000; GAIT MJ, 1995, TRENDS BIOTECHNOL, V13, P430, DOI 10.1016/S0167-7799(00)88998-2; Gallego J, 2001, ACCOUNTS CHEM RES, V34, P836, DOI 10.1021/ar000118k; Garbett NC, 2004, BIOPHYS J, V87, P3974, DOI 10.1529/biophysj.104.047415; Gesteland R., 2006, RNA WORLD, V3rd edn. Cold Spring Harbor; Giri P, 2006, BIOORG MED CHEM LETT, V16, P2364, DOI 10.1016/j.bmcl.2006.01.124; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Giri P, 2008, J PHOTOCH PHOTOBIO A, V194, P111, DOI 10.1016/j.jphotochem.2007.07.022; Giri P, 2006, INT J BIOL MACROMOL, V39, P210, DOI 10.1016/j.ijbiomac.2006.03.026; Giri P, 2010, MINI-REV MED CHEM, V10, P568, DOI 10.2174/138955710791384009; Giri P, 2009, CURR MED CHEM, V16, P965, DOI 10.2174/092986709787581932; Guthrie KM, 2007, BIOPHYS CHEM, V126, P117, DOI 10.1016/j.bpc.2006.05.006; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Hermann T, 1998, CURR OPIN BIOTECH, V9, P66, DOI 10.1016/S0958-1669(98)80086-4; HILL ZD, 1986, J CHEM EDUC, V63, P162, DOI 10.1021/ed063p162; Hoenigman SM, 1996, ANAL CHEM, V68, P3274, DOI 10.1021/ac960336k; Hossain M, 2012, J BIOMOL STRUCT DYN, V30, P223, DOI 10.1080/07391102.2012.677774; Hossain M, 2009, MOL BIOSYST, V5, P1311, DOI 10.1039/b909563b; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Islam MM, 2011, MEDCHEMCOMM, V2, P631, DOI 10.1039/c0md00209g; Islam MM, 2011, DNA CELL BIOL, V30, P123, DOI 10.1089/dna.2010.1109; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Islam MM, 2008, J MOL STRUCT, V891, P498, DOI 10.1016/j.molstruc.2008.04.043; Islam MM, 2009, MOL BIOSYST, V5, P244, DOI 10.1039/b816480k; Iwasa K, 1998, EUR J MED CHEM, V33, P65, DOI 10.1016/S0223-5234(99)80077-4; Janbaz KH, 2000, FITOTERAPIA, V71, P25, DOI 10.1016/S0367-326X(99)00098-2; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; Job P, 1928, ANN CHIM FRANCE, V9, P113; Kanakis CD, 2009, SPECTROSC-INT J, V23, P29, DOI 10.1155/2009/154321; Krishnan P, 2000, ANTI-CANCER DRUG DES, V15, P255; Kumar GS, 2012, J BIOSCIENCES, V37, P539, DOI 10.1007/s12038-012-9217-3; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; Liu JC, 1999, PHARMACOLOGY, V59, P283, DOI 10.1159/000028331; Lo CY, 2013, BIOORG MED CHEM LETT, V23, P305, DOI 10.1016/j.bmcl.2012.10.098; Long YH, 2006, BIOORGAN MED CHEM, V14, P4670, DOI 10.1016/j.bmc.2006.03.004; Ma Y, 2008, BIOORGAN MED CHEM, V16, P7582, DOI 10.1016/j.bmc.2008.07.029; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Murphy FV, 2000, STRUCT FOLD DES, V8, pR83, DOI 10.1016/S0969-2126(00)00126-X; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; N'soukpoe-Kossi CN, 2009, BIOCHEM CELL BIOL, V87, P621, DOI [10.1139/O09-036, 10.1139/o09-036]; NANDI R, 1990, BIOCHIM BIOPHYS ACTA, V1049, P339, DOI 10.1016/0167-4781(90)90107-D; Ouameur AA, 2010, RNA, V16, P1968, DOI 10.1261/rna.1994310; Pang JY, 2005, BIOORGAN MED CHEM, V13, P5835, DOI 10.1016/j.bmc.2005.05.048; Peng WH, 2007, LIFE SCI, V81, P933, DOI 10.1016/j.lfs.2007.08.003; Qin Y, 2006, BIOORGAN MED CHEM, V14, P25, DOI 10.1016/j.bmc.2005.07.069; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Ren JS, 2000, BIOCHEMISTRY-US, V39, P8439, DOI 10.1021/bi000474a; Shirwaikar A, 2006, BIOL PHARM BULL, V29, P1906, DOI 10.1248/bpb.29.1906; Sinha R, 2009, J PHYS CHEM B, V113, P13410, DOI 10.1021/jp9069515; Sun T, 2008, NUCLEIC ACIDS RES, V36, P1654, DOI 10.1093/nar/gkm1180; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Xavier KA, 2000, TRENDS BIOTECHNOL, V18, P349, DOI 10.1016/S0167-7799(00)01464-5; Yadav RC, 2005, BIOORGAN MED CHEM, V13, P165, DOI 10.1016/j.bmc.2004.09.045; Yan D, 2008, J BIOCHEM BIOPH METH, V70, P845, DOI 10.1016/j.jbbm.2007.07.009; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050	79	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58279	10.1371/journal.pone.0058279	http://dx.doi.org/10.1371/journal.pone.0058279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526972	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100020
J	Behrendt, JM; Nagel, D; Chundoo, E; Alexander, LM; Dupin, D; Hine, AV; Bradley, M; Sutherland, AJ				Behrendt, Jonathan M.; Nagel, David; Chundoo, Evita; Alexander, Lois M.; Dupin, Damien; Hine, Anna V.; Bradley, Mark; Sutherland, Andrew J.			Synthesis and Characterization of Dual-Functionalized Core-Shell Fluorescent Microspheres for Bioconjugation and Cellular Delivery	PLOS ONE			English	Article							NANOPARTICLES; IMMOBILIZATION; SURFACE; SIRNA; QUANTITATION; CELLS; BEADS; SIZE	The efficient transport of micron-sized beads into cells, via a non-endocytosis mediated mechanism, has only recently been described. As such there is considerable scope for optimization and exploitation of this procedure to enable imaging and sensing applications to be realized. Herein, we report the design, synthesis and characterization of fluorescent microsphere-based cellular delivery agents that can also carry biological cargoes. These core-shell polymer microspheres possess two distinct chemical environments; the core is hydrophobic and can be labeled with fluorescent dye, to permit visual tracking of the microsphere during and after cellular delivery, whilst the outer shell renders the external surfaces of the microspheres hydrophilic, thus facilitating both bioconjugation and cellular compatibility. Cross-linked core particles were prepared in a dispersion polymerization reaction employing styrene, divinylbenzene and a thiol-functionalized co-monomer. These core particles were then shelled in a seeded emulsion polymerization reaction, employing styrene, divinylbenzene and methacrylic acid, to generate orthogonally functionalized core-shell microspheres which were internally labeled via the core thiol moieties through reaction with a thiol reactive dye (DY630-maleimide). Following internal labeling, bioconjugation of green fluorescent protein (GFP) to their carboxyl-functionalized surfaces was successfully accomplished using standard coupling protocols. The resultant dual-labeled microspheres were visualized by both of the fully resolvable fluorescence emissions of their cores (DY630) and shells (GFP). In vitro cellular uptake of these microspheres by HeLa cells was demonstrated conventionally by fluorescence-based flow cytometry, whilst MTT assays demonstrated that 92% of HeLa cells remained viable after uptake. Due to their size and surface functionalities, these far-red-labeled microspheres are ideal candidates for in vitro, cellular delivery of proteins.	[Behrendt, Jonathan M.; Chundoo, Evita; Sutherland, Andrew J.] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England; [Nagel, David; Hine, Anna V.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Alexander, Lois M.; Bradley, Mark] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland; [Dupin, Damien] Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England	Aston University; Aston University; University of Edinburgh; University of Sheffield	Sutherland, AJ (corresponding author), Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England.	a.j.sutherland@aston.ac.uk	Dupin, Damien/ABE-5635-2020; Behrendt, Jonathan/L-2885-2013	Dupin, Damien/0000-0003-0868-9028; Behrendt, Jonathan/0000-0002-9246-4667; Hine, Anna/0000-0003-4065-831X; Sutherland, Andrew/0000-0003-3651-1809	Engineering and Physical Sciences Research Council of the United Kingdom [EP/D038197/1, EP/D038057/1]; Advantage West Midlands; European Regional Development Fund; EPSRC [EP/D038057/1, EP/J501724/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D038057/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Advantage West Midlands(General Electric); European Regional Development Fund(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council of the United Kingdom through the provision of grants EP/D038197/1 and EP/D038057/1. The Beckmann Coulter Delta Nano C Particle Analyzer used in this research was obtained, through Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials Project 2), with support from Advantage West Midlands and part funded by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami RC, 2011, MOL THER, V19, P1141, DOI 10.1038/mt.2011.56; Alexander LM, 2010, MOL BIOSYST, V6, P399, DOI 10.1039/b914428e; Alexander LM, 2009, BIOCONJUGATE CHEM, V20, P422, DOI 10.1021/bc800529r; Algar WR, 2011, BIOCONJUGATE CHEM, V22, P825, DOI 10.1021/bc200065z; Behrendt JM, 2009, J MATER CHEM, V19, P215, DOI 10.1039/b814261k; Bousalem S, 2005, J MATER CHEM, V15, P3109, DOI 10.1039/b500982k; Bradley M, 2008, BIOORG MED CHEM LETT, V18, P313, DOI 10.1016/j.bmcl.2007.10.075; Braeckmans K, 2010, J CONTROL RELEASE, V148, P69, DOI 10.1016/j.jconrel.2010.08.029; Dhar S, 2009, J AM CHEM SOC, V131, P14652, DOI 10.1021/ja9071282; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Fubini B, 2011, NANOMEDICINE-UK, V6, P899, DOI [10.2217/nnm.11.80, 10.2217/NNM.11.80]; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gennet N, 2009, NEW BIOTECHNOL, V25, P442, DOI 10.1016/j.nbt.2009.05.006; Gude M, 2002, LETT PEPT SCI, V9, P203, DOI 10.1007/BF02538384; Higuchi Y, 2011, BIOMATERIALS, V32, P6676, DOI 10.1016/j.biomaterials.2011.05.076; Jose AJ, 2005, POLYMER, V46, P2880, DOI 10.1016/j.polymer.2005.02.001; KOBAYASHI K, 1992, J APPL POLYM SCI, V46, P27, DOI 10.1002/app.1992.070460104; Kutschera U, 2005, THEOR BIOSCI, V124, P1, DOI 10.1016/j.thbio.2005.04.001; Li X, 2011, BIOMATERIALS, V32, P9546, DOI 10.1016/j.biomaterials.2011.08.068; Nelson Jr SJ, 1966, United States Patent, Patent No. 3260748; PAINE AJ, 1990, MACROMOLECULES, V23, P3104, DOI 10.1021/ma00214a012; Pallen MJ, 2011, TRENDS MICROBIOL, V19, P58, DOI 10.1016/j.tim.2010.11.001; Petkau K, 2011, J AM CHEM SOC, V133, P17063, DOI 10.1021/ja2075345; Reetz MT, 2002, TETRAHEDRON, V58, P8465, DOI 10.1016/S0040-4020(02)01052-9; Sanchez-Martin RM, 2005, CHEMBIOCHEM, V6, P1341, DOI 10.1002/cbic.200500059; Sanchez-Martin RM, 2006, ANGEW CHEM INT EDIT, V45, P5472, DOI 10.1002/anie.200601242; Sanchez-Martin RM, 2009, CHEMBIOCHEM, V10, P1453, DOI 10.1002/cbic.200900136; Scutaru AM, 2010, BIOCONJUGATE CHEM, V21, P2222, DOI 10.1021/bc1001906; Slomkowski S, 2002, POLYM ADVAN TECHNOL, V13, P906, DOI 10.1002/pat.283; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Tantra R, 2011, NANOTOXICOLOGY, V5, P381, DOI 10.3109/17435390.2010.512987; Tsakiridis A, 2009, BIOMATERIALS, V30, P5853, DOI 10.1016/j.biomaterials.2009.06.024; Vagner J, 1996, P NATL ACAD SCI USA, V93, P8194, DOI 10.1073/pnas.93.16.8194; Wang JT, 2011, SMALL, V7, P1728, DOI 10.1002/smll.201001913; Wang SH, 2011, J NANOBIOTECHNOL, V8; Zhao EY, 2012, NANOSCALE, V4, P5102, DOI 10.1039/c2nr31290e	36	11	11	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e50713	10.1371/journal.pone.0050713	http://dx.doi.org/10.1371/journal.pone.0050713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526923	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000317562100001
J	Durante-Rodriguez, G; Mancheno, JM; Rivas, G; Alfonso, C; Garcia, JL; Diaz, E; Carmona, M				Durante-Rodriguez, Gonzalo; Miguel Mancheno, Jose; Rivas, German; Alfonso, Carlos; Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel			Identification of a Missing Link in the Evolution of an Enzyme into a Transcriptional Regulator	PLOS ONE			English	Article							ANAEROBIC CATABOLISM; PHENYLACETIC ACID; ESCHERICHIA-COLI; GENE; REPRESSOR; SEQUENCE; BZDR	The evolution of transcriptional regulators through the recruitment of DNA-binding domains by enzymes is a widely held notion. However, few experimental approaches have directly addressed this hypothesis. Here we report the reconstruction of a plausible pathway for the evolution of an enzyme into a transcriptional regulator. The BzdR protein is the prototype of a subfamily of prokaryotic transcriptional regulators that controls the expression of genes involved in the anaerobic degradation of benzoate. We have shown that BzdR consists of an N-terminal DNA-binding domain connected through a linker to a C-terminal effector-binding domain that shows significant identity to the shikimate kinase (SK). The construction of active synthetic BzdR-like regulators by fusing the DNA-binding domain of BzdR to the Escherichia coli SKI protein strongly supports the notion that an ancestral SK domain could have been involved in the evolutionary origin of BzdR. The loss of the enzymatic activity of the ancestral SK domain was essential for it to evolve as a regulatory domain in the current BzdR protein. This work also supports the view that enzymes precede the emergence of the regulatory systems that may control their expression.	[Durante-Rodriguez, Gonzalo; Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel] Ctr Invest Biol CSIC, Dept Environm Biol, Madrid, Spain; [Miguel Mancheno, Jose] CSIC, Inst Phys Chem Rocasolano, Grp Crystallog & Struct Biol, Madrid, Spain; [Rivas, German; Alfonso, Carlos] Ctr Invest Biol CSIC, Dept Chem & Phys Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Carmona, M (corresponding author), Ctr Invest Biol CSIC, Dept Environm Biol, Madrid, Spain.	mcarmona@cib.csic.es	Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Durante-Rodríguez, Gonzalo/H-3000-2013; Mancheno, Jose/K-4984-2014; Diaz, Eduardo/F-8605-2016; Garcia Lopez, Jose Luis/G-9139-2015	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Durante-Rodríguez, Gonzalo/0000-0003-3113-9868; Mancheno, Jose/0000-0001-6943-3291; Carmona, Manuel/0000-0002-1591-7618; Diaz, Eduardo/0000-0002-9731-6524; Garcia Lopez, Jose Luis/0000-0002-9238-2485	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2008-04478-C03-03, BFU2010-17929, CSD-2006-00015]	Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by the Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2008-04478-C03-03, BFU2010-17929, CSD-2006-00015]. GD-R was the recipient of a FPI fellowship from the Ministry of Economy and Competitiveness of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; ALLISON SL, 1990, J BACTERIOL, V172, P5470, DOI 10.1128/jb.172.9.5470-5476.1990; Aravind L, 1998, CURR BIOL, V8, pR111, DOI 10.1016/S0960-9822(98)70982-0; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; COGGINS JR, 1987, METHOD ENZYMOL, V142, P325; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; DEFEYTER R, 1987, METHOD ENZYMOL, V142, P355; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fucile G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000292; Galvao TC, 2007, MOL MICROBIOL, V65, P907, DOI 10.1111/j.1365-2958.2007.05832.x; Hartmann MD, 2006, J MOL BIOL, V364, P411, DOI 10.1016/j.jmb.2006.09.001; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Krell T, 1998, J MOL BIOL, V278, P983, DOI 10.1006/jmbi.1998.1755; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOBNEROLESEN A, 1992, J BACTERIOL, V174, P525, DOI 10.1128/jb.174.2.525-529.1992; LOHR D, 1995, J BIOL CHEM, V270, P27671, DOI 10.1074/jbc.270.46.27671; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; MILLAR G, 1986, BIOCHEM J, V237, P427, DOI 10.1042/bj2370427; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; QUAIL MA, 1994, FEBS LETT, V356, P183, DOI 10.1016/0014-5793(94)01264-4; Sambrook J, 2001, MOL CLONING LAB MANU; Silhavy T.J., 1984, EXPT GENE FUSIONS; Vinella D, 1996, J BACTERIOL, V178, P3818, DOI 10.1128/jb.178.13.3818-3828.1996; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; WHIPP MJ, 1995, J BACTERIOL, V177, P1627, DOI 10.1128/jb.177.6.1627-1629.1995	33	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57518	10.1371/journal.pone.0057518	http://dx.doi.org/10.1371/journal.pone.0057518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526945	Green Published, gold			2022-12-25	WOS:000317562100013
J	Huang, CF; Dai, CY; Yeh, ML; Huang, JF; Huang, CI; Hsieh, MY; Lin, ZY; Chen, SC; Wang, LY; Juo, SHH; Chuang, WL; Lin, YC; Yu, ML				Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Jee-Fu; Huang, Ching-I; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Lin, Yi-Ching; Yu, Ming-Lung			Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients	PLOS ONE			English	Article							INTERLEUKIN-28B GENETIC-VARIANTS; PEGINTERFERON ALPHA-2B; ANTIVIRAL THERAPY; RIBAVIRIN; INTERFERON; MULTICENTER; IDENTIFICATION; POLYMORPHISMS; METAANALYSIS	Background/Aims: The impact of virological factors and interleukin-28B (IL-28B) genetic variants on retreatment of hepatitis C virus genotype 2 (HCV-2) treatment-experienced patients remains unknown. Methods: On-treatment virological responses and IL-28B rs8099917 genotype were determined in 46 HCV-2 treatment-experienced patients (42 previous relapsers; four previous non-responders) retreated with 24-week peginterferon/ribavirin. Results: Forty (87.0%) patients carried the rs8099917 TT genotype and 6 patients (13.0%) carried the TG/GG genotype. The sustained virological response (SVR; seronegativity of HCV RNA throughout 24 weeks of the post-treatment follow-up period) rate was 71.7%. Compared with previous non-responders, previous relapsers had a significantly higher SVR rate (78.6% vs. 0%, P = 0.004) and a lower relapse rate (17.5% vs. 100%, P = 0.04). All the previous non-responders were with the rs8099917 TT genotype. As for those who relapsed, treatment responses, including the rates of rapid virological response (RVR, 80.6% vs. 66.7%, P = 0.59), early virological response (EVR, 97.2% vs. 83.3%, P = 0.27), end-of-treatment virological response (97.2% vs. 83.3%, P = 0.27) and SVR (80.6% vs. 66.7%, P = 0.59) and relapse rate (17.1% vs. 20.0%, P = 1) did not differ significantly between patients with the rs8099917 TT and those with the non-TT genotype. Multivariate analysis revealed that the most important factor predictive of an SVR in the retreatment of HCV-2 was previous relapse; the only factor predictive of an SVR for previous relapsers was the achievement of an EVR. Compared with the achievement of a RVR, the attainment of an EVR was more accurate in predicting an SVR (88% vs. 74%). Conclusions: Peginterferon/ribavirin is effective in the retreatment of HCV-2 relapsers, especially among those who achieved an EVR.	[Huang, Chung-Feng; Lin, Yi-Ching] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan; [Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Jee-Fu; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Jee-Fu; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ching-I; Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Lin, Yi-Ching] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Dai, CY (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.	fish6069@gmail.com	Juo, Suh-Hang/C-9545-2009; Huang, Jee-Fu/AAX-4622-2020; Chuang, Wan-Long/ABF-7427-2021; Yu, Ming-Lung/AAZ-4306-2020	Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X; Yu, Ming-Lung/0000-0001-8145-1900; Lin, Yi-Ching/0000-0002-0849-6149	Kaohsiung Medical University Hospital [KMUH100-9I02]; National Science Council, Taiwan [NSC 100-2314-B-037-014-MY2]	Kaohsiung Medical University Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Kaohsiung Medical University Hospital (KMUH100-9I02) and a grant from the National Science Council, Taiwan (NSC 100-2314-B-037-014-MY2). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso M, 2007, DIGEST LIVER DIS, V39, P47, DOI 10.1016/j.dld.2006.08.007; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Huang JF, 2007, ALIMENT PHARM THER, V25, P1029, DOI 10.1111/j.1365-2036.2007.03297.x; Jacobson IM, 2005, AM J GASTROENTEROL, V100, P2453, DOI 10.1111/j.1572-0241.2005.00282.x; Jensen DM, 2009, ANN INTERN MED, V150, P528, DOI 10.7326/0003-4819-150-8-200904210-00007; Kozuka R, 2012, HEPATOL RES IN PRESS; Krawitt EL, 2005, J HEPATOL, V43, P243, DOI 10.1016/j.jhep.2005.03.015; Liu CH, 2012, ANTIVIR THE IN PRESS; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2012, LIVER INT, V32, P135, DOI 10.1111/j.1478-3231.2011.02710.x; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Omata M, 2012, HEPATOL INT IN PRESS; Oze T, 2011, J GASTROENTEROL, V46, P1031, DOI 10.1007/s00535-011-0409-7; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Schreiber J, 2012, ALIMENT PHARM THER, V36, P353, DOI 10.1111/j.1365-2036.2012.05197.x; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Singal AG, 2010, ALIMENT PHARM THER, V32, P969, DOI 10.1111/j.1365-2036.2010.04427.x; Thompson AJ, 2012, HEPATOLOGY, V56, P373, DOI 10.1002/hep.25792; Vermehren J, 2011, J CLIN VIROL, V52, P133, DOI 10.1016/j.jcv.2011.07.007; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5; Yu ML, 2007, ONCOLOGY-BASEL, V72, P16, DOI 10.1159/000111703; Yu ML, 2006, ANTIVIR THER, V11, P985; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58882	10.1371/journal.pone.0058882	http://dx.doi.org/10.1371/journal.pone.0058882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527043	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562100054
J	Zou, JY; Yang, H; Cui, HJ; Shu, YL; Xu, PP; Xu, CL; Chen, T				Zou, Jingyang; Yang, Hua; Cui, Hengjian; Shu, Yuelong; Xu, Peipei; Xu, Cuiling; Chen, Tao			Geographic Divisions and Modeling of Virological Data on Seasonal Influenza in the Chinese Mainland during the 2006-2009 Monitoring Years	PLOS ONE			English	Article								Background: Seasonal influenza epidemics occur annually with bimodality in southern China and unimodality in northern China. Regional differences exist in surveillance data collected by the National Influenza Surveillance Network of the Chinese mainland. Qualitative and quantitative analyses on the spatiotemporal rules of the influenza virus's activities are needed to lay the foundation for the surveillance, prevention and control of seasonal influenza. Methods: The peak performance analysis and Fourier harmonic extraction methods were used to explore the spatiotemporal characteristics of the seasonal influenza virus activity and to obtain geographic divisions. In the first method, the concept of quality control was introduced and robust estimators were chosen to make the results more convincing. The dominant Fourier harmonics of the provincial time series were extracted in the second method, and the VARiable CLUSter (VARCLUS) procedure was used to variably cluster the extracted results. On the basis of the above geographic division results, three typical districts were selected and corresponding sinusoidal models were applied to fit the time series of the virological data. Results: The predominant virus during every peak is visible from the bar charts of the virological data. The results of the two methods that were used to obtain the geographic divisions have some consistencies with each other and with the virus activity mechanism. Quantitative models were established for three typical districts: the south1 district, including Guangdong, Guangxi, Jiangxi and Fujian; the south2 district, including Hunan, Hubei, Shanghai, Jiangsu and Zhejiang; and the north district, including the 14 northern provinces except Qinghai. The sinusoidal fitting models showed that the south1 district had strong annual periodicity with strong winter peaks and weak summer peaks. The south2 district had strong semi-annual periodicity with similarly strong summer and winter peaks, and the north district had strong annual periodicity with only winter peaks.	[Zou, Jingyang] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Yang, Hua; Xu, Peipei] Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Yang, Hua] Beijing Normal Univ, Inst Remote Sensing Applicat CAS, Sch Geog & Remote Sensing Sci, Beijing 100875, Peoples R China; [Cui, Hengjian] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Shu, Yuelong; Xu, Cuiling; Chen, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Capital Normal University; Chinese Center for Disease Control & Prevention	Yang, H (corresponding author), Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.	yh_crs@bnu.edu.cn			"Special Program for Prevention and Control of Infectious Diseases'' from the Ministry of Science and Technology of China [2008ZX10004-012]	"Special Program for Prevention and Control of Infectious Diseases'' from the Ministry of Science and Technology of China	This work is supported by the "Special Program for Prevention and Control of Infectious Diseases'' (No. 2008ZX10004-012) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdesmaki M, 2012, PACKAGE GENECYCLE; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; [Anonymous], 2002, SAS HELP DOC; Arkema JM, 2008, EURO SURVEILL, V13; Brockwell PJ, 1988, TIME SERIES THEORY M; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Gao Yan, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1097; Huang W, 2008, DIS SURVEILLANCE, V23, P469; Huang W, 2008, DIS SURVEILLANCE, V23, P463; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Maronna RA, 2006, ROUST STAT THEORY ME; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mei YuFa, 2008, Disease Surveillance, V23, P682; Meijer A, 2007, EURO SURVEILL, V12; Meijer A, 2006, EURO SURVEILL, V11, P623; Montgomery D.C., 2004, INTRO STAT QUALITY C; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WHO, 2012, WHO INT GLOB EP SURV; [闫磊 Yan Lei], 2010, 地球信息科学学报, V12, P410; Zhu H, 2006, MODERN PREVENTIVE ME, V33, P913	23	13	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58434	10.1371/journal.pone.0058434	http://dx.doi.org/10.1371/journal.pone.0058434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526984	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562100026
J	Cherng, YG; Liao, CC; Chen, TH; Xiao, D; Wu, CH; Chen, TL				Cherng, Yih-Giun; Liao, Chien-Chang; Chen, Tso-Hsiao; Xiao, Duan; Wu, Chih-Hsiung; Chen, Ta-Liang			Are Non-cardiac Surgeries Safe for Dialysis Patients? - A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							STAGE RENAL-FAILURE; PERITONEAL-DIALYSIS; FLUID MANAGEMENT; MEDICAL PROGRESS; CARDIAC-SURGERY; MORTALITY; RISK; HEMODIALYSIS; SURVIVAL; DISEASE	Background: End-stage renal disease represents a risk complex that complicates surgical results. The surgical outcomes of dialysis patients have been studied in specific fields, but the global features of postoperative adverse outcomes in dialysis patients receiving non-cardiac surgeries have not been examined. Methods: Taiwan's National Health Insurance Research Database was used to study 8,937 patients under regular dialysis with 8,937 propensity-score matched-pair controls receiving non-cardiac surgery between 2004 and 2007. We investigated the influence of hemodialysis and peritoneal dialysis, effects of hypertension and diabetes, and impact of additional comorbidities on postoperative adverse outcomes. Results: Postoperative mortality in dialysis patients was higher than in controls (odds ratio [OR] 3.33, 95% confidence interval [CI] 2.56 to 4.33) when receiving non-cardiac surgeries. Complications such as acute myocardial infarction, pneumonia, bleeding, and septicemia were significantly increased. Postoperative mortality was significantly increased among peritoneal dialysis patients (OR 2.71, 95% CI 1.70 to 4.31) and hemodialysis patients (OR 3.42, 95% CI 2.62 to 4.47) than in controls. Dialysis patients with both hypertension and diabetes had the highest risk of postoperative complications; these risks increased with number of preoperative medical conditions. Patients under dialysis also showed significantly increased length of hospitalization, more ICU stays and higher medical expenditures. Conclusion: Surgical patients under dialysis encountered significantly higher postoperative complications and mortality than controls when receiving non-cardiac surgeries. Different dialysis techniques, pre-existing hypertension/diabetes, and various comorbidities had complication-specific impacts on surgical adverse outcomes. These findings can help surgical teams provide better risk assessment and postoperative care for dialysis patients.	[Cherng, Yih-Giun] Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, New Taipei City, Taiwan; [Cherng, Yih-Giun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Tso-Hsiao] Taipei Med Univ, Dept Nephrol, Dept Internal Med, Coll Med,Wan Fang Med Ctr, Taipei, Taiwan; [Xiao, Duan] Second Peoples Hosp Shi Fang City, Dept Coloproctol, Shi Fang City, Sichuan Provinc, Peoples R China; [Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, New Taipei City, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chen, TL (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan.	tlc@tmu.edu.tw		Cherng, Yih-Giun/0000-0002-0201-4380	Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital	Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital without conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Bechtel JFM, 2008, ANN THORAC SURG, V85, P147, DOI 10.1016/j.athoracsur.2007.08.048; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; de Peppo AP, 2002, ANN THORAC SURG, V74, P378, DOI 10.1016/S0003-4975(02)03711-6; Drolet S, 2010, DIS COLON RECTUM, V53, P1508, DOI 10.1007/DCR.0b013e3181e8fc8e; Guh JY, 2007, AM J KIDNEY DIS, V49, P626, DOI 10.1053/j.ajkd.2007.02.259; Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Huang CC, 2008, ACTA NEPHROLOGICA, V22, P215; Ifudu O, 1998, NEW ENGL J MED, V339, P1054, DOI 10.1056/NEJM199810083391507; Jaar BG, 2005, ANN INTERN MED, V143, P174, DOI 10.7326/0003-4819-143-3-200508020-00003; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Kuo HW, 2010, PHARMACOEPIDEM DR S, V19, P743, DOI 10.1002/pds.1962; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Lin JL, 2003, NEW ENGL J MED, V348, P277, DOI 10.1056/NEJMoa021672; Lin JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026977; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Miller RD, 2009, ANESTHETIC IMPLICATI, P1067; Murphy SW, 2000, KIDNEY INT, V57, P1720, DOI 10.1046/j.1523-1755.2000.00017.x; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Noordzij M, 2006, NEPHROL DIAL TRANSPL, V21, P2513, DOI 10.1093/ndt/gfl257; Parquin F, 1996, EUR J CARDIO-THORAC, V10, P929, DOI 10.1016/S1010-7940(96)80392-7; Pastan S, 1998, NEW ENGL J MED, V338, P1428, DOI 10.1056/NEJM199805143382006; Perrinet M, 2010, J CLIN PHARM THER, V35, P395, DOI 10.1111/j.1365-2710.2009.01106.x; Prichard SS, 2000, KIDNEY INT, V57, pS100, DOI 10.1046/j.1523-1755.2000.07417.x; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; SLINGER PD, 1995, J CARDIOTHOR VASC AN, V9, P442, DOI 10.1016/S1053-0770(05)80103-X; Tsai SY, 2009, J EPIDEMIOL, V19, P169, DOI 10.2188/jea.JE20080099; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76; Yu YH, 2011, SPINE, V36, P660, DOI 10.1097/BRS.0b013e3181dc9a33	39	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58942	10.1371/journal.pone.0058942	http://dx.doi.org/10.1371/journal.pone.0058942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516581	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400080
J	Huang, TC; Wang, YC				Huang, Tzung-Chi; Wang, Yao-Ching			Deformation Effect on SUVmax Changes in Thoracic Tumors Using 4-D PET/CT Scan	PLOS ONE			English	Article							FDG-PET; CT; MOTION; THERAPY; IMAGES; 3D	Respiratory motion blurs the standardized uptake value (SUV) and leads to a further signal reduction and changes in the SUV maxima. 4D PET can provide accurate tumor localization as a function of the respiratory phase in PET/CT imaging. We investigated thoracic tumor motion by respiratory 4D CT and assessed its deformation effect on the SUV changes in 4D PET imaging using clinical patient data. Twelve radiation oncology patients with thoracic cancer, including five lung cancer patients and seven esophageal cancer patients, were recruited to the present study. The 4D CT and PET image sets were acquired and reconstructed for 10 respiratory phases across the whole respiratory cycle. The optical flow method was applied to the 4D CT data to calculate the maximum displacements of the tumor motion in respiration. Our results show that increased tumor motion has a significant degree of association with the SUVmax loss for lung cancer. The results also show that the SUVmax loss has a higher correlation with tumors located at lower lobe of lung or at lower regions of esophagus.	[Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Wang, Yao-Ching] China Med Univ Hosp, Div Radiat Oncol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		school project of China Medical University, Taiwan [CMU99-S-46]	school project of China Medical University, Taiwan	This study was financially supported by the school project of China Medical University, Taiwan (CMU99-S-46), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramyuk A, 2009, RADIOTHER ONCOL, V91, P399, DOI 10.1016/j.radonc.2009.01.003; Aristophanous M, 2012, INT J RADIAT ONCOL, V82, P99, DOI DOI 10.1016/J.IJR0BP.2010.12.060; Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Callahan J, 2011, AUSTRALAS PHYS ENG S, V34, P489, DOI 10.1007/s13246-011-0109-x; Cerfolio RJ, 2004, ANN THORAC SURG, V78, P1903, DOI 10.1016/j.athoracsur.2004.06.102; Guerrero T, 2004, PHYS MED BIOL, V49, P4147, DOI 10.1088/0031-9155/49/17/022; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huang TC, 2011, PHYS MED BIOL, V56, P2559, DOI 10.1088/0031-9155/56/8/014; Huang TC, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-45; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; MacManus M, 2009, RADIOTHER ONCOL, V91, P85, DOI 10.1016/j.radonc.2008.11.008; Nehmeh SA, 2004, MED PHYS, V31, P3179, DOI 10.1118/1.1809778; Park SJ, 2008, PHYS MED BIOL, V53, P3661, DOI 10.1088/0031-9155/53/13/018; Pevsner A, 2005, MED PHYS, V32, P2358, DOI 10.1118/1.1943809; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wang SZ, 2012, KOREAN J RADIOL, V13, P417, DOI 10.3348/kjr.2012.13.4.417; Wolthaus JWH, 2005, PHYS MED BIOL, V50, P1569, DOI 10.1088/0031-9155/50/7/017	17	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58886	10.1371/journal.pone.0058886	http://dx.doi.org/10.1371/journal.pone.0058886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516568	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400071
J	Le Saux, CJ; Davy, P; Brampton, C; Ahuja, SS; Fauce, S; Shivshankar, P; Nguyen, H; Ramaseshan, M; Tressler, R; Pirot, Z; Harley, CB; Allsopp, R				Le Saux, Claude Jourdan; Davy, Philip; Brampton, Christopher; Ahuja, Seema S.; Fauce, Steven; Shivshankar, Pooja; Hieu Nguyen; Ramaseshan, Mahesh; Tressler, Robert; Pirot, Zhu; Harley, Calvin B.; Allsopp, Richard			A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; CELLULAR SENESCENCE; IN-VIVO; CELLS; MUTATIONS; ASSOCIATION; EXPRESSION; GENE; MICE	The emergence of diseases associated with telomere dysfunction, including AIDS, aplastic anemia and pulmonary fibrosis, has bolstered interest in telomerase activators. We report identification of a new small molecule activator, GRN510, with activity ex vivo and in vivo. Using a novel mouse model, we tested the potential of GRN510 to limit fibrosis induced by bleomycin in mTERT heterozygous mice. Treatment with GRN510 at 10 mg/kg/day activated telomerase 2-4 fold both in hematopoietic progenitors ex vivo and in bone marrow and lung tissue in vivo, respectively. Telomerase activation was countered by co-treatment with Imetelstat (GRN163L), a potent telomerase inhibitor. In this model of bleomycin-induced fibrosis, treatment with GRN510 suppressed the development of fibrosis and accumulation of senescent cells in the lung via a mechanism dependent upon telomerase activation. Treatment of small airway epithelial cells (SAEC) or lung fibroblasts ex vivo with GRN510 revealed telomerase activating and replicative lifespan promoting effects only in the SAEC, suggesting that the mechanism accounting for the protective effects of GRN510 against induced lung fibrosis involves specific types of lung cells. Together, these results support the use of small molecule activators of telomerase in therapies to treat idiopathic pulmonary fibrosis.	[Le Saux, Claude Jourdan; Ahuja, Seema S.; Shivshankar, Pooja] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Davy, Philip; Brampton, Christopher; Hieu Nguyen; Allsopp, Richard] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Fauce, Steven; Ramaseshan, Mahesh; Tressler, Robert; Pirot, Zhu; Harley, Calvin B.] Geron Corp, Menlo Pk, CA USA; [Tressler, Robert] Cellerant, Redwood City, CA USA; [Fauce, Steven] Beckman Coulter Inc, Brea, CA USA	University of Texas System; University of Texas Health San Antonio; University of Hawaii System; Geron Corporation; Beckman Coulter Inc.	Allsopp, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA.	allsopp@hawaii.edu	Le Saux, Claude/AGF-7659-2022	Le Saux, Claude/0000-0002-6041-2870	Geron Corporation	Geron Corporation	This study was funded by a small grant from Geron Corporation. Those individuals at Geron Corporation specifically responsible for funding this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Diaz de Leon A, PLOS ONE, V5; Drakopanagiotakis F, 2008, EUR RESPIR J, V32, P1631, DOI 10.1183/09031936.00176807; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fauce SR, 2008, J IMMUNOL, V181, P7400, DOI 10.4049/jimmunol.181.10.7400; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Keane MP, 1999, J IMMUNOL, V162, P5511; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kottmann RM, 2009, RESPIROLOGY, V14, P917, DOI 10.1111/j.1440-1843.2009.01624.x; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2002, AM J RESP CELL MOL, V26, P534, DOI 10.1165/ajrcmb.26.5.4668; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Mallick S, 2008, RESP MED, V102, P1355, DOI 10.1016/j.rmed.2008.06.003; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Mazzucchelli GD, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-12; Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Roth A, 2010, RECENT RESULTS CANC, V184, P221, DOI 10.1007/978-3-642-01222-8_16; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shivshankar P, 2011, AGING CELL, V10, P798, DOI 10.1111/j.1474-9726.2011.00720.x; STACK BHR, 1972, THORAX, V27, P535, DOI 10.1136/thx.27.5.535; STELLATO C, 1995, J IMMUNOL, V155, P410; Thannickal VJ, 2008, AM J RESP CRIT CARE, V178, P663, DOI 10.1164/rccm.200807-1127ED; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Verma S, 2007, NEW ENGL J MED, V356, P1370, DOI 10.1056/NEJMcibr070490; Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	46	44	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58423	10.1371/journal.pone.0058423	http://dx.doi.org/10.1371/journal.pone.0058423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516479	Green Submitted, gold, Green Published			2022-12-25	WOS:000316407400028
J	McQuade, KJ; Nakajima, A; Ilacqua, AN; Shimada, N; Sawai, S				McQuade, Kyle J.; Nakajima, Akihiko; Ilacqua, April N.; Shimada, Nao; Sawai, Satoshi			The Green Tea Catechin Epigallocatechin Gallate (EGCG) Blocks Cell Motility, Chemotaxis and Development in Dictyostelium discoideum	PLOS ONE			English	Article							DENSITY WAVE-PROPAGATION; GALLOYL MOIETY; ADENYLYL-CYCLASE; MOUND FORMATION; PRESTALK CELLS; DIFFERENTIATION; AGGREGATION; EXPRESSION; POLYPHENOLS; MECHANISMS	Catechins, flavanols found at high levels in green tea, have received significant attention due to their potential health benefits related to cancer, autoimmunity and metabolic disease, but little is known about the mechanisms by which these compounds affect cellular behavior. Here, we assess whether the model organism Dictyostelium discoideum is a useful tool with which to characterize the effects of catechins. Epigallocatechin gallate (EGCG), the most abundant and potent catechin in green tea, has significant effects on the Dictyostelium life cycle. In the presence of EGCG aggregation is delayed, cells do not stream and development is typically stalled at the loose aggregate stage. The developmental effects very likely result from defects in motility, as EGCG reduces both random movement and chemotaxis of Dictyostelium amoebae. These results suggest that catechins and their derivatives may be useful tools with which to better understand cell motility and development in Dictyostelium and that this organism is a useful model to further characterize the activities of catechins.	[McQuade, Kyle J.; Ilacqua, April N.] Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA; [Nakajima, Akihiko; Shimada, Nao; Sawai, Satoshi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Sawai, Satoshi] Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan; [Sawai, Satoshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	McQuade, KJ (corresponding author), Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA.	kmcquade@coloradomesa.edu	Nakajima, Akihiko/U-1973-2019; Sawai, Satoshi/AAX-8536-2020	Nakajima, Akihiko/0000-0002-2690-6973; Sawai, Satoshi/0000-0003-3764-219X	JSPS [22680024, 23870006]; JST PRESTO program; Human Frontier Science Program [RGY 70/2008]; Platform for Dynamic Approaches to Living Systems from MEXT, Japan; Colorado Mesa University (CMU) Biology Department; Faculty Development Awards from CMU; Beta Beta Beta Honor Society;  [23111506]; Grants-in-Aid for Scientific Research [22680024] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST PRESTO program; Human Frontier Science Program(Human Frontier Science Program); Platform for Dynamic Approaches to Living Systems from MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Colorado Mesa University (CMU) Biology Department; Faculty Development Awards from CMU; Beta Beta Beta Honor Society; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work in the Sawai Lab was supported by JSPS Grant-in-Aid for Young Scientists (A) (22680024), Grant-in-Aid for Scientific Research on Innovative Areas (23111506), JST PRESTO program and in part by Human Frontier Science Program (RGY 70/2008) and Platform for Dynamic Approaches to Living Systems from MEXT, Japan. AN was supported by JSPS Grant-in-Aid for Research Activity Start-up (23870006). KJM was supported by the Colorado Mesa University (CMU) Biology Department and by Faculty Development Awards from CMU. ANI was supported by an undergraduate research award from Beta Beta Beta Honor Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; BERKS M, 1990, DEVELOPMENT, V110, P977; Clow PA, 2000, DEVELOPMENT, V127, P2715; Comer FI, 2006, MOL BIOL CELL, V17, P357, DOI 10.1091/mbc.E05-08-0781; Dannat K, 2003, PHARMAZIE, V58, P204; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; EARLY A, 1995, CELL, V83, P91, DOI 10.1016/0092-8674(95)90237-6; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; GROSS JD, 1976, J CELL SCI, V22, P645; Haque AM, 2008, J NUTR BIOCHEM, V19, P619, DOI 10.1016/j.jnutbio.2007.08.008; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Jackson JK, 2010, J MATER SCI-MATER M, V21, P1435, DOI 10.1007/s10856-010-4019-3; Jaeger S, 2009, BIOINFORMATICS, V25, P2383, DOI 10.1093/bioinformatics/btp405; Jiang F, 2010, CLIN IMMUNOL, V137, P347, DOI 10.1016/j.clim.2010.08.007; Jiang Y, 1998, BIOPHYS J, V75, P2615, DOI 10.1016/S0006-3495(98)77707-0; Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161; King JS, 2009, DIS MODEL MECH, V2, P306, DOI 10.1242/dmm.001271; Kotsifas M, 2002, J MUSCLE RES CELL M, V23, P839, DOI 10.1023/A:1024444215766; Kurahashi N, 2008, AM J EPIDEMIOL, V167, P71, DOI 10.1093/aje/kwm249; Kuzuhara Takashi, 2009, PLoS Curr, V1, pRRN1052; Lang M, 2009, LIVER INT, V29, P670, DOI 10.1111/j.1478-3231.2009.01984.x; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; Loomis WF, 2011, DEV GROWTH DIFFER, V53, P567, DOI 10.1111/j.1440-169X.2010.01241.x; MATSUKUMA S, 1979, J EMBRYOL EXP MORPH, V50, P243; Myre MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002052; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; NELLEN W, 1984, MOL CELL BIOL, V4, P2890, DOI 10.1128/MCB.4.12.2890; Ogunleye AA, 2010, BREAST CANCER RES TR, V119, P477, DOI 10.1007/s10549-009-0415-0; Patel H, 2000, EMBO J, V19, P2247, DOI 10.1093/emboj/19.10.2247; Rietdorf J, 1996, DEV BIOL, V177, P427, DOI 10.1006/dbio.1996.0175; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Sawai S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r144; SCHNITZLER GR, 1994, GENE DEV, V8, P502, DOI 10.1101/gad.8.4.502; SIEGERT F, 1991, PHYSICA D, V49, P224, DOI 10.1016/0167-2789(91)90210-Z; SIEGERT F, 1989, J CELL SCI, V93, P325; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205; Suganuma M, 2011, CANCER SCI, V102, P317, DOI 10.1111/j.1349-7006.2010.01805.x; Sugatani J, 2004, INT ARCH ALLERGY IMM, V134, P17, DOI 10.1159/000077529; Szabo CM, 2002, J MED CHEM, V45, P2894, DOI 10.1021/jm010279+; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; Tillner J, 1998, TOXICOL IN VITRO, V12, P463, DOI 10.1016/S0887-2333(98)00016-2; TRAYNOR D, 1992, P NATL ACAD SCI USA, V89, P8303, DOI 10.1073/pnas.89.17.8303; Van Aller GS, 2011, BIOCHEM BIOPH RES CO, V406, P194, DOI 10.1016/j.bbrc.2011.02.010; Van Driessche N, 2007, P NATL ACAD SCI USA, V104, P15406, DOI 10.1073/pnas.0705996104; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Wang X, 2003, BIOCHEM PHARMACOL, V66, P2039, DOI 10.1016/S0006-2952(03)00585-9; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; YAMAMOTO A, 1983, DIFFERENTIATION, V24, P83, DOI 10.1111/j.1432-0436.1983.tb01307.x; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	57	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59275	10.1371/journal.pone.0059275	http://dx.doi.org/10.1371/journal.pone.0059275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516620	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400104
J	Song, N; Liang, AP				Song, Nan; Liang, Ai-Ping			A Preliminary Molecular Phylogeny of Planthoppers (Hemiptera: Fulgoroidea) Based on Nuclear and Mitochondrial DNA Sequences	PLOS ONE			English	Article							FULGOROMORPHA; SELECTION; EVOLUTION; INSECTA	The planthopper superfamily Fulgoroidea (Insecta: Hemiptera) is one of the most dominant groups of phytophagous insects. It comprises about 20 families, containing a total of 9000 species worldwide. Despite several recent studies, the phylogeny of Fulgoroidea is not yet satisfactorily resolved and the phylogenetic positions of several key families, especially Cixiidae, Delphacidae, Tettigometridae, Nogodinidae, Acanaloniidae and Issidae, are contentious. Here, we expand upon recent phylogenetic work using additional nuclear (18S and 28S) and novel mitochondrial (16S and cytb) markers. Maximum likelihood and Bayesian analyses yielded robust phylogenetic trees. In these topologies, a group containing Cixiidae and Delphacidae is recovered as the sister group to the remaining taxa. Tettigometridae is placed in a more nested position and is grouped with Caliscelidae. Sister relationships are found between Flatidae and Ricaniidae, and between Dictyopharidae and Fulgoridae. Nogodinidae and Issidae are confirmed to be non-monophyletic families. For major nodes of interest, divergence date estimates are generally older than those from the fossil record.	[Song, Nan; Liang, Ai-Ping] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Song, Nan] Henan Entry Exit Inspect & Quarantine Bur, Zhengzhou, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	liangap@ioz.ac.cn			National Basic Research Program of China (973 Program) [2007CB411601]; National Natural Science Foundation of China [30530110, 30770269, 30970400]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Science Fund for Fostering Talents in Basic Research [NSFCJ0630964/J0109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research	This study was supported by grants from the National Basic Research Program of China (973 Program) grant # 2007CB411601, the National Natural Science Foundation of China grants # 30530110, 30770269 and 30970400, the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences grant # O529YX5105, and the National Science Fund for Fostering Talents in Basic Research, Special subjects in animal taxonomy, grant # NSFCJ0630964/J0109, all awarded to APL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Asche M, 1987, P 6 AUCH M TUR IT 7, P47; BOURGOIN T, 1993, ANN SOC ENTOMOL FR, V29, P225; Bourgoin T, 1997, CLADISTICS, V13, P207, DOI 10.1111/j.1096-0031.1997.tb00316.x; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Chen Shuo, 1995, Chinese Journal of Entomology, V15, P257; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyck V. A., 1979, International Rice Research Institute: Brown planthopper: threat to rice production in Asia., P3; EMEL'YANOV A F, 1990, Entomologicheskoe Obozrenie, V69, P353; Emeljanov A.F., 1999, Zoosystematica Rossica, V8, P61; FENNAH R. G., 1954, TRANS ROY ENT SOC LONDON, V105, P455; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamilton K.G. Andrew, 2011, Cicadina, V12, P57; HAMILTON KGA, 1990, B AM MUS NAT HIST, P82; Kukalova-Peck J., 1991, INSECTS AUSTR, VI, P141; Liang AP, 2001, RAFFLES B ZOOL, V49, P221; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Metcalf ZP, 1932, GEN CATALOGUE HOMO 1; Metcalf ZP, 1958, GEN CATALOGUE HOMOPT, V4, P561; Muir F, 1930, ANN MAGAZINE NATURAL, V10, P461; Muir F.A.G., 1923, P HAWAII ENTOMOL SOC, V5, P205; Nylander J, 2004, MR MODELTEST V2 PROG; O'Brien L.B., 1985, P61; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2009, FIGTREE V1 3 1; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Shcherbakov DE, 1996, ENTOMOL SOC AM, P31; Shcherbakov DE, 2005, 12 INT AUCH C BERK 7, pI; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Soulier-Perkins A, 2001, CLADISTICS, V17, P56, DOI 10.1006/clad.2000.0152; SWOFFORD DL, 1996, MOL SYSTEMATICS; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Szwedo J, 2005, 12 INT AUCH C 6 INT, P30; Szwedo Jacek, 2004, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urban JM, 2007, MOL PHYLOGENET EVOL, V42, P556, DOI 10.1016/j.ympev.2006.08.009; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia X, 2003, FUNDAMENTAL CONCEPTS, P149; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeh W.B., 1999, CHINESE J ENTOMOLOGY, V11, P87; Yeh WB, 1998, ZOOL STUD, V37, P45; Yeh WB, 2005, ZOOL STUD, V44, P519; Zwickl D., 2006, GARLI GENETIC ALGORI	50	53	59	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58400	10.1371/journal.pone.0058400	http://dx.doi.org/10.1371/journal.pone.0058400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516472	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400025
J	Toldo, S; Goehe, RW; Lotrionte, M; Mezzaroma, E; Sumner, ET; Biondi-Zoccai, GGL; Seropian, IM; Van Tassell, BW; Loperfido, F; Palazzoni, G; Voelkel, NF; Abbate, A; Gewirtz, DA				Toldo, Stefano; Goehe, Rachel W.; Lotrionte, Marzia; Mezzaroma, Eleonora; Sumner, Evan T.; Biondi-Zoccai, Giuseppe G. L.; Seropian, Ignacio M.; Van Tassell, Benjamin W.; Loperfido, Francesco; Palazzoni, Giovanni; Voelkel, Norbert F.; Abbate, Antonio; Gewirtz, David A.			Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse	PLOS ONE			English	Article							CELL-LINE; CANCER; CARDIOTOXICITY; STIMULATION; DOXORUBICIN; EPIRUBICIN; ADRIAMYCIN; NATION; TUMORS; HEART	Purpose: The antineoplastic efficacy of anthracyclines is limited by their cardiac toxicity. In this study, we evaluated the toxicity of doxorubicin, non-pegylated liposomal-delivered doxorubicin, and epirubicin in HL-1 adult cardiomyocytes in culture as well as in the mouse in vivo. Methods: The cardiomyocytes were incubated with the three anthracyclines (1 mu M) to assess reactive oxygen generation, DNA damage and apoptotic cell death. CF-1 mice (10/group) received doxorubicin, epirubicin or non-pegylated liposomal-doxorubicin (10 mg/kg) and cardiac function was monitored by Doppler echocardiography to measure left ventricular ejection fraction (LVEF), heart rate (HR) and cardiac output (CO) both prior to and 10 days after drug treatment. Results: In HL-1 cells, non-pegylated liposomal-doxorubicin generated significantly less reactive oxygen species (ROS), as well as less DNA damage and apoptosis activation when compared with doxorubicin and epirubicin. Cultured breast tumor cells showed similar sensitivity to the three anthracyclines. In the healthy mouse, non-pegylated liposomal doxorubicin showed a minimal and non-significant decrease in LVEF with no change in HR or CO, compared to doxorubicin and epirubicin. Conclusion: This study provides evidence for reduced cardiac toxicity of non-pegylated-liposomal doxorubicin characterized by attenuation of ROS generation, DNA damage and apoptosis in comparison to epirubicin and doxorubicin.	[Toldo, Stefano; Mezzaroma, Eleonora; Seropian, Ignacio M.; Van Tassell, Benjamin W.; Voelkel, Norbert F.; Abbate, Antonio] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA 23284 USA; [Toldo, Stefano; Mezzaroma, Eleonora; Seropian, Ignacio M.; Van Tassell, Benjamin W.; Voelkel, Norbert F.; Abbate, Antonio] Virginia Commonwealth Univ, Victoria Johnson Ctr, Richmond, VA USA; [Goehe, Rachel W.; Sumner, Evan T.; Gewirtz, David A.] Virginia Commonwealth Univ, Dept Pharmacol & Massey Canc, Richmond, VA USA; [Lotrionte, Marzia; Loperfido, Francesco] Univ Cattolica Sacro Cuore, Div Cardiol, I-00168 Rome, Italy; [Biondi-Zoccai, Giuseppe G. L.] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Rome, Italy; [Palazzoni, Giovanni] Univ Cattolica Sacro Cuore, Div Radiotherapy, I-00168 Rome, Italy	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Toldo, S (corresponding author), Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA 23284 USA.	stoldo2@vcu.edu	Biondi-Zoccai, Giuseppe/C-9670-2012; Abbate, Antonio/E-3405-2014; Abbate, Antonio/G-8805-2016; Sumner, Evan/B-3426-2014	Biondi-Zoccai, Giuseppe/0000-0001-6103-8510; Abbate, Antonio/0000-0002-1930-785X; Seropian, Ignacio Miguel/0000-0002-6823-4001; Toldo, Stefano/0000-0002-1588-4019	Cephalon, Rome, Italy; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	Cephalon, Rome, Italy; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	ML and GGLBZ have received research support from Cephalon, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Calderone A, 1998, J CLIN INVEST, V101, P812, DOI 10.1172/JCI119883; Chan S, 2004, ANN ONCOL, V15, P1527, DOI 10.1093/annonc/mdh393; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cortes-Funes H, 2007, CARDIOVASC TOXICOL, V7, P56, DOI 10.1007/s12012-007-0015-3; Fernandez A, 2009, TRENDS PHARMACOL SCI, V30, P403, DOI 10.1016/j.tips.2009.06.001; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Henderson IC, 2011, ONCOLOGY-NY, V25, P115; Hoyano Y, 1996, J CARDIOVASC PHARM, V27, P37, DOI 10.1097/00005344-199601000-00007; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Krischer JP, 1997, J CLIN ONCOL, V15, P1544, DOI 10.1200/JCO.1997.15.4.1544; Kuo LJ, 2008, IN VIVO, V22, P305; L'Ecuyer T, 2001, MOL GENET METAB, V74, P370, DOI 10.1006/mgme.2001.3243; Leonard RCF, 2009, BREAST, V18, P218, DOI 10.1016/j.breast.2009.05.004; Lotrionte M, 2007, Minerva Cardioangiol, V55, P711; Lotrionte M, 2012, INT J CARDI IN PRESS; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Montaigne D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951539; Mordente A, 2012, ADV EXP MED BIOL, V942, P385, DOI 10.1007/978-94-007-2869-1_18; NERI B, 1984, BIOCHEM BIOPH RES CO, V125, P954, DOI 10.1016/0006-291X(84)91376-7; Salvatorelli E, 2007, J PHARMACOL EXP THER, V320, P790, DOI 10.1124/jpet.106.116160; Schafer M, 2001, J AM COLL CARDIOL, V37, P300, DOI 10.1016/S0735-1097(00)01065-2; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; SOLAINI G, 1985, DRUG EXP CLIN RES, V11, P115; Sreeramoju P, 2010, ADV GENET, V69, P135, DOI 10.1016/S0065-2660(10)69015-3; Strigun A, 2012, TOXICOL SCI, V125, P595, DOI 10.1093/toxsci/kfr298; Toldo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018102	31	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58421	10.1371/journal.pone.0058421	http://dx.doi.org/10.1371/journal.pone.0058421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516478	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400027
J	Boel, ME; Rijken, MJ; Leenstra, T; Phyo, AP; Pimanpanarak, M; Keereecharoen, NL; Proux, S; Laochan, N; Imwong, M; Singhasivanon, P; White, NJ; McGready, R; Nosten, FH				Boel, Machteld E.; Rijken, Marcus J.; Leenstra, Tjalling; Phyo, Aung Pyae; Pimanpanarak, Mupawjay; Keereecharoen, Naw Lily; Proux, Stephane; Laochan, Natthapon; Imwong, Mallika; Singhasivanon, Pratap; White, Nicholas J.; McGready, Rose; Nosten, Francois H.			Malaria in the Post-Partum Period; a Prospective Cohort Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM PARASITEMIA; AFRICAN ISOLATES SENEGAL; IN-VITRO ACTIVITY; PREGNANT-WOMEN; VIVAX MALARIA; THAILAND; EPIDEMIOLOGY; CHLOROQUINE; CLEARANCE; BORDER	Background: Several studies have shown a prolonged or increased susceptibility to malaria in the post-partum period. A matched cohort study was conducted to evaluate prospectively the susceptibility to malaria of post-partum women in an area where P.falciparum and P.vivax are prevalent. Methods: In an area of low seasonal malaria transmission on the Thai-Myanmar border pregnant women attending antenatal clinics were matched to a non-pregnant, non-post-partum control and followed up prospectively until 12 weeks after delivery. Results: Post-partum women (n = 744) experienced significantly less P.falciparum episodes than controls (hazard ratio (HR) 0.39 (95%CI 0.21-0.72) p = 0.003) but significantly more P.vivax (HR 1.34 (1.05-1.72) p = 0.018). The reduced risk of falciparum malaria was accounted for by reduced exposure, whereas a history of P.vivax infection during pregnancy was a strong risk factor for P.vivax in post-partum women (HR 13.98 (9.13-21.41), p<0.001). After controlling for effect modification by history of P.vivax, post-partum women were not more susceptible to P.vivax than controls (HR: 0.33 (0.21-0.51), p<0.001). Genotyping of pre- and post-partum infections (n circle plus = circle plus 10) showed that each post-partum P.falciparum was a newly acquired infection. Conclusions: In this area of low seasonal malaria transmission post-partum women were less likely to develop falciparum malaria but more likely to develop vivax malaria than controls. This was explained by reduced risk of exposure and increased risk of relapse, respectively. There was no evidence for altered susceptibility to malaria in the post-partum period. The treatment of vivax malaria during and immediately after pregnancy needs to be improved.	[Boel, Machteld E.; Rijken, Marcus J.; Phyo, Aung Pyae; Pimanpanarak, Mupawjay; Keereecharoen, Naw Lily; Proux, Stephane; Laochan, Natthapon; McGready, Rose; Nosten, Francois H.] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Boel, Machteld E.; Leenstra, Tjalling] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, NL-1105 AZ Amsterdam, Netherlands; [Imwong, Mallika; Singhasivanon, Pratap; White, Nicholas J.; McGready, Rose; Nosten, Francois H.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [White, Nicholas J.; McGready, Rose; Nosten, Francois H.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Mahidol University; University of Amsterdam; Academic Medical Center Amsterdam; Mahidol University; University of Oxford	Boel, ME (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand.	machteld@shoklo-unit.com	McGready, Rose/A-3290-2014; Imwong, Mallika/ABE-6493-2020; White, Nick/AAC-6527-2019; Phyo, Aung Pyae/GYU-6181-2022; Phyo, Aung Pyae/K-2413-2019; Nosten, Francois/AAC-5509-2019	McGready, Rose/0000-0003-1621-3257; White, Nick/0000-0002-1897-1978; Phyo, Aung Pyae/0000-0002-0383-9624; Phyo, Aung Pyae/0000-0002-0383-9624; Nosten, Francois/0000-0002-7951-0745; Rijken, Marcus/0000-0003-0914-5508; Singhasivanon, Pratap/0000-0002-9759-1702	Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Christophe and Rodolphe Merieux Foundation	Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Christophe and Rodolphe Merieux Foundation	SMRU is supported by The Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. The Christophe and Rodolphe Merieux Foundation supported the study through a prize (2008) to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boel ME, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-114; Bottero J, 2011, AM J TROP MED HYG, V84, P267, DOI 10.4269/ajtmh.2011.10-0139; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Diagne N, 2000, NEW ENGL J MED, V343, P598, DOI 10.1056/NEJM200008313430901; DOLAN G, 1993, T ROY SOC TROP MED H, V87, P620, DOI 10.1016/0035-9203(93)90262-O; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; NGUYENDINH P, 1988, LANCET, V2, P751; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Phyo AP, 2011, CLIN INFECT DIS, V53, P977, DOI 10.1093/cid/cir631; Plewes K, 2008, INT J STD AIDS, V19, P833, DOI 10.1258/ijsa.2008.008034; Pradines B, 1998, AM J TROP MED HYG, V58, P354, DOI 10.4269/ajtmh.1998.58.354; Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333; Ramharter M, 2005, J INFECT DIS, V191, P1005, DOI 10.1086/427781; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Serra-Casas E, 2011, INFECT IMMUN, V79, P298, DOI 10.1128/IAI.00814-10; SMRU, 2011, TREATM GUID; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Villegas L, 2007, TROP MED INT HEALTH, V12, P209, DOI [10.1111/j.1365-3165.2006.01778.x, 10.1111/j.1365-3156.2006.01778.x]; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2010, GUID TREATM MAL, V2nd; WICKRAMASURIYA GAW, 1936, MALARIA ANKYLOSTOMIA	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57890	10.1371/journal.pone.0057890	http://dx.doi.org/10.1371/journal.pone.0057890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516418	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200020
J	Brunnschweiler, JM; Barnett, A				Brunnschweiler, Juerg M.; Barnett, Adam			Opportunistic Visitors: Long-Term Behavioural Response of Bull Sharks to Food Provisioning in Fiji	PLOS ONE			English	Article							REEF-MARINE-RESERVE; SITE FIDELITY; CARCHARHINUS-LEUCAS; MOVEMENT PATTERNS; ECOTOURISM; WILDLIFE; TOURISM; CONSERVATION; FREQUENCY; TRACKING	Shark-based tourism that uses bait to reliably attract certain species to specific sites so that divers can view them is a growing industry globally, but remains a controversial issue. We evaluate multi-year (2004-2011) underwater visual (n = 48 individuals) and acoustic tracking data (n = 82 transmitters; array of up to 16 receivers) of bull sharks Carcharhinus leucas from a long-term shark feeding site at the Shark Reef Marine Reserve and reefs along the Beqa Channel on the southern coast of Viti Levu, Fiji. Individual C. leucas showed varying degrees of site fidelity. Determined from acoustic tagging, the majority of C. leucas had site fidelity indexes >0.5 for the marine reserve (including the feeding site) and neighbouring reefs. However, during the time of the day (09:00-12:00) when feeding takes place, sharks mainly had site fidelity indexes <0.5 for the feeding site, regardless of feeding or non-feeding days. Site fidelity indexes determined by direct diver observation of sharks at the feeding site were lower compared to such values determined by acoustic tagging. The overall pattern for C. leucas is that, if present in the area, they are attracted to the feeding site regardless of whether feeding or non-feeding days, but they remain for longer periods of time (consecutive hours) on feeding days. The overall diel patterns in movement are for C. leucas to use the area around the feeding site in the morning before spreading out over Shark Reef throughout the day and dispersing over the entire array at night. Both focal observation and acoustic monitoring show that C. leucas intermittently leave the area for a few consecutive days throughout the year, and for longer time periods (weeks to months) at the end of the calendar year before returning to the feeding site.	[Barnett, Adam] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Barnett, Adam] Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia	Deakin University; University of Tasmania		juerg@gluecklich.net	Brunnschweiler, Juerg/A-2110-2008	Brunnschweiler, Juerg/0000-0002-9901-3279; , Adam/0000-0001-7430-8428	Save Our Seas Foundation; Shark Foundation Switzerland	Save Our Seas Foundation; Shark Foundation Switzerland	This work was funded through grants to JMB from the Save Our Seas Foundation (http://saveourseas.com/) and the Shark Foundation Switzerland (http://www.shark.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, INFECT DIS POVERTY, DOI DOI 10.1186/s40249-020-00640-3; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Bessudo S, 2011, ENVIRON BIOL FISH, V91, P165, DOI 10.1007/s10641-011-9769-3; BLACKMAN R, 1958, MEASUREMENT POWER SP; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2009, MAR FRESHW BEHAV PHY, V42, P201, DOI 10.1080/10236240903033519; Brunnschweiler JM, 2006, CYBIUM, V30, P133; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Brunnschweiler JM, 2010, J SUSTAIN TOUR, V18, P29, DOI 10.1080/09669580903071987; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Clarke C, 2011, MAR FRESHWATER RES, V62, P668, DOI 10.1071/MF10171; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Dobson J, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P49, DOI 10.1079/9781845933456.0049; Driggers WB, 2012, MAR ECOL PROG SER, V465, P185, DOI 10.3354/meps09901; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Gaspar C, 2008, CYBIUM, V32, P153; Goetze JS, 2013, CORAL REEFS IN PRESS; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Knight J, 2009, SOC ANIM, V17, P167, DOI 10.1163/156853009X418091; Knip DM, 2012, MAR BIOL, V159, P1647, DOI 10.1007/s00227-012-1950-5; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Maljkovic A, 2011, BIOL CONSERV, V144, P859, DOI 10.1016/j.biocon.2010.11.019; McCord ME, 2009, AFR J MAR SCI, V31, P107, DOI 10.2989/AJMS.2009.31.1.11.782; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Milazzo M, 2006, MAR ECOL PROG SER, V310, P165, DOI 10.3354/meps310165; Milazzo M, 2011, ENVIRON BIOL FISH, V91, P127, DOI 10.1007/s10641-011-9784-4; Newsome David., 2005, WILDLIFE TOURISM; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Papastamatiou YP, 2010, MAR FRESHWATER RES, V61, P1366, DOI 10.1071/MF10056; Rasalato E, 2010, ENVIRON CONSERV, V37, P90, DOI 10.1017/S0376892910000317; Semeniuk CAD, 2008, MAR ECOL PROG SER, V357, P271, DOI 10.3354/meps07299; Semeniuk CAD, 2007, ENVIRON MANAGE, V40, P665, DOI 10.1007/s00267-006-0321-8; Semeniuk CAD, 2009, BIOL CONSERV, V142, P1818, DOI 10.1016/j.biocon.2009.03.022; Shackley M., 1998, Journal of Sustainable Tourism, V6, P328, DOI 10.1080/09669589808667320; Speed CW, 2012, CORAL REEFS, V31, P357, DOI 10.1007/s00338-011-0850-3; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Taylor S, 2011, MAR FRESHWATER RES, V62, P638, DOI 10.1071/MF10154; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1	47	66	67	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58522	10.1371/journal.pone.0058522	http://dx.doi.org/10.1371/journal.pone.0058522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516496	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000316849200077
J	Kesisova, IA; Nakos, KC; Tsolou, A; Angelis, D; Lewis, J; Chatzaki, A; Agianian, B; Giannis, A; Koffa, MD				Kesisova, Iliana A.; Nakos, Konstantinos C.; Tsolou, Avgi; Angelis, Dimitrios; Lewis, Joe; Chatzaki, Aikaterini; Agianian, Bogos; Giannis, Athanassios; Koffa, Maria D.			Tripolin A, a Novel Small-Molecule Inhibitor of Aurora A Kinase, Reveals New Regulation of HURP's Distribution on Microtubules	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; A KINASE; MITOTIC SPINDLE; CENTROSOME AMPLIFICATION; CHROMOSOME CONGRESSION; HUMAN-CELLS; MLN8054; TPX2; OVEREXPRESSION; DYNAMICS	Mitotic regulators exhibiting gain of function in tumor cells are considered useful cancer therapeutic targets for the development of small-molecule inhibitors. The human Aurora kinases are a family of such targets. In this study, from a panel of 105 potential small-molecule inhibitors, two compounds Tripolin A and Tripolin B, inhibited Aurora A kinase activity in vitro. In human cells however, only Tripolin A acted as an Aurora A inhibitor. We combined in vitro, in vivo single cell and in silico studies to demonstrate the biological action of Tripolin A, a non-ATP competitive inhibitor. Tripolin A reduced the localization of pAurora A on spindle microtubules (MTs), affected centrosome integrity, spindle formation and length, as well as MT dynamics in interphase, consistent with Aurora A inhibition by RNAi or other specific inhibitors, such as MLN8054 or MLN8237. Interestingly, Tripolin A affected the gradient distribution towards the chromosomes, but not the MT binding of HURP (Hepatoma Up-Regulated Protein), a MT-associated protein (MAP) and substrate of the Aurora A kinase. Therefore Tripolin A reveals a new way of regulating mitotic MT stabilizers through Aurora A phosphorylation. Tripolin A is predicted to bind Aurora A similarly but not identical to MLN8054, therefore it could be used to dissect pathways orchestrated by Aurora kinases as well as a scaffold for further inhibitor development.	[Kesisova, Iliana A.; Nakos, Konstantinos C.; Tsolou, Avgi; Angelis, Dimitrios; Agianian, Bogos; Koffa, Maria D.] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Lewis, Joe] European Mol Biol Lab, Chem Biol Core Facil, D-69012 Heidelberg, Germany; [Chatzaki, Aikaterini] Democritus Univ Thrace, Dept Med, Alexandroupolis, Greece; [Giannis, Athanassios] Univ Leipzig, Inst Organ Chem, D-04109 Leipzig, Germany	Democritus University of Thrace; European Molecular Biology Laboratory (EMBL); Democritus University of Thrace; Leipzig University	Koffa, MD (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece.	mkoffa@mbg.duth.gr	Tsolou, Avgi/L-7776-2017; Koffa, Maria/AAP-3999-2020; Agianian, Bogos/O-8019-2016	Agianian, Bogos/0000-0003-1295-6846; Lewis, Joe/0000-0002-9926-1328; Koffa, Maria (Margy)/0000-0003-2255-3426	Bodossaki Foundation; European Community's Seventh Framework Programme (FP7) [227764]; FP7-REGPOT-2008 [229971]	Bodossaki Foundation; European Community's Seventh Framework Programme (FP7); FP7-REGPOT-2008	IAK was supported by a Bodossaki Foundation postgraduate fellowship (http://www.bodossaki.gr/Default.aspx?lang=2) and by a p-cube short-term fellowship. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 227764 (P-CUBE). The CIBIT facility was supported by a FP7-REGPOT-2008 grant (no 229971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; De Luca M, 2006, CELL CYCLE, V5, P296; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Goepfert TM, 2002, CANCER RES, V62, P4115; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hu W, 2005, ONCOL RES, V15, P49, DOI 10.3727/096504005775082101; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lorenzo C, 2009, CELL CYCLE, V8, P1733, DOI 10.4161/cc.8.11.8617; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Santarella RA, 2007, J MOL BIOL, V365, P1587, DOI 10.1016/j.jmb.2006.10.064; Sardon T, 2009, CHEMBIOCHEM, V10, P464, DOI 10.1002/cbic.200800600; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Song DS, 2010, ANAL QUANT CYTOL, V32, P280; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yang Y, 2012, MOL BIOSYST, V8, P3049, DOI 10.1039/c2mb25217a; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005	41	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58485	10.1371/journal.pone.0058485	http://dx.doi.org/10.1371/journal.pone.0058485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516487	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200072
J	Kloepper, JW; McInroy, JA; Liu, K; Hu, CH				Kloepper, Joseph W.; McInroy, John A.; Liu, Ke; Hu, Chia-Hui			Symptoms of Fern Distortion Syndrome Resulting from Inoculation with Opportunistic Endophytic Fluorescent Pseudomonas spp.	PLOS ONE			English	Article							LEATHERLEAF FERN; BACTERIA; RHIZOSPHERE; GROWTH	Background: Fern Distortion Syndrome (FDS) is a serious disease of Leatherleaf fern (Rumohra adiantiformis). The main symptom of FDS is distortion of fronds, making them unmarketable. Additional symptoms include stunting, irregular sporulation, decreased rhizome diameter, and internal discoloration of rhizomes. We previously reported an association of symptoms with increased endophytic rhizome populations of fluorescent pseudomonads (FPs). The aim of the current study was to determine if FPs from ferns in Costa Rica with typical FDS symptoms would recreate symptoms of FDS. Methodology and Findings: Greenhouse tests were conducted over a 29-month period. Micro-propagated ferns derived from tissue culture were first grown one year to produce rhizomes. Then, using an 8x9 randomized complete block experimental design, 8 replicate rhizomes were inoculated by dipping into 9 different treatments before planting. Treatments included water without bacteria (control), and four different groups of FPs, each at a two concentrations. The four groups of FPs included one group from healthy ferns without symptoms (another control treatment), two groups isolated from inside rhizomes of symptomatic ferns, and one group isolated from inside roots of symptomatic ferns. Symptoms were assessed 12 and 17 months later, and populations of FPs inside newly formed rhizomes were determined after 17 months. Results showed that inoculation with mixtures of FPs from ferns with FDS symptoms, but not from healthy ferns, recreated the primary symptom of frond deformities and also the secondary symptoms of irregular sporulation, decreased rhizome diameter, and internal discoloration of rhizomes. Conclusions: These results suggest a model of causation of FDS in which symptoms result from latent infections by multiple species of opportunistic endophytic bacteria containing virulence genes that are expressed when populations inside the plant reach a minimum level.	[Kloepper, Joseph W.; McInroy, John A.; Liu, Ke; Hu, Chia-Hui] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Kloepper, JW (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	kloepjw@auburn.edu			Alabama Agricultural Experiment Station (AAES)	Alabama Agricultural Experiment Station (AAES)	Funding was provided by the Alabama Agricultural Experiment Station (AAES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barazani O, 2001, CRIT REV MICROBIOL, V27, P41, DOI 10.1080/20014091096693; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; CAMPBELL JN, 1986, CAN J MICROBIOL, V32, P201, DOI 10.1139/m86-041; FRANKENBERGER WT, 1988, SOIL BIOL BIOCHEM, V20, P299, DOI 10.1016/0038-0717(88)90007-7; GARDNER JM, 1982, APPL ENVIRON MICROB, V43, P1335, DOI 10.1128/AEM.43.6.1335-1342.1982; Gonzalez AJ, 2003, APPL ENVIRON MICROB, V69, P2936, DOI 10.1128/AEM.69.5.2936-2941.2003; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Kloepper JW, 2010, PLANT DIS, V94, P940, DOI 10.1094/PDIS-94-8-0940; Kloepper JW, 2012, APPL SOIL ECOL, V61, P236, DOI 10.1016/j.apsoil.2011.09.009; Kremer RJ, 1996, J PLANT NUTR, V19, P939, DOI 10.1080/01904169609365171; Laasik E, 2006, FEMS MICROBIOL LETT, V258, P227, DOI 10.1111/j.1574-6968.2006.00222.x; Lindow SE, 1998, PHYTOPATHOLOGY, V88, P1149, DOI 10.1094/PHYTO.1998.88.11.1149; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; Mills HA, 1996, J PLANT NUTR, V19, P917, DOI 10.1080/01904169609365170; Okon Y, 1997, ASM NEWS, V63, P366; Preston GM, 2004, PHILOS T R SOC B, V359, P907, DOI 10.1098/rstb.2003.1384; Strandberg JO, 1999, EFFECTS LIGHT INTENS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	20	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58531	10.1371/journal.pone.0058531	http://dx.doi.org/10.1371/journal.pone.0058531			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516499	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200080
J	Lewis, NS; Javakhishvili, Z; Russell, CA; Machablishvili, A; Lexmond, P; Verhagen, JH; Vuong, O; Onashvili, T; Donduashvili, M; Smith, DJ; Fouchier, RAM				Lewis, Nicola S.; Javakhishvili, Zurab; Russell, Colin A.; Machablishvili, Ann; Lexmond, Pascal; Verhagen, Josanne H.; Oanh Vuong; Onashvili, Tinatin; Donduashvili, Marina; Smith, Derek J.; Fouchier, Ron A. M.			Avian Influenza Virus Surveillance in Wild Birds in Georgia: 2009-2011	PLOS ONE			English	Article							A VIRUS; HEMAGGLUTININ	The Caucasus, at the border of Europe and Asia, is important for migration and over-wintering of wild waterbirds. Three flyways, the Central Asian, East Africa-West Asia, and Mediterranean/Black Sea flyways, converge in the Caucasus region. Thus, the Caucasus region might act as a migratory bridge for influenza virus transmission when birds aggregate in high concentrations in the post-breeding, migrating and overwintering periods. Since August 2009, we have established a surveillance network for influenza viruses in wild birds, using five sample areas geographically spread throughout suitable habitats in both eastern and western Georgia. We took paired tracheal and cloacal swabs and fresh feces samples. We collected 8343 swabs from 76 species belonging to 17 families in 11 orders of birds, of which 84 were real-time RT-PCR positive for avian influenza virus (AIV). No highly pathogenic AIV (HPAIV) H5 or H7 viruses were detected. The overall AIV prevalence was 1.6%. We observed peak prevalence in large gulls during the autumn migration (5.3-9.8%), but peak prevalence in Black-headed Gulls in spring (4.2-13%). In ducks, we observed increased AIV prevalence during the autumn post-moult aggregations and migration stop-over period (6.3%) but at lower levels to those observed in other more northerly post-moult areas in Eurasia. We observed another prevalence peak in the overwintering period (0.14-5.9%). Serological and virological monitoring of a breeding colony of Armenian Gulls showed that adult birds were seropositive on arrival at the breeding colony, but juveniles remained serologically and virologically negative for AIV throughout their time on the breeding grounds, in contrast to gull AIV data from other geographic regions. We show that close phylogenetic relatives of viruses isolated in Georgia are sourced from a wide geographic area throughout Western and Central Eurasia, and from areas that are represented by multiple different flyways, likely linking different host sub-populations.	[Lewis, Nicola S.; Russell, Colin A.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England; [Lexmond, Pascal; Verhagen, Josanne H.; Oanh Vuong; Smith, Derek J.; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Lexmond, Pascal; Verhagen, Josanne H.; Oanh Vuong; Smith, Derek J.; Fouchier, Ron A. M.] Erasmus MC, Natl Influenza Ctr, Rotterdam, Netherlands; [Russell, Colin A.; Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Javakhishvili, Zurab] Ilia State Univ, Inst Ecol, Tbilisi, Georgia; [Machablishvili, Ann] Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia; [Machablishvili, Ann] Natl Ctr Dis Control, Influenza Sect, Tbilisi, Georgia; [Onashvili, Tinatin; Donduashvili, Marina] Lab Minist Agr, Tbilisi, Georgia	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Ilia State University; Ivane Javakhishvili Tbilisi State University; National Center for Disease Control & Public Health - Georgia	Lewis, NS (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	nsl25@cam.ac.uk	Smith, Derek/Z-3075-2019; Russell, Colin/ABE-7106-2020; Javakhishvili, Zura/ACR-6041-2022; Fouchier, Ron A/A-1911-2014	Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Tripp, Ralph/0000-0002-2924-9956; Russell, Colin/0000-0002-2113-162X; Verhagen, Josanne/0000-0003-3133-5228	Wellcome Trust Fellowship [WT089235MF]; NIAID-NIH "NIAID Centres of Excellence for Influenza Research and Surveillance'' [HHSN266200700010C]	Wellcome Trust Fellowship(Wellcome Trust); NIAID-NIH "NIAID Centres of Excellence for Influenza Research and Surveillance''	This work was supported by a Wellcome Trust Fellowship WT089235MF http://www.wellcome.ac.uk/index.htm and by NIAID-NIH contract No. HHSN266200700010C "NIAID Centres of Excellence for Influenza Research and Surveillance'' http://www.niaid.nih.gov/LabsAndResources/resources/ceirs/Pages/crip.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Beruchashvili N, 2000, P 1 NAT C BIOL LANDS, P221; CHAMBERS TM, 1989, VIROLOGY, V172, P180, DOI 10.1016/0042-6822(89)90119-0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Jackwood MW, 2007, AVIAN DIS, V51, P448, DOI 10.1637/7536-032706R.1; Jourdain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024155; Karamendin K, 2011, VIRUS GENES, V43, P46, DOI 10.1007/s11262-011-0603-y; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; PODCHERNYAEVA RY, 1979, VOP VIRUSOL+, P227; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramsar, 2013, RAMS LIST WETL INT I; ROSLAYA IG, 1984, VOP VIRUSOL+, P155; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; Yamnikova S. S., 2009, Voprosy Virusologii, V54, P10	22	35	35	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58534	10.1371/journal.pone.0058534	http://dx.doi.org/10.1371/journal.pone.0058534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516501	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200081
J	Liu, XK; Wang, DS; Ren, JX; Tong, C; Feng, EL; Wang, XF; Zhu, L; Wang, HL				Liu, Xiankai; Wang, Dongshu; Ren, Jingxiao; Tong, Chao; Feng, Erling; Wang, Xuefang; Zhu, Li; Wang, Hengliang			Identification of the Immunogenic Spore and Vegetative Proteins of Bacillus anthracis Vaccine Strain A16R	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; CELL-SURFACE; PROTEOMICS; CEREUS; COMPONENT; ANTIGENS; EXOSPORIUM; CANDIDATES; INFECTION; EFFICACY	Immunoproteomics was used to screen the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R. The spore and vegetative proteins were separated by 2D gel electrophoresis and transferred to polyvinylidene difluoride membranes, and then western blotting was performed with rabbit immune serum against B. anthracis live spores. Immunogenic spots were cut and digested by trypsin. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was performed to identify the proteins. As a result, 11 and 45 immunogenic proteins were identified in the spores and vegetative cells, respectively; 26 of which have not been reported previously. To verify their immunogenicity, 12 of the identified proteins were selected to be expressed, and the immune sera from the mice vaccinated by the 12 expressed proteins, except BA0887, had a specific western blot band with the A16R whole cellular lytic proteins. Some of these immunogenic proteins might be used as novel vaccine candidates themselves or for enhancing the protective efficacy of a protective-antigen-based vaccine.	[Liu, Xiankai; Wang, Dongshu; Ren, Jingxiao; Tong, Chao; Feng, Erling; Wang, Xuefang; Zhu, Li; Wang, Hengliang] Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China		Zhu, L (corresponding author), Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	jewly54@126.com; wanghl@nic.bmi.ac.cn	Wang, Hengliang/AAL-5340-2021; wang, hengliang/AAA-8300-2020; Wang, Hengliang/AAT-4586-2021; Zhu, Li/Q-7499-2017; zhang, xiaoyan/F-4789-2013	Wang, Hengliang/0000-0001-8476-4320; Zhu, Li/0000-0001-9975-8978; 	State Major Science and Technology Special Projects of China [2012ZX10004215]; National Natural Science Foundation of China [81125012, 81271785]	State Major Science and Technology Special Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Major Science and Technology Special Projects of China (number 2012ZX10004215) and the National Natural Science Foundation of China (numbers 81125012 and 81271785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel N, 2003, INFECT IMMUN, V71, P4563, DOI 10.1128/IAI.71.8.4563-4579.2003; Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; Blendon Robert J, 2002, MedGenMed, V4, P1; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brossier F, 2002, INFECT IMMUN, V70, P661; BUCHMEIER NA, 1990, SCIENCE, V248, P730, DOI 10.1126/science.1970672; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Cohen S, 2000, INFECT IMMUN, V68, P4549, DOI 10.1128/IAI.68.8.4549-4558.2000; Cordwell SJ, 2002, METHOD ENZYMOL, V358, P207; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Dong S, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P135; Drake RR, 2005, EXPERT REV PROTEOMIC, V2, P203, DOI 10.1586/14789450.2.2.203; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fouet A, 2002, CURR TOP MICROBIOL, V271, P87; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; HAMBLETON P, 1984, Vaccine, V2, P125, DOI 10.1016/0264-410X(84)90003-3; Hanna P, 1998, CURR TOP MICROBIOL, V225, P13; Klade CS, 2002, CURR OPIN MOL THER, V4, P216; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; March JB, 2006, INFECT IMMUN, V74, P167, DOI 10.1128/IAI.74.1.167-174.2006; Mesnage S, 1999, INFECT IMMUN, V67, P4847, DOI 10.1128/IAI.67.9.4847-4850.1999; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Mukhopadhyay S, 2009, MOL CELL PROTEOMICS, V8, P1174, DOI 10.1074/mcp.M800403-MCP200; Nakamura T, 2004, ARCH MICROBIOL, V181, P74, DOI 10.1007/s00203-003-0632-6; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Shin GW, 2007, J CHROMATOGR B, V849, P315, DOI 10.1016/j.jchromb.2006.11.009; Shin GW, 2006, DIS AQUAT ORGAN, V70, P71, DOI 10.3354/dao070071; SHLYAKHOV EN, 1994, VACCINE, V12, P727, DOI 10.1016/0264-410X(94)90223-2; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Wang JJ, 2005, PROTEOMICS, V5, P4488, DOI 10.1002/pmic.200401322; WELKOS SL, 1988, MICROB PATHOGENESIS, V5, P127, DOI 10.1016/0882-4010(88)90015-0; Whiting GC, 2004, VACCINE, V22, P4245, DOI 10.1016/j.vaccine.2004.04.036; Wu M, 2002, ELECTROPHORESIS, V23, P2373, DOI 10.1002/1522-2683(200208)23:15<2373::AID-ELPS2373>3.0.CO;2-W; Yan Q, 2009, BIOTECHNOLOGY B, P15	45	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57959	10.1371/journal.pone.0057959	http://dx.doi.org/10.1371/journal.pone.0057959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516421	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200021
J	Meredith, JM; Underhill, A; McArthur, CC; Eggleston, P				Meredith, Janet M.; Underhill, Ann; McArthur, Clare C.; Eggleston, Paul			Next-Generation Site-Directed Transgenesis in the Malaria Vector Mosquito Anopheles gambiae: Self-Docking Strains Expressing Germline-Specific phiC31 Integrase	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; GENETIC-TRANSFORMATION; LINE TRANSFORMATION; TRANSPOSON VECTOR; REGULATORY REGION; HIGH-EFFICIENCY; AEDES-AEGYPTI; DROSOPHILA; PIGGYBAC; DNA	Diseases transmitted by mosquitoes have a devastating impact on global health and the situation is complicated due to difficulties with both existing control measures and the impact of climate change. Genetically modified mosquitoes that are refractory to disease transmission are seen as having great potential in the delivery of novel control strategies. The Streptomyces phage phiC31 integrase system has been successfully adapted for site-directed transgene integration in a range of insects, thus overcoming many limitations due to size constraints and random integration associated with transposon-mediated transformation. Using this technology, we previously published the first site-directed transformation of Anopheles gambiae, the principal vector of human malaria. Mosquitoes were initially engineered to incorporate the phiC31 docking site at a defined genomic location. A second phase of genetic modification then achieved site-directed integration of an anti-malarial effector gene. In the current publication we report improved efficiency and utility of the phiC31 integrase system following the generation of Anopheles gambiae self-docking strains. Four independent strains, with docking sites at known locations on three different chromosome arms, were engineered to express integrase under control of the regulatory regions of the nanos gene from Anopheles gambiae. The resulting protein accumulates in the posterior oocyte to provide integrase activity at the site of germline development. Two self-docking strains, exhibiting significantly different levels of integrase expression, were assessed for site-directed transgene integration and found to demonstrate greatly improved survival and efficiency of transformation. In the fight against malaria, it is imperative to establish a broad repertoire of both anti-malarial effector genes and tissue-specific promoters to regulate their expression, enabling those offering maximum effect with minimum fitness cost to be identified. The improved technology we describe here will facilitate comparative studies of effector transgenes, allowing informed choices to be made that potentially lead to transmission blockade.	[Meredith, Janet M.; Underhill, Ann; McArthur, Clare C.; Eggleston, Paul] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England	Keele University	Eggleston, P (corresponding author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England.	p.eggleston@keele.ac.uk			Wellcome Trust [084582]; European Union through FP7 Infrastructures Award [228421]	Wellcome Trust(Wellcome TrustEuropean Commission); European Union through FP7 Infrastructures Award	The authors are grateful for financial support from the Wellcome Trust (http://www.wellcome.ac.uk/) through Programme Grant 084582 to PE and to the European Union (http://cordis.europa.eu/fp7/home_en.html) through FP7 Infrastructures Award 228421 to PE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, INSECT MOL BIOL, V14, P271, DOI 10.1111/j.1365-2583.2004.00557.x; Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000402; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Besansky N.J., 1993, Insect Molecular Biology, V1, P171, DOI 10.1111/j.1365-2583.1993.tb00089.x; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; CHATER KF, 1981, GENE, V15, P249, DOI 10.1016/0378-1119(81)90134-7; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Jahan N, 1997, ANN TROP MED PARASIT, V91, P365, DOI 10.1080/00034989760987; Jasinskiene N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng148; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; Labbe GMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000788; Lombardo Fabrizio, 2009, BMC Res Notes, V2, P24, DOI 10.1186/1756-0500-2-24; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Lorenzen MD, 2002, INSECT MOL BIOL, V11, P399, DOI 10.1046/j.1365-2583.2002.00349.x; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Nolan T, 2011, GENETICA, V139, P33, DOI 10.1007/s10709-010-9482-8; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; Perera OP, 2002, INSECT MOL BIOL, V11, P291, DOI 10.1046/j.1365-2583.2002.00336.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Rodrigues FG, 2006, MEM I OSWALDO CRUZ, V101, P755, DOI 10.1590/S0074-02762006000700008; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192	51	27	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59264	10.1371/journal.pone.0059264	http://dx.doi.org/10.1371/journal.pone.0059264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516619	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000316849200139
J	Nagayasu, E; Ishikawa, SA; Taketani, S; Chakraborty, G; Yoshida, A; Inagaki, Y; Maruyama, H				Nagayasu, Eiji; Ishikawa, Sohta A.; Taketani, Shigeru; Chakraborty, Gunimala; Yoshida, Ayako; Inagaki, Yuji; Maruyama, Haruhiko			Identification of a Bacteria-Like Ferrochelatase in Strongyloides venezuelensis, an Animal Parasitic Nematode	PLOS ONE			English	Article							HEME-BIOSYNTHESIS; DRAFT GENOME; HAEMOPHILUS-INFLUENZAE; BRUGIA-MALAYI; CLASSIC RACE; LIFE-STYLE; SEQUENCE; PATHWAY; INFECTIONS; HEMOGLOBIN	Heme is an essential molecule for vast majority of organisms serving as a prosthetic group for various hemoproteins. Although most organisms synthesize heme from 5-aminolevulinic acid through a conserved heme biosynthetic pathway composed of seven consecutive enzymatic reactions, nematodes are known to be natural heme auxotrophs. The completely sequenced Caenorhabditis elegans genome, for example, lacks all seven genes for heme biosynthesis. However, genome/transcriptome sequencing of Strongyloides venezuelensis, an important model nematode species for studying human strongyloidiasis, indicated the presence of a gene for ferrochelatase (FeCH), which catalyzes the terminal step of heme biosynthesis, whereas the other six heme biosynthesis genes are apparently missing. Phylogenetic analyses indicated that nematode FeCH genes, including that of S. venezuelensis (SvFeCH) have a fundamentally different evolutionally origin from the FeCH genes of non-nematode metazoa. Although all non-nematode metazoan FeCH genes appear to be inherited vertically from an ancestral opisthokont, nematode FeCH may have been acquired from an alpha-proteobacterium, horizontally. The identified SvFeCH sequence was found to function as FeCH as expected based on both in vitro chelatase assays using recombinant SvFeCH and in vivo complementation experiments using an FeCH-deficient strain of Escherichia coli. Messenger RNA expression levels during the S. venezuelensis lifecycle were examined by real-time RT-PCR. SvFeCH mRNA was expressed at all the stages examined with a marked reduction at the infective third-stage larvae. Our study demonstrates the presence of a bacteria-like FeCH gene in the S. venezuelensis genome. It appeared that S. venezuelensis and some other animal parasitic nematodes reacquired the once-lost FeCH gene. Although the underlying evolutionary pressures that necessitated this reacquisition remain to be investigated, it is interesting that the presence of FeCH genes in the absence of other heme biosynthesis genes has been reported only for animal pathogens, and this finding may be related to nutritional availability in animal hosts.	[Nagayasu, Eiji; Chakraborty, Gunimala; Yoshida, Ayako; Maruyama, Haruhiko] Miyazaki Univ, Fac Med, Div Parasitol, Dept Infect Dis, Miyazaki, Japan; [Ishikawa, Sohta A.; Inagaki, Yuji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Kyoto 606, Japan	University of Miyazaki; University of Tsukuba; Kyoto Institute of Technology	Maruyama, H (corresponding author), Miyazaki Univ, Fac Med, Div Parasitol, Dept Infect Dis, Miyazaki, Japan.	hikomaru@med.miyazaki-u.ac.jp	Chakraborty, Gunimala/AAP-1273-2021	Chakraborty, Gunimala/0000-0001-5904-492X; Inagaki, Yuji/0000-0003-0101-8483	Japan Society for the Promotion of Science (JSPS) [23790461]; MEXT [21590466, 21022041, H23-Shinko-Ippan-014, H21-kokui-shitei-004]; Japan Society for Promotion of Sciences for Young Scientists [00007]; Grants-in-Aid for Scientific Research [21247010] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Sciences for Young Scientists; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Young Scientists (B) (23790461) from Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research C (21590466), Grant-in-aid for Scientific Research on Priority Areas 'Matrix of Infection Phenomena' (21022041), Health Labor Sciences Research Grant (H23-Shinko-Ippan-014, H21-kokui-shitei-004), and Grant-in-Aid for Scientific Research on Innovative Areas "Genome Science" from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SI is a research fellow supported by the Japan Society for Promotion of Sciences for Young Scientists (No. 00007). We thank Dr. Tadasuke Ooka (University of Miyazaki, Japan) for helpful discussions and Amy Hombu (University of Miyazaki) for critical reading of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Amino H, 2003, MOL BIOCHEM PARASIT, V128, P175, DOI 10.1016/S0166-6851(03)00074-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; BLAXTER ML, 1993, PARASITOL TODAY, V9, P353, DOI 10.1016/0169-4758(93)90082-Q; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHANG KP, 1974, SCIENCE, V183, P531, DOI 10.1126/science.183.4124.531; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Dailey HA, 1997, J BIOL INORG CHEM, V2, P411, DOI 10.1007/s007750050151; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Ferreira GC, 1999, INT J BIOCHEM CELL B, V31, P995, DOI 10.1016/S1357-2725(99)00066-7; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KOHNO H, 1994, BBA-PROTEIN STRUCT M, V1209, P95, DOI 10.1016/0167-4838(94)90142-2; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Koreny L, 2011, GENOME BIOL EVOL, V3, P359, DOI 10.1093/gbe/evr029; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOEB MR, 1995, J BACTERIOL, V177, P3613, DOI 10.1128/jb.177.12.3613-3615.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maruyama H, 2003, PARASITOLOGY, V126, P165, DOI 10.1017/S0031182002002718; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Montes M, 2010, CURR OPIN INFECT DIS, V23, P500, DOI 10.1097/QCO.0b013e32833df718; Nagayasu E, 2013, PARASITOL INT, V62, P57, DOI 10.1016/j.parint.2012.09.006; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; Nakayama T, 2009, CURR BIOL, V19, pR284, DOI 10.1016/j.cub.2009.02.043; Obornik M, 2005, MOL BIOL EVOL, V22, P2343, DOI 10.1093/molbev/msi230; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sato S, 2003, CURR GENET, V42, P292, DOI 10.1007/s00294-002-0360-5; SATO Y, 1990, INT J PARASITOL, V20, P57, DOI 10.1016/0020-7519(90)90173-K; Schlor S, 2000, INFECT IMMUN, V68, P3007, DOI 10.1128/IAI.68.5.3007-3009.2000; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Takamiya S, 2009, PARASITOL INT, V58, P278, DOI 10.1016/j.parint.2009.03.003; Taketani S, 2007, BIOCHEMISTRY-US, V46, P15054, DOI 10.1021/bi701460x; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Viney Mark E, 2007, WormBook, P1; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475	56	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58458	10.1371/journal.pone.0058458	http://dx.doi.org/10.1371/journal.pone.0058458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516484	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200070
J	Ng, YH; Rome, S; Jalabert, A; Forterre, A; Singh, H; Hincks, CL; Salamonsen, LA				Ng, York Hunt; Rome, Sophie; Jalabert, Audrey; Forterre, Alexis; Singh, Harmeet; Hincks, Cassandra L.; Salamonsen, Lois A.			Endometrial Exosomes/Microvesicles in the Uterine Microenvironment: A New Paradigm for Embryo-Endometrial Cross Talk at Implantation	PLOS ONE			English	Article							CHORIONIC-GONADOTROPIN; DENDRITIC CELLS; EXOSOMES; MECHANISM; EXPRESSION; MICRORNAS; MICROVESICLES; PROGESTERONE; RECEPTIVITY; PROTEINS	Exosomes are nanoparticles (similar to 100 nm diameter) released from cells, which can transfer small RNAs and mRNA via the extracellular environment to cells at distant sites. We hypothesised that exosomes or the slightly larger microvesicles (100-300 nm) are released from the endometrial epithelium into the uterine cavity, and that these contain specific micro (mi)RNA that could be transferred to either the trophectodermal cells of the blastocyst or to endometrial epithelial cells, to promote implantation. The aim of this study was to specifically identify and characterise exosomes/microvesicles (mv) released from endometrial epithelial cells and to determine whether exosomes/mv are present in uterine fluid. Immunostaining demonstrated that the tetraspanins, CD9 and CD63 used as cell surface markers of exosomes are present on the apical surfaces of endometrial epithelial cells in tissue sections taken across the menstrual cycle: CD63 showed cyclical regulation. Exosome/mv pellets were prepared from culture medium of endometrial epithelial cell (ECC1 cells) and from uterine fluid and its associated mucus by sequential ultracentifugation. Exosomes/mv were positively identified in all preparations by FACS and immunofluorescence staining following exosome binding to beads. Size particle analysis confirmed the predominance of particles of 50-150 nm in each of these fluids. MiRNA analysis of the ECC1 cells and their exosomes/mv demonstrated sorting of miRNA into exosomes/mv: 13 of the 227 miRNA were specific to exosomes/mv, while a further 5 were not present in these. The most abundant miRNA in exosomes/mv were hsa-miR-200c, hsa-miR-17 and hsa-miR-106a. Bioinformatic analysis showed that the exosome/mv-specific miRNAs have potential targets in biological pathways highly relevant for embryo implantation. Thus exosomes/mv containing specific miRNA are present in the microenvironment in which embryo implantation occurs and may contribute to the endometrial-embryo cross talk essential for this process.	[Ng, York Hunt; Singh, Harmeet; Hincks, Cassandra L.; Salamonsen, Lois A.] Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Rome, Sophie; Jalabert, Audrey; Forterre, Alexis] Univ Lyon, Fac Med Lyon Sud, INSA, Lab CarMeN,Inserm 1060,INRA 1235, Oullins, France	Prince Henry's Institute of Medical Research; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Salamonsen, LA (corresponding author), Prince Henrys Inst Med Res, Melbourne, Vic, Australia.	lois.salamonsen@princehenrys.org	Salamonsen, Lois/J-9822-2019	Forterre, Alexis/0000-0002-5000-9009; Salamonsen, Lois/0000-0003-0558-7325; ROME, SOPHIE/0000-0003-3986-5936	National Health and Medical Research Council of Australia [494802, 1002028]; Victorian Government's Operational Infrastructure Support Program; Australian Government; Fondation pour la Recherche Medicale; Association Francaise de recherche sur les Myopathies; Association Francaise de Diabetologie; INRA specific grant - ANSSD	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian Government(Australian GovernmentCGIAR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise de recherche sur les Myopathies; Association Francaise de Diabetologie; INRA specific grant - ANSSD	Work in the Salamonsen Laboratory was supported by the National Health and Medical Research Council of Australia, Program grant #494802 and Fellowship #1002028 to LAS (www.nhmrc.gov.au). The Victorian Government's Operational Infrastructure Support Program (www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program). YHN was the recipient of an Endeavour Fellowship from the Australian Government (http://www.innovation.gov.au/INTERNATIONALEDUCATION/ENDEAVOURAWARDS). The Rome laboratory is supported by Fondation pour la Recherche Medicale (www.frm.org), Association Francaise de recherche sur les Myopathies (www.afm-telethon.com), Association Francaise de Diabetologie (www.sfdiabete.org) and an INRA specific grant - ANSSD (www.international.inra.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PHI Data Audit 12-28.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Altmae S, 2012, REPROD SCI IN PRESS; Aplin JD, 2006, REPROD BIOMED ONLINE, V13, P833, DOI 10.1016/S1472-6483(10)61032-2; Apparao KBC, 2001, J CLIN ENDOCR METAB, V86, P4991, DOI 10.1210/jc.86.10.4991; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Burnett LA, 2012, J CLIN ENDOCR METAB, V97, P4613, DOI 10.1210/jc.2012-2098; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Dominguez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013380; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Forterre A, 2013, MYOTUBES SO IN PRESS; Germeyer A, 2007, FERTIL STERIL, V87, P657, DOI 10.1016/j.fertnstert.2006.07.1526; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hessvik NP, 2012, BBA-GENE REGUL MECH, V1819, P1154, DOI 10.1016/j.bbagrm.2012.08.016; Jones CJP, 2009, GLYCOCONJUGATE J, V26, P359, DOI 10.1007/s10719-008-9152-6; Kaneko Y, 2013, J MORPHOL, V274, P63, DOI 10.1002/jmor.20076; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; LESSEY BA, 1995, FERTIL STERIL, V63, P535, DOI 10.1016/S0015-0282(16)57422-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li R, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-29; Licht P, 2007, MOL CELL ENDOCRINOL, V269, P85, DOI 10.1016/j.mce.2006.09.016; Liu WM, 2006, J MOL ENDOCRINOL, V36, P121, DOI 10.1677/jme.1.01910; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McCallie B, 2010, FERTIL STERIL, V93, P2374, DOI 10.1016/j.fertnstert.2009.01.069; Meseguer M, 2001, BIOL REPROD, V64, P590, DOI 10.1095/biolreprod64.2.590; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Murphy CR, 2000, HUM REPROD, V15, P182, DOI 10.1093/humrep/15.suppl_3.182; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Okada H, 1999, MOL HUM REPROD, V5, P554, DOI 10.1093/molehr/5.6.554; Paiva P, 2011, HUM REPROD, V26, P1153, DOI 10.1093/humrep/der027; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Rana S, 2011, INT J BIOCHEM CELL B, V43, P106, DOI 10.1016/j.biocel.2010.10.002; Salamonsen LA, 2012, FERTIL STER IN PRESS; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489; Sha AG, 2011, FERTIL STERIL, V96, P150, DOI 10.1016/j.fertnstert.2011.04.072; Sherwin JRA, 2007, ENDOCRINOLOGY, V148, P618, DOI 10.1210/en.2006-0832; Shimomura Y, 2006, MOL HUM REPROD, V12, P491, DOI 10.1093/molehr/gal019; Silveira CGT, 2012, HUM REPROD, V27, P3187, DOI 10.1093/humrep/des282; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; Wang J, 2002, CELLS TISSUES ORGANS, V172, P190, DOI 10.1159/000066970	59	238	247	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58502	10.1371/journal.pone.0058502	http://dx.doi.org/10.1371/journal.pone.0058502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516492	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200074
J	Robinson, DP; Jaidah, MY; Jabado, RW; Lee-Brooks, K; El-Din, NMN; Al Malki, AA; Elmeer, K; McCormick, PA; Henderson, AC; Pierce, SJ; Ormond, RFG				Robinson, David P.; Jaidah, Mohammed Y.; Jabado, Rima W.; Lee-Brooks, Katie; El-Din, Nehad M. Nour; Al Malki, Ameena A.; Elmeer, Khaled; McCormick, Paul A.; Henderson, Aaron C.; Pierce, Simon J.; Ormond, Rupert F. G.			Whale Sharks, Rhincodon typus, Aggregate around Offshore Platforms in Qatari Waters of the Arabian Gulf to Feed on Fish Spawn	PLOS ONE			English	Article							SATELLITE TRACKING; DIVING BEHAVIOR; POPULATION; MOVEMENTS; BIOLOGY; SEA; IDENTIFICATION; ABUNDANCE; ECOLOGY; ISLAND	Whale sharks, Rhincodon typus, are known to aggregate to feed in a small number of locations in tropical and subtropical waters. Here we document a newly discovered major aggregation site for whale sharks within the Al Shaheen oil field, 90 km off the coast of Qatar in the Arabian Gulf. Whale sharks were observed between April and September, with peak numbers observed between May and August. Density estimates of up to 100 sharks within an area of 1 km(2) were recorded. Sharks ranged between four and eight metres' estimated total length (mean 6.92 +/- 1.53 m). Most animals observed were actively feeding on surface zooplankton, consisting primarily of mackerel tuna, Euthynnus affinis, eggs.	[Robinson, David P.; Ormond, Rupert F. G.] Herriot Watt Univ, Edinburgh, Midlothian, Scotland; [Jaidah, Mohammed Y.; El-Din, Nehad M. Nour; Al Malki, Ameena A.; Elmeer, Khaled; McCormick, Paul A.] Qatar Minist Environm, Doha, Qatar; [Jabado, Rima W.] UAE Univ, Abu Dhabi, U Arab Emirates; [Lee-Brooks, Katie] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Pierce, Simon J.] Marine Megafauna Fdn, ECOCEAN USA, Tofo Beach, Mozambique; [Ormond, Rupert F. G.] Marine Conservat Int, Edinburgh, Midlothian, Scotland	Heriot Watt University; United Arab Emirates University; University of York - UK	Robinson, DP (corresponding author), Herriot Watt Univ, Edinburgh, Midlothian, Scotland.	sharkwatcharabia@gmail.com	Elmeer, Khaled/GWQ-5808-2022	Jabado, Rima/0000-0001-6239-6723; Henderson, Aaron/0000-0001-8873-0785; Elmeer, Khaled/0000-0002-7855-5319	Qatar Ministry of Environment. Direct collaborators within the Qatar Ministry of Environment; Save Our Seas Foundation; Shark Foundation	Qatar Ministry of Environment. Direct collaborators within the Qatar Ministry of Environment; Save Our Seas Foundation; Shark Foundation	The research project was funded through the Qatar Ministry of Environment. Direct collaborators within the Qatar Ministry of Environment also provided advice, support in study design, data collection and analysis. DPR's work on this manuscript was supported by funding from the Save Our Seas Foundation. SJP's work on this manuscript was supported by the Shark Foundation and private donors. The journal publication fees for this manuscript were provided by Maersk Oil. All other funders, apart from collaborators from the Qatar Ministry of Environment, had no role in the preparation or decision to publish the manuscript.	Alava M, 1997, FISHERY TRADE WHALE; Alava MNR, 2002, ELASMOBRANCH BIODIVE, P132; Anderson R.C., 1993, SHARK FISHERIES MALD; [Anonymous], [No title captured]; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Beech MJ, 2005, EMIRATES NATURAL HIS; BISHOP JM, 1993, J FISH BIOL, V43, P939, DOI 10.1006/jfbi.1993.1197; Blegvad H, 1944, DANISH SCI INVESTI 3; Brooks Katie, 2010, Western Indian Ocean Journal of Marine Science, V9, P185; Brown J, 1992, TRIBULUS, V2.1, P22; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Che-Tsimg C, 1997, PRELIMINARY REPORT T; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno LJ, 1984, FAO FISH SYNOP, V125, P209; Compango LJV, 2001, SHARKS WORLD ANNOTAT; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Gifford A, 2007, FISH RES, V84, P17, DOI 10.1016/j.fishres.2006.11.011; Girard C, 2004, ANIM BEHAV, V67, P319, DOI 10.1016/j.anbehav.2003.07.007; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Hanfee F, 2001, GENTLE GIANTS SEA IN; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Itano D, 2004, DEV DESIGN RECENT ST; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Mahdi, 1971, ADDITIONS MARINE FIS; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Meekan MG, 2009, MAR FRESHWATER RES, V60, P607, DOI 10.1071/MF08254; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Motlagh SAT, 2010, IRAN J FISH SCI, V9, P315; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Newell G. E., 1979, MARINE PLANKTON PRAC; Newman H.E., 2002, Occasional Papers of the IUCN Species Survival Commission, V25, P230; Norman B, 2005, IUCN 2012 IUCN RED L; Norman B. M., 1999, ASPECTS BIOL ECOTOUR; Pierce SJ, 2010, AQUAT CONSERV, V20, P782, DOI 10.1002/aqc.1149; RAMACHANDRAN A, 1990, Fishery Technology, V27, P138; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Riley MJ, 2010, AQUAT BIOL, V8, P145, DOI 10.3354/ab00215; Rose M., 1933, FAUNE FRANCE, V26; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; ROWAT D, 1997, PHELSUMA NATURE PROT, V5, P77; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Sequeira A, 2011, DIVERSITY DISTRIBUTI; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Sivasubramaniam K, 1981, DEMERSAL RESOURCES G; Sivasubramaniam K., 1983, QATAR SCI B, V3, P297; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Struthers I, 2009, PLANKTON GUIDE THEIR; Todd CD, 1991, COASTAL MARINE ZOOPL; Trono R., 1996, IUCN NEWSLETTER SHAR, V7, P13; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; White A.W., 1971, COMMON SEA FISHES AR; White AE, 1971, SURVEY TRUCIAL STATE, V1; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8; Yamaji I, 1986, ILLUSTRATIONS MARINE	64	75	77	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58255	10.1371/journal.pone.0058255	http://dx.doi.org/10.1371/journal.pone.0058255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516456	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200050
J	Shi, GX; Cui, WJ; Benchimol, M; Liu, YT; Mattrey, RF; Mukthavaram, R; Kesari, S; Esener, SC; Simberg, D				Shi, Guixin; Cui, Wenjin; Benchimol, Michael; Liu, Yu-Tsueng; Mattrey, Robert F.; Mukthavaram, Rajesh; Kesari, Santosh; Esener, Sadik C.; Simberg, Dmitri			Isolation of Rare Tumor Cells from Blood Cells with Buoyant Immuno-Microbubbles	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; CONTRAST AGENTS; GENE-EXPRESSION; BONE-MARROW; ULTRASOUND; CARCINOMA; NANOPARTICLES; TECHNOLOGY; DELIVERY	Circulating tumor cells (CTCs) are exfoliated at various stages of cancer, and could provide invaluable information for the diagnosis and prognosis of cancers. There is an urgent need for the development of cost-efficient and scalable technologies for rare CTC enrichment from blood. Here we report a novel method for isolation of rare tumor cells from excess of blood cells using gas-filled buoyant immuno-microbubbles (MBs). MBs were prepared by emulsification of perfluorocarbon gas in phospholipids and decorated with anti-epithelial cell adhesion molecule (EpCAM) antibody. EpCAM-targeted MBs efficiently (85%) and rapidly (within 15 minutes) bound to various epithelial tumor cells suspended in cell medium. EpCAM-targeted MBs efficiently (88%) isolated frequent tumor cells that were spiked at 100,000 cells/ml into plasma-depleted blood. Anti-EpCAM MBs efficiently (>77%) isolated rare mouse breast 4T1, human prostate PC-3 and pancreatic cancer BxPC-3 cells spiked into 1, 3 and 7 ml (respectively) of plasma-depleted blood. Using EpCAM targeted MBs CTCs from metastatic cancer patients were isolated, suggesting that this technique could be developed into a valuable clinical tool for isolation, enumeration and analysis of rare cells.	[Shi, Guixin; Liu, Yu-Tsueng; Mattrey, Robert F.; Esener, Sadik C.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Cui, Wenjin; Mattrey, Robert F.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Benchimol, Michael] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Mukthavaram, Rajesh; Kesari, Santosh] Univ Calif San Diego, Neurooncol Program, Moores Canc Ctr, La Jolla, CA 92093 USA; [Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Esener, Sadik C.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Simberg, Dmitri] Univ Calif San Diego, Solid Tumor Therapeut Program, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Simberg, D (corresponding author), Univ Calif San Diego, Solid Tumor Therapeut Program, Moores Canc Ctr, La Jolla, CA 92093 USA.	dsimberg@ucsd.edu	Kesari, Santosh/E-8461-2013		United States National Institutes of Health (NIH) [1R21CA137721-01]; UCSD Cancer Center Specialized Support Grant [P30 CA23100]; NIH [P50CA128346]; NCI [5U54CA119335]; NATIONAL CANCER INSTITUTE [U54CA119335, P50CA128346, R21CA137721, P30CA023100] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Cancer Center Specialized Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the United States National Institutes of Health (NIH) 1R21CA137721-01 IMAT grant awarded to D. S. and by the UCSD Cancer Center Specialized Support Grant P30 CA23100. W.C. was partially supported by the NIH P50CA128346 (ICMIC) grant. M.B. was partially supported by the NCI 5U54CA119335 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Bauer KD, 2000, CLIN CANCER RES, V6, P3552; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Cevc G., 1987, PHOSPHOLIPID BILAYER; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Fehm T, 2002, CLIN CANCER RES, V8, P2073; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Hager G, 2005, GYNECOL ONCOL, V98, P211, DOI 10.1016/j.ygyno.2005.04.042; Hettiarachchi K, 2007, LAB CHIP, V7, P463, DOI 10.1039/b701481n; Huang J, 2001, J SURG RES, V99, P222, DOI 10.1006/jsre.2001.6195; Karmali PP, 2012, MOL PHARMACEUT, V9, P539, DOI 10.1021/mp200375x; Khoja L, 2011, BR J CANC; Kraeft SK, 2004, CLIN CANCER RES, V10, P3020, DOI 10.1158/1078-0432.CCR-03-0361; Krag D. N., 1999, Breast J, V5, P354, DOI 10.1046/j.1524-4741.1999.99016.x; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Marth C, 2002, CANCER-AM CANCER SOC, V94, P707, DOI 10.1002/cncr.10250; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Myrset AH, 2011, ULTRASOUND MED BIOL, V37, P136, DOI 10.1016/j.ultrasmedbio.2010.10.010; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Podell S, 1999, BIOTECHNOL APPL BIOC, V30, P213; Rao CG, 2005, INT J ONCOL, V27, P49; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Sboros V, 2007, ULTRASONICS, V46, P349, DOI 10.1016/j.ultras.2007.06.004; Schutt EG, 2003, ANGEW CHEM INT EDIT, V42, P3218, DOI 10.1002/anie.200200550; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Simberg D, 2009, J DRUG TARGET, V17, P392, DOI 10.1080/10611860902902797; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Tveito S, 2007, CLIN EXP METASTAS, V24, P317, DOI 10.1007/s10585-006-9052-8; von Bibra H, 1999, ECHOCARDIOGR-J CARD, V16, P733, DOI 10.1111/j.1540-8175.1999.tb00143.x; Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820; Xu T, 2010, CANCER RES, V70, P6420, DOI 10.1158/0008-5472.CAN-10-0686; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	39	28	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58017	10.1371/journal.pone.0058017	http://dx.doi.org/10.1371/journal.pone.0058017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516425	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200025
J	Xin, HP; Zhu, W; Wang, LN; Xiang, Y; Fang, LC; Li, JT; Sun, XM; Wang, NA; Londo, JP; Li, SH				Xin, Haiping; Zhu, Wei; Wang, Lina; Xiang, Yue; Fang, Linchuan; Li, Jitao; Sun, Xiaoming; Wang, Nian; Londo, Jason P.; Li, Shaohua			Genome Wide Transcriptional Profile Analysis of Vitis amurensis and Vitis vinifera in Response to Cold Stress	PLOS ONE			English	Article							LOW-TEMPERATURE; FREEZING TOLERANCE; ABSCISIC-ACID; GENE-EXPRESSION; PROTEIN-KINASE; ABIOTIC STRESS; ARABIDOPSIS; DROUGHT; GRAPEVINE; ACCLIMATION	Grape is one of the most important fruit crops worldwide. The suitable geographical locations and productivity of grapes are largely limited by temperature. Vitis amurensis is a wild grapevine species with remarkable cold-tolerance, exceeding that of Vitis vinifera, the dominant cultivated species of grapevine. However, the molecular mechanisms that contribute to the enhanced freezing tolerance of V. amurensis remain unknown. Here we used deep sequencing data from restriction endonuclease-generated cDNA fragments to evaluate the whole genome wide modification of transcriptome of V. amurensis under cold treatment. Vitis vinifera cv. Muscat of Hamburg was used as control to help investigate the distinctive features of V. amruensis in responding to cold stress. Approximately 9 million tags were sequenced from non-cold treatment (NCT) and cold treatment (CT) cDNA libraries in each species of grapevine sampled from shoot apices. Alignment of tags into V. vinifera cv. Pinot noir (PN40024) annotated genome identified over 15,000 transcripts in each library in V. amruensis and more than 16,000 in Muscat of Hamburg. Comparative analysis between NCT and CT libraries indicate that V. amurensis has fewer differential expressed genes (DEGs, 1314 transcripts) than Muscat of Hamburg (2307 transcripts) when exposed to cold stress. Common DEGs (408 transcripts) suggest that some genes provide fundamental roles during cold stress in grapes. The most robust DEGs (more than 20-fold change) also demonstrated significant differences between two kinds of grapevine, indicating that cold stress may trigger species specific pathways in V. amurensis. Functional categories of DEGs indicated that the proportion of up-regulated transcripts related to metabolism, transport, signal transduction and transcription were more abundant in V. amurensis. Several highly expressed transcripts that were found uniquely accumulated in V. amurensis are discussed in detail. This subset of unique candidate transcripts may contribute to the excellent cold-hardiness of V. amurensis.	[Xin, Haiping; Zhu, Wei; Wang, Lina; Xiang, Yue; Fang, Linchuan; Li, Jitao; Sun, Xiaoming; Wang, Nian; Li, Shaohua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Xin, Haiping; Wang, Nian; Li, Shaohua] Chinese Acad Sci, Inst Bot, Lab Plant Resources, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Zhu, Wei; Wang, Lina; Xiang, Yue; Fang, Linchuan; Li, Jitao; Sun, Xiaoming] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Londo, Jason P.] ARS, USDA, Grape Genet Res Unit, Geneva, NY USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Agriculture (USDA)	Li, SH (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	shhli@wbgcas.cn	Sun, Xiaoming/AHA-6034-2022; Zhu, Wei/HGA-4471-2022; fang, lin chuan/K-4923-2013	Sun, Xiaoming/0000-0002-0788-3382; Zhu, Wei/0000-0003-1459-6733; Wang, lina/0000-0001-5526-5979; Londo, Jason/0000-0003-0535-4820; /0000-0001-9185-4199; fang, lin chuan/0000-0003-1923-7908	National Natural Science Foundation of China (NSFC) [31130047, 31000902, 31171931]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC Accession No.: 31130047, 31000902 and 31171931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2006, METHOD MOL BIOL, V639, P39; Cho SK, 2006, FEBS LETT, V580, P3136, DOI 10.1016/j.febslet.2006.04.062; Delvalle D, 2005, PLANT J, V43, P398, DOI 10.1111/j.1365-313X.2005.02462.x; Fennell A., 2004, J CROP IMPROV, V10, P201, DOI DOI 10.1300/J411v10n01_09; Fuller MP, 1999, ANN APPL BIOL, V135, P589, DOI 10.1111/j.1744-7348.1999.tb00891.x; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; GOSTI F, 1995, MOL GEN GENET, V246, P10, DOI 10.1007/BF00290128; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Hofmann NR, 2008, PLANT CELL, V20, P1732, DOI 10.1105/tpc.108.200711; Hong SW, 1997, PLANT PHYSIOL, V113, P1203, DOI 10.1104/pp.113.4.1203; Huang Y, 2011, EUPHYTICA, V177, P25, DOI 10.1007/s10681-010-0243-7; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jan N, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue3-fulltext-3; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee HE, 2007, BIOCHEM BIOPH RES CO, V353, P863, DOI 10.1016/j.bbrc.2006.12.095; Lissarre M, 2010, PLANT SIGNAL BEHAV, V5, P948, DOI 10.4161/psb.5.8.12135; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Miura K, 2008, PLANT SIGNAL BEHAV, V3, P52, DOI 10.4161/psb.3.1.4865; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nemoto Y, 2000, PLANT SCI, V158, P53, DOI 10.1016/S0168-9452(00)00305-8; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takuhara Y, 2011, J PLANT PHYSIOL, V168, P967, DOI 10.1016/j.jplph.2010.11.008; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tillett RL, 2012, PLANT BIOTECHNOL J, V10, P105, DOI 10.1111/j.1467-7652.2011.00648.x; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Vannozzi A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-130; Wagstaff C, 2010, J EXP BOT, V61, P2905, DOI 10.1093/jxb/erq113; Whitham S, 1996, P NATL ACAD SCI USA, V93, P8776, DOI 10.1073/pnas.93.16.8776; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Xiao H, 2008, PLANT CELL ENVIRON, V31, P1, DOI 10.1111/j.1365-3040.2007.01741.x; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Xu WR, 2010, PLANTA, V231, P475, DOI 10.1007/s00425-009-1062-8; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Zhou MQ, 2011, CRIT REV BIOTECHNOL, V31, P186, DOI 10.3109/07388551.2010.505910; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102	66	77	86	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58740	10.1371/journal.pone.0058740	http://dx.doi.org/10.1371/journal.pone.0058740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516547	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200108
J	Zhao, Y; Tao, LJ; Jiang, DP; Chen, XY; Li, P; Ning, YL; Xiong, RP; Liu, P; Peng, YZ; Zhou, YG				Zhao, Yan; Tao, Liju; Jiang, Dongpo; Chen, Xingyun; Li, Ping; Ning, Yalei; Xiong, Renping; Liu, Ping; Peng, Yizhi; Zhou, Yuan-Guo			The-144C/A Polymorphism in the Promoter of HSP90beta Is Associated with Multiple Organ Dysfunction Scores	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; POSTISCHEMIC VENTRICULAR RECOVERY; NITRIC-OXIDE SYNTHASE; SEPTIC SHOCK; RECEPTOR; GENE; ACTIVATION; EXPRESSION; SEPSIS; TRAUMA	Introduction: Variations in genetic background are the leading cause of differential susceptibility to traumatic infection. Heat shock protein 90 (HSP90), a broadly distributed and conserved molecule, regulates inflammation under stressful and traumatic conditions. However, the relationships between HSP90 genetic polymorphisms, post-traumatic inflammatory responses and organ function remain unknown. Methods: A total of 286 healthy volunteers and patients with severe trauma took part in a single nucleotide polymorphism (SNP)-based analysis of the HSP90beta gene and a clinical association analysis. HSP90beta and TNF-alpha levels were determined using quantitative PCR and western blot. The transcriptional activity of the HSP90beta promoter was assayed using the Dual-Luciferase Reporter Assay System. Results: The minor allele frequencies for the SNP located at -144 bp relative to the HSP90beta transcriptional start site were 28.47% and 28.52% in the normal and trauma populations, respectively; no significant differences were found between these two distributions. However, the results showed that a promoter containing the -144A allele had a higher transcriptional activity than did a promoter containing the wild-type -144C allele. Furthermore, the -144A promoter induced high expression of HSP90beta and low expression of the inflammatory factor TNF-alpha in a lipopolysaccharide-induced inflammatory model. A clinical association analysis showed that the multiple organ dysfunction scores for -144AA genotype carriers were significantly lower than those of -144CC carriers following trauma. No significant correlations were found between the presence of the two alleles and the incidence of sepsis. Conclusions: These results indicate that differences in expression caused by the -144 polymorphism in the HSP90beta promoter are associated with cellular inflammatory responses and the severity of organ injury. These findings will aid in risk assessment and early prevention of complications for patients with severe trauma.	[Zhao, Yan; Chen, Xingyun; Li, Ping; Ning, Yalei; Xiong, Renping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, Chongqing, Peoples R China; [Zhao, Yan; Chen, Xingyun; Li, Ping; Ning, Yalei; Xiong, Renping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Tao, Liju; Peng, Yizhi] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Jiang, Dongpo] Third Mil Med Univ, Daping Hosp, Intens Care Unit, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Peng, YZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	yizhipen@sina.com; yuanguo.zhou@gmail.com	Li, ping/J-6507-2019	Li, Ping/0000-0002-4926-3835	Foundation for the Author of National Excellent Doctoral Dissertation of China [200156]; National Natural Science Foundation of China [81000832]; National Basic Research Program of China [2005CB522602]; Innovation Grants of the Third Military Medical University [2010XQN32]	Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Innovation Grants of the Third Military Medical University	This work was supported by the Foundation for the Author of National Excellent Doctoral Dissertation of China [grant 200156], the National Natural Science Foundation of China [grant 81000832], National Basic Research Program of China [grant 2005CB522602] and Innovation Grants of the Third Military Medical University [grant 2010XQN32]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani M, 1998, J THORAC CARDIOV SUR, V115, P200, DOI 10.1016/S0022-5223(98)70458-1; Bhattacharyya S, 2010, BLOOD, V115, P1921, DOI 10.1182/blood-2009-06-224782; BOHEN SP, 1995, J BIOL CHEM, V270, P29433, DOI 10.1074/jbc.270.49.29433; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen KH, 2011, BRIT J SURG, V98, P1252, DOI 10.1002/bjs.7532; Chen KH, 2011, SHOCK, V35, P35, DOI 10.1097/SHK.0b013e3181eb45b3; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Duan ZX, 2011, J TRAUMA, V70, P954, DOI 10.1097/TA.0b013e3181e88adf; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Ekambaram P, 2012, TOXICOL MECH METHOD, V22, P367, DOI 10.3109/15376516.2012.673091; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Garcia-Segarra G, 2007, INTENS CARE MED, V33, P1354, DOI 10.1007/s00134-007-0695-y; Glushkova OV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P702, DOI 10.1134/S0006297910060040; Gu W, 2011, J TRAUMA; Hsu HY, 2007, MOL PHARMACOL, V71, P344, DOI 10.1124/mol.106.024240; Kainuma E, 2009, PSYCHONEUROENDOCRINO, V34, P1459, DOI 10.1016/j.psyneuen.2009.04.021; KARMAZYN M, 1990, AM J PHYSIOL, V259, pH424, DOI 10.1152/ajpheart.1990.259.2.H424; Lannan EA, 2012, ENDOCRINOLOGY; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Latchman DS, 2004, CURR NEUROVASC RES, V1, P21, DOI 10.2174/1567202043480206; MacLean MJ, 2005, BIOCHEM BIOPH RES CO, V337, P133, DOI 10.1016/j.bbrc.2005.09.025; Madach K, 2010, CRIT CARE, V14, DOI 10.1186/cc8992; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Nielsen ER, 2006, ANN NY ACAD SCI, V1067, P343, DOI 10.1196/annals.1354.048; Padmini E, 2012, CELL BIOCH BIOPHYS; Passarino G, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9141; Pribenszky C, 2010, BIOL REPROD, V83, P690, DOI 10.1095/biolreprod.110.083386; Scale TAI, 2005, SCAL TAI; Shen HY, 2010, J NEUROTRAUM, V27, P373, DOI 10.1089/neu.2009.0926; Sonna LA, 2002, J APPL PHYSIOL, V92, P2208, DOI 10.1152/japplphysiol.01002.2001; Taiyab A, 2010, BIOCH BIOPHYS ACTA; Tominaga M, 2009, J GASTROEN HEPATOL, V24, P1136, DOI 10.1111/j.1440-1746.2008.05763.x; Tsantes AE, 2010, BLOOD COAGUL FIBRIN, V21, P175, DOI 10.1097/MBC.0b013e32833678a1; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Voss AK, 2000, DEVELOPMENT, V127, P1; Waterer Grant W, 2010, Expert Rev Respir Med, V4, P229, DOI 10.1586/ers.10.13; Wong HR, 2012, CRIT CARE MED, V40, P1618, DOI 10.1097/CCM.0b013e318246b546; Yang C, 2011, CYTOKINE, V54, P29, DOI 10.1016/j.cyto.2010.12.011; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Zhao Y, 2010, CELL PHYSIOL BIOCHEM, V25, P359, DOI 10.1159/000303039	47	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58646	10.1371/journal.pone.0058646	http://dx.doi.org/10.1371/journal.pone.0058646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516526	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200100
J	Ali, M; Broadhurst, RW				Ali, Muzaffar; Broadhurst, R. William			Solution Structure of the QUA1 Dimerization Domain of pXqua, the Xenopus Ortholog of Quaking	PLOS ONE			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; SIGNAL-TRANSDUCTION; QKI PROTEINS; SAM68; STAR; EXPRESSION; GLD-1; HOMODIMERIZATION; FAMILY	The STAR protein family member Quaking is essential for early development in vertebrates. For example, in oligodendrocyte cells it regulates the splicing, localization, translation and lifetime of a set of mRNAs that code for crucial components of myelin. The Quaking protein contains three contiguous conserved regions: a QUA1 oligomerization element, followed by a single-stranded RNA binding motif comprising the KH and QUA2 domains. An embryonic lethal point mutation in the QUA1 domain, E48G, is known to affect both the aggregation state and RNA-binding properties of the murine Quaking ortholog (QKI). Here we report the NMR solution structure of the QUA1 domain from the Xenopus laevis Quaking ortholog (pXqua), which forms a dimer composed of two perpendicularly docked a-helical hairpin motifs. Size exclusion chromatography studies of a range of mutants demonstrate that the dimeric state of the pXqua QUA1 domain is stabilized by a network of interactions between side-chains, with significant roles played by an intra-molecular hydrogen bond between Y41 and E72 (the counterpart to QKI E48) and an inter-protomer salt bridge between E72 and R67. These results are compared with recent structural and mutagenesis studies of QUA1 domains from the STAR family members QKI, GLD-1 and Sam68.	[Ali, Muzaffar; Broadhurst, R. William] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Broadhurst, RW (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	rwb1002@cam.ac.uk	Broadhurst, Bill William/J-6710-2017	Broadhurst, Bill William/0000-0002-0264-4593	Slater Fund, University of Cambridge; Wellcome Trust [094252/Z/10/Z]	Slater Fund, University of Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Slater Fund, University of Cambridge, and a project grant from the Wellcome Trust, http://www.wellcome.ac.uk/(R. William Broadhurst; 094252/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Backx L, 2010, AM J MED GENET A, V152A, P319, DOI 10.1002/ajmg.a.33202; Bardiaux B, 2009, PROTEINS, V75, P569, DOI 10.1002/prot.22268; Beuck C, 2012, J MOL BIOL, V423, P766, DOI 10.1016/j.jmb.2012.08.027; Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016; Biedermann B, 2010, CELL CYCLE, V9, P1929, DOI 10.4161/cc.9.10.11533; Bockbrader K, 2008, FUTUR NEUROL, V3, P655, DOI 10.2217/14796708.3.6.655; Bohnsack BL, 2006, GENESIS, V44, P93, DOI 10.1002/gene.20189; Carmel AB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-48; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Corioni M, 2011, NUCLEIC ACIDS RES, V39, P1868, DOI 10.1093/nar/gkq1042; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; EBERSOLE T, 1992, GENETICS, V131, P183; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47; Guo WG, 2011, CELL PHYSIOL BIOCHEM, V28, P593, DOI 10.1159/000335755; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hocine S, 2010, COLD SPRING HARB PER; Itoh M, 2002, NUCLEIC ACIDS RES, V30, P5452, DOI 10.1093/nar/gkf673; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; Klempan TA, 2009, BIOL PSYCHIAT, V66, P824, DOI 10.1016/j.biopsych.2009.05.010; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Li ZZ, 2002, JPN J CANCER RES, V93, P167, DOI 10.1111/j.1349-7006.2002.tb01255.x; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lobbardi R, 2011, DEVELOPMENT, V138, P1783, DOI 10.1242/dev.059121; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mackereth CD, 2012, CURR OPIN STRUC BIOL, V22, P287, DOI 10.1016/j.sbi.2012.03.013; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Nir R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002632; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Sun H, 2012, IEEE ACM T COMPUT BI, V9, P249, DOI 10.1109/TCBB.2011.67; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wang YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012824; Winzor DJ, 2003, J BIOCHEM BIOPH METH, V56, P15, DOI 10.1016/S0165-022X(03)00071-X; Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334; Wu HY, 2001, MOL CELL NEUROSCI, V17, P292, DOI 10.1006/mcne.2000.0941; Yang GD, 2010, GASTROENTEROLOGY, V138, P231, DOI 10.1053/j.gastro.2009.08.001; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107; Zorn AM, 1997, GENE DEV, V11, P2176, DOI 10.1101/gad.11.17.2176; Zorn AM, 1997, GENE, V188, P199, DOI 10.1016/S0378-1119(96)00795-0; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	67	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57345	10.1371/journal.pone.0057345	http://dx.doi.org/10.1371/journal.pone.0057345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520467	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900026
J	Franci, C; Zhou, J; Jiang, ZS; Modrusan, Z; Good, Z; Jackson, E; Kouros-Mehr, H				Franci, Christian; Zhou, Jenny; Jiang, Zhaoshi; Modrusan, Zora; Good, Zinaida; Jackson, Erica; Kouros-Mehr, Hosein			Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MOLECULAR PORTRAITS; TRANSCRIPTION FACTORS; TARGETING NOTCH; STAT FAMILY; RESISTANCE; DISTINCT; INTERLEUKIN-6; SIGNATURE; PATHWAY	Cancer metastases arise in part from disseminated tumor cells originating from the primary tumor and from residual disease persisting after therapy. The identification of biomarkers on micro-metastases, disseminated tumors, and residual disease may yield novel tools for early detection and treatment of these disease states prior to their development into metastases and recurrent tumors. Here we describe the molecular profiling of disseminated tumor cells in lungs, lung metastases, and residual tumor cells in the MMTV-PyMT breast cancer model. MMTV-PyMT mice were bred with actin-GFP mice, and focal hyperplastic lesions from pubertal MMTV-PyMT;actin-GFP mice were orthotopically transplanted into FVB/n mice to track single tumor foci. Tumor-bearing mice were treated with TAC chemotherapy (docetaxel, doxorubicin, cyclophosphamide), and residual and relapsed tumor cells were sorted and profiled by mRNA microarray analysis. Data analysis revealed enrichment of the Jak/Stat pathway, Notch pathway, and epigenetic regulators in residual tumors. Stat1 was significantly up-regulated in a DNA-damage-resistant population of residual tumor cells, and a pre-existing Stat1 sub-population was identified in untreated tumors. Tumor cells from adenomas, carcinomas, lung disseminated tumor cells, and lung metastases were also sorted from MMTV-PyMT transplant mice and profiled by mRNA microarray. Whereas disseminated tumors cells appeared similar to carcinoma cells at the mRNA level, lung metastases were genotypically very different from disseminated cells and primary tumors. Lung metastases were enriched for a number of chromatin-modifying genes and stem cell-associated genes. Histone analysis of H3K4 and H3K9 suggested that lung metastases had been reprogrammed during malignant progression. These data identify novel biomarkers of residual tumor cells and disseminated tumor cells and implicate pathways that may mediate metastasis formation and tumor relapse after therapy.	[Franci, Christian; Zhou, Jenny; Jiang, Zhaoshi; Modrusan, Zora; Good, Zinaida; Jackson, Erica; Kouros-Mehr, Hosein] Genentech Inc, Res Oncol Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech	Kouros-Mehr, H (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	kouros.mehr@gmail.com		Good, Zinaida/0000-0003-2343-5771	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Funding was provided by Genentech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carmo CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019861; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Duan ZF, 2006, CANCER CHEMOTH PHARM, V57, P25, DOI 10.1007/s00280-005-0026-3; Ezponda T, 2012, ONCOGENE; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hall C, 2012, CANCER-AM CANCER SOC, V118, P342, DOI 10.1002/cncr.26202; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Martin M, 2006, ANN ONCOL, V17, P1205, DOI 10.1093/annonc/mdl135; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Popovic R, 2012, CANCER DISCOV, V2, P405, DOI 10.1158/2159-8290.CD-12-0076; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Rickardson L, 2005, BRIT J CANCER, V93, P483, DOI 10.1038/sj.bjc.6602699; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Rodriguez-Viciana P, 2006, P NATL ACAD SCI USA, V103, P19290, DOI 10.1073/pnas.0609343103; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sheen-Chen SM, 2007, ANTICANCER RES, V27, P2481; Slade MJ, 2007, NAT CLIN PRACT ONCOL, V4, P30, DOI 10.1038/ncponc0685; Sorlie T, 2004, EUR J CANCER, V40, P2667, DOI 10.1016/j.ejca.2004.08.021; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vecchi M, 2008, ONCOGENE, V27, P2148, DOI 10.1038/sj.onc.1210858; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020965	73	27	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58183	10.1371/journal.pone.0058183	http://dx.doi.org/10.1371/journal.pone.0058183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520493	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900052
J	Glasgow, SD; Chapman, CA				Glasgow, Stephen D.; Chapman, C. Andrew			Muscarinic Depolarization of Layer II Neurons of the Parasubiculum	PLOS ONE			English	Article							MEDIAL ENTORHINAL CORTEX; HIPPOCAMPAL PYRAMIDAL CELLS; MEMBRANE-POTENTIAL OSCILLATIONS; CHOLINERGIC MODULATION; RAT-BRAIN; STELLATE CELLS; AFTER-HYPERPOLARIZATION; RETROHIPPOCAMPAL REGION; DENDRITIC EXCITABILITY; SYNAPTIC-TRANSMISSION	The parasubiculum (PaS) is a component of the hippocampal formation that sends its major output to layer II of the entorhinal cortex. The PaS receives strong cholinergic innervation from the basal forebrain that is likely to modulate neuronal excitability and contribute to theta-frequency network activity. The present study used whole cell current- and voltage-clamp recordings to determine the effects of cholinergic receptor activation on layer II PaS neurons. Bath application of carbachol (CCh; 10-50 mu M) resulted in a dose-dependent depolarization of morphologically-identified layer II stellate and pyramidal cells that was not prevented by blockade of excitatory and inhibitory synaptic inputs. Bath application of the M-1 receptor antagonist pirenzepine (1 mu M), but not the M-2-preferring antagonist methoctramine (1 mu M), blocked the depolarization, suggesting that it is dependent on M1 receptors. Voltage-clamp experiments using ramped voltage commands showed that CCh resulted in the gradual development of an inward current that was partially blocked by concurrent application of the selective Kv7.2/3 channel antagonist XE-991, which inhibits the muscarine-dependent K+ current I-M. The remaining inward current also reversed near E-K and was inhibited by the K+ channel blocker Ba2+, suggesting that M-1 receptor activation attenuates both I-M as well as an additional K+ current. The additional K+ current showed rectification at depolarized voltages, similar to K+ conductances mediated by Kir 2.3 channels. The cholinergic depolarization of layer II PaS neurons therefore appears to occur through M-1-mediated effects on I-M as well as an additional K+ conductance.	[Glasgow, Stephen D.; Chapman, C. Andrew] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Chapman, CA (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada.	andrew.chapman@concordia.ca		Glasgow, Stephen/0000-0002-9809-4812	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Doctoral Postgraduate Scholarship; Fonds de Recherche du Quebec-Sante (FRQS)	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Doctoral Postgraduate Scholarship; Fonds de Recherche du Quebec-Sante (FRQS)	This work was supported by grants to C.A.C. from the Natural Sciences and Engineering Research Council (NSERC) of Canada (www.nserc-crsng.gc.ca). S.D.G. was funded by an NSERC Doctoral Postgraduate Scholarship. C.A.C. is a member of the Center for Studies in Behavioral Neurobiology, funded by the Fonds de Recherche du Quebec-Sante (FRQS; www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1984, J COMP NEUROL, V225, P327, DOI 10.1002/cne.902250303; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BENSON DM, 1988, J PHYSIOL-LONDON, V404, P479, DOI 10.1113/jphysiol.1988.sp017301; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bland BH, 2002, J NEUROPHYSIOL, V88, P3046, DOI 10.1152/jn.00315.2002; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; BULATKO AK, 1995, J PHYSIOL-LONDON, V484, P307, DOI 10.1113/jphysiol.1995.sp020666; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Caruana DA, 2004, J NEUROPHYSIOL, V92, P1226, DOI 10.1152/jn.00038.2004; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chapman CA, 1999, J NEUROSCI, V19, P8637; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; DUTAR P, 1988, J NEUROSCI, V8, P4214; Elmedyb P, 2007, BASIC CLIN PHARMACOL, V100, P316, DOI 10.1111/j.1742-7843.2007.00048.x; Figenschou A, 1996, EUR J NEUROSCI, V8, P211, DOI 10.1111/j.1460-9568.1996.tb01182.x; Funahashi M, 1997, HIPPOCAMPUS, V7, P117, DOI 10.1002/(SICI)1098-1063(1997)7:2<117::AID-HIPO1>3.0.CO;2-K; Funahashi M, 1997, J PHYSIOL-LONDON, V501, P387, DOI 10.1111/j.1469-7793.1997.387bn.x; GAHWILER BH, 1987, NEUROSCI LETT, V76, P301, DOI 10.1016/0304-3940(87)90419-8; Glasgow SD, 2012, NEUROSCIENCE, V201, P1, DOI 10.1016/j.neuroscience.2011.11.039; Glasgow SD, 2008, J NEUROPHYSIOL, V100, P2746, DOI 10.1152/jn.90351.2008; Glasgow SD, 2007, J NEUROPHYSIOL, V97, P3868, DOI 10.1152/jn.01306.2006; HajDahmane S, 1996, J NEUROSCI, V16, P3848; Hamam BN, 2003, J NEUROSCI METH, V123, P61, DOI 10.1016/S0165-0270(02)00341-2; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Heys JG, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00032; Heys JG, 2012, J NEUROSCI, V32, P9066, DOI 10.1523/JNEUROSCI.0868-12.2012; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; HOWE AR, 1995, J NEUROSCI, V15, P458; Hsu KS, 1996, NEUROSCIENCE, V73, P751, DOI 10.1016/0306-4522(96)00066-8; Karschin C, 1996, J NEUROSCI, V16, P3559; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Klink R, 1997, J NEUROPHYSIOL, V77, P1829, DOI 10.1152/jn.1997.77.4.1829; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linley JE, 2012, J PHYSIOL-LONDON, V590, P793, DOI 10.1113/jphysiol.2011.223404; Liu LW, 2008, J CELL PHYSIOL, V216, P91, DOI 10.1002/jcp.21378; Ma L, 2007, HIPPOCAMPUS, V17, P114, DOI 10.1002/hipo.20250; MADISON DV, 1987, J NEUROSCI, V7, P733; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; MASH DC, 1986, NEUROSCIENCE, V19, P551, DOI 10.1016/0306-4522(86)90280-0; Mittmann T, 1998, J NEUROPHYSIOL, V79, P1579, DOI 10.1152/jn.1998.79.3.1579; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Qian J, 1997, BRIT J PHARMACOL, V122, P511, DOI 10.1038/sj.bjp.0701400; Reboreda A, 2007, J NEUROPHYSIOL, V97, P3937, DOI 10.1152/jn.01233.2006; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Shalinsky MH, 2002, J NEUROPHYSIOL, V88, P1197, DOI 10.1152/jn.2002.88.3.1197; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; SHIBATA H, 1993, J COMP NEUROL, V337, P431, DOI 10.1002/cne.903370307; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; Tu B, 2009, J NEUROSCI, V29, P10436, DOI 10.1523/JNEUROSCI.2580-09.2009; UCHIMURA N, 1990, J PHYSIOL-LONDON, V422, P369, DOI 10.1113/jphysiol.1990.sp017989; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Yoshida M, 2007, J NEUROPHYSIOL, V98, P2779, DOI 10.1152/jn.00033.2007; Zaczek R, 1998, J PHARMACOL EXP THER, V285, P724; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	74	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58901	10.1371/journal.pone.0058901	http://dx.doi.org/10.1371/journal.pone.0058901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520542	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000318679900102
J	Kawano, Y; Higgins, C; Yamamoto, Y; Nyhus, J; Bernard, A; Dong, HW; Karten, HJ; Schilling, T				Kawano, Yoshihiro; Higgins, Christopher; Yamamoto, Yasuhito; Nyhus, Julie; Bernard, Amy; Dong, Hong-Wei; Karten, Harvey J.; Schilling, Tobias			Darkfield Adapter for Whole Slide Imaging: Adapting a Darkfield Internal Reflection Illumination System to Extend WSI Applications	PLOS ONE			English	Article							STRIA TERMINALIS; BED NUCLEI; RAT-BRAIN; PROJECTIONS; PATHOLOGY; EXPRESSION	We present a new method for whole slide darkfield imaging. Whole Slide Imaging (WSI), also sometimes called virtual slide or virtual microscopy technology, produces images that simultaneously provide high resolution and a wide field of observation that can encompass the entire section, extending far beyond any single field of view. For example, a brain slice can be imaged so that both overall morphology and individual neuronal detail can be seen. We extended the capabilities of traditional whole slide systems and developed a prototype system for darkfield internal reflection illumination (DIRI). Our darkfield system uses an ultra-thin light-emitting diode (LED) light source to illuminate slide specimens from the edge of the slide. We used a new type of side illumination, a variation on the internal reflection method, to illuminate the specimen and create a darkfield image. This system has four main advantages over traditional darkfield: (1) no oil condenser is required for high resolution imaging (2) there is less scatter from dust and dirt on the slide specimen (3) there is less halo, providing a more natural darkfield contrast image, and (4) the motorized system produces darkfield, brightfield and fluorescence images. The WSI method sometimes allows us to image using fewer stains. For instance, diaminobenzidine (DAB) and fluorescent staining are helpful tools for observing protein localization and volume in tissues. However, these methods usually require counter-staining in order to visualize tissue structure, limiting the accuracy of localization of labeled cells within the complex multiple regions of typical neurohistological preparations. Darkfield imaging works on the basis of light scattering from refractive index mismatches in the sample. It is a label-free method of producing contrast in a sample. We propose that adapting darkfield imaging to WSI is very useful, particularly when researchers require additional structural information without the use of further staining.	[Kawano, Yoshihiro; Higgins, Christopher] Olympus Amer, Center Valley, PA USA; [Yamamoto, Yasuhito] Olympus Corp, Hachioji, Tokyo, Japan; [Nyhus, Julie; Bernard, Amy] Allen Inst Brain Sci, Seattle, WA USA; [Dong, Hong-Wei] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Karten, Harvey J.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Schilling, Tobias] Olympus Soft Imaging Solut GmbH, Munster, Germany	Olympus Corporation; Olympus Corporation; Allen Institute for Brain Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; Olympus Corporation	Kawano, Y (corresponding author), Olympus Amer, Center Valley, PA USA.	yoshihiro.kawano@olympus.com	; Kawano, Yoshihiro/B-6208-2016	Bernard, Amy/0000-0003-2540-1153; Kawano, Yoshihiro/0000-0001-6442-8733				Abramowitz M, 1987, CONTRAST METHODS MIC, V2; Abramowitz M, 1990, REFLECTED LIGHT MICR, V3; Abramowitz M, 1987, MICROSCOPE BASICS, V1; Bass M, 1995, HDB OPTICS 2, P171; Blake Charles A., 2003, Anatomical Record, V275B, P196, DOI 10.1002/ar.b.10037; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Costello SSP, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.2.e11; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2003, J COMP NEUROL, V463, P434, DOI 10.1002/cne.10758; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Hecht E, 2002, OPTICS, V4th, P86; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leong FJWM, 2001, J PATHOL, V195, P508, DOI 10.1002/path.972; Long RE, 2013, TOXICOL PATHOL, V41, P115, DOI 10.1177/0192623312451162; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Murphy DB, 2001, FUNDAMENTALS LIGHT M, P112; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Pantanowitz Liron, 2011, J Pathol Inform, V2, P36, DOI 10.4103/2153-3539.83746; Pluta M., 1989, ADV LIGHT MICROSCOPY, V2, P102; Reyes-Irisarri E, 2005, NEUROSCIENCE, V132, P1173, DOI 10.1016/j.neuroscience.2005.01.050; Weinstein RS, 2009, HUM PATHOL, V40, P1057, DOI 10.1016/j.humpath.2009.04.006; Yagi Y, 2005, J TELEMED TELECARE, V11, P109, DOI 10.1258/1357633053688705	23	8	8	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58344	10.1371/journal.pone.0058344	http://dx.doi.org/10.1371/journal.pone.0058344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520500	Green Submitted, gold, Green Published			2022-12-25	WOS:000318679900059
J	Moita, E; Gil-Izquierdo, A; Sousa, C; Ferreres, F; Silva, LR; Valentao, P; Dominguez-Perles, R; Baenas, N; Andrade, PB				Moita, Eduarda; Gil-Izquierdo, Angel; Sousa, Carla; Ferreres, Federico; Silva, Luis R.; Valentao, Patricia; Dominguez-Perles, Raul; Baenas, Nieves; Andrade, Paula B.			Integrated Analysis of COX-2 and iNOS Derived Inflammatory Mediators in LPS-Stimulated RAW Macrophages Pre-Exposed to Echium plantagineum L. Bee Pollen Extract	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; BIOACTIVE COMPOUNDS; PROSTAGLANDIN E(2); FLAVONOIDS; CYCLOOXYGENASE; EXPRESSION; PRODUCTS; BIOSYNTHESIS; EICOSANOIDS	Oxidative stress and inflammation play important roles in disease development. This study intended to evaluate the anti-inflammatory and antioxidant potential of Echium plantagineum L. bee pollen to support its claimed health beneficial effects. The hydromethanol extract efficiently scavenged nitric oxide ((NO)-N-center dot) although against superoxide (O-2(center dot-)) it behaved as antioxidant at lower concentrations and as pro-oxidant at higher concentrations. The anti-inflammatory potential was evaluated in LPS-stimulated macrophages. The levels of (NO)-N-center dot and L-citrulline decreased for all extract concentrations tested, while the levels of prostaglandins, their metabolites and isoprostanes, evaluated by UPLC-MS, decreased with low extract concentrations. So, E. plantagineum bee pollen extract can exert anti-inflammatory activity by reducing (NO)-N-center dot and prostaglandins. The extract is able to scavenge the reactive species (NO)-N-center dot and O-2(center dot-) and reduce markers of oxidative stress in cells at low concentrations.	[Moita, Eduarda; Sousa, Carla; Silva, Luis R.; Valentao, Patricia; Andrade, Paula B.] Univ Porto, Fac Farm, Dept Quim, Rede Quim & Tecnol REQUIMTE,Lab Farmacognosia, P-4100 Oporto, Portugal; [Gil-Izquierdo, Angel; Ferreres, Federico; Dominguez-Perles, Raul; Baenas, Nieves] CSIC, CEBAS, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain	Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Gil-Izquierdo, A (corresponding author), CSIC, CEBAS, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain.	angelgil@cebas.csic.es; pandrade@ff.up.pt	BAENAS, NIEVES/M-2171-2014; REQUIMTE, PHYTO/M-4633-2013; Valentão, Patrícia/D-4818-2013; Silva, Luís R./D-5485-2013; Sousa, Carla/D-4989-2013; Gil-Izquierdo, Angel/B-5563-2008; Dominguez-Perles, Raul/AAK-4212-2021; Andrade, Paula B/A-5900-2008; Baenas, Nieves/AAG-8215-2019; Ferreres, Federico/H-5028-2011; Domínguez-Perles, Raul/J-7456-2013	Valentão, Patrícia/0000-0002-0740-4396; Silva, Luís R./0000-0001-5264-3516; Sousa, Carla/0000-0003-2734-7461; Gil-Izquierdo, Angel/0000-0001-7646-0386; Dominguez-Perles, Raul/0000-0001-6232-712X; Andrade, Paula B/0000-0002-9764-3920; Ferreres, Federico/0000-0002-8682-0004; Domínguez-Perles, Raul/0000-0001-6232-712X; BAENAS, NIEVES/0000-0001-7404-2623	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/EQB/LA0006/2011]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) for grant PEst-C/EQB/LA0006/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Basu S, 2007, MED RES REV, V27, P435, DOI 10.1002/med.20098; Boppre M, 2005, J AGR FOOD CHEM, V53, P594, DOI 10.1021/jf0484531; Bruneton J, 1999, PHYTOCHIMIE PLANTES; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chen YC, 2001, J CELL BIOCHEM, V82, P537, DOI 10.1002/jcb.1184; Clancy R, 2000, J IMMUNOL, V165, P1582, DOI 10.4049/jimmunol.165.3.1582; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Di Paola-Naranjo RD, 2004, J CHROMATOGR A, V1054, P205, DOI 10.1016/j.chroma.2004.05.023; Escuredo O, 2012, FOOD CHEM, V130, P671, DOI 10.1016/j.foodchem.2011.07.107; Fernandes F, 2012, MOLECULES, V17, P5269, DOI 10.3390/molecules17055269; Ferreres F, 2010, RAPID COMMUN MASS SP, V24, P801, DOI 10.1002/rcm.4454; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Harada Y, 1996, PROSTAG OTH LIPID M, V51, P19, DOI 10.1016/0090-6980(95)00168-9; Hodek P, 2002, CHEM-BIOL INTERACT, V139, P1, DOI 10.1016/S0009-2797(01)00285-X; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Kim JH, 2012, MOL NUTR FOOD RES, V56, P454, DOI 10.1002/mnfr.201100270; Kim JY, 2008, EUR J PHARMACOL, V584, P175, DOI 10.1016/j.ejphar.2008.01.032; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Lopes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031145; Luthria DL, 2006, J SCI FOOD AGR, V86, P2266, DOI 10.1002/jsfa.2666; Marnett LJ, 2000, J BIOL CHEM, V275, P13427, DOI 10.1074/jbc.275.18.13427; MAROTTA P, 1992, BRIT J PHARMACOL, V107, P640, DOI 10.1111/j.1476-5381.1992.tb14499.x; Marzinzig M, 1997, NITRIC OXIDE-BIOL CH, V1, P177, DOI 10.1006/niox.1997.0116; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; Medina S, 2012, RAPID COMMUN MASS SP, V26, P1249, DOI 10.1002/rcm.6224; Medina S, 2012, PROSTAG OTH LIPID M, V99, P79, DOI 10.1016/j.prostaglandins.2012.07.002; MOORE KP, 1995, CIRC RES, V77, P335, DOI 10.1161/01.RES.77.2.335; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Okoli CO, 2004, PHARMACOL BIOCHEM BE, V79, P473, DOI 10.1016/j.pbb.2004.08.012; Oliveira AP, 2009, FOOD CHEM TOXICOL, V47, P2841, DOI 10.1016/j.fct.2009.09.004; Ozdol NC, 2004, EUR J PHARMACOL, V506, P189, DOI 10.1016/j.ejphar.2004.10.050; Paramas AMG, 2006, FOOD CHEM, V95, P148, DOI 10.1016/j.foodchem.2005.02.008; Pinho BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024098; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Roberts LJ, 2002, CELL MOL LIFE SCI, V59, P808, DOI 10.1007/s00018-002-8469-8; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Song WL, 2008, J BIOL CHEM, V283, P1179, DOI 10.1074/jbc.M706839200; SWIERKOSZ TA, 1995, BRIT J PHARMACOL, V114, P1335, DOI 10.1111/j.1476-5381.1995.tb13353.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Trottein F, 2009, GLYCOCONJUGATE J, V26, P1259, DOI 10.1007/s10719-009-9244-y; VATSIS KP, 1982, J BIOL CHEM, V257, P1221; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Yan Z, 2010, ANAL BIOCHEM, V403, P126, DOI 10.1016/j.ab.2010.04.016	48	69	69	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59131	10.1371/journal.pone.0059131	http://dx.doi.org/10.1371/journal.pone.0059131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520554	gold, Green Published, Green Submitted			2022-12-25	WOS:000318679900114
J	Qiu, WJ; Wee, KN; Takeda, K; Lim, XM; Sugii, S; Radda, GK; Han, WP				Qiu, Wenjie; Wee, Kenneth; Takeda, Kosuke; Lim, Xuemei; Sugii, Shigeki; Radda, George K.; Han, Weiping			Suppression of Adipogenesis by Pathogenic Seipin Mutant Is Associated with Inflammatory Response	PLOS ONE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; LIPID DROPLET FORMATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; ADJUVANT ARTHRITIS; METABOLIC DISEASE; 3T3-L1 ADIPOCYTES	Background: While pathogenic mutations in BSCL2/Seipin cause congenital generalized lipodystrophy, the underlying mechanism is largely unknown. In this study, we investigated whether and how the pathogenic missense A212P mutation of Seipin (Seipin-A212P) inhibits adipogenesis. Methodology/Results: We analyzed gene expression and lipid accumulation in stable 3T3-L1 cell lines expressing wild type (3T3-WT), non-lipodystrophic mutants N88S (3T3-N88S) and S90L (3T3-S90L), or lipodystrophic mutant A212P Seipin (3T3-A212P). When treated with adipogenic cocktail, 3T3-WT, 3T3-N88S and 3T3-S90L cells exhibited proper differentiation into mature adipocytes, indistinguishable from control 3T3-L1 cells. In contrast, adipogenesis was significantly impaired in 3T3-A212P cells. The defective adipogenesis in 3T3-A212P cells could be partially rescued by either PPAR gamma agonist or PPAR gamma overexpression. Gene expression profiling by microarray revealed that inhibition of adipogenesis was associated with activation of inflammatory genes including IL-6 and iNOS. We further demonstrated that Seipin-A212P expression at pre-differentiation stages significantly activated inflammatory responses by using an inducible expression system. The inflammation-associated inhibition of adipogenesis could be rescued by treatment with anti-inflammatory agents. Conclusions: These results suggest that pathogenic Seipin-A212P inhibits adipogenesis and the inhibition is associated with activation of inflammatory pathways at pre-differentiation stages. Use of anti-inflammatory drugs may be a potential strategy for the treatment of lipodystrophy.	[Qiu, Wenjie; Wee, Kenneth; Takeda, Kosuke; Lim, Xuemei; Sugii, Shigeki; Radda, George K.; Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Sugii, Shigeki; Han, Weiping] Duke Natl Univ Singapore, Grad Sch Med, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Han, Weiping] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Sugii, S (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.	shigeki_sugii@sbic.a-star.edu.sg; weiping_han@sbic.a-star.edu.sg		Sugii, Shigeki/0000-0002-2537-9534	Agency for Science, Technology and Research, Singapore Biomedical Research Council	Agency for Science, Technology and Research, Singapore Biomedical Research Council	This study was supported by an intramural funding from Agency for Science, Technology and Research, Singapore Biomedical Research Council (WH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Capeau J, 2005, BIOCHEM SOC T, V33, P1073, DOI 10.1042/BST0331073; Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; DANESCH U, 1992, J BIOL CHEM, V267, P7185; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; GWYNN B, 1990, MOL CELL BIOL, V10, P5244, DOI 10.1128/MCB.10.10.5244; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; MacDougald OA, 2007, CELL METAB, V6, P159, DOI 10.1016/j.cmet.2007.08.010; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Nunes AF, 2012, MOL NEUROBIOL, V45, P440, DOI 10.1007/s12035-012-8256-y; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Perrey S, 2001, METABOLISM, V50, P36, DOI 10.1053/meta.2001.19505; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Rosenbaum SE, 1998, MOL ENDOCRINOL, V12, P1150, DOI 10.1210/me.12.8.1150; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; THEISENPOPP P, 1992, INT J IMMUNOPHARMACO, V14, P565, DOI 10.1016/0192-0561(92)90117-4; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; TSUBOI I, 1995, CYTOKINE, V7, P372, DOI 10.1006/cyto.1995.0047; Victoria B, 2010, DIABETIC MED, V27, P1178, DOI 10.1111/j.1464-5491.2010.03052.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Woo SJ, 2010, J OCUL PHARMACOL TH, V26, P223, DOI 10.1089/jop.2010.0012; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Yang W, 2012, BIOCH J; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	62	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57874	10.1371/journal.pone.0057874	http://dx.doi.org/10.1371/journal.pone.0057874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520483	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900042
J	Yan, J; Zhang, Y; Zhang, JP; Liang, J; Li, L; Zheng, LM				Yan, Jing; Zhang, Yi; Zhang, Jing-Ping; Liang, Jing; Li, Lian; Zheng, Limin			Tim-3 Expression Defines Regulatory T Cells in Human Tumors	PLOS ONE			English	Article							INTERFERON-GAMMA PRODUCTION; ACTIVATED MONOCYTES; PERITUMORAL STROMA; POOR-PROGNOSIS; UP-REGULATION; PATHWAY; GALECTIN-9; IMMUNITY; CANCER; EXHAUSTION	Tim-3, a member of the novel Tim (T cell immunoglobulin and mucin domain) family, has been reported to negatively regulate the immune responses against viral infection and had implications for autoimmune disease. However, the nature and role of Tim-3(+) CD4 T cells in human tumors remain largely unknown. In the present study, we characterized Tim-3(+) CD4 T cells in 100 specimens from human hepatocellular, cervical, colorectal and ovarian carcinoma patients. Compared with peripheral blood and nontumor-infiltrating lymphocytes, the lymphocytes isolated from the corresponding tumor tissues of hepatocellular, cervical, colorectal and ovarian carcinoma patients contained significantly greater proportion of Tim-3(+) CD4 T cells. The majority of tumor-derived Tim-3(+) CD4 T cells exhibited an impaired capacity to produce IFN-gamma and IL-2, but expressed higher levels of CD25, Foxp3, CTLA-4 and GITR than their Tim-3 2 CD4 T cell counterparts. In contrast, most Tim-3(+) CD4 T cells isolated from the paired nontumor tissues and peripheral blood did not express these molecules. Moreover, tumor-derived Tim-3(+) CD4 T cells, but not tumor-derived Tim-3(+) CD4 T cells, significantly suppressed the proliferation of autologous CD8(+) T cells in vitro. Notably, multi-color immunofluorescence and confocal microscopy demonstrated that Tim-3(+) Foxp3(+) CD4(+) cells were preferentially distributed in the tumor nest rather than the peritumoral stroma of hepatocellular carcinoma. Together, our data indicate that Tim-3-expressing CD4 T cells in human tumors could represent the functional regulatory T cells which contribute to the formation of the immune-suppressive tumor micromilieu.	[Yan, Jing; Zhang, Jing-Ping; Zheng, Limin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yi; Liang, Jing; Li, Lian; Zheng, Limin] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zheng, LM (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	zhenglm@mail.sysu.edu.cn	zhang, jingping/AAM-2751-2021; zheng, limin/HGB-2510-2022; ZHANG, JINGPING/AAT-8229-2021	zhang, jingping/0000-0003-0090-6710; Zheng, Limin/0000-0002-8281-1450	National Basic Research Program of China [2010CB529904, 2011CB811305]; National Natural Science Foundation of China [81230073, 91029737]; Ministry of Health of China [2012ZX10002-011]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of China	This work was supported by project grants from the National Basic Research Program of China (2010CB529904 and 2011CB811305; http://www.973.gov.cn/Default_3.aspx), the National Natural Science Foundation of China (81230073 and 91029737; http://www.nsfc.gov.cn/Portal0/default152.htm), and the Ministry of Health of China (2012ZX10002-011; http://www.moh.gov.cn/publicfiles//business/htmlfiles/wsb/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Chen MG, 2012, CELL MOL IMMUNOL, V9, P375, DOI 10.1038/cmi.2012.18; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Gao Q, 2011, CANCER SCI, V102, P1522, DOI 10.1111/j.1349-7006.2011.01981.x; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; He J, 2012, CHIN J CANCER, V31, P287, DOI 10.5732/cjc.011.10376; Hu GZ, 2010, CELL MOL IMMUNOL, V7, P414, DOI 10.1038/cmi.2010.39; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2009, CELL MOL IMMUNOL, V6, P35, DOI 10.1038/cmi.2009.5; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moorman JP, 2012, J IMMUNOL, V189, P755, DOI 10.4049/jimmunol.1200162; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Ngiow SF, 2011, CANCER RES, V71, P6567, DOI 10.1158/0008-5472.CAN-11-1487; Piersma SJ, 2008, HUM IMMUNOL, V69, P241, DOI 10.1016/j.humimm.2008.02.005; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Simmons WJ, 2005, J IMMUNOL, V174, P1405, DOI 10.4049/jimmunol.174.3.1405; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Wiersma V. R., 2011, MED RES REV; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou J, 2009, INT J CANCER, V125, P1640, DOI 10.1002/ijc.24556; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	56	119	135	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58006	10.1371/journal.pone.0058006	http://dx.doi.org/10.1371/journal.pone.0058006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526963	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900072
J	Nguyen, S; Jones, DC; Wyllie, S; Fairlamb, AH; Phillips, MA				Suong Nguyen; Jones, Deuan C.; Wyllie, Susan; Fairlamb, Alan H.; Phillips, Margaret A.			Allosteric Activation of Trypanosomatid Deoxyhypusine Synthase by a Catalytically Dead Paralog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES TRANSLATION ELONGATION; BLOOD-STREAM FORMS; GENE-EXPRESSION; DRUG TARGET; AFRICAN TRYPANOSOMES; EF-P; BRUCEI; ENZYME; PROTEINS; KINETOPLASTIDS	Polyamine biosynthesis is a key drug target in African trypanosomes. The "resurrection drug" eflornithine (difluoromethylornithine), which is used clinically to treathuman African trypanosomiasis, inhibits the first step in polyamine (spermidine) biosynthesis, a highly regulated pathway in most eukaryotic cells. Previously, we showed that activity of a key trypanosomatid spermidine biosynthetic enzyme, S-adenosylmethionine decarboxylase, is regulated by heterodimer formation with a catalytically dead paralog (a prozyme). Here, we describe an expansion of this prozyme paradigm to the enzyme deoxyhypusine synthase, which is required for spermidine-dependent hypusine modification of a lysine residue in the essential translation factor eIF5A. Trypanosoma brucei encodes two deoxyhypusine synthase paralogs, one that is catalytically functional but grossly impaired, and the other is inactive. Co-expression in Escherichia coli results in heterotetramer formation with a 3000-fold increase in enzyme activity. This functional complex is also present in T. brucei, and conditional knock-out studies indicate that both DHS genes are essential for in vitro growth and infectivity in mice. The recurrent evolution of paralogous, catalytically dead enzyme-based activating mechanisms may be a consequence of the unusual gene expression in the parasites, which lack transcriptional regulation. Our results suggest that this mechanism may be more widely used by trypanosomatids to control enzyme activity and ultimately influence pathogenesis than currently appreciated.	[Suong Nguyen; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Jones, Deuan C.; Wyllie, Susan; Fairlamb, Alan H.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Dundee	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu	Fairlamb, Alan/A-5272-2009; Wyllie, Susan/AAI-4430-2021	Fairlamb, Alan/0000-0001-5134-0329; Wyllie, Susan/0000-0001-8810-5605	National Institutes of Health [2R37 AI034432]; Welch Foundation [I-1257]; Wellcome Trust [079838, 083481]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R37 AI034432 (to M. A. P.). This work was also supported by Welch Foundation Grant I-1257 (to M. A. P.).; Wellcome Trust Principal Research Fellow supported by Wellcome Trust Grants 079838 and 083481.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chawla B, 2010, J BIOL CHEM, V285, P453, DOI 10.1074/jbc.M109.048850; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Force A, 1999, GENETICS, V151, P1531; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Ivanov IP, 2010, NUCLEIC ACIDS RES, V38, P353, DOI 10.1093/nar/gkp1037; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; Jones DC, 2012, MOL MICROBIOL, V86, P51, DOI 10.1111/j.1365-2958.2012.08189.x; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; LEE YB, 1995, J MED CHEM, V38, P3053, DOI 10.1021/jm00016a008; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Monnerat S, 2004, MOL BIOCHEM PARASIT, V134, P233, DOI 10.1016/j.molbiopara.2003.12.004; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Sommer MN, 2004, J BIOMOL SCREEN, V9, P434, DOI 10.1177/1087057104264031; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170; Wolff EC, 2011, METHODS MOL BIOL, V720, P195, DOI 10.1007/978-1-61779-034-8_12; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001	44	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15256	15267		10.1074/jbc.M113.461137	http://dx.doi.org/10.1074/jbc.M113.461137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23525104	Green Published, hybrid			2022-12-25	WOS:000319452100052
J	Hoeferlin, LA; Fekry, B; Ogretmen, B; Krupenko, SA; Krupenko, NI				Hoeferlin, L. Alexis; Fekry, Baharan; Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.			Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; SPHINGOLIPID METABOLISM; TNF-ALPHA; CANCER; P53; EXPRESSION; CELLS; DEFICIENCY; GENERATION	We have investigated the role of ceramide in the cellular adaptation to folate stress induced by Aldh1l1, the enzyme involved in the regulation of folate metabolism. Our previous studies demonstrated that Aldh1l1, similar to folate deficiency, evokes metabolic stress and causes apoptosis in cancer cells. Here we report that the expression of Aldh1l1 in A549 or HCT116 cells results in the elevation of C-16-ceramide and a transient up-regulation of ceramide synthase 6 (CerS6) mRNA and protein. Pretreatment with ceramide synthesis inhibitors myriocin and fumonisin B1 or siRNA silencing of CerS6 prevented C-16-ceramide accumulation and rescued cells supporting the role of CerS6/C-16-ceramide as effectors of Aldh1l1-induced apoptosis. The CerS6 activation by Aldh1l1 and increased ceramide generation were p53-dependent; this effect was ablated in p53-null cells. Furthermore, the expression of wild type p53 but not transcriptionally inactive R175H p53 mutant strongly elevated CerS6. Also, this dominant negative mutant prevented accumulation of CerS6 in response to Aldh1l1, indicating that CerS6 is a transcriptional target of p53. In support of this mechanism, bioinformatics analysis revealed the p53 binding site 3 kb downstream of the CerS6 transcription start. Interestingly, ceramide elevation in response to Aldh1l1 was inhibited by silencing of PUMA, a proapoptotic downstream effector of p53 whereas the transient expression of CerS6 elevated PUMA in a p53-dependent manner indicating reciprocal relationships between ceramide and p53/PUMA pathways. Importantly, folate withdrawal also induced CerS6/C-16-ceramide elevation accompanied by p53 accumulation. Overall, these novel findings link folate and de novo ceramide pathways in cellular stress response.	[Hoeferlin, L. Alexis; Fekry, Baharan; Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu; krupenkn@musc.edu	Fekry, Baharan/GLT-6510-2022	Fekry, Baharan/0000-0003-1218-4161; Hoeferlin, L. Alexis/0000-0001-7569-8712	National Institutes of Health [DK54388, CA095030, CA88932, CA97165, DE16572]; South Carolina Lipidomics and Pathobiology Center of Biomedical Research Excellence [P20 RR017677]; U.S. Department of Education Graduate Assistance in Areas of National Need Training [P200A100105]; Cancer Center Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA095030, R01CA173687, R01CA088932, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Lipidomics and Pathobiology Center of Biomedical Research Excellence; U.S. Department of Education Graduate Assistance in Areas of National Need Training; Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work supported, in whole or in part, by National Institutes of Health Grants DK54388 and CA095030 (to S.A.K.). This work was also supported by the South Carolina Lipidomics and Pathobiology Center of Biomedical Research Excellence Grant P20 RR017677 (to N.I.K.) and the U.S. Department of Education Graduate Assistance in Areas of National Need Training Grant P200A100105 (to L.A.H.). The Flow Cytometry and Lipidomics Shared Resource Facilities were supported in part by Cancer Center Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina.; Supported by the National Institutes of Health Grants CA88932, CA97165, and DE16572.	Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Aoyama M, 2008, J DERMATOL, V35, P33, DOI 10.1111/j.1346-8138.2007.00408.x; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Bedia C, 2011, ANTI-CANCER AGENT ME, V11, P844, DOI 10.2174/187152011797655131; Bertino JR, 2009, BEST PRACT RES CL HA, V22, P577, DOI 10.1016/j.beha.2009.09.004; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bohnsack BL, 2004, ANNU REV NUTR, V24, P433, DOI 10.1146/annurev.nutr.23.011702.073203; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chen XQ, 2012, MED ONCOL, V29, P1843, DOI 10.1007/s12032-011-0075-x; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Ghose S, 2009, MOL CANCER RES, V7, P99, DOI 10.1158/1541-7786.MCR-08-0309; Goldman ID, 2010, CURR OPIN INVEST DR, V11, P1409; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Katula KS, 2007, J NUTR BIOCHEM, V18, P541, DOI 10.1016/j.jnutbio.2006.11.002; KIM MY, 1991, J BIOL CHEM, V266, P484; Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Laethem RM, 1998, BLOOD, V91, P4350, DOI 10.1182/blood.V91.11.4350.411k27_4350_4360; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li GM, 2003, J NUTR BIOCHEM, V14, P568, DOI 10.1016/S0955-2863(03)00115-3; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; Martinez-Borra J, 2012, ADV EXP MED BIOL, V738, P169, DOI 10.1007/978-1-4614-1680-7_11; Meyers-Needham M, 2012, EMBO MOL MED, V4, P78, DOI 10.1002/emmm.201100189; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Oleinik Natalia V, 2011, Genes Cancer, V2, P130, DOI 10.1177/1947601911405841; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Oleinik NV, 2003, MOL CANCER RES, V1, P577; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rodriguez FJ, 2008, J NEUROPATH EXP NEUR, V67, P1194, DOI 10.1097/NEN.0b013e31818fbe1e; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Separovic D, 2012, ANTICANCER RES, V32, P753; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Szak ST, 1999, J BIOL CHEM, V274, P3904, DOI 10.1074/jbc.274.6.3904; WANG E, 1991, J BIOL CHEM, V266, P14486; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6	63	51	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12880	12890		10.1074/jbc.M113.461798	http://dx.doi.org/10.1074/jbc.M113.461798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519469	hybrid, Green Published			2022-12-25	WOS:000318555100042
J	Leal, MC; Magnani, N; Villordo, S; Buslje, CM; Evelson, P; Castano, EM; Morelli, L				Leal, Maria C.; Magnani, Natalia; Villordo, Sergio; Marino Buslje, Cristina; Evelson, Pablo; Castano, Eduardo M.; Morelli, Laura			Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid beta (A beta) Peptide Catabolism and Functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RESPIRATORY FACTOR-1; ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; INDUCIBLE COACTIVATOR; CONVERTING ENZYME; OXIDATIVE STRESS; PROTEIN; DYSFUNCTION; GENE; BRAIN	Studies of post-mortem brains from Alzheimer disease patients suggest that oxidative damage induced by mitochondrial amyloid beta (mitA beta) accumulation is associated with mitochondrial dysfunction. However, the regulation of mitA beta metabolism is unknown. One of the proteases involved in mitA beta catabolism is the long insulin-degrading enzyme (IDE) isoform (IDE-Met(1)). However, the mechanisms of its expression are unknown, and its presence in brain is uncertain. We detected IDE-Met(1) in brain and showed that its expression is regulated by the mitochondrial biogenesis pathway (PGC-1 alpha/NRF-1). A strong positive correlation between PGC-1 alpha or NRF-1 and long IDE isoform transcripts was found in non-demented brains. This correlation was weaker in Alzheimer disease. In vitro inhibition of IDE increased mitA beta and impaired mitochondrial respiration. These changes were restored by inhibition of gamma-secretase or promotion of mitochondrial biogenesis. Our results suggest that IDE-Met(1) links the mitochondrial biogenesis pathway with mitA beta levels and organelle functionality.	[Leal, Maria C.; Villordo, Sergio; Marino Buslje, Cristina; Castano, Eduardo M.; Morelli, Laura] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Magnani, Natalia; Evelson, Pablo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Quim Gen & Inorgan, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Morelli, L (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, RA-1033 Buenos Aires, DF, Argentina.	lmorelli@leloir.org.ar	Evelson, Pablo/J-1245-2014; Marino-Buslje, Cristina/J-7438-2019; Soriano, Vicente/O-5730-2018	Evelson, Pablo/0000-0001-7920-7968; Marino-Buslje, Cristina/0000-0002-6564-1920; Soriano, Vicente/0000-0002-4624-5199	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [PIP693]; Florencio Fiorini Fundation; International Society for Neurochemistry-Committee for Aid and Education in Neurochemistry; John Simon Guggenheim Memorial Foundation; Alzheimer's Association [IIRG-11-205127]; United States Public Health Service [R24-MH 068855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Florencio Fiorini Fundation; International Society for Neurochemistry-Committee for Aid and Education in Neurochemistry; John Simon Guggenheim Memorial Foundation; Alzheimer's Association(Alzheimer's Association); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)-PIP693 and Florencio Fiorini Fundation (to L.M.), the International Society for Neurochemistry-Committee for Aid and Education in Neurochemistry (to M.C.L.), and the John Simon Guggenheim Memorial Foundation and Alzheimer's Association Grant IIRG-11-205127) (to E.M.C.).; We acknowledge Dr. Fernando Pitossi and Dr. Osvaldo Podhajcer (Fundacion Instituto Leloir) for providing personal equipment, technical assistance, and molecular reagents. We thank Leonardo Sganga for cooperation in the measurement of the mitochondrial mass by flow cytometry. The brain tissues were provided by the Harvard Brain Tissue Resource Center, which is supported in part by United States Public Health Service Grant R24-MH 068855.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Alikhani N, 2011, J ALZHEIMERS DIS, V27, P75, DOI 10.3233/JAD-2011-101716; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; Blass JP, 2000, ANN NY ACAD SCI, V924, P170; Boveris A, 1999, METHOD ENZYMOL, V301, P188; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chan CB, 2006, BIOCHEM SOC T, V34, P802, DOI 10.1042/BST0340802; Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660; Cho YM, 2005, DIABETOLOGIA, V48, P2033, DOI 10.1007/s00125-005-1855-7; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Fernandez-Gamba A, 2012, J NEUROCHEM, V121, P985, DOI 10.1111/j.1471-4159.2012.07742.x; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; GOLBUS J, 1990, EUR J IMMUNOL, V20, P1869, DOI 10.1002/eji.1830200836; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; Leal MC, 2012, BBA-MOL CELL RES, V1823, P227, DOI 10.1016/j.bbamcr.2011.09.014; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Y, 2008, DIABETES, V57, P777, DOI 10.2337/db07-0008; Llovera RE, 2008, J BIOL CHEM, V283, P17039, DOI 10.1074/jbc.M706316200; Miners JS, 2010, BRAIN PATHOL, V20, P794, DOI 10.1111/j.1750-3639.2010.00375.x; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Morelli L, 2004, J BIOL CHEM, V279, P56004, DOI 10.1074/jbc.M407283200; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Prat MI, 2002, NEUROSCI LETT, V326, P9, DOI 10.1016/S0304-3940(02)00298-7; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shinall H, 2005, BIOCHEMISTRY-US, V44, P15345, DOI 10.1021/bi050650l; Tanabe T, 2006, INTERNAL MED, V45, P1243, DOI 10.2169/internalmedicine.45.1759; Walls KC, 2012, J BIOL CHEM, V287, P30317, DOI 10.1074/jbc.M112.365890; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042035; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147; Zuo XM, 2009, BRAIN RES, V1249, P1, DOI 10.1016/j.brainres.2008.10.034	60	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12920	12931		10.1074/jbc.M112.424820	http://dx.doi.org/10.1074/jbc.M112.424820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525105	Green Published, hybrid			2022-12-25	WOS:000318555100046
J	Rao, S; Liu, XH; Freedman, BD; Behrens, EM				Rao, Sheila; Liu, Xiaohong; Freedman, Bruce D.; Behrens, Edward M.			Spleen Tyrosine Kinase (Syk)-dependent Calcium Signals Mediate Efficient CpG-induced Exocytosis of Tumor Necrosis Factor alpha (TNF alpha) in Innate Immune Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTORS; NF-KAPPA-B; CYTOKINE SECRETION; TGF-BETA; IN-VITRO; T-CELLS; SYK; MACROPHAGES; ACTIVATION; PHOSPHORYLATION	Pattern recognition receptors expressed by cells of the innate immune system initiate the immune response upon recognition of microbial products. Activation of pattern recognition receptors result in the production and release of proinflammatory cytokines, including TNF alpha and IL-6. Because these cytokines promote disparate effector cell responses, understanding the signaling pathways involved in their regulation is critical for directing the immune response. Using macrophages and dendritic cells deficient in spleen tyrosine kinase (Syk), we identified a novel pathway by which TNF alpha trafficking and secretion are regulated by Syk following stimulation with CpG DNA. In the absence of PLC gamma 2, a Syk substrate, or the calcium-responsive kinase calcium calmodulin kinase II, CpG-induced TNF alpha secretion was impaired. Forced calcium mobilization rescued the TNF alpha secretion defect in Syk-deficient cells. In contrast to its effect on TNF alpha, Syk deficiency did not affect IL-6 secretion, suggesting that Syk-dependent signals participate in differential sorting of cytokines, thus tailoring the cytokine response. Our data report a novel pathway for TNF alpha regulation and provide insight into non-transcriptional mechanisms for shaping cytokine responses.	[Rao, Sheila; Behrens, Edward M.] Childrens Hosp Philadelphia, Div Pediat Rheumatol, Philadelphia, PA 19104 USA; [Rao, Sheila; Behrens, Edward M.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Liu, Xiaohong; Freedman, Bruce D.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Behrens, EM (corresponding author), Childrens Hosp Philadelphia, Dept Pediat Rheumatol, 3615 Civ Ctr Blvd,ARC Rm 1102, Philadelphia, PA 19104 USA.	behrens@email.chop.edu			National Institutes of Health [K08-A179396]; Howard Hughes Medical Institute Early Career Physician Scientist Award; Arthritis Foundation Innovative Research Grant; Nancy Taylor Foundation for Chronic Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Early Career Physician Scientist Award; Arthritis Foundation Innovative Research Grant; Nancy Taylor Foundation for Chronic Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant K08-A179396 (to E. M. B.). This work was also supported by a Howard Hughes Medical Institute Early Career Physician Scientist Award, by an Arthritis Foundation Innovative Research Grant, and by the Nancy Taylor Foundation for Chronic Diseases.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; El Gazzar MA, 2007, BBA-GEN SUBJECTS, V1770, P556, DOI 10.1016/j.bbagen.2007.01.002; El-Hage N, 2011, IMMUNOL INVEST, V40, P498, DOI 10.3109/08820139.2011.561904; Flavell RA, 2002, CURR TOP MICROBIOL, V266, P1; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hilfiker S, 1999, J NEUROCHEM, V73, P921, DOI 10.1046/j.1471-4159.1999.0730921.x; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Law CL, 1996, MOL CELL BIOL, V16, P1305; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Liu QH, 2002, J EXP MED, V196, P897, DOI 10.1084/jem.20020381; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verona M, 2000, J NEUROCHEM, V74, P209, DOI 10.1046/j.1471-4159.2000.0740209.x; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zhu PM, 2009, J BIOL CHEM, V284, P22878, DOI 10.1074/jbc.M109.018580	51	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12448	12458		10.1074/jbc.M113.454405	http://dx.doi.org/10.1074/jbc.M113.454405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23515313	Green Published, hybrid			2022-12-25	WOS:000318555100004
J	Wang, YX; Ding, M; Chaudhari, S; Ding, YF; Yuan, J; Stankowska, D; He, SQ; Krishnamoorthy, R; Cunningham, JT; Ma, R				Wang, Yanxia; Ding, Min; Chaudhari, Sarika; Ding, Yanfeng; Yuan, Joseph; Stankowska, Dorota; He, Shaoqing; Krishnamoorthy, Raghu; Cunningham, Joseph T.; Ma, Rong			Nuclear Factor kappa B Mediates Suppression of Canonical Transient Receptor Potential 6 Expression by Reactive Oxygen Species and Protein Kinase C in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; TUMOR-NECROSIS-FACTOR; TRPC6 CHANNEL; OXIDATIVE STRESS; DOWN-REGULATION; FACTOR-ALPHA; ACTIVATION; PHOSPHORYLATION; MECHANISM; PROLIFERATION	This study was carried out to explore the molecular mechanism for down-regulation of TRPC6 expression in the reactive oxygen species (ROS)/PKC signaling in kidney cells. In cultured human mesangial cells, H2O2 and TNF-alpha inhibited TRPC6 mRNA expression in a time-dependent manner. Inhibition of NF-kappa B reversed both H2O2-and phorbol 12-myristate 13-acetate (PMA)-induced decrease in TRPC6 protein expression. Activation of NF-kappa B by knocking down I kappa B alpha using siRNA could mimic the suppressive effect of ROS/PKC on TRPC6. a Ca2+ imaging study showed that activation and inhibition of NF-kappa B significantly decreased and increased the TRPC6-mediated Ca2+ entry, respectively. Further experiments showed that PMA, but not its inactive analog 4 alpha-phorbol 12, 13-didecanoate (4 alpha-PDD), caused phosphorylation of I kappa B alpha and stimulated the nuclear translocation of NF-kappa B p50 and p65 subunits. The PMA-dependent I kappa B alpha phosphorylation was significantly inhibited by Go6976. Electrophoretic mobility shift assay revealed that PMA stimulated DNA binding activity of NF-kappa B. Furthermore, specific knockdown of p65, but not p50, prevented an H2O2 inhibitory effect on TRPC6 protein expression, suggesting p65 as a predominant NF-kappa B subunit repressing TRPC6. In agreement with a major role of p65, chromatin immunoprecipitation assays showed that PMA treatment induced p65 binding to the TRPC6 promoter. Moreover, PMA treatment increased the association of p65 with histone deacetylase (HDAC) and decreased histone acetylation at the TRPC6 promoter. Consistently, knockdown of HDAC2 by siRNA or inhibition of HDAC with trichostatin A prevented a H2O2-induced decrease in TRPC6 mRNA and protein expressions, respectively. Taken together, our findings imply an important role of NF-kappa B in a negative regulation of TRPC6 expression at the gene transcription level in kidney cells.	[Wang, Yanxia; Ding, Min; Chaudhari, Sarika; Ding, Yanfeng; Yuan, Joseph; Cunningham, Joseph T.; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [Wang, Yanxia; Ding, Min; Chaudhari, Sarika; Ding, Yanfeng; Yuan, Joseph; Cunningham, Joseph T.; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX 76107 USA; [Stankowska, Dorota; He, Shaoqing; Krishnamoorthy, Raghu] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Ma, R (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	rong.ma@unthsc.edu	ma, rong/GVU-3096-2022	Chaudhari, Sarika/0000-0002-2590-6365	National Institutes of Health [5 RO1 DK079968-01A2]; American Heart Association South Central Affiliate [11GRNT7560013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association South Central Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 RO1 DK079968-01A2 (NIDDK; to R.M.). This work was also supported by American Heart Association South Central Affiliate Grant-in-aid 11GRNT7560013 (to R.M.).	Aarenstrup L, 2008, J INVEST DERMATOL, V128, P1095, DOI 10.1038/sj.jid.5701146; Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Banday AA, 2007, J AM SOC NEPHROL, V18, P1446, DOI 10.1681/ASN.2006121373; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bottero V, 2001, CANCER RES, V61, P7785; Bousquet SM, 2010, J BIOL CHEM, V285, P40534, DOI 10.1074/jbc.M110.160051; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Canty TG, 1999, CIRCULATION, V100, P361; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Ding YF, 2011, J BIOL CHEM, V286, P31799, DOI 10.1074/jbc.M111.248344; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Freidkin I, 2010, AM J PHYSIOL-RENAL, V298, pF426, DOI 10.1152/ajprenal.00107.2009; Gastonguay AJ, 2012, CANCER BIOL THER, V13, P647, DOI 10.4161/cbt.20082; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; Graham S, 2011, AM J PHYSIOL-CELL PH, V301, pC304, DOI 10.1152/ajpcell.00014.2011; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Hamid R, 2009, CIRCULATION, V119, P2297, DOI 10.1161/CIRCULATIONAHA.109.855197; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P865, DOI 10.1089/ars.2007.1640; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; Hocherl K, 2010, AM J PHYSIOL-RENAL, V298, pF196, DOI 10.1152/ajprenal.90607.2008; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kanwar YS, 2005, NEPHRON EXP NEPHROL, V101, P100, DOI 10.1159/000087339; KASHGARIAN M, 1992, KIDNEY INT, V41, P524, DOI 10.1038/ki.1992.74; Kim JM, 2012, CELL PHYSIOL BIOCHEM, V30, P49, DOI 10.1159/000339045; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; Mizuno N, 1999, MOL BRAIN RES, V64, P41, DOI 10.1016/S0169-328X(98)00296-4; Monet M, 2012, J BIOL CHEM, V287, P17672, DOI 10.1074/jbc.M112.341354; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Muller M, 2008, J BIOL CHEM, V283, P33942, DOI 10.1074/jbc.M801844200; Nicolls MR, 2007, ANTIOXID REDOX SIGN, V9, P879, DOI 10.1089/ars.2007.1631; Nishikori M, 2005, J CLIN EXP HEMATOP, V45, P15, DOI 10.3960/jslrt.45.15; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Satou R, 2010, AM J PHYSIOL-CELL PH, V299, pC750, DOI 10.1152/ajpcell.00078.2010; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Scindia YM, 2010, ADV DRUG DELIVER REV, V62, P1337, DOI 10.1016/j.addr.2010.08.011; Sel S, 2008, CLIN EXP ALLERGY, V38, P1548, DOI 10.1111/j.1365-2222.2008.03043.x; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Shi XZ, 2003, GASTROENTEROLOGY, V124, P1369, DOI 10.1016/S0016-5085(03)00263-4; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; Sours-Brorhers S, 2009, EXP BIOL MED, V234, P673, DOI 10.3181/0809-RM-279; Stockand JD, 1998, PHYSIOL REV, V78, P723, DOI 10.1152/physrev.1998.78.3.723; Tsai KL, 2012, CELL BIOCHEM BIOPHYS, V62, P467, DOI 10.1007/s12013-011-9333-y; Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660; Winn MP, 2006, J AM SOC NEPHROL, V17, P378, DOI 10.1681/ASN.2005090962; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1; Yu ZY, 2006, AM J PHYSIOL-RENAL, V290, pF496, DOI 10.1152/ajprenal.00316.2005; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	65	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12852	12865		10.1074/jbc.M112.410357	http://dx.doi.org/10.1074/jbc.M112.410357			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525112	Green Published, hybrid			2022-12-25	WOS:000318555100040
J	Hill, EJ; Nagel, DA; O'Neil, JD; Torr, E; Woehrling, EK; Devitt, A; Coleman, MD				Hill, Eric J.; Nagel, David A.; O'Neil, John D.; Torr, Elizabeth; Woehrling, Elizabeth K.; Devitt, Andrew; Coleman, Michael D.			Effects of Lithium and Valproic Acid on Gene Expression and Phenotypic Markers in an NT2 Neurosphere Model of Neural Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEURONAL DIFFERENTIATION; HISTONE DEACETYLASE; PROGENITOR CELLS; PROTEIN BINDING; RETINOIC ACID; INHIBITION; INDUCTION; SYSTEM; TARGET	Mood stabilising drugs such as lithium (LiCl) and valproic acid (VPA) are the first line agents for treating conditions such as Bipolar disorder and Epilepsy. However, these drugs have potential developmental effects that are not fully understood. This study explores the use of a simple human neurosphere-based in vitro model to characterise the pharmacological and toxicological effects of LiCl and VPA using gene expression changes linked to phenotypic alterations in cells. Treatment with VPA and LiCl resulted in the differential expression of 331 and 164 genes respectively. In the subset of VPA targeted genes, 114 were downregulated whilst 217 genes were upregulated. In the subset of LiCl targeted genes, 73 were downregulated and 91 were upregulated. Gene ontology (GO) term enrichment analysis was used to highlight the most relevant GO terms associated with a given gene list following toxin exposure. In addition, in order to phenotypically anchor the gene expression data, changes in the heterogeneity of cell subtype populations and cell cycle phase were monitored using flow cytometry. Whilst LiCl exposure did not significantly alter the proportion of cells expressing markers for stem cells/undifferentiated cells (Oct4, SSEA4), neurons (Neurofilament M), astrocytes (GFAP) or cell cycle phase, the drug caused a 1.4-fold increase in total cell number. In contrast, exposure to VPA resulted in significant upregulation of Oct4, SSEA, Neurofilament M and GFAP with significant decreases in both G2/M phase cells and cell number. This neurosphere model might provide the basis of a human-based cellular approach for the regulatory exploration of developmental impact of potential toxic chemicals.	[Hill, Eric J.; Nagel, David A.; O'Neil, John D.; Torr, Elizabeth; Woehrling, Elizabeth K.; Devitt, Andrew; Coleman, Michael D.] Aston Univ, Sch Life & Hlth Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England	Aston University	Hill, EJ (corresponding author), Aston Univ, Sch Life & Hlth Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.	hillej@aston.ac.uk	Coleman, Michael Damian/AAD-5503-2019	Devitt, Andrew/0000-0002-4651-6761; Coleman, MIchael D/0000-0002-5510-6852; Hill, Eric/0000-0002-9419-1500	Humane Research Trust (Stockport, UK)	Humane Research Trust (Stockport, UK)	This study was funded by the Humane Research Trust (Stockport, UK). The authors declare that the sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Breier JM, 2010, NEUROTOXICOL TERATOL, V32, P4, DOI 10.1016/j.ntt.2009.06.005; Brodie MJ, 1996, NEW ENGL J MED, V334, P168, DOI 10.1056/NEJM199601183340308; Bug G, 2005, CANCER, V104, P2717, DOI 10.1002/cncr.21589; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Daston GP, 2008, TOXICOL SCI, V105, P233, DOI 10.1093/toxsci/kfn138; Fielden MR, 2001, TOXICOL SCI, V60, P6, DOI 10.1093/toxsci/60.1.6; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Hill EJ, 2008, TOXICOLOGY, V249, P243, DOI 10.1016/j.tox.2008.05.014; Hill EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036098; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hogberg HT, 2009, TOXICOL APPL PHARM, V235, P268, DOI 10.1016/j.taap.2008.12.014; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Johnson G, 1998, NEUROPSYCHOPHARMACOL, V19, P200, DOI 10.1016/S0893-133X(98)00019-0; Jung GA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-66; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kultima K, 2004, ENVIRON HEALTH PERSP, V112, P1225, DOI 10.1289/txg.7034; Kumar S, 2000, DRUG METAB DISPOS, V28, P845; Lee T, 2008, BMC BIOINFORM S9, V9, pS20; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; NAU H, 1984, J PEDIATR-US, V104, P627, DOI 10.1016/S0022-3476(84)80567-3; Newport DJ, 2005, AM J PSYCHIAT, V162, P2162, DOI 10.1176/appi.ajp.162.11.2162; Nguyen HTT, 2009, ADV THER, V26, P281, DOI 10.1007/s12325-009-0011-z; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PRICE LH, 1994, NEW ENGL J MED, V331, P591; ROBERT E, 1982, LANCET, V2, P937, DOI 10.1016/s0140-6736(82)90908-4; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Scholz G, 1998, ALTEX-ALTERN TIEREXP, V15, P3; Seiler A, 2002, ALTEX-ALTERN TIEREXP, V19, P55; Teng HF, 2010, J CELL BIOCHEM, V110, P995, DOI 10.1002/jcb.22613; Turner CE, 2000, J CELL SCI, V113, P4139; Walmod PS, 1999, CELL MOTIL CYTOSKEL, V42, P241, DOI 10.1002/(SICI)1097-0169(1999)42:3<241::AID-CM7>3.0.CO;2-3; Werling U, 2001, MOL PHARMACOL, V59, P1269, DOI 10.1124/mol.59.5.1269; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003	39	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58822	10.1371/journal.pone.0058822	http://dx.doi.org/10.1371/journal.pone.0058822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527032	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000317562100047
J	Chung, JY; Kim, MW; Bang, MS; Kim, M				Chung, Jin-Young; Kim, Min-Wook; Bang, Moon-Suk; Kim, Manho			Increased Expression of Neurotrophin 4 Following Focal Cerebral Ischemia in Adult Rat Brain with Treadmill Exercise	PLOS ONE			English	Article							ARTERY OCCLUSION; GENE-EXPRESSION; ENVIRONMENTAL ENRICHMENT; HIPPOCAMPUS; PLASTICITY; INJURY; BDNF; TRKB; DAMAGE	Neurotrophin 4 (NT-4) belongs to the family of neurotrophic factors, and it interacts with the tyrosine kinase B (trkB) receptor. NT-4 has neuroprotective effects following cerebral ischemia. Its role might be similar to brain-derived neurotrophic factor (BDNF), because both interact with trkB. Exercise also improves neural function by increasing neurotrophic factors. However, expression profiles of NT-4 in the brain during exercise are unknown. Here, we assessed the expressions of NT-4 and its receptor, trkB, following cerebral ischemia and hypothesized that exercise changes the expressions of NT-4 and trkB. Results showed that in a permanent middle cerebral artery occlusion rat model, ischemia decreased NT-4 and trkB expression. Immunohistochemistry showed their immunoreactivities around the region of the ischemic area. Treadmill exercise changed the expression of NT-4, which increased in the contralateral hemisphere in rats with ischemic injury. TrkB also showed similar patterns to its neurotophins. The change in NT-4 suggested that exercise might have primed NT4 production so that further injury causes slightly greater increases in NT4 compared with non-exercise controls.	[Chung, Jin-Young; Kim, Manho] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Kim, Min-Wook] Catholic Univ Korea, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Kim, Min-Wook] Incheon St Marys Hosp, ICIM, Inchon, South Korea; [Bang, Moon-Suk] Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul National University (SNU); Seoul National University Hospital	Kim, M (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	kimmanho@snu.ac.kr			Korea Health 21 RD Project; Ministry of Health and Welfare [A092058]; WCU-Neurocytomics program; 21C Frontier Functional Proteomics Project [FPR08K1301-02210]	Korea Health 21 RD Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); WCU-Neurocytomics program; 21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Korea Health 21 R&D Project, Ministry of Health and Welfare (A092058) and WCU-Neurocytomics program and by grants from 21C Frontier Functional Proteomics Project (FPR08K1301-02210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; Bang OY, 2009, J CLIN NEUROL, V5, P107, DOI 10.3988/jcn.2009.5.3.107; Burette A, 1997, BRAIN RES, V776, P10, DOI 10.1016/S0006-8993(97)00934-7; Chan KM, 1996, NEUROCHEM RES, V21, P763, DOI 10.1007/BF02532298; Chang HC, 2009, BEHAV BRAIN RES, V205, P450, DOI 10.1016/j.bbr.2009.07.033; Chung JY, 2010, BRAIN RES, V1353, P187, DOI 10.1016/j.brainres.2010.06.057; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Goutan E, 1998, MOL BRAIN RES, V59, P154, DOI 10.1016/S0169-328X(98)00156-9; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Johansson BB, 1999, ACT NEUR S, V73, P51; Keyvani K, 2004, J NEUROPATH EXP NEUR, V63, P598, DOI 10.1093/jnen/63.6.598; Kim MW, 2005, BRAIN RES, V1052, P16, DOI 10.1016/j.brainres.2005.05.070; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; PERSSON H, 1993, CURR OPIN NEUROL NEU, V6, P11; Ploughman M, 2007, EUR J NEUROSCI, V25, P3453, DOI 10.1111/j.1460-9568.2007.05591.x; Russo-Neustadt A, 2001, BEHAV BRAIN RES, V120, P87, DOI 10.1016/S0166-4328(00)00364-8; Semkova I, 1999, BRAIN RES REV, V30, P176, DOI 10.1016/S0165-0173(99)00013-2; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Widenfalk J, 1999, NEUROSCI RES, V34, P125, DOI 10.1016/S0168-0102(99)00051-6; Zhang WR, 1999, NEUROSCI LETT, V276, P161, DOI 10.1016/S0304-3940(99)00848-4	27	32	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e52461	10.1371/journal.pone.0052461	http://dx.doi.org/10.1371/journal.pone.0052461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526925	Green Submitted, Green Published, gold			2022-12-25	WOS:000316411600001
J	Chen, XY; Wang, SM; Li, N; Hu, Y; Zhang, Y; Xu, JF; Li, X; Ren, J; Su, B; Yuan, WZ; Teng, XR; Zhang, RX; Jiang, DH; Mulet, X; Li, HP				Chen, Xue-Yuan; Wang, Shan-Mei; Li, Nan; Hu, Yang; Zhang, Yuan; Xu, Jin-Fu; Li, Xia; Ren, Jie; Su, Bo; Yuan, Wei-Zhong; Teng, Xin-Rong; Zhang, Rong-Xuan; Jiang, Dian-hua; Mulet, Xavier; Li, Hui-Ping			Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats	PLOS ONE			English	Article							DISTRESS-SYNDROME ARDS; CORTICOSTEROIDS; LIPOSOMES; DELIVERY; DOXORUBICIN; INHIBITION; EXPRESSION; PREVENTION; STRATEGY; BRAIN	Objective: Acute lung injury (ALI), is a major cause of morbidity and mortality, which is routinely treated with the administration of systemic glucocorticoids. The current study investigated the distribution and therapeutic effect of a dexamethasone(DXM)-loaded immunoliposome (NLP) functionalized with pulmonary surfactant protein A (SP-A) antibody (SPA-DXM-NLP) in an animal model. Methods: DXM-NLP was prepared using film dispersion combined with extrusion techniques. SP-A antibody was used as the lung targeting agent. Tissue distribution of SPA-DXM-NLP was investigated in liver, spleen, kidney and lung tissue. The efficacy of SPA-DXM-NLP against lung injury was assessed in a rat model of bleomycin-induced acute lung injury. Results: The SPA-DXM-NLP complex was successfully synthesized and the particles were stable at 4 degrees C. Pulmonary dexamethasone levels were 40 times higher with SPA-DXM-NLP than conventional dexamethasone injection. Administration of SPA-DXM-NLP significantly attenuated lung injury and inflammation, decreased incidence of infection, and increased survival in animal models. Conclusions: The administration of SPA-DXM-NLP to animal models resulted in increased levels of DXM in the lungs, indicating active targeting. The efficacy against ALI of the immunoliposomes was shown to be superior to conventional dexamethasone administration. These results demonstrate the potential of actively targeted glucocorticoid therapy in the treatment of lung disease in clinical practice.	[Chen, Xue-Yuan; Wang, Shan-Mei; Li, Nan; Hu, Yang; Zhang, Yuan; Xu, Jin-Fu; Li, Xia; Li, Hui-Ping] Tongji Univ, Sch Med, Dept Resp Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Ren, Jie; Yuan, Wei-Zhong; Teng, Xin-Rong] Tongji Univ, Inst Nano & Biopolymer Mat, Shanghai 200092, Peoples R China; [Su, Bo] Tongji Univ, Sch Med, Centrol Lab, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Zhang, Rong-Xuan] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pathol, Shanghai 200092, Peoples R China; [Jiang, Dian-hua] Duke Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27706 USA; [Mulet, Xavier] CSIRO Mat Sci & Engn, Clayton, Vic, Australia	Tongji University; Tongji University; Tongji University; Tongji University; Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Li, HP (corresponding author), Tongji Univ, Sch Med, Dept Resp Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China.	liw2013@126.com	Jiang, Dianhua/B-1421-2009; Mulet, Xavier/B-1650-2009; Ren, Jie/J-2811-2012	Jiang, Dianhua/0000-0002-4508-3829; Mulet, Xavier/0000-0001-8241-0924; Ren, Jie/0000-0002-3744-1470	National Science Foundation of China [30971323, 81170011]; Science and Technology Commission of Shanghai Municipality [11430702100, 114119b2200, 09411951500]; International Science & Technology Cooperation Program of China [2011DFB30010]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); International Science & Technology Cooperation Program of China	The study was funded by grants from the National Science Foundation of China ( No: 30971323, 81170011); Science and Technology Commission of Shanghai Municipality (No: 11430702100, 114119b2200, 09411951500); and International Science & Technology Cooperation Program of China (2011DFB30010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afergan E, 2008, J CONTROL RELEASE, V132, P84, DOI 10.1016/j.jconrel.2008.08.017; ALLEN TM, 1995, BBA-BIOMEMBRANES, V1237, P99, DOI 10.1016/0005-2736(95)00085-H; Asgeirdottir SA, 2007, MOL PHARMACOL, V72, P121, DOI 10.1124/mol.107.034140; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bellingan GJ, 2002, THORAX, V57, P540, DOI 10.1136/thorax.57.6.540; Bendas G, 2001, BIODRUGS, V15, P215, DOI 10.2165/00063030-200115040-00002; Berlin M, 2010, EXPERT OPIN THER PAT, V20, P855, DOI 10.1517/13543776.2010.493876; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; Bertorelli G, 2008, PULM PHARMACOL THER, V21, P214, DOI 10.1016/j.pupt.2007.03.001; BETAGERI GV, 1993, J PHARM PHARMACOL, V45, P48, DOI 10.1111/j.2042-7158.1993.tb03678.x; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Devos S, 2003, BIOCHEM PHARMACOL, V65, P303, DOI 10.1016/S0006-2952(02)01507-1; Dik WA, 2003, THORAX, V58, P765, DOI 10.1136/thorax.58.9.765; Drescher W, 2011, NEPHROL DIAL TRANSPL, V26, P2728, DOI 10.1093/ndt/gfr212; Eachempati SR, 2007, J TRAUMA, V63, P344, DOI 10.1097/TA.0b013e3180eea5a1; ElBayoumi TA, 2010, METHODS MOL BIOL, V605, P1, DOI 10.1007/978-1-60327-360-2_1; Fernandes ABS, 2005, BRAZ J MED BIOL RES, V38, P147, DOI 10.1590/S0100-879X2005000200003; Gregoriadis G, 2008, J DRUG TARGET, V16, P520, DOI 10.1080/10611860802228350; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; Gupta N, 2006, AM J PHYSIOL-LUNG C, V291, pL436, DOI 10.1152/ajplung.00415.2005; Hao H, 2003, AM J PHYSIOL-LUNG C, V285, pL593, DOI 10.1152/ajplung.00037.2003; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kwak H W, 1995, Korean J Ophthalmol, V9, P79; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Mamot C, 2004, J NEURO-ONCOL, V68, P1, DOI 10.1023/B:NEON.0000024743.56415.4b; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Metselaar JM, 2003, ARTHRITIS RHEUM-US, V48, P2059, DOI 10.1002/art.11140; Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13; Pan Hong, 2006, Yao Xue Xue Bao, V41, P506; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Sadzuka Y, 2002, INT J PHARM, V238, P171, DOI 10.1016/S0378-5173(02)00075-3; Scherphof GL, 2001, PROG LIPID RES, V40, P149, DOI 10.1016/S0163-7827(00)00020-5; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Thompson BT, 2010, MINERVA ANESTESIOL, V76, P441; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wang XQ, 2008, RESPIROLOGY, V13, P772, DOI 10.1111/j.1440-1843.2008.01344.x; Yokoe JI, 2008, INT J PHARMACEUT, V353, P28, DOI 10.1016/j.ijpharm.2007.11.008	40	21	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58275	10.1371/journal.pone.0058275	http://dx.doi.org/10.1371/journal.pone.0058275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516459	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400022
J	Olivan-Viguera, A; Valero, MS; Murillo, MD; Wulff, H; Garcia-Otin, AL; Arbones-Mainar, JM; Kohler, R				Olivan-Viguera, Aida; Sofia Valero, Marta; Divina Murillo, Maria; Wulff, Heike; Garcia-Otin, Angel-Luis; Arbones-Mainar, Jose-Miguel; Koehler, Ralf			Novel Phenolic Inhibitors of Small/IntermediateConductance Ca2+-Activated K+ Channels, KCa3.1 and KCa2.3	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; AORTIC SMOOTH-MUSCLE; CD4 T-CELLS; INTERMEDIATE-CONDUCTANCE; HYPERPOLARIZING FACTOR; ENDOTHELIAL-CELLS; ION CHANNELS; CA-CHANNELS; CALCIUM; BLOCK	Background: KCa3.1 channels are calcium/calmodulin-regulated voltage-independent K+ channels that produce membrane hyperpolarization and shape Ca2+-signaling and thereby physiological functions in epithelia, blood vessels, and white and red blood cells. Up-regulation of KCa3.1 is evident in fibrotic and inflamed tissues and some tumors rendering the channel a potential drug target. In the present study, we searched for novel potent small molecule inhibitors of KCa3.1 by testing a series of 20 selected natural and synthetic (poly) phenols, synthetic benzoic acids, and non-steroidal anti-inflammatory drugs (NSAIDs), with known cytoprotective, anti-inflammatory, and/or cytostatic activities. Methodology/Principal Findings: In electrophysiological experiments, we identified the natural phenols, caffeic acid (EC50 1.3 mu M) and resveratrol (EC50 10 mu M) as KCa3.1 inhibitors with moderate potency. The phenols, vanillic acid, gallic acid, and hydroxytyrosol had weak or no blocking effects. Out of the NSAIDs, flufenamic acid was moderately potent (EC50 1.6 mu M), followed by mesalamine (EC50 >= 10 mu M). The synthetic fluoro-trivanillic ester, 13b ([3,5-bis[(3-fluoro-4-hydroxy-benzoyl) oxymethyl] phenyl] methyl 3-fluoro-4-hydroxy-benzoate), was identified as a potent mixed KCa2/3 channel inhibitor with an EC50 of 19 nM for KCa3.1 and 360 pM for KCa2.3, which affected KCa1.1 and Kv channels only at micromolar concentrations. The KCa3.1/KCa2-activator SKA-31 antagonized the 13b-blockade. In proliferation assays, 13b was not cytotoxic and reduced proliferation of 3T3 fibroblasts as well as caffeic acid. In isometric vessel myography, 13b increased contractions of porcine coronary arteries to serotonin and antagonized endothelium-derived hyperpolarization-mediated vasorelaxation to pharmacological KCa3.1/KCa2.3 activation. Conclusions/Significance: We identified the natural phenols, caffeic acid and resveratrol, the NSAID, flufenamic acid, and the polyphenol 13b as novel KCa3.1 inhibitors. The high potency of 13b with pan-activity on KCa3.1/KCa2 channels makes 13b a new pharmacological tool to manipulate inflammation and cancer growth through KCa3.1/KCa2 blockade and a promising template for new drug design.	[Olivan-Viguera, Aida; Garcia-Otin, Angel-Luis; Arbones-Mainar, Jose-Miguel; Koehler, Ralf] Aragon Inst Hlth Sci I CS, Zaragoza, Spain; [Olivan-Viguera, Aida; Koehler, Ralf] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Sofia Valero, Marta] Univ San Jorge, Fac Hlth Sci, GIMACES, Villanueva De Gallego, Spain; [Divina Murillo, Maria] Univ Zaragoza, Fac Vet, Dept Physiol & Pharmacol, Zaragoza, Spain; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Garcia-Otin, Angel-Luis] Hosp Univ Miguel Servet, Lab Invest Mol, GIPASC, Zaragoza, Spain; [Arbones-Mainar, Jose-Miguel] Hosp Univ Miguel Servet, Adipocyte & Fat Biol Lab, Zaragoza, Spain; [Koehler, Ralf] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain	University of Southern Denmark; Universidad San Jorge; University of Zaragoza; University of California System; University of California Davis; Miguel Servet University Hospital; Miguel Servet University Hospital	Kohler, R (corresponding author), Aragon Inst Hlth Sci I CS, Zaragoza, Spain.	rkohler.iacs@aragon.es	Murillo, M Divina/K-8591-2014; wulff, Heike/Z-2056-2019; Garcia-Otin, Angel-Luis/P-9595-2016; Oliván-Viguera, Aida/I-4260-2015; Arbones-Mainar, Jose M/AGL-8624-2022; Oliván-Viguera, Aida/ABG-4048-2020; Valero, Marta Sofía/AAV-5643-2020	Murillo, M Divina/0000-0002-3917-4740; Garcia-Otin, Angel-Luis/0000-0002-5123-2480; Oliván-Viguera, Aida/0000-0001-5348-924X; Arbones-Mainar, Jose M/0000-0002-8982-3737; Oliván-Viguera, Aida/0000-0001-5348-924X; Valero, Marta Sofía/0000-0002-2231-7565; Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft [KO1899/11-1]; Lundbeckfonden; National Institutes of Health [R21 NS072585]; Miguel Servet program from the Instituto de Salud Carlos III (Spain); European Commission [303717-APOMET]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072585] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeckfonden(Lundbeckfonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miguel Servet program from the Instituto de Salud Carlos III (Spain); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Deutsche Forschungsgemeinschaft (KO1899/11-1 to RK), Lundbeckfonden (to RK) and the National Institutes of Health (R21 NS072585 to HW). JMA-M is supported by the Miguel Servet program from the Instituto de Salud Carlos III (Spain) and by the Marie-Curie Action: 303717-APOMET from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Alda JO, 2009, J PHARM PHARMACOL, V61, P641, DOI 10.1211/jpp/61.05.0013; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Cao YJ, 1999, FEBS LETT, V446, P137, DOI 10.1016/S0014-5793(99)00194-5; Choi S, 2012, PHARMACOL RES, V66, P51, DOI 10.1016/j.phrs.2012.02.009; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; HUANG MT, 1988, CANCER RES, V48, P5941; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jenkins DP, 2011, MOL PHARMACOL, V79, P899, DOI 10.1124/mol.110.069807; Kohler R, 2000, CIRC RES, V87, P496; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; Lambertsen KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047744; Lamoral-Theys D, 2012, J CELL MOL MED, V16, P1421, DOI 10.1111/j.1582-4934.2011.01403.x; Lamoral-Theys D, 2010, BIOORGAN MED CHEM, V18, P3823, DOI 10.1016/j.bmc.2010.04.047; Ledoux J, 2008, J GEN PHYSIOL, V131, P125, DOI 10.1085/jgp.200709875; Malykhina AP, 2002, EUR J PHARMACOL, V452, P269, DOI 10.1016/S0014-2999(02)02330-0; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; OTTOLIA M, 1994, BIOPHYS J, V67, P2272, DOI 10.1016/S0006-3495(94)80712-X; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; Phipps DJ, 1996, CELL SIGNAL, V8, P141, DOI 10.1016/0898-6568(95)02039-X; Raspotnig G, 1999, ANAL BIOCHEM, V275, P74, DOI 10.1006/abio.1999.4309; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Srivastava S, 2008, P NATL ACAD SCI USA, V105, P14442, DOI 10.1073/pnas.0803678105; Srivastava S, 2009, MOL BIOL CELL, V20, P3783, DOI 10.1091/mbc.E09-05-0390; Strobaek D, 2012, BR J PHARM; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Valero MS, 2011, J PHARM PHARMACOL, V63, P222, DOI 10.1111/j.2042-7158.2010.01203.x; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; WERKMAN TR, 1992, NEUROSCIENCE, V50, P935, DOI 10.1016/0306-4522(92)90216-O; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Zhang M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2017; Zhang XH, 2012, J CELL PHYSIOL, V227, P1972, DOI 10.1002/jcp.22925	47	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58614	10.1371/journal.pone.0058614	http://dx.doi.org/10.1371/journal.pone.0058614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516517	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400040
J	Pannetier, NA; Debacker, CS; Mauconduit, F; Christen, T; Barbier, EL				Pannetier, Nicolas Adrien; Debacker, Clement Stephan; Mauconduit, Franck; Christen, Thomas; Barbier, Emmanuel Luc			A Simulation Tool for Dynamic Contrast Enhanced MRI	PLOS ONE			English	Article							MAGNETIC-FIELD STRENGTHS; VESSEL SIZE; NMR SIGNAL; IN-VIVO; WATER EXCHANGE; BOLUS-TRACKING; RAT GLIOMA; SUSCEPTIBILITY; DIFFUSION; PERFUSION	The quantification of bolus-tracking MRI techniques remains challenging. The acquisition usually relies on one contrast and the analysis on a simplified model of the various phenomena that arise within a voxel, leading to inaccurate perfusion estimates. To evaluate how simplifications in the interstitial model impact perfusion estimates, we propose a numerical tool to simulate the MR signal provided by a dynamic contrast enhanced (DCE) MRI experiment. Our model encompasses the intrinsic R-1 and R-2 relaxations, the magnetic field perturbations induced by susceptibility interfaces (vessels and cells), the diffusion of the water protons, the blood flow, the permeability of the vessel wall to the the contrast agent (CA) and the constrained diffusion of the CA within the voxel. The blood compartment is modeled as a uniform compartment. The different blocks of the simulation are validated and compared to classical models. The impact of the CA diffusivity on the permeability and blood volume estimates is evaluated. Simulations demonstrate that the CA diffusivity slightly impacts the permeability estimates (<5% for classical blood flow and CA diffusion). The effect of long echo times is investigated. Simulations show that DCE-MRI performed with an echo time T-E=5ms may already lead to significant underestimation of the blood volume (up to 30% lower for brain tumor permeability values). The potential and the versatility of the proposed implementation are evaluated by running the simulation with realistic vascular geometry obtained from two photons microscopy and with impermeable cells in the extravascular environment. In conclusion, the proposed simulation tool describes DCE-MRI experiments and may be used to evaluate and optimize acquisition and processing strategies.	[Pannetier, Nicolas Adrien; Debacker, Clement Stephan; Mauconduit, Franck; Barbier, Emmanuel Luc] INSERM, U836, Grenoble, France; [Pannetier, Nicolas Adrien; Debacker, Clement Stephan; Mauconduit, Franck; Barbier, Emmanuel Luc] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Christen, Thomas] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Stanford University	Pannetier, NA (corresponding author), INSERM, U836, Grenoble, France.	nicolas.pannetier@gmail.com	christen, thomas/O-4482-2018; Barbier, Emmanuel/E-6302-2011; Debacker, Clement/GVS-6487-2022	christen, thomas/0000-0002-8791-9145; Barbier, Emmanuel/0000-0002-4952-1240; Debacker, Clement/0000-0003-4887-7920; Pannetier, Nicolas/0000-0002-0744-5155; Mauconduit, Franck/0000-0002-0128-061X	Institut National du Cancer; Association pour la Recherche sur le Cancer; Ministry for Higher Education and Research of France	Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministry for Higher Education and Research of France	This work was funded by the Institut National du Cancer, the Association pour la Recherche sur le Cancer and the Ministry for Higher Education and Research of France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDETTINI PA, 1995, INT J IMAG SYST TECH, V6, P133, DOI 10.1002/ima.1850060203; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161; Buckley DL, 2008, MAGN RESON MED, V60, P1011, DOI 10.1002/mrm.21748; Christen T, 2012, MAGN RESON MED, V67, P1458, DOI 10.1002/mrm.23094; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Dickson JD, 2010, J MAGN RESON IMAGING, V32, P953, DOI 10.1002/jmri.22151; Dobre MC, 2007, MAGN RESON IMAGING, V25, P733, DOI 10.1016/j.mri.2006.10.020; Donahue KM, 1997, JMRI-J MAGN RESON IM, V7, P102, DOI 10.1002/jmri.1880070114; Donaldson SB, 2010, MAGN RESON MED, V63, P691, DOI 10.1002/mrm.22217; Franiel T, 2011, EUR RADIOL, V21, P616, DOI 10.1007/s00330-010-2037-7; Guibert R, 2012, NEUROIMAGE, V62, P408, DOI 10.1016/j.neuroimage.2012.04.030; Hall MG, 2009, IEEE T MED IMAGING, V28, P1354, DOI 10.1109/TMI.2009.2015756; Jensen JH, 2000, MAGNET RESON MED, V43, P226, DOI 10.1002/(SICI)1522-2594(200002)43:2<226::AID-MRM9>3.0.CO;2-P; KENNAN RP, 1994, MAGNET RESON MED, V31, P9, DOI 10.1002/mrm.1910310103; Kettunen MI, 2007, RADIOLOGY, V243, P796, DOI 10.1148/radiol.2433052077; Kiselev VG, 1998, PHYS REV LETT, V81, P5696, DOI 10.1103/PhysRevLett.81.5696; Kiselev VG, 2001, MAGN RESON MED, V46, P1113, DOI 10.1002/mrm.1307; Klassen LM, 2007, BIOPHYS J, V92, P1014, DOI 10.1529/biophysj.106.087965; Le Bihan D, 1995, DIUSION PERFUSION MA; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; Lemasson B, 2011, NMR BIOMED, V24, P473, DOI 10.1002/nbm.1611; Marinovich ML, 2012, BREAST IN PRESS; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Marty B, 2010, ISMRM 2010 STOCKH SW; Novikov DS, 2012, ISMRM 2012 MELB AUST; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Pathak AP, 2008, NEUROIMAGE, V40, P1130, DOI 10.1016/j.neuroimage.2008.01.022; Pellerin M, 2007, MAGN RESON MED, V58, P1124, DOI 10.1002/mrm.21400; Pollack GH, 2003, ADV COLLOID INTERFAC, V103, P173, DOI 10.1016/S0001-8686(02)00095-7; Quarles CC, 2009, PHYS MED BIOL, V54, P5749, DOI 10.1088/0031-9155/54/19/006; Risser L, 2007, J CEREBR BLOOD F MET, V27, P293, DOI 10.1038/sj.jcbfm.9600332; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Schmiedeskamp H, 2012, MAGN RESON MED, V68, P30, DOI 10.1002/mrm.23195; Sourbron S, 2009, MAGN RESON MED, V62, P672, DOI 10.1002/mrm.22042; Sourbron S, 2012, MAGNETIC RE IN PRESS; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Lawrence KS, 2012, MAGN RESON MED, V67, P1275, DOI 10.1002/mrm.23104; Sukstanskii AL, 2003, J MAGN RESON, V163, P236, DOI 10.1016/S1090-7807(03)00131-9; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tropres I, 2004, MAGN RESON MED, V51, P533, DOI 10.1002/mrm.20017; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Xu C, 2012, CEREBROVASC DIS, V33, P303, DOI 10.1159/000335302; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yankeelov TE, 2008, MAGN RESON MED, V59, P326, DOI 10.1002/mrm.21449; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342	49	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57636	10.1371/journal.pone.0057636	http://dx.doi.org/10.1371/journal.pone.0057636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516414	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400012
J	Baixeries, J; Elvevag, B; Ferrer-i-Cancho, R				Baixeries, Jaume; Elvevag, Brita; Ferrer-i-Cancho, Ramon			The Evolution of the Exponent of Zipf's Law in Language Ontogeny	PLOS ONE			English	Article							ACQUISITION; WORD; COMMUNICATION; SYNTAX	It is well-known that word frequencies arrange themselves according to Zipf's law. However, little is known about the dependency of the parameters of the law and the complexity of a communication system. Many models of the evolution of language assume that the exponent of the law remains constant as the complexity of a communication systems increases. Using longitudinal studies of child language, we analysed the word rank distribution for the speech of children and adults participating in conversations. The adults typically included family members (e.g., parents) or the investigators conducting the research. Our analysis of the evolution of Zipf's law yields two main unexpected results. First, in children the exponent of the law tends to decrease over time while this tendency is weaker in adults, thus suggesting this is not a mere mirror effect of adult speech. Second, although the exponent of the law is more stable in adults, their exponents fall below 1 which is the typical value of the exponent assumed in both children and adults. Our analysis also shows a tendency of the mean length of utterances (MLU), a simple estimate of syntactic complexity, to increase as the exponent decreases. The parallel evolution of the exponent and a simple indicator of syntactic complexity (MLU) supports the hypothesis that the exponent of Zipf's law and linguistic complexity are inter-related. The assumption that Zipf's law for word ranks is a power-law with a constant exponent of one in both adults and children needs to be revised.	[Baixeries, Jaume] Univ Politecn Cataluna, Dept Llenguatges & Sistemes Informat, Lab Relat Algorithm Complex & Learning LARCA, Barcelona, Catalonia, Spain; [Baixeries, Jaume; Ferrer-i-Cancho, Ramon] Univ Politecn Cataluna, Ctr Language & Speech Technol & Applicat TALP Res, Dept Llenguatges & Sistemes Informat, Complex & Quantitat Linguist Lab, Barcelona, Catalonia, Spain; [Elvevag, Brita] Univ Tromso, Dept Clin Med, Psychiat Res Grp, Tromso, Norway; [Elvevag, Brita] Univ Hosp North Norway, Norwegian Ctr Integrated Care & Telemed NST, Tromso, Norway	Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Ferrer-i-Cancho, R (corresponding author), Univ Politecn Cataluna, Ctr Language & Speech Technol & Applicat TALP Res, Dept Llenguatges & Sistemes Informat, Complex & Quantitat Linguist Lab, Barcelona, Catalonia, Spain.	rferrericancho@lsi.upc.edu	Elvevåg, Brita/ABC-1835-2021; Ferrer-i-Cancho, Ramon/A-5424-2011; Baixeries, Jaume/L-5804-2014	Elvevåg, Brita/0000-0003-0441-3729; Ferrer-i-Cancho, Ramon/0000-0002-7820-923X; Baixeries, Jaume/0000-0003-2896-2247	grant 'Iniciacio i reincorporacio a la recerca' from the Universitat Politecnica de Catalunya; grant 'Biological and Social Data Mining: Algorithms, Theory, and Implementations' from the Spanish Ministry of Science and Innovation [TIN2011-27479-C04-03]; Northern Norwegian Regional Health Authority, Helse Nord RHF	grant 'Iniciacio i reincorporacio a la recerca' from the Universitat Politecnica de Catalunya; grant 'Biological and Social Data Mining: Algorithms, Theory, and Implementations' from the Spanish Ministry of Science and Innovation; Northern Norwegian Regional Health Authority, Helse Nord RHF	This work was supported by grant 'Iniciacio i reincorporacio a la recerca' from the Universitat Politecnica de Catalunya (http://www.upc.cat) and the grant 'Biological and Social Data Mining: Algorithms, Theory, and Implementations' (TIN2011-27479-C04-03) from the Spanish Ministry of Science and Innovation (http://www.micinn.es/) (JB and RFC). This work was supported by the Northern Norwegian Regional Health Authority, Helse Nord RHF (BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann G., 1999, THESAURUS UNIVARIATE; American English Corpora, CHILDES DAT MAN; [Anonymous], DAT MAN; [Anonymous], 2007, MATH STAT METASTATIS; Baayen R. Harald, 2001, WORD FREQUENCY DISTR; Bates E, 1995, HDB CHILD LANGUAGE, P86; Behrens H, 2006, LANG COGNITIVE PROC, V21, P2, DOI 10.1080/01690960400001721; Bernhardsson S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123015; BLOOM L, 1974, COGNITIVE PSYCHOL, V6, P380, DOI 10.1016/0010-0285(74)90018-8; BLOOM L, 1975, MONOGR SOC RES CHILD, V40, P1, DOI 10.2307/1165986; Bloom Lois., 1970, LANGUAGE DEV FUNCTIO; BOL GW, 1995, AMSTERDAM SERIES CHI, V3, P1; British English Corpora, DAT MAN; Brown R., 1973, 1 LANGUAGE EARLY STA; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cancho RFI, 2006, BIOSYSTEMS, V84, P242, DOI 10.1016/j.biosystems.2005.12.001; Cancho RFI, 2005, P ROY SOC B-BIOL SCI, V272, P561, DOI 10.1098/rspb.2004.2957; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Castro Sotos A, 2007, B ISI, V62, P4609; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Corominas-Murtra B, 2009, ADV COMPLEX SYST, V12, P371, DOI 10.1142/S0219525909002192; Demuth K, 2006, LANG SPEECH, V49, P137, DOI 10.1177/00238309060490020201; Ferrer i Cancho R, 2001, J QUANT LINGUIST, V8, P165; Ferrer i Cancho R, 2008, CAMBRIDGE ENCY LANGU, P555; Ferrer-i-Cancho R, 2012, GLOTTOTHEORY, V4; Germanic Corpora, CHILDES DAT MAN; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Howes D., 1964, DISORDERS COMMUNICAT, P229; KUCZAJ SA, 1977, J VERB LEARN VERB BE, V16, P589, DOI 10.1016/S0022-5371(77)80021-2; Li WT, 2010, ENTROPY-SWITZ, V12, P1743, DOI 10.3390/e12071743; MacWhinney B., 2000, CHILDES PROJECT TOOL, V2; Mandelbrot B., 1961, STRUCTURE LANGUAGE I, P190, DOI 10.1090/psapm/012/9970; McCowan B, 2002, J COMP PSYCHOL, V116, P166, DOI 10.1037//0735-7036.116.2.166; Montemurro M.A., 2002, GLOTTOMETRICS, V87, P99; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Nowak MA, 2000, J THEOR BIOL, V204, P179, DOI 10.1006/jtbi.2000.1085; Piotrowski R.G., 2007, EXACT METHODS STUDY, P545; Plotkin J. B., 2001, Entropy, V3, DOI 10.3390/e3040227; Plunkett K., 1992, CROSS LINGUISTIC STU, P457; Reich P., 1986, LANGUAGE DEV; Rescorla L, 2001, J SPEECH LANG HEAR R, V44, P598, DOI 10.1044/1092-4388(2001/049); Rowland CF, 2006, J CHILD LANG, V33, P859, DOI 10.1017/S0305000906007537; Sachs J., 1983, CHILDRENS LANGUAGE, V4, P1; Saxton M., 2010, CHILD LANGUAGE ACQUI; Schaerlaekens AnneMarie., 1973, 2 WORD SENTENCE CHIL; Snow C. E., 1995, HDB CHILD LANGUAGE, P180; Stromqvist S, 1993, GOTHENBURG PAPERS TH, V66; SUPPES P, 1974, AM PSYCHOL, V29, P103, DOI 10.1037/h0036026; SZAGUN G, 2001, 1 LANGUAGE, V0021; Theakston AL, 2001, J CHILD LANG, V28, P127, DOI 10.1017/S0305000900004608; van Kampen, 1994, LINGUISTICS NETHERLA, V199, P83, DOI [10.1075/avt.11.10kam, DOI 10.1075/AVT]; Wells CG, 1981, LEARNING INTERACTION; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; [No title captured]; [No title captured]	56	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e53227	10.1371/journal.pone.0053227	http://dx.doi.org/10.1371/journal.pone.0053227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516390	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200001
J	Danielsen, L; Lohaus, G; Sirrenberg, A; Karlovsky, P; Bastien, C; Pilate, G; Polle, A				Danielsen, Lara; Lohaus, Gertrud; Sirrenberg, Anke; Karlovsky, Petr; Bastien, Catherine; Pilate, Gilles; Polle, Andrea			Ectomycorrhizal Colonization and Diversity in Relation to Tree Biomass and Nutrition in a Plantation of Transgenic Poplars with Modified Lignin Biosynthesis	PLOS ONE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; NITROGEN-USE EFFICIENCY; MYCORRHIZAL COLONIZATION; COMMUNITY COMPOSITION; MOLECULAR PHYSIOLOGY; POPULUS-TREMULOIDES; DOWN-REGULATION; GROWTH; FIELD; LIGNIFICATION	Wood from biomass plantations with fast growing tree species such as poplars can be used as an alternative feedstock for production of biofuels. To facilitate utilization of lignocellulose for saccharification, transgenic poplars with modified or reduced lignin contents may be useful. However, the potential impact of poplars modified in the lignification pathway on ectomycorrhizal (EM) fungi, which play important roles for plant nutrition, is not known. The goal of this study was to investigate EM colonization and community composition in relation to biomass and nutrient status in wildtype (WT, Populus tremula x Populus alba) and transgenic poplar lines with suppressed activities of cinnamyl alcohol dehydrogenase, caffeate/5-hydroxyferulate O-methyltransferase, and cinnamoyl-CoA reductase in a biomass plantation. In different one-year-old poplar lines EM colonization varied from 58% to 86%, but the EM community composition of WT and transgenic poplars were indistinguishable. After two years, the colonization rate of all lines was increased to about 100%, but separation of EM communities between distinct transgenic poplar genotypes was observed. The differentiation of the EM assemblages was similar to that found between different genotypes of commercial clones of Populus x euramericana. The transgenic poplars exhibited significant growth and nutrient element differences in wood, with generally higher nutrient accumulation in stems of genotypes with lower than in those with higher biomass. A general linear mixed model simulated biomass of one-year-old poplar stems with high accuracy (adjusted R-2 = 97%) by two factors: EM colonization and inverse wood N concentration. These results imply a link between N allocation and EM colonization, which may be crucial for wood production in the establishment phase of poplar biomass plantations. Our data further support that multiple poplar genotypes regardless whether generated by transgenic approaches or conventional breeding increase the variation in EM community composition in biomass plantations.	[Danielsen, Lara; Lohaus, Gertrud; Polle, Andrea] Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, D-37073 Gottingen, Germany; [Sirrenberg, Anke; Karlovsky, Petr] Univ Gottingen, Dept Mol Phytopathol & Mycotoxin Res, D-37073 Gottingen, Germany; [Bastien, Catherine; Pilate, Gilles] INRA, Ameliorat Genet & Physiol Forestieres UR0588, CS Ardon 40001, Orleans, France	University of Gottingen; University of Gottingen; INRAE	Polle, A (corresponding author), Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, D-37073 Gottingen, Germany.	apolle@gwdg.de	BASTIEN, Catherine/GWQ-2951-2022; Pilate, Gilles/E-8784-2017	Pilate, Gilles/0000-0003-4802-8849; Polle, Andrea/0000-0001-8697-6394; Karlovsky, Petr/0000-0002-6532-5856	European Commission within the Seventh Framework Program for the Research, Project Energypoplar [FP7-211917]	European Commission within the Seventh Framework Program for the Research, Project Energypoplar	The authors gratefully acknowledge financial support by the European Commission within the Seventh Framework Program for the Research, Project Energypoplar (FP7-211917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R., 1987, COLOUR ATLAS ECTOMYC; [Anonymous], 2009, LANG ENV STAT COMP; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Baucher M, 2003, CRIT REV BIOCHEM MOL, V38, P305, DOI 10.1080/10409230390242443; Baucher M, 1996, PLANT PHYSIOL, V112, P1479, DOI 10.1104/pp.112.4.1479; Baum C, 2002, FOREST ECOL MANAG, V163, P1, DOI 10.1016/S0378-1127(01)00534-5; Beniwal RS, 2010, ENVIRON EXP BOT, V69, P189, DOI 10.1016/j.envexpbot.2010.02.005; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bradley KL, 2007, PLANT SOIL, V294, P185, DOI 10.1007/s11104-007-9246-0; Calfapietra C, 2007, TREE PHYSIOL, V27, P1153, DOI 10.1093/treephys/27.8.1153; Chen F, 2003, PHYTOCHEMISTRY, V64, P1013, DOI 10.1016/S0031-9422(03)00463-1; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500; Cooke JEK, 2005, NEW PHYTOL, V167, P19, DOI 10.1111/j.1469-8137.2005.01451.x; Courty PE, 2011, J EXP BOT, V62, P249, DOI 10.1093/jxb/erq274; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; Druebert C, 2009, PLANT CELL ENVIRON, V32, P992, DOI 10.1111/j.1365-3040.2009.01983.x; Ducic T, 2009, SOIL BIOL BIOCHEM, V41, P742, DOI 10.1016/j.soilbio.2009.01.013; Euring D, 2012, TREES-STRUCT FUNCT, V26, P1933, DOI 10.1007/s00468-012-0761-0; Finzi AC, 2007, P NATL ACAD SCI USA, V104, P14014, DOI 10.1073/pnas.0706518104; Gehring CA, 2006, OECOLOGIA, V149, P158, DOI 10.1007/s00442-006-0437-9; Glynn C, 2004, ENTOMOL EXP APPL, V113, P1, DOI 10.1111/j.0013-8703.2004.00199.x; Gotelli N.J., 2005, ECOSIM NULL MODELS S; Halupa Dimitri, 2006, ENZYKLOPADIE LAUBBAU, P367; HEINRICHS H, 1986, Z PFLANZ BODENKUNDE, V149, P350, DOI 10.1002/jpln.19861490313; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Holeski LM, 2009, BIOCHEM SYST ECOL, V37, P139, DOI 10.1016/j.bse.2009.02.003; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jones MD, 2004, CAN J BOT, V82, P1089, DOI [10.1139/B04-110, 10.1139/b04-110]; Joshi CP, 2004, NEW PHYTOL, V164, P53, DOI 10.1111/j.1469-8137.2004.01155.x; Jouanin L, 2000, PLANT PHYSIOL, V123, P1363, DOI 10.1104/pp.123.4.1363; Jug A, 1999, FOREST ECOL MANAG, V121, P85, DOI 10.1016/S0378-1127(98)00558-1; Kaldorf M, 2002, PLANTA, V214, P653, DOI 10.1007/s004250100658; Karp A, 2011, J EXP BOT, V62, P3263, DOI 10.1093/jxb/err099; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Khasa PD, 2002, BIOMASS BIOENERG, V22, P99, DOI 10.1016/S0961-9534(01)00072-1; Kleemann F, 2011, EUR J FOREST RES, V130, P707, DOI 10.1007/s10342-010-0460-6; Komsta L, 2010, OUTLIERS TEST OUTLIE; Labbe J, 2011, TREE GENET GENOMES, V7, P617, DOI 10.1007/s11295-010-0361-3; Langenfeld-Heyser R, 2007, MYCORRHIZA, V17, P121, DOI 10.1007/s00572-006-0084-3; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Li H, 2012, J EXP BOT, V63, P6173, DOI 10.1093/jxb/ers271; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Luo ZB, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest:2008073; Millard P, 2010, TREE PHYSIOL, V30, P1083, DOI 10.1093/treephys/tpq042; Muhsin TM, 2002, NEW PHYTOL, V153, P153, DOI 10.1046/j.0028-646X.2001.00297.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neville J, 2002, APPL SOIL ECOL, V19, P209, DOI 10.1016/S0929-1393(01)00193-7; Oksanen J, 2010, R PACKAGE VERSION 1; Orians CM, 1997, ENTOMOL EXP APPL, V83, P285, DOI 10.1046/j.1570-7458.1997.00183.x; Parrent JL, 2006, ECOLOGY, V87, P2278, DOI 10.1890/0012-9658(2006)87[2278:CANAAE]2.0.CO;2; Pena R, 2010, APPL ENVIRON MICROB, V76, P1831, DOI 10.1128/AEM.01703-09; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; Polle A, 2010, PLANT BIOLOGY, V12, P239, DOI 10.1111/j.1438-8677.2009.00318.x; PREGITZER KS, 1990, TREE PHYSIOL, V7, P79, DOI 10.1093/treephys/7.1-2-3-4.79; Quoreshi AM, 2008, BIOMASS BIOENERG, V32, P381, DOI 10.1016/j.biombioe.2007.10.010; Rennenberg H, 2010, PLANT BIOLOGY, V12, P275, DOI 10.1111/j.1438-8677.2009.00309.x; Rooney DC, 2011, BIOMASS BIOENERG, V35, P4605, DOI 10.1016/j.biombioe.2011.08.015; Rooney DC, 2009, TRENDS PLANT SCI, V14, P542, DOI 10.1016/j.tplants.2009.08.004; Sims REH, 2006, GLOBAL CHANGE BIOL, V12, P2054, DOI 10.1111/j.1365-2486.2006.01163.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Stanton BJ, 2009, FAO IPC POPLARS WILL, V86, P26; Stettler RF, 2012, BOLOGY POPULUS ITS I, P87; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Swaty RL, 2004, ECOLOGY, V85, P1072, DOI 10.1890/03-0224; Tagu D, 2001, MYCORRHIZA, V10, P237, DOI 10.1007/PL00009997; Tamm S, 2006, ENZYKLOPADIE LAUBBAU, P405; Tilsner J, 2005, PLANTA, V221, P328, DOI 10.1007/s00425-004-1446-8; VanDoorsselaere J, 1995, PLANT J, V8, P855, DOI 10.1046/j.1365-313X.1995.8060855.x; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; White T., 1990, PCR PROTOCOLS GUIDE, P315	74	36	40	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59207	10.1371/journal.pone.0059207	http://dx.doi.org/10.1371/journal.pone.0059207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516610	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200137
J	Dong, YJ; Pan, JS; Zhang, LP				Dong, Yanjun; Pan, Jenny S.; Zhang, Liping			Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell Dysfunction	PLOS ONE			English	Article							SKELETAL-MUSCLE ATROPHY; PROMYOGENIC FACTOR; GENE; REGENERATION; EXPRESSION; DIFFERENTIATION; GROWTH; TRANSCRIPTION; LOCALIZATION; DEPLETION	Glucocorticoids production is increased in many pathological conditions that are associated with muscle loss, but their role in causing muscle wasting is not fully understood. We have demonstrated a new mechanism of glucocorticoid-induced muscle atrophy: Dexamethasone (Dex) suppresses satellite cell function contributing to the development of muscle atrophy. Specifically, we found that Dex decreases satellite cell proliferation and differentiation in vitro and in vivo. The mechanism involved Dex-induced upregulation of myostatin and suppression of Akirin1, a promyogenic gene. When myostatin was inhibited in Dex-treated mice, Akirin1 expression increased as did satellite cell activity, muscle regeneration and muscle growth. In addition, silencing myostatin in myoblasts or satellite cells prevented Dex from suppressing Akirin1 expression and cellular proliferation and differentiation. Finally, overexpression of Akirin1 in myoblasts increased their expression of MyoD and myogenin and improved cellular proliferation and differentiation, theses improvements were no longer suppressed by Dex. We conclude that glucocorticoids stimulate myostatin which inhibits Akirin1 expression and the reparative functions of satellite cells. These responses attribute to muscle atrophy. Thus, inhibition of myostatin or increasing Akirin1 expression could lead to therapeutic strategies for improving satellite cell activation and enhancing muscle growth in diseases associated with increased glucocorticoid production.	[Dong, Yanjun; Pan, Jenny S.; Zhang, Liping] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA	Baylor College of Medicine	Zhang, LP (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	lipingz@bcm.edu		Dong, Yanjun/0000-0001-6396-8949	Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association [1-11-BS-194]; United States National Institutes of Health (NIH) grant [R37 DK37175, NIH T32 DK062706]; Satellite Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062706, R37DK037175] Funding Source: NIH RePORTER	Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association; United States National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the generous support of Dr. and Mrs. Harold Selzman, the Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association (1-11-BS-194) to L.Z. and support from the United States National Institutes of Health (NIH) grant R37 DK37175 and NIH T32 DK062706. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by Satellite Health. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Artaza JN, 2002, J CELL PHYSIOL, V190, P170, DOI 10.1002/JCP.10044; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Chen JCJ, 2005, GENESIS, V41, P116, DOI 10.1002/gene.20104; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hu Zhaoyong, 2009, J Clin Invest, V119, P3059, DOI 10.1172/JCI38770; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Kawada S, 2001, J MUSCLE RES CELL M, V22, P627, DOI 10.1023/A:1016366409691; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; Lang CH, 2002, AM J PHYSIOL-REG I, V282, pR207, DOI 10.1152/ajpregu.00319.2001; Lang CH, 2001, FASEB J, V15, P1807, DOI 10.1096/fj.00-0849fje; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Marshall A, 2008, EXP CELL RES, V314, P1013, DOI 10.1016/j.yexcr.2008.01.004; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; May RC, 1996, KIDNEY INT, V49, P679, DOI 10.1038/ki.1996.96; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; ROULEAU G, 1987, MUSCLE NERVE, V10, P428, DOI 10.1002/mus.880100509; ROY RR, 1983, ARCH ORAL BIOL, V28, P639, DOI 10.1016/0003-9969(83)90012-2; Salerno MS, 2009, EXP CELL RES, V315, P2012, DOI 10.1016/j.yexcr.2009.04.014; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; te Pas MFW, 2000, MOL BIOL REP, V27, P87, DOI 10.1023/A:1007120921064; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	41	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58554	10.1371/journal.pone.0058554	http://dx.doi.org/10.1371/journal.pone.0058554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516508	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200087
J	Huang, SG; Liu, F; Niu, Q; Li, Y; Liu, C; Zhang, LL; Ni, DN; Pu, XY				Huang, Shaoguang; Liu, Fei; Niu, Qin; Li, Yi; Liu, Chang; Zhang, Lele; Ni, Danni; Pu, Xiaoyun			GLIPR-2 Overexpression in HK-2 Cells Promotes Cell EMT and Migration through ERK1/2 Activation	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; ENRICHED MICRODOMAINS; DIABETIC-NEPHROPATHY; GOLGI-COMPLEX; FIBROSIS; KIDNEY; MYOFIBROBLASTS; IDENTIFICATION; FIBROBLASTS	The epithelial-to-mesenchymal transition (EMT) of tubular epithelial cells in the adult kidney is one of the key events in renal interstitial fibrosis. Glioma pathogenesis related-2 (GLIPR-2) has been shown to be up-regulated in proximal tubular cells (PTCs) in the fibrotic kidney. However, the biological function of GLIPR-2 remains unknown. In this study, we found that GLIPR-2 expression is elevated in the kidney tissue samples of patients with diabetic nephropathy (DN). Human proximal renal tubular epithelial cells (HK-2 cells) were transfected with pcDNA3.0-GLIPR-2 and selected with G418. To identify the biological function of GLIPR-2, an epithelial-to-mesenchymal transition (EMT) PCR array analysis was performed, and genes that had statistically significantly altered expression levels with more than a two-fold difference compared with the pcDNA3.0-transfected HK-2 cells were considered. Key elements of the EMT process, such as E-cadherin and vimentin, were transcriptionally activated in the pcDNA3.0-GLIPR-2-transfected sublines. In addition, alpha-SMA gene expression, which is a marker of myofibroblasts, increased in the pcDNA3.0-GLIPR-2-transfected HK-2 cells. The cell migration assay demonstrated that the transfection of HK-2 with GLIPR-2 promoted cell migration following an EMT. Additionally, consistent with the effects of increased EGFR expression levels, we found that the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) was highly elevated in the pcDNA3.0-GLIPR-2-transfected group. Our study demonstrates that GLIPR-2 overexpression in HK-2 cells can potentiate EMT-like processes in this cell type through the ERK1/2 signaling pathway. GLIPR-2 may be responsible for the development of renal fibrosis by increasing the accumulation of interstitial fibroblasts.	[Huang, Shaoguang; Liu, Fei; Li, Yi; Liu, Chang; Zhang, Lele; Ni, Danni; Pu, Xiaoyun] Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Niu, Qin] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Pu, XY (corresponding author), Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China.	puxiaoyong@yahoo.com			National Natural Science Foundation of China [2009ZX10601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Contract grant sponsor is the National Natural Science Foundation of China, contract grant number No. 2009ZX10601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Xia Zhang (Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing, China) for a critical reading of the manuscript. We further acknowledge the National Natural Science Foundation of China for financial support, and Dr. Bo Zhu and Dr. Yifang Ping (Institute of Cancer, Xinqiao Hospital, Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing, China) for kindly giving helpful advice.	Baxter RM, 2007, MATRIX BIOL, V26, P20, DOI 10.1016/j.matbio.2006.09.005; Chiarelli F, 2003, PANMINERVA MED, V45, P23; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenberg I, 2002, GENE, V293, P141, DOI 10.1016/S0378-1119(02)00703-5; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Van Galen J, 2010, MOL MEMBR BIOL, V27, P81, DOI 10.3109/09687680903507080; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Zeisberg M, 2002, AM J PATHOL, V160, P2001, DOI 10.1016/S0002-9440(10)61150-9; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang WJ, 2012, J BIOL CHEM, V287, P11850, DOI 10.1074/jbc.M111.258236	24	16	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58574	10.1371/journal.pone.0058574	http://dx.doi.org/10.1371/journal.pone.0058574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516513	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200093
J	Lewis, JS; Wartzok, D; Heithaus, M; Krutzen, M				Lewis, Jennifer S.; Wartzok, Douglas; Heithaus, Michael; Kruetzen, Michael			Could Relatedness Help Explain Why Individuals Lead in Bottlenose Dolphin Groups?	PLOS ONE			English	Article							PATERNAL KIN DISCRIMINATION; REPRODUCTIVE SUCCESS; INBREEDING AVOIDANCE; SOCIAL-STRUCTURE; DECISION-MAKING; SITE FIDELITY; WHALES; LEADERSHIP; DOMINANCE; MOVEMENTS	In many species, particular individuals consistently lead group travel. While benefits to followers often are relatively obvious, including access to resources, benefits to leaders are often less obvious. This is especially true for species that feed on patchy mobile resources where all group members may locate prey simultaneously and food intake likely decreases with increasing group size. Leaders in highly complex habitats, however, could provide access to foraging resources for less informed relatives, thereby gaining indirect benefits by helping kin. Recently, leadership has been documented in a population of bottlenose dolphins (Tursiops truncatus) where direct benefits to leaders appear unlikely. To test whether leaders could benefit indirectly we examined relatedness between leader-follower pairs and compared these levels to pairs who associated but did not have leader-follower relationship (neither ever led the other). We found the average relatedness value for leader-follower pairs was greater than expected based on chance. The same was not found when examining non leader-follower pairs. Additionally, relatedness for leader-follower pairs was positively correlated with association index values, but no correlation was found for this measure in non leader-follower pairs. Interestingly, haplotypes were not frequently shared between leader-follower pairs (25%). Together, these results suggest that bottlenose dolphin leaders have the opportunity to gain indirect benefits by leading relatives. These findings provide a potential mechanism for the maintenance of leadership in a highly dynamic fission-fusion population with few obvious direct benefits to leaders.	[Lewis, Jennifer S.; Wartzok, Douglas] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Heithaus, Michael] Florida Int Univ, Dept Biol Sci, North Miami, FL USA; [Kruetzen, Michael] Univ Zurich, Anthropol Inst & Museum, Evolutionary Genet Grp, Zurich, Switzerland	State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of Zurich	Lewis, JS (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	jennifer.lewis1@fiu.edu	Heithaus, Michael/AAF-9914-2020; Krutzen, Michael C/D-9550-2011	Heithaus, Michael/0000-0002-3219-1003; Krutzen, Michael/0000-0003-1055-5299	Sigma Xi; Project Aware; Harbor Branch Oceanographic Institute Protect Wild Dolphins Grant; Florida International University's Dissertation Acquisition and Dissertation Year Fellowships	Sigma Xi; Project Aware; Harbor Branch Oceanographic Institute Protect Wild Dolphins Grant; Florida International University's Dissertation Acquisition and Dissertation Year Fellowships	This research was supported through funding from Sigma Xi, Project Aware, and Harbor Branch Oceanographic Institute Protect Wild Dolphins Grant. J Lewis was supported while conducting this research and writing this manuscript by Florida International University's Dissertation Acquisition and Dissertation Year Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 1999, P ROY SOC B-BIOL SCI, V266, P1501, DOI 10.1098/rspb.1999.0807; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; Baird RW, 2008, MAR MAMMAL SCI, V24, P591, DOI 10.1111/j.1748-7692.2008.00200.x; Baird RW, 2000, CETACEAN SOCIETIES, P127; BAKER CS, 1993, J HERED, V84, P281, DOI 10.1093/oxfordjournals.jhered.a111340; Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Barros N.B., 1990, P309; Bates LA, 2008, BIOL LETTERS, V4, P34, DOI 10.1098/rsbl.2007.0529; BREATHNACH AS, 1960, BIOL REV, V35, P187, DOI 10.1111/j.1469-185X.1960.tb01414.x; Charpentier M, 2005, BEHAV ECOL, V16, P614, DOI 10.1093/beheco/ari034; Connor RC, 2000, CETACEAN SOCIETIES, P91; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Di Bitetti MS, 2001, ANIM BEHAV, V62, P47, DOI 10.1006/anbe.2000.1730; Dugatkin L.A., 1997, COOPERATION ANIMALS; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fripp D, 2005, ANIM COGN, V8, P17, DOI 10.1007/s10071-004-0225-z; Gero S, 2008, BEHAV ECOL SOCIOBIOL, V63, P143, DOI 10.1007/s00265-008-0645-x; Gero S, 2009, BEHAV ECOL, V20, P838, DOI 10.1093/beheco/arp068; Gilson A, 1998, CALIF FISH GAME, V84, P159; Hain TJA, 2006, CURR BIOL, V16, P1807, DOI 10.1016/j.cub.2006.07.021; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hoelzel AR, 1998, P ROY SOC B-BIOL SCI, V265, P1177, DOI 10.1098/rspb.1998.0416; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; Lewis Jennifer S., 2003, Gulf of Mexico Science, V21, P92; Lewis JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1061, DOI 10.1007/s00265-010-1113-y; Lewis JS, 2010, THESIS FLORIDA INT U; Lewis JS, 2002, THESIS U ALABAMA; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Maher CR, 2009, ANIM BEHAV, V78, P925, DOI 10.1016/j.anbehav.2009.06.027; Markowitz TM, 2004, AQUAT CONSERV, V14, P133, DOI 10.1002/aqc.602; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; McSweeney DJ, 2009, MAR MAMMAL SCI, V25, P557, DOI 10.1111/j.1748-7692.2008.00267.x; Mehlis M, 2008, ANIM COGN, V11, P643, DOI 10.1007/s10071-008-0154-3; Milton K, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P375; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Muniz L, 2010, AM J PRIMATOL, V72, P1118, DOI 10.1002/ajp.20876; Nater A, 2009, MOL ECOL RESOUR, V9, P531, DOI 10.1111/j.1755-0998.2008.02246.x; Payne K, 2003, ANIMAL SOCIAL COMPLEXITY, P57; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Piyapong C, 2007, ETHOLOGY, V113, P821, DOI 10.1111/j.1439-0310.2007.01382.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Ralls K, 2001, J MAMMAL, V82, P858, DOI 10.1644/1545-1542(2001)082<0858:KSRADS>2.0.CO;2; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruch J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-257; Samuels A, 1997, MAR MAMMAL SCI, V13, P70, DOI 10.1111/j.1748-7692.1997.tb00613.x; Schwacke L, 2005, RERAT RELATEDNESS ES; Shinohara M, 1997, MOL ECOL, V6, P695, DOI 10.1046/j.1365-294X.1997.00231.x; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; Smolker R, 1999, ETHOLOGY, V105, P595, DOI 10.1046/j.1439-0310.1999.00441.x; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Watwood SL, 2004, BEHAV ECOL SOCIOBIOL, V55, P531, DOI 10.1007/s00265-003-0724-y; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1991, BEHAV ECOL SOCIOBIOL, V29, P385, DOI 10.1007/BF00165964; Whitehead H, 2008, ANIM BEHAV, V75, P1093, DOI 10.1016/j.anbehav.2007.08.022; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x	69	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58162	10.1371/journal.pone.0058162	http://dx.doi.org/10.1371/journal.pone.0058162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516445	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000316849200040
J	Pandi, G; Nakka, VP; Dharap, A; Roopra, A; Vemuganti, R				Pandi, Gopal; Nakka, Venkata P.; Dharap, Ashutosh; Roopra, Avtar; Vemuganti, Raghu			MicroRNA miR-29c Down-Regulation Leading to De-Repression of Its Target DNA Methyltransferase 3a Promotes Ischemic Brain Damage	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; CEREBRAL-ISCHEMIA; NONCODING RNAS; IN-VITRO; EXPRESSION; NEUROPROTECTION; CONTRIBUTES; INJURY; DEATH; WELL	Recent studies showed that stroke extensively alters cerebral microRNA (miRNA) expression profiles and several miRNAs play a role in mediating ischemic pathophysiology. We currently evaluated the significance of miR-29c, a highly expressed miRNA in rodent brain that was significantly down-regulated after focal ischemia in adult rats as well as after oxygen-glucose deprivation in PC12 cells. Bioinformatics indicated that DNA methyltransferase 3a (DNMT3a) is a major target of miR-29c and co-transfection with premiR-29c prevented DNMT3a 3'UTR vector expression. In PC12 cells, treatment with premiR-29c prevented OGD-induced cell death (by 58 +/- 6%; p<0.05). Furthermore, treatment with antagomiR-29c resulted in a 46 +/- 5% cell death in PC12 cells. When rats were treated with premiR-29c and subjected to transient focal ischemia, post-ischemic miR-29c levels were restored and the infarct volume decreased significantly (by 34 +/- 6%; p<0.05) compared to control premiR treated group. DNMT3a siRNA treatment also significantly curtailed the post-OGD cell death in PC12 cells (by 54 +/- 6%; p<0.05) and decreased the post-ischemic infarct volume in rats (by 30 +/- 5%; p<0.05) compared to respective control siRNA treated groups. The miR-29c gene promoter showed specific binding sites for the transcription factor REST and the miR-29c promoter vector expression was curtailed when cotransfected with a REST expressing plasmid. Furthermore, treatment with REST siRNA prevented the post-ischemic miR-29c down-regulation and DNMT3a induction in PC12 cells and curtailed ischemic cell death (by 64 +/- 9%; p<0.05) compared to control siRNA treatment. These studies suggest that miR-29c is a pro-survival miRNA and its down-regulation is a promoter of ischemic brain damage by acting through its target DNMT3a. Furthermore, REST is an upstream transcriptional controller of miR-29c and curtailing REST induction prevents miR-29c down-regulation and ischemic neuronal death.	[Pandi, Gopal; Nakka, Venkata P.; Dharap, Ashutosh; Vemuganti, Raghu] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53715 USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vemuganti, R (corresponding author), Univ Wisconsin, Dept Neurol Surg, Madison, WI 53715 USA.	vemuganti@neurosurgery.wisc.edu	Dharap, Ashutosh/H-7466-2013; Pandi, Gopal/M-2465-2019	Pandi, Gopal/0000-0002-2186-2473; Nakka, Venkata Prasuja/0000-0001-5509-6925	National Institutes of Health [NS074444, NS079585, NS065067]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079585, R21NS074444, R01NS065067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were funded by National Institutes of Health grants NS074444, NS079585 and NS065067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dharap A, 2011, STROKE, V42, P1105, DOI 10.1161/STROKEAHA.110.598391; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Ouyang YB, 2012, NEUROBIOL DIS, V45, P555, DOI 10.1016/j.nbd.2011.09.012; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tureyen K, 2008, J NEUROCHEM, V105, P1313, DOI 10.1111/j.1471-4159.2008.05233.x; Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021	27	82	86	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58039	10.1371/journal.pone.0058039	http://dx.doi.org/10.1371/journal.pone.0058039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516428	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200028
J	Shao, XT; Qian, Y; Xu, CH; Hong, B; Xu, WH; Shen, L; Jin, CZ; Wu, ZG; Tong, XM; Yao, HP				Shao, Xueting; Qian, Yun; Xu, Chenhuai; Hong, Bo; Xu, Wanhong; Shen, Ling; Jin, Changzhong; Wu, Zhigang; Tong, Xiangmin; Yao, Hangping			The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-Induced Hepatitis in Mice	PLOS ONE			English	Article							A-INDUCED HEPATITIS; NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; INDUCED LIVER-INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INFLAMMATORY-BOWEL-DISEASE; IL-18 BINDING-PROTEIN; TUMOR-NECROSIS-FACTOR; CONCANAVALIN-A; IN-VIVO	Background: Concanavalin A (ConA)-induced hepatitis is an experimental murine model mirroring the pathology of human autoimmune hepatitis. Aim: To investigate the effects of intrasplenically transplanted fetal hepatocytes (BNL.CL2) transfected with recombinant adenovirus vector expressing the IL-18 binding protein (IL-18BP) and IL-4 fusion protein on ConA-induced hepatitis in mice. Methods: Ad-IL-18BP/IL-4 was used to infect BNL.CL2 cells. IL-4 and IL-18BP fusion protein expression were detected by ELISA and Western blotting. BNL.CL2 cells infected with Ad-IL-18BP/IL-4 were intrasplenically transplanted into mice. After 10 days, mice were injected with ConA (15 mg/kg), and sacrificed 18 hours later. Liver injury was assessed by serum transaminase and liver histology. TNF-alpha, IL-18, IL-4, IL-10, IL-12p70 and monocyte-chemoattracting protein (MCP)-1 levels in serum and liver homogenates were detected by ELISA. Signaling molecules in liver homogenates were analyzed by Western blotting. Results: Ad-IL-18BP/IL-4 effectively expressed the IL-18BP/IL-4 fusion protein for more than 14 days in BNL.CL12 cells. Treatment of mice with Ad-IL-18BP/IL-4-BNL.CL2 before ConA injection significantly reduced the elevated plasma levels of transaminases compared with ConA control groups. TNF-alpha, IL-18, IL-12p70 and MCP-1 levels in serum and liver homogenates from mice transplanted with Ad-IL-18BP/IL-4-BNL.CL2 were lower and IL-4 and IL-10 levels were higher than control groups. Phosphorylation levels of NF-kappa B p65, AKT, p38 and JNK1/2 in liver homogenates were markedly suppressed by Ad-IL-18BP/IL-4. Conclusions: Ad-IL-18BP/IL-4 was effectively transfected into mouse BNL.CL2 cells. Intrasplenic transplantation of Ad-IL-18BP/IL-4-BNL.CL12 cells alleviated the severity of inflammation in ConA-induced experimental hepatitis and provides a useful basis for the targeted gene therapy of liver disease.	[Shao, Xueting; Qian, Yun; Xu, Chenhuai; Shen, Ling; Jin, Changzhong; Wu, Zhigang; Tong, Xiangmin; Yao, Hangping] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Hong, Bo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Wanhong] ACEA Bio, Hangzhou High Throughput Drug Screening Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yao, HP (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yaohangping@zju.edu.cn			National Natural Science Foundation of China [30972777]; Zhejiang Province Natural Science Foundation [Y207521]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was partially supported by National Natural Science Foundation of China (No. 30972777) and Zhejiang Province Natural Science Foundation (No.Y207521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, EUR J IMMUNOL, V36, P37, DOI 10.1002/eji.200535138; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Bulau AM, 2011, THESCIENTIFICWORLDJO, V11, P2480, DOI 10.1100/2011/968479; Cao X, 1996, NATL MED J CHINA, V76, P646; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fujino M, 2003, GENE THER, V10, P1781, DOI 10.1038/sj.gt.3302067; Grimm MC, 1996, J LEUKOCYTE BIOL, V59, P804, DOI 10.1002/jlb.59.6.804; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; GUPTA S, 1991, HEPATOLOGY, V14, P144, DOI 10.1002/hep.1840140124; Hamalainen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673; Hu XD, 2010, ACTA PHARMACOL SIN, V31, P703, DOI 10.1038/aps.2010.53; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Kawayama T, 2012, J INTERF CYTOK RES, V32, P443, DOI 10.1089/jir.2012.0029; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; Kremer L, 1999, J IMMUNOL, V163, P3226; Kucharzik T, 1998, CLIN EXP IMMUNOL, V111, P152; Lamacchia C, 2012, EUR J IMMUNOL, V42, P1294, DOI 10.1002/eji.201142204; Lavon I, 2003, MOL PHARMACOL, V64, P1334, DOI 10.1124/mol.64.6.1334; Leng JH, 2008, ACTA BIOCH BIOPH SIN, V40, P116, DOI 10.1111/j.1745-7270.2008.00384.x; LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97, DOI 10.1016/0167-5699(90)90035-8; Li CY, 2011, J CELL PHYSIOL, V226, P2338, DOI 10.1002/jcp.22576; Li Y, 2012, CELL PHYSIOL BIOCHEM, V29, P31, DOI 10.1159/000337584; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Mase A, 2010, J ETHNOPHARMACOL, V127, P742, DOI 10.1016/j.jep.2009.11.029; Massaguer A, 2002, J LEUKOCYTE BIOL, V72, P262; Navarro-Alvarez N, 2010, J HEPATOL, V52, P211, DOI 10.1016/j.jhep.2009.11.019; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; Qian Y, 2011, EUR J MED RES, V16, P295, DOI 10.1186/2047-783X-16-7-295; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sarra GM, 2002, VISION RES, V42, P541, DOI 10.1016/S0042-6989(01)00230-9; Schumann J, 1998, J IMMUNOL, V161, P5745; Smeets RL, 2003, GENE THER, V10, P1004, DOI 10.1038/sj.gt.3301986; TEVELDE AA, 1990, BLOOD, V76, P1392; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Toyabe S, 1997, J IMMUNOL, V159, P1537; van Holten J, 2004, ARTHRITIS RES THER, V6, pR239, DOI 10.1186/ar1165; WONG HL, 1993, J EXP MED, V177, P775, DOI 10.1084/jem.177.3.775; Yao HP, 2010, INFLAMM RES, V59, P97, DOI 10.1007/s00011-009-0072-0; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324; Yin H, 2010, LIVER INT, V30, P623, DOI 10.1111/j.1478-3231.2009.02199.x; Zhang LH, 2001, GENE THER, V8, P1333, DOI 10.1038/sj.gt.3301524; Zhang LH, 2001, PARASITE IMMUNOL, V23, P11, DOI 10.1046/j.1365-3024.2001.00349.x; Zhang WP, 1997, SCI CHINA SER C, V40, P554, DOI 10.1007/BF03183596; Zhou YC, 2012, DIGEST LIVER DIS, V44, P398, DOI 10.1016/j.dld.2011.11.013	47	19	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58836	10.1371/journal.pone.0058836	http://dx.doi.org/10.1371/journal.pone.0058836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516562	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200117
J	Bradshaw-Pierce, EL; Pitts, TM; Kulikowski, G; Selby, H; Merz, AL; Gustafson, DL; Serkova, NJ; Eckhardt, SG; Weekes, CD				Bradshaw-Pierce, Erica L.; Pitts, Todd M.; Kulikowski, Gillian; Selby, Heather; Merz, Andrea L.; Gustafson, Daniel L.; Serkova, Natalie J.; Eckhardt, S. Gail; Weekes, Colin D.			Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; ADVANCED SOLID TUMORS; RAD001 EVEROLIMUS; PHASE-I; MAMMALIAN TARGET; PIK3CA MUTATION; MTOR INHIBITORS; COLON-CANCER; RAT-BRAIN; PHARMACOKINETICS	Purpose: The PI3K/AKT/mTOR pathway is frequently dysregulated in cancers and inhibition of mTOR has demonstrated the ability to modulate pro-survival pathways. As such, we sought to determine the ability of the mTOR inhibitor everolimus to potentiate the antitumor effects of irinotecan in colorectal cancer (CRC). Experimental Design: The combinatorial effects of everolimus and irinotecan were evaluated in vitro and in vivo in CRC cell lines harboring commonly found mutations in PIK3CA, KRAS and/or BRAF. Pharmacokinetically-directed dosing protocols of everolimus and irinotecan were established and used to assess the in vivo antitumor effects of the agents. At the end of treatment, 3-6 tumors per treatment arm were harvested for biomarker analysis by NMR metabolomics. Results: Everolimus and irinotecan/SN38 demonstrated synergistic anti-proliferative effects in multiple CRC cell lines in vitro. Combination effects of everolimus and irinotecan were determined in CRC xenograft models using clinically-relevant dosing protocols. Everolimus demonstrated significant tumor growth inhibition alone and when combined with irinotecan in HT29 and HCT116 tumor xenografts. Metabolomic analysis showed that HT29 tumors were more metabolically responsive than HCT116 tumors. Everolimus caused a decrease in glycolysis in both tumor types whilst irinotecan treatment resulted in a profound accumulation of lipids in HT29 tumors indicating a cytotoxic effect. Conclusions: Quantitative analysis of tumor growth and metabolomic data showed that the combination of everolimus and irinotecan was more beneficial in the BRAF/PIK3CA mutant HT29 tumor xenografts, which had an additive effect, than the KRAS/PIK3CA mutant HCT116 tumor xenografts, which had a less than additive effect.	[Bradshaw-Pierce, Erica L.; Pitts, Todd M.; Kulikowski, Gillian; Selby, Heather; Eckhardt, S. Gail; Weekes, Colin D.] Univ Colorado Anschutz Med Campus, Div Med Oncol, Aurora, CO USA; [Bradshaw-Pierce, Erica L.; Merz, Andrea L.; Serkova, Natalie J.] Univ Colorado Anschutz Med Campus, Dept Anesthesiol, Aurora, CO USA; [Bradshaw-Pierce, Erica L.; Pitts, Todd M.; Gustafson, Daniel L.; Serkova, Natalie J.; Eckhardt, S. Gail; Weekes, Colin D.] Univ Colorado Anschutz Med Campus, Univ Colorado, Ctr Canc, Aurora, CO USA; [Gustafson, Daniel L.] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [Gustafson, Daniel L.] Colorado State Univ, Anim Canc Ctr, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; Colorado State University	Bradshaw-Pierce, EL (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	Erica.Pierce@ucdenver.edu			Novartis International AG; University of Colorado Cancer Center [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Novartis International AG(Novartis); University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Novartis International AG and University of Colorado Cancer Center Grant P30 CA046934. Novartis had some input in the study design, but did not play a role in data collection analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, CANC FACTS FIG, P5; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Boros L G, 2007, Ernst Schering Found Symp Proc, P189; Calvo E, 2012, EUR J CANCER, V48, P333, DOI 10.1016/j.ejca.2011.11.027; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Delbaldo C, 2005, EUR J CANCER, V41, P1739, DOI 10.1016/j.ejca.2005.04.029; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Gabrielsson J, 2009, J PHARMACOL EXP THER, V331, P767, DOI 10.1124/jpet.109.157172; Gabrielsson J, 2010, J PHARMACOL TOXICOL, V61, P146, DOI 10.1016/j.vascn.2010.02.002; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Guichard S, 1998, CANCER CHEMOTH PHARM, V42, P165, DOI 10.1007/s002800050801; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; JOSHI SS, 1989, TUMOR BIOL, V10, P117, DOI 10.1159/000217607; KANEDA N, 1990, CANCER RES, V50, P1715; Klawitter J, 2010, CHEM RES TOXICOL, V23, P608, DOI 10.1021/tx900351q; Koch G, 2009, J PHARMACOKINET PHAR, V36, P179, DOI 10.1007/s10928-009-9117-9; Lane HA, 2009, CLIN CANCER RES, V15, P1612, DOI 10.1158/1078-0432.CCR-08-2057; Laplanche R, 2007, J PHARMACOKINET PHAR, V34, P373, DOI 10.1007/s10928-007-9051-7; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Manegold PC, 2008, CLIN CANCER RES, V14, P892, DOI 10.1158/1078-0432.CCR-07-0955; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Messersmith WA, 2004, CLIN CANCER RES, V10, P6522, DOI 10.1158/1078-0432.CCR-04-0746; Mohseni M, 2010, J CLIN INVEST, V120, P2655, DOI 10.1172/JCI44026; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mordant P, 2010, MOL CANCER THER, V9, P358, DOI 10.1158/1535-7163.MCT-09-1014; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; O'Reilly T, 2011, ANTI-CANCER DRUG, V22, P58, DOI 10.1097/CAD.0b013e3283400a20; Ocvirk J, 2010, WORLD J GASTROENTERO, V16, P3133, DOI 10.3748/wjg.v16.i25.3133; Okamoto I, 2010, JPN J CLIN ONCOL, V40, P17, DOI 10.1093/jjco/hyp120; Pfizer I, 2010, IRINOTECAN FULL PRES; Phan A, 2012, CANC TREAT REV; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Saunders MP, 2009, CANCER CHEMOTH PHARM, V64, P665, DOI 10.1007/s00280-008-0914-4; Serkova N, 2001, BRIT J PHARMACOL, V133, P875, DOI 10.1038/sj.bjp.0704142; Serkova NJ, 2007, CURR OPIN MOL THER, V9, P572; Serkova NJ, 2006, EXPERT REV MOL DIAGN, V6, P717, DOI 10.1586/14737159.6.5.717; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Slatter JG, 2000, DRUG METAB DISPOS, V28, P423; Stewart CF, 1997, CANCER CHEMOTH PHARM, V40, P259, DOI 10.1007/s002800050656; Suntharalingam M, 2012, INT J RADIAT ONCOL, V82, P1845, DOI 10.1016/j.ijrobp.2011.02.062; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Yao K, 2005, BRIT J CANCER, V93, P1356, DOI 10.1038/sj.bjc.6602864; Zamboni WC, 1998, CLIN CANCER RES, V4, P743; Zamboni WC, 1998, CLIN CANCER RES, V4, P455	50	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58089	10.1371/journal.pone.0058089	http://dx.doi.org/10.1371/journal.pone.0058089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520486	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900045
J	Padler-Karavani, V; Tremoulet, AH; Yu, H; Chen, X; Burns, JC; Varki, A				Padler-Karavani, Vered; Tremoulet, Adriana H.; Yu, Hai; Chen, Xi; Burns, Jane C.; Varki, Ajit			A Simple Method for Assessment of Human Anti-Neu5Gc Antibodies Applied to Kawasaki Disease	PLOS ONE			English	Article							N-GLYCOLYLNEURAMINIC ACID; NONHUMAN SIALIC-ACID; HANGANUTZIU-DEICHER ANTIBODIES; HUMAN XENO-AUTOANTIBODIES; VERTEBRATE AMINO-SUGARS; SENSITIVE DETERMINATION; MAACKIA-AMURENSIS; HEALTHY-CHILDREN; HUMAN-SERUM; CELLS	N-Glycolylneuraminic acid (Neu5Gc) is an immunogenic sugar of dietary origin that metabolically incorporates into diverse native glycoconjugates in humans. Anti-Neu5Gc antibodies are detected in all human sera, though with variable levels and epitope-recognition profiles. These antibodies likely play a role in several inflammation-mediated pathologies including cardiovascular diseases and cancer. In cancer, they have dualistic and opposing roles, either stimulating or repressing disease, as a function of their dose, and some of these antibodies serve as carcinoma biomarkers. Thus, anti-Neu5Gc antibodies may signify risk of inflammation-mediated diseases, and changes in their levels could potentially be used to monitor disease progression and/or response to therapy. Currently, it is difficult to determine levels of anti-Neu5Gc antibodies in individual human samples because these antibodies recognize multiple Neu5Gc-epitopes. Here we describe a simple and specific method for detection and overall estimation of human anti-Neu5Gc antibodies. We exploit the difference between two mouse models that differ only by Neu5Gc-presence (wild-type) or Neu5Gc-absence (Cmah(-/-) knockout). We characterize mouse serum from both strains by HPLC, lectin and mass-spectrometry analysis and show the target Neu5Gc-epitopes. We then use Cmah(-/-) knockout sera to inhibit all non-Neu5Gc-reactivity followed by binding to wild-type sera to detect overall anti-Neu5Gc response in a single assay. We applied this methodology to characterize and quantify anti-Neu5Gc IgG and IgA in sera of patients with Kawasaki disease (KD) at various stages compared to controls. KD is an acute childhood febrile disease characterized by inflammation of coronary arteries that untreated may lead to coronary artery aneurysms with risk of thrombosis and myocardial infarction. This estimated response is comparable to the average of detailed anti-Neu5Gc IgG profile analyzed by a sialoglycan microarray. Both assays revealed an elevated response in acute KD patients with normal coronaries compared to patients with aneurysm or dilated coronaries. Implications of these findings are discussed.	[Padler-Karavani, Vered; Varki, Ajit] Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Padler-Karavani, Vered; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, Rady Childrens Hosp, Dept Pediat, San Diego, CA 92103 USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California Davis	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	PADLER-KARAVANI, VERED/AAC-6055-2022; Chen, Xi/H-1811-2018	PADLER-KARAVANI, VERED/0000-0002-4761-3571; Chen, Xi/0000-0002-3160-614X	National Institutes of Health [R01GM32373, R01CA38701]; ISEF Fellowship; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISEF Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM32373 and R01CA38701 to A.V. and ISEF Fellowship to V.P-K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; ARITA K, 1982, BIKEN J, V25, P157; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Brinkman-Van der Linden ECM, 2002, ANAL BIOCHEM, V303, P98, DOI 10.1006/abio.2001.5539; Burns JC, 2007, NEW ENGL J MED, V356, P659, DOI 10.1056/NEJMp068268; Burns JC, 2009, INDIAN J PEDIATR, V76, P71, DOI 10.1007/s12098-009-0031-3; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; CHERESH DA, 1984, SCIENCE, V225, P844, DOI 10.1126/science.6206564; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Giordani L, 2011, CLIN EXP IMMUNOL, V163, P346, DOI 10.1111/j.1365-2249.2010.04297.x; Goodarzi MT, 1998, GLYCOCONJUGATE J, V15, P469, DOI 10.1023/A:1006930902625; HARA S, 1986, J CHROMATOGR, V377, P111, DOI 10.1016/S0378-4347(00)80766-5; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Irie A, 1998, BIOCHEM BIOPH RES CO, V248, P330, DOI 10.1006/bbrc.1998.8946; KAWAMORI J, 1989, Acta Paediatrica Japonica, V31, P537; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; Kotani N, 1997, ANAL BIOCHEM, V252, P40, DOI 10.1006/abio.1997.2300; Lee HH, 2009, YONSEI MED J, V50, P493, DOI 10.3349/ymj.2009.50.4.493; Lu QZ, 2012, ANAL CHEM, V84, P2761, DOI 10.1021/ac2030893; Luca NJC, 2012, DRUGS, V72, P1029, DOI 10.2165/11631440-000000000-00000; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Matsubara T, 2005, CLIN EXP IMMUNOL, V141, P381, DOI 10.1111/j.1365-2249.2005.02821.x; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; NORGARD KE, 1993, P NATL ACAD SCI USA, V90, P1068, DOI 10.1073/pnas.90.3.1068; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2012, J BIOL CHEM, V287, P22593, DOI 10.1074/jbc.M112.359323; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Padler-Karavani V, 2011, XENOTRANSPLANTATION, V18, P1, DOI 10.1111/j.1399-3089.2011.00622.x; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; STOOP JW, 1969, CLIN EXP IMMUNOL, V4, P101; TAKIGUCHI M, 1984, CLIN EXP IMMUNOL, V56, P345; TAMURA T, 1984, DIAGN CLIN IMMUNOL, V2, P101; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Yellen ES, 2010, PEDIATRICS, V125, pE234, DOI 10.1542/peds.2009-0606; ZEGERS BJM, 1975, CLIN CHIM ACTA, V65, P319, DOI 10.1016/0009-8981(75)90257-0; Zhu A, 2002, XENOTRANSPLANTATION, V9, P376, DOI 10.1034/j.1399-3089.2002.02138.x	50	52	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58443	10.1371/journal.pone.0058443	http://dx.doi.org/10.1371/journal.pone.0058443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520510	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900069
J	Dejean, A; Orivel, J; Rossi, V; Roux, O; Lauth, J; Male, PJG; Cereghino, R; Leroy, C				Dejean, Alain; Orivel, Jerome; Rossi, Vivien; Roux, Olivier; Lauth, Jeremie; Male, Pierre-Jean G.; Cereghino, Regis; Leroy, Celine			Predation Success by a Plant-Ant Indirectly Favours the Growth and Fitness of Its Host Myrmecophyte	PLOS ONE			English	Article							MUTUALISM; EVOLUTION; CONFLICT; CASTRATION; SANCTIONS; BEHAVIOR; BENEFITS; RATIOS; SEX	Mutualisms, or interactions between species that lead to net fitness benefits for each species involved, are stable and ubiquitous in nature mostly due to "byproduct benefits'' stemming from the intrinsic traits of one partner that generate an indirect and positive outcome for the other. Here we verify if myrmecotrophy (where plants obtain nutrients from the refuse of their associated ants) can explain the stability of the tripartite association between the myrmecophyte Hirtella physophora, the ant Allomerus decemarticulatus and an Ascomycota fungus. The plant shelters and provides the ants with extrafloral nectar. The ants protect the plant from herbivores and integrate the fungus into the construction of a trap that they use to capture prey; they also provide the fungus and their host plant with nutrients. During a 9-month field study, we over-provisioned experimental ant colonies with insects, enhancing colony fitness (i.e., more winged females were produced). The rate of partial castration of the host plant, previously demonstrated, was not influenced by the experiment. Experimental plants showed higher delta N-15 values (confirming myrmecotrophy), plus enhanced vegetative growth (e. g., more leaves produced increased the possibility of lodging ants in leaf pouches) and fitness (i.e., more fruits produced and more flowers that matured into fruit). This study highlights the importance of myrmecotrophy on host plant fitness and the stability of ant-myrmecophyte mutualisms.	[Dejean, Alain; Cereghino, Regis] Univ Toulouse, UPS, Ecolab, Toulouse, France; [Dejean, Alain; Orivel, Jerome; Lauth, Jeremie] CNRS, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Rossi, Vivien] CIRAD, Ecofog UMR CIRAD 93, Kourou, France; [Roux, Olivier] IRD, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Bobo Dioulasso, Burkina Faso; [Male, Pierre-Jean G.] CNRS, EDB UMR CNRS 5174, Toulouse, France; [Cereghino, Regis] CNRS, Lab Ecol Fonct UMR CNRS 5245, Toulouse, France; [Leroy, Celine] IRD, AMAP BotAn & BioinforMat Architecture Plantes, UMR IRD 123, Montpellier, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Dejean, A (corresponding author), Univ Toulouse, UPS, Ecolab, Toulouse, France.	alain.dejean@wanadoo.fr	Rossi, Vivien/C-9721-2009; Leroy, Celine/I-4857-2016; Roux, Olivier/A-1181-2011; Male, Pierre-Jean G./A-7618-2010; Roux, Olivier/I-5675-2016	Rossi, Vivien/0000-0001-5458-1523; Leroy, Celine/0000-0003-4859-8040; Male, Pierre-Jean G./0000-0003-0896-726X; Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; Cereghino, Regis/0000-0003-3981-3159; Roux, Olivier/0000-0001-5440-0219	French Labex CEBA(The laboratory of Excellence Centre for Studies of Amazonian Biodiversity), Tripartite associations and Plant Nutrition (Tri-Nutri)	French Labex CEBA(The laboratory of Excellence Centre for Studies of Amazonian Biodiversity), Tripartite associations and Plant Nutrition (Tri-Nutri)	This work was supported by the French Labex CEBA 2012 (The laboratory of Excellence Centre for Studies of Amazonian Biodiversity), Tripartite associations and Plant Nutrition (Tri-Nutri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Aron S, 2001, J ANIM ECOL, V70, P831, DOI 10.1046/j.0021-8790.2001.00545.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bono JM, 2003, P ROY SOC B-BIOL SCI, V270, P811, DOI 10.1098/rspb.2002.2287; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; CONNOR RC, 1995, BIOL REV, V70, P427, DOI 10.1111/j.1469-185X.1995.tb01196.x; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Dejean A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037683; Dejean A, 2012, NATURWISSENSCHAFTEN, V99, P265, DOI 10.1007/s00114-012-0895-3; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Douglas A.E., 2010, SYMBIOTIC HABIT; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Edwards DP, 2006, P ROY SOC B-BIOL SCI, V273, P595, DOI 10.1098/rspb.2005.3273; Frederickson ME, 2009, AM NAT, V173, P675, DOI 10.1086/597608; Gaume L, 2005, EVOL ECOL RES, V7, P435; Grangier J, 2008, NATURWISSENSCHAFTEN, V95, P909, DOI 10.1007/s00114-008-0398-4; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Holland J. Nathaniel, 2005, P17; Izzo TJ, 2002, OECOLOGIA, V133, P200, DOI 10.1007/s00442-002-1027-0; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Leimar O, 2003, DAHL WS ENV, P203; Leimar O, 2010, PHILOS T R SOC B, V365, P2619, DOI 10.1098/rstb.2010.0116; Leroy C, 2011, J ECOL, V99, P583, DOI 10.1111/j.1365-2745.2010.01763.x; Male PJG, 2012, EVOL ECOL, V26, P55, DOI 10.1007/s10682-011-9485-7; O'Keefe KJ, 2002, AM NAT, V159, P597, DOI 10.1086/339990; Orivel J, 2011, OECOLOGIA, V165, P369, DOI 10.1007/s00442-010-1739-5; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Ruiz-Gonzalez MX, 2011, BIOL LETTERS, V7, P475, DOI 10.1098/rsbl.2010.0920; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Szilagyi A, 2009, ECOL LETT, V12, P1306, DOI 10.1111/j.1461-0248.2009.01382.x; Thornham DG, 2012, FUNCT ECOL, V26, P11, DOI 10.1111/j.1365-2435.2011.01937.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x; Willmer PG, 2009, FUNCT ECOL, V23, P888, DOI 10.1111/j.1365-2435.2009.01632.x; Young TP, 1997, OECOLOGIA, V109, P98, DOI 10.1007/s004420050063; Yu DW, 1998, P ROY SOC B-BIOL SCI, V265, P375, DOI 10.1098/rspb.1998.0305	39	8	8	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59405	10.1371/journal.pone.0059405	http://dx.doi.org/10.1371/journal.pone.0059405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516632	gold, Green Submitted, Green Published			2022-12-25	WOS:000316407400109
J	Hansen, JT; Lyngso, C; Speerschneider, T; Hansen, PBL; Gales, C; Weiner, DM; Sheikh, SP; Burstein, ES; Hansen, JL				Hansen, Jonas Tind; Lyngso, Christina; Speerschneider, Tobias; Hansen, Pernille B. L.; Gales, Celine; Weiner, David M.; Sheikh, Soren P.; Burstein, Ethan S.; Hansen, Jakob Lerche			Functional Enhancement of AT1R Potency in the Presence of the TP alpha R Is Revealed by a Comprehensive 7TM Receptor Co-Expression Screen	PLOS ONE			English	Article							ANGIOTENSIN-II TYPE-1; THROMBOXANE RECEPTORS; DOPAMINE-RECEPTORS; AT(1); ACTIVATION; PHARMACOLOGY; HETERODIMERS; INHIBITION; FORM; MAS	Background: Functional cross-talk between seven transmembrane (7TM) receptors can dramatically alter their pharmacological properties, both in vitro and in vivo. This represents an opportunity for the development of novel therapeutics that potentially target more specific biological effects while causing fewer adverse events. Although several studies convincingly have established the existence of 7TM receptor cross-talk, little is known about the frequencey and biological significance of this phenomenon. Methodology/Principal Findings: To evaluate the extent of synergism in 7TM receptor signaling, we took a comprehensive approach and co-expressed 123 different 7TM receptors together with the angiotensin II type 1 receptor (AT1R) and analyzed how each receptor affected the angiotensin II (AngII) response. To monitor the effect we used integrative receptor activation/signaling assay called Receptor Selection and Amplification Technology (R-SAT). In this screen the thromboxane A2 alpha receptor (TP alpha R) was the only receptor which significantly enhanced the AngII-mediated response. The TP alpha R-mediated enhancement of AngII signaling was significantly reduced when a signaling deficient receptor mutant (TP alpha R R130V) was co-expressed instead of the wild-type TP alpha R, and was completely blocked both by TP alpha R antagonists and COX inhibitors inhibiting formation of thromboxane A(2) (TXA(2)). Conclusions/Significance: We found a functional enhancement of AT1R only when co-expressed with TP alpha R, but not with 122 other 7TM receptors. In addition, the TP alpha R must be functionally active, indicating the AT1R enhancement is mediated by a paracrine mechanism. Since we only found one receptor enhancing AT1R potency, our results suggest that functional augmentation through 7TM receptor cross-talk is a rare event that may require specific conditions to occur.	[Hansen, Jonas Tind; Lyngso, Christina; Speerschneider, Tobias; Hansen, Jakob Lerche] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Mol Cardiol Lab, Copenhagen, Denmark; [Hansen, Jonas Tind; Lyngso, Christina; Speerschneider, Tobias; Hansen, Jakob Lerche] Univ Copenhagen, Fac Hlth Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Hansen, Jonas Tind; Lyngso, Christina] Glostrup Cty Hosp, Dept Clin Biochem, Glostrup, Denmark; [Hansen, Pernille B. L.] Univ Southern Denmark, Odense C, Denmark; [Gales, Celine] Univ Toulouse III Paul Sabatier, Inst Natl Sante & Rech Med, Inst Malad Metabol & Cardiovasc I2MC, Toulouse, France; [Weiner, David M.] Proteostasis Therapeut Inc, Cambridge, MA USA; [Sheikh, Soren P.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Lab Mol & Cellular Cardiol, DK-5000 Odense, Denmark; [Burstein, Ethan S.] ACADIA Pharmaceut Inc, San Diego, CA USA; [Hansen, Jakob Lerche] Diabet NBEs & Obes Biol, Novo Nordisk, Maolov, Denmark	University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Southern Denmark; Odense University Hospital	Hansen, JL (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Mol Cardiol Lab, Copenhagen, Denmark.	JLHH@novonordisk.com		Hansen, Pernille B. Laerkegaard/0000-0003-0661-1665; GALES, Celine/0000-0002-4938-1583	Danish Council for Independent Research \ Medical Sciences; Danish National Research Foundation; Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat; Novo Nordisk Foundation	Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by The Danish Council for Independent Research vertical bar Medical Sciences, the Danish National Research Foundation, The Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat, and The Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Bachschmid M, 2003, FASEB J, V17, P914, DOI 10.1096/fj.02-0530fje; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Brauner-Osborne H, 1996, EUR J PHARMACOL, V295, P93, DOI 10.1016/0014-2999(95)00639-7; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Burstein ES, 2006, CURR PHARM DESIGN, V12, P1717, DOI 10.2174/138161206776873662; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Capra V, 2004, MOL PHARMACOL, V66, P880, DOI 10.1124/mol.104.001487; Castillo-Hernandez JR, 2004, VASC PHARMACOL, V41, P147, DOI 10.1016/j.vph.2004.08.002; Chien CC, 2009, J CELL PHYSIOL, V218, P405, DOI 10.1002/jcp.21613; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; de Lourdes Gonzalez-Hernandez M., 2010, Autonomic & Autacoid Pharmacology, V30, P167, DOI 10.1111/j.1474-8673.2009.00446.x; Espanol AJ, 2010, INFLAMM RES, V59, P227, DOI 10.1007/s00011-009-0097-4; Francois H, 2004, HYPERTENSION, V43, P364, DOI 10.1161/01.HYP.0000112225.27560.24; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hansen JL, 2009, J BIOL CHEM, V284, P1831, DOI 10.1074/jbc.M804607200; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Karip E, 2007, NEUROCHEM INT, V51, P261, DOI 10.1016/j.neuint.2007.05.018; Kawada N, 2004, AM J PHYSIOL-RENAL, V287, pF753, DOI 10.1152/ajprenal.00423.2003; KELNER MJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P240, DOI 10.1006/abbi.1994.1305; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; Miggin SM, 1998, BBA-GEN SUBJECTS, V1425, P543, DOI 10.1016/S0304-4165(98)00109-3; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; Oro C, 2007, PHARMACOL THERAPEUT, V113, P210, DOI 10.1016/j.pharmthera.2006.10.001; Pedersen SF, 2006, AM J PHYSIOL-CELL PH, V291, pC1286, DOI 10.1152/ajpcell.00325.2005; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Santos EL, 2007, REGUL PEPTIDES, V141, P159, DOI 10.1016/j.regpep.2006.12.030; Sauliere A, 2012, NAT CHEM BIOL; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; SMITH EF, 1981, J CARDIOVASC PHARM, V3, P791, DOI 10.1097/00005344-198107000-00012; Sparks MA, 2013, HYPERTENSION, V61, P166, DOI 10.1161/HYPERTENSIONAHA.112.193250; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Turu G, 2009, J BIOL CHEM, V284, P16914, DOI 10.1074/jbc.M109.003681; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; Wilcox CS, 1996, AM J PHYSIOL-REG I, V271, pR891, DOI 10.1152/ajpregu.1996.271.4.R891; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zeng CY, 2005, HYPERTENSION, V45, P804, DOI 10.1161/01.HYP.0000155212.33212.99; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E; Zeng CY, 2003, HYPERTENSION, V41, P724, DOI 10.1161/01.HYP.0000047880.78462.0E	51	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58890	10.1371/journal.pone.0058890	http://dx.doi.org/10.1371/journal.pone.0058890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516570	Green Submitted, gold, Green Published			2022-12-25	WOS:000316407400073
J	Martin, R; Albrecht-Eckardt, D; Brunke, S; Hube, B; Hunniger, K; Kurzai, O				Martin, Ronny; Albrecht-Eckardt, Daniela; Brunke, Sascha; Hube, Bernhard; Huenniger, Kerstin; Kurzai, Oliver			A Core Filamentation Response Network in Candida albicans Is Restricted to Eight Genes	PLOS ONE			English	Article							PH-REGULATED GENE; MORPHOLOGICAL DEVELOPMENT; HYPHAL FORMATION; LARGE-SCALE; GROWTH; EXPRESSION; MORPHOGENESIS; INDUCTION; YEAST; EFG1	Although morphological plasticity is a central virulence trait of Candida albicans, the number of filament-associated genes and the interplay of mechanisms regulating their expression remain unknown. By correlation-based network modeling of the transcriptional response to different defined external stimuli for morphogenesis we identified a set of eight genes with highly correlated expression patterns, forming a core filamentation response. This group of genes included ALS3, ECE1, HGT2, HWP1, IHD1 and RBT1 which are known or supposed to encode for cell-wall associated proteins as well as the Rac1 guanine nucleotide exchange factor encoding gene DCK1 and the unknown function open reading frame orf19.2457. The validity of network modeling was confirmed using a dataset of advanced complexity that describes the transcriptional response of C. albicans during epithelial invasion as well as comparing our results with other previously published transcriptome studies. Although the set of core filamentation response genes was quite small, several transcriptional regulators are involved in the control of their expression, depending on the environmental condition.	[Martin, Ronny; Huenniger, Kerstin; Kurzai, Oliver] Univ Jena, Sept Res Ctr, Jena, Germany; [Martin, Ronny; Huenniger, Kerstin; Kurzai, Oliver] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Albrecht-Eckardt, Daniela] BioControl Jena GmbH, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Univ Jena, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kurzai, O (corresponding author), Univ Jena, Sept Res Ctr, Jena, Germany.	oliver.kurzai@hki-jena.de	Brunke, Sascha/G-1486-2012	Brunke, Sascha/0000-0001-7740-4570; Kurzai, Oliver/0000-0002-7277-2646	German Ministry for Education and Science in the program Unternehmen Region [BMBF 03Z2JN21]	German Ministry for Education and Science in the program Unternehmen Region	This work was financed by the German Ministry for Education and Science in the program Unternehmen Region (BMBF 03Z2JN21 to OK). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Arnaud MB, 2007, NUCLEIC ACIDS RES, V35, pD452, DOI 10.1093/nar/gkl899; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; BUFFO J, 1984, MYCOPATHOLOGIA, V85, P21, DOI 10.1007/BF00436698; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; El Barkani A, 2000, MOL CELL BIOL, V20, P4635, DOI 10.1128/MCB.20.13.4635-4647.2000; Ene IV, 2009, EUKARYOT CELL, V8, P1909, DOI 10.1128/EC.00245-09; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gunasekera A, 2010, EUKARYOT CELL, V9, P1476, DOI 10.1128/EC.00178-10; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Holton NJ, 2001, NUCLEIC ACIDS RES, V29, P4014, DOI 10.1093/nar/29.19.4014; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kamthan M, 2012, FUNGAL GENET BIOL, V49, P369, DOI 10.1016/j.fgb.2012.02.006; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; Kurzai O, 2005, INT J MED MICROBIOL, V295, P121, DOI 10.1016/j.ijmm.2005.02.003; Lamarre C, 2000, MOL MICROBIOL, V35, P444, DOI 10.1046/j.1365-2958.2000.01715.x; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; Lu YQ, 2012, PLANT METHODS, V8, DOI [10.1186/1746-4811-8-9, 10.1371/journal.ppat.1002663]; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Martin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018394; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Naseem S, 2011, J BIOL CHEM, V286, P28671, DOI 10.1074/jbc.M111.249854; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Ramon AM, 1999, J BACTERIOL, V181, P7524, DOI 10.1128/JB.181.24.7524-7530.1999; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; SIMS W, 1986, J MED MICROBIOL, V22, P203, DOI 10.1099/00222615-22-3-203; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	65	61	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58613	10.1371/journal.pone.0058613	http://dx.doi.org/10.1371/journal.pone.0058613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516516	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400039
J	Zheng, MJ; Schaal, M; Chen, Y; Li, XK; Shentu, WH; Zhang, PY; Ashraf, M; Ge, SP; Sahn, DJ				Zheng, Minjuan; Schaal, Micheal; Chen, Yan; Li, Xiaokui; Shentu, Weihui; Zhang, Pengyuan; Ashraf, Muhammad; Ge, Shuping; Sahn, David J.			Real-Time 3-Dimensional Echocardiographic Assessment of Ventricular Volume, Mass, and Function in Human Fetuses	PLOS ONE			English	Article							FETAL CARDIAC-OUTPUT; COMPUTER-AIDED ANALYSIS; EJECTION FRACTION; 2-DIMENSIONAL ECHOCARDIOGRAPHY; 4-DIMENSIONAL ULTRASOUND; PICTORIAL ESSAY; 4D ULTRASOUND; STROKE VOLUME; HEART-VOLUME; MATRIX-ARRAY	Objectives: We sought to determine the feasibility and reproducibility of real-time 3-dimensional echocardiography (RT3DE) for evaluation of cardiac volume, mass, and function and to characterize maturational changes of these measurements in human fetuses. Methods: Eighty pregnant women in the 2nd and 3rd trimesters (59 with normal fetuses and 21 with fetuses with congenital heart disease [CHD]) were enrolled. We acquired RT3DE images using a matrix-array transducer. RT3DE measurements of volume, mass, stroke volume (SV), combined cardiac output (CCO), and ejection fraction (EF) were obtained. Images were scored and analyzed by two blinded independent observers. Inter-and intraobserver variabilities and correlations between fetal cardiac indices and gestational age were determined. Results: Fifty-two of 59 normal data sets (88%) and 9 of 21 CHD data sets (43%) were feasible for analysis. In normal fetuses, the right ventricle (RV) is larger than the left ventricle (LV) (P<0.05), but no difference exists between the LV and RV in mass, SV, CO, and CO/CCO. The EFs for the LV and RV were diminished; the RVSV/LVSV was reduced in CHD fetuses compared with normal fetuses (P<0.05). Fetal ventricular volumes, mass, SV, and CCO fit best into exponential curves with gestational age, but LVEF, RVEF, and RVSV/LVSV remain relatively constant. Conclusions: RT3DE is feasible and reproducible for assessment of LV and RV volume, mass, and function, especially in normal fetuses. Gestational growth of these measures, except for EF, is exponential in normal and CHD fetuses. CHD fetuses exhibit diminished LV and RV EFs.	[Zheng, Minjuan; Schaal, Micheal; Li, Xiaokui; Shentu, Weihui; Zhang, Pengyuan; Ashraf, Muhammad; Sahn, David J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Zheng, Minjuan] Fourth Mil Med Univ, Xijing Hosp, Dept Ultrasound, Xian 710032, Peoples R China; [Chen, Yan] Fourth Mil Med Univ, Xijing Hosp, Dept Oncol, Xian 710032, Peoples R China; [Ge, Shuping] Drexel Univ, St Christophers Hosp Children, Coll Med, Cardiol Sect, Philadelphia, PA 19104 USA	Oregon Health & Science University; Air Force Military Medical University; Air Force Military Medical University; Drexel University	Ge, SP (corresponding author), Drexel Univ, St Christophers Hosp Children, Coll Med, Cardiol Sect, Philadelphia, PA 19104 USA.	shuping.ge@tenethealth.com; sahnd@ohsu.edu			Oregon Health and Science University	Oregon Health and Science University	This work was supported by Oregon Health and Science University (http://www.ohsu.edu/xd/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar P, 2005, PRENATAL DIAG, V25, P370, DOI 10.1002/pd.1159; Bhat AH, 2004, CIRCULATION, V110, P1054, DOI 10.1161/01.CIR.0000139848.33468.22; Chang FM, 1997, ULTRASOUND OBST GYN, V9, P42, DOI 10.1046/j.1469-0705.1997.09010042.x; Barreto EQD, 2012, J ULTRAS MED, V31, P673; DeKoninck P, 2012, FETAL DIAGN THER, V32, P72, DOI 10.1159/000336128; DESMEDT MCH, 1987, AM J CARDIOL, V60, P338, DOI 10.1016/0002-9149(87)90238-4; DEVORE GR, 1985, J ULTRAS MED, V4, P335; Goncalves LF, 2006, J ULTRAS MED, V25, P745, DOI 10.7863/jum.2006.25.6.745; Goncalves LF, 2006, J ULTRAS MED, V25, P691, DOI 10.7863/jum.2006.25.6.691; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Hung J, 2007, J AM SOC ECHOCARDIOG, V20, P213, DOI 10.1016/j.echo.2007.01.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lu XZ, 2008, AM HEART J, V155, P946, DOI 10.1016/j.ahj.2007.11.034; Lu XZ, 2008, J AM SOC ECHOCARDIOG, V21, P84, DOI 10.1016/j.echo.2007.05.009; Messing B, 2007, ULTRASOUND OBST GYN, V30, P142, DOI 10.1002/uog.4036; Messing B, 2011, ULTRASOUND OBST GYN, V38, P191, DOI 10.1002/uog.8980; Mielke G, 2001, CIRCULATION, V103, P1662, DOI 10.1161/01.CIR.103.12.1662; Molina FS, 2008, ULTRASOUND OBST GYN, V32, P181, DOI 10.1002/uog.5374; Myerson SG, 2002, HYPERTENSION, V40, P673, DOI 10.1161/01.HYP.0000036401.99908.DB; Rizzo G, 2007, PRENATAL DIAG, V27, P1147, DOI 10.1002/pd.1870; Rizzo G, 2010, J ULTRAS MED, V29, P261, DOI 10.7863/jum.2010.29.2.261; RUDOLPH AM, 1976, AM J OBSTET GYNECOL, V124, P183, DOI 10.1016/S0002-9378(16)33296-3; Sapin PM, 1996, AM J HYPERTENS, V9, P467, DOI 10.1016/0895-7061(95)00394-0; SCHMIDT KG, 1995, AM J CARDIOL, V76, P1313, DOI 10.1016/S0002-9149(99)80365-8; SCHMIDT KG, 1990, CIRCULATION, V81, P325, DOI 10.1161/01.CIR.81.1.325; SIIMES ASI, 1978, AM J OBSTET GYNECOL, V132, P42, DOI 10.1016/0002-9378(78)90796-2; Simioni C, 2012, REV BRAS CIR CARDIOV, V27, P275, DOI 10.5935/1678-9741.20120058; Simioni C, 2011, J MATERN-FETAL NEO M, V24, P1159, DOI 10.3109/14767058.2010.545921; Simpson JM, 2002, ULTRASOUND OBST GYN, V20, P332, DOI 10.1046/j.1469-0705.2002.00799.x; Sklansky MS, 2004, J ULTRAS MED, V23, P283, DOI 10.7863/jum.2004.23.2.283; Soriano BD, 2008, CIRCULATION, V117, P1842, DOI 10.1161/CIRCULATIONAHA.107.715854; Yagel S, 2007, ULTRASOUND OBST GYN, V29, P81, DOI 10.1002/uog.3912	32	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58494	10.1371/journal.pone.0058494	http://dx.doi.org/10.1371/journal.pone.0058494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516490	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400035
J	Candolin, U; Vlieger, L				Candolin, Ulrika; Vlieger, Leon			Should Attractive Males Sneak: The Trade-Off between Current and Future Offspring	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; SEXUAL SELECTION; GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACK; THREESPINE STICKLEBACK; REPRODUCTIVE SUCCESS; MALE COMPETITION; MALE PHENOTYPE; EVOLUTION; TACTICS	Alternative reproductive tactics are predicted to be adopted by less competitive males when competition for fertilization is intense. Yet, in some species, competitively superior males use an alternative tactic alongside the conventional tactic. This can jeopardize their success through the conventional tactic, but surprisingly little attention has been paid to this cost. We investigated 1) the degree to which competitive males sneak fertilize eggs in the polygamous threespine stickleback, Gasterosteus aculeatus, and 2) if males balance the cost of sneaking against its benefit. We found competitive males that succeeded in establishing a territory and in attracting spawning females to perform most sneak fertilizations. However, when we reduced the benefit of sneak attempts, by reducing visibility and the success rate of sneak attempts, males sneaked less. When we increased the cost of sneak attempts, by increasing the perceived value of current offspring (by mating males to preferred females rather than unpreferred females or no females), the interest of males in sneak opportunities decreased. Intriguingly, larger males, who presumably had a higher probability of future reproduction, were more willing to risk their current offspring for sneak opportunities. These findings suggest that competitive males that are attractive to females carefully balance costs against benefits in their sneaking decisions. More broadly, our results imply that changes in the environment can influence the cost-benefit ratio of sneaking and alter the distribution of fertilizations in a population. We end with discussing the implications that alterations in sneaking behavior could have for the operation of sexual selection in changing environments.	[Candolin, Ulrika; Vlieger, Leon] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki	Candolin, U (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ulrika.candolin@helsinki.fi		Candolin, Ulrika/0000-0001-8736-7793	Academy of Finland	Academy of Finland(Academy of Finland)	The work was funded by the Academy of Finland to UC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAK A, 1988, ANIM BEHAV, V36, P416, DOI 10.1016/S0003-3472(88)80012-5; Bergman M, 2009, ANIM BEHAV, V78, P1161, DOI 10.1016/j.anbehav.2009.08.003; Birkhead TR, 1998, SPERM COMPETITION SE; Boughman JW, 2005, EVOLUTION, V59, P361; Briffa M, 2007, FUNCT ECOL, V21, P627, DOI 10.1111/j.1365-2435.2006.01188.x; Candolin U, 1999, P ROY SOC B-BIOL SCI, V266, P785, DOI 10.1098/rspb.1999.0706; Candolin U, 2003, EVOLUTION, V57, P862, DOI 10.1111/j.0014-3820.2003.tb00297.x; Candolin U, 2002, BEHAV ECOL SOCIOBIOL, V51, P146, DOI 10.1007/s00265-001-0422-6; Candolin U, 2009, J FISH BIOL, V75, P2108, DOI 10.1111/j.1095-8649.2009.02405.x; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Candolin U, 2000, P ROY SOC B-BIOL SCI, V267, P2425, DOI 10.1098/rspb.2000.1301; Candolin U, 1997, BEHAV ECOL SOCIOBIOL, V41, P81, DOI 10.1007/s002650050367; Candolin U, 2007, J EVOLUTION BIOL, V20, P233, DOI 10.1111/j.1420-9101.2006.01207.x; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Candolin U, 2008, OIKOS, V117, P459, DOI 10.1111/j.2007.0030-1299.16302.x; Candolin U, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P201; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dzieweczynski TL, 2004, ANIM BEHAV, V68, P465, DOI 10.1016/j.anbehav.2003.08.024; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Fu P, 2001, P ROY SOC B-BIOL SCI, V268, P1105, DOI 10.1098/rspb.2001.1625; GOLDSCHMIDT T, 1992, ANIM BEHAV, V44, P793, DOI 10.1016/S0003-3472(05)80310-0; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2001, ANIM BEHAV, V61, P987, DOI 10.1006/anbe.2000.1666; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Heuschele J, 2012, ANIM BEHAV, V83, P1505, DOI 10.1016/j.anbehav.2012.03.027; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Mori S, 1995, BEHAVIOUR, V132, P1011, DOI 10.1163/156853995X00423; Oliveira RF, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Reichard M, 2007, ANIM BEHAV, V74, P679, DOI 10.1016/j.anbehav.2007.03.005; SARGENT RC, 1985, BEHAVIOUR, V93, P217, DOI 10.1163/156853986X00892; SARGENT RC, 1980, BEHAV ECOL SOCIOBIOL, V7, P137, DOI 10.1007/BF00299519; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2011, J ANIM ECOL, V80, P905, DOI 10.1111/j.1365-2656.2011.01890.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Tomkins JL, 2011, CURR BIOL, V21, P569, DOI 10.1016/j.cub.2011.02.032; Townsend AK, 2010, AM NAT, V175, pE1, DOI 10.1086/648553; van Iersel JJA., 1953, BEHAVIOUR, V3, P1; VANDENASSEM J, 1967, BEHAVIOUR S, V16, P1; Vlieger L, 2009, J FISH BIOL, V75, P2163, DOI 10.1111/j.1095-8649.2009.02403.x; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531; Watters JV, 2005, ANIM BEHAV, V70, P1055, DOI 10.1016/j.anbehav.2005.01.025; WEATHERHEAD PJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P81, DOI 10.1007/s0026550370081; Westneat DF, 2005, MOL ECOL, V14, P2155, DOI 10.1111/j.1365-294X.2005.02562.x; WHORISKEY FG, 1985, BEHAV ECOL SOCIOBIOL, V18, P15; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Wootton R.J., 1976, BIOL STICKLEBACKS	55	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57992	10.1371/journal.pone.0057992	http://dx.doi.org/10.1371/journal.pone.0057992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516423	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200023
J	Bisseleua, HBD; Fotio, D; Yede; Missoup, AD; Vidal, S				Bisseleua, Herve Bertin Daghela; Fotio, Daniel; Yede; Missoup, Alain Didier; Vidal, Stefan			Shade Tree Diversity, Cocoa Pest Damage, Yield Compensating Inputs and Farmers' Net Returns in West Africa	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; BIODIVERSITY CONSERVATION; AGROFORESTRY SYSTEMS; CACAO AGROFORESTS; SPECIES RICHNESS; THEOBROMA-CACAO; BIRDS; ANTS; HYMENOPTERA; CULTIVATION	Cocoa agroforests can significantly support biodiversity, yet intensification of farming practices is degrading agroforestry habitats and compromising ecosystem services such as biological pest control. Effective conservation strategies depend on the type of relationship between agricultural matrix, biodiversity and ecosystem services, but to date the shape of this relationship is unknown. We linked shade index calculated from eight vegetation variables, with insect pests and beneficial insects (ants, wasps and spiders) in 20 cocoa agroforests differing in woody and herbaceous vegetation diversity. We measured herbivory and predatory rates, and quantified resulting increases in cocoa yield and net returns. We found that number of spider webs and wasp nests significantly decreased with increasing density of exotic shade tree species. Greater species richness of native shade tree species was associated with a higher number of wasp nests and spider webs while species richness of understory plants did not have a strong impact on these beneficial species. Species richness of ants, wasp nests and spider webs peaked at higher levels of plant species richness. The number of herbivore species (mirid bugs and cocoa pod borers) and the rate of herbivory on cocoa pods decreased with increasing shade index. Shade index was negatively related to yield, with yield significantly higher at shade and herb covers < 50%. However, higher inputs in the cocoa farms do not necessarily result in a higher net return. In conclusion, our study shows the importance of a diverse shade canopy in reducing damage caused by cocoa pests. It also highlights the importance of conservation initiatives in tropical agroforestry landscapes.	[Bisseleua, Herve Bertin Daghela] MDG Ctr West & Cent Afr, Dakar, Senegal; [Bisseleua, Herve Bertin Daghela; Fotio, Daniel; Yede; Missoup, Alain Didier] IRAD, Entomol Lab, Yaounde, Cameroon; [Bisseleua, Herve Bertin Daghela; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, Entomol Sect, D-37073 Gottingen, Germany; [Bisseleua, Herve Bertin Daghela] Columbia Univ, Earth Inst, Ctr Environm Res & Conservat, New York, NY USA	University of Gottingen; Columbia University	Bisseleua, HBD (corresponding author), MDG Ctr West & Cent Afr, Dakar, Senegal.	herve.bisseleua@mdgwca.org	Vidal, Stefan/AAC-3130-2020	Vidal, Stefan/0000-0002-1673-4055	Georg-August University of Goettingen (Dept of Crop Sciences, Entomological section)	Georg-August University of Goettingen (Dept of Crop Sciences, Entomological section)	Financial support was provided by Georg-August University of Goettingen (Dept of Crop Sciences, Entomological section). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisseleua DHB, 2011, ENVIRON ENTOMOL, V40, P111, DOI 10.1603/EN09101; Bisseleua DHB, 2009, CONSERV BIOL, V23, P1176, DOI 10.1111/j.1523-1739.2009.01220.x; Bobo KS, 2006, BIODIVERS CONSERV, V15, P4097, DOI 10.1007/s10531-005-3368-6; Bos MM, 2008, BIOL INVASIONS, V10, P1399, DOI 10.1007/s10530-008-9215-4; Bos MM, 2007, BIODIVERS CONSERV, V16, P2429, DOI 10.1007/s10531-007-9196-0; Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Cicuzza D, 2011, BIOTROPICA, P1, DOI [10.1111/j.1744-7429.2010.00741x, DOI 10.1111/J.1744-7429.2010.00741X]; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; COLWELL RK, 2006, ESTIMATES S STAT EST; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Duguma B, 2001, AGROFOREST SYST, V51, P177, DOI 10.1023/A:1010747224249; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Greenberg R, 2000, ANIM CONSERV, V3, P105, DOI 10.1111/j.1469-1795.2000.tb00235.x; Herve BD, 2008, BIODIVERS CONSERV, V17, P1821, DOI 10.1007/s10531-007-9276-1; Jagoret P, 2009, BIOTECH AGRO SOC ENV, V12, P367; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; Laird SA, 2007, BIODIVERS CONSERV, V16, P2401, DOI 10.1007/s10531-007-9188-0; Laube I, 2008, J ORNITHOL, V149, P181, DOI 10.1007/s10336-007-0258-6; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Ndoye O, 2000, J MOD AFR STUD, V38, P225, DOI 10.1017/S0022278X00003347; Norgrove L, 2009, TROP ECOL, V50, P71; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Philpott SM, 2005, BIOTROPICA, V37, P468, DOI 10.1111/j.1744-7429.2005.00063.x; Philpott SM, 2004, OECOLOGIA, V140, P140, DOI 10.1007/s00442-004-1561-z; Philpott SM, 2008, BIODIVERS CONSERV, V17, P1805, DOI 10.1007/s10531-007-9267-2; Philpott SM, 2006, ECOL ENTOMOL, V31, P369, DOI 10.1111/j.1365-2311.2006.00793.x; Rice RA, 2000, AMBIO, V29, P167, DOI 10.1579/0044-7447-29.3.167; Schroth G, 2004, AGROFORESTRY BIODIVE; See YA, 1996, B ENTOMOL RES, V86, P467, DOI 10.1017/S0007485300035045; Snoeck D, 2010, AGROFOREST SYST, V78, P323, DOI 10.1007/s10457-009-9254-6; Sonwa DJ, 2007, BIODIVERS CONSERV, V16, P2385, DOI 10.1007/s10531-007-9187-1; Sperber CF, 2004, BASIC APPL ECOL, V5, P241, DOI 10.1016/j.baae.2004.04.001; SPSS Inc, 2000, SYST 11 WIND; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Sunderlin WD, 2000, ENVIRON CONSERV, V27, P284, DOI 10.1017/S0376892900000321; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Wielgoss A, 2010, AGR ECOSYST ENVIRON, V135, P253, DOI 10.1016/j.agee.2009.10.003; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zapfack L, 2002, BIODIVERS CONSERV, V11, P2047, DOI 10.1023/A:1020861925294	45	42	43	3	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56115	10.1371/journal.pone.0056115	http://dx.doi.org/10.1371/journal.pone.0056115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520451	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900010
J	Wang, L; Fan, J; Chen, SQ; Zhang, Y; Curiel, TJ; Zhang, B				Wang, Long; Fan, Jie; Chen, Siqi; Zhang, Yi; Curiel, Tyler J.; Zhang, Bin			Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ECTO-5'-NUCLEOTIDASE CD73; ADENOSINE GENERATION; TARGETED DISRUPTION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; TUMOR-GROWTH; TRANSPLANTATION; LYMPHOCYTES; EXPRESSION	CD73 functions as an ecto-5-nucleotidase to produce extracellular adenosine that has anti-inflammatory and immunosuppressive activity. We here demonstrate that CD73 helps control graft-versus-host disease (GVHD) in mouse models. Survival of wild-type (WT) recipients of either allogeneic donor naive CD73 knock-out (KO) or WT T cells was similar suggesting that donor naive T cell CD73 did not contribute to GVHD. By contrast, donor CD73 KO CD4(+)CD25(+) regulatory T cells (Treg) had significantly impaired ability to mitigate GVHD mortality compared to WT Treg, suggesting that CD73 on Treg is critical for GVHD protection. However, compared to donor CD73, recipient CD73 is more effective in limiting GVHD. Pharmacological blockade of A2A receptor exacerbated GVHD in WT recipients, but not in CD73 KO recipients, suggesting that A2 receptor signaling is primarily implicated in CD73-mediated GVHD protection. Moreover, pharmacological blockade of CD73 enzymatic activity induced stronger alloreactive T cell activity, worsened GVHD and enhanced the graft-versusleukemia (GVL) effect. These findings suggest that both donor and recipient CD73 protects against GVHD but also limits GVL effects. Thus, either enhancing or blocking CD73 activity has great potential clinical application in allogeneic bone marrow transplants.	[Wang, Long; Curiel, Tyler J.; Zhang, Bin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Fan, Jie; Chen, Siqi; Zhang, Bin] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, Chicago, IL 60611 USA; [Zhang, Yi; Zhang, Bin] Zhengzhou Univ, Affiliated Hosp 1, Ctr Cell Biotherapy, Dept Bioengn, Zhengzhou, Henan Province, Peoples R China	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Zhengzhou University	Zhang, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA.	bin.zhang@northwestern.edu	Chen, Siqi/AAJ-1568-2020	Chen, Siqi/0000-0002-9498-3823; Zhang, Yi/0000-0001-9861-4681	National Institutes of Health [CA149669]; Liz Tilberis Scholar Award, CTSA [UL1RR025767]; National Natural Science Foundation of China [81171985, 81171986]; Cancer Therapy and Research Center [2P30 CA054174-17]; Hayes and Voelcker Endowments; Holly Beach Public Library Association; Texas STARS Award; Hogg Foundation; Owens Foundation; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA149669] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Liz Tilberis Scholar Award, CTSA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Therapy and Research Center; Hayes and Voelcker Endowments; Holly Beach Public Library Association; Texas STARS Award; Hogg Foundation; Owens Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was in part supported by National Institutes of Health grant CA149669, Liz Tilberis Scholar Award, CTSA grant (UL1RR025767), the National Natural Science Foundation of China (No. 81171985) (BZ), and the Cancer Therapy and Research Center (2P30 CA054174-17) (BZ, TJC); the Hayes and Voelcker Endowments, the Holly Beach Public Library Association, Texas STARS Award, The Hogg Foundation and the Owens Foundation (TJC); the National Natural Science Foundation of China (No. 81171986) (YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas L, 1996, BLOOD, V88, P1755, DOI 10.1182/blood.V88.5.1755.bloodjournal8851755; Airas L, 2000, J IMMUNOL, V165, P5411, DOI 10.4049/jimmunol.165.10.5411; Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Algars A, 2011, BLOOD, V117, P4387, DOI 10.1182/blood-2010-11-321646; Antonioli L, 2011, EUR J PHARMACOL, V650, P639, DOI 10.1016/j.ejphar.2010.10.041; Chen BJ, 2004, BLOOD, V103, P1534, DOI 10.1182/blood-2003-08-2987; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Holler E, 2002, CURR OPIN HEMATOL, V9, P479, DOI 10.1097/00062752-200211000-00002; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Lappas CM, 2010, J LEUKOCYTE BIOL, V87, P345, DOI 10.1189/jlb.0609388; Liang Y, 2008, BLOOD, V111, P954, DOI 10.1182/blood-2007-05-089573; Louis NA, 2008, J IMMUNOL, V180, P4246, DOI 10.4049/jimmunol.180.6.4246; Mikhailov A, 2008, J IMMUNOL, V181, P464, DOI 10.4049/jimmunol.181.1.464; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Ohtsuka T, 2010, J IMMUNOL, V185, P1321, DOI 10.4049/jimmunol.0901847; Regateiro FS, 2011, EUR J IMMUNOL; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Robson SC, 2005, SEMIN THROMB HEMOST, V31, P217, DOI 10.1055/s-2005-869527; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Salcido-Ochoa F, 2010, TRANSPLANT REV-ORLAN, V24, P52, DOI 10.1016/j.trre.2010.01.002; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Tsukamoto H, 2012, BLOOD, V119, P4554, DOI 10.1182/blood-2011-09-375899; van den Brink MRM, 2002, NAT REV IMMUNOL, V2, P273, DOI 10.1038/nri775; Wang L, 2011, J CLIN INVEST, V121, P2371, DOI 10.1172/JCI45559; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yamashita Y, 1998, EUR J IMMUNOL, V28, P2981, DOI 10.1002/(SICI)1521-4141(199810)28:10<2981::AID-IMMU2981>3.0.CO;2-D; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2011, EUR J IMMUNOL, V41, P1231, DOI 10.1002/eji.201041292; Zhang B, 2010, CANCER RES, V70, P6407, DOI 10.1158/0008-5472.CAN-10-1544	53	32	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58397	10.1371/journal.pone.0058397	http://dx.doi.org/10.1371/journal.pone.0058397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520507	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900066
J	Wozniak, MB; Le Calvez-Kelm, F; Abedi-Ardekani, B; Byrnes, G; Durand, G; Carreira, C; Michelon, J; Janout, V; Holcatova, I; Foretova, L; Brisuda, A; Lesueur, F; McKay, J; Brennan, P; Scelo, G				Wozniak, Magdalena B.; Le Calvez-Kelm, Florence; Abedi-Ardekani, Behnoush; Byrnes, Graham; Durand, Geoffroy; Carreira, Christine; Michelon, Jocelyne; Janout, Vladimir; Holcatova, Ivana; Foretova, Lenka; Brisuda, Antonin; Lesueur, Fabienne; McKay, James; Brennan, Paul; Scelo, Ghislaine			Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States	PLOS ONE			English	Article							KIDNEY CANCER; DIFFERENTIAL EXPRESSION; BETA-CATENIN; RNA-SEQ; IDENTIFICATION; SURVIVAL; TUMOR; MICROARRAY; SIGNATURES; VHL	Gene expression microarray and next generation sequencing efforts on conventional, clear cell renal cell carcinoma (ccRCC) have been mostly performed in North American and Western European populations, while the highest incidence rates are found in Central/Eastern Europe. We conducted whole-genome expression profiling on 101 pairs of ccRCC tumours and adjacent non-tumour renal tissue from Czech patients recruited within the "K2 Study'', using the Illumina HumanHT-12 v4 Expression BeadChips to explore the molecular variations underlying the biological and clinical heterogeneity of this cancer. Differential expression analysis identified 1650 significant probes (fold change >= 2 and false discovery rate <0.05) mapping to 630 up- and 720 down-regulated unique genes. We performed similar statistical analysis on the RNA sequencing data of 65 ccRCC cases from the Cancer Genome Atlas (TCGA) project and identified 60% (402) of the downregulated and 74% (469) of the upregulated genes found in the K2 series. The biological characterization of the significantly deregulated genes demonstrated involvement of downregulated genes in metabolic and catabolic processes, excretion, oxidation reduction, ion transport and response to chemical stimulus, while simultaneously upregulated genes were associated with immune and inflammatory responses, response to hypoxia, stress, wounding, vasculature development and cell activation. Furthermore, genome-wide DNA methylation analysis of 317 TCGA ccRCC/adjacent non-tumour renal tissue pairs indicated that deregulation of approximately 7% of genes could be explained by epigenetic changes. Finally, survival analysis conducted on 89 K2 and 464 TCGA cases identified 8 genes associated with differential prognostic outcomes. In conclusion, a large proportion of ccRCC molecular characteristics were common to the two populations and several may have clinical implications when validated further through large clinical cohorts.	[Wozniak, Magdalena B.; Le Calvez-Kelm, Florence; Abedi-Ardekani, Behnoush; Byrnes, Graham; Durand, Geoffroy; Carreira, Christine; Michelon, Jocelyne; Lesueur, Fabienne; McKay, James; Brennan, Paul; Scelo, Ghislaine] Int Agcy Res Canc, F-69372 Lyon, France; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Holcatova, Ivana] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Brisuda, Antonin] Univ Hosp Motol, Fac Med 2, Dept Urol, Prague, Czech Republic	World Health Organization; International Agency for Research on Cancer (IARC); Palacky University Olomouc; Charles University Prague; Masaryk Memorial Cancer Institute; Charles University Prague; Motol University Hospital	Scelo, G (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	SceloG@iarc.fr	Abedi-Ardekani, Behnoush/O-7829-2016; Scelo, Ghislaine/CAF-8077-2022; Lesueur, Fabienne/R-2178-2017; Holcatova, Ivana/C-8327-2017; Janout, Vladimir/M-5133-2014	Abedi-Ardekani, Behnoush/0000-0002-0980-0587; Lesueur, Fabienne/0000-0001-7404-4549; Holcatova, Ivana/0000-0002-1366-0337; Foretova, Lenka/0000-0003-0494-2620; Byrnes, Graham/0000-0003-3893-7539; Brisuda, Antonin/0000-0001-5103-1358; Le Calvez-Kelm, Florence/0000-0003-0063-5068	US NCI U01 [CA155309]; EC [241669]; European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; NATIONAL CANCER INSTITUTE [U01CA155309] Funding Source: NIH RePORTER	US NCI U01; EC(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fund(European Commission); State Budget of the Czech Republic (RECAMO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US NCI U01 grant # CA155309. Additional support for the Czech Republic sample collection and follow-up was provided by the EC FP7 CAGEKID project # 241669, and the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Beleut M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-310; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Boer JM, 2001, GENOME RES, V11, P1861, DOI 10.1101/gr.184501; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Brannon A Rose, 2010, Genes Cancer, V1, P152; Cho M, 2001, BRIT J CANCER, V85, P563, DOI 10.1054/bjoc.2001.1951; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Davidson B, 2012, HUM PATHOL, V43, P684, DOI 10.1016/j.humpath.2011.06.015; Delahunt B, 2009, MODERN PATHOL, V22, pS24, DOI 10.1038/modpathol.2008.183; Diaz-Uriarte R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-30; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Eble JN, 2004, PATHOLOGY GENETICS T; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ficarra V, 2005, CANCER, V103, P68, DOI 10.1002/cncr.20749; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gieseg MA, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-26; Girgis AH, 2012, CANC RES; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kearsey J, 2004, EUR J BIOCHEM, V271, P2584, DOI 10.1111/j.1432-1033.2004.04186.x; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Lane BR, 2009, J UROLOGY, V181, P849, DOI 10.1016/j.juro.2008.10.069; Lin F, 2006, ANN CLIN LAB SCI, V36, P283; Monga SPS, 2002, CANCER RES, V62, P2064; Morikawa T, 2007, CLIN CANCER RES, V13, P5703, DOI 10.1158/1078-0432.CCR-07-0603; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Pantuck AJ, 2003, CLIN CANCER RES, V9, P4641; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sanjmyatav J, 2011, J UROLOGY, V186, P289, DOI 10.1016/j.juro.2011.03.033; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tan WQ, 2011, J UROLOGY, V186, P2071, DOI 10.1016/j.juro.2011.06.049; Tang XX, 2000, P NATL ACAD SCI USA, V97, P10936, DOI 10.1073/pnas.190123297; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vasselli JR, 2003, P NATL ACAD SCI USA, V100, P6958, DOI 10.1073/pnas.1131754100; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wuttig D, 2012, INT J CANCER, V131, pE693, DOI 10.1002/ijc.27419; Wuttig D, 2009, INT J CANCER, V125, P474, DOI 10.1002/ijc.24353; Yoshida Y, 2010, J NEURO-ONCOL, V98, P41, DOI 10.1007/s11060-009-0064-5; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	64	81	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57886	10.1371/journal.pone.0057886	http://dx.doi.org/10.1371/journal.pone.0057886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526956	gold, Green Published, Green Submitted			2022-12-25	WOS:000315637900059
J	Wilson, CH; Indarto, D; Doucet, A; Pogson, LD; Pitman, MR; McNicholas, K; Menz, RI; Overall, CM; Abbott, CA				Wilson, Claire H.; Indarto, Dono; Doucet, Alain; Pogson, Lisa D.; Pitman, Melissa R.; McNicholas, Kym; Menz, R. Ian; Overall, Christopher M.; Abbott, Catherine A.			Identifying Natural Substrates for Dipeptidyl Peptidases 8 and 9 Using Terminal Amine Isotopic Labeling of Substrates (TAILS) Reveals in Vivo Roles in Cellular Homeostasis and Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; STRESS GRANULES; IV; EXPRESSION; CALRETICULIN; ENZYMES; DIPEPTIDYL-PEPTIDASE-4; LOCALIZATION; ARGINYLATION; SPECIFICITY	Dipeptidyl peptidases (DP) 8 and 9 are homologous, cytoplasmic N-terminal post-proline-cleaving enzymes that are anti-targets for the development of DP4 (DPPIV/CD26) inhibitors for treating type II diabetes. To date, DP8 and DP9 have been implicated in immune responses and cancer biology, but their pathophysiological functions and substrate repertoire remain unknown. This study utilizes terminal amine isotopic labeling of substrates (TAILS), an N-terminal positional proteomic approach, for the discovery of in vivo DP8 and DP9 substrates. In vivo roles for DP8 and DP9 in cellular metabolism and homeostasis were revealed via the identification of more than 29 candidate natural substrates and pathways affected by DP8/DP9 overexpression. Cleavage of 14 substrates was investigated in vitro; 9/14 substrates for both DP8 and DP9 were confirmed by MALDI-TOF MS, including two of high confidence, calreticulin and adenylate kinase 2. Adenylate kinase 2 plays key roles in cellular energy and nucleotide homeostasis. These results demonstrate remarkable in vivo substrate overlap between DP8/DP9, suggesting compensatory roles for these enzymes. This work provides the first global investigation into DP8 and DP9 substrates, providing a number of leads for future investigations into the biological roles and significance of DP8 and DP9 in human health and disease.	[Wilson, Claire H.; Indarto, Dono; Pogson, Lisa D.; Pitman, Melissa R.; McNicholas, Kym; Menz, R. Ian; Abbott, Catherine A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Indarto, Dono; Pogson, Lisa D.; Abbott, Catherine A.] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Adelaide, SA 5001, Australia; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Dept Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Dept Med Sci, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Fac Dent, Vancouver, BC V6T 1Z3, Canada	Flinders University South Australia; Flinders University South Australia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca; cathy.abbott@flinders.edu.au	Abbott, Catherine A/A-9121-2008; Indarto, Dono/V-8219-2019	Abbott, Catherine A/0000-0001-8215-4406; Indarto, Dono/0000-0001-7420-5816; McNicholas, Kym/0000-0002-1556-8796; Pitman, Melissa/0000-0002-9587-3837	Canadian Institutes of Health Research Grant [MOP-37937]; Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); Trevor Prescott Freemasons Memorial Scholarship (The Masonic Foundation, Australia); Flinders University Overseas Field Trip Grant; Flinders University Research Scholarship (Flinders University, Australia); Directorate General of Higher Education Ph.D. scholarship from the Indonesian Government; British Columbia Proteomics Network	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); Trevor Prescott Freemasons Memorial Scholarship (The Masonic Foundation, Australia); Flinders University Overseas Field Trip Grant; Flinders University Research Scholarship (Flinders University, Australia); Directorate General of Higher Education Ph.D. scholarship from the Indonesian Government; British Columbia Proteomics Network	This work was supported in part by an anonymous philanthropic grant (to C. A. A.), Canadian Institutes of Health Research Grant MOP-37937 (to C. M. O.), an infrastructure grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research), and by the British Columbia Proteomics Network (to C. M. O.).; Supported by a Trevor Prescott Freemasons Memorial Scholarship (The Masonic Foundation, Australia), a Flinders University Overseas Field Trip Grant to visit the Overall Laboratory (February 2007 to August 2008), and a Flinders University Research Scholarship (Flinders University, Australia).; Employee of the Faculty of Medicine, Sebelas Maret University, Surakarta 57126, Indonesia. Supported by a Directorate General of Higher Education Ph.D. scholarship from the Indonesian Government.	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Ajami K, 2008, FEBS LETT, V582, P819, DOI 10.1016/j.febslet.2008.02.005; Ansorge S, 2009, CLIN CHEM LAB MED, V47, P253, DOI 10.1515/CCLM.2009.063; Bjelke JR, 2006, BIOCHEM J, V396, P391, DOI 10.1042/BJ20060079; Carpio MA, 2010, BIOCHEM J, V429, P63, DOI 10.1042/BJ20091953; Chen YS, 2004, PROTEIN EXPRES PURIF, V35, P142, DOI 10.1016/j.pep.2003.12.019; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Huth W, 2002, BIOCHEM J, V364, P275, DOI 10.1042/bj3640275; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Keller UAD, 2012, BIOL CHEM, V393, P1477, DOI 10.1515/hsz-2012-0269; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lange PF, 2013, CURR OPIN CHEM BIOL, V17, P73, DOI 10.1016/j.cbpa.2012.11.025; Lange PF, 2011, NAT METHODS, V8, P703, DOI 10.1038/nmeth.1669; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; Lee HJ, 2006, J BIOL CHEM, V281, P38653, DOI 10.1074/jbc.M603895200; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Pitman MR, 2010, BIOL CHEM, V391, P959, DOI 10.1515/BC.2010.111; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Reinhold D, 2009, CLIN CHEM LAB MED, V47, P268, DOI 10.1515/CCLM.2009.062; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schlauderer GJ, 1996, PROTEIN SCI, V5, P434; Stremenova J, 2010, INT J ONCOL, V36, P351, DOI 10.3892/ijo_00000506; Sulda ML, 2010, CANCER BIOL THER, V10, P180, DOI 10.4161/cbt.10.2.12168; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wilson CH, 2012, INT J ONCOL, V41, P919, DOI 10.3892/ijo.2012.1522; Yazbeck R, 2010, INFLAMM BOWEL DIS, V16, P1340, DOI 10.1002/ibd.21241; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760	43	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13936	13949		10.1074/jbc.M112.445841	http://dx.doi.org/10.1074/jbc.M112.445841			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23519473	Green Published, hybrid			2022-12-25	WOS:000319253500002
J	Ishii, TM; Kotlova, N; Tapsoba, F; Steinberg, SV				Ishii, Tetsu M.; Kotlova, Natalia; Tapsoba, Franck; Steinberg, Sergey V.			The Long D-stem of the Selenocysteine tRNA Provides Resilience at the Expense of Maximal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; AMINO-ACID; DETERMINANTS; SECONDARY; FEATURES; KINASE; SERINE; LOOP	The D-stem of the selenocysteine tRNA (tRNA(Sec)) contains 2 additional base pairs, which replace tertiary interactions 8-14 and 15-48 universally present in all other cytosolic tRNAs. To study the role of these additional base pairs in the tRNA(Sec) function, we used the instant evolution approach. In vivo screening of six combinatorial gene libraries provided 158 functional variants of the Escherichia coli tRNA(Sec). Analysis of these variants showed that the additional base pairs in the D-stem were not required for the tRNA(Sec) function. Moreover, at lower temperatures, these base pairs notably harmed the tRNA(Sec) activity. However, at elevated temperatures, these base pairs became essential as they made the tRNA structure more stable. The alternative way to stabilize the structure through formation of the standard tertiary interactions was not an option for tRNA(Sec) variants, which suggests that the absence of these interactions and the resulting flexibility of the tertiary structure are essential for tRNA(Sec) function.	[Ishii, Tetsu M.; Kotlova, Natalia; Tapsoba, Franck; Steinberg, Sergey V.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Steinberg, SV (corresponding author), Univ Montreal, Dept Biochem, Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	serguei.chteinberg@umontreal.ca						BARRETT EL, 1979, MOL GEN GENET, V177, P95, DOI 10.1007/BF00267258; BURKARD U, 1988, NUCLEIC ACIDS RES, V16, P11617, DOI 10.1093/nar/16.24.11617; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chiba S, 2010, MOL CELL, V39, P410, DOI 10.1016/j.molcel.2010.07.018; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kotlova N, 2007, J MOL BIOL, V373, P462, DOI 10.1016/j.jmb.2007.07.058; Lee KS, 1997, J MOL BIOL, V269, P732, DOI 10.1006/jmbi.1997.1092; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; STURCHLER C, 1993, NUCLEIC ACIDS RES, V21, P1073, DOI 10.1093/nar/21.5.1073; Takahata M, 2008, J BIOCHEM, V143, P467, DOI 10.1093/jb/mvm247; Tormay P, 1996, MOL MICROBIOL, V21, P1253, DOI 10.1046/j.1365-2958.1996.881450.x; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; WU XQ, 1994, EMBO J, V13, P241, DOI 10.1002/j.1460-2075.1994.tb06254.x; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; Zagryadskaya EI, 2003, NUCLEIC ACIDS RES, V31, P3946, DOI 10.1093/nar/gkg448; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13337	13344		10.1074/jbc.M112.434704	http://dx.doi.org/10.1074/jbc.M112.434704			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525102	Green Published, hybrid			2022-12-25	WOS:000318850300019
J	Gupta, S; Purohit, P; Auerbach, A				Gupta, Shaweta; Purohit, Prasad; Auerbach, Anthony			Function of Interfacial Prolines at the Transmitter-binding Sites of the Neuromuscular Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP; GATING ISOMERIZATION; TRANSITION-STATE; PLAUSIBLE MODEL; CHANNEL; DYNAMICS; PROTEINS; NICOTINE; SUBUNIT; ENERGY	The neuromuscular acetylcholine (ACh) receptor has two conserved prolines in loop D of the complementary subunit at each of its two transmitter-binding sites (alpha-epsilon and alpha-delta). We used single-channel electrophysiology to estimate the energy changes caused by mutations of these prolines with regard to unliganded gating (Delta G(0)) and the affinity change for ACh that increases the open channel probability (Delta G(B)). The effects of mutations of ProD2 (epsilon Pro-121/delta Pro-123) were greater than those of its neighbor (epsilon Pro-120/delta Pro-122) and were greater at alpha-epsilon versus alpha-delta. The main consequence of the congenital myasthenic syndrome mutation epsilon ProD2-L was to impair the establishment of a high affinity for ACh and thus make Delta G(B) less favorable. At both binding sites, most ProD2 mutations decreased constitutive activity (increased Delta G(0)). LRYHQG and RL substitutions reduced substantially the net binding energy (made Delta G(B)(ACh) less favorable) by >= 2 kcal/mol at alpha-epsilon and alpha-delta, respectively. Mutant cycle analyses were used to estimate energy coupling between the two ProD2 residues and between each ProD2 and glycine residues (alpha Gly-147 and alpha Gly-153) on the primary (alpha subunit) side of each binding pocket. The distant binding site prolines interact weakly. ProD2 interacts strongly with alpha Gly-147 but only at alpha-epsilon and only when ACh is present. The results suggest that in the low to-high affinity change there is a concerted inter-subunit strain in the backbones at epsilon ProD2 and alpha Gly-147. It is possible to engineer receptors having a single functional binding site by using a alpha-epsilon or alpha-delta ProD2-R knock-out mutation. In adult-type ACh receptors, the energy from the affinity change for ACh is approximately the same at the two binding sites (approximately -5 kcal/mol).	[Gupta, Shaweta; Purohit, Prasad; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	auerbach@buffalo.edu			National Institutes of Health [NS-23513, NS-064969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064969, R01NS023513, R56NS023513, R37NS023513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-23513 and NS-064969.	Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A., 2013, J MOL BIOL IN PRESS; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bafna PA, 2009, J BIOL CHEM, V284, P8582, DOI 10.1074/jbc.M807152200; Cadugan DJ, 2007, BIOPHYS J, V93, P859, DOI 10.1529/biophysj.107.105171; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Christoph P, 2005, PFLUG ARCH EUR J PHY, V450, P178, DOI 10.1007/s00424-005-1387-5; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; Gupta S, 2011, BIOPHYS J, V100, P904, DOI 10.1016/j.bpj.2010.12.3739; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jadey S, 2013, J GEN PHYSIOL, V141, P95, DOI 10.1085/jgp.201210896; Jadey S, 2012, J GEN PHYSIOL, V140, P17, DOI 10.1085/jgp.201210801; Jadey SV, 2011, P NATL ACAD SCI USA, V108, P4328, DOI 10.1073/pnas.1016617108; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Jha A, 2010, BIOPHYS J, V98, P1840, DOI 10.1016/j.bpj.2010.01.025; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nayak TK, 2012, J GEN PHYSIOL, V139, P349, DOI 10.1085/jgp.201110752; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2012, P NATL ACAD SCI USA, V109, P9384, DOI 10.1073/pnas.1203633109; Purohit P, 2011, MOL PHARMACOL, V79, P351, DOI 10.1124/mol.110.068767; Purohit P, 2010, J GEN PHYSIOL, V135, P321, DOI 10.1085/jgp.200910384; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466	35	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12667	12679		10.1074/jbc.M112.443911	http://dx.doi.org/10.1074/jbc.M112.443911			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519471	hybrid, Green Published			2022-12-25	WOS:000318555100024
J	Ariefiandy, A; Purwandana, D; Seno, A; Ciofi, C; Jessop, TS				Ariefiandy, Achmad; Purwandana, Deni; Seno, Aganto; Ciofi, Claudio; Jessop, Tim S.			Can Camera Traps Monitor Komodo Dragons a Large Ectothermic Predator?	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; CONSERVATION; POPULATIONS; DENSITIES; ABUNDANCE; CONFLICT; WINBUGS; PACKAGE; TIGERS; PREY	Camera trapping has greatly enhanced population monitoring of often cryptic and low abundance apex carnivores. Effectiveness of passive infrared camera trapping, and ultimately population monitoring, relies on temperature mediated differences between the animal and its ambient environment to ensure good camera detection. In ectothermic predators such as large varanid lizards, this criterion is presumed less certain. Here we evaluated the effectiveness of camera trapping to potentially monitor the population status of the Komodo dragon (Varanus komodoensis), an apex predator, using site occupancy approaches. We compared site-specific estimates of site occupancy and detection derived using camera traps and cage traps at 181 trapping locations established across six sites on four islands within Komodo National Park, Eastern Indonesia. Detection and site occupancy at each site were estimated using eight competing models that considered site-specific variation in occupancy (psi) and varied detection probabilities (p) according to detection method, site and survey number using a single season site occupancy modelling approach. The most parsimonious model [psi (site), p (site*survey); omega = 0.74] suggested that site occupancy estimates differed among sites. Detection probability varied as an interaction between site and survey number. Our results indicate that overall camera traps produced similar estimates of detection and site occupancy to cage traps, irrespective of being paired, or unpaired, with cage traps. Whilst one site showed some evidence detection was affected by trapping method detection was too low to produce an accurate occupancy estimate. Overall, as camera trapping is logistically more feasible it may provide, with further validation, an alternative method for evaluating long-term site occupancy patterns in Komodo dragons, and potentially other large reptiles, aiding conservation of this species.	[Ariefiandy, Achmad; Purwandana, Deni] Komodo Survival Program, Denpasar, Bali, Indonesia; [Seno, Aganto] Komodo Natl Pk, Labuan Bajo, Flores, Indonesia; [Ciofi, Claudio] Univ Florence, Dept Anim Biol & Genet, Florence, Italy; [Jessop, Tim S.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Florence; University of Melbourne	Jessop, TS (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	tjessop@unimelb.edu.au	Jessop, Tim/Q-2473-2019; Ciofi, Claudio/AAH-9461-2019	CIOFI, CLAUDIO/0000-0001-8537-8659; Jessop, Tim S./0000-0002-7712-4373; Ariefiandy, Achmad/0000-0003-4085-8354	American Zoological Association	American Zoological Association	Funding was provided through members of the American Zoological Association contributing to the Komodo Species Survival Plan (to AA, DP, TSJ, CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffenberg W, 1981, THE BEHAVIOURAL ECOL; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Ciofi C, 2004, HERPETOL J, V14, P99; Ciofi C, 2002, ZOO AND AQUARIUM BIO, P129; Ciofi C, 2007, COPEIA, P462; Doody JS, 2009, ANIM CONSERV, V12, P46, DOI 10.1111/j.1469-1795.2008.00219.x; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Enge KM, 2004, SOUTHEAST NAT, V3, P571, DOI 10.1656/1528-7092(2004)003[0571:SOTNMV]2.0.CO;2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Green B, 1993, GOANNA THE BIOLOGY O; Griffiths AD, 2007, WILDLIFE RES, V34, P609, DOI 10.1071/WR07024; Harlow Henry J., 2010, International Journal of Zoology, V2010, P1, DOI 10.1155/2010/921371; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE, 2006, PRESENCE 2 4 SOFTWAR; Huey R.B., 1982, Biology of Reptilia, V12, P25; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; IUCN, 2012, THE IUCN RED LIST OF; Jenkins M, 1994, INT TRADE REPTILE SK; Jessop TS, 2007, BIOL CONSERV, V135, P247, DOI 10.1016/j.biocon.2006.10.025; Jessop TS, 2013, BIOL INVASIONS, V15, P1653, DOI 10.1007/s10530-012-0398-3; Jessop TS, 2006, OIKOS, V112, P422, DOI 10.1111/j.0030-1299.2006.14371.x; Jessop TS, 2004, BIOL CONSERV, V117, P463, DOI 10.1016/j.biocon.2003.08.005; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Karanth KU, 1998, ECOLOGY, V79, P2852; Kery M., 2010, INTRO WINBUGS ECOLOG, P302; Khatiwada J.R, 2009, BIAWAK, V3, P100; Laver RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045398; Linkie M, 2010, INTEGR ZOOL, V5, P342, DOI 10.1111/j.1749-4877.2010.00215.x; Luiselli L, 2006, J TROP ECOL, V22, P555, DOI 10.1017/S0266467406003397; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luxmoore R, 1990, REPORT TO THE CITES; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin J, 2009, BIOL CONSERV, V142, P2726, DOI 10.1016/j.biocon.2009.06.027; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; O'Connell AF, 2010, CAMERA TRAPS IN ANIM; Pernetta Angelo P., 2009, Biawak, V3, P37; Ray J. C., 2005, LARGE CARNIVORES CON; Rosellini S, 2008, WILDLIFE RES, V35, P434, DOI 10.1071/WR07030; Roughton CM, 2006, WILDLIFE RES, V33, P193, DOI 10.1071/WR05045; Shine R, 1998, WILDLIFE RES, V25, P437, DOI 10.1071/WR97118; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Sutherland DR, 2011, P ROY SOC B-BIOL SCI, V278, P641, DOI 10.1098/rspb.2010.2103; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thorn M, 2011, BIOL CONSERV, V144, P1799, DOI 10.1016/j.biocon.2011.03.009; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Vanak AT, 2007, WILDLIFE BIOL, V13, P219, DOI 10.2981/0909-6396(2007)13[219:EONTFS]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM	57	28	34	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58800	10.1371/journal.pone.0058800	http://dx.doi.org/10.1371/journal.pone.0058800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527027	Green Published, gold			2022-12-25	WOS:000317562600040
J	Cao, CW; Wang, ZY; Niu, CY; Desneux, N; Gao, XW				Cao, Chuanwang; Wang, Zhiying; Niu, Changying; Desneux, Nicolas; Gao, Xiwu			Transcriptome Profiling of Chironomus kiinensis under Phenol Stress Using Solexa Sequencing Technology	PLOS ONE			English	Article							HYDROCARBON RECEPTOR; TOXICITY; PESTICIDES; QSAR; ANNOTATION; HERBICIDES; BLAST2GO; METAL; TOOL	Phenol is a major pollutant in aquatic ecosystems due to its chemical stability, water solubility and environmental mobility. To date, little is known about the molecular modifications of invertebrates under phenol stress. In the present study, we used Solexa sequencing technology to investigate the transcriptome and differentially expressed genes (DEGs) of midges (Chironomus kiinensis) in response to phenol stress. A total of 51,518,972 and 51,150,832 clean reads in the phenol-treated and control libraries, respectively, were obtained and assembled into 51,014 non-redundant (Nr) consensus sequences. A total of 6,032 unigenes were classified by Gene Ontology (GO), and 18,366 unigenes were categorized into 238 Kyoto Encyclopedia of Genes and Genomes (KEGG) categories. These genes included representatives from almost all functional categories. A total of 10,724 differentially expressed genes (P value <0.05) were detected in a comparative analysis of the expression profiles between phenol-treated and control C. kiinensis including 8,390 upregulated and 2,334 downregulated genes. The expression levels of 20 differentially expressed genes were confirmed by real-time RT-PCR, and the trends in gene expression that were observed matched the Solexa expression profiles, although the magnitude of the variations was different. Through pathway enrichment analysis, significantly enriched pathways were identified for the DEGs, including metabolic pathways, aryl hydrocarbon receptor (AhR), pancreatic secretion and neuroactive ligand-receptor interaction pathways, which may be associated with the phenol responses of C. kiinensis. Using Solexa sequencing technology, we identified several groups of key candidate genes as well as important biological pathways involved in the molecular modifications of chironomids under phenol stress.	[Cao, Chuanwang; Wang, Zhiying] NE Forestry Univ, Dept Forest Protect, Harbin, Peoples R China; [Niu, Changying] Huazhong Agr Univ, Hubei Key Lab Utilizat Insect Resources & Sustain, Wuhan, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France; [Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	Northeast Forestry University - China; Huazhong Agricultural University; INRAE; China Agricultural University	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	gaoxiwu@263.net.cn	Desneux, Nicolas/J-6262-2013		Natural Science Foundation of China [31101676]; Harbin Science and Technology Innovation Talents Special Foundation [2010RFQXS055]; State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences [KF-2008-23]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology Innovation Talents Special Foundation; State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was partly supported by Natural Science Foundation of China (31101676); Harbin Science and Technology Innovation Talents Special Foundation (2010RFQXS055) and State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences (KF-2008-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; AWRC, 1984, 82 AWRC, P224; BARBER JT, 1995, CHEMOSPHERE, V31, P3567, DOI 10.1016/0045-6535(95)00205-M; Budavari S., 1996, MERCK INDEX ENCY CHE; Carstanjen D, 2005, J IMMUNOL, V174, P4613, DOI 10.4049/jimmunol.174.8.4613; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crane M, 2002, ECOTOX ENVIRON SAFE, V53, P361, DOI 10.1016/S0147-6513(02)00038-6; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devillers J, 2004, SAR QSAR ENVIRON RES, V15, P237, DOI 10.1080/10629360410001724905; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Eullaffroy P, 2003, WATER RES, V37, P1983, DOI 10.1016/S0043-1354(02)00621-8; Faria MS, 2007, ECOTOX ENVIRON SAFE, V67, P218, DOI 10.1016/j.ecoenv.2006.11.018; Ge Shi-lin, 2011, Yingyong Shengtai Xuebao, V22, P1900; Ge ShiLin, 2011, Journal of Northeast Forestry University, V39, P108; Goh S.H., 1986, CRITERIA STANDARDS O, V4, P224; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Ibrahim H, 1998, B ENVIRON CONTAM TOX, V60, P448, DOI 10.1007/s001289900646; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kar S, 2010, SAR QSAR ENVIRON RES, V21, P149, DOI 10.1080/10629360903568697; Kumar K. S., 2010, TOXICOL ENV HEALTH, V2, P39; Kuncewicz T, 2001, AM J PHYSIOL-RENAL, V281, pF326, DOI 10.1152/ajprenal.2001.281.2.F326; Lauss M, 2007, PHARMACOGENOMICS, V8, P1063, DOI 10.2217/14622416.8.8.1063; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032288; Maleki A, 2005, AL HAITHAM J SCI TEC, V1, P73; Maleki S, 2008, Pak J Biol Sci, V11, P1286, DOI 10.3923/pjbs.2008.1286.1289; Michalowicz J, 2007, POL J ENVIRON STUD, V16, P347; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; Park JS, 2012, AQUAT TOXICOL, V106, P182, DOI 10.1016/j.aquatox.2011.10.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Rice-Evans C. A., 1998, FLAVONOIDS HLTH DIS; Schuler LJ, 2005, ARCH ENVIRON CON TOX, V49, P173, DOI 10.1007/s00244-004-0224-8; STOM DI, 1981, B ENVIRON CONTAM TOX, V27, P332, DOI 10.1007/BF01611028; Su SY, 2009, J ETHNOPHARMACOL, V123, P68, DOI 10.1016/j.jep.2009.02.027; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; *USEPA, 2000, EPA600R99064 OFF RES; USEPA, 2006, ENERGY STAR OV 2006; VERNIER P, 1995, TRENDS PHARMACOL SCI, V16, P375, DOI 10.1016/S0165-6147(00)89078-1; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XD, 2001, CHEMOSPHERE, V44, P447, DOI 10.1016/S0045-6535(00)00198-3; WARNER MA, 1985, ANESTHESIOLOGY, V62, P366, DOI 10.1097/00000542-198503000-00030; Wilczek G, 2003, COMP BIOCHEM PHYS C, V134, P501, DOI 10.1016/S1532-0456(03)00039-5; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhu H, 2008, J CHEM INF MODEL, V48, P766, DOI 10.1021/ci700443v	58	11	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58914	10.1371/journal.pone.0058914	http://dx.doi.org/10.1371/journal.pone.0058914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527048	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562600044
J	Howick, J; Bishop, FL; Heneghan, C; Wolstenholme, J; Stevens, S; Hobbs, FDR; Lewith, G				Howick, Jeremy; Bishop, Felicity L.; Heneghan, Carl; Wolstenholme, Jane; Stevens, Sarah; Hobbs, F. D. Richard; Lewith, George			Placebo Use in the United Kingdom: Results from a National Survey of Primary Care Practitioners	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CLINICAL-PRACTICE; QUESTIONNAIRE SURVEY; GENERAL-PRACTICE; RESPONSE BIAS; INTERVENTIONS; MEDICINE	Objectives: Surveys in various countries suggest 17% to 80% of doctors prescribe 'placebos' in routine practice, but prevalence of placebo use in UK primary care is unknown. Methods: We administered a web-based questionnaire to a representative sample of UK general practitioners. Following surveys conducted in other countries we divided placebos into 'pure' and 'impure'. 'Impure' placebos are interventions with clear efficacy for certain conditions but are prescribed for ailments where their efficacy is unknown, such as antibiotics for suspected viral infections. 'Pure' placebos are interventions such as sugar pills or saline injections without direct pharmacologically active ingredients for the condition being treated. We initiated the survey in April 2012. Two reminders were sent and electronic data collection closed after 4 weeks. Results: We surveyed 1715 general practitioners and 783 (46%) completed our questionnaire. Our respondents were similar to those of all registered UK doctors suggesting our results are generalizable. 12% (95% CI 10 to 15) of respondents used pure placebos while 97% (95% CI 96 to 98) used impure placebos at least once in their career. 1% of respondents used pure placebos, and 77% (95% CI 74 to 79) used impure placebos at least once per week. Most (66% for pure, 84% for impure) respondents stated placebos were ethical in some circumstances. Conclusion and implications: Placebo use is common in primary care but questions remain about their benefits, harms, costs, and whether they can be delivered ethically. Further research is required to investigate ethically acceptable and cost-effective placebo interventions.	[Howick, Jeremy; Heneghan, Carl; Stevens, Sarah; Hobbs, F. D. Richard] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Bishop, Felicity L.] Univ Southampton, Fac Social & Human Sci, Ctr Applicat Hlth Psychol, Southampton, Hants, England; [Wolstenholme, Jane] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England; [Lewith, George] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Oxford; University of Southampton; University of Oxford; University of Southampton	Howick, J (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	Jeremy.howick@phc.ox.ac.uk	Howick, Jeremy/ADP-7644-2022	Wolstenholme, Jane/0000-0001-7493-1850; Howick, Jeremy/0000-0003-0280-7206; Lay-Flurrie, Sarah/0000-0003-1094-8455; Lewith, George/0000-0002-2364-3960; hobbs, richard/0000-0001-7976-7172; Bishop, Felicity/0000-0002-8737-6662	University of Oxford Department of Primary Care Health Sciences; Southampton Complementary Medical Research Trust [1094802]	University of Oxford Department of Primary Care Health Sciences; Southampton Complementary Medical Research Trust	Jeremy Howick is an NSPCR-NIHR Fellow. The University of Oxford Department of Primary Care Health Sciences and The Southampton Complementary Medical Research Trust (Registered Charity No: 1094802) funded part of the research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti F, 2007, Handb Exp Pharmacol, P393; Benedetti F, 1998, PAIN, V75, P313, DOI 10.1016/S0304-3959(98)00010-4; Benedetti F., 2020, PLACEBO EFFECTS, DOI [10.1093/oso/9780198843177.001.0001, DOI 10.1093/OSO/9780198843177.001.0001]; Benedetti F, 2011, PSYCHOPHARMACOLOGY, V213, P791, DOI 10.1007/s00213-010-2037-y; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Berger JT, 1999, WESTERN J MED, V170, P93; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; COMAROFF J, 1976, SOCIOL REV, V24, P79, DOI 10.1111/j.1467-954X.1976.tb00574.x; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Cunha BA, 2001, MED CLIN N AM, V85, P149, DOI 10.1016/S0025-7125(05)70309-6; de Craen AJM, 1999, J ROY SOC MED, V92, P511, DOI 10.1177/014107689909201005; de Jong V, 2011, J MIND BODY REGULATI, P1; Department of Health, 2011, 2010 11 REF COSTS PU; ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Ernst E, 2000, BMJ-BRIT MED J, V321, P1133, DOI 10.1136/bmj.321.7269.1133; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Foddy B, 2009, AM J BIOETHICS, V9, P4, DOI 10.1080/15265160903318350; Gill P, 1996, BRIT MED J, V312, P819; GMC, 2012, LIST REG MED PRACT S; Golomb B, 2002, JAMA; GOODWIN JS, 1979, ANN INTERN MED, V91, P106, DOI 10.7326/0003-4819-91-1-106; GOTZSCHE PC, 1994, LANCET, V344, P925; GRUNBAUM A, 1986, PSYCHOL MED, V16, P19, DOI 10.1017/S0033291700002506; Health and Social Care Information Centre, 2012, PRESCR COST AN ENGL; Heneghan C, 2007, BRIT J GEN PRACT, V57, P948, DOI 10.3399/096016407782604965; Howick J, 2008, PHILOS ISSUES EVIDEN; Howick J, 2009, AM J BIOETHICS, V9, P34, DOI 10.1080/15265160903090041; Howick JH., 2011, PHILOS EVIDENCE BASE; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Imrie R, 2000, COMPLEMENT THER MED, V8, P123, DOI 10.1054/ctim.2000.0370; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Makris UE, 2010, J RHEUMATOL, V37, P1236, DOI 10.3899/jrheum.090935; Mayr A, 2012, J CLIN EPIDEMIOL, V65, P970, DOI 10.1016/j.jclinepi.2012.03.005; Meissner K, 2012, FAM PRACT, V29, P79, DOI 10.1093/fampra/cmr045; Moerman Daniel E., 2002, CAMBRIDGE STUDIES ME; Murray E, 2007, BRIT J GEN PRACT, V57, P939, DOI 10.3399/096016407782605045; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; Nunn R., 2009, BMJ-BRIT MED J, V338, P1015; Reame NK, 2005, MENOPAUSE, V12, P4, DOI 10.1097/00042192-200512010-00003; Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3; Shapiro AK, 1978, HDB PSYCHOTHERAPY BE, P369; Shermon R, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0332-z; SMITH R, 1991, BRIT MED J, V303, P798, DOI 10.1136/bmj.303.6806.798; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Ward KE, 2010, AM J HEALTH-SYST PH, V67, P206, DOI 10.2146/ajhp080603; World Medical Association (WMA), 2008, DECL HELS; WORSLEY A, 1984, HUM NUTR-APPL NUTR, V38A, P29	53	96	96	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58247	10.1371/journal.pone.0058247	http://dx.doi.org/10.1371/journal.pone.0058247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23526969	Green Published, gold, Green Accepted			2022-12-25	WOS:000317562600014
J	Naish, D; Simpson, M; Dyke, G				Naish, Darren; Simpson, Martin; Dyke, Gareth			A New Small-Bodied Azhdarchoid Pterosaur from the Lower Cretaceous of England and Its Implications for Pterosaur Anatomy, Diversity and Phylogeny	PLOS ONE			English	Article							ISLE-OF-WIGHT; NORTHEASTERN CHINA; LIAONING PROVINCE; PTERODACTYLOID PTEROSAUR; FEATHERED DINOSAURS; YIXIAN FORMATION; GERMANY; TAPEJARIDAE; EVOLUTION; LIMESTONE	Background: Pterosaurs have been known from the Cretaceous sediments of the Isle of Wight (southern England, United Kingdom) since 1870. We describe the three-dimensional pelvic girdle and associated vertebrae of a small near-adult pterodactyloid from the Atherfield Clay Formation (lower Aptian, Lower Cretaceous). Despite acknowledged variation in the pterosaur pelvis, previous studies have not adequately sampled or incorporated pelvic characters into phylogenetic analyses. Methodology/Principal Findings: The new specimen represents the new taxon Vectidraco daisymorrisae gen. et sp. nov., diagnosed by the presence of a concavity posterodorsal to the acetabulum and the form of its postacetabular process on the ilium. Several characters suggest that Vectidraco belongs to Azhdarchoidea. We constructed a pelvis-only phylogenetic analysis to test whether the pterosaur pelvis carries a useful phylogenetic signal. Resolution in recovered trees was poor, but they approximately matched trees recovered from analyses of total evidence. We also added Vectidraco and our pelvic characters to an existing total-evidence matrix for pterosaurs. Both analyses recovered Vectidraco within Azhdarchoidea. Conclusions/Significance: The Lower Cretaceous strata of western Europe have yielded members of several pterosaur lineages, but Aptian pterosaurs from western Europe are rare. With a pelvis length of 40 mm, the new animal would have had a total length of c. 350 mm, and a wingspan of c. 750 mm. Barremian and Aptian pterodactyloids from western Europe show that small-bodied azhdarchoids lived alongside ornithocheirids and istiodactylids. This assemblage is similar in terms of which lineages are represented to the coeval beds of Liaoning, China; however, the number of species and specimens present at Liaoning is much higher. While the general phylogenetic composition of western European and Chinese communities appear to have been approximately similar, the differences may be due to different palaeoenvironmental and depositional settings. The western Europe pterodactyloid record may therefore be artificially low in diversity due to preservational factors.	[Naish, Darren; Simpson, Martin; Dyke, Gareth] Univ Southampton, Southampton, Hants, England; [Dyke, Gareth] Univ Southampton, Inst Life Sci, Southampton, Hants, England	University of Southampton; University of Southampton	Naish, D (corresponding author), Univ Southampton, Southampton, Hants, England.	eotyrannus@gmail.com	Dyke, Gareth/AAJ-9320-2020	Dyke, Gareth/0000-0002-8390-7817				Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Andres B, 2010, J VERTEBR PALEONTOL, V30, P163, DOI 10.1080/02724630903409220; Averianov A. O., 2010, P ZOOLOGICAL I RUSSI, V314, P246; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett S.C., 1990, Journal of Vertebrate Paleontology, V10, P80; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Bennett SC, 1996, J VERTEBR PALEONTOL, V16, P432, DOI 10.1080/02724634.1996.10011332; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Elgin R, 2012, TAPEJARA WELLNHOFERI; Elgin Ross A., 2011, Swiss Journal of Palaeontology, V130, P259, DOI 10.1007/s13358-011-0017-4; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Frey Eberhard, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P379; Vidarte CF, 2010, BOL GEOL MIN, V121, P311; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Guo ZF, 2003, SCI CHINA SER D, V46, P1261, DOI 10.1360/03yd0071; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019790; Hooley R. W., 1913, Quarterly Journal of the Geological Society of London, V69; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Hooley R. W., 1907, Quarterly Journal of the Geological Society of London, V63; Howse S.C.B., 2001, DINOSAURS ISLE WIGHT, P324; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hyder ES, 2012, ACTA PALAEONTOLOGICA; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jiang Shun-Xing, 2011, Vertebrata Palasiatica, V49, P172; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P683; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Lu JC, 2010, ACTA GEOL SIN-ENGL, V84, P241; Lue Junchang, 2008, Zitteliana Reihe B, V28, P229; Maisch MW, 2004, CRETACEOUS RES, V25, P625, DOI 10.1016/j.cretres.2004.06.002; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Martill David M., 2008, Zitteliana Reihe B, V28, P209; Martill DM., 2001, DINOSAURS ISLE WIGHT; Martill DM, 2011, ENGLISH WEALDEN FOSS, P370; Martill DM, 2001, DINOSAURS ISLE WIGHT, P49; Naish D., 2011, ENGLISH WEALDEN FOSS, P526; Naish D, 2011, CRETACEOUS RES, V32, P464, DOI 10.1016/j.cretres.2011.03.001; Norman D., 2011, ENGLISH WEALDEN FOSS, P407; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Owen R., 1861, PALAEONTOGRAPHICAL 1, P1; OWEN R, 1870, PALAEONTOGRAPHICAL S, P41; Owen R, 1874, PALAEONTOGRAPHICAL S, P1; Romer A, 1956, OSTEOLOGY REPTILES; Salisbury S.W., 2011, ENGLISH WEALDEN FOSS, P305; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Sayao J.M., 2006, ESTUDOS GEOL GICOS, V16, P16; Seeley H. G., 1901, DRAGONS AIR ACCOUNT; SIMPSON M I, 1985, Proceedings of the Geologists' Association, V96, P23; Steel L, 2005, CRETACEOUS RES, V26, P686, DOI 10.1016/j.cretres.2005.03.005; Sweetman SC, 2010, J IBER GEOL, V36, P225, DOI 10.5209/rev_JIGE.2010.v36.n2.9; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Unwin D., 2007, CRATO FOSSIL BEDS BR, P475, DOI 10.1017/CBO9780511535512.018; UNWIN D M, 1992, Journal of Vertebrate Paleontology, V12, p57A; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2004, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V22, P39; Unwin David M., 2000, P420; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Veldmeijer Andre J., 2003, Scripta Geologica, V125, P35; Vullo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038900; Vullo R, 2009, GEOL MAG, V146, P931, DOI 10.1017/S0016756809990525; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wang XL, 2010, AN ACAD BRAS CIENC, V82, P1045, DOI 10.1590/S0001-37652010000400024; Wang XL, 2009, AN ACAD BRAS CIENC, V81, P793, DOI 10.1590/S0001-37652009000400016; Wellnhofer P., 1988, Historical Biology, V1, P3; WELLNHOFER P, 1974, Annals of Carnegie Museum, V45, P5; Wellnhofer P., 1978, TEIL 19 PTEROSAURIA, P82; WELLNHOFER P, 1970, BAYERISCHE AKAD WISS, V141, P1; Wellnhofer P., 1975, ALLGEMEINE SKELETTMO, VA148, P1; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176; Williston SW, 1903, FIELD COLUMBIAN MUSE, V78, P125; Witton MP, 2009, CRETACEOUS RES, V30, P676, DOI 10.1016/j.cretres.2008.12.004; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Xiaolin W, 2012, NATURWISSENSCHAFTEN, V99, P249; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Young C.C, 1964, VERTEBRATA PALA SIAT, V8, P221	84	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58451	10.1371/journal.pone.0058451	http://dx.doi.org/10.1371/journal.pone.0058451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526986	Green Published, Green Accepted, gold			2022-12-25	WOS:000316411600007
J	Yoshimura, T; Howard, OMZ; Ito, T; Kuwabara, M; Matsukawa, A; Chen, KQ; Liu, Y; Liu, MY; Oppenheim, JJ; Wang, JM				Yoshimura, Teizo; Howard, O. M. Zack; Ito, Toshihiro; Kuwabara, Masaki; Matsukawa, Akihiro; Chen, Keqiang; Liu, Ying; Liu, Mingyong; Oppenheim, Joost J.; Wang, Ji Ming			Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells	PLOS ONE			English	Article							MACROPHAGE INFILTRATION; TUMOR MICROENVIRONMENT; INFLAMMATORY MONOCYTES; SUPPRESSOR-CELLS; MAMMARY-TUMORS; RECRUITMENT; MCP-1; PURIFICATION; ANGIOGENESIS; EXPRESSION	MCP-1/CCL2 plays an important role in the initiation and progression of cancer. Since tumor cells produce MCP-1, they are considered to be the main source of this chemokine. Here, we examined whether MCP-1 produced by non-tumor cells affects the growth and lung metastasis of 4T1 breast cancer cells by transplanting them into the mammary pad of WT or MCP-1(-/-) mice. Primary tumors at the injected site grew similarly in both mice; however, lung metastases were markedly reduced in MCP-1(-/-) mice, with significantly longer mouse survival. High levels of MCP-1 mRNA were detected in tumors growing in WT, but not MCP-1(-/-) mice. Serum MCP-1 levels were increased in tumor-bearing WT, but not MCP-1(-/-) mice. Transplantation of MCP-1(-/-) bone marrow cells into WT mice did not alter the incidence of lung metastasis, whereas transplantation of WT bone marrow cells into MCP-1(-/-) mice increased lung metastasis. The primary tumors of MCP-1(-/-) mice consistently developed necrosis earlier than those of WT mice and showed decreased infiltration by macrophages and reduced angiogenesis. Interestingly, 4T1 cells that metastasized to the lung constitutively expressed elevated levels of MCP-1, and intravenous injection of 4T1 cells producing a high level of MCP-1 resulted in increased tumor foci in the lung of WT and MCP-1(-/-) mice. Thus, stromal cell-derived MCP-1 in the primary tumors promotes lung metastasis of 4T1 cells, but tumor cell-derived MCP-1 can also contribute once tumor cells enter the circulation. A greater understanding of the source and role of this chemokine may lead to novel strategies for cancer treatment.	[Yoshimura, Teizo; Howard, O. M. Zack; Chen, Keqiang; Liu, Ying; Liu, Mingyong; Oppenheim, Joost J.; Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Ito, Toshihiro; Kuwabara, Masaki; Matsukawa, Akihiro] Okayama Univ, Dept Pathol & Expt Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Okayama University	Yoshimura, T (corresponding author), NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA.	yoshimut@mail.nih.gov	Howard, O M Zack/B-6117-2012	Howard, O M Zack/0000-0002-0505-7052; Yoshimura, Teizo/0000-0002-3853-2075; Matsukawa, Akihiro/0000-0002-5081-6089	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC010015] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Arderiu G, 2011, ARTERIOSCL THROM VAS, V31, P2607, DOI 10.1161/ATVBAHA.111.233536; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BOTTAZZI B, 1990, INT J CANCER, V45, P795, DOI 10.1002/ijc.2910450436; BOTTAZZI B, 1992, J IMMUNOL, V148, P1280; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Davidson B, 2008, BREAST J, V14, P476, DOI 10.1111/j.1524-4741.2008.00625.x; FRANCI C, 1995, J IMMUNOL, V154, P6511; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Garber K, 2009, J NATL CANCER I, V101, P1110, DOI 10.1093/jnci/djp266; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Heppner GH, 2000, BREAST CANCER RES, V2, P331; HIROSE K, 1995, BRIT J CANCER, V72, P708, DOI 10.1038/bjc.1995.398; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; ROLLINS BJ, 1991, MOL CELL BIOL, V11, P3125, DOI 10.1128/MCB.11.6.3125; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Stathopoulos GT, 2008, JNCI-J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Wang JM, 1998, INT J CANCER, V75, P900, DOI 10.1002/(SICI)1097-0215(19980316)75:6<900::AID-IJC13>3.0.CO;2-6; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; YAMASHIRO S, 1994, AM J PATHOL, V145, P856; YOSHIMURA T, 1993, J IMMUNOL, V151, P6225; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449	49	74	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58791	10.1371/journal.pone.0058791	http://dx.doi.org/10.1371/journal.pone.0058791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527025	Green Submitted, gold, Green Published			2022-12-25	WOS:000316411600011
J	Zhuang, PY; Shen, J; Zhu, XD; Zhang, JB; Tang, ZY; Qin, LX; Sun, HC				Zhuang, Peng-Yuan; Shen, Jun; Zhu, Xiao-Dong; Zhang, Ju-Bo; Tang, Zhao-You; Qin, Lun-Xiu; Sun, Hui-Chuan			Direct Transformation of Lung Microenvironment by Interferon- a Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-C VIRUS; IN-VIVO SELECTION; COMBINATION THERAPY; CURATIVE RESECTION; NUDE-MICE; EXTRAHEPATIC METASTASES; INTRAHEPATIC RECURRENCE; PULMONARY METASTASIS; TUMOR ANGIOGENESIS; CONTROLLED-TRIAL	Background: Interferon (IFN)-alpha is effective in inhibiting tumor growth and metastasis of hepatocellular carcinoma (HCC). However, the biologic mechanisms of IFN-alpha treatment in lung metastasis are not yet clear. Methods: The effect of IFN-alpha treatment was studied by using an orthotopic xenograft model and measuring tumor size and lung metastasis. Pretreatment with IFN-alpha before implantation of tumor was done to explore the effect of IFN-alpha on lung tissues. Cytokines and macrophages were measured by immunohistochemistry and/or PCR assay, using human origin or mouse origin primers to differentiate the sources. Circulating tumor cells (CTCs) were also assayed by flow cytometry. Results: IFN-alpha treatment did not decrease the number of CTCs (0.075%+/- 0.020% versus 0.063%+/- 0.018%, P = 0.574, IFN-alpha-treated versus control groups), but did decrease the number and size of lung metastasis (number: 1.75 +/- 1.0 versus 28.0 +/- 6.3, P = 0.008; size [pixels]: 116.8 +/- 72.2 versus 5226.4 +/- 1355.7, P = 0.020), and inhibited macrophage infiltration (0.20% +/- 0.04% versus 1.36%+/- 0.21%, P = 0.0058) and alteration of matrix metalloproteinase (MMP)-9 expression (mean integrated optical density (IOD): 5.1 +/- 1.7 versus 21.9 +/- 0.4, P<0.000) in the lung, which was independent of the primary tumor. Conclusion: IFN-alpha inhibited lung metastasis by directly modulating the lung microenvironment.	[Zhuang, Peng-Yuan; Shen, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China; [Zhuang, Peng-Yuan; Zhu, Xiao-Dong; Zhang, Ju-Bo; Tang, Zhao-You; Qin, Lun-Xiu; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Zhuang, Peng-Yuan; Zhu, Xiao-Dong; Zhang, Ju-Bo; Tang, Zhao-You; Qin, Lun-Xiu; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China.	toxoy@163.com	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81101851]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant support, National Natural Science Foundation of China (No. 81101851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii S, 1998, J Hepatobiliary Pancreat Surg, V5, P86, DOI 10.1007/PL00009956; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kubo S, 2001, ANN INTERN MED, V134, P963, DOI 10.7326/0003-4819-134-10-200105150-00010; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Lin SM, 2004, CANCER-AM CANCER SOC, V100, P376, DOI 10.1002/cncr.20004; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Nagano H, 2007, CANCER-AM CANCER SOC, V110, P2493, DOI 10.1002/cncr.23033; Nakamura M, 2008, CANCER, V112, P1765, DOI 10.1002/cncr.23356; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poon RTP, 2002, J AM COLL SURGEONS, V195, P311, DOI 10.1016/S1072-7515(02)01226-7; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Shiratori Y, 2003, ANN INTERN MED, V138, P299, DOI 10.7326/0003-4819-138-4-200302180-00008; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Titus B, 2005, CANCER RES, V65, P7320, DOI 10.1158/0008-5472.CAN-05-1403; Tomimaru Y, 2006, AM J SURG, V192, P46, DOI 10.1016/j.amjsurg.2005.12.006; Uka K, 2008, ONCOLOGY-BASEL, V75, P8, DOI 10.1159/000151614; van Deventer HW, 2005, CANCER RES, V65, P3374, DOI 10.1158/0008-5472.CAN-04-2616; von Marschall Z, 2003, J NATL CANCER I, V95, P437, DOI 10.1093/jnci/95.6.437; Wada H, 2007, ONCOL REP, V18, P801; Wang L, 2003, J GASTROINTEST SURG, V7, P587, DOI 10.1016/S1091-255X(03)00072-6; Wang L, 2000, HEPATOLOGY, V32, P43, DOI 10.1053/jhep.2000.8525; Yang BW, 2008, EUR J GASTROEN HEPAT, V20, P1077, DOI 10.1097/MEG.0b013e3283050a67; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521; Zhuang PY, 2010, J CANCER RES CLIN, V136, P1891, DOI 10.1007/s00432-010-0848-1	39	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58913	10.1371/journal.pone.0058913	http://dx.doi.org/10.1371/journal.pone.0058913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527047	Green Published, gold, Green Submitted			2022-12-25	WOS:000316411600017
J	Orimoto, A; Suzuki, T; Ueno, A; Kawai, T; Nakamura, H; Kanamori, T				Orimoto, Ai; Suzuki, Takahiro; Ueno, Atsuko; Kawai, Tatsushi; Nakamura, Hiroshi; Kanamori, Takao			Effect of 2-Hydroxyethyl Methacrylate on Antioxidant Responsive Element-Mediated Transcription: A Possible Indication of Its Cytotoxicity	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; REGULATORY MECHANISMS; DENTAL ADHESIVES; PHASE-2 RESPONSE; EPITHELIAL-CELLS; RESIN MONOMERS; IN-VITRO; KEAP1; NRF2	Background: The resin monomer 2-hydroxyethyl methacrylate (HEMA) is known to be more cytotoxic than methyl methacrylate (MMA). Using a luciferase reporter assay system, we previously showed that MMA activates the glutathione S-transferase alpha 1 gene (Gsta1) promoter through the anti-oxidant responsive element (ARE). However, it is not known whether HEMA induces ARE-mediated transcription. Methodology/Principal Findings: We further developed the reporter system and studied the concentration-dependent effect of HEMA on ARE enhancer activity. The revised system employed HepG2 cells stably transfected with a destabilized luciferase reporter vector carrying 2 copies of the 41-bp ARE region of Gsta1. In this system, MMA increased ARE activity by 244-fold at 30 mM; HEMA augmented ARE activity at 3 mM more intensely than MMA (36-fold versus 11-fold) and was equipotent as MMA at 10 mM (56-fold activation); however, HEMA failed to increase ARE activity at 30 mM. In HepG2 cells, HEMA detectably lowered the cellular glutathione levels at 10 mM and cell viability at 30 mM, but MMA did not. Conclusions: These results suggest that the low-concentration effect of HEMA on ARE activity reflects its cytotoxicity. Our reporter system used to examine ARE activity may be useful for evaluating cytotoxicities of resin monomers at concentrations lower than those for which cell viabilities are reduced.	[Orimoto, Ai; Nakamura, Hiroshi] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 464, Japan; [Suzuki, Takahiro; Kanamori, Takao] Aichi Gakuin Univ, Sch Dent, Dept Biochem, Nagoya, Aichi 464, Japan; [Ueno, Atsuko] Aichi Gakuin Univ, Sch Dent, Dept Gerodontol, Nagoya, Aichi 464, Japan; [Kawai, Tatsushi] Aichi Gakuin Univ, Sch Dent, Dept Dent Mat Sci, Nagoya, Aichi 464, Japan	Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University	Orimoto, A (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Endodont, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	orimoto@dpc.agu.ac.jp; tsuzuki@dpc.agu.ac.jp			Strategic Research AGU-Platform Formation; Japan Society for the Promotion of Science (JSPS)	Strategic Research AGU-Platform Formation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Strategic Research AGU-Platform Formation (2008 "2012") and by Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS, to T. Kawai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakopoulou A, 2009, INT J MOL SCI, V10, P3861, DOI 10.3390/ijms10093861; Bouillaguet S, 1996, J ENDODONT, V22, P244, DOI 10.1016/S0099-2399(06)80141-X; Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Demirci M, 2008, DENT MATER, V24, P362, DOI 10.1016/j.dental.2007.06.009; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430; Filing RS, 1992, P NATL ACAD SCI USA, V89, P668; Fujisawa S, 2009, DENT MATER J, V28, P722, DOI 10.4012/dmj.28.722; Geurtsen W, 1998, J DENT RES, V77, P2012, DOI 10.1177/00220345980770121001; Geurtsen W, 1999, J BIOMED MATER RES, V48, P772, DOI 10.1002/(SICI)1097-4636(1999)48:6<772::AID-JBM2>3.0.CO;2-X; HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201; Hara H, 2006, J NEUROSCI RES, V84, P860, DOI 10.1002/jnr.20974; Hattori N, 2008, J DENT RES, V87, P1117, DOI 10.1177/154405910808701214; Ishikawa A, 2006, DENT MATER J, V25, P205, DOI 10.4012/dmj.25.205; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Kaspar JW, 2012, J CELL SCI, V125, P1027, DOI 10.1242/jcs.097295; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; NAKABAYASHI N, 1992, DENT MATER, V8, P125, DOI 10.1016/0109-5641(92)90067-M; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nyberg SL, 2005, LIVER TRANSPLANT, V11, P901, DOI 10.1002/lt.20446; Paranjpe A, 2005, J DENT RES, V84, P172, DOI 10.1177/154405910508400212; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001; Schweikl H, 2001, J DENT RES, V80, P1615, DOI 10.1177/00220345010800070401; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Van Landuyt KL, 2008, DENT MATER, V24, P1412, DOI 10.1016/j.dental.2008.02.018; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58907	10.1371/journal.pone.0058907	http://dx.doi.org/10.1371/journal.pone.0058907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516576	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400076
J	Dressaire, C; Picard, F; Redon, E; Loubiere, P; Queinnec, I; Girbal, L; Cocaign-Bousquet, M				Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Queinnec, Isabelle; Girbal, Laurence; Cocaign-Bousquet, Muriel			Role of mRNA Stability during Bacterial Adaptation	PLOS ONE			English	Article							RATE REGULATED GENES; CODON USAGE BIAS; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; DECAY; TRANSCRIPTOME; DEGRADATION; EXPRESSION; EFFICIENCY; CLEAVAGE	Bacterial adaptation involves extensive cellular reorganization. In particular, growth rate adjustments are associated with substantial modifications of gene expression and mRNA abundance. In this work we aimed to assess the role of mRNA degradation during such variations. A genome-wide transcriptomic-based method was used to determine mRNA half-lives. The model bacterium Lactococcus lactis was used and different growth rates were studied in continuous cultures under isoleucine-limitation and in batch cultures during the adaptation to the isoleucine starvation. During continuous isoleucine-limited growth, the mRNAs of different genes had different half-lives. The stability of most of the transcripts was not constant, and increased as the growth rate decreased. This half-life diversity was analyzed to investigate determinants of mRNA stability. The concentration, length, codon adaptation index and secondary structures of mRNAs were found to contribute to the determination of mRNA stability in these conditions. However, the growth rate was, by far, the most influential determinant. The respective influences of mRNA degradation and transcription on the regulation of intra-cellular transcript concentration were estimated. The role of degradation on mRNA homeostasis was clearly evidenced: for more than 90% of the mRNAs studied during continuous isoleucine-limited growth of L. lactis, degradation was antagonistic to transcription. Although both transcription and degradation had, opposite effects, the mRNA changes in response to growth rate were driven by transcription. Interestingly, degradation control increased during the dynamic adaptation of bacteria as the growth rate reduced due to progressive isoleucine starvation in batch cultures. This work shows that mRNA decay differs between gene transcripts and according to the growth rate. It demonstrates that mRNA degradation is an important regulatory process involved in bacterial adaptation. However, its impact on the regulation of mRNA levels is smaller than that of transcription in the conditions studied.	[Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Queinnec, Isabelle; Girbal, Laurence; Cocaign-Bousquet, Muriel] Univ Toulouse, Toulouse, France; [Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Girbal, Laurence; Cocaign-Bousquet, Muriel] Inst Natl Sci Appl, UPS, INP, LISBP, F-31077 Toulouse, France; [Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Girbal, Laurence; Cocaign-Bousquet, Muriel] INRA, Ing Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Girbal, Laurence; Cocaign-Bousquet, Muriel] CNRS, UMR5504, Toulouse, France; [Queinnec, Isabelle] CNRS, LAAS, F-31077 Toulouse, France	Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Dressaire, C (corresponding author), Univ Toulouse, Toulouse, France.	clementine.dressaire@insa-toulouse.fr		GIRBAL, Laurence/0000-0002-8773-4829	Institut National de la Recherche Agronomique Integrative Biology Program (agroBI)	Institut National de la Recherche Agronomique Integrative Biology Program (agroBI)	This work was supported by the Institut National de la Recherche Agronomique Integrative Biology Program (agroBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Babu MMG, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-49; BECHHOFER DH, 1989, J BACTERIOL, V171, P5803, DOI 10.1128/jb.171.11.5803-5811.1989; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Condon C, 2011, CURR OPIN MICROBIOL, V14, P148, DOI 10.1016/j.mib.2011.01.010; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Dressaire C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S18; Dressaire C, 2010, MOL BIOSYST, V6, P1255, DOI 10.1039/c001702g; Dressaire C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000606; Dressaire C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-343; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Feng HH, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/617509; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; FISHOV I, 1995, MOL MICROBIOL, V15, P789, DOI 10.1111/j.1365-2958.1995.tb02349.x; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; Lackner DH, 2008, INT REV CEL MOL BIO, V271, P199, DOI 10.1016/S1937-6448(08)01205-7; Lahtvee PJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-12; Lenz G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028544; Mackie GA, 1997, J BIOL CHEM, V272, P609; Picard F, 2012, BMC GENOMIC IN PRESS; Redon E, 2005, J BIOL CHEM, V280, P36380, DOI 10.1074/jbc.M506006200; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591; SANDLER P, 1989, J BACTERIOL, V171, P6680, DOI 10.1128/jb.171.12.6680-6688.1989; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Silva IJ, 2011, WIRES RNA, V2, P818, DOI 10.1002/wrna.94; Takayama K, 2000, ENVIRON MICROBIOL, V2, P355, DOI 10.1046/j.1462-2920.2000.00119.x; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410	43	36	37	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59059	10.1371/journal.pone.0059059	http://dx.doi.org/10.1371/journal.pone.0059059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516597	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200130
J	Mathews, P; Sear, R				Mathews, Paul; Sear, Rebecca			Family and Fertility: Kin Influence on the Progression to a Second Birth in the British Household Panel Study	PLOS ONE			English	Article							CHILD-CARE; DEMOGRAPHIC-TRANSITION; WESTERN-GERMANY; EVOLUTION; GRANDPARENTS; PERSONALITY; EUROPE; TIME; UK; REPRODUCTION	Particular features of human female life history, such as short birth intervals and the early cessation of female reproduction (menopause), are argued to be evidence that humans are 'cooperative breeders', with a reproductive strategy adapted to conditions where mothers receive substantial assistance in childraising. Evolutionary anthropologists have so far largely focussed on measuring the influence of kin on reproduction in natural fertility populations. Here we look at the effect in a present-day low-fertility population, by analysing whether kin affect parity progression in the British Household Panel Study. Two explanatory variables related to kin influence significantly increase the odds of a female having a second birth: i) having relatives who provide childcare and ii) having a larger number of frequently contacted and emotionally close relatives. Both effects were measured subject to numerous socio-economic controls and appear to be independent of one another. We therefore conclude that kin may influence the progression to a second birth. This influence is possibly due to two proximate mechanisms: kin priming through communication and kin assistance with childcare.	[Mathews, Paul] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England; [Sear, Rebecca] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England	University of Essex; University of London; London School of Hygiene & Tropical Medicine	Mathews, P (corresponding author), Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England.	pmathews@essex.ac.uk	Sear, Rebecca/K-9616-2019	Sear, Rebecca/0000-0002-4315-0223	Economic and Social Research Council [EBB5800]; ESRC [ES/H00811X/1, ES/I03727X/1] Funding Source: UKRI; Economic and Social Research Council [ES/H00811X/1, ES/I03727X/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The first author was funded by the Economic and Social Research Council award EBB5800. http://www.esrc.ac.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.D., 1984, EVENT HIST ANAL REGR; Alvergne A, 2010, P NATL ACAD SCI; [Anonymous], 2007, ENDS MEANS FUTURE RO; Asendorpf JB, 1998, J PERS SOC PSYCHOL, V74, P1531, DOI 10.1037/0022-3514.74.6.1531; Attias-Donfut Claudine, 2005, Eur J Ageing, V2, P161, DOI 10.1007/s10433-005-0008-7; AXINN WG, 1994, DEMOGRAPHY, V31, P65, DOI 10.2307/2061908; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; Bell A, 2005, USE CHILDCARE FAMILI; Box-Steffensmeier JanetM., 2004, EVENT HIST MODELING; Burgless RL, 2005, EVOLUTIONARY PERSPEC; CASPI A, 1999, HDB PERSONALITY THEO; Clarke L, 2003, GRANDPARENTHOOD ITS; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Coleman DA, 2010, POP STUD-J DEMOG, V64, P19, DOI 10.1080/00324720903391201; COSTA PT, 1992, PERS INDIV DIFFER, V13, P653, DOI 10.1016/0191-8869(92)90236-I; DAVIS K, 1956, ECON DEV CULT CHANGE, V4, P211, DOI 10.1086/449714; Del Boca D, 2002, J POPUL ECON, V15, P549, DOI 10.1007/s001480100089; Engelhardt H, 2004, EUR J POPUL, V20, P35, DOI 10.1023/B:EUJP.0000014543.95571.3b; Fergusson E, 2008, J CHILD PSYCHOL PSYC, V49, P161, DOI 10.1111/j.1469-7610.2007.01840.x; Gray A, 2005, J SOC POLICY, V34, P557, DOI 10.1017/S0047279405009153; Greene ME, 2000, POPUL DEV REV, V26, P81, DOI 10.1111/j.1728-4457.2000.00081.x; Grundy E., 2006, CAMBRIDGE SOCIOLEGAL, P195; Grundy E., 1999, POPULATION TRENDS, V97, P19; Gutman D, 1988, RECLAIMED POWERS NEW; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hank K, 2003, J MARRIAGE FAM, V65, P584, DOI 10.1111/j.1741-3737.2003.00584.x; Hank K, 2009, J FAM ISSUES, V30, P53, DOI 10.1177/0192513X08322627; Hansen K, 2009, J SOC POLICY, V38, P211, DOI 10.1017/S004727940800281X; Hawkes D, 2007, MILLENNIUM COHORT ST; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hrdy S. B., 2006, ATTACHMENT BONDING N; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Iacovou M, 2011, POPUL DEV REV, V37, P89, DOI 10.1111/j.1728-4457.2011.00391.x; Igel C, 2011, J EUR SOC POLICY, V21, P210, DOI 10.1177/0958928711401766; Jappens M, 2012, DEMOGR RES, V27, P85, DOI 10.4054/DemRes.2012.27.4; Jokela M, 2009, J PERS SOC PSYCHOL, V96, P218, DOI 10.1037/a0014058; Joshi H., 2008, MILLENNIUM COHORT ST, P76; Kaptijn R, 2010, HUM NATURE-INT BIOS, V21, P393, DOI 10.1007/s12110-010-9098-9; Keim S, 2009, CURR SOCIOL, V57, P888, DOI 10.1177/0011392109342226; Kramer KL, 2005, EVOL ANTHROPOL, V14, P224, DOI 10.1002/evan.20082; Lang FR, 2006, HDB PERSONALITY DEV; LEHRER EL, 1985, DEMOGRAPHY, V22, P499, DOI 10.2307/2061585; Lundberg S, 2005, OXFORD REV ECON POL, V21, P340, DOI 10.1093/oxrep/gri020; Mace R., 2005, GRANDMOTHERHOOD EVOL, P143; Mathews P, 2012, DEMOGRAPHIC IN PRESS; McQuillan K, 2004, POPUL DEV REV, V30, P25, DOI 10.1111/j.1728-4457.2004.00002.x; Mulder MB, 1998, TRENDS ECOL EVOL, V13, P266, DOI 10.1016/S0169-5347(98)01357-3; Murphy M, 1999, SOC BIOL, V46, P122; Murphy M, 2008, POPUL DEV REV, V34, P19, DOI 10.1111/j.1728-4457.2008.00204.x; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; NEWMAN JL, 1983, AM ECON REV, V73, P33; Newson L, 2005, PERS SOC PSYCHOL REV, V9, P360, DOI 10.1207/s15327957pspr0904_5; Newson L, 2007, EVOL HUM BEHAV, V28, P199, DOI 10.1016/j.evolhumbehav.2007.01.003; Nolan J, 2006, KINSHIP MATTERS, P175; Owen C, 2004, MILLENNIUM COHORT ST, P51; Pahl R, 2005, BRIT J SOCIOL, V56, P433, DOI 10.1111/j.1468-4446.2005.00076.x; Rendall Michael S, 2003, Popul Trends, P18; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sear R, 2011, POPUL DEV REV, V37, P81, DOI 10.1111/j.1728-4457.2011.00379.x; Shiner R. L., 2006, HDB PERSONALITY DEV; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Strassmann BI, 2011, P NATL ACAD SCI USA, V108, P10894, DOI 10.1073/pnas.1100306108; Tan JP, 2010, J FAM ISSUES, V31, P992, DOI 10.1177/0192513X09360499; Tavares L.P., 2010, ISER WORKING PAPER S; TURKE PW, 1989, POPUL DEV REV, V15, P61, DOI 10.2307/1973405; Vandell DL, 2003, J MARRIAGE FAM, V65, P375, DOI 10.1111/j.1741-3737.2003.00375.x; Waynforth D., 2011, P ROYAL SOC B; Wheelock J, 2002, J SOC POLICY, V31, P441, DOI 10.1017/S0047279402006657; Young Michael, 1957, FAMILY KINSHIP E LON	74	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56941	10.1371/journal.pone.0056941	http://dx.doi.org/10.1371/journal.pone.0056941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516398	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000316849200006
J	Mayer, G; Kauschke, S; Rudiger, J; Stevenson, PA				Mayer, Georg; Kauschke, Susann; Ruediger, Jan; Stevenson, Paul A.			Neural Markers Reveal a One-Segmented Head in Tardigrades (Water Bears)	PLOS ONE			English	Article							HOX GENE-EXPRESSION; NERVOUS-SYSTEM; 3-DIMENSIONAL RECONSTRUCTION; PHYLOGENETIC POSITION; VELVET WORMS; EVOLUTION; ONYCHOPHORA; ARTHROPODS; FMRFAMIDE; BRAIN	Background: While recent neuroanatomical and gene expression studies have clarified the alignment of cephalic segments in arthropods and onychophorans, the identity of head segments in tardigrades remains controversial. In particular, it is unclear whether the tardigrade head and its enclosed brain comprises one, or several segments, or a non-segmental structure. To clarify this, we applied a variety of histochemical and immunocytochemical markers to specimens of the tardigrade Macrobiotus cf. harmsworthi and the onychophoran Euperipatoides rowelli. Methodology/Principal Findings: Our immunolabelling against serotonin, FMRFamide and alpha-tubulin reveals that the tardigrade brain is a dorsal, bilaterally symmetric structure that resembles the brain of onychophorans and arthropods rather than a circumoesophageal ring typical of cycloneuralians (nematodes and allies). A suboesophageal ganglion is clearly lacking. Our data further reveal a hitherto unknown, unpaired stomatogastric ganglion in Macrobiotus cf. harmsworthi, which innervates the ectodermal oesophagus and the endodermal midgut and is associated with the second leg-bearing segment. In contrast, the oesophagus of the onychophoran E. rowelli possesses no immunoreactive neurons, whereas scattered bipolar, serotonin-like immunoreactive cell bodies are found in the midgut wall. Furthermore, our results show that the onychophoran pharynx is innervated by a medullary loop nerve accompanied by monopolar, serotonin-like immunoreactive cell bodies. Conclusions/Significance: A comparison of the nervous system innervating the foregut and midgut structures in tardigrades and onychophorans to that of arthropods indicates that the stomatogastric ganglion is a potential synapomorphy of Tardigrada and Arthropoda. Its association with the second leg-bearing segment in tardigrades suggests that the second trunk ganglion is a homologue of the arthropod tritocerebrum, whereas the first ganglion corresponds to the deutocerebrum. We therefore conclude that the tardigrade brain consists of a single segmental region corresponding to the arthropod protocerebrum and, accordingly, that the tardigrade head is a non-composite, one-segmented structure.	[Mayer, Georg; Kauschke, Susann; Ruediger, Jan; Stevenson, Paul A.] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany	Leipzig University	Mayer, G (corresponding author), Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany.	gmayer@onychophora.com	Stevenson, Paul A/A-2048-2010; Mayer, Georg/Y-9581-2018	Mayer, Georg/0000-0003-0737-2440	German Research Foundation (DFG) [Ma 4147/3-1]; Emmy Noether Programme of the DFG	German Research Foundation (DFG)(German Research Foundation (DFG)); Emmy Noether Programme of the DFG(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG, http://www.dfg.de/index.jsp) to GM (Ma 4147/3-1). GM is a Research Group Leader supported by the Emmy Noether Programme of the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenhakker MP, 2004, J NEUROPHYSIOL, V91, P78, DOI 10.1152/jn.00741.2003; Bitsch J, 2007, ACTA ZOOL-STOCKHOLM, V88, P317, DOI 10.1111/j.1463-6395.2007.00284.x; Bitsch J, 2010, ACTA ZOOL-STOCKHOLM, V91, P249, DOI 10.1111/j.1463-6395.2009.00402.x; Brenneis G, 2010, J MORPHOL, V271, P169, DOI 10.1002/jmor.10789; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Bullock T. H., 1965, STRUCTURE FUNCTION N, VI; BULLOCK TH, 1965, STRUCTURE FUNCTION N, V2, P802; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Dearden PK, 2002, DEVELOPMENT, V129, P5461, DOI 10.1242/dev.00099; Dewel RA, 1999, ZOOL ANZ, V238, P191; Dewel RA, 1996, ZOOL J LINN SOC-LOND, V116, P35; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; Eriksson BJ, 2010, DEV GENES EVOL, V220, P117, DOI 10.1007/s00427-010-0329-1; Gabriel WN, 2007, DEV GENES EVOL, V217, P421, DOI 10.1007/s00427-007-0152-5; Girosi L, 2005, CELL TISSUE RES, V320, P331, DOI 10.1007/s00441-004-1072-6; Halberg KA, 2009, J MORPHOL, V270, P996, DOI 10.1002/jmor.10734; Hanstrom B., 1935, BEMERKUNGEN GEHIRN S, V31, P1; Hartenstein V, 1997, TRENDS NEUROSCI, V20, P421, DOI 10.1016/S0166-2236(97)01066-7; Hejnol A, 2005, DEVELOPMENT, V132, P1349, DOI 10.1242/dev.01701; Hejnol A, 2008, NATURE, V456, P382, DOI 10.1038/nature07309; HENRY LAURA M., 1948, MICROENTOMOLOGY, V13, P27; HENRY LAURA M., 1953, MICROENTOMOLOGY, V18, P16; Ishida Y, 1998, BRAIN RES, V788, P207, DOI 10.1016/S0006-8993(97)01541-2; Jager M, 2006, NATURE, V441, P506, DOI 10.1038/nature04591; Jellies J, 1996, J COMP NEUROL, V373, P1, DOI 10.1002/(SICI)1096-9861(19960909)373:1<1::AID-CNE1>3.0.CO;2-8; Kotikova EA, 2005, HYDROBIOLOGIA, V546, P239, DOI 10.1007/s10750-005-4203-5; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; KRISTENSEN R M, 1984, Smithsonian Contributions to Zoology, V391, P1; KRISTENSEN RM, 1984, T AM MICROSC SOC, V103, P295, DOI 10.2307/3226191; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Ma XY, 2009, ARTHROPOD STRUCT DEV, V38, P271, DOI 10.1016/j.asd.2009.03.001; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Mallatt J, 2010, MOL PHYLOGENET EVOL, V55, P1, DOI 10.1016/j.ympev.2009.09.028; Marcus E, 1929, TARDIGRADA HG BRONNS, P1; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Matsuda R., 1965, MEM AM ENTOMOL I, V4, P1; Mayer G, 2005, ARTHROPOD STRUCT DEV, V34, P471, DOI 10.1016/j.asd.2005.03.004; Mayer G, 2005, J MORPHOL, V263, P60, DOI 10.1002/jmor.10289; Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603; Mayer G, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-118; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Mayer G, 2009, P ROY SOC B-BIOL SCI, V276, P3571, DOI 10.1098/rspb.2009.0950; Michel S, 2000, J COMP NEUROL, V425, P244, DOI 10.1002/1096-9861(20000918)425:2<244::AID-CNE7>3.0.CO;2-A; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; MOROZ L, 1994, CELL TISSUE RES, V275, P277, DOI 10.1007/BF00319425; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Oliveira IS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019973; Ou Q, 2012, NATURE COMM IN PRESS; Persson DK, 2012, J MORPHOL, V273, P1227, DOI 10.1002/jmor.20054; Plate L., 1888, ZOOLOGISCHE JB, V3, P487, DOI DOI 10.5962/BHL.PART.1265; Poprawa I, 2005, TISSUE CELL, V37, P385, DOI 10.1016/j.tice.2005.06.003; PROSS ARMIN, 1966, Z MORPHOL OKDL TIERE, V58, P38, DOI 10.1007/BF00409640; Raikova OI, 2000, TISSUE CELL, V32, P358, DOI 10.1054/tice.2000.0121; Reglodi D, 1997, CELL TISSUE RES, V288, P575, DOI 10.1007/s004410050843; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rieger V, 2010, INVERTEBR BIOL, V129, P77, DOI 10.1111/j.1744-7410.2010.00189.x; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; SCHOLL G, 1977, ZOOMORPHOLOGIE, V86, P99; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; SIDDIQUI SS, 1989, J NEUROSCI, V9, P2963; Sivasubramanian P, 2004, COMP BIOCH PHYS A, V99, P507; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Thomas M.B., 1991, P91; TIEGS OW, 1947, Q J MICROSC SCI, V88, P165; Tiegs OW, 1940, Q J MICROSC SCI, V82, P1; WEYGOLDT P, 1975, ZOOMORPHOLOGIE, V82, P137, DOI 10.1007/BF00993587; Whitington PM, 2011, ARTHROPOD STRUCT DEV, V40, P193, DOI 10.1016/j.asd.2011.01.006; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Wiederhoft H, 1996, ZOOL J LINN SOC-LOND, V116, P71; Zantke J, 2008, ZOOMORPHOLOGY, V127, P21, DOI 10.1007/s00435-007-0045-1	79	51	52	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59090	10.1371/journal.pone.0059090	http://dx.doi.org/10.1371/journal.pone.0059090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516602	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200132
J	Todd, J; Riedner, G; Maboko, L; Hoelscher, M; Weiss, HA; Lyamuya, E; Mabey, D; Rusizoka, M; Belec, L; Hayes, R				Todd, Jim; Riedner, Gabriele; Maboko, Leonard; Hoelscher, Michael; Weiss, Helen A.; Lyamuya, Eligius; Mabey, David; Rusizoka, Mary; Belec, Laurent; Hayes, Richard			Effect of Genital Herpes on Cervicovaginal HIV Shedding in Women Co-Infected with HIV AND HSV-2 in Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLACEBO-CONTROLLED TRIAL; FEMALE BAR WORKERS; SIMPLEX-VIRUS; SEX WORKERS; SUPPRESSIVE THERAPY; TYPE-2 INFECTION; AFRICAN WOMEN; SOUTH-AFRICA; ACYCLOVIR	Objectives: To compare the presence and quantity of cervicovaginal HIV among HIV seropositive women with clinical herpes, subclinical HSV-2 infection and without HSV-2 infection respectively; to evaluate the association between cervicovaginal HIV and HSV shedding; and identify factors associated with quantity of cervicovaginal HIV. Design: Four groups of HIV seropositive adult female barworkers were identified and examined at three-monthly intervals between October 2000 and March 2003 in Mbeya, Tanzania: (1) 57 women at 70 clinic visits with clinical genital herpes; (2) 39 of the same women at 46 clinic visits when asymptomatic; (3) 55 HSV-2 seropositive women at 60 clinic visits who were never observed with herpetic lesions; (4) 18 HSV-2 seronegative women at 45 clinic visits. Associations of genital HIV shedding with HIV plasma viral load (PVL), herpetic lesions, HSV shedding and other factors were examined. Results: Prevalence of detectable genital HIV RNA varied from 73% in HSV-2 seronegative women to 94% in women with herpetic lesions (geometric means 1634 vs 3339 copies/ml, p = 0.03). In paired specimens from HSV-2 positive women, genital HIV viral shedding was similar during symptomatic and asymptomatic visits. On multivariate regression, genital HIV RNA (log(10) copies/mL) was closely associated with HIV PVL (beta = 0.51 per log(10) copies/ml increase, 95%CI:0.41-0.60, p<0.001) and HSV shedding (beta = 0.24 per log(10) copies/ml increase, 95% CI:0.16-0.32, p<0.001) but not the presence of herpetic lesions (beta = -0.10, 95%CI:-0.28-0.08, p = 0.27). Conclusions: HIV PVL and HSV shedding were more important determinants of genital HIV than the presence of herpetic lesions. These data support a role of HSV-2 infection in enhancing HIV transmissibility.	[Todd, Jim; Riedner, Gabriele; Weiss, Helen A.; Mabey, David; Hayes, Richard] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Riedner, Gabriele; Maboko, Leonard; Rusizoka, Mary] Natl Inst Med Res, Mbeya Med Res Programme, Mbeya, Tanzania; [Hoelscher, Michael] Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; [Lyamuya, Eligius] Muhimbili Univ Coll Hlth Sci, Dar Es Salaam, Tanzania; [Belec, Laurent] Hop Europeen Georges Pompidou, Microbiol Lab, Paris, France; [Belec, Laurent] Univ Paris 05, Fac Med Paris Descartes, Paris, France	University of London; London School of Hygiene & Tropical Medicine; University of Munich; Muhimbili University of Health & Allied Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Todd, J (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England.	jim.todd@lshtm.ac.uk	Hoelscher, Michael/D-3436-2012; weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Mabey, David/0000-0002-0031-8276; Todd, Jim/0000-0001-5918-4914; Hayes, Richard/0000-0002-1729-9892	European Commission, DGXII, INCO-DC [ICA-CT-1998-10007]; Wellcome Trust [060145/Z/00/A]; Department for International Development [RD638]; Tanzanian Minister of Health and Social Welfare; Medical Research Council [MR/K012126/1] Funding Source: researchfish	European Commission, DGXII, INCO-DC; Wellcome Trust(Wellcome TrustEuropean Commission); Department for International Development; Tanzanian Minister of Health and Social Welfare; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: European Commission, DGXII, INCO-DC, Grant nummber: ICA-CT-1998-10007; Wellcome Trust, Grant number: 060145/Z/00/A; and Department for International Development, Grant number: RD638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the women who participated in the study and the research team of the NIMR-Mbeya Medical Research Programme, and the Director and personnel in Mbeya Referral Hospital clinics and laboratories for making this study possible. We acknowledge the Medical officer in charge of Mbeya municipality, and the Tanzanian Minister of Health and Social Welfare for their support. We thank Oliver Hoffmann, Karl-Heinz Herbinger, Britta Dechamps, Gudrun Schoen and Frowin Nichombe for their active support in Mbeya, and Heiner Grosskurth and Mar Pujades-Rodrigues for their support in London. We acknowledge the help of Dr Jerome Legoff in quantifying the HSV DNA in this study.	ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; Ashley RL, 1999, CLIN MICROBIOL REV, V12, P1; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Behets FMT, 1999, J INFECT DIS, V180, P1382, DOI 10.1086/315005; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C.L., 2004, HERPES, V11, p36A; Chen CY, 2000, SEX TRANSM DIS, V27, P21, DOI 10.1097/00007435-200001000-00005; Chu K, 2006, INT J STD AIDS, V17, P681, DOI 10.1258/095646206780071108; CLEMETSON DBA, 1993, JAMA-J AM MED ASSOC, V269, P2860, DOI 10.1001/jama.269.22.2860; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cowan FM, 2008, SEX TRANSM INFECT, V84, P548, DOI 10.1136/sti.2008.031153; Cowan FF, 2006, AIDS, V20, P261, DOI 10.1097/01.aids.0000198086.39831.4a; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Espy MJ, 2000, J CLIN MICROBIOL, V38, P795, DOI 10.1128/JCM.38.2.795-799.2000; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Keou FXM, 1999, AIDS, V13, P536, DOI 10.1097/00002030-199903110-00021; LeGoff J, 2007, AIDS, V21, P1569, DOI 10.1097/QAD.0b013e32825a69bd; Limpakarnjanarat K, 1999, THAILAND SEX TRANSM, V75, P30; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; McClelland RS, 2002, AIDS, V16, P2425, DOI 10.1097/00002030-200212060-00007; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; MOSCA JD, 1987, P NATL ACAD SCI USA, V84, P7408, DOI 10.1073/pnas.84.21.7408; MOSS GB, 1995, J INFECT DIS, V172, P1469, DOI 10.1093/infdis/172.6.1469; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P632; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; Riedner G, 2007, SEX TRANSM INFECT, V83, P91, DOI 10.1136/sti.2006.021287; Rodriguez MDM, 2002, AIDS, V16, P451; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Tanton C, 2010, J INFECT DIS, V201, P1285, DOI 10.1086/651696; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	42	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59037	10.1371/journal.pone.0059037	http://dx.doi.org/10.1371/journal.pone.0059037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516595	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000316849200128
J	Lin, F; Lasry, A; Sansom, SL; Wolitski, RJ				Lin, Feng; Lasry, Arielle; Sansom, Stephanie L.; Wolitski, Richard J.			Estimating the Impact of State Budget Cuts and Redirection of Prevention Resources on the HIV Epidemic in 59 California Local Health Departments	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE SYSTEM; UNITED-STATES; SEXUAL-BEHAVIOR; CONDOM USE; ANTIRETROVIRAL THERAPY; TESTING BEHAVIORS; PERCEIVED HEALTH; AGES 14; TRANSMISSION; RISK	Background: In the wake of a national economic downturn, the state of California, in 2009-2010, implemented budget cuts that eliminated state funding of HIV prevention and testing. To mitigate the effect of these cuts remaining federal funds were redirected. This analysis estimates the impact of these budget cuts and reallocation of resources on HIV transmission and associated HIV treatment costs. Methods and Findings: We estimated the effect of the budget cuts and reallocation for California county health departments (excluding Los Angeles and San Francisco) on the number of individuals living with or at-risk for HIV who received HIV prevention services. We used a Bernoulli model to estimate the number of new infections that would occur each year as a result of the changes, and assigned lifetime treatment costs to those new infections. We explored the effect of redirecting federal funds to more cost-effective programs, as well as the potential effect of allocating funds proportionately by transmission category. We estimated that cutting HIV prevention resulted in 55 new infections that were associated with $20 million in lifetime treatment costs. The redirection of federal funds to more cost-effective programs averted 15 HIV infections. If HIV prevention funding were allocated proportionately to transmission categories, we estimated that HIV infections could be reduced below the number that occurred annually before the state budget cuts. Conclusions: Reducing funding for HIV prevention may result in short-term savings at the expense of additional HIV infections and increased HIV treatment costs. Existing HIV prevention funds would likely have a greater impact on the epidemic if they were allocated to the more cost-effective programs and the populations most likely to acquire and transmit the infection.	[Lin, Feng; Lasry, Arielle; Sansom, Stephanie L.; Wolitski, Richard J.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Sansom, SL (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	sos9@cdc.gov						[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Arnold EA, 2010, EXAMINING IMPACT HIV; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Camoni L, 2011, ANN I SUPER SANITA, V47, P214, DOI 10.4415/ANN_11_02_14; Centers for Disease Control and Prevention, 2012, DIV HIV AIDS PREV PR; Centers for Disease Control and Prevention, 2010, HIV SURV REP; Centers for Disease Control and Prevention, 2011, HIV TEST CDC FUND SI; Chandra Anjani, 2011, Natl Health Stat Report, P1; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Crosby R, 2009, INT J SEX HEALTH, V21, P183, DOI 10.1080/19317610903205627; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fortenberry JD, 2010, J SEX MED, V7, P305, DOI 10.1111/j.1743-6109.2010.02018.x; Friedman SR, 2005, J URBAN HEALTH, V82, P434, DOI 10.1093/jurban/jti088; Grigoryan A, 2010, JAMA-J AM MED ASSOC, V303, P126; Herbenick D, 2010, J SEX MED, V7, P277, DOI 10.1111/j.1743-6109.2010.02010.x; Holtgrave DR, 2010, JAIDS-J ACQ IMM DEF, V55, P139, DOI 10.1097/QAI.0b013e3181f4107a; Holtgrave DR, 2006, ANNU REV PUBL HEALTH, V27, P261, DOI 10.1146/annurev.publhealth.26.021304.144454; Holtgrave DR, 2004, INT J STD AIDS, V15, P789, DOI 10.1258/0956462042563639; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Lansky A., 2009, Morbidity and Mortality Weekly Report, V58, P329; Lasry A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037545; Leibowitz AA, 2011, JAIDS-J ACQ IMM DEF, V58, pE11, DOI 10.1097/QAI.0b013e31822101c8; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; Metsch L, 2007, 2007 NAT HIV PREV C; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; National Association of State and Territorial Apprenticeship Directors (NASTAD) National Coalition of STD Directors (NCSD), 2011, 2010 STAT GEN REV HI; Office of National AIDS Policy, 2010, NATL HIV AIDS STRAT; Pinkerton SD, 1998, HDB EC EVALUATION HI; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Reece M, 2010, J SEX MED, V7, P266, DOI 10.1111/j.1743-6109.2010.02017.x; Reece M, 2010, J SEX MED, V7, P291, DOI 10.1111/j.1743-6109.2010.02009.x; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scholes D, 2003, AIDS, V17, P1547, DOI 10.1097/00002030-200307040-00016; The California State Office of AIDS, 2009, OFF AIDS FY2009 10 B; The Kaiser Family Foundation, 2011, US FED FUND HIV AIDS; The Kaiser Family Foundation National Association of State and Territorial Apprenticeship Directors (NASTAD), 2009, NAT HIV PREV INV; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Viall Abigail H., 2011, Morbidity and Mortality Weekly Report, V60, P805; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; Xia Q, 2006, JAIDS-J ACQ IMM DEF, V41, P238, DOI 10.1097/01.qai.0000185574.98472.36; [No title captured]	55	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55713	10.1371/journal.pone.0055713	http://dx.doi.org/10.1371/journal.pone.0055713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520447	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900006
J	Sudo, H; Yamada, K; Iwasaki, K; Higashi, H; Ito, M; Minami, A; Iwasaki, N				Sudo, Hideki; Yamada, Katsuhisa; Iwasaki, Koji; Higashi, Hideaki; Ito, Manabu; Minami, Akio; Iwasaki, Norimasa			Global Identification of Genes Related to Nutrient Deficiency in Intervertebral Disc Cells in an Experimental Nutrient Deprivation Model	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; MICROARRAY ANALYSIS; CASPASE 3; DEGENERATION; EXPRESSION; APOPTOSIS; P21(CIP1/WAF1); PATHOGENESIS; INHIBITION; ACTIVATION	Background: Intervertebral disc degeneration is a significant cause of degenerative spinal diseases. Nucleus pulposus (NP) cells reportedly fail to survive in large degenerated discs with limited nutrient availability. Therefore, understanding the regulatory mechanism of the molecular response of NP cells to nutrient deprivation may reveal a new strategy to treat disc degeneration. This study aimed to identify genes related to nutrient deprivation in NP cells on a global scale in an experimental nutrient deprivation model. Methodology/Principal Findings: Rat NP cells were subjected to serum starvation. Global gene expression was profiled by microarray analysis. Confirmation of the selected genes was obtained by real-time polymerase chain reaction array analysis. Western blotting was used to confirm the expression of selected genes. Functional interactions between p21(Cip1) and caspase 3 were examined. Finally, flow cytometric analyses of NP cells were performed. Microarray analysis revealed 2922 differentially expressed probe sets with >= 1.5-fold changes in expression. Serum starvation of NP cells significantly affected the expression of several genes involved in DNA damage checkpoints of the cell cycle, including Atm, Brca1, Cdc25, Gadd45, Hus1, Ppm1D, Rad 9, Tp53, and Cyclin D1. Both p27(Kip1) and p53 protein expression was upregulated in serum-starved cells. p21(Cip1) expression remained in NP cells transfected with short interfering RNA targeting caspase 3 (caspase 3 siRNA). Both G1 arrest and apoptosis induced by serum starvation were inhibited in cells transfected with caspase 3 siRNA. Conclusions/Significance: Nutrient deprivation in NP cells results in the activation of a signaling response including DNA damage checkpoint genes regulating the cell cycle. These results provide novel possibilities to improve the success of intervertebral disc regenerative techniques.	[Sudo, Hideki; Ito, Manabu] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan; [Yamada, Katsuhisa; Iwasaki, Koji; Minami, Akio; Iwasaki, Norimasa] Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Higashi, Hideaki] Hokkaido Univ, Div Infect & Immun, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Sudo, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp	Higashi, Hideaki/F-6872-2012; Sudo, Hideki/G-2748-2012	Iwasaki, Koji/0000-0002-4525-9150	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20591733]; Japan Orthopaedics and Traumatology Foundation (JOTF); Takeda Science Foundation; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Orthopaedics and Traumatology Foundation (JOTF); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (20591733), the Japan Orthopaedics and Traumatology Foundation (JOTF), the Takeda Science Foundation, and the Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladin DMK, 2007, SPINE, V32, P2820, DOI 10.1097/BRS.0b013e31815b75c5; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cheung KMC, 2010, SPINE J, V10, P958, DOI 10.1016/j.spinee.2010.09.011; Chung SA, 2007, SPINE, V32, P1188, DOI 10.1097/BRS.0b013e31805471a3; Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639; Evans C, 2006, J BONE JOINT SURG AM, V88A, P95, DOI 10.2106/JBJS.E.01328; Feng Z, 2007, BRAIN RES, V1177, P103, DOI 10.1016/j.brainres.2007.07.047; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Gruber HE, 2007, SPINE, V32, P1181, DOI 10.1097/BRS.0b013e318053ec89; Gruber HE, 2011, SPINE J, V11, P782, DOI 10.1016/j.spinee.2011.06.012; Guehring T, 2009, ARTHRITIS RHEUM-US, V60, P1026, DOI 10.1002/art.24407; Hristova GI, 2011, J ORTHOP RES, V29, P1888, DOI 10.1002/jor.21456; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kokkonen SM, 2002, SPINE, V27, P2274, DOI 10.1097/00007632-200210150-00017; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lin JY, 1996, MOL CELL BIOL, V16, P1786; Mavrogonatou E, 2010, J ORTHOP RES, V28, P1276, DOI 10.1002/jor.21140; Moskalev AA, 2012, AGEING RES REV, V11, P51, DOI 10.1016/j.arr.2011.09.003; Nakai T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2567; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Reddi AH, 2011, ARTHRITIS RHEUM-US, V63, P1477, DOI 10.1002/art.30252; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sudo H, 2011, ARTHRITIS RHEUM-US, V63, P1648, DOI 10.1002/art.30251; Sudo H, 2010, J ORTHOP RES, V28, P1608, DOI 10.1002/jor.21185; Tang JJ, 2006, MOL CELL BIOCHEM, V291, P139, DOI 10.1007/s11010-006-9206-7; Uchida K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-84; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005	33	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58806	10.1371/journal.pone.0058806	http://dx.doi.org/10.1371/journal.pone.0058806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520533	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900093
J	Perrini, S; Ficarella, R; Picardi, E; Cignarelli, A; Barbaro, M; Nigro, P; Peschechera, A; Palumbo, O; Carella, M; De Fazio, M; Natalicchio, A; Laviola, L; Pesole, G; Giorgino, F				Perrini, Sebastio; Ficarella, Romina; Picardi, Ernesto; Cignarelli, Angelo; Barbaro, Maria; Nigro, Pasquale; Peschechera, Alessandro; Palumbo, Orazio; Carella, Massimo; De Fazio, Michele; Natalicchio, Annalisa; Laviola, Luigi; Pesole, Graziano; Giorgino, Francesco			Differences in Gene Expression and Cytokine Release Profiles Highlight the Heterogeneity of Distinct Subsets of Adipose Tissue-Derived Stem Cells in the Subcutaneous and Visceral Adipose Tissue in Humans	PLOS ONE			English	Article							GLUCOSE-UPTAKE; BONE-MARROW; CORD BLOOD; FAT-CELLS; IN-VITRO; ADIPOCYTES; POPULATIONS; SIGNATURES; OBESITY; MASS	Differences in the inherent properties of adipose tissue-derived stem cells (ASC) may contribute to the biological specificity of the subcutaneous (Sc) and visceral (V) adipose tissue depots. In this study, three distinct subpopulations of ASC, i.e. ASC(SVF), ASC(Bottom), and ASC(Ceiling), were isolated from Sc and V fat biopsies of non-obese subjects, and their gene expression and functional characteristics were investigated. Genome-wide mRNA expression profiles of ASC(SVF), ASC(Bottom) and ASC(Ceiling) from Sc fat were significantly different as compared to their homologous subsets of V-ASCs. Furthermore, ASC(SVF), ASC(Ceiling) and ASC(Bottom) from the same fat depot were also distinct from each other. In this respect, both principal component analysis and hierarchical clusters analysis showed that ASC(Ceiling) and ASC(SVF) shared a similar pattern of closely related genes, which was highly different when compared to that of ASC(Bottom). However, larger variations in gene expression were found in inter-depot than in intra-depot comparisons. The analysis of connectivity of genes differently expressed in each ASC subset demonstrated that, although there was some overlap, there was also a clear distinction between each Sc-ASC and their corresponding V-ASC subsets, and among ASC(SVF), ASC(Bottom), and ASC(Ceiling) of Sc or V fat depots in regard to networks associated with regulation of cell cycle, cell organization and development, inflammation and metabolic responses. Finally, the release of several cytokines and growth factors in the ASC cultured medium also showed both inter-and intra-depot differences. Thus, ASC(Ceiling) and ASC(Bottom) can be identified as two genetically and functionally heterogeneous ASC populations in addition to the ASC(SVF), with ASC(Bottom) showing the highest degree of unmatched gene expression. On the other hand, inter-depot seem to prevail over intra-depot differences in the ASC gene expression assets and network functions, contributing to the high degree of specificity of Sc and V adipose tissue in humans.	[Perrini, Sebastio; Ficarella, Romina; Cignarelli, Angelo; Barbaro, Maria; Nigro, Pasquale; Peschechera, Alessandro; Natalicchio, Annalisa; Laviola, Luigi; Giorgino, Francesco] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Internal Med Endocrinol Androl & Metab Dis, Bari, Italy; [De Fazio, Michele] Univ Bari Aldo Moro, Sect Gen Surg & Liver Transplantat, Bari, Italy; [Picardi, Ernesto; Pesole, Graziano] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Pharmacol Sci, Bari, Italy; [Pesole, Graziano] CNR, Inst Biomembranes & Bioenerget, Bari, Italy; [Palumbo, Orazio; Carella, Massimo] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, San Giovanni Rotondo, FG, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Giorgino, F (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Internal Med Endocrinol Androl & Metab Dis, Bari, Italy.	francesco.giorgino@uniba.it	Picardi, Ernesto/A-5863-2015; PALUMBO, ORAZIO/C-1133-2014; Laviola, Luigi/AAC-2237-2022; Pesole, Graziano/E-9051-2014; Giorgino, Francesco/K-7262-2016; Cignarelli, Angelo/I-6353-2013; Pesole, Graziano/K-5283-2019; Carella, Massimo/A-2804-2014	Picardi, Ernesto/0000-0002-6549-0114; PALUMBO, ORAZIO/0000-0001-6583-3482; Pesole, Graziano/0000-0003-3663-0859; Giorgino, Francesco/0000-0001-7372-2678; Cignarelli, Angelo/0000-0001-6477-9031; FOSCHINO BARBARO, MARIA PIA/0000-0001-9939-2697; Carella, Massimo/0000-0002-6830-6829; Perrini, Sebastio/0000-0002-2728-7721	Ministero dell'Universita e Ricerca (Italy); COST Action BM0602; Fondazione della Societa Italiana di Diabetologia per la Ricerca in Diabetologia e Malattie Metaboliche (Fo.Ri.SID); NovoNordisk	Ministero dell'Universita e Ricerca (Italy)(Ministry of Education, Universities and Research (MIUR)); COST Action BM0602(European Cooperation in Science and Technology (COST)); Fondazione della Societa Italiana di Diabetologia per la Ricerca in Diabetologia e Malattie Metaboliche (Fo.Ri.SID); NovoNordisk(Novo Nordisk)	This work was supported in part by grants from the Ministero dell'Universita e Ricerca (Italy), the COST Action BM0602, the Fondazione della Societa Italiana di Diabetologia per la Ricerca in Diabetologia e Malattie Metaboliche (Fo.Ri.SID), and NovoNordisk to F. Giorgino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Bluher M, 2007, DIABETES CARE, V30, P3110, DOI 10.2337/dc07-1257; Bombelli M, 2011, HYPERTENSION, V58, P1029, DOI 10.1161/HYPERTENSIONAHA.111.175125; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Fain JN, 2008, INT J OBESITY, V32, P429, DOI 10.1038/sj.ijo.0803745; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hausman GJ, 2006, J CLIN INVEST, V116, P3103, DOI 10.1172/JCI30666; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892; Kovsan J, 2009, AM J PHYSIOL-ENDOC M, V296, pE315, DOI 10.1152/ajpendo.90486.2008; Laviola L, 2006, DIABETES, V55, P952, DOI 10.2337/diabetes.55.04.06.db05-1414; Lundgren M, 2004, J CLIN ENDOCR METAB, V89, P2989, DOI 10.1210/jc.2003-031157; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Miyazaki T, 2005, DIFFERENTIATION, V73, P69, DOI 10.1111/j.1432-0436.2005.07302004.x; Peinado JR, 2012, PROTEOMICS, V12, P607, DOI 10.1002/pmic.201100355; Peng LY, 2008, STEM CELLS DEV, V17, P761, DOI 10.1089/scd.2007.0217; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Perrini S, 2008, ENDOCRINOLOGY, V149, P1302, DOI 10.1210/en.2007-1349; Perrini Sebastio, 2009, Archives of Physiology and Biochemistry, V115, P218, DOI 10.1080/13813450903260864; Perrini Sebastio, 2008, Archives of Physiology and Biochemistry, V114, P277, DOI [10.1080/13813450802334752, 10.1080/13813450802334752 ]; Piantoni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-331; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Tam CS, 2011, INT J PEDIATR OBES, V6, pE360, DOI 10.3109/17477166.2011.575152; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Nora CCV, 2012, STEM CELLS DEV, V21, P1761, DOI 10.1089/scd.2011.0030; Virtanen KA, 2002, J CLIN ENDOCR METAB, V87, P3902, DOI 10.1210/jc.87.8.3902	41	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57892	10.1371/journal.pone.0057892	http://dx.doi.org/10.1371/journal.pone.0057892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526958	Green Published, gold, Green Submitted			2022-12-25	WOS:000315637900060
J	Li, Y; Zhang, Q; Carreira-Rosario, A; Maines, JZ; McKearin, DM; Buszczak, M				Li, Yun; Zhang, Qiao; Carreira-Rosario, Arnaldo; Maines, Jean Z.; McKearin, Dennis M.; Buszczak, Michael			Mei-P26 Cooperates with Bam, Bgcn and Sxl to Promote Early Germline Development in the Drosophila Ovary	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; SEX-LETHAL; OF-MARBLES; PROTEIN-LEVELS; SELF-RENEWAL; GENE; NANOS; PROLIFERATION; TRANSCRIPTION; MAINTENANCE	In the Drosophila female germline, spatially and temporally specific translation of mRNAs governs both stem cell maintenance and the differentiation of their progeny. However, the mechanisms that control and coordinate different modes of translational repression within this lineage remain incompletely understood. Here we present data showing that Mei-P26 associates with Bam, Bgcn and Sxl and nanos mRNA during early cyst development, suggesting that this protein helps to repress the translation of nanos mRNA. Together with recently published studies, these data suggest that Mei-P26 mediates both GSC self-renewal and germline differentiation through distinct modes of translational repression depending on the presence of Bam.	[Li, Yun; Zhang, Qiao; Carreira-Rosario, Arnaldo; Maines, Jean Z.; Buszczak, Michael] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [McKearin, Dennis M.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Buszczak, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	michael.buszczak@utsouthwestern.edu		Buszczak, Michael/0000-0001-6361-3654; Carreira-Rosario, Arnlado/0000-0003-0202-3858	E.E. and Greer Garson Fogelson endowment for scholars program (UTSW Medical Center); National Institutes of Health [GM045820]; National Institutes of Health, National Research Service Award from the National Institute of General Medical Sciences [T32GM083831]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083831, R01GM045820] Funding Source: NIH RePORTER	E.E. and Greer Garson Fogelson endowment for scholars program (UTSW Medical Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Research Service Award from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by the E.E. and Greer Garson Fogelson endowment for scholars program (UTSW Medical Center), the National Institutes of Health (GM045820) (MB) and by the National Institutes of Health, National Research Service Award T32GM083831 from the National Institute of General Medical Sciences (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casper A, 2006, DEVELOPMENT, V133, P2783, DOI 10.1242/dev.02415; Chau J, 2012, P NATL ACAD SCI USA, V109, P9465, DOI 10.1073/pnas.1120473109; Chau J, 2009, GENETICS, V182, P121, DOI 10.1534/genetics.109.100693; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Forbes A, 1998, DEVELOPMENT, V125, P679; Glasscock E, 2005, GENETICS, V170, P1677, DOI 10.1534/genetics.105.043174; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Herranz H, 2010, EMBO J, V29, P1688, DOI 10.1038/emboj.2010.69; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Liu NK, 2009, GENE DEV, V23, P2742, DOI 10.1101/gad.1820709; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Ohlstein B, 2000, GENETICS, V155, P1809; Page SL, 2000, GENETICS, V155, P1757; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; SALZ HK, 1992, GENETICS, V130, P547; SCHUPBACH T, 1985, GENETICS, V109, P529; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Staab S, 1996, DEVELOPMENT, V122, P4065; Tastan OY, 2010, DEVELOPMENT, V137, P3167, DOI 10.1242/dev.050575; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; WEI G, 1994, DEV BIOL, V161, P318, DOI 10.1006/dbio.1994.1032; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159	31	41	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58301	10.1371/journal.pone.0058301	http://dx.doi.org/10.1371/journal.pone.0058301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526974	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562600017
J	Pan, YX; Trojan, J; Guo, YJ; Anthony, DD				Pan, Yuexin; Trojan, Jerzy; Guo, Yajun; Anthony, Donald D.			Rescue of MHC-1 Antigen Processing Machinery by Down-Regulation in Expression of IGF-1 in Human Glioblastoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR-I; GLIOMA-CELLS; RAT GLIOBLASTOMA; INTERFERON-GAMMA; GENE-THERAPY; IFN-GAMMA; TRANSPORTER; INSULIN; MELANOMA; CANCER	Escape from immune recognition has been hypothesized to be a factor in carcinogenesis. It may be mediated for many cancers through down-regulation in the MHC class 1 antigen processing and presentation pathway. TAP-1, TAP-2, tightly linked to LMP-2 and LMP-7 are multiple components of the endogenous, antigen presentation pathway machinery. We addressed the question of alterations in this pathway in human Glioblastoma (HGB) and of its relationship to modulation in expression of IGF-1 that is highly expressed in this cancer. Deficiencies in expression of TAP-1 were demonstrated by RT-PCR and/or by immuno-flow cytometry in the HGB cell line T98G obtained from ATCC, and in 3 of 4 human cell lines established from patients with Glioblastoma Multiforme. Deficiencies in expression of TAP-2 were observed in 3 of 4, deficiencies in expression of LMP-2 in 4 of 4 and deficiencies in LMP-7 in 3 of 4 HGB cell lines examined by RT-PCR and Western blot. Following down-regulation of IGF-1 by transfection with the pAnti IGF-1 vector that expresses IGF-1 RNA in antisense orientation, or by the exogenous addition of IGF-1 receptor monoclonal antibody to cell culture media, the deficiencies in components of the MHC-1 antigen presentation pathway were up-regulated and/or rescued in all HGB cell lines tested. Moreover, this up-regulation in expression was aborted by addition of 100 ng/ml of IGF-1 to the culture media. Unlike in the case of IFN-gamma, the restoration of TAP-1 and LMP-2 by down-regulation of IGF-1 in Glioblastoma cells was not correlated to the tyrosine phosphorylation of STAT 1. In summary, the simultaneous reversion in expression of the multiple constituents of MHC-1 antigen processing path and up-regulation in expression of MHC-1 occurring with down-regulation in IGF-1 may have a role in reinforcement of immunity against tumor antigen(s) in some animal cancers and in humans with Glioblastoma Multiforme.	[Pan, Yuexin; Anthony, Donald D.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci, Cleveland, OH 44106 USA; [Pan, Yuexin; Anthony, Donald D.] Univ Hosp Cleveland, Dept Med, Cleveland, OH 44106 USA; [Trojan, Jerzy] Univ Paris 11, Paul Brousse Hosp, INSERM, U542, Villejuif, France; [Trojan, Jerzy] Univ Paris 11, Paul Brousse Hosp, U602, Villejuif, France; [Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China	Case Western Reserve University; University Hospitals of Cleveland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Naval Medical University	Anthony, DD (corresponding author), Case Western Reserve Univ, Sch Med, Div Gen Med Sci, Cleveland, OH 44106 USA.	dda2@case.edu	Trojan, Jerzy/AAL-5183-2020		American Cancer Society [CN-8 A]; Ohio Board of Regents	American Cancer Society(American Cancer Society); Ohio Board of Regents	The work was supported by American Cancer Society grant CN-8 A, a grant from the Ohio Board of Regents and by gifts from the following benefactors: Marcia & Robert Williams, Regina & David Letterman, the Paul Newman Foundation, Mrs. Helen Wright, Mr. & Mrs. Edward Yoman, Mrs. Elizabeth Becker, Kimberly Birn & family, Mrs. Verna Warpula, Herbert Braverman, John D. Proctor, Harold & Clare Minoff, James & Rosemary Koehler, Wm. Gustaferro & family, Edward & Mary Lasko, and other unnamed donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Alyssa J, 1998, CANCER RES, V58, P3600; [Anonymous], J BIOL CHEM, V273, P16177; Anthony DD, 1998, ADV EXP MED BIOL, V451, P27; Baik I, 2005, CANCER RES, V65, P358; Beck S, 1996, J MOL BIOL, V255, P1, DOI 10.1006/jmbi.1996.0001; Brucet M, 2004, GENES IMMUN, V5, P26, DOI 10.1038/sj.gene.6364035; Cramer LA, 2000, J IMMUNOL, V165, P3190, DOI 10.4049/jimmunol.165.6.3190; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Flutter B, 2004, CELL MOL IMMUNOL, V1, P22; Gibson JM, 2001, MOL HUM REPROD, V7, P79, DOI 10.1093/molehr/7.1.79; Giuliani C, 2006, J ENDOCRINOL, V189, P605, DOI 10.1677/joe.1.06486; Groettrup M, 2001, CRIT REV IMMUNOL, V21, P339; Guo Y, 2002, INT IMMUNOL, V14, P189, DOI 10.1093/intimm/14.2.189; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hofmann Matthias, 2001, Expert Opin Ther Targets, V5, P379, DOI 10.1517/14728222.5.3.379; Inoue M, 2012, ONCOIMMUNOLOGY, V1, P1104, DOI 10.4161/onci.21056; Kamarashev J, 2001, INT J CANCER, V95, P23, DOI 10.1002/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4; LafargeFrayssinet C, 1997, CANCER GENE THER, V4, P276; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lankat-Buttgereit B, 1999, FEBS LETT, V464, P108, DOI 10.1016/S0014-5793(99)01676-2; Li P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011859; Liu YJ, 2000, CANCER GENE THER, V7, P456, DOI 10.1038/sj.cgt.7700137; Ly A, 2001, J CLIN PATHOL-MOL PA, V54, P230, DOI 10.1136/mp.54.4.230; Ly A, 2000, NEUROSCI LETT, V281, P13, DOI 10.1016/S0304-3940(00)00758-8; Ma XM, 2012, MOL MED REP, V6, P1433, DOI 10.3892/mmr.2012.1110; Matsui M, 2002, J GASTROEN HEPATOL, V17, P897, DOI 10.1046/j.1440-1746.2002.02837.x; MONACO JJ, 1995, J LEUKOCYTE BIOL, V57, P543, DOI 10.1002/jlb.57.4.543; Murray JL, 2000, J IMMUNOTHER, V23, P28, DOI 10.1097/00002371-200001000-00005; Niedermann G, 2002, CURR TOP MICROBIOL, V268, P91; Pan YX, 2000, METH MOLEC MED, V35, P189, DOI 10.1385/1-59259-086-1:189; Petersson M, 1998, J IMMUNOL, V161, P2099; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Seliger B, 2001, CANCER RES, V61, P8647; Straten PT, 1997, INT J CANCER, V70, P582; TROJAN J, 1993, SCIENCE, V259, P94, DOI 10.1126/science.8418502; TROJAN J, 1994, P NATL ACAD SCI USA, V91, P6088, DOI 10.1073/pnas.91.13.6088; Trojan J, 1996, NEUROSCI LETT, V212, P9, DOI 10.1016/0304-3940(96)12770-1; TROJAN J, 1992, P NATL ACAD SCI USA, V89, P4874, DOI 10.1073/pnas.89.11.4874; Upegui-Gonzalez LC, 2001, HEPATO-GASTROENTEROL, V48, P660; Vitale M, 1998, CANCER RES, V58, P737; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58428	10.1371/journal.pone.0058428	http://dx.doi.org/10.1371/journal.pone.0058428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526983	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600022
J	Feng, HJ; Tian, XH; Liu, YC; Li, YJ; Zhang, XY; Jones, BJ; Sun, YQ; Sun, J				Feng, Hongjie; Tian, Xinhui; Liu, Yongchang; Li, Yanjun; Zhang, Xinyu; Jones, Brian Joseph; Sun, Yuqiang; Sun, Jie			Analysis of Flavonoids and the Flavonoid Structural Genes in Brown Fiber of Upland Cotton	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; FRUIT-DEVELOPMENT; COLORFUL MODEL; GRAPE BERRIES; HUMAN HEALTH; EXPRESSION; PROANTHOCYANIDIN; IDENTIFICATION; BIOTECHNOLOGY; BIOCHEMISTRY	Backgroud: As a result of changing consumer preferences, cotton (Gossypium Hirsutum L.) from varieties with naturally colored fibers is becoming increasingly sought after in the textile industry. The molecular mechanisms leading to colored fiber development are still largely unknown, although it is expected that the color is derived from flavanoids. Experimental Design: Firstly, four key genes of the flavonoid biosynthetic pathway in cotton (GhC4H, GhCHS, GhF3'H, and GhF3'5'H) were cloned and studied their expression profiles during the development of brown-and white cotton fibers by QRT-PCR. And then, the concentrations of four components of the flavonoid biosynthetic pathway, naringenin, quercetin, kaempferol and myricetin in brown-and white fibers were analyzed at different developmental stages by HPLC. Result: The predicted proteins of the four flavonoid structural genes corresponding to these genes exhibit strong sequence similarity to their counterparts in various plant species. Transcript levels for all four genes were considerably higher in developing brown fibers than in white fibers from a near isogenic line (NIL). The contents of four flavonoids (naringenin, quercetin, kaempferol and myricetin) were significantly higher in brown than in white fibers and corresponding to the biosynthetic gene expression levels. Conclusions: Flavonoid structural gene expression and flavonoid metabolism are important in the development of pigmentation in brown cotton fibers.	[Feng, Hongjie; Tian, Xinhui; Liu, Yongchang; Li, Yanjun; Zhang, Xinyu; Sun, Jie] Shihezi Univ, Coll Agr, Key Lab Oasis Ecoagr, Shihezi, Peoples R China; [Jones, Brian Joseph] Univ Sydney, Fac Agr & Environm, Sydney, NSW 2006, Australia; [Sun, Yuqiang] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Shihezi University; University of Sydney; Hangzhou Normal University	Sun, YQ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	yqsun@hznu.edu.cn; sunjiezh@yahoo.com.cn	Jones, Brian m/E-8848-2016	Sun, Jie/0000-0002-8068-8102; Feng, Hongjie/0000-0001-8039-3227	National Basic Research Priorities Program [2007CD116210]; National Transgenic Major Projects [2011ZX08005]	National Basic Research Priorities Program(National Basic Research Program of China); National Transgenic Major Projects	This work was supported by the National Basic Research Priorities Program (Grant No: 2007CD116210) and National Transgenic Major Projects (No. 2011ZX08005). The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, AGRON ABROAD COTTON, V3, P172; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Castellarin SD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-12; Chen HJ, 2012, INT J MOL SCI, V13, P260, DOI 10.3390/ijms13010260; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; Gutha LR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-187; HALL TC, 1978, P NATL ACAD SCI USA, V75, P3196, DOI 10.1073/pnas.75.7.3196; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jaakola L, 2002, PLANT PHYSIOL, V130, P729, DOI 10.1104/pp.006957; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOHEL RJ, 1985, CROP SCI, V25, P793, DOI 10.2135/cropsci1985.0011183X0025000500017x; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Lunkenbein S, 2006, J AGR FOOD CHEM, V54, P2145, DOI 10.1021/jf052574z; Luo Ming, 2003, Acta Genetica Sinica, V30, P175; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; [邱新棉 Qiu Xinmian], 2004, [棉花学报, Cotton Science], V16, P249; Qiu XinMian, 2002, Scientia Agricultura Sinica, V35, P610; RYSER U, 1983, PROTOPLASMA, V117, P196, DOI 10.1007/BF01281823; Schoch GA, 2003, EUR J BIOCHEM, V270, P3684, DOI 10.1046/j.1432-1033.2003.03739.x; [Shi Yuzhen 石玉真], 2002, [棉花学报, Acta Gossypii Sinica], V14, P242; Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turnbull JJ, 2004, J BIOL CHEM, V279, P1206, DOI 10.1074/jbc.M309228200; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Vreeland JM, 1999, SCI AM, V280, P112, DOI 10.1038/scientificamerican0499-112; Wang J, 2012, PHARMACOGN MAG, V8, P166, DOI 10.4103/0973-1296.96581; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V358, P73, DOI 10.1016/j.bbrc.2007.04.084; YATSU LY, 1983, PLANT PHYSIOL, V73, P521, DOI 10.1104/pp.73.2.521; Zhan SH, 2008, CHINESE AGR SCI B, V24, P146; Zhao XiangQian, 2005, Acta Agronomica Sinica, V31, P456	40	42	50	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58820	10.1371/journal.pone.0058820	http://dx.doi.org/10.1371/journal.pone.0058820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527031	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100046
J	Dan, JQ; Zhang, YJ; Peng, ZW; Huang, JT; Gao, HJ; Xu, L; Chen, MS				Dan, Jiaqiang; Zhang, Yaojun; Peng, Zhenwei; Huang, Junting; Gao, Hengjun; Xu, Li; Chen, Minshan			Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation	PLOS ONE			English	Article							ELEVATED PREOPERATIVE NEUTROPHIL; PROSPECTIVE RANDOMIZED-TRIAL; RENAL-CELL CARCINOMA; CURATIVE RESECTION; GASTRIC-CANCER; RISK-FACTORS; LOCAL RECURRENCE; THERAPY; TUMOR; METASTASES	Background: An elevated preoperative neutrophil-to-lymphocyte ratio (NLR) has been reported to be a prognostic factor for hepatocellular carcinoma (HCC) patients after treatment. However, the clinical implication of postoperative NLR change remains unclear. Materials and Methods: From May 2005 to Aug 2008, a cohort of consecutive 178 small HCC patients treated with radiofrequency ablation (RFA) was retrospectively reviewed. The NLR was recorded within 3 days before and 1 month after RFA. Baseline characteristics, overall survival (OS) and recurrence free survival (RFS) were compared according to preoperative NLR and/or postoperative NLR change. Prognostic factors were assessed by multivariate analysis. Results: Compared with preoperative NLR level, postoperative NLR decreased in 87 patients and increased in 91 patients after RFA. No significant differences were identified between two groups in commonly used clinic-pathologic features. The 1, 3, 5 years OS was 98.8%, 78.6%, 67.1% for NLR decreased group, and 92.2%, 55.5%, 35.4% for NLR increased group respectively (P<0.001); the corresponding RFS was 94.2%, 65.2%, 33.8% and 81.7%, 46.1%, 12.4% respectively (P<0.001). In subgroup analysis, the survival of patients with lower or higher preoperative NLR can be distinguished more accurate by postoperative NLR change. Multivariate analysis showed that postoperative NLR change, but not preoperative NLR, was an independent prognostic factor for both OS (P<0.001, HR = 2.39, 95% CI 1.53-3.72) and RFS (P = 0.003, HR = 1.69, 95% CI 1.87-8.24). Conclusion: The postoperative NLR change was an independent prognostic factor for small HCC patient undergoing RFA, and patients with decreased NLR indicated better survival than those with increased NLR.	[Dan, Jiaqiang; Zhang, Yaojun; Peng, Zhenwei; Huang, Junting; Gao, Hengjun; Xu, Li; Chen, Minshan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Dan, Jiaqiang; Zhang, Yaojun; Peng, Zhenwei; Huang, Junting; Gao, Hengjun; Xu, Li; Chen, Minshan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Zhenwei] Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Chen, MS (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China.	Chminsh@mail.sysu.edu.cn	peng-cheng, chen/K-8100-2013; Huang, Junting/Q-4839-2019; Zhang, Yaojun/U-2965-2019	peng-cheng, chen/0000-0001-9763-6459; Huang, Junting/0000-0002-2448-5837; Zhang, Yaojun/0000-0002-9752-4729	Nature Science Foundation of China [30872995]; medical science research grant Guangdong Province [B2010114]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); medical science research grant Guangdong Province	This study was supported by a grant from the Nature Science Foundation of China (No. 30872995) and the medical science research grant Guangdong Province (B2010114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Chua W, 2011, SUPPORT CARE CANC; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; Fagnoni FF, 2008, FRONT BIOSCI-LANDMRK, V13, P369, DOI 10.2741/2686; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Guglielmi A, 2008, J GASTROINTEST SURG, V12, P192, DOI 10.1007/s11605-007-0392-8; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; He JR, 2012, HEAD NECK; Hong SN, 2005, J CLIN GASTROENTEROL, V39, P247, DOI 10.1097/01.mcg.0000152746.72149.31; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; Hung HY, 2011, INT J COLORECTAL DIS, V26, P1059, DOI 10.1007/s00384-011-1192-x; Jung MR, 2011, J SURG ONCOL, V104, P504, DOI 10.1002/jso.21986; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lam VWT, 2008, J AM COLL SURGEONS, V207, P20, DOI 10.1016/j.jamcollsurg.2008.01.020; Lau WY, 2003, ANN SURG, V237, P171, DOI 10.1097/00000658-200302000-00005; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lin SM, 2010, ONCOLOGY-BASEL, V78, P102, DOI 10.1159/000315237; Lupo L, 2007, HPB (Oxford), V9, P429, DOI 10.1080/13651820701713758; Mulier S, 2002, BRIT J SURG, V89, P1206, DOI 10.1046/j.1365-2168.2002.02168.x; Ng KK, 2008, J GASTROINTEST SURG, V12, P183, DOI 10.1007/s11605-007-0276-y; Ohno Y, 2012, J UROLOGY, V187, P411, DOI 10.1016/j.juro.2011.10.026; Peng ZW, 2008, SURG ONCOL, V17, P23, DOI 10.1016/j.suronc.2007.08.002; Rao P, 2011, CARDIOVASC INTER RAD, V34, P424, DOI 10.1007/s00270-010-9896-9; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Shiozawa K, 2009, MOL MED REP, V2, P89, DOI 10.3892/mmr_00000067; Takahashi S, 2007, ONCOLOGY-BASEL, V72, P98, DOI 10.1159/000111714; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Thavaramara Thaovalai, 2011, Journal of the Medical Association of Thailand, V94, P871; Wang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025295; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang YJ, 2007, RADIOLOGY, V244, P599, DOI 10.1148/radiol.2442060826; Zhang YJ, 2012, INT J HYPERTHER, V28, P132, DOI 10.3109/02656736.2011.654374	40	98	104	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58184	10.1371/journal.pone.0058184	http://dx.doi.org/10.1371/journal.pone.0058184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516447	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400021
J	He, W; Zhang, S; Song, AH; Yang, M; Jiao, JJ; Allison, DB; Heymsfield, SB; Zhu, SK				He, Wei; Zhang, Sha; Song, Aihua; Yang, Min; Jiao, Jingjing; Allison, David B.; Heymsfield, Steven B.; Zhu, Shankuan			Greater Abdominal Fat Accumulation Is Associated with Higher Metabolic Risk in Chinese than in White People: An Ethnicity Study	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; OBESITY; HYPERTENSION; PREVALENCE; DISEASE; WEIGHT; WOMEN; MEN; BMI	Introductin: Chinese are reported to have a higher percent body fat (%BF) and a higher percent trunk fat (%TF) than whites for a given body mass index (BMI). However, the associations of these ethnic differences in body composition with metabolic risks remain unknown. Methods and Procedures: A total of 1 029 Chinese from Hangzhou, China, and 207 whites from New York, NY, USA, were recruited in the present study. Body composition was measured using dual-energy X-ray absorptiometry (DXA). Analysis of covariance was used to assess the ethnic differences in fat, fat distribution, and metabolic risk factors. Results: After adjusting for BMI, age, and height, Chinese men had an average of 3.9% more % BF and 12.1% more % TF than white men; Chinese women had an average of 2.3% more % BF and 11.8% more % TF than white women. Compared with whites, higher metabolic risks were detected in Chinese for a given BMI after adjusting for age and height. Further adjustment for % BF did not change these ethnic disparities. However, after adjusting for % TF, the ethnic differences decreased and become insignificant in triglyceride, high-density lipoprotein cholesterol, and blood pressure (except for systolic blood pressure in men). For fasting plasma glucose, the ethnic differences persisted after adjustment for % BF, but decreased significantly from 0.910 to 0.686 mmol/L among men, and from 0.629 to 0.355 mmol/L among women, when the analyses were further controlled for % TF. Discussion: Chinese have both higher % BF and % TF than white people for a given BMI. However, only % TF could in part account for the higher metabolic risk observed in Chinese men and women.	[He, Wei; Zhang, Sha; Song, Aihua; Yang, Min; Jiao, Jingjing; Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Chron Dis Res Inst, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Min; Jiao, Jingjing; Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Hangzhou 310003, Zhejiang, Peoples R China; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Allison, David B.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Zhejiang University; Zhejiang University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Zhu, SK (corresponding author), Zhejiang Univ, Sch Publ Hlth, Chron Dis Res Inst, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	zsk@zju.edu.cn	Heymsfield, Steven B/N-1968-2017; He, Wei/C-8441-2015	Heymsfield, Steven B/0000-0003-1127-9425; He, Wei/0000-0003-0161-3274; Allison, David/0000-0003-3566-9399	China Medical Board (CMB) [10-014]; Scholarship Award for Excellent Doctoral Student; Ministry of Education, China	China Medical Board (CMB); Scholarship Award for Excellent Doctoral Student; Ministry of Education, China(Ministry of Education, China)	This study was supported, in part, by funding from the China Medical Board (CMB) (grant 10-014) and the Scholarship Award for Excellent Doctoral Student granted by the Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Deurenberg P, 2001, CURR OPIN CLIN NUTR, V4, P377, DOI 10.1097/00075197-200109000-00007; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Engeland A, 2003, EPIDEMIOLOGY, V14, P293, DOI 10.1097/00001648-200305000-00008; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Herrera BM, 2010, CURR DIABETES REP, V10, P498, DOI 10.1007/s11892-010-0153-z; Heymsfield SB, 2009, INT J OBESITY, V33, P1363, DOI 10.1038/ijo.2009.184; Juhaeri, 2002, INT J OBESITY, V26, P58, DOI 10.1038/sj.ijo.0801846; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Ko GTC, 2001, BRIT J NUTR, V85, P239, DOI 10.1079/BJN2000251; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Levine JA, 2008, CHINESE MED J-PEKING, V121, P1043, DOI 10.1097/00029330-200806010-00015; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lu H, 2011, OSTEOPOROSIS INT, V22, P3029, DOI 10.1007/s00198-010-1522-9; Luke A, 1997, AM J EPIDEMIOL, V145, P620, DOI 10.1093/oxfordjournals.aje.a009159; Meeuwsen S, 2010, CLIN NUTR, V29, P560, DOI 10.1016/j.clnu.2009.12.011; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Wang DY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019629, 10.1371/journal.pone.0019835]; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; World Health Organization, 2000, ASIA PACIFIC PERSPEC; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization Consultation on Obesity, 2000, OB PREV MAN GLOB EP; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P431; Zhu SK, 2011, CAN MED ASSOC J, V183, P645, DOI 10.1503/cmaj.110142; Zhu SK, 2005, AM J CLIN NUTR, V81, P409	37	30	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58688	10.1371/journal.pone.0058688	http://dx.doi.org/10.1371/journal.pone.0058688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516538	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400051
J	Cunha, MCR; Lima, FD; Vinolo, MAR; Hastreiter, A; Curi, R; Borelli, P; Fock, RA				Ramos Cunha, Mayara Caldas; Lima, Fabiana da Silva; Ramirez Vinolo, Marco Aurelio; Hastreiter, Araceli; Curi, Rui; Borelli, Primavera; Fock, Ricardo Ambrosio			Protein Malnutrition Induces Bone Marrow Mesenchymal Stem Cells Commitment to Adipogenic Differentiation Leading to Hematopoietic Failure	PLOS ONE			English	Article							C-KIT; EXPRESSION; RATS; INTERLEUKIN-3; GRANULOCYTE; ADIPOCYTES; GENERATION; DECREASES; COLONIES; THERAPY	Protein malnutrition (PM) results in pathological changes that are associated with peripheral leukopenia, bone marrow (BM) hypoplasia and alterations in the BM microenvironment leading to hematopoietic failure; however, the mechanisms involved are poorly understood. In this context, the BM mesenchymal stem cells (MSCs) are cells intimately related to the formation of the BM microenvironment, and their differentiation into adipocytes is important because adipocytes are cells that have the capability to negatively modulate hematopoiesis. Two-month-old male Balb/c mice were subjected to protein-energy malnutrition with a low-protein diet containing 2% protein, whereas control animals were fed a diet containing 12% protein. The hematopoietic parameters and the expression of CD45 and CD117 positive cells in the BM were evaluated. MSCs were isolated from BM, and their capability to produce SCF, IL-3, G-CSF and GM-CSF were analyzed. The expression of PPAR-gamma and C/EBP-alpha as well as the expression of PPAR-gamma and SREBP mRNAs were evaluated in MSCs together with their capability to differentiate into adipocytes in vitro. The malnourished animals had anemia and leukopenia as well as spleen and bone marrow hypoplasia and a reduction in the expression of CD45 and CD117 positive cells from BM. The MSCs of the malnourished mice presented an increased capability to produce SCF and reduced production of G-CSF and GM-CSF. The MSCs from the malnourished animals showed increased expression of PPAR-gamma protein and PPAR-gamma mRNA associated with an increased capability to differentiate into adipocytes. The alterations found in the malnourished animals allowed us to conclude that malnutrition committed MSC differentiation leading to adipocyte decision and compromised their capacity for cytokine production, contributing to an impaired hematopoietic microenvironment and inducing the bone marrow failure commonly observed in protein malnutrition states.	[Ramos Cunha, Mayara Caldas; Lima, Fabiana da Silva; Hastreiter, Araceli; Borelli, Primavera; Fock, Ricardo Ambrosio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil; [Ramirez Vinolo, Marco Aurelio] Univ Campinas Unicamp, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, Brazil; [Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Fock, RA (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil.	hemato@usp.br	Curi, Rui/C-9351-2012; Vinolo, Marco Aurélio R/K-3753-2012; Lima, Fabiana/AAZ-6275-2020; Borelli, Primavera/G-3422-2012; Lima, Fabiana/H-2479-2017; Hastreiter, Araceli A/K-3806-2012; Fock, Ricardo Ambrosio/C-6105-2012	Lima, Fabiana/0000-0003-3695-4458; Borelli, Primavera/0000-0001-9454-4372; Lima, Fabiana/0000-0003-3695-4458; Hastreiter, Araceli A/0000-0001-6226-8772; Fock, Ricardo Ambrosio/0000-0002-7964-5973; Vinolo, Marco Aurelio/0000-0003-1335-760X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2010/51747-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This investigation was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (2010/51747-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHKENASY A, 1957, AM J CLIN NUTR, V5, P14, DOI 10.1093/ajcn/5.1.14; BERNSTEIN ID, 1991, BLOOD, V77, P2316; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Borelli P, 2009, BRAZ J MED BIOL RES, V42, P523, DOI 10.1590/S0100-879X2009000600008; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Carrancio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026241; CATCHATOURIAN R, 1980, BLOOD, V55, P625; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; Fernandez-Varon E, 2007, VET J, V174, P33, DOI 10.1016/j.tvjl.2006.08.001; Flo J, 1996, CLIN IMMUNOL IMMUNOP, V80, P147, DOI 10.1006/clin.1996.0108; Fock RA, 2009, NUTRITION, V10, P1021; Fock RA, 2007, CYTOKINE, V40, P105, DOI 10.1016/j.cyto.2007.08.007; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kimura T, 1997, BLOOD, V90, P4767; KORNBERG A, 1946, SCIENCE, V103, P646, DOI 10.1126/science.103.2682.646; Landgraf MAV, 2005, J NUTR, V135, P1480, DOI 10.1093/jn/135.6.1480; Li T, 2011, BONE MARROW RES, DOI 10.1155/2011/353878; LIESVELD JL, 1995, EXP HEMATOL, V23, P202; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marti J, 2001, MED CLIN-BARCELONA, V116, P446, DOI 10.1016/S0025-7753(01)71865-9; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mourcin F, 2005, RADIAT RES, V164, P1, DOI 10.1667/RR3384; Musri MM, 2012, CURR OPIN CLIN NUTR, V15, P342, DOI 10.1097/MCO.0b013e3283546fba; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Olmos S, 2001, METABOLISM, V50, P1025, DOI 10.1053/meta.2001.25657; Ortiz M, 1999, IMMUNITY, V10, P173, DOI 10.1016/S1074-7613(00)80018-7; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rosen ED, 2000, GENE DEV, V14, P1293; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vituri CL, 2000, BRAZ J MED BIOL RES, V33, P889, DOI 10.1590/S0100-879X2000000800004; WARD P G, 1963, J Med Lab Technol, V20, P191; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Zapata AG, 2012, ADV EXP MED BIOL, V741, P135, DOI 10.1007/978-1-4614-2098-9_10	40	39	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58872	10.1371/journal.pone.0058872	http://dx.doi.org/10.1371/journal.pone.0058872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516566	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400070
J	Zhang, X; Li, YH; Zhang, Y; Song, JC; Wang, QM; Zheng, LP; Liu, D				Zhang, Xian; Li, Yinghua; Zhang, Yang; Song, Jincheng; Wang, Qimin; Zheng, Luping; Liu, Dan			Beta-Elemene Blocks Epithelial-Mesenchymal Transition in Human Breast Cancer Cell Line MCF-7 through Smad3-Mediated Down-Regulation of Nuclear Transcription Factors	PLOS ONE			English	Article							NF-KAPPA-B; TGF-BETA; INDUCED EMT; E-CADHERIN; SNAIL; METASTASIS; MECHANISMS; APOPTOSIS; ARREST; COOPERATION	Epithelial-mesenchymal transition (EMT) is the first step required for breast cancer to initiate metastasis. However, the potential of drugs to block and reverse the EMT process are not well explored. In the present study, we investigated the inhibitory effect of beta-elemene (ELE), an active component of a natural plant-derived anti-neoplastic agent in an established EMT model mediated by transforming growth factor-beta1 (TGF-beta 1). We found that ELE (40 mu g/ml) blocked the TGF-beta 1-induced phenotypic transition in the human breast cancer cell line MCF-7. ELE was able to inhibit TGF-beta 1-mediated upregulation of mRNA and protein expression of nuclear transcription factors (SNAI1, SNAI2, TWIST and SIP1), potentially through decreasing the expression and phosphorylation of Smad3, a central protein mediating the TGF-beta 1 signalling pathway. These findings suggest a potential therapeutic benefit of ELE in treating basal-like breast cancer.	[Zhang, Xian; Li, Yinghua; Zhang, Yang] Dalian Med Univ, Affiliated Hosp 2, Dept Oncol, Dalian, Peoples R China; [Zhang, Xian; Zheng, Luping] Dalian Med Univ, Res Inst Integrated Tradit & Western Med, Dalian, Peoples R China; [Song, Jincheng; Liu, Dan] Dalian Med Univ, Grad Inst, Dalian, Peoples R China; [Wang, Qimin] Dalian Med Univ, Affiliated Hosp 2, Dept Pathol, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Zhang, Y (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Oncol, Dalian, Peoples R China.	dlzlzx001@yahoo.com.cn						Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chen X, 2012, MOL MED REPORT; Coradini D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/254085; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Drabsch Y, 2012, CANC METASTASIS REV; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Giordano A, 2012, MOL CANC THER; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Hsu HY, 2012, CARCINOGENESIS; Huang T, 2013, ONCOL REP, V29, P117, DOI 10.3892/or.2012.2080; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ismail IA, 2013, BREAST CANC RES TREA; Ito I, 2010, J BIOL CHEM, V285, P14747, DOI 10.1074/jbc.M109.093039; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Li L, 2011, MOL MED REP, V4, P1243, DOI 10.3892/mmr.2011.548; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Li X, 2005, CELL MOL LIFE SCI, V62, P894, DOI 10.1007/s00018-005-5027-1; Liu J, 2012, J PHARM PHARMACOL, V64, P146, DOI 10.1111/j.2042-7158.2011.01371.x; Liu J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-183; Lu JJ, 2012, J ETHNOPHARMACOL; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Meyer T, 1998, EUR J CANCER, V34, P214, DOI 10.1016/S0959-8049(97)10129-0; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Sehrawat A, 2012, CARCINOGENESIS; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yao YQ, 2008, CANCER LETT, V264, P127, DOI 10.1016/j.canlet.2008.01.049; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang B, 2012, BREAST CANCER RES TR, V136, P399, DOI 10.1007/s10549-012-2263-6; Zhao YS, 2012, J NEURO-ONCOL, V107, P307, DOI 10.1007/s11060-011-0770-7	51	39	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58719	10.1371/journal.pone.0058719	http://dx.doi.org/10.1371/journal.pone.0058719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516540	Green Submitted, gold, Green Published			2022-12-25	WOS:000316407400052
J	Fairless, R; Beck, A; Kravchenko, M; Williams, SK; Wissenbach, U; Diem, R; Cavalie, A				Fairless, Richard; Beck, Andreas; Kravchenko, Mykola; Williams, Sarah K.; Wissenbach, Ulrich; Diem, Ricarda; Cavalie, Adolfo			Membrane Potential Measurements of Isolated Neurons Using a Voltage-Sensitive Dye	PLOS ONE			English	Article							TRP CHANNELS; FLUORESCENCE; IDENTIFICATION; VALIDATION; INDICATORS; FLIPR; GABA	The ability to monitor changes in membrane potential is a useful tool for studying neuronal function, but there are only limited options available at present. Here, we have investigated the potential of a commercially available FLIPR membrane potential (FMP) dye, developed originally for high throughput screening using a plate reader, for imaging the membrane potential of cultured cells using an epifluorescence-based single cell imaging system. We found that the properties of the FMP dye make it highly suitable for such imaging since 1) its fluorescence displayed a high signal-to-noise ratio, 2) robust signals meant only minimal exposure times of around 5 ms were necessary, and 3) bidirectional changes in fluorescence were detectable resulting from hyper- or depolarising conditions, reaching equilibrium with a time constant of 4-8 s. Measurements were possible independently of whether membrane potential changes were induced by voltage clamping, or manipulating the ionic distribution of either Na+ or K+. Since FMP behaves as a charged molecule which accumulates in the cytosol, equations based on the Boltzmann distribution were developed determining that the apparent charge of FMP which represents a measure of the voltage sensitivity of the dye, is between -0.62 and -0.72. Finally, we demonstrated that FMP is suitable for use in a variety of neuronal cell types and detects membrane potential changes arising from spontaneous firing of action potentials and through stimulation with a variety of excitatory and inhibitory neurotransmitters.	[Fairless, Richard; Williams, Sarah K.; Diem, Ricarda] Univ Clin Heidelberg, Dept Neurooncol, Heidelberg, Germany; [Fairless, Richard; Williams, Sarah K.; Diem, Ricarda] Univ Saarland, Dept Neurol, Homburg, Germany; [Beck, Andreas; Kravchenko, Mykola; Wissenbach, Ulrich; Cavalie, Adolfo] Univ Saarland, Dept Pharmacol & Toxicol, Homburg, Germany	Ruprecht Karls University Heidelberg; Saarland University; Saarland University	Cavalie, A (corresponding author), Univ Saarland, Dept Pharmacol & Toxicol, Homburg, Germany.	adolfo.cavalie@uks.eu			Deutsche Forschungsgemeinschaft [SFB 894, GK 1326]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (SFB 894, GK 1326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RH, 1956, J PHYSIOL-LONDON, V133, P631, DOI 10.1113/jphysiol.1956.sp005615; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; ANDREOLI TE, 1967, J GEN PHYSIOL, V50, P2527, DOI 10.1085/jgp.50.11.2527; Baker BJ, 2005, CELL MOL NEUROBIOL, V25, P245, DOI 10.1007/s10571-005-3059-6; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Briggman KL, 2010, MEMBRANE POTENTIAL IMAGING IN THE NERVOUS SYSTEMS: METHODS AND APPLICATIONS, P61, DOI 10.1007/978-1-4419-6558-5_6; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024; COHEN L, 1989, ANNU REV PHYSIOL, V51, P487, DOI 10.1146/annurev.physiol.51.1.487; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Goslin K., 1998, CULTURING NERVE CELL, P339; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Homma R, 2011, PHIL T R SOC B, V364, P2453; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; Joesch C, 2008, J BIOMOL SCREEN, V13, P218, DOI 10.1177/1087057108315036; Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Loew LM, 2010, MEMBRANE POTENTIAL IMAGING IN THE NERVOUS SYSTEMS: METHODS AND APPLICATIONS, P13, DOI 10.1007/978-1-4419-6558-5_2; MCCORMICK DA, 1985, P NATL ACAD SCI USA, V82, P6344, DOI 10.1073/pnas.82.18.6344; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MINTA A, 1989, J BIOL CHEM, V264, P19449; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Nakagawa T, 2006, J NEURAL ENG, V3, P79, DOI 10.1088/1741-2560/3/2/001; Pages S, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00020; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Schnitzler AC, 2008, NAT PROTOC, V3, P34, DOI 10.1038/nprot.2007.477; Whiteaker KL, 2001, J BIOMOL SCREEN, V6, P305, DOI 10.1177/108705710100600504; Wolff C, 2003, J BIOMOL SCREEN, V8, P533, DOI 10.1177/1087057103257806; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Zhang J, 1998, BIOPHYS J, V74, P48, DOI 10.1016/S0006-3495(98)77765-3; Zheng F, 1996, J NEUROSCI, V16, P6079	41	23	23	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58260	10.1371/journal.pone.0058260	http://dx.doi.org/10.1371/journal.pone.0058260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516458	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200052
J	Mathur, A; Blais, S; Goparaju, CMV; Neubert, T; Pass, H; Levon, K				Mathur, Aabhas; Blais, Steven; Goparaju, Chandra M. V.; Neubert, Thomas; Pass, Harvey; Levon, Kalle			Development of a Biosensor for Detection of Pleural Mesothelioma Cancer Biomarker Using Surface Imprinting	PLOS ONE			English	Article							HEPARANASE; HYALURONAN; ANGIOGENESIS; RECOGNITION; GROWTH; EXPRESSION; CARCINOMA; PROTEINS; POLYMERS; PEPTIDE	Hyaluronan-linked protein 1 (HAPLN1) which has been shown to be highly expressed in malignant pleural mesotheliomas (MPM), was detected in serum using an electrochemical surface-imprinting method. First, the detection method was optimized using Bovine serum albumin (BSA) as a model protein to mimic the optimal conditions required to imprint the similar molecular weight protein HAPLN1. BSA was imprinted on the gold electrode with hydroxyl terminated alkane thiols, which formed a self-assembled monolayer (SAM) around BSA. The analyte (BSA) was then washed away and its imprint (empty cavity with shape-memory) was used for detection of BSA in a solution, using electrochemical open-circuit potential method, namely potentiometry. Factors considered to optimize the conditions include incubation time, protein concentration, limit of detection and size of electrode. Matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) was used to confirm selectivity of imprints. With the obtained imprinting control parameters, HAPLN1 was imprinted in duplicate and the detection of spiked HAPLN1 was successfully conducted in serum.	[Mathur, Aabhas; Levon, Kalle] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA; [Blais, Steven; Neubert, Thomas] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Blais, Steven; Neubert, Thomas] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Goparaju, Chandra M. V.; Pass, Harvey] NYU, Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA	New York University; New York University Tandon School of Engineering; New York University; New York University; New York University	Levon, K (corresponding author), NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA.	kalle.levon@gmail.com	Levon, Kalle/H-7990-2016	Levon, Kalle/0000-0001-6833-6254; Pass, Harvey/0000-0003-3222-3471; neubert, Thomas/0000-0001-7049-2088	 [W911NF-09-1-0499]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study has been funded by an army grant (W911NF-09-1-0499) for Potentiomeric detection of pathogens. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Anttila MA, 2000, CANCER RES, V60, P150; ARSHADY R, 1981, MACROMOL CHEM PHYS, V182, P687; Bossi A, 2007, BIOSENS BIOELECTRON, V22, P1131, DOI 10.1016/j.bios.2006.06.023; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cohen-Kaplan V, 2012, J BIOL CHEM, V287, P6668, DOI 10.1074/jbc.M111.271346; Creaney J, 2009, CURR OPIN PULM MED, V15, P366, DOI 10.1097/MCP.0b013e32832b98eb; Das K, 2003, LANGMUIR, V19, P3921, DOI 10.1021/la026781u; DICKEY FH, 1949, P NATL ACAD SCI USA, V35, P227, DOI 10.1073/pnas.35.5.227; Du XZ, 2005, BIOSENS BIOELECTRON, V20, P2053, DOI 10.1016/j.bios.2004.08.044; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Huo H, 2007, ACS SYM SER, V963, P312; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; JANATA J, 1975, J AM CHEM SOC, V97, P2914, DOI 10.1021/ja00843a058; Jeyachandran YL, 2010, J COLLOID INTERF SCI, V341, P136, DOI 10.1016/j.jcis.2009.09.007; Lavignac N, 2004, ANAL CHIM ACTA, V510, P139, DOI 10.1016/j.aca.2003.12.066; Li X, 2006, LANGMUIR, V22, P9658, DOI 10.1021/la0612163; Liu HC, 2012, TUMOR BIOL, V33, P1327, DOI 10.1007/s13277-012-0380-9; Mirsky VM, 1999, ANGEW CHEM INT EDIT, V38, P1108, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1108::AID-ANIE1108>3.0.CO;2-C; Nelson GM, 2007, NEOPLASIA, V9, P1038, DOI 10.1593/neo.07643; Okawa T, 2005, CLIN CANCER RES, V11, P7995, DOI 10.1158/1078-0432.CCR-05-1103; Piletsky SA, 1999, SENSOR ACTUAT B-CHEM, V60, P216, DOI 10.1016/S0925-4005(99)00273-7; Polyakov M. V., 1931, ZH FIZ KHIM, V2, P799; PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011; Quiros RM, 2006, CANCER-AM CANCER SOC, V106, P532, DOI 10.1002/cncr.21648; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Ropponen K, 1998, CANCER RES, V58, P342; Turner NW, 2006, BIOTECHNOL PROGR, V22, P1474, DOI 10.1021/bp060122g; Wang YT, 2008, BIOSENS BIOELECTRON, V24, P162, DOI 10.1016/j.bios.2008.04.010; Wang YT, 2010, SENSOR ACTUAT B-CHEM, V146, P381, DOI 10.1016/j.snb.2010.02.032; WULFF G, 1972, ANGEW CHEM INT EDIT, V11, P341; Xu XM, 2003, CANCER RES, V63, P5685; Zhang J, 2012, ONCOL LETT, V4, P178, DOI 10.3892/ol.2012.703; Zhou YX, 2005, BIOSENS BIOELECTRON, V20, P1851, DOI 10.1016/j.bios.2004.05.005	36	17	18	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57681	10.1371/journal.pone.0057681	http://dx.doi.org/10.1371/journal.pone.0057681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516416	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200018
J	Zubacova, Z; Novak, L; Bublikova, J; Vacek, V; Fousek, J; Ridl, J; Tachezy, J; Dolezal, P; Vlcek, C; Hampl, V				Zubacova, Zuzana; Novak, Lukas; Bublikova, Jitka; Vacek, Vojtech; Fousek, Jan; Ridl, Jakub; Tachezy, Jan; Dolezal, Pavel; Vlcek, Cestmir; Hampl, Vladimir			The Mitochondrion-Like Organelle of Trimastix pyriformis Contains the Complete Glycine Cleavage System	PLOS ONE			English	Article							GENOME SEQUENCE; PROTEINS; EVOLUTION; ULTRASTRUCTURE; HYDROGENOSOMES; BLASTOCYSTIS; METABOLISM; TRANSFORMATION; LOCALIZATION; PURIFICATION	All eukaryotic organisms contain mitochondria or organelles that evolved from the same endosymbiotic event like classical mitochondria. Organisms inhabiting low oxygen environments often contain mitochondrial derivates known as hydrogenosomes, mitosomes or neutrally as mitochondrion-like organelles. The detailed investigation has shown unexpected evolutionary plasticity in the biochemistry and protein composition of these organelles in various protists. We investigated the mitochondrion-like organelle in Trimastix pyriformis, a free-living member of one of the three lineages of anaerobic group Metamonada. Using 454 sequencing we have obtained 7 037 contigs from its transcriptome and on the basis of sequence homology and presence of N-terminal extensions we have selected contigs coding for proteins that putatively function in the organelle. Together with the results of a previous transcriptome survey, the list now consists of 23 proteins = mostly enzymes involved in amino acid metabolism, transporters and maturases of proteins and transporters of metabolites. We have no evidence of the production of ATP in the mitochondrion-like organelle of Trimastix but we have obtained experimental evidence for the presence of enzymes of the glycine cleavage system (GCS), which is part of amino acid metabolism. Using homologous antibody we have shown that H-protein of GCS localizes into vesicles in the cell of Trimastix. When overexpressed in yeast, H- and P-protein of GCS and cpn60 were transported into mitochondrion. In case of H- protein we have demonstrated that the first 16 amino acids are necessary for this transport. Glycine cleavage system is at the moment the only experimentally localized pathway in the mitochondrial derivate of Trimastix pyriformis.	[Zubacova, Zuzana; Novak, Lukas; Bublikova, Jitka; Vacek, Vojtech; Tachezy, Jan; Dolezal, Pavel; Hampl, Vladimir] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Fousek, Jan; Ridl, Jakub; Vlcek, Cestmir] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Hampl, V (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	vlada@natur.cuni.cz	Dolezal, Pavel/V-1907-2017; Tachezy, Jan/R-4945-2017; Hampl, Vladimir/A-4339-2008; Novák, Lukáš V. F./V-8805-2019; Fousek, Jan/F-8213-2014; Novak, Lukas V. F./U-5687-2017; Vlcek, Cestmir/I-8820-2014	Dolezal, Pavel/0000-0003-1285-9026; Tachezy, Jan/0000-0001-6976-8446; Hampl, Vladimir/0000-0002-5430-7564; Novák, Lukáš V. F./0000-0001-7773-9119; Novak, Lukas V. F./0000-0001-7773-9119; Vacek, Vojtech/0000-0002-3158-0752	Grant Agency of the Charles University [97309]; Czech Science Foundation [P506/12/1010]	Grant Agency of the Charles University; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Grant Agency of the Charles University 97309 (to JB) and by Czech Science Foundation P506/12/1010 (to VH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Yousuf M, 2010, EUKARYOT CELL, V9, P926, DOI 10.1128/EC.00011-10; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BESSON V, 1995, PLANT PHYSIOL BIOCH, V33, P665; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Brugerolle G, 1997, EUR J PROTISTOL, V33, P121, DOI 10.1016/S0932-4739(97)80029-6; Touz MC, 2008, J CELL SCI, V121, P2930, DOI 10.1242/jcs.026963; Carpenter KJ, 2008, PROTIST, V159, P209, DOI 10.1016/j.protis.2007.09.002; Cavalier-Smith T, 2003, INT J SYST EVOL MICR, V53, P1741, DOI 10.1099/ijs.0.02548-0; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Dawson SC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-71; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Dolezal P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000812; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fujiwara K, 1997, J BIOL CHEM, V272, P19880, DOI 10.1074/jbc.272.32.19880; Gelius-Dietrich G, 2007, J EUKARYOT MICROBIOL, V54, P42, DOI 10.1111/j.1550-7408.2006.00146.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hampl V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001383; Hampl Vladimir, 2011, Mob Genet Elements, V1, P71; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hjort K, 2010, PHILOS T R SOC B, V365, P713, DOI 10.1098/rstb.2009.0224; HRDY I, 2008, MICROBIOL MONOGR, V9, P113, DOI DOI 10.1007/7171_2007_110; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Mi-ichi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001263; Mogi T, 2010, PARASITOL INT, V59, P305, DOI 10.1016/j.parint.2010.04.005; Morada M, 2011, MOL BIOCHEM PARASIT, V176, P51, DOI 10.1016/j.molbiopara.2010.10.004; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; O'Kelly CJ, 1999, PROTIST, V150, P149, DOI 10.1016/S1434-4610(99)70018-0; OLAUSSON T, 1995, BBA-BIOENERGETICS, V1231, P1, DOI 10.1016/0005-2728(95)00058-Q; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Perez-Brocal V, 2008, MOL BIOL EVOL, V25, P2475, DOI 10.1093/molbev/msn193; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Rada P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024428; Satre M, 2007, BIOCHIMIE, V89, P1058, DOI 10.1016/j.biochi.2007.03.004; Schneider RE, 2011, INT J PARASITOL, V41, P1421, DOI 10.1016/j.ijpara.2011.10.001; Shiflett AM, 2010, ANNU REV MICROBIOL, V64, P409, DOI 10.1146/annurev.micro.62.081307.162826; Simpson AGB, 2000, EUR J PROTISTOL, V36, P229, DOI 10.1016/S0932-4739(00)80001-2; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stairs CW, 2011, MOL BIOL EVOL, V28, P2087, DOI 10.1093/molbev/msr032; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945	54	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e55417	10.1371/journal.pone.0055417	http://dx.doi.org/10.1371/journal.pone.0055417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516392	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200002
J	Chen, TC; Liu, YW; Huang, YH; Yeh, YC; Chou, TY; Wu, YC; Wu, CC; Chen, YR; Cheng, HC; Lu, PJ; Lai, JM; Huang, CYF				Chen, Tzu-Chi; Liu, Yu-Wen; Huang, Yei-Hsuan; Yeh, Yi-Chen; Chou, Teh-Ying; Wu, Yu-Chung; Wu, Chun-Chi; Chen, Yi-Rong; Cheng, Hui-Chuan; Lu, Pei-Jung; Lai, Jin-Mei; Huang, Chi-Ying F.			Protein Phosphorylation Profiling Using an In Situ Proximity Ligation Assay: Phosphorylation of AURKA-Elicited EGFR-Thr654 and EGFR-Ser1046 in Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ERBB SIGNALING NETWORK; AURORA-A; TYROSINE KINASE; GENE-EXPRESSION; POOR-PROGNOSIS; BREAST-CANCER; EGF RECEPTOR; MUTATIONS; GEFITINIB	The epidermal growth factor receptor (EGFR), which is up-regulated in lung cancer, involves the activation of mitogenic signals and triggers multiple signaling cascades. To dissect these EGFR cascades, we used 14 different phospho-EGFR antibodies to quantify protein phosphorylation using an in situ proximity ligation assay (in situ PLA). Phosphorylation at EGFR-Thr654 and -Ser1046 was EGF-dependent in the wild-type (WT) receptor but EGF-independent in a cell line carrying the EGFR-L858R mutation. Using a ProtoAarray (TM) containing similar to 5000 recombinant proteins on the protein chip, we found that AURKA interacted with the EGFR-L861Q mutant. Moreover, overexpression of EGFR could form a complex with AURKA, and the inhibitors of AURKA and EGFR decreased EGFR-Thr654 and -Ser1046 phosphorylation. Immunohistochemical staining of stage I lung adenocarcinoma tissues demonstrated a positive correlation between AURKA expression and phosphorylation of EGFR at Thr654 and Ser1046 in EGFR-mutant specimens, but not in EGFR-WT specimens. The interplay between EGFR and AURKA provides an explanation for the difference in EGF dependency between EGFR-WT and EGFR-mutant cells and may provide a new therapeutic strategy for lung cancer patients carrying EGFR mutations.	[Chen, Tzu-Chi; Huang, Yei-Hsuan; Yeh, Yi-Chen; Chou, Teh-Ying; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Liu, Yu-Wen; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Yeh, Yi-Chen; Chou, Teh-Ying] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Wu, Yu-Chung] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Wu, Chun-Chi] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, Yi-Rong] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Taiwan; [Cheng, Hui-Chuan; Lu, Pei-Jung] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chung Shan Medical University; National Health Research Institutes - Taiwan; National Cheng Kung University; Fu Jen Catholic University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	cyhuang5@ym.edu.tw	Chen, Yi-Rong/CAH-7991-2022; Huang, Chi-Ying/AFL-7729-2022; Chen, Yi-Rong/CAF-2186-2022; Chen, Yi-Rong/E-3991-2010; Huang, Chi-Ying/AAG-7672-2022	Chen, Yi-Rong/0000-0002-4307-3002; Huang, Chi-Ying/0000-0003-4898-4937; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002; Huang, Chi-Ying/0000-0003-4898-4937	National Science Council [NSC101-2325-B-010-011, NSC101-2627-B-010-001]; Center of Excellence for Cancer Research at Taipei Veterans General Hospital [DOH101-TD-C-111-007]; Ministry of Education, Aim for the Top University Plan (National Yang Ming University)	National Science Council(Ministry of Science and Technology, Taiwan); Center of Excellence for Cancer Research at Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education, Aim for the Top University Plan (National Yang Ming University)	This research was supported by grants from the National Science Council (NSC101-2325-B-010-011 and NSC101-2627-B-010-001), the Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH101-TD-C-111-007), and the Ministry of Education, Aim for the Top University Plan (National Yang Ming University) to CYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 2005, CANCER RES, V65, P226; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Chen YR, 2006, ONCOGENE, V25, P1205, DOI 10.1038/sj.onc.1209159; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Erba EB, 2007, J PROTEOME RES, V6, P2768, DOI 10.1021/pr060675m; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lai CH, 2010, J CELL MOL MED, V14, P1520, DOI 10.1111/j.1582-4934.2009.00919.x; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lin YS, 2006, GENE EXPRESSION, V13, P15, DOI 10.3727/000000006783991962; Lo H-W, 2007, Br J Cancer, V96 Suppl, pR16; Lo HW, 2005, CANCER RES, V65, P338; LUND KA, 1990, J BIOL CHEM, V265, P20517; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2006, PHARMACOGENOMICS, V7, P597, DOI 10.2217/14622416.7.4.597; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Oberg K, 2010, ANN ONCOL, V21, pv220, DOI 10.1093/annonc/mdq191; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Ohsaki Y, 2000, ONCOL REP, V7, P603; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; RUSCH V, 1993, CANCER RES, V53, P2379; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sugimoto K, 2002, CELL STRUCT FUNCT, V27, P457, DOI 10.1247/csf.27.457; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	57	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55657	10.1371/journal.pone.0055657	http://dx.doi.org/10.1371/journal.pone.0055657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520446	Green Submitted, gold, Green Published			2022-12-25	WOS:000318679900005
J	Riggins, DP; Narvaez, MJ; Martinez, KA; Harden, MM; Slonczewski, JL				Riggins, Daniel P.; Narvaez, Maria J.; Martinez, Keith A.; Harden, Mark M.; Slonczewski, Joan L.			Escherichia coli K-12 Survives Anaerobic Exposure at pH 2 without RpoS, Gad, or Hydrogenases, but Shows Sensitivity to Autoclaved Broth Products	PLOS ONE			English	Article							DEPENDENT ACID RESISTANCE; CYCLOPROPANE FATTY-ACIDS; DECARBOXYLASE GENES; SHIGELLA-FLEXNERI; FNR; CATABOLISM; EXPRESSION; PEROXIDE; PROTEINS; BACTERIA	Escherichia coli and other enteric bacteria survive exposure to extreme acid (pH 2 or lower) in gastric fluid. Aerated cultures survive via regulons expressing glutamate decarboxylase (Gad, activated by RpoS), cyclopropane fatty acid synthase (Cfa) and others. But extreme-acid survival is rarely tested under low oxygen, a condition found in the stomach and the intestinal tract. We observed survival of E. coli K-12 W3110 at pH 1.2-pH 2.0, conducting all manipulations (overnight culture at pH 5.5, extreme-acid exposure, dilution and plating) in a glove box excluding oxygen (10% H-2, 5% CO2, balance N-2). With dissolved O-2 concentrations maintained below 6 mM, survival at pH 2 required Cfa but did not require GadC, RpoS, or hydrogenases. Extreme-acid survival in broth (containing tryptone and yeast extract) was diminished in media that had been autoclaved compared to media that had been filtered. The effect of autoclaved media on extreme-acid survival was most pronounced when oxygen was excluded. Exposure to H2O2 during extreme-acid treatment increased the death rate slightly for W3110 and to a greater extent for the rpoS deletion strain. Survival at pH 2 was increased in strains lacking the anaerobic regulator fnr. During anaerobic growth at pH 5.5, strains deleted for fnr showed enhanced transcription of acid-survival genes gadB, cfa, and hdeA, as well as catalase (katE). We show that E. coli cultured under oxygen exclusion (<6 mu M O-2) requires mechanisms different from those of aerated cultures. Extreme acid survival is more sensitive to autoclave products under oxygen exclusion.	[Riggins, Daniel P.; Narvaez, Maria J.; Martinez, Keith A.; Harden, Mark M.; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA	Kenyon College	Slonczewski, JL (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu	Riggins, Daniel P/C-6560-2011	Riggins, Daniel P/0000-0002-6240-6212; Martinez II, Keith/0000-0002-4760-5221	National Science Foundation [MCB-1050080, STEM DUE-0965895]; Kenyon College	National Science Foundation(National Science Foundation (NSF)); Kenyon College	The funding is from grant MCB-1050080 from the National Science Foundation (http://www.nsf.gov/). M. Narvaez received a summer stipend from the National Science Foundation STEM DUE-0965895 to Kenyon College, and M. Harden received a summer stipend from Kenyon College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Andersen L.P., 2001, HELICOBACTER PYLORI; AUGER EA, 1989, MOL MICROBIOL, V3, P609, DOI 10.1111/j.1365-2958.1989.tb00208.x; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Due VL, 2003, ACTA ANAESTH SCAND, V47, P372, DOI 10.1034/j.1399-6576.2003.00542.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Hegele J, 2009, MOL NUTR FOOD RES, V53, P760, DOI 10.1002/mnfr.200800221; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2008, MOL MICROBIOL, V68, P801, DOI 10.1111/j.1365-2958.2008.06213.x; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kumar R, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-3; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; MOORE WEC, 1969, J INFECT DIS, V119, P641, DOI 10.1093/infdis/119.6.641; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; SCHROEDER LJ, 1955, J BIOL CHEM, V212, P973; Shabala L, 2008, RES MICROBIOL, V159, P458, DOI 10.1016/j.resmic.2008.04.011; Shalel-Levanon S, 2005, BIOTECHNOL BIOENG, V92, P147, DOI 10.1002/bit.20583; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; SMITH DK, 1992, J BACTERIOL, V174, P5820, DOI 10.1128/jb.174.18.5820-5826.1992; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Tolla DA, 2011, MOL MICROBIOL, V79, P149, DOI 10.1111/j.1365-2958.2010.07437.x; Unden G, 1997, MOL MICROBIOL, V25, P205, DOI 10.1046/j.1365-2958.1997.4731841.x; Zilberstein B, 2007, CLINICS, V62, P47, DOI 10.1590/S1807-59322007000100008	45	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56796	10.1371/journal.pone.0056796	http://dx.doi.org/10.1371/journal.pone.0056796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520457	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900016
J	Goicoechea, SM; Garcia-Mata, R; Staub, J; Valdivia, A; Sharek, L; McCulloch, CG; Hwang, RF; Urrutia, R; Yeh, JJ; Kim, HJ; Otey, CA				Goicoechea, S. M.; Garcia-Mata, R.; Staub, J.; Valdivia, A.; Sharek, L.; McCulloch, C. G.; Hwang, R. F.; Urrutia, R.; Yeh, J. J.; Kim, H. J.; Otey, C. A.			Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts	ONCOGENE			English	Article						invasion; GTPases; Cdc42; actin; invadopodia; myofibroblasts	SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX DEGRADATION; STROMAL FIBROBLASTS; PODOSOME FORMATION; PROTEIN PALLADIN; BINDING PARTNER; RHO; SRC; CYTOSKELETON; PROGRESSION	The stromal compartment surrounding epithelial-derived pancreatic tumors is thought to have a key role in the aggressive phenotype of this malignancy. Emerging evidence suggests that cancer-associated fibroblasts (CAFs), the most abundant cells in the stroma of pancreatic tumors, contribute to the tumor's invasion, metastasis and resistance to therapy, but the precise molecular mechanisms that regulate CAFs behavior are poorly understood. In this study, we utilized immortalized human pancreatic CAFs to investigate molecular pathways that control the matrix-remodeling and invasion-promoting activity of CAFs. We showed previously that palladin, an actin-associated protein, is expressed at high levels in CAFs of pancreatic tumors and other solid tumors, and also in an immortalized line of human CAFs. In this study, we found that short-term exposure of CAFs to phorbol esters reduced the number of stress fibers and triggered the appearance of individual invadopodia and invadopodial rosettes in CAFs. Molecular analysis of invadopodia revealed that their composition resembled that of similar structures (that is, invadopodia and podosomes) described in other cell types. Pharmacological inhibition and small interfering RNA knockdown experiments demonstrated that protein kinase C, the small GTPase Cdc42 and palladin were necessary for the efficient assembly of invadopodia by CAFs. In addition, GTPase activity assays showed that palladin contributes to the activation of Cdc42. In mouse xenograft experiments using a mixture of CAFs and tumor cells, palladin expression in CAFs promoted the rapid growth and metastasis of human pancreatic tumor cells. Overall, these results indicate that high levels of palladin expression in CAFs enhance their ability to remodel the extracellular matrix by regulating the activity of Cdc42, which in turn promotes the assembly of matrix-degrading invadopodia in CAFs and tumor cell invasion. Together, these results identify a novel molecular signaling pathway that may provide new molecular targets for the inhibition of pancreatic cancer metastasis.	[Goicoechea, S. M.; Garcia-Mata, R.; Staub, J.; Valdivia, A.; Sharek, L.; Otey, C. A.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Hwang, R. F.] Univ Toronto, Fac Dent, CIHR Grp Matrix Dynam, Toronto, ON, Canada; [Hwang, R. F.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Urrutia, R.] Mayo Clin, Dept Biochem & Mol Biol, Epigenet & Chromatin Dynam Lab,CIM, Div Gastroenterol & Hepatol,Translat Epigen Progr, Rochester, MN USA; [Yeh, J. J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Yeh, J. J.; Kim, H. J.; Otey, C. A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yeh, J. J.; Kim, H. J.] Univ N Carolina, Dept Surg, UNC Sch Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Goicoechea, SM (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Silvia.Goicoechea@utoledo.edu	, Animal Studies Core/ADK-4234-2022; , Animal Studies Core/AAF-4432-2022	Valdivia, Alejandra/0000-0003-1492-5066; Garcia-Mata, Rafael/0000-0002-7116-4411	NIH [GM081505, CA161136, DK52913]; NSF [MCB-1121365]; Elsa U Pardee Foundation; UNC University Cancer Research Fund; CIHR [MOP-36332]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; Div Of Molecular and Cellular Bioscience [1121365] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R03CA161136, R01CA140424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R56DK052913, P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Elsa U Pardee Foundation; UNC University Cancer Research Fund; CIHR(Canadian Institutes of Health Research (CIHR)); Mayo Clinic Center for Cell Signaling in Gastroenterology; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Angela Mathison (Mayo Clinic College of Medicine) for assistance in generating the imPSCs (imPSC-C2 and imPSC-C3) and Gabriela Herrera for assistance with the AsPC-1 pancreatic tumor cells labeled with firefly luciferase. We also thank Dr Teresa Brentnall (University of Washington) for helpful discussions, and the Lineberger Comprehensive Cancer Center Animal Studies Core for assistance with xenograft experiments. This study was supported by grants from the NIH (GM081505 to CAO; CA161136 to SMG; DK52913 to RU), the NSF (MCB-1121365 to CAO), the Elsa U Pardee Foundation (CAO), the UNC University Cancer Research Fund (SMG), the CIHR (MOP-36332 to CAGM) and the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567 to RU).	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Alves F, 2001, PANCREAS, V23, P227, DOI 10.1097/00006676-200110000-00002; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Ayala I, 2009, CANCER RES, V69, P747, DOI 10.1158/0008-5472.CAN-08-1980; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Furmaniak-Kazmierczak E, 2007, CIRC RES, V100, P1328, DOI 10.1161/CIRCRESAHA.106.147744; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Gupta V, PLOS ONE, V6; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Mathison A, 2010, PANCREATOLOGY, V10, P505, DOI [10.1016/S1424-3903(10)80035-3, 10.1159/000320540]; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Mizutani K, 2002, CANCER RES, V62, P669; MONSKY WL, 1994, CANCER RES, V54, P5702; Murphy DA, NAT REV MOL CELL BIO, V12, P413; Nakahara H, 2003, GENES CELLS, V8, P1019, DOI 10.1111/j.1365-2443.2003.00695.x; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Ronty M, 2007, EXP CELL RES, V313, P2575, DOI 10.1016/j.yexcr.2007.04.030; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; TETI A, 1992, AM J PHYSIOL, V263, pC130, DOI 10.1152/ajpcell.1992.263.1.C130; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004	52	77	79	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 6	2014	33	10					1265	1273		10.1038/onc.2013.68	http://dx.doi.org/10.1038/onc.2013.68			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AC6KI	23524582	Green Accepted, Green Published			2022-12-25	WOS:000332631100007
J	Zhang, S; Mercado-Uribe, I; Xing, Z; Sun, B; Kuang, J; Liu, J				Zhang, S.; Mercado-Uribe, I.; Xing, Z.; Sun, B.; Kuang, J.; Liu, J.			Generation of cancer stem-like cells through the formation of polyploid giant cancer cells	ONCOGENE			English	Article						polyploid giant cancer cells; cancer stem cells; endocycle; cell fusion; asymmetric cell division	TUMOR-CELLS; NEOSIS; OXYGEN; DEATH; GENE	Polyploid giant cancer cells (PGCCs) have been observed by pathologists for over a century. PGCCs contribute to solid tumor heterogeneity, but their functions are largely undefined. Little attention has been given to these cells, largely because PGCCs have been generally thought to originate from repeated failure of mitosis/cytokinesis and have no capacity for long-term survival or proliferation. Here we report our successful purification and culture of PGCCs from human ovarian cancer cell lines and primary ovarian cancer. These cells are highly resistant to oxygen deprivation and could form through endoreduplication or cell fusion, generating regular-sized cancer cells quickly through budding or bursting similar to simple organisms like fungi. They express normal and cancer stem cell markers, they divide asymmetrically and they cycle slowly. They can differentiate into adipose, cartilage and bone. A single PGCC formed cancer spheroids in vitro and generated tumors in immunodeficient mice. These PGCC-derived tumors gained a mesenchymal phenotype with increased expression of cancer stem cell markers CD44 and CD133 and become more resistant to treatment with cisplatin. Taken together, our results reveal that PGCCs represent a resistant form of human cancer using an ancient, evolutionarily conserved mechanism in response to hypoxia stress; they can contribute to the generation of cancer stem-like cells, and also play a fundamental role in regulating tumor heterogeneity, tumor growth and chemoresistance in human cancer.	[Zhang, S.; Mercado-Uribe, I.; Xing, Z.; Liu, J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhang, S.] Nankai Univ, Affiliated Hosp, Dept Pathol, Tianjin 300071, Peoples R China; [Sun, B.] Tianjin Med Univ, Dept Pathol, Tianjin, Peoples R China; [Sun, B.] Tianjin Canc Inst, Tianjin, Peoples R China; [Kuang, J.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Nankai University; Tianjin Medical University; Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center	Liu, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, 1515 Holcombe Blvd,Box 0085, Houston, TX 77030 USA.	jliu@mdanderson.org			National Institutes of Health [R01CA131183-01A2, P50CA83638]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP1105995]; Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P50CA083639, P30CA016672, P50CA083638, R01CA131183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Department of Scientific Publications and Ms Christine Wogan for their excellent editorial assistance on the manuscript and Ms Kim Vu for help in figure preparation. Jinsong Liu was supported by an R01 Grant (R01CA131183-01A2) and an ovarian cancer Specialized Programs of Research Excellence (SPORE) grant (P50CA83638) from the National Institutes of Health and a multi-investigator grant from Cancer Prevention and Research Institute of Texas (CPRIT) (RP1105995). Short tandem repeat DNA fingerprinting was carried out by the Cancer Center Support Grant-funded Characterized Cell Line core, NCI No. CA016672.	Alberts B, 2002, MOL BIOL CELL; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erenpreisa J, 2005, CELL BIOL INT, V29, P1012, DOI 10.1016/j.cellbi.2005.10.005; Erenpreisa J, 2005, CELL BIOL INT, V29, P1005, DOI 10.1016/j.cellbi.2005.10.008; Erenpreisa J, 2007, CELL BIOL INT, V31, P1507, DOI 10.1016/j.cellbi.2007.08.013; Erenpreisa J, 2011, CELL BIOL INT, V35, P687, DOI 10.1042/CBI20100762; Erenpreisa Jekaterina, 2001, Cancer Cell Int, V1, P1, DOI 10.1186/1475-2867-1-1; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; HEPPNER GH, 1984, CANCER RES, V44, P2259; Ho VT, 1996, BIOCHEM BIOPH RES CO, V223, P175, DOI 10.1006/bbrc.1996.0865; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Knop M, 2011, CR BIOL, V334, P599, DOI 10.1016/j.crvi.2011.05.007; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Kumar V.A., 2010, ROBBINS CONTRAN PATH, P262; Kusumbe AP, 2009, CANCER RES, V69, P9245, DOI 10.1158/0008-5472.CAN-09-2802; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Rajaraman R, 2005, CELL BIOL INT, V29, P1084, DOI 10.1016/j.cellbi.2005.10.003; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Walen KH, 2006, IN VITRO CELL DEV-AN, V42, P216; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Yang G, 2004, J BIOL CHEM, V279, P4339, DOI 10.1074/jbc.M311153200; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021	37	250	264	0	41	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					116	128		10.1038/onc.2013.96	http://dx.doi.org/10.1038/onc.2013.96			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23524583	Green Accepted			2022-12-25	WOS:000329212000013
J	Tahmasebi, S; Ghorbani, M; Savage, P; Yan, KZ; Gocevski, G; Xiao, L; You, LY; Yang, XJ				Tahmasebi, Soroush; Ghorbani, Mohammad; Savage, Paul; Yan, Kezhi; Gocevski, Goran; Xiao, Lin; You, Linya; Yang, Xiang-Jiao			Sumoylation of Kruppel-like Factor 4 Inhibits Pluripotency Induction but Promotes Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TRANSCRIPTIONAL ACTIVITY; SUMO-1 MODIFICATION; DIRECT CONVERSION; HUMAN FIBROBLASTS; DNA-BINDING; PHOSPHORYLATION; MOTIF; KLF4; UBIQUITIN	Ectopic expression of transcription factors has been shown to reprogram somatic cells into induced pluripotent stem (iPS) cells. It remains largely unexplored how this process is regulated by post-translational modifications. Several reprogramming factors possess conserved sumoylation sites, so we investigated whether and how this modification regulates reprogramming of fibroblasts into iPS cells. Substitution of the sole sumoylation site of the Kruppel-like factor (KLF4), a well known reprogramming factor, promoted iPS cell formation. In comparison, much smaller effects on reprogramming were observed for sumoylation-deficient mutants of SOX2 and OCT4, two other classical reprogramming factors. We also analyzed KLF2, a KLF4 homolog and a member of the KLF family of transcription factors with a known role in reprogramming. KLF2 was sumoylated at two conserved neighboring motifs, but substitution of the key lysine residues only stimulated reprogramming slightly. KLF5 is another KLF member with an established link to embryonic stem cell pluripotency. Interestingly, although it was much more efficiently sumoylated than either KLF2 or KLF4, KLF5 was inactive in reprogramming, and its sumoylation was not responsible for this deficiency. Furthermore, sumoylation of KLF4 but not KLF2 or KLF5 stimulated adipocyte differentiation. These results thus demonstrate the importance KLF4 sumoylation in regulating pluripotency and adipocyte differentiation.	[Tahmasebi, Soroush; Ghorbani, Mohammad; Savage, Paul; Yan, Kezhi; Gocevski, Goran; Xiao, Lin; You, Linya; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Tahmasebi, Soroush; Yang, Xiang-Jiao] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Savage, Paul; Yan, Kezhi; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Ghorbani, Mohammad; Gocevski, Goran; Xiao, Lin; You, Linya; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		You, Linya/0000-0002-2569-0269	Natural Sciences and Engineering Research Council of Canada; Ministere du Developpement Economique, Innovation et Exportation du Quebec; Faculty of Medicine, McGill University; Goodman Cancer Research Center, McGill University, Montreal, Quebec, Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministere du Developpement Economique, Innovation et Exportation du Quebec; Faculty of Medicine, McGill University; Goodman Cancer Research Center, McGill University, Montreal, Quebec, Canada	This work was supported in part by operating grants from Natural Sciences and Engineering Research Council of Canada and Ministere du Developpement Economique, Innovation et Exportation du Quebec (to X. J. Y.).; Supported in part by studentships from the Faculty of Medicine, McGill University.; Awarded a studentship by the Natural Sciences and Engineering Research Council of Canada.; Recipient of a Canderel studentship from Goodman Cancer Research Center, McGill University, Montreal, Quebec, Canada.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brey CW, 2009, INT J BIOL SCI, V5, P622; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gagnon AM, 1998, OBES RES, V6, P157, DOI 10.1002/j.1550-8528.1998.tb00330.x; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gray JS, 2010, BIOLOGICALS, V38, P273, DOI 10.1016/j.biologicals.2009.09.006; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tolkunova E, 2007, J MOL BIOL, V374, P1200, DOI 10.1016/j.jmb.2007.09.081; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039606; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	72	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12791	12804		10.1074/jbc.M113.465443	http://dx.doi.org/10.1074/jbc.M113.465443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23515309	Green Published, hybrid			2022-12-25	WOS:000318555100035
J	Wang, JB; Sun, Z; Zhang, ZC; Saadi, I; Wang, J; Li, X; Gao, S; Engle, JJ; Kuburas, A; Fu, XY; Yu, WJ; Klein, WH; Russo, AF; Amendt, BA				Wang, Jianbo; Sun, Zhao; Zhang, Zichao; Saadi, Irfan; Wang, Jun; Li, Xiao; Gao, Shan; Engle, Jamison J.; Kuburas, Adisa; Fu, Xueyao; Yu, Wenjie; Klein, William H.; Russo, Andrew F.; Amendt, Brad A.			Protein Inhibitors of Activated STAT (Pias1 and Piasy) Differentially Regulate Pituitary Homeobox 2 (PITX2) Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; RIEGER-SYNDROME; HOMEODOMAIN PROTEIN; GENE-ACTIVATION; FLUORESCENCE COMPLEMENTATION; FUNCTIONAL INTERACTIONS; MEDIATED REPRESSION; ANDROGEN RECEPTOR; NUCLEAR-BODIES; BETA-CATENIN	Protein inhibitors of activated STAT (Pias) proteins can act independent of sumoylation to modulate the activity of transcription factors and Pias proteins interacting with transcription factors can either activate or repress their activity. Pias proteins are expressed in many tissues and cells during development and we asked if Pias proteins regulated the pituitary homeobox 2 (PITX2) homeodomain protein, which modulates developmental gene expression. Piasy and Pias1 proteins are expressed during craniofacial/tooth development and directly interact and differentially regulate PITX2 transcriptional activity. Piasy and Pias1 are co-expressed in craniofacial tissues with PITX2. Yeast two-hybrid, co-immunoprecipitation and pull-down experiments demonstrate Piasy and Pias1 interactions with the PITX2 protein. Piasy interacts with the PITX2 C-terminal tail to attenuate its transcriptional activity. In contrast, Pias1 interacts with the PITX2 C-terminal tail to increase PITX2 transcriptional activity. The E3 ligase activity associated with the RING domain in Piasy is not required for the attenuation of PITX2 activity, however, the RING domain of Pias1 is required for enhanced PITX2 transcriptional activity. Bimolecular fluorescence complementation assays reveal PITX2 interactions with Piasy and Pias1 in the nucleus. Piasy represses the synergistic activation of PITX2 with interacting co-factors and Piasy represses Pias1 activation of PITX2 transcriptional activity. In contrast, Pias1 did not affect the synergistic interaction of PITX2 with transcriptional co-factors. Last, we demonstrate that Pias proteins form a complex with PITX2 and Lef-1, and PITX2 and beta-catenin. Lef-1, beta-catenin, and Pias interactions with PITX2 provide new molecular mechanisms for the regulation of PITX2 transcriptional activity and the activity of Pias proteins.	[Wang, Jianbo; Sun, Zhao; Zhang, Zichao; Gao, Shan] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Environm & Genet Med, Houston, TX 77030 USA; [Saadi, Irfan; Engle, Jamison J.; Kuburas, Adisa; Russo, Andrew F.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Li, Xiao; Yu, Wenjie; Amendt, Brad A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Amendt, Brad A.] Univ Iowa, Craniofacial Anomalies Res Ctr, Iowa City, IA 52242 USA; [Wang, Jun] Texas Heart Inst, Ctr Stem Cell Engn, Houston, TX 77030 USA; [Fu, Xueyao; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Iowa; University of Iowa; University of Iowa; Texas Heart Institute; University of Texas System; UTMD Anderson Cancer Center	Amendt, BA (corresponding author), Univ Iowa, Craniofacial Anomalies Res Ctr, Dept Anat & Cell Biol, 1-675 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	Li, Xiao/X-3429-2019; sun, zhao/B-3291-2018; Saadi, Irfan/I-5989-2019	Li, Xiao/0000-0001-8527-4438; Saadi, Irfan/0000-0002-6250-6651; Russo, Andrew/0000-0002-8156-5649; Amendt, Brad A./0000-0001-6524-1006; Yu, Wenjie/0000-0002-3013-1218	National Institutes of Health from the NEI [EY011930, EY010608]; NIDCR [DE 016511, DE 13941]; Robert A. Welch Foundation [G-0010]; NATIONAL EYE INSTITUTE [P30EY010608, R01EY011930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016511] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011930 and EY010608 from the NEI, Grants DE 016511 (to A. F. R.) and DE 13941 (to B. A. A.) from the NIDCR, and Robert A. Welch Foundation Grant G-0010 (to W. H. K.).	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Gross M, 2001, ONCOGENE, V20, P3880, DOI 10.1038/sj.onc.1204489; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ilmarinen T, 2008, MOL IMMUNOL, V45, P1847, DOI 10.1016/j.molimm.2007.10.045; Imoto S, 2004, BIOCHEM BIOPH RES CO, V319, P275, DOI 10.1016/j.bbrc.2004.04.161; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Oh HJ, 2007, MOL REPROD DEV, V74, P1446, DOI 10.1002/mrd.20737; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Toro R, 2004, J BIOL CHEM, V279, P52087, DOI 10.1074/jbc.M404802200; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	48	6	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12580	12595		10.1074/jbc.M112.374561	http://dx.doi.org/10.1074/jbc.M112.374561			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23515314	Green Published, hybrid			2022-12-25	WOS:000318555100017
J	Barrett, CL; Schwab, RB; Jung, H; Crain, B; Goff, DJ; Jamieson, CHM; Thistlethwaite, PA; Harismendy, O; Carson, DA; Frazer, KA				Barrett, Christian L.; Schwab, Richard B.; Jung, HyunChul; Crain, Brian; Goff, Daniel J.; Jamieson, Catriona H. M.; Thistlethwaite, Patricia A.; Harismendy, Olivier; Carson, Dennis A.; Frazer, Kelly A.			Transcriptome Sequencing of Tumor Subpopulations Reveals a Spectrum of Therapeutic Options for Squamous Cell Lung Cancer	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; TRAIL-INDUCED APOPTOSIS; PROSTATE-CANCER; OVARIAN-CANCER; STEM-CELLS; MULTIDRUG-RESISTANCE; SPLICING FACTORS; GENE-EXPRESSION; DOWN-REGULATION; C-FLIPL	Background: The only therapeutic options that exist for squamous cell lung carcinoma (SCC) are standard radiation and cytotoxic chemotherapy. Cancer stem cells (CSCs) are hypothesized to account for therapeutic resistance, suggesting that CSCs must be specifically targeted. Here, we analyze the transcriptome of CSC and non-CSC subpopulations by RNA-seq to identify new potential therapeutic strategies for SCC. Methods: We sorted a SCC into CD133- and CD133+ subpopulations and then examined both by copy number analysis (CNA) and whole genome and transcriptome sequencing. We analyzed The Cancer Genome Atlas (TCGA) transcriptome data of 221 SCCs to determine the generality of our observations. Results: Both subpopulations highly expressed numerous mRNA isoforms whose protein products are active drug targets for other cancers; 31 (25%) correspond to 18 genes under active investigation as mAb targets and an additional 4 (3%) are of therapeutic interest. Moreover, we found evidence that both subpopulations were proliferatively driven by very high levels of c-Myc and the TRAIL long isoform (TRAIL(L)) and that normal apoptotic responses to high expression of these genes was prevented through high levels of Mcl-1(L) and Bcl-x(L) and c-Flip(L)-isoforms for which drugs are now in clinical development. SCC RNA-seq data (n = 221) from TCGA supported our findings. Our analysis is inconsistent with the CSC concept that most cells in a cancer have lost their proliferative potential. Furthermore, our study suggests how to target both the CSC and non-CSC subpopulations with one treatment strategy. Conclusions: Our study is relevant to SCC in particular for it presents numerous potential options to standard therapy that target the entire tumor. In so doing, it demonstrates how transcriptome sequencing provides insights into the molecular underpinnings of cancer propagating cells that, importantly, can be leveraged to identify new potential therapeutic options for cancers beyond what is possible with DNA sequencing.	[Barrett, Christian L.; Schwab, Richard B.; Jung, HyunChul; Crain, Brian; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Barrett, Christian L.; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Barrett, Christian L.; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Rady Childrens Hosp, La Jolla, CA 92093 USA; [Jung, HyunChul] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Schwab, Richard B.; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Clin & Translat Res Inst, La Jolla, CA 92093 USA; [Thistlethwaite, Patricia A.] Univ Calif San Diego, Div Cardiothorac Surg, La Jolla, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Goff, Daniel J.; Jamieson, Catriona H. M.] Univ Calif San Diego, Dept Med, Stem Cell & Moores Canc Ctr, La Jolla, CA 92093 USA; [Carson, Dennis A.] Sanford Consortium Regenerat Med, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Frazer, KA (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	kafrazer@ucsd.edu	Schwab, Richard/AAX-9262-2020; Harismendy, Olivier/AAM-2072-2021	Harismendy, Olivier/0000-0002-8098-9888; Frazer, Kelly/0000-0002-6060-8902; Goff, Daniel/0000-0003-2109-1696	Center for Translational Science Award from the National Center for Research Resources [UL1RR031980, UL1TR000100]; National Cancer Institute [1R21CA152613-01, 1R21CA155615-01A1, CA69375]; California Institute for Regenerative Medicine [CL1-00502, RT1-01108, TR1-01250, TR2-01789]; National Institute of Allergy and Infectious Diseases [P30 AI036214]; NATIONAL CANCER INSTITUTE [R21CA155615, R21CA152613, R01CA069375] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	Center for Translational Science Award from the National Center for Research Resources; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for Translational Science Award (UL1RR031980 and UL1TR000100) from the National Center for Research Resources, three grants (1R21CA152613-01, 1R21CA155615-01A1, CA69375) from the National Cancer Institute, four grants from the California Institute for Regenerative Medicine (CL1-00502, RT1-01108, TR1-01250, TR2-01789) and a grant from the National Institute of Allergy and Infectious Diseases (P30 AI036214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2011, CANCER RES, V71, P2212, DOI 10.1158/0008-5472.CAN-10-3590; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dash R, 2011, P NATL ACAD SCI USA, V108, P8785, DOI 10.1073/pnas.1100769108; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding WX, 2009, ESSENTIALS OF APOPTOSIS, SECOND EDITION, P25, DOI 10.1007/978-1-60327-381-7_2; DiPaola RS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-1; Dunkle A, 2010, CELL DEATH DIFFER, V17, P994, DOI 10.1038/cdd.2009.201; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; El-Gazzar A, 2010, GYNECOL ONCOL, V117, P451, DOI 10.1016/j.ygyno.2010.02.024; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fagan DH, 2012, CANC RES IN PRESS, DOI 10.1158/0008-5472.CAN-12-0684; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Govindan SV, 2009, CLIN CANCER RES, V15, P6052, DOI 10.1158/1078-0432.CCR-09-0586; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haag C, 2011, GUT, V60, P225, DOI 10.1136/gut.2009.202325; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Heukamp LC, 2011, INTERNIST, V52, P146, DOI 10.1007/s00108-010-2698-y; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hwang JR, 2012, CARCINOGENESIS, V33, P77, DOI 10.1093/carcin/bgr257; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Kanekura T, 2010, J DERMATOL SCI, V57, P149, DOI 10.1016/j.jdermsci.2009.12.008; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Koehler BC, 2009, WORLD J GASTROENTERO, V15, P5924, DOI 10.3748/wjg.15.5924; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Krieg A, 2003, BRIT J CANCER, V88, P918, DOI 10.1038/sj.bjc.6600772; Lacour S, 2001, CANCER RES, V61, P1645; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P7; Murayama Y, 2004, J CELL SCI, V117, P3379, DOI 10.1242/jcs.01201; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nakamoto T, 2009, J GASTROENTEROL, V44, P889, DOI 10.1007/s00535-009-0081-3; Ovalle S, 2007, INT J CANCER, V121, P2140, DOI 10.1002/ijc.22902; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Pham PV, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-209; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Raclaw KA, 2008, PROSTATE, V68, P1696, DOI 10.1002/pros.20844; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Roth A, 2007, MOL CANCER THER, V6, P2737, DOI 10.1158/1535-7163.MCT-07-0140; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Ueyama H, 2011, BIOCHEM BIOPH RES CO, V414, P60, DOI 10.1016/j.bbrc.2011.09.021; Uluckan O, 2009, CANCER RES, V69, P3196, DOI 10.1158/0008-5472.CAN-08-3358; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wiiger MT, 2010, CANCER IMMUNOL IMMUN, V59, P1665, DOI 10.1007/s00262-010-0892-3; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yamazaki M, 2012, ONCOL REP, V28, P49, DOI 10.3892/or.2012.1803; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Yu F, 2011, J NEURO-ONCOL, V103, P187, DOI 10.1007/s11060-010-0377-4; Zhang B, 2010, CANCER RES, V70, P6407, DOI 10.1158/0008-5472.CAN-10-1544; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559; Zhu HB, 2005, CANCER BIOL THER, V4, P393; Zierler S, 2011, J BIOL CHEM, V286, P39328, DOI 10.1074/jbc.M111.264341; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	91	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58714	10.1371/journal.pone.0058714	http://dx.doi.org/10.1371/journal.pone.0058714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527012	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562600034
J	Niedringhaus, M; Chen, X; Conant, K; Dzakpasu, R				Niedringhaus, Mark; Chen, Xin; Conant, Katherine; Dzakpasu, Rhonda			Synaptic Potentiation Facilitates Memory-like Attractor Dynamics in Cultured In Vitro Hippocampal Networks	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PERSISTENT ACTIVITY; NEURAL-NETWORKS; DENTATE AREA; PLASTICITY; SYNAPSES; MODEL; GAMMA; THETA; INFORMATION	Collective rhythmic dynamics from neurons is vital for cognitive functions such as memory formation but how neurons self-organize to produce such activity is not well understood. Attractor-based computational models have been successfully implemented as a theoretical framework for memory storage in networks of neurons. Additionally, activity-dependent modification of synaptic transmission is thought to be the physiological basis of learning and memory. The goal of this study is to demonstrate that using a pharmacological treatment that has been shown to increase synaptic strength within in vitro networks of hippocampal neurons follows the dynamical postulates theorized by attractor models. We use a grid of extracellular electrodes to study changes in network activity after this perturbation and show that there is a persistent increase in overall spiking and bursting activity after treatment. This increase in activity appears to recruit more "errant" spikes into bursts. Phase plots indicate a conserved activity pattern suggesting that a synaptic potentiation perturbation to the attractor leaves it unchanged. Lastly, we construct a computational model to demonstrate that these synaptic perturbations can account for the dynamical changes seen within the network.	[Niedringhaus, Mark; Conant, Katherine; Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Dept Phys, Washington, DC 20007 USA; [Conant, Katherine] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University	Dzakpasu, R (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	dzakpasu@physics.georgetown.edu	Dzakpasu, Rhonda/F-8060-2019	Dzakpasu, Rhonda/0000-0002-7223-4602	Luce Foundation; National Institutes of Health, National Institute on Aging [029806]	Luce Foundation; National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Niedringhaus, Dr. Chen and Dr. Dzakpasu were supported by the Luce Foundation. Dr. Conant was supported by a grant from the National Institutes of Health, National Institute on Aging (grant no. 029806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1987, PHYS REV A, V35, P2293, DOI 10.1103/PhysRevA.35.2293; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P275, DOI 10.1088/0954-898X/2/3/004; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1970, J PHYSIOL-LONDON, V207, pP61; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Brunel N, 2003, CEREB CORTEX, V13, P1151, DOI 10.1093/cercor/bhg096; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; Carnevale NT, 2006, NEURON BOOK; Chen X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031907; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Enoki R, 2009, NEURON, V62, P242, DOI 10.1016/j.neuron.2009.02.026; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GREBOGI C, 1987, SCIENCE, V238, P632, DOI 10.1126/science.238.4827.632; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Ide AN, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016008; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; Maffei A, 2009, CURR OPIN NEUROBIOL, V19, P168, DOI 10.1016/j.conb.2009.05.012; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Payne HL, 2008, MOL MEMBR BIOL, V25, P353, DOI 10.1080/09687680801986480; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Rachmuth G, 2011, P NATL ACAD SCI USA, V108, pE1266, DOI 10.1073/pnas.1106161108; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Stegenga J, 2010, BIOPHYS J, V98, P2452, DOI 10.1016/j.bpj.2010.02.026; Tiesinga PH, 2004, J PHYSIOL-PARIS, V98, P296, DOI 10.1016/j.jphysparis.2005.09.002; Tiesinga PHE, 2004, NEUROCOMPUTING, V58, P641, DOI 10.1016/j.neucom.2004.01.108; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vajda I, 2008, BIOPHYS J, V94, P5028, DOI 10.1529/biophysj.107.112730; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051907; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Winograd M, 2008, P NATL ACAD SCI USA, V105, P7298, DOI 10.1073/pnas.0800360105	68	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57144	10.1371/journal.pone.0057144	http://dx.doi.org/10.1371/journal.pone.0057144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526935	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562600006
J	Savage, T; Derraik, JGB; Miles, HL; Mouat, F; Hofman, PL; Cutfield, WS				Savage, Tim; Derraik, Jose G. B.; Miles, Harriet L.; Mouat, Fran; Hofman, Paul L.; Cutfield, Wayne S.			Increasing Maternal Age Is Associated with Taller Stature and Reduced Abdominal Fat in Their Children	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; INSULIN-RESISTANCE; BIRTH-WEIGHT; CHILDHOOD OBESITY; GENE-EXPRESSION; RISK-FACTORS; YOUNG-ADULTS; LIFE; PREGNANCY; GROWTH	Background: Maternal age at childbirth continues to increase worldwide. We aimed to assess whether increasing maternal age is associated with changes in childhood height, body composition, and metabolism. Methods: 277 healthy pre-pubertal children, born 37-41 weeks gestation were studied. Assessments included: height and weight corrected for parental measurements, DEXA-derived body composition, fasting lipids, glucose, insulin, and hormonal profiles. Subjects were separated according to maternal age at childbirth: <30, 30-35, and >35 years. Results: Our cohort consisted of 126 girls and 151 boys, aged 7.4 +/- 2.2 years (range 3-10); maternal age at childbirth was 33.3 +/- 4.7 years (range 19-44). Children of mothers aged >35 and 30-35 years at childbirth were taller than children of mothers aged <30 years by 0.26 (p = 0.002) and 0.23 (p = 0.042) SDS, respectively. There was a reduction in childhood BMISDS with increasing maternal age at childbirth, and children of mothers aged >35 years at childbirth were 0.61 SDS slimmer than those of mothers <30 years (p = 0.049). Children of mothers aged 30-35 (p = 0.022) and >35 (p = 0.036) years at childbirth had abdominal adiposity reduced by 10% and 13%, respectively, compared to those in the <30 group. Children of mothers aged 30-35 years at childbirth displayed a 19% increase in IGF-concentrations compared to offspring in <30 group (p = 0.042). Conversely, IGF-II concentrations were lower among the children born to mothers aged 30-35 (6.5%; p = 0.004) and >35 (8.1%; p = 0.005) compared to those of mothers aged <30 years. Girls of mothers aged 30-35 years at childbirth also displayed improved HOMA-IR insulin sensitivity (p = 0.010) compared to girls born to mothers aged <30 years. Conclusions: Increasing maternal age at childbirth is associated with a more favourable phenotype (taller stature and reduced abdominal fat) in their children, as well as improved insulin sensitivity in girls.	[Savage, Tim; Derraik, Jose G. B.; Miles, Harriet L.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Savage, Tim; Miles, Harriet L.; Hofman, Paul L.; Cutfield, Wayne S.] Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Mouat, Fran] Starship Childrens Hosp, Auckland Dist Hlth Board, Auckland, New Zealand	University of Auckland; Auckland District Health Board; Starship Children's Hospital	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956	National Research Centre for Growth and Development (New Zealand)	National Research Centre for Growth and Development (New Zealand)	This study was supported by grants from the National Research Centre for Growth and Development (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; BINKIN NJ, 1988, PEDIATRICS, V82, P828; Blair NJ, 2007, ARCH DIS CHILD, V92, P866, DOI 10.1136/adc.2007.116855; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; CANO F, 1995, FERTIL STERIL, V64, P584, DOI 10.1016/S0015-0282(16)57797-8; Cardwell CR, 2010, DIABETES, V59, P486, DOI 10.2337/db09-1166; Crespi EJ, 2006, J PHYSIOL-LONDON, V572, P119, DOI 10.1113/jphysiol.2005.103929; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dursun P, 2006, MED HYPOTHESES, V66, P143, DOI 10.1016/j.mehy.2004.10.022; EBBIARY NAA, 1994, CLIN ENDOCRINOL, V41, P199, DOI 10.1111/j.1365-2265.1994.tb02530.x; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Fowke JH, 2010, ENDOCR-RELAT CANCER, V17, P51, DOI 10.1677/ERC-09-0023; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gerritsen S, 2008, PORTRAIT HLTH KEY RE; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lammi N, 2007, DIABETOLOGIA, V50, P2433, DOI 10.1007/s00125-007-0843-5; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Lawlor DA, 2004, CIRCULATION, V110, P2417, DOI 10.1161/01.CIR.0000145165.80130.B5; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miles HL, 2005, REV ENDOCR METAB DIS, V6, P261, DOI 10.1007/s11154-005-6184-0; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; OECD, 2018, OECD FAM DAT; PANAGIOTOPOULOU K, 1990, CANCER CAUSE CONTROL, V1, P119, DOI 10.1007/BF00053162; Pearce J, 2007, AM J PREV MED, V32, P375, DOI 10.1016/j.amepre.2007.01.009; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Savage T, 2012, HUM REPROD, V27, P3092, DOI 10.1093/humrep/des249; SHEAR CL, 1987, HYPERTENSION, V9, P236, DOI 10.1161/01.HYP.9.3.236; Statistics New Zealand, 2012, TOT CONF DISTR HLTH; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Tanner, 1989, FOETUS MAN PHYS GROW; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; The University of Auckland, 2011, TE KUAKA, V3, P4; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Troisi R, 2003, CANCER CAUSE CONTROL, V14, P347, DOI 10.1023/A:1023934518975; VANNOORDZAADSTRA BM, 1991, BMJ-BRIT MED J, V302, P1361, DOI 10.1136/bmj.302.6789.1361; Wang MH, 2000, NATURE, V407, P469, DOI 10.1038/35035156; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Weiss R, 2005, BEST PRACT RES CL EN, V19, P405, DOI 10.1016/j.beem.2005.04.009; WHINCUP P, 1995, BRIT MED J, V311, P773, DOI 10.1136/bmj.311.7008.773; Whitley E, 2008, ANN HUM BIOL, V35, P518, DOI 10.1080/03014460802294250	58	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58869	10.1371/journal.pone.0058869	http://dx.doi.org/10.1371/journal.pone.0058869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527040	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562600042
J	Srivastava, VK; Srivastava, S; Arora, A; Pratap, JV				Srivastava, Vijay Kumar; Srivastava, Shubra; Arora, Ashish; Pratap, J. Venkatesh			Structural Insights into Putative Molybdenum Cofactor Biosynthesis Protein C (MoaC2) from Mycobacterium tuberculosis H37Rv	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLYBDOPTERIN SYNTHASE; SEQUENCE ALIGNMENT; AUTOMATED DOCKING; ENZYME MOAA; EARLY STEPS; BINDING; MODEL	The Molybdenum cofactor (Moco) biosynthesis pathway is an evolutionary conserved pathway seen in almost all eukaryotes including the pathogenic species Mycobacterium tuberculosis. This pathway comprises of several novel reactions which include the initial formation of precursor Z from guanosine triphosphate (GTP), catalysed by two enzymes MoaA and MoaC. Although Moco biosynthesis is well understood, the first step is still not clear. In M. tuberculosis H37Rv, three orthologous genes of MoaC have been annotated: moaC1 (Rv3111), moaC2 (Rv0864) and moaC3 (Rv3324c). Rv0864 (MoaC2) is a 17.5 kDa protein and is reported to be down-regulated by similar to 3 times in the nutrient starvation model for Mycobacterium tuberculosis. The crystal structure of Moco-biosynthesis protein MoaC2 from Mycobacterium tuberculosis (2.20 angstrom resolution, space group P2(1)3) has been determined. Based on a comparative analysis of structures of homologous proteins, conserved residues were identified and are implicated in structural and functional roles. Molecular docking studies with probable ligands carried out in order to identify its ligand, suggests that pteridinebenzomonophosphate as the most likely ligand. Sequence based interaction study identified MoaA1 to interact with MoaC2. A homology model of MoaA1 was then complexed with MoaC2 and protein-protein interactions are also discussed.	[Srivastava, Vijay Kumar; Srivastava, Shubra; Arora, Ashish; Pratap, J. Venkatesh] CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Arora, A (corresponding author), CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, India.	ashish_arora@cdri.res.in; jvpratap@cdri.res.in		Srivastava, Vijay/0000-0003-3395-2051	Council of Scientific and Industrial Research, India (CSIR) [NWP0038]; CSIR [CMM0017]; DST	Council of Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was supported by a Council of Scientific and Industrial Research, India (CSIR) network grant NWP0038 to AA. Computational support was from CSIR grant CMM0017 and DST grant to JVP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2000, ACCELRYS VER 1 1, P92121; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; HOFF T, 1995, J BIOL CHEM, V270, P6100, DOI 10.1074/jbc.270.11.6100; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Kanaujia SP, 2010, ACTA CRYSTALLOGR D, V66, P821, DOI 10.1107/S0907444910019074; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Rieder C, 1998, EUR J BIOCHEM, V255, P24, DOI 10.1046/j.1432-1327.1998.2550024.x; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Srivastava S, 2012, ACTA CRYSTALLOGR F, V68, P687, DOI 10.1107/S174430911201665X; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Unkles SE, 1997, J BIOL CHEM, V272, P28381, DOI 10.1074/jbc.272.45.28381; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; Wuebbens MM, 2000, STRUCTURE, V8, P709, DOI 10.1016/S0969-2126(00)00157-X; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Yoshida H, 2008, ACTA CRYSTALLOGR F, V64, P589, DOI 10.1107/S174430910801590X	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58333	10.1371/journal.pone.0058333	http://dx.doi.org/10.1371/journal.pone.0058333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526978	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100024
J	Wang, Y; Rawi, R; Wilms, C; Heider, D; Yang, RG; Hoffmann, D				Wang, Yan; Rawi, Reda; Wilms, Christoph; Heider, Dominik; Yang, Rongge; Hoffmann, Daniel			A Small Set of Succinct Signature Patterns Distinguishes Chinese and Non-Chinese HIV-1 Genomes	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; TYPE-1; CCR5; BINDING; LOOP; POTENT; GP120; SUSCEPTIBILITY; ASSOCIATIONS; RESISTANCE	The epidemiology of HIV-1 in China has unique features that may have led to unique viral strains. We therefore tested the hypothesis that it is possible to find distinctive patterns in HIV-1 genomes sampled in China. Using a rule inference algorithm we could indeed extract from sequences of the third variable loop (V3) of HIV-1 gp120 a set of 14 signature patterns that with 89% accuracy distinguished Chinese from non-Chinese sequences. These patterns were found to be specific to HIV-1 subtype, i.e. sequences complying with pattern 1 were of subtype B, pattern 2 almost exclusively covered sequences of subtype 01_AE, etc. We then analyzed the first of these signature patterns in depth, namely that L and W at two V3 positions are specifically occurring in Chinese sequences of subtype B/B' (3% false positives). This pattern was found to be in agreement with the phylogeny of HIV-1 of subtype B inside and outside of China. We could neither reject nor convincingly confirm that the pattern is stabilized by immune escape. For further interpretation of the signature pattern we used the recently developed measure of Direct Information, and in this way discovered evidence for physical interactions between V2 and V3. We conclude by a discussion of limitations of signature patterns, and the applicability of the approach to other genomic regions and other countries.	[Wang, Yan; Rawi, Reda; Wilms, Christoph; Heider, Dominik; Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biol, Res Grp Bioinformat, Essen, Germany; [Wang, Yan; Yang, Rongge] Chinese Acad Sci, Wuhan Inst Virol, AIDS & HIV Res Grp, State Key Lab Virol, Wuhan, Peoples R China	University of Duisburg Essen; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Yang, RG (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, AIDS & HIV Res Grp, State Key Lab Virol, Wuhan, Peoples R China.	ryang@wh.iov.cn; daniel.hoffmann@uni-due.de	Hoffmann, Daniel/B-1314-2018; Hoffmann, Daniel/P-5624-2019; Heider, Dominik/F-8545-2010	Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869; Heider, Dominik/0000-0002-3108-8311	Deutsche Forschungsgemeinschaft [TRR60/A6]; University of Duisburg-Essen; Chinese Key National Science and Technology Program [2012ZX10001006-002]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Duisburg-Essen; Chinese Key National Science and Technology Program	The authors gratefully acknowledge funding by Deutsche Forschungsgemeinschaft (http://www.dfg.de), grant TRR60/A6; the University of Duisburg-Essen (http://www.uni-due.de); and the Chinese Key National Science and Technology Program in the 12th Five-Year Period, grant 2012ZX10001006-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Cohen W W, 1995, P 12 INT C MACH LEAR, V95, P115, DOI DOI 10.1016/B978-1-55860-377-6.50023-2; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng XT, 2008, ALGORITHMICA, V52, P1, DOI 10.1007/s00453-007-9001-1; Derdeyn CA, 2008, CURR OPIN HIV AIDS, V3, P16, DOI 10.1097/COH.0b013e3282f2982c; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Gerberry DJ, 2010, AIDS, V24, P1604, DOI 10.1097/QAD.0b013e328337b973; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hardie RA, 2008, AIDS, V22, P807, DOI 10.1097/QAD.0b013e3282f51b71; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; KALISH ML, 1994, AIDS RES HUM RETROV, V10, P1573, DOI 10.1089/aid.1994.10.1573; KASPER P, 1994, AIDS RES HUM RETROV, V10, P1669, DOI 10.1089/aid.1994.10.1669; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lacap PA, 2008, AIDS, V22, P1029, DOI 10.1097/QAD.0b013e3282ffb3db; LEITNER T, 2005, HIV SEQUENCE COMPEND; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; MANN DL, 1988, J IMMUNOL, V141, P1131; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Development Core Team, 2006, R LANG ENV STAT COMP; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Wainberg MA, 2004, AIDS, V18, pS63, DOI 10.1097/00002030-200406003-00012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WITTEN IH, 2005, DATA MINING PRACTICA; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Yang Z, 2001, Pac Symp Biocomput, P226; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473	51	0	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58804	10.1371/journal.pone.0058804	http://dx.doi.org/10.1371/journal.pone.0058804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527028	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562100044
J	Du, NN; Peng, ZG; Bi, CW; Tang, S; Li, YH; Li, JR; Zhu, YP; Zhang, JP; Wang, YX; Jiang, JD; Song, DQ				Du, Na-Na; Peng, Zong-Gen; Bi, Chong-Wen; Tang, Sheng; Li, Ying-Hong; Li, Jian-Rui; Zhu, Yan-Ping; Zhang, Jing-Pu; Wang, Yan-Xiang; Jiang, Jian-Dong; Song, Dan-Qing			N-Substituted Benzyl Matrinic Acid Derivatives Inhibit Hepatitis C Virus (HCV) Replication through Down-Regulating Host Heat-Stress Cognate 70 (Hsc70) Expression	PLOS ONE			English	Article							PROTEASE INHIBITOR; RESISTANCE MUTATIONS; INFECTION; THERAPIES; PEGINTERFERON; BOCEPREVIR; RIBAVIRIN; NS3	Heat-stress cognate 70 (Hsc70) is a host factor that helps hepatitis C virus (HCV) to complete its life cycle in infected hepatocytes. Using Hsc70 as a target for HCV inhibition, a series of novel N-substituted benzyl matrinic/sophoridinic acid derivatives was synthesized and evaluated for their anti-HCV activity in vitro. Among these analogues, compound 7c possessing N-p-methylbenzyl afforded an appealing ability to inhibit HCV replication with SI value over 53. Furthermore, it showed a good oral pharmacokinetic profile with area-under-curve (AUC) of 13.4 mu M.h, and a considerably good safety in oral administration in mice (LD50>1000 mg/kg). As 7c suppresses HCV replication via an action mode distinctly different from that of the marketed anti-HCV drugs, it has been selected as a new mechanism anti-HCV candidate for further investigation, with an advantage of no or decreased chance to induce drug-resistant mutations.	[Du, Na-Na; Peng, Zong-Gen; Bi, Chong-Wen; Tang, Sheng; Li, Ying-Hong; Li, Jian-Rui; Zhu, Yan-Ping; Zhang, Jing-Pu; Wang, Yan-Xiang; Jiang, Jian-Dong; Song, Dan-Qing] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Du, Na-Na; Peng, Zong-Gen; Bi, Chong-Wen; Tang, Sheng; Li, Ying-Hong; Li, Jian-Rui; Zhu, Yan-Ping; Zhang, Jing-Pu; Wang, Yan-Xiang; Jiang, Jian-Dong; Song, Dan-Qing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Jiang, JD (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	jiang.jdong@163.com; songdanqingsdq@hotmail.com	Peng, Zong-Gen/GVU-2327-2022	Peng, Zong-Gen/0000-0001-7662-6892	Beijing Natural Science Foundation [7121009]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09103101-037, 2012ZX09301002-001]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National S&T Major Special Project on Major New Drug Innovation	This work was supported by Beijing Natural Science Foundation (7121009) and the National S&T Major Special Project on Major New Drug Innovation (2012ZX09103101-037 and 2012ZX09301002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begisheva AI, 1968, KHIM PRIR SOEDIN, V4, P371; BROWN HC, 1973, J ORG CHEM, V38, P912, DOI 10.1021/jo00945a015; Du NN, 2011, BIOORG MED CHEM LETT, V21, P4732, DOI 10.1016/j.bmcl.2011.06.071; Gao LM, 2011, J MED CHEM, V54, P869, DOI 10.1021/jm101325h; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Kamaev FG, 1974, CHEM NAT COM, V10, P765; KELLY RC, 1979, J AM CHEM SOC, V101, P1054, DOI 10.1021/ja00498a056; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lv Q, 2008, HUAXUE SHIJI, V30, P147; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mederacke I, 2009, CURR OPIN INVEST DR, V10, P181; NAGANO N, 1991, J ANTIBIOT, V44, P422, DOI 10.7164/antibiotics.44.422; OCHIAI E, 1961, CHEM PHARM BULL, V9, P92; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Peng ZG, 2010, HEPATOLOGY, V52, P845, DOI 10.1002/hep.23766; Pereira AA, 2009, NAT REV GASTRO HEPAT, V6, P403, DOI 10.1038/nrgastro.2009.92; Piai G, 2006, DIGEST DIS SCI, V51, P1619, DOI 10.1007/s10620-006-9110-8; Qiu P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp251; Smith RET, 2006, NAT REV DRUG DISCOV, V5, P715, DOI 10.1038/nrd2134; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274	24	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58675	10.1371/journal.pone.0058675	http://dx.doi.org/10.1371/journal.pone.0058675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516533	gold, Green Submitted, Green Published			2022-12-25	WOS:000316407400047
J	Mehta, V; Pei, W; Yang, G; Li, SY; Swamy, E; Boster, A; Schmalbrock, P; Pitt, D				Mehta, Veela; Pei, Wei; Yang, Grant; Li, Suyang; Swamy, Eashwar; Boster, Aaron; Schmalbrock, Petra; Pitt, David			Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions	PLOS ONE			English	Article							POLARIZATION; DEPOSITION; MACROPHAGES; EXPRESSION; MONOCYTE; DISEASE; PHASE	MRI phase imaging in multiple sclerosis (MS) patients and in autopsy tissue have demonstrated the presence of iron depositions in white matter lesions. The accumulation of iron in some but not all lesions suggests a specific, potentially disease-relevant process, however; its pathophysiological significance remains unknown. Here, we explore the role of lesional iron in multiple sclerosis using multiple approaches: immunohistochemical examination of autoptic MS tissue, an in vitro model of iron-uptake in human cultured macrophages and ultra-highfield phase imaging of highly active and of secondary progressive MS patients. Using Perls' stain and immunohistochemistry, iron was detected in MS tissue sections predominantly in non-phagocytosing macrophages/microglia at the edge of established, demyelinated lesions. Moreover, iron-containing macrophages but not myelin-laden macrophages expressed markers of proinflammatory (M1) polarization. Similarly, in human macrophage cultures, iron was preferentially taken up by non-phagocytosing, M1-polarized macrophages and induced M1 (super) polarization. Iron uptake was minimal in myelin-laden macrophages and active myelin phagocytosis led to depletion of intracellular iron. Finally, we demonstrated in MS patients using GRE phase imaging with ultra-highfield MRI that phase hypointense lesions were significantly more prevalent in patients with active relapsing than with secondary progressive MS. Taken together, our data provide a basis to interpret iron-sensitive GRE phase imaging in MS patients: iron is present in non-phagocytosing, M1-polarized microglia/macrophages at the rim of chronic active white matter demyelinating lesions. Phase imaging may therefore visualize specific, chronic proinflammatory activity in established MS lesions and thus provide important clinical information on disease status and treatment efficacy in MS patients.	[Mehta, Veela; Pei, Wei; Li, Suyang; Swamy, Eashwar; Boster, Aaron; Pitt, David] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Yang, Grant; Schmalbrock, Petra] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Pitt, David] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Yale University	Pitt, D (corresponding author), Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA.	david.pitt@yale.edu			Teva Neuroscience	Teva Neuroscience(Teva Pharmaceutical Industries)	This study was funded in part by Teva Neuroscience. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduljalil AM, 2003, J MAGN RESON IMAGING, V18, P284, DOI 10.1002/jmri.10362; ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236; Bian W, 2012, MULT SCLER; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Hagemeier J, 2012, J MAGN RESON IMAGING, V36, P73, DOI 10.1002/jmri.23603; Hammond KE, 2008, ANN NEUROL, V64, P707, DOI 10.1002/ana.21582; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Larocca Jorge N, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0325s33; Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, P563, DOI 10.1016/j.nic.2008.06.005; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Vellinga MM, 2008, BRAIN, V131, P800, DOI 10.1093/brain/awn009; Yao B, 2012, RADIOLOGY, V262, P206, DOI 10.1148/radiol.11110601	31	143	144	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57573	10.1371/journal.pone.0057573	http://dx.doi.org/10.1371/journal.pone.0057573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516409	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400010
J	Szabo, M; Veres, Z; Baranyai, Z; Jakab, F; Jemnitz, K				Szabo, Monika; Veres, Zsuzsa; Baranyai, Zsolt; Jakab, Ferenc; Jemnitz, Katalin			Comparison of Human Hepatoma HepaRG Cells with Human and Rat Hepatocytes in Uptake Transport Assays in Order to Predict a Risk of Drug Induced Hepatotoxicity	PLOS ONE			English	Article							SALT EXPORT PUMP; COTRANSPORTING POLYPEPTIDE NTCP; CYCLOSPORINE-A; FUNCTIONAL EXPRESSION; CYTOCHROMES P450; CULTURED HUMAN; BILE-ACIDS; INHIBITION; TAUROCHOLATE; METABOLISM	Human hepatocytes are the gold standard for toxicological studies but they have several drawbacks, like scarce availability, high inter-individual variability, a short lifetime, which limits their applicability. The aim of our investigations was to determine, whether HepaRG cells could replace human hepatocytes in uptake experiments for toxicity studies. HepaRG is a hepatoma cell line with most hepatic functions, including a considerable expression of uptake transporters in contrast to other hepatic immortalized cell lines. We compared the effect of cholestatic drugs (bosentan, cyclosporinA, troglitazone,) and bromosulfophthalein on the uptake of taurocholate and estrone-3-sulfate in human and rat hepatocytes and HepaRG cells. The substrate uptake was significantly slower in HepaRG cells than in human hepatocytes, still, in the presence of drugs we observed a concentration dependent decrease in uptake. In all cell types, the culture time had a significant impact not only on the uptake process but on the inhibitory effect of drugs too. The most significant drug effect was measured at 4 h after seeding. Our report is among the first concerning interactions of the uptake transporters in the HepaRG, at the functional level. Results of the present study clearly show that concerning the inhibition of taurocholate uptake by cholestatic drugs, HepaRG cells are closer to human hepatocytes than rat hepatocytes. In conclusion, we demonstrated that HepaRG cells may provide a suitable tool for hepatic uptake studies.	[Szabo, Monika; Veres, Zsuzsa; Jemnitz, Katalin] Hungarian Acad Sci, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary; [Baranyai, Zsolt; Jakab, Ferenc] Uzsoki Teaching Hosp, Dept Surg, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Jemnitz, K (corresponding author), Hungarian Acad Sci, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary.	jemnitz.katalin@ttk.mta.hu	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973; Jemnitz, Katalin/0000-0003-1943-3108	 [KMOP-1.2-07/1-2008-0002];  [GOP-1.1.1-09/1-009-0054];  [ETT 2009-2011]	; ; 	This study was supported by KMOP-1.2-07/1-2008-0002, GOP-1.1.1-09/1-009-0054 and ETT 2009-2011 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini G, 2001, GASTROENTEROLOGY, V120, pA6; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; ARIAS IM, 1993, GASTROENTEROLOGY, V104, P1558, DOI 10.1016/0016-5085(93)90371-I; AZER SA, 1993, TRANSPL P, V25, P2892; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hariparsad N, 2008, DRUG METAB DISPOS, V36, P1046, DOI 10.1124/dmd.108.020677; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Jemnitz K, 2012, TOXICOL IN VITRO, V26, P174, DOI 10.1016/j.tiv.2011.11.005; Jemnitz K, 2010, TOXICOL SCI, V115, P80, DOI 10.1093/toxsci/kfq044; Jigorel E, 2005, DRUG METAB DISPOS, V33, P1418, DOI 10.1124/dmd.105.004762; Kaplowitz N, 2001, DRUG SAFETY, V24, P483, DOI 10.2165/00002018-200124070-00001; Kemp DC, 2005, TOXICOL SCI, V83, P207, DOI 10.1093/toxsci/kfi020; Kostrubsky VE, 2003, TOXICOL SCI, V76, P220, DOI 10.1093/toxsci/kfg217; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Kouzuki H, 2000, J PHARMACOL EXP THER, V292, P505; Kusuhara H, 2009, DRUG METAB PHARMACOK, V24, P37, DOI 10.2133/dmpk.24.37; Le Vee M, 2006, EUR J PHARM SCI, V28, P109, DOI 10.1016/j.ejps.2006.01.004; Lengyel G, 2005, DRUG METAB DISPOS, V33, P1355, DOI 10.1124/dmd.105.004481; Leslie EM, 2007, J PHARMACOL EXP THER, V321, P1170, DOI 10.1124/jpet.106.119073; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacDonald JS, 2009, TOXICOL SCI, V110, P40, DOI 10.1093/toxsci/kfp088; Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421; Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002; Rippin SJ, 2001, HEPATOLOGY, V33, P776, DOI 10.1053/jhep.2001.23433; SASSA S, 1987, BIOCHEM BIOPH RES CO, V143, P52, DOI 10.1016/0006-291X(87)90628-0; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Smith MT, 2003, CHEM RES TOXICOL, V16, P679, DOI 10.1021/tx034033e; STACEY NH, 1988, GASTROENTEROLOGY, V95, P780, DOI 10.1016/S0016-5085(88)80028-3; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Treiber A, 2004, J PHARMACOL EXP THER, V308, P1121, DOI 10.1124/jpet.103.061614; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615	39	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059432	10.1371/journal.pone.0059432	http://dx.doi.org/10.1371/journal.pone.0059432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516635	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400111
J	Caetano-Anolles, K; Caetano-Anolles, G				Caetano-Anolles, Kelsey; Caetano-Anolles, Gustavo			Structural Phylogenomics Reveals Gradual Evolutionary Replacement of Abiotic Chemistries by Protein Enzymes in Purine Metabolism	PLOS ONE			English	Article							PREBIOTIC SYNTHESIS; DOMAIN ORGANIZATION; AEROBIC METABOLISM; MOLECULAR CLOCK; ORIGIN; HISTORY; ARCHITECTURE; PROTEOMES; NETWORKS; WORLD	The origin of metabolism has been linked to abiotic chemistries that existed in our planet at the beginning of life. While plausible chemical pathways have been proposed, including the synthesis of nucleobases, ribose and ribonucleotides, the cooption of these reactions by modern enzymes remains shrouded in mystery. Here we study the emergence of purine metabolism. The ages of protein domains derived from a census of fold family structure in hundreds of genomes were mapped onto enzymes in metabolic diagrams. We find that the origin of the nucleotide interconversion pathway benefited most parsimoniously from the prebiotic formation of adenine nucleosides. In turn, pathways of nucleotide biosynthesis, catabolism and salvage originated similar to 300 million years later by concerted enzymatic recruitments and gradual replacement of abiotic chemistries. Remarkably, this process led to the emergence of the fully enzymatic biosynthetic pathway similar to 3 billion years ago, concurrently with the appearance of a functional ribosome. The simultaneous appearance of purine biosynthesis and the ribosome probably fulfilled the expanding matter-energy and processing needs of genomic information.	[Caetano-Anolles, Kelsey; Caetano-Anolles, Gustavo] Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA; [Caetano-Anolles, Kelsey] Chicago Sch Profess Psychol, Chicago, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA.	gca@uiuc.edu		Caetano-Anolles, Gustavo/0000-0001-5854-4121; Caetano-Anolles, Kelsey/0000-0001-6310-6679	National Science Foundation [MCB-0749836]; CREES-USDA	National Science Foundation(National Science Foundation (NSF)); CREES-USDA	Research was supported by the National Science Foundation (MCB-0749836) and CREES-USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301; Becerra A, 1998, ORIGINS LIFE EVOL B, V28, P539, DOI 10.1023/A:1006500327962; Benner SA, 2012, ACCOUNTS CHEM RES, V45, P2025, DOI 10.1021/ar200332w; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Caetano-Anolles D, 2011, J MOL EVOL, V72, P14, DOI 10.1007/s00239-010-9400-9; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2012, J MOL MICRO IN PRESS; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2012, J MOL EVOL, V74, P1, DOI 10.1007/s00239-011-9480-1; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Danchin A, 2007, PROTEOMICS, V7, P875, DOI 10.1002/pmic.200600442; Delidovich IV, 2009, KINET CATAL+, V50, P297, DOI 10.1134/S0023158409020219; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Ferris JP, 2005, REV MINERAL GEOCHEM, V59, P187, DOI 10.2138/rmg.2005.59.8; FERRIS JP, 1984, TETRAHEDRON, V40, P1093, DOI 10.1016/S0040-4020(01)99315-9; FERRIS JP, 1984, CHEM ENG NEWS, V62, P22; FULLER WD, 1972, J MOL BIOL, V67, P25, DOI 10.1016/0022-2836(72)90383-X; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grant T, 2002, CLADISTICS, V18, P94, DOI 10.1006/clad.2002.0186; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Harish A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032776; Holm NG, 2012, GEOBIOLOGY, V10, P269, DOI 10.1111/j.1472-4669.2012.00323.x; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jiang YY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002426; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; Kim HS, 2013, J INTEGR BIOINFORMAT, V10, DOI 10.2390/biecoll-jib-2013-214; Kim KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-13; Kim KM, 2012, STRUCTURE, V20, P67, DOI 10.1016/j.str.2011.11.003; Kim KM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-140; Kim KM, 2010, MOL BIOL EVOL, V27, P1710, DOI 10.1093/molbev/msq106; Lambert JB, 2010, SCIENCE, V327, P984, DOI 10.1126/science.1182669; Lazcano A, 1999, J MOL EVOL, V49, P424, DOI 10.1007/PL00006565; LOHRMANN R, 1977, J MOL EVOL, V10, P137, DOI 10.1007/BF01751807; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nasir A, 2011, GENES-BASEL, V2, P869, DOI 10.3390/genes2040869; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; ORO J, 1962, ARCH BIOCHEM BIOPHYS, V96, P293, DOI 10.1016/0003-9861(62)90412-5; OSTERBERG R, 1973, J MOL EVOL, V2, P231, DOI 10.1007/BF01654004; OSTERBERG R, 1972, J MOL EVOL, V1, P241, DOI 10.1007/BF01660243; Pereto J, 2012, CHEM SOC REV, V41, P5394, DOI 10.1039/c2cs35054h; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Saladino R, 2011, ORIGINS LIFE EVOL B, V41, P317, DOI 10.1007/s11084-011-9236-3; Srinivasan V, 2009, BIOL BULL-US, V217, P222, DOI 10.1086/BBLv217n3p222; Sun FJ, 2009, J MOL EVOL, V69, P430, DOI 10.1007/s00239-009-9264-z; Swofford D.L., 1999, PHYLOGENETIC ANAL US; Teichmann SA, 2001, TRENDS BIOTECHNOL, V19, P482, DOI 10.1016/S0167-7799(01)01813-3; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; YCAS M, 1974, J THEOR BIOL, V44, P145, DOI 10.1016/S0022-5193(74)80035-4; Zubay G, 2001, ORIGINS LIFE EVOL B, V31, P87, DOI 10.1023/A:1006722423070; Zubay G, 1994, CHEMTRACTS BIOCH MOL, V5, P179; Zubay G, 1993, CHEMTRACTS BIOCH MOL, V4, P317	61	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59300	10.1371/journal.pone.0059300	http://dx.doi.org/10.1371/journal.pone.0059300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516625	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200142
J	Cone, JJ; Chartoff, EH; Potter, DN; Ebner, SR; Roitman, MF				Cone, Jackson J.; Chartoff, Elena H.; Potter, David N.; Ebner, Stephanie R.; Roitman, Mitchell F.			Prolonged High Fat Diet Reduces Dopamine Reuptake without Altering DAT Gene Expression	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; VENTRAL TEGMENTAL AREA; BODY-MASS INDEX; NUCLEUS-ACCUMBENS; CAUDATE-PUTAMEN; ENERGY DENSITY; D2 RECEPTORS; TRANSPORTER; OBESITY; REWARD	The development of diet-induced obesity (DIO) can potently alter multiple aspects of dopamine signaling, including dopamine transporter (DAT) expression and dopamine reuptake. However, the time-course of diet-induced changes in DAT expression and function and whether such changes are dependent upon the development of DIO remains unresolved. Here, we fed rats a high (HFD) or low (LFD) fat diet for 2 or 6 weeks. Following diet exposure, rats were anesthetized with urethane and striatal DAT function was assessed by electrically stimulating the dopamine cell bodies in the ventral tegmental area (VTA) and recording resultant changes in dopamine concentration in the ventral striatum using fast-scan cyclic voltammetry. We also quantified the effect of HFD on membrane associated DAT in striatal cell fractions from a separate group of rats following exposure to the same diet protocol. Notably, none of our treatment groups differed in body weight. We found a deficit in the rate of dopamine reuptake in HFD rats relative to LFD rats after 6 but not 2 weeks of diet exposure. Additionally, the increase in evoked dopamine following a pharmacological challenge of cocaine was significantly attenuated in HFD relative to LFD rats. Western blot analysis revealed that there was no effect of diet on total DAT protein. However, 6 weeks of HFD exposure significantly reduced the 50 kDa DAT isoform in a synaptosomal membrane-associated fraction, but not in a fraction associated with recycling endosomes. Our data provide further evidence for diet-induced alterations in dopamine reuptake independent of changes in DAT production and demonstrates that such changes can manifest without the development of DIO.	[Cone, Jackson J.] Univ Illinois, Grad Program Neurosci, Chicago, IL 60680 USA; [Chartoff, Elena H.; Potter, David N.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Ebner, Stephanie R.; Roitman, Mitchell F.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; McLean Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Roitman, MF (corresponding author), Univ Illinois, Dept Psychol, Chicago, IL 60680 USA.	mroitman@uic.edu		Cone, Jackson/0000-0002-1430-6946	National Institutes of Health (NIH) from the Biomedical Neuroscience Training Program [DA025634, T32-MH067631]; National Center for Research Resources; National Center for Advancing Translational Sciences, NIH [UL1RR029877]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR029877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025634] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Biomedical Neuroscience Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by National Institutes of Health (NIH) grants DA025634 (MFR) and T32-MH067631 from the Biomedical Neuroscience Training Program (JJC). Additional support was provided by the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH, through grant UL1RR029877 (JJC) and by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust (JJC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Chicago Biomedical Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Oramas D, 2009, NEUROBIOL DIS, V36, P494, DOI 10.1016/j.nbd.2009.09.002; [Anonymous], 2010, FAT DETECTION TASTE; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Cruz-Muros I, 2009, NEUROBIOL AGING, V30, P973, DOI 10.1016/j.neurobiolaging.2007.09.009; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; FIGLEWICZ DP, 1994, BRAIN RES, V644, P331, DOI 10.1016/0006-8993(94)91698-5; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Grabenhorst F, 2010, CEREB CORTEX, V20, P1082, DOI 10.1093/cercor/bhp169; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; JONES SR, 1995, J NEUROCHEM, V64, P2581; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Ledikwe JH, 2006, AM J CLIN NUTR, V83, P1362, DOI 10.1093/ajcn/83.6.1362; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; McCutcheon JE, 2012, SYNAPSE, V66, P346, DOI 10.1002/syn.21519; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Meng SZ, 1999, BRAIN RES, V843, P136, DOI 10.1016/S0006-8993(99)01933-2; Moll GH, 2000, DEV BRAIN RES, V119, P251, DOI 10.1016/S0165-3806(99)00182-0; Morris JK, 2011, EXP NEUROL, V231, P171, DOI 10.1016/j.expneurol.2011.06.005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Roitman MF, 2010, PHARMACOL BIOCHEM BE, V97, P138, DOI 10.1016/j.pbb.2010.05.010; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; Shi WX, 2004, NEUROPSYCHOPHARMACOL, V29, P2160, DOI 10.1038/sj.npp.1300534; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sinkala E, 2012, LAB CHIP, V12, P2403, DOI 10.1039/c2lc40168a; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; South T, 2008, NEUROCHEM RES, V33, P598, DOI 10.1007/s11064-007-9483-x; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Steffensen SC, 2008, EUR J NEUROSCI, V28, P2028, DOI 10.1111/j.1460-9568.2008.06479.x; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Szczypka MS, 1999, NEURON, V22, P167, DOI 10.1016/S0896-6273(00)80688-1; Thanos PK, 2010, PHYSIOL BEHAV, V101, P713, DOI 10.1016/j.physbeh.2010.08.011; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Venton BJ, 2006, J NEUROSCI, V26, P4901; Vucetic Z, 2012, J NEUROCHEM, V120, P891, DOI 10.1111/j.1471-4159.2012.07649.x; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001	54	74	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58251	10.1371/journal.pone.0058251	http://dx.doi.org/10.1371/journal.pone.0058251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516454	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200048
J	Jaworska, K; Gupta, S; Durda, K; Muszynska, M; Sukiennicki, G; Jaworowska, E; Grodzki, T; Sulikowski, M; Woloszczyk, P; Wojcik, J; Lubinski, J; Cybulski, C; Debniak, T; Lener, M; Morawski, AW; Krzystolik, K; Narod, SA; Sun, P; Lubinski, J; Jakubowska, A				Jaworska, Katrzyna; Gupta, Satish; Durda, Katarzyna; Muszynska, Magdalena; Sukiennicki, Grzegorz; Jaworowska, Ewa; Grodzki, Tomasz; Sulikowski, Mieczyslaw; Woloszczyk, Piotr; Wojcik, Janusz; Lubinski, Jakub; Cybulski, Cezary; Debniak, Tadeusz; Lener, Marcin; Morawski, Antoni W.; Krzystolik, Karol; Narod, Steven A.; Sun, Ping; Lubinski, Jan; Jakubowska, Anna			A Low Selenium Level Is Associated with Lung and Laryngeal Cancers	PLOS ONE			English	Article							SERUM SELENIUM; NUTRITIONAL PREVENTION; PROSTATE-CANCER; SUBSEQUENT RISK; VITAMIN-E; POLYMORPHISM; TRIAL; SUPPLEMENTATION; METABOLISM; SMOKING	Purpose: It has been suggested that selenium deficiency is a risk factor for several cancer types. We conducted a case-control study in Szczecin, a region of northwestern Poland, on 95 cases of lung cancer, 113 cases of laryngeal cancer and corresponding healthy controls. Methods: We measured the serum level of selenium and established genotypes for four variants in four selenoprotein genes (GPX1, GPX4, TXNRD2 and SEP15). Selenium levels in the cases were measured after diagnosis but before treatment. We calculated the odds of being diagnosed with lung or laryngeal cancer, conditional on selenium level and genotype. Results: Among lung cancer cases, the mean selenium level was 63.2 mu g/l, compared to a mean level of 74.6 mu g/l for their matched controls (p<0.0001). Among laryngeal cancer cases, the mean selenium level was 64.8 mu g/l, compared to a mean level of 77.1 mu g/l for their matched controls (p<0.0001). Compared to a serum selenium value below 60 mu g/l, a selenium level above 80 mu g/l was associated with an odds ratio of 0.10 (95% CI 0.03 to 0.34; p = 0.0002) for lung cancer and 0.23 (95% CI 0.09 to 0.56; p = 0.001) for laryngeal cancer. In analysis of four selenoprotein genes we found a modest evidence of association of genetic variant in GPX1 with the risk of lung and laryngeal cancers. Conclusion: A selenium level below 60 mu g/l is associated with a high risk of both lung and laryngeal cancer.	[Jaworska, Katrzyna; Gupta, Satish; Durda, Katarzyna; Muszynska, Magdalena; Sukiennicki, Grzegorz; Cybulski, Cezary; Debniak, Tadeusz; Lener, Marcin; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Jaworska, Katrzyna; Gupta, Satish] Warsaw Med Univ, Postgrad Sch Mol Med, Warsaw, Poland; [Jaworowska, Ewa; Lubinski, Jakub] Pomeranian Med Univ, Dept Otolaryngol & Laryngol Oncol, Szczecin, Poland; [Grodzki, Tomasz; Wojcik, Janusz] Pomeranian Med Univ, Dept Gen Thorac Surg, Szczecin, Poland; [Sulikowski, Mieczyslaw] Pomeranian Med Univ, Szczecin, Poland; [Woloszczyk, Piotr] Pomeranian Med Univ, Dept Toxicol & Mol Pathobiochem, Szczecin, Poland; [Morawski, Antoni W.] West Pomeranian Univ Technol, Inst Chem & Environm Engn, Dept Water Technol & Environm Engn, Szczecin, Poland; [Krzystolik, Karol] Pomeranian Med Univ, Chair & Clin Ophthalmol, Szczecin, Poland; [Narod, Steven A.; Sun, Ping] Womens Coll Res Inst, Toronto, ON, Canada	Pomeranian Medical University; Medical University of Warsaw; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; West Pomeranian University of Technology; Pomeranian Medical University; University of Toronto; University Toronto Affiliates; Womens College Hospital	Jakubowska, A (corresponding author), Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland.	aniaj@sci.pam.szczecin.pl	Narod, Steven A/AAA-6112-2022; Jaworowska, Ewa/B-1211-2015; Waloszczyk, Piotr/A-8399-2015; Jakubowska, Anna/O-8050-2014; Krzystolik, Karol/A-8245-2015; Lubinski, Jan/C-4420-2017	Jaworowska, Ewa/0000-0001-9050-5042; Jakubowska, Anna/0000-0002-5650-0501; Krzystolik, Karol/0000-0002-7695-0788; Lubinski, Jan/0000-0003-2931-3003; Morawski, Antoni Waldemar/0000-0002-2606-4104	International PhD Projects Programme (MPD) of Foundation for Polish Science; European Union, Regional Development Fund; National Science Centre (NCN) grant [UMO-2011/03/N/NZ2/01539]	International PhD Projects Programme (MPD) of Foundation for Polish Science; European Union, Regional Development Fund; National Science Centre (NCN) grant	This project was realized within the International PhD Projects Programme (MPD) of Foundation for Polish Science, co-financed from European Union, Regional Development Fund. This study was supported by the National Science Centre (NCN) grant UMO-2011/03/N/NZ2/01539. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no financial or other relationships that might lead to a conflict of interests.	Comstock GW, 1997, CANCER EPIDEM BIOMAR, V6, P907; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duncan A, 2012, AM J CLIN NUTR, V95, P64, DOI 10.3945/ajcn.111.023812; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P1962, DOI 10.1158/1055-9965.EPI-09-0003; GARLAND M, 1995, J NATL CANCER I, V87, P497, DOI 10.1093/jnci/87.7.497; Goodman GE, 2001, CANCER EPIDEM BIOMAR, V10, P1069; Hartman TJ, 2002, CANCER CAUSE CONTROL, V13, P923, DOI 10.1023/A:1021912117067; Jablonska E, 2008, EUR J NUTR, V47, P47, DOI 10.1007/s00394-008-0696-9; KABUTO M, 1994, CANCER EPIDEM BIOMAR, V3, P465; Knekt P, 1998, AM J EPIDEMIOL, V148, P975, DOI 10.1093/oxfordjournals.aje.a009574; KNEKT P, 1990, J NATL CANCER I, V82, P864, DOI 10.1093/jnci/82.10.864; KROMHOUT D, 1987, AM J CLIN NUTR, V45, P1361, DOI 10.1093/ajcn/45.5.1361; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MENKES MS, 1986, NEW ENGL J MED, V315, P1250, DOI 10.1056/NEJM198611133152003; NOMURA A, 1987, J NATL CANCER I, V79, P103; Raaschou-Nielsen O, 2007, CANCER LETT, V247, P293, DOI 10.1016/j.canlet.2006.05.006; Ratnasinghe D, 2000, CANCER CAUSE CONTROL, V11, P129, DOI 10.1023/A:1008977320811; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Renko K, 2009, FASEB J, V23, P1758, DOI 10.1096/fj.08-119370; Rosenberger A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-60; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Skuladottir H, 2005, LUNG CANCER, V48, P187, DOI 10.1016/j.lungcan.2004.10.013; Sutherland A, 2010, GENES NUTR, V5, P215, DOI 10.1007/s12263-010-0176-8; VANDENBRANDT PA, 1993, CANCER RES, V53, P4860; Yang P, 2004, CARCINOGENESIS, V25, P1935, DOI 10.1093/carcin/bgh203; Zhou Lan, 2011, Zhongguo Fei Ai Za Zhi, V14, P39, DOI 10.3779/j.issn.1009-3419.2011.01.08; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	32	50	51	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59051	10.1371/journal.pone.0059051	http://dx.doi.org/10.1371/journal.pone.0059051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516596	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200129
J	Peng, XB; Guo, W; Ren, TT; Lou, ZY; Lu, XC; Zhang, S; Lu, QS; Sun, YF				Peng, Xianbo; Guo, Wei; Ren, Tingting; Lou, Zhiyuan; Lu, Xinchang; Zhang, Shuai; Lu, Qunshan; Sun, Yifeng			Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FACTOR-KAPPA-B; HUMAN PROSTATE-CANCER; RECEPTOR ACTIVATOR; OSTEOCLAST DIFFERENTIATION; RANK-FC; OSTEOPROTEGERIN LIGAND; POSSIBLE INVOLVEMENT; IN-VITRO; TUMOR; MIGRATION	Background: Human non-small cell lung cancer (NSCLC) patients exhibit a high propensity to develop skeletal metastasis, resulting in excessive osteolytic activity. The RANKL/RANK/OPG system, which plays a pivotal role in bone remodeling by regulating osteoclast formation and activity, is of potential interest in this context. Materials and Methods: Reverse transcriptase polymerase chain reaction, western blotting, and immunohistochemical analysis were used to examine the expression of RANKL, RANK, and OPG in human NSCLC cell lines with different metastatic potentials, as well as in 52 primary NSCLC samples and 75 NSCLC bone metastasis samples. In primary NSCLC patients, the expression of these proteins was correlated with clinicopathological parameters. Recombinant human RANKL and transfected RANKL cDNA were added to the PAa cell line to evaluate the promoter action of RANKL during the process of metastasis in vitro and in vivo. Results: Up-regulated RANKL, RANK, and OPG expression and increased RANKL:OPG ratio were detected in NSCLC cell lines and in tumor tissues with bone metastasis, and were correlated with higher metastatic potential. The metastatic potential of NSCLC in vitro and in vivo, including migration and invasion ability, was significantly enhanced by recombinant human RANKL and the transfection of RANKL cDNA, and was impaired after OPG was added. The increased expression of RANKL and OPG correlated with tumor stage, lymph node metastasis, and distant metastasis. Conclusions: Differential expression of RANKL, RANK, and OPG is associated with the metastatic potential of human NSCLC to skeleton, raising the possibility that the RANKL/RANK/OPG system could be a therapeutic target for the treatment of metastatic NSCLC patients.	[Peng, Xianbo; Guo, Wei; Ren, Tingting; Lou, Zhiyuan; Lu, Xinchang; Zhang, Shuai; Lu, Qunshan; Sun, Yifeng] Peking Univ, Peoples Hosp, Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China	Peking University	Guo, W (corresponding author), Peking Univ, Peoples Hosp, Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China.	guowei_bonetumor@126.com			National Natural Science Foundation of China [30973020, 81001193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 30973020 and 81001193). Http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2010, J PHARM PHARMACOL, V62, P470, DOI 10.1211/jpp.62.04.0009; Bhatia P, 2005, CLIN CANCER RES, V11, P162; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brown JE, 2005, JNCI-J NATL CANCER I, V97, P59, DOI 10.1093/jnci/dji002; Chen G, 2006, CANCER-AM CANCER SOC, V107, P289, DOI 10.1002/cncr.21978; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Demers LM, 2003, CLIN ORTHOP RELAT R, pS138, DOI 10.1097/01.blo.0000092979.12414.54; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Farrugia AN, 2003, CANCER RES, V63, P5438; Feeley BT, 2006, J BONE MINER RES, V21, P1571, DOI 10.1359/JBMR.060706; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Fiumara P, 2001, BLOOD, V98, P2784, DOI 10.1182/blood.V98.9.2784; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Holen I, 2005, BREAST CANCER RES TR, V92, P207, DOI 10.1007/s10549-005-2419-8; Hsu WK, 2008, J NUCL MED, V49, P414, DOI 10.2967/jnumed.107.045666; Huang L, 2003, J CLIN PATHOL-MOL PA, V56, P116, DOI 10.1136/mp.56.2.116; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karapanagiotou EM, 2010, MED ONCOL, V27, P332, DOI 10.1007/s12032-009-9214-z; Kitazawa S, 2002, J PATHOL, V198, P228, DOI 10.1002/path.1199; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee Y, 2003, J ORTHOP RES, V21, P62, DOI 10.1016/S0736-0266(02)00095-5; Mikami S, 2009, J PATHOL, V218, P530, DOI 10.1002/path.2567; Mori K, 2007, BONE, V40, P981, DOI 10.1016/j.bone.2006.11.006; Mountzios G, 2007, ACTA ONCOL, V46, P221, DOI 10.1080/02841860600635870; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Navolotski A, 1997, CANCER LETT, V118, P181, DOI 10.1016/S0304-3835(97)00329-7; Roodman G David, 2004, Discov Med, V4, P144; Roux S, 2002, AM J CLIN PATHOL, V117, P210; Santini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019234; Siegel G, 1998, MICROSC RES TECHNIQ, V43, P276, DOI 10.1002/(SICI)1097-0029(19981101)43:3<276::AID-JEMT10>3.0.CO;2-G; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sordillo EM, 2003, CANCER-AM CANCER SOC, V97, P802, DOI 10.1002/cncr.11134; Tada T, 2005, INT J CANCER, V116, P253, DOI 10.1002/ijc.21008; Tang XD, 2010, EUR J CANCER PREV, V19, P466, DOI 10.1097/CEJ.0b013e32833d942f; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Virk MS, 2009, BONE, V44, P160, DOI 10.1016/j.bone.2008.09.009; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Whang PG, 2005, J ORTHOP RES, V23, P1475, DOI 10.1016/j.orthres.2005.05.004; Yin JJ, 2005, CELL RES, V15, P57, DOI 10.1038/sj.cr.7290266; Yoneda T, 2005, BIOCHEM BIOPH RES CO, V328, P679, DOI 10.1016/j.bbrc.2004.11.070; Yoshino I, 2001, Ann Thorac Cardiovasc Surg, V7, P204; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zhang J, 2003, CANCER RES, V63, P7883	46	52	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58361	10.1371/journal.pone.0058361	http://dx.doi.org/10.1371/journal.pone.0058361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516466	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200058
J	Li, H; Redinbo, MR; Venkatesh, M; Ekins, S; Chaudhry, A; Bloch, N; Negassa, A; Mukherjee, P; Kalpana, G; Mani, S				Li, Hao; Redinbo, Matthew R.; Venkatesh, Madhukumar; Ekins, Sean; Chaudhry, Anik; Bloch, Nicolin; Negassa, Abdissa; Mukherjee, Paromita; Kalpana, Ganjam; Mani, Sridhar			Novel Yeast-based Strategy Unveils Antagonist Binding Regions on the Nuclear Xenobiotic Receptor PXR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; ANDROGEN RECEPTOR; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; PROSTATE-CANCER; CELL-GROWTH; CANDIDA-ALBICANS; GENOTOXIC AGENTS; 2-HYBRID SYSTEM	The pregnane X receptor (PXR) is a master regulator of xenobiotic metabolism, and its activity is critical toward understanding the pathophysiology of several diseases, including inflammation, cancer, and steatosis. Previous studies have demonstrated that ketoconazole binds to ligand-activated PXR and antagonizes receptor control of gene expression. Structure-function as well as computational docking analysis suggested a putative binding region containing critical charge clamp residues Gln-272, and Phe-264 on the AF-2 surface of PXR. To define the antagonist binding surface(s) of PXR, we developed a novel assay to identify key amino acid residues on PXR based on a yeast two-hybrid screen that examined mutant forms of PXR. This screen identified multiple "gain-of-function" mutants that were "resistant" to the PXR antagonist effects of ketoconazole. We then compared our screen results identifying key PXR residues to those predicted by computational methods. Of 15 potential or putative binding residues based on docking, we identified three residues in the yeast screen that were then systematically verified to functionally interact with ketoconazole using mammalian assays. Among the residues confirmed by our study was Ser-208, which is on the opposite side of the protein from the AF-2 region critical for receptor regulation. The identification of new locations for antagonist binding on the surface or buried in PXR indicates novel aspects to the mechanism of receptor antagonism. These results significantly expand our understanding of antagonist binding sites on the surface of PXR and suggest new avenues to regulate this receptor for clinical applications.	[Li, Hao; Venkatesh, Madhukumar; Chaudhry, Anik; Bloch, Nicolin; Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Negassa, Abdissa] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Mukherjee, Paromita; Kalpana, Ganjam] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC 27526 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Mani, S (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave,Chanin 302D-1, Bronx, NY 10461 USA.	sridhar.mani@einstein.yu.edu		Kalpana, Ganjam/0000-0003-4111-0604	National Institutes of Health [CA127231]; Damon Runyon Foundation [CI 1502]; NATIONAL CANCER INSTITUTE [R01CA127231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA127231. This work was also supported by a Damon Runyon Foundation Clinical Investigator Award (CI 1502) (to S. M.).	BARD M, 1993, LIPIDS, V28, P963, DOI 10.1007/BF02537115; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Biswas A, 2011, BIOCHEM BIOPH RES CO, V406, P371, DOI 10.1016/j.bbrc.2011.02.048; Biswas A, 2009, PHARM RES-DORDR, V26, P1807, DOI 10.1007/s11095-009-9901-7; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Buzon V, 2012, MOL CELL ENDOCRINOL, V348, P394, DOI 10.1016/j.mce.2011.08.012; Carnahan VE, 2005, CURR DRUG METAB, V6, P357, DOI 10.2174/1389200054633844; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Clark FS, 1996, ANTIMICROB AGENTS CH, V40, P419, DOI 10.1128/AAC.40.2.419; Das BC, 2008, BIOORG MED CHEM LETT, V18, P3974, DOI 10.1016/j.bmcl.2008.06.018; Das Supratik, 2009, V485, P271, DOI 10.1007/978-1-59745-170-3_19; Dong HQ, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-23; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Egner R, 2000, MOL MICROBIOL, V35, P1255, DOI 10.1046/j.1365-2958.2000.01798.x; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Ekins S, 2008, MOL PHARMACOL, V74, P662, DOI 10.1124/mol.108.049437; Ekins S, 2007, MOL PHARMACOL, V72, P592, DOI 10.1124/mol.107.038398; Ekins S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000594; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gunther JR, 2009, ACS CHEM BIOL, V4, P435, DOI 10.1021/cb900043e; Healan-Greenberg C, 2008, DRUG METAB DISPOS, V36, P500, DOI 10.1124/dmd.107.019547; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Joseph JD, 2009, P NATL ACAD SCI USA, V106, P12178, DOI 10.1073/pnas.0900185106; KALPANA GV, 1993, P NATL ACAD SCI USA, V90, P10593, DOI 10.1073/pnas.90.22.10593; Kaur R, 1999, MICROBIOL-UK, V145, P809, DOI 10.1099/13500872-145-4-809; Kim JY, 2007, MOL CELL PROTEOMICS, V6, P1727, DOI 10.1074/mcp.M700079-MCP200; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Lei F., 2009, THESIS U TENNESSEE H; Mani S, 2005, CLIN CANCER RES, V11, P6359, DOI 10.1158/1078-0432.CCR-05-0252; Mani S, 2013, DRUG METAB REV, V45, P60, DOI 10.3109/03602532.2012.746363; Masuyama H, 2005, MOL ENDOCRINOL, V19, P1170, DOI 10.1210/me.2004-0434; Mellado E, 2005, ANTIMICROB AGENTS CH, V49, P2536, DOI 10.1128/AAC.49.6.2536-2538.2005; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Moore TW, 2010, MOL ENDOCRINOL, V24, P683, DOI 10.1210/me.2009-0362; Mukherjee PK, 2003, INFECT IMMUN, V71, P4333, DOI 10.1128/IAI.71.8.4333-4340.2003; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Noble SM, 2006, BIOCHEMISTRY-US, V45, P8579, DOI 10.1021/bi0602821; Pondugula SR, 2013, CANCER LETT, V328, P1, DOI 10.1016/j.canlet.2012.08.030; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Serebriiskii IG, 2002, GENOME RES, V12, P1785, DOI 10.1101/gr.450702; Sharifi N, 2010, EXPERT OPIN INV DRUG, V19, P837, DOI 10.1517/13543784.2010.494178; Staudinger JL, 2011, PHARMACOL RES, V64, P4, DOI 10.1016/j.phrs.2011.02.011; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Takeshita A, 2002, J BIOL CHEM, V277, P32453, DOI 10.1074/jbc.M111245200; Teotico D. G., 2008, COMPUT BIOL, V4; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang HW, 2008, MOL ENDOCRINOL, V22, P838, DOI 10.1210/me.2007-0218; Wang HW, 2007, CLIN CANCER RES, V13, P2488, DOI 10.1158/1078-0432.CCR-06-1592; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Xue Y, 2007, BIOORGAN MED CHEM, V15, P2156, DOI 10.1016/j.bmc.2006.12.026; Zhou CC, 2007, MOL PHARMACOL, V71, P220, DOI 10.1124/mol.106.029264	60	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13655	13668		10.1074/jbc.M113.455485	http://dx.doi.org/10.1074/jbc.M113.455485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525103	Green Published, hybrid			2022-12-25	WOS:000318850300049
J	Wilkie-Grantham, RP; Matsuzawa, SI; Reed, JC				Wilkie-Grantham, Rachel P.; Matsuzawa, Shu-Ichi; Reed, John C.			Novel Phosphorylation and Ubiquitination Sites Regulate Reactive Oxygen Species-dependent Degradation of Anti-apoptotic c-FLIP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRAIL-INDUCED APOPTOSIS; FAS-MEDIATED APOPTOSIS; DOWN-REGULATION; CELL-DEATH; TRITERPENOID CDDO; SIGNALING PATHWAY; OXIDATIVE STRESS; INDUCE APOPTOSIS; JNK ACTIVATION	The cytosolic protein c-FLIP (cellular Fas-associated death domain-like interleukin 1 beta-converting enzyme inhibitory protein) is an inhibitor of death receptor-mediated apoptosis that is up-regulated in a variety of cancers, contributing to apoptosis resistance. Several compounds found to restore sensitivity of cancer cells to TRAIL, a TNF family death ligand with promising therapeutic potential, act by targeting c-FLIP ubiquitination and degradation by the proteasome. The generation of reactive oxygen species (ROS) has been implicated in c-FLIP protein degradation. However, the mechanism by which ROS post-transcriptionally regulate c-FLIP protein levels is not well understood. We show here that treatment of prostate cancer PPC-1 cells with the superoxide generators menadione, paraquat, or buthionine sulfoximine down-regulates c-FLIP long (c-FLIPL) protein levels, which is prevented by the proteasome inhibitor MG132. Furthermore, pretreatment of PPC-1 cells with a ROS scavenger prevented ubiquitination and loss of c-FLIPL protein induced by menadione or paraquat. We identified lysine 167 as a novel ubiquitination site of c-FLIPL important for ROS-dependent degradation. We also identified threonine 166 as a novel phosphorylation site and demonstrate that Thr-166 phosphorylation is required for ROS-induced Lys-167 ubiquitination. The mutation of either Thr-166 or Lys-167 was sufficient to stabilize c-FLIP protein levels in PPC-1, HEK293T, and HeLa cancer cells treated with menadione or paraquat. Accordingly, expression of c-FLIP T166A or K167R mutants protected cells from ROS-mediated sensitization to TRAIL-induced cell death. Our findings reveal novel ROS-dependent post-translational modifications of the c-FLIP protein that regulate its stability, thus impacting sensitivity of cancer cells to TRAIL.	[Wilkie-Grantham, Rachel P.; Matsuzawa, Shu-Ichi; Reed, John C.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanfordburnham.org			National Institutes of Health Grant [R01-CA-163743]; NATIONAL CANCER INSTITUTE [R01CA163743] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA-163743.	Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; Chen YW, 2012, ARCH TOXICOL, V86, P1547, DOI 10.1007/s00204-012-0873-8; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Deeb D, 2010, BIOCHEM PHARMACOL, V79, P350, DOI 10.1016/j.bcp.2009.09.006; Dejeans N, 2010, BIOCHEM PHARMACOL, V79, P1221, DOI 10.1016/j.bcp.2009.12.009; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Ge W, 2010, FREE RADICAL BIO MED, V49, P2068, DOI 10.1016/j.freeradbiomed.2010.10.686; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Higuchi H, 2003, J BIOL CHEM, V278, P454, DOI 10.1074/jbc.M209387200; Ikeda T, 2003, CANCER RES, V63, P5551; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kaunisto A, 2009, CELL DEATH DIFFER, V16, P1215, DOI 10.1038/cdd.2009.35; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Lee SJ, 2011, INT J ONCOL, V38, P485, DOI 10.3892/ijo.2010.878; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Martin-Perez R, 2012, APOPTOSIS, V17, P349, DOI 10.1007/s10495-011-0673-2; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; McCourt C, 2012, CLIN CANCER RES, V18, P3822, DOI 10.1158/1078-0432.CCR-11-3277; Muruganandan S, 2006, TOXICOL SCI, V94, P118, DOI 10.1093/toxsci/kfl084; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nitobe J, 2003, CARDIOVASC RES, V57, P119, DOI 10.1016/S0008-6363(02)00646-6; Noh HJ, 2012, J CELL BIOCHEM, V113, P3692, DOI 10.1002/jcb.24242; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park SK, 2010, BREAST CANCER RES TR, V124, P361, DOI 10.1007/s10549-010-0786-2; Ravanan P, 2011, MOL CANCER THER, V10, P1635, DOI 10.1158/1535-7163.MCT-10-0887; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Roth W, 2004, VITAM HORM, V67, P189; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Schattenberg JM, 2012, FREE RADICAL BIO MED, V52, P1911, DOI 10.1016/j.freeradbiomed.2012.02.049; Sharma M, 2012, MOL PHARMACOL, V82, P1001, DOI 10.1124/mol.112.079863; Shi B, 2009, J BIOL CHEM, V284, P14513, DOI 10.1074/jbc.M807918200; Stagni V, 2010, CARCINOGENESIS, V31, P1956, DOI 10.1093/carcin/bgq193; Suh WS, 2003, LEUKEMIA, V17, P2122, DOI 10.1038/sj.leu.2403112; Tiwary R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011865; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang LY, 2008, J IMMUNOL, V180, P3072, DOI 10.4049/jimmunol.180.5.3072; Xiao C, 2005, EXP CELL RES, V304, P244, DOI 10.1016/j.yexcr.2004.11.002; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang BF, 2007, CLIN EXP PHARMACOL P, V34, P1245, DOI 10.1111/j.1440-1681.2007.04711.x; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200; Yang JF, 2012, CANCER CHEMOTH PHARM, V69, P195, DOI 10.1007/s00280-011-1686-9; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Yerbes R, 2012, INVEST NEW DRUG, V30, P541, DOI 10.1007/s10637-010-9597-x; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249; Zhu DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018291	64	43	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12777	12790		10.1074/jbc.M112.431320	http://dx.doi.org/10.1074/jbc.M112.431320			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519470	Green Published, hybrid			2022-12-25	WOS:000318555100034
J	Li, W; Yang, G; Zhang, AL; Xu, LX				Li, Wei; Yang, Geer; Zhang, Aili; Xu, Lisa X.			Numerical Study of Cell Cryo-Preservation: A Network Model of Intracellular Ice Formation	PLOS ONE			English	Article							REFERENCE PHASE ANALYSIS; BIOLOGICAL CELLS; THERMAL-STRESSES; DIFFUSION; GROWTH; PERMEABILITY; POTASSIUM; TRANSPORT; KINETICS; TRACHEA	In this study, a new intracellular ice formation network model, coupled with an improved cell dehydration model has been developed. The non-uniform dehydration of the cell during freezing is simulated with moving boundary condition. Internal cell structures like cell nucleus are taken into consideration. The IIF network model is developed from classic diffusion limited IIF model in order to simulate spatial ice growth pattern inside cells. Simulation results suggest that cell nuclear plays a significant role in cryo-dehydration and would affect water/CPA concentration gradient inside the cell. At the same time, the ice growth pattern of exogenous IIF hypothesis is examined in the model. It is consistent with our previous experiments, in which we witnessed the intracellular ice first grown into the nucleus before spreading to the whole intercellular space. According to this model, the water concentration difference between nucleus and cytoplasm during cryo-dehydration could partly explain why ice crystal in the nucleus grows faster. However, it is not the dominate factor. Higher diffusion coefficient in cell nucleus might play a more important role in the phenomenon.	[Li, Wei; Yang, Geer; Zhang, Aili; Xu, Lisa X.] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zhang, Aili; Xu, Lisa X.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, AL (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	zhangaili@sjtu.edu.cn; lisaxu@sjtu.edu.cn			National Natural Science Foundation of China [NSFC51076095]; Shanghai Municipal Science and Technology Commission [11DZ2211000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work has been supported by the National Natural Science Foundation of China (NSFC51076095) and Shanghai Municipal Science and Technology Commission (11DZ2211000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JJH, 2011, DIFFUSION MRI THEORY, P110; [Anonymous], 2002, THEORY TRANSFORMATIO; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Brockbank KGM, 2012, CELL TISSUE BANK, V13, P663, DOI 10.1007/s10561-011-9288-7; Bruna P, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337407; Brunette I, 2001, CORNEA, V20, P590, DOI 10.1097/00003226-200108000-00007; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Chen C, 2008, CRYOLETTERS, V29, P371; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; FELDHERR CM, 1973, EXPERIENTIA, V29, P546, DOI 10.1007/BF01926655; Grant SC, 2001, MAGN RESON MED, V46, P1107, DOI 10.1002/mrm.1306; He X, 2006, J APPL PHYS, V100; He XM, 2005, J BIOMECH ENG-T ASME, V127, P656, DOI 10.1115/1.1934021; HOROWITZ SB, 1979, BIOPHYS J, V25, P33, DOI 10.1016/S0006-3495(79)85276-5; HOROWITZ SB, 1972, J CELL BIOL, V54, P609, DOI 10.1083/jcb.54.3.609; HOROWITZ SB, 1981, MOL CELL BIOL, V1, P769, DOI 10.1128/MCB.1.9.769; HOROWITZ SB, 1979, BIOPHYS J, V25, P45, DOI 10.1016/S0006-3495(79)85277-7; HOROWITZ SB, 1974, J CELL BIOL, V60, P405, DOI 10.1083/jcb.60.2.405; HOROWITZ SB, 1968, J GEN PHYSIOL, V51, P703, DOI 10.1085/jgp.51.6.703; Jaeger M, 1999, BIOPHYS J, V77, P1257, DOI 10.1016/S0006-3495(99)76977-8; KARLSSON JOM, 1994, J APPL PHYS, V75, P4442, DOI 10.1063/1.355959; LEVIN RL, 1976, BIOPHYS J, V16, P1411, DOI 10.1016/S0006-3495(76)85784-0; Mabrut JY, 2001, TRANSPLANT P, V33, P609, DOI 10.1016/S0041-1345(00)02166-7; Mao L, 2003, INT J HEAT MASS TRAN, V46, P5123, DOI 10.1016/S0017-9310(03)00364-8; MASTRO AM, 1984, P NATL ACAD SCI-BIOL, V81, P3414, DOI 10.1073/pnas.81.11.3414; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Peters Reiner, 2006, V322, P235; Rabin Y, 1998, J APPL MECH-T ASME, V65, P328, DOI 10.1115/1.2789058; RUBINSKY B, 1980, CRYOBIOLOGY, V17, P66, DOI 10.1016/0011-2240(80)90009-7; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; Toner Mehmet, 1993, Advances in Low-Temperature Biology, V2, P1; Xu H, 2009, CRYOBIOLOGY, V58, P225, DOI 10.1016/j.cryobiol.2008.12.009; Yang G, 2009, J APPL PHYS, V105, DOI 10.1063/1.3124371; Yang G, 2009, CRYOBIOLOGY, V58, P96, DOI 10.1016/j.cryobiol.2008.10.123; Zhao G, 2006, AICHE J, V52, P2596, DOI 10.1002/aic.10851; Zhao G, 2005, CRYOLETTERS, V26, P239	38	2	3	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58343	10.1371/journal.pone.0058343	http://dx.doi.org/10.1371/journal.pone.0058343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526979	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562600019
J	You, B; Huang, SD; Qin, Q; Yi, B; Yuan, Y; Xu, ZY; Sun, JX				You, Bei; Huang, Shengdong; Qin, Qing; Yi, Bing; Yuan, Yang; Xu, Zhiyun; Sun, Jianxin			Glyceraldehyde-3-Phosphate Dehydrogenase Interacts with Proapoptotic Kinase Mst1 to Promote Cardiomyocyte Apoptosis	PLOS ONE			English	Article							STE20-LIKE PROTEIN-KINASE; NUCLEAR TRANSLOCATION; CANCER DEVELOPMENT; CARDIAC MYOCYTES; HIPPO PATHWAY; PHOSPHORYLATION; GAPDH; BINDING; INHIBITION; ACTIVATION	Mammalian sterile 20-like kinase 1 (Mst1) is a critical component of the Hippo signaling pathway, which regulates a variety of biological processes ranging from cell contact inhibition, organ size control, apoptosis and tumor suppression in mammals. Mst1 plays essential roles in the heart disease since its activation causes cardiomyocyte apoptosis and dilated cardiomyopathy. However, the mechanism underlying Mst1 activation in the heart remains unknown. In a yeast two-hybrid screen of a human heart cDNA library with Mst1 as bait, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified as an Mst1-interacting protein. The interaction of GAPDH with Mst1 was confirmed by co-immunoprecipitation in both co-transfected HEK293 cells and mouse heart homogenates, in which GAPDH interacted with the kinase domain of Mst1, whereas the C-terminal catalytic domain of GAPDH mediated its interaction with Mst1. Moreover, interaction of Mst1 with GAPDH caused a robust phosphorylation of GAPDH and markedly increased the Mst1 activity in cells. Chelerythrine, a potent inducer of apoptosis, substantially increased the nuclear translocation and interaction of GAPDH and Mst1 in cardiomyocytes. Overexpression of GAPDH significantly augmented the Mst1 mediated apoptosis, whereas knockdown of GAPDH markedly attenuated the Mst1 activation and cardiomyocyte apoptosis in response to either chelerythrine or hypoxia/reoxygenation. These findings reveal a novel function of GAPDH in Mst1 activation and cardiomyocyte apoptosis and suggest that disruption of GAPDH interaction with Mst1 may prevent apoptosis related heart diseases such as heart failure and ischemic heart disease.	[You, Bei; Huang, Shengdong; Yuan, Yang; Xu, Zhiyun; Sun, Jianxin] Second Mil Med Univ, Changhai Hosp, Inst Cardiothorac Surg, Shanghai, Peoples R China; [Qin, Qing; Yi, Bing; Sun, Jianxin] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Naval Medical University; Jefferson University	Sun, JX (corresponding author), Second Mil Med Univ, Changhai Hosp, Inst Cardiothorac Surg, Shanghai, Peoples R China.	jianxin.sun@jefferson.edu			National Natural Science Foundation of China [381170114]; National Institutes of Health [R01HL103869]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Natural Science Foundation of China [grant number 381170114] and the National Institutes of Health [grant number R01HL103869] (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Inadomi C, 2012, BIOCHEM BIOPH RES CO, V425, P656, DOI 10.1016/j.bbrc.2012.07.118; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Madsen-Bouterse S, 2010, INVEST OPHTH VIS SCI, V51, P1765, DOI 10.1167/iovs.09-4171; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Ren AX, 2008, CANCER RES, V68, P2266, DOI 10.1158/0008-5472.CAN-07-6248; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sun JX, 2006, CIRC RES, V99, P468, DOI 10.1161/01.RES.0000239410.65551.b3; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tajima H, 1999, NEUROREPORT, V10, P2029, DOI 10.1097/00001756-199907130-00007; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yao LL, 2012, J CELL PHYSIOL, V227, P3518, DOI 10.1002/jcp.24053; You B, 2009, BIOCHEM J, V418, P93, DOI 10.1042/BJ20081340; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011	40	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58697	10.1371/journal.pone.0058697	http://dx.doi.org/10.1371/journal.pone.0058697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527007	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600032
J	Li, B; Li, F; Chi, LY; Zhang, LW; Zhu, SG				Li, Bo; Li, Feng; Chi, Lingyi; Zhang, Liangwen; Zhu, Shugan			The Expression of SPARC in Human Intracranial Aneurysms and Its Relationship with MMP-2/-9	PLOS ONE			English	Article							SECRETED PROTEIN; RISK-FACTORS; CYSTEINE SPARC; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; CEREBRAL ANEURYSMS; CANCER; RICH; RUPTURE	Objective: SPARC is a key determinant of invasion and metastasis in some tumors, such as gliomas, melanomas and prostate tumors. SPARC can change the composition and structure of the matrix and promote angiogenesis; these effects are closely related to clinical stage and the prognosis of tumors such as meningiomas. However, little is known about the expression of SPARC in intracranial aneurysms. The goal of this study was to establish the role of SPARC in human intracranial aneurysms. Methods: Thirty-one intracranial aneurysms were immunohistochemically stained for SPARC, MMP-2 and MMP-9. As controls, normal Circle of Willis arteries were similarly immunostained. All specimens were retrieved during autopsies and were embedded in paraffin. To evaluate the expression levels of SPARC, MMP-2 and MMP-9, western blotting was also performed in three available intracranial aneurysm specimens. The limited availability of fresh intracranial aneurysm tissue was the result of the majority of patients choosing endovascular embolization. Results: The results showed that SPARC, MMP-2 and MMP-9 were strongly expressed in intracranial aneurysm tissues; however, these proteins were expressed minimally or not at all in normal Circle of Willis arteries. The western blot results showed that the expression levels of SPARC, MMP-2 and MMP-9 were significantly up-regulated in intracranial aneurysms relative to the expression levels in the normal Circle of Willis arteries. Data analysis showed that SPARC was significantly correlated with MMP-2 and MMP-9, also with age and risk factors but not with the Hunt-Hess grade or with sex. Conclusion: The results indicate that SPARC is widely expressed in human intracranial aneurysms, and its expression correlates with MMP-2 and MMP-9 expression, age and risk factors but not with the Hunt-Hess grade. The results of this study suggest that SPARC has a pathogenic role in the alteration of the extracellular matrix of intracranial arteries during aneurysm formation.	[Li, Bo; Li, Feng; Chi, Lingyi; Zhang, Liangwen; Zhu, Shugan] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250100, Peoples R China	Shandong University	Zhu, SG (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250100, Peoples R China.	libo5479937@yahoo.cn			National Natural Science Foundation of Chin [81171172]	National Natural Science Foundation of Chin(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81171172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhoopathi P, 2010, BRIT J CANCER, V102, P530, DOI 10.1038/sj.bjc.6605538; Biros E, 2008, NEUROSCI LETT, V431, P31, DOI 10.1016/j.neulet.2007.11.014; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Caird J, 2006, EUR J NEUROL, V13, P1098, DOI 10.1111/j.1468-1331.2006.01469.x; Capper D, 2010, NEUROPATH APPL NEURO, V36, P183, DOI 10.1111/j.1365-2990.2010.01072.x; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; Chen G, 2010, BRIT J CANCER, V102, P188, DOI 10.1038/sj.bjc.6605440; Chlenski A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-138; D'Armiento FP, 2001, STROKE, V32, P2472, DOI 10.1161/hs1101.098520; DiMartino JF, 2006, LEUKEMIA, V20, P426, DOI 10.1038/sj.leu.2404102; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gilles C, 1998, CANCER RES, V58, P5529; Ginsbach CG, 2002, STROKE, V33, P2192, DOI 10.1161/01.STR.000026863.51751.DE; HIROTA S, 1993, AM J PATHOL, V143, P1003; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Jin DS, 2007, SURG NEUROL, V68, P11, DOI 10.1016/j.sumeu.2007.02.060; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Juvela S, 2003, STROKE, V34, P1852, DOI 10.1161/01.STR.0000080380.56799.DD; Kassam AB, 2004, NEUROSURGERY, V54, P1450, DOI 10.1227/01.NEU.0000125005.67850.F8; Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396; Koukourakis MI, 2003, CANCER RES, V63, P5376; Krischek B, 2008, ADV TECH STAND NEURO, V33, P131, DOI 10.1007/978-3-211-72283-1_3; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Le Bail B, 1999, J PATHOL, V189, P46; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; McCurdy S, 2010, J MOL CELL CARDIOL, V48, P544, DOI 10.1016/j.yjmcc.2009.06.018; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Motamed K, 2003, J CELL BIOCHEM, V90, P408, DOI 10.1002/jcb.10645; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; Napoli C, 2005, NEUROBIOL AGING, V26, P293, DOI 10.1016/j.neurobiolaging.2004.02.031; Nishie A, 2001, CLIN CANCER RES, V7, P2145; Peters DG, 2001, STROKE, V32, P1036, DOI 10.1161/01.STR.32.4.1036; Pichler RH, 1996, KIDNEY INT, V50, P1978, DOI 10.1038/ki.1996.520; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; Porte H, 1998, CLIN CANCER RES, V4, P1375; PORTER PL, 1995, J HISTOCHEM CYTOCHEM, V43, P791, DOI 10.1177/43.8.7622842; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Rahme RJ, 2010, NEUROSURGERY, V67, pN15, DOI 10.1227/01.NEU.0000386963.24172.F7; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Ribourtout E, 2004, STROKE, V35, P786, DOI 10.1161/01.STR.0000117577.94345.CC; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Seet LF, 2012, J CELL MOL MED, V16, P1245, DOI 10.1111/j.1582-4934.2011.01400.x; Seet LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009415; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Wang WJ, 2006, NEPHROL DIAL TRANSPL, V21, P1278, DOI 10.1093/ndt/gfk036; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu HW, 2011, STROKE, V42, P204, DOI 10.1161/STROKEAHA.110.578740; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	58	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58490	10.1371/journal.pone.0058490	http://dx.doi.org/10.1371/journal.pone.0058490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516489	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400034
J	Li, QL; Kang, T; Tian, XH; Ma, YM; Li, M; Richards, J; Bythwood, T; Wang, YL; Li, X; Liu, D; Ma, L; Song, Q				Li, Qiling; Kang, Ting; Tian, Xiaohua; Ma, Yamin; Li, Min; Richards, Jendai; Bythwood, Tameka; Wang, Yueling; Li, Xu; Liu, Dong; Ma, Li; Song, Qing			Multimeric Stability of Human C-reactive Protein in Archived Specimens	PLOS ONE			English	Article							GIANT-CELL ARTERITIS; COMPLEMENT FACTOR-H; PENTAMERIC SYMMETRY; HUMAN-NEUTROPHILS; POLYMYALGIA-RHEUMATICA; CARDIOVASCULAR-DISEASE; MACULAR DEGENERATION; DIABETES-MELLITUS; DNA-SEQUENCE; INFLAMMATION	Background: C-reactive protein (CRP) is a marker of inflammation and a risk predictor of cardiovascular disease. Current CRP assays are focused on the quantification of the CRP levels as pentamers. However, CRP can be present as other multimeric forms. There will be a market need to measure the CRP multimeric structure in addition to the levels in human populations. To meet this need, we investigated whether the long-term archived samples could be used instead of freshly collected samples. Methodology/Principal Findings: The specimens of serum, plasma and tissues were collected from transgenic rats expressing the human CRP. These samples were stored at 4 degrees C, -20 degrees C and -80 degrees C for different periods. Non-denaturing Western blot analysis was used to observe the influence of storage conditions to multimeric structures of human CRP. Our results showed that there was no difference on multimeric structures of human CRP between samples stored at 4 degrees C, -20 degrees C and -80 degrees C, between samples stored at -80 degrees C for twenty-four hours and three months, and between plasma and serum. Conclusions/Significance: This study implicated that archived samples stored at these conditions in those large longitudinal studies could be used for investigating the multimeric structures of CRP. Our report may speed up these researches and save labors and budget by enabling them to use currently available archived samples rather than freshly collected samples.	[Li, Qiling; Wang, Yueling; Li, Xu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China; [Li, Qiling; Kang, Ting; Tian, Xiaohua; Ma, Yamin; Richards, Jendai; Bythwood, Tameka; Liu, Dong; Ma, Li; Song, Qing] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Li, Min] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China	Xi'an Jiaotong University; Morehouse School of Medicine; Central South University	Song, Q (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA.	qsong@msm.edu	Ma, Li/AIF-3892-2022; LI, MIN/U-3131-2018	LI, MIN/0000-0002-0188-1394; Li, Qiling/0000-0003-3763-4456	United States National Institutes of Health [R21HG006173, RC4MD005964, HL003676, HL095098, RR014758, RR003034, GM74913]; American Heart Association grant [09GRNT2300003]; Baltimore Research Enhancement Award Program in Stroke; Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR014758, G12RR003034] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC4MD005964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003676, SC2HL095098] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074913] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); Baltimore Research Enhancement Award Program in Stroke; Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by United States National Institutes of Health grants (R21HG006173, RC4MD005964, HL003676, HL095098, RR014758, RR003034, GM74913), an American Heart Association grant (09GRNT2300003), and in part by the Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy TJ, 1941, J EXP MED, V73, P173, DOI 10.1084/jem.73.2.173; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; Dehghan A, 2007, DIABETES, V56, P872, DOI 10.2337/db06-0922; Diehl EE, 2000, AM J MED SCI, V319, P79, DOI 10.1097/00000441-200002000-00002; Dobson CM, 2004, SCIENCE, V304, P1259, DOI 10.1126/science.1093078; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Goel R, 2010, CLIN RHEUMATOL, V29, P329, DOI 10.1007/s10067-009-1333-6; Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805; Kelly JW, 2006, NATURE, V442, P255, DOI 10.1038/442255a; Kermani TA, 2012, SEMIN ARTHRITIS RHEU, V41, P866, DOI 10.1016/j.semarthrit.2011.10.005; Khreiss T, 2004, CIRCULATION, V110, P2713, DOI 10.1161/01.CIR.0000146846.00816.DD; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Khreiss T, 2002, J BIOL CHEM, V277, P40775, DOI 10.1074/jbc.M205378200; KILPATRICK JM, 1991, IMMUNOL RES, V10, P43, DOI 10.1007/BF02918166; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Koyanagi H, 1997, ACTA PAEDIATR, V86, P613, DOI 10.1111/j.1651-2227.1997.tb08944.x; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Lee GY, 2012, INT J CARDIOL, V159, P14, DOI 10.1016/j.ijcard.2011.01.094; LEI KJ, 1985, J BIOL CHEM, V260, P3377; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Merz CNB, 2009, J AM COLL CARDIOL, V54, P1336, DOI 10.1016/j.jacc.2009.05.019; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Nothnagl T, 2006, DRUG AGING, V23, P391, DOI 10.2165/00002512-200623050-00003; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Park YS, 2012, J KOREAN MED SCI, V27, P243, DOI 10.3346/jkms.2012.27.3.243; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pfutzner A, 2006, DIABETES TECHNOL THE, V8, P28, DOI 10.1089/dia.2006.8.28; Pirro M, 2012, J INTERN MED, V272, P177, DOI 10.1111/j.1365-2796.2011.02510.x; POTEMPA LA, 1988, INFLAMMATION, V12, P391, DOI 10.1007/BF00915774; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; ROBEY FA, 1984, J BIOL CHEM, V259, P7311; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Sims M, 2012, AM J PUBLIC HLTH; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Visvanathan S, 2011, RHEUMATOLOGY, V50, P2061, DOI 10.1093/rheumatology/ker163; WOO P, 1985, J BIOL CHEM, V260, P3384; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zhao J, 2010, CELL MOL BIOL LETT, V15, P485, DOI 10.2478/s11658-010-0022-4; Zouki C, 2001, J IMMUNOL, V167, P5355, DOI 10.4049/jimmunol.167.9.5355	46	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58094	10.1371/journal.pone.0058094	http://dx.doi.org/10.1371/journal.pone.0058094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516433	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400016
J	Rahman, MA; Shinjo, R; Oomori, T; Worheide, G				Rahman, M. Azizur; Shinjo, Ryuichi; Oomori, Tamotsu; Woerheide, Gert			Analysis of the Proteinaceous Components of the Organic Matrix of Calcitic Sclerites from the Soft Coral Sinularia sp.	PLOS ONE			English	Article							ACTIN-BINDING PROTEINS; SEA-URCHIN EGG; GORGONIAN LEPTOGORGIA-VIRGULATA; CARBONIC-ANHYDRASE; CALCIFIED ENDOSKELETON; PROTEOMIC ANALYSIS; MOLECULAR-WEIGHT; STRUCTURAL PROTEINS; SPICULE FORMATION; GELATION PROTEIN	An organic matrix consisting of a protein-polysaccharide complex is generally accepted as an important medium for the calcification process. While the role this "calcified organic matrix'' plays in the calcification process has long been appreciated, the complex mixture of proteins that is induced and assembled during the mineral phase of calcification remains uncharacterized in many organisms. Thus, we investigated organic matrices from the calcitic sclerites of a soft coral, Sinularia sp., and used a proteomic approach to identify the functional matrix proteins that might be involved in the biocalcification process. We purified eight organic matrix proteins and performed in-gel digestion using trypsin. The tryptic peptides were separated by nano-liquid chromatography (nano-LC) and analyzed by tandem mass spectrometry (MS/MS) using a matrix-assisted laser desorption/ionization (MALDI) - time-of-flight-time-of-flight (TOF-TOF) mass spectrometer. Periodic acid Schiff staining of an SDS-PAGE gel indicated that four proteins were glycosylated. We identified several proteins, including a form of actin, from which we identified a total of 183 potential peptides. Our findings suggest that many of those peptides may contribute to biocalcification in soft corals.	[Rahman, M. Azizur; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Shinjo, Ryuichi] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan; [Oomori, Tamotsu] Univ Ryukyus, Dept Chem, Nishihara, Okinawa 90301, Japan; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBio Ctr, Munich, Germany	University of Munich; University of the Ryukyus; University of the Ryukyus; University of Munich	Rahman, MA (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Toronto, ON, Canada.	azizur31@yahoo.com	Wörheide, Gert/C-1080-2008; Rahman, Dr. Azizur/A-9413-2018	Wörheide, Gert/0000-0002-6380-7421; Rahman, Dr. Azizur/0000-0002-7648-8642	Alexander von Humboldt Foundation Research Fellowship; German Science Foundation (DFG); Grants-in-Aid for Scientific Research [25400519] Funding Source: KAKEN	Alexander von Humboldt Foundation Research Fellowship(Alexander von Humboldt Foundation); German Science Foundation (DFG)(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by an Alexander von Humboldt Foundation Research Fellowship to MAR. GW is supported by the German Science Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340; Aizenberg J, 1996, Connect Tissue Res, V34, P255, DOI 10.3109/03008209609005269; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; CRAIG SW, 1982, METHOD ENZYMOL, V85, P316; DECARO A, 1982, BIOCHEM J, V205, P543, DOI 10.1042/bj2050543; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI 10.1038/NCHEM.899; Floquet N, 2011, AM MINERAL, V96, P1228, DOI 10.2138/am.2011.3805; Fukuda I, 2002, DNA RES, V9, P217, DOI 10.1093/dnares/9.6.217; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; GOLDBERG WM, 1987, B MAR SCI, V40, P287; HAGMANN J, 1992, J BIOL CHEM, V267, P14424; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; HARTWIG JH, 1979, J MOL BIOL, V134, P539, DOI 10.1016/0022-2836(79)90366-8; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; KINGSLEY RJ, 1982, CELL TISSUE RES, V223, P325, DOI 10.1007/BF01258493; KINGSLEY RJ, 1983, COMP BIOCHEM PHYS B, V76, P443, DOI 10.1016/0305-0491(83)90273-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWENSTAM HA, 1989, B MAR SCI, V45, P243; MABUCHI I, 1987, J BIOCHEM-TOKYO, V102, P947, DOI 10.1093/oxfordjournals.jbchem.a122136; MAEKAWA S, 1986, ZOOL SCI, V3, P1029; MAJORAN S, 1987, ZOOL SCR, V16, P277, DOI 10.1111/j.1463-6409.1987.tb00074.x; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-33; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; MARUYAMA K, 1977, J BIOCHEM-TOKYO, V81, P215, DOI 10.1093/oxfordjournals.jbchem.a131438; MITTERER RM, 1978, B MAR SCI, V28, P173; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nemoto M, 2012, PROTEOMICS, V12, P2890, DOI 10.1002/pmic.201100473; POLLARD TD, 1981, J BIOL CHEM, V256, P7666; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; POLLARD TD, 1984, J CELL BIOL, V99, P1970, DOI 10.1083/jcb.99.6.1970; POLLARD TD, 1986, BIOPHYS J, V49, P149, DOI 10.1016/S0006-3495(86)83630-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Quinn P, 2006, APPL ENVIRON MICROB, V72, P5512, DOI 10.1128/AEM.00343-06; Rahman MA, 2008, J CRYST GROWTH, V310, P3528, DOI 10.1016/j.jcrysgro.2008.04.056; Rahman MA, 2008, MAR BIOTECHNOL, V10, P31, DOI 10.1007/s10126-007-9030-4; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Rahman MA, 2011, J BIOL CHEM, V286, P31638, DOI 10.1074/jbc.M109.070185; Rahman MA, 2011, J CRYST GROWTH, V324, P177, DOI 10.1016/j.jcrysgro.2011.03.021; Rahman MA, 2009, CONNECT TISSUE RES, V50, P285, DOI 10.3109/03008200802714933; Rahman MA, 2005, PROTEOMICS, V5, P885, DOI 10.1002/pmic.200401130; Rahman MA, 2005, J EXP MAR BIOL ECOL, V321, P71, DOI 10.1016/j.jembe.2005.01.012; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmidt W.J., 1924, BAUSTEINE TIERKORPER; SEGREST JP, 1971, BIOCHEM BIOPH RES CO, V44, P390, DOI 10.1016/0006-291X(71)90612-7; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tentori E, 2011, J MORPHOL, V272, P614, DOI 10.1002/jmor.10942; TOMPA AS, 1977, COMP BIOCHEM PHYS B, V56, P279, DOI 10.1016/0305-0491(77)90016-5; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; YONEMURA S, 1987, CELL MOTIL CYTOSKEL, V7, P46, DOI 10.1002/cm.970070107; YOUNG SD, 1971, COMP BIOCHEM PHYSIOL, V40, P113, DOI 10.1016/0305-0491(71)90067-8	59	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58781	10.1371/journal.pone.0058781	http://dx.doi.org/10.1371/journal.pone.0058781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23527022	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400062
J	Rusk, CL; Walters, EL; Koenig, WD				Rusk, Caroline L.; Walters, Eric L.; Koenig, Walter D.			Cooperative Breeding and Long-Distance Dispersal: A Test Using Vagrant Records	PLOS ONE			English	Article							GENETICAL EVOLUTION; LIFE-HISTORY; BIRDS	Cooperative breeding is generally associated with increased philopatry and sedentariness, presumably because short-distance dispersal facilitates the maintenance of kin groups. There are, however, few data on long-distance dispersal in cooperative breeders-the variable likely to be important for genetic diversification and speciation. We tested the hypothesis that cooperative breeders are less likely to engage in long-distance dispersal events by comparing records of vagrants outside their normal geographic range for matched pairs (cooperatively vs. non-cooperatively breeding) of North American species of birds. Results failed to support the hypothesis of reduced long-distance dispersal among cooperative breeders. Thus, our results counter the conclusion that the lower rate of speciation among cooperative breeding taxa found in recent analyses is a consequence of reduced vagility.	[Rusk, Caroline L.; Koenig, Walter D.] Cornell Lab Ornithol, Ithaca, NY USA; [Walters, Eric L.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Koenig, Walter D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Old Dominion University; Cornell University	Walters, EL (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	ewalters@odu.edu	Amoroso, Caroline R./AAV-7410-2021; Walters, Eric L./C-1685-2008	Amoroso, Caroline R./0000-0001-5456-7975; Walters, Eric L./0000-0002-9414-5758; Koenig, Walter/0000-0001-6207-1427	National Science Foundation [IOS-0918944]; Division Of Integrative Organismal Systems [0918944] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this project came from National Science Foundation grant IOS-0918944. There were no other external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; Brown J.L., 1987, HELPING COMMUNAL BRE; Cockburn A, 2003, P ROY SOC B-BIOL SCI, V270, P2207, DOI 10.1098/rspb.2003.2503; Deetz C. H., 1934, ELEMENTS MAP PROJECT, V4; ESRI, 2011, ARCGIS DESKT REL 10; Guinan J.A., 2008, BIRDS N AM ONLINE; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Kesler DC, 2010, BEHAV ECOL, V21, P1337, DOI 10.1093/beheco/arq158; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Koenig WD, 2000, CONDOR, V102, P492, DOI 10.1650/0010-5422(2000)102[0492:NDITCB]2.0.CO;2; LIGON JD, 1989, AUK, V106, P700; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; NGA, 2006, VECT MAP VMAP LEV 0; Power H. W., 1996, BIRDS N AM ONLINE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rich T. D., 2004, PARTNERS FLIGHT LAND; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; United States Geological Survey (USGS), 2010, GEOGR NAM INF SYST; Veit RR, 2000, AUK, V117, P242, DOI 10.1642/0004-8038(2000)117[0242:VATEFO]2.0.CO;2; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; ZACK S, 1990, ETHOLOGY, V86, P265; [No title captured]	24	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58624	10.1371/journal.pone.0058624	http://dx.doi.org/10.1371/journal.pone.0058624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516519	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400042
J	Volpato, GL; Bovi, TS; de Freitas, RHA; da Silva, DF; Delicio, HC; Giaquinto, PC; Barreto, RE				Volpato, Gilson L.; Bovi, Thais S.; de Freitas, Renato H. A.; da Silva, Danielle F.; Delicio, Helton C.; Giaquinto, Percilia C.; Barreto, Rodrigo Egydio			Red Light Stimulates Feeding Motivation in Fish but Does Not Improve Growth	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RECIRCULATING SYSTEM CONDITIONS; JUNDIA RHAMDIA-QUELEN; NILE TILAPIA; OREOCHROMIS-NILOTICUS; STRESS-RESPONSE; ENVIRONMENTAL COLOR; REARING DENSITY; EURASIAN PERCH; FOOD-INTAKE	Nile tilapia fish were individually reared under similar light levels for 8 weeks under five colored light spectra (maximum wavelength absorbance): white (full light spectrum), blue (similar to 452 nm), green (similar to 516 nm), yellow (similar to 520 nm) or red (similar to 628 nm). The effects of light on feeding, latency to begin feeding, growth and feed conversion were measured during the last 4 weeks of the study (i.e., after acclimation). We found that red light stimulates feeding, as in humans, most likely by affecting central control centers, but the extra feeding is not converted into growth.	[Volpato, Gilson L.; Bovi, Thais S.; da Silva, Danielle F.; Delicio, Helton C.; Giaquinto, Percilia C.; Barreto, Rodrigo Egydio] Sao Paulo State Univ UNESP, Biosci Inst, Dept Physiol, Caunesp, Botucatu, SP, Brazil; [de Freitas, Renato H. A.] Sao Paulo State Univ UNESP, Biosci Inst, Lab Fish Biol & Genet, Dept Morphol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Volpato, GL (corresponding author), Sao Paulo State Univ UNESP, Biosci Inst, Dept Physiol, Caunesp, Botucatu, SP, Brazil.	volpgil@gmail.com	Volpato, Gilson/B-2304-2008; Barreto, Rodrigo E/A-3440-2013; Delicio, Helton/B-5443-2014; Giaquinto, Percilia/A-8395-2018	Barreto, Rodrigo E/0000-0002-4611-0059; Giaquinto, Percilia/0000-0003-4591-4415; Freitas, Renato H A/0000-0002-9053-9186	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [proc. 302022/2006-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; proc. 302022/2006-6; G.L. Volpato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Tawwab M, 2010, AQUACULTURE, V298, P267, DOI 10.1016/j.aquaculture.2009.10.027; Azaza MS, 2010, AQUACULTURE, V309, P193, DOI 10.1016/j.aquaculture.2010.09.026; Biswas AK, 2005, AQUACULTURE, V250, P666, DOI 10.1016/j.aquaculture.2005.04.047; Barcellos Leonardo José Gil, 2006, Cienc. Rural, V36, P1249, DOI 10.1590/S0103-84782006000400031; Barcellos LJG, 2009, AQUACULTURE, V288, P51, DOI 10.1016/j.aquaculture.2008.11.002; Han D, 2005, AQUACULTURE, V248, P299, DOI 10.1016/j.aquaculture.2005.03.016; Karakatsouli N, 2008, AQUACULT ENG, V38, P36, DOI 10.1016/j.aquaeng.2007.10.006; Karakatsouli N, 2007, AQUAC RES, V38, P1152, DOI 10.1111/j.1365-2109.2007.01780.x; Karakatsouli N, 2007, AQUACULT ENG, V36, P302, DOI 10.1016/j.aquaeng.2007.01.005; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; Leonardi MO, 2003, AQUACULTURE, V221, P581, DOI 10.1016/S0044-8486(03)00032-2; Lisney TJ, 2010, J EXP BIOL, V213, P1453, DOI 10.1242/jeb.036897; Luchiari AC, 2008, J FISH BIOL, V72, P1504, DOI 10.1111/j.1095-8649.2008.01824.x; Luchiari AC, 2009, J APPL ICHTHYOL, V25, P162, DOI 10.1111/j.1439-0426.2008.01203.x; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Pottinger TG, 2006, AQUACULTURE, V256, P140, DOI 10.1016/j.aquaculture.2006.01.023; Puvanendran V, 2002, AQUACULTURE, V248, P299; Ruchin A.B., 2002, J ICHTHYOL, V42, P191; Ruchin AB, 2004, FISH PHYSIOL BIOCHEM, V30, P175, DOI 10.1007/s10695-005-1263-4; Singh S., 2006, MANAG DECIS ECON, V44, P783; Stoner AW, 2006, FISH RES, V81, P202, DOI 10.1016/j.fishres.2006.07.005; Strand A, 2007, AQUACULTURE, V272, P312, DOI 10.1016/j.aquaculture.2007.08.052; Tamazouzt L, 2000, AQUACULTURE, V182, P85, DOI 10.1016/S0044-8486(99)00244-6; Villamizar N, 2011, AQUACULTURE, V315, P86, DOI 10.1016/j.aquaculture.2010.10.036; Volpato GL, 2004, BRAZ J MED BIOL RES, V37, P479, DOI 10.1590/S0100-879X2004000400004; Volpato GL, 2001, BRAZ J MED BIOL RES, V34, P1041, DOI 10.1590/S0100-879X2001000800011; Xie S, 2011, AQUACULT NUTR, V17, pE683, DOI 10.1111/j.1365-2095.2010.00827.x	27	23	29	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59134	10.1371/journal.pone.0059134	http://dx.doi.org/10.1371/journal.pone.0059134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516606	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400094
J	Lu, SY; Wang, Y; Huang, H; Pan, YJ; Chaney, EJ; Boppart, SA; Ozer, H; Strongin, AY; Wang, YX				Lu, Shaoying; Wang, Yi; Huang, He; Pan, Yijia; Chaney, Eric J.; Boppart, Stephen A.; Ozer, Howard; Strongin, Alex Y.; Wang, Yingxiao			Quantitative FRET Imaging to Visualize the Invasiveness of Live Breast Cancer Cells	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; RESONANCE ENERGY-TRANSFER; TUMOR-CELLS; BONE-MARROW; MT1-MMP; INVASION; ACTIVATION; EXPRESSION; LINES; PROGRESSION	Matrix metalloproteinases (MMPs) remodel tumor microenvironment and promote cancer metastasis. Among the MMP family proteases, the proteolytic activity of the pro-tumorigenic and pro-metastatic membrane-type 1 (MT1)-MMP constitutes a promising and targetable biomarker of aggressive cancer tumors. In this study, we systematically developed and characterized several highly sensitive and specific biosensors based on fluorescence resonant energy transfer (FRET), for visualizing MT1-MMP activity in live cells. The sensitivity of the AHLR-MT1-MMP biosensor was the highest and five times that of a reported version. Hence, the AHLR biosensor was employed to quantitatively profile the MT1-MMP activity in multiple breast cancer cell lines, and to visualize the spatiotemporal MT1-MMP activity simultaneously with the underlying collagen matrix at the single cell level. We detected a significantly higher level of MT1-MMP activity in invasive cancer cells than those in benign or non-invasive cells. Our results further show that the high MT1-MMP activity was stimulated by the adhesion of invasive cancer cells onto the extracellular matrix, which is precisely correlated with the cell's ability to degrade the collagen matrix. Thus, we systematically optimized a FRET-based biosensor, which provides a powerful tool to detect the pro-invasive MT1-MMP activity at single cell levels. This readout can be applied to profile the invasiveness of single cells from clinical samples, and to serve as an indicator for screening anti-cancer inhibitors.	[Lu, Shaoying; Wang, Yi; Huang, He; Chaney, Eric J.; Boppart, Stephen A.; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Pan, Yijia; Wang, Yingxiao] Univ Illinois, Neurosci Program, Urbana, IL USA; [Chaney, Eric J.; Boppart, Stephen A.; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Wang, Yingxiao] Univ Illinois, Dept Mol & Integrat Physiol, Ctr Biophys & Computat Biol, Dept Chem Engn, Urbana, IL USA; [Ozer, Howard] Univ Illinois, Ctr Canc, Chicago, IL USA; [Ozer, Howard] Univ Illinois, Dept Med, Chicago, IL USA; [Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Wang, Yingxiao] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Wang, YX (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	yiw015@ucsd.edu	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016; Boppart, Stephen/0000-0002-9386-5630	NIH [HL098472, CA139272, NS063405, NSF CBET0846429, CMMI0800870]; UIC Cancer Center Seed Grant; NATIONAL CANCER INSTITUTE [R21CA139272] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UIC Cancer Center Seed Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from NIH HL098472, CA139272, NS063405, NSF CBET0846429, CMMI0800870 (Yingxiao W. and S.L.), and the UIC Cancer Center Seed Grant (Yingxiao W. and H.O.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Binder C, 2002, MOL HUM REPROD, V8, P789, DOI 10.1093/molehr/8.9.789; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2011, BIOCHEM J, V440, P319, DOI 10.1042/BJ20110424; Jabaiah A, 2011, CHEM BIOL, V18, P392, DOI 10.1016/j.chembiol.2010.12.017; Jang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-391; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jiang WG, 2006, INT J MOL MED, V17, P583; Kachgal S, 2012, J CELL PHYSIOL, V227, P3546, DOI 10.1002/jcp.24056; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Lafleur MA, 2006, J BIOL CHEM, V281, P6826, DOI 10.1074/jbc.M513084200; Lu SY, 2010, CLIN CANCER RES, V16, P3822, DOI 10.1158/1078-0432.CCR-10-1333; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Nagakawa O, 2000, CANCER LETT, V155, P173, DOI 10.1016/S0304-3835(00)00425-0; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Ouyang MX, 2008, J BIOL CHEM, V283, P17740, DOI 10.1074/jbc.M709872200; Ouyang MX, 2010, CANCER RES, V70, P2204, DOI 10.1158/0008-5472.CAN-09-3698; Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Ratnikov Boris, 2009, V539, P93, DOI 10.1007/978-1-60327-003-8_6; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Rezaeipoor R, 2009, J INNOV OPT HEAL SCI, V2, P387, DOI 10.1142/S1793545809000693; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Yamamoto M, 1998, J MED CHEM, V41, P1209, DOI 10.1021/jm970404a; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	56	24	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58569	10.1371/journal.pone.0058569	http://dx.doi.org/10.1371/journal.pone.0058569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516511	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200091
J	Holland, B; Wong, J; Li, M; Rasheed, S				Holland, Bryan; Wong, Jonathan; Li, Meng; Rasheed, Suraiya			Identification of Human MicroRNA-Like Sequences Embedded within the Protein-Encoding Genes of the Human Immunodeficiency Virus	PLOS ONE			English	Article							RNA INTERFERENCE; HIV-1 INFECTION; CELLS; EXPRESSION; RETROVIRUSES; TARGET; CD4; SUSCEPTIBILITY; REPLICATION; BIOGENESIS	Background: MicroRNAs (miRNAs) are highly conserved, short (18-22 nts), non-coding RNA molecules that regulate gene expression by binding to the 3' untranslated regions (3'UTRs) of mRNAs. While numerous cellular microRNAs have been associated with the progression of various diseases including cancer, miRNAs associated with retroviruses have not been well characterized. Herein we report identification of microRNA-like sequences in coding regions of several HIV-1 genomes. Results: Based on our earlier proteomics and bioinformatics studies, we have identified 8 cellular miRNAs that are predicted to bind to the mRNAs of multiple proteins that are dysregulated during HIV-infection of CD4+ T-cells in vitro. In silico analysis of the full length and mature sequences of these 8 miRNAs and comparisons with all the genomic and subgenomic sequences of HIV-1 strains in global databases revealed that the first 18/18 sequences of the mature hsa-miR-195 sequence (including the short seed sequence), matched perfectly (100%), or with one nucleotide mismatch, within the envelope (env) genes of five HIV-1 genomes from Africa. In addition, we have identified 4 other miRNA-like sequences (hsa-miR-30d, hsamiR- 30e, hsa-miR-374a and hsa-miR-424) within the env and the gag-pol encoding regions of several HIV-1 strains, albeit with reduced homology. Mapping of the miRNA-homologues of env within HIV-1 genomes localized these sequence to the functionally significant variable regions of the env glycoprotein gp120 designated V1, V2, V4 and V5. Conclusions: We conclude that microRNA-like sequences are embedded within the protein-encoding regions of several HIV1 genomes. Given that the V1 to V5 regions of HIV-1 envelopes contain specific, well-characterized domains that are critical for immune responses, virus neutralization and disease progression, we propose that the newly discovered miRNA-like sequences within the HIV-1 genomes may have evolved to self-regulate survival of the virus in the host by evading innate immune responses and therefore influencing persistence, replication and/or pathogenicity.	[Holland, Bryan; Wong, Jonathan; Li, Meng; Rasheed, Suraiya] Univ So Calif, Keck Sch Med, Lab Viral Oncol & Prote Res, Los Angeles, CA 90033 USA	University of Southern California	Rasheed, S (corresponding author), Univ So Calif, Keck Sch Med, Lab Viral Oncol & Prote Res, Los Angeles, CA 90033 USA.	srasheed@usc.edu			University of Southern California-Rasheed Research Endowment Fund	University of Southern California-Rasheed Research Endowment Fund	This study was supported by the University of Southern California-Rasheed Research Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Antonov AV, 2009, NUCLEIC ACIDS RES, V37, pW323, DOI 10.1093/nar/gkp313; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041574; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; Gong TWL, 2001, MAMM GENOME, V12, P852, DOI 10.1007/s00335-001-3037-3; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hakim ST, 2008, BIOCHEM BIOPH RES CO, V369, P357, DOI 10.1016/j.bbrc.2008.02.025; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kaul D, 2009, MOL CELL BIOCHEM, V323, P143, DOI 10.1007/s11010-008-9973-4; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Meissner EG, 2005, VIROLOGY, V336, P184, DOI 10.1016/j.virol.2005.03.032; Morikita T, 1997, AIDS RES HUM RETROV, V13, P1291, DOI 10.1089/aid.1997.13.1291; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pilakka-Kanthikeel S, 2011, J NEUROVIROL, V17, P416, DOI 10.1007/s13365-011-0046-1; RASHEED S, 1986, VIROLOGY, V150, P1, DOI 10.1016/0042-6822(86)90260-6; Rasheed S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-75; Rasheed S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003003; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sun GH, 2011, TRENDS PHARMACOL SCI, V32, P675, DOI 10.1016/j.tips.2011.07.003; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Wang WF, 2012, J BIOL CHEM, V287, P35455, DOI 10.1074/jbc.M112.362400; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145	47	18	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58586	10.1371/journal.pone.0058586	http://dx.doi.org/10.1371/journal.pone.0058586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520522	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900082
J	Lacotte, S; Decossas, M; Le Coz, C; Brun, S; Muller, S; Dumortier, H				Lacotte, Stephanie; Decossas, Marion; Le Coz, Carole; Brun, Susana; Muller, Sylviane; Dumortier, Helene			Early Differentiated CD138(high)MHCII(+)IgG(+) Plasma Cells Express CXCR3 and Localize into Inflamed Kidneys of Lupus Mice	PLOS ONE			English	Article							CHEMOKINE RECEPTOR EXPRESSION; B-LYMPHOCYTE HOMEOSTASIS; AUTOANTIBODY PRODUCTION; RHEUMATOID-ARTHRITIS; IMMUNOLOGICAL MEMORY; SECRETING CELLS; RESPONSIVENESS; ERYTHEMATOSUS; MAINTENANCE; SUBSETS	Humoral responses are central to the development of chronic autoimmune diseases such as systemic lupus erythematosus. Indeed, autoantibody deposition is responsible for tissue damage, the kidneys being one of the main target organs. As the source of pathogenic antibodies, plasma cells are therefore critical players in this harmful scenario, both at systemic and local levels. The aim of the present study was to analyze plasma cells in NZB/W lupus mice and to get a better understanding of the mechanisms underlying their involvement in the renal inflammation process. Using various techniques (i.e. flow cytometry, quantitative PCR, ELISpot), we identified and extensively characterized three plasma cell intermediates, according to their B220/CD138/MHCII expression levels. Each of these cell subsets displays specific proliferation and antibody secretion capacities. Moreover, we evidenced that the inflammation-related CXCR3 chemokine receptor is uniquely expressed by CD138(high)MHCII(+) plasma cells, which encompass both short-and long-lived cells and mostly produce IgG (auto) antibodies. Expression of CXCR3 allows efficient chemotactic responsiveness of these cells to cognate chemokines, which production is up-regulated in the kidneys of diseased NZB/W mice. Finally, using fluorescence and electron microscopy, we demonstrated the presence of CD138(+)CXCR3(+)IgG(+) cells in inflammatory areas in the kidneys, where they are very likely involved in the injury process. Thus, early differentiated CD138(high)MHCII(+) rather than terminally differentiated CD138(high)MHCII(low) plasma cells may be involved in the renal inflammatory injury in lupus, due to CXCR3 expression and IgG secretion.	[Lacotte, Stephanie; Decossas, Marion; Le Coz, Carole; Brun, Susana; Muller, Sylviane; Dumortier, Helene] CNRS, Inst Biol Mol & Cellulaire, Lab Excellence Medalis, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dumortier, H (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Lab Excellence Medalis, F-67084 Strasbourg, France.	H.Dumortier@ibmc-cnrs.unistra.fr	Brun, Susana/J-9865-2016; Muller, Sylviane/J-5319-2014; Stéphanie, LACOTTE/I-1693-2019	Brun, Susana/0000-0002-7031-9733; Stéphanie, LACOTTE/0000-0002-5921-6389; Le Coz, Carole/0000-0002-9228-5896; decossas, marion/0000-0003-0810-4309	Centre National pour la Recherche Scientifique (CNRS); Roche (Apollo-B grant); Fondation Arthritis-Courtin; Fondation pour la Recherche Medicale	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Roche (Apollo-B grant); Fondation Arthritis-Courtin; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National pour la Recherche Scientifique (CNRS) and by Roche (Apollo-B grant). Stephanie Lacotte and Susana Brun wish to thank the Fondation Arthritis-Courtin and Fondation pour la Recherche Medicale, respectively, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Arch JRS, 2002, J ENDOCRINOL INVEST, V25, P867, DOI 10.1007/BF03344050; Astorri E, 2010, J IMMUNOL, V185, P3359, DOI 10.4049/jimmunol.1001836; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Decossas M, 2003, J COMP NEUROL, V462, P302, DOI 10.1002/cne.10734; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Enghard P, 2009, ARTHRITIS RHEUM, V60, P199, DOI 10.1002/art.24136; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Gomez-Puerta JA, 2008, AUTOIMMUN REV, V7, P606, DOI 10.1016/j.autrev.2008.06.005; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Johansson C, 2005, CLIN EXP IMMUNOL, V141, P279, DOI 10.1111/j.1365-2249.2005.02843.x; Katrin M, 2012, ARTHRITIS RHEUM, V64, P1237; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Lacotte S, 2010, J IMMUNOL, V184, P3937, DOI 10.4049/jimmunol.0902595; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Le Pottier L, 2009, J IMMUNOL, V182, P3540, DOI 10.4049/jimmunol.0803588; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Marques CP, 2011, J VIROL, V85, P6136, DOI 10.1128/JVI.00202-11; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; MULLER S, 1987, MOL IMMUNOL, V24, P779, DOI 10.1016/0161-5890(87)90062-9; Nacionales DC, 2009, J IMMUNOL, V182, P4226, DOI 10.4049/jimmunol.0800771; Nanki T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2823; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Odendahl M, 2003, ANN RHEUM DIS, V62, P851, DOI 10.1136/ard.62.9.851; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Plum L, 2005, PHYSIOLOGY, V20, P152, DOI 10.1152/physiol.00049.2004; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P2750, DOI 10.1002/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C; Starke C, 2011, EUR J IMMUNOL, V41, P2107, DOI 10.1002/eji.201041315; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; STEWARD MW, 1976, CLIN EXP IMMUNOL, V26, P363; THEOFILOPOULOS AN, 1980, J EXP MED, V151, P446, DOI 10.1084/jem.151.2.446; Tokoyoda K, 2009, EUR J IMMUNOL, V39, P2095, DOI 10.1002/eji.200939500; Traynor AE, 2000, LANCET, V356, P701, DOI 10.1016/S0140-6736(00)02627-1; Tsubaki T, 2005, CLIN EXP IMMUNOL, V141, P363, DOI 10.1111/j.1365-2249.2005.02850.x; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Wehrli N, 2001, EUR J IMMUNOL, V31, P609, DOI 10.1002/1521-4141(200102)31:2<609::AID-IMMU609>3.0.CO;2-9; Wijtmans M, 2008, CHEMMEDCHEM, V3, P861, DOI 10.1002/cmdc.200700365; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Wrammert J, 2002, EUR J IMMUNOL, V32, P97, DOI 10.1002/1521-4141(200201)32:1<97::AID-IMMU97>3.0.CO;2-Y	55	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58140	10.1371/journal.pone.0058140	http://dx.doi.org/10.1371/journal.pone.0058140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520491	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900050
J	Veronesi, E; Henstock, M; Gubbins, S; Batten, C; Manley, R; Barber, J; Hoffmann, B; Beer, M; Attoui, H; Mertens, PPC; Carpenter, S				Veronesi, Eva; Henstock, Mark; Gubbins, Simon; Batten, Carrie; Manley, Robyn; Barber, James; Hoffmann, Bernd; Beer, Martin; Attoui, Houssam; Mertens, Peter Paul Clement; Carpenter, Simon			Implicating Culicoides Biting Midges as Vectors of Schmallenberg Virus Using Semi-Quantitative RT-PCR	PLOS ONE			English	Article							BLUETONGUE VIRUS; AKABANE VIRUS; ARBOVIRUS VECTORS; CERATOPOGONIDAE; DIPTERA; VARIIPENNIS; INFECTION; EUROPE; CATTLE; JAPAN	Background: The recent unprecedented emergence of arboviruses transmitted by Culicoides biting midges in northern Europe has necessitated the development of techniques to differentiate competent vector species. At present these techniques are entirely reliant upon interpretation of semi-quantitative RT-PCR (sqPCR) data in the form of C-q values used to infer the presence of viral RNA in samples. Methodology/Principal Findings: This study investigates the advantages and limitations of sqPCR in this role by comparing infection and dissemination rates of Schmallenberg virus (SBV) in two colony lines of Culicoides. Through the use of these behaviorally malleable lines we provide tools for demarcating arbovirus infection and dissemination rates in Culicoides which to date have prevented clear implication of primary vector species in northern Europe. The study demonstrates biological transmission of SBV in an arthropod vector, supporting the conclusions from field-caught Culicoides and provides a general framework for future assessment of vector competence of Culicoides for arboviruses using sqPCR. Conclusions/Significance: When adopting novel diagnostic technologies, correctly implicating vectors of arboviral pathogens requires a coherent laboratory framework to fully understand the implications of results produced in the field. This study illustrates these difficulties and provides a full examination of sqPCR in this role for the Culicoides-arbovirus system.	[Veronesi, Eva; Henstock, Mark; Gubbins, Simon; Batten, Carrie; Manley, Robyn; Barber, James; Attoui, Houssam; Mertens, Peter Paul Clement; Carpenter, Simon] Pirbright Inst, VVD Program, Pirbright, Surrey, England; [Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Friedrich Loeffler Institute	Carpenter, S (corresponding author), Pirbright Inst, VVD Program, Pirbright, Surrey, England.	simon.carpenter@pirbright.ac.uk		Gubbins, Simon/0000-0003-0538-4173; Batten, Carrie/0000-0003-4274-7375; Mertens, Peter/0000-0002-3438-3738; Veronesi, Eva/0000-0003-3411-7891; Attoui, Houssam/0000-0001-9639-9981	Department for Environment, Food and Rural Affairs (Defra) [SE0542]; European Union [EDENext: FP7-HEALTH-353 2010/nr.261504]; Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/I/00001445]; BBSRC [BBS/E/I/00001445, BBS/E/I/00001701] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001445, BBS/E/I/00001701] Funding Source: researchfish	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); European Union(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Department for Environment, Food and Rural Affairs (Defra) (grant code SE0542), the European Union (grant code EDENext: FP7-HEALTH-353 2010/nr.261504) and the Biotechnology and Biological Sciences Research Council (BBSRC) (grant code: BBS/E/I/00001445). This manuscript is cataloged as paper 066 of EDENext. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUSAIDY SM, 1991, EPIDEMIOL INFECT, V106, P403, DOI 10.1017/S095026880004855X; Becker ME, 2010, J MED ENTOMOL, V47, P269, DOI 10.1603/ME09211; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x; BOORMAN J, 1974, B ENTOMOL RES, V64, P371, DOI 10.1017/S0007485300031254; BRAVERMAN Y, 1981, INSECT SCI APPL, V2, P157, DOI 10.1017/S1742758400000953; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; De Regge N, 2012, TRANSBOUNDARY EMERGI; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; Elbers ARW, 2013, EMERGING INFECT DIS; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Gelman A., 2004, BAYESIAN DATA ANAL, P668; Goller KV, 2012, EMERGING IN IN PRESS, V18; Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoffmann B, 2009, EMERG INFECT DIS, V15, P1481, DOI 10.3201/eid1509.090562; JENNINGS DM, 1988, VET MICROBIOL, V17, P1, DOI 10.1016/0378-1135(88)90074-0; JENNINGS M, 1989, VET MICROBIOL, V21, P125, DOI 10.1016/0378-1135(89)90024-2; JOCHIM MM, 1966, AM J EPIDEMIOL, V84, P241; JONES RH, 1974, J MED ENTOMOL, V11, P316, DOI 10.1093/jmedent/11.3.316; KUROGI H, 1987, VET MICROBIOL, V15, P243, DOI 10.1016/0378-1135(87)90078-2; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Muller M. J., 1982, Arbovirus research in Australia. Proceedings 3rd symposium. 15-17 February 1982, P43; MULLER MJ, 1995, VET MICROBIOL, V46, P101, DOI 10.1016/0378-1135(95)00076-M; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; RFfS Computing, 2012, R LANG PROGR ENV STA; Sabio IJ, 2006, J MED ENTOMOL, V43, P1020, DOI 10.1603/0022-2585(2006)43[1020:DOWNVR]2.0.CO;2; Sarkar D., 2019, NLME LINEAR NONLINEA; Stram Y, 2004, VIRUS RES, V104, P93, DOI 10.1016/j.virusres.2004.03.004; THEODORIDIS A, 1979, ONDERSTEPOORT J VET, V46, P191; Vanbinst T, 2009, TRANSBOUND EMERG DIS, V56, P170, DOI 10.1111/j.1865-1682.2009.01077.x; Veronesi E, 2009, VET PARASITOL, V163, P370, DOI 10.1016/j.vetpar.2009.04.031; Veronesi E, 2008, J MED ENTOMOL, V45, P129, DOI 10.1603/0022-2585(2008)45[129:QBVIAC]2.0.CO;2; Yanase T, 2005, ARCH VIROL, V150, P361, DOI 10.1007/s00705-004-0419-3; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2	41	97	103	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57747	10.1371/journal.pone.0057747	http://dx.doi.org/10.1371/journal.pone.0057747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520481	Green Submitted, gold, Green Published			2022-12-25	WOS:000318679900040
J	Vilar, S; Uriarte, E; Santana, L; Tatonetti, NP; Friedman, C				Vilar, Santiago; Uriarte, Eugenio; Santana, Lourdes; Tatonetti, Nicholas P.; Friedman, Carol			Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints	PLOS ONE			English	Article							IN-VITRO; MECHANISM; FRAMEWORK; QSAR	Drug-drug interactions (DDIs) constitute an important problem in postmarketing pharmacovigilance and in the development of new drugs. The effectiveness or toxicity of a medication could be affected by the co-administration of other drugs that share pharmacokinetic or pharmacodynamic pathways. For this reason, a great effort is being made to develop new methodologies to detect and assess DDIs. In this article, we present a novel method based on drug interaction profile fingerprints (IPFs) with successful application to DDI detection. IPFs were generated based on the DrugBank database, which provided 9,454 well-established DDIs as a primary source of interaction data. The model uses IPFs to measure the similarity of pairs of drugs and generates new putative DDIs from the non-intersecting interactions of a pair. We described as part of our analysis the pharmacological and biological effects associated with the putative interactions; for example, the interaction between haloperidol and dicyclomine can cause increased risk of psychosis and tardive dyskinesia. First, we evaluated the method through hold-out validation and then by using four independent test sets that did not overlap with DrugBank. Precision for the test sets ranged from 0.4-0.5 with more than two fold enrichment factor enhancement. In conclusion, we demonstrated the usefulness of the method in pharmacovigilance as a DDI predictor, and created a dataset of potential DDIs, highlighting the etiology or pharmacological effect of the DDI, and providing an exploratory tool to facilitate decision support in DDI detection and patient safety.	[Vilar, Santiago; Tatonetti, Nicholas P.; Friedman, Carol] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA; [Vilar, Santiago; Uriarte, Eugenio; Santana, Lourdes] Univ Santiago de Compostela, Fac Pharm, Dept Organ Chem, Santiago De Compostela, Spain	Columbia University; Universidade de Santiago de Compostela	Vilar, S (corresponding author), Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA.	sav7003@dbmi.columbia.edu	Uriarte, Eugenio EU/F-5691-2012; Santana, Lourdes/L-2981-2014	Uriarte, Eugenio EU/0000-0001-6218-2899; Santana, Lourdes/0000-0001-6056-8253; Tatonetti, Nicholas/0000-0002-2700-2597; Vilar Varela, Santiago/0000-0003-2663-4370	Plan Galego de Investigacion, Innovacion e Crece-mento (I2C); European Social Fund (ESF); Angeles Alvarino program from Xunta de Galicia (Spain);  [R01 LM010016];  [R01 LM010016-0S1];  [R01 LM010016-0S2];  [R01 LM008635]; NATIONAL LIBRARY OF MEDICINE [R01LM010016, R01LM008635] Funding Source: NIH RePORTER	Plan Galego de Investigacion, Innovacion e Crece-mento (I2C); European Social Fund (ESF)(European Social Fund (ESF)); Angeles Alvarino program from Xunta de Galicia (Spain); ; ; ; ; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants R01 LM010016 (CF), R01 LM010016- 0S1 (CF), R01 LM010016-0S2 (CF), R01 LM008635 (CF), "Plan Galego de Investigacion, Innovacion e Crece-mento 2011-2015 (I2C)", European Social Fund (ESF) and Angeles Alvarino program from Xunta de Galicia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOE VERS 2011 10; [Anonymous], 2011, DRUGD H SYST MICR HE; Arikuma T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S11; Bjornsson TD, 2003, DRUG METAB DISPOS, V31, P815, DOI 10.1124/dmd.31.7.815; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Costanzi S, 2011, CHEMMEDCHEM, V6, P1452, DOI 10.1002/cmdc.201100139; Dickins M., 2004, DRUG DISCOV TODAY BI, V2, P38, DOI [DOI 10.1016/S1741-8364(04)02388-1, 10.1016/S1741-8364(04)02388-1]; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Eckert H, 2006, J CHEM INF MODEL, V46, P2515, DOI 10.1021/ci600303b; Ewing T, 2006, J CHEM INF MODEL, V46, P2423, DOI 10.1021/ci060155b; Fowler S, 2008, AAPS J, V10, P410, DOI 10.1208/s12248-008-9042-7; Gedeck P, 2008, CURR OPIN DRUG DISC, V11, P569; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Harpaz R, 2011, CLIN PHARMACOL THER, V89, P243, DOI 10.1038/clpt.2010.285; Harpaz Rave, 2010, AMIA Annu Symp Proc, V2010, P281; Hudelson MG, 2008, J MED CHEM, V51, P648, DOI 10.1021/jm701130z; Jonker DM, 2005, PHARMACOL THERAPEUT, V106, P1, DOI 10.1016/j.pharmthera.2004.10.014; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Meinertz T, 2001, EUR HEART J SUPPL, V3, pK89, DOI 10.1016/S1520-765X(01)90011-2; Nisius B, 2009, CHEMMEDCHEM, V4, P1859, DOI 10.1002/cmdc.200900243; Percha B, 2012, BIOCOMPUT-PAC SYM, P410; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Vilar S, 2006, J MED CHEM, V49, P1118, DOI 10.1021/jm050932j; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; Winkler David A, 2002, Brief Bioinform, V3, P73, DOI 10.1093/bib/3.1.73; Zhang L, 2009, AAPS J, V11, P300, DOI 10.1208/s12248-009-9106-3	29	67	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58321	10.1371/journal.pone.0058321	http://dx.doi.org/10.1371/journal.pone.0058321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520498	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900057
J	Zhao, J; Mialki, RK; Wei, JX; Coon, TA; Zou, CB; Chen, BB; Mallampalli, RK; Zhao, YT				Zhao, Jing; Mialki, Rachel K.; Wei, Jianxin; Coon, Tiffany A.; Zou, Chunbin; Chen, Bill B.; Mallampalli, Rama K.; Zhao, Yutong			SCF E3 ligase F-box protein complex SCFFBXL19 regulates cell migration by mediating Rac1 ubiquitination and degradation	FASEB JOURNAL			English	Article						small GTPase protein; protein stability; phosphorylation; cell motility	I-KAPPA-B; SIGNAL-INDUCED UBIQUITINATION; BRONCHIAL EPITHELIAL-CELLS; DEPENDENT PROTEOLYSIS; C-MYC; PHOSPHORYLATION; KINASE; UBIQUITYLATION; ACETYLATION; RECEPTOR	Rac1, a member of the Rho family of GTPases, regulates diverse cellular functions, including cytoskeleton reorganization and cell migration. F-box proteins are major subunits within the Skp1-Cul1-F-box (SCF) E3 ubiquitin ligases that recognize specific substrates for ubiquitination. The role of F-box proteins in regulating Rac1 stability has not been studied. Mouse lung epithelial (MLE12) cells were used to investigate Rac1 stability and cell migration. Screening of an F-box protein library and in vitro ubiquitination assays identified FBXL19, a relatively new member of the F-box protein family that targets Rac1 for its polyubiquitination and proteasomal degradation. Overexpression of FBXL19 decreased both Rac1 active and inactive forms and significantly reduced cellular migration. Protein kinase AKT-mediated phosphorylation of Rac1 at serine(71) was essential for FBXL19-mediated Rac1 ubiquitination and depletion. Lysine(166) within Rac1 was identified as a polyubiquitination acceptor site. Rac1(S71A) and Rac1(K166R) mutant proteins were resistant to FBXL19-mediated ubiquitination and degradation. Further, ectopically expressed FBXL19 reduced cell migration in Rac1-overexpressing cells (P<0.01, Rac1 cells vs. FBXL19+Rac1 cells), but not in Rac1 lysine(166) mutant-overexpressing cells. FBXL19 diminished formation of the migratory leading edge. Thus, SCFFBXL19 targets Rac1 for its disposal, a process regulated by AKT. These findings provide the first evidence of an F-box protein targeting a small G protein for ubiquitination and degradation to modulate cell migration.Zhao, J., Mialki, R. K., Wei, J., Coon, T. A., Zou, C., Chen, B. B., Mallampalli, R. K., Zhao, Y. SCF E3 ligase F-box protein complex SCFFBXL19 regulates cell migration by mediating Rac1 ubiquitination and degradation.	[Zhao, Jing; Mialki, Rachel K.; Wei, Jianxin; Coon, Tiffany A.; Zou, Chunbin; Chen, Bill B.; Mallampalli, Rama K.; Zhao, Yutong] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Zhao, Jing; Mialki, Rachel K.; Wei, Jianxin; Coon, Tiffany A.; Zou, Chunbin; Chen, Bill B.; Mallampalli, Rama K.; Zhao, Yutong] Univ Pittsburgh, Sch Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zhao, YT (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, 3459 5th Ave,NW 628 MUH, Pittsburgh, PA 15213 USA.	zhaoy3@upmc.edu	Zou, Chunbin/L-7488-2019; Wei, Jianxin/P-5431-2016	Zou, Chunbin/0000-0003-1355-4726; 	U.S. National Institutes of Health [RO1 HL01916, HL112791, HL097376, HL098174, HL116472]; American Heart Association [12SDG9050005, 12SDG12040330]; Merit Review Award from the United States; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472, R01HL098174, R01HL091916, R01HL097376, R01HL112791] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Merit Review Award from the United States; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by U.S. National Institutes of Health grants RO1 HL01916 and HL112791 (to Y.Z.), HL097376 and HL098174 (to R. K. M.), and HL116472 (to B. B. C.); American Heart Association awards 12SDG9050005 (to J.Z.) and 12SDG12040330 (to C.Z.); and a Merit Review Award from the United States (to R. K. M.). The authors declare no conflicts of interest.	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chen BB, 2011, CELL CYCLE, V10, P3487, DOI 10.4161/cc.10.20.17742; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Desai LP, 2004, AM J PHYSIOL-LUNG C, V287, pL1134, DOI 10.1152/ajplung.00022.2004; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Filippi MD, 2007, BLOOD, V109, P1257, DOI 10.1182/blood-2006-04-017731; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gustin C, 2008, AM J PHYSIOL-CELL PH, V295, pC905, DOI 10.1152/ajpcell.00544.2007; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Klotz K, 2009, EXP CELL RES, V315, P1832, DOI 10.1016/j.yexcr.2008.11.017; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tanaka K, 2001, BIOCHIMIE, V83, P351, DOI 10.1016/S0300-9084(01)01237-8; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang YP, 2008, EXP MOL PATHOL, V85, P122, DOI 10.1016/j.yexmp.2008.06.001; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Willems AR, 1999, PHILOS T ROY SOC B, V354, P1533, DOI 10.1098/rstb.1999.0497; Wu C, 1999, J BIOL CHEM, V274, P29591, DOI 10.1074/jbc.274.42.29591; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Zhao J, 2011, BIOCHEM J, V439, P45, DOI 10.1042/BJ20110274; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	45	50	51	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2611	2619		10.1096/fj.12-223099	http://dx.doi.org/10.1096/fj.12-223099			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23512198	Green Published			2022-12-25	WOS:000328841000010
J	Alfassy, OS; Cohen, I; Reiss, Y; Tirosh, B; Ravid, T				Alfassy, Omri S.; Cohen, Itamar; Reiss, Yuval; Tirosh, Boaz; Ravid, Tommer			Placing a Disrupted Degradation Motif at the C Terminus of Proteasome Substrates Attenuates Degradation without Impairing Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; NUCLEAR-QUALITY CONTROL; SACCHAROMYCES-CEREVISIAE; ORNITHINE-DECARBOXYLASE; MAT-ALPHA-2 REPRESSOR; MESSENGER-RNA; UBIQUITIN; RETICULUM; SYSTEM; SIGNAL	Protein elimination by the ubiquitin-proteasome system requires the presence of a cis-acting degradation signal. Efforts to discern degradation signals of misfolded proteasome substrates thus far revealed a general mechanism whereby the exposure of cryptic hydrophobic motifs provides a degradation determinant. We have previously characterized such a determinant, employing the yeast kinetochore protein Ndc10 as a model substrate. Ndc10 is essentially a stable protein that is rapidly degraded upon exposure of a hydrophobic motif located at the C-terminal region. The degradation motif comprises two distinct and essential elements: DegA, encompassing two amphipathic helices, and DegB, a hydrophobic sequence within the loosely structured C-terminal tail of Ndc10. Here we show that the hydrophobic nature of DegB is irrelevant for the ubiquitylation of substrates containing the Ndc10 degradation motif, but is essential for proteasomal degradation. Mutant DegB, in which the hydrophobic sequence was disrupted, acted as a dominant degradation inhibitory element when expressed at the C-terminal regions of ubiquitin-dependent and -independent substrates of the 26S proteasome. This mutant stabilized substrates in both yeast and mammalian cells, indicative of a modular recognition moiety. The dominant function of the mutant DegB provides a powerful experimental tool for evaluating the physiological implications of stabilization of specific proteasome substrates in intact cells and for studying the associated pathological effects.	[Alfassy, Omri S.; Cohen, Itamar; Reiss, Yuval; Ravid, Tommer] Hebrew Univ Jerusalem, A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Tirosh, Boaz] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ravid, T (corresponding author), Hebrew Univ Jerusalem, A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	travid@cc.huji.ac.il			Israel Science Foundation [786/08]; Marie Curie International Reintegration Grant [MIRG-CT-2007-205425]; Lejwa Fund for Biochemistry; Israeli Multiple Myeloma Foundation; Israeli Cancer Association	Israel Science Foundation(Israel Science Foundation); Marie Curie International Reintegration Grant(European Commission); Lejwa Fund for Biochemistry; Israeli Multiple Myeloma Foundation; Israeli Cancer Association	This work was supported by Israel Science Foundation Grant 786/08, Marie Curie International Reintegration Grant MIRG-CT-2007-205425, and the Lejwa Fund for Biochemistry (to T. R.), the Israeli Multiple Myeloma Foundation and the Israeli Cancer Association (to B.T.).	Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kahana Chaim, 2005, V301, P83; Kim HT, 2012, METHODS MOL BIOL, V832, P653, DOI 10.1007/978-1-61779-474-2_46; Lambertson D, 1999, GENETICS, V153, P69; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lipinszki Z, 2012, BIOCHEMISTRY-US, V51, P2461, DOI 10.1021/bi3001006; Loayza D, 1998, MOL CELL BIOL, V18, P779, DOI 10.1128/MCB.18.2.779; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MAMROUDKIDRON E, 1994, FEBS LETT, V356, P162, DOI 10.1016/0014-5793(94)01260-1; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURAKAMI Y, 1992, BIOCHEM J, V283, P661, DOI 10.1042/bj2830661; Navon A, 2010, FEBS LETT, V584, P67, DOI 10.1016/j.febslet.2009.11.069; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	35	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12645	12653		10.1074/jbc.M113.453027	http://dx.doi.org/10.1074/jbc.M113.453027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519465	Green Published, hybrid			2022-12-25	WOS:000318555100022
J	Vandenwijngaert, S; Pokreisz, P; Hermans, H; Gillijns, H; Pellens, M; Bax, NAM; Coppiello, G; Oosterlinck, W; Balogh, A; Papp, Z; Bouten, CVC; Bartunek, J; D'hooge, J; Luttun, A; Verbeken, E; Herregods, MC; Herijgers, P; Bloch, KD; Janssens, S				Vandenwijngaert, Sara; Pokreisz, Peter; Hermans, Hadewich; Gillijns, Hilde; Pellens, Marijke; Bax, Noortje A. M.; Coppiello, Giulia; Oosterlinck, Wouter; Balogh, Agnes; Papp, Zoltan; Bouten, Carlijn V. C.; Bartunek, Jozef; D'hooge, Jan; Luttun, Aernout; Verbeken, Erik; Herregods, Marie Christine; Herijgers, Paul; Bloch, Kenneth D.; Janssens, Stefan			Increased Cardiac Myocyte PDE5 Levels in Human and Murine Pressure Overload Hypertrophy Contribute to Adverse LV Remodeling	PLOS ONE			English	Article							PHOSPHODIESTERASE TYPE 5; ADVANCED HEART-FAILURE; PULMONARY-HYPERTENSION; INHIBITION; SILDENAFIL; EXPRESSION; CONTRACTILITY; MYOCARDIUM; STIFFNESS; 1-YEAR	Background: The intracellular second messenger cGMP protects the heart under pathological conditions. We examined expression of phosphodiesterase 5 (PDE5), an enzyme that hydrolyzes cGMP, in human and mouse hearts subjected to sustained left ventricular (LV) pressure overload. We also determined the role of cardiac myocyte-specific PDE5 expression in adverse LV remodeling in mice after transverse aortic constriction (TAC). Methodology/Principal Findings: In patients with severe aortic stenosis (AS) undergoing valve replacement, we detected greater myocardial PDE5 expression than in control hearts. We observed robust expression in scattered cardiac myocytes of those AS patients with higher LV filling pressures and BNP serum levels. Following TAC, we detected similar, focal PDE5 expression in cardiac myocytes of C57BL/6NTac mice exhibiting the most pronounced LV remodeling. To examine the effect of cell-specific PDE5 expression, we subjected transgenic mice with cardiac myocyte-specific PDE5 overexpression (PDE5TG) to TAC. LV hypertrophy and fibrosis were similar as in WT, but PDE5-TG had increased cardiac dimensions, and decreased dP/dt(max) and dP/dt(min) with prolonged tau (P, 0.05 for all). Greater cardiac dysfunction in PDE5-TG was associated with reduced myocardial cGMP and SERCA2 levels, and higher passive force in cardiac myocytes in vitro. Conclusions/Significance: Myocardial PDE5 expression is increased in the hearts of humans and mice with chronic pressure overload. Increased cardiac myocyte-specific PDE5 expression is a molecular hallmark in hypertrophic hearts with contractile failure, and represents an important therapeutic target.	[Vandenwijngaert, Sara; Pokreisz, Peter; Hermans, Hadewich; Gillijns, Hilde; Pellens, Marijke; Coppiello, Giulia; Oosterlinck, Wouter; Bartunek, Jozef; D'hooge, Jan; Luttun, Aernout; Herregods, Marie Christine; Herijgers, Paul; Janssens, Stefan] Katholieke Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium; [Bax, Noortje A. M.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Balogh, Agnes; Papp, Zoltan] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, Div Clin Physiol,Inst Cardiol, H-4012 Debrecen, Hungary; [Bartunek, Jozef] Onze Lieve Vrouw Hosp, Ctr Cardiovasc, Aalst, Belgium; [Verbeken, Erik] Katholieke Univ Leuven, Dept Imaging & Pathol, Louvain, Belgium; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA; [Bloch, Kenneth D.] Harvard Univ, Sch Med, Boston, MA USA	KU Leuven; Eindhoven University of Technology; University of Debrecen; Cardiovascular Center Aalst; KU Leuven; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Janssens, S (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium.	stefan.janssens@med.kuleuven.be	Bouten, Carlijn/AAT-5187-2020; Herijgers, Paul/B-8064-2013; Luttun, Aernout/AAZ-6540-2020; Pokreisz, Peter/AAY-7350-2020	Bouten, Carlijn/0000-0003-1035-5094; Herijgers, Paul/0000-0003-0951-8132; Luttun, Aernout/0000-0001-7902-9524; Pokreisz, Peter/0000-0003-2810-9000; Coppiello, Giulia/0000-0001-6896-1084; Bax, Noortje/0000-0002-3602-6400; D'hooge, Jan/0000-0002-2346-142X	Fund for Scientific Research Flanders; Departmental Research Grant of KU Leuven [PF10/014]; European Research Council [FP-7-StG-IMAGINED 203291];  [TAMOP-4.2.2.A-11/1/KONV-2012-0045]	Fund for Scientific Research Flanders(FWO); Departmental Research Grant of KU Leuven; European Research Council(European Research Council (ERC)European Commission); 	This work was supported by the Fund for Scientific Research Flanders (to SV, PP, and SJ), and a Departmental Research Grant of KU Leuven (PF10/014). The work was also supported by the TAMOP-4.2.2.A-11/1/KONV-2012-0045 project (to AB and ZP), and a European Research Council Starting Grant FP-7-StG-IMAGINED 203291 (to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Hammond J, 2012, J MOL CELL CARDIOL, V52, P330, DOI 10.1016/j.yjmcc.2011.07.029; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kukreja RC, 2012, J AM COLL CARDIOL, V59, P1921, DOI 10.1016/j.jacc.2011.09.086; Lehnart SE, 2009, HEART FAIL REV, V14, P213, DOI 10.1007/s10741-009-9146-x; Lindman BR, 2012, CIRCULATION, V125, P2353, DOI 10.1161/CIRCULATIONAHA.111.081125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZB, 2010, CIRCULATION, V121, P1474, DOI 10.1161/CIRCULATIONAHA.109.906818; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Papp Z, 2002, J PHYSIOL-LONDON, V543, P177, DOI 10.1113/jphysiol.2002.022145; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Sastry BKS, 2004, J AM COLL CARDIOL, V43, P1149, DOI 10.1016/j.jacc.2003.10.056; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Vandeput F, 2009, J PHARMACOL EXP THER, V330, P884, DOI 10.1124/jpet.109.154468; Zhang ML, 2010, J AM COLL CARDIOL, V56, P2021, DOI 10.1016/j.jacc.2010.08.612	24	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58841	10.1371/journal.pone.0058841	http://dx.doi.org/10.1371/journal.pone.0058841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527037	Green Published, gold, Green Submitted			2022-12-25	WOS:000316411600013
J	Meunier, C; Van der Kraak, L; Turbide, C; Groulx, N; Labouba, I; Cingolani, P; Blanchette, M; Yeretssian, G; Mes-Masson, AM; Saleh, M; Beauchemin, N; Gros, P				Meunier, Charles; Van der Kraak, Lauren; Turbide, Claire; Groulx, Normand; Labouba, Ingrid; Cingolani, Pablo; Blanchette, Mathieu; Yeretssian, Garabet; Mes-Masson, Anne-Marie; Saleh, Maya; Beauchemin, Nicole; Gros, Philippe			Positional Mapping and Candidate Gene Analysis of the Mouse Ccs3 Locus That Regulates Differential Susceptibility to Carcinogen-Induced Colorectal Cancer	PLOS ONE			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; COLON-CANCER; CROHNS-DISEASE; IKK-BETA; SECONDARY STRUCTURE; ULCERATIVE-COLITIS; MULTIPLE-MYELOMA; INNATE IMMUNITY; CHROMOSOME 3	The Ccs3 locus on mouse chromosome 3 regulates differential susceptibility of A/J (A, susceptible) and C57BL/6J (B6, resistant) mouse strains to chemically-induced colorectal cancer (CRC). Here, we report the high-resolution positional mapping of the gene underlying the Ccs3 effect. Using phenotype/genotype correlation in a series of 33 AcB/BcA recombinant congenic mouse strains, as well as in groups of backcross populations bearing unique recombinant chromosomes for the interval, and in subcongenic strains, we have delineated the maximum size of the Ccs3 physical interval to a similar to 2.15 Mb segment. This interval contains 12 annotated transcripts. Sequencing of positional candidates in A and B6 identified many either low-priority coding changes or non-protein coding variants. We found a unique copy number variant (CNV) in intron 15 of the Nfkb1 gene. The CNV consists of two copies of a 54 bp sequence immediately adjacent to the exon 15 splice site, while only one copy is found in CRC-susceptible A. The Nfkb1 protein (p105/p50) expression is much reduced in A tumors compared to normal A colonic epithelium as analyzed by immunohistochemistry. Studies in primary macrophages from A and B6 mice demonstrate a marked differential activation of the Nf kappa B pathway by lipopolysaccharide (kinetics of stimulation and maximum levels of phosphorylated I kappa B alpha), with a more robust activation being associated with resistance to CRC. Nf kappa B has been previously implicated in regulating homeostasis and inflammatory response in the intestinal mucosa. The interval contains another positional candidate Slc39a8 that is differentially expressed in A vs B6 colons, and that has recently been associated in CRC tumor aggressiveness in humans.	[Meunier, Charles; Van der Kraak, Lauren; Groulx, Normand; Beauchemin, Nicole; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Turbide, Claire; Beauchemin, Nicole; Gros, Philippe] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Labouba, Ingrid; Mes-Masson, Anne-Marie] Univ Montreal, CHU Montreal, Ctr Rech, Montreal, PQ, Canada; [Labouba, Ingrid; Mes-Masson, Anne-Marie] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Cingolani, Pablo; Blanchette, Mathieu] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Yeretssian, Garabet; Saleh, Maya; Gros, Philippe] McGill Univ, McGill Complex Traits Grp, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University	Gros, P (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	philippe.gros@mcgill.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Saleh, Maya/0000-0003-1538-9146	Canadian Cancer Society Research Institute; Cancer Research Society Inc.; Goodman Cancer Research Centre; McGill Integrated Cancer Research Training Program (MICRTP); Peter Quinlan Foundation through the McGill University Faculty of Medicine	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society Inc.; Goodman Cancer Research Centre; McGill Integrated Cancer Research Training Program (MICRTP); Peter Quinlan Foundation through the McGill University Faculty of Medicine	This work was supported by research grants to PG and NB from the Canadian Cancer Society Research Institute [www.cancer.ca/Research.aspx], the Cancer Research Society Inc. [www.src-crs.ca/en-CA] and the Canderel Initiative Program [www.deficanderel.com/3/donate.htm] of the Goodman Cancer Research Centre [cancercentre.mcgill.ca/research/]. PG is a James McGill Professor of Biochemistry. CM received studentship support and travel awards from the McGill Integrated Cancer Research Training Program (MICRTP) and the Peter Quinlan Foundation [www.mcgill.ca/gcc-research/funding/] through the McGill University Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alkhayat AH, 1998, HUM MOL GENET, V7, P75, DOI 10.1093/hmg/7.1.75; Angel JM, 2000, MOL CARCINOGEN, V27, P47, DOI 10.1002/(SICI)1098-2744(200001)27:1<47::AID-MC7>3.0.CO;2-7; Balkwill GD, 2007, ORG BIOMOL CHEM, V5, P832, DOI 10.1039/b616820e; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Cazier JB, 2010, J PATHOL, V220, P255, DOI 10.1002/path.2650; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Dragani TA, 2003, CANCER RES, V63, P3011; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIJNEMAN RJA, 1995, CANCER RES, V55, P3179; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; JACOBY RF, 1994, GENOMICS, V22, P381, DOI 10.1006/geno.1994.1399; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; Landt SG, 2005, J MOL BIOL, V351, P982, DOI 10.1016/j.jmb.2005.07.001; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lubbe SJ, 2012, CARCINOGENESIS, V33, P108, DOI 10.1093/carcin/bgr243; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; Meunier C, 2011, CELL CYCLE, V10, P1739, DOI 10.4161/cc.10.11.15817; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nambiar PR, 2003, INT J ONCOL, V22, P145; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Ruivenkamp CAL, 2003, ONCOGENE, V22, P7258, DOI 10.1038/sj.onc.1207096; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Spiro C, 1997, J BIOL CHEM, V272, P33145, DOI 10.1074/jbc.272.52.33145; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; Suzui M, 2002, CANCER LETT, V183, P31, DOI 10.1016/S0304-3835(02)00114-3; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tong X, 2004, MOL CELL BIOCHEM, V265, P171, DOI 10.1023/B:MCBI.0000044394.66951.4d; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982	75	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58733	10.1371/journal.pone.0058733	http://dx.doi.org/10.1371/journal.pone.0058733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516545	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400057
J	Mudau, M; Jacobson, R; Minenza, N; Kuonza, L; Morris, V; Engelbrecht, H; Nicol, MP; Bamford, C				Mudau, Maanda; Jacobson, Rachael; Minenza, Nadia; Kuonza, Lazarus; Morris, Vida; Engelbrecht, Heather; Nicol, Mark P.; Bamford, Colleen			Outbreak of Multi-Drug Resistant Pseudomonas aeruginosa Bloodstream Infection in the Haematology Unit of a South African Academic Hospital	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; NOSOCOMIAL OUTBREAK; CANCER; TRANSMISSION; BACTEREMIA; MECHANISMS; THERAPY	Objective: To describe an outbreak of multi-resistant Pseudomonas aeruginosa bloodstream infections (MRPA-BSI) that occurred in the haematology ward of a tertiary academic hospital in Cape Town, South Africa, and determine risk factors for acquisition of MRPA-BSI. Methods: The outbreak investigation included a search for additional cases, review of patient records, environmental and staff screening, molecular typing using pulsed-field gel electrophoresis (PFGE) and Multi-locus sequencing (MLST) and a retrospective case-control study. Results: Ten MRPA-BSI cases occurred in the haematology ward between January 2010 and January 2011. The case fatality rate was 80%. Staff screening specimens were negative for MRPA and an environmental source was not identified. PFGE showed that 9/10 isolates were related. MLST showed that 3 of these 9 isolates belonged to Sequence type (ST) 233 while the unrelated isolate belonged to ST260. Conclusion: We have described an outbreak of MRPA-BSI occurring over an extended period of time among neutropenic haematology patients. Molecular typing confirms that the outbreak was predominantly due to a single strain. The source of the outbreak was not identified, but the outbreak appears to have been controlled following intensive infection control measures.	[Mudau, Maanda; Jacobson, Rachael; Nicol, Mark P.; Bamford, Colleen] Ctr Trop Opportunist & Hosp Infect, Natl Inst Communicable Dis, Johannesburg, South Africa; [Minenza, Nadia; Nicol, Mark P.; Bamford, Colleen] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Mudau, Maanda; Kuonza, Lazarus] South African Field Epidemiol & Lab Training Prog, Johannesburg, South Africa; [Mudau, Maanda; Kuonza, Lazarus] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Fac Hlth Sci, ZA-0002 Pretoria, South Africa; [Morris, Vida; Engelbrecht, Heather] Prov Govt Western Cape Dept Hlth, Cape Town, South Africa	National Institute for Communicable Diseases (NICD); University of Cape Town; University of Pretoria	Bamford, C (corresponding author), Ctr Trop Opportunist & Hosp Infect, Natl Inst Communicable Dis, Johannesburg, South Africa.	colleen.bamford@nhls.ac.za	Nicol, Mark/W-4149-2019; Mudau, Maanda/U-9649-2017	Nicol, Mark/0000-0002-1366-4805; Mudau, Maanda/0000-0003-0697-2460; Kuonza, Lazarus/0000-0001-5338-320X	National Research Foundation, South Africa; University of Cape Town, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa); University of Cape Town, South Africa	Nadia Minenza received financial support from the National Research Foundation, South Africa and from the University of Cape Town, South Africa (both unrestricted educational grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes JA, 2009, BRAZ J INFECT DIS, V13, P99, DOI 10.1590/S1413-86702009000200005; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Clinical and Laboratory Standards Institute, 2010, PERF STAND ANT SUSC; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Dwivedi M, 2009, INDIAN J PATHOL MICR, V52, P509, DOI 10.4103/0377-4929.56143; Engelhart S, 2002, J HOSP INFECT, V52, P93, DOI 10.1053/jhin.2002.1279; Hammami S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-106; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Harris AD, 2002, CLIN INFECT DIS, V34, P1558, DOI 10.1086/340533; Harris AD, 2002, ANTIMICROB AGENTS CH, V46, P854, DOI 10.1128/AAC.46.3.854-858.2002; Jacobson RK, 2012, J ANTIMICROB CHEMOTH, V67, P1797, DOI 10.1093/jac/dks100; Joo EJ, 2011, J INFECTION, V63, P207, DOI 10.1016/j.jinf.2011.06.011; Klastersky J, 2000, INT J ANTIMICROB AG, V16, P131, DOI 10.1016/S0924-8579(00)00238-7; KOMINOS SD, 1972, APPL MICROBIOL, V23, P309, DOI 10.1128/AEM.23.2.309-312.1972; Lambert PA, 2002, J ROY SOC MED, V95, P22; Micol JB, 2006, HAEMATOLOGICA, V91, P1134; National Health Laboratory Service Standard Operating Procedure MIC1605v1, 2011, TEST PATH WAT MEMBR; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Pitout JDD, 2008, CLIN MICROBIOL INFEC, V14, P755, DOI 10.1111/j.1469-0691.2008.02030.x; Poirel L, 2002, J ANTIMICROB CHEMOTH, V49, P561, DOI 10.1093/jac/49.3.561; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; SCHIMPFF S, 1971, NEW ENGL J MED, V284, P1061, DOI 10.1056/NEJM197105132841904; SCHIMPFF SC, 1986, AM J MED, V80, P13; TANCREDE CH, 1985, J INFECT DIS, V152, P99, DOI 10.1093/infdis/152.1.99; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsutsui A, 2011, J HOSP INFECT, V78, P317, DOI 10.1016/j.jhin.2011.04.013; WIDMER AF, 1993, CLIN INFECT DIS, V16, P372, DOI 10.1093/clind/16.3.372	28	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e55985	10.1371/journal.pone.0055985	http://dx.doi.org/10.1371/journal.pone.0055985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516393	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400004
J	Rahn, JJ; Stackley, KD; Chan, SSL				Rahn, Jennifer J.; Stackley, Krista D.; Chan, Sherine S. L.			Opa1 Is Required for Proper Mitochondrial Metabolism in Early Development	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; MOUSE MODEL; ZEBRAFISH; MUTATIONS; FUSION; GENE; MORPHOLOGY; MTDNA; PATHOPHYSIOLOGY; DEFICIENCY	Opa1 catalyzes fusion of inner mitochondrial membranes and formation of the cristae. OPA1 mutations in humans lead to autosomal dominant optic atrophy. OPA1 knockout mice lose viability around embryonic day 9 from unknown reasons, indicating that OPA1 is essential for embryonic development. Zebrafish are an attractive model for studying vertebrate development and have been used for many years to describe developmental events that are difficult or impractical to view in mammalian models. In this study, Opa1 was successfully depleted in zebrafish embryos using antisense morpholinos, which resulted in disrupted mitochondrial morphology. Phenotypically, these embryos exhibited abnormal blood circulation and heart defects, as well as small eyes and small pectoral fin buds. Additionally, startle response was reduced and locomotor activity was impaired. Furthermore, Opa1 depletion caused bioenergetic defects, without impairing mitochondrial efficiency. In response to mitochondrial dysfunction, a transient upregulation of the master regulator of mitochondrial biogenesis, pgc1a, was observed. These results not only reveal a new Opa1-associated phenotype in a vertebrate model system, but also further elucidates the absolute requirement of Opa1 for successful vertebrate development.	[Rahn, Jennifer J.; Stackley, Krista D.; Chan, Sherine S. L.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina	Chan, SSL (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	chans@musc.edu			National Institutes of Health [R00ES015555, 5P20RR024485-02, 8 P20 GM103542-02]; Medical University of South Carolina; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, National Institutes of Health/National Center for Research Resources [UL1RR029882, UL1 TR000062]; Cancer Center Support [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024485, UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, National Institutes of Health/National Center for Research Resources; Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health awards R00ES015555, 5P20RR024485-02 and 8 P20 GM103542-02, startup funds provided by the Medical University of South Carolina, and the South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, National Institutes of Health/National Center for Research Resources (UL1RR029882 and UL1 TR000062). Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akepati VR, 2008, J NEUROCHEM, V106, P372, DOI 10.1111/j.1471-4159.2008.05401.x; Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Ferre M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gottlieb RA, 2011, BBA-MOL CELL RES, V1813, P1295, DOI 10.1016/j.bbamcr.2010.11.017; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1; Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Liu JD, 2012, CIRC RES, V110, P870, DOI 10.1161/CIRCRESAHA.111.246504; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; Ong SB, 2012, ANTIOXID REDOX SIGNA; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Ranieri M, 2012, J NEUROL SCI, V315, P146, DOI 10.1016/j.jns.2011.12.002; Sambrook J, 2001, MOL CLONING LAB MANU; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Teixido E, 2012, TOXICOL IN VITRO; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; van der Bliek AM, 2009, EMBO J, V28, P1533, DOI 10.1038/emboj.2009.130; Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams PA, 2011, VISION RES, V51, P229, DOI 10.1016/j.visres.2010.08.031; Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218; Ylikallio E, 2010, NUCLEIC ACIDS RES, V38, P8208, DOI 10.1093/nar/gkq735	54	37	37	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59218	10.1371/journal.pone.0059218	http://dx.doi.org/10.1371/journal.pone.0059218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516612	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400097
J	Lin, MW; Ho, JWK; Harrison, LC; dos Remedios, CG; Adelstein, S				Lin, Ming-Wei; Ho, Joshua W. K.; Harrison, Leonard C.; dos Remedios, Cristobal G.; Adelstein, Stephen			An Antibody-Based Leukocyte-Capture Microarray for the Diagnosis of Systemic Lupus Erythematosus	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; ANTIGEN MICROARRAY; DISEASE-ACTIVITY; EXPRESSION; CLASSIFICATION; DISCOVERY; LEUKEMIAS; CLUSTER; CANCER; SLE	The diagnosis of Systemic Lupus Erythematosus (SLE) is challenging due to its heterogeneous clinical presentation and the lack of robust biomarkers to distinguish it from other autoimmune diseases. Further, currently used laboratory tests do not readily distinguish active and inactive disease. Several groups have attempted to apply emerging high throughput profiling technologies to diagnose and monitor SLE. Despite showing promise, many are expensive and technically challenging for routine clinical use. The goal of this work is to develop a better diagnostic and monitoring tool for SLE. We report a highly customisable antibody microarray that consists of a duplicate arrangement of 82 antibodies directed against surface antigens on peripheral blood mononuclear cells (PMBCs). This high-throughput array was used to profile SLE patients (n = 60) with varying disease activity, compared to healthy controls (n = 24), patients with rheumatoid arthritis (n = 25), and other autoimmune diseases (n = 28). We used a computational algorithm to calculate a score from the entire microarray profile and correlated it with SLE disease activity. Our results demonstrate that leukocyte-capture microarray profiles can readily distinguish active SLE patients from healthy controls (AUROC = 0.84). When combined with the standard laboratory tests (serum anti-dsDNA, complements C3 and C4), the microarrays provide significantly increased discrimination. The antibody microarrays can be enhanced by the addition of other markers for potential application to the diagnosis and stratification of SLE, paving the way for the customised and accurate diagnosis and monitoring of SLE.	[Lin, Ming-Wei; Adelstein, Stephen] Royal Prince Alfred Hosp, Dept Clin Immunol, Sydney, NSW, Australia; [Lin, Ming-Wei; Adelstein, Stephen] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia; [Ho, Joshua W. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Harrison, Leonard C.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Dept Clin Immunol, Parkville, Vic 3050, Australia; [Harrison, Leonard C.] Royal Melbourne Hosp, Burnet Clin Res Unit, Parkville, Vic 3050, Australia; [dos Remedios, Cristobal G.] Univ Sydney, Bosch Inst, Discipline Anat, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; University of Sydney	Adelstein, S (corresponding author), Royal Prince Alfred Hosp, Dept Clin Immunol, Sydney, NSW, Australia.	stephen.adelstein@sydney.edu.au	Adelstein, Stephen/I-7936-2016; Ho, Joshua W. K./AAK-7759-2020	Adelstein, Stephen/0000-0001-7221-6298; Ho, Joshua W. K./0000-0003-2331-7011	NWG Macintosh Memorial Fund of the Department of Anatomy Histology; University of Sydney; Special Purposes Trust Fund	NWG Macintosh Memorial Fund of the Department of Anatomy Histology; University of Sydney(University of Sydney); Special Purposes Trust Fund	Studies were supported by the NWG Macintosh Memorial Fund of the Department of Anatomy & Histology, University of Sydney and the Special Purposes Trust Fund and generous donors to the Department of Clinical Immunology, Royal Prince Alfred Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belov L, 2001, CANCER RES, V61, P4483; Belov L, 2006, BRIT J HAEMATOL, V135, P184, DOI 10.1111/j.1365-2141.2006.06266.x; Bijl M, 2001, LUPUS, V10, P866, DOI 10.1191/096120301701548517; Bijl M, 2001, ANN RHEUM DIS, V60, P523, DOI 10.1136/ard.60.5.523; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brown A, 2008, PROTEOM CLIN APPL, V2, P90, DOI 10.1002/prca.200780090; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianani N, 2000, INTRO SUPPORT VECTOR; Fattal I, 2010, IMMUNOLOGY, V130, P337, DOI 10.1111/j.1365-2567.2010.03245.x; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Ho JWK, 2010, PROTEOM CLIN APPL, V4, P179, DOI 10.1002/prca.200900165; Ho JWK, 2008, GENOME INFORM SER, V21, P126; Huang RP, 2001, ANAL BIOCHEM, V294, P55, DOI 10.1006/abio.2001.5156; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Joos TO, 2000, ELECTROPHORESIS, V21, P2641, DOI 10.1002/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.3.CO;2-X; Lal S, 2004, PROTEOMICS, V4, P1918, DOI 10.1002/pmic.200300756; Lal S, 2009, MOL CELL PROTEOMICS, V8, P799, DOI 10.1074/mcp.M800335-MCP200; LUI R, 2008, CLIN PROTEOMICS DIAG, P571; Mohamed AN, 2010, CARDIOL RES CLIN DEV, P195; Morris DL, 2009, GENES IMMUN, V10, P404, DOI 10.1038/gene.2009.17; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359	27	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							SICI e58199	10.1371/journal.pone.0058199	http://dx.doi.org/10.1371/journal.pone.0058199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516448	Green Published, gold			2022-12-25	WOS:000316849200041
J	Qian, LW; Zheng, HR; Zhou, H; Qin, RB; Li, JL				Qian, Liwei; Zheng, Haoran; Zhou, Hong; Qin, Ruibin; Li, Jinlong			Classification of Time Series Gene Expression in Clinical Studies via Integration of Biological Network	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; INTERFERON-BETA; MICROARRAY DATA; RT-PCR; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDICTION; PROTEOMICS; PROFILES	The increasing availability of time series expression datasets, although promising, raises a number of new computational challenges. Accordingly, the development of suitable classification methods to make reliable and sound predictions is becoming a pressing issue. We propose, here, a new method to classify time series gene expression via integration of biological networks. We evaluated our approach on 2 different datasets and showed that the use of a hidden Markov model/Gaussian mixture models hybrid explores the time-dependence of the expression data, thereby leading to better prediction results. We demonstrated that the biclustering procedure identifies function-related genes as a whole, giving rise to high accordance in prognosis prediction across independent time series datasets. In addition, we showed that integration of biological networks into our method significantly improves prediction performance. Moreover, we compared our approach with several state-of-the-art algorithms and found that our method outperformed previous approaches with regard to various criteria. Finally, our approach achieved better prediction results on early-stage data, implying the potential of our method for practical prediction.	[Qian, Liwei; Zheng, Haoran; Zhou, Hong; Qin, Ruibin; Li, Jinlong] Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Peoples R China; [Zheng, Haoran] Univ Sci & Technol China, Anhui Key Lab Software Engn Comp & Commun, Hefei 230026, Peoples R China; [Zheng, Haoran] Univ Sci & Technol China, Dept Syst Biol, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zheng, HR (corresponding author), Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Peoples R China.	hrzheng@ustc.edu.cn			National Key Technologies RD Program [2011CB910200]	National Key Technologies RD Program(National Key Technology R&D Program)	The authors gratefully acknowledge funding support from the National Key Technologies R&D Program (2011CB910200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraldi E, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-30; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Borgwardt Karsten M, 2006, Pac Symp Biocomput, P547, DOI 10.1142/9789812701626_0051; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Carreiro AV, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-175; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa IG, 2009, BIOINFORMATICS, V25, pI6, DOI 10.1093/bioinformatics/btp222; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Dao P, 2011, BIOINFORMATICS, V27, pI205, DOI 10.1093/bioinformatics/btr245; Dudoit S, 2002, GENOME BIOL, V3; Espinosa E, 2012, CANCER METAST REV, P1; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Friedman J, 2001, SPRINGER SERIES STAT, V10; Ginsburg GS, 2001, TRENDS BIOTECHNOL, V19, P491, DOI 10.1016/S0167-7799(01)01814-5; Goertsches RH, 2010, PHARMACOGENOMICS, V11, P147, DOI [10.2217/pgs.09.152, 10.2217/PGS.09.152]; Goldenberg A, 2011, BIOINFORMATICS, V27, P3166, DOI 10.1093/bioinformatics/btr533; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Ji LP, 2005, BIOINFORMATICS, V21, P509, DOI 10.1093/bioinformatics/bti026; Ji-Bin Qu, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P388, DOI 10.1109/ISB.2011.6033184; Junjie S, 2010, BMC BIOINFORMATICS, V11; Kaminski N, 2007, J COMPUT BIOL, V14, P324, DOI 10.1089/cmb.2007.0001; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Langer-Gould A, 2004, NEUROLOGY, V63, pS35, DOI 10.1212/WNL.63.11_suppl_5.S35; Li WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033653; Li YF, 2011, LECT N BIOINFORMAT, V6685, P275, DOI 10.1007/978-3-642-21946-7_22; Lin TH, 2008, BIOINFORMATICS, V24, pI147, DOI 10.1093/bioinformatics/btn152; Lottaz Claudio, 2008, V453, P281, DOI 10.1007/978-1-60327-429-6_15; Madeira S. C, 2005, 42 I ENG SIST COMP I; Madeira SC, 2010, IEEE ACM T COMPUT BI, V7, P153, DOI 10.1109/TCBB.2008.34; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Olson DL, 2008, ADV DATA MINING TECH, DOI DOI 10.1007/978-3-540-76917-0; Ostrowski J, 2009, EXPERT REV MOL DIAGN, V9, P623, DOI 10.1586/ERM.09.41; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Rio J, 2002, ANN NEUROL, V52, P400, DOI 10.1002/ana.10290; Rodriguez E, 1997, LECT NOTES COMPUT SC, V1206, P227, DOI 10.1007/BFb0016000; Ruiz-Pena JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-3; Schliep A, 2005, IEEE ACM T COMPUT BI, V2, P179, DOI 10.1109/TCBB.2005.31; Schliep A, 2003, BIOINFORMATICS, V19, pi255, DOI 10.1093/bioinformatics/btg1036; Storey John D, 2003, Methods Mol Biol, V224, P149; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Zhang H., 2006, IEEE INT C COMP VIS, V2, P2126; Zhang Y, 2005, INF TECHN COD COMP I, P32	55	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58383	10.1371/journal.pone.0058383	http://dx.doi.org/10.1371/journal.pone.0058383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516469	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200061
J	Zhang, SF; Zhao, FP; Wei, CH; Sheng, XH; Ren, HX; Xu, LY; Lu, J; Liu, JS; Zhang, L; Du, LX				Zhang, Shifang; Zhao, Fuping; Wei, Caihong; Sheng, Xihui; Ren, Hangxing; Xu, Lingyang; Lu, Jian; Liu, Jiasen; Zhang, Li; Du, Lixin			Identification and Characterization of the miRNA Transcriptome of Ovis aries	PLOS ONE			English	Article							MICRORNA CATALOG; GENES; RNAS; SPECIFICITY; EXPRESSION; MECHANISM; EVOLUTION; MUTATION; CLONING; MOUSE	The discovery and identification of Ovis aries (sheep) miRNAs will further promote the study of miRNA functions and gene regulatory mechanisms. To explore the microRNAome (miRNAome) of sheep in depth, samples were collected that included eight developmental stages: the longissimus dorsi muscles of Texel fetuses at 70, 85, 100, 120, and 135 days, and the longissimus dorsi muscles of Ujumqin fetuses at 70, 85, 100, 120, and 135 d, and lambs at 0 (birth), 35, and 70 d. These samples covered all of the representative periods of Ovis aries growth and development throughout gestation (about 150 d) and 70 d after birth. Texel and Ujumqin libraries were separately subjected to Solexa deep sequencing; 35,700,772 raw reads were obtained overall. We used ACGT101-miR v4.2 to analyze the sequence data. Following meticulous comparisons with mammalian mature miRNAs, precursor hairpins (pre-miRNAs), and the latest sheep genome, we substantially extended the Ovis aries miRNAome. The list of pre-miRNAs was extended to 2,319, expressing 2,914 mature miRNAs. Among those, 1,879 were genome mapped to unique miRNAs, representing 2,436 genome locations, and 1,754 pre-miRNAs were mapped to chromosomes. Furthermore, the Ovis aries miRNAome was processed using an elaborate bioinformatic analysis that examined multiple end sequence variation in miRNAs, precursors, chromosomal localizations, species-specific expressions, and conservative properties. Taken together, this study provides the most comprehensive and accurate exploration of the sheep miRNAome, and draws conclusions about numerous characteristics of Ovis aries miRNAs, including miRNAs and isomiRs.	[Zhang, Shifang; Zhao, Fuping; Wei, Caihong; Sheng, Xihui; Ren, Hangxing; Xu, Lingyang; Lu, Jian; Liu, Jiasen; Zhang, Li; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China; [Sheng, Xihui] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Ren, Hangxing] Chongqing Acad Anim Sci, Chongqing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Beijing University of Agriculture	Zhang, L (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China.	zhangli@263.net; lxdu@263.net	Xu, Lingyang/W-8664-2019		Twelfth Five-Year-Plan of the Chinese 863 Program [2011AA100307-02]; National Natural Science Foundation of China [30972094]; China Agriculture Research System [CARS-39]	Twelfth Five-Year-Plan of the Chinese 863 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by funding from the Twelfth Five-Year-Plan of the Chinese 863 Program (2011AA100307-02), the National Natural Science Foundation of China (30972094) and the China Agriculture Research System (CARS-39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren HX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-411; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Sheng XH, 2011, MOL BIOL REP, V38, P3161, DOI 10.1007/s11033-010-9987-3; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yao J, 2011, BIOSCI BIOTECH BIOCH, V75, P54, DOI 10.1271/bbb.100530; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhang YF, 2009, SCI CHINA SER C, V52, P261, DOI 10.1007/s11427-009-0032-5	43	20	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58905	10.1371/journal.pone.0058905	http://dx.doi.org/10.1371/journal.pone.0058905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516575	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200121
J	Landis, RC; Branch-Beckles, SL; Crichlow, S; Hambleton, IR; Best, A				Landis, R. Clive; Branch-Beckles, Songee Lynn; Crichlow, Shawna; Hambleton, Ian R.; Best, Anton			Ten Year Trends in Community HIV Viral Load in Barbados: Implications for Treatment as Prevention	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; PROSPECTIVE COHORT; TRANSMISSION; CARE; INFECTION; ACCESS; METAANALYSIS; STRATEGIES; EPIDEMIC	Background: Treatment as prevention is a paradigm in HIV medicine which describes the public health benefit of antiretroviral therapy (ART). It is based on research showing substantial reductions in the risk of HIV transmission in persons with optimally suppressed HIV-1 Viral Loads (VL). The present study describes ten year VL trends at the national HIV treatment unit and estimates VL suppression at a population level in Barbados, a Caribbean island with a population of 277,000, an estimated adult HIV prevalence of 1.2%, and served by a single treatment unit. Methods: The national HIV treatment centre of the Barbados Ministry of Health has a client VL database extending back to inception of the clinic in 2002 (n = 1,462 clients, n = 17,067 VL measurements). Optimal VL suppression was defined at a threshold value of <= 200 viral copies/mL. Results: Analysis of VL trends showed a statistically significant improvement in VL suppression between 2002 to 2011, from 33.6% of clients achieving the 200 copies/mL threshold in 2002 to 70.3% in 2011 (P<0.001). Taking into account the proportion of clients alive and in care and on ART, the known diagnosed HIV population in Barbados, and estimates of unknown HIV infections, this translates into an estimated 26.2% VL suppression at a population level at the end of 2010. Conclusions: We have demonstrated a significant trend towards optimal VL suppression in clients utilizing the services of the national HIV treatment program in Barbados over a 10-year period. Estimates of VL suppression at a population level are similar to reports in developed countries that applied similar methodologies and this could suggest a public health benefit of ART in minimizing the risk of sexual transmission of HIV. Continued efforts are warranted to extend HIV testing to hidden populations in Barbados and linking infected persons to care earlier in their disease.	[Landis, R. Clive; Branch-Beckles, Songee Lynn; Hambleton, Ian R.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Branch-Beckles, Songee Lynn; Crichlow, Shawna; Best, Anton] Minist Hlth, HIV STI Programme, Ladymeade Reference Unit, Bridgetown, Barbados	University West Indies Mona Jamaica; University of the West Indies Open Campus	Landis, RC (corresponding author), Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados.	clive.landis@cavehill.uwi.edu	Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794	Ministry of Health, Government of Barbados	Ministry of Health, Government of Barbados	Ministry of Health, Government of Barbados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A., 2011, COCHRANE DATABASE SY; [Anonymous], 2011, BARB HIV AIDS SURV R; [Anonymous], 2011, UNAIDS WORLD AIDS DA; [Anonymous], 2007, REP BARB NAT YOUTH K; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P1618; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bombereau G., 2008, SOCIAL CULTURAL FACT; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2011, GUID COMM VIR LOAD F; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Figueroa JP, 2008, W INDIAN MED J, V57, P195; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gomez AM, 2009, J ADOLESCENT HEALTH, V44, P508, DOI 10.1016/j.jadohealth.2008.09.012; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Holder L., 2011, EC IMPACT ANAL HIV E; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kempadoo K., 2006, GENDER SEXUALITY IMP; Law MG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-10; Le Franc E, 2008, REV PANAM SALUD PUBL, V24, P409, DOI 10.1590/S1020-49892008001200005; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; National Centre in HIV Research, 2011, HIV AIDS HEP SEX TRA; Ogunnaike-Cooke S, 2007, G BEHAV SURVEILLANCE; Organisation of Eastern Caribbean States and Health Economics Unit, 2011, KNOWL ATT BEL PRACT; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Stanley SK, 1996, NEW ENGL J MED, V334, P1222, DOI 10.1056/NEJM199605093341903; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231	40	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58590	10.1371/journal.pone.0058590	http://dx.doi.org/10.1371/journal.pone.0058590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520523	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900083
J	Munshaw, RG; Palen, WJ; Courcelles, DM; Finlay, JC				Munshaw, Robin G.; Palen, Wendy J.; Courcelles, Danielle M.; Finlay, Jacques C.			Predator-Driven Nutrient Recycling in California Stream Ecosystems	PLOS ONE			English	Article							CRITICAL THERMAL MAXIMA; FOOD-WEB STRUCTURE; FRESH-WATER; PHOSPHORUS-LIMITATION; WESTERN OREGON; GIZZARD SHAD; FISH; NITROGEN; STOICHIOMETRY; EXCRETION	Nutrient recycling by consumers in streams can influence ecosystem nutrient availability and the assemblage and growth of photoautotrophs. Stream fishes can play a large role in nutrient recycling, but contributions by other vertebrates to overall recycling rates remain poorly studied. In tributaries of the Pacific Northwest, coastal giant salamanders (Dicamptodon tenebrosus) occur at high densities alongside steelhead trout (Oncorhynchus mykiss) and are top aquatic predators. We surveyed the density and body size distributions of D. tenebrosus and O. mykiss in a California tributary stream, combined with a field study to determine mass-specific excretion rates of ammonium (N) and total dissolved phosphorus (P) for D. tenebrosus. We estimated O. mykiss excretion rates (N, P) by bioenergetics using field-collected data on the nutrient composition of O. mykiss diets from the same system. Despite lower abundance, D. tenebrosus biomass was 2.5 times higher than O. mykiss. Mass-specific excretion summed over 170 m of stream revealed that O. mykiss recycle 1.7 times more N, and 1.2 times more P than D. tenebrosus, and had a higher N:P ratio (8.7) than that of D. tenebrosus (6.0), or the two species combined (7.5). Through simulated trade-offs in biomass, we estimate that shifts from salamander biomass toward fish biomass have the potential to ease nutrient limitation in forested tributary streams. These results suggest that natural and anthropogenic heterogeneity in the relative abundance of these vertebrates and variation in the uptake rates across river networks can affect broad-scale patterns of nutrient limitation.	[Munshaw, Robin G.; Palen, Wendy J.; Courcelles, Danielle M.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Finlay, Jacques C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Simon Fraser University; University of Minnesota System; University of Minnesota Twin Cities	Munshaw, RG (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	rgm1@sfu.ca	Finlay, Jacques/B-6081-2011	Finlay, Jacques/0000-0002-7968-7030; Munshaw, Robin/0000-0002-6203-8923	National Science and Engineering Research Council of Canada's USRA; National Science and Engineering Research Council of Canada's Discovery Grant program; Canada Research Chairs program	National Science and Engineering Research Council of Canada's USRA; National Science and Engineering Research Council of Canada's Discovery Grant program; Canada Research Chairs program(Canada Research Chairs)	This work was supported by the National Science and Engineering Research Council of Canada's USRA and Discovery Grant program (www.nserc-crsng.gc.ca), and the Canada Research Chairs program (www.chairs-chaires.gc.ca). No individuals employed or contracted by the funders played any role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	ANTONELLI A L, 1972, Northwest Science, V46, P277; Atkinson CL, 2010, STABLE ISOTOPIC SIGN, DOI DOI 10.1899/09-083.1.ACCESSED; Attayde JL, 1999, OECOLOGIA, V121, P47, DOI 10.1007/s004420050906; AZAD HS, 1970, ENVIRON SCI TECHNOL, V4, P737, DOI 10.1021/es60044a008; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; BENKE AC, 1993, PROC INT ASSOC THEOR, V25, P15; BORMANN FH, 1967, SCIENCE, V155, P424, DOI 10.1126/science.155.3761.424; Bowman MF, 2005, FRESHWATER BIOL, V50, P1836, DOI 10.1111/j.1365-2427.2005.01454.x; Brodman Robert, 2003, Herpetological Review, V34, P116; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BURTON TM, 1975, ECOLOGY, V56, P1068, DOI 10.2307/1936147; Busby P. J., 1996, STATUS REV W COAST S; CORN PS, 1989, FOREST ECOL MANAG, V29, P39, DOI 10.1016/0378-1127(89)90055-8; Davic R.D., 1983, THESIS KENT STATE U; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; DAVIC RD, 1987, HERPETOLOGICA, V43, P357; DeMott WR, 1998, LIMNOL OCEANOGR, V43, P1147, DOI 10.4319/lo.1998.43.6.1147; Efron B., 1994, INTRO BOOTSTRAP; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Evans DH, 1999, PHYSL FISHES; Ewing RD, 2002, AQUACULTURE, V209, P139, DOI 10.1016/S0044-8486(01)00755-4; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Feminella JW, 1995, J N AM BENTHOL SOC, V14, P465, DOI 10.2307/1467536; Filippelli GM, 2002, REV MINERAL GEOCHEM, V48, P391, DOI 10.2138/rmg.2002.48.10; Fillatre EK, 2003, MOL ECOL, V12, P1793, DOI 10.1046/j.1365-294X.2003.01869.x; Finlay JC, 2011, ECOLOGY, V92, P140, DOI 10.1890/09-2243.1; FITZPATRICK LC, 1973, ECOL MONOGR, V43, P43, DOI 10.2307/1942158; GOOD DA, 1989, EVOLUTION, V43, P728, DOI 10.1111/j.1558-5646.1989.tb05172.x; GRANDE M, 1991, J FRESHWATER ECOL, V6, P275, DOI 10.1080/02705060.1991.9665304; GRIFFITHS D, 1994, BIOL J LINN SOC, V51, P337, DOI 10.1006/bijl.1994.1028; HAWKINS CP, 1983, CAN J FISH AQUAT SCI, V40, P1173, DOI 10.1139/f83-134; HE X, 1993, T AM FISH SOC, V122, P773, DOI 10.1577/1548-8659(1993)122<0773:FWSALT>2.3.CO;2; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Hillebrand H, 2005, J ECOL, V93, P758, DOI 10.1111/j.1365-2745.2005.00978.x; Hood JM, 2005, OECOLOGIA, V146, P247, DOI 10.1007/s00442-005-0202-5; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; Kajimura M, 2004, J EXP BIOL, V207, P1993, DOI 10.1242/jeb.00901; Knoll LB, 2009, OIKOS, V118, P1732, DOI 10.1111/j.1600-0706.2009.17367.x; KRAFT CE, 1992, CAN J FISH AQUAT SCI, V49, P2596, DOI 10.1139/f92-287; Lau MR, 1984, THESIS CALIFORNIA ST; LEE RM, 1980, T AM FISH SOC, V109, P632, DOI 10.1577/1548-8659(1980)109&lt;632:CTMOFT&gt;2.0.CO;2; Leroux SJ, 2010, ECOLOGY, V91, P2162, DOI 10.1890/09-0133.1; Liess A, 2009, GASTROPOD GRAZERS AF, DOI DOI 10.1899/08-115.1.ACCESSED; Mather ME, 1995, CAN J FISH AQUAT SCI, V52, P2327, DOI 10.1139/f95-825; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McManamay RA, 2010, DOES DIET INFLUENCE, DOI DOI 10.1899/09-152.1.ACCESSED; MORRIS DP, 1988, FRESHWATER BIOL, V20, P315, DOI 10.1111/j.1365-2427.1988.tb00457.x; Moslemi JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038806; MUNRO AF, 1953, BIOCHEM J, V54, P29, DOI 10.1042/bj0540029; Nehlsen W, 1997, PACIFIC SALMON THEIR; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; NUSSBAUM R A, 1973, Northwest Science, V47, P218; Nussbaum RA., 1983, AMPHIBIANS REPTILES; Parker Michael S., 1994, Northwestern Naturalist, V74, P77, DOI 10.2307/3536601; PARKER MS, 1991, J HERPETOL, V25, P355, DOI 10.2307/1564597; PARKER MS, 1994, COPEIA, P705, DOI 10.2307/1447187; PARKER MS, 1992, THESIS U CALIFORNIA; Pough F.H., 1983, P141; Power ME, 2002, ECOL RES, V17, P451, DOI 10.1046/j.1440-1703.2002.00503.x; POWER ME, 1985, ECOLOGY, V66, P1448, DOI 10.2307/1938007; RAO GMM, 1968, CAN J ZOOLOG, V46, P781, DOI 10.1139/z68-108; Roni P, 2002, T AM FISH SOC, V131, P743, DOI 10.1577/1548-8659(2002)131<0743:HUBFAP>2.0.CO;2; Sabo JL, 2002, J N AM BENTHOL SOC, V21, P336, DOI 10.2307/1468420; Sanches LF, 2011, HYDROBIOLOGIA, V669, P35, DOI 10.1007/s10750-011-0661-0; Schade JD, 2011, FRESHWATER BIOL, V56, P424, DOI 10.1111/j.1365-2427.2010.02509.x; Schaus MH, 1997, LIMNOL OCEANOGR, V42, P1386, DOI 10.4319/lo.1997.42.6.1386; Schindler DE, 2001, ECOSYSTEMS, V4, P308, DOI 10.1007/s10021-001-0013-4; SCHINDLER DE, 1993, T AM FISH SOC, V122, P756, DOI 10.1577/1548-8659(1993)122<0756:FWSAPC>2.3.CO;2; Schindler DE, 1997, ECOLOGY, V78, P1816; SCHINDLER DW, 1978, LIMNOL OCEANOGR, V23, P478, DOI 10.4319/lo.1978.23.3.0478; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Shapovalov L., 1954, LIFE HIST STEELHEAD; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Smith HW, 1929, J BIOL CHEM, V81, P407; Spooner DE, 2008, OECOLOGIA, V158, P307, DOI 10.1007/s00442-008-1132-9; Taylor JM, 2011, NUTR ENRICHMENT EFFE; THORPE JE, 1982, AQUACULTURE, V28, P123, DOI 10.1016/0044-8486(82)90015-1; UNDERHAY EE, 1955, BIOCHEM J, V61, P544, DOI 10.1042/bj0610544; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; Vanni MJ, 1997, ECOLOGY, V78, P21; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Veraart AJ, 2008, J PHYCOL, V44, P564, DOI 10.1111/j.1529-8817.2008.00503.x; Villeger S, 2012, FRESHWATER BIOL, V57, P2330, DOI 10.1111/fwb.12009; Welsh HH, 1998, ECOL APPL, V8, P1118; Welsh HH, 2002, J WILDLIFE MANAGE, V66, P581, DOI 10.2307/3803126; Whiles MR, 2009, LIMNOL OCEANOGR-METH, V7, P1; Whiles MR, 2012, ECOSYSTEMS; WHITFORD WG, 1967, PHYSIOL ZOOL, V40, P127, DOI 10.1086/physzool.40.2.30152447; Whitledge GW, 1997, T AM FISH SOC, V126, P1030, DOI 10.1577/1548-8659(1997)126&lt;1030:LEOABM&gt;2.3.CO;2; Wilson HF, 2011, GLOBAL CHANGE BIOL, V17, P130, DOI 10.1111/j.1365-2486.2010.02284.x; Wright PM, 1996, PHYSIOL ZOOL, V69, P1057, DOI 10.1086/physzool.69.5.30164246; ZWEIFEL RG, 1957, ECOLOGY, V38, P64, DOI 10.2307/1932126	95	17	17	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58542	10.1371/journal.pone.0058542	http://dx.doi.org/10.1371/journal.pone.0058542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520520	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900079
J	Nymark, M; Valle, KC; Hancke, K; Winge, P; Andresen, K; Johnsen, G; Bones, AM; Brembu, T				Nymark, Marianne; Valle, Kristin C.; Hancke, Kasper; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Bones, Atle M.; Brembu, Tore			Molecular and Photosynthetic Responses to Prolonged Darkness and Subsequent Acclimation to Re-Illumination the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							FLUORESCENCE EXCITATION-SPECTRA; CHLOROPHYLL-BINDING-PROTEINS; DIADINOXANTHIN DE-EPOXIDASE; XANTHOPHYLL-CYCLE ACTIVITY; MESSENGER-RNA CHANGES; PHOTOSYSTEM-II; CELL-CYCLE; ENERGY-TRANSFER; PROTON GRADIENT; HIGH LIGHT	Photosynthetic diatoms that live suspended throughout the water column will constantly be swept up and down by vertical mixing. When returned to the photic zone after experiencing longer periods in darkness, mechanisms exist that enable the diatoms both to survive sudden light exposure and immediately utilize the available energy in photosynthesis and growth. We have investigated both the response to prolonged darkness and the re-acclimation to moderate intensity white irradiance (E = 100 mu mol m(-2) s(-1)) in the diatom Phaeodactylum tricornutum, using an integrated approach involving global transcriptional profiling, pigment analyses, imaging and photo-physiological measurements. The responses were studied during continuous white light, after 48 h of dark treatment and after 0.5 h, 6 h, and 24 h of re-exposure to the initial irradiance. The analyses resulted in several intriguing findings. Dark treatment of the cells led to 1) significantly decreased nuclear transcriptional activity, 2) distinct intracellular changes, 3) fixed ratios of the light-harvesting pigments despite a decrease in the total cell pigment pool, and 4) only a minor drop in photosynthetic efficiency (Phi(PSII_max)). Re-introduction of the cells to the initial light conditions revealed 5) distinct expression profiles for nuclear genes involved in photosynthesis and those involved in photoprotection, 6) rapid rise in photosynthetic parameters (alpha and rETR(max)) within 0.5 h of reexposure to light despite a very modest de novo synthesis of photosynthetic compounds, and 7) increasingly efficient resonance energy transfer from fucoxanthin chlorophyll a/c-binding protein complexes to photosystem II reaction centers during the first 0.5 h, supporting the observations stated in 6). In summary, the results show that despite extensive transcriptional, metabolic and intracellular changes, the ability of cells to perform photosynthesis was kept intact during the length of the experiment. We conclude that P. tricornutum maintains a functional photosynthetic apparatus during dark periods that enables prompt recovery upon re-illumination.	[Nymark, Marianne; Valle, Kristin C.; Hancke, Kasper; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Bones, Atle M.; Brembu, Tore] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bones, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	atle.bones@ntnu.no; tore.brembu@ntnu.no	Nymark, Marianne/H-2535-2016; Bones, Atle M/C-6202-2014; Brembu, Tore/J-7166-2015	Nymark, Marianne/0000-0002-0672-0653; Bones, Atle M/0000-0003-0544-7437; Brembu, Tore/0000-0001-5622-8037	Norwegian Research Council [184146]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council (grant # 184146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska I, 2004, REGULATION PHOTOSYNT, P487; ANDERSON OR, 1975, J PHYCOL, V11, P272, DOI 10.1111/j.0022-3646.1975.00272.x; Andersson U, 2003, PLANT PHYSIOL, V132, P811, DOI 10.1104/pp.102.019281; Antia NJ, 1970, PHYCOLOGIA, V9, P272; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Barber J, 2000, BBA-BIOENERGETICS, V1459, P239, DOI 10.1016/S0005-2728(00)00158-4; Ramos JBE, 2012, MAR ECOL PROG SER, V452, P11, DOI 10.3354/meps09606; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOROWITZKA MA, 1978, J PHYCOL, V14, P10; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brunet C., 2011, PHYTOPLANKTON PIGMEN, P445, DOI [10.1017/CBO9780511732263.017, DOI 10.1017/CBO9780511732263.017]; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; Butler W.L., SPECTRAL CHARACTERIS, P343, DOI [10.1016/C2013-0-12536-6, DOI 10.1016/C2013-0-12536-6]; CLAYTON R, 1980, PHOTOSYNTHESIS PHYS; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Cruz S, 2011, J EXP BOT, V62, P509, DOI 10.1093/jxb/erq284; Dambek M, 2012, J EXP BOT, V63, P5607, DOI 10.1093/jxb/ers211; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; de Weerd FL, 2002, BIOPHYS J, V82, P1586, DOI 10.1016/S0006-3495(02)75510-0; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Dittami SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-365; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Engelken J, 2012, ADV PHOTOSYNTH RESP, V33, P265, DOI 10.1007/978-94-007-1533-2_11; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gildenhoff N, 2010, BBA-BIOENERGETICS, V1797, P543, DOI 10.1016/j.bbabio.2010.01.024; GOEDHEER JC, 1969, BIOCHIM BIOPHYS ACTA, V172, P252, DOI 10.1016/0005-2728(69)90068-1; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; GRIFFITHS DJ, 1973, MAR BIOL, V21, P91, DOI 10.1007/BF00354603; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; Gundermann K, 2008, PHOTOSYNTH RES, V95, P229, DOI 10.1007/s11120-007-9262-1; Hannah MA, 2008, NAT BIOTECHNOL, V26, P741, DOI 10.1038/nbt0708-741; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; HERRIN DL, 1986, J CELL BIOL, V103, P1837, DOI 10.1083/jcb.103.5.1837; Hoffman GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-101; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huysman MJJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r17; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; Jeffrey S.W., 2011, PHYTOPLANKTON PIGMEN, P3, DOI [10.1017/cbo9780511732263, DOI 10.1017/CBO9780511732263.004]; Johnsen G, 1997, LIMNOL OCEANOGR, V42, P1166, DOI 10.4319/lo.1997.42.5_part_2.1166; Johnsen G., 2011, PHYTOPLANKTON PIGMEN, P496, DOI DOI 10.1017/CB09780511732263.019; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Juhas M, 2012, J EXP BOT, V63, P3673, DOI 10.1093/jxb/ers049; KIEFER DA, 1992, ENVIR SCI R, V43, P155; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; KOPF U, 1984, ANAL CHEM, V56, P1931, DOI 10.1021/ac00275a039; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Leblanc C, 1999, PLANT MOL BIOL, V40, P1031, DOI 10.1023/A:1006256300969; Lee J, 2002, PHOTOSYNTH RES, V72, P295, DOI 10.1023/A:1019881306640; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; LEWIS MR, 1984, NATURE, V311, P49, DOI 10.1038/311049a0; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LODISH H, 2003, MOL CELL BIOL; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lutz VA, 1998, J PHYCOL, V34, P214, DOI 10.1046/j.1529-8817.1998.340214.x; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Misquitta Rachel W., 2005, Plant Tissue Culture, V15, P83; Montechiaro F, 2006, PHYCOLOGIA, V45, P704, DOI 10.2216/06-15.1; NEORI A, 1988, MAR ECOL PROG SER, V44, P297, DOI 10.3354/meps044297; Nicholas K.B., 1997, EMBNEW NEWS, V4, P1; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Oeltjen A, 2004, INT MICROBIOL, V7, P127; Oeltjen A, 2002, PLANT BIOLOGY, V4, P250, DOI 10.1055/s-2002-25737; OWENS TG, 1989, BIOPHYS J, V56, P95, DOI 10.1016/S0006-3495(89)82654-2; PELTIER G, 1991, P NATL ACAD SCI USA, V88, P4791, DOI 10.1073/pnas.88.11.4791; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P25, DOI 10.1016/S0022-0981(96)02520-8; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P43, DOI 10.1016/0022-0981(95)02519-7; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porra R. J., 2011, PHYTOPLANKTON PIGMEN, P78; Premvardhan L, 2010, BBA-BIOENERGETICS, V1797, P1647, DOI 10.1016/j.bbabio.2010.05.002; PREZELIN BB, 1981, CAN B FISH AQUAT SCI, P1; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rayko E, 2010, NEW PHYTOL, V188, P52, DOI 10.1111/j.1469-8137.2010.03371.x; Rodriguez F, 2006, MAR BIOL, V148, P963, DOI 10.1007/s00227-005-0138-7; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SAKSHAUG E, 1991, DEEP-SEA RES, V38, P415, DOI 10.1016/0198-0149(91)90044-G; Savard F, 1996, PLANT MOL BIOL, V32, P461, DOI 10.1007/BF00019098; SETIF P, 1980, ARCH BIOCHEM BIOPHYS, V204, P477, DOI 10.1016/0003-9861(80)90059-4; SICKOGOAD L, 1986, J PHYCOL, V22, P22, DOI 10.1111/j.1529-8817.1986.tb02510.x; SICKOGOAD L, 1989, J PLANKTON RES, V11, P375, DOI 10.1093/plankt/11.2.375; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; VERNOTTE C, 1992, PHOTOSYNTH RES, V32, P45, DOI 10.1007/BF00028797; VIERLING E, 1983, PLANT PHYSIOL, V72, P625, DOI 10.1104/pp.72.3.625; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Zhu SH, 2008, ENERGY SUN, P261; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	107	88	88	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58722	10.1371/journal.pone.0058722	http://dx.doi.org/10.1371/journal.pone.0058722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520530	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900090
J	van den Berg, S; Laman, JD; Boon, L; ten Kate, MT; de Knegt, GJ; Verdijk, RM; Verbrugh, HA; Nouwen, JL; Bakker-Woudenberg, IAJM				van den Berg, Sanne; Laman, Jon D.; Boon, Louis; ten Kate, Marian T.; de Knegt, Gerjo J.; Verdijk, Rob M.; Verbrugh, Henri A.; Nouwen, Jan L.; Bakker-Woudenberg, Irma A. J. M.			Distinctive Cytokines as Biomarkers Predicting Fatal Outcome of Severe Staphylococcus aureus Bacteremia in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; INTERLEUKIN-1 RECEPTOR ANTAGONIST; SEVERE SEPSIS; FACTOR-ALPHA; MONOCLONAL-ANTIBODY; SEPTIC SHOCK; DOUBLE-BLIND; MULTICENTER; SERUM	Invasive Staphylococcus aureus infections are frequently associated with bacteraemia. To support clinical decisions on antibiotic therapy, there is an urgent need for reliable markers as predictors of infection outcome. In the present study in mice, bacteraemia was established by intravenous inoculation of a clinical S. aureus isolate at the LD50 inoculum. As potential biomarkers for fatal outcome, blood culture (qualitative and quantitative), serum levels of C-reactive protein (CRP), as well as 31 selected cytokines and chemokines were assessed during the first three days of infection. A positive S. aureus blood culture, the quantitative blood culture, CRP levels, and levels of eight cytokines were indicative for the presence of S. aureus bacteraemia. However, only tumor necrosis factor (TNF) alpha, interleukin (IL) 1 alpha, and keratinocyte chemoattractant (KC; a functional homologue of human IL-8) were each significantly elevated in eventually non-surviving infected mice versus eventually surviving infected mice. In severe S. aureus bacteraemia in mice, TNF-alpha, IL-1 alpha, and KC are biomarkers predicting fatal outcome of infection. KC was a biomarker elevated irrespective the progression of infection, which is very interesting regarding clinical application in view of the heterogeneity of patients experiencing bacteraemia in this respect.	[van den Berg, Sanne; ten Kate, Marian T.; de Knegt, Gerjo J.; Verbrugh, Henri A.; Nouwen, Jan L.; Bakker-Woudenberg, Irma A. J. M.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Laman, Jon D.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Verdijk, Rob M.] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Bioceros B.V.; Erasmus University Rotterdam; Erasmus MC	van den Berg, S (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.vandenberg@erasmusmc.nl	Boon, Laurence/HCI-3629-2022	van den Berg, Sanne/0000-0001-9209-0178; Boon, Louis/0000-0002-0937-9171; Verdijk, Robert M/0000-0003-1437-214X	Top Institute Pharma project [T4-213]	Top Institute Pharma project	This work was in part supported by Top Institute Pharma project T4-213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Arnalich F, 1999, J INFECT DIS, V180, P908, DOI 10.1086/314963; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; Ashare A, 2005, AM J PHYSIOL-LUNG C, V288, pL633, DOI 10.1152/ajplung.00231.2004; Balci C, 2003, CRIT CARE, V7, P85, DOI 10.1186/cc1843; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cohen J, 1996, CRIT CARE MED, V24, P1431, DOI 10.1097/00003246-199609000-00002; Cohen J, 1999, J INFECT DIS, V180, P116, DOI 10.1086/314839; DANDONA P, 1994, J CLIN ENDOCR METAB, V79, P1605, DOI 10.1210/jc.79.6.1605; De Steenwinkel JEM, 2009, INT J IMMUNOPATH PH, V22, P723, DOI 10.1177/039463200902200318; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Grobmyer SR, 2000, CRIT CARE MED, V28, P1276, DOI 10.1097/00003246-200005000-00003; Johansson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026928; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lausevic Z, 2010, VOJNOSANIT PREGL, V67, P893, DOI 10.2298/VSP1011893L; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mathiak G, 2001, SHOCK, V15, P176, DOI 10.1097/00024382-200115030-00003; MATHISON JC, 1988, J CLIN INVEST, V81, P1925, DOI 10.1172/JCI113540; Meisner M, 2002, CLIN CHIM ACTA, V323, P17, DOI 10.1016/S0009-8981(02)00101-8; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Osuchowski MF, 2007, J IMMUNOL, V179, P623, DOI 10.4049/jimmunol.179.1.623; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Reichelt ME, 2011, INT J CARDIOL; Reinhart K, 1996, CRIT CARE MED, V24, P733, DOI 10.1097/00003246-199605000-00003; Seishima M, 2009, CLIN EXP DERMATOL, V34, pE632, DOI 10.1111/j.1365-2230.2009.03353.x; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; van den Berg S, 2011, J IMMUNOL METHODS, V365, P142, DOI 10.1016/j.jim.2010.12.013; vanderPoll T, 1997, J INFECT DIS, V175, P118, DOI 10.1093/infdis/175.1.118; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; WAKABAYASHI GO, 1991, FASEB J, V5, P338, DOI 10.1096/fasebj.5.3.1825816; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	39	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59107	10.1371/journal.pone.0059107	http://dx.doi.org/10.1371/journal.pone.0059107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520553	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900113
J	Gustafsson, RKL; Engdahl, EE; Hammarfjord, O; Adikari, SB; Lourda, M; Klingstrom, J; Svensson, M; Fogdell-Hahn, A				Gustafsson, Rasmus K. L.; Engdahl, Elin E.; Hammarfjord, Oscar; Adikari, Sanjaya B.; Lourda, Magda; Klingstrom, Jonas; Svensson, Mattias; Fogdell-Hahn, Anna			Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication	PLOS ONE			English	Article							MXA GENE-EXPRESSION; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; HUMAN-HERPESVIRUS-6 INFECTION; EXANTHEM-SUBITUM; VIRUS; RECEPTOR; DIFFERENTIATION; VALIDATION; MATURATION	Human herpesvirus 6A (HHV-6A) is a common virus with a worldwide distribution that has been associated with multiple sclerosis. Whether HHV-6A can replicate in dendritic cells (DC) and how the infection might modulate the functional properties of the cell are currently not well known and need further investigations. Here, we show that a non-productive infection of HHV-6A in DC leads to the up-regulation of HLA-ABC, via autocrine IFN-alpha signaling, as well as the up-regulation of HLA-DR and CD86. However, HHV-6A exposure reduces IL-8 secretion by DC and their capacity to stimulate allogenic T cell proliferation. The ability to suppress DC functions important for activation of innate and adaptive immune responses might be one successful strategy by which HHV-6A avoids the induction of appropriate host defense mechanisms, and thus facilitating persistent infection.	[Gustafsson, Rasmus K. L.; Engdahl, Elin E.; Fogdell-Hahn, Anna] Karolinska Inst, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Stockholm, Sweden; [Hammarfjord, Oscar; Lourda, Magda; Klingstrom, Jonas; Svensson, Mattias] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Adikari, Sanjaya B.] Univ Peradeniya, Fac Med, Peradeniya, Sri Lanka; [Lourda, Magda] Karolinska Univ Hosp, Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Klingstrom, Jonas] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; University of Peradeniya; Karolinska Institutet; Karolinska University Hospital; Swedish Institute for Infectious Disease Control	Gustafsson, RKL (corresponding author), Karolinska Inst, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Stockholm, Sweden.	Rasmus.Gustafsson@ki.se	Lourda, Magdalini/AFT-2982-2022	Lourda, Magdalini/0000-0003-3155-1123; Adikari, Sanjaya/0000-0002-9069-7475; Svensson, Mattias/0000-0003-1695-7934; Klingstrom, Jonas/0000-0001-9076-1441; Fogdell-Hahn, Anna/0000-0002-0311-9184	Board of Doctoral Education at Karolinska Institutet [4769/07-225]; Swedish Association for Persons with Neurological Disabilities; Swedish Dental Society; BiogenIdec; Merck Serono; Sanofi-Aventis; Swedish Research Council; KI Funds [2008Fobi0783]; IMI-grant (ABIRISK project)	Board of Doctoral Education at Karolinska Institutet; Swedish Association for Persons with Neurological Disabilities; Swedish Dental Society; BiogenIdec(Biogen); Merck Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Swedish Research Council(Swedish Research CouncilEuropean Commission); KI Funds; IMI-grant (ABIRISK project)	This work was supported from grant 4769/07-225 from faculty funds from the Board of Doctoral Education at Karolinska Institutet and a grant from the Swedish Association for Persons with Neurological Disabilities; grant from the Swedish Dental Society; unrestricted grant from BiogenIdec, Merck Serono and Sanofi-Aventis; grant from The Swedish Research Council; grants from KI Funds; grant 2008Fobi0783 from KI funds; IMI-grant (ABIRISK project); and unrestricted grant from BiogenIdec, Merck Serono and Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; Atta-ur-Rahman, 1999, CURR PHARM DESIGN, V5, P241; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bertelsen LB, 2010, SCAND J IMMUNOL, V71, P431, DOI 10.1111/j.1365-3083.2010.02389.x; Bertolotto A, 2007, J IMMUNOL METHODS, V321, P19, DOI 10.1016/j.jim.2006.12.012; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Goodman AD, 2003, J INFECT DIS, V187, P1365, DOI 10.1086/368172; Gustafsson RKL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-311; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Harberts E, 2011, P NATL ACAD SCI USA, V108, P13734, DOI 10.1073/pnas.1105143108; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Hirata Y, 2001, J MED VIROL, V65, P576, DOI 10.1002/jmv.2075; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Jaworska J, 2010, P NATL ACAD SCI USA, V107, P8369, DOI 10.1073/pnas.0909951107; Kakimoto M, 2002, J VIROL, V76, P10338, DOI 10.1128/JVI.76.20.10338-10345.2002; Liszewski MK, 2005, SPRINGER SEMIN IMMUN, V27, P345, DOI 10.1007/s00281-005-0002-3; LUSSO P, 1988, J EXP MED, V167, P1659, DOI 10.1084/jem.167.5.1659; Murakami Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-91; Nitsche A, 2001, J INFECT DIS, V183, P130, DOI 10.1086/317651; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; REED L. J., 1938, AMER JOUR HYG, V27, P493; RONNI T, 1993, J IMMUNOL, V150, P1715; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SCHIRMER EC, 1991, P NATL ACAD SCI USA, V88, P5922, DOI 10.1073/pnas.88.13.5922; Smith AP, 2005, J VIROL, V79, P2807, DOI 10.1128/JVI.79.5.2807-2813.2005; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Suga S, 1998, PEDIATRICS, V102, P900, DOI 10.1542/peds.102.4.900; Sullivan BM, 2008, J VIROL, V82, P602, DOI 10.1128/JVI.01571-07; TAKAHASHI K, 1989, J VIROL, V63, P3161, DOI 10.1128/JVI.63.7.3161-3163.1989; Takemoto M, 2009, VIROLOGY; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; YAMANISHI K, 1988, LANCET, V1, P1065; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58122	10.1371/journal.pone.0058122	http://dx.doi.org/10.1371/journal.pone.0058122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526966	Green Published, Green Submitted, gold			2022-12-25	WOS:000315637900091
J	Alt, J; Stathis, M; Rojas, C; Slusher, B				Alt, Jesse; Stathis, Marigo; Rojas, Camilo; Slusher, Barbara			Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme	FASEB JOURNAL			English	Article						Alzheimer's disease; prostate-specific membrane antigen	ACIDIC DIPEPTIDASE ACTIVITY; N-ACETYLASPARTYLGLUTAMATE; REACTION-MECHANISM; MEMBRANE ANTIGEN; INHIBITION; NAALADASE; NAAG; NEUROTRANSMITTER; NEUROPATHY; SUBSTRATE	Glutamate carboxypeptidase II (GCPII) is an exopeptidase that catalyzes the hydrolysis of N-acetylated aspartate-glutamate (NAAG) to N-acetyl aspartate (NAA) and glutamate. Consequently, GCPII inhibition has been of interest for the treatment of central and peripheral nervous system diseases associated with excess glutamate. Recently, it was reported that GCPII can also serve as an endopeptidase cleaving amyloid (A) peptides and that its inhibition could increase the risk of Alzheimer's disease by increasing brain A levels. This study aimed to corroborate and extend these new findings. We incubated A peptides (20 M) with human recombinant GCPII (300 ng/ml) and monitored the appearance of degradation products by mass spectrometry. A peptides remained intact after 18 h incubation with GCPII. Under the same experimental conditions, A(1-40) (20 M) was incubated with neprilysin (300 ng/ml), an endopeptidase known to hydrolyze A(1-40) and the expected cleavage products were observed. GCPII was confirmed active by catalyzing the complete hydrolysis of NAAG (100 M). We also studied the hydrolysis of [H-3]-NAAG (30 nM) catalyzed by GCPII (40 pM) in the presence of A peptides (picomolar to micromolar range). The addition of A peptides did not alter [H-3]-NAAG hydrolysis. We conclude that GCPII is not an amyloid peptide-degrading enzyme.Alt, J., Stathis, M., Rojas, C., Slusher. Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme.	[Alt, Jesse; Stathis, Marigo; Rojas, Camilo; Slusher, Barbara] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Neurotranslat Drug Discovery Program, Baltimore, MD 21205 USA; [Slusher, Barbara] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Slusher, Barbara] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Slusher, B (corresponding author), Johns Hopkins Univ, Sch Med, Brain Sci Inst, 855 North Wolfe St, Baltimore, MD 21205 USA.	bslusher@jhmi.edu			NCI NIH HHS [R01 CA161056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA161056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barinka C, 2012, CURR MED CHEM, V19, P856, DOI 10.2174/092986712799034888; Barinka C, 2002, J NEUROCHEM, V80, P477, DOI 10.1046/j.0022-3042.2001.00715.x; Berger UV, 1999, J COMP NEUROL, V415, P52, DOI 10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K; Carozzi VA, 2010, NEUROTOX RES, V17, P380, DOI 10.1007/s12640-009-9114-1; Carpenter KJ, 2003, NEUROPEPTIDES, V37, P298, DOI 10.1016/j.npep.2003.08.001; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; Chen SR, 2002, J PHARMACOL EXP THER, V300, P662, DOI 10.1124/jpet.300.2.662; Devlin AM, 2000, HUM MOL GENET, V9, P2837, DOI 10.1093/hmg/9.19.2837; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Ferraris DV, 2012, CURR MED CHEM, V19, P1282; Ghadge GD, 2003, P NATL ACAD SCI USA, V100, P9554, DOI 10.1073/pnas.1530168100; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Hlouchova K, 2012, CURR MED CHEM, V19, P1316, DOI 10.2174/092986712799462676; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Kim MJ, 2010, FASEB J, V24, P4491, DOI 10.1096/fj.09-148825; Klusak V, 2009, BIOCHEMISTRY-US, V48, P4126, DOI 10.1021/bi900220s; Long JB, 2005, EUR J PHARMACOL, V508, P115, DOI 10.1016/j.ejphar.2004.12.008; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Pavlicek J, 2012, CURR MED CHEM, V19, P1300, DOI 10.2174/092986712799462667; Peng XQ, 2010, EUR J PHARMACOL, V627, P156, DOI 10.1016/j.ejphar.2009.10.062; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; Rojas C, 2002, ANAL BIOCHEM, V310, P50, DOI 10.1016/S0003-2697(02)00286-5; SERVAL V, 1990, J NEUROCHEM, V55, P39, DOI 10.1111/j.1471-4159.1990.tb08818.x; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; SLUSHER BS, 1990, J BIOL CHEM, V265, P21297; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; van der Post JP, 2005, BRIT J CLIN PHARMACO, V60, P128, DOI 10.1111/j.1365-2125.2005.02396.x; Witkin JM, 2002, NEUROPHARMACOLOGY, V43, P348, DOI 10.1016/S0028-3908(02)00124-7; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Xi ZX, 2010, J NEUROCHEM, V112, P564, DOI 10.1111/j.1471-4159.2009.06478.x; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Zhang W, 2006, J NEUROL SCI, V247, P217, DOI 10.1016/j.jns.2006.05.052; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	36	3	3	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2620	2625		10.1096/fj.12-225102	http://dx.doi.org/10.1096/fj.12-225102			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23525278	Green Published			2022-12-25	WOS:000328841000011
J	Corti, F; Finetti, F; Ziche, M; Simons, M				Corti, Federico; Finetti, Federica; Ziche, Marina; Simons, Michael			The Syndecan-4/Protein Kinase C alpha Pathway Mediates Prostaglandin E-2-induced Extracellular Regulated Kinase (ERK) Activation in Endothelial Cells and Angiogenesis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANDOMIZED CONTROLLED-TRIALS; GROWTH-FACTOR; PKC-ALPHA; DAILY ASPIRIN; PROTEIN; CANCER; MIGRATION; E-2; RECEPTOR; EP4	Prostaglandin E-2 (PGE(2)) is regarded as the main mediator of inflammatory symptoms. In addition, it also plays an important role in tumor growth and angiogenesis. In this study, we examined the mechanism of PGE(2)-induced angiogenic response. We show that in the absence of proteoglycan syndecan-4 (Sdc4), PGE(2)-induced ERK activation is decreased significantly, as is endothelial cell migration and cord formation in a two-dimensional Matrigel assay. In vivo, PGE(2)-induced angiogenesis is reduced dramatically in Sdc4(-/-) mice. The mechanism was traced to Sdc4-dependent activation of protein kinase C alpha (PKC alpha). Transduction of an Sdc4 S183E mutant (a cytoplasmic domain mutation that blocks Sdc4-dependent PKC alpha activation) into Sdc4(-/-) endothelial cells was not able to rescue the loss of PGE(2)-induced ERK activation, whereas a transduction with full-length Sdc4 resulted in full rescue. Furthermore, PGE(2)-induced angiogenesis was also reduced in PKC alpha(-/-) mice. Taken together, these results demonstrate that PGE(2)-induced activation of angiogenesis is mediated via syndecan-4-dependent activation of PKC alpha.	[Corti, Federico; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Yale Cardiovasc Res Ctr, New Haven, CT 06520 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Finetti, Federica; Ziche, Marina] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy	Yale University; Yale University; University of Siena	Simons, M (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Yale Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06520 USA.	michael.simons@yale.edu	Simons, Michael/G-8553-2014; Corti, Federico/R-6262-2016; Finetti, Federica/J-9089-2016	Simons, Michael/0000-0003-0348-7734; Corti, Federico/0000-0003-2160-245X; Ziche, Marina/0000-0002-9564-214X	National Institutes of Health Grant [R01 HL062289]; Fondazione Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC); Societa Italiana di Farmacologia (SIF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062289] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Societa Italiana di Farmacologia (SIF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL062289 (to M. S.). This work was also supported by the Fondazione Istituto Toscano Tumori (to F. C.) and the Associazione Italiana per la Ricerca sul Cancro (AIRC) (to M. Z.).; We thank Sandra Donnini for guidance and helpful suggestions, the Societa Italiana di Farmacologia (SIF) for initial support for this project, Jiasheng Zhang for technical help in endothelial cell preparation, John Rhodes and Rong Ju for discussion and technical help, and Antony Lanahan for helpful suggestions during manuscript revision.	Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chua CC, 2004, CIRC RES, V94, P316, DOI 10.1161/01.RES.0000112965.70691.AC; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; COLEMAN RA, 1994, PROSTAGLANDINS, V47, P151, DOI 10.1016/0090-6980(94)90084-1; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Harris R. E., 2009, Inflammopharmacology, V17, P55, DOI 10.1007/s10787-009-8049-8; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Mastyugin V, 2004, J BIOMOL SCREEN, V9, P712, DOI 10.1177/1087057104269495; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Pai R, 2001, BIOCHEM BIOPH RES CO, V286, P923, DOI 10.1006/bbrc.2001.5494; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Salcedo R, 2003, BLOOD, V102, P1966, DOI 10.1182/blood-2002-11-3400; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Volk R, 1999, J BIOL CHEM, V274, P24417, DOI 10.1074/jbc.274.34.24417; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Xin XP, 2012, LAB INVEST, V92, P1115, DOI 10.1038/labinvest.2012.90; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zhang YS, 2011, BLOOD, V118, P5355, DOI 10.1182/blood-2011-04-350587	44	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12712	12721		10.1074/jbc.M113.452383	http://dx.doi.org/10.1074/jbc.M113.452383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525101	Green Published, hybrid			2022-12-25	WOS:000318555100028
J	Campeanu, S; Craik, FIM; Alain, C				Campeanu, Sandra; Craik, Fergus I. M.; Alain, Claude			Voice Congruency Facilitates Word Recognition	PLOS ONE			English	Article							LONG-TERM-MEMORY; SPEAKERS VOICE; SPOKEN WORDS; ITEM MEMORY; RETRIEVAL; CONTEXT; IMPLICIT; TALKER; YOUNG	Behavioral studies of spoken word memory have shown that context congruency facilitates both word and source recognition, though the level at which context exerts its influence remains equivocal. We measured event-related potentials (ERPs) while participants performed both types of recognition task with words spoken in four voices. Two voice parameters (i.e., gender and accent) varied between speakers, with the possibility that none, one or two of these parameters was congruent between study and test. Results indicated that reinstating the study voice at test facilitated both word and source recognition, compared to similar or no context congruency at test. Behavioral effects were paralleled by two ERP modulations. First, in the word recognition test, the left parietal old/new effect showed a positive deflection reflective of context congruency between study and test words. Namely, the same speaker condition provided the most positive deflection of all correctly identified old words. In the source recognition test, a right frontal positivity was found for the same speaker condition compared to the different speaker conditions, regardless of response success. Taken together, the results of this study suggest that the benefit of context congruency is reflected behaviorally and in ERP modulations traditionally associated with recognition memory.	[Campeanu, Sandra; Craik, Fergus I. M.; Alain, Claude] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Campeanu, Sandra; Craik, Fergus I. M.; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Campeanu, S (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	scampeanu@research.baycrest.org		Craik, Fergus/0000-0001-8073-3236	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by grants from the Canadian Institutes of Health Research to Claude Alain and from the Natural Sciences and Engineering Research Council of Canada to Claude Alain and to Fergus Craik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan K, 1998, ACTA PSYCHOL, V98, P231, DOI 10.1016/S0001-6918(97)00044-9; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P206, DOI 10.3758/BF03206883; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; CRAIK FIM, 1974, Q J EXP PSYCHOL, V26, P274, DOI 10.1080/14640747408400413; GEISELMAN RE, 1977, MEM COGNITION, V5, P658, DOI 10.3758/BF03197412; GEISELMAN RE, 1976, MEM COGNITION, V4, P483, DOI 10.3758/BF03213208; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Johnson R, 1998, INT J PSYCHOPHYSIOL, V29, P83, DOI 10.1016/S0167-8760(98)00006-3; Kucera H., 1967, COMPUTATIONAL ANAL P; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; NAVEHBENJAMIN M, 1995, PSYCHOL AGING, V10, P284, DOI 10.1037/0882-7974.10.2.284; NavehBenjamin M, 1996, Q J EXP PSYCHOL-A, V49, P780, DOI 10.1080/027249896392595; PALMERI TJ, 1993, J EXP PSYCHOL LEARN, V19, P309, DOI 10.1037/0278-7393.19.2.309; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; Pilotti M, 2002, MEM COGNITION, V30, P226, DOI 10.3758/BF03195283; PISONI DB, 1993, SPEECH COMMUN, V13, P109, DOI 10.1016/0167-6393(93)90063-Q; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; Schloerscheidt AM, 2004, NEUROPSYCHOLOGIA, V42, P451, DOI 10.1016/j.neuropsychologia.2003.08.010; Senkfor AJ, 1998, J EXP PSYCHOL LEARN, V24, P1005, DOI 10.1037/0278-7393.24.4.1005; Tendolkar I, 2004, BIOL PSYCHOL, V66, P235, DOI 10.1016/j.biopsycho.2003.10.009; WILDING EL, 1995, NEUROPSYCHOLOGIA, V33, P743, DOI 10.1016/0028-3932(95)00017-W; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594	24	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58778	10.1371/journal.pone.0058778	http://dx.doi.org/10.1371/journal.pone.0058778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23527021	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562600039
J	Eini, O; Yang, NN; Pyvovarenko, T; Pillman, K; Bazanova, N; Tikhomirov, N; Eliby, S; Shirley, N; Sivasankar, S; Tingey, S; Langridge, P; Hrmova, M; Lopato, S				Eini, Omid; Yang, Nannan; Pyvovarenko, Tatiana; Pillman, Katherine; Bazanova, Natalia; Tikhomirov, Natalia; Eliby, Serik; Shirley, Neil; Sivasankar, Shoba; Tingey, Scott; Langridge, Peter; Hrmova, Maria; Lopato, Sergiy			Complex Regulation by Apetala2 Domain-Containing Transcription Factors Revealed through Analysis of the Stress-Responsive TdCor410b Promoter from Durum Wheat	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; TRITICUM-AESTIVUM L.; DNA-BINDING DOMAIN; GCC-BOX; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; DIFFERENTIAL EXPRESSION; FREEZING TOLERANCE; ACIDIC DEHYDRIN; LOW-TEMPERATURE	Expression of the wheat dehydrin gene Cor410b is induced several fold above its non-stressed levels upon exposure to stresses such as cold, drought and wounding. Deletion analysis of the TdCor410b promoter revealed a single functional C-repeat (CRT) element. Seven transcription factors (TFs) were shown to bind to this CRT element using yeast one-hybrid screens of wheat and barley cDNA libraries, of which only one belonged to the DREB class of TFs. The remaining six encoded ethylene response factors (ERFs) belong to three separate subfamilies. Analysis of binding selectivity of these TFs indicated that all seven could bind to the CRT element (GCCGAC), and that three of the six ERFs could bind both to the CRT element and the ethylene-responsive GCC-box (GCCGCC). The TaERF4 subfamily members specifically bound the CRT element, and did not bind either the GCC-box or DRE element (ACCGAC). Molecular modeling and site-directed mutagenesis identified a single residue Pro42 in the Apetala2 (AP2) domain of TaERF4-like proteins that is conserved in monocotyledonous plants and is responsible for the recognition selectivity of this subfamily. We suggest that both DREB and ERF proteins regulate expression of the Cor410b gene through a single, critical CRT element. Members of the TaERF4 subfamily are specific, positive regulators of Cor410b gene expression.	[Eini, Omid; Yang, Nannan; Pyvovarenko, Tatiana; Pillman, Katherine; Bazanova, Natalia; Tikhomirov, Natalia; Eliby, Serik; Shirley, Neil; Langridge, Peter; Hrmova, Maria; Lopato, Sergiy] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Sivasankar, Shoba] DuPont Ag Biotechnol, Johnston, IA USA; [Tingey, Scott] DuPont Ag Biotechnol, Wilmington, DE USA	University of Adelaide; DuPont; DuPont	Hrmova, M (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia.	maria.hrmova@adeaide.edu.au; sergiy.lopato@acpfg.com.au	Langridge, Peter/G-5864-2010; Hrmova, Maria/AAH-3951-2020; Pillman, Katherine A/M-5723-2019	Langridge, Peter/0000-0001-9494-400X; Pillman, Katherine A/0000-0002-5869-889X; Yang, Nannan/0000-0002-0032-6348; Eliby, Serik/0000-0003-1134-4960; Shirley, Neil/0000-0001-8114-9891; Hrmova, Maria/0000-0002-3545-0605	Masters of Plant Biotechnology Project at the University of Adelaide [Plant SC 7229A WT, SC7229B WT]; Australian Research Council; Grains Research and Development Corporation; Government of South Australia; DuPont Ag Biotechnology Company	Masters of Plant Biotechnology Project at the University of Adelaide; Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); Government of South Australia; DuPont Ag Biotechnology Company	This work was supported by the Masters of Plant Biotechnology Project (Plant SC 7229A WT & SC7229B WT) at the University of Adelaide, by the Australian Research Council, the Grains Research and Development Corporation, the Government of South Australia and the DuPont Ag Biotechnology Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except SS and ST (DuPont Ag Biotechnology Company), who were involved in the manuscript preparation.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Canella D, 2010, BBA-GENE REGUL MECH, V1799, P454, DOI 10.1016/j.bbagrm.2009.11.017; Cao WH, 2006, PLANT CELL ENVIRON, V29, P1210, DOI 10.1111/j.1365-3040.2006.01501.x; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chen XJ, 2008, INT J MOL SCI, V9, P2601, DOI 10.3390/ijms9122601; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; CLOSE TJ, 1989, PLANT MOL BIOL, V13, P95, DOI 10.1007/BF00027338; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; DANYLUK J, 1994, FEBS LETT, V344, P20, DOI 10.1016/0014-5793(94)00353-X; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Ganeshan S, 2008, J EXP BOT, V59, P2393, DOI 10.1093/jxb/ern112; Gao MJ, 2002, PLANT MOL BIOL, V49, P459, DOI 10.1023/A:1015570308704; Ginalski K, 2003, NUCLEIC ACIDS RES, V31, P3804, DOI 10.1093/nar/gkg504; GROSSI M, 1995, PLANT SCI, V105, P71, DOI 10.1016/0168-9452(94)04043-G; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Hao DY, 2002, BIOCHEMISTRY-US, V41, P4202, DOI 10.1021/bi015979v; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Houde M, 2004, PLANT BIOTECHNOL J, V2, P381, DOI 10.1111/j.1467-7652.2004.00082.x; Huang ZeJun, 2004, Acta Phytopathologica Sinica, V34, P193; James VA, 2008, TRANSGENIC RES, V17, P93, DOI 10.1007/s11248-007-9086-y; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Kovalchuk N, 2009, PLANT MOL BIOL, V71, P81, DOI 10.1007/s11103-009-9510-1; Lascombe MB, 2008, PROTEIN SCI, V17, P1522, DOI 10.1110/ps.035972.108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, 2004, PLANT MOL BIOL, V55, P61, DOI 10.1007/s11103-004-0417-6; Lee SC, 2005, MOL CELLS, V19, P212; Li M, 2008, PLANT BIOTECHNOL J, V6, P465, DOI 10.1111/j.1467-7652.2008.00333.x; LIN CT, 1990, PLANT PHYSIOL, V94, P1078, DOI 10.1104/pp.94.3.1078; Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lopato S, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-3; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; Nishiuchi T, 2002, PLANT MOL BIOL, V49, P473, DOI 10.1023/A:1015553232309; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Pasquato L, 2005, SUPRAMOL CHEM, V17, P163, DOI 10.1080/10610270412331328817; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SANFORD JC, 1993, METHOD ENZYMOL, V217, P483; Sasaki K, 2007, PLANT J, V50, P1079, DOI 10.1111/j.1365-313X.2007.03111.x; SHIMADA T, 1969, CAN J GENET CYTOL, V11, P294, DOI 10.1139/g69-037; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Solano R, 1998, CURR OPIN PLANT BIOL, V1, P393, DOI 10.1016/S1369-5266(98)80262-8; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wang SC, 2009, J MOL RECOGNIT, V22, P474, DOI 10.1002/jmr.965; WELIN BV, 1994, PLANT MOL BIOL, V26, P131, DOI 10.1007/BF00039526; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Xue GP, 2002, BBA-GENE STRUCT EXPR, V1577, P63, DOI 10.1016/S0167-4781(02)00410-4; Yamaguchi-Shinozaki K., 1994, JIRCAS Journal, P69; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Yi SY, 2004, PLANT PHYSIOL, V136, P2862, DOI 10.1104/pp.104.042903; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151	87	25	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58713	10.1371/journal.pone.0058713	http://dx.doi.org/10.1371/journal.pone.0058713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527011	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562100037
J	Kratchmarov, R; Taylor, MP; Enquist, LW				Kratchmarov, Radomir; Taylor, Matthew P.; Enquist, Lynn W.			Role of Us9 Phosphorylation in Axonal Sorting and Anterograde Transport of Pseudorabies Virus	PLOS ONE			English	Article							II MEMBRANE-PROTEIN; CELLS; ALPHAHERPESVIRUS; INFECTION; KINESIN; CULTURE; MOTOR; MOTIF; TAIL	Alphaherpes viruses, such as pseudorabies virus (PRV), undergo anterograde transport in neuronal axons to facilitate anterograde spread within hosts. Axonal sorting and anterograde transport of virions is dependent on the viral membrane protein Us9, which interacts with the host motor protein Kif1A to direct transport. Us9-Kif1A interactions are necessary but not sufficient for these processes, indicating that additional cofactors or post-translational modifications are needed. In this study, we characterized two conserved serine phosphorylation sites (S51 and S53) in the PRV Us9 protein that are necessary for anterograde spread in vivo. We assessed the subcellular localization of phospho-Us9 subspecies during infection of neurons and found that the phospho-form is detectable on the majority, but not all, of axonal vesicles containing Us9 protein. In biochemical assays, phospho-Us9 was enriched in lipid raft membrane microdomains, though Us9 phosphorylation did not require prior lipid raft association. During infections of chambered neuronal cultures, we observed only a modest reduction in anterograde spread capacity for diserine mutant Us9, and no defect for monoserine mutants. Conversely, mutation of the kinase recognition sequence residues adjacent to the phosphorylation sites completely abrogated anterograde spread. In live-cell imaging analyses, anterograde transport of virions was reduced during infection with a recombinant PRV strain expressing GFP-tagged diserine mutant Us9. Phosphorylation was not required for Us9-Kif1A interaction, suggesting that Us9-Kif1A binding is a distinct step from the activation and/or stabilization of the transport complex. Taken together, our findings indicate that, while not essential, Us9 phosphorylation enhances Us9-Kif1A-based transport of virions in axons to modulate the overall efficiency of long-distance anterograde spread of infection.	[Kratchmarov, Radomir; Taylor, Matthew P.; Enquist, Lynn W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Enquist, LW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	lenquist@princeton.edu		Kratchmarov, Radomir/0000-0002-6796-8564; Taylor, Matthew/0000-0003-0199-7175	United States National Institutes of Health [R37 NS033506-16, R01 NS060699-03]; American Cancer Society [PF-10-057-01-MPC]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033506, R01NS033506, R01NS060699] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	LWE and RK are supported by the United States National Institutes of Health grants R37 NS033506-16 and R01 NS060699-03. MPT is supported by an American Cancer Society Postdoctoral Research Fellowship (PF-10-057-01-MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brideau AD, 2000, J VIROL, V74, P4549, DOI 10.1128/JVI.74.10.4549-4561.2000; Brideau AD, 1998, J VIROL, V72, P4560, DOI 10.1128/JVI.72.6.4560-4570.1998; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Ch'ng Toh Hean, 2005, Methods Mol Biol, V292, P299; Chowdhury SI, 2011, VET MICROBIOL, V152, P270, DOI 10.1016/j.vetmic.2011.05.012; Cohen JI, 2001, VIROLOGY, V280, P62, DOI 10.1006/viro.2000.0741; Cristea Ileana M, 2011, Cold Spring Harb Protoc, V2011, DOI [10.1101/pdb.prot5611, 10.1101/pdb.prot5610]; Curanovic Dusica, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2604s43; Daheshia M, 1998, CURR OPIN MICROBIOL, V1, P430, DOI 10.1016/S1369-5274(98)80061-1; Favoreel HW, 2004, J VIROL, V78, P5279, DOI 10.1128/JVI.78.10.5279-5287.2004; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Kramer T, 2012, CELL HOST MICROBE, V12, P806, DOI 10.1016/j.chom.2012.10.013; Kratchmarov R, 2012, REV MED VIROL, V22, P378, DOI 10.1002/rmv.1724; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; Lyman MG, 2009, J VIROL, V83, P6978, DOI 10.1128/JVI.00598-09; Lyman MG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000065; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Smith G, 2012, ANNU REV MICROBIOL, V66, P153, DOI 10.1146/annurev-micro-092611-150051; Taylor MP, 2012, MBIO, V3, DOI 10.1128/mBio.00063-12; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0	26	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58776	10.1371/journal.pone.0058776	http://dx.doi.org/10.1371/journal.pone.0058776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527020	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562100040
J	Linnman, C; Becerra, L; Lebel, A; Berde, C; Grant, PE; Borsook, D				Linnman, Clas; Becerra, Lino; Lebel, Alyssa; Berde, Charles; Grant, P. Ellen; Borsook, David			Transient and Persistent Pain Induced Connectivity Alterations in Pediatric Complex Regional Pain Syndrome	PLOS ONE			English	Article							SYNDROME TYPE-I; FUNCTIONAL CONNECTIVITY; BASAL GANGLIA; CINGULATE CORTEX; PERIAQUEDUCTAL GRAY; SYNDROME TYPE-1; NOXIOUS HEAT; BRAIN; CHILDREN; FMRI	Evaluation of pain-induced changes in functional connectivity was performed in pediatric complex regional pain syndrome (CRPS) patients. High field functional magnetic resonance imaging was done in the symptomatic painful state and at follow up in the asymptomatic pain free/recovered state. Two types of connectivity alterations were defined: (1) Transient increases in functional connectivity that identified regions with increased cold-induced functional connectivity in the affected limb vs. unaffected limb in the CRPS state, but with normalized connectivity patterns in the recovered state; and (2) Persistent increases in functional connectivity that identified regions with increased cold-induced functional connectivity in the affected limb as compared to the unaffected limb that persisted also in the recovered state (recovered affected limb versus recovered unaffected limb). The data support the notion that even after symptomatic recovery, alterations in brain systems persist, particularly in amygdala and basal ganglia systems. Connectivity analysis may provide a measure of temporal normalization of different circuits/regions when evaluating therapeutic interventions for this condition. The results add emphasis to the importance of early recognition and management in improving outcome of pediatric CRPS.	[Linnman, Clas; Becerra, Lino; Lebel, Alyssa; Berde, Charles; Borsook, David] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Pain & Analgesia Imaging Neurosci PAIN Grp, Boston, MA USA; [Linnman, Clas; Becerra, Lino; Lebel, Alyssa; Grant, P. Ellen; Borsook, David] Harvard Univ, Sch Med, Ctr Pain & Brain, Boston, MA USA; [Grant, P. Ellen] Boston Childrens Hosp, Dept Med, Ctr Fetal Neonatal Neuroimaging & Dev Sci, Boston, MA USA; [Grant, P. Ellen] Boston Childrens Hosp, Dept Radiol, Ctr Fetal Neonatal Neuroimaging & Dev Sci, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Linnman, C (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Pain & Analgesia Imaging Neurosci PAIN Grp, Boston, MA USA.	Clas.Linnman@childrens.harvard.edu		Linnman, Clas/0000-0001-8449-894X; Grant, Patricia/0000-0003-1005-4013	Mayday Foundation, New York; NINDS [R01NS065051]; Sara Page Mayo Endowment for Pediatric Pain Research; L Herlands Fund for Pain Research; International Association for the Study of Pain Early Career Award; Swedish Society for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065051, K24NS064050] Funding Source: NIH RePORTER	Mayday Foundation, New York; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sara Page Mayo Endowment for Pediatric Pain Research; L Herlands Fund for Pain Research; International Association for the Study of Pain Early Career Award; Swedish Society for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by a grant from the Mayday Foundation, New York (D. B. A. L. C. B.). NINDS R01NS065051 (D. B.), the Sara Page Mayo Endowment for Pediatric Pain Research (C. B.), L Herlands Fund for Pain Research (D. B., L. B.), the International Association for the Study of Pain Early Career Award (C. L.) and the Swedish Society for Medical Research (C. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Becerra L, 2009, CNS MEASURES PAIN RE; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; de Jong JR, 2005, PAIN, V116, P264, DOI 10.1016/j.pain.2005.04.019; Diers M, 2012, EXP BRAIN RES, V218, P619, DOI 10.1007/s00221-012-3055-2; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Freund W, 2010, CLIN J PAIN, V26, P339, DOI 10.1097/AJP.0b013e3181cb4055; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fukumoto M, 1999, LANCET, V354, P1790, DOI 10.1016/S0140-6736(99)03746-0; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Goni J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017408; Gustin SM, 2010, PAIN, V151, P69, DOI 10.1016/j.pain.2010.06.022; Harris EJ, 2012, J AM PODIAT MED ASSN, V102, P99, DOI 10.7547/1020099; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Janig W, 2002, CLIN AUTON RES, V12, P150, DOI 10.1007/s10286-002-0022-1; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Kachko L, 2008, PEDIATR INT, V50, P523, DOI 10.1111/j.1442-200X.2008.02625.x; Kishima H, 2010, NEUROIMAGE, V49, P2564, DOI 10.1016/j.neuroimage.2009.10.054; Klega A, 2010, NEUROLOGY, V75, P129, DOI 10.1212/WNL.0b013e3181e7ca2e; Krause P, 2006, CLIN NEUROPHYSIOL, V117, P169, DOI 10.1016/j.clinph.2005.09.012; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lebel A, 2008, BRAIN, V131, P1854, DOI 10.1093/brain/awn123; Libon DJ, 2010, J INT NEUROPSYCH SOC, V16, P566, DOI 10.1017/S1355617710000214; Linnman C, 2012, PAIN, V153, P444, DOI 10.1016/j.pain.2011.11.006; Low AK, 2007, J PEDIATR ORTHOPED, V27, P567, DOI 10.1097/BPO.0b013e318070cc4d; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Maihofner C, 2005, PAIN, V114, P93, DOI 10.1016/j.pain.2004.12.001; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Moulton EA, 2007, NEUROIMAGE, V35, P1586, DOI 10.1016/j.neuroimage.2007.02.001; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Mutso AA, 2012, J NEUROSCI, V32, P5747, DOI 10.1523/JNEUROSCI.0587-12.2012; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Pantazatos SP, 2012, NEUROIMAGE; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sherry DD, 1999, CLIN J PAIN, V15, P218, DOI 10.1097/00002508-199909000-00009; Shiraishi Satoe, 2006, Radiat Med, V24, P335, DOI 10.1007/s11604-006-0035-0; Simons LE, 2012, HUMAN BRAIN MAPPING; Starr CJ, 2011, BRAIN, V134, P1987, DOI 10.1093/brain/awr117; Strawn JR, 2012, DEPRESS ANXIETY, V29, P328, DOI 10.1002/da.21913; Talairach J., 1988, COPLANAR STEREOTAXIC; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Upadhyay J, 2012, NEUROIMAGE, V59, P3762, DOI 10.1016/j.neuroimage.2011.11.034; Ushida T, 2010, OPEN NEUROIMAGING J, V24, P182; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Villablanca J R, 1975, Acta Neurol Latinoam, V21, P157; Villablanca JR, 2010, ACTA NEUROBIOL EXP, V70, P95; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Walton KD, 2010, PAIN, V150, P41, DOI 10.1016/j.pain.2010.02.023; Wu CT, 2006, CLIN NUCL MED, V31, P317, DOI 10.1097/01.rlu.0000218538.06832.69; Wunderlich Arthur P, 2011, Open Neuroimag J, V5, P1, DOI 10.2174/1874440001105010001	64	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57205	10.1371/journal.pone.0057205	http://dx.doi.org/10.1371/journal.pone.0057205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526938	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100009
J	Richardson, SJ; Allen, RB; Buxton, RP; Easdale, TA; Hurst, JM; Morse, CW; Smissen, RD; Peltzer, DA				Richardson, Sarah J.; Allen, Robert B.; Buxton, Rowan P.; Easdale, Tomas A.; Hurst, Jennifer M.; Morse, Christopher W.; Smissen, Rob D.; Peltzer, Duane A.			Intraspecific Relationships among Wood Density, Leaf Structural Traits and Environment in Four Co-Occurring Species of Nothofagus in New Zealand	PLOS ONE			English	Article							DRY-MATTER CONTENT; 2 TROPICAL FORESTS; FUNCTIONAL TRAIT; SOIL CHRONOSEQUENCE; GLOBAL PATTERNS; CARBON GAIN; STEM TRAITS; ROOT TRAITS; LIFE-SPAN; AREA	Plant functional traits capture important variation in plant strategy and function. Recent literature has revealed that within-species variation in traits is greater than previously supposed. However, we still have a poor understanding of how intraspecific variation is coordinated among different traits, and how it is driven by environment. We quantified intraspecific variation in wood density and five leaf traits underpinning the leaf economics spectrum (leaf dry matter content, leaf mass per unit area, size, thickness and density) within and among four widespread Nothofagus tree species in southern New Zealand. We tested whether intraspecific relationships between wood density and leaf traits followed widely reported interspecific relationships, and whether variation in these traits was coordinated through shared responses to environmental factors. Sample sites varied widely in environmental variables, including soil fertility (25-900 mg kg(-1) total P), precipitation (668-4875 mm yr(-1)), temperature (5.2-12.4 degrees C mean annual temperature) and latitude (41-46 degrees S). Leaf traits were strongly correlated with one another within species, but not with wood density. There was some evidence for a positive relationship between wood density and leaf tissue density and dry matter content, but no evidence that leaf mass or leaf size were correlated with wood density; this highlights that leaf mass per unit area cannot be used as a surrogate for component leaf traits such as tissue density. Trait variation was predicted by environmental factors, but not consistently among different traits; e. g., only leaf thickness and leaf density responded to the same environmental cues as wood density. We conclude that although intraspecific variation in wood density and leaf traits is strongly driven by environmental factors, these responses are not strongly coordinated among functional traits even across co-occurring, closely-related plant species.	[Richardson, Sarah J.; Allen, Robert B.; Buxton, Rowan P.; Easdale, Tomas A.; Hurst, Jennifer M.; Morse, Christopher W.; Smissen, Rob D.; Peltzer, Duane A.] Landcare Res, Lincoln, New Zealand	Landcare Research - New Zealand	Richardson, SJ (corresponding author), Landcare Res, Lincoln, New Zealand.	richardsons@landcareresearch.co.nz	Peltzer, Duane A/A-9463-2009; Richardson, Sarah J/D-3353-2015	Peltzer, Duane A/0000-0001-7724-3738; Richardson, Sarah J/0000-0002-4097-0381; Easdale, Tomas A./0000-0001-5086-8527; Smissen, Rob/0000-0001-6299-1987	Landcare Research Capability Funding; New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group; National Vegetation Survey Databank	Landcare Research Capability Funding; New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group(New Zealand Ministry of Business, Innovation and Employment (MBIE)); National Vegetation Survey Databank	Funding provided by Landcare Research Capability Funding; Core funding for Crown Research Institutes from the New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group; and the National Vegetation Survey Databank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Ackerly DD, 2002, PHYS PLANT EC 39 S B, P391; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baltzer JL, 2009, AM J BOT, V96, P2214, DOI 10.3732/ajb.0800414; BARAJASMORALES J, 1987, IAWA BULL, V8, P143, DOI 10.1163/22941932-90001041; BARAJASMORALES J, 1985, IAWA BULL, V6, P355, DOI 10.1163/22941932-90000962; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Castro-Diez P, 2000, OECOLOGIA, V124, P476, DOI 10.1007/PL00008873; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Craine JM, 2003, OECOLOGIA, V134, P471, DOI 10.1007/s00442-002-1155-6; Craine JM, 2010, PLANT SOIL, V337, P193, DOI 10.1007/s11104-010-0515-y; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; De Frenne P, 2011, ECOGRAPHY, V34, P132, DOI 10.1111/j.1600-0587.2010.06399.x; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Holdaway RJ, 2011, J ECOL, V99, P954, DOI 10.1111/j.1365-2745.2011.01821.x; Hovenden MJ, 2006, NEW PHYTOL, V169, P291, DOI 10.1111/j.1469-8137.2005.01585.x; Hulshof CM, 2010, FUNCT ECOL, V24, P217, DOI 10.1111/j.1365-2435.2009.01614.x; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019992; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Kooyman RM, 2009, ANN BOT-LONDON, V104, P987, DOI 10.1093/aob/mcp185; Leathwick JR, 2003, CONSERV BIOL, V17, P1612, DOI 10.1111/j.1523-1739.2003.00469.x; Leathwick JR, 1998, J VEG SCI, V9, P719, DOI 10.2307/3237290; Leathwick JR, 2001, NEW ZEAL J BOT, V39, P447; Lusk CH, 2008, TRENDS ECOL EVOL, V23, P299, DOI 10.1016/j.tree.2008.02.006; Magnani F, 2009, NEW PHYTOL, V184, P277, DOI 10.1111/j.1469-8137.2009.03035.x; Malhado ACM, 2009, BIOGEOSCIENCES, V6, P1563, DOI 10.5194/bg-6-1563-2009; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; Martinez-Cabrera HI, 2009, AM J BOT, V96, P1388, DOI 10.3732/ajb.0800237; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; Mason NWH, 2012, J ECOL, V100, P678, DOI [10.1111/j.1365-2745.2012.01965.x, 10.1111/j.1365-2745.2012.01965.X]; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 2002, ANN BOT-LONDON, V89, P191, DOI 10.1093/aob/mcf025; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Palow DT, 2012, FUNCT ECOL, V26, P1144, DOI 10.1111/j.1365-2435.2012.02019.x; Pickup M, 2005, FUNCT ECOL, V19, P88, DOI 10.1111/j.0269-8463.2005.00927.x; Pohlman CL, 2005, J BIOGEOGR, V32, P341, DOI 10.1111/j.1365-2699.2004.01181.x; POOLE A. L., 1958, TRANS ROY SOC NEW ZEALAND, V85, P551; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Richardson SJ, 2008, FUNCT ECOL, V22, P738, DOI 10.1111/j.1365-2435.2008.01426.x; Richardson SJ, 2010, NEW ZEAL J ECOL, V34, P306; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Silvertown J, 1996, PHILOS T ROY SOC B, V351, P1233, DOI 10.1098/rstb.1996.0106; Sugiyama S, 2003, PLANT ECOL, V169, P295, DOI 10.1023/A:1026081122985; Sundqvist MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027056; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Wardle J., 1984, NZ BEECHES ECOLOGY U; WEBB LJ, 1959, J ECOL, V47, P551, DOI 10.2307/2257290; Wiemann MC, 2002, WOOD FIBER SCI, V34, P96; WILCOX MD, 1983, NEW ZEAL J ECOL, V6, P19; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wiser SK, 2011, APPL VEG SCI, V14, P506, DOI 10.1111/j.1654-109X.2011.01146.x; WITKOWSKI ETF, 1991, OECOLOGIA, V88, P486, DOI 10.1007/BF00317710; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2006, PHYSIOL PLANTARUM, V127, P445, DOI 10.1111/j.1399-3054.2006.00699.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zhang JL, 2009, FUNCT ECOL, V23, P658, DOI 10.1111/j.1365-2435.2009.01552.x	71	29	33	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58878	10.1371/journal.pone.0058878	http://dx.doi.org/10.1371/journal.pone.0058878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527041	Green Published, Green Submitted, gold			2022-12-25	WOS:000316411600014
J	Buttigieg, PL; Hankeln, W; Kostadinov, I; Kottmann, R; Yilmaz, P; Duhaime, MB; Glockner, FO				Buttigieg, Pier Luigi; Hankeln, Wolfgang; Kostadinov, Ivaylo; Kottmann, Renzo; Yilmaz, Pelin; Duhaime, Melissa Beth; Gloeckner, Frank Oliver			Ecogenomic Perspectives on Domains of Unknown Function: Correlation-Based Exploration of Marine Metagenomes	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BIOLOGICAL DATA; DNA-DAMAGE; GLUTATHIONE; METABOLISM; GLUTAREDOXINS; PATTERNS; FAMILIES; BACTERIA; INSIGHTS	Background: The proportion of conserved DNA sequences with no clear function is steadily growing in bioinformatics databases. Studies of sequence and structural homology have indicated that many uncharacterized protein domain sequences are variants of functionally described domains. If these variants promote an organism's ecological fitness, they are likely to be conserved in the genome of its progeny and the population at large. The genetic composition of microbial communities in their native ecosystems is accessible through metagenomics. We hypothesize the co-variation of protein domain sequences across metagenomes from similar ecosystems will provide insights into their potential roles and aid further investigation. Methodology/Principal findings: We calculated the correlation of Pfam protein domain sequences across the Global Ocean Sampling metagenome collection, employing conservative detection and correlation thresholds to limit results to well-supported hits and associations. We then examined intercorrelations between domains of unknown function (DUFs) and domains involved in known metabolic pathways using network visualization and cluster-detection tools. We used a cautious "guilty-by-association'' approach, referencing knowledge-level resources to identify and discuss associations that offer insight into DUF function. We observed numerous DUFs associated to photobiologically active domains and prevalent in the Cyanobacteria. Other clusters included DUFs associated with DNA maintenance and repair, inorganic nutrient metabolism, and sodium-translocating transport domains. We also observed a number of clusters reflecting known metabolic associations and cases that predicted functional reclassification of DUFs. Conclusion/Significance: Critically examining domain covariation across metagenomic datasets can grant new perspectives on the roles and associations of DUFs in an ecological setting. Targeted attempts at DUF characterization in the laboratory or in silico may draw from these insights and opportunities to discover new associations and corroborate existing ones will arise as more large-scale metagenomic datasets emerge.	[Buttigieg, Pier Luigi; Hankeln, Wolfgang; Kottmann, Renzo; Yilmaz, Pelin; Gloeckner, Frank Oliver] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Grp, Bremen, Germany; [Buttigieg, Pier Luigi; Gloeckner, Frank Oliver] Jacobs Univ gGmbH, Bremen, Germany; [Kostadinov, Ivaylo] Inst Ciencias Mar, Dept Biol Marina & Oceanog, E-08039 Barcelona, Spain; [Duhaime, Melissa Beth] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Max Planck Society; Jacobs University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Michigan System; University of Michigan	Buttigieg, PL (corresponding author), Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Grp, Bremen, Germany.	pbuttigi@mpi-bremen.de		Buttigieg, Pier Luigi/0000-0002-4366-3088; Duhaime, Melissa/0000-0001-7884-5087; Kostadinov, Ivaylo/0000-0003-4476-6764; Yilmaz, Pelin/0000-0003-4724-323X	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the Max Planck Society (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Bornke F, 2008, ANAL BIOL NETWORKS, P207; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Csardi N., 2006, INT J COMP SYST, V1695, P1; Delmont TO, 2011, ISME J, V5, P1837, DOI 10.1038/ismej.2011.61; DeLong EF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000359; Deng H, 2009, CHEMBIOCHEM, V10, P2455, DOI 10.1002/cbic.200900369; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Goonesekere NCW, 2010, COMPUT BIOL CHEM, V34, P210, DOI 10.1016/j.compbiolchem.2010.04.001; Iyer LM, 2009, MOL BIOSYST, V5, P1636, DOI 10.1039/b917682a; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kannan R, 1996, J BIOL CHEM, V271, P9754, DOI 10.1074/jbc.271.16.9754; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; LASH LH, 1984, J BIOL CHEM, V259, P4508; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Meador JA, 2009, PHOTOCHEM PHOTOBIOL, V85, P412, DOI 10.1111/j.1751-1097.2008.00462.x; Merico D, 2009, NAT BIOTECHNOL, V27, P921, DOI 10.1038/nbt.1567; Milligan JR, 2003, NUCLEIC ACIDS RES, V31, P6258, DOI 10.1093/nar/gkg816; Miyazono K, 2009, PROTEINS, V74, P256, DOI 10.1002/prot.22255; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Toulza E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030931; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; Wittkop T, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.197; Wittkop T, 2010, NAT METHODS, V7, P419, DOI 10.1038/nmeth0610-419; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	46	9	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e50869	10.1371/journal.pone.0050869	http://dx.doi.org/10.1371/journal.pone.0050869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516388	gold, Green Published			2022-12-25	WOS:000316407400001
J	Johnen, H; Gonzalez-Silva, L; Carramolino, L; Flores, JM; Torres, M; Salvador, JM				Johnen, Heiko; Gonzalez-Silva, Laura; Carramolino, Laura; Maria Flores, Juana; Torres, Miguel; Salvador, Jesus M.			Gadd45g Is Essential for Primary Sex Determination, Male Fertility and Testis Development	PLOS ONE			English	Article							CRITICAL TIME WINDOW; SRY EXPRESSION; GENOTOXIC-STRESS; CELL-CYCLE; MICE; FAMILY; REVERSAL; GENE; GADD45A-DEFICIENT; DIFFERENTIATION	In humans and most mammals, differentiation of the embryonic gonad into ovaries or testes is controlled by the Y-linked gene SRY. Here we show a role for the Gadd45g protein in this primary sex differentiation. We characterized mice deficient in Gadd45a, Gadd45b and Gadd45g, as well as double-knockout mice for Gadd45ab, Gadd45ag and Gadd45bg, and found a specific role for Gadd45g in male fertility and testis development. Gadd45g-deficient XY mice on a mixed 129/C57BL/6 background showed varying degrees of disorders of sexual development (DSD), ranging from male infertility to an intersex phenotype or complete gonadal dysgenesis (CGD). On a pure C57BL/6 (B6) background, all Gadd45g(-/-) XY mice were born as completely sex-reversed XY-females, whereas lack of Gadd45a and/or Gadd45b did not affect primary sex determination or testis development. Gadd45g expression was similar in female and male embryonic gonads, and peaked around the time of sex differentiation at 11.5 days post-coitum (dpc). The molecular cause of the sex reversal was the failure of Gadd45g(-/-) XY gonads to achieve the SRY expression threshold necessary for testes differentiation, resulting in ovary and Mullerian duct development. These results identify Gadd45g as a candidate gene for male infertility and 46, XY sex reversal in humans.	[Johnen, Heiko; Gonzalez-Silva, Laura; Salvador, Jesus M.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Carramolino, Laura; Torres, Miguel] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Dev & Repair, Madrid, Spain; [Maria Flores, Juana] Univ Complutense Madrid, Sch Vet, Anim Surg & Med Dept, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid	Salvador, JM (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Campus Cantoblanco, Madrid, Spain.	jmsalvador@cnb.csic.es	Torres, Miguel/CAG-0003-2022; Torres, Miguel/A-7388-2013; Carramolino, Laura/H-5886-2015	Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767; Carramolino, Laura/0000-0002-1661-618X; Gonzalez-Silva, Laura/0000-0001-8625-1473; Salvador, Jesus Maria/0000-0002-1087-9675	European Research Council (ERC) [FP7-208250-1]; Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias) [PI081718, PI1101411]; Ministerio de Ciencia e Innovacion [200820I109]; Spanish Ministry of Science and Innovation (MICINN) JAE Programme (CSIC)	European Research Council (ERC)(European Research Council (ERC)European Commission); Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation (MICINN) JAE Programme (CSIC)	This work was supported by grants from the European Research Council (ERC; FP7-208250-1), the Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias, PI081718, PI1101411), and the Ministerio de Ciencia e Innovacion (200820I109) to JMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank V Cano for technical support, B Pintado for technical advice, E Samper for performing the FISH chromosome painting, and C Mark for editorial assistance. LGS receives a predoctoral fellowship from the Spanish Ministry of Science and Innovation (MICINN) JAE Programme (CSIC).	Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Blackless M, 2000, AM J HUM BIOL, V12, P151, DOI 10.1002/(SICI)1520-6300(200003/04)12:2<151::AID-AJHB1>3.0.CO;2-F; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Cai Q, 2006, AM J PHYSIOL-RENAL, V291, pF341, DOI 10.1152/ajprenal.00518.2005; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kaufmann LT, 2011, MECH DEVELOP, V128, P401, DOI 10.1016/j.mod.2011.08.002; Kaufmann LT, 2011, GENE EXPR PATTERNS, V11, P465, DOI 10.1016/j.gep.2011.07.005; Li YM, 2012, METHODS MOL BIOL, V825, P3, DOI 10.1007/978-1-61779-436-0_1; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Munger SC, 2009, GENE DEV, V23, P2521, DOI 10.1101/gad.1835809; Nakayama K, 1999, J BIOL CHEM, V274, P24766, DOI 10.1074/jbc.274.35.24766; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006	32	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58751	10.1371/journal.pone.0058751	http://dx.doi.org/10.1371/journal.pone.0058751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516551	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200110
J	Borgeaud, C; van de Waal, E; Bshary, R				Borgeaud, Christele; van de Waal, Erica; Bshary, Redouan			Third-Party Ranks Knowledge in Wild Vervet Monkeys (Chlorocebus aethiops pygerythrus)	PLOS ONE			English	Article							TRANSITIVE INFERENCE; GROUP-SIZE; CLASSIFICATION; CONTEXT; KINSHIP	The Machiavellian/Social Intelligence Hypothesis proposes that a complex social environment selected for advanced cognitive abilities in vertebrates. In primates it has been proposed that sophisticated social strategies like obtaining suitable coalition partners are an important component of social intelligence. Knowing the rank relationships between group members is a basic requirement for the efficient use of coalitions and the anticipation of counter-coalitions. Experimental evidence for such knowledge currently exists in only few species. Here, we conducted rank reversal playback experiments on adult females belonging to three different groups of free-ranging vervet monkeys (Chlorocebus aethiops pygerythrus) to test their knowledge of the female hierarchy. Playbacks simulating rank reversals (subordinate aggressing a dominant) induced longer looking times than playbacks simulating a dominant aggressing a subordinate. Vervet monkey females therefore seem to compute the rank relationships between other females. Our results suggest that detailed social knowledge about rank relationships may be widespread in primates and potentially also in other species living in stable groups.	[Borgeaud, Christele; Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [van de Waal, Erica] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Borgeaud, Christele; van de Waal, Erica; Bshary, Redouan] Inkawu Vervet Project, Swart Mfolozi, KwaZulu Natal, South Africa	University of Neuchatel; University of St Andrews	Borgeaud, C (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	christele.borgeaud@unine.ch		van de Waal, Erica/0000-0001-7778-418X; Bshary, Redouan/0000-0001-7198-8472	Swiss National Science Foundation (Sinergia) [CRSI33_133040]	Swiss National Science Foundation (Sinergia)(Swiss National Science Foundation (SNSF))	This study was financed by the Swiss National Science Foundation (Sinergia: CRSI33_133040), www.snsf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN C, 1980, BEHAV ECOL SOCIOBIOL, V6, P315, DOI 10.1007/BF00292774; Barton R. A., 1997, EVOLUTION SOCIAL BRA; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bshary R, 2002, BEHAV ECOL SOCIOBIOL, V52, P365, DOI 10.1007/s00265-002-0527-6; Bshary Redouan, 2011, P209; Byrne R., 1988, MACHIAVELLIAN INTELL; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; CHENEY DL, 1995, J COMP PSYCHOL, V109, P134, DOI 10.1037/0735-7036.109.2.134; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; DAVIS H, 1992, J COMP PSYCHOL, V106, P342, DOI 10.1037/0735-7036.106.4.342; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; DEWAAL F, 1982, CHIMPANZEE POLITICS; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Engh AL, 2005, ANIM BEHAV, V69, P209, DOI 10.1016/j.anbehav.2004.04.013; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; McGregor PK, 2005, ANIMAL COMMUNICATION; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Schino G, 2006, ANIM BEHAV, V71, P1069, DOI 10.1016/j.anbehav.2005.07.019; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Taborsky B, 2012, TRENDS ECOL EVOL, V27, P679, DOI 10.1016/j.tree.2012.09.003; Whiten A., 1997, MACHIAVELLIAN INTELL, DOI [10.1017/CBO9780511525636, DOI 10.1017/CBO9780511525636]; Xing J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-5	31	23	23	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58562	10.1371/journal.pone.0058562	http://dx.doi.org/10.1371/journal.pone.0058562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520521	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900081
J	Hernandez-Sanabria, E; Goonewardene, LA; Wang, ZQ; Zhou, M; Moore, SS; Guan, LL				Hernandez-Sanabria, Emma; Goonewardene, Laksiri A.; Wang, Zhiquan; Zhou, Mi; Moore, Stephen S.; Guan, Le Luo			Influence of Sire Breed on the Interplay among Rumen Microbial Populations Inhabiting the Rumen Liquid of the Progeny in Beef Cattle	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; FEED-EFFICIENCY; BACTERIAL COMMUNITY; GUT MICROBIOME; PERFORMANCE; PREVOTELLA; DIVERSITY; METHANE; TRAITS; FLUID	This study aimed to evaluate whether the host genetic background impact the ruminal microbial communities of the progeny of sires from three different breeds under different diets. Eighty five bacterial and twenty eight methanogen phylotypes from 49 individuals of diverging sire breed (Angus, ANG; Charolais, CHA; and Hybrid, HYB), fed high energy density (HE) and low energy density (LE) diets were determined and correlated with breed, rumen fermentation and phenotypic variables, using multivariate statistical approaches. When bacterial phylotypes were compared between diets, ANG offspring showed the lowest number of diet-associated phylotypes, whereas CHA and HYB progenies had seventeen and twenty-three diet-associated phylotypes, respectively. For the methanogen phylotypes, there were no sire breed-associated phylotypes; however, seven phylotypes were significantly different among breeds on either diet (P<0.05). Sire breed did not influence the metabolic variables measured when high energy diet was fed. A correlation matrix of all pairwise comparisons among frequencies of bacterial and methanogen phylotypes uncovered their relationships with sire breed. A cluster containing methanogen phylotypes M16 (Methanobrevibacter gottschalkii) and M20 (Methanobrevibacter smithii), and bacterial phylotype B62 (Robinsoniella sp.) in Angus offspring fed low energy diet reflected the metabolic interactions among microbial consortia. The clustering of the phylotype frequencies from the three breeds indicated that phylotypes detected in CHA and HYB progenies are more similar among them, compared to ANG animals. Our results revealed that the frequency of particular microbial phylotypes in the progeny of cattle may be influenced by the sire breed when different diets are fed and ultimately further impact host metabolic functions, such as feed efficiency.	[Hernandez-Sanabria, Emma; Goonewardene, Laksiri A.; Wang, Zhiquan; Zhou, Mi; Moore, Stephen S.; Guan, Le Luo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Moore, Stephen S.] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	University of Alberta; University of Queensland	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca		Hernandez Sanabria, Emma/0000-0002-5845-9821; Moore, Stephen/0000-0002-9758-166X; Zhou, Mi/0000-0001-9056-9468	Alberta Livestock Industry Development Fund; Alberta Livestock Meat Agency; Alberta Agricultural Research Institute [ALIDF/ALMA/AARI 2007F041R, ALMA2010R086R]; CONACyT Scholarship	Alberta Livestock Industry Development Fund; Alberta Livestock Meat Agency; Alberta Agricultural Research Institute; CONACyT Scholarship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Alberta Livestock Industry Development Fund, Alberta Livestock Meat Agency, Alberta Agricultural Research Institute (ALIDF/ALMA/AARI 2007F041R and ALMA2010R086R), and by a CONACyT Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan R, 2008, J PEDIATR GASTR NUTR, V46, P514, DOI 10.1097/MPG.0b013e31815ce599; Beh EJ, 2004, INT STAT REV, V72, P257; Ben-Dov E, 2006, APPL ENVIRON MICROB, V72, P6902, DOI 10.1128/AEM.00849-06; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bevans DW, 2005, J ANIM SCI, V83, P1116; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Crater AR, 2007, J MAMMAL, V88, P625, DOI 10.1644/06-MAMM-A-170R1.1; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Dickinson W, 2008, PROC CORRESP CATEGOR; Durunna ON, 2011, J ANIM SCI, V89, P158, DOI 10.2527/jas.2009-2514; Edwards JE, 2008, ANIMAL, V2, P653, DOI 10.1017/S1751731108002164; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Ferrell CL, 2006, J ANIM SCI, V84, P2515, DOI 10.2527/jas.2005-746; GOMEZALARCON RA, 1982, APPL ENVIRON MICROB, V44, P346, DOI 10.1128/AEM.44.2.346-350.1982; Goonewardene LA, 2003, LIVEST PROD SCI, V81, P47, DOI 10.1016/S0301-6226(02)00194-X; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Hernandez-Sanabria E, 2012, APPL ENVIRON MICROB, V78, P1203, DOI 10.1128/AEM.05114-11; Hernandez-Sanabria E, 2010, APPL ENVIRON MICROB, V76, P6338, DOI 10.1128/AEM.01052-10; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kim C.C., 2012, IDENTIFICATION RUMEN; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Lodge-Ivey SL, 2009, J ANIM SCI, V87, P2333, DOI 10.2527/jas.2008-1472; Mader CJ, 2009, J ANIM SCI, V87, P1548, DOI 10.2527/jas.2008-0914; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; Michelland RJ, 2009, J APPL MICROBIOL, V107, P1642, DOI 10.1111/j.1365-2672.2009.04346.x; Mujibi FDN, 2010, J ANIM SCI, V88, P3789, DOI 10.2527/jas.2009-2407; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nkrumah JD, 2006, J ANIM SCI, V84, P145; OHERRIN SM, 1993, APPL ENVIRON MICROB, V59, P748, DOI 10.1128/AEM.59.3.748-755.1993; Olfert E.D., 1993, CANADIAN COUNCIL ANI, V1; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; SAS Institute Inc, 2010, SAS IML STUD 3 2 US; Sasaki K, 2011, APPL MICROBIOL BIOT, V90, P1555, DOI 10.1007/s00253-011-3215-5; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Sun YZ, 2010, ANIMAL, V4, P210, DOI 10.1017/S175173110999111X; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tims S, 2011, METHAGENOMICS HUMAN; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Wallace RJ, 2008, ANIMAL, V2, P661, DOI 10.1017/S1751731108001687; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Webster NS, 2007, FEMS MICROBIOL ECOL, V59, P81, DOI 10.1111/j.1574-6941.2006.00195.x; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Zhou M, 2010, APPL ENVIRON MICROB, V76, P3776, DOI 10.1128/AEM.00010-10; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	53	55	56	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58461	10.1371/journal.pone.0058461	http://dx.doi.org/10.1371/journal.pone.0058461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520513	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900072
J	Sun, Y; Zhang, WJ; Xu, YH; Quinn, B; Dasgupta, N; Liou, B; Setchell, KDR; Grabowski, GA				Sun, Ying; Zhang, Wujuan; Xu, You-Hai; Quinn, Brian; Dasgupta, Nupur; Liou, Benjamin; Setchell, Kenneth D. R.; Grabowski, Gregory A.			Substrate Compositional Variation with Tissue/Region and Gba1 Mutations in Mouse Models-Implications for Gaucher Disease	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; SAPOSIN C DEFICIENCY; GLUCOSYLSPHINGOSINE ACCUMULATION; GLUCOCEREBROSIDASE GENE; GLUCOSYLCERAMIDE; PHENOTYPE; VARIANTS; GENOTYPE; TISSUES; SPLEEN	Gaucher disease results from GBA1 mutations that lead to defective acid beta-glucosidase (GCase) mediated cleavage of glucosylceramide (GC) and glucosylsphingosine as well as heterogeneous manifestations in the viscera and CNS. The mutation, tissue, and age-dependent accumulations of different GC species were characterized in mice with Gba1 missense mutations alone or in combination with isolated saposin C deficiency (C*). Gba1 heteroallelism for D409V and null alleles (9V/null) led to GC excesses primarily in the visceral tissues with preferential accumulations of lung GC24:0, but not in liver, spleen, or brain. Age-dependent increases of different GC species were observed. The combined saposin C deficiency (C*) with V394L homozygosity (4L;C*) showed major GC18:0 degradation defects in the brain, whereas the analogous mice with D409H homozygosity and C* (9H;C*) led to all GC species accumulating in visceral tissues. Glucosylsphingosine was poorly degraded in brain by V394L and D409H GCases and in visceral tissues by D409V GCase. The neonatal lethal N370S/N370S genotype had insignificant substrate accumulations in any tissue. These results demonstrate age, organ, and mutation-specific quantitative differences in GC species and glucosylsphingosine accumulations that can have influence in the tissue/regional expression of Gaucher disease phenotypes.	[Sun, Ying; Xu, You-Hai; Quinn, Brian; Dasgupta, Nupur; Liou, Benjamin; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Univ Cincinnati, Coll Med, Div Pathol & Lab Med, Cincinnati, OH USA; [Sun, Ying; Xu, You-Hai; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Sun, Ying; Xu, You-Hai; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Grabowski, GA (corresponding author), Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH USA.	greg.grabowski@cchmc.org			National Institutes of Health grant [R01 NS/DK 36729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an National Institutes of Health grant to GAG (R01 NS/DK 36729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONRADI NG, 1984, ACTA NEUROPATHOL, V65, P99, DOI 10.1007/BF00690463; Elstein D, 2005, GENET TEST, V9, P26, DOI 10.1089/gte.2005.9.26; Gornati R, 2002, J INHERIT METAB DIS, V25, P47, DOI 10.1023/A:1015137917508; Grabowski GA, 2010, ONLINE METABOLIC MOL; Grabowski GA, 2006, METABOLIC MOL BASES; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; KUSKE TT, 1972, J LAB CLIN MED, V80, P523; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; MARINETTI GV, 1960, J LIPID RES, V1, P203; Michelin K, 2005, CLIN CHIM ACTA, V362, P101, DOI 10.1016/j.cccn.2005.06.010; MIYATAKE T, 1972, BIOCHEM BIOPH RES CO, V48, P538, DOI 10.1016/0006-291X(72)90381-6; NILSSON O, 1982, CLIN GENET, V22, P274; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; NILSSON O, 1982, BIOCHIM BIOPHYS ACTA, V712, P453, DOI 10.1016/0005-2760(82)90272-7; NILSSON O, 1985, CLIN GENET, V27, P443; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; RAGHAVAN SS, 1973, BIOCHEM BIOPH RES CO, V54, P256, DOI 10.1016/0006-291X(73)90916-9; Saadat L, 2010, GLIA, V58, P391, DOI 10.1002/glia.20930; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Sun Y, 2010, HUM MOL GENET, V19, P634, DOI 10.1093/hmg/ddp531; SUOMI WD, 1965, J LIPID RES, V6, P211; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	34	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57560	10.1371/journal.pone.0057560	http://dx.doi.org/10.1371/journal.pone.0057560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520473	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900032
J	Ohgita, T; Hayashi, N; Hama, S; Tsuchiya, H; Gotoh, N; Kogure, K				Ohgita, Takashi; Hayashi, Naoki; Hama, Susumu; Tsuchiya, Hiroyuki; Gotoh, Naomasa; Kogure, Kentaro			A novel effector secretion mechanism based on proton-motive force-dependent type III secretion apparatus rotation	FASEB JOURNAL			English	Article						Pseudomonas aeruginosa; flagellum; ATP synthase; PcrV; Strep tagII	BASAL BODY COMPLEX; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; PROTEIN EXPORT; FLAGELLA; HOOK; INJECTISOME; F-1-ATPASE	The type III secretion apparatus (T3SA) participates in the secretion of bacterial proteins called effectors, although the detailed mechanism of effector secretion remains unclear. T3SA and flagellum were shown to branch from a common ancestor and also show structural similarity. In addition, both T3SA-dependent effector secretion and flagellar rotation were reported to require proton-motive force (PMF) for activity. From these reports, we hypothesized that T3SA, like the flagellum, would rotate via PMF and that this rotation is responsible for effector secretion. To observe T3SA rotation, we constructed a novel observation system by modifying the tip of T3SA on bacterial cell membranes with an observation probe, which allowed documentation of T3SA rotation for the first time. T3SA rotation was stopped by the addition of a protonophore that decreases PMF. Moreover, increased viscosity of the observation medium inhibited both rotation of T3SA associated with beads and effector secretion. These results suggested that effector secretion would follow the PMF-dependent rotation of T3SA and could be inhibited by preventing T3SA rotation. Moreover, the motion-track analysis of bead rotation suggested that the T3SA needle might be flexible. Consequently, we propose a rotational secretion model as a novel effector secretion mechanism of T3SA.Ohgita, T., Hayashi, N., Hama, S., Tsuchiya, H., Gotoh, N., Kogure, K. A novel effector secretion mechanism based on proton-motive force-dependent type III secretion apparatus rotation.	[Ohgita, Takashi; Hama, Susumu; Tsuchiya, Hiroyuki; Kogure, Kentaro] Kyoto Pharmaceut Univ, Dept Biophys Chem, Kyoto 6078414, Japan; [Hayashi, Naoki; Gotoh, Naomasa] Kyoto Pharmaceut Univ, Dept Microbiol & Infect Control Sci, Kyoto 6078414, Japan	Kyoto Pharmaceutical University; Kyoto Pharmaceutical University	Kogure, K (corresponding author), Kyoto Pharmaceut Univ, Dept Biophys Chem, Yamashina Ku, Misasagi Nakauchicho 5, Kyoto 6078414, Japan.	kogure@mb.kyoto-phu.ac.jp		Hama, Susumu/0000-0002-2989-6168				AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P384, DOI 10.1128/JB.105.1.384-395.1971; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Gabel CV, 2003, P NATL ACAD SCI USA, V100, P8748, DOI 10.1073/pnas.1533395100; GONZALEZTELLO P, 1994, J CHEM ENG DATA, V39, P611, DOI 10.1021/je00015a050; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Hashimoto M, 2008, J MOL BIOL, V375, P367, DOI 10.1016/j.jmb.2007.09.046; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Kinosita K, 1999, FASEB J, V13, pS201; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Magariyama Y, 2001, FEMS MICROBIOL LETT, V199, P125; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Okuda J, 2010, INFECT IMMUN, V78, P4511, DOI 10.1128/IAI.00428-10; Oster G, 2003, TRENDS CELL BIOL, V13, P114, DOI 10.1016/S0962-8924(03)00004-7; Rathinavelan T, 2010, BIOPHYS J, V98, P452, DOI 10.1016/j.bpj.2009.10.030; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; SHIOI J, 1980, J BACTERIOL, V144, P891, DOI 10.1128/JB.144.3.891-897.1980; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	31	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2862	2872		10.1096/fj.13-229054	http://dx.doi.org/10.1096/fj.13-229054			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23515444				2022-12-25	WOS:000328841000034
J	Taylor, H; Barua, N; Bienemann, A; Wyatt, M; Castrique, E; Foster, R; Luz, M; Fibiger, C; Mohr, E; Gill, S				Taylor, Hannah; Barua, Neil; Bienemann, Alison; Wyatt, Marcella; Castrique, Emma; Foster, Rebecca; Luz, Matthias; Fibiger, Christian; Mohr, Erich; Gill, Steven			Clearance and Toxicity of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHu GDNF) Following Acute Convection-Enhanced Delivery into the Striatum	PLOS ONE			English	Article							AGED RHESUS-MONKEYS; NEURONS IN-VITRO; INTRAPUTAMENAL INFUSION; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; RECEPTOR; PROTEIN; BRAIN; PROTECTION; PUTAMEN	Background: Despite promising early results, clinical trials involving the continuous delivery of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) into the putamen for the treatment of Parkinson's disease have shown evidence of poor distribution and toxicity due to point-source accumulation. Convection-enhanced delivery (CED) has the potential to facilitate more widespread and clinically effective drug distribution. Aims: We investigated acute CED of r-metHuGDNF into the striatum of normal rats in order to assess tissue clearance, toxicity (neuron loss, gliosis, microglial activation, and decreases in synaptophysin), synaptogenesis and neurite-outgrowth. We investigated a range of clinically relevant infused concentrations (0.1, 0.2, 0.6 and 1.0 mu g/mu L) and time points (2 and 4 weeks) in order to rationalise a dosing regimen suitable for clinical translation. Results: Two weeks after single dose CED, r-metHuGDNF was below the limit of detection by ELISA but detectable by immunohistochemistry when infused at low concentrations (0.1 and 0.2 mu g/mu L). At these concentrations, there was no associated neuronal loss (neuronal nuclei, NeuN, immunohistochemistry) or synaptic toxicity (synaptophysin ELISA). CED at an infused concentration of 0.2 mu g/mu L was associated with a significant increase in synaptogenesis (p < 0.01). In contrast, high concentrations of r-metHuGDNF (above 0.6 mu g/mu L) were associated with neuronal and synaptic toxicity (p < 0.01). Markers for gliosis (glial fibrillary acidic protein, GFAP) and microglia (ionized calcium-binding adapter molecule 1, Iba1) were restricted to the needle track and the presence of microglia had diminished by 4 weeks post-infusion. No change in neurite outgrowth (Growth associated protein 43, GAP43, mRNA) compared to artificial cerebral spinal fluid (aCSF) control was observed with any infused concentration. Conclusion: The results of this study suggest that acute CED of low concentrations of GDNF, with dosing intervals determined by tissue clearance, has most potential for effective clinical translation by optimising distribution and minimising the risk of toxic accumulation.	[Taylor, Hannah; Barua, Neil; Bienemann, Alison; Wyatt, Marcella; Castrique, Emma; Foster, Rebecca; Gill, Steven] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Barua, Neil; Gill, Steven] Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England; [Luz, Matthias; Fibiger, Christian; Mohr, Erich] MedGenesis Therapeutix Inc, Victoria, BC, Canada	University of Bristol	Gill, S (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	steven.gill@nbt.nhs.uk	Foster, Rebecca/GSM-6886-2022	Luz, Matthias/0000-0001-6646-3655	Functional Neurosurgery Research Fund; Medgenesis Therapeutix Inc.	Functional Neurosurgery Research Fund; Medgenesis Therapeutix Inc.	Functional Neurosurgery Research Fund and Medgenesis Therapeutix Inc. The funders had no role in data collection and analysis, or decision to publish.	Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Alfano I, 2007, BIOCHEM J, V404, P131, DOI 10.1042/BJ20061747; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bienemann A, 2012, J NEUROSCI METH, V203, P284, DOI 10.1016/j.jneumeth.2011.10.002; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Clarkson ED, 1995, NEUROREPORT, V7, P145, DOI 10.1097/00001756-199512290-00035; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gimenez F, 2011, NEUROIMAGE, V54, pS189, DOI 10.1016/j.neuroimage.2010.01.023; Grondin R, 2003, J NEUROSCI, V23, P1974; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; Hou JGG, 1996, BRAIN RES, V724, P145, DOI 10.1016/0006-8993(96)00311-3; Hovland DN, 2007, TOXICOL PATHOL, V35, P1013, DOI 10.1177/01926230701481899; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kearns CM, 1997, J NEUROSCI, V17, P7111; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lang AE, 2006, LANCET NEUROL, V5, P200, DOI 10.1016/S1474-4422(06)70359-3; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Love S, 2005, NAT MED, V11, P703, DOI 10.1038/nm0705-703; Maswood N, 2002, NEUROBIOL AGING, V23, P881, DOI 10.1016/S0197-4580(02)00022-2; Morrison PF, 2007, J NEUROSURG, V107, P74, DOI 10.3171/JNS-07/07/0074; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Piltonen M, 2009, EXP NEUROL, V219, P499, DOI 10.1016/j.expneurol.2009.07.002; Salvatore MF, 2006, EXP NEUROL, V202, P497, DOI 10.1016/j.expneurol.2006.07.015; Sarabi A, 2001, J COMP NEUROL, V441, P106, DOI 10.1002/cne.1400; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Siew LK, 2004, J NEUROSCI METH, V139, P153, DOI 10.1016/j.jneumeth.2004.04.020; Slevin John T, 2006, Neurosurg Focus, V20, pE1; Sullivan AM, 1998, EUR J NEUROSCI, V10, P57; Tatarewicz SM, 2007, J CLIN IMMUNOL, V27, P620, DOI 10.1007/s10875-007-9117-8; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e56186	10.1371/journal.pone.0056186	http://dx.doi.org/10.1371/journal.pone.0056186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526931	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562600004
J	Kogel, T; Rudolf, R; Hodneland, E; Copier, J; Regazzi, R; Tooze, SA; Gerdes, HH				Kogel, Tanja; Rudolf, Rudiger; Hodneland, Erlend; Copier, John; Regazzi, Romano; Tooze, Sharon A.; Gerdes, Hans-Hermann			Rab3D Is Critical for Secretory Granule Maturation in PC12 Cells	PLOS ONE			English	Article							AP-1 ADAPTER COMPLEX; MYOSIN VA; NEUROENDOCRINE CELLS; SECRETOGRANIN-II; LINKS RAB27A; PROTEIN; EXOCYTOSIS; ACTIN; BIOGENESIS; TRANSPORT	Neuropeptide-and hormone-containing secretory granules (SGs) are synthesized at the trans-Golgi network (TGN) as immature secretory granules (ISGs) and complete their maturation in the F-actin-rich cell cortex. This maturation process is characterized by acidification-dependent processing of cargo proteins, condensation of the SG matrix and removal of membrane and proteins not destined to mature secretory granules (MSGs). Here we addressed a potential role of Rab3 isoforms in these maturation steps by expressing their nucleotide-binding deficient mutants in PC12 cells. Our data show that the presence of Rab3D(N135I) decreases the restriction of maturing SGs to the F-actin-rich cell cortex, blocks the removal of the endoprotease furin from SGs and impedes the processing of the luminal SG protein secretogranin II. This strongly suggests that Rab3D is implicated in the subcellular localization and maturation of ISGs.	[Kogel, Tanja; Hodneland, Erlend; Gerdes, Hans-Hermann] Univ Bergen, Dept Biomed, Bergen, Norway; [Rudolf, Rudiger; Gerdes, Hans-Hermann] Heidelberg Univ, Interdisciplinary Ctr Neurobiol, Heidelberg, Germany; [Copier, John; Tooze, Sharon A.] London Res Inst Canc Res United Kingdom, Lincolns Inn Fields Labs, London, England; [Regazzi, Romano] Univ Lausanne, Dept Fundamental Neurosci, CH-1000 Lausanne, Switzerland	University of Bergen; Ruprecht Karls University Heidelberg; University of Lausanne	Gerdes, HH (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	hans-hermann.gerdes@biomed.uib.no	Rudolf, Rüdiger/A-6476-2009	Rudolf, Rüdiger/0000-0002-0833-1053; Tooze, Sharon/0000-0002-2182-3116; Regazzi, Romano/0000-0002-9773-2915; Kogel, Tanja/0000-0002-3507-3395; Kogel, Tanja/0000-0002-6876-2998	Landesgraduiertenkolleg Baden-Wurttemberg, Germany; Studienstiftung des deutschen Volkes; SFB [Ge 550/3-1, Ge 550/3-2, Ge 550/3-3]; Norwegian Research Council; Norwegian Cancer Society; Cancer Research UK; Cancer Research UK [15153] Funding Source: researchfish	Landesgraduiertenkolleg Baden-Wurttemberg, Germany; Studienstiftung des deutschen Volkes; SFB(Austrian Science Fund (FWF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	TK was supported by stipends of the Landesgraduiertenkolleg Baden-Wurttemberg, Germany. R. Rudolf was supported by a stipend from the "Studienstiftung des deutschen Volkes". HHG was a recipient of grants of the SFB (Ge 550/3-1,-2,-3), the Norwegian Research Council and the Norwegian Cancer Society. ST and JC were supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahras M, 2006, J CELL BIOL, V173, P241, DOI 10.1083/jcb.200506163; Baldini G, 1998, J CELL BIOL, V140, P305, DOI 10.1083/jcb.140.2.305; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Dittie AS, 1996, J CELL BIOL, V132, P523, DOI 10.1083/jcb.132.4.523; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; Dittie AS, 1999, J CELL SCI, V112, P3955; Eaton BA, 2000, J NEUROSCI, V20, P7334; ERMAK TH, 1983, ANAT RECORD, V207, P487, DOI 10.1002/ar.1092070310; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; Ferraro F, 2007, MOL BIOL CELL; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda Mitsunori, 2004, Tanpakushitsu Kakusan Koso, V49, P2186; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Hannah MJ, 2003, J CELL SCI, V116, P3939, DOI 10.1242/jcs.00711; HEUMANN R, 1983, EXP CELL RES, V145, P179, DOI 10.1016/S0014-4827(83)80019-6; Huttner WB, 1989, CURR OPIN CELL BIOL, V1, P648, DOI 10.1016/0955-0674(89)90029-X; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; Kaether C, 1997, EUR J CELL BIOL, V74, P133; Kakhlon O, 2006, EMBO J, V25, P1590, DOI 10.1038/sj.emboj.7601067; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; Kogel T, 2010, TRAFFIC, V11, P637, DOI 10.1111/j.1600-0854.2010.01048.x; Kogel T, 2010, TRAFFIC; Martelli AM, 2000, TRAFFIC, V1, P976, DOI 10.1034/j.1600-0854.2000.011207.x; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Miller KE, 2000, J BIOL CHEM, V275, P2598, DOI 10.1074/jbc.275.4.2598; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; OHASHI M, 1994, J BIOL CHEM, V269, P24897; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Urbe S, 1997, BIOCHEM J, V321, P65, DOI 10.1042/bj3210065; Urbe S, 1998, J CELL BIOL, V143, P1831, DOI 10.1083/jcb.143.7.1831; van Weeren L, 2004, AM J RESP CELL MOL, V30, P288, DOI 10.1165/rcmb.2003-0264OC; Wu XF, 1998, CELL MOTIL CYTOSKEL, V40, P286, DOI 10.1002/(SICI)1097-0169(1998)40:3<286::AID-CM7>3.0.CO;2-B; Wu XF, 1997, J CELL SCI, V110, P847	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57321	10.1371/journal.pone.0057321	http://dx.doi.org/10.1371/journal.pone.0057321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526941	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000317562100011
J	Rola-Luszczak, M; Pluta, A; Olech, M; Donnik, I; Petropavlovskiy, M; Gerilovych, A; Vinogradova, I; Choudhury, B; Kuzmak, J				Rola-Luszczak, Marzena; Pluta, Aneta; Olech, Monika; Donnik, Irina; Petropavlovskiy, Maxim; Gerilovych, Anton; Vinogradova, Irina; Choudhury, Bhudipa; Kuzmak, Jacek			The Molecular Characterization of Bovine Leukaemia Virus Isolates from Eastern Europe and Siberia and Its Impact on Phylogeny	PLOS ONE			English	Article							ENV GENE; MUTATIONS; GENOTYPES; BLV; SUBSTITUTIONS; SEQUENCE; FUSION; MODEL; DNA	Recent studies have shown that bovine leukemia virus (BLV) sequences can be classified into seven distinct genotypes based on full gp51 sequence. This classification was based on available sequence data that mainly represented the BLV population that is circulating in cattle from the US and South America. In order to aid with a global perspective inclusion of data from Eastern Europe is required. In this study we examined 44 BLV isolates from different geographical regions of Poland, Belarus, Ukraine, and Russia. Phylogenetic analysis based on a 444bp fragment of env gene revealed that most of isolates belonged to genotypes 4 and 7. Furthermore, we confirmed the existence of a new genotype, genotype 8, which was highly supported by phylogenetic computations. A significant number of amino acid substitutions were found in the sequences of the studied Eastern European isolates, of which 71% have not been described previously. The substitutions encompassed mainly the C-part of the CD4+ epitope, zinc binding peptide region, CD8+ T cell epitope, and overlapping linear epitope E. These observations highlight the use of sequence data to both elucidate phylogenetic relationships and the potential effect on serological detection of geographically diverse isolates.	[Rola-Luszczak, Marzena; Pluta, Aneta; Olech, Monika; Kuzmak, Jacek] Natl Inst Vet Res, Dept Biochem, Pulawy, Poland; [Donnik, Irina; Petropavlovskiy, Maxim] State Sci Res Inst Vet Med, Ekaterinburg, Russia; [Gerilovych, Anton] Natl Sci Ctr Inst Expt & Clin Vet Med, Kharkov, Ukraine; [Vinogradova, Irina] All Russian Res Inst Anim Breeding, Dubrovitsy, Moscow Region, Russia; [Choudhury, Bhudipa] Anim Hlth & Vet Labs Agcy AHVLA, Dept Virol, New Haw, Surrey, England	National Veterinary Institute - National Research Institute; Russian Academy of Sciences; Ural Federal Agrarian Scientific Research Centre; National Academy of Agrarian Sciences of Ukraine; National Scientific Center "Institute of Experimental & Clinical Veterinary Medicine"; L.K. Ernst Federal Science Center for Animal Husbandry	Rola-Luszczak, M (corresponding author), Natl Inst Vet Res, Dept Biochem, Pulawy, Poland.	mrolka@piwet.pulawy.pl	Petropavlovskiy, Maxim/E-1178-2017; Donnik, Irina/AAD-4952-2022; Choudhury, Bhudipa/D-3863-2011; Donnik, Irina/R-6535-2017; Sergeevna, Krivonogova Anna/U-8086-2017; Vinogradova, Irina/GSO-2033-2022; Gerilovych, Anton/N-5608-2019	Petropavlovskiy, Maxim/0000-0002-9892-6092; Choudhury, Bhudipa/0000-0002-1392-6414; Rola-Luszczak, Marzena/0000-0003-3209-3427; Gerilovych, Anton/0000-0002-3280-4172; Donnik, Irina/0000-0002-8593-7470				Asfaw Y, 2005, ARCH VIROL, V150, P493, DOI 10.1007/s00705-004-0433-5; Balic D, 2012, ARCH VIROL, V157, P1281, DOI 10.1007/s00705-012-1300-4; Beier D, 2001, BERL MUNCH TIERARZTL, V114, P252; BRUCK C, 1984, VIROLOGY, V136, P20, DOI 10.1016/0042-6822(84)90244-7; Camargos MF, 2007, VIRUS GENES, V34, P343, DOI 10.1007/s11262-006-0011-x; Camargos MF, 2002, J VET MED B, V49, P325, DOI 10.1046/j.1439-0450.2002.00582.x; COULSTON J, 1990, J GEN VIROL, V71, P1737, DOI 10.1099/0022-1317-71-8-1737; Drummond AJ, 2010, GENEIOUS V5 5 CREATE; Dube S, 2000, VIROLOGY, V277, P379, DOI 10.1006/viro.2000.0622; Fechner H, 1997, VIROLOGY, V237, P261, DOI 10.1006/viro.1997.8784; Felmer R, 2005, VET MICROBIOL, V108, P39, DOI 10.1016/j.vetmic.2005.04.005; Gatot JS, 2002, J VIROL, V76, P7956, DOI 10.1128/JVI.76.16.7956-7967.2002; GHYSDAEL J, 1984, CURR TOP MICROBIOL, V112, P1; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Hall BG, 2006, ANN EPIDEMIOL, V16, P157, DOI 10.1016/j.annepidem.2005.04.010; Hemmatzadeh F, 2007, VET RES COMMUN, V31, P783, DOI 10.1007/s11259-007-0012-9; Inoue E, 2011, ARCH VIROL, V156, P1137, DOI 10.1007/s00705-011-0955-6; Johnson R., 1992, Veterinary Bulletin, V62, P287; Johnston ER, 2002, J VIROL, V76, P10861, DOI 10.1128/JVI.76.21.10861-10872.2002; Kettmann R., 1994, The retroviridae: Volume 3, P39; King A. M., 2012, VIRUS TAXONOMY CLASS; Licursi M, 2002, VIRUS RES, V86, P101, DOI 10.1016/S0168-1702(02)00059-X; MAMOUN RZ, 1990, J VIROL, V64, P4180, DOI 10.1128/JVI.64.9.4180-4188.1990; MANSKY LM, 1994, J VIROL, V68, P494, DOI 10.1128/JVI.68.1.494-499.1994; Matsumura K, 2011, VIRUS RES, V155, P343, DOI 10.1016/j.virusres.2010.11.005; Moratorio G, 2010, ARCH VIROL, V155, P481, DOI 10.1007/s00705-010-0606-3; Rodriguez SM, 2011, VIRUSES-BASEL, V3, P1210, DOI 10.3390/v3071210; Rodriguez SM, 2009, J GEN VIROL, V90, P2788, DOI 10.1099/vir.0.011791-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salemi M, 2003, PHYLOGENETIC HDB, P101; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WILLEMS L, 1993, J VIROL, V67, P1086, DOI 10.1128/JVI.67.2.1086-1089.1993; Zavorotinskaya T, 1999, J VIROL, V73, P5034, DOI 10.1128/JVI.73.6.5034-5042.1999; Zhao XR, 2007, GENOMICS, V89, P502, DOI 10.1016/j.ygeno.2006.12.007	35	50	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58705	10.1371/journal.pone.0058705	http://dx.doi.org/10.1371/journal.pone.0058705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527009	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562100036
J	Subramaniyan, M; Ecker, AS; Berens, P; Tolias, AS				Subramaniyan, Manivannan; Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.			Macaque Monkeys Perceive the Flash Lag Illusion	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; MOTION EXTRAPOLATION; MOVING-OBJECTS; PSYCHOPHYSICS; PERCEPTION; MECHANISMS; LATENCIES; MOVEMENT; DELAYS	Transmission of neural signals in the brain takes time due to the slow biological mechanisms that mediate it. During such delays, the position of moving objects can change substantially. The brain could use statistical regularities in the natural world to compensate neural delays and represent moving stimuli closer to real time. This possibility has been explored in the context of the flash lag illusion, where a briefly flashed stimulus in alignment with a moving one appears to lag behind the moving stimulus. Despite numerous psychophysical studies, the neural mechanisms underlying the flash lag illusion remain poorly understood, partly because it has never been studied electrophysiologically in behaving animals. Macaques are a prime model for such studies, but it is unknown if they perceive the illusion. By training monkeys to report their percepts unbiased by reward, we show that they indeed perceive the illusion qualitatively similar to humans. Importantly, the magnitude of the illusion is smaller in monkeys than in humans, but it increases linearly with the speed of the moving stimulus in both species. These results provide further evidence for the similarity of sensory information processing in macaques and humans and pave the way for detailed neurophysiological investigations of the flash lag illusion in behaving macaques.	[Subramaniyan, Manivannan; Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ecker, Alexander S.; Berens, Philipp] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Tolias, Andreas S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Tolias, Andreas S.] Rice Univ, Dept Computat & Appl Math, Houston, TX USA	Baylor College of Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society; Baylor College of Medicine; Rice University	Tolias, AS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	astolias@bcm.edu	Berens, Philipp/A-5653-2009; Ecker, Alexander S/A-5184-2010	Berens, Philipp/0000-0002-0199-4727; Ecker, Alexander S/0000-0003-2392-5105	National Eye Institute-United States National Institutes of Health (NIH) [R01 EY018847, 5-T32-EY07001-37, 5-P30-EY002520-33]; NIH-Pioneer award [DPI EY023176]; McKnight Endowment Fund; Arnold & Beckman Foundation; German Excellency Initiative through the Werner Reichardt Centre for Integrative Neuroscience Tubingen [EXC307, 2008/15]; German National Academic Foundation; NATIONAL EYE INSTITUTE [P30EY002520, T32EY007001, DP1EY023176, R01EY018847] Funding Source: NIH RePORTER	National Eye Institute-United States National Institutes of Health (NIH); NIH-Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund; Arnold & Beckman Foundation; German Excellency Initiative through the Werner Reichardt Centre for Integrative Neuroscience Tubingen; German National Academic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute-United States National Institutes of Health (NIH) Grants R01 EY018847, 5-T32-EY07001-37, 5-P30-EY002520-33, the NIH-Pioneer award DPI EY023176, the McKnight Endowment Fund, the Arnold & Beckman Foundation, the German Excellency Initiative through the Werner Reichardt Centre for Integrative Neuroscience Tubingen (EXC307), grant 2008/15 and the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2003, CURR BIOL, V13, P59, DOI 10.1016/S0960-9822(02)01402-1; Bachmann T, 2001, VISION RES, V41, P1103, DOI 10.1016/S0042-6989(01)00003-7; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Baldo MVC, 2002, PERCEPTION, V31, P17, DOI 10.1068/p3302; Bedell HE, 2000, J OPT SOC AM A, V17, P947, DOI 10.1364/JOSAA.17.000947; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brenner E, 2000, VISION RES, V40, P1645, DOI 10.1016/S0042-6989(00)00067-5; Dash S, 2009, J VISION, V9, DOI 10.1167/9.9.5; DOMINGUEZ KE, 1954, J GENET PSYCHOL, V85, P105, DOI 10.1080/00221325.1954.10532865; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Friedman HS, 1999, PERCEPTION, V28, P1383, DOI 10.1068/p2831; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Huang X, 2002, J NEUROSCI, V22, P9618; Jancke D, 2004, J PHYSIOL-LONDON, V556, P971, DOI 10.1113/jphysiol.2003.058941; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; Kerzel D, 2003, CURR BIOL, V13, P1975, DOI 10.1016/j.cub.2003.10.054; Kleiner M, 2007, PERCEPTION, V36, P14; Krekelberg B, 1999, VISION RES, V39, P2669, DOI 10.1016/S0042-6989(98)00287-9; Krekelberg B, 2000, VISION RES, V40, P201, DOI 10.1016/S0042-6989(99)00168-6; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Lebedev MA, 2001, J NEUROPHYSIOL, V85, P1395, DOI 10.1152/jn.2001.85.4.1395; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Libedinsky C, 2009, J VISION, V9, DOI 10.1167/9.1.14; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; MAGUIRE WM, 1980, INVEST OPHTH VIS SCI, V19, P321; Murakami I, 2001, VISION RES, V41, P3101, DOI 10.1016/S0042-6989(01)00193-6; Murakami I, 2001, J VISION, V1, P126, DOI 10.1167/1.2.6; Nijhawan R, 2003, CURR BIOL, V13, P749, DOI 10.1016/S0960-9822(03)00248-3; Nijhawan R, 2001, PERCEPTION, V30, P263, DOI 10.1068/p3172; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Ogmen H, 2004, VISION RES, V44, P2109, DOI 10.1016/j.visres.2004.04.003; Patel S S, 2000, Science, V290, P1051; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; Sary G, 2008, EUR J NEUROSCI, V28, P2137, DOI 10.1111/j.1460-9568.2008.06499.x; Schlag J, 2000, NATURE, V403, P38, DOI 10.1038/47402; Sheth BR, 2008, BEHAV BRAIN SCI, V31, P215, DOI 10.1017/S0140525X08003981; Sheth BR, 2000, NAT NEUROSCI, V3, P489, DOI 10.1038/74865; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023; WALKER JT, 1982, HUM FACTORS, V24, P213, DOI 10.1177/001872088202400207; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	48	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58788	10.1371/journal.pone.0058788	http://dx.doi.org/10.1371/journal.pone.0058788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527024	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100042
J	Mansour, H; McColm, JR; Cole, L; Weible, M; Korlimbinis, A; Chan-Ling, T				Mansour, Hussein; McColm, Janet R.; Cole, Louise; Weible, Michael, II; Korlimbinis, Anastasia; Chan-Ling, Tailoi			Connexin 30 Expression and Frequency of Connexin Heterogeneity in Astrocyte Gap Junction Plaques Increase with Age in the Rat Retina	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CULTURED ASTROCYTES; GLIAL-CELLS; VESSEL STABILITY; FREEZE-FRACTURE; MAUTHNER CELL; HUMAN BRAIN; BLOOD-FLOW; CHANNELS; RODENT	We investigated age-associated changes in retinal astrocyte connexins (Cx) by assaying Cx numbers, plaque sizes, protein expression levels and heterogeneity of gap junctions utilizing six-marker immunohistochemistry (IHC). We compared Wistar rat retinal wholemounts in animals aged 3 (young adult), 9 (middle-aged) and 22 months (aged). We determined that retinal astrocytes have gap junctions composed of Cx26, -30, -43 and -45. Cx30 was consistently elevated at 22 months compared to younger ages both when associated with parenchymal astrocytes and vascular-associated astrocytes. Not only was the absolute number of Cx30 plaques significantly higher (P<0.05) but the size of the plaques was significantly larger at 22 months compared to younger ages (p<0.05). With age, Cx26 increased significantly initially, but returned to basal levels; whereas Cx43 expression remained low and stable with age. Evidence that astrocytes alter connexin compositions of gap junctions was demonstrated by the significant increase in the number of Cx26/Cx45 gap junctions with age. We also found gap junctions comprised of 1, 2, 3 or 4 Cx proteins suggesting that retinal astrocytes use various connexin protein combinations in their gap junctions during development and aging. These data provides new insight into the dynamic and extensive Cx network utilized by retinal astrocytes for communication within both the parenchyma and vasculature for the maintenance of normal retinal physiology with age. This characterisation of the changes in astrocytic gap junctional communication with age in the CNS is crucial to the understanding of physiological aging and age-related neurodegenerative diseases.	[Mansour, Hussein; McColm, Janet R.; Weible, Michael, II; Korlimbinis, Anastasia; Chan-Ling, Tailoi] Univ Sydney, Sch Med Sci, Dept Anat, Sydney, NSW 2006, Australia; [Mansour, Hussein; McColm, Janet R.; Weible, Michael, II; Korlimbinis, Anastasia; Chan-Ling, Tailoi] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Cole, Louise] Univ Sydney, Adv Microscopy Facil, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Chan-Ling, T (corresponding author), Univ Sydney, Sch Med Sci, Dept Anat, Sydney, NSW 2006, Australia.	tailoi@anatomy.usyd.edu.au	Chan-Ling, Tailoi/X-2718-2019; Chan-Ling, Tailoi/A-2177-2008; Mansour, Hussein/S-2883-2019	Chan-Ling, Tailoi/0000-0002-8225-3671; Mansour, Hussein/0000-0002-9559-3229; Higgins, Janet/0000-0002-5342-382X; Cole, Louise/0000-0001-9206-9272	National Health and Medical Research Council of Australia [1005730, 571100]; Baxter Charitable Foundation; Rebecca L. Cooper Medical Research Foundation (Sydney, Australia); Brian M. Kirby Foundation (Gift of Sight Initiative); University of Sydney Medical Foundation/Blues and Research Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Baxter Charitable Foundation; Rebecca L. Cooper Medical Research Foundation (Sydney, Australia); Brian M. Kirby Foundation (Gift of Sight Initiative); University of Sydney Medical Foundation/Blues and Research Scholarship(University of Sydney)	This work was supported by grants to TC-L from the National Health and Medical Research Council of Australia (Nos. 1005730 and 571100), the Baxter Charitable Foundation, the Rebecca L. Cooper Medical Research Foundation (Sydney, Australia) and the Brian M. Kirby Foundation (Gift of Sight Initiative). HM was the recipient of a University of Sydney Medical Foundation/Blues and Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Ball KK, 2011, J NEUROSCIENCE RES; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Beyer EC, 2001, CELL COMMUN ADHES, V8, P199, DOI 10.3109/15419060109080723; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Chan-Ling T, 2007, MICROCIRCULATION, V14, P63, DOI 10.1080/10739680601073451; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; ChanLing T, 1997, MICROSC RES TECHNIQ, V36, P1; COLLIER TJ, 1991, NEUROBIOL AGING, V12, P685, DOI 10.1016/0197-4580(91)90122-Z; Cotrina ML, 2001, BRAIN RES, V901, P55, DOI 10.1016/S0006-8993(01)02258-2; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Harman AM, 2003, GERONTOLOGY, V49, P350, DOI 10.1159/000073762; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hughes S, 2000, MICROCIRCULATION, V7, P317, DOI 10.1038/sj.mn.7300119; Hughes S, 2006, NEUROBIOL AGING, V27, P1838, DOI 10.1016/j.neurobiolaging.2005.10.021; Janssen-Bienhold U, 1998, J COMP NEUROL, V396, P310, DOI 10.1002/(SICI)1096-9861(19980706)396:3<310::AID-CNE3>3.0.CO;2-5; Kerr NM, 2010, INVEST OPHTH VIS SCI, V51, P4028, DOI 10.1167/iovs.09-4847; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Kruger O, 2000, DEVELOPMENT, V127, P4179; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Kuo IY, 2008, J COMP NEUROL, V511, P773, DOI 10.1002/cne.21873; Li X, 2001, AM J PHYSIOL-HEART C, V281, pH1890, DOI 10.1152/ajpheart.2001.281.5.H1890; Li X, 2008, J NEUROSCI, V28, P9769, DOI 10.1523/JNEUROSCI.2137-08.2008; Mansour H, 2008, AGING CELL, V7, P526, DOI 10.1111/j.1474-9726.2008.00402.x; Manthey D, 2001, J MEMBRANE BIOL, V181, P137, DOI 10.1007/s00232-001-0017-1; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; NAKAJIMA Y, 1987, J ELECTRON MICR TECH, V6, P143, DOI 10.1002/jemt.1060060205; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; ROBINSON SR, 1993, SCIENCE, V262, P1072; Rouach N, 2004, NEUROCHEM INT, V45, P265, DOI 10.1016/j.neuint.2003.07.004; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; TUTTLE R, 1986, J COMP NEUROL, V246, P202, DOI 10.1002/cne.902460206; Vis JC, 1998, CELL BIOL INT, V22, P837, DOI 10.1006/cbir.1998.0388; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zahs KR, 2006, VISUAL NEUROSCI, V23, P1, DOI 10.1017/S0952523806231018; Zahs KR, 2003, J COMP NEUROL, V455, P531, DOI 10.1002/cne.10524	50	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57038	10.1371/journal.pone.0057038	http://dx.doi.org/10.1371/journal.pone.0057038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516399	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400006
J	Nicolau, DV; Paszek, E; Fulga, F; Nicolau, DV				Nicolau, Dan V.; Paszek, Ewa; Fulga, Florin; Nicolau, Dan V., Jr.			Protein Molecular Surface Mapped at Different Geometrical Resolutions	PLOS ONE			English	Article							VORONOI DIAGRAM; SHAPE; AREA; ADSORPTION; HYDROPHOBICITY; RECOGNITION; EFFICIENT; PACKING; VOLUME; HEMOGLOBIN	Many areas of biochemistry and molecular biology, both fundamental and applications-orientated, require an accurate construction, representation and understanding of the protein molecular surface and its interaction with other, usually small, molecules. There are however many situations when the protein molecular surface gets in physical contact with larger objects, either biological, such as membranes, or artificial, such as nanoparticles. The contribution presents a methodology for describing and quantifying the molecular properties of proteins, by geometrical and physico-chemical mapping of the molecular surfaces, with several analytical relationships being proposed for molecular surface properties. The relevance of the molecular surface-derived properties has been demonstrated through the calculation of the statistical strength of the prediction of protein adsorption. It is expected that the extension of this methodology to other phenomena involving proteins near solid surfaces, in particular the protein interaction with nanoparticles, will result in important benefits in the understanding and design of protein-specific solid surfaces.	[Nicolau, Dan V.; Paszek, Ewa; Fulga, Florin] Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England; [Nicolau, Dan V.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Nicolau, Dan V., Jr.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Liverpool; McGill University; University of California System; University of California Berkeley	Nicolau, DV (corresponding author), Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England.	dan.nicolau@mcgill.ca		Nicolau, Dan V/0000-0002-9956-0600	Defense Advanced Research Projects Agency (DARPA) [F30602-00-2-0614]; European Union Seventh Framework Programme [214538]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Union Seventh Framework Programme(European Commission)	This work has been supported by the Defense Advanced Research Projects Agency (DARPA), under SymBioSys Program, Grant Contract No. F30602-00-2-0614); and by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 214538, project Bio-Inspired Self-assembled Nano-Enabled Surfaces (BISNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayeyard J, 2010, MICROELECTRON ENG, V87, P760, DOI 10.1016/j.mee.2009.11.136; Banerji A, 2011, CELL MOL LIFE SCI, V68, P2711, DOI 10.1007/s00018-011-0722-6; Banerji A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007361; Banerji A, 2009, EUR BIOPHYS J BIOPHY, V38, P577, DOI 10.1007/s00249-009-0409-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Brockwell DJ, 2000, CURR OPIN STRUC BIOL, V10, P16, DOI 10.1016/S0959-440X(99)00043-3; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1985, J APPL CRYSTALLOGR, V18, P499, DOI 10.1107/S0021889885010779; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Cristea PD, 2012, MATER SCI FORUM, V721, P319, DOI 10.4028/www.scientific.net/MSF.721.319; Dawson KA, 2009, NAT NANOTECHNOL, V4, P84, DOI 10.1038/nnano.2008.426; DODD LR, 1991, MOL PHYS, V72, P1313, DOI 10.1080/00268979100100941; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y; Fersht A., 1985, ENZYME STRUCTURE MEC; Filipponi L, 2009, BIOSENS BIOELECTRON, V24, P1850, DOI 10.1016/j.bios.2008.09.015; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; GIBSON KD, 1988, MOL PHYS, V64, P641, DOI 10.1080/00268978800100453; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; Hawkins KR, 2007, LAB CHIP, V7, P281, DOI 10.1039/b612894g; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; Kavanaugh JS, 1998, BIOCHEMISTRY-US, V37, P4358, DOI 10.1021/bi9708702; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; KELLOGG GE, 1991, J COMPUT AID MOL DES, V5, P545, DOI 10.1007/BF00135313; Kim DS, 2006, COMPUT AIDED DESIGN, V38, P431, DOI 10.1016/j.cad.2005.11.008; Kim D, 2008, J MOL GRAPH MODEL, V26, P1104, DOI 10.1016/j.jmgm.2007.10.002; Kinjo AR, 2005, BIOINFORMATICS, V21, P2167, DOI 10.1093/bioinformatics/bti330; Kinjo AR, 2005, PROTEINS, V58, P158, DOI 10.1002/prot.20300; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202; LEGRAND SM, 1993, J COMPUT CHEM, V14, P349, DOI 10.1002/jcc.540140309; Lin SL, 1996, J MOL GRAPHICS, V14, P78, DOI 10.1016/0263-7855(96)00030-6; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Mukhopadhyay R, 2006, ANAL CHEM, V78, P7379, DOI 10.1021/ac069476c; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; Nicolau DV, 2008, LANGMUIR, V24, P4420, DOI 10.1021/la8004486; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; Putta S, 2007, CURR TOP MED CHEM, V7, P1514, DOI 10.2174/156802607782194770; Rawat N, 2012, J PHYS CHEM B, V116, P6326, DOI 10.1021/jp3016529; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rosen M, 1998, PROTEIN ENG, V11, P263, DOI 10.1093/protein/11.4.263; Ryu J, 2007, COMPUT AIDED DESIGN, V39, P1042, DOI 10.1016/j.cad.2006.10.008; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Sawant PD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2132080; Scarsi M, 1999, PROTEINS, V37, P565, DOI 10.1002/(SICI)1097-0134(19991201)37:4<565::AID-PROT7>3.0.CO;2-V; Serdyuk IN, 1997, BIOFIZIKA, V42, P1206; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Vasina EN, 2009, LAB CHIP, V9, P891, DOI 10.1039/b813475h; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang B, 2008, P NATL ACAD SCI USA, V105, P18171, DOI 10.1073/pnas.0807296105; WANG HJ, 1991, J COMPUT CHEM, V12, P868, DOI 10.1002/jcc.540120712; Wilson R, 2011, ANGEW CHEM INT EDIT, V50, P2151, DOI 10.1002/anie.201005975; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; ZAUHAR RJ, 1990, J COMPUT CHEM, V11, P603, DOI 10.1002/jcc.540110509	73	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58896	10.1371/journal.pone.0058896	http://dx.doi.org/10.1371/journal.pone.0058896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516572	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400074
J	Chen, J; Ingham, N; Clare, S; Raisen, C; Vancollie, VE; Ismail, O; McIntyre, RE; Tsang, SH; Mahajan, VB; Dougan, G; Adams, DJ; White, JK; Steel, KP				Chen, Jing; Ingham, Neil; Clare, Simon; Raisen, Claire; Vancollie, Valerie E.; Ismail, Ozama; McIntyre, Rebecca E.; Tsang, Stephen H.; Mahajan, Vinit B.; Dougan, Gordon; Adams, David J.; White, Jacqueline K.; Steel, Karen P.			Mcph1-Deficient Mice Reveal a Role for MCPH1 in Otitis Media	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; EUSTACHIAN-TUBE; MITOTIC ENTRY; MOUSE MODEL; INNER-EAR; HEARING; ULTRASTRUCTURE; SUSCEPTIBILITY; HERITABILITY; DYSFUNCTION	Otitis media is a common reason for hearing loss, especially in children. Otitis media is a multifactorial disease and environmental factors, anatomic dysmorphology and genetic predisposition can all contribute to its pathogenesis. However, the reasons for the variable susceptibility to otitis media are elusive. MCPH1 mutations cause primary microcephaly in humans. So far, no hearing impairment has been reported either in the MCPH1 patients or mouse models with Mcph1 deficiency. In this study, Mcph1-deficient (Mcph1(tm1a/tm1a)) mice were produced using embryonic stem cells with a targeted mutation by the Sanger Institute's Mouse Genetics Project. Auditory brainstem response measurements revealed that Mcph1(tm1a/tm1a) mice had mild to moderate hearing impairment with around 70% penetrance. We found otitis media with effusion in the hearing-impaired Mcph1(tm1a/tm1a) mice by anatomic and histological examinations. Expression of Mcph1 in the epithelial cells of middle ear cavities supported its involvement in the development of otitis media. Other defects of Mcph1(tm1a/tm1a) mice included small skull sizes, increased micronuclei in red blood cells, increased B cells and ocular abnormalities. These findings not only recapitulated the defects found in other Mcph1-deficient mice or MCPH1 patients, but also revealed an unexpected phenotype, otitis media with hearing impairment, which suggests Mcph1 is a new gene underlying genetic predisposition to otitis media.	[Chen, Jing; Ingham, Neil; Clare, Simon; Raisen, Claire; Vancollie, Valerie E.; Ismail, Ozama; McIntyre, Rebecca E.; Dougan, Gordon; Adams, David J.; White, Jacqueline K.; Steel, Karen P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Tsang, Stephen H.] Columbia Univ, Edward S Harkness Eye Inst, New York, NY USA; [Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Omics Lab, Iowa City, IA USA	Wellcome Trust Sanger Institute; Columbia University; University of Iowa	Steel, KP (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	karen.steel@kcl.ac.uk	Ismail, Ozama/AFQ-9517-2022	Mahajan, Vinit/0000-0003-1886-1741; Ismail, Ozama/0000-0002-0871-3924; Adams, David/0000-0001-9490-0306	Wellcome Trust [098051]; Medical Research Council [G0300212]; European Commission (EUMODIC) [LSHG-CT-2006-037188]; Cancer Research UK [C20510/A13031]; NATIONAL EYE INSTITUTE [R01EY018213, P30EY019007] Funding Source: NIH RePORTER; Cancer Research UK [13031, 12401] Funding Source: researchfish; Medical Research Council [MC_qA137918] Funding Source: researchfish; MRC [G0300212, MC_qA137918] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission (EUMODIC)(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant number 098051) www.wellcome.ac.uk, Medical Research Council (grant number G0300212) http://www.mrc.ac.uk, European Commission (EUMODIC contract no. LSHG-CT-2006-037188) www.eumodic.org and Cancer Research UK (grant number C20510/A13031) http://www.cancerresearchuk.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; CHOLE RA, 1985, ACTA OTO-LARYNGOL, V100, P273, DOI 10.3109/00016488509104790; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; GLODDEK B, 1992, LARYNGOSCOPE, V102, P177; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Harkness P, 1998, LARYNGOSCOPE, V108, P1539, DOI 10.1097/00005537-199810000-00021; HENTZER E, 1984, ACTA OTO-LARYNGOL, P19; Hilton JM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r90; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; IZHAR M, 1990, INFECT IMMUN, V58, P2258, DOI 10.1128/IAI.58.7.2258-2261.1990; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Jero J, 2001, ACTA OTO-LARYNGOL, V121, P585, DOI 10.1080/000164801316878863; Juhn SK, 1997, ANN NY ACAD SCI, V830, P130, DOI 10.1111/j.1749-6632.1997.tb51885.x; Kawauchi H, 1989, ACTA OTO-LARYNGOL, V457, P100; Kubba H, 2000, CLIN OTOLARYNGOL, V25, P181, DOI 10.1046/j.1365-2273.2000.00350.x; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukens A, 2012, EUR RADIOL, V22, P533, DOI 10.1007/s00330-011-2303-3; MacArthur CJ, 2006, HEARING RES, V219, P12, DOI 10.1016/j.heares.2006.05.012; Mahajan VB, 2011, J VIS EXP; Marseglia GL, 2011, INT J IMMUNOPATH PH, V24, P1, DOI 10.1177/03946320110240S401; Miura M, 2002, INT J PEDIATR OTORHI, V64, P207, DOI 10.1016/S0165-5876(02)00070-8; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Ryding M, 2002, ANN OTO RHINOL LARYN, V111, P261, DOI 10.1177/000348940211100311; Rye MS, 2011, MAMM GENOME, V22, P66, DOI 10.1007/s00335-010-9295-1; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Shima N, 2003, GENETICS, V163, P1031; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SORRI M, 1995, ACTA OTO-LARYNGOL, V115, P193, DOI 10.3109/00016489509139290; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; SUZUKI M, 1989, ANN OTO RHINOL LARYN, V98, P980, DOI 10.1177/000348948909801212; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yoshida K, 1999, HEARING RES, V137, P155, DOI 10.1016/S0378-5955(99)00134-3	45	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58156	10.1371/journal.pone.0058156	http://dx.doi.org/10.1371/journal.pone.0058156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516444	Green Published, gold			2022-12-25	WOS:000316849200039
J	Jia, CH; Hayoz, S; Hutch, CR; Iqbal, TR; Pooley, AE; Hegg, CC				Jia, Cuihong; Hayoz, Sebastien; Hutch, Chelsea R.; Iqbal, Tania R.; Pooley, Apryl E.; Hegg, Colleen C.			An IP3R3-and NPY-Expressing Microvillous Cell Mediates Tissue Homeostasis and Regeneration in the Mouse Olfactory Epithelium	PLOS ONE			English	Article							PURINERGIC RECEPTOR ACTIVATION; NEUROPEPTIDE-Y; NEURONAL DIFFERENTIATION; CALCIUM; RELEASE; NEUROGENESIS; SIGNAL; ADULT; SYSTEM; ATP	Calcium-dependent release of neurotrophic factors plays an important role in the maintenance of neurons, yet the release mechanisms are understudied. The inositol triphosphate (IP3) receptor is a calcium release channel that has a physiological role in cell growth, development, sensory perception, neuronal signaling and secretion. In the olfactory system, the IP3 receptor subtype 3 (IP3R3) is expressed exclusively in a microvillous cell subtype that is the predominant cell expressing neurotrophic factor neuropeptide Y (NPY). We hypothesized that IP3R3-expressing microvillous cells secrete sufficient NPY needed for both the continual maintenance of the neuronal population and for neuroregeneration following injury. We addressed this question by assessing the release of NPY and the regenerative capabilities of wild type, IP3R3(+/-), and IP3R3(-/-) mice. Injury, simulated using extracellular ATP, induced IP3 receptor-mediated NPY release in wild-type mice. ATP-evoked NPY release was impaired in IP3R3(-/-) mice, suggesting that IP3R3 contributes to NPY release following injury. Under normal physiological conditions, both IP3R3(-/-) mice and explants from these mice had fewer progenitor cells that proliferate and differentiate into immature neurons. Although the number of mature neurons and the in vivo rate of proliferation were not altered, the proliferative response to the olfactotoxicant satratoxin G and olfactory bulb ablation injury was compromised in the olfactory epithelium of IP3R3(-/-) mice. The reductions in both NPY release and number of progenitor cells in IP3R3(-/-) mice point to a role of the IP3R3 in tissue homeostasis and neuroregeneration. Collectively, these data suggest that IP3R3 expressing microvillous cells are actively responsive to injury and promote recovery.	[Jia, Cuihong; Hayoz, Sebastien; Hegg, Colleen C.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Hutch, Chelsea R.; Iqbal, Tania R.; Pooley, Apryl E.; Hegg, Colleen C.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Hutch, Chelsea R.; Hegg, Colleen C.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Hegg, CC (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA.	hegg@msu.edu	Pooley, Apryl/K-6592-2019	Iqbal, Tania/0000-0002-6982-7650	NIH [DC006897]; MSU institutional funds; NIEHS [T32 ES007255]; NINDS [T32 NS044928]; Swiss Fellowship for Advanced Researchers [PA 00P3_131493]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS044928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSU institutional funds; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss Fellowship for Advanced Researchers; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by NIH DC006897 and MSU institutional funds. CRH was supported by NIEHS T32 ES007255. TRI and AP was supported by NINDS T32 NS044928. SH was supported by Swiss Fellowship for Advanced Researchers PA 00P3_131493. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Bauer S, 2003, J NEUROSCI, V23, P1792; BERNATH S, 1988, NEUROSCIENCE, V27, P563, DOI 10.1016/0306-4522(88)90289-8; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLONDEL O, 1994, J BIOL CHEM, V269, P27167; Carr VM, 1998, J NEUROBIOL, V34, P377, DOI 10.1002/(SICI)1097-4695(199803)34:4<377::AID-NEU7>3.0.CO;2-3; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cowan CM, 2002, MICROSC RES TECHNIQ, V58, P204, DOI 10.1002/jemt.10150; Doyle KL, 2008, J NEUROCHEM, V105, P641, DOI 10.1111/j.1471-4159.2007.05188.x; Elsaesser R, 2005, EUR J NEUROSCI, V21, P2692, DOI 10.1111/j.1460-9568.2005.04108.x; Fang KM, 2009, J NEUROCHEM, V111, P1225, DOI 10.1111/j.1471-4159.2009.06409.x; Fukuda N, 2008, EUR J NEUROSCI, V27, P2665, DOI 10.1111/j.1460-9568.2008.06240.x; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gayle S, 2005, CELL TISSUE RES, V319, P27, DOI 10.1007/s00441-004-0979-2; Goetze B, 2002, CHEM SENSES, V27, P817, DOI 10.1093/chemse/27.9.817; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Gutierrez-Martin Y, 2011, J BIOL CHEM, V286, P11370, DOI 10.1074/jbc.M110.139410; Hansel DE, 2001, J NEUROSCI RES, V66, P1, DOI 10.1002/jnr.1191; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hayoz S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-53; Hegg CC, 2006, GLIA, V53, P182, DOI 10.1002/glia.20258; Hegg CC, 2003, J NEUROSCI, V23, P8291; Hegg CC, 2010, EUR J NEUROSCI, V32, P1632, DOI 10.1111/j.1460-9568.2010.07449.x; Huard JMT, 1998, J COMP NEUROL, V400, P469; Jia C, 2011, NEUROSCIENCE, V177, P335, DOI 10.1016/j.neuroscience.2010.12.039; Jia C, 2009, NEUROSCIENCE, V163, P120, DOI 10.1016/j.neuroscience.2009.06.040; Jia CH, 2012, MOL CELL NEUROSCI, V49, P158, DOI 10.1016/j.mcn.2011.11.004; Jia CH, 2011, TOXICOL SCI, V124, P169, DOI 10.1093/toxsci/kfr213; Jia CH, 2010, TOXICOL SCI, V115, P547, DOI 10.1093/toxsci/kfq071; Jia CH, 2010, NEUROBIOL DIS, V38, P405, DOI 10.1016/j.nbd.2010.02.013; Kanekar S, 2009, J NEUROSCI RES, V87, P1424, DOI 10.1002/jnr.21954; LAZAROWSKI ER, 1995, BRIT J PHARMACOL, V116, P1619, DOI 10.1111/j.1476-5381.1995.tb16382.x; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; MacDonald KPA, 1996, J NEUROSCI RES, V44, P27, DOI 10.1002/(SICI)1097-4547(19960401)44:1<27::AID-JNR4>3.0.CO;2-K; Mackay-Sim A, 2000, PROG NEUROBIOL, V62, P527, DOI 10.1016/S0301-0082(00)00009-5; Montani G, 2006, EUR J NEUROSCI, V24, P20, DOI 10.1111/j.1460-9568.2006.04878.x; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Nucifora FC, 1996, MOL BIOL CELL, V7, P949, DOI 10.1091/mbc.7.6.949; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; Sharp AH, 1999, J COMP NEUROL, V406, P207; Trudeau LE, 1996, J NEUROSCI, V16, P46; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Young J T, 1981, Fundam Appl Toxicol, V1, P309, DOI 10.1016/S0272-0590(81)80037-1	46	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58668	10.1371/journal.pone.0058668	http://dx.doi.org/10.1371/journal.pone.0058668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516531	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200105
J	Maki-Marttunen, T; Kesseli, J; Nykter, M				Maki-Marttunen, Tuomo; Kesseli, Juha; Nykter, Matti			Balance between Noise and Information Flow Maximizes Set Complexity of Network Dynamics	PLOS ONE			English	Article								Boolean networks have been used as a discrete model for several biological systems, including metabolic and genetic regulatory networks. Due to their simplicity they offer a firm foundation for generic studies of physical systems. In this work we show, using a measure of context-dependent information, set complexity, that prior to reaching an attractor, random Boolean networks pass through a transient state characterized by high complexity. We justify this finding with a use of another measure of complexity, namely, the statistical complexity. We show that the networks can be tuned to the regime of maximal complexity by adding a suitable amount of noise to the deterministic Boolean dynamics. In fact, we show that for networks with Poisson degree distributions, all networks ranging from subcritical to slightly supercritical can be tuned with noise to reach maximal set complexity in their dynamics. For networks with a fixed number of inputs this is true for near-to-critical networks. This increase in complexity is obtained at the expense of disruption in information flow. For a large ensemble of networks showing maximal complexity, there exists a balance between noise and contracting dynamics in the state space. In networks that are close to critical the intrinsic noise required for the tuning is smaller and thus also has the smallest effect in terms of the information processing in the system. Our results suggest that the maximization of complexity near to the state transition might be a more general phenomenon in physical systems, and that noise present in a system may in fact be useful in retaining the system in a state with high information content.	[Maki-Marttunen, Tuomo; Kesseli, Juha; Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Maki-Marttunen, Tuomo] Tampere Univ Technol, Dept Math, FIN-33101 Tampere, Finland	Tampere University; Tampere University	Maki-Marttunen, T (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	tuomo.maki-marttunen@tut.fi		Maki-Marttunen, Tuomo/0000-0002-7082-2507	TISE doctoral school; Academy of Finland [132877, 251937]	TISE doctoral school; Academy of Finland(Academy of Finland)	This work was funded by TISE doctoral school and Academy of Finland projects 132877, 251937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M., 2003, BOOLEAN DYNAMICS RAN, P23; ALON N, 1987, COMBINATORICA, V7, P1, DOI 10.1007/BF02579196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; CLEARY JG, 1984, IEEE T COMMUN, V32, P396, DOI 10.1109/TCOM.1984.1096090; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; DERRIDA B, 1986, J PHYS-PARIS, V47, P1297, DOI 10.1051/jphys:019860047080129700; DERRIDA B, 1986, EUROPHYS LETT, V2, P739, DOI 10.1209/0295-5075/2/10/001; Galas DJ, 2010, IEEE T INFORM THEORY, V56, P667, DOI 10.1109/TIT.2009.2037046; GALBIATI G, 1981, THEOR COMPUT SCI, V16, P177, DOI 10.1016/0304-3975(81)90074-8; Gershenson C, 2004, ARTIFICIAL LIFE IX, P238; Gong XW, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066107; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; Hahne L, 2011, TICSP SERIES; Harvey I, 1997, FROM ANIM ANIMAT, P67; Ignac TM, 2012, COMPLEXITY, V17, P23, DOI 10.1002/cplx.21383; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Krawitz P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158701; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Lizier JT, 2011, ARTIF LIFE, V17, P293, DOI 10.1162/artl_a_00040; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maki-Marttunen T., 2011, TICSP SERIES; Maki-Marttunen T, 2011, FRONTIERS COMPUTATIO, P5; Mesot B, 2003, LECT NOTES ARTIF INT, V2801, P367; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Nykter M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058702; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Peixoto TP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036108; Ramo P, 2007, PHYSICA D, V227, P100, DOI 10.1016/j.physd.2006.12.005; Ribeiro AS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011901; Sakhanenko NA, 2011, COMPLEXITY, V17, P51, DOI 10.1002/cplx.20382; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; SHALIZI C. R, 2003, DISCRETE MATH THEOR, VAB, P11; Shalizi CR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118701; Shiner JS, 1999, PHYS REV E, V59, P1459, DOI 10.1103/PhysRevE.59.1459; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	46	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56523	10.1371/journal.pone.0056523	http://dx.doi.org/10.1371/journal.pone.0056523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516395	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200004
J	Wood, M; Rae, GM; Wu, RM; Walton, EF; Xue, B; Hellens, RP; Uversky, VN				Wood, Marion; Rae, Georgina M.; Wu, Rong-Mei; Walton, Eric F.; Xue, Bin; Hellens, Roger P.; Uversky, Vladimir N.			Actinidia DRM1-An Intrinsically Disordered Protein Whose mRNA Expression Is Inversely Correlated with Spring Budbreak in Kiwifruit	PLOS ONE			English	Article							AXILLARY BUD OUTGROWTH; COLD-ACCLIMATION; HYDROGEN CYANAMIDE; DORMANCY INDUCTION; RELEASE; IDENTIFICATION; GROWTH; PHOTOPERIOD; DISCOVERY; GENES	Intrinsically disordered proteins (IDPs) are a relatively recently defined class of proteins which, under native conditions, lack a unique tertiary structure whilst maintaining essential biological functions. Functional classification of IDPs have implicated such proteins as being involved in various physiological processes including transcription and translation regulation, signal transduction and protein modification. Actinidia DRM1 (Ade DORMANCY ASSOCIATED GENE 1), represents a robust dormancy marker whose mRNA transcript expression exhibits a strong inverse correlation with the onset of growth following periods of physiological dormancy. Bioinformatic analyses suggest that DRM1 is plant specific and highly conserved at both the nucleotide and protein levels. It is predicted to be an intrinsically disordered protein with two distinct highly conserved domains. Several Actinidia DRM1 homologues, which align into two distinct Actinidia-specific families, Type I and Type II, have been identified. No candidates for the Arabidopsis DRM1-Homologue (AtDRM2) an additional family member, has been identified in Actinidia.	[Wood, Marion; Rae, Georgina M.; Wu, Rong-Mei; Hellens, Roger P.] New Zealand Inst Plant & Food Res Ltd, Genom Res, Auckland, New Zealand; [Walton, Eric F.] Univ Otago, Auckland, New Zealand; [Xue, Bin; Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	New Zealand Institute for Plant & Food Research Ltd; University of Otago; State University System of Florida; University of South Florida; Russian Academy of Sciences	Wood, M (corresponding author), New Zealand Inst Plant & Food Res Ltd, Genom Res, Auckland, New Zealand.	marion.wood@plantandfood.co.nz	Wood, Marion/A-5995-2019; Uversky, Vladimir N./F-4515-2011	Wood, Marion/0000-0002-7161-315X; Uversky, Vladimir N./0000-0002-4037-5857; Hellens, Roger/0000-0003-2094-0887	New Zealand Kiwifruit Royalty Investment Programme KRIP: Regulation of Dormancy; Programs of the Russian Academy of Sciences for the 'Molecular and Cellular Biology'	New Zealand Kiwifruit Royalty Investment Programme KRIP: Regulation of Dormancy; Programs of the Russian Academy of Sciences for the 'Molecular and Cellular Biology'	This work was funded by the New Zealand Kiwifruit Royalty Investment Programme KRIP: Regulation of Dormancy and supported in part by the Programs of the Russian Academy of Sciences for the 'Molecular and Cellular Biology' (to V.N.U). The funders had no role in study design, data collection and analysis, decision to publish to preparation of the manuscript.	Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; BRUNDELL D J, 1976, Scientia Horticulturae (Amsterdam), V4, P175, DOI 10.1016/S0304-4238(76)80010-6; Chakravarthy S, 2010, MOL PLANT MICROBE IN, V23, P715, DOI 10.1094/MPMI-23-6-0715; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; Emes Michael J, 2009, Biochem J, V422, pe1, DOI 10.1042/BJ20091063; Faust M, 1997, HORTSCIENCE, V32, P623, DOI 10.21273/HORTSCI.32.4.623; FENNELL A, 1991, J AM SOC HORTIC SCI, V116, P270, DOI 10.21273/JASHS.116.2.270; Finlayson SA, 2007, PLANT CELL PHYSIOL, V48, P667, DOI 10.1093/pcp/pcm044; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Huang F, 2012, BIOCOMPUT-PAC SYM, P128; Hwang EW, 2005, J BIOSCIENCE, V30, P101; Kebrom TH, 2010, PLANT CELL ENVIRON, V33, P48, DOI 10.1111/j.1365-3040.2009.02050.x; Kim HB, 2007, MOL CELLS, V23, P115; Kovalchuk I., 2010, REACTIVE OXYGEN SPEC, P31, DOI DOI 10.1201/9781439854082-3; Li CY, 2003, PHYSIOL PLANTARUM, V117, P206, DOI 10.1034/j.1399-3054.2003.00002.x; Liu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-158; McPherson HG, 2001, NEW ZEAL J CROP HORT, V29, P277, DOI 10.1080/01140671.2001.9514189; McPherson HG, 1997, ANN BOT-LONDON, V80, P411, DOI 10.1006/anbo.1997.0455; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Pang XQ, 2007, J EXP BOT, V58, P3249, DOI 10.1093/jxb/erm172; Park S, 2003, TREE PHYSIOL, V23, P815, DOI 10.1093/treephys/23.12.815; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Rozen S, 2000, Methods Mol Biol, V132, P365; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Stafstrom JP, 1998, PLANTA, V205, P547, DOI 10.1007/s004250050354; Steiner C, 2003, BBA-GENE STRUCT EXPR, V1625, P123, DOI 10.1016/S0167-4781(02)00598-5; Sun XL, 2010, J BIOL CHEM, V285, P11557, DOI 10.1074/jbc.M109.027011; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Toth-Petroczy A, 2008, OPEN PROTEOM J, V1, P46, DOI [10.2174/1875039700801010046, DOI 10.2174/1875039700801010046]; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vergara R, 2012, J EXP BOT, V63, P4123, DOI 10.1093/jxb/ers094; Walton EF, 2009, J EXP BOT, V60, P3835, DOI 10.1093/jxb/erp231; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welling A, 2006, PHYSIOL PLANTARUM, V127, P167, DOI 10.1111/j.1399-3054.2006.00672.x; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070	48	14	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57354	10.1371/journal.pone.0057354	http://dx.doi.org/10.1371/journal.pone.0057354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516402	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200008
J	Jeong, SJ; Ho, CH; Choi, SD; Kim, J; Lee, EJ; Gim, HJ				Jeong, Su-Jong; Ho, Chang-Hoi; Choi, Sung-Deuk; Kim, Jinwon; Lee, Eun-Ju; Gim, Hyeon-Ju			Satellite Data-Based Phenological Evaluation of the Nationwide Reforestation of South Korea	PLOS ONE			English	Article							CARBON-DIOXIDE; FOREST; SEASON; TRANSITIONS; RESPONSES; IMPACTS; TRENDS	Through the past 60 years, forests, now of various age classes, have been established in the southern part of the Korean Peninsula through nationwide efforts to reestablish forests since the Korean War (1950-53), during which more than 65% of the nation's forest was destroyed. Careful evaluation of long-term changes in vegetation growth after reforestation is one of the essential steps to ensuring sustainable forest management. This study investigated nationwide variations in vegetation phenology using satellite-based growing season estimates for 1982-2008. The start of the growing season calculated from the normalized difference vegetation index (NDVI) agrees reasonably with the ground-observed first flowering date both temporally (correlation coefficient, r = 0.54) and spatially (r = 0.64) at the 95% confidence level. Over the entire 27-year period, South Korea, on average, experienced a lengthening of the growing season of 4.5 days decade(-1), perhaps due to recent global warming. The lengthening of the growing season is attributed mostly to delays in the end of the growing season. The retrieved nationwide growing season data were used to compare the spatial variations in forest biomass carbon density with the time-averaged growing season length for 61 forests. Relatively higher forest biomass carbon density was observed over the regions having a longer growing season, especially for the regions dominated by young (<30 year) forests. These results imply that a lengthening of the growing season related to the ongoing global warming may have positive impacts on carbon sequestration, an important aspect of large-scale forest management for sustainable development.	[Jeong, Su-Jong] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ho, Chang-Hoi; Gim, Hyeon-Ju] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Choi, Sung-Deuk] Ulsan Natl Inst Sci & Technol, Sch Urban & Environm Engn, Ulsan, South Korea; [Kim, Jinwon] Univ Calif Los Angeles, Dept Meteorol, Los Angeles, CA USA; [Lee, Eun-Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Princeton University; Seoul National University (SNU); Ulsan National Institute of Science & Technology (UNIST); University of California System; University of California Los Angeles; Seoul National University (SNU)	Ho, CH (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	hoch@cpl.snu.ac.kr	Ho, Chang-Hoi/H-8354-2015; Jeong, Su-Jong/J-4110-2014; Choi, Sung-Deuk/F-4827-2010	Choi, Sung-Deuk/0000-0003-1024-2620	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0093458]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2011, FOREST TRANSITION S, P198; Choi SD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001914; Choi SD, 2004, ENVIRON SCI TECHNOL, V38, P484, DOI 10.1021/es034533u; Chung U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027439; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Dragoni D, 2012, AGR FOREST METEOROL, V157, P96, DOI 10.1016/j.agrformet.2012.01.019; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Fisher JI, 2006, REMOTE SENS ENVIRON, V100, P265, DOI 10.1016/j.rse.2005.10.022; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Gonsamo A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002070; Ho CH, 2006, INT J CLIMATOL, V26, P2117, DOI 10.1002/joc.1356; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; Intergovernmental Panel on Climate Change, 1996, IPCC GUID NAT GREENH; Jeong JH, 2011, INT J CLIMATOL, V31, P1488, DOI 10.1002/joc.2178; Jeong SJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001868; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Julien Y, 2009, INT J REMOTE SENS, V30, P3495, DOI 10.1080/01431160802562255; Kang JH, 2009, ATMOS-KOREA, V19, P169; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kim KD, 1988, J KOREAN FOR ENG, V8, P94; Korea Forest Research Institute, 1996, KOR FOR GREENH GAS; Korea Forest Service, 1988, HIST FOR REH S KOR; Korea Forest Service, 2000, STAT YB FOR 1954 200; Lee KyeongHak, 1997, FRI Journal of Forest Science (Seoul), P152; Lee MH, 2012, CLIMATIC CHANGE, V113, P301, DOI 10.1007/s10584-011-0345-9; Liang LA, 2011, REMOTE SENS ENVIRON, V115, P143, DOI 10.1016/j.rse.2010.08.013; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Pan Y, 2011, SCIENCE, V14, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rotzer T, 2004, INT J BIOMETEOROL, V48, P109, DOI 10.1007/s00484-003-0191-1; Schwartz MD, 2010, INT J CLIMATOL, V30, P1614, DOI 10.1002/joc.2008; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Wu CY, 2012, AGR FOREST METEOROL, V164, P29, DOI 10.1016/j.agrformet.2012.05.002; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	44	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58900	10.1371/journal.pone.0058900	http://dx.doi.org/10.1371/journal.pone.0058900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520541	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900101
J	Lenz, F; Chechkin, AV; Klages, R				Lenz, Friedrich; Chechkin, Aleksei V.; Klages, Rainer			Constructing a Stochastic Model of Bumblebee Flights from Experimental Data	PLOS ONE			English	Article							SEARCH PATTERNS; LEVY FLIGHT; SAMPLING RATE; MOVEMENT; ANIMALS; DISPERSAL; SUCCESS	The movement of organisms is subject to a multitude of influences of widely varying character: from the bio-mechanics of the individual, over the interaction with the complex environment many animals live in, to evolutionary pressure and energy constraints. As the number of factors is large, it is very hard to build comprehensive movement models. Even when movement patterns in simple environments are analysed, the organisms can display very complex behaviours. While for largely undirected motion or long observation times the dynamics can sometimes be described by isotropic random walks, usually the directional persistence due to a preference to move forward has to be accounted for, e. g., by a correlated random walk. In this paper we generalise these descriptions to a model in terms of stochastic differential equations of Langevin type, which we use to analyse experimental search flight data of foraging bumblebees. Using parameter estimates we discuss the differences and similarities to correlated random walks. From simulations we generate artificial bumblebee trajectories which we use as a validation by comparing the generated ones to the experimental data.	[Lenz, Friedrich; Klages, Rainer] Queen Mary Univ London, Sch Math Sci, London, England; [Chechkin, Aleksei V.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Chechkin, Aleksei V.] NSC KIPT, Inst Theoret Phys, Kharkov, Ukraine	University of London; Queen Mary University London; Max Planck Society	Lenz, F (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.	f.lenz@qmul.ac.uk	Chechkin, Aleksei/D-2147-2015; Klages, Rainer/B-7194-2008	Klages, Rainer/0000-0003-3811-3070; Chechkin, Aleksei/0000-0002-3803-1174				Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Batschelet E, 1981, CIRCULAR STAT BIOL; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; BOVET P, 1988, J THEOR BIOL, V131, P419, DOI 10.1016/S0022-5193(88)80038-9; Codling EA, 2005, J THEOR BIOL, V233, P573, DOI 10.1016/j.jtbi.2004.11.008; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Friedrich R, 1997, PHYS REV LETT, V78, P863, DOI 10.1103/PhysRevLett.78.863; Giuggioli L, 2012, J MATH BIOL, V64, P647, DOI 10.1007/s00285-011-0431-7; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Ings TC, 2008, CURR BIOL, V18, P1520, DOI 10.1016/j.cub.2008.07.074; Ings TC, 2009, P ROY SOC B-BIOL SCI, V276, P2031, DOI 10.1098/rspb.2008.1748; James A, 2010, B MATH BIOL, V72, P896, DOI 10.1007/s11538-009-9473-z; Kai ET, 2009, P NATL ACAD SCI USA, V106, P8245, DOI 10.1073/pnas.0811034106; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Lenz F, 2009, EUR PHYS J B, V72, P467, DOI 10.1140/epjb/e2009-00364-3; Lenz F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.098103; Lindner B, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/063026; Mashanova A, 2010, J R SOC INTERFACE, V7, P199, DOI 10.1098/rsif.2009.0121; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Pearson K, 1905, NATURE, V72; Peruani F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.010602; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; Press W. H., 1992, ART SCI COMPUTING; Ragwitz M, 2001, PHYS REV LETT, P87; Reynolds AM, 2010, PHYSICA A, V389, P4740, DOI 10.1016/j.physa.2010.06.027; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Romanczuk P, 2012, EUR PHYS J-SPEC TOP, V202, P1, DOI 10.1140/epjst/e2012-01529-y; Romanczuk P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230601; Santos MC, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434017; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	40	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59036	10.1371/journal.pone.0059036	http://dx.doi.org/10.1371/journal.pone.0059036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520551	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900111
J	Salvucci, M; Neufeld, Z; Newsholme, P				Salvucci, Manuela; Neufeld, Zoltan; Newsholme, Philip			Mathematical Model of Metabolism and Electrophysiology of Amino Acid and Glucose Stimulated Insulin Secretion: In Vitro Validation Using a beta-Cell Line	PLOS ONE			English	Article							MITOCHONDRIAL CALCIUM; L-ALANINE; AMPLIFYING PATHWAYS; ELECTRICAL-ACTIVITY; PANCREATIC-ISLETS; L-GLUTAMINE; OSCILLATIONS; RAT; BRIN-BD11; MESSENGER	We integrated biological experimental data with mathematical modelling to gain insights into the role played by L-alanine in amino acid-stimulated insulin secretion (AASIS) and in D-glucose-stimulated insulin secretion (GSIS), details important to the understanding of complex beta-cell metabolic coupling relationships. We present an ordinary differential equations (ODEs) based simplified kinetic model of core metabolic processes leading to ATP production (glycolysis, TCA cycle, L-alanine-specific reactions, respiratory chain, ATPase and proton leak) and Ca2+ handling (essential channels and pumps in the plasma membrane) in pancreatic beta-cells and relate these to insulin secretion. Experimental work was performed using a clonal rat insulin-secreting cell line (BRIN-BD11) to measure the consumption or production of a range of important biochemical parameters (D-glucose, L-alanine, ATP, insulin secretion) and Ca2+ levels. These measurements were then used to validate the theoretical model and fine-tune the parameters. Mathematical modelling was used to predict L-lactate and L-glutamate concentrations following D-glucose and/or L-alanine challenge and Ca2+ levels upon stimulation with a non metabolizable L-alanine analogue. Experimental data and mathematical model simulations combined suggest that L-alanine produces a potent insulinotropic effect via both a stimulatory impact on b-cell metabolism and as a direct result of the membrane depolarization due to Ca2+ influx triggered by L-alanine/Na+ co-transport. Our simulations indicate that both high intracellular ATP and Ca2+ concentrations are required in order to develop full insulin secretory responses. The model confirmed that K-ATP(+) channel independent mechanisms of stimulation of intracellular Ca2+ levels, via generation of mitochondrial coupling messengers, are essential for promotion of the full and sustained insulin secretion response in beta-cells.	[Salvucci, Manuela; Newsholme, Philip] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Neufeld, Zoltan] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Newsholme, Philip] Curtin Univ, Sch Biomed Sci, Perth, WA, Australia	University College Dublin; University of Queensland; Curtin University	Salvucci, M (corresponding author), Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland.	manuela.salvucci@gmail.com	Newsholme, Philip/D-4939-2016; Neufeld, Zoltan/C-3008-2011	Newsholme, Philip/0000-0002-0500-6984; Neufeld, Zoltan/0000-0003-3236-9278	Irish Research Council for Science, Engineering and Technology; School of Biomolecular and Biomedical Science, University College Dublin	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology); School of Biomolecular and Biomedical Science, University College Dublin	This work was supported by a postgraduate award to MS from the Irish Research Council for Science, Engineering and Technology. The study was additionally supported by the School of Biomolecular and Biomedical Science, University College Dublin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHS MJ, 1991, J THEOR BIOL, V150, P109, DOI 10.1016/S0022-5193(05)80478-3; Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BOHNENSACK R, 1981, BIOCHIM BIOPHYS ACTA, V634, P203, DOI 10.1016/0005-2728(81)90139-0; Brennan L, 2003, DIABETOLOGIA, V46, P1512, DOI 10.1007/s00125-003-1184-7; Brennan L, 2002, DIABETES, V51, P1714, DOI 10.2337/diabetes.51.6.1714; Cunningham GA, 2005, CLIN SCI, V109, P447, DOI 10.1042/CS20050149; Dixon G, 2003, J ENDOCRINOL, V179, P447, DOI 10.1677/joe.0.1790447; DUNNE MJ, 1990, EXP PHYSIOL, V75, P771, DOI 10.1113/expphysiol.1990.sp003459; Fridlyand LE, 2010, AM J PHYSIOL-ENDOC M, V299, pE517, DOI 10.1152/ajpendo.00177.2010; Fridlyand LE, 2009, BIOPHYS J, V96, P3126, DOI 10.1016/j.bpj.2009.01.029; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Fridlyand LE, 2011, PROG BIOPHYS MOL BIO, V107, P293, DOI 10.1016/j.pbiomolbio.2011.09.001; Fridlyand LE, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-15; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; HELLMAN B, 1971, ENDOCRINOLOGY, V89, P1432, DOI 10.1210/endo-89-6-1432; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Jiang N, 2007, MAMM GENOME, V18, P508, DOI 10.1007/s00335-007-9011-y; Kiely A, 2007, J ENDOCRINOL, V195, P113, DOI 10.1677/JOE-07-0306; Korzeniewski B, 2000, BIOPHYS CHEM, V83, P19, DOI 10.1016/S0301-4622(99)00120-9; Krause MS, 2011, J ENDOCRINOL, V211, P87, DOI 10.1530/JOE-11-0236; Liu Zhenping LY, 2008, DIABETES METAB, V27, P12; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1174, DOI 10.1152/ajpcell.1998.274.4.C1174; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1158, DOI 10.1152/ajpcell.1998.274.4.C1158; MALAISSE WJ, 1982, J BIOL CHEM, V257, P8731; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Mao CS, 2004, AM J PHYSIOL-ENDOC M, V287, pE50, DOI 10.1152/ajpendo.00555.2003; McClenaghan NH, 2009, CLIN SCI, V116, P341, DOI 10.1042/CS20080138; McClenaghan NH, 1998, BIOCHEM BIOPH RES CO, V249, P299, DOI 10.1006/bbrc.1998.9136; McClenaghan NH, 1996, J ENDOCRINOL, V151, P349, DOI 10.1677/joe.0.1510349; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; Miwa Y, 1999, JPN J PHYSIOL, V49, P353, DOI 10.2170/jjphysiol.49.353; Nazaret C, 2009, J THEOR BIOL, V258, P455, DOI 10.1016/j.jtbi.2008.09.037; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Nielsen K, 1998, BIOPHYS CHEM, V72, P49, DOI 10.1016/S0301-4622(98)00122-7; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; PRENTKI M, 1983, J BIOL CHEM, V258, P4239; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Sherman A, 2010, MATH BIOSCI, V227, P12, DOI 10.1016/j.mbs.2010.05.005; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; Westermark PO, 2007, AM J PHYSIOL-ENDOC M, V292, pE373, DOI 10.1152/ajpendo.00589.2005; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; Yugi K, 2004, BIOINFORMATICS, V20, P1795, DOI 10.1093/bioinformatics/bth125	61	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e52611	10.1371/journal.pone.0052611	http://dx.doi.org/10.1371/journal.pone.0052611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520444	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900003
J	Lee, JH; Mand, MR; Deshpande, RA; Kinoshita, E; Yang, SH; Wyman, C; Paull, TT				Lee, Ji-Hoon; Mand, Michael R.; Deshpande, Rajashree A.; Kinoshita, Eri; Yang, Soo-Hyun; Wyman, Claire; Paull, Tanya T.			Ataxia Telangiectasia-Mutated (ATM) Kinase Activity Is Regulated by ATP-driven Conformational Changes in the Mre11/Rad50/Nbs1 (MRN) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND-BREAK; RAD50 ZINC-HOOK; MRE11 COMPLEX; DNA-DAMAGE; MRE11-RAD50-NBS1 COMPLEX; NUCLEASE ACTIVITY; HUMAN RAD50/MRE11; REPAIR; ACTIVATION; BINDING	The Ataxia Telangiectasia-Mutated (ATM) protein kinase is recruited to sites of double-strand DNA breaks by the Mre11/Rad50/Nbs1 (MRN) complex, which also facilitates ATM monomerization and activation. MRN exists in at least two distinct conformational states, dependent on ATP binding and hydrolysis by the Rad50 protein. Here we use an ATP analog-sensitive form of ATM to determine that ATP binding, but not hydrolysis, by Rad50 is essential for MRN stimulation of ATM. Mre11 nuclease activity is dispensable, although some mutations in the Mre11 catalytic domain block ATM activation independent of nuclease function, as does the mirin compound. The coiled-coil domains of Rad50 are important for the DNA binding ability of MRN and are essential for ATM activation, but loss of the zinc hook connection can be substituted by higher levels of the complex. Nbs1 binds to the "closed" form of the MR complex, promoted by the zinc hook and by ATP binding. Thus the primary role of the hook is to tether Rad50 monomers together, promoting the association of the Rad50 catalytic domains into a form that binds ATP and also binds Nbs1. Collectively, these results show that the ATP-bound form of MRN is the critical conformation for ATM activation.	[Lee, Ji-Hoon; Mand, Michael R.; Deshpande, Rajashree A.; Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Lee, Ji-Hoon; Mand, Michael R.; Deshpande, Rajashree A.; Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Kinoshita, Eri] Erasmus Univ, Med Ctr, Dept Genet, NL-3000 CA Rotterdam, Netherlands; [Wyman, Claire] Erasmus Univ, Med Ctr, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Paull, TT (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@utexas.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X; Mand, Michael/0000-0002-3457-3822; Deshpande, Rajashree/0000-0001-5728-716X	National Institutes of Health [CA094008, CA132813]; Netherlands Organization for Scientific Research (NWO) [VICI 700.56.441, STW NWONano-11425]; NATIONAL CANCER INSTITUTE [R01CA132813, R01CA094008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grants CA094008 and CA132813 (to T.P.). This work was also supported by grants from the Netherlands Organization for Scientific Research (NWO) VICI 700.56.441, and STW NWONano-11425 (to C.W.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bressan DA, 1998, GENETICS, V150, P591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; de Jager M, 2004, J MOL BIOL, V339, P937, DOI 10.1016/j.jmb.2004.04.014; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Jager M, 2002, NUCLEIC ACIDS RES, V30, P4425, DOI 10.1093/nar/gkf574; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928	41	70	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12840	12851		10.1074/jbc.M113.460378	http://dx.doi.org/10.1074/jbc.M113.460378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525106	hybrid, Green Published			2022-12-25	WOS:000318555100039
J	Fu, HL; Sohail, A; Valiathan, RR; Wasinski, BD; Kumarasiri, M; Mahasenan, KV; Bernardo, MM; Tokmina-Roszyk, D; Fields, GB; Mobashery, S; Fridman, R				Fu, Hsueh-Liang; Sohail, Anjum; Valiathan, Rajeshwari R.; Wasinski, Benjamin D.; Kumarasiri, Malika; Mahasenan, Kiran V.; Bernardo, M. Margarida; Tokmina-Roszyk, Dorota; Fields, Gregg B.; Mobashery, Shahriar; Fridman, Rafael			Shedding of Discoidin Domain Receptor 1 by Membrane-type Matrix Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASES; COLLAGEN-BINDING; TISSUE INHIBITOR; ECTODOMAIN; IDENTIFICATION; MT1-MMP; DDR1; SITE; CLEAVAGE; CELLS	The discoidin domain receptors (DDRs) are receptor tyrosine kinases that upon binding to collagens undergo receptor phosphorylation, which in turn activates signal transduction pathways that regulate cell-collagen interactions. We report here that collagen-dependent DDR1 activation is partly regulated by the proteolytic activity of the membrane-anchored collagenases, MT1-, MT2-, and MT3-matrix metalloproteinase (MMP). These collagenases cleave DDR1 and attenuate collagen I-and IV-induced receptor phosphorylation. This effect is not due to ligand degradation, as it proceeds even when the receptor is stimulated with collagenase-resistant collagen I (r/r) or with a triple-helical peptide harboring the DDR recognition motif in collagens. Moreover, the secreted collagenases MMP-1 and MMP-13 and the glycosylphosphatidylinositol-anchored membrane-type MMPs (MT4- and MT6-MMP) have no effect on DDR1 cleavage or activation. N-terminal sequencing of the MT1-MMP-mediated cleaved products and mutational analyses show that cleavage of DDR1 takes place within the extracellular juxtamembrane region, generating a membrane-anchored C-terminal fragment. Metalloproteinase inhibitor studies show that constitutive shedding of endogenous DDR1 in breast cancer HCC1806 cells is partly mediated by MT1-MMP, which also regulates collagen-induced receptor activation. Taken together, these data suggest a role for the collagenase of membrane-type MMPs in regulation of DDR1 cleavage and activation at the cell-matrix interface.	[Fu, Hsueh-Liang; Sohail, Anjum; Valiathan, Rajeshwari R.; Wasinski, Benjamin D.; Bernardo, M. Margarida; Fridman, Rafael] Wayne State Univ, Dept Pathol, Sch Med, Detroit, MI 48201 USA; [Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Tokmina-Roszyk, Dorota; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	Wayne State University; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Torrey Pines Institute for Molecular Studies, Florida	Fridman, R (corresponding author), Wayne State Univ, Dept Pathol, Sch Med, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu		Sohail, Anjum/0000-0001-5567-9645	National Institutes of Health [CA-61986, CA-98799]; NATIONAL CANCER INSTITUTE [R01CA061986, R01CA098799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-61986 (to R. F.) and CA-98799 (to G. B. F.).	Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; Abdulhussein R, 2008, J BIOL CHEM, V283, P12026, DOI 10.1074/jbc.M704592200; Agarwal G, 2007, J MOL BIOL, V367, P443, DOI 10.1016/j.jmb.2006.12.073; ALVES F, 1995, ONCOGENE, V10, P609; Ancot F, 2009, ONCOGENE, V28, P2185, DOI 10.1038/onc.2009.88; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; Flynn LA, 2010, J MOL BIOL, V395, P533, DOI 10.1016/j.jmb.2009.10.073; GRAMS F, 1995, BIOCHEMISTRY-US, V34, P14012, DOI 10.1021/bi00043a007; Hachehouche LN, 2010, MOL IMMUNOL, V47, P1866, DOI 10.1016/j.molimm.2010.02.023; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Higashiyama S, 2011, J BIOCHEM, V150, P15, DOI 10.1093/jb/mvr068; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; L'hote CGML, 2001, FASEB J, V15, P234, DOI 10.1096/fj.01-0414fje; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lemeer S, 2012, J PROTEOMICS, V75, P3465, DOI 10.1016/j.jprot.2011.10.007; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Ohkubo S, 1999, BIOCHEM BIOPH RES CO, V266, P308, DOI 10.1006/bbrc.1999.1816; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Slack BE, 2006, J CELL BIOCHEM, V98, P672, DOI 10.1002/jcb.20812; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Toth M, 2005, BIOCHEM J, V387, P497, DOI 10.1042/BJ20041324; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; van Kilsdonk JWJ, 2010, EUR J CELL BIOL, V89, P415, DOI 10.1016/j.ejcb.2009.11.026; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2002, FEBS LETT, V514, P175, DOI 10.1016/S0014-5793(02)02360-8; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004	54	62	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12114	12129		10.1074/jbc.M112.409599	http://dx.doi.org/10.1074/jbc.M112.409599			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23519472	hybrid, Green Published			2022-12-25	WOS:000318157600044
J	Hu, SW; Ni, W; Sai, WJF; Zi, H; Qiao, J; Wang, PY; Sheng, JL; Chen, CF				Hu, Shengwei; Ni, Wei; Sai, Wujiafu; Zi, Ha; Qiao, Jun; Wang, Pengyang; Sheng, Jinliang; Chen, Chuangfu			Knockdown of Myostatin Expression by RNAi Enhances Muscle Growth in Transgenic Sheep	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; IN-VIVO; GENE; PROMOTER; CATTLE; MASS; HYPERTROPHY; MUTATION; MICE; INTERFERENCE	Myostatin (MSTN) has been shown to be a negative regulator of skeletal muscle development and growth. MSTN dysfunction therefore offers a strategy for promoting animal growth performance in livestock production. In this study, we investigated the possibility of using RNAi-based technology to generate transgenic sheep with a double-muscle phenotype. A shRNA expression cassette targeting sheep MSTN was used to generate stable shRNA-expressing fibroblast clones. Transgenic sheep were further produced by somatic cell nuclear transfer (SCNT) technology. Five lambs developed to term and three live lambs were obtained. Integration of shRNA expression cassette in three live lambs was confirmed by PCR. RNase protection assay showed that the shRNAs targeting MSTN were expressed in muscle tissues of three transgenic sheep. MSTN expression was significantly inhibited in muscle tissues of transgenic sheep when compared with control sheep. Moreover, transgenic sheep showed a tendency to faster increase in body weight than control sheep. Histological analysis showed that myofiber diameter of transgenic sheep M17 were bigger than that of control sheep. Our findings demonstrate a promising approach to promoting muscle growth in livestock production.	[Hu, Shengwei; Ni, Wei; Sai, Wujiafu; Zi, Ha; Qiao, Jun; Wang, Pengyang; Sheng, Jinliang; Chen, Chuangfu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Peoples R China; [Hu, Shengwei; Ni, Wei; Chen, Chuangfu] Shihezi Univ, Key Lab Agrobiotechnol, Shihezi, Peoples R China	Shihezi University; Shihezi University	Chen, CF (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Peoples R China.	chencf1962@yahoo.com	Hu, Shengwei/AGP-1699-2022		973 Program [2010CB530200]; National Natural Science Foundation of China (NSFC) [31201800, 31260534]; Bingtuan Twelve Five-year Special Projects [2012BB051]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Bingtuan Twelve Five-year Special Projects	This work was supported by grants from the 973 Program (2010CB530200), The National Natural Science Foundation of China (NSFC) (31201800, 31260534) and the Bingtuan Twelve Five-year Special Projects (2012BB051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta J, 2005, J BIOTECHNOL, V119, P324, DOI 10.1016/j.jbiotec.2005.04.023; Arthur PF, 1995, AUST J AGR RES, V46, P1493, DOI 10.1071/AR9951493; Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Fletcher CJ, 2007, REPRODUCTION, V133, P243, DOI 10.1530/rep.1.01203; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Guo ZS, 1996, GENE THER, V3, P802; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hu SW, 2012, J ANIM VET ADV, V11, P1868; Hu SW, 2011, BIOTECHNOL LETT, V33, P1949, DOI 10.1007/s10529-011-0667-8; Hu SW, 2011, ANIM BIOTECHNOL, V22, P170, DOI 10.1080/10495398.2011.580669; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Lee CY, 2009, BIOCHEM BIOPH RES CO, V387, P766, DOI 10.1016/j.bbrc.2009.07.110; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; [赛务加甫 SAI Wujiafu], 2008, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V39, P1343; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Tessanne K, 2012, MOL REPROD DEV, V79, P176, DOI 10.1002/mrd.22007; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; Wang PY, 2010, ANTIVIR RES, V87, P265, DOI 10.1016/j.antiviral.2010.02.319; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	32	34	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58521	10.1371/journal.pone.0058521	http://dx.doi.org/10.1371/journal.pone.0058521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526994	gold, Green Submitted, Green Published			2022-12-25	WOS:000317562600027
J	Nordin, O; Donald, W; Ming, WH; Ney, TG; Mohamed, KA; Halim, NAA; Winskill, P; Hadi, AA; Muhammad, ZS; Lacroix, R; Scaife, S; McKemey, AR; Beech, C; Shahnaz, M; Alphey, L; Nimmo, DD; Nazni, WA; Lee, HL				Nordin, Oreenaiza; Donald, Wesley; Ming, Wong Hong; Ney, Teoh Guat; Mohamed, Khairul Asuad; Halim, Nor Azlina Abdul; Winskill, Peter; Hadi, Azahari Abdul; Muhammad, Zulkamal Safi'in; Lacroix, Renaud; Scaife, Sarah; McKemey, Andrew Robert; Beech, Camilla; Shahnaz, Murad; Alphey, Luke; Nimmo, Derric David; Nazni, Wasi Ahmed; Lee, Han Lim			Oral Ingestion of Transgenic RIDL Ae. aegypti Larvae Has No Negative Effect on Two Predator Toxorhynchites Species	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; AEDES-AEGYPTI; GENE-EXPRESSION; NATURAL TRANSFORMATION; CULICIDAE; DIPTERA; DOMINANT; DENGUE; CELLS; PATTERNS	Dengue is the most important mosquito-borne viral disease. No specific treatment or vaccine is currently available; traditional vector control methods can rarely achieve adequate control. Recently, the RIDL (Release of Insect carrying Dominant Lethality) approach has been developed, based on the sterile insect technique, in which genetically engineered 'sterile' homozygous RIDL male insects are released to mate wild females; the offspring inherit a copy of the RIDL construct and die. A RIDL strain of the dengue mosquito, Aedes aegypti, OX513A, expresses a fluorescent marker gene for identification (DsRed2) and a protein (tTAV) that causes the offspring to die. We examined whether these proteins could adversely affect predators that may feed on the insect. Aedes aegypti is a peri-domestic mosquito that typically breeds in small, rain-water-filled containers and has no specific predators. Toxorhynchites larvae feed on small aquatic organisms and are easily reared in the laboratory where they can be fed exclusively on mosquito larvae. To evaluate the effect of a predator feeding on a diet of RIDL insects, OX513A Ae. aegypti larvae were fed to two different species of Toxorhynchites (Tx. splendens and Tx. amboinensis) and effects on life table parameters of all life stages were compared to being fed on wild type larvae. No significant negative effect was observed on any life table parameter studied; this outcome and the benign nature of the expressed proteins (tTAV and DsRed2) indicate that Ae. aegypti OX513A RIDL strain is unlikely to have any adverse effects on predators in the environment.	[Nordin, Oreenaiza; Donald, Wesley; Ming, Wong Hong; Ney, Teoh Guat; Mohamed, Khairul Asuad; Halim, Nor Azlina Abdul; Hadi, Azahari Abdul; Muhammad, Zulkamal Safi'in; Shahnaz, Murad; Nazni, Wasi Ahmed; Lee, Han Lim] Inst Med Res, Med Entomol Unit, Kuala Lumpur 50588, Malaysia; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Winskill, Peter; Lacroix, Renaud; Scaife, Sarah; McKemey, Andrew Robert; Beech, Camilla; Alphey, Luke; Nimmo, Derric David] Oxitec Ltd, Oxford, England; [Winskill, Peter] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council Ctr Outbreak Anal & Modelling, London, England	Kementerian Kesihatan Malaysia; University of Oxford; Imperial College London	Nimmo, DD (corresponding author), Oxitec Ltd, Oxford, England.	derric.nimmo@oxitec.com	Ahmad, Nazni/AAN-2498-2021	Alphey, Luke/0000-0002-2916-3802; Winskill, Peter/0000-0003-3001-4959; Beech, Camilla/0000-0001-8348-9566	Malaysian National Institutes of Health Research Grant [JPP-IMR-06-053]; Biotechnology and Biological Sciences Research Council training grant [BB/I015957/1]; National Institutes of Health from the Ministry of Health, Malaysia [JPP-IMR 06-053]; Oxitec Ltd.	Malaysian National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council training grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health from the Ministry of Health, Malaysia; Oxitec Ltd.	This project was financially supported by a Malaysian National Institutes of Health Research Grant (JPP-IMR-06-053); a Biotechnology and Biological Sciences Research Council training grant (BB/I015957/1); and a grant from the National Institutes of Health from the Ministry of Health, Malaysia (code: JPP-IMR 06-053). Oxitec Ltd. provided salary and other support for the research program of those authors employed by the company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Those authors affiliated to Oxitec Limited or Oxitec Sdn Bhd (as noted in the author list) are past or present employees or sponsored students of Oxitec Limited or Oxitec Sdn Bhd, which therefore provided salary and other support for the research program. Also, some of these employees have shares or share options in Oxitec Ltd. Oxitec and the University of Oxford own intellectual property related to the subject matter of this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors declare no conflicting interests.	Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Amalraj D. Dominic, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P177; Amalraj DD, 2005, MEM I OSWALDO CRUZ, V100, P893, DOI 10.1590/S0074-02762005000800012; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Bertolla F, 1999, RES MICROBIOL, V150, P375, DOI 10.1016/S0923-2508(99)80072-2; Blum S, 1997, J VECTOR ECOL, V22, P23; Campos RE, 2000, J MED ENTOMOL, V37, P385, DOI 10.1603/0022-2585(2000)037[0385:LTOTRD]2.0.CO;2; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Chadee DD, 2009, TROP MED INT HEALTH, V14, P220, DOI 10.1111/j.1365-3156.2008.02216.x; Dyck V, 2005, INTEGRATED PEST MANA; FOCKS DA, 1985, J ECON ENTOMOL, V78, P622, DOI 10.1093/jee/78.3.622; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129; Harbach R.E., 1980, TAXONOMISTS GLOSSARY; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2; JONES JC, 1973, BIOL BULL, V145, P127, DOI 10.2307/1540353; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Koenraadt CJM, 2008, AM J TROP MED HYG, V79, P230, DOI 10.4269/ajtmh.2008.79.230; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Lee HL, 2013, TRANSGENIC RES, V22, P47, DOI 10.1007/s11248-012-9625-z; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657; Nielsen KM, 1998, APMIS, V106, P77, DOI 10.1111/j.1600-0463.1998.tb05653.x; Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x; Nyamah MA, 2011, TROP BIOMED, V28, P312; Pavely C, 2006, EARLY FOOD SAFETY EV; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Richards HA, 2003, J NUTR, V133, P1909, DOI 10.1093/jn/133.6.1909; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Schonig Kai, 2003, Methods Mol Biol, V209, P69; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Smrchek JC, 1998, HDB ENV RISK ASSESSM, P24; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wenck A, 2003, PLANT CELL REP, V22, P244, DOI 10.1007/s00299-003-0690-x; WHO/TDR, 2009, DENG GUID DIAGN TREA; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319; Zhou HX, 2009, INT J BIOL SCI, V5, P171	46	8	10	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58805	10.1371/journal.pone.0058805	http://dx.doi.org/10.1371/journal.pone.0058805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527029	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562600041
J	Seibold, MA; Smith, RW; Urbanek, C; Groshong, SD; Cosgrove, GP; Brown, KK; Schwarz, MI; Schwartz, DA; Reynolds, SD				Seibold, Max A.; Smith, Russell W.; Urbanek, Cydney; Groshong, Steve D.; Cosgrove, Gregory P.; Brown, Kevin K.; Schwarz, Marvin I.; Schwartz, David A.; Reynolds, Susan D.			The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; INTERSTITIAL PNEUMONIA; MARKER EXPRESSION; STEM-CELLS; LUNG; MUC5B; PROMOTER	Background: We previously identified a MUC5B gene promoter-variant that is a risk allele for sporadic and familial Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia (IPF/UIP). This allele was strongly associated with increased MUC5B gene expression in lung tissue from unaffected subjects. Despite the strong association of this airway epithelial marker with disease, little is known of mucin expressing structures or of airway involvement in IPF/UIP. Methods: Immunofluorescence was used to subtype mucus cells according to MUC5B and MUC5AC expression and to identify ciliated, basal, and alveolar type II (ATII) cells in tissue sections from control and IPF/UIP subjects. Staining patterns were quantified for distal airways (Control and IPF/UIP) and in honeycomb cysts (HC). Results: MUC5B-expressing cells (EC) were detected in the majority of control distal airways. MUC5AC-EC were identified in half of these airways and only in airways that contained MUC5B-EC. The frequency of MUC5B+ and MUC5AC+ distal airways was increased in IPF/UIP subjects. MUC5B-EC were the dominant mucus cell type in the HC epithelium. The distal airway epithelium from control and IPF/UIP subjects and HC was populated by basal and ciliated cells. Most honeycombing regions were distinct from ATII hyperplasic regions. ATII cells were undetectable in the overwhelming majority of HC. Conclusions: The distal airway contains a pseudostratified mucocilary epithelium that is defined by basal epithelial cells and mucus cells that express MUC5B predominantly. These data suggest that the HC is derived from the distal airway.	[Seibold, Max A.; Urbanek, Cydney; Schwartz, David A.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Seibold, Max A.; Smith, Russell W.; Reynolds, Susan D.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Groshong, Steve D.; Cosgrove, Gregory P.; Brown, Kevin K.; Schwarz, Marvin I.; Schwartz, David A.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Reynolds, SD (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	reynoldss@njhealth.org	Brown, Kevin/ABF-2544-2020		Chapman Foundation; NIH [HL075585, HL075585-S1, RC1HL099461]; National Heart, Lung and Blood Institute [R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, RC2-HL101715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075585, R01HL095397, RC1HL099461, R01HL097163, R01HL095393, RC2HL101715, P01HL092870] Funding Source: NIH RePORTER	Chapman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by the Chapman Foundation (MAS, DAS), NIH RO1 (HL075585) and Supplement (HL075585-S1) to SDR and RC1HL099461 (SDR), and National Heart, Lung and Blood Institute (R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, and RC2-HL101715) awarded to DAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2011, AM J ROENTGENOL, V196, P773, DOI 10.2214/AJR.10.4873; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Chilosi M, 2002, LAB INVEST, V82, P1335, DOI 10.1097/01.LAB.0000032380.82232.67; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; COALSON JJ, 1982, VIRCHOWS ARCH A, V395, P181, DOI 10.1007/BF00429611; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; Daly HE, 1997, TOXICOL APPL PHARM, V142, P303, DOI 10.1006/taap.1996.8056; Dupuit F, 2000, AM J PHYSIOL-LUNG C, V278, pL165, DOI 10.1152/ajplung.2000.278.1.L165; ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031; Hegab A. E., 2011, STEM CELLS; HYDE DM, 1992, AM REV RESPIR DIS, V146, P1042, DOI 10.1164/ajrccm/146.4.1042; Iyonaga K, 1997, J PATHOL, V182, P217; Johkoh T, 1999, J COMPUT ASSIST TOMO, V23, P174, DOI 10.1097/00004728-199903000-00003; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Rock JR, 2010, DIS MODEL MECH; Rousseau K, 2003, HYBRIDOMA HYBRIDOM, V22, P293, DOI 10.1089/153685903322538818; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	26	154	155	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58658	10.1371/journal.pone.0058658	http://dx.doi.org/10.1371/journal.pone.0058658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527003	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562600029
J	Chattoraj, P; Yang, Q; Khandai, A; Al-Hendy, O; Ismail, N				Chattoraj, Partho; Yang, Qin; Khandai, Ankita; Al-Hendy, Omar; Ismail, Nahed			TLR2 and Nod2 Mediate Resistance or Susceptibility to Fatal Intracellular Ehrlichia Infection in Murine Models of Ehrlichiosis	PLOS ONE			English	Article							CD4(+) T-CELLS; ANIMAL-MODEL; IFN-GAMMA; MONOCYTOTROPIC EHRLICHIOSIS; INFLAMMATORY RESPONSES; EFFECTOR MECHANISM; TNF-ALPHA; CHAFFEENSIS; RECOGNITION; IMMUNITY	Our murine models of human monocytic ehrlichiosis (HME) have shown that severe and fatal ehrlichiosis is due to generation of pathogenic T cell responses causing immunopathology and multi-organ failure. However, the early events in the liver, the main site of infection, are not well understood. In this study, we examined the liver transcriptome during the course of lethal and nonlethal infections caused by Ixodes ovatus Ehrlichia and Ehrlichia muris, respectively. On day 3 post-infection (p.i.), although most host genes were down regulated in the two groups of infected mice compared to naive counterparts, lethal infection induced significantly higher expression of caspase 1, caspase 4, nucleotide binding oligomerization domain-containing proteins (Nod1), tumor necrosis factor-alpha, interleukin 10, and CCL7 compared to nonlethal infection. On day 7 p.i., lethal infection induced highly significant upregulation of type-1 interferon, several inflammatory cytokines and chemokines, which was associated with increased expression levels of Toll-like receptor-2 (TLR2), Nod2, MyD88, nuclear factor-kappa B (NF-kB), Caspase 4, NLRP1, NLRP12, Pycard, and IL-1 beta, suggesting enhanced TLR signals and inflammasomes activation. We next evaluated the participation of TLR2 and Nod2 in the host response during lethal Ehrlichia infection. Although lack of TLR2 impaired bacterial elimination and increased tissue necrosis, Nod2 deficiency attenuated pathology and enhanced bacterial clearance, which correlated with increased interferon-gamma and interleukin-10 levels and a decreased frequency of pathogenic CD8(+) T cells in response to lethal infection. Thus, these data indicate that Nod2, but not TLR2, contributes to susceptibility to severe Ehrlichia-induced shock. Together, our studies provide, for the first time, insight into the diversity of host factors and novel molecular pathogenic mechanisms that may contribute to severe HME.	[Chattoraj, Partho; Yang, Qin; Khandai, Ankita; Al-Hendy, Omar; Ismail, Nahed] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ismail, N (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	ismailn@upmc.edu		Yang, Qin/0000-0001-8690-4809	National Institutes of Health [R56AI097679-01A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by National Institutes of Health grants (R56AI097679-01A, to NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Carrol ED, 2011, J IMMUNOL, V186, P2329, DOI 10.4049/jimmunol.1002402; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DUMLER JS, 1993, HUM PATHOL, V24, P391; FICHTENBAUM CJ, 1993, AM J MED, V95, P351, DOI 10.1016/0002-9343(93)90302-6; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; Hamburg BJ, 2008, MEDICINE, V87, P53, DOI 10.1097/MD.0b013e318168da1d; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08; Hokeness-Antonelli KL, 2007, J IMMUNOL, V179, P6176, DOI 10.4049/jimmunol.179.9.6176; Huang HB, 2008, INFECT IMMUN, V76, P3405, DOI 10.1128/IAI.00056-08; Humann J, 2010, J IMMUNOL, V184, P5172, DOI 10.4049/jimmunol.0903759; Ismail N, 2006, INFECT IMMUN, V74, P1846, DOI 10.1128/IAI.74.3.1846-1856.2006; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Ismail N, 2007, INFECT IMMUN, V75, P4608, DOI 10.1128/IAI.00198-07; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Mercier BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042170; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miura K, 2009, INFECT IMMUN, V77, P245, DOI 10.1128/IAI.00979-08; Miura K, 2007, INFECT IMMUN, V75, P3604, DOI 10.1128/IAI.02028-06; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Okada H, 2001, J COMP PATHOL, V124, P165, DOI 10.1053/jcpa.2000.0447; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Olano JP, 2002, MED CLIN N AM, V86, P375, DOI 10.1016/S0025-7125(03)00093-2; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pedra JHF, 2007, J IMMUNOL, V179, P4783, DOI 10.4049/jimmunol.179.7.4783; Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rahman MA, 2012, J INFECT DIS, V206, P110, DOI 10.1093/infdis/jis313; Ratnasamy N, 1996, CLIN INFECT DIS, V23, P314, DOI 10.1093/clinids/23.2.314; Sehdev AES, 2003, AM J CLIN PATHOL, V119, P859, DOI 10.1309/F7EAB5P7321716LJ; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Sotomayor EA, 2001, AM J PATHOL, V158, P757, DOI 10.1016/S0002-9440(10)64018-7; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Stevenson HL, 2010, AM J PATHOL, V177, P766, DOI 10.2353/ajpath.2010.091110; Stevenson HL, 2006, INFECT IMMUN, V76, P1434; Szymczak WA, 2009, J IMMUNOL, V183, P1964, DOI 10.4049/jimmunol.0901316; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Walker DH, 1997, ARCH PATHOL LAB MED, V121, P785; Winslow GM, 1998, INFECT IMMUN, V66, P3892, DOI 10.1128/IAI.66.8.3892-3899.1998; Yamauchi K, 2008, J IMMUNOL, V180, P1207, DOI 10.4049/jimmunol.180.2.1207	63	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58514	10.1371/journal.pone.0058514	http://dx.doi.org/10.1371/journal.pone.0058514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526993	Green Published, gold, Green Accepted			2022-12-25	WOS:000317562100029
J	Range, H; Poitou, C; Boillot, A; Ciangura, C; Katsahian, S; Lacorte, JM; Czernichow, S; Meilhac, O; Bouchard, P; Chaussain, C				Range, Helene; Poitou, Christine; Boillot, Adrien; Ciangura, Cecile; Katsahian, Sandrine; Lacorte, Jean-Marc; Czernichow, Sebastien; Meilhac, Olivier; Bouchard, Philippe; Chaussain, Catherine			Orosomucoid, a New Biomarker in the Association between Obesity and Periodontitis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ALPHA(1)-ACID GLYCOPROTEIN; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; EUROPEAN WORKSHOP; SERUM; HEALTH; POPULATION; ADIPOSITY	Epidemiological data indicate an association between periodontitis and obesity. The biological mechanisms of this relationship remain unclear. A cross-sectional study was conducted to evaluate the relationship between periodontitis and the common systemic inflammatory markers in 32 morbidly obese patients recruited in a Clinical Nutrition department. Periodontal condition was evaluated using pocket depth (PD) measurement, a classical clinical marker of ongoing periodontitis. Major periodontal risk factors were recorded (age, gender, diabetes and smoking status), as well as plasma levels of inflammatory markers (CRP, orosomucoid, IL-6) and adipokines (adiponectin, leptin). All patients included in the sample exhibited evidence of periodontitis, 16 of whom were diagnosed as having severe disease. Adjusted logistic regression analysis indicated that the severity of periodontitis was associated with the plasma level of orosomucoid (p < 0.04) after adjustment for age, gender and smoking. Our study thus suggests that the severity of periodontitis, in morbidly obese patients, is associated with the increase of orosomucoid levels.	[Range, Helene; Boillot, Adrien; Bouchard, Philippe] Univ Paris 07, Rothschild Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR Odontol, Paris, France; [Range, Helene; Meilhac, Olivier] Univ Paris 07, Bichat Hosp, AP HP, INSERM,Cardiovasc Hematol Bioengn & Remodeling U6, Paris, France; [Poitou, Christine; Ciangura, Cecile] Hop La Pitie Salpetriere, AP HP, Nutr & Endocrinol Dept, Paris, France; [Poitou, Christine; Ciangura, Cecile] CRNH Ile France, Paris, France; [Poitou, Christine; Ciangura, Cecile] Inst Cardiometab & Nutr ICAN, Paris, France; [Poitou, Christine] Cordeliers Res Ctr, Team Nutri 7, INSERM, U872, Paris, France; [Poitou, Christine] Univ Paris 06, UMR S 872, Paris, France; [Boillot, Adrien; Czernichow, Sebastien] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Katsahian, Sandrine] Univ Paris 07, St Louis Hosp, AP HP, Dept Biostat, Paris, France; [Lacorte, Jean-Marc] Hop La Pitie Salpetriere, AP HP, Dept Endocrinol & Oncol Biochem, Paris, France; [Czernichow, Sebastien] Versailles St Quentin Univ, Ambroise Pare Hosp, AP HP, Dept Nutr, Boulogne, France; [Chaussain, Catherine] Univ Paris 05, Bretonneau Hosp, AP HP, Serv Odontol,UFR Odontol,EA 2496, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite	Bouchard, P (corresponding author), Univ Paris 07, Rothschild Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR Odontol, Paris, France.	phbouch@noos.fr	Rangé, Hélène/ABA-6442-2020; Poitou, Christine/GVT-6117-2022; Meilhac, Olivier/N-4385-2017	Rangé, Hélène/0000-0002-4761-0805; Poitou, Christine/0000-0001-7769-6331; Bouchard, Philippe/0000-0003-2500-3219; Chaussain, Catherine/0000-0002-3463-3936; KATSAHIAN, Sandrine/0000-0002-7261-0671; Meilhac, Olivier/0000-0002-3740-7539	Assistance Publique-Hopitaux de Paris (AP-HP) (Contrat de Recherche Clinique) [NCT 0047658]	Assistance Publique-Hopitaux de Paris (AP-HP) (Contrat de Recherche Clinique)	This clinical investigation was promoted and supported by Assistance Publique-Hopitaux de Paris (AP-HP) (Contrat de Recherche Clinique, NCT 0047658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2002, PERIODONTOL 2000, V29, P31, DOI 10.1034/j.1600-0757.2002.290103.x; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Benguigui C, 2012, ORAL DIS, V18, P748, DOI 10.1111/j.1601-0825.2012.01940.x; Boillot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021508; Bouchard P, 2006, J PERIODONTOL, V77, P479, DOI 10.1902/jop.2006.050128; Bouchard P, 2010, EUR HEART J SUPPL, V12, pB13, DOI 10.1093/eurheartj/suq001; Bourgeois D, 2007, J PERIODONTAL RES, V42, P219, DOI 10.1111/j.1600-0765.2006.00936.x; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Charles MA, 2008, OBESITY, V16, P2180, DOI [10.1038/oby.2008.285, 10.1038/oby.2008.286]; Chen LP, 2006, AM J KIDNEY DIS, V47, P815, DOI 10.1053/j.ajkd.2006.01.018; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; DEGRAAF TW, 1994, J RHEUMATOL, V21, P2209; Endo Y, 2010, J PERIODONTOL, V81, P520, DOI 10.1902/jop.2009.090574; Engstrom G, 2004, ARTERIOSCL THROM VAS, V24, P1498, DOI 10.1161/01.ATV.0000134293.31512.be; Fillol F, 2011, BRIT J NUTR, V106, P1602, DOI 10.1017/S0007114511002030; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Glurich I, 2002, CLIN DIAGN LAB IMMUN, V9, P425, DOI 10.1128/CDLI.9.2.425-432.2002; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Hayashi S, 2001, VET RES COMMUN, V25, P117, DOI 10.1023/A:1006404902214; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Jimenez M, 2012, OBESITY, V20, P1718, DOI 10.1038/oby.2011.291; Kinane D, 2008, J CLIN PERIODONTOL, V35, P333, DOI 10.1111/j.1600-051X.2008.01278.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Machin D, 2009, SAMPLE SIZE TABLES C, P256; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Page R C, 1998, Ann Periodontol, V3, P108, DOI 10.1902/annals.1998.3.1.108; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Range H, 2012, J CLIN PERIODONTOL, V39, P799, DOI 10.1111/j.1600-051X.2012.01913.x; Richette P, 2011, ANN RHEUM DIS, V70, P139, DOI 10.1136/ard.2010.134015; Saito T, 2008, J DENT RES, V87, P319, DOI 10.1177/154405910808700416; Saito T, 2007, PERIODONTOL 2000, V43, P254, DOI 10.1111/j.1600-0757.2006.00186.x; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Spiller F, 2012, DIABETES, V61, P1584, DOI 10.2337/db11-0825; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; van Dielen FMH, 2004, J CLIN ENDOCR METAB, V89, P4062, DOI 10.1210/jc.2003-032125; Veyrune JL, 2008, OBES SURG, V18, P1467, DOI 10.1007/s11695-008-9443-9; Ziakas A, 2009, MED SCI MONITOR, V15, pCR177	44	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57645	10.1371/journal.pone.0057645	http://dx.doi.org/10.1371/journal.pone.0057645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526947	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562100015
J	Sun, XW; Liu, DY; Zhang, XF; Li, WB; Liu, H; Hong, WG; Jiang, CB; Guan, N; Ma, CX; Zeng, HP; Xu, CH; Song, J; Huang, L; Wang, CM; Shi, JJ; Wang, R; Zheng, XH; Lu, CY; Wang, XW; Zheng, HK				Sun, Xiaowen; Liu, Dongyuan; Zhang, Xiaofeng; Li, Wenbin; Liu, Hui; Hong, Weiguo; Jiang, Chuanbei; Guan, Ning; Ma, Chouxian; Zeng, Huaping; Xu, Chunhua; Song, Jun; Huang, Long; Wang, Chunmei; Shi, Junjie; Wang, Rui; Zheng, Xianhu; Lu, Cuiyun; Wang, Xiaowu; Zheng, Hongkun			SLAF-seq: An Efficient Method of Large-Scale De Novo SNP Discovery and Genotyping Using High-Throughput Sequencing	PLOS ONE			English	Article							GENOME SEQUENCE; MAP; DNA; DOMESTICATION; POLYMORPHISMS; TECHNOLOGY; DIVERSITY; SELECTION; PRIMERS; MARKERS	Large-scale genotyping plays an important role in genetic association studies. It has provided new opportunities for gene discovery, especially when combined with high-throughput sequencing technologies. Here, we report an efficient solution for large-scale genotyping. We call it specific-locus amplified fragment sequencing (SLAF-seq). SLAF-seq technology has several distinguishing characteristics: i) deep sequencing to ensure genotyping accuracy; ii) reduced representation strategy to reduce sequencing costs; iii) pre-designed reduced representation scheme to optimize marker efficiency; and iv) double barcode system for large populations. In this study, we tested the efficiency of SLAF-seq on rice and soybean data. Both sets of results showed strong consistency between predicted and practical SLAFs and considerable genotyping accuracy. We also report the highest density genetic map yet created for any organism without a reference genome sequence, common carp in this case, using SLAF-seq data. We detected 50,530 high-quality SLAFs with 13,291 SNPs genotyped in 211 individual carp. The genetic map contained 5,885 markers with 0.68 cM intervals on average. A comparative genomics study between common carp genetic map and zebrafish genome sequence map showed high-quality SLAF-seq genotyping results. SLAF-seq provides a high-resolution strategy for large-scale genotyping and can be generally applicable to various species and populations.	[Sun, Xiaowen; Zhang, Xiaofeng; Zheng, Xianhu; Lu, Cuiyun] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Peoples R China; [Liu, Dongyuan; Li, Wenbin; Liu, Hui; Hong, Weiguo; Jiang, Chuanbei; Guan, Ning; Ma, Chouxian; Zeng, Huaping; Xu, Chunhua; Song, Jun; Huang, Long; Wang, Chunmei; Shi, Junjie; Wang, Rui; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China; [Li, Wenbin] Northeast Agr Univ, Key Lab Soybean Biol, Chinese Minist Educ, Harbin, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Sun, XW (corresponding author), Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Peoples R China.	sunxw2002@163.com; zhenghk@biomarker.com.cn	Zheng, xianhu/F-1739-2014; Hong, Weiguo/ABD-4294-2020; Sun, Xiaowen/F-1516-2014; Wang, Xiaowu/L-2579-2019	Zheng, xianhu/0000-0002-6206-8567; 	Key Project of Chinese National Programs for Fundamental Research and Development [2010CB126305]; National High Technology Research and Development Program of China [2011AA100402]	Key Project of Chinese National Programs for Fundamental Research and Development; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by Key Project of Chinese National Programs for Fundamental Research and Development (No. 2010CB126305) and the National High Technology Research and Development Program of China (2011AA100402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bindler G, 2011, THEOR APPL GENET, V123, P219, DOI 10.1007/s00122-011-1578-8; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lucito R, 1998, P NATL ACAD SCI USA, V95, P4487, DOI 10.1073/pnas.95.8.4487; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	32	533	626	7	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58700	10.1371/journal.pone.0058700	http://dx.doi.org/10.1371/journal.pone.0058700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527008	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100035
J	Narayanaswamy, BE; Coll, M; Danovaro, R; Davidson, K; Ojaveer, H; Renaud, PE				Narayanaswamy, Bhavani E.; Coll, Marta; Danovaro, Roberto; Davidson, Keith; Ojaveer, Henn; Renaud, Paul E.			Synthesis of Knowledge on Marine Biodiversity in European Seas: From Census to Sustainable Management	PLOS ONE			English	Article							MICROBIAL DIVERSITY; ECOSYSTEM; CONSERVATION; RESILIENCE; HABITATS; PATTERNS; IMPACTS; DECLINE; SHARKS	The recently completed European Census of Marine Life, conducted within the framework of the global Census of Marine Life programme (2000-2010), markedly enhanced our understanding of marine biodiversity in European Seas, its importance within ecological systems, and the implications for human use. Here we undertake a synthesis of present knowledge of biodiversity in European Seas and identify remaining challenges that prevent sustainable management of marine biodiversity in one of the most exploited continents of the globe. Our analysis demonstrates that changes in faunal standing stock with depth depends on the size of the fauna, with macrofaunal abundance only declining with increasing water depth below 1000 m, whilst there was no obvious decrease in meiofauna with increasing depth. Species richness was highly variable for both deep water macro-and meio-fauna along latitudinal and longitudinal gradients. Nematode biodiversity decreased from the Atlantic into the Mediterranean whilst latitudinal related biodiversity patterns were similar for both faunal groups investigated, suggesting that the same environmental drivers were influencing the fauna. While climate change and habitat degradation are the most frequently implicated stressors affecting biodiversity throughout European Seas, quantitative understanding, both at individual and cumulative/synergistic level, of their influences are often lacking. Full identification and quantification of species, in even a single marine habitat, remains a distant goal, as we lack integrated data-sets to quantify these. While the importance of safeguarding marine biodiversity is recognised by policy makers, the lack of advanced understanding of species diversity and of a full survey of any single habitat raises huge challenges in quantifying change, and facilitating/prioritising habitat/ecosystem protection. Our study highlights a pressing requirement for more complete biodiversity surveys to be undertaken within contrasting habitats, together with investigations in biodiversity-ecosystem functioning links and identification of separate and synergistic/cumulative humaninduced impacts on biodiversity.	[Narayanaswamy, Bhavani E.; Davidson, Keith] Scottish Assoc Marine Sci, Scottish Marine Inst, Oban, Argyll, Scotland; [Coll, Marta] Sci Spanish Council ICM CSIC, Inst Ciencies Mar, Barcelona, Spain; [Danovaro, Roberto] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Renaud, Paul E.] Akvaplan NIVA, Fram Ctr Climate & Environm, Tromso, Norway; [Renaud, Paul E.] Univ Ctr Svalbard, Longyearbyen, Norway	UHI Millennium Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Marche Polytechnic University; University of Tartu; Estonian Marine Institute; Akvaplan-niva; University Centre Svalbard (UNIS)	Narayanaswamy, BE (corresponding author), Scottish Assoc Marine Sci, Scottish Marine Inst, Oban, Argyll, Scotland.	Bhavani.Narayanaswamy@sams.ac.uk	Ojaveer, Henn/K-2160-2016; Renaud, Paul E/C-7191-2008; Davidson, Keith/A-5474-2013; Coll, Marta/A-9488-2012	Ojaveer, Henn/0000-0003-2742-6063; Davidson, Keith/0000-0001-9269-3227; Coll, Marta/0000-0001-6235-5868; Narayanaswamy, Bhavani/0000-0002-5810-9127	Total Foundation; Census of Marine Life [OL100098]; European Community; Spanish National program Ramon y Cajal; national funding within the frame of the project RITMARE; Estonian Ministry of Education and Research [SF0180005s10]; European Community [266445]; project 'The status of marine biodiversity and its potential futures in the Estonian coastal sea' of Environmental Protection and Technology Programme of the European Regional Fund [3.2.0802.11-0029]; European Census of Marine Life; Census of Marine Life; EU	Total Foundation(Total SA); Census of Marine Life; European Community(European Commission); Spanish National program Ramon y Cajal(German Research Foundation (DFG)); national funding within the frame of the project RITMARE; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Community(European Commission); project 'The status of marine biodiversity and its potential futures in the Estonian coastal sea' of Environmental Protection and Technology Programme of the European Regional Fund; European Census of Marine Life; Census of Marine Life; EU(European Commission)	BN was supported by the Total Foundation and a grant from the Census of Marine Life (OL100098), funding to MC was given by a European Community Marie-Curie Postdoctoral Fellowship through the International Outgoing Fellowships to ECOFUN, and by the Spanish National program Ramon y Cajal whilst RD was supported by the national funding within the frame of the project RITMARE. The contribution of HO was partially financed by the Estonian Ministry of Education and Research (grant SF0180005s10) and by the European Community's Seventh Framework Programme (FP7/2007-2013 under Grant Agreement No. 266445) for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS). Contribution of HO was also supported by the project 'The status of marine biodiversity and its potential futures in the Estonian coastal sea' 3.2.0802.11-0029 of Environmental Protection and Technology Programme of the European Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the support given by the European Census of Marine Life and the Census of Marine Life. The authors are also indebted to all those who have undertaken the research through the various Census of Marine Life projects, EU-funded MarBEF, HERMES and HERMIONE programmes, as well as those that have been nationally funded. We would also like to thank all the regional experts who have provided their input into estimating biodiversity threats both for now and the future.	Abdul Malak D., 2011, OVERVIEW CONSERVATIO; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2000, NATURE BIODIVERSITY, P1; Ausubel J.H., 1999, OCEANOGRAPHY, V12, P4, DOI [10.5670/oceanog.1999.17, DOI 10.5670/OCEANOG.1999.17]; Beaumont NJ, 2008, MAR POLLUT BULL, V56, P386, DOI 10.1016/j.marpolbul.2007.11.013; Becking L.G.M.B, 1934, GEOBIOLOGIE INLEIDIN; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Boedeker Dieter, 2007, Baltic Sea Environment Proceedings, V113, P1; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; Boxshall C., 2009, MARINE BIODIVERSITY; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2012, FISH FISH, V13, P60, DOI 10.1111/j.1467-2979.2011.00420.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Commission of the European Communities (CEC), 2010, OFFICIAL J EUROPEAN, V232, P14; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2007, ESTUAR COAST SHELF S, V75, P4, DOI 10.1016/j.ecss.2007.02.030; Danovaro R, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P115; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Ferreira JG, 2011, ESTUAR COAST SHELF S, V93, P117, DOI 10.1016/j.ecss.2011.03.014; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fonselius S, 2003, J SEA RES, V49, P229, DOI 10.1016/S1385-1101(03)00035-2; Fraschetti S, 2011, AQUAT CONSERV, V21, P299, DOI 10.1002/aqc.1185; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; HELCOM, 2009, BALT SEA ENV P B, V116B, P1; ICES, 2011, ICES ADV 2011; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Kroncke I, 2003, MAR ECOL-P S Z N I, V24, P193, DOI 10.1046/j.0173-9565.2003.00825.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Lotze HK, 2005, HELGOLAND MAR RES, V59, P84, DOI 10.1007/s10152-004-0209-z; MarBEF, 2004, EUR NOD OC BIOG INF; May RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001130; McCann K, 2007, NATURE, V446, P29, DOI 10.1038/446029a; McCarthy J., 2005, CLIMATE CHANGE CONTE; Medlin Linda K., 2010, Diversity, V2, P973, DOI 10.3390/d2070973; Meynard CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036443; MFSD, 2008, **NON-TRADITIONAL**, V164, P19; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Narayanaswamy BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014295; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Ojaveer H, 2007, FISH RES, V87, P102, DOI 10.1016/j.fishres.2007.08.011; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Olenin S, 1999, HYDROBIOLOGIA, V393, P233, DOI 10.1023/A:1003511003766; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Portman ME, 2012, AMBIO IN PRESS; Queffelec B, 2009, MAR POLICY, V33, P871, DOI 10.1016/j.marpol.2009.04.016; Rees H.L., 2007, ICES COOPERATIVE RES, V288, P258; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; Rilov G, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-10; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Stein Ulrike, 1990, Mitteilungen aus dem Zoologischen Museum der Christian-Albrechts-Universitaet zu Kiel Supplement, V3, P1; Stelzenmuller V, 2012, MAR POLICY IN PRESS; Vandepitte L, 2011, HYDROBIOLOGIA, V667, P1, DOI 10.1007/s10750-011-0656-x; Vira B, 2009, CONSERV LETT, V2, P158, DOI 10.1111/j.1755-263X.2009.00063.x; Whitfield J, 2005, SCIENCE, V310, P960, DOI 10.1126/science.310.5750.960; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; *WSSD, 2002, WORLD SUMM SUST DEV; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	78	29	30	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58909	10.1371/journal.pone.0058909	http://dx.doi.org/10.1371/journal.pone.0058909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527045	Green Published, Green Submitted, gold			2022-12-25	WOS:000316411600015
J	DesRochers, TM; Suter, L; Roth, A; Kaplan, DL				DesRochers, Teresa M.; Suter, Laura; Roth, Adrian; Kaplan, David L.			Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity	PLOS ONE			English	Article							CIS-PLATINUM NEPHROTOXICITY; PROXIMAL TUBULAR CELLS; PRIMARY CULTURES; COCULTURE MODEL; 2 STRAINS; BIOMARKERS; TOXICITY; INJURY; CYTOTOXICITY; TRANSPORTERS	The staggering cost of bringing a drug to market coupled with the extremely high failure rate of prospective compounds in early phase clinical trials due to unexpected human toxicity makes it imperative that more relevant human models be developed to better predict drug toxicity. Drug-induced nephrotoxicity remains especially difficult to predict in both preclinical and clinical settings and is often undetected until patient hospitalization. Current pre-clinical methods of determining renal toxicity include 2D cell cultures and animal models, both of which are incapable of fully recapitulating the in vivo human response to drugs, contributing to the high failure rate upon clinical trials. We have bioengineered a 3D kidney tissue model using immortalized human renal cortical epithelial cells with kidney functions similar to that found in vivo. These 3D tissues were compared to 2D cells in terms of both acute (3 days) and chronic (2 weeks) toxicity induced by Cisplatin, Gentamicin, and Doxorubicin using both traditional LDH secretion and the pre-clinical biomarkers Kim-1 and NGAL as assessments of toxicity. The 3D tissues were more sensitive to drug-induced toxicity and, unlike the 2D cells, were capable of being used to monitor chronic toxicity due to repeat dosing. The inclusion of this tissue model in drug testing prior to the initiation of phase I clinical trials would allow for better prediction of the nephrotoxic effects of new drugs.	[DesRochers, Teresa M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA USA; [Suter, Laura; Roth, Adrian] F Hoffmann La Roche & Co Ltd, Nonclin Safety, CH-4002 Basel, Switzerland	Tufts University; Roche Holding	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA USA.	david.kaplan@tufts.edu	Suter-Dick, Laura/A-9093-2019	Suter-Dick, Laura/0000-0002-1449-3913; DesRochers, Teresa/0000-0003-3819-5491	National Institutes of Health [EB002520]; F. Hoffmann La Roche, Ltd.; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F. Hoffmann La Roche, Ltd.(Hoffmann-La Roche); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by the National Institutes of Health (EB002520) and F. Hoffmann La Roche, Ltd. 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astashkina AI, 2012, BIOMATERIALS, V33, P4712, DOI 10.1016/j.biomaterials.2012.03.001; Astashkina AI, 2012, BIOMATERIALS, V33, P4700, DOI 10.1016/j.biomaterials.2012.02.063; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Canton I, 2010, BIOTECHNOL BIOENG, V106, P794, DOI 10.1002/bit.22742; CHABARDES D, 1980, J CLIN INVEST, V65, P439, DOI 10.1172/JCI109687; Chang R, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045004; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; CHEN JC, 1990, TOXICOL APPL PHARM, V103, P463, DOI 10.1016/0041-008X(90)90319-P; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; Cummings BS, 2000, J PHARMACOL EXP THER, V293, P677; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DOBYAN DC, 1980, J PHARMACOL EXP THER, V213, P551; El Mouedden M, 2000, TOXICOL SCI, V56, P229, DOI 10.1093/toxsci/56.1.229; Food and Drug Administration, 2004, INN STAGN CHALL OPP; Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x; Garrett SH, 1998, ENVIRON HEALTH PERSP, V106, P587, DOI 10.2307/3434234; Gautier JC, 2010, TOXICOL PATHOL, V38, P943, DOI 10.1177/0192623310379139; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; GOLDSTEIN RS, 1981, TOXICOL APPL PHARM, V60, P163, DOI 10.1016/0041-008X(91)90220-9; Guo QS, 2008, EUR J CELL BIOL, V87, P251, DOI 10.1016/j.ejcb.2007.11.004; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Harpur E, 2011, TOXICOL SCI, V122, P235, DOI 10.1093/toxsci/kfr112; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hoffmann D, 2010, TOXICOL SCI, V116, P8, DOI 10.1093/toxsci/kfq029; Hu T, 2010, TOXICOL IN VITRO, V24, P1450, DOI 10.1016/j.tiv.2010.03.013; Kirsch-Volders M, 2011, MUTAGENESIS, V26, P177, DOI 10.1093/mutage/geq068; Knight A, 2008, REV RECENT CLIN TRIA, V3, P89, DOI 10.2174/157488708784223844; Lan SF, 2011, TOXICOL APPL PHARM, V256, P62, DOI 10.1016/j.taap.2011.07.013; LEVI J, 1980, J PHARMACOL EXP THER, V213, P545; Li W, 2006, TOXICOL IN VITRO, V20, P669, DOI 10.1016/j.tiv.2005.09.016; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Nakamura K, 2011, J BIOSCI BIOENG, V111, P78, DOI 10.1016/j.jbiosc.2010.08.008; NANUS DM, 1991, ONCOGENE, V6, P2105; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Presnell SC, 2011, TISSUE ENG PART C-ME, V17, P261, DOI [10.1089/ten.tec.2010.0399, 10.1089/ten.TEC.2010.0399]; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; Rached E, 2008, TOXICOL SCI, V103, P371, DOI 10.1093/toxsci/kfn040; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sasaki D, 2011, BIOMARKERS, V16, P553, DOI 10.3109/1354750X.2011.613123; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; Servais H, 2006, ANTIMICROB AGENTS CH, V50, P1213, DOI 10.1128/AAC.50.4.1213-1221.2006; Sung JH, 2009, LAB CHIP, V9, P1385, DOI 10.1039/b901377f; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; TURNER RJ, 1977, P NATL ACAD SCI USA, V74, P2825, DOI 10.1073/pnas.74.7.2825; Weiland C, 2007, TOXICOL IN VITRO, V21, P466, DOI 10.1016/j.tiv.2006.10.008; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wu Y, 2009, TOXICOL IN VITRO, V23, P1170, DOI 10.1016/j.tiv.2009.06.003	48	87	92	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59219	10.1371/journal.pone.0059219	http://dx.doi.org/10.1371/journal.pone.0059219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516613	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400098
J	Silva, EM; Conde, JN; Allonso, D; Nogueira, ML; Mohana-Borges, R				Silva, Emiliana M.; Conde, Jonas N.; Allonso, Diego; Nogueira, Mauricio L.; Mohana-Borges, Ronaldo			Mapping the Interactions of Dengue Virus NS1 Protein with Human Liver Proteins Using a Yeast Two-Hybrid System: Identification of C1q as an Interacting Partner	PLOS ONE			English	Article							NONSTRUCTURAL GLYCOPROTEIN NS1; ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; WEST-NILE-VIRUS; NF-KAPPA-B; HEMORRHAGIC-FEVER; COMPLEMENT ACTIVATION; INFECTED PATIENTS; SERUM-LEVELS	Dengue constitutes a global health concern. The clinical manifestation of this disease varies from mild febrile illness to severe hemorrhage and/or fatal hypovolemic shock. Flavivirus nonstructural protein 1 (NS1) is a secreted glycoprotein that is displayed on the surface of infected cells but is absent in viral particles. NS1 accumulates at high levels in the plasma of dengue virus (DENV)-infected patients, and previous reports highlight its involvement in immune evasion, dengue severity, liver dysfunction and pathogenesis. In the present study, we performed a yeast two-hybrid screen to search for DENV2 NS1-interacting partners using a human liver cDNA library. We identified fifty genes, including human complement component 1 (C1q), which was confirmed by coimmunoprecipitation, ELISA and immunofluorescence assays, revealing for the first time the direct binding of this protein to NS1. Furthermore, the majority of the identified genes encode proteins that are secreted into the plasma of patients, and most of these proteins are classified as acute-phase proteins (APPs), such as plasminogen, haptoglobin, hemopexin, a-2-HS-glycoprotein, retinol binding protein 4, transferrin, and C4. The results presented here confirm the direct interaction of DENV NS1 with a key protein of the complement system and suggest a role for this complement protein in the pathogenesis of DENV infection.	[Silva, Emiliana M.; Conde, Jonas N.; Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil; [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Dept Doencas Dermatol Infecciosas & Parasitarias, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro	Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil.	mohana@biof.ufrj.br	Nascimento conde, Jonas/D-4481-2019; Nogueira, Mauricio L/B-7599-2012; Borges, Ronaldo S Mohana/C-5575-2013; Allonso, Diego/Y-3446-2018	Nogueira, Mauricio L/0000-0003-1102-2419; Allonso, Diego/0000-0002-1410-480X; Nascimento Conde, Jonas/0000-0001-5895-1114	Brazilian Health Ministry; CNPq; FAPERJ; IMBEBB; FINEP (GENOPROT Dengue); National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB)	Brazilian Health Ministry; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); IMBEBB; FINEP (GENOPROT Dengue)(Financiadora de Inovacao e Pesquisa (Finep)); National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB)	This work was supported by the following funding agencies: the Brazilian Health Ministry, CNPq, FAPERJ, IMBEBB, FINEP (GENOPROT Dengue), and the National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029; Armbrust T, 1997, HEPATOLOGY, V26, P98; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Avirutnan P, 2008, VACCINE, V26, pI100, DOI 10.1016/j.vaccine.2008.11.061; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; BARTHOLOMEW RM, 1978, J EXP MED, V147, P844, DOI 10.1084/jem.147.3.844; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; BOKISCH VA, 1973, NEW ENGL J MED, V289, P996, DOI 10.1056/NEJM197311082891902; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; CHANG NS, 1994, J LEUKOCYTE BIOL, V55, P778, DOI 10.1002/jlb.55.6.778; Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; EBENBICHLER CF, 1991, J EXP MED, V174, P1417, DOI 10.1084/jem.174.6.1417; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Falconar AKI, 2008, CLIN VACCINE IMMUNOL, V15, P549, DOI 10.1128/CVI.00351-07; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395; Loos M, 1989, Behring Inst Mitt, P32; Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183; Restrepo BN, 2008, REV SOC BRAS MED TRO, V41, P6, DOI 10.1590/S0037-86822008000100002; Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Silva BM, 2011, ARCH VIROL, V156, P1275, DOI 10.1007/s00705-011-0969-0; SUSAL C, 1994, J IMMUNOL, V152, P6028; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Volanakis JE, 2002, CURR TOP MICROBIOL, V266, P41; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704; World Health Organization, 2009, DENGUE GUIDELINES DI; Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000	62	29	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57514	10.1371/journal.pone.0057514	http://dx.doi.org/10.1371/journal.pone.0057514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516407	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400008
J	Zhao, W; Zhang, JT; Xing, XW; Huang, DH; Tian, CL; Jia, WQ; Huang, XS; Wu, WP; Pu, CQ; Lang, SY; Yu, SY				Zhao, Wei; Zhang, Jia-Tang; Xing, Xiao-Wei; Huang, De-Hui; Tian, Cheng-Lin; Jia, Wei-Quan; Huang, Xu-Sheng; Wu, Wei-Ping; Pu, Chuan-Qiang; Lang, Sen-Yang; Yu, Sheng-Yuan			Chinese Specific Characteristics of Sporadic Creutzfeldt-Jakob Disease: A Retrospective Analysis of 57 Cases	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; 14-3-3 PROTEIN; UNITED-STATES; LIFE; PHYSICIANS; DECISIONS; JAPANESE; END; EEG; CJD	Objective: Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal and transmissible neurodegenerative disorder. However, no studies have reported Chinese specific characteristics of sCJD. We aimed to identify differences in sCJD between Chinese patients and patients from other countries. Methods: The data from 57 Chinese sCJD patients were retrospectively analyzed, including demographic data, clinical manifestations, laboratory examinations, electroencephalograms (EEGs), diffusion-weighted imaging (DWI) scans, positron emission tomography (PET) scans, and pathological results. Result: The disease was pathologically confirmed in 11 patients. 39 cases were diagnosed as probable sCJD, and 7 were possible. Of the total cases, 33 were male, and 24 were female. The onset age ranged from 36 to 75 years (mean: 55.5, median: 57). Disease onset before the age of 60 occurred in 57.9% of patients. The disease duration from onset to death ranged 5-22 months (mean: 11.6, median: 11), and 51.9% of patients died 7 to 12 months after disease onset. The majority of patients presented with sub-acute onset with progressive dementia. 3 of the 9 patients who took 14-3-3 protein analysis had positive results (33.3%). The sensitivity of EEG was 79.6% (43/54). For DWI and PET examinations, the sensitivities were 94% (47/50) and 94.1% (16/17), respectively. In seven patients who did not show typical hyper-intensities on the first DWI examination, abnormalities of hypo-metabolism in the cerebral cortex were clearly detected by PET. In 13 out of the 17 patients, PET detected extra abnormal regions in addition to the hyper-intense areas observed in DWI. Conclusion: This is the first study to indicate that Chinese sCJD patients have a much earlier onset age and a longer disease duration than other populations, which is most likely related to racial differences. The longer disease duration may also be a probable characteristic of Asian populations. PET had high sensitivity for the diagnosis of sCJD.	[Zhao, Wei; Zhang, Jia-Tang; Xing, Xiao-Wei; Huang, De-Hui; Tian, Cheng-Lin; Jia, Wei-Quan; Huang, Xu-Sheng; Wu, Wei-Ping; Pu, Chuan-Qiang; Lang, Sen-Yang; Yu, Sheng-Yuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, JT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China.	edwin-zhang@263.net		Zhang, Jia-Tang/0000-0002-9714-0944; Xing, Xiao-Wei/0000-0002-2573-1446				Asai A, 1997, J MED ETHICS, V23, P323, DOI 10.1136/jme.23.5.323; ASAI A, 1995, LANCET, V346, P356, DOI 10.1016/S0140-6736(95)92230-X; Baldeiras IE, 2009, J NEUROL, V256, P1540, DOI 10.1007/s00415-009-5160-0; Belay ED, 2003, NEUROLOGY, V60, P176, DOI 10.1212/01.WNL.0000036913.87823.D6; Chen HL, 2008, J CLIN NEUROL, V21, P345; Collins S, 2002, NEUROLOGY, V59, P1365, DOI 10.1212/01.WNL.0000031793.11602.8C; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Henkel K, 2002, J NEUROL, V249, P699, DOI 10.1007/s00415-002-0695-3; Hirose Y, 1998, Rinsho Shinkeigaku, V38, P779; Iwasaki Yasushi, 2009, Rinsho Shinkeigaku, V49, P463; Kamogawa Kenji, 2009, Nihon Ronen Igakkai Zasshi, V46, P458; Ko K. F., 2010, Hong Kong Medical Journal, V16, P487; Li S, 2007, J BRAIN NERVOUS DIS, V15; Maddox RA, 2006, NEUROLOGY, V66, P439, DOI 10.1212/01.wnl.0000196473.46805.61; Meissner B, 2004, NEUROLOGY, V63, P450, DOI 10.1212/01.WNL.0000136225.80445.C9; Nagoshi K, 2011, J EPIDEMIOL, V21, P255, DOI 10.2188/jea.JE20100085; Panagariya A, 1999, J Assoc Physicians India, V47, P548; Shiga Y, 2004, NEUROLOGY, V63, P443, DOI 10.1212/01.WNL.0000134555.59460.5D; Smyth A, 1997, J NEUROL SCI, V152, pS93, DOI 10.1016/S0022-510X(97)00253-0; Steinhoff BJ, 2004, ANN NEUROL, V56, P702, DOI 10.1002/ana.20261; Tian Chan, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P713; Vitali P, 2011, NEUROLOGY, V76, P1711, DOI 10.1212/WNL.0b013e31821a4439; Wieser HG, 2004, CLIN NEUROPHYSIOL, V115, P2467, DOI 10.1016/j.clinph.2004.05.032; Zerr I, 2000, NEUROLOGY, V55, P811, DOI 10.1212/WNL.55.6.811; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zhang JT, 2008, MED J CHIN PLA, V33	28	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58442	10.1371/journal.pone.0058442	http://dx.doi.org/10.1371/journal.pone.0058442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516482	gold, Green Submitted, Green Published			2022-12-25	WOS:000316407400030
J	Zhuang, L; Sachdev, PS; Trollor, JN; Reppermund, S; Kochan, NA; Brodaty, H; Wen, W				Zhuang, Lin; Sachdev, Perminder S.; Trollor, Julian N.; Reppermund, Simone; Kochan, Nicole A.; Brodaty, Henry; Wen, Wei			Microstructural White Matter Changes, Not Hippocampal Atrophy, Detect Early Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							APOE EPSILON-4 ALLELE; ALZHEIMERS-DISEASE; WALLERIAN DEGENERATION; NEUROTROPHIC FACTOR; FORNIX INFARCTION; CORPUS-CALLOSUM; WATER DIFFUSION; TAU PATHOLOGY; BRAIN; MRI	Background: Alzheimer's disease (AD) is generally considered to be characterized by pathology in gray matter of the brain, but convergent evidence suggests that white matter degradation also plays a vital role in its pathogenesis. The evolution of white matter deterioration and its relationship with gray matter atrophy remains elusive in amnestic mild cognitive impairment (aMCI), a prodromal stage of AD. Methods: We studied 155 cognitively normal (CN) and 27 'late' aMCI individuals with stable diagnosis over 2 years, and 39 'early' aMCI individuals who had converted from CN to aMCI at 2-year follow up. Diffusion tensor imaging (DTI) tractography was used to reconstruct six white matter tracts three limbic tracts critical for episodic memory function - the fornix, the parahippocampal cingulum, and the uncinate fasciculus; two cortico-cortical association fiber tracts - superior longitudinal fasciculus and inferior longitudinal fasciculus; and one projection fiber tract - corticospinal tract. Microstructural integrity as measured by fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AxD) was assessed for these tracts. Results: Compared with CN, late aMCI had lower white matter integrity in the fornix, the parahippocampal cingulum, and the uncinate fasciculus, while early aMCI showed white matter damage in the fornix. In addition, fornical measures were correlated with hippocampal atrophy in late aMCI, whereas abnormality of the fornix in early aMCI occurred in the absence of hippocampal atrophy and did not correlate with hippocampal volumes. Conclusions: Limbic white matter tracts are preferentially affected in the early stages of cognitive dysfunction. Microstructural degradation of the fornix preceding hippocampal atrophy may serve as a novel imaging marker for aMCI at an early stage.	[Zhuang, Lin; Sachdev, Perminder S.; Trollor, Julian N.; Reppermund, Simone; Kochan, Nicole A.; Brodaty, Henry; Wen, Wei] Univ New S Wales, Ctr Healthy Brain Ageing, Randwick, NSW, Australia; [Sachdev, Perminder S.; Kochan, Nicole A.; Wen, Wei] Prince Wales Hosp, Neuropsychiat Inst, Euroa Ctr, Randwick, NSW 2031, Australia; [Brodaty, Henry] Univ New S Wales, Fac Med, Sch Psychiat, Primary Dementia Collaborat Res Ctr, Randwick, NSW, Australia; [Trollor, Julian N.] Univ New S Wales, Fac Med, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Randwick, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Wen, W (corresponding author), Univ New S Wales, Ctr Healthy Brain Ageing, Randwick, NSW, Australia.	w.wen@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Trollor, Julian/0000-0002-7685-2977; Wen, Wei/0000-0003-2753-3870	Australian National Health and Medical Research Council (NHMRC) [350833, 510175]; Australian Research Council Discovery Grant [ARC DP-0774213]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Grant(Australian Research Council)	This study was funded by an Australian National Health and Medical Research Council (NHMRC) Program Grant ID 350833, NHMRC Project Grant ID 510175, and Australian Research Council Discovery Grant ID ARC DP-0774213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Aggleton JP, 2000, BRAIN, V123, P800, DOI 10.1093/brain/123.4.800; Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belarbi K, 2011, CURR ALZHEIMER RES, V8, P633, DOI 10.2174/156720511796717230; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Bozoki AC, HUM BRAIN M IN PRESS; Brickman AM, 2012, ARCH NEUROL-CHICAGO, P1; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Desai MK, 2010, AM J PATHOL, V177, P1422, DOI 10.2353/ajpath.2010.100087; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Dickerson BC, 2001, NEUROBIOL AGING, V22, P747, DOI 10.1016/S0197-4580(01)00271-8; Dickerson B, 2011, NEUROLOGY, V76, pA659; Duara R, 2008, NEUROLOGY, V71, P1986, DOI 10.1212/01.wnl.0000336925.79704.9f; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Gold BT, 2010, NEUROIMAGE, V52, P1487, DOI 10.1016/j.neuroimage.2010.05.036; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Hattingen E, 2007, J NEUROL NEUROSUR PS, V78, P655, DOI 10.1136/jnnp.2006.109801; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Lee DY, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00001; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Moudgil SS, 2000, STROKE, V31, P1418, DOI 10.1161/01.STR.31.6.1418; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Niewiadomska G, 2005, ANN NY ACAD SCI, V1048, P287, DOI 10.1196/annals.1342.026; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Salo A, 2001, INT PSYCHOGERIATR, V13, P451, DOI 10.1017/S1041610201007864; Selnes Per, 2012, Alzheimers Dement, V8, pS112, DOI 10.1016/j.jalz.2011.07.001; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Strauss E, 2006, COMPENDIUM NEUROPSYC; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yaffe K, 2006, DEMENT GERIATR COGN, V22, P312, DOI 10.1159/000095427; Zhang HB, 2011, J NEUROL NEUROSUR PS, V82, P487, DOI 10.1136/jnnp.2010.217133; Zhuang L, 2012, NEUROLOGY, V79, P748, DOI 10.1212/WNL.0b013e3182661f4d	64	98	100	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58887	10.1371/journal.pone.0058887	http://dx.doi.org/10.1371/journal.pone.0058887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516569	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400072
J	den Haan, AD; Veldkamp, MW; Bakker, D; Boink, GJJ; Janssen, RB; de Bakker, JMT; Tan, HL				den Haan, A. Denise; Veldkamp, Marieke W.; Bakker, Diane; Boink, Geert J. J.; Janssen, Rob B.; de Bakker, Jacques M. T.; Tan, Hanno L.			Organ Explant Culture of Neonatal Rat Ventricles: A New Model to Study Gene and Cell Therapy	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; SMOOTH MUSCLE ACTIN; IN-VITRO; IMPULSE PROPAGATION; CONDUCTION-VELOCITY; ELECTRICAL-PROPERTIES; POTASSIUM CHANNEL; CARDIAC MYOCYTES; INWARD RECTIFIER; HEART-CELLS	Testing cardiac gene and cell therapies in vitro requires a tissue substrate that survives for several days in culture while maintaining its physiological properties. The purpose of this study was to test whether culture of intact cardiac tissue of neonatal rat ventricles (organ explant culture) may be used as a model to study gene and cell therapy. We compared (immuno) histology and electrophysiology of organ explant cultures to both freshly isolated neonatal rat ventricular tissue and monolayers. (Immuno) histologic studies showed that organ explant cultures retained their fiber orientation, and that expression patterns of alpha-actinin, connexin-43, and alpha-smooth muscle actin did not change during culture. Intracellular voltage recordings showed that spontaneous beating was rare in organ explant cultures (20%) and freshly isolated tissue (17%), but common (82%) in monolayers. Accordingly, resting membrane potential was -83.9 +/- 4.4 mV in organ explant cultures, -80.5 +/- 3.5 mV in freshly isolated tissue, and -60.9 +/- 4.3 mV in monolayers. Conduction velocity, measured by optical mapping, was 18.2 +/- 1.0 cm/s in organ explant cultures, 18.0 +/- 1.2 cm/s in freshly isolated tissue, and 24.3 +/- 0.7 cm/s in monolayers. We found no differences in action potential duration (APD) between organ explant cultures and freshly isolated tissue, while APD of monolayers was prolonged (APD at 70% repolarization 88.8 +/- 7.8, 79.1 +/- 2.9, and 134.0 +/- 4.5 ms, respectively). Organ explant cultures and freshly isolated tissue could be paced up to frequencies within the normal range for neonatal rat (CL 150 ms), while monolayers could not. Successful lentiviral (LV) transduction was shown via Egfp gene transfer. Co-culture of organ explant cultures with spontaneously beating cardiomyocytes increased the occurrence of spontaneous beating activity of organ explant cultures to 86%. We conclude that organ explant cultures of neonatal rat ventricle are structurally and electrophysiologically similar to freshly isolated tissue and a suitable new model to study the effects of gene and cell therapy.	[den Haan, A. Denise; Veldkamp, Marieke W.; Bakker, Diane; Boink, Geert J. J.; Janssen, Rob B.; de Bakker, Jacques M. T.; Tan, Hanno L.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [de Bakker, Jacques M. T.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Tan, HL (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Heart, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.l.tan@amc.uva.nl	Boink, Gerard/H-4843-2015	Boink, Gerard/0000-0002-6592-5106	the Netherlands Organization for Scientific Research (NWO) [ZonMW-Vici 918.86.616]	the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO, ZonMW-Vici 918.86.616, to HLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea S, 1999, CIRC RES, V84, P1365; Askar SFA, 2011, CARDIOVASC RES, V90, P295, DOI 10.1093/cvr/cvr011; Ausma J, 1997, AM J PATHOL, V151, P985; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Boink GJJ, 2008, J GENE MED, V10, P487, DOI 10.1002/jgm.1172; BUCHANAN JW, 1985, CIRC RES, V56, P696, DOI 10.1161/01.RES.56.5.696; Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433; Bursac N, 2003, TISSUE ENG, V9, P1243, DOI 10.1089/10763270360728152; Coppen SR, 1998, CIRC RES, V82, P232; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; DEJONG F, 1992, CIRC RES, V71, P240, DOI 10.1161/01.RES.71.2.240; Desplantez T, 2004, PFLUG ARCH EUR J PHY, V448, P363, DOI 10.1007/s00424-004-1250-0; FAST VG, 1995, CARDIOVASC RES, V30, P449, DOI 10.1016/0008-6363(95)00071-2; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Formigli L, 2005, AM J PHYSIOL-CELL PH, V288, pC795, DOI 10.1152/ajpcell.00345.2004; Gaughan JP, 1998, AM J PHYSIOL-HEART C, V275, pH577, DOI 10.1152/ajpheart.1998.275.2.H577; GILES WR, 1985, J PHYSIOL-LONDON, V368, P243, DOI 10.1113/jphysiol.1985.sp015856; Habeler W, 2009, CARDIOVASC RES, V81, P253, DOI 10.1093/cvr/cvn299; JONGSMA HJ, 1983, J MOL CELL CARDIOL, V15, P123, DOI 10.1016/0022-2828(83)90288-2; JOURDON P, 1980, J MOL CELL CARDIOL, V12, P1441, DOI 10.1016/0022-2828(80)90127-3; JOYNER RW, 1982, CIRC RES, V50, P192, DOI 10.1161/01.RES.50.2.192; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; KOVAL M, 1995, J CELL BIOL, V130, P987, DOI 10.1083/jcb.130.4.987; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; LESLIE KO, 1991, AM J PATHOL, V139, P207; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Martinez AD, 2002, CIRC RES, V90, P1100, DOI 10.1161/01.RES.0000019580.64013.31; McCain ML, 2012, AM J PHYSIOL-HEART C, V302, pH443, DOI 10.1152/ajpheart.01218.2010; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Munoz V, 2007, CIRC RES, V101, P475, DOI 10.1161/CIRCRESAHA.107.149617; Nygren A, 2003, AM J PHYSIOL-HEART C, V284, pH892, DOI 10.1152/ajpheart.00648.2002; Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168, DOI 10.1152/ajpheart.2001.280.1.H168; Pillekamp F, 2007, STEM CELLS, V25, P174, DOI 10.1634/stemcells.2006-0094; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; ROHR S, 1991, CIRC RES, V68, P114, DOI 10.1161/01.RES.68.1.114; ROSEN MR, 1981, AM J PHYSIOL, V240, pH546, DOI 10.1152/ajpheart.1981.240.4.H546; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Salameh A, 2004, EUR J PHARMACOL, V503, P9, DOI 10.1016/j.ejphar.2004.09.024; Sekar RB, 2007, AM J PHYSIOL-HEART C, V293, pH2757, DOI 10.1152/ajpheart.00477.2007; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; SMOTHERMAN WP, 1991, PHYSIOL BEHAV, V50, P47, DOI 10.1016/0031-9384(91)90496-B; Spach MS, 2000, CIRC RES, V86, pE23; Stuckmann I, 2003, DEV BIOL, V255, P334, DOI 10.1016/S0012-1606(02)00078-7; SUN LS, 1993, CARDIOVASC RES, V27, P459, DOI 10.1093/cvr/27.3.459; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TUCKER DC, 1985, AM J PHYSIOL, V248, pR601, DOI 10.1152/ajpregu.1985.248.5.R601; van den Hoff MJB, 1999, DEV BIOL, V212, P477, DOI 10.1006/dbio.1999.9366; VANKEMPEN MJA, 1991, CIRC RES, V68, P1638, DOI 10.1161/01.RES.68.6.1638; VARMUS HE, 1973, P NATL ACAD SCI USA, V70, P3067, DOI 10.1073/pnas.70.11.3067; Veldkamp MW, 1999, CARDIOVASC RES, V42, P424, DOI 10.1016/S0008-6363(99)00046-2; Walsh KB, 2002, CARDIOVASC RES, V55, P64, DOI 10.1016/S0008-6363(02)00403-0; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59290	10.1371/journal.pone.0059290	http://dx.doi.org/10.1371/journal.pone.0059290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516623	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200140
J	Molfetti, E; Vilaca, ST; Georges, JY; Plot, V; Delcroix, E; Le Scao, R; Lavergne, A; Barrioz, S; dos Santos, FR; de Thoisy, B				Molfetti, Erica; Vilaca, Sibelle Torres; Georges, Jean-Yves; Plot, Virginie; Delcroix, Eric; Le Scao, Rozen; Lavergne, Anne; Barrioz, Sebastien; dos Santos, Fabricio Rodrigues; de Thoisy, Benoit			Recent Demographic History and Present Fine-Scale Structure in the Northwest Atlantic Leatherback (Dermochelys coriacea) Turtle Population	PLOS ONE			English	Article							SEA-TURTLES; GENETIC DIVERSITY; CLIMATE-CHANGE; METAPOPULATION DYNAMICS; GLOBAL PHYLOGEOGRAPHY; NEUTRAL THEORY; EFFECTIVE SIZE; FRENCH-GUIANA; ISLAND MODEL; NULL ALLELES	The leatherback turtle Dermochelys coriacea is the most widely distributed sea turtle species in the world. It exhibits complex life traits: female homing and migration, migrations of juveniles and males that remain poorly known, and a strong climatic influence on resources, breeding success and sex-ratio. It is consequently challenging to understand population dynamics. Leatherbacks are critically endangered, yet the group from the Northwest Atlantic is currently considered to be under lower risk than other populations while hosting some of the largest rookeries. Here, we investigated the genetic diversity and the demographic history of contrasted rookeries from this group, namely two large nesting populations in French Guiana, and a smaller one in the French West Indies. We used 10 microsatellite loci, of which four are newly isolated, and mitochondrial DNA sequences of the control region and cytochrome b. Both mitochondrial and nuclear markers revealed that the Northwest Atlantic stock of leatherbacks derives from a single ancestral origin, but show current genetic structuration at the scale of nesting sites, with the maintenance of migrants amongst rookeries. Low nuclear genetic diversities are related to founder effects that followed consequent bottlenecks during the late Pleistocene/Holocene. Most probably in response to climatic oscillations, with a possible influence of early human hunting, female effective population sizes collapsed from 2 million to 200. Evidence of founder effects and high numbers of migrants make it possible to reconsider the population dynamics of the species, formerly considered as a metapopulation model: we propose a more relaxed island model, which we expect to be a key element in the currently observed recovering of populations. Although these Northwest Atlantic rookeries should be considered as a single evolutionary unit, we stress that local conservation efforts remain necessary since each nesting site hosts part of the genetic diversity and species history.	[Molfetti, Erica; dos Santos, Fabricio Rodrigues] Univ Fed Minas Gerais, ICB, Dept Biol Geral, BR-31270010 Belo Horizonte, MG, Brazil; [Vilaca, Sibelle Torres] Univ Ferrara, Sez Biol Evolutiva, Dipartimento Biol & Evoluz, I-44100 Ferrara, Italy; [Georges, Jean-Yves; Plot, Virginie] Univ Strasbourg, IPHC, F-67087 Strasbourg, France; [Georges, Jean-Yves; Plot, Virginie] CNRS, UMR 7178, F-67087 Strasbourg, France; [Delcroix, Eric] Off Natl Chasse & Faune Sauvage Guadeloupe, F-97129 Lamentin, Guadeloupe, France; [Le Scao, Rozen] Off Natl Chasse & Faune Sauvage, F-97200 Martinique, Martinique, France; [Lavergne, Anne; de Thoisy, Benoit] Inst Pasteur, Cayenne 97300, French Guiana; [Barrioz, Sebastien; de Thoisy, Benoit] Kwata NGO, Cayenne 97300, French Guiana	Universidade Federal de Minas Gerais; University of Ferrara; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	de Thoisy, B (corresponding author), Inst Pasteur, Cayenne 97300, French Guiana.	benoit@kwata.net	Vilaca, Sibelle/AAA-4573-2020; Vilaça, Sibelle Torres/K-1965-2012; Santos, Fabrício Rodrigues/H-2370-2011	Vilaca, Sibelle/0000-0002-6887-4703; Vilaça, Sibelle Torres/0000-0002-6887-4703; Santos, Fabrício Rodrigues/0000-0001-9088-1750; GEORGES, Jean Yves/0000-0003-1161-2275	DEAL Guyane; Kwata NGO; CNPq; Fapemig; CNPq (Brazil); Agence Nationale pour la Recherche through the MIRETTE project [ANR-07-JCJC-0122]	DEAL Guyane; Kwata NGO; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Agence Nationale pour la Recherche through the MIRETTE project(French National Research Agency (ANR))	Part of the laboratory work (processing of West Indies, Cayenne and Awala samples) was funded by DEAL Guyane and Kwata NGO (www.kwata.net). The authors thank CNPq and Fapemig for fundings for the part of the research realized in Brazil (microsatellite databank). EM, FRS and STV were supported by CNPq (Brazil). The authors' thanks go to CNPq and Fapemig for their funding of the research carried out in Brazil (microsatellite databank). EM, FRS and STV were supported by CNPq (Brazil) and to Agence Nationale pour la Recherche through the MIRETTE project (http://projetmirette.fr, ANR-07-JCJC-0122) led by JYG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2004, MOL ECOL NOTES, V4, P77, DOI 10.1046/j.1471-8286.2003.00574.x; ALLARD MW, 1994, COPEIA, P34; Alstad TI, 2011, CONSERV GENET RESOUR, V3, P457, DOI 10.1007/s12686-010-9378-z; Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Bailey H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036401; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beerli P., 2008, MIGRATE VERSION 3 0; Billotte N., 1999, Fruits (Paris), V54, P277; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN BW, 1994, EVOLUTION, V48, P1820, DOI 10.1111/j.1558-5646.1994.tb02217.x; Brook BW, 2002, P NATL ACAD SCI USA, V99, P14624, DOI 10.1073/pnas.232126899; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Clarke AL, 2001, POPUL DEV REV, V27, P633, DOI 10.1111/j.1728-4457.2001.00633.x; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cole CT, 2003, ANNU REV ECOL EVOL S, V34, P213, DOI 10.1146/annurev.ecolsys.34.030102.151717; Cornuet JM, 1996, GENETICS, V144, P2001; Crim JL, 2002, MOL ECOL, V11, P2097, DOI 10.1046/j.1365-294X.2002.01591.x; de Bruyn M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000554; Delcroix Eric, 2011, Bulletin de la Societe Herpetologique de France, P21; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duffaud Marc-Henri, 2011, Bulletin de la Societe Herpetologique de France, P71; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Dutton PH, 2007, CHELONIAN CONSERV BI, V6, P47, DOI 10.2744/1071-8443(2007)6[47:SAGSON]2.0.CO;2; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; Dutton PH, 1995, THESIS; Dutton PH, 1996, P INT S SEA TURTL CO; ECKERT KL, 1989, HERPETOLOGICA, V45, P190; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Esler D, 2000, CONSERV BIOL, V14, P366, DOI 10.1046/j.1523-1739.2000.98147.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fitzsimmons NN, 1998, MOL ECOL, V7, P575, DOI 10.1046/j.1365-294x.1998.00355.x; Fossette S, 2008, J EXP MAR BIOL ECOL, V356, P69, DOI 10.1016/j.jembe.2007.12.024; Frankham R, 2012, HEREDITY, V108, P167, DOI 10.1038/hdy.2011.66; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Georges JY, 2007, MAR ECOL PROG SER, V338, P225, DOI 10.3354/meps338225; GILPIN M, 1991, BIOL J LINN SOC, V42, P165, DOI 10.1111/j.1095-8312.1991.tb00558.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Girondot Marc, 1996, Chelonian Conservation and Biology, V2, P204; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; IUCN, 2022, IUCN RED LIST THREAT; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; LANDE R, 1992, EVOLUTION, V46, P381, DOI 10.1111/j.1558-5646.1992.tb02046.x; LATTER BDH, 1973, GENETICS, V73, P147; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Moore MK, 2003, CONSERV GENET, V4, P95, DOI 10.1023/A:1021881319271; Nance HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021459; Naro-Maciel E, 2008, MOL PHYLOGENET EVOL, V49, P659, DOI 10.1016/j.ympev.2008.08.004; Nesje A, 2005, GEOPH MONOG SERIES, V158, P289; Nylander J, 2004, MR MODELTEST V2 PROG; Oleas NH, 2012, J HERED, V103, P557, DOI 10.1093/jhered/ess020; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Parham JF, 1996, J HERPETOL, V30, P401, DOI 10.2307/1565178; Plot V, 2012, J ANIM ECOL, V81, P341, DOI 10.1111/j.1365-2656.2011.01915.x; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD PCH, 1976, COPEIA, P749; Rambaut A., 2007, TRACER V1 4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reis EC, 2010, CONSERV GENET, V11, P1467, DOI 10.1007/s10592-009-9975-0; Rimbu N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016570; Rivalan P, 2006, BIOL CONSERV, V130, P1, DOI 10.1016/j.biocon.2005.11.027; Roden SE, 2011, CONSERV GENET RESOUR, V3, P49, DOI 10.1007/s12686-010-9284-4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAMBROOK E, 1989, MOL CLONING LAB MANU; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; Shamblin BM, 2007, MOL ECOL NOTES, V7, P784, DOI 10.1111/j.1471-8286.2007.01701.x; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Stewart K, 2011, ECOL APPL, V21, P263, DOI 10.1890/09-1838.1; Storz JF, 2002, EVOLUTION, V56, P154; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thornalley DJR, 2009, NATURE, V457, P711, DOI 10.1038/nature07717; Troeng S, 2004, ORYX, V38, P395, DOI 10.1017/S0030605304000766; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargas SM, 2008, J HERED, V99, P215, DOI 10.1093/jhered/esm120; Wakeley J, 2001, GENETICS, V159, P893; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Whitlock MC, 1997, GENETICS, V146, P427; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wright S, 1943, GENETICS, V28, P114; Wu CH, 2011, GENETICS, V188, P151, DOI 10.1534/genetics.110.125260; YASUDA N, 1968, BIOMETRICS, V24, P915, DOI 10.2307/2528880	105	19	20	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58061	10.1371/journal.pone.0058061	http://dx.doi.org/10.1371/journal.pone.0058061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516429	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200029
J	Carrington, LB; Armijos, MV; Lambrechts, L; Barker, CM; Scott, TW				Carrington, Lauren B.; Armijos, M. Veronica; Lambrechts, Louis; Barker, Christopher M.; Scott, Thomas W.			Effects of Fluctuating Daily Temperatures at Critical Thermal Extremes on Aedes aegypti Life-History Traits	PLOS ONE			English	Article							DENGUE VIRUS TRANSMISSION; CLIMATE-CHANGE; CULICIDAE; DIPTERA; MOSQUITOS; SURVIVAL; VECTOR; AUSTRALIA; MICROCLIMATE; CALIFORNIA	Background: The effect of temperature on insect biology is well understood under constant temperature conditions, but less so under more natural, fluctuating conditions. A fluctuating temperature profile around a mean of 26 degrees C can alter Aedes aegypti vector competence for dengue viruses as well as numerous life-history traits, however, the effect of fluctuations on mosquitoes at critical thermal limits is unknown. Methodology/Principal Findings: We investigated the effects of large and small daily temperature fluctuations at low (16 degrees C) and high (35-37 degrees C) mean temperatures, after we identified these temperatures as being thresholds for immature development and/or adult reproduction under constant temperature conditions. We found that temperature effects on larval development time, larval survival and adult reproduction depend on the combination of mean temperature and magnitude of fluctuations. Importantly, observed degree-day estimates for mosquito development under fluctuating temperature profiles depart significantly (around 10-20%) from that predicted by constant temperatures of the same mean. At low mean temperatures, fluctuations reduce the thermal energy required to reach pupation relative to constant temperature, whereas at high mean temperatures additional thermal energy is required to complete development. A stage-structured model based on these empirical data predicts that fluctuations can significantly affect the intrinsic growth rate of mosquito populations. Conclusions/Significance: Our results indicate that by using constant temperatures, one could under- or over-estimate values for numerous life-history traits compared to more natural field conditions dependent upon the mean temperature. This complexity may in turn reduce the accuracy of population dynamics modeling and downstream applications for mosquito surveillance and disease prevention.	[Carrington, Lauren B.; Armijos, M. Veronica; Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Carrington, Lauren B.; Armijos, M. Veronica; Barker, Christopher M.; Scott, Thomas W.] Univ Calif Davis, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Lambrechts, Louis] Inst Pasteur, CNRS URA 3012, Paris, France; [Barker, Christopher M.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Barker, Christopher M.; Scott, Thomas W.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of California System; University of California Davis; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Carrington, LB (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	lbcarrington@gmail.com	Lambrechts, Louis/A-2057-2010; Barker, Christopher/K-1415-2018	Lambrechts, Louis/0000-0001-5958-2138; Barker, Christopher/0000-0002-7941-346X; Carrington, Lauren Bree/0000-0001-9273-7912	Ecology of Infectious Disease program of the National Science Foundation [EF-0914384]; CDC, Climate Change: Environmental Impact on Human Health [U01 EH000418]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000418] Funding Source: NIH RePORTER	Ecology of Infectious Disease program of the National Science Foundation; CDC, Climate Change: Environmental Impact on Human Health; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work was funded by grant EF-0914384 from the Ecology of Infectious Disease program of the National Science Foundation. CMB also acknowledges financial support from grant U01 EH000418 from CDC, Climate Change: Environmental Impact on Human Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499; Barbazan P, 2010, MED VET ENTOMOL, V24, P66, DOI 10.1111/j.1365-2915.2009.00848.x; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; Carrington LB, 2013, AM J TROPICAL MED HY; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Christophers, 1960, AEDES AEGYPTI L YELL; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342; Koenraadt CJM, 2008, AM J TROP MED HYG, V79, P230, DOI 10.4269/ajtmh.2008.79.230; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Le Van JH, 1940, PUBLIC HEALTH REP, V55, P900, DOI 10.2307/4583293; MCLEAN DM, 1975, MOSQ NEWS, V35, P322; MEYER RP, 1990, J MED ENTOMOL, V27, P607, DOI 10.1093/jmedent/27.4.607; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9; Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021; R Core Team, 2012, R LANG ENV STAT COMP; Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x; Schaffner F, 2009, EUROPEAN CTR DIS PRE; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149	28	115	120	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58824	10.1371/journal.pone.0058824	http://dx.doi.org/10.1371/journal.pone.0058824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520534	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900094
J	Chen, HQ; Gu, ZN; Zhang, H; Wang, MX; Chen, W; Lowther, WT; Chen, YQ				Chen, Haiqin; Gu, Zhennan; Zhang, Hao; Wang, Mingxuan; Chen, Wei; Lowther, W. Todd; Chen, Yong Q.			Expression and Purification of Integral Membrane Fatty Acid Desaturases	PLOS ONE			English	Article							MORTIERELLA-ALPINA; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; SUBSTRATE-SPECIFICITY; GENE; IDENTIFICATION; CANCER; FUNGUS; YEAST	Fatty acid desaturase enzymes perform dehydrogenation reactions leading to the insertion of double bonds in fatty acids, and are divided into soluble and integral membrane classes. Crystal structures of soluble desaturases are available; however, membrane desaturases have defied decades of efforts due largely to the difficulty of generating recombinant desaturase proteins for crystallographic analysis. Mortierella alpina is an oleaginous fungus which possesses eight membrane desaturases involved in the synthesis of saturated, monounsaturated and polyunsaturated fatty acids. Here, we describe the successful expression, purification and enzymatic assay of three M. alpina desaturases (FADS15, FADS12, and FADS9-I). Estimated yields of desaturases with purity >95% are approximately 3.5% (Ca. 4.6 mg/L of culture) for FADS15, 2.3% (Ca. 2.5 mg/L of culture) for FADS12 and 10.7% (Ca. 37.5 mg/L of culture) for FADS9-I. Successful expression of high amounts of recombinant proteins represents a critical step towards the structural elucidation of membrane fatty acid desaturases.	[Chen, Haiqin; Gu, Zhennan; Zhang, Hao; Wang, Mingxuan; Chen, Wei; Chen, Yong Q.] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Chen, Haiqin; Gu, Zhennan; Chen, Yong Q.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA	Jiangnan University; Wake Forest University; Wake Forest University	Chen, YQ (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	yqchen@wakehealth.edu	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	National Institutes of Health [R01CA107668, R01CA163273, P01CA106742]; Program for Changjiang Scholars; National Natural Science Foundation of China [21276108, 31125021]; Fundamental Research Funds for the Central Universities [JUSRP51320B]; State Scholarship Fund from the China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA163273, R01CA107668, P30CA012197, P01CA106742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Scholarship Fund from the China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health grants R01CA107668, R01CA163273 and P01CA106742, the Program for Changjiang Scholars, the National Natural Science Foundation of China (No. 21276108 and No. 31125021), the Fundamental Research Funds for the Central Universities (No. JUSRP51320B), and the State Scholarship Fund from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berquin IM, 2011, CANCER METAST REV, V30, P295, DOI 10.1007/s10555-011-9299-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCH K, 1969, ACCOUNTS CHEM RES, V2, P193, DOI 10.1021/ar50019a001; Chen YQ, 2007, CANCER METAST REV, V26, P535, DOI 10.1007/s10555-007-9075-x; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Jonsson TJ, 2009, J BIOL CHEM, V284, P33305, DOI 10.1074/jbc.M109.036400; Kim SH, 2011, BIOTECHNOL LETT, V33, P1185, DOI 10.1007/s10529-011-0555-2; Knutzon DS, 1998, J BIOL CHEM, V273, P29360, DOI 10.1074/jbc.273.45.29360; Li M, 2011, BIOTECHNOL LETT, V33, P1823, DOI 10.1007/s10529-011-0626-4; MacKenzie DA, 2002, MICROBIOL-SGM, V148, P1725, DOI 10.1099/00221287-148-6-1725; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Reed DW, 2000, PLANT PHYSIOL, V122, P715, DOI 10.1104/pp.122.3.715; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Sakuradani E, 2003, BIOSCI BIOTECH BIOCH, V67, P704, DOI 10.1271/bbb.67.704; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028319	21	22	24	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58139	10.1371/journal.pone.0058139	http://dx.doi.org/10.1371/journal.pone.0058139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520490	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900049
J	Savary, K; Caglayan, D; Caja, L; Tzavlaki, K; Bin Nayeem, S; Bergstrom, T; Jiang, Y; Uhrbom, L; Forsberg-Nilsson, K; Westermark, B; Heldin, CH; Ferletta, M; Moustakas, A				Savary, K.; Caglayan, D.; Caja, L.; Tzavlaki, K.; Bin Nayeem, S.; Bergstrom, T.; Jiang, Y.; Uhrbom, L.; Forsberg-Nilsson, K.; Westermark, B.; Heldin, C-H; Ferletta, M.; Moustakas, A.			Snail depletes the tumorigenic potential of glioblastoma	ONCOGENE			English	Article						BMP; glioblastoma multiforme; glioma-initiating cells; invasiveness; snail	GROWTH-FACTOR-BETA; NEURAL STEM-CELLS; HIGH-GRADE GLIOMA; INITIATING CELLS; MESENCHYMAL TRANSITION; RECEPTOR; BRAIN; DIFFERENTIATION; PROGRESSION; SUPPRESSES	Glioblastoma multiforme (GBM) is an aggressive brain malignancy characterized by high heterogeneity and invasiveness. It is increasingly accepted that the refractory feature of GBM to current therapies stems from the existence of few tumorigenic cells that sustain tumor growth and spreading, the so-called glioma-initiating cells (GICs). Previous studies showed that cytokines of the bone morphogenetic protein (BMP) family induce differentiation of the GICs, and thus act as tumor suppressors. Molecular pathways that explain this behavior of BMP cytokines remain largely elusive. Here, we show that BMP signaling induces Smad-dependent expression of the transcriptional regulator Snail in a rapid and sustained manner. Consistent with its already established promigratory function in other cell types, we report that Snail silencing decreases GBM cell migration. Consequently, overexpression of Snail increases GBM invasiveness in a mouse xenograft model. Surprisingly, we found that Snail depletes the GBM capacity to form gliomaspheres in vitro and to grow tumors in vivo, both of which are important features shared by GICs. Thus Snail, acting downstream of BMP signaling, dissociates the invasive capacity of GBM cells from their tumorigenic potential.	[Savary, K.; Caja, L.; Bin Nayeem, S.; Heldin, C-H; Moustakas, A.] Uppsala Univ, Biomed Ctr, Sci Life Lab, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Caglayan, D.; Bergstrom, T.; Jiang, Y.; Uhrbom, L.; Forsberg-Nilsson, K.; Westermark, B.; Ferletta, M.] Uppsala Univ, Rudbeck Lab, Sci Life Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Tzavlaki, K.; Moustakas, A.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Biomed Ctr, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University; Uppsala University	Ferletta, M (corresponding author), Uppsala Univ, Rudbeck Lab, Sci Life Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden.	Maria.Ferletta@igp.uu.se; Aris.Moustakas@LICR.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Caja, Laia/J-4618-2019	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Caja, Laia/0000-0002-8786-8763; Westermark, Bengt/0000-0001-7153-5545	Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program; Goran Gustafsson Foundation; Swedish Cancer Society	Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program; Goran Gustafsson Foundation; Swedish Cancer Society(Swedish Cancer Society)	We thank: J Grawe, Uppsala University FACS facility; M Kastemar for tumor sampling; I Alafuzoff for tumor pathology; A Ahgren, M Vanlandewijck for tumor immunohistochemistry; H Goransson-Kultima, A Andersson, Uppsala University Microarray facility; A Ostman (Karolinska Institute) for encouragement; M Brenner, A Cano for reagents; K Sampath (Curis, Inc,) for BMP7; T Gahman and A Shiau (Ludwig Institute for Cancer Research, San Diego, USA) for GW6604 and DMH1 inhibitor synthesis; S Thuault, E-J Tan, K Kahata and other group members for discussion. Funding of the authors' work was provided by the Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program, the Goran Gustafsson Foundation and the Swedish Cancer Society.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chirasani SR, 2010, BRAIN, V133, P1961, DOI 10.1093/brain/awq128; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kim MY, 2010, NEUROSCIENCE, V170, P8, DOI 10.1016/j.neuroscience.2010.07.020; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Maire CL, 2010, STEM CELLS, V28, P1611, DOI 10.1002/stem.480; McLendon RE, 2011, J ONCOL, V2011; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Myung J, 2010, NEUROPATHOLOGY, V30, P224, DOI 10.1111/j.1440-1789.2009.01072.x; Nagane Motoo, 1997, Current Opinion in Oncology, V9, P215, DOI 10.1097/00001622-199709030-00001; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Tate CM, 2012, CELL DEATH DIFFER, V19, P1644, DOI 10.1038/cdd.2012.44; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Westermark Bengt, 1995, Current Opinion in Oncology, V7, P220, DOI 10.1097/00001622-199505000-00005; Yamada N, 1996, BRIT J CANCER, V73, P624, DOI 10.1038/bjc.1996.108; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301	45	50	50	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2013	32	47					5409	5420		10.1038/onc.2013.67	http://dx.doi.org/10.1038/onc.2013.67			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	254PM	23524585	hybrid, Green Published			2022-12-25	WOS:000327177600004
J	Schroeder, JH; Bell, LS; Janas, ML; Turner, M				Schroeder, Jan-Hendrik; Bell, Lewis S.; Janas, Michelle L.; Turner, Martin			Pharmacological Inhibition of Glycogen Synthase Kinase 3 Regulates T Cell Development In Vitro	PLOS ONE			English	Article							BETA-SELECTION CHECKPOINT; THYMOCYTE DEVELOPMENT; THYMIC DEVELOPMENT; PRE-TCR; NOTCH; DIFFERENTIATION; ACTIVATION; RECEPTOR; IL-7; PHOSPHORYLATION	The development of functional T cells requires receptor-mediated transition through multiple checkpoints in the thymus. Double negative 3 (DN3) thymocytes are selected for the presence of a rearranged TCR beta chain in a process termed beta-selection which requires signalling via the pre-TCR, Notch1 and CXCL12. Signal integration by these receptors converges on core pathways including the Phosphatidylinositol-3-kinase (PI3K) pathway. Glycogen Synthase Kinase 3 (GSK3) is generally thought to be negatively regulated by the PI3K pathway but its role in beta-selection has not been characterised. Here we show that developmental progression of DN3 thymocytes is promoted following inhibition of GSK3 by the synthetic compound CHIR99021. CHIR99021 allows differentiation in the absence of pre-TCR-, Notch1- or CXCL12-mediated signalling. It antagonizes IL-7-mediated inhibition of DP thymocyte differentiation and increases IL-7-promoted cell recovery. These data indicate a potentially important role for inactivation of GSK3 during beta-selection. They might help to establish an in vitro stromal cell-free culture system of thymocyte development and offer a new platform for screening regulators of proliferation, differentiation and apoptosis.	[Schroeder, Jan-Hendrik; Bell, Lewis S.; Janas, Michelle L.; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge, England.	martin.turner@babraham.ac.uk	Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Bell, Lewis/0000-0002-9412-7066; Schroeder, Jan-Hendrik/0000-0001-5114-4918	Biotechnology and Biological Sciences Research Council; BBSRC [BB/F02066X/1, BB/H023690/1, BBS/E/B/000C0407] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/F02066X/1, 976494, BB/H023690/1, BBS/E/B/0000C206, BB/C51889X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Pooter R, 2007, CURR OPIN IMMUNOL, V19, P163, DOI 10.1016/j.coi.2007.02.011; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; Falk I, 1996, J EXP MED, V184, P2327, DOI 10.1084/jem.184.6.2327; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Janas ML, 2011, J IMMUNOL, V187, P4667, DOI 10.4049/jimmunol.1101949; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008	31	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58501	10.1371/journal.pone.0058501	http://dx.doi.org/10.1371/journal.pone.0058501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526989	Green Published, gold			2022-12-25	WOS:000317562600026
J	Scott, TP; Fischer, M; Khaiseb, S; Freuling, C; Hoper, D; Hoffmann, B; Markotter, W; Muller, T; Nel, LH				Scott, Terence P.; Fischer, Melina; Khaiseb, Siegfried; Freuling, Conrad; Hoeper, Dirk; Hoffmann, Bernd; Markotter, Wanda; Mueller, Thomas; Nel, Louis H.			Complete Genome and Molecular Epidemiological Data Infer the Maintenance of Rabies among Kudu (Tragelaphus strepsiceros) in Namibia	PLOS ONE			English	Article							VIRUS; TRANSMISSION; EMERGENCE; EVOLUTION; AFRICA	Rabies in kudu is unique to Namibia and two major peaks in the epizootic have occurred since it was first noted in 1977. Due to the large numbers of kudu that were affected, it was suspected that horizontal transmission of rabies occurs among kudu and that rabies was being maintained independently within the Namibian kudu population - separate from canid cycles, despite geographic overlap. In this study, it was our aim to show, through phylogenetic analyses, that rabies was being maintained independently within the Namibian kudu population. We also tested, through complete genome sequencing of four rabies virus isolates from jackal and kudu, whether specific mutations occurred in the virus genome due to host adaptation. We found the separate grouping of all rabies isolates from kudu to those of any other canid species in Namibia, suggesting that rabies was being maintained independently in kudu. Additionally, we noted several mutations unique to isolates from kudu, suggesting that these mutations may be due to the adaptation of rabies to a new host. In conclusion, we show clear evidence that rabies is being maintained independently in the Namibian kudu population - a unique phenomenon with ecological and economic impacts.	[Scott, Terence P.; Markotter, Wanda; Nel, Louis H.] Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa; [Fischer, Melina; Freuling, Conrad; Hoeper, Dirk; Hoffmann, Bernd; Mueller, Thomas] Friedrich Loeffler Inst, Greifswald, Germany; [Khaiseb, Siegfried] Cent Vet Labs, Windhoek, Namibia	University of Pretoria; Friedrich Loeffler Institute	Nel, LH (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa.	louis.nel@up.ac.za	Nel, Louis H/F-1001-2012; Scott, Terence/J-8877-2019	Nel, Louis H/0000-0001-8963-0153; Scott, Terence/0000-0001-5027-0031; Markotter, Wanda/0000-0002-7550-0080; Hoper, Dirk/0000-0001-8408-2274	National Research Foundation; German federal ministry for education and research (BMBF) [01KI1016A]	National Research Foundation; German federal ministry for education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	TS, WM and LHN would like to thank the National Research Foundation for funding. MF, BH, CF, DH and TM would like to thank the German federal ministry for education and research (BMBF, grant 01KI1016A) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNARD BJH, 1981, J S AFR VET ASSOC, V52, P309; BARNARD BJH, 1982, ONDERSTEPOORT J VET, V49, P191; BARNARD BJH, 1979, ONDERSTEPOORT J VET, V46, P155; BECK AM, 1987, AM J PUBLIC HEALTH, V77, P42, DOI 10.2105/AJPH.77.1.42; Bourhy H, 1999, J GEN VIROL, V80, P2545, DOI 10.1099/0022-1317-80-10-2545; Cherian SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030315; Cohen C, 2007, EMERG INFECT DIS, V13, P1879, DOI 10.3201/eid1312.070836; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; HUBSCHLE OJB, 1988, REV INFECT DIS, V10, pS629; Johnson N, 2004, VET MICROBIOL, V101, P31, DOI 10.1016/j.vetmic.2004.03.007; Kuzmin IV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002786; Mansfield Karen, 2006, BMC Vet Res, V2, P2, DOI 10.1186/1746-6148-2-2; Markotter W, 2006, EMERG INFECT DIS, V12, P1913; Nel LH, 2007, CURR TOP MICROBIOL, V315, P161; Petersen B, 2012, EMERG INFECT DIS, V18, P2007; Sabeta CT, 2007, VIRUS RES, V129, P1, DOI 10.1016/j.virusres.2007.04.024; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TORDO N, 1986, P NATL ACAD SCI USA, V83, P3914, DOI 10.1073/pnas.83.11.3914	21	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58739	10.1371/journal.pone.0058739	http://dx.doi.org/10.1371/journal.pone.0058739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527015	gold, Green Published			2022-12-25	WOS:000317562600037
J	Guardo, AC; Alvarez-Fernandez, C; Arberas, H; Garcia-Perez, J; Garcia, F; Bargallo, ME; Maleno, MJ; Gatell, JM; Mothe, B; Alcami, J; Sanchez-Palomino, S; Plana, M				Crespo Guardo, Alberto; Alvarez-Fernandez, Carmen; Arberas, Hodei; Garcia-Perez, Javier; Garcia, Felipe; Enric Bargallo, Manuel; Jose Maleno, Maria; Maria Gatell, Jose; Mothe, Beatriz; Alcami, Jose; Sanchez-Palomino, Sonsoles; Plana, Montserrat			Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; VIRAL REPLICATION; PEPTIDE SETS; SUBTYPE-A; ALVAC-HIV; HLA-B; PROTEINS; IMMUNITY	Background: Generation of new reagents that can be used to screen or monitor HIV-1-specific responses constituted an interesting field in the development of HIV vaccines to improve their efficacy. Methods: We have evaluated the specific T cell response against different types of NL4-3 virions (including NL4-3 aldrithiol-2 treated, NL4-3/DRT and R5 envelopes: NL4-3/Delta RT/Delta Env[AC10] and NL4-3/Delta RT/Delta Env[Bal]) and against pools of overlapping peptides (15 mer) encompassing the HIV-1 Gag and Nef regions. Cryopreserved PBMC from a subset of 69 chronic asymptomatic HIV positive individuals have been employed using different techniques including IFN-gamma ELISPOT assay, surface activation markers and intracellular cytokine staining (ICS) by flow cytometry. Results: The differential response obtained against NL4-3 aldrithiol-2 treated and NL4-3/Delta RT virions (25% vs 55%, respectively) allow us to divide the population in three groups: "full-responders" (positive response against both viral particles), "partial-responders" (positive response only against NL4-3/Delta RT virions) and "non-responders" (negative responses). There was no difference between X4 and R5 envelopes. The magnitude of the total responses was higher against NL4-3/Delta RT and was positively correlated with gender and inverse correlated with viral load. On the contrary CD4+ T cell count was not associated with this response. In any case responses to the viruses tended to be lower in magnitude than those detected by the overlapping peptides tested. Finally we have found an increased frequency of HLA-B27 allele (23% vs 9%) and a significant reduction in some activation markers (CD69 and CD38) on T cells surface in responders vs non-responders individuals. Conclusions: In summary these virions could be considered as alternative and useful reagents for screening HIV-1-specific T cell responses in HIV exposed uninfected people, HIV infected patients and to assess immunogenicity of new prototypes both in vitro and in vaccine trials, by a feasible, simply, effective and low cost assay.	[Crespo Guardo, Alberto; Alvarez-Fernandez, Carmen; Arberas, Hodei; Enric Bargallo, Manuel; Jose Maleno, Maria; Sanchez-Palomino, Sonsoles; Plana, Montserrat] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Retrovirol & Viral Immunopathol Lab, Barcelona, Spain; [Crespo Guardo, Alberto; Alvarez-Fernandez, Carmen; Arberas, Hodei; Garcia, Felipe; Enric Bargallo, Manuel; Jose Maleno, Maria; Maria Gatell, Jose; Sanchez-Palomino, Sonsoles; Plana, Montserrat] Catalan Program HIV Vaccine Dev HIVACAT, Barcelona, Spain; [Garcia, Felipe; Maria Gatell, Jose] Univ Barcelona, Hosp Clin, IDIBAPS, Infect Dis Unit, Barcelona, Spain; [Garcia-Perez, Javier; Alcami, Jose] Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid, Spain; [Mothe, Beatriz] Hosp Badalona Germans Trias & Pujol, Inst Recerca SIDA IrsiCaixa HIVACAT, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Plana, M (corresponding author), Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Retrovirol & Viral Immunopathol Lab, Barcelona, Spain.	mplana@clinic.ub.es	Alcami, Pepe/T-2242-2018; García-Pérez, Javier/F-9248-2019; , Felipe/F-4242-2014; Plana, Montserrat/AAA-5124-2020	Alcami, Pepe/0000-0003-0023-7377; García-Pérez, Javier/0000-0001-7551-7803; , Felipe/0000-0001-7658-5832; Mothe, Beatriz/0000-0001-9975-407X; Alvarez-Fernandez, Carmen/0000-0003-0060-0447	RIS - Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [ISCIII-RETIC RD06/0006]; HIVACAT - Catalan Program for HIV Vaccine Development; Spanish Health Institute Carlos III (ISCIII); Health Department of the Catalan Government (Generalitat de Catalunya);  [FIS PI040503];  [FIS PI070291];  [FIS PI1200969]	RIS - Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III; HIVACAT - Catalan Program for HIV Vaccine Development; Spanish Health Institute Carlos III (ISCIII); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); ; ; 	This study was partially supported by grants FIS PI040503, FIS PI070291, FIS PI1200969, RIS - Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (ISCIII-RETIC RD06/0006), HIVACAT - Catalan Program for HIV Vaccine Development. Dr. Montserrat Plana is a researcher from the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and is supported by the Spanish Health Institute Carlos III (ISCIII) and the Health Department of the Catalan Government (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Alvarez-Fernandez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048848; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Currier JR, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-8; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gomez C, 2005, CELL MICROBIOL, V7, P621, DOI 10.1111/j.1462-5822.2005.00516.x; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Karlsson RK, 2004, J IMMUNOL METHODS, V285, P89, DOI 10.1016/j.jim.2003.11.013; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; Lopez A, 2009, VACCINE, V27, P6166, DOI 10.1016/j.vaccine.2009.08.021; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles Stephen A., 2002, Curr Infect Dis Rep, V4, P461, DOI 10.1007/s11908-002-0014-2; Migueles SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002002; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Paris R, 2004, TISSUE ANTIGENS, V64, P251, DOI 10.1111/j.1399-0039.2004.00270.x; Paris R, 2012, VACCINE, V30, P832, DOI 10.1016/j.vaccine.2011.11.002; Plana M, 2004, JAIDS-J ACQ IMM DEF, V36, P791, DOI 10.1097/00126334-200407010-00005; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Russell ND, 2003, J INFECT DIS, V187, P226, DOI 10.1086/367702; Rutebemberwa A, 2007, AIDS RES HUM RETROV, V23, P532, DOI 10.1089/aid.2006.0136; Sabado RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004256; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Shacklett BL, 2002, CLIN EXP IMMUNOL, V130, P172, DOI 10.1046/j.1365-2249.2002.01981.x; Sun Y, 2003, J IMMUNOL METHODS, V272, P23, DOI 10.1016/S0022-1759(02)00328-9; Trigona WL, 2003, J INTERF CYTOK RES, V23, P369, DOI 10.1089/107999003322226023; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x	48	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58927	10.1371/journal.pone.0058927	http://dx.doi.org/10.1371/journal.pone.0058927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516578	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400077
J	Kim, JH; Yoon, YJ; Lee, J; Choi, EJ; Yi, N; Park, KS; Park, J; Lotvall, J; Kim, YK; Gho, YS				Kim, Ji Hyun; Yoon, Yae Jin; Lee, Jaewook; Choi, Eun-Jeong; Yi, Namwoo; Park, Kyong-Su; Park, Jaesung; Lotvall, Jan; Kim, Yoon-Keun; Gho, Yong Song			Outer Membrane Vesicles Derived from Escherichia coli Up-Regulate Expression of Endothelial Cell Adhesion Molecules In Vitro and In Vivo	PLOS ONE			English	Article							MULTIPLE ORGAN DYSFUNCTION; INNATE IMMUNE-RESPONSE; LEUKOCYTE ADHESION; EPITHELIAL-CELLS; E-SELECTIN; PSEUDOMONAS-AERUGINOSA; NEUTROPHIL MIGRATION; LIPOPOLYSACCHARIDE; INFLAMMATION; SEPSIS	Escherichia coli, as one of the gut microbiota, can evoke severe inflammatory diseases including peritonitis and sepsis. Gram-negative bacteria including E. coli constitutively release nano-sized outer membrane vesicles (OMVs). Although E. coli OMVs can induce the inflammatory responses without live bacteria, the effect of E. coli OMVs in vivo on endothelial cell function has not been previously elucidated. In this study, we show that bacteria-free OMVs increased the expression of endothelial intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1, and enhanced the leukocyte binding on human microvascular endothelial cells in vitro. Inhibition of NF-kappa B and TLR4 reduced the expression of cell adhesion molecules in vitro. OMVs given intraperitoneally to the mice induced ICAM-1 expression and neutrophil sequestration in the lung endothelium, and the effects were reduced in ICAM-1(-/-) and TLR4(-/-) mice. When compared to free lipopolysaccharide, OMVs were more potent in inducing both ICAM-1 expression as well as leukocyte adhesion in vitro, and ICAM-1 expression and neutrophil sequestration in the lungs in vivo. This study shows that OMVs potently up-regulate functional cell adhesion molecules via NF-kappa B- and TLR4-dependent pathways, and that OMVs are more potent than free lipopolysaccharide.	[Kim, Ji Hyun; Lee, Jaewook; Choi, Eun-Jeong; Park, Kyong-Su; Kim, Yoon-Keun; Gho, Yong Song] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea; [Yoon, Yae Jin] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Yi, Namwoo; Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, South Korea; [Lotvall, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med,Krefting Res Ctr, Gothenburg, Sweden	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Gothenburg	Kim, YK (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea.	juinea@postech.ac.kr; ysgho@postech.ac.kr	Lee, Jaewook/AAO-9331-2020	Lotvall, Jan/0000-0001-9195-9249	Korean Ministry of Education, Science and Technology [FPR08B1-240]; National Research Foundation of Korea (NRF); Korea government (MEST) [20120005634]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the Korean Ministry of Education, Science and Technology, FPR08B1-240 of the 21C Frontier Functional Proteomics Program, and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 20120005634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACE WW, 1995, INFECT IMMUN, V63, P4054, DOI 10.1128/IAI.63.10.4054-4062.1995; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Batra S, 2012, J IMMUNOL, V188, P3458, DOI 10.4049/jimmunol.1101985; Baumgarten G, 2006, EUR J ANAESTH, V23, P1041, DOI 10.1017/S0265021506001098; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; DRAKE TA, 1993, AM J PATHOL, V142, P1458; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Harding M, 2012, CURR OPIN MICROBIOL, V15, P85, DOI 10.1016/j.mib.2011.11.010; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee HM, 2010, BIOCHEM BIOPH RES CO, V397, P251, DOI 10.1016/j.bbrc.2010.05.094; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; May AK, 2000, INFECT IMMUN, V68, P176, DOI 10.1128/IAI.68.1.176-183.2000; Mirlashari MR, 2002, APMIS, V110, P193, DOI 10.1034/j.1600-0463.2002.100301.x; Mirlashari MR, 2002, PLATELETS, V13, P91, DOI 10.1080/09537100220122448; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Shin TS, 2010, ALLERGY, V65, P1256, DOI 10.1111/j.1398-9995.2010.02359.x; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Srisatjaluk R, 1999, MICROB PATHOGENESIS, V27, P81, DOI 10.1006/mpat.1999.0287; Winzer K, 2003, NAT MED, V9, P1118, DOI 10.1038/nm0903-1118; Xu HL, 2010, J PATHOL, V220, P490, DOI 10.1002/path.2666	41	28	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59276	10.1371/journal.pone.0059276	http://dx.doi.org/10.1371/journal.pone.0059276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516621	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400105
J	Vakorin, VA; McIntosh, AR; Misic, B; Krakovska, O; Poulsen, C; Martinu, K; Paus, T				Vakorin, Vasily A.; McIntosh, Anthony R.; Misic, Bratislav; Krakovska, Olga; Poulsen, Catherine; Martinu, Kristina; Paus, Tomas			Exploring Age-Related Changes in Dynamical Non-Stationarity in Electroencephalographic Signals during Early Adolescence	PLOS ONE			English	Article							SPATIOTEMPORAL ANALYSIS; TIME; EEG; BRAIN; NONSTATIONARITY; ENTROPY; SERIES; METASTABILITY; CONNECTIVITY; DELAY	Dynamics of brain signals such as electroencephalogram (EEG) can be characterized as a sequence of quasi-stable patterns. Such patterns in the brain signals can be associated with coordinated neural oscillations, which can be modeled by non-linear systems. Further, these patterns can be quantified through dynamical non-stationarity based on detection of qualitative changes in the state of the systems underlying the observed brain signals. This study explored age-related changes in dynamical non-stationarity of the brain signals recorded at rest, longitudinally with 128-channel EEG during early adolescence (10 to 13 years of age, 56 participants). Dynamical non-stationarity was analyzed based on segmentation of the time series with subsequent grouping of the segments into clusters with similar dynamics. Age-related changes in dynamical non-stationarity were described in terms of the number of stationary states and the duration of the stationary segments. We found that the EEG signal became more non-stationary with age. Specifically, the number of states increased whereas the mean duration of the stationary segment decreased with age. These two effects had global and parieto-occipital distribution, respectively, with the later effect being most dominant in the alpha (around 10 Hz) frequency band.	[Vakorin, Vasily A.; McIntosh, Anthony R.; Misic, Bratislav; Paus, Tomas] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [McIntosh, Anthony R.; Misic, Bratislav; Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Krakovska, Olga] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Poulsen, Catherine; Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Martinu, Kristina] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; York University - Canada; McGill University; Universite de Montreal	Vakorin, VA (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	vvakorin@research.baycrest.org	Vakorin, Vasily/AAY-3249-2021	Vakorin, Vasily/0000-0003-0489-1552; McIntosh, Anthony/0000-0002-1784-5662	J.S. McDonnell Foundation	J.S. McDonnell Foundation	This research was supported by research grants from the J.S. McDonnell Foundation to Dr. Anthony R. McIntosh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cragg L, 2011, DEVELOPMENTAL SCI, V14, P935, DOI 10.1111/j.1467-7687.2010.01031.x; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dikanev T, 2005, CLIN NEUROPHYSIOL, V116, P1796, DOI 10.1016/j.clinph.2005.04.013; Duzel E, 2003, NEUROIMAGE, V18, P185, DOI 10.1016/S1053-8119(02)00031-9; Fingelkurts AA, 2004, INT J NEUROSCI, V114, P843, DOI 10.1080/00207450490450046; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Freyer F, 2009, J NEUROSCI, V29, P8512, DOI 10.1523/JNEUROSCI.0754-09.2009; Ghosh A, 2008, COGN NEURODYNAMICS, V2, P115, DOI 10.1007/s11571-008-9044-2; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Gribkov D, 2000, PHYS REV E, V6; HAKEN H, 1996, PRINCIPLES BRAIN FUN, DOI [10.1007/978-3-642-79570-1_11, DOI 10.1007/978-3-642-79570-1_11]; Hay JF, 2002, NEUROPSYCHOLOGIA, V40, P260, DOI 10.1016/S0028-3932(01)00127-0; Kaffashi F, 2008, PHYSICA D, V237, P3069, DOI 10.1016/j.physd.2008.06.005; Kaplan A. Ya, 1998, Uspekhi Fiziologicheskikh Nauk, V29, P35; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Kohlmorgen J, 2000, BIOL CYBERN, V83, P73, DOI 10.1007/s004220000144; KOLMOGOROV AN, 1959, DOKL AKAD NAUK SSSR+, V124, P754; Kudryavtsev L, 1989, COURSE MATH ANAL; Latchoumane CFV, 2008, LECT NOTES COMPUT SC, V4985, P921; Le van Quyen M, 2003, LANCET, V361, P970, DOI 10.1016/S0140-6736(03)12755-9; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Lippe S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.048.2009; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; Manuca R, 1996, PHYSICA D, V99, P134, DOI 10.1016/S0167-2789(96)00139-X; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Schreiber T, 1997, PHYS REV LETT, V79, P1475, DOI 10.1103/PhysRevLett.79.1475; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Vakorin VA, 2011, J NEUROSCI, V31, P6405, DOI 10.1523/JNEUROSCI.3153-10.2011; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57217	10.1371/journal.pone.0057217	http://dx.doi.org/10.1371/journal.pone.0057217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516400	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400007
J	Hokke, SN; Armitage, JA; Puelles, VG; Short, KM; Jones, L; Smyth, IM; Bertram, JF; Cullen-McEwen, LA				Hokke, Stacey N.; Armitage, James A.; Puelles, Victor G.; Short, Kieran M.; Jones, Lynelle; Smyth, Ian M.; Bertram, John F.; Cullen-McEwen, Luise A.			Altered Ureteric Branching Morphogenesis and Nephron Endowment in Offspring of Diabetic and Insulin-Treated Pregnancy	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; LOW-BIRTH-WEIGHT; GLOMERULAR NUMBER; GLYCEMIC CONTROL; BLOOD-PRESSURE; RENAL-FUNCTION; MELLITUS; EXPOSURE; GLUCOSE; QUANTIFICATION	There is strong evidence from human and animal models that exposure to maternal hyperglycemia during in utero development can detrimentally affect fetal kidney development. Notwithstanding this knowledge, the precise effects of diabetic pregnancy on the key processes of kidney development are unclear due to a paucity of studies and limitations in previously used methodologies. The purpose of the present study was to elucidate the effects of hyperglycemia on ureteric branching morphogenesis and nephrogenesis using unbiased techniques. Diabetes was induced in pregnant C57Bl/6J mice using multiple doses of streptozotocin (STZ) on embryonic days (E) 6.5-8.5. Branching morphogenesis was quantified ex vivo using Optical Projection Tomography, and nephrons were counted using unbiased stereology. Maternal hyperglycemia was recognised from E12.5. At E14.5, offspring of diabetic mice demonstrated fetal growth restriction and a marked deficit in ureteric tip number (control 283.7 +/- 23.3 vs. STZ 153.2 +/- 24.6, mean +/- SEM, p<0.01) and ureteric tree length (control 33.1 +/- 2.6 mm vs. STZ 17.6 +/- 2.7 mm, p=0.001) vs. controls. At E18.5, fetal growth restriction was still present in offspring of STZ dams and a deficit in nephron endowment was observed (control 1246.2 +/- 64.9 vs. STZ 822.4 +/- 74.0, p<0.001). Kidney malformations in the form of duplex ureter and hydroureter were a common observation (26%) in embryos of diabetic pregnancy compared with controls (0%). Maternal insulin treatment from E13.5 normalised maternal glycaemia but did not normalise fetal weight nor prevent the nephron deficit. The detrimental effect of hyperglycemia on ureteric branching morphogenesis and, in turn, nephron endowment in the growth-restricted fetus highlights the importance of glycemic control in early gestation and during the initial stages of renal development.	[Hokke, Stacey N.; Armitage, James A.; Puelles, Victor G.; Smyth, Ian M.; Bertram, John F.; Cullen-McEwen, Luise A.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Short, Kieran M.; Smyth, Ian M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Armitage, James A.; Jones, Lynelle] Deakin Univ, Sch Med Optometry, Waurn Ponds, Vic, Australia	Monash University; Monash University; Deakin University	Cullen-McEwen, LA (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	luise.cullen-mcewen@monash.edu	Short, Kieran/A-2604-2012; Bertram, John F/I-2588-2014; Short, Kieran/O-4476-2019; Armitage, James/AAX-1294-2021	Short, Kieran/0000-0001-9137-008X; Bertram, John F/0000-0001-5863-6464; Short, Kieran/0000-0001-9137-008X; Hokke, Stacey/0000-0003-1338-0156; Puelles, Victor/0000-0002-7735-5462; Armitage, James/0000-0002-3762-0911; Smyth, Ian/0000-0002-1727-7829; Cullen-McEwen, Luise/0000-0003-2229-5762	John Shaw Postdoctoral Fellow (National Heart Foundation); Monash Fellow; ARC Future fellowship; Monash Fellowship; Human Frontiers Science Program [RGP0039/2011]	John Shaw Postdoctoral Fellow (National Heart Foundation); Monash Fellow; ARC Future fellowship(Australian Research Council); Monash Fellowship(Monash University); Human Frontiers Science Program(Human Frontier Science Program)	James A. Armitage acknowledges support as a John Shaw Postdoctoral Fellow (National Heart Foundation) and Monash Fellow. Ian M. Smyth acknowledges an ARC Future fellowship and a Monash Fellowship, and project grant support from the Human Frontiers Science Program (RGP0039/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS L, 1990, DIABETES METAB REV, V6, P147, DOI 10.1002/dmr.5610060303; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; Ballas J, 2012, CURR DIABETES REP, V12, P33, DOI 10.1007/s11892-011-0249-0; BECERRA JE, 1990, PEDIATRICS, V85, P1; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Chen YW, 2011, AM J PHYSIOL-RENAL, V300, pF147, DOI 10.1152/ajprenal.00361.2010; Chen YW, 2010, PEDIATR NEPHROL, V25, P1319, DOI 10.1007/s00467-010-1506-1; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Cullen-McEwen LA, 2011, AM J PHYSIOL-RENAL, V300, pF1448, DOI 10.1152/ajprenal.00055.2011; Cunha AR, 2008, INT J EXP PATHOL, V89, P284, DOI 10.1111/j.1365-2613.2008.00593.x; Davis EM, 2010, BIRTH DEFECTS RES A, V88, P722, DOI 10.1002/bdra.20702; Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001; Ferenc B, 2010, CONGENIT ANOM, V50, P115, DOI 10.1111/j.1741-4520.2010.00275.x; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; Giuliani S, 2008, J UROLOGY, V179, P365, DOI 10.1016/j.juro.2007.08.092; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; Howarth C, 2007, DIABETIC MED, V24, P1229, DOI 10.1111/j.1464-5491.2007.02254.x; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Kamdem AF, 2005, PROG UROL, V15, P53; Kanwar YS, 2005, PEDIATR NEPHROL, V20, P858, DOI 10.1007/s00467-005-1888-7; Kanwar YS, 1996, J CLIN INVEST, V98, P2478, DOI 10.1172/JCI119066; Kaufman M.H., 1992, ATLAS MOUSE DEV; Khalil CA, 2010, DIABETES, V59, P2631, DOI 10.2337/db10-0419; Khan NA, 2006, J AUTOIMMUN, V26, P268, DOI 10.1016/j.jaut.2006.03.003; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Merzouk H, 2000, CLIN SCI, V98, P21, DOI 10.1042/cs0980021; Moritz KM, 2008, ADV ANAT EMBRYOL CEL, V196, P1; Myrie SB, 2011, NEONATOLOGY, V100, P380, DOI 10.1159/000326341; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Nelson RG, 1998, DIABETES, V47, P1489, DOI 10.2337/diabetes.47.9.1489; Nielsen GL, 2005, DIABETIC MED, V22, P693, DOI 10.1111/j.1464-5491.2005.01477.x; Padmanabhan R, 2001, Arch Physiol Biochem, V109, P260, DOI 10.1076/apab.109.3.260.11596; Parikh RM, 2007, MED HYPOTHESES, V69, P203, DOI 10.1016/j.mehy.2006.10.020; Pavkov ME, 2010, DIABETES CARE, V33, P2396, DOI 10.2337/dc10-0811; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Rocha SO, 2005, PEDIATR RES, V58, P1274, DOI 10.1203/01.pdr.0000188698.58021.ff; Rosenn B M, 2000, J Matern Fetal Med, V9, P29, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<29::AID-MFM7>3.0.CO;2-Z; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Schreuder MF, 2005, J AM SOC NEPHROL, V16, P2913, DOI 10.1681/ASN.2004100875; Shnorhavorian M, 2011, UROLOGY, V78, P1156, DOI 10.1016/j.urology.2011.04.022; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Short Kieran M, 2012, Methods Mol Biol, V886, P95, DOI 10.1007/978-1-61779-851-1_9; Short KM, 2010, KIDNEY INT, V77, P1132, DOI 10.1038/ki.2010.42; Silverman BL, 1998, DIABETES CARE, V21, pB142; Tein MSC, 1998, EXP PHYSIOL, V83, P165, DOI 10.1113/expphysiol.1998.sp004099; Tran S, 2008, J AM SOC NEPHROL, V19, P943, DOI 10.1681/ASN.2007080864; Weintrob N, 1996, J DIABETES COMPLICAT, V10, P294, DOI 10.1016/1056-8727(95)00080-1; Zhang SL, 2007, J AM SOC NEPHROL, V18, P2105, DOI 10.1681/ASN.2006101124; Zimyani MA, 2000, IMAGE ANAL STEREOL, V19, P219	56	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58243	10.1371/journal.pone.0058243	http://dx.doi.org/10.1371/journal.pone.0058243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516451	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200044
J	Luo, YP; Li, C; Gong, X; Wang, YL; Zhang, KS; Cui, YR; Sun, YE; Li, SG				Luo, Yuping; Li, Chun; Gong, Xi; Wang, Yanlu; Zhang, Kunshan; Cui, Yaru; Sun, Yi Eve; Li, Siguang			Splicing-Related Features of Introns Serve to Propel Evolution	PLOS ONE			English	Article							NONCODING RNAS REVEALS; SPLICEOSOMAL INTRONS; GENOME EVOLUTION; GENES; IDENTIFICATION; ANNOTATION; SEQUENCE; ELEMENTS; YEAST	The role of spliceosomal intronic structures played in evolution has only begun to be elucidated. Comparative genomic analyses of fungal snoRNA sequences, which are often contained within introns and/or exons, revealed that about one-third of snoRNA-associated introns in three major snoRNA gene clusters manifested polymorphisms, likely resulting from intron loss and gain events during fungi evolution. Genomic deletions can clearly be observed as one mechanism underlying intron and exon loss, as well as generation of complex introns where several introns lie in juxtaposition without intercalating exons. Strikingly, by tracking conserved snoRNAs in introns, we found that some introns had moved from one position to another by excision from donor sites and insertion into target sties elsewhere in the genome without needing transposon structures. This study revealed the origin of many newly gained introns. Moreover, our analyses suggested that intron-containing sequences were more prone to sustainable structural changes than DNA sequences without introns due to intron's ability to jump within the genome via unknown mechanisms. We propose that splicing-related structural features of introns serve as an additional motor to propel evolution.	[Luo, Yuping; Zhang, Kunshan; Cui, Yaru; Sun, Yi Eve; Li, Siguang] Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200092, Peoples R China; [Luo, Yuping; Gong, Xi; Wang, Yanlu; Li, Siguang] Nanchang Univ, Coll Life Sci, Nanchang, Peoples R China; [Li, Chun] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Stem Cell Inst, Shanghai 200030, Peoples R China	Tongji University; Nanchang University; Shanghai Jiao Tong University	Luo, YP (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200092, Peoples R China.	luoyuping@163.com; yi.eve.sun@gmail.com; siguangli@163.com			National Key Basic Research Program of China [2011CBA01106, 2011CB965102, 2010CB945600]; National Natural Foundation of China [31171317, 30971473, 31271375, 31271450]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China Grants 2011CBA01106, 2011CB965102 and 2010CB945600; National Natural Foundation of China Grants 31171317, 30971473, 31271375 and 31271450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN LB, 1983, CELL, V32, P461, DOI 10.1016/0092-8674(83)90466-X; Bhattacharya D, 2000, MOL BIOL EVOL, V17, P1971, DOI 10.1093/oxfordjournals.molbev.a026298; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Derr LK, 1998, GENETICS, V148, P937; DOOLITTLE WF, 1978, NATURE, V272, P581, DOI 10.1038/272581a0; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; JEFFREYS AJ, 1977, CELL, V12, P1097, DOI 10.1016/0092-8674(77)90172-6; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Koonin EV, 2009, J HERED, V100, P618, DOI 10.1093/jhered/esp056; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Kupfer DM, 2004, EUKARYOT CELL, V3, P1088, DOI 10.1128/EC.3.5.1088-1100.2004; LEWIN R, 1983, SCIENCE, V219, P1052, DOI 10.1126/science.6186029; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Mitrovich QM, 2010, SCIENCE, V330, P838, DOI 10.1126/science.1194554; Nicolas E, 2010, J BACTERIOL, V192, P4233, DOI 10.1128/JB.00477-10; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; Torriani SFF, 2011, CURR BIOL, V21, P2017, DOI 10.1016/j.cub.2011.10.041; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wolfe KH, 2006, PHILOS T ROY SOC B, V361, P403, DOI 10.1098/rstb.2005.1799; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yenerall P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-364	35	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58547	10.1371/journal.pone.0058547	http://dx.doi.org/10.1371/journal.pone.0058547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516505	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200084
J	Mann, DL; Spratford, W; Abernethy, B				Mann, David L.; Spratford, Wayne; Abernethy, Bruce			The Head Tracks and Gaze Predicts: How the World's Best Batters Hit a Ball	PLOS ONE			English	Article							INFORMATION; EYE; MOVEMENTS; PERFORMANCE; TARGET; TIME	Hitters in fast ball-sports do not align their gaze with the ball throughout ball-flight; rather, they use predictive eye movement strategies that contribute towards their level of interceptive skill. Existing studies claim that (i) baseball and cricket batters cannot track the ball because it moves too quickly to be tracked by the eyes, and that consequently (ii) batters do not - and possibly cannot - watch the ball at the moment they hit it. However, to date no studies have examined the gaze of truly elite batters. We examined the eye and head movements of two of the world's best cricket batters and found both claims do not apply to these batters. Remarkably, the batters coupled the rotation of their head to the movement of the ball, ensuring the ball remained in a consistent direction relative to their head. To this end, the ball could be followed if the batters simply moved their head and kept their eyes still. Instead of doing so, we show the elite batters used distinctive eye movement strategies, usually relying on two predictive saccades to anticipate (i) the location of ball-bounce, and (ii) the location of bat-ball contact, ensuring they could direct their gaze towards the ball as they hit it. These specific head and eye movement strategies play important functional roles in contributing towards interceptive expertise.	[Mann, David L.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands; [Mann, David L.; Abernethy, Bruce] Univ Hong Kong, Inst Human Performance, Pokfulam, Hong Kong, Peoples R China; [Spratford, Wayne] Australian Inst Sport, Canberra, ACT, Australia; [Spratford, Wayne] Cricket Australia Ctr Excellence, Brisbane, Qld, Australia; [Abernethy, Bruce] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld, Australia	Vrije Universiteit Amsterdam; University of Hong Kong; Australian Institute of Sport; University of Queensland	Mann, DL (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands.	d.mann@vu.nl	Mann, David/D-1429-2011	Mann, David/0000-0001-7476-6939; Spratford, Wayne/0000-0002-6207-8829	Rubicon Grant [446-10-029]; Netherlands Organisation for Scientific Research (NWO); Marie Curie Actions Cofund	Rubicon Grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Marie Curie Actions Cofund	David Mann was supported by a Rubicon Grant (446-10-029) awarded by The Netherlands Organisation for Scientific Research (NWO) and the Marie Curie Actions Cofund (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1984, AM SCI, V72, P249; Bates BT, 1996, MED SCI SPORT EXER, V28, P631, DOI 10.1097/00005768-199605000-00016; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Benguigui N, 2003, J EXP PSYCHOL HUMAN, V29, P1083, DOI 10.1037/0096-1523.29.6.1083; Bongers RM, 2008, J EXP PSYCHOL HUMAN, V34, P1515, DOI 10.1037/a0011974; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; de Oliveira RF, 2007, EXP PSYCHOL, V54, P180, DOI 10.1027/1618-3169.54.3.180; De Wit MM, 2012, CONSCIOUS COGN, V21, P1410, DOI 10.1016/j.concog.2012.07.008; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Gibson JJ., 1966, SENSES CONSIDERED PE; Gray R, 2009, REV HUMAN FACTORS ER, V5, P114, DOI DOI 10.1518/155723409X448035; Hayhoe MM, 2012, EXP BRAIN RES, V217, P125, DOI 10.1007/s00221-011-2979-2; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; Herlihey TA, 2012, J VISION, V12, DOI 10.1167/12.3.4; Hubbard AW, 1954, RES QUART, V25, P42, DOI 10.1080/10671188.1954.10624942; LaFont D, 2007, WATCH BALL ITF COACH, V43, P11; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; LEE DN, 1992, J EXP PSYCHOL HUMAN, V18, P1195, DOI 10.1037/0096-1523.18.4.1195; Mann DL, 2010, ACTA PSYCHOL, V135, P17, DOI 10.1016/j.actpsy.2010.04.006; Mann DL, 2010, ATTEN PERCEPT PSYCHO, V72, P1317, DOI 10.3758/APP.72.5.1317; Mann DL, 2010, HUM MOVEMENT SCI, V29, P386, DOI 10.1016/j.humov.2010.02.007; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Milner A. D., 1995, VISUAL BRAIN ACTION; Muller S, 2006, J SCI MED SPORT, V9, P446, DOI 10.1016/j.jsams.2006.03.029; Oudejans RRD, 1999, J EXP PSYCHOL HUMAN, V25, P531, DOI 10.1037/0096-1523.25.2.531; Pinder RA, 2011, ATTEN PERCEPT PSYCHO, V73, P1242, DOI 10.3758/s13414-011-0102-1; Pinder RA, 2009, HUM MOVEMENT SCI, V28, P468, DOI 10.1016/j.humov.2009.02.003; Regan D, 1997, J SPORT SCI, V15, P533, DOI 10.1080/026404197366985; RIPOLL H, 1988, ERGONOMICS, V31, P1647, DOI 10.1080/00140138808966814; RIPOLL H, 1986, HUM MOVEMENT SCI, V5, P47, DOI 10.1016/0167-9457(86)90005-9; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; Sarpeshkar V, 2011, SPORT BIOMECH, V10, P306, DOI 10.1080/14763141.2011.629207; Shim J, 2005, J MOTOR BEHAV, V37, P164, DOI 10.3200/JMBR.37.2.164-175; TYLDESLEY DA, 1975, J HUMAN MOVEMENT STU, V1, P172; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Zaal FTJM, 2003, J EXP PSYCHOL HUMAN, V29, P537, DOI 10.1037/0096-1523.29.3.537	40	99	99	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58289	10.1371/journal.pone.0058289	http://dx.doi.org/10.1371/journal.pone.0058289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516460	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200053
J	Choi, SJ; Shin, IJ; Je, KH; Min, EK; Kim, EJ; Kim, HS; Choe, S; Kim, DE; Lee, DK				Choi, Sung Ji; Shin, Ik Jae; Je, Kang-Hoon; Min, Eun Kyoung; Kim, Eun Ji; Kim, Hee-Sun; Choe, Senyon; Kim, Dong-Eog; Lee, Dong Kun			Hypoxia Antagonizes Glucose Deprivation on Interleukin 6 Expression in an Akt Dependent, but HIF-1/2 alpha Independent Manner	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; INFLAMMATORY RESPONSE; GENE-EXPRESSION; BRAIN; INDUCTION; RECEPTOR; CELLS; NEUROPROTECTION	Although both glucose deprivation and hypoxia have been reported to promote cascades of biological alterations that lead to induction of inflammatory mediators, we hypothesized that glucose deprivation and hypoxia might show neutral, synergistic or antagonistic effects to each other on gene expression of inflammatory mediators depending on the regulatory components in their promoters. Gene expression of interleukin 6 (IL-6) was analyzed by real-time PCR, ELISA, or Western blot. Effects of glucose deprivation and/or hypoxia on activation of signaling pathways were analyzed by time-dependent phosphorylation patterns of signaling molecules. We demonstrate that hypoxia antagonized the effects of glucose deprivation on induction of IL-6 gene expression in microglia, macrophages, and monocytes. Hypoxia also antagonized thapsigargin-induced IL-6 gene expression. Hypoxia enhanced phosphorylation of Akt, and inhibition of Akt was able to reverse the effects of hypoxia on IL-6 gene expression. However, inhibition of HIF-1/2 alpha did not reverse the effects of hypoxia on IL-6 gene expression. In addition, phosphorylation of p38, but not JNK, was responsible for the effects of glucose deprivation on IL-6 gene expression.	[Choi, Sung Ji; Min, Eun Kyoung; Kim, Eun Ji; Choe, Senyon; Lee, Dong Kun] Joint Ctr Biosci, Lab Genome Drug Med, Inchon, South Korea; [Shin, Ik Jae; Je, Kang-Hoon; Kim, Dong-Eog] Dongguk Univ, Ilsan Hosp, Dept Neurol, Mol Imaging & Neurovasc Res MINER Lab, Goyang, South Korea; [Kim, Hee-Sun] Ewha Womans Univ, Coll Med, Dept Neurosci, Seoul, South Korea	Dongguk University; NHIS Ilsan Hospital; Ewha Womans University	Kim, DE (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Neurol, Mol Imaging & Neurovasc Res MINER Lab, Goyang, South Korea.	kdongeog@duih.org; dklee.jcb@gmail.com		Shin, Ikjae/0000-0001-6582-8827	IFEZ; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs [A101904]	IFEZ; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs	This study was supported by IFEZ and a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs (A101904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Deguchi JO, 2009, ARTERIOSCL THROM VAS, V29, P1664, DOI 10.1161/ATVBAHA.109.194043; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Faggioli L, 1997, EUR J IMMUNOL, V27, P3022, DOI 10.1002/eji.1830271140; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Fougeray S, 2011, Cell Death Dis, V2, pe143, DOI 10.1038/cddis.2011.26; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Ishibashi N, 2002, J IMMUNOL, V168, P1926, DOI 10.4049/jimmunol.168.4.1926; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Kim NG, 2003, MOL BRAIN RES, V114, P107, DOI 10.1016/S0169-328X(03)00135-9; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Klausen T, 1997, EUR J APPL PHYSIOL, V76, P480, DOI 10.1007/s004210050278; Kraskiewicz H, 2012, TRENDS PHARMACOL SCI, V33, P53, DOI 10.1016/j.tips.2011.10.002; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee DK, 2012, CELL PHYSIOL BIOCHEM, V30, P499, DOI 10.1159/000341433; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; McNay EC, 2006, DIABETES, V55, P1088, DOI 10.2337/diabetes.55.04.06.db05-1314; Montero M, 2002, FASEB J, V16, P1955, DOI 10.1096/fj.02-0553fje; Olli K, 2013, BRIT J NUTR, V109, P43, DOI 10.1017/S0007114512000888; Pan H, 2012, BIOCHEM BIOPH RES CO, V420, P685, DOI 10.1016/j.bbrc.2012.03.069; Peters LR, 2011, J IMMUNOL, V187, P919, DOI 10.4049/jimmunol.1100690; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Urner M, 2012, CLIN EXP IMMUNOL, V169, P119, DOI 10.1111/j.1365-2249.2012.04595.x; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang MJ, 2001, J NEUROIMMUNOL, V112, P28, DOI 10.1016/S0165-5728(00)00374-X; Whiteley W, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000145; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamada K, 2002, NEWS PHYSIOL SCI, V17, P127, DOI 10.1152/nips.01384.2001; Yamada KA, 2004, PEDIATR RES, V55, P372, DOI 10.1203/01.PDR.0000110523.07240.C1; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yuskaitis CJ, 2009, CELL SIGNAL, V21, P264, DOI 10.1016/j.cellsig.2008.10.014	46	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58662	10.1371/journal.pone.0058662	http://dx.doi.org/10.1371/journal.pone.0058662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520526	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900086
J	Lane, KR; Yu, YB; Lackey, PE; Chen, X; Marzluff, WF; Cook, JG				Lane, Karen R.; Yu, Yanbao; Lackey, Patrick E.; Chen, Xian; Marzluff, William F.; Cook, Jeanette Gowen			Cell Cycle-Regulated Protein Abundance Changes in Synchronously Proliferating HeLa Cells Include Regulation of Pre-mRNA Splicing Proteins	PLOS ONE			English	Article							LOOP BINDING-PROTEIN; DNA-REPLICATION; QUANTITATIVE PHOSPHOPROTEOMICS; TRIGGERS DEGRADATION; UBIQUITIN LIGASE; CDT1 DEGRADATION; HNRNP A1; END; PHOSPHORYLATION; IDENTIFICATION	Cell proliferation involves dramatic changes in DNA metabolism and cell division, and control of DNA replication, mitosis, and cytokinesis have received the greatest attention in the cell cycle field. To catalogue a wider range of cell cycle-regulated processes, we employed quantitative proteomics of synchronized HeLa cells. We quantified changes in protein abundance as cells actively progress from G1 to S phase and from S to G2 phase. We also describe a cohort of proteins whose abundance changes in response to pharmacological inhibition of the proteasome. Our analysis reveals not only the expected changes in proteins required for DNA replication and mitosis but also cell cycle-associated changes in proteins required for biological processes not known to be cell-cycle regulated. For example, many pre-mRNA alternative splicing proteins are down-regulated in S phase. Comparison of this dataset to several other proteomic datasets sheds light on global mechanisms of cell cycle phase transitions and underscores the importance of both phosphorylation and ubiquitination in cell cycle changes.	[Lane, Karen R.; Marzluff, William F.; Cook, Jeanette Gowen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Yu, Yanbao; Lackey, Patrick E.; Chen, Xian; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Chen, Xian; Cook, Jeanette Gowen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Marzluff, William F.] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	jgcook@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Yu, Yanbao/G-3035-2010	Yu, Yanbao/0000-0003-2994-1974; Cook, Jeanette/0000-0003-0849-7405	NCI Center Core Support Grant [P30CA06086]; University Cancer Research Fund; United States National Institutes of Health (NIH) [R01AI064806, 1U24CA160035]; NIH [GM29832, GM083024]; NATIONAL CANCER INSTITUTE [U24CA160035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083024, R01GM029832] Funding Source: NIH RePORTER	NCI Center Core Support Grant; University Cancer Research Fund; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Flow cytometry was performed in the Flow Cytometry Core Facility at the University of North Carolina at Chapel Hill which is supported in part by an NCI Center Core Support Grant (P30CA06086) to the UNC Lineberger Comprehensive Cancer Center. A portion of this work was supported by a pilot grant from the University Cancer Research Fund. XC is supported by United States National Institutes of Health (NIH) R01AI064806 and 1U24CA160035. WFM is supported by NIH GM29832. JGC is supported by NIH GM083024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chen X, 2000, ANAL CHEM, V72, P1134, DOI 10.1021/ac9911600; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Han YH, 2009, ONCOL REP, V22, P215, DOI 10.3892/or_00000427; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Koseoglu MM, 2008, MOL CELL BIOL, V28, P4469, DOI 10.1128/MCB.01416-07; Koseoglu MM, 2010, CELL CYCLE, V9, P3857, DOI 10.4161/cc.9.19.13300; Lam BJ, 2002, RNA, V8, P1233, DOI 10.1017/S1355838202028030; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McCormack PL, 2012, DRUGS; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Takahashi Y, 2000, GENE DEV, V14, P804; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; Vij R, 2012, BRIT J HAEMATOL, V158, P739, DOI 10.1111/j.1365-2141.2012.09232.x; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	67	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58456	10.1371/journal.pone.0058456	http://dx.doi.org/10.1371/journal.pone.0058456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520512	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900071
J	James, ER; Okamoto, N; Burki, F; Scheffrahn, RH; Keeling, PJ				James, Erick R.; Okamoto, Noriko; Burki, Fabien; Scheffrahn, Rudolf H.; Keeling, Patrick J.			Cthulhu Macrofasciculumque n. g., n. sp and Cthylla Microfasciculumque n. g., n. sp., a Newly Identified Lineage of Parabasalian Termite Symbionts	PLOS ONE			English	Article							PHYLOGENETIC POSITION; MOLECULAR PHYLOGENY; SEQUENCE ALIGNMENT; MORPHOLOGY; HYPERMASTIGIDA; TERMOPSIDIS; FLAGELLATE	The parabasalian symbionts of lower termite hindgut communities are well-known for their large size and structural complexity. The most complex forms evolved multiple times independently from smaller and simpler flagellates, but we know little of the diversity of these small flagellates or their phylogenetic relationships to more complex lineages. To understand the true diversity of Parabasalia and how their unique cellular complexity arose, more data from smaller and simpler flagellates are needed. Here, we describe two new genera of small-to-intermediate size and complexity, represented by the type species Cthulhu macrofasciculumque and Cthylla microfasciculumque from Prorhinotermes simplex and Reticulitermes virginicus, respectively (both hosts confirmed by DNA barcoding). Both genera have a single anterior nucleus embeded in a robust protruding axostyle, and an anterior bundle flagella (and likely a single posterior flagellum) that emerge slightly subanteriorly and have a distinctive beat pattern. Cthulhu is relatively large and has a distinctive bundle of over 20 flagella whereas Cthylla is smaller, has only 5 anterior flagella and closely resembles several other parababsalian genera. Molecular phylogenies based on small subunit ribosomal RNA (SSU rRNA) show both genera are related to previously unidentified environmental sequences from other termites (possibly from members of the Tricercomitidae), which all branch as sisters to the Hexamastigitae. Altogether, Cthulhu likely represents another independent origin of relatively high cellular complexity within parabasalia, and points to the need for molecular characterization of other key taxa, such as Tricercomitus.	[James, Erick R.; Okamoto, Noriko; Burki, Fabien; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada; [Scheffrahn, Rudolf H.] Univ Florida, Res & Educ Ctr, Davie, FL USA	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; State University System of Florida; University of Florida	Keeling, PJ (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada.	pkeeling@mail.ubc.ca	James, Erick R/D-4725-2012; Burki, Fabien/F-4818-2010	Burki, Fabien/0000-0002-8248-8462; Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council of Canada [227301]; Tula Foundation; Terminix International	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tula Foundation; Terminix International	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (227301) and a grant from the Tula Foundation to the Centre for Microbial Diversity and Evolution. Specimens of P. simplex were collected as part of a Caribbean Basin survey of termite diversity funded by Terminix International. PJK is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUGEROLLE G, 1991, PROTOPLASMA, V164, P70, DOI 10.1007/BF01320816; Brugerolle G, 2001, EUR J PROTISTOL, V37, P103, DOI 10.1078/0932-4739-00814; Brugerolle G., 1977, Proceedings of the 5th International Congress of Protozoology, New York, 26 June - 2 July 1977., P14; Brugerolle Guy, 2002, P1196; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carpenter KJ, 2007, J EUKARYOT MICROBIOL, V54, P325, DOI 10.1111/j.1550-7408.2007.00263.x; Carpenter KJ, 2009, J EUKARYOT MICROBIOL, V56, P305, DOI 10.1111/j.1550-7408.2009.00406.x; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; CLEVELAND LR, 1934, MEM AM ACAD ARTS, V17, P1; Dolan MF, 2000, ACTA PROTOZOOL, V39, P275; Gile GH, 2011, INT J SYST EVOL MICR, V61, P2547, DOI 10.1099/ijs.0.028480-0; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grasse P.-P., 1945, ANN SCI NAT ZOOL, V11, P147; Grassi B, 1917, ATTI R ACCAD LINCE 5, V12, P331; Guindon S, 2003, SYST BIOL, V61, P539; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Keelig PJ, 2002, EUR J PROTISTOL, V38, P279, DOI 10.1078/0932-4739-00874; Kirby H., 1942, University of California Publications in Zoology, V45, P93; Kirby H, 1939, P CAL ACAD SCI, V22, P270; KIRBY HAROLD, 1929, UNIV CALIFORNIA PUBL ZOOL, V31, P417; Kirby Harold, 1944, UNIV CALIFORNIA PUBL ZOOL, V49, P185; KIRBY HAROLD, 1932, UNIV CALIFORNIA PUBL ZOOL, V37, P349; KIRBY HAROLD, 1930, UNIV CALIFORNIA PUBL ZOOL, V33, P393; Maass A, 2006, EUR J PROTISTOL, V42, P125, DOI 10.1016/j.ejop.2006.03.001; Noda S, 2009, MOL PHYLOGENET EVOL, V52, P217, DOI 10.1016/j.ympev.2009.03.011; Nylander J. A. A., 2004, MRAIC PL PROGRAM DIS; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saldarriaga JF, 2011, J EUKARYOT MICROBIOL, V58, P487, DOI 10.1111/j.1550-7408.2011.00575.x; Trager W, 1934, BIOL BULL-US, V66, P182, DOI 10.2307/1537331; Yamin M.A., 1979, Sociobiology, V4, P1	30	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58509	10.1371/journal.pone.0058509	http://dx.doi.org/10.1371/journal.pone.0058509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526991	Green Published, Green Submitted, gold			2022-12-25	WOS:000316411600008
J	Biedermann, L; Zeitz, J; Mwinyi, J; Sutter-Minder, E; Rehman, A; Ott, SJ; Steurer-Stey, C; Frei, A; Frei, P; Scharl, M; Loessner, MJ; Vavricka, SR; Fried, M; Schreiber, S; Schuppler, M; Rogler, G				Biedermann, Luc; Zeitz, Jonas; Mwinyi, Jessica; Sutter-Minder, Eveline; Rehman, Ateequr; Ott, Stephan J.; Steurer-Stey, Claudia; Frei, Anja; Frei, Pascal; Scharl, Michael; Loessner, Martin J.; Vavricka, Stephan R.; Fried, Michael; Schreiber, Stefan; Schuppler, Markus; Rogler, Gerhard			Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; PHYLOGENETIC DIVERSITY; ENVIRONMENTAL-FACTORS; CLINICAL-COURSE; GUT MICROBIOME; IMMUNE-SYSTEM; WEIGHT-GAIN; OBESITY; ECOLOGY	Background: The human intestinal microbiota is a crucial factor in the pathogenesis of various diseases, such as metabolic syndrome or inflammatory bowel disease (IBD). Yet, knowledge about the role of environmental factors such as smoking (which is known to influence theses aforementioned disease states) on the complex microbial composition is sparse. We aimed to investigate the role of smoking cessation on intestinal microbial composition in 10 healthy smoking subjects undergoing controlled smoking cessation. Methods: During the observational period of 9 weeks repetitive stool samples were collected. Based on abundance of 16S rRNA genes bacterial composition was analysed and compared to 10 control subjects (5 continuing smokers and 5 non-smokers) by means of Terminal Restriction Fragment Length Polymorphism analysis and high-throughput sequencing. Results: Profound shifts in the microbial composition after smoking cessation were observed with an increase of Firmicutes and Actinobacteria and a lower proportion of Bacteroidetes and Proteobacteria on the phylum level. In addition, after smoking cessation there was an increase in microbial diversity. Conclusions: These results indicate that smoking is an environmental factor modulating the composition of human gut microbiota. The observed changes after smoking cessation revealed to be similar to the previously reported differences in obese compared to lean humans and mice respectively, suggesting a potential pathogenetic link between weight gain and smoking cessation. In addition they give rise to a potential association of smoking status and the course of IBD.	[Biedermann, Luc; Mwinyi, Jessica; Frei, Pascal; Scharl, Michael; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Zeitz, Jonas] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Mwinyi, Jessica] Univ Zurich Hosp, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Sutter-Minder, Eveline; Loessner, Martin J.; Schuppler, Markus] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Rehman, Ateequr; Ott, Stephan J.; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Ott, Stephan J.; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Div Gen Internal Med, Kiel, Germany; [Steurer-Stey, Claudia; Frei, Anja] Univ Zurich, Inst Gen Practice, Zurich, Switzerland; [Steurer-Stey, Claudia; Frei, Anja] Univ Zurich Hosp, Smoking Consulting Programme, CH-8091 Zurich, Switzerland; [Vavricka, Stephan R.] Hosp Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Zurich; University of Zurich; University Zurich Hospital; Triemli Hospital	Rogler, G (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	gerhard.rogler@usz.ch	Biedermann, Luc/J-2654-2017; Ott, Stephan J/G-1965-2010; Schuppler, Markus/B-3713-2016; Hofmann, Martina/ABB-7916-2020; Rogler, Gerhard/O-5308-2015; Loessner, Martin J/B-4316-2012; Rehman, Ateequr/O-3727-2016	Rogler, Gerhard/0000-0002-1733-9188; Loessner, Martin J/0000-0002-8162-2631; Rehman, Ateequr/0000-0002-5664-4628; Scharl, Michael/0000-0002-6729-1469; Frei, Anja/0000-0002-7134-1000	Swiss National Science Foundation [320000-114009/1, 310030-120312]; Swiss IBD Cohort [3347CO-108792]; Zurich Centre for Integrative Human Physiology of the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort; Zurich Centre for Integrative Human Physiology of the University of Zurich	This research was supported by research grants from the Swiss National Science Foundation to SRV (Grant No 320000-114009/1), to GR (Grant No. 310030-120312) and the Swiss IBD Cohort (Grant No. 3347CO-108792), and by the Zurich Centre for Integrative Human Physiology of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Beaugerie L, 2001, AM J GASTROENTEROL, V96, P2113, DOI 10.1016/S0002-9270(01)02507-2; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cosnes J, 2006, ACTA ENDOSC, V36, P679, DOI 10.1007/BF03018510; Cosnes J, 1996, GASTROENTEROLOGY, V110, P424, DOI 10.1053/gast.1996.v110.pm8566589; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; DALLOSSO HM, 1984, INT J OBESITY, V8, P365; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faith DP, 2004, CONSERV BIOL, V18, P255, DOI 10.1111/j.1523-1739.2004.00330.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Ferrara CM, 2001, INT J OBESITY, V25, P1322, DOI 10.1038/sj.ijo.0801716; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HOLDSTOCK G, 1984, BRIT MED J, V288, P362, DOI 10.1136/bmj.288.6414.362; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LINDBERG E, 1992, GUT, V33, P779, DOI 10.1136/gut.33.6.779; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Minh BQ, 2006, SYST BIOL, V55, P769, DOI 10.1080/10635150600981604; Nos P, 2011, WORLD J GASTROENTERO, V17, P3567, DOI 10.3748/wjg.v17.i31.3567; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; RODIN J, 1987, ADDICT BEHAV, V12, P303, DOI 10.1016/0306-4603(87)90045-1; Seksik P, 2009, INFLAMM BOWEL DIS, V15, P734, DOI 10.1002/ibd.20828; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stamler J, 1997, AM J CLIN NUTR, V65, P374; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu GD, 2011, SCIENCE	42	241	248	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59260	10.1371/journal.pone.0059260	http://dx.doi.org/10.1371/journal.pone.0059260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516617	Green Published, Green Accepted, gold			2022-12-25	WOS:000316407400102
J	Bohringer, D; Lang, S; Reinhard, T				Boehringer, Daniel; Lang, Stefan; Reinhard, Thomas			Cell-by-Cell Alignment of Repeated Specular Microscopy Images from the Same Eye	PLOS ONE			English	Article							CORNEAL ENDOTHELIUM; CLINICAL-TRIALS	Purpose: Modern specular microscopes (SM) robustly depict the same central area of the corneal endothelium at different time points through a built-in fixation light. However, repeated image acquisitions slightly shift and rotate because of minute changes in head position in the chin and forehead rest. This prevents the manual retrieval of individual corneal endothelial cells (CECs) in repeated measurements because SM images usually lack obvious landmarks. We devised and validated an image registration algorithm that aligns SM images from the same eye to make corresponding CECs coincide. Methods: We retrospectively selected 27 image pairs for the presence of significant image overlap. Each image pair had been recorded on the same day and of the same eye. We applied our registration method in each image pair. Two observers independently validated, by means of alternation flicker, that the image pairs had been correctly aligned. We also repeatedly applied our registration method on unrelated image pairs by randomly drawing images and making certain that the images did not originate from the same eye. This was done to assess the specifity of our method. Results: All automated registrations of the same-day and same-eye image pairs were accurate. However, one single image incorrectly failed to trigger the non-match diagnosis twice in 81 registration attempts between unrelated images. As it turned out, this particular image depicted only 73 CECs. The average number of CECs was 253 (range 73-393). Conclusion: Repeated non-contact SM images can be automatedly aligned so that the corresponding CECs coincide. Any successful alignment can be considered as proof of the retrieval of identical CECs as soon as at least 100 CEC centroids have been identified. We believe our method is the first to robustly confirm endothelial stability in individual eyes.	[Boehringer, Daniel; Lang, Stefan; Reinhard, Thomas] Univ Eye Hosp, Cornea Reading Ctr, Freiburg, Germany	University of Freiburg	Bohringer, D (corresponding author), Univ Eye Hosp, Cornea Reading Ctr, Freiburg, Germany.	daniel.boehringer@uniklinik-freiburg.de	Lang, Stefan J./I-5169-2019	Lang, Stefan J./0000-0002-5324-7002				Abib FC, 2012, CORNEA, V31, P546, DOI 10.1097/ICO.0b013e3181cc7961; Berger JW, 2000, OPHTHALMOLOGY, V107, P1316, DOI 10.1016/S0161-6420(00)00157-3; Bohringer D, 2012, KLIN MONATSBL AUGENH, V229, P628, DOI 10.1055/s-0031-1299508; Bohringer D, 2012, CORNEA IN PRESS; Bucht C, 2011, ACTA OPHTHALMOL, V89, pe242, DOI 10.1111/j.1755-3768.2010.01974.x; Erickson BJ, 2011, AM J NEURORADIOL, V32, P1652, DOI 10.3174/ajnr.A2596; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Mamalis N, 2000, Curr Opin Ophthalmol, V11, P289, DOI 10.1097/00055735-200008000-00011; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; SHERRARD ES, 1976, EXP EYE RES, V22, P347, DOI 10.1016/0014-4835(76)90227-X; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222	12	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59261	10.1371/journal.pone.0059261	http://dx.doi.org/10.1371/journal.pone.0059261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516618	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400103
J	Iqbal, AJ; Regan-Komito, D; Christou, I; White, GE; McNeill, E; Kenyon, A; Taylor, L; Kapellos, TS; Fisher, EA; Channon, KM; Greaves, DR				Iqbal, Asif J.; Regan-Komito, Daniel; Christou, Ivy; White, Gemma E.; McNeill, Eileen; Kenyon, Amy; Taylor, Lewis; Kapellos, Theodore S.; Fisher, Edward A.; Channon, Keith M.; Greaves, David R.			A Real Time Chemotaxis Assay Unveils Unique Migratory Profiles amongst Different Primary Murine Macrophages	PLOS ONE			English	Article							CC-CHEMOKINE BLOCKADE; CHRONIC INFLAMMATION; GENE-EXPRESSION; CELL-MIGRATION; RESOLUTION; ANTIGEN; RECRUITMENT; RECEPTORS; PATHWAYS; CHEMERIN	Chemotaxis assays are an invaluable tool for studying the biological activity of inflammatory mediators such as CC chemokines, which have been implicated in a wide range of chronic inflammatory diseases. Conventional chemotaxis systems such as the modified Boyden chamber are limited in terms of the data captured given that the assays are analysed at a single time-point. We report the optimisation and validation of a label-free, real-time cell migration assay based on electrical cell impedance to measure chemotaxis of different primary murine macrophage populations in response to a range of CC chemokines and other chemoattractant signalling molecules. We clearly demonstrate key differences in the migratory behavior of different murine macrophage populations and show that this dynamic system measures true macrophage chemotaxis rather than chemokinesis or fugetaxis. We highlight an absolute requirement for G alpha i signaling and actin cytoskeletal rearrangement as demonstrated by Pertussis toxin and cytochalasin D inhibition. We also studied the chemotaxis of CD14(+) human monocytes and demonstrate distinct chemotactic profiles amongst different monocyte donors to CCL2. This real-time chemotaxis assay will allow a detailed analysis of factors that regulate macrophage responses to chemoattractant cytokines and inflammatory mediators.	[Iqbal, Asif J.; Regan-Komito, Daniel; Christou, Ivy; White, Gemma E.; Kenyon, Amy; Taylor, Lewis; Kapellos, Theodore S.; Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [McNeill, Eileen; Channon, Keith M.] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY USA; [Fisher, Edward A.] Marc & Ruti Bell Program Vasc Biol, New York, NY USA	University of Oxford; University of Oxford; New York University	Iqbal, AJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	asif.iqbal@path.ox.ac.uk; david.greaves@path.ox.ac.uk	Fisher, Edward/ABE-7469-2020	Kenyon, Amy/0000-0001-9248-576X; Greaves, David/0000-0003-2856-9410; Fisher, Edward/0000-0001-9802-143X; channon, keith/0000-0002-1043-4342; McNeill, Eileen/0000-0003-0971-9858; Iqbal, Asif/0000-0002-3224-3651	British Heart Foundation [RG/10/15/28578]; British Heart Foundation [PG/10/60/28496, RG/12/5/29576] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10247] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the British Heart Foundation (RG/10/15/28578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1997, J CELL SCI, V110, P707; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BUECHI M, 1979, J CELL BIOL, V83, P338, DOI 10.1083/jcb.83.2.338; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; Davies John Q, 2005, Methods Mol Biol, V290, P105; Davies John Q, 2005, Methods Mol Biol, V290, P91; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gilbert J, 2011, AM J CARDIOL, V107, P906, DOI 10.1016/j.amjcard.2010.11.005; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kamdar SJ, 1996, CELL IMMUNOL, V174, P165, DOI 10.1006/cimm.1996.0306; KOWOLENKO M, 1990, J IMMUNOL METHODS, V127, P71, DOI 10.1016/0022-1759(90)90342-S; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Su YC, 2012, BIOCH BIOPHYS ACTA; Sun MJ, 2012, ANAL BIOCHEM, V425, P96, DOI 10.1016/j.ab.2012.03.010; Szekanecz Z, 2011, NETH J MED, V69, P356; Turchyn LR, 2007, COMPARATIVE MED, V57, P574; Ungefroren H, 2011, INT J ONCOL, V38, P797, DOI 10.3892/ijo.2011.897; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; White GE, 2011, MOL PHARMACOL, V80, P328, DOI 10.1124/mol.111.071985; Willoughby DA, 2000, INT J IMMUNOPHARMACO, V22, P1131, DOI 10.1016/S0192-0561(00)00064-3; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; ZICHA D, 1991, J CELL SCI, V99, P769	36	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58744	10.1371/journal.pone.0058744	http://dx.doi.org/10.1371/journal.pone.0058744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516549	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400060
J	Johansson, T; Norris, T; Peilot-Sjogren, H				Johansson, Teres; Norris, Tyrrell; Peilot-Sjogren, Helena			Yellow Fluorescent Protein-Based Assay to Measure GABA(A) Channel Activation and Allosteric Modulation in CHO-K1 Cells	PLOS ONE			English	Article							CHLORIDE CHANNELS; RECEPTOR FUNCTION; SUBTYPES; PHARMACOLOGY; AGONISTS	The gamma-aminobutyric acid A (GABA(A)) ion channels are important drug targets for treatment of neurological and psychiatric disorders. Finding GABA(A) channel subtype selective allosteric modulators could lead to new improved treatments. However, the progress in this area has been obstructed by the challenging task of developing functional assays to support screening efforts and the generation of cells expressing functional GABA(A) ion channels with the desired subtype composition. To address these challenges, we developed a yellow fluorescent protein (YFP)-based assay to be able to study allosteric modulation of the GABA(A) ion channel using cryopreserved, transiently transfected, assay-ready cells. We show for the first time how the MaxCyte STX electroporation instrument can be used to generate CHO-K1 cells expressing functional GABA(A) alpha 2 beta 3 gamma 2 along with a halide sensing YFP-H148Q/I152L (YFP-GABA(A2) cells). As a basis for a cell-based assay capable of detecting allosteric modulators, experiments with antagonist, ion channel blocker and modulators were used to verify GABA(A) subunit composition and functionality. We found that the I- concentration used in the YFP assay affected both basal quench of YFP and potency of GABA. For the first time the assay was used to study modulation of GABA with 7 known modulators where statistical analysis showed that the assay can distinguish modulatory pEC(50) differences of 0.15. In conclusion, the YFP assay proved to be a robust, reproducible and inexpensive assay. These data provide evidence that the assay is suitable for high throughput screening (HTS) and could be used to discover novel modulators acting on GABA(A) ion channels.	[Johansson, Teres; Norris, Tyrrell; Peilot-Sjogren, Helena] AstraZeneca Res & Dev, Discovery Sci Cellular Reagents & Assay Dev, Molndal, Sweden	AstraZeneca	Peilot-Sjogren, H (corresponding author), AstraZeneca Res & Dev, Discovery Sci Cellular Reagents & Assay Dev, Molndal, Sweden.	Helena.Peilot@astrazeneca.com			AstraZeneca Research Development	AstraZeneca Research Development	The study was funded by AstraZeneca Research & Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atack JR, 2011, CURR TOP MED CHEM, V11, P1176; Atack JR, 2006, J PHARMACOL EXP THER, V316, P410, DOI 10.1124/jpet.105.089920; Barnard EA, 1998, PHARMACOL REV, V50, P291; Chang YC, 1996, J NEUROSCI, V16, P5415; Elagoz A, 2004, BRIT J PHARMACOL, V141, P37, DOI 10.1038/sj.bjp.0705592; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gamper Nikita, 2005, Journal of Pharmacological and Toxicological Methods, V51, P177, DOI 10.1016/j.vascn.2004.08.008; Gilbert D, 2009, J BIOMOL SCREEN, V14, P86, DOI 10.1177/1087057108328017; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; Liu J, 2008, ASSAY DRUG DEV TECHN, V6, P781, DOI [10.1089/adt.2008.161, 10.1089/adt.2008.0161]; McCabe C, 2004, NEUROPHARMACOLOGY, V46, P171, DOI 10.1016/j.neuropharm.2003.09.004; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mennerick S, 2010, J NEUROSCI, V30, P2871, DOI 10.1523/JNEUROSCI.5607-09.2010; Phez E, 2005, BBA-GEN SUBJECTS, V1724, P248, DOI 10.1016/j.bbagen.2005.04.005; ROBERTSON B, 1989, J PHYSIOL-LONDON, V411, P285, DOI 10.1113/jphysiol.1989.sp017574; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Smith AJ, 2003, ANAL BIOANAL CHEM, V377, P843, DOI 10.1007/s00216-003-2172-y; Sui JL, 2010, ASSAY DRUG DEV TECHN, V8, P656, DOI 10.1089/adt.2010.0312; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wolff C, 2003, J BIOMOL SCREEN, V8, P533, DOI 10.1177/1087057103257806	24	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59429	10.1371/journal.pone.0059429	http://dx.doi.org/10.1371/journal.pone.0059429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516634	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400110
J	Lamber, EP; Beuron, F; Morris, EP; Svergun, DI; Mittnacht, S				Lamber, Ekaterina P.; Beuron, Fabienne; Morris, Edward P.; Svergun, Dmitri I.; Mittnacht, Sibylle			Structural Insights into the Mechanism of Phosphoregulation of the Retinoblastoma Protein	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PHOSPHORYLATION; CANCER; DOMAIN; E2F; RB	The retinoblastoma susceptibility protein RB1 is a key regulator of cell proliferation and fate. RB1 operates through nucleating the formation of multi-component protein complexes involved in the regulation of gene transcription, chromatin structure and protein stability. Phosphorylation of RB1 by cyclin-dependent kinases leads to conformational alterations and inactivates the capability of RB1 to bind partner protein. Using small angle X-ray scattering in combination with single particle analysis of transmission electron microscope images of negative-stained material we present the first three-dimensional reconstruction of non-phosphorylated RB1 revealing an extended architecture and deduce the domain arrangement within the molecule. Phosphorylation results in an overt alteration of the molecular shape and dimensions, consistent with the transition to a compact globular architecture. The work presented provides what is to our knowledge the first description of the relative domain arrangement in active RB1 and predicts the molecular movement that leads to RB1 inactivation following protein phosphorylation.	[Lamber, Ekaterina P.; Mittnacht, Sibylle] Inst Canc Res, Div Canc Biol, London SW3 6JB, England; [Beuron, Fabienne; Morris, Edward P.] Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, Hamburg, Germany; [Mittnacht, Sibylle] UCL Canc Inst, Res Dept Canc Biol, London, England; [Mittnacht, Sibylle] Univ Coll London Hosp, Biomed Res Ctr, Univ Coll London, Natl Inst Hlth Res, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Lamber, EP (corresponding author), Univ London Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England.	e.lamber@mail.cryst.bbk.ac.uk; s.mittnacht@cancer.ucl.ac.uk	Lamber, Ekaterina/AAD-3490-2019	Svergun, Dmitri/0000-0003-0830-5696; Morris, Edward/0000-0003-3544-0041	International Human Frontier Science Program fellowship [LT000665/2009-L]; Cancer Research UK [CRUK/A7640, CRUK/A15043]; National Institute for Health Research, University College London Hospitals Biomedical Research Centre; Institute of Cancer Research; EU [261572]	International Human Frontier Science Program fellowship; Cancer Research UK(Cancer Research UK); National Institute for Health Research, University College London Hospitals Biomedical Research Centre; Institute of Cancer Research; EU(European Commission)	Ekaterina Lamber acknowledges financial support from The International Human Frontier Science Program fellowship LT000665/2009-L (web: http://www.hfsp.org/). This work was supported by Cancer Research UK grants CRUK/A7640 and CRUK/A15043 to Sibylle Mittnacht (web: http://www.cancerresearchuk.org/), with further support from the National Institute for Health Research, University College London Hospitals Biomedical Research Centre. Ed Morris acknowledges support from the Institute of Cancer Research (web: http://www.icr.ac.uk/). Dmitri Svergun acknowledges support from the EU FP7 e-Infrastructure grant WeNMR, contract number 261572 (web: http://www.wenmr.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Chemes LB, 2012, J MOL BIOL, V422, P336, DOI 10.1016/j.jmb.2012.05.036; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Goo YH, 2004, J BIOL CHEM, V279, P7131, DOI 10.1074/jbc.M312563200; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lohmann D, 2010, ADV EXP MED BIOL, V685, P220; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MITTNACHT S, 1994, EMBO J, V13, P118, DOI 10.1002/j.1460-2075.1994.tb06241.x; Mittnacht S, 2005, EUR J CELL BIOL, V84, P97, DOI 10.1016/j.ejcb.2004.12.012; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Moll AC, 1997, OPHTHALMIC GENET, V18, P27, DOI 10.3109/13816819709057880; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Palmero I, 1996, CANCER SURV, V27, P351; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Shao ZH, 1997, ONCOGENE, V15, P385, DOI 10.1038/sj.onc.1201204; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhu LA, 2005, EUR J CANCER, V41, P2415, DOI 10.1016/j.ejca.2005.08.009	46	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58463	10.1371/journal.pone.0058463	http://dx.doi.org/10.1371/journal.pone.0058463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516486	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400032
J	Thung, L; Chakravorty, D; Trusov, Y; Jones, AM; Botella, JR				Thung, Leena; Chakravorty, David; Trusov, Yuri; Jones, Alan M.; Botella, Jose Ramon			Signaling Specificity Provided by the Arabidopsis thaliana Heterotrimeric G-Protein gamma Subunits AGG1 and AGG2 Is Partially but Not Exclusively Provided through Transcriptional Regulation	PLOS ONE			English	Article							G-BETA SUBUNIT; ALPHA-SUBUNIT; ABSCISIC-ACID; NECROTROPHIC PATHOGENS; CHANNEL REGULATION; COUPLED RECEPTORS; MOLECULAR-CLONING; BINDING PROTEIN; CELL-DIVISION; BLUE-LIGHT	The heterotrimeric G-protein complex in Arabidopsis thaliana consists of one alpha, one beta and three gamma subunits. While two of the gamma subunits, AGG1 and AGG2 have been shown to provide functional selectivity to the G beta gamma dimer in Arabidopsis, it is unclear if such selectivity is embedded in their molecular structures or conferred by the different expression patterns observed in both subunits. In order to study the molecular basis for such selectivity we tested genetic complementation of AGG1- and AGG2 driven by the respectively swapped gene promoters. When expressed in the same tissues as AGG1, AGG2 rescues some agg1 mutant phenotypes such as the hypersensitivity to Fusarium oxysporum and D-mannitol as well as the altered levels of lateral roots, but does not rescue the early flowering phenotype. Similarly, AGG1 when expressed in the same tissues as AGG2 rescues the osmotic stress and lateral-root phenotypes observed in agg2 mutants but failed to rescue the heat-stress induction of flowering. The fact that AGG1 and AGG2 are functionally interchangeable in some pathways implies that, at least for those pathways, signaling specificity resides in the distinctive spatiotemporal expression patterns exhibited by each gamma subunit. On the other hand, the lack of complementation for some phenotypes indicates that there are pathways in which signaling specificity is provided by differences in the primary AGG1 and AGG2 amino acid sequences.	[Thung, Leena; Chakravorty, David; Trusov, Yuri; Botella, Jose Ramon] Univ Queensland, Sch Agr & Food Sci, Plant Genet Engn Lab, Brisbane, Qld, Australia; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Botella, JR (corresponding author), Univ Queensland, Sch Agr & Food Sci, Plant Genet Engn Lab, Brisbane, Qld, Australia.	J.botella@uq.edu.au	Botella, Jose R/D-9766-2011	Botella, Jose R/0000-0002-4446-3432; Chakravorty, David/0000-0002-6591-4853; Trusov, Yuri/0000-0001-8215-5492	Australian Research Council [DP1094152]; National Institute of General Medical Sciences [R01GM065989]; National Science Foundation [MCB-0723515, MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-05er15671]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1158054] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Australian Research Council [Grant number DP1094152]. This work was supported by grants from the National Institute of General Medical Sciences (R01GM065989 and National Science Foundation (MCB-0723515 and MCB-0718202) to AMJ. The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through the grant DE-FG02-05er15671 to AMJ funded preliminary studies on lateral root phenotypes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Agrios G. N., 2005, PLANT PATHOL; Anderson DJ, 2007, PLANT CELL REP, V26, P1469, DOI 10.1007/s00299-007-0356-1; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; ARMSTRONG F, 1995, PLANT J, V8, P187, DOI 10.1046/j.1365-313X.1995.08020187.x; Assmann SM, 1996, TRENDS PLANT SCI, V1, P73, DOI 10.1016/S1360-1385(96)89035-2; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balcueva EA, 2000, EXP CELL RES, V257, P310, DOI 10.1006/excr.2000.4893; Bhardwaj D, 2012, PLANT PHYSIOL BIOCH, V58, P1, DOI 10.1016/j.plaphy.2012.06.005; Booker FL, 2004, NEW PHYTOL, V162, P633, DOI 10.1111/j.1469-8137.2004.01081.x; Botella JR, 2012, TRENDS PLANT SCI, V17, P563, DOI 10.1016/j.tplants.2012.06.002; Botto JF, 2009, PHOTOCHEM PHOTOBIOL, V85, P949, DOI 10.1111/j.1751-1097.2008.00505.x; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Chakravorty D, 2012, PLANTA, V235, P615, DOI 10.1007/s00425-011-1526-5; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2004, PLANT PHYSIOL, V135, P1; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; ESKINS K, 1992, PHYSIOL PLANTARUM, V86, P439, DOI 10.1111/j.1399-3054.1992.tb01341.x; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; Hooley R, 1999, PLANT PHYSIOL BIOCH, V37, P393, DOI 10.1016/S0981-9428(99)80045-X; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Jiang K, 2012, PLANT PHYSIOL, V159, P975, DOI 10.1104/pp.112.196337; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2003, PLANT PHYSIOL, V131, P1623, DOI 10.1104/pp.102.017624; Jones JC, 2011, CHEM ENG PROG, V107, P4; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kelly MN, 2003, PLANTA, V216, P674, DOI 10.1007/s00425-002-0900-8; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Koornneef M, 1998, PLANT PHYSIOL BIOCH, V36, P83, DOI 10.1016/S0981-9428(98)80093-4; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kushwah S, 2011, PLANT PHYSIOL, V156, P1851, DOI 10.1104/pp.111.175794; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; LEE RH, 1992, J BIOL CHEM, V267, P24776; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Liu MY, 1997, J BIOL CHEM, V272, P18801, DOI 10.1074/jbc.272.30.18801; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Madueno F, 1996, SEMIN CELL DEV BIOL, V7, P401, DOI 10.1006/scdb.1996.0050; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; MAUCHMANI B, 1994, MOL PLANT MICROBE IN, V7, P378, DOI 10.1094/MPMI-7-0378; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; McIntire WE, 2002, METHOD ENZYMOL, V343, P372; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Misra S, 2007, PLANT J, V51, P656, DOI 10.1111/j.1365-313X.2007.03169.x; Moro S, 2003, CHEM COMMUN, P2949, DOI 10.1039/b303439a; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Okamoto H, 2001, PLANT CELL, V13, P1639, DOI 10.1105/tpc.13.7.1639; Okamoto H, 2009, J EXP BOT, V60, P1991, DOI 10.1093/jxb/erp060; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Purnell MP, 2007, PLANT PHYSIOL, V143, P530, DOI 10.1104/pp.106.091330; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Smrcka AV, 2010, P NATL ACAD SCI USA, V107, P639, DOI 10.1073/pnas.0909503107; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; STERNWEIS PC, 1994, CURR OPIN CELL BIOL, V6, P198, DOI 10.1016/0955-0674(94)90136-8; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Trusov Y, 2012, J PLANT BIOCHEM BIOT, V21, pS40, DOI 10.1007/s13562-012-0140-3; Trusov Yuri, 2012, BMC Res Notes, V5, P608, DOI 10.1186/1756-0500-5-608; Trusov Y, 2010, SIGNAL COMMUN PLANTS, P221, DOI 10.1007/978-3-642-03524-1_12; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang L, 2006, CELL RES, V16, P916, DOI 10.1038/sj.cr.7310111; Wang L, 2010, SIGNAL COMMUN PLANTS, P135, DOI 10.1007/978-3-642-03524-1_8; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; WARPEHA KMF, 1991, P NATL ACAD SCI USA, V88, P8925, DOI 10.1073/pnas.88.20.8925; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Wever W, 2010, TRANSGENIC RES, V19, P667, DOI 10.1007/s11248-009-9332-6; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zhang W, 2008, PLANT J, V56, P984, DOI 10.1111/j.1365-313X.2008.03657.x; Zhu HF, 2009, MOL PLANT, V2, P513, DOI 10.1093/mp/ssp001	102	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58503	10.1371/journal.pone.0058503	http://dx.doi.org/10.1371/journal.pone.0058503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520518	gold, Green Published			2022-12-25	WOS:000318679900077
J	Sedlak, F; Sacha, P; Blechova, M; Brezinova, A; Safarik, M; Sebestik, J; Konvalinka, J				Sedlak, Frantisek; Sacha, Pavel; Blechova, Miroslava; Brezinova, Anna; Safarik, Martin; Sebestik, Jaroslav; Konvalinka, Jan			Glutamate carboxypeptidase II does not process amyloid-beta peptide	FASEB JOURNAL			English	Article						PSMA; Alzheimer's disease; disaggregation; exopeptidase; substrate specificity; depsipeptide	CLEARANCE	The accumulation of amyloid- (A) peptide is thought to be a major causative mechanism of Alzheimer's disease. A accumulation could be caused by dysregulated processing of amyloid precursor protein, yielding excessive amounts of A, and/or by inefficient proteolytic degradation of the peptide itself. Several proteases have been described as A degradation enzymes, most notably metalloendopeptidases, aspartic endopeptidases, and some exopeptidases. Recently a report suggested that another metallopeptidase, glutamate carboxypeptidase II (GCPII), can also cleave A. GCPII is a zinc exopeptidase that cleaves glutamate from N-acetyl-l-aspartyl-l-glutamate in the central nervous system and from pteroylpoly--glutamate in the jejunum. GCPII has been proposed as a promising therapeutic target for disorders caused by glutamate neurotoxicity. However, an A-degrading activity of GCPII would compromise potential pharmaceutical use of GCPII inhibitors, because the enzyme inhibition might lead to increased A levels and consequently to Alzheimer's disease. Therefore, we analyzed the reported A-degrading activity of GCPII using highly purified recombinant enzyme and synthetic A. We did not detect any A degradation activity of GCPII or its homologue even under prolonged incubation at a high enzyme to substrate ratio. These results are in good agreement with the current detailed structural understanding of the substrate specificity and enzyme-ligand interactions of GCPII.Sedlak, F., Sacha, P., Blechova, M., Bezinova, A., Safaik, M., Sebestik, J., Konvalinka, J. Glutamate carboxypeptidase II does not process amyloid- peptide.	[Sedlak, Frantisek; Sacha, Pavel; Blechova, Miroslava; Brezinova, Anna; Safarik, Martin; Sebestik, Jaroslav; Konvalinka, Jan] Gilead Sci, Prague, Czech Republic; [Sedlak, Frantisek; Sacha, Pavel; Blechova, Miroslava; Brezinova, Anna; Safarik, Martin; Sebestik, Jaroslav; Konvalinka, Jan] Acad Sci Czech Republ, Res Ctr, IOCB, Prague, Czech Republic; [Sacha, Pavel; Konvalinka, Jan] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic	Gilead Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague	Konvalinka, J (corresponding author), Inst Organ Chem & Biochem, Flemingovo 2, Prague 16610 6, Czech Republic.	konval@uochb.cas.cz	Konvalinka, Jan/G-7518-2014; Sebestik, Jaroslav/C-9166-2012; Sedlak, Frantisek/T-1788-2019; Sedlak, Frantisek/H-1420-2014; Sacha, Pavel/G-9729-2014	Sebestik, Jaroslav/0000-0002-0614-2064; Sacha, Pavel/0000-0001-6198-9826; Sedlak, Frantisek/0000-0002-5565-8462; Konvalinka, Jan/0000-0003-0695-9266	Grant Agency of the Czech Republic [P304/12/0847]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The authors thank Tomas Knedlik for the GCPII activity determination by radioenzymatic assay and Radko Soucek for skillful amino acid analysis of A beta<INF>1-42</INF> samples. This research was funded by grant P304/12/0847 from the Grant Agency of the Czech Republic.	Barinka C, 2004, EUR J BIOCHEM, V271, P2782, DOI 10.1111/j.1432-1033.2004.04209.x; Barinka C, 2012, CURR MED CHEM, V19, P856, DOI 10.2174/092986712799034888; Barinka C, 2002, J NEUROCHEM, V80, P477, DOI 10.1046/j.0022-3042.2001.00715.x; Barinka C, 2008, J MOL BIOL, V376, P1438, DOI 10.1016/j.jmb.2007.12.066; Carpino LA, 2004, TETRAHEDRON LETT, V45, P7519, DOI 10.1016/j.tetlet.2004.07.162; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Hamazaki H, 1996, FEBS LETT, V396, P139, DOI 10.1016/0014-5793(96)01087-3; Hlouchova K, 2012, CURR MED CHEM, V19, P1316, DOI 10.2174/092986712799462676; Hlouchova K., 2012, PROTEINASES DRUG TAR, P63; Hlouchova K, 2007, J NEUROCHEM, V101, P682, DOI 10.1111/j.1471-4159.2006.04341.x; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kim MJ, 2010, FASEB J, V24, P4491, DOI 10.1096/fj.09-148825; Klusak V, 2009, BIOCHEMISTRY-US, V48, P4126, DOI 10.1021/bi900220s; Numata K, 2010, BIOCHEMISTRY-US, V49, P3254, DOI 10.1021/bi902134p; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plechanovova A, 2011, J MED CHEM, V54, P7535, DOI 10.1021/jm200807m; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; Selkoe DJ, 2001, ALZHEIMER'S DISEASE, P421, DOI 10.1002/0470846453.ch38; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tykvart J, 2012, PROTEIN EXPRES PURIF, V82, P106, DOI 10.1016/j.pep.2011.11.016; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Yamin R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-33; Yoo C, 2010, FEBS LETT, V584, P4157, DOI 10.1016/j.febslet.2010.08.048; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	31	3	3	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2626	2632		10.1096/fj.12-225094	http://dx.doi.org/10.1096/fj.12-225094			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23525279				2022-12-25	WOS:000328841000012
J	Aria, V; De Felice, M; Di Perna, R; Uno, S; Masai, H; Syvaoja, JE; van Loon, B; Hubscher, U; Pisani, FM				Aria, Valentina; De Felice, Mariarita; Di Perna, Roberta; Uno, Shuji; Masai, Hisao; Syvaoja, Juhani E.; van Loon, Barbara; Huebscher, Ulrich; Pisani, Francesca M.			The Human Tim-Tipin Complex Interacts Directly with DNA Polymerase epsilon and Stimulates Its Synthetic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK PROTECTION; SISTER-CHROMATID COHESION; S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC DNA; FISSION YEAST; HUMAN CLASPIN; TIMELESS; MRC1; PROTEIN	The Tim-Tipin complex plays an important role in the S phase checkpoint and replication fork stability in metazoans, but the molecular mechanism underlying its biological function is poorly understood. Here, we present evidence that the recombinant human Tim-Tipin complex (and Tim alone) markedly enhances the synthetic activity of DNA polymerase epsilon. In contrast, no significant effect on the synthetic ability of human DNA polymerase alpha and delta by Tim-Tipin was observed. Surface plasmon resonance measurements and co-immunoprecipitation experiments revealed that recombinant DNA polymerase epsilon directly interacts with either Tim or Tipin. In addition, the results of DNA band shift assays suggest that the Tim-Tipin complex (or Tim alone) is able to associate with DNA polymerase epsilon bound to a 40-/80-mer DNA ligand. Our results are discussed in view of the molecular dynamics at the human DNA replication fork.	[Aria, Valentina; De Felice, Mariarita; Di Perna, Roberta; Pisani, Francesca M.] CNR, Ist Biochim Proteine, I-80131 Naples, Italy; [Uno, Shuji; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan; [Syvaoja, Juhani E.] Univ Eastern Finland, Inst Biomed, FI-70211 Kuopio, Finland; [van Loon, Barbara; Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Tokyo Metropolitan Institute of Medical Science; University of Eastern Finland; University of Zurich	Pisani, FM (corresponding author), CNR, Ist Biochim Proteine, Via P Castellino 111, I-80131 Naples, Italy.	fm.pisani@ibp.cnr.it	Pisani, Francesca M./AAX-4025-2020; van Loon, Barbara/E-6771-2014	van Loon, Barbara/0000-0002-7597-207X	Associazione Italiana per la Ricerca sul Cancro Grant [IG 9087]; European Molecular Biology Organization Short Term Fellowship [ASTF 239.00-2009]; Academy of Finland [123082, 251576]; Swiss National Science Foundation; University of Zurich; Ministry of Education, Culture, Sports, Science, and Technology of Japan [14208079, 17080014]; Grants-in-Aid for Scientific Research [23657081] Funding Source: KAKEN	Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro); European Molecular Biology Organization Short Term Fellowship; Academy of Finland(Academy of Finland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grant IG 9087 (to F. M. P.), European Molecular Biology Organization Short Term Fellowship ASTF 239.00-2009 (to V. A.), Academy of Finland Grants 123082 and 251576 (to J. E. S.), Swiss National Science Foundation and University of Zurich grants (to B. v. L. and U. H.), and Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research A 14208079 and Grant-in-aid for Scientific Research on Priority Area Chromosome Cycle 17080014 (to S. U. and H. M.).	Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Foss EJ, 2001, GENETICS, V157, P567; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Li ZX, 2000, P NATL ACAD SCI USA, V97, P10038, DOI 10.1073/pnas.97.18.10038; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Sercin O, 2011, CELL CYCLE, V10, P1599, DOI 10.4161/cc.10.10.15562; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka T, 2010, J BIOL CHEM, V285, P39609, DOI 10.1074/jbc.M110.173344; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Uno S, 2012, METHODS, V57, P214, DOI 10.1016/j.ymeth.2012.06.016; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; WEISER T, 1991, J BIOL CHEM, V266, P10420; Xiao J, 2003, DEV DYNAM, V228, P82, DOI 10.1002/dvdy.10346; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	40	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12742	12752		10.1074/jbc.M112.398073	http://dx.doi.org/10.1074/jbc.M112.398073			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511638	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000318555100031
J	Lee, JE; Gohda, T; Walker, WH; Skupien, J; Smiles, AM; Holak, RR; Jeong, J; McDonnell, KP; Krolewski, AS; Niewczas, MA				Lee, Jung Eun; Gohda, Tomohito; Walker, William H.; Skupien, Jan; Smiles, Adam M.; Holak, Rita R.; Jeong, Jackson; McDonnell, Kevin P.; Krolewski, Andrzej S.; Niewczas, Monika A.			Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1	PLOS ONE			English	Article							GROWTH-FACTOR 23; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; RECEPTORS 1; KLOTHO; INFLAMMATION; FACTOR-23; FGF23; FIBROBLAST-GROWTH-FACTOR-23; MICROALBUMINURIA	Introduction: Recent studies demonstrated that circulating fibroblast growth factor (FGF)-23 was associated with risk of end stage renal disease (ESRD) and mortality. This study aims to examine whether the predictive effect of FGF-23 is independent from circulating levels of tumor necrosis factor receptor 1 (TNFR1), a strong predictor of ESRD in Type 2 diabetes (T2D). Methods: We studied 380 patients with T2D who were followed for 8-12 years and were used previously to examine the effect of TNFR1. Baseline plasma FGF-23 was measured by immunoassay. Results: During follow-up, 48 patients (13%) developed ESRD and 83 patients (22%) died without ESRD. In a univariate analysis, baseline circulating levels of FGF-23 and TNFR1 were significantly higher in subjects who subsequently developed ESRD or died without ESRD than in those who remained alive. In a Cox proportional hazard model, baseline concentration of FGF-23 was associated with increased risk of ESRD, however its effect was no longer significant after controlling for TNFR1 and other clinical characteristics (HR 1.3, p = 0.15). The strong effect of circulating level of TNFR1 on risk of ESRD was not changed by including circulating levels of FGF-23 (HR 8.7, p<0.001). In the Cox multivariate model, circulating levels of FGF-23 remained a significant independent predictor of all-cause mortality unrelated to ESRD (HR 1.5, p<0.001). Conclusions: We demonstrated that the effect of circulating levels of FGF-23 on the risk of ESRD is accounted for by circulating levels of TNFR1. We confirmed that circulating levels of FGF-23 have an independent effect on all-cause mortality in T2D.	[Lee, Jung Eun; Gohda, Tomohito; Walker, William H.; Skupien, Jan; Smiles, Adam M.; Holak, Rita R.; Jeong, Jackson; McDonnell, Kevin P.; Krolewski, Andrzej S.; Niewczas, Monika A.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Lee, Jung Eun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Nephrol, Seoul, South Korea; [Lee, Jung Eun; Gohda, Tomohito; Skupien, Jan; Krolewski, Andrzej S.; Niewczas, Monika A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gohda, Tomohito] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan; [Skupien, Jan] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland	Harvard University; Joslin Diabetes Center, Inc.; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Harvard Medical School; Juntendo University; Jagiellonian University; Collegium Medicum Jagiellonian University	Niewczas, MA (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	Monika.Niewczas@joslin.harvard.edu	lee, je/O-6247-2014; GOHDA, TOMOHITO/Y-6867-2019	GOHDA, TOMOHITO/0000-0002-0513-4433	National Institutes of Health [DK041526, DK067638]; DERC Joslin Diabetes Center Pilot and Feasibility grant; JDRF [3-2009-397]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526, R01DK067638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DERC Joslin Diabetes Center Pilot and Feasibility grant; JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health DK041526 and DK067638 (ASK), DERC Joslin Diabetes Center Pilot and Feasibility grant (MAN) and a JDRF fellowship grant 3-2009-397 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3; AGODOA LY, 1995, AM J KIDNEY DIS, V25, P119, DOI 10.1016/0272-6386(95)90638-X; Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; Baum M, 2005, KIDNEY INT, V68, P1148, DOI 10.1111/j.1523-1755.2005.00506.x; Bergstralh E., SAS MACRO PERFORMS C; Bernheim J, 2011, NEPHROL DIAL TRANSPL, V26, P2433, DOI 10.1093/ndt/gfr208; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Krieger NS, 2012, AM J PHYSIOL-RENAL, V303, pF431, DOI 10.1152/ajprenal.00199.2012; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; MacIsaac RJ, 2011, CURR OPIN NEPHROL HY, V20, P246, DOI 10.1097/MNH.0b013e3283456546; McEwen LN, 2011, DIABETES CARE, pdc11; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Prie D, 2010, CLIN J AM SOC NEPHRO, V5, P1717, DOI 10.2215/CJN.02680310; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Shab-Bidar S, 2012, DIABETES-METAB RES, V28, P424, DOI 10.1002/dmrr.2290; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	38	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58007	10.1371/journal.pone.0058007	http://dx.doi.org/10.1371/journal.pone.0058007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526964	gold, Green Published			2022-12-25	WOS:000317562600012
J	Weaver, JM; Yang, HM; Roumanes, D; Lee, FEH; Wu, HL; Treanor, JJ; Mosmann, TR				Weaver, Jason M.; Yang, Hongmei; Roumanes, David; Lee, F. Eun-Hyung; Wu, Hulin; Treanor, John J.; Mosmann, Tim R.			Increase in IFN gamma-IL-2(+) Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; CENTRAL MEMORY; IN-VIVO; IMMUNE-RESPONSES; VIRUS; VACCINES; PROTECTION; SUBSETS; BINDING; LIVE	Human CD4 T cell recall responses to influenza virus are strongly biased towards Type 1 cytokines, producing IFN gamma, IL-2 and TNF alpha. We have now examined the effector phenotypes of CD4 T cells in more detail, particularly focusing on differences between recent versus long-term, multiply-boosted responses. Peptides spanning the proteome of temporally distinct influenza viruses were distributed into pools enriched for cross-reactivity to different influenza strains, and used to stimulate antigen-specific CD4 T cells representing recent or long-term memory. In the general population, peptides unique to the long-circulating influenza A/New Caledonia/20/99 (H1N1) induced Th1-like responses biased toward the expression of IFN gamma+TNF alpha(+) CD4 T cells. In contrast, peptide pools enriched for non-cross-reactive peptides of the pandemic influenza A/California/04/09 (H1N1) induced more IFN gamma-IL-2(+)TNF alpha(+) T cells, similar to the IFN gamma-IL-2(+) non-polarized, primed precursor T cells (Thpp) that are a predominant response to protein vaccination. These results were confirmed in a second study that compared samples taken before the 2009 pandemic to samples taken one month after PCR-confirmed A/California/04/09 infection. There were striking increases in influenza-specific TNF alpha(+), IFN gamma(+), and IL-2(+) cells in the post-infection samples. Importantly, peptides enriched for non-cross-reactive A/California/04/09 specificities induced a higher proportion of Thpp-like IFN gamma-IL-2(+)TNF alpha(+) CD4 T cells than peptide pools cross-reactive with previous influenza strains, which induced more Th1 (IFN gamma+TNF alpha(+)) responses. These IFN gamma-IL-2(+)TNF alpha(+) CD4 T cells may be an important target population for vaccination regimens, as these cells are induced upon infection, may have high proliferative potential, and may play a role in providing future effector cells during subsequent infections.	[Weaver, Jason M.; Roumanes, David; Mosmann, Tim R.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Yang, Hongmei; Wu, Hulin] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Lee, F. Eun-Hyung] Univ Rochester, Med Ctr, Dept Med, Div Pulm Med, Rochester, NY 14642 USA; [Treanor, John J.] Univ Rochester, Med Ctr, Dept Med, Div Infect Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Mosmann, TR (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu			National Institutes of Health [K23 AI67501, HHSN266200500030C (N01-AI50029), AI054953];  [HHSN266200700008C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050029, K23AI067501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract HHSN266200700008C to JJT, and by grants K23 AI67501 and HHSN266200500030C (N01-AI50029) to FEL and AI054953 to TRM from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Bartz AE, 1999, BASIC STATISTICAL CO; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P631; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chaves FA, 2012, J IMMUNOL, V188, P4235, DOI 10.4049/jimmunol.1103640; Coffman RL, 1999, CURR TOP MICROBIOL, V238, P1; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2011, VACCINE; Diethelm-Okita BM, 2000, J INFECT DIS, V181, P1001, DOI 10.1086/315324; DiethelmOkita BM, 1997, J INFECT DIS, V175, P382, DOI 10.1093/infdis/175.2.382; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Durando P, 2011, HUM VACCINES, V7, P29, DOI 10.4161/hv.7.0.14560; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Fearon DT, 2006, IMMUNOL REV, V211, P104, DOI 10.1111/j.0105-2896.2006.00390.x; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geginat J, 2003, PATHOL BIOL, V51, P64, DOI 10.1016/S0369-8114(03)00098-1; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; He XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002574; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Jelley-Gibbs DM, 2005, J EXP MED, V201, P1101, DOI 10.1084/jem.20041852; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mosmann TR, 2009, IMMUNOL RES; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; SAD S, 1994, J IMMUNOL, V153, P3514; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Stubbe M, 2006, J IMMUNOL, V177, P8185, DOI 10.4049/jimmunol.177.11.8185; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Wang JCE, 2009, J IMMUNOL METHODS, V341, P106, DOI 10.1016/j.jim.2008.11.002; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Wirth TC, 2011, EUR J IMMUNOL, V41, P1321, DOI 10.1002/eji.201040730; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang L, 2005, J IMMUNOL, V175, P6458, DOI 10.4049/jimmunol.175.10.6458; Yu K, 2001, THEORETICAL DETERMIN; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	63	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57275	10.1371/journal.pone.0057275	http://dx.doi.org/10.1371/journal.pone.0057275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526940	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562600007
J	Anderson, MJ; Tolimieri, N; Millar, RB				Anderson, Marti J.; Tolimieri, Nick; Millar, Russell B.			Beta Diversity of Demersal Fish Assemblages in the North-Eastern Pacific: Interactions of Latitude and Depth	PLOS ONE			English	Article							SPECIES-RICHNESS; GROUNDFISH ASSEMBLAGES; HABITAT HETEROGENEITY; SPATIAL-PATTERNS; SCALE PATTERNS; TAXONOMIC DISTINCTNESS; BENTHIC BIODIVERSITY; CONTINENTAL-SLOPE; GLOBAL PATTERNS; ATLANTIC-OCEAN	Knowledge of broad-scale global patterns in beta diversity (i.e., variation or turnover in identities of species) for marine systems is in its infancy. We analysed the beta diversity of groundfish communities along the North American Pacific coast, from trawl data spanning 32.57 degrees N to 48.52 degrees N and 51 m to 1200 m depth. Analyses were based on both the Jaccard measure and the probabilistic Raup-Crick measure, which accounts for variation in alpha diversity. Overall, beta diversity decreased with depth, and this effect was strongest at lower latitudes. Superimposed on this trend were peaks in beta diversity at around 400-600 m and also around 1000-1200 m, which may indicate high turnover around the edges of the oxygen minimum zone. Beta diversity was also observed to decrease with latitude, but this effect was only observed in shallower waters (<200 m); latitudinal turnover began to disappear at depths >800 m. At shallower depths (, 200 m), peaks in latitudinal turnover were observed at similar to 43 degrees N, 39 degrees N, 35 degrees N and 31 degrees N, which corresponded well with several classically observed oceanographic boundaries. Turnover with depth was stronger than latitudinal turnover, and is likely to reflect strong environmental filtering over relatively short distances. Patterns in beta diversity, including latitude-by-depth interactions, should be integrated with other biodiversity measures in ecosystem-based management and conservation of groundfish communities.	[Anderson, Marti J.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Tolimieri, Nick] Natl Ocean & Atmospher Adm, Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA USA; [Millar, Russell B.] Univ Auckland, Dept Stat, Auckland 1, New Zealand	Massey University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Auckland	Anderson, MJ (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.	m.j.anderson@massey.ac.nz	Anderson, Marti J./AAQ-9038-2021	Anderson, Marti J./0000-0002-4018-4049	Royal Society of New Zealand Marsden Grant [MAU0713]	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ))	M.J. Anderson was supported by a Royal Society of New Zealand Marsden Grant no. MAU0713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2005, J ANIM ECOL, V74, P636, DOI 10.1111/j.1365-2656.2005.00959.x; Anderson MJ, 2005, J EXP MAR BIOL ECOL, V320, P35, DOI 10.1016/j.jembe.2004.12.023; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Builder-Ramsey T, 2002, NMFSNWFSC55 NOAA US; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Fahr J, 2011, ECOGRAPHY, V34, P177, DOI 10.1111/j.1600-0587.2010.05510.x; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Garcia SM, 2005, ICES J MAR SCI, V62, P311, DOI 10.1016/j.icesjms.2004.12.003; Gaston Kevin J., 1996, P202; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1995, P ROY SOC B-BIOL SCI, V260, P149, DOI 10.1098/rspb.1995.0072; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Gooday AJ, 2010, MAR ECOL-EVOL PERSP, V31, P125, DOI 10.1111/j.1439-0485.2009.00348.x; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Harrison S, 1997, ECOLOGY, V78, P1898, DOI 10.1890/0012-9658(1997)078[1898:HNHPAT]2.0.CO;2; Harte J, 1997, OIKOS, V80, P417, DOI 10.2307/3546614; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; HORN MH, 1978, J BIOGEOGR, V5, P23, DOI 10.2307/3038105; Horn MH, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P3; Juan-Jorda MJ, 2009, FISH OCEANOGR, V18, P1, DOI 10.1111/j.1365-2419.2008.00489.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Keller AA, 2007, 2003 US W COAST BOTT; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Lecchini D, 2007, CORAL REEFS, V26, P423, DOI 10.1007/s00338-007-0212-3; Levin LA, 2009, MARINE ECOLOGY, V31, P94; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Manthey M, 2009, J ECOL, V97, P18, DOI 10.1111/j.1365-2745.2008.01450.x; McClain CR, 2012, P ROY SOC B-BIOL SCI, V279, P1993, DOI 10.1098/rspb.2011.2166; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; MCNEILL SE, 1994, BIODIVERS CONSERV, V3, P586, DOI 10.1007/BF00114203; Merigot B, 2007, FISH RES, V88, P120, DOI 10.1016/j.fishres.2007.08.003; Merigot B, 2007, ESTUAR COAST SHELF S, V73, P123, DOI 10.1016/j.ecss.2006.12.017; Millar RB, 2011, ECOLOGY, V92, P1717, DOI 10.1890/11-0029.1; Mumby PJ, 2001, OECOLOGIA, V128, P274, DOI 10.1007/s004420100643; MURRAY SN, 1981, J BIOGEOGR, V8, P339, DOI 10.2307/2844755; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nelson JS, 1984, FISHES WORLD; NEWELL IRWIN M., 1948, PROC AMER PHIL SOC, V92, P155; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; POFF NL, 1990, ENVIRON MANAGE, V14, P629, DOI 10.1007/BF02394714; Price ARG, 1999, BIOL J LINN SOC, V66, P187, DOI 10.1111/j.1095-8312.1999.tb01883.x; Priede IG, 2010, MAR ECOL-EVOL PERSP, V31, P247, DOI 10.1111/j.1439-0485.2009.00330.x; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; RAUP DM, 1979, J PALEONTOL, V53, P1213; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; SAMSON FB, 1982, TRANS N AM WILDL NAT, V47, P421; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Stuart CT, 2009, MAR ECOL-EVOL PERSP, V30, P164, DOI 10.1111/j.1439-0485.2008.00269.x; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vellend M, 2001, J VEG SCI, V12, P545, DOI 10.2307/3237006; Vellend M, 2007, J ECOL, V95, P565, DOI 10.1111/j.1365-2745.2007.01233.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yeh J, 2009, DEEP-SEA RES PT I, V56, P251, DOI 10.1016/j.dsr.2008.08.005; Zintzen V, 2011, ECOGRAPHY, V34, P306, DOI 10.1111/j.1600-0587.2010.06546.x	89	38	39	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57918	10.1371/journal.pone.0057918	http://dx.doi.org/10.1371/journal.pone.0057918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526960	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100018
J	Lensen, KJDF; Voskuyl, AE; van der Laken, CJ; Comans, EFI; van Schaardenburg, D; Arntzenius, AB; Zwijnenburg, T; Stam, F; Gompelman, M; van der Zant, FM; van Paassen, AQA; Voerman, BJ; Smit, F; Anten, S; Siegert, CE; Binnerts, A; Smulders, YM				Lensen, Karel-Jan D. F.; Voskuyl, Alexandre E.; van der Laken, Conny J.; Comans, Emile F. I.; van Schaardenburg, Dirkjan; Arntzenius, Alex B.; Zwijnenburg, Ton; Stam, Frank; Gompelman, Michelle; v. d. Zant, Friso M.; van Paassen, Anneke Q. A.; Voerman, Bert J.; Smit, Frits; Anten, Sander; Siegert, Carl E.; Binnerts, Arjen; Smulders, Yvo M.			18F-Fluorodeoxyglucose Positron Emission Tomography in Elderly Patients with an Elevated Erythrocyte Sedimentation Rate of Unknown Origin	PLOS ONE			English	Article							GIANT-CELL ARTERITIS; DIAGNOSTIC PERFORMANCE; POLYMYALGIA-RHEUMATICA; FDG-PET; FEVER; MULTICENTER; INVOLVEMENT; MRI; CT	Patients with an elevated erythrocyte sedimentation rate (ESR) and non-specific symptoms often pose a diagnostic dilemma. PET/CT visualises infection, inflammation and malignancy, all of which may cause elevated ESR. The objective of this study was to determine the contribution of 18F-fluorodeoxglucose positron emission tomography (PET/CT) in the diagnostic work-up of referred patients with an elevated ESR, in whom initial routine evaluation did not reveal a diagnosis. We conducted a combined retrospective (A) and prospective (B) study in elderly (>50 years) patients with a significantly elevated ESR of >= 50 mm/h and non-specific complaints. In study A, 30 patients were included. Malignancy (8 patients), auto-inflammatory disease (8 patients, including 5 with large-vessel vasculitis) and infection (3 patients) were suggested by PET/CT. Two scans showed non-specific abnormalities and 9 scans were normal. Of the 21 abnormal PET/CT results, 12 diagnoses were independently confirmed and two alternative diagnosis were made. Two diagnoses were established in patients with a normal scan. In study B, 58 patients in whom a prior protocolised work-up was non-diagnostic, were included. Of these, 25 PET/CT-scans showed suspected auto-inflammatory disease, particularly large-vessel vasculitis (14 cases). Infection and malignancy was suspected in 5 and 3 cases, respectively. Seven scans demonstrated non-specific abnormalities, 20 were normal. Of the 40 abnormal PET/CT results, 22 diagnoses were confirmed, 3 alternative diagnoses were established. Only one diagnosis was established in the 20 patients with a normal scan. In both studies, the final diagnosis was based on histology, clinical follow-up, response to therapy or additional imaging. In conclusion, PET/CT may be of potential value in the diagnostic work-up of patients with elevated ESR if routine evaluation reveals no diagnosis. In particular, large-vessel vasculitis appears to be a common finding. A normal PET/CT scan in these patients suggests that it is safe to follow a wait-and-see policy.	[Lensen, Karel-Jan D. F.; Smulders, Yvo M.] VU Univ Med Ctr Amsterdam, Dept Internal Med, Amsterdam, Netherlands; [Lensen, Karel-Jan D. F.; Smulders, Yvo M.] VU Univ Med Ctr Amsterdam, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands; [Voskuyl, Alexandre E.; van der Laken, Conny J.] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Comans, Emile F. I.] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [van Schaardenburg, Dirkjan] Jan van Breemen Inst Reade, Dept Rheumatol, Amsterdam, Netherlands; [Arntzenius, Alex B.] Spaarne Hosp, Dept Internal Med, Hoofddorp, Netherlands; [Zwijnenburg, Ton] Spaarne Hosp, Dept Nucl Med, Hoofddorp, Netherlands; [Stam, Frank; Gompelman, Michelle] Med Ctr Alkmaar, Dept Internal Med, Alkmaar, Netherlands; [v. d. Zant, Friso M.] Med Ctr Alkmaar, Dept Nucl Med, Alkmaar, Netherlands; [van Paassen, Anneke Q. A.] Kennemer Gasthuis, Dept Internal Med, Haarlem, Netherlands; [Voerman, Bert J.] Amstelland Hosp, Dept Internal Med, Amstelveen, Netherlands; [Smit, Frits] Rijnland Hosp, Dept Internal Med, Leiderdorp, Netherlands; [Anten, Sander] Rijnland Hosp, Dept Nucl Med, Leiderdorp, Netherlands; [Siegert, Carl E.] Sint Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Binnerts, Arjen] Zaans Med Ctr, Dept Internal Med, Zaandam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Spaarne Hospital; Spaarne Hospital; Medical Center Of Alkmaar; Medical Center Of Alkmaar; Spaarne Hospital; Rijnland Hospital; Rijnland Hospital; Sint Lucas Andreas Hospital	Smulders, YM (corresponding author), VU Univ Med Ctr Amsterdam, Dept Internal Med, Amsterdam, Netherlands.	y.smulders@vumc.nl	Smulders, YM/AAG-7506-2021; Gompelman, Michelle/H-2503-2017	Anten, Sander/0000-0002-6371-6255; Gompelman, Michelle/0000-0002-8568-5437; Voskuyl, Alexandre/0000-0002-9699-1827	dutch arthritis foundation	dutch arthritis foundation	The work was sponsored by a grant provided by the dutch arthritis foundation (www.reumafonds.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balink H, 2009, CLIN NUCL MED, V34, P862, DOI 10.1097/RLU.0b013e3181becfb1; Belhocine T, 2004, EUR J NUCL MED MOL I, V31, P1055, DOI 10.1007/s00259-004-1547-4; Besson FL, 2011, EUR J NUCL MED MOL I, V38, P1764, DOI 10.1007/s00259-011-1830-0; Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Bleeker-Rovers CP, 2009, SEMIN NUCL MED, V39, P81, DOI 10.1053/j.semnuclmed.2008.10.002; Bley TA, 2005, MAGN RESON MATER PHY, V18, P193, DOI 10.1007/s10334-005-0119-3; Blockmans D, 2000, AM J MED, V108, P246, DOI 10.1016/S0002-9343(99)00424-6; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; Buysschaert Ian, 2004, Eur J Intern Med, V15, P151, DOI 10.1016/j.ejim.2004.01.018; Cankurtaran M, 2009, ARCH GERONTOL GERIAT; Federici L, 2010, INT J CLIN PRACT, V64, P55, DOI 10.1111/j.1742-1241.2008.01774.x; Fuchs M, 2012, EUR J NUCL MED MOL I, V39, P344, DOI 10.1007/s00259-011-1967-x; GERBER NJ, 1984, EUR NEUROL, V23, P410, DOI 10.1159/000115723; Henes JC, 2008, CLIN EXP RHEUMATOL, V26, pS47; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Janssen SP, 2008, J VASC SURG, V48, P1025, DOI 10.1016/j.jvs.2008.04.054; Jaruskova M, 2006, EUR J NUCL MED MOL I, V33, P913, DOI 10.1007/s00259-006-0064-z; Keidar Z, 2008, J NUCL MED, V49, P1980, DOI 10.2967/jnumed.108.054692; Kubota K, 2011, ANN NUCL MED, V25, P355, DOI 10.1007/s12149-011-0470-6; LIE JT, 1995, SEMIN ARTHRITIS RHEU, V24, P422, DOI 10.1016/S0049-0172(95)80010-7; Lorenzen J, 2001, NUCL MED COMMUN, V22, P779, DOI 10.1097/00006231-200107000-00009; Markl M, 2006, J MAGN RESON IMAGING, V24, P423, DOI 10.1002/jmri.20639; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; Narvaez J, 2005, RHEUMATOLOGY, V44, P479, DOI 10.1093/rheumatology/keh513; Nuenninghoff DM, 2003, ARTHRITIS RHEUM-US, V48, P3522, DOI 10.1002/art.11353; Ostberg G, 1973, ACTA PATHOL MICR S59, P59; Ostberg G, 1973, ACTA PATHOL MIC S237, P237; Prieto-Gonzalez S, 2012, ANN RHEUM DIS, V71, P1170, DOI 10.1136/annrheumdis-2011-200865; Rosenbaum J, 2011, HELL J NUCL MED, V14, P255; Saadeh C, 1998, SOUTHERN MED J, V91, P220; Sheng JF, 2011, EUR J INTERN MED, V22, P112, DOI 10.1016/j.ejim.2010.09.015; SHUSTERMAN N, 1985, ARCH INTERN MED, V145, P1796, DOI 10.1001/archinte.145.10.1796; Townsend DW, 2008, SEMIN NUCL MED, V38, P152, DOI 10.1053/j.semnuclmed.2008.01.003; Vanderschueren S, 2009, EUR J INTERN MED, V20, P415, DOI 10.1016/j.ejim.2009.01.002; Wagner AD, 2005, ANN RHEUM DIS, V64, P105, DOI 10.1136/ard.2003.018259; WYLER DJ, 1977, SOUTHERN MED J, V70, P1428, DOI 10.1097/00007611-197712000-00015; Younge BR, 2004, MAYO CLIN PROC, V79, P483, DOI 10.4065/79.4.483	38	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58917	10.1371/journal.pone.0058917	http://dx.doi.org/10.1371/journal.pone.0058917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527049	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100055
J	Siekmeier, PJ; vanMaanen, DP				Siekmeier, Peter J.; vanMaanen, David P.			Development of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal Neuropathology	PLOS ONE			English	Article							PERSISTENT NA+ CURRENT; BIPOLAR DISORDER; SCHIZOPHRENIA-PATIENTS; SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; GAMMA-OSCILLATIONS; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; MAJOR DEPRESSION; RECOMBINANT AMPA	A large number of cellular level abnormalities have been identified in the hippocampus of schizophrenic subjects. Nonetheless, it remains uncertain how these pathologies interact at a system level to create clinical symptoms, and this has hindered the development of more effective antipsychotic medications. Using a 72-processor supercomputer, we created a tissue level hippocampal simulation, featuring multicompartmental neuron models with multiple ion channel subtypes and synaptic channels with realistic temporal dynamics. As an index of the schizophrenic phenotype, we used the specific inability of the model to attune to 40 Hz (gamma band) stimulation, a well-characterized abnormality in schizophrenia. We examined several possible combinations of putatively schizophrenogenic cellular lesions by systematically varying model parameters representing NMDA channel function, dendritic spine density, and GABA system integrity, conducting 910 trials in total. Two discrete "clusters'' of neuropathological changes were identified. The most robust was characterized by co-occurring modest reductions in NMDA system function (-30%) and dendritic spine density (-30%). Another set of lesions had greater NMDA hypofunction along with low level GABA system dysregulation. To the schizophrenic model, we applied the effects of 1,500 virtual medications, which were implemented by varying five model parameters, independently, in a graded manner; the effects of known drugs were also applied. The simulation accurately distinguished agents that are known to lack clinical efficacy, and identified novel mechanisms (e.g., decrease in AMPA conductance decay time constant, increase in projection strength of calretinin-positive interneurons) and combinations of mechanisms that could re-equilibrate model behavior. These findings shed light on the mechanistic links between schizophrenic neuropathology and the gamma band oscillatory abnormalities observed in the illness. As such, they generate specific falsifiable hypotheses, which can guide postmortem and other laboratory research. Significantly, this work also suggests specific non-obvious targets for potential pharmacologic agents.	[Siekmeier, Peter J.; vanMaanen, David P.] McLean Hosp, Lab Computat Neurosci, Belmont, MA 02178 USA; [Siekmeier, Peter J.; vanMaanen, David P.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Siekmeier, PJ (corresponding author), McLean Hosp, Lab Computat Neurosci, 115 Mill St, Belmont, MA 02178 USA.	psiekmeier@mclean.harvard.edu			National Institute of Mental Health [K08 MH072771, P50 MH060450]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060450, K08MH072771] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by National Institute of Mental Health grants K08 MH072771 and P50 MH060450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Arai AC, 2002, J PHARMACOL EXP THER, V303, P1075, DOI 10.1124/jpet.102.040360; Atack JR, 2010, J PHARMACOL EXP THER, V332, P17, DOI 10.1124/jpet.109.157909; Bayarri MJ, 2007, ANN STAT, V35, P1874, DOI 10.1214/009053607000000163; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Benes FM, 1996, SYNAPSE, V22, P338; Bergeron R, 2005, NEUROPSYCHOPHARMACOL, V30, P7, DOI 10.1038/sj.npp.1300559; Berk R, 2007, STAT SCI, V17, P173; BIRD ED, 1977, LANCET, V2, P1157, DOI 10.1016/S0140-6736(77)91542-2; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; CHAO TI, 1995, NEUROREPORT, V6, P1778, DOI 10.1097/00001756-199509000-00017; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Coyle JT, 2010, DIALOGUES CLIN NEURO, V12; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Denolle T, 2002, FUND CLIN PHARMACOL, V16, P527, DOI 10.1046/j.1472-8206.2002.00110.x; DEUTZ NEP, 1986, EUR J PHARMACOL, V125, P429, DOI 10.1016/0014-2999(86)90799-5; DeVito LM, 2011, GENES BRAIN BEHAV, V10, P210, DOI 10.1111/j.1601-183X.2010.00656.x; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Easterling R, 2002, STAT FDN VALIDATION; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; FINK M, 1979, THER DRUG MONIT, V1, P93, DOI 10.1097/00007691-197901000-00010; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Goff DC, 2008, NEUROPSYCHOPHARMACOL, V33, P465, DOI 10.1038/sj.npp.1301444; Greene R, 2001, HIPPOCAMPUS, V11, P569, DOI 10.1002/hipo.1072.abs; Grove SJA, 2010, J MED CHEM, V53, P7271, DOI 10.1021/jm1000419; Harrison PJ, 2003, ANN NY ACAD SCI, V1003, P94, DOI 10.1196/annals.1300.006; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Heckers S, 2010, CURR TOP BEHAV NEURO, V4, P529, DOI 10.1007/7854_2010_43; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; HERKES GK, 1993, J CLIN NEUROPHYSIOL, V10, P210, DOI 10.1097/00004691-199304000-00008; Hirano S, 2008, J NEUROSCI, V28, P4897, DOI 10.1523/JNEUROSCI.5031-07.2008; HOFFMAN RE, 1989, SCHIZOPHRENIA BULL, V15, P477, DOI 10.1093/schbul/15.3.477; HOFFMAN RE, 1987, ARCH GEN PSYCHIAT, V44, P178; Hoffman RE, 2003, KAPLAN SADOCKS SYNOP; JOHANSEN TH, 1995, MOL PHARMACOL, V48, P946; KILPATRICK CJ, 1984, BRIT J CLIN PHARMACO, V17, P539, DOI 10.1111/j.1365-2125.1984.tb02387.x; Kissler J, 2000, CLIN NEUROPHYSIOL, V111, P2079, DOI 10.1016/S1388-2457(00)00425-9; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lampl I, 1998, J PHARMACOL EXP THER, V284, P228; Law AJ, 2004, AM J PSYCHIAT, V161, P1848, DOI 10.1176/appi.ajp.161.10.1848; Law AJ, 2001, NEUROREPORT, V12, P2971, DOI 10.1097/00001756-200109170-00043; Lewis DA, 2008, AM J PSYCHIAT, V165, P1585, DOI 10.1176/appi.ajp.2008.08030395; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Lisman J, 2012, CURR OPIN NEUROBIOL, V22, P537, DOI 10.1016/j.conb.2011.10.018; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Sannita WG, 1999, NEUROPSYCHOBIOLOGY, V40, P158, DOI 10.1159/000026614; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Siekmeier PJ, 2007, SCHIZOPHR RES, V89, P177, DOI 10.1016/j.schres.2006.08.007; Siekmeier PJ, 2009, BEHAV BRAIN RES, V200, P220, DOI 10.1016/j.bbr.2009.01.021; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Stilo Simona A, 2010, Dialogues Clin Neurosci, V12, P305; Teale P, 2008, NEUROIMAGE, V42, P1481, DOI 10.1016/j.neuroimage.2008.06.020; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Traub RD, 1995, J COMPUT NEUROSCI, V2, P291, DOI 10.1007/BF00961441; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VANWIERINGEN A, 1989, NEUROPSYCHOBIOLOGY, V21, P157, DOI 10.1159/000118570; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wang XJ, 2006, PHARMACOPSYCHIATRY, V39, pS80, DOI 10.1055/s-2006-931501	73	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58607	10.1371/journal.pone.0058607	http://dx.doi.org/10.1371/journal.pone.0058607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526999	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100032
J	Perez-Madrid, A; Lapas, LC; Rubi, JM				Perez-Madrid, Agustin; Lapas, Luciano C.; Miguel Rubi, J.			A Thermokinetic Approach to Radiative Heat Transfer at the Nanoscale	PLOS ONE			English	Article								Radiative heat exchange at the nanoscale presents a challenge for several areas due to its scope and nature. Here, we provide a thermokinetic description of microscale radiative energy transfer including phonon-photon coupling manifested through a non-Debye relaxation behavior. We show that a lognormal-like distribution of modes of relaxation accounts for this non-Debye relaxation behavior leading to the thermal conductance. We also discuss the validity of the fluctuation-dissipation theorem. The general expression for the thermal conductance we obtain fits existing experimental results with remarkable accuracy. Accordingly, our approach offers an overall explanation of radiative energy transfer through micrometric gaps regardless of geometrical configurations and distances.	[Perez-Madrid, Agustin; Miguel Rubi, J.] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Catalunya, Spain; [Lapas, Luciano C.] Univ Fed Integracao, Inst Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil	University of Barcelona	Perez-Madrid, A (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Catalunya, Spain.	agustiperezmadrid@ub.edu; luciano.lapas@pq.cnpq.br; mrubi@ub.edu	Lapas, Luciano/F-8718-2012; Lapas, Luciano Calheiros/O-7628-2019; Lapas, Luciano/B-1581-2008	Lapas, Luciano/0000-0002-0029-5625; Lapas, Luciano Calheiros/0000-0002-0029-5625; Lapas, Luciano/0000-0002-0029-5625	MICINN of the Spanish Government [FIS2008-04386]; Fundacao Araucaria and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian Government; Generalitat de Catalunya	MICINN of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacao Araucaria and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian Government; Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by MICINN of the Spanish Government, under Grant No. FIS2008-04386, and by Fundacao Araucaria and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian Government. JMR acknowledges financial support from Generalitat de Catalunya under program ICREA Academia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2007, INT J ENERG RES, V31, P689, DOI 10.1002/er.1286; Biehs SA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.234301; CALLEN HB, 1951, PHYS REV, V83, P34, DOI 10.1103/PhysRev.83.34; Chumakov AI, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225501; de Groot S., 1984, NONEQUILIBRIUM THERM; Debye PJW, 1929, POLAR MOL; DENISOV YV, 1990, JETP LETT+, V52, P411; Domingues G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.085901; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GRAEBNER JE, 1986, PHYS REV B, V34, P5696, DOI 10.1103/PhysRevB.34.5696; LYNN JW, 1973, PHYS REV B, V8, P3493, DOI 10.1103/PhysRevB.8.3493; Morozhenko V., 2012, INFRARED RAD; Mulet JP, 2002, MICROSCALE THERM ENG, V6, P209, DOI 10.1080/10893950290053321; Pan JL, 2000, OPT LETT, V25, P369, DOI 10.1364/OL.25.000369; Pendry JB, 1999, J PHYS-CONDENS MAT, V11, P6621, DOI 10.1088/0953-8984/11/35/301; Perez-Madrid A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155417; Perez-Madrid A, 2010, J NON-EQUIL THERMODY, V35, P279, DOI 10.1515/JNETDY.2010.17; Perez-Madrid A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.048301; Planck M. K. E. L., 1991, THEORY HEAT RAD; POLDER D, 1971, PHYS REV B, V4, P3303, DOI 10.1103/PhysRevB.4.3303; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; RYTOV S. M., 1959, THEORY ELECT FLUCTUA; Sasihithlu K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.161406; Shen S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723713; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; Shintani H, 2008, NAT MATER, V7, P870, DOI 10.1038/nmat2293; Yager WA, 1936, PHYSICS-J GEN APPL P, V7, P434, DOI 10.1063/1.1745355; Zanatta M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.212201; Zhang Z.M., 2007, NANOMICROSCALE HEAT	29	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58770	10.1371/journal.pone.0058770	http://dx.doi.org/10.1371/journal.pone.0058770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527019	Green Published, Green Submitted, gold			2022-12-25	WOS:000316411600010
J	Nurena, CR; Brown, B; Galea, JT; Sanchez, H; Blas, MM				Nurena, Cesar R.; Brown, Brandon; Galea, Jerome T.; Sanchez, Hugo; Blas, Magaly M.			HPV and Genital Warts among Peruvian Men Who Have Sex with Men and Transgender People: Knowledge, Attitudes and Treatment Experiences	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SEXUALLY-TRANSMITTED INFECTIONS; QUALITY-OF-LIFE; ANOGENITAL WARTS; THE-LITERATURE; ANAL CANCER; HIV; PREVALENCE; BURDEN; IMPACT	Background: Several studies have assessed the epidemiology of HPV infection among MSM, but no qualitative studies have specifically assessed how HPV and genital warts (GW) affect South American men who have sex with men (MSM) and maleto-female transgendered women (TG). This study explored the knowledge, attitudes and experiences of Peruvian MSM and TG regarding HPV and GW. Methods: We performed a qualitative study consisting of fifteen in-depth interviews and three focus groups carried out in Lima, Peru with diverse MSM and TG groups, including sex workers. Resulting data were analyzed by applying a systematic comparative and descriptive content analysis. Results: While knowledge of HPV was limited, awareness of GW was common, particularly among TG persons and sex workers. Still, few participants recognized that GW are sexually transmitted, and many had problems differentiating between GW and other STI/anogenital conditions. Stigmatizing experiences were common during sexual encounters with people who had visible GW. Shame, emotional and physical troubles, and embarrassing sexual experiences were reported by individuals with GW. Search for treatment was mediated by peers, but stigma and apparent health services' inability to deal with GW limited the access to effective medical care. Conclusions: In Peru, public health interventions should strengthen services for HPV/GW management and increase accurate knowledge of the transmission, treatment, and sequelae of HPV/GW in MSM and TG populations.	[Nurena, Cesar R.] Univ Nacl Mayor San Marcos, Escuela Antropol, Lima 14, Peru; [Brown, Brandon] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA; [Galea, Jerome T.; Sanchez, Hugo] Epicentro, Lima, Peru; [Blas, Magaly M.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru	Universidad Nacional Mayor de San Marcos; University of California System; University of California Irvine; Universidad Peruana Cayetano Heredia	Brown, B (corresponding author), Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA.	brandojb@uci.edu	Galea, Jerome T./AAF-2172-2019; Galea, Jerome T/HGV-0203-2022	Galea, Jerome T./0000-0001-8732-6959; Galea, Jerome T/0000-0001-8732-6959; Nurena, Cesar R./0000-0002-3290-7948; Brown, Brandon/0000-0002-6348-4108	NIH [T32 MH080634]; FIC/NIH [1R01TW008398]; UCLA AIDS Institute International Travel grant; Merck Investigator-Initiated Studies Program of Merck Co Inc.; FOGARTY INTERNATIONAL CENTER [R01TW008398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIC/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); UCLA AIDS Institute International Travel grant; Merck Investigator-Initiated Studies Program of Merck Co Inc.; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded, in part, by NIH grant T32 MH080634, FIC/NIH grant 1R01TW008398 to Magaly Blas, and the UCLA AIDS Institute International Travel grant. Supported in part by a research grant from the Merck Investigator-Initiated Studies Program of Merck & Co Inc. The opinions expressed in this paper are of the authors and do not necessarily represent those of Merck & Co Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badia Xavier, 2005, Health Qual Life Outcomes, V3, P24, DOI 10.1186/1477-7525-3-24; Baer H, 2000, J COMMUN HEALTH, V25, P67, DOI 10.1023/A:1005192902137; Bertram CC, 2008, AM J HEALTH EDUC, V39, P15, DOI 10.1080/19325037.2008.10599009; Blackwell CW, 2011, J ASSOC NURSE AIDS C, V22, P444, DOI 10.1016/j.jana.2011.08.004; Blas MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027334; Brewer NT, 2010, J BEHAV MED, V33, P274, DOI 10.1007/s10865-010-9251-2; Brown B, 2012, VIRUSES-BASEL, V4, P3851, DOI 10.3390/v4123851; Brown B, 2010, VACCINE, V28, P7743, DOI 10.1016/j.vaccine.2010.09.063; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Colon-Lopez V, 2010, P R HEALTH SCI J, V29, P232; Cuschieri KS, 2006, J MED SCREEN, V13, P201, DOI 10.1177/096914130601300408; Dediol I, 2009, J EUR ACAD DERMATOL, V23, P1035, DOI 10.1111/j.1468-3083.2009.03242.x; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Gorbach P, 2007, QUALITATIVE METHODS, P447; Hammarlund K, 2007, INT J MENS HLTH, V6, P100; Ireland JA, 2005, INT J STD AIDS, V16, P667, DOI 10.1258/095646205774357334; Jeynes C, 2009, INT J STD AIDS, V20, P557, DOI 10.1258/ijsa.2008.008412; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Klug SJ, 2008, PREV MED, V46, P87, DOI 10.1016/j.ypmed.2007.09.003; Lee Mortensen Gitte, 2010, BMC Res Notes, V3, P280, DOI 10.1186/1756-0500-3-280; Malta M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-18; Maw RD, 1998, INT J STD AIDS, V9, P571, DOI 10.1258/0956462981921143; Mortensen GL, 2010, DAN MED BULL, V57; Mortensen GL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-113; Nurena CR, 2011, CULT HEALTH SEX, V13, P1207, DOI 10.1080/13691058.2011.609908; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pitts MK, 2007, SEX TRANSM DIS, V34, P170, DOI 10.1097/01.olq.0000230436.83029.ce; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Salazar Ximena, 2006, Cad. Saúde Pública, V22, P2097, DOI 10.1590/S0102-311X2006001000015; Sanchez DM, 2012, INT J STD AIDS, V23, P41, DOI 10.1258/ijsa.2011.011163; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Skaaby S, 2011, INT J STD AIDS, V22, P214, DOI 10.1258/ijsa.2011.010372; Tider DS, 2005, INT J STD AIDS, V16, P707, DOI 10.1258/095646205774357389; Woodhall S, 2008, SEX TRANSM INFECT, V84, P161, DOI 10.1136/sti.2007.029512	38	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58684	10.1371/journal.pone.0058684	http://dx.doi.org/10.1371/journal.pone.0058684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516536	Green Published, gold			2022-12-25	WOS:000316407400049
J	Taib, N; Mangot, JF; Domaizon, I; Bronner, G; Debroas, D				Taib, Najwa; Mangot, Jean-Francois; Domaizon, Isabelle; Bronner, Gisele; Debroas, Didier			Phylogenetic Affiliation of SSU rRNA Genes Generated by Massively Parallel Sequencing: New Insights into the Freshwater Protist Diversity	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SMALL EUKARYOTES; DEEP-SEA; ENVIRONMENTAL SURVEYS; MOLECULAR DIVERSITY; MAXIMUM-LIKELIHOOD; MARINE ECOSYSTEMS; TROPHIC STATUS; COMMUNITY; RARE	Recent advances in next-generation sequencing (NGS) technologies spur progress in determining the microbial diversity in various ecosystems by highlighting, for example, the rare biosphere. Currently, high-throughput pyrotag sequencing of PCR-amplified SSU rRNA gene regions is mainly used to characterize bacterial and archaeal communities, and rarely to characterize protist communities. In addition, although taxonomic assessment through phylogeny is considered as the most robust approach, similarity and probabilistic approaches remain the most commonly used for taxonomic affiliation. In a first part of this work, a tree-based method was compared with different approaches of taxonomic affiliation (BLAST and RDP) of 18S rRNA gene sequences and was shown to be the most accurate for near full-length sequences and for 400 bp amplicons, with the exception of amplicons covering the V5-V6 region. Secondly, the applicability of this method was tested by running a full scale test using an original pyrosequencing dataset of 18S rRNA genes of small lacustrine protists (0.2-5 mu m) from eight freshwater ecosystems. Our results revealed that i) fewer than 5% of the operational taxonomic units (OTUs) identified through clustering and phylogenetic affiliation had been previously detected in lakes, based on comparison to sequence in public databases; ii) the sequencing depth provided by the NGS coupled with a phylogenetic approach allowed to shed light on clades of freshwater protists rarely or never detected with classical molecular ecology approaches; and iii) phylogenetic methods are more robust in describing the structuring of under-studied or highly divergent populations. More precisely, new putative clades belonging to Mamiellophyceae, Foraminifera, Dictyochophyceae and Euglenida were detected. Beyond the study of protists, these results illustrate that the tree-based approach for NGS based diversity characterization allows an in-depth description of microbial communities including taxonomic profiling, community structuring and the description of clades of any microorganisms (protists, Bacteria and Archaea).	[Taib, Najwa; Mangot, Jean-Francois; Bronner, Gisele; Debroas, Didier] Univ Clermont Ferrand 2, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Taib, Najwa; Mangot, Jean-Francois; Bronner, Gisele; Debroas, Didier] CNRS, LMGE, UMR 6023, Aubiere, France; [Mangot, Jean-Francois; Domaizon, Isabelle] INRA, UMR CARRTEL 42, Thonon Les Bains, France; [Mangot, Jean-Francois; Domaizon, Isabelle] Univ Savoie, UMR CARRTEL 42, Le Bourget Du Lac, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); INRAE; Universite de Savoie	Debroas, D (corresponding author), Univ Clermont Ferrand 2, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, BP 10448, Clermont Ferrand, France.	Didier.Debroas@univ-bpclermont.fr	Domaizon, Isabelle/A-2517-2011; Mangot, Jean-François/A-8918-2010	Domaizon, Isabelle/0000-0001-9785-3082; Mangot, Jean-François/0000-0002-6225-8889; Bronner, Gisele/0000-0002-4863-4518	Le sonseil regional d'auvergne	Le sonseil regional d'auvergne	Funding came from Le sonseil regional d'auvergne "http://www.conseil-general.com/conseil-regional/conseil-regional-auvergne.htm". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Alverson AJ, 2005, J PHYCOL, V41, P1248, DOI 10.1111/j.1529-8817.2005.00136.x; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; De Leon KB, 2012, MICROB ECOL, V64, P499, DOI 10.1007/s00248-012-0043-9; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Groisillier A, 2006, AQUAT MICROB ECOL, V42, P277, DOI 10.3354/ame042277; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartman AL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-317; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Holzmann M, 2003, J EUKARYOT MICROBIOL, V50, P135, DOI 10.1111/j.1550-7408.2003.tb00248.x; Hugenholtz P, 2002, GENOME BIOL, V3; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005; Lepere C, 2006, APPL ENVIRON MICROB, V72, P2971, DOI 10.1128/AEM.72.4.2971-2981.2006; Lepere C, 2008, APPL ENV MICROBIOLOG; Lepere C, 2007, FEMS MICROBIOL ECOL, V61, P483, DOI 10.1111/j.1574-6941.2007.00359.x; Lepere C, 2010, ISME J, V4, P1509, DOI 10.1038/ismej.2010.83; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Mangot JF, 2011, HYDROBIOLOGIA, V659, P37, DOI 10.1007/s10750-010-0268-x; Marin B, 2010, PROTIST, V161, P304, DOI 10.1016/j.protis.2009.10.002; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Mori H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-332; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Core Team, 2012, R LANG ENV STAT COMP; Rasconi S, 2011, AQUAT MICROB ECOL, V62, P123, DOI 10.3354/ame01448; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Tarbe AL, 2011, AQUAT MICROB ECOL, V62, P177, DOI 10.3354/ame01465; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 1999, NUCLEIC ACIDS RES, V27, P179, DOI 10.1093/nar/27.1.179; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DM, 2008, HEREDITY, V100, P207, DOI 10.1038/sj.hdy.6801011; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	80	70	71	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58950	10.1371/journal.pone.0058950	http://dx.doi.org/10.1371/journal.pone.0058950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516585	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400082
J	Tsai, CA; Liu, LYD				Tsai, Chen-An; Liu, Li-Yu Daisy			Identifying Gene Set Association Enrichment Using the Coefficient of Intrinsic Dependence	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; KYOTO ENCYCLOPEDIA; TARGET GENES; CANCER; PATHWAY; KEGG	Gene set testing problem has become the focus of microarray data analysis. A gene set is a group of genes that are defined by a priori biological knowledge. Several statistical methods have been proposed to determine whether functional gene sets express differentially (enrichment and/or deletion) in variations of phenotypes. However, little attention has been given to analyzing the dependence structure among gene sets. In this study, we have proposed a novel statistical method of gene set association analysis to identify significantly associated gene sets using the coefficient of intrinsic dependence. The simulation studies show that the proposed method outperforms the conventional methods to detect general forms of association in terms of control of type I error and power. The correlation of intrinsic dependence has been applied to a breast cancer microarray dataset to quantify the un-supervised relationship between two sets of genes in the tumor and non-tumor samples. It was observed that the existence of gene-set association differed across various clinical cohorts. In addition, a supervised learning was employed to illustrate how gene sets, in signaling transduction pathways or subnetworks regulated by a set of transcription factors, can be discovered using microarray data. In conclusion, the coefficient of intrinsic dependence provides a powerful tool for detecting general types of association. Hence, it can be useful to associate gene sets using microarray expression data. Through connecting relevant gene sets, our approach has the potential to reveal underlying associations by drawing a statistically relevant network in a given population, and it can also be used to complement the conventional gene set analysis.	[Tsai, Chen-An; Liu, Li-Yu Daisy] Natl Taiwan Univ, Dept Agron, Div Biometr, Taipei, Taiwan	National Taiwan University	Liu, LYD (corresponding author), Natl Taiwan Univ, Dept Agron, Div Biometr, Taipei, Taiwan.	lyliu@ntu.edu.tw		Tsai, Chen-An/0000-0002-7490-4331; Liu, Li-yu/0000-0001-6997-8101	National Science of Council, Taiwan [NSC 101-2118-M-002-005, NSC99-2118-M-002-004]	National Science of Council, Taiwan	This study was supported by National Science of Council grants (NSC 101-2118-M-002-005 to Dr. CA Tsai and NSC99-2118-M-002-004 to Dr. LYD Liu), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, HDB METHODS APPL STA; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bellman R., 1961, ADAPTIVE CONTROL PRO; Cover T.M., 2005, ELEMENTS INFORM THEO, DOI 10.1002/047174882x.ch2; FRIEDMAN JH, 1981, J AM STAT ASSOC, V76, P817, DOI 10.2307/2287576; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fung DCY, 2011, METHODS MOL BIOL, V781, P311, DOI 10.1007/978-1-61779-276-2_15; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hsing TL, 2005, PATTERN RECOGN, V38, P623, DOI 10.1016/j.patcog.2004.09.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung J-H, 2011, BRIEFINGS BIOINFORMA; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Jung JH, 2010, MOL CELLS, V29, P449, DOI 10.1007/s10059-010-0055-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Lee Eunjee, 2007, BMC Proc, V1 Suppl 1, pS90; LEURGANS SE, 1993, J ROY STAT SOC B MET, V55, P725; Liese F, 2008, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-73194-0_1; Liu L-YD, 2005, THESIS TEXAS A M U C; Liu LYD, 2012, CANCER INFORM, V11, P87, DOI 10.4137/CIN.S8633; Liu LYD, 2012, CANCER INFORM, V11, P113, DOI 10.4137/CIN.S8470; Liu LYD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-85; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nasser S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Stephens M.A., 1986, GOODNESS OF FIT TECH, DOI DOI 10.1201/9780203753064-4; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Todd AT, 2010, PLANT J, V62, P589, DOI 10.1111/j.1365-313X.2010.04186.x; Ziegler S, 2005, FEBS J, V272, P1600, DOI 10.1111/j.1742-4658.2005.04581.x	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58851	10.1371/journal.pone.0058851	http://dx.doi.org/10.1371/journal.pone.0058851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516564	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400068
J	Kohaya, N; Fujiwara, K; Ito, J; Kashiwazaki, N				Kohaya, Natsuki; Fujiwara, Katsuyoshi; Ito, Junya; Kashiwazaki, Naomi			Generation of Live Offspring from Vitrified Mouse Oocytes of C57BL/6J Strain	PLOS ONE			English	Article							HIGHLY EFFICIENT VITRIFICATION; SUCCESSFUL CRYOPRESERVATION; PREIMPLANTATION DEVELOPMENT; EMBRYOS; FERTILIZATION; SURVIVAL; ZYGOTES; INVITRO; FROZEN; TRANSGENESIS	In mammals, unfertilized oocytes are one of the most available stages for cryopreservation because the cryopreserved oocytes can be used for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection. However, it has generally been reported that the fertility and developmental ability of the oocytes are reduced by cryopreservation. C57BL/6J mice, an inbred strain, are used extensively for the production of transgenic and knockout mice. If the oocytes from C57BL/6J mice can be successfully cryopreserved, the cryopreservation protocol used will contribute to the high-speed production of not only gene-modified mice but also hybrid mice. Very recently, we succeeded in the vitrification of mouse oocytes derived from ICR (outbred) mice. However, our protocol can be applied to the vitrification of oocytes from an inbred strain. The aim of the present study was to establish the vitrification of oocytes from C57BL/6J mice. First, the effect of cumulus cells on the ability of C57BL/6J mouse oocytes to fertilize and develop in vitro was examined. The fertility and developmental ability of oocyte-removed cumulus cells (i.e., denuded oocytes, or DOs) after IVF were reduced compared to cumulus oocyte complexes (COCs) in both fresh and cryopreserved groups. Vitrified COCs showed significantly (P<0.05) higher fertility and ability to develop into the 2-cell and blastocyst stages compared to the vitrified DOs with cumulus cells and vitrified DOs alone. The vitrified COCs developed to term at a high success rate, equivalent to the rate obtained with IVF using fresh COCs. Taken together, our results demonstrate that we succeeded for the first time in the vitrification of mouse oocytes from C57BL/6J mice. Our findings will also contribute to the improvement of oocyte vitrification not only in animals but also in clinical applications for human infertility.	[Kohaya, Natsuki; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Lab Anim Reprod, Sagamihara, Kanagawa, Japan; [Fujiwara, Katsuyoshi; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Sagamihara, Kanagawa, Japan	Azabu University; Azabu University	Ito, J (corresponding author), Azabu Univ, Sch Vet Med, Lab Anim Reprod, Sagamihara, Kanagawa, Japan.	itoj@azabu-u.ac.jp			JSPS (KAKENHI) [21780253, 22658085]; Azabu University Research Services Division; Grants-in-Aid for Scientific Research [12J10249] Funding Source: KAKEN	JSPS (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Azabu University Research Services Division; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS (KAKENHI, 21780253 to J.I. and 22658085 to N.K.). This research was partially supported by a research project grant awarded by the Azabu University Research Services Division to J.I. and N.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2005, BIOL REPROD, V72, P1416, DOI 10.1095/biolreprod.104.037051; ALHASANI S, 1989, HUM REPROD, V4, P77; Brown SDM, 1998, HUM MOL GENET, V7, P1627, DOI 10.1093/hmg/7.10.1627; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Endoh K, 2007, J REPROD DEVELOP, V53, P1199, DOI 10.1262/jrd.19058; Eroglu A, 2009, BIOL REPROD, V80, P70, DOI 10.1095/biolreprod.108.070383; FUKU E, 1992, CRYOBIOLOGY, V29, P485, DOI 10.1016/0011-2240(92)90051-3; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Hochi S, 2004, THERIOGENOLOGY, V61, P267, DOI 10.1016/S0093-691X(03)00232-2; Hochi S, 2003, J REPROD DEVELOP, V49, P13; Ito J, 2010, J REPROD ENG, V13, P21; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Katayama KP, 2003, FERTIL STERIL, V80, P223, DOI 10.1016/S0015-0282(03)00551-X; Kohaya N, 2011, J REPROD DEVELOP, V57, P675, DOI 10.1262/jrd.11-066H; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Kuwayama M, 2008, FERTIL STERIL, V90, P281; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Lane M, 1999, FERTIL STERIL, V72, P1073, DOI 10.1016/S0015-0282(99)00418-5; Liu Y, 2008, CRYOLETTERS, V29, P315; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; PALMITER RD, 1985, CELL, V41, P343, DOI 10.1016/S0092-8674(85)80004-0; Papis K, 2000, THERIOGENOLOGY, V54, P651, DOI 10.1016/S0093-691X(00)00380-0; Park SE, 2001, FERTIL STERIL, V75, P1177, DOI 10.1016/S0015-0282(01)01809-X; PARKENING TA, 1977, BIOL REPROD, V17, P527, DOI 10.1095/biolreprod17.4.527; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; RALL WF, 1987, CRYOBIOLOGY, V24, P387, DOI 10.1016/0011-2240(87)90042-3; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanchez-Partida LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021597; Seita Y, 2009, CRYOBIOLOGY, V59, P226, DOI 10.1016/j.cryobiol.2009.07.007; Sheehan CB, 2006, HUM REPROD, V21, P2978, DOI 10.1093/humrep/del253; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; TAKESHIMA T, 1991, EXP ANIM TOKYO, V40, P493, DOI 10.1538/expanim1978.40.4_493; Tamba S, 2008, P NATL ACAD SCI USA, V105, P14539, DOI 10.1073/pnas.0805699105; Vajta G, 1997, ACTA VET SCAND, V38, P349; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; WHITTINGHAM DG, 1977, J REPROD FERTIL, V49, P89, DOI 10.1530/jrf.0.0490089; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	43	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58063	10.1371/journal.pone.0058063	http://dx.doi.org/10.1371/journal.pone.0058063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516430	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200030
J	Kumazawa-Manita, N; Hama, H; Miyawaki, A; Iriki, A				Kumazawa-Manita, Noriko; Hama, Hiroshi; Miyawaki, Atsushi; Iriki, Atsushi			Tool Use Specific Adult Neurogenesis and Synaptogenesis in Rodent (Octodon degus) Hippocampus	PLOS ONE			English	Article							SYNAPSIN-I; ENRICHED ENVIRONMENT; PREFRONTAL CORTEX; NEURONS; ACTIVATION; PROTEINS	We previously demonstrated that degus (Octodon degus), which are a species of small caviomorph rodents, could be trained to use a T-shaped rake as a hand tool to expand accessible spaces. To elucidate the neurobiological underpinnings of this higher brain function, we compared this tool use learning task with a simple spatial (radial maze) memory task and investigated the changes that were induced in the hippocampal neural circuits known to subserve spatial perception and learning. With the exposure to an enriched environment in home cage, adult neurogenesis in the dentate gyrus of the hippocampus was augmented by tool use learning, but not radial maze learning, when compared to control conditions. Furthermore, the proportion of new synapses formed in the CA3 region of the hippocampus, the target area for projections of mossy fiber axons emanating from newborn neurons, was specifically increased by tool use learning. Thus, active tool use behavior by rodents, learned through multiple training sessions, requires the hippocampus to generate more novel neurons and synapses than spatial information processing in radial maze learning.	[Kumazawa-Manita, Noriko; Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Hama, Hiroshi; Miyawaki, Atsushi] RIKEN Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan	RIKEN; RIKEN	Iriki, A (corresponding author), RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan.	iriki@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235	Funding Program for World-leading Innovative R&D on Science and Technology; JSPS, MEXT Japan	Funding Program for World-leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS, MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS, MEXT Japan, and the Funding Program for World-leading Innovative R&D on Science and Technology (AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00173; Akchiche N, 2010, HIPPOCAMPUS, V20, P949, DOI 10.1002/hipo.20690; Ambrogini P, 2010, HIPPOCAMPUS, V20, P799, DOI 10.1002/hipo.20679; ANDERSON JR, 1990, FOLIA PRIMATOL, V54, P138, DOI 10.1159/000156437; Baber C, 2006, APPL ERGON, V37, P3, DOI 10.1016/j.apergo.2005.06.004; Bernabeu R, 2000, J CEREBR BLOOD F MET, V20, P1669, DOI 10.1097/00004647-200012000-00006; Bluff LA, 2010, P ROY SOC B-BIOL SCI, V277, P1377, DOI 10.1098/rspb.2009.1953; Braun K, 2001, NEUROSCIENCE, V103, P861, DOI 10.1016/S0306-4522(01)00074-4; Breuer T, 2005, PLOS BIOL, V3, P2041, DOI 10.1371/journal.pbio.0030380; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Cheke LG, 2011, ANIM COGN; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Clark PJ, 2012, HIPPOCAMPUS, V22, P1860, DOI 10.1002/hipo.22020; Dubreuil D, 2003, NEUROBIOL LEARN MEM, V79, P109, DOI 10.1016/S1074-7427(02)00023-0; ELFERINK LA, 1993, J CELL SCI, P75; Epp JR, 2011, NEUROBIOL LEARN MEM, V95, P316, DOI 10.1016/j.nlm.2011.01.001; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; HAYASHI T, 1994, CELL STRUCT FUNCT, V19, P253, DOI 10.1247/csf.19.253; Helmeke C, 2009, NEUROSCIENCE, V163, P790, DOI 10.1016/j.neuroscience.2009.07.008; Iriki A, 1996, NEUROREPORT, V7, P2325; Jacobs GH, 2003, J COMP PHYSIOL A, V189, P347, DOI 10.1007/s00359-003-0408-0; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Markakis EA, 1999, J COMP NEUROL, V406, P449; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; MELLONI RH, 1993, J COMP NEUROL, V327, P507, DOI 10.1002/cne.903270404; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mustroph ML, 2012, NEUROSCIENCE, V219, P62, DOI 10.1016/j.neuroscience.2012.06.007; Okanoya K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001860; Pechstein Arndt, 2010, Front Synaptic Neurosci, V2, P143, DOI 10.3389/fnsyn.2010.00143; Poeggel G, 1996, BRAIN RES, V743, P162, DOI 10.1016/S0006-8993(96)01039-6; Poeggel G, 2005, J NEUROBIOL, V62, P42, DOI 10.1002/neu.20070; Poeggel G, 2003, NEUROSCIENCE, V116, P617, DOI 10.1016/S0306-4522(02)00751-0; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; Thomsen LR, 2007, ANIM COGN, V10, P477, DOI 10.1007/s10071-007-0075-6	42	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58649	10.1371/journal.pone.0058649	http://dx.doi.org/10.1371/journal.pone.0058649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516527	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200101
J	Lericollais, R; Gauthier, A; Bessot, N; Zouabi, A; Davenne, D				Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien			Morning Anaerobic Performance Is Not Altered by Vigilance Impairment	PLOS ONE			English	Article							NIGHTS SLEEP-DEPRIVATION; BREAKFAST INTAKE PRIOR; PHYSICAL PERFORMANCE; CIRCADIAN-RHYTHM; CORE TEMPERATURE; WAKING TIME; MUSCLE; EXERCISE; POWER; PSYCHOMOTOR	The aim of this study was to determine the role played by vigilance on the anaerobic performance recorded during a Wingate test performed at the bathyphase (nadir) of the circadian rhythmicity. Twenty active male participants performed a 60-s Wingate test at 6 a. m. during 3 test sessions in counter-balanced order the day after either (i) a normal reference night, (ii) a total sleep deprivation night, or (iii) a total sleep deprivation night associated with an extended simulated driving task from 9 p.m. to 5 a.m. During this task, the number of inappropriate line crossings (ILCs) was used to control and quantify the effective decrease in the level of vigilance. The main findings show that (i) vigilance of each participant was significantly altered (i.e., a drastic and progressive increase in ILCs is shown during the 7.5 hours of driving) by the sleep deprivation night associated with an extended driving task; (ii) the subjective evaluation of vigilance performed by self-rated scale revealed an increased impairment of the vigilance level between the normal reference night, the total sleep deprivation night and the total sleep deprivation night associated with an extended driving task; and (iii) the morning following this last condition, during the Wingate test, the recorded cycling biomechanical parameters (peak power, mean power and fatigue index values, power decrease, and cycling kinetic and kinematic patterns) were not significantly different from the two other conditions. Consequently, these results show that anaerobic performances recorded during a Wingate test performed at the bathyphase of the circadian rhythmicity are not altered by a drastic impairment in vigilance. These findings seem to indicate that vigilance is probably not a factor that contributes to circadian variations in anaerobic performance.	[Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien] Normandie Univ, Caen, France; [Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien] UniCaen, Unite Rech COMETE, Caen, France; [Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien] INSERM, Unite Rech COMETE U1075, Caen, France; [Lericollais, Romain] CHU Caen, Dept Clin Physiol, F-14000 Caen, France	Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie	Davenne, D (corresponding author), Normandie Univ, Caen, France.	damien.davenne@unicaen.fr	Davenne, Damien/K-2959-2015; Bessot, Nicolas/O-2265-2015; bessot, nicolas/AFQ-7881-2022; Davenne, Damien/K-2432-2019	Davenne, Damien/0000-0002-9399-9970; Davenne, Damien/0000-0002-9399-9970; Bessot, Nicolas/0000-0002-0587-2022	French Ministry of Higher Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); French National Agency for Research (ANR) (VIGISIM) [0566C0136]	French Ministry of Higher Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); French National Agency for Research (ANR) (VIGISIM)(French National Research Agency (ANR))	This study was funded by the French Ministry of Higher Education and Research (Ministere de l'Enseignement Superieur et de la Recherche) and a small part of a grant from the French National Agency for Research (ANR) (VIGISIM; No. 0566C0136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Bessot N, 2007, J ELECTROMYOGR KINES, V17, P176, DOI 10.1016/j.jelekin.2006.01.007; Bini RR, 2010, J ELECTROMYOGR KINES, V20, P102, DOI 10.1016/j.jelekin.2008.10.003; Bougard C, 2009, CHRONOBIOL INT, V26, P324, DOI 10.1080/07420520902774540; Bougard C, 2009, CHRONOBIOL INT, V26, P307, DOI 10.1080/07420520902774532; Brisswalter J, 2007, CHRONOBIOL INT, V24, P495, DOI 10.1080/07420520701420691; Davenne D, 2012, ACCIDENT ANAL PREV, V45, P677, DOI 10.1016/j.aap.2011.09.046; DAVENNE D, 1995, MED SCI RES, V23, P767; Dorel S, 2009, SCAND J MED SCI SPOR, V19, P44, DOI 10.1111/j.1600-0838.2007.00765.x; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 2004, SLEEP, V27, P445; Gauthier A, 1996, CHRONOBIOL INT, V13, P135, DOI 10.3109/07420529609037077; Hill DW, 1994, J SPORT SCI, V12, P455, DOI 10.1080/02640419408732195; HILL DW, 1991, CAN J SPORT SCI, V16, P30; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Lericollais R, 2011, SCAND J MED SCI SPOR, V21, pE106, DOI 10.1111/j.1600-0838.2010.01172.x; Lericollais R, 2009, CHRONOBIOL INT, V26, P1622, DOI 10.3109/07420520903534492; Lim CL, 2008, ANN ACAD MED SINGAP, V37, P347; Martin JC, 2009, J BIOMECH, V42, P474, DOI 10.1016/j.jbiomech.2008.11.015; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; McLester JR, 2004, J STRENGTH COND RES, V18, P816; MELHIM AF, 1993, INT J SPORTS MED, V14, P303, DOI 10.1055/s-2007-1021182; Meney I, 1998, CHRONOBIOL INT, V15, P349, DOI 10.3109/07420529808998695; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nicolas A, 2005, CHRONOBIOL INT, V22, P997, DOI 10.1080/07420520500397892; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Peveler WW, 2007, J STRENGTH COND RES, V21, P1023; Portaluppi F, 2008, CHRONOBIOL INT, V25, P999, DOI 10.1080/07420520802544530; Raasch CC, 1999, J NEUROPHYSIOL, V82, P515, DOI 10.1152/jn.1999.82.2.515; Racinais S, 2005, CHRONOBIOL INT, V22, P1029, DOI 10.1080/07420520500397918; REILLY T, 1983, J HUM MOVEMENT STUD, V9, P157; RODGERS CD, 1995, SLEEP, V18, P30, DOI 10.1093/sleep/18.1.30; Sagaspe P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003493; SHEPHARD RJ, 1984, SPORTS MED, V1, P11, DOI 10.2165/00007256-198401010-00003; Souissi N, 2004, INT J SPORTS MED, V25, P14; Souissi N, 2003, EUR J APPL PHYSIOL, V89, P359, DOI 10.1007/s00421-003-0793-7; Souissi N, 2007, CHRONOBIOL INT, V24, P739, DOI 10.1080/07420520701535811; SYMONS JD, 1988, CAN J SPORT SCI, V13, P225; SYMONS JD, 1988, MED SCI SPORT EXER, V20, P374, DOI 10.1249/00005768-198808000-00008; VANDEWALLE H, 1987, SPORTS MED, V4, P268, DOI 10.2165/00007256-198704040-00004; Wakeling JM, 2009, J NEUROPHYSIOL, V101, P843, DOI 10.1152/jn.90679.2008; Waterhouse J, 2005, CHRONOBIOL INT, V22, P207, DOI 10.1081/CBI-200053477; WITHERS RT, 1991, EUR J APPL PHYSIOL, V63, P354, DOI 10.1007/BF00364462; WITHERS RT, 1993, EUR J APPL PHYSIOL O, V67, P185, DOI 10.1007/BF00376665	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58638	10.1371/journal.pone.0058638	http://dx.doi.org/10.1371/journal.pone.0058638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516522	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200097
J	Liu, X; Pei, XH; Li, NS; Zhang, YN; Zhang, X; Chen, JX; Lv, LS; Ma, HJ; Wu, XM; Zhao, WH; Lou, TQ				Liu, Xun; Pei, Xiaohua; Li, Ningshan; Zhang, Yunong; Zhang, Xiang; Chen, Jinxia; Lv, Linsheng; Ma, Huijuan; Wu, Xiaoming; Zhao, Weihong; Lou, Tanqi			Improved Glomerular Filtration Rate Estimation by an Artificial Neural Network	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CKD-EPI EQUATION; SERUM CREATININE; PREDICTION; PREVALENCE; VALIDATION; MODEL; GAMMA; MDRD; RISK	Background: Accurate evaluation of glomerular filtration rates (GFRs) is of critical importance in clinical practice. A previous study showed that models based on artificial neural networks (ANNs) could achieve a better performance than traditional equations. However, large-sample cross-sectional surveys have not resolved questions about ANN performance. Methods: A total of 1,180 patients that had chronic kidney disease (CKD) were enrolled in the development data set, the internal validation data set and the external validation data set. Additional 222 patients that were admitted to two independent institutions were externally validated. Several ANNs were constructed and finally a Back Propagation network optimized by a genetic algorithm (GABP network) was chosen as a superior model, which included six input variables; i.e., serum creatinine, serum urea nitrogen, age, height, weight and gender, and estimated GFR as the one output variable. Performance was then compared with the Cockcroft-Gault equation, the MDRD equations and the CKD-EPI equation. Results: In the external validation data set, Bland-Altman analysis demonstrated that the precision of the six-variable GABP network was the highest among all of the estimation models; i.e., 46.7 ml/min/1.73 m(2) vs. a range from 71.3 to 101.7 ml/min/1.73 m(2), allowing improvement in accuracy (15% accuracy, 49.0%; 30% accuracy, 75.1%; 50% accuracy, 90.5% [P<0.001 for all]) and CKD stage classification (misclassification rate of CKD stage, 32.4% vs. a range from 47.3% to 53.3% [P<0.001 for all]). Furthermore, in the additional external validation data set, precision and accuracy were improved by the six-variable GABP network. Conclusions: A new ANN model (the six-variable GABP network) for CKD patients was developed that could provide a simple, more accurate and reliable means for the estimation of GFR and stage of CKD than traditional equations. Further validations are needed to assess the ability of the ANN model in diverse populations.	[Liu, Xun; Chen, Jinxia; Ma, Huijuan; Lou, Tanqi] Sun Yat Sen Univ, Dept Internal Med, Div Nephrol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Xun; Li, Ningshan; Wu, Xiaoming] S China Univ Technol, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Pei, Xiaohua; Zhao, Weihong] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Div Nephrol, Nanjing, Jiangsu, Peoples R China; [Li, Ningshan] Chengdu Int Canc Treatment Hosp, Dept Radiat Oncol, Chengdu, Peoples R China; [Zhang, Yunong] Sun Yat Sen Univ, Sch Informat Sci & Technol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xiang] JieYang Peoples Hosp, Dept Internal Med, Jieyang, Peoples R China; [Lv, Linsheng] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology; Nanjing Medical University; Sun Yat Sen University; Sun Yat Sen University	Wu, XM (corresponding author), S China Univ Technol, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	bmxmwus@scut.edu.cn; zhaoweihong_1@medmail.com.cn; naturestyle@163.com		Li, Ningshan/0000-0003-1916-2563	National Natural Science Foundation of China [81070612]; China Postdoctoral Science Foundation [201104335]; Guangdong Science and Technology Plan [2011B031800084]; Fundamental Research Funds for the Central Universities [11ykpy38]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	Project 81070612 supported by National Natural Science Foundation of China. This work was also supported by the China Postdoctoral Science Foundation (Grant No. 201104335), Guangdong Science and Technology Plan (Grant No. 2011B031800084), the Fundamental Research Funds for the Central Universities (Grant No. 11ykpy38) and the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant No. 2011BAI10B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxt WG, 1996, LANCET, V347, P12, DOI 10.1016/S0140-6736(96)91555-X; Botev R, 2011, CLIN J AM SOC NEPHRO, V6, P937, DOI 10.2215/CJN.09241010; Carlsen O, 2004, NUCL MED COMMUN, V25, P1021, DOI 10.1097/00006231-200410000-00006; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Du X, 2012, NEPHROLOGY, V17, P407, DOI 10.1111/j.1440-1797.2012.01568.x; Du X, 2011, RENAL FAILURE, V33, P859, DOI 10.3109/0886022X.2011.605533; Dybowski R, 1996, LANCET, V347, P1146, DOI 10.1016/S0140-6736(96)90609-1; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Emoto T, 2012, PHYSIOL MEAS, V33, P1675, DOI 10.1088/0967-3334/33/10/1675; Gaweda AE, 2008, AM J KIDNEY DIS, V51, P71, DOI 10.1053/j.ajkd.2007.10.003; Goldfarb-Rumyantzev AS, 2002, AM J KIDNEY DIS, V40, P252, DOI 10.1053/ajkd.2002.34503; Guh JY, 1998, AM J KIDNEY DIS, V31, P638, DOI 10.1053/ajkd.1998.v31.pm9531180; Hagan MT., 1997, NEURAL NETWORK DESIG; Hu K, 2012, J ENVIRON SCI HEAL A, V47, P744, DOI 10.1080/10934529.2012.660102; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu X, 2012, INTERN MED J, V42, pe59, DOI 10.1111/j.1445-5994.2010.02398.x; Liu Xun, 2012, Proceedings of the 2012 International Conference on Computer Science and Electronics Engineering (ICCSEE 2012), P334, DOI 10.1109/ICCSEE.2012.104; Liu Xun, 2010, 2010 International Conference on Computer Application and System Modeling (ICCASM 2010), P332, DOI 10.1109/ICCASM.2010.5622616; Magosso E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042503; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Seguritan V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002657; Shi H, 2012, DIABETES TECHNOL THE, V14, P293, DOI 10.1089/dia.2011.0071; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tong DL, 2011, ARTIF INTELL MED, V53, P47, DOI 10.1016/j.artmed.2011.06.008; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Xie FB, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-11; Young J, 2012, J ACOUST SOC AM, V132, P3234, DOI 10.1121/1.4754556; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	36	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58242	10.1371/journal.pone.0058242	http://dx.doi.org/10.1371/journal.pone.0058242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516450	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200043
J	Tiukova, IA; Petterson, ME; Tellgren-Roth, C; Bunikis, I; Eberhard, T; Pettersson, OV; Passoth, V				Tiukova, Ievgeniia A.; Petterson, Mats E.; Tellgren-Roth, Christian; Bunikis, Ignas; Eberhard, Thomas; Pettersson, Olga Vinnere; Passoth, Volkmar			Transcriptome of the Alternative Ethanol Production Strain Dekkera bruxellensis CBS 11270 in Sugar Limited, Low Oxygen Cultivation	PLOS ONE			English	Article							BUDDING YEAST TRANSCRIPTOME; SACCHAROMYCES-CEREVISIAE; BRETTANOMYCES-BRUXELLENSIS; ALDEHYDE DEHYDROGENASES; ANAEROBIC CONDITIONS; HEXOSE TRANSPORTERS; GENE-EXPRESSION; PICHIA-STIPITIS; HXT GENES; GENOME	Dekkera bruxellensis can outcompete Saccharomyces cerevisiae in environments with low sugar concentrations. It is usually regarded as a spoilage yeast but has lately been identified as an alternative ethanol production organism. In this study, global gene expression in the industrial isolate D. bruxellensis CBS 11270 under oxygen and glucose limitation was investigated by whole transcriptome sequencing using the AB SOLiD technology. Among other observations, we noted expression of respiratory complex I NADH-ubiquinone reductase although D. bruxellensis is a Crabtree positive yeast. The observed higher expression of NADH-generating enzymes compared to NAD(+)-generating enzymes might be the reason for the previously observed NADH imbalance and resulting Custer effect in D. bruxellensis. Low expression of genes involved in glycerol production is probably the molecular basis for high efficiency of D. bruxellensis metabolism under nutrient limitation. No D. bruxellensis homologs to the genes involved in the final reactions of glycerol biosynthesis were detected. A high number of expressed sugar transporter genes is consistent with the hypothesis that the competitiveness of D. bruxellensis is due to a higher affinity for the limiting substrate.	[Tiukova, Ievgeniia A.; Eberhard, Thomas; Passoth, Volkmar] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Microbiol, Uppsala, Sweden; [Petterson, Mats E.] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Anim Breeding & Genet, Uppsala, Sweden; [Tellgren-Roth, Christian; Bunikis, Ignas; Pettersson, Olga Vinnere] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Rudbeck Lab,Uppsala Genome Ctr, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University	Passoth, V (corresponding author), Swedish Univ Agr Sci, Uppsala Bioctr, Dept Microbiol, Uppsala, Sweden.	Volkmar.Passoth@slu.se	Passoth, Volkmar/AFP-0775-2022; Pettersson, Mats E/E-4523-2011; Pettersson, Olga Vinnere/AAD-3212-2021	Passoth, Volkmar/0000-0002-2059-9044; Tellgren-Roth, Christian/0000-0003-0502-3693; Vinnere Pettersson, Olga/0000-0002-5597-1870	Swedish Energy Authority (Statens Energimyndigheten, STEM) [34134-1]; Research program MicroDrivE at the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; RFI/VR "SNISS" (Swedish National Infrastructure for large Scale Sequencing and Science for Life Laboratory) Uppsala	Swedish Energy Authority (Statens Energimyndigheten, STEM); Research program MicroDrivE at the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; RFI/VR "SNISS" (Swedish National Infrastructure for large Scale Sequencing and Science for Life Laboratory) Uppsala	This study has been supported by the Swedish Energy Authority (Statens Energimyndigheten, STEM), project number 34134-1 and the Research program MicroDrivE at the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences. Work performed at Uppsala Genome Center has been funded by RFI/VR "SNISS" (Swedish National Infrastructure for large Scale Sequencing and Science for Life Laboratory) Uppsala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist J, 2011, LETT APPL MICROBIOL, V53, P73, DOI 10.1111/j.1472-765X.2011.03067.x; Blomqvist J, 2012, YEAST, V29, P265, DOI 10.1002/yea.2904; Blomqvist J, 2010, APPL MICROBIOL BIOT, V87, P1487, DOI 10.1007/s00253-010-2619-y; Conterno L, 2006, AM J ENOL VITICULT, V57, P139; Curtin CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033840; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Pita WD, 2011, ANTON LEEUW INT J G, V100, P99, DOI 10.1007/s10482-011-9568-z; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Fiaux J, 2003, EUKARYOT CELL, V2, P170, DOI 10.1128/EC.2.1.170-180.2003; Fredlund E, 2004, APPL ENVIRON MICROB, V70, P5905, DOI 10.1128/AEM.70.10.5905-5911.2004; Galafassi S, 2011, J IND MICROBIOL BIOT, V38, P1079, DOI 10.1007/s10295-010-0885-4; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Greatrix BW, 2006, CURR GENET, V49, P205, DOI 10.1007/s00294-005-0046-x; Ito T, 2008, IUBMB LIFE, V60, P775, DOI 10.1002/iub.121; Martens H, 1997, J I BREWING, V103, P85, DOI 10.1002/j.2050-0416.1997.tb00939.x; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; NEIGEBORN L, 1984, GENETICS, V108, P845; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Passoth V, 1996, APPL BIOCHEM BIOTECH, V57-8, P201, DOI 10.1007/BF02941701; Passoth V, 2007, APPL ENVIRON MICROB, V73, P4354, DOI 10.1128/AEM.00437-07; Piskur J, 2012, INT J FOOD MICROBIOL, V157, P202, DOI 10.1016/j.ijfoodmicro.2012.05.008; Prochazka E, 2010, FEMS YEAST RES, V10, P545, DOI 10.1111/j.1567-1364.2010.00644.x; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Rintala E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-53; SCHEFFER.WA, 1966, NATURE, V210, P533, DOI 10.1038/210533a0; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Shah T, 2006, GENE, V366, P104, DOI 10.1016/j.gene.2005.08.011; Silva P, 2004, AM J ENOL VITICULT, V55, P65; SMITH MT, 1990, YEAST, V6, P299, DOI 10.1002/yea.320060403; Tessier WD, 1998, FEMS MICROBIOL LETT, V164, P29, DOI 10.1111/j.1574-6968.1998.tb13063.x; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang XP, 1997, ADV EXP MED BIOL, V414, P277; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Xue YT, 2004, YEAST, V21, P25, DOI 10.1002/yea.1053; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	43	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58455	10.1371/journal.pone.0058455	http://dx.doi.org/10.1371/journal.pone.0058455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516483	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200069
J	Lund, TC; Kobs, AJ; Kramer, A; Nyquist, M; Kuroki, MT; Osborn, J; Lidke, DS; Low-Nam, ST; Blazar, BR; Tolar, J				Lund, Troy C.; Kobs, Amanda J.; Kramer, Ashley; Nyquist, Mick; Kuroki, Marcos T.; Osborn, John; Lidke, Diane S.; Low-Nam, Shalini T.; Blazar, Bruce R.; Tolar, Jakub			Bone Marrow Stromal and Vascular Smooth Muscle Cells Have Chemosensory Capacity via Bitter Taste Receptor Expression	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MILK-PROTEINS; TRANSDUCTION; PRESSURE; SWEET; BLOOD; BUDS	The ability of cells to detect changes in the microenvironment is important in cell signaling and responsiveness to environmental fluctuations. Our interest is in understanding how human bone marrow stromal-derived cells (MSC) and their relatives, vascular smooth muscle cells (VSMC), interact with their environment through novel receptors. We found, through a proteomics screen, that MSC express the bitter taste receptor, TAS2R46, a protein more typically localized to the taste bud. Expression was also confirmed in VSMCs. A prototypical bitter compound that binds to the bitter taste receptor class, denatonium, increased intracellular calcium release and decreased cAMP levels as well as increased the extracellular release of ATP in human MSC. Denatonium also bound and activated rodent VSMC with a change in morphology upon compound exposure. Finally, rodents given denatonium in vivo had a significant drop in blood pressure indicating a vasodilator response. This is the first description of chemosensory detection by MSC and VSMCs via a taste receptor. These data open a new avenue of research into discovering novel compounds that operate through taste receptors expressed by cells in the marrow and vascular microenvironments.	[Lund, Troy C.; Kobs, Amanda J.; Kramer, Ashley; Nyquist, Mick; Blazar, Bruce R.; Tolar, Jakub] Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA; [Kuroki, Marcos T.; Osborn, John] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Lidke, Diane S.; Low-Nam, Shalini T.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Lidke, Diane S.; Low-Nam, Shalini T.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of New Mexico; University of New Mexico	Lund, TC (corresponding author), Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA.	lundx072@umn.edu		Kuroki, Marcos/0000-0001-7343-2873; Tolar, Jakub/0000-0002-0957-4380				Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Deshpande DA, 2010, NATURE MED; Faroni A, 2011, J NEUROSCI RES, V89, P1351, DOI 10.1002/jnr.22652; GALMICHE MC, 1993, BLOOD, V82, P66, DOI 10.1182/blood.V82.1.66.bloodjournal82166; Hoogduijn MJ, 2009, STEM CELLS DEV, V18, P103, DOI 10.1089/scd.2008.0032; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2010, J PHYSIOL-LONDON, V588, P2343, DOI 10.1113/jphysiol.2010.191106; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; Ishimaru Y, 2009, ODONTOLOGY, V97, P1, DOI 10.1007/s10266-008-0095-y; Kim UK, 2004, J DENT RES, V83, P448, DOI 10.1177/154405910408300603; Kinnamon SC, 2009, ANN NY ACAD SCI, V1170, P55, DOI 10.1111/j.1749-6632.2009.04106.x; Kinnamon SC, 2009, SCIENCE, V325, P1081, DOI 10.1126/science.1179180; Lindemann B, 1996, CURR BIOL, V6, P1234, DOI 10.1016/S0960-9822(96)00704-X; Lund TC, 2008, HAEMATOLOGICA, V93, P908, DOI 10.3324/haematol.12384; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meisel H, 1999, ANTON LEEUW INT J G, V76, P207, DOI 10.1023/A:1002063805780; Palmer RK, 2007, MOL INTERV, V7, P87, DOI 10.1124/mi.7.2.9; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; SCHLIMME E, 1995, NAHRUNG, V39, P1, DOI 10.1002/food.19950390102; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Slack J. P., 2010, CURR BIOL; Veitenheimer B, 2011, AM J PHYSIOL-REG I, V300, pR460, DOI 10.1152/ajpregu.00371.2010; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Zhang Y, 2010, NEUROSCIENCE, V169, P1421, DOI 10.1016/j.neuroscience.2010.05.021	29	46	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58945	10.1371/journal.pone.0058945	http://dx.doi.org/10.1371/journal.pone.0058945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520545	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900105
J	Quan, QK; Wang, J; Li, X; Wang, Y				Quan, QianKun; Wang, Jue; Li, Xi; Wang, Yi			Ginsenoside Rg1 Decreases A beta(1-42) Level by Upregulating PPAR gamma and IDE Expression in the Hippocampus of a Rat Model of Alzheimer's Disease	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; AMYLOID-BETA-PEPTIDE; A-BETA; TRANSGENIC MICE; IN-VITRO; BRAIN; PROTECTS; ROSIGLITAZONE; PIOGLITAZONE; NEPRILYSIN	Background and Purpose: The present study was designed to examine the effects of ginsenoside Rg1 on expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) and insulin-degrading enzyme (IDE) in the hippocampus of rat model of Alzheimer's disease (AD) to determine how ginsenoside Rg1 (Rg1) decreases A beta levels in AD. Experimental Approach: Experimental AD was induced in rats by a bilateral injection of 10 mg soluble beta-amyloid peptide 1-42 (A beta(1-42)) into the CA1 region of the hippocampus, and the rats were treated with Rg1 (10 mg.kg(-1), intraperitoneally) for 28 days. The Morris water maze was used to test spatial learning and memory performance. Hematoxylin-eosin staining was performed to analyze the hippocampal histopathological damage. Immunohistochemistry, western blotting, and realtime PCR were used to detect A beta(1-42), PPAR gamma, and insulin-degrading enzyme (IDE) expression in the hippocampus. Key Results: Injection of soluble A beta(1-42) into the hippocampus led to significant dysfunction of learning and memory, hippocampal histopathological abnormalities and increased A beta(1-42) levels in the hippocampus. Rg1 treatment significantly improved learning and memory function, attenuated hippocampal histopathological abnormalities, reduced A beta(1-42) levels and increased PPAR gamma and IDE expression in the hippocampus; these effects of Rg1 could be effectively inhibited by GW9662, a PPAR gamma antagonist. Conclusions and Implications: Given that PPAR gamma can upregulate IDE expression and IDE can degrade A beta(1-42), these results indicate that Rg1 can increase IDE expression in the hippocampus by upregulating PPAR gamma, leading to decreased A beta levels, attenuated hippocampal histopathological abnormalities and improved learning and memory in a rat model of AD.	[Quan, QianKun; Wang, Jue; Wang, Yi] Xi An Jiao Tong Univ, Natl Engn Res Ctr Hlth Care & Med Devices, Xian Jiaotong Univ Branch, Key Lab Biomed Informat Engn,Minist Educ,Sch Life, Xian 710049, Peoples R China; [Quan, QianKun; Wang, Jue; Wang, Yi] Xi An Jiao Tong Univ, Natl Engn Res Ctr Hlth Care & Med Devices, Xian Jiaotong Univ Branch, Inst Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Li, Xi] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Geriatr, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, J (corresponding author), Xi An Jiao Tong Univ, Natl Engn Res Ctr Hlth Care & Med Devices, Xian Jiaotong Univ Branch, Key Lab Biomed Informat Engn,Minist Educ,Sch Life, Xian 710049, Peoples R China.	juewang@mail.xjtu.edu.cn	Wang, Jue/GVU-0480-2022		National Natural Science Foundation of China [81071150, 30670660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81071150 and 30670660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Aubert RE, 2010, DIABETES OBES METAB, V12, P716, DOI 10.1111/j.1463-1326.2010.01225.x; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Dorfman VB, 2010, NEUROBIOL AGING, V31, P1743, DOI 10.1016/j.neurobiolaging.2008.09.016; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Chen YB, 2009, NEURAL REGEN RES, V4, P590, DOI 10.3969/j.issn.1673-5374.2009.08.005; Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Gong L, 2011, PHARM BIOL, V49, P501, DOI 10.3109/13880209.2010.521514; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Kumar A, 2007, PHARMACOL REP, V59, P274; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Logroscino G, 2004, BMJ-BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Luo DZ, 2011, EUR J PHARMACOL, V664, P14, DOI 10.1016/j.ejphar.2011.04.045; Marr RA, 2003, J NEUROSCI, V23, P1992; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; Ni HX, 2010, MOL BIOL REP, V37, P2975, DOI 10.1007/s11033-009-9864-0; Peila R, 2004, NEUROLOGY, V63, P228, DOI 10.1212/01.WNL.0000129989.28404.9B; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Rosi S, 2005, NEUROSCIENCE, V134, P671, DOI 10.1016/j.neuroscience.2005.04.029; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Shi YQ, 2010, J ALZHEIMERS DIS, V19, P977, DOI 10.3233/JAD-2010-1296; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tucker HM, 2000, J NEUROSCI, V20, P3937; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Vepsalainen S, 2008, NEUROSCI LETT, V438, P216, DOI 10.1016/j.neulet.2008.04.025; Wang AT, 2010, ANN INTERN MED, V153, DOI 10.7326/0003-4819-153-12-201012210-02011; Wang YJ, 2010, BRAIN BEHAV IMMUN, V24, P1281, DOI 10.1016/j.bbi.2010.05.010; Wang YH, 2009, J ASIAN NAT PROD RES, V11, P604, DOI 10.1080/10286020902843152; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Yamaguchi Y, 1997, EUR J PHARMACOL, V329, P37, DOI 10.1016/S0014-2999(97)10115-7; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001; Zhou J, 2011, BRAIN RES, V1388, P141, DOI 10.1016/j.brainres.2011.02.064; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	52	61	74	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59155	10.1371/journal.pone.0059155	http://dx.doi.org/10.1371/journal.pone.0059155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520555	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900115
J	Shibayama, J; Taylor, TG; Venable, PW; Rhodes, NL; Gil, RB; Warren, M; Wende, AR; Abel, ED; Cox, J; Spitzer, KW; Zaitsev, AV				Shibayama, Junko; Taylor, Tyson G.; Venable, Paul W.; Rhodes, Nathaniel L.; Gil, Ryan B.; Warren, Mark; Wende, Adam R.; Abel, E. Dale; Cox, James; Spitzer, Kenneth W.; Zaitsev, Alexey V.			Metabolic Determinants of Electrical Failure in Ex-Vivo Canine Model of Cardiac Arrest: Evidence for the Protective Role of Inorganic Pyrophosphate	PLOS ONE			English	Article							DURATION VENTRICULAR-FIBRILLATION; K-ATP CHANNEL; INHIBITION; ACTIVATION; HEART; POTASSIUM; ISCHEMIA; CARDIOMYOCYTES; OSCILLATIONS; ASYSTOLE	Rationale: Deterioration of ventricular fibrillation (VF) into asystole or severe bradycardia (electrical failure) heralds a fatal outcome of cardiac arrest. The role of metabolism in the timing of electrical failure remains unknown. Objective: To determine metabolic factors of early electrical failure in an Ex-vivo canine model of cardiac arrest (VF+global ischemia). Methods and Results: Metabolomic screening was performed in left ventricular biopsies collected before and after 0.3, 2, 5, 10 and 20 min of VF and global ischemia. Electrical activity was monitored via plunge needle electrodes and pseudo-ECG. Four out of nine hearts exhibited electrical failure at 10.1 +/- 0.9 min (early-asys), while 5/9 hearts maintained VF for at least 19.7 min (late-asys). As compared to late-asys, early-asys hearts had more ADP, less phosphocreatine, and higher levels of lactate at some time points during VF/ischemia (all comparisons p < 0.05). Pre-ischemic samples from late-asys hearts contained similar to 25 times more inorganic pyrophosphate (PPi) than early-asys hearts. A mechanistic role of PPi in cardioprotection was then tested by monitoring mitochondrial membrane potential (Delta Psi) during 20 min of simulated-demand ischemia using potentiometric probe TMRM in rabbit adult ventricular myocytes incubated with PPi versus control group. Untreated myocytes experienced significant loss of Delta Psi while in the PPi-treated myocytes DY was relatively maintained throughout 20 min of simulated-demand ischemia as compared to control (p < 0.05). Conclusions: High tissue level of PPi may prevent Delta Psi m loss and electrical failure at the early phase of ischemic stress. The link between the two protective effects may involve decreased rates of mitochondrial ATP hydrolysis and lactate accumulation.	[Shibayama, Junko; Taylor, Tyson G.; Venable, Paul W.; Rhodes, Nathaniel L.; Gil, Ryan B.; Warren, Mark; Spitzer, Kenneth W.; Zaitsev, Alexey V.] Univ Utah, Nora Eccles Harrison Cardiovascr Res & Training I, Salt Lake City, UT 84112 USA; [Wende, Adam R.; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Program Mol Med, Salt Lake City, UT USA; [Cox, James] Univ Utah, Metab Core Res Facil, Salt Lake City, UT USA; [Cox, James] Univ Utah, Dept Biochem, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zaitsev, AV (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovascr Res & Training I, Salt Lake City, UT 84112 USA.	zaitsev@cvrti.utah.edu	Wende, Adam/AFG-8878-2022	Wende, Adam/0000-0002-5536-4675; Taylor, Tyson/0000-0003-0116-0770; Abel, E. Dale/0000-0001-5290-0738; Zaitsev, Artem/0000-0002-2314-0482	NIH NRSA fellowship [5-F32-HL-097576]; NIH [5-R01-HL-088444, 5 R01 HL103877-02, 5R37HL0042873-24]; Nora Eccles Treadwell Foundation research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042873, F32HL097576, R01HL103877, R01HL088444] Funding Source: NIH RePORTER	NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nora Eccles Treadwell Foundation research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH NRSA fellowship 5-F32-HL-097576 (J.S.), NIH Grants 5-R01-HL-088444 (A.V.Z.), 5 R01 HL103877-02 (A.V.Z.) and 5R37HL0042873-24 (K.W.S.), and Nora Eccles Treadwell Foundation research grant (A.V.Z.).	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; Ayoub IM, 2007, CRIT CARE MED, V35, P2329, DOI 10.1097/01.CCM.0000280569.87413.74; Baker M, 2011, NAT METHODS, V8, P117, DOI 10.1038/nmeth0211-117; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Cross HR, 1996, CIRC RES, V78, P482, DOI 10.1161/01.RES.78.3.482; DAVIDSON AM, 1989, BIOCHEM J, V258, P817, DOI 10.1042/bj2580817; Gang UJO, 2010, EUROPACE, V12, P254, DOI 10.1093/europace/eup383; Ganitkevich V, 2010, J GEN PHYSIOL, V135, P307, DOI 10.1085/jgp.200910332; HALESTRAP AP, 1986, BIOCHEM J, V239, P559, DOI 10.1042/bj2390559; Hallstrom A, 2009, RESUSCITATION, V80, P975, DOI 10.1016/j.resuscitation.2009.05.019; Henry P, 1996, CARDIOVASC RES, V32, P930; Hong MY, 2011, FASEB J, V25, P2456, DOI 10.1096/fj.10-176669; JENNINGS RB, 1985, ANNU REV PHYSIOL, V47, P727, DOI 10.1146/annurev.ph.47.030185.003455; JENNINGS RB, 1981, CIRC RES, V49, P892, DOI 10.1161/01.RES.49.4.892; KEUNG EC, 1991, J CLIN INVEST, V88, P1772, DOI 10.1172/JCI115497; KOYANO T, 1993, J PHYSIOL-LONDON, V463, P747, DOI 10.1113/jphysiol.1993.sp019620; KUSUOKA H, 1992, CIRC RES, V71, P1111, DOI 10.1161/01.RES.71.5.1111; MANSUROVA SE, 1975, FEBS LETT, V55, P94, DOI 10.1016/0014-5793(75)80967-7; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; PEREIRADASILVA L, 1993, ARCH BIOCHEM BIOPHYS, V304, P310, DOI 10.1006/abbi.1993.1355; PEUHKURINEN KJ, 1983, AM J PHYSIOL, V244, pH281, DOI 10.1152/ajpheart.1983.244.2.H281; ROVETTO MJ, 1975, CIRC RES, V37, P742, DOI 10.1161/01.RES.37.6.742; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Tang WC, 2000, AM J PHYSIOL-HEART C, V279, pH1609, DOI 10.1152/ajpheart.2000.279.4.H1609; Taylor TG, 2012, AM J PHYSIOL-HEART C, V302, pH2396, DOI 10.1152/ajpheart.00752.2011; Taylor TG, 2011, CIRCULATION, V124; VANHEEL B, 1992, CARDIOVASC RES, V26, P1030, DOI 10.1093/cvr/26.11.1030; Venable PW, 2010, AM J PHYSIOL-HEART C, V299, pH1405, DOI 10.1152/ajpheart.00419.2010; Volonte MG, 2004, J PHARMACEUT BIOMED, V35, P647, DOI 10.1016/j.jpba.2004.02.002; Warren M, 2010, AM J PHYSIOL-HEART C, V299, pH1271, DOI 10.1152/ajpheart.00248.2010; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Wiggers CJ, 1930, AM HEART J, V5, P351, DOI 10.1016/S0002-8703(30)90334-1; WORLEY SJ, 1985, AM J CARDIOL, V55, P813, DOI 10.1016/0002-9149(85)90162-6; Xu HX, 2001, J BIOL CHEM, V276, P12898, DOI 10.1074/jbc.M009631200; Yi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034524; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57821	10.1371/journal.pone.0057821	http://dx.doi.org/10.1371/journal.pone.0057821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520482	Green Submitted, gold, Green Published			2022-12-25	WOS:000318679900041
J	Sung, M; Giannakakou, P				Sung, M.; Giannakakou, P.			BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling	ONCOGENE			English	Article						BRCA1; microtubule; dynamics; taxane; drug resistance	MESSENGER-RNA EXPRESSION; POSITIVE BREAST-CANCER; GAMMA-TUBULIN-BINDING; ADJUVANT CHEMOTHERAPY; NUCLEAR ACCUMULATION; TUMOR-SUPPRESSOR; SUPPORTIVE CARE; DOCETAXEL PLUS; PROTEIN; PACLITAXEL	The taxanes are effective microtubule-stabilizing chemotherapy drugs used in the treatment of various solid tumors. However, the emergence of drug resistance hampers their clinical efficacy. The molecular basis of clinical taxane resistance remains poorly understood. Breast cancer 1, early onset gene, BRCA1, is a tumor-suppressor gene, whose expression has been correlated with taxane sensitivity in many solid tumors including non-small cell lung cancer. However, the molecular mechanism underlying the relationship between BRCA1 (B1) expression and taxane activity remains unclear. To this end, we created a stable B1 knockdown A549 cell line (B1-KD) to investigate B1's role in microtubule biology and response to taxane treatment. We show that B1-KD rendered A549 cells resistant to paclitaxel (PTX), phenocopying clinical studies showing that low B1 expression correlated with taxane resistance. As previously reported, we show that loss of B1 enhanced centrosomal g-tubulin localization and microtubule nucleation. Interestingly, we found that the B1-KD cells exhibited increased microtubule dynamics as compared with parental A549 cells, as assessed by live-cell confocal microscopy using enhanced green fluorescent protein-tagged a-tubulin or EB1 protein. In addition, we showed that loss of B1 impairs the ability of PTX to induce microtubule polymerization using immunofluorescence microscopy and a cell-based tubulin polymerization assay. Furthermore, B1-KD cells exhibited significantly lower intracellular binding of a fluorescently labeled PTX to microtubules. Recent studies have shown that PTX-stabilized microtubules serves as a scaffold for pro-caspase-8 binding and induction of apoptosis downstream of induced-proximity activation of caspase-8. Here we show that loss of B1 reduces the association of pro-caspase-8 with microtubules and subsequently leads to impaired PTX-induced activation of apoptosis. Taken together, our data show that B1 regulates indirectly endogenous microtubule dynamics and stability while its loss leads to microtubules that are more dynamic and less susceptible to PTX-induced stabilization conferring taxane resistance.	[Sung, M.; Giannakakou, P.] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA	Cornell University	Giannakakou, P (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Med Oncol, 1300 York Ave,C610C, New York, NY 10065 USA.	pag2015@med.cornell.edu			National Institutes of Health [T32 CA062948, RO1 CA137020, NCI U54 CA143876]; NATIONAL CANCER INSTITUTE [R01CA137020, U54CA143876, T32CA062948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dr Geri Kreitzer (Weill Cornell Medical College), Dr Mary Ann Jordan (University of California, Santa Barbara) and Dr Richard Baer (Columbia University) for their kind gifts. We would also like to thank Dr Siddhartha Sen for help with the flow cytometry experiments. Work by Matthew Sung was supported by the National Institutes of Health (T32 CA062948, RO1 CA137020, NCI U54 CA143876).	Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Buzdar AU, 2002, CLIN CANCER RES, V8, P1073; Byrski T, 2008, BREAST CANCER RES TR, V108, P289, DOI 10.1007/s10549-007-9600-1; Carbonaro M, 2012, J BIOL CHEM, V287, P11859, DOI 10.1074/jbc.M112.345587; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Chen L, 2012, P NATL ACAD SCI USA, V109, P11842, DOI 10.1073/pnas.1121180109; Choy H, 1999, ONCOLOGY-NY, V13, P23; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Font A, 2011, ANN ONCOL, V22, P139, DOI 10.1093/annonc/mdq333; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hsu LC, 2001, CANCER RES, V61, P7713; Jin SQ, 2009, J BIOL CHEM, V284, P22970, DOI 10.1074/jbc.M109.009134; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kauh J, 2011, CANCER-AM CANCER SOC, V117, P4049, DOI 10.1002/cncr.26004; Komlodi-Pasztor E, 2011, NAT REV CLIN ONCOL, V8, DOI 10.1038/nrclinonc.2010.228-c2; Lynch HT, 2008, BREAST J, V14, P3, DOI 10.1111/j.1524-4741.2007.00515.x; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; Marcus AI, 2006, CANCER RES, V66, P8838, DOI 10.1158/0008-5472.CAN-06-0699; Marcus AI, 2005, CANCER RES, V65, P3883, DOI 10.1158/0008-5472.CAN-04-3757; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Martin M, 2010, NEW ENGL J MED, V363, P2200, DOI 10.1056/NEJMoa0910320; McAlpine JN, 2012, MODERN PATHOL, V25, P740, DOI 10.1038/modpathol.2011.211; Mielgo A, 2009, ONCOGENE, V28, P3551, DOI 10.1038/onc.2009.210; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Parvin JD, 2009, ENVIRON MOL MUTAGEN, V50, P649, DOI 10.1002/em.20475; PARYSEK LM, 1984, J CELL BIOL, V99, P1309, DOI 10.1083/jcb.99.4.1309; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Ranson M, 2000, JNCI-J NATL CANCER I, V92, P1074, DOI 10.1093/jnci/92.13.1074; Reguart N, 2008, CLIN LUNG CANCER, V9, P331, DOI 10.3816/CLC.2008.n.048; Rhiem K, 2010, ANTICANCER RES, V30, P3445; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Rosell R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005133; Roszkowski K, 2000, LUNG CANCER-J IASLC, V27, P145, DOI 10.1016/S0169-5002(00)00094-5; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; Saiki Y, 2011, INT J OTOLARYNGOL, V2011; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Schoffski P, 2011, EUR J CANCER, V47, P1006, DOI 10.1016/j.ejca.2011.01.016; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Wen YD, 2004, KENYON REV, V26, P1; WILSON L, 1995, CHEM BIOL, V2, P569, DOI 10.1016/1074-5521(95)90119-1; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	63	40	40	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1418	1428		10.1038/onc.2013.85	http://dx.doi.org/10.1038/onc.2013.85			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23524581	Green Accepted			2022-12-25	WOS:000332943500009
J	Lin, Y; Meng, Y; Wang, YX; Luo, J; Katsuma, S; Yang, CW; Banno, Y; Kusakabe, T; Shimada, T; Xia, QY				Lin, Ying; Meng, Yan; Wang, Yan-Xia; Luo, Juan; Katsuma, Susumu; Yang, Cong-Wen; Banno, Yutaka; Kusakabe, Takahiro; Shimada, Toru; Xia, Qing-You			Vitellogenin Receptor Mutation Leads to the Oogenesis Mutant Phenotype "scanty vitellin" of the Silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MOLECULAR CHARACTERIZATION; FIRE ANT; PROTEIN; LDL; YOLK; EXPRESSION; COCKROACH; CLONING; BINDING	In insects, the vitellogenin receptor (VgR) mediates the uptake of vitellogenin (Vg) from the hemolymph by developing oocytes. The oogenesis mutant scanty vitellin (vit) of Bombyx mori (Bm) lacks vitellin and 30-kDa proteins, but B. mori egg-specific protein and BmVg are normal. The vit eggs are white and smaller compared with the pale yellow eggs of the wild type and are embryonic lethal. This study found that a mutation in the B. mori VgR gene (BmVgR) is responsible for the vit phenotype. We cloned the cDNA sequences encoding WT and vit BmVgR. The functional domains of BmVgR are similar to those of other low-density lipoprotein receptors. When compared with the wild type, a 235-bp genomic sequence in vit BmVgR is substituted for a 7-bp sequence. This mutation has resulted in a 50-amino acid deletion in the third Class B region of the first epidermal growth factor (EGF1) domain. BmVgR is expressed specifically in oocytes, and the transcriptional level is changed dramatically and consistently with maturation of oocytes during the previtellogenic periods. Linkage analysis confirmed that BmVgR is mutated in the vit mutant. The coimmunoprecipitation assay confirmed that mutated BmVgR is able to bind BmVg but that BmVg cannot be dissociated under acidic conditions. The WT phenotype determined by RNA interference was similar to that of the vit phenotype for nutritional deficiency, such as BmVg and 30-kDa proteins. These results showed that BmVgR has an important role in transporting proteins for egg formation and embryonic development in B. mori.	[Lin, Ying; Wang, Yan-Xia; Luo, Juan; Yang, Cong-Wen; Xia, Qing-You] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Meng, Yan] Anhui Agr Univ, Sch Life Sci, Hefei 230036, Anhui, Peoples R China; [Meng, Yan; Katsuma, Susumu; Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Banno, Yutaka; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 8128581, Japan	Southwest University - China; Anhui Agricultural University; University of Tokyo; Kyushu University	Shimada, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	shimada@ss.ab.a.u-tokyo.ac.jp; xiaqy@swu.edu.cn	Meng, Yan/HGC-0394-2022; Shimada, Toru/A-2033-2011; meng, yan/GSE-2653-2022; Shimada, Toru/AAZ-2703-2021	Shimada, Toru/0000-0002-5791-0000; Shimada, Toru/0000-0002-5791-0000; Yang, Congwen/0000-0001-7865-7158	National Basic Research Program of China [2012CB114600]; Hi-Tech Research and Development Program of China [2011AA100306]; National Natural Science Foundation of China [31101768, 31172270]; Fundamental Research Funds for the Central Universities of China [XDJK2010C100]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Japan [21658017, 22128004]; Professional Program for Agricultural Bioinformatics from MEXT; Science and Technological Fund of Anhui Province for Outstanding Youth of China [10040606Y16]; Anhui Agricultural University Fund for Excellent Talents of China [yj2009-17]	National Basic Research Program of China(National Basic Research Program of China); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Professional Program for Agricultural Bioinformatics from MEXT; Science and Technological Fund of Anhui Province for Outstanding Youth of China; Anhui Agricultural University Fund for Excellent Talents of China	This work was supported by National Basic Research Program of China Grant 2012CB114600 (to Q. Y. X.), by Hi-Tech Research and Development Program of China Grant 2011AA100306 (to Q. Y. X.), by National Natural Science Foundation of China Grant 31101768 (to Y. L.), by Fundamental Research Funds for the Central Universities of China Grant XDJK2010C100 (to Y. L.), by Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Japan Grants-in-Aid for Scientific Research 21658017 and 22128004 (to T. S.), by the Professional Program for Agricultural Bioinformatics from MEXT (to T. S.), by National Natural Science Foundation of China Grant 31172270 (to Y. M.), by Science and Technological Fund of Anhui Province for Outstanding Youth of China Grant 10040606Y16 (to Y. M.), and by Anhui Agricultural University Fund for Excellent Talents of China Grant yj2009-17 (to Y. M.).	Boldbaatar D, 2008, BIOCHEM CELL BIOL, V86, P331, DOI [10.1139/O08-071, 10.1139/o08-071]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUJO H, 1995, P NATL ACAD SCI USA, V92, P9905, DOI 10.1073/pnas.92.21.9905; Chen ME, 2004, INSECT MOL BIOL, V13, P195, DOI 10.1111/j.0962-1075.2004.00477.x; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DHADIALLA TS, 1992, INSECT BIOCHEM MOLEC, V22, P803, DOI 10.1016/0965-1748(92)90107-P; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FERENZ HJ, 1993, INT J INSECT MORPHOL, V22, P295, DOI 10.1016/0020-7322(93)90016-T; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Fujikawa K, 1995, COMP BIOCHEM PHYS A, V112, P585, DOI 10.1016/0300-9629(95)02031-4; Fujikawa Kazuhiro, 2003, Journal of Insect Biotechnology and Sericology, V72, P111; Fujikawa Kazuhiro, 1993, Journal of Sericultural Science of Japan, V62, P286; Fujikawa Kazuhiro, 1996, Journal of Sericultural Science of Japan, V65, P145; Fujikawa Kazuhiro, 1993, Journal of Sericultural Science of Japan, V62, P88; Guidugli-Lazzarini KR, 2008, J INSECT PHYSIOL, V54, P1138, DOI 10.1016/j.jinsphys.2008.04.021; HIESBERGER T, 1995, J BIOL CHEM, V270, P18219, DOI 10.1074/jbc.270.31.18219; Innerarity TL, 2002, SCIENCE, V298, P2337, DOI 10.1126/science.1080669; Jeon H, 2003, STRUCTURE, V11, P133, DOI 10.1016/S0969-2126(03)00010-8; Kawaguchi Yutaka, 2008, Journal of Insect Biotechnology and Sericology, V77, P121; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Lin Ying, 2005, Acta Zoologica Sinica, V51, P117; Liu QN, 2011, B INSECTOL, V64, P167; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Meng Y, 2008, ARCH INSECT BIOCHEM, V67, P9, DOI 10.1002/arch.20214; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OGISO M, 1986, GEN COMP ENDOCR, V61, P82, DOI 10.1016/0016-6480(86)90252-2; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Reading BJ, 2011, BIOL REPROD, V84, P392, DOI 10.1095/biolreprod.110.087981; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Sappington TW, 2005, REPRO BIOL, V12, P229; Sappington TW, 1996, P NATL ACAD SCI USA, V93, P8934, DOI 10.1073/pnas.93.17.8934; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; SAPPINGTON TW, 1995, INSECT BIOCHEM MOLEC, V25, P807, DOI 10.1016/0965-1748(95)00016-O; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511, DOI 10.1091/mbc.11.2.511; Shu YH, 2011, INSECT MOL BIOL, V20, P61, DOI 10.1111/j.1365-2583.2010.01054.x; Snigirevskaya ES, 2005, REPRO BIOL, V12, P199; STIFANI S, 1990, P NATL ACAD SCI USA, V87, P1955, DOI 10.1073/pnas.87.5.1955; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tufail M, 2005, INSECT MOL BIOL, V14, P389, DOI 10.1111/j.1365-2583.2005.00570.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Tufail M, 2007, INSECT BIOCHEM MOLEC, V37, P235, DOI 10.1016/j.ibmb.2006.11.007; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Xu YingYing, 2012, African Journal of Agricultural Research, V7, P3166, DOI 10.5897/AJAR12.009; YAMASHITA O, 1980, NATURE, V283, P385, DOI 10.1038/283385a0; [No title captured]	55	59	65	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13345	13355		10.1074/jbc.M113.462556	http://dx.doi.org/10.1074/jbc.M113.462556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23515308	hybrid, Green Published			2022-12-25	WOS:000318850300020
J	Ahn, RW; Barrett, SL; Raja, MR; Jozefik, JK; Spaho, L; Chen, HM; Bally, MB; Mazar, AP; Avram, MJ; Winter, JN; Gordon, LI; Shea, LD; O'Halloran, TV; Woodruff, TK				Ahn, Richard W.; Barrett, Susan L.; Raja, Meera R.; Jozefik, Jennifer K.; Spaho, Lidia; Chen, Haimei; Bally, Marcel B.; Mazar, Andrew P.; Avram, Michael J.; Winter, Jane N.; Gordon, Leo I.; Shea, Lonnie D.; O'Halloran, Thomas V.; Woodruff, Teresa K.			Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PHASE-II TRIAL; ANTITUMOR-ACTIVITY; BREAST-CANCER; CELL LINES; FERTILITY; PHARMACOKINETICS; TOXICITY; MICE; PRESERVATION	Advances in cancer therapy have increased the rate of survival of young cancer patients; however, female lymphoma patients frequently face a temporary or permanent loss of fertility when treated with traditional cytotoxic agents. The potential loss of fertility is an important concern that can influence treatment decisions for many premenopausal cancer patients. The negative effect of chemotherapeutic agents and treatment protocols to patients' fertility-referred to as fertotoxicity-are thus an increasingly important cancer survivorship issue. We have developed a novel nanoscale formulation of arsenic trioxide, a potent drug for treatment of hematological malignancies, and demonstrate that it has significantly better activity in a murine lymphoma model than the free drug. In parallel, we have developed a novel in vitro assay of ovarian follicle function that predicts in vivo ovarian toxicity of therapeutic agents. Our results reveal that the nanotherapeutic agent is not only more active against lymphoma, but is fertoprotective, i.e., it is much less deleterious to ovarian function than the parent drug. Thus, our in vitro assay allows rapid evaluation of both established and experimental anticancer drugs on ovarian reserve and can inform the selection of efficacious and fertility-sparing treatment regimens for reproductive-age women diagnosed with cancer.	[Ahn, Richard W.; Raja, Meera R.; Chen, Haimei; Mazar, Andrew P.; O'Halloran, Thomas V.] Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60201 USA; [Ahn, Richard W.; Chen, Haimei; Mazar, Andrew P.; Avram, Michael J.; Winter, Jane N.; Gordon, Leo I.; O'Halloran, Thomas V.; Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [Barrett, Susan L.; Jozefik, Jennifer K.; Spaho, Lidia; Woodruff, Teresa K.] Northwestern Univ, Dept Obstet & Gynecol, Evanston, IL USA; [Barrett, Susan L.] Northwestern Univ, Ctr Reprod Sci, Reprod Biol Training Program, Evanston, IL USA; [Bally, Marcel B.] Univ British Columbia, Ctr Drug Res & Dev, Vancouver, BC V5Z 1M9, Canada; [Avram, Michael J.] Northwestern Univ, Feinberg Sch Med, Dept Anesthesiol, Chicago, IL 60611 USA; [Avram, Michael J.] Northwestern Univ, Feinberg Sch Med, Mary Beth Donnelley Clin Pharmacol Core Facil, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Winter, Jane N.; Gordon, Leo I.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Winter, Jane N.; Gordon, Leo I.] Northwestern Univ, Lymphoma Program, Feinberg Sch Med, Chicago, IL 60611 USA; [Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Bally, Marcel B.] BC Canc Agcy, Dept Adv Therapeut, Vancouver, BC, Canada	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University; University of British Columbia; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; British Columbia Cancer Agency	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60201 USA.	t-ohalloran@northwestern.edu; tkw@northwestern.edu	Avram, Michael/M-7681-2019; O'Halloran, Thomas/ABE-6125-2021; Shea, Lonnie D/B-7615-2009	O'Halloran, Thomas/0000-0001-8732-5059; Gordon, Leo/0000-0003-1666-7064; Ahn, Richard/0000-0001-6728-0009; Dague, Etienne/0000-0003-3290-9166; Woodruff, Teresa/0000-0002-1197-3399; Bally, Marcel/0000-0002-1994-4787; Winter, Jane/0000-0001-7542-3305	Oncofertility Consortium Grants National Institutes of Health (NIH) [RL1HD058295, PL1EB008542]; Reproductive Biology Training Grant [T32 HD07068]; NIH-NCI Cancer Nanotechnology Platform Partnerships [U01CA151461]; Center of Cancer Nanotechnology Excellence Grant [U54CA119341]; Northwestern University [P30CA060553];  [BC073413]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RL1HD058295, T32HD007068] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA151461, P30CA060553, U54CA119341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [PL1EB008542] Funding Source: NIH RePORTER	Oncofertility Consortium Grants National Institutes of Health (NIH); Reproductive Biology Training Grant; NIH-NCI Cancer Nanotechnology Platform Partnerships; Center of Cancer Nanotechnology Excellence Grant; Northwestern University; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Oncofertility Consortium Grants National Institutes of Health (NIH) RL1HD058295 and PL1EB008542 to TKW; Reproductive Biology Training Grant T32 HD07068; NIH-NCI Cancer Nanotechnology Platform Partnerships Grant U01CA151461 to TVO; Center of Cancer Nanotechnology Excellence Grant U54CA119341; and Core Grant P30CA060553 to the Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University (http://nih.gov/). RWA was a CDMRP Breast Cancer Research Program Predoctoral Fellow (Grant #BC073413, http://cdmrp.army.mil/) and Malkin Fellow of the RHLCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Sanjay K., 2007, V138, P15; Ahn RW, 2010, CLIN CANCER RES, V16, P3607, DOI 10.1158/1078-0432.CCR-10-0068; Bael TE, 2008, MELANOMA RES, V18, P147, DOI 10.1097/CMR.0b013e3282f2a7ae; Baljeyic M, 2011, HEMATOL ONCOL CLIN N, V25, P1215, DOI 10.1016/j.hoc.2011.10.002; Barrett SL, 2010, BIOL REPROD, V82, P1180, DOI 10.1095/biolreprod.109.082933; Bhalla S, 2010, BRIT J HAEMATOL, V150, P365, DOI 10.1111/j.1365-2141.2010.08197.x; Chen HM, 2006, J AM CHEM SOC, V128, P13348, DOI 10.1021/ja064864h; Chen H, 2009, MOL CANCER THER, V8, P1955, DOI 10.1158/1535-7163.MCT-09-0045; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; DIEHL V, 1981, J CANCER RES CLIN, V101, P111, DOI 10.1007/BF00405072; Dolniak B, 2008, J BIOL CHEM, V283, P12034, DOI 10.1074/jbc.M708816200; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552; Gracia Clarisa R., 2007, V138, P57; Griffin RJ, 2003, INT J HYPERTHER, V19, P575, DOI 10.1080/0265673031000124316; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Holson JF, 2000, FOOD CHEM TOXICOL, V38, P459, DOI 10.1016/S0278-6915(00)00015-6; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kchour G, 2009, BLOOD, V113, P6528, DOI 10.1182/blood-2009-03-211821; Kindler HL, 2008, AM J CLIN ONCOL-CANC, V31, P553, DOI 10.1097/COC.0b013e318178e4cd; Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016; Levine J, 2010, J CLIN ONCOL, V28, P4831, DOI 10.1200/JCO.2009.22.8312; Lu WL, 2004, J PHARMACOL SCI, V95, P381, DOI 10.1254/jphs.FPJ04001X; MAYHEW EG, 1992, INT J CANCER, V51, P302, DOI 10.1002/ijc.2910510221; Maziasz T, 2010, TOXICOL PATHOL, V38, P148, DOI 10.1177/0192623309356448; Miller WH, 2002, CANCER RES, V62, P3893; Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586; NILSSON K, 1977, INT J CANCER, V19, P337, DOI 10.1002/ijc.2910190309; Oktay K, 2008, CURR OPIN OBSTET GYN, V20, P408, DOI 10.1097/GCO.0b013e328307ebad; Partridge AH, 2004, J CLIN ONCOL, V22, P4174, DOI 10.1200/jco.2004.01.159; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Tallman MS, 2009, BLOOD, V114, P5126, DOI 10.1182/blood-2009-07-216457; Tucker CA, 2008, MOL CANCER THER, V7, P749, DOI 10.1158/1535-7163.MCT-07-0302; Vernaeve V, 2007, HUM REPROD, V22, P2863, DOI 10.1093/humrep/dem276; Walters KA, 2008, BIOL REPROD, V78, P380, DOI 10.1095/biolreprod.107.064089; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81; Xu M, 2011, BIOL REPROD, V84, P689, DOI 10.1095/biolreprod.110.088674	40	58	60	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58491	10.1371/journal.pone.0058491	http://dx.doi.org/10.1371/journal.pone.0058491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526987	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600024
J	Weiger, MC; Vedham, V; Stuelten, CH; Shou, KR; Herrera, M; Sato, M; Losert, W; Parent, CA				Weiger, Michael C.; Vedham, Vidya; Stuelten, Christina H.; Shou, Karen; Herrera, Mark; Sato, Misako; Losert, Wolfgang; Parent, Carole A.			Real-Time Motion Analysis Reveals Cell Directionality as an Indicator of Breast Cancer Progression	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; MIGRATION; INVASION; EXPRESSION; MODEL; BETA; MOTILITY; METASTASIS	Cancer cells alter their migratory properties during tumor progression to invade surrounding tissues and metastasize to distant sites. However, it remains unclear how migratory behaviors differ between tumor cells of different malignancy and whether these migratory behaviors can be utilized to assess the malignant potential of tumor cells. Here, we analyzed the migratory behaviors of cell lines representing different stages of breast cancer progression using conventional migration assays or time-lapse imaging and particle image velocimetry (PIV) to capture migration dynamics. We find that the number of migrating cells in transwell assays, and the distance and speed of migration in unconstrained 2D assays, show no correlation with malignant potential. However, the directionality of cell motion during 2D migration nicely distinguishes benign and tumorigenic cell lines, with tumorigenic cell lines harboring less directed, more random motion. Furthermore, the migratory behaviors of epithelial sheets observed under basal conditions and in response to stimulation with epidermal growth factor (EGF) or lysophosphatitic acid (LPA) are distinct for each cell line with regard to cell speed, directionality, and spatiotemporal motion patterns. Surprisingly, treatment with LPA promotes a more cohesive, directional sheet movement in lung colony forming MCF10CA1a cells compared to basal conditions or EGF stimulation, implying that the LPA signaling pathway may alter the invasive potential of MCF10CA1a cells. Together, our findings identify cell directionality as a promising indicator for assessing the tumorigenic potential of breast cancer cell lines and show that LPA induces more cohesive motility in a subset of metastatic breast cancer cells.	[Weiger, Michael C.; Vedham, Vidya; Stuelten, Christina H.; Shou, Karen; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Herrera, Mark; Losert, Wolfgang] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Sato, Misako] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Parent, CA (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	parentc@mail.nih.gov		Stuelten, Christina/0000-0002-2850-5399	Center for Cancer Research, NCI, National Institutes of Health; NIH [R01GM085574]; NATIONAL CANCER INSTITUTE [ZIABC011216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085574] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25871241] Funding Source: KAKEN	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health. WL acknowledges support by NIH grant R01GM085574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CJ, 2003, CANCER METAST REV, V22, P301, DOI 10.1023/A:1023726827771; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Dawson PJ, 1996, AM J PATHOL, V148, P313; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Ferrero JM, 2001, ANN ONCOL, V12, P841, DOI 10.1023/A:1011183421477; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Garcia R, 2006, CELL CYCLE, V5, P2820, DOI 10.4161/cc.5.23.3535; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harma V, 2012, ONCOGENE, V31, P2075, DOI 10.1038/onc.2011.396; Howlader N, 2011, SEER CANC STAT REV 1; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Komachi M, 2009, CARCINOGENESIS, V30, P457, DOI 10.1093/carcin/bgp011; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nie F, 2012, CANCER-AM CANCER SOC, V118, P5198, DOI 10.1002/cncr.27553; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Nnetu KD, 2012, SOFT MATTER, V8, P6913, DOI 10.1039/c2sm07208d; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Pradeep CR, 2012, ONCOGENE, V31, P3569, DOI 10.1038/onc.2011.547; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; ROSEN P, 1980, P NATL ACAD SCI-BIOL, V77, P4760, DOI 10.1073/pnas.77.8.4760; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; SOULE HD, 1990, CANCER RES, V50, P6075; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Stuelten CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009832; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Verbeek BS, 1998, FEBS LETT, V425, P145, DOI 10.1016/S0014-5793(98)00224-5; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302	66	46	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58859	10.1371/journal.pone.0058859	http://dx.doi.org/10.1371/journal.pone.0058859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527039	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562100052
J	Lin, YJ; Huang, LH; Huang, CT				Lin, Yu-Ju; Huang, Li-Hsin; Huang, Ching-Tsan			Enhancement of Heterologous Gene Expression in Flammulina velutipes Using Polycistronic Vectors Containing a Viral 2A Cleavage Sequence	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; MULTIPLE PROTEINS; MEDIATED TRANSFORMATION; SCHIZOPHYLLUM-COMMUNE; AGARICUS-BISPORUS; COPRINUS-CINEREUS; GPD PROMOTER; POLYPROTEIN; INTRONS; PEPTIDE	Agrobacterium tumefaciens-mediated transformation for edible mushrooms has been previously established. However, the enhancement of heterologous protein production and the expression of multi-target genes remains a challenge. In this study, heterologous protein expression in the enoki mushroom Flammulina velutipes was notably enhanced using 2A peptide-mediated cleavage to co-express multiple copies of single gene. The polycistronic expression vectors were constructed by connecting multi copies of the enhanced green fluorescent protein (egfp) gene using 2A peptides derived from porcine teschovirus-1. The P2A peptides properly self-cleaved as shown by the formation of the transformants with antibiotic resistant capacity and exciting green fluorescence levels after introducing the vectors into F. velutipes mycelia. The results of western blot analysis, epifluorescent microscopy and EGFP production showed that heterologous protein expression in F. velutipes using the polycistronic strategy increased proportionally as the gene copy number increased from one to three copies. In contrast, much lower EGFP levels were detected in the F. velutipes transformants harboring four copies of the egfp gene due to mRNA instability. The polycistronic strategy using 2A peptide-mediated cleavage developed in this study can not only be used to express single gene in multiple copies, but also to express multiple genes in a single reading frame. It is a promising strategy for the application of mushroom molecular pharming.	[Lin, Yu-Ju; Huang, Li-Hsin; Huang, Ching-Tsan] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	National Taiwan University	Huang, CT (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	cthuang@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013; Huang, Ching-Tsan/B-5359-2009	Huang, Ching-Tsan/0000-0003-1019-784X; Huang, Li-Hsin/0000-0003-4593-9268; Lin, Yu Ju/0000-0001-9911-0602	National Science Council ROC [NSC99-2313-B-002-033-MY3]	National Science Council ROC(Ministry of Science and Technology, Taiwan)	The financial support of the National Science Council of the ROC (Grant No. NSC99-2313-B-002-033-MY3) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Burns C, 2005, FUNGAL GENET BIOL, V42, P191, DOI 10.1016/j.fgb.2004.11.005; Chang SW, 2006, J AGR FOOD CHEM, V54, P815, DOI 10.1021/jf052183k; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Cheng SJ, 2009, BIORESOURCE TECHNOL, V100, P4475, DOI 10.1016/j.biortech.2009.04.021; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Ding Y, 2011, MICROBIOL RES, V166, P314, DOI 10.1016/j.micres.2010.07.001; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Horn ME, 2004, PLANT CELL REP, V22, P711, DOI 10.1007/s00299-004-0767-1; Hu T, 2009, BIOTECHNOL LETT, V31, P353, DOI 10.1007/s10529-008-9882-3; Kilaru S, 2006, APPL MICROBIOL BIOT, V71, P200, DOI 10.1007/s00253-005-0128-1; Kuo CY, 2010, BOT STUD, V51, P303; Kuo CY, 2004, APPL MICROBIOL BIOT, V65, P593, DOI 10.1007/s00253-004-1635-1; Lugones LG, 1999, MOL MICROBIOL, V32, P681, DOI 10.1046/j.1365-2958.1999.01373.x; Okamoto T, 2010, BIOSCI BIOTECH BIOCH, V74, P2327, DOI 10.1271/bbb.100398; Park S, 2009, BIOTECHNOL LETT, V31, P911, DOI 10.1007/s10529-009-9951-2; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Scholtmeijer K, 2001, APPL ENVIRON MICROB, V67, P481, DOI 10.1128/AEM.67.1.481-483.2001; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Zeng QD, 2001, TRENDS GENET, V17, P682, DOI 10.1016/S0168-9525(01)02498-2	35	16	19	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59099	10.1371/journal.pone.0059099	http://dx.doi.org/10.1371/journal.pone.0059099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516605	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400093
J	Rath, T; Hage, L; Kugler, M; Menendez, KM; Zachoval, R; Naehrlich, L; Schulz, R; Roderfeld, M; Roeb, E				Rath, Timo; Hage, Lisa; Kuegler, Marion; Menendez, Katrin Menendez; Zachoval, Reinhart; Naehrlich, Lutz; Schulz, Richard; Roderfeld, Martin; Roeb, Elke			Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; TISSUE INHIBITOR; LONG PENTRAXIN; EXPRESSION; ENDOGLIN; METALLOPROTEINASES; BIOPSY; PTX3	Background and Aims: Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CFLD. Methods: 45 CF patients were included in the study and received transient elastography. Differential regulation of 220 different serum proteins was assessed in a subgroup of patients with and without CFLD. Most interesting candidate proteins were further quantified and validated by ELISA in the whole patient cohort. To assess a potential relation of biomarker expression to the degree of hepatic fibrosis, serum biomarkers were further determined in 18 HCV patients where liver histology was available. Results: 43 serum proteins differed at least 2-fold in patients with CFLD compared to those without liver disease as identified in proteome profiling. In ELISA quantifications, TIMP-4 and Endoglin were significantly up-regulated in patients with CFLD as diagnosed by clinical guidelines or increased liver stiffness. Pentraxin-3 was significantly decreased in patients with CFLD. Serum TIMP-4 and Endoglin showed highest values in HCV patients with liver cirrhosis compared to those with fibrosis but without cirrhosis. At a cut-off value of 6.3 kPa, transient elastography compassed a very high diagnostic accuracy and specificity for the detection of CFLD. Among the biomarkers, TIMP-4 and Endoglin exhibited a high diagnostic accuracy for CFLD. Diagnostic sensitivities and negative predictive values were increased when elastography and TIMP-4 and Endoglin were combined for the detection of CFLD. Conclusions: Serum TIMP-4 and Endoglin are increased in CFLD and their expression correlates with hepatic staging. Determination of TIMP-4 and Endoglin together with transient elastography can increase the sensitivity for the non-invasive diagnosis of CFLD.	[Rath, Timo; Hage, Lisa; Kuegler, Marion; Menendez, Katrin Menendez; Roderfeld, Martin; Roeb, Elke] Univ Giessen, Dept Internal Med, Div Gastroenterol, Giessen, Germany; [Zachoval, Reinhart] Univ Munich, Dept Gastroenterol, Munich, Germany; [Naehrlich, Lutz] Univ Giessen, Dept Pediat, Div Pulmonol, D-35390 Giessen, Germany; [Schulz, Richard] Univ Giessen, Dept Internal Med, Div Pulmonol, Giessen, Germany	Justus Liebig University Giessen; University of Munich; Justus Liebig University Giessen; Justus Liebig University Giessen	Roeb, E (corresponding author), Univ Giessen, Dept Internal Med, Div Gastroenterol, Giessen, Germany.	Elke.Roeb@innere.med.uni-giessen.de	Naehrlich, Lutz/F-4574-2015; , Martin/AHD-5202-2022	Naehrlich, Lutz/0000-0002-7146-6997; , Martin/0000-0002-3232-1277; Rath, Timo/0000-0002-7728-9338	Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]; University Medical Center Giessen and Marburg [UKGM 10/2010GI]; ZooMAP (Bundesministerium fA 1/4 Jr Bildung und Forschung, BMBF) [01KI1003E]; Justus-Liebig-University Giessen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Center Giessen and Marburg; ZooMAP (Bundesministerium fA 1/4 Jr Bildung und Forschung, BMBF); Justus-Liebig-University Giessen	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 957/7-1 and RO 957/8-1), a research Grant of the University Medical Center Giessen and Marburg (UKGM 10/2010GI), and from ZooMAP (01KI1003E, Bundesministerium fA 1/4 Jr Bildung und Forschung, BMBF). Dr. Timo Rath has received grants for young researchers ("Anschubfinanzierung'') from the Justus-Liebig-University Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892; Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boker KHW, 2000, HEPATO-GASTROENTEROL, V47, P812; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Breton E, 2009, ARCH PEDIATRIE, V16, P1005, DOI 10.1016/j.arcped.2009.03.021; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Castera L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624; Castera L, 2011, BEST PRACT RES CL GA, V25, P291, DOI 10.1016/j.bpg.2011.02.003; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Clemente M, 2006, J VIRAL HEPATITIS, V13, P625, DOI 10.1111/j.1365-2893.2006.00733.x; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; Colombo C, 2006, J PEDIATR GASTR NUTR, V43, pS49, DOI 10.1097/01.mpg.0000226390.02355.52; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Garcia-Alvarez M, 2011, CYTOKINE, V54, P244, DOI 10.1016/j.cyto.2011.03.001; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gault Rachel, 2002, Pediatr Phys Ther, V14, P157; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gressner AM, 2009, WORLD J GASTROENTERO, V15, P2433, DOI 10.3748/wjg.15.2433; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Herrmann U, 2010, BEST PRACT RES CL GA, V24, P585, DOI 10.1016/j.bpg.2010.08.003; Karlas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042139; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Lichtinghagen R, 2003, CLIN SCI, V105, P373, DOI 10.1042/CS20030098; Lindblad A, 1999, HEPATOLOGY, V30, P1151, DOI 10.1002/hep.510300527; Malbrunot-Wagner AC, 2011, J CYST FIBROS; Menten R, 2010, PEDIATR RADIOL, V40, P1231, DOI 10.1007/s00247-009-1531-z; Meurer SK, 2005, J BIOL CHEM, V280, P3078, DOI 10.1074/jbc.M405411200; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Moriyama M, 2005, INTERVIROLOGY, V48, P223, DOI 10.1159/000084599; Moyer K, 2009, CURR OPIN GASTROEN, V25, P272, DOI 10.1097/MOG.0b013e3283298865; Nadler EP, 2010, J SURG RES, V159, P611, DOI 10.1016/j.jss.2009.10.038; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Patel K, 2004, J HEPATOL, V41, P935, DOI 10.1016/j.jhep.2004.08.008; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; RAMSEY BW, 1994, J PEDIATR-US, V124, P177, DOI 10.1016/S0022-3476(94)70301-9; Rath T, 2012, DIGEST LIVER DIS, V44, P780, DOI 10.1016/j.dld.2012.04.008; Rath T, 2011, SCAND J GASTROENTERO, V46, P1369, DOI 10.3109/00365521.2011.613949; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rodgarkia-Dara C, 2006, MUTAT RES-REV MUTAT, V613, P123, DOI 10.1016/j.mrrev.2006.07.002; Rodriguez-Barbero A, 2001, BIOCHEM BIOPH RES CO, V282, P142, DOI 10.1006/bbrc.2001.4526; Roeb E, 1997, J HEPATOL, V27, P535, DOI 10.1016/S0168-8278(97)80359-5; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1002/hep.1840210119; Sokol RJ, 1999, J PEDIATR GASTR NUTR, V28, pS1, DOI 10.1097/00005176-199900001-00001; TSUBOUCHI H, 1992, LANCET, V340, P307, DOI 10.1016/0140-6736(92)92396-W; Witters P, 2009, J CYST FIBROS, V8, P392, DOI 10.1016/j.jcf.2009.08.001; Yagmur E, 2007, EUR J GASTROEN HEPAT, V19, P755, DOI 10.1097/MEG.0b013e3282202bea; Yamagami H, 2001, INTERVIROLOGY, V44, P36, DOI 10.1159/000050028; Yata Y, 1999, J HEPATOL, V30, P425, DOI 10.1016/S0168-8278(99)80101-9; Yoneda M, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-53; Zhang LP, 1999, J HEPATOL, V31, P703, DOI 10.1016/S0168-8278(99)80351-1	63	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58955	10.1371/journal.pone.0058955	http://dx.doi.org/10.1371/journal.pone.0058955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516586	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400083
J	Tsuji, M; Yokota, Y; Shimohara, K; Kudoh, S; Hoshino, T				Tsuji, Masaharu; Yokota, Yuji; Shimohara, Kodai; Kudoh, Sakae; Hoshino, Tamotsu			An Application of Wastewater Treatment in a Cold Environment and Stable Lipase Production of Antarctic Basidiomycetous Yeast Mrakia blollopis	PLOS ONE			English	Article							SP NOV.; PURIFICATION; TEMPERATURE	Milk fat curdle in sewage is one of the refractory materials for active sludge treatment under low temperature conditions. For the purpose of solving this problem by using a bio-remediation agent, we screened Antarctic yeasts and isolated SK-4 strain from algal mat of sediments of Naga-ike, a lake in Skarvsnes, East Antarctica. The yeast strain showed high nucleotide sequence homologies (> 99.6%) to Mrakia blollopis CBS8921(T) in ITS and D1/D2 sequences and had two unique characteristics when applied on an active sludge; i.e., it showed a potential to use various carbon sources and to grow under vitamin-free conditions. Indeed, it showed a biochemical oxygen demand (BOD) removal rate that was 1.25-fold higher than that of the control. We considered that the improved BOD removal rate by applying SK-4 strain was based on its lipase activity and characteristics. Finally, we purified the lipase from SK-4 and found that the enzyme was quite stable under wide ranges of temperatures and pH, even in the presence of various metal ions and organic solvents. SK-4, therefore, is a promising bio-remediation agent for cleaning up unwanted milk fat curdles from dairy milk wastewater under low temperature conditions.	[Tsuji, Masaharu; Hoshino, Tamotsu] Natl Inst Adv Ind Sci & Technol, BRRC, Higashihiroshima, Hiroshima, Japan; [Yokota, Yuji] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido, Japan; [Shimohara, Kodai] Hokkaido High Technol Coll HHT, Eniwa, Hokkaido, Japan; [Kudoh, Sakae] NIPR, Tachikawa, Tokyo, Japan; [Hoshino, Tamotsu] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Hokkaido University	Hoshino, T (corresponding author), Natl Inst Adv Ind Sci & Technol, BRRC, Higashihiroshima, Hiroshima, Japan.	tamotsu.hoshino@aist.go.jp		Tsuji, Masaharu/0000-0002-9375-7998				Bab'eva IP, 2002, MICROBIOLOGY+, V71, P449, DOI 10.1023/A:1019801828620; Berekaa MM, 2009, WORLD J MICROB BIOT, V25, P287, DOI 10.1007/s11274-008-9891-3; BIDDLESTONE AJ, 1991, PROCESS BIOCHEM, V26, P265, DOI 10.1016/0032-9592(91)85012-D; Chevalier P, 2000, J APPL PHYCOL, V12, P105, DOI 10.1023/A:1008168128654; Fadiloglu Sibel, 2002, Turkish Journal of Engineering and Environmental Sciences, V26, P249; FELL JW, 1969, ANTON VAN LEE J M S, V35, P433, DOI 10.1007/BF02219163; Healy MG, 2007, BIORESOURCE TECHNOL, V98, P2268, DOI 10.1016/j.biortech.2006.07.036; Hirayama-Katayama K, 2003, POLAR BIOSCIENCE, V16, P43; Hoshino T, 1997, EUR J PLANT PATHOL, V103, P357, DOI 10.1023/A:1008646303944; IEFUJI H, 1994, BIOSCI BIOTECH BIOCH, V58, P2261, DOI 10.1271/bbb.58.2261; IIZUMI T, 1990, AGR BIOL CHEM TOKYO, V54, P1253, DOI 10.1080/00021369.1990.10870128; Kamini NR, 2000, PROCESS BIOCHEM, V36, P317, DOI 10.1016/S0032-9592(00)00228-4; Kato K, 2010, 12 INT C WETL SYST W; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CY, 2001, ENZYME MICROB TECH, V29, P258, DOI 10.1016/S0141-0229(01)00396-9; Margesin R, 2008, INT J SYST EVOL MICR, V58, P2977, DOI 10.1099/ijs.0.2008/000836-0; Shah SB, 2002, J ENVIRON SCI HEAL B, V37, P493, DOI 10.1081/PFC-120014879; Shimohara K., 2012, J WATER WASTE, V54, P691; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taoka Y, 2011, J BIOSCI BIOENG, V111, P420, DOI 10.1016/j.jbiosc.2010.12.010; Thomas-Hall SR, 2010, EXTREMOPHILES, V14, P47, DOI 10.1007/s00792-009-0286-7; Xin Ming-xiu, 2007, Journal of Zhejiang University-Science B, V8, P260, DOI 10.1631/jzus.2007.B0260; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Ying C, 2010, BIORESOURCE TECHNOL, V101, P4349, DOI 10.1016/j.biortech.2010.01.087	24	38	40	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59376	10.1371/journal.pone.0059376	http://dx.doi.org/10.1371/journal.pone.0059376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516630	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400108
J	Chebli, Y; Pujol, L; Shojaeifard, A; Brouwer, I; van Loon, JJWA; Geitmann, A				Chebli, Youssef; Pujol, Lauranne; Shojaeifard, Anahid; Brouwer, Iman; van Loon, Jack J. W. A.; Geitmann, Anja			Cell Wall Assembly and Intracellular Trafficking in Plant Cells Are Directly Affected by Changes in the Magnitude of Gravitational Acceleration	PLOS ONE			English	Article							POLLEN-TUBE; SPATIAL-DISTRIBUTION; CELLULOSE; GRAVITY; GROWTH; ENDOCYTOSIS; DYNAMICS; TIP; VISUALIZATION; CALLOSE	Plants are able to sense the magnitude and direction of gravity. This capacity is thought to reside in selected cell types within the plant body that are equipped with specialized organelles called statoliths. However, most plant cells do not possess statoliths, yet they respond to changes in gravitational acceleration. To understand the effect of gravity on the metabolism and cellular functioning of non-specialized plant cells, we investigated a rapidly growing plant cell devoid of known statoliths and without gravitropic behavior, the pollen tube. The effects of hyper-gravity and omnidirectional exposure to gravity on intracellular trafficking and on cell wall assembly were assessed in Camellia pollen tubes, a model system with highly reproducible growth behavior in vitro. Using an epi-fluorescence microscope mounted on the Large Diameter Centrifuge at the European Space Agency, we were able to demonstrate that vesicular trafficking is reduced under hyper-gravity conditions. Immuno-cytochemistry confirmed that both in hyper and omnidirectional gravity conditions, the characteristic spatial profiles of cellulose and callose distribution in the pollen tube wall were altered, in accordance with a dose-dependent effect on pollen tube diameter. Our findings suggest that in response to gravity induced stress, the pollen tube responds by modifying cell wall assembly to compensate for the altered mechanical load. The effect was reversible within few minutes demonstrating that the pollen tube is able to quickly adapt to changing stress conditions.	[Chebli, Youssef; Pujol, Lauranne; Shojaeifard, Anahid; Geitmann, Anja] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada; [Brouwer, Iman] Epona Med, Rotterdam, Netherlands; [van Loon, Jack J. W. A.] Univ Amsterdam, Acad Ctr Tandheelkunde Amsterdam ACTA, Dept Craniofacial Surg & Oral Cell Biol, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] European Space Agcy ESA, Life & Phys Sci Instrumentat & Life Support Sect, Noordwijk, Netherlands	Universite de Montreal; University of Amsterdam; Vrije Universiteit Amsterdam; European Space Agency	Geitmann, A (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	anja.geitmann@umontreal.ca	Geitmann, Anja/D-4696-2012	Geitmann, Anja/0000-0003-0390-0517; Chebli, Youssef/0000-0001-6508-5250; van Loon, Jack/0000-0001-9051-6016	European Space Agency Spin Your Thesis! programme; Natural Sciences and Engineering Research Council of Canada (NSERC); Ann Oaks doctoral scholarship of The Canadian Society of Plant Biologists/La Societe canadienne de biologie vegetale; Microgravity Research Program of NWO-Netherlands Space Office (NSO) [ALW-GO-MG-057]	European Space Agency Spin Your Thesis! programme; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ann Oaks doctoral scholarship of The Canadian Society of Plant Biologists/La Societe canadienne de biologie vegetale; Microgravity Research Program of NWO-Netherlands Space Office (NSO)	This project was financed by the European Space Agency Spin Your Thesis! programme. Research in the Geitmann lab is supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC). Youssef Chebli is funded by the Ann Oaks doctoral scholarship of The Canadian Society of Plant Biologists/La Societe canadienne de biologie vegetale. Van Loon is supported by Microgravity Research Program of NWO-Netherlands Space Office (NSO), grant ALW-GO-MG-057. Personnel of ESA assisted with the study design and data collection on the Large Diameter Centrifuge. The funders had no role in decision to publish, or preparation of the manuscript.	Anderson JR, 2002, J PLANT PHYSIOL, V159, P61, DOI 10.1078/0176-1617-00651; Aouar L, 2010, SEX PLANT REPROD, V23, P15, DOI 10.1007/s00497-009-0110-7; Baluska F, 1997, PLANTA, V203, pS69, DOI 10.1007/PL00008117; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Chebli Y, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00056; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Daher FB, 2011, TRAFFIC, V12, P1537, DOI 10.1111/j.1600-0854.2011.01256.x; De Micco V, 2006, PROTOPLASMA, V228, P121, DOI 10.1007/s00709-006-0161-7; Eggen E, 2011, J THEOR BIOL, V283, P113, DOI 10.1016/j.jtbi.2011.05.034; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Geitmann A, 2004, SEX PLANT REPROD, V17, P9, DOI 10.1007/s00497-004-0210-3; Geitmann A, 2006, PLANT CELL MONOGR, V3, P177, DOI 10.1007/7089_049; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; HESLOPHARRISON J, 1987, INT REV CYTOL, V107, P1, DOI 10.1016/S0074-7696(08)61072-4; Kroeger JH, 2009, BIOPHYS J, V97, P1822, DOI 10.1016/j.bpj.2009.07.038; Kuang AX, 1996, PLANTA, V198, P588; Lazzaro MD, 2003, PROTOPLASMA, V220, P201, DOI 10.1007/s00709-002-0042-7; Lisboa S, 2008, PLANT CELL REP, V27, P21, DOI 10.1007/s00299-007-0437-1; LISBOA YS, 2002, J GRAVIT PHYSL, V9, P239; Lovy-Wheeler A, 2005, PLANTA, V221, P95, DOI 10.1007/s00425-004-1423-2; Matsumoto S, 2010, PLANT PHYSIOL, V152, P918, DOI 10.1104/pp.109.147330; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Musgrave ME, 2009, PLANTA, V230, P863, DOI 10.1007/s00425-009-0992-5; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Parre E, 2005, PLANT PHYSIOL, V137, P274, DOI 10.1104/pp.104.050773; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; SCHLUPMANN H, 1994, PLANT PHYSIOL, V105, P659, DOI 10.1104/pp.105.2.659; Van Loon J., 2008, P LIF SPAC LIF EARTH, P22; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; VANDERWOUDE WJ, 1971, J CELL SCI, V8, P331; Volkmann D, 2006, PROTOPLASMA, V229, P143, DOI 10.1007/s00709-006-0200-4; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	38	18	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58246	10.1371/journal.pone.0058246	http://dx.doi.org/10.1371/journal.pone.0058246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516452	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200045
J	Kruger, R; Schutte, R; Huisman, HW; Hindersson, P; Olsen, MH; Eugen-Olsen, J; Schutte, AE				Kruger, Ruan; Schutte, Rudolph; Huisman, Hugo W.; Hindersson, Peter; Olsen, Michael H.; Eugen-Olsen, Jesper; Schutte, Aletta E.			NT-proBNP, C-Reactive Protein and Soluble uPAR in a Bi-Ethnic Male Population: The SAfrEIC Study	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; ATHEROSCLEROSIS; RISK; HYPERTENSION; INFLAMMATION; PREDICTORS; BIOMARKERS; RECEPTOR; DISEASE; BURDEN	Objective and design: This cross-sectional study aimed to investigate associations between a marker of cardiac strain, the N-terminal prohormone B-type natriuretic peptide (NT-proBNP), and inflammation as reflected by either a conventional or novel inflammatory marker in a bi-ethnic South African cohort. Methods and subjects: We measured NT-proBNP, C-reactive protein (CRP) and plasma-soluble urokinase plasminogen activator receptor (suPAR) levels along with conventional biomarkers in black (n = 117) and white (n = 116) men. Results: NT-proBNP, CRP and suPAR levels were higher in black compared to white men. NT-proBNP was significantly associated with both CRP (r = 0.38; p = 0.001) and suPAR (r = 0.42; p<0.001) in black men only. After full adjustment in multiple regression analyses, the above associations of NT-proBNP with CRP (beta = 0.199; p = 0.018) and suPAR (beta = 0.257; p<0.01) were confirmed in black men. Conclusion: These results suggest that a low-grade inflammatory state as reflected by both a conventional and novel marker of inflammation may contribute to higher cardiovascular risk as reflected by the associations obtained with a marker of cardiac strain in black South African men.	[Kruger, Ruan; Schutte, Rudolph; Huisman, Hugo W.; Olsen, Michael H.; Schutte, Aletta E.] North West Univ, Dept Physiol, HART, Potchefstroom, North West Prov, South Africa; [Hindersson, Peter] Hosp Vendsyssel, Dept Biochem, Hjorring, Denmark; [Olsen, Michael H.] Univ So Denmark, Odense Univ Hosp, Dept Endocrinol, Cardiovasc Prevent Clin, Odense, Denmark; [Eugen-Olsen, Jesper] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr 136, DK-2650 Hvidovre, Denmark	North West University - South Africa; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Kruger, R (corresponding author), North West Univ, Dept Physiol, HART, Potchefstroom, North West Prov, South Africa.	ruan.kruger@nwu.ac.za	Kruger, Ruan/N-7618-2015; Schutte, Aletta E/E-5126-2018; Olsen, Michael H/H-8176-2014	Kruger, Ruan/0000-0001-7680-2032; Schutte, Aletta E/0000-0001-9217-4937; Olsen, Michael Hecht/0000-0003-2230-5780; Eugen-Olsen, Jesper/0000-0002-4630-4275; Huisman, Hugo/0000-0002-2114-4789	South African National Research Foundation Grant [GUN 2073040]; Medical Research Council (South Africa); Africa Unit for Trans-disciplinary Health Research of the North-West University (Potchefstroom campus, South Africa); Novo Nordisk Fonden [NNF13OC0003736] Funding Source: researchfish	South African National Research Foundation Grant; Medical Research Council (South Africa); Africa Unit for Trans-disciplinary Health Research of the North-West University (Potchefstroom campus, South Africa); Novo Nordisk Fonden(Novo Nordisk Foundation)	The SAfrEIC study was supported by the South African National Research Foundation Grant (GUN 2073040), the Medical Research Council (South Africa) and the Africa Unit for Trans-disciplinary Health Research of the North-West University (Potchefstroom campus, South Africa). The funding parties had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fourie CMT, 2012, INFLAMMATION, V35, P221, DOI 10.1007/s10753-011-9308-6; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Guelen I, 2008, J HYPERTENS, V26, P1321, DOI 10.1097/HJH.0b013e3282fe1d28; Hall C, 2005, J CARD FAIL, V11, pS81, DOI 10.1016/j.cardfail.2005.04.019; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4; Jensen J, 2010, CLIN RES CARDIOL, V99, P445, DOI 10.1007/s00392-010-0140-z; Kengne AP, 2006, INT J STROKE, V1, P180, DOI 10.1111/j.1747-4949.2006.00064.x; Marfell-Jones M, 2006, INT STANDARDS ANTHRO, P32; McCullough PA, 2003, HEART FAIL REV, V8, P355, DOI 10.1023/A:1026195332025; McDade TW, 2003, YEARB PHYS ANTHROPOL, V46, P100, DOI 10.1002/ajpa.10398; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nielsen SE, 2013, J RENIN-ANGIO-ALDO S, V14, P161, DOI 10.1177/1470320312460290; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Pemberton CJ, 2000, HYPERTENSION, V36, P355, DOI 10.1161/01.HYP.36.3.355; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Prager GW, 2004, BLOOD, V103, P955, DOI 10.1182/blood-2003-07-2214; Raizada V, 2001, MOL CELL BIOCHEM, V216, P137, DOI 10.1023/A:1011027231702; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Sackner-Bernstein J D, 2000, Curr Cardiol Rep, V2, P112, DOI 10.1007/s11886-000-0007-4; Sehestedt T, 2011, ATHEROSCLEROSIS, V216, P237, DOI 10.1016/j.atherosclerosis.2011.01.049; Tamakoshi K, 2003, INT J OBESITY, V27, P443, DOI 10.1038/sj.ijo.0802260; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Uusimaa P, 2004, INT J CARDIOL, V97, P251, DOI 10.1016/j.ijcard.2003.10.015; Yap LB, 2004, HEART FAIL REV, V9, P99, DOI 10.1023/B:HREV.0000046364.68371.b0; Yu H, 2000, CLIN BIOCHEM, V33, P601, DOI 10.1016/S0009-9120(00)00186-7	35	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58506	10.1371/journal.pone.0058506	http://dx.doi.org/10.1371/journal.pone.0058506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516493	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849200075
J	Mirebeau-Prunier, D; Le Pennec, S; Jacques, C; Fontaine, JF; Gueguen, N; Boutet-Bouzamondo, N; Donnart, A; Malthiery, Y; Savagner, F				Mirebeau-Prunier, Delphine; Le Pennec, Soazig; Jacques, Caroline; Fontaine, Jean-Fred; Gueguen, Naig; Boutet-Bouzamondo, Nathalie; Donnart, Audrey; Malthiery, Yves; Savagner, Frederique			Estrogen-Related Receptor Alpha Modulates Lactate Dehydrogenase Activity in Thyroid Tumors	PLOS ONE			English	Article							ERR-ALPHA; MITOCHONDRIAL BIOGENESIS; CANCER METABOLISM; GAMMA; GENE; PHOSPHOFRUCTOKINASE; RESPIRATION; PROGRESSION; GLYCOLYSIS; EXPRESSION	Metabolic modifications of tumor cells are hallmarks of cancer. They exhibit an altered metabolism that allows them to sustain higher proliferation rates in hostile environment outside the cell. In thyroid tumors, the expression of the estrogen-related receptor alpha (ERR alpha), a major factor of metabolic adaptation, is closely related to the oxidative metabolism and the proliferative status of the cells. To elucidate the role played by ERR alpha in the glycolytic adaptation of tumor cells, we focused on the regulation of lactate dehydrogenases A and B (LDHA, LDHB) and the LDHA/LDHB ratio. Our study included tissue samples from 10 classical and 10 oncocytic variants of follicular thyroid tumors and 10 normal thyroid tissues, as well as samples from three human thyroid tumor cell lines: FTC-133, XTC.UC1 and RO82W-1. We identified multiple cis-acting promoter elements for ERR alpha, in both the LDHA and LDHB genes. The interaction between ERR alpha and LDH promoters was confirmed by chromatin immunoprecipitation assays and in vitro analysis for LDHB. Using knock-in and knock-out cellular models, we found an inverse correlation between ERR alpha expression and LDH activity. This suggests that thyroid tumor cells may reprogram their metabolic pathways through the up-regulation of ERR alpha by a process distinct from that proposed by the recently revisited Warburg hypothesis.	[Mirebeau-Prunier, Delphine; Le Pennec, Soazig; Jacques, Caroline; Boutet-Bouzamondo, Nathalie; Malthiery, Yves; Savagner, Frederique] INSERM, UMR694, Angers, France; [Mirebeau-Prunier, Delphine; Le Pennec, Soazig; Jacques, Caroline; Boutet-Bouzamondo, Nathalie; Malthiery, Yves; Savagner, Frederique] Univ Angers, Angers, France; [Mirebeau-Prunier, Delphine; Gueguen, Naig; Malthiery, Yves; Savagner, Frederique] CHU Angers, Dept Biochim Genet, Angers, France; [Fontaine, Jean-Fred] Max Delbruck Ctr Mol Med, Berlin, Germany; [Donnart, Audrey] INSERM, UMR915, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mirebeau-Prunier, D (corresponding author), INSERM, UMR694, Angers, France.	deprunier@chu-angers.fr	Fontaine, Jean-Fred/GNP-2904-2022; Prunier, Delphine/K-3301-2015; LE PENNEC, Soazig/H-3817-2017; Donnart, Audrey/D-4055-2015	Fontaine, Jean-Fred/0000-0002-1101-4091; 	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Cai Q, 2012, ONCOGENE; Charest-Marcotte A, 2010, GENE DEV, V24, P537, DOI 10.1101/gad.1871610; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Downer J, 2006, J THEOR BIOL, V240, P464, DOI 10.1016/j.jtbi.2005.10.007; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; DUMONT JE, 1962, BIOCHIM BIOPHYS ACTA, V56, P382, DOI 10.1016/0006-3002(62)90586-3; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; He X, 2012, DEV DYNAM, V241, P975, DOI 10.1002/dvdy.23769; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Jacques C, 2009, BRIT J CANCER, V101, P132, DOI 10.1038/sj.bjc.6605111; Jose C., 2010, BIOCHIM BIOPHYS ACTA, V1807, P552; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; de Souza ECL, 2011, EXPERT OPIN THER TAR, V15, P1099, DOI 10.1517/14728222.2011.594044; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x; Nie YH, 2009, J CELL MOL MED, V13, P3051, DOI 10.1111/j.1582-4934.2008.00382.x; Quistorff B, 2011, AGING-US, V3, P457, DOI 10.18632/aging.100329; SanchezMartinez C, 1997, FEBS LETT, V409, P86, DOI 10.1016/S0014-5793(97)00496-1; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Swiderek K, 2011, ARCH BIOCHEM BIOPHYS, V505, P33, DOI 10.1016/j.abb.2010.10.010; TYLER DD, 1968, BIOCHEM J, V106, P123, DOI 10.1042/bj1060123; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; VORA S, 1985, CANCER RES, V45, P2993; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	39	42	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58683	10.1371/journal.pone.0058683	http://dx.doi.org/10.1371/journal.pone.0058683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516535	Green Published, gold, Green Accepted			2022-12-25	WOS:000316849200106
J	Azad, GK; Singh, V; Golla, U; Tomar, RS				Azad, Gajendra Kumar; Singh, Vikash; Golla, Upendarrao; Tomar, Raghuvir S.			Depletion of Cellular Iron by Curcumin Leads to Alteration in Histone Acetylation and Degradation of Sml1p in Saccharomyces cerevisiae	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; DNA-DAMAGE; CHROMATIN DYNAMICS; PROTEIN; TRANSCRIPTION; REPLICATION; ACTIVATION; INHIBITOR; GENES; HYPOACETYLATION	Curcumin, a naturally occurring polyphenolic compound, is known to possess diverse pharmacological properties. There is a scarcity of literature documenting the exact mechanism by which curcumin modulates its biological effects. In the present study, we have used yeast as a model organism to dissect the mechanism underlying the action of curcumin. We found that the yeast mutants of histone proteins and chromatin modifying enzymes were sensitive to curcumin and further supplementation of iron resulted in reversal of the changes induced by curcumin. Additionally, treatment of curcumin caused the iron starvation induced expression of FET3, FRE1 genes. We also demonstrated that curcumin induces degradation of Sml1p, a ribonucleotide reductase inhibitor involved in regulating dNTPs production. The degradation of Sml1p was mediated through proteasome and vacuole dependent protein degradation pathways. Furthermore, curcumin exerts biological effect by altering global proteome profile without affecting chromatin architecture. These findings suggest that the medicinal properties of curcumin are largely contributed by its cumulative effect of iron starvation and epigenetic modifications.	[Azad, Gajendra Kumar; Singh, Vikash; Golla, Upendarrao; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India.	rst@iiserb.ac.in	Golla, Upendar Rao/D-5933-2017; Azad, Gajendra/K-3381-2014; Azad, Gajendra Kumar/AAC-7014-2019; Singh, Vikash/HCI-9902-2022	Golla, Upendar Rao/0000-0003-0519-7087; Azad, Gajendra/0000-0003-0338-3265; Singh, Vikash/0000-0002-5325-1386; Azad, Gajendra Kumar/0000-0001-5478-526X	Department of Biotechnology (DBT) Government of India; Council of Scientific and Industrial Research (CSIR) Government of India; Council of Scientific and Industrial Research (CSIR)	Department of Biotechnology (DBT) Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was fiancially supported by the funds from Department of Biotechnology (DBT) and Council of Scientific and Industrial Research (CSIR) Government of India to RST. No external funding for this study was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Toshi Tsukiyama, Randall Morse, J. D. Boeke, Mark Parthun, John Wyrick, Peter Samson, Yuki Yamaguchi, Michael. S. Kobor, C. D. Allis, Zhiguo Zhang and Joseph Reese for providing yeast strains. Authors acknowledge Naveen Verma and Prabhat Singh for critical reading of this manuscript. We are thankful to the Director of IISER Bhopal for providing infrastructure facility and funds for this study. Members of the chromatin biology laboratory are acknowledged for helpful discussions throughout this work. Council of Scientific and Industrial Research (CSIR) is acknowledged for fellowship support to GKA.	Agrawal Shyam Sunder, 2012, Cardiovasc Psychiatry Neurol, V2012, P942981, DOI 10.1155/2012/942981; Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Azad GK, 2012, BIOCHEM PHARMACOL, V83, P296, DOI 10.1016/j.bcp.2011.10.011; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam M, 2003, J BIOSCIENCES, V28, P715, DOI 10.1007/BF02708432; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; Burgis NE, 2007, CHEM RES TOXICOL, V20, P1843, DOI 10.1021/tx700126e; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Chen H, 1999, ANTICANCER RES, V19, P3675; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chuengsamarn S, 2012, DIABETES CARE; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; Erlich RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003717; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gao SM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-27; Gray S. G., 2001, Current Molecular Medicine (Hilversum), V1, P401, DOI 10.2174/1566524013363537; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Gunjan A, 2010, FUTURE MED CHEM, V2, P543, DOI 10.4155/FMC.10.18; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Huertas D, 2009, EPIGENETICS-US, V4, P31, DOI 10.4161/epi.4.1.7733; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Jiao Y, 2009, BLOOD, V113, P462, DOI 10.1182/blood-2008-05-155952; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kang JH, 2005, BIOCHEM PHARMACOL, V69, P1205, DOI 10.1016/j.bcp.2005.01.014; Kang SK, 2006, STEM CELLS DEV, V15, P165, DOI 10.1089/scd.2006.15.165; Kawano A, 2011, GENES CELLS, V16, P590, DOI 10.1111/j.1365-2443.2011.01512.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurup VP, 2008, MOL NUTR FOOD RES, V52, P1031, DOI 10.1002/mnfr.200700293; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P603, DOI 10.1111/j.1745-7254.2005.00081.x; Liu YH, 1997, ONCOL RES, V9, P19; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Messner DJ, 2009, LIVER INT, V29, P63, DOI 10.1111/j.1478-3231.2008.01793.x; Minear S, 2011, EUKARYOT CELL, V10, P1574, DOI 10.1128/EC.05163-11; Munshi A, 2009, J GENET GENOMICS, V36, P75, DOI 10.1016/S1673-8527(08)60094-6; Neely KE, 2002, MOL GENET METAB, V76, P1, DOI 10.1016/S1096-7192(02)00014-8; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Puig S, 2004, J BIOL CHEM, V279, P30298, DOI 10.1074/jbc.M313463200; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Sanvisens N, 2011, MOL CELL, V44, P759, DOI 10.1016/j.molcel.2011.09.021; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Scully R, 2010, NAT REV MOL CELL BIO, V11, P164, DOI 10.1038/nrm2855; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Shu LM, 2011, AAPS J, V13, P606, DOI 10.1208/s12248-011-9300-y; Srividya I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031288; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Theil EC, 2011, J NUTR, V141, p724S, DOI 10.3945/jn.110.127639; Tsaponina O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002061; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	67	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59003	10.1371/journal.pone.0059003	http://dx.doi.org/10.1371/journal.pone.0059003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520547	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900107
J	Doncic, A; Eser, U; Atay, O; Skotheim, JM				Doncic, Andreas; Eser, Umut; Atay, Oguzhan; Skotheim, Jan M.			An Algorithm to Automate Yeast Segmentation and Tracking	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IMAGE-ANALYSIS; BUDDING YEAST; BIOLOGICAL NOISE; CELL-CYCLE; TRANSCRIPTION; LOCALIZATION; VARIABILITY; FEEDBACK; WHI5	Our understanding of dynamic cellular processes has been greatly enhanced by rapid advances in quantitative fluorescence microscopy. Imaging single cells has emphasized the prevalence of phenomena that can be difficult to infer from population measurements, such as all-or-none cellular decisions, cell-to-cell variability, and oscillations. Examination of these phenomena requires segmenting and tracking individual cells over long periods of time. However, accurate segmentation and tracking of cells is difficult and is often the rate-limiting step in an experimental pipeline. Here, we present an algorithm that accomplishes fully automated segmentation and tracking of budding yeast cells within growing colonies. The algorithm incorporates prior information of yeast-specific traits, such as immobility and growth rate, to segment an image using a set of threshold values rather than one specific optimized threshold. Results from the entire set of thresholds are then used to perform a robust final segmentation.	[Doncic, Andreas; Atay, Oguzhan; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Eser, Umut] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Skotheim, JM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skotheim@stanford.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820; Atay, Oguzhan/0000-0002-7203-9575	National Institutes of Health [GM092925]; Burroughs Wellcome Fund CASI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund CASI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health grant GM092925 and Burroughs Wellcome Fund CASI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chen S-C, 2006, 2006 IEEE S COMP INT, DOI [10.1109/CIBCB.2006.330975, DOI 10.1109/CIBCB.2006.330975]; Chen SC, 2007, BIOINFORMATICS, V23, pI66, DOI 10.1093/bioinformatics/btm206; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Carvalho MAG, 2007, IMAGE VISION COMPUT, V25, P34, DOI 10.1016/j.imavis.2006.01.006; Delgado-Gonzalo R, 2010, I S BIOMED IMAGING, P544, DOI 10.1109/ISBI.2010.5490288; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; Eser U, 2011, MOL CELL, V43, P515, DOI 10.1016/j.molcel.2011.06.024; Haidekker MA, 2011, ADV BIOMEDICAL IMAGE, Vxi; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Huh S, 2009, CYTOM PART A, V75A, P934, DOI 10.1002/cyto.a.20793; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kim K, 2010, PROC SPIE, V7798, DOI 10.1117/12.859770; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Lee PJ, 2008, BIOTECHNIQUES, V44, P91, DOI 10.2144/000112673; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Niemisto Antti, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2353; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Pelet S, 2012, INTEGR BIOL-UK, V4, P1274, DOI 10.1039/c2ib20139a; Robinson A, 1998, BIOTECHNOL TECH, V12, P763, DOI 10.1023/A:1008816702162; Rue H, 1998, STAT COMPUT, V8, P221, DOI 10.1023/A:1008953210305; Saito TL, 2005, NUCLEIC ACIDS RES, V33, pW753, DOI 10.1093/nar/gki451; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012	32	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57970	10.1371/journal.pone.0057970	http://dx.doi.org/10.1371/journal.pone.0057970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520484	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900043
J	Volta, V; Ranzato, E; Martinotti, S; Gallo, S; Russo, MV; Mutti, L; Biffo, S; Burlando, B				Volta, Viviana; Ranzato, Elia; Martinotti, Simona; Gallo, Simone; Russo, Maria Veronica; Mutti, Luciano; Biffo, Stefano; Burlando, Bruno			Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma	PLOS ONE			English	Article							GAMMA-CATENIN; CANCER CELLS; GREEN TEA; VITAMIN-E; IN-VIVO; ASCORBATE; GEMCITABINE; EPIGALLOCATECHIN-3-GALLATE; INHIBITION; MANAGEMENT	Malignant pleural mesothelioma (MPM) is a poor prognosis disease lacking adequate therapy. We have previously shown that ascorbic acid administration is toxic to MPM cells. Here we evaluated a new combined therapy consisting of ascorbate/epigallocatechin-3-gallate/gemcitabine mixture (called AND, for Active Nutrients/Drug). In vitro effects of AND therapy on various MPM cell lines revealed a synergistic cytotoxic mechanism. In vivo experiments on a xenograft mouse model for MPM, obtained by REN cells injection in immunocompromised mice, showed that AND strongly reduced the size of primary tumor as well as the number and size of metastases, and prevented abdominal hemorrhage. Kaplan Meier curves and the log-rank test indicated a marked increase in the survival of AND-treated animals. Histochemical analysis of dissected tumors showed that AND induced a shift from cell proliferation to apoptosis in cancer cells. Lysates of tumors from AND-treated mice, analyzed with an antibody array, revealed decreased TIMP-1 and -2 expressions and no effects on angiogenesis regulating factors. Multiplex analysis for signaling protein phosphorylation exhibited inactivation of cell proliferation pathways. The complex of data showed that the AND treatment is synergistic in vitro on MPM cells, and blocks in vivo tumor progression and metastasization in REN-based xenografts. Hence, the AND combination is proposed as a new treatment for MPM.	[Volta, Viviana; Gallo, Simone; Russo, Maria Veronica; Biffo, Stefano] Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, I-20132 Milan, Italy; [Ranzato, Elia; Martinotti, Simona; Biffo, Stefano; Burlando, Bruno] Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy; [Mutti, Luciano] Vercelli Natl Hlth Trust, Dept Gen Med, Vercelli, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Eastern Piedmont Amedeo Avogadro	Burlando, B (corresponding author), Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy.	burlando@unipmn.it	Martinotti, Simona/ABF-3600-2020; Mutti, Luciano/A-3545-2011	Mutti, Luciano/0000-0002-1578-2637; Martinotti, Simona/0000-0003-2891-1810; Burlando, Bruno/0000-0001-7545-0311; biffo, stefano/0000-0002-3780-1050; Volta, Viviana/0000-0001-9999-3732	Fondazione Buzzi Unicem (Casale Monferrato, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC); University of Piemonte Orientale; Italian Ministry of University and Research (MIUR)	Fondazione Buzzi Unicem (Casale Monferrato, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); University of Piemonte Orientale; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione Buzzi Unicem (Casale Monferrato, Italy, www.fondazionebuzziunicem.org) and Associazione Italiana per la Ricerca sul Cancro (AIRC, www.airc.it). ER is recipient of a Research Fellowship from the University of Piemonte Orientale. SM is recipient of a PhD scholarship from the Italian Ministry of University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2006, ANTICANCER RES, V26, P3237; Azam S, 2004, TOXICOL IN VITRO, V18, P555, DOI 10.1016/j.tiv.2003.12.012; Belli C, 2009, EXPERT OPIN EMERG DR, V14, P423, DOI 10.1517/14728210903074563; Bertino P, 2008, CLIN CANCER RES, V14, P541, DOI 10.1158/1078-0432.CCR-07-1388; Bocci G, 2005, BRIT J CANCER, V93, P319, DOI 10.1038/sj.bjc.6602720; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; Carbone M, 2007, NAT REV CANCER, V7, P147, DOI 10.1038/nrc2068; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Ellis P, 2006, J THORAC ONCOL, V1, P591, DOI 10.1097/01243894-200607000-00017; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; Feng MQ, 2011, J CANCER, V2, P123, DOI 10.7150/jca.2.123; Frizelle SP, 2000, CANCER GENE THER, V7, P1421, DOI 10.1038/sj.cgt.7700241; Grad JM, 2001, DRUG RESIST UPDATE, V4, P85, DOI 10.1054/drup.2001.0192; Harris JE, 2011, J SURG RES, V171, pE75, DOI 10.1016/j.jss.2011.06.058; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P626, DOI 10.1016/j.fct.2005.07.005; Kindler HL, 2002, SEMIN ONCOL, V29, P70, DOI 10.1053/sonc.2002.30232; Kroczynska B, 2006, P NATL ACAD SCI USA, V103, P14128, DOI 10.1073/pnas.0604544103; Lang M, 2009, LIVER INT, V29, P670, DOI 10.1111/j.1478-3231.2009.01984.x; Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039; Luo T, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2473; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Martinotti S, 2011, TOXICOL IN VITRO, V25, P1568, DOI 10.1016/j.tiv.2011.05.023; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Montanaro F, 2009, INT J CANCER, V124, P201, DOI 10.1002/ijc.23874; Nagy B, 2002, ANTICANCER RES, V22, P135; Orecchia S, 2004, LUNG CANCER, V45, pS37, DOI 10.1016/j.lungcan.2004.04.027; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; Padayatty SJ, 2000, J AM COLL NUTR, V19, P423, DOI 10.1080/07315724.2000.10718941; PEPE MS, 1989, BIOMETRICS, V45, P497, DOI 10.2307/2531492; Ranzato E, 2012, J CELL MOL MED, V16, P2667, DOI 10.1111/j.1582-4934.2012.01584.x; Ranzato E, 2011, AM J RESP CELL MOL, V44, P108, DOI 10.1165/rcmb.2009-0340OC; Reagan-Shaw S, 2008, PROSTATE, V68, P1624, DOI 10.1002/pros.20824; Riordan Hugh D, 2005, P R Health Sci J, V24, P269; Scherpereel A, 2010, EUR RESPIR J, V35, P479, DOI [10.3779/j.issn.1009-3419.2010.10.14, 10.1183/09031936.00063109]; SMYTHE WR, 1994, CANCER RES, V54, P2055; Sugarbaker DJ, 1998, CHEST, V113, p61S, DOI 10.1378/chest.113.1_Supplement.61S; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Wang Lin-Run, 2005, J Zhejiang Univ Sci B, V6, P446, DOI 10.1631/jzus.2005.B0446; West SD, 2006, CLIN CHEST MED, V27, P335, DOI 10.1016/j.ccm.2006.01.004; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Zauderer MG, 2011, CURR TREAT OPTION ON, V12, P163, DOI 10.1007/s11864-011-0146-4	49	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58051	10.1371/journal.pone.0058051	http://dx.doi.org/10.1371/journal.pone.0058051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23526965	Green Published, gold, Green Submitted			2022-12-25	WOS:000316936100070
J	Georgescauld, F; Moynie, L; Habersetzer, J; Cervoni, L; Mocan, I; Borza, T; Harris, P; Dautant, A; Lascu, I				Georgescauld, Florian; Moynie, Lucile; Habersetzer, Johann; Cervoni, Laura; Mocan, Iulia; Borza, Tudor; Harris, Pernile; Dautant, Alain; Lascu, Ioan			Intersubunit Ionic Interactions Stabilize the Nucleoside Diphosphate Kinase of Mycobacterium tuberculosis	PLOS ONE			English	Article							THERMAL-STABILITY; ESCHERICHIA-COLI; DICTYOSTELIUM-DISCOIDEUM; MOLTEN-GLOBULE; PROTEIN; ENZYME; SALT; DNA; THERMOSTABILITY; DENATURATION	Most nucleoside diphosphate kinases (NDPKs) are hexamers. The C-terminal tail interacting with the neighboring subunits is crucial for hexamer stability. In the NDPK from Mycobacterium tuberculosis (Mt) this tail is missing. The quaternary structure of Mt-NDPK is essential for full enzymatic activity and for protein stability to thermal and chemical denaturation. We identified the intersubunit salt bridge Arg(80) -Asp(93) as essential for hexamer stability, compensating for the decreased intersubunit contact area. Breaking the salt bridge by the mutation D93N dramatically decreased protein thermal stability. The mutation also decreased stability to denaturation by urea and guanidinium. The D93N mutant was still hexameric and retained full activity. When exposed to low concentrations of urea it dissociated into folded monomers followed by unfolding while dissociation and unfolding of the wild type simultaneously occur at higher urea concentrations. The dissociation step was not observed in guanidine hydrochloride, suggesting that low concentration of salt may stabilize the hexamer. Indeed, guanidinium and many other salts stabilized the hexamer with a half maximum effect of about 0.1 M, increasing protein thermostability. The crystal structure of the D93N mutant has been solved.	[Georgescauld, Florian; Moynie, Lucile; Habersetzer, Johann; Mocan, Iulia; Dautant, Alain; Lascu, Ioan] Univ Bordeaux, IBGC, Bordeaux, France; [Georgescauld, Florian; Moynie, Lucile; Habersetzer, Johann; Mocan, Iulia; Dautant, Alain; Lascu, Ioan] CNRS UMR 5095, IBGC, Bordeaux, France; [Cervoni, Laura] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Rome, Italy; [Borza, Tudor] Inst Pasteur, CNRS URA 2185, Lab Chim Struct Macromol, Paris, France; [Harris, Pernile] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Sapienza University Rome; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen	Dautant, A (corresponding author), Univ Bordeaux, IBGC, Bordeaux, France.	A.Dautant@ibgc.cnrs.fr; I.Lascu@ibgc.cnrs.fr	Harris, Pernille/G-7289-2011; Borza, Tudor/A-8510-2012; Georgescauld, Florian/AAH-7125-2019; Borza, Tudor/M-4937-2019	Harris, Pernille/0000-0002-6806-4903; Borza, Tudor/0000-0002-2527-6551; Borza, Tudor/0000-0002-2527-6551; Georgescauld, Florian/0000-0003-0530-1884; Moynie, Lucile/0000-0002-4097-4331	Centre National de la Recherche scientifique; Region Aquitaine; University Bordeaux Segalen	Centre National de la Recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Aquitaine(Region Nouvelle-Aquitaine); University Bordeaux Segalen	This work was supported by grants from the Centre National de la Recherche scientifique (http://www.cnrs.fr/), the Region Aquitaine (http://aquitaine.fr/) and the University Bordeaux Segalen (http://www.univ-bordeauxsegalen.fr/fr/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, CCP4 NEWSL, V42; Arai S, 2012, PROTEIN SCI, V21, P498, DOI 10.1002/pro.2032; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Bogin O, 2002, PROTEIN SCI, V11, P2561, DOI 10.1110/ps.0222102; Boissier F, 2012, PROTEINS, V80, P1658, DOI 10.1002/prot.24062; Cervoni L, 2003, BIOCHEMISTRY-US, V42, P14599, DOI 10.1021/bi035273w; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Chopra P, 2004, FEBS LETT, V571, P212, DOI 10.1016/j.febslet.2004.06.073; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erent M, 2001, EUR J BIOCHEM, V268, P1972, DOI 10.1046/j.1432-1327.2001.2076.doc.x; Ganaie AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027590; Gianni S, 2001, PROTEIN SCI, V10, P1685, DOI 10.1110/ps.5101; Giartosio A, 1996, J BIOL CHEM, V271, P17845, DOI 10.1074/jbc.271.30.17845; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Janin J, 2002, METHOD ENZYMOL, V354, P118; Karlsson A, 1996, J BIOL CHEM, V271, P19928, DOI 10.1074/jbc.271.33.19928; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2005, NUCLEIC ACIDS RES, V33, P2707, DOI 10.1093/nar/gki568; Kwon WS, 1996, PROTEIN ENG, V9, P1197, DOI 10.1093/protein/9.12.1197; Lack NA, 2009, BIOCHEM J, V418, P369, DOI 10.1042/BJ20082011; Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p; LASCU I, 1983, EUR J BIOCHEM, V135, P497, DOI 10.1111/j.1432-1033.1983.tb07679.x; LASCU I, 1993, J BIOL CHEM, V268, P20268; Lascu I, 1997, J BIOL CHEM, V272, P15599, DOI 10.1074/jbc.272.25.15599; LASCU I, 1992, J BIOL CHEM, V267, P12775; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lascu I, 2006, J BIOENERG BIOMEMBR, V38, P265, DOI 10.1007/s10863-006-9042-1; Leslie A, 1992, NEWSLETTER PROTEIN C; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Luke K, 2006, ARCH BIOCHEM BIOPHYS, V456, P8, DOI 10.1016/j.abb.2006.10.003; Ma DQ, 2004, J BIOL CHEM, V279, P18073, DOI 10.1074/jbc.M400185200; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Mei G, 2005, FEBS J, V272, P16, DOI 10.1111/j.1432-1033.2004.04407.x; Mesnildrey S, 1998, J BIOL CHEM, V273, P4436, DOI 10.1074/jbc.273.8.4436; Moynie L, 2007, PROTEINS, V67, P755, DOI 10.1002/prot.21316; Munier-Lehmann H, 1999, PROTEINS, V36, P238, DOI 10.1002/(SICI)1097-0134(19990801)36:2<238::AID-PROT9>3.0.CO;2-K; Munier-Lehmann H, 2001, PROTEIN SCI, V10, P1195, DOI 10.1110/ps.45701; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Saini AK, 2004, J BIOL CHEM, V279, P50142, DOI 10.1074/jbc.M409944200; Sedlak E, 2008, ARCH BIOCHEM BIOPHYS, V474, P128, DOI 10.1016/j.abb.2008.02.037; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; STEIF C, 1993, BIOCHEMISTRY-US, V32, P3867, DOI 10.1021/bi00066a005; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Timmons L, 2000, J BIOENERG BIOMEMBR, V32, P293, DOI 10.1023/A:1005545214937; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Tokunaga H, 2008, FEBS LETT, V582, P1049, DOI 10.1016/j.febslet.2008.02.054; Tokunaga H, 2010, ENZYME MICROB TECH, V46, P129, DOI 10.1016/j.enzmictec.2009.10.009; WILLIAMS RL, 1993, J MOL BIOL, V234, P1230, DOI 10.1006/jmbi.1993.1673	56	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57867	10.1371/journal.pone.0057867	http://dx.doi.org/10.1371/journal.pone.0057867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526954	gold, Green Submitted, Green Published			2022-12-25	WOS:000315637900055
J	Ganapathy, S; Xiao, S; Seo, SJ; Lall, R; Yang, M; Xu, T; Su, H; Shadfan, M; Ha, CS; Yuan, ZM				Ganapathy, S.; Xiao, S.; Seo, S-J; Lall, R.; Yang, M.; Xu, T.; Su, H.; Shadfan, M.; Ha, C. S.; Yuan, Z-M			Low-dose arsenic induces chemotherapy protection via p53/NF-kappa B-mediated metabolic regulation	ONCOGENE			English	Article						chemoprotection; p53; NF-kappa B; metabolism; colon cancer	NF-KAPPA-B; SIGNALING PATHWAYS; DRINKING-WATER; P53; CANCER; CROSSTALK; CELLS	Most chemotherapeutical drugs kill cancer cells chiefly by inducing DNA damage, which unfortunately also causes undesirable injuries to normal tissues, mainly due to p53 activation. We report a novel strategy of normal tissue protection that involves p53/NF-kappa B coordinated metabolic regulation. Pretreatment of untransformed cells with low doses of arsenic induced concerted p53 suppression and NF-kappa B activation, which elicited a marked induction of glycolysis. Significantly, this metabolic shift provided cells effective protection against cytotoxic chemotherapy, coupling the metabolic pathway to cellular resistance. Using both in vitro and in vivo models, we demonstrated an absolute requirement of functional p53 in arsenic-mediated protection. Consistently, a brief arsenic pretreatment selectively protected only normal tissues, but not tumors, from toxicity of chemotherapy. An indispensable role of glycolysis in protecting normal tissues was demonstrated by using an inhibitor of glycolysis, 2-deoxyglucose, which almost totally abolished low-dose arsenic-mediated protection. Together, our work demonstrates that low-dose arsenic renders normal cells and tissues resistant to chemotherapy-induced toxicity by inducting glycolysis.	[Ganapathy, S.; Xiao, S.; Seo, S-J; Lall, R.; Yang, M.; Xu, T.; Su, H.; Shadfan, M.; Ha, C. S.; Yuan, Z-M] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Dept Radiat Oncol, San Antonio, TX 78229 USA; [Ganapathy, S.; Yang, M.; Yuan, Z-M] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 655 Huntington Ave,SPH Bldg 1, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu	Ha, C/GZL-9046-2022	yang, mei/0000-0001-9574-2282	NCI/NIH [2 R01 CA085679, R01 CA125144]; NATIONAL CANCER INSTITUTE [R01CA125144, R01CA085679, R01CA167814] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI/NIH grants 2 R01 CA085679 and R01 CA125144 (to ZMY). We are grateful to Dr Gigi Lozano (The University of Texas MD Anderson Cancer Center, Houston, TX, USA) for the p53-mutant mice. Mouse imaging was performed by Suresh Prajapati, gratefully acknowledged.	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hinkal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006654; Huang YL, 2008, CANCER RES, V68, P9131, DOI 10.1158/0008-5472.CAN-08-3025; KAPLAN HS, 1952, J NATL CANCER I, V13, P185; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lamm SH, 2004, J OCCUP ENVIRON MED, V46, P298, DOI 10.1097/01.jom.0000116801.67556.8f; Mahata J, 2004, MUTAGENESIS, V19, P223, DOI 10.1093/mutage/geh022; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0	16	19	20	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 13	2014	33	11					1359	1366		10.1038/onc.2013.81	http://dx.doi.org/10.1038/onc.2013.81			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AD0SD	23524579	Green Accepted, Green Submitted			2022-12-25	WOS:000332943500003
J	Stelling, AL; Toher, D; Uckermann, O; Tavkin, J; Leipnitz, E; Schweizer, J; Cramm, H; Steiner, G; Geiger, KD; Kirsch, M				Stelling, Allison L.; Toher, Deirdre; Uckermann, Ortrud; Tavkin, Jelena; Leipnitz, Elke; Schweizer, Julia; Cramm, Holger; Steiner, Gerald; Geiger, Kathrin D.; Kirsch, Matthias			Infrared Spectroscopic Studies of Cells and Tissues: Triple Helix Proteins as a Potential Biomarker for Tumors	PLOS ONE			English	Article							ATTENUATED TOTAL REFLECTION; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-SPACE; FTIR SPECTROSCOPY; GLIOMA INVASION; BRAIN; IR; GLIOBLASTOMA; CLASSIFICATION; EXPRESSION	In this work, the infrared (IR) spectra of living neural cells in suspension, native brain tissue, and native brain tumor tissue were investigated. Methods were developed to overcome the strong IR signal of liquid water so that the signal from the cellular biochemicals could be seen. Measurements could be performed during surgeries, within minutes after resection. Comparison between normal tissue, different cell lineages in suspension, and tumors allowed preliminary assignments of IR bands to be made. The most dramatic difference between tissues and cells was found to be in weaker IR absorbances usually assigned to the triple helix of collagens. Triple helix domains are common in larger structural proteins, and are typically found in the extracellular matrix (ECM) of tissues. An algorithm to correct offsets and calculate the band heights and positions of these bands was developed, so the variance between identical measurements could be assessed. The initial results indicate the triple helix signal is surprisingly consistent between different individuals, and is altered in tumor tissues. Taken together, these preliminary investigations indicate this triple helix signal may be a reliable biomarker for a tumor-like microenvironment. Thus, this signal has potential to aid in the intra-operational delineation of brain tumor borders.	[Stelling, Allison L.; Tavkin, Jelena; Schweizer, Julia; Cramm, Holger; Steiner, Gerald] Tech Univ Dresden, Fac Med, Dresden, Germany; [Toher, Deirdre] Univ W England, Dept Engn Design & Math, Fac Environm & Technol, Bristol BS16 1QY, Avon, England; [Uckermann, Ortrud; Leipnitz, Elke; Kirsch, Matthias] Tech Univ Dresden, Fac Med, Dept Neurosurg, Dresden, Germany; [Uckermann, Ortrud; Leipnitz, Elke; Geiger, Kathrin D.; Kirsch, Matthias] Tech Univ Dresden, Univ Hosp, Dresden, Germany; [Geiger, Kathrin D.] Tech Univ Dresden, Fac Med, Inst Pathol, Dept Neuropathol, Dresden, Germany; [Kirsch, Matthias] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; University of West England; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Stelling, AL (corresponding author), Tech Univ Dresden, Fac Med, Dresden, Germany.	antistokes@gmail.com; Kathrin.Geiger@uniklinikum-dresden.de	Kirsch, Matthias/F-2824-2014; Toher, Deirdre/M-3952-2015	Stelling, Allison/0000-0002-0368-0852; Toher, Deirdre/0000-0003-0788-6142	Grant: Medi-CARS; Bundesministerium fur Bildung und Forschung, Germany	Grant: Medi-CARS; Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF))	Funding provided by Grant: Medi-CARS, funding source: Bundesministerium fur Bildung und Forschung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campos B, 2011, GLIA, V59, P1974, DOI 10.1002/glia.21239; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Diem M, 2009, APPL SPECTROSC, V63, p307A, DOI 10.1366/000370209789806894; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; FAHRENFORT J, 1962, SPECTROCHIM ACTA, V18, P1103, DOI 10.1016/S0371-1951(62)80230-6; Franco SJ, 2011, DEV NEUROBIOL, V71, P889, DOI 10.1002/dneu.20946; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; Gonzalez-Segura A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027442; GRENELL RG, 1958, J NEUROCHEM, V2, P138, DOI 10.1111/j.1471-4159.1958.tb12359.x; HARRICK NJ, 1960, J PHYS CHEM-US, V64, P1110, DOI 10.1021/j100838a005; HARRICK NJ, 1960, PHYS REV LETT, V4, P224, DOI 10.1103/PhysRevLett.4.224; Hertzburg G, 1945, MOL SPECTRA MOL STRU; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Iconomidou VA, 2007, INT J BIOL MACROMOL, V41, P102, DOI 10.1016/j.ijbiomac.2007.01.002; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; Knels L, 2011, EUR J NEUROSCI, V34, P548, DOI 10.1111/j.1460-9568.2011.07790.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mackanos MA, 2010, TRENDS BIOTECHNOL, V28, P317, DOI 10.1016/j.tibtech.2010.04.001; Marcsisin EJ, 2010, ANALYST, V135, P3227, DOI 10.1039/c0an00548g; Marechal Y, 2011, J MOL STRUCT, V1004, P146, DOI 10.1016/j.molstruc.2011.07.054; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Noreen R, 2011, ANAL BIOANAL CHEM, V401, P845, DOI 10.1007/s00216-011-4899-1; Okuyama K, 2009, BIOPOLYMERS, V91, P361, DOI 10.1002/bip.21138; Pacifico A, 2003, VIB SPECTROSC, V32, P107, DOI 10.1016/S0924-2031(03)00051-1; PARKER FS, 1967, ANAL BIOCHEM, V18, P414, DOI 10.1016/0003-2697(67)90099-1; Pellegatta S, 2006, NEUROBIOL DIS, V21, P314, DOI 10.1016/j.nbd.2005.07.016; Pope WB, 2012, AM J NEURORADIOL, V33, P1059, DOI 10.3174/ajnr.A2917; R Development Core Team, 2012, R LANG ENV STAT COMP; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; RIGAS B, 1992, CANCER RES, V52, P84; Salzer R., 2014, INFRARED RAMAN SPECT; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Seppanen A, 2007, BRAIN RES, V1158, P50, DOI 10.1016/j.brainres.2007.04.073; Steiner G, 2008, CYTOM PART A, V73A, P1158, DOI 10.1002/cyto.a.20639; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Taylor AM, 1933, J OPT SOC AM, V23, P206, DOI 10.1364/JOSA.23.000206; Whelan DR, 2011, NUCLEIC ACIDS RES, V39, P5439, DOI 10.1093/nar/gkr175; Zhang H, 2010, BIOPHYS J, V99, P1284, DOI 10.1016/j.bpj.2010.06.023; Zhang XQ, 2011, J SURG RES, V171, P650, DOI 10.1016/j.jss.2010.05.031; Zhao R, 2010, ANALYST, V135, P53, DOI 10.1039/b914311d	42	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58332	10.1371/journal.pone.0058332	http://dx.doi.org/10.1371/journal.pone.0058332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526977	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562600018
J	Bonin, RP; Zurek, AA; Yu, JY; Bayliss, DA; Orser, BA				Bonin, Robert P.; Zurek, Agnieszka A.; Yu, Jieying; Bayliss, Douglas A.; Orser, Beverley A.			Hyperpolarization-Activated Current (I-h) Is Reduced in Hippocampal Neurons from Gabra5-/- Mice	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; SUBUNIT-DEFICIENT MICE; GABA(A) RECEPTOR; ALPHA-5 SUBUNIT; TONIC INHIBITION; INTRINSIC EXCITABILITY; PHYSIOLOGICAL-FUNCTION; STATUS EPILEPTICUS; KNOCKOUT MICE; A RECEPTORS	Changes in the expression of gamma-aminobutyric acid type A (GABA(A)) receptors can either drive or mediate homeostatic alterations in neuronal excitability. A homeostatic relationship between alpha 5 subunit-containing GABA(A) (alpha 5GABA(A)) receptors that generate a tonic inhibitory conductance, and HCN channels that generate a hyperpolarization-activated cation current (I-h) was recently described for cortical neurons, where a reduction in I-h was accompanied by a reciprocal increase in the expression of alpha 5GABA(A) receptors resulting in the preservation of dendritosomatic synaptic function. Here, we report that in mice that lack the alpha 5 subunit gene (Gabra5-/-), cultured embryonic hippocampal pyramidal neurons and ex vivo CA1 hippocampal neurons unexpectedly exhibited a decrease in I-h current density (by 40% and 28%, respectively), compared with neurons from wild-type (WT) mice. The resting membrane potential and membrane hyperpolarization induced by blockade of I-h with ZD-7288 were similar in cultured WT and Gabra5-/- neurons. In contrast, membrane hyperpolarization measured after a train of action potentials was lower in Gabra5-/- neurons than in WT neurons. Also, membrane impedance measured in response to low frequency stimulation was greater in cultured Gabra5-/- neurons. Finally, the expression of HCN1 protein that generates I-h was reduced by 41% in the hippocampus of Gabra5-/- mice. These data indicate that loss of a tonic GABAergic inhibitory conductance was followed by a compensatory reduction in I-h. The results further suggest that the maintenance of resting membrane potential is preferentially maintained in mature and immature hippocampal neurons through the homeostatic co-regulation of structurally and biophysically distinct cation and anion channels.	[Bonin, Robert P.; Zurek, Agnieszka A.; Yu, Jieying; Orser, Beverley A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Bayliss, Douglas A.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA USA; [Orser, Beverley A.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Orser, Beverley A.] Sunnybrook Hlth Sci Ctr, Dept Anesthesia, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Virginia; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Orser, BA (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	beverley.orser@utoronto.ca		Bonin, Robert/0000-0002-3287-6803; Zurek, Agnieszka/0000-0001-9957-3324	National Institutes of Health [GM66181]; Canadian Institutes of Health Research [MOP 38028, MOP 79428]; Canada Research Chair; Fonds de Recherche du Quebec - Sante; Natural Sciences and Engineering Council; Ontario Students Opportunity Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Students Opportunity Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by a grant from the National Institutes of Health (GM66181) to DAB, a grant from the Canadian Institutes of Health Research (MOP 38028, MOP 79428) and a Canada Research Chair to BAO. RPB is supported by Fonds de Recherche du Quebec - Sante, RPB and AAZ by the Natural Sciences and Engineering Council, and JY is supported by the Ontario Students Opportunity Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bonin RP, 2007, J NEUROPHYSIOL, V98, P2244, DOI 10.1152/jn.00482.2007; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Caraiscos VB, 2007, MOL PHARMACOL, V71, P1277, DOI 10.1124/mol.106.033563; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Collinson N, 2002, J NEUROSCI, V22, P5572; Disterhoft JF, 2004, AGEING RES REV, V3, P383, DOI 10.1016/j.arr.2004.07.001; Fu XW, 1997, J NEUROPHYSIOL, V78, P2235, DOI 10.1152/jn.1997.78.5.2235; Gibson JR, 2006, J NEUROPHYSIOL, V96, P420, DOI 10.1152/jn.01203.2005; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Jung S, 2011, J NEUROSCI, V31, P14291, DOI 10.1523/JNEUROSCI.1148-11.2011; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1998, J NEUROSCI, V18, P7613; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; STORM JF, 1990, PROG BRAIN RES, V83, P161; Stradleigh TW, 2011, J COMP NEUROL, V519, P2546, DOI 10.1002/cne.22638; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vargas-Caballero M, 2010, NEUROPHARMACOLOGY, V58, P668, DOI 10.1016/j.neuropharm.2009.11.005; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; WISDEN W, 1992, J NEUROSCI, V12, P1040; Zurek AA, 2012, ANESTH ANALG, V114, P845, DOI 10.1213/ANE.0b013e31824720da	37	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58679	10.1371/journal.pone.0058679	http://dx.doi.org/10.1371/journal.pone.0058679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516534	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400048
J	Diehl, WE; Johnson, WE; Hunter, E				Diehl, William E.; Johnson, Welkin E.; Hunter, Eric			Elevated Rate of Fixation of Endogenous Retroviral Elements in Haplorhini TRIM5 and TRIM22 Genomic Sequences: Impact on Transcriptional Regulation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; OLD-WORLD; TRIM5-ALPHA DETERMINES; POSTENTRY RESTRICTION; TRANSPOSABLE ELEMENTS; B30.2(SPRY) DOMAIN; POSITIVE SELECTION; L1 RETROTRANSPOSON; ANTIVIRAL ACTIVITY; B30.2/SPRY DOMAIN	All genes in the TRIM6/TRIM34/TRIM5/TRIM22 locus are type I interferon inducible, with TRIM5 and TRIM22 possessing antiviral properties. Evolutionary studies involving the TRIM6/34/5/22 locus have predominantly focused on the coding sequence of the genes, finding that TRIM5 and TRIM22 have undergone high rates of both non-synonymous nucleotide replacements and in-frame insertions and deletions. We sought to understand if divergent evolutionary pressures on TRIM6/34/5/22 coding regions have selected for modifications in the non-coding regions of these genes and explore whether such non-coding changes may influence the biological function of these genes. The transcribed genomic regions, including the introns, of TRIM6, TRIM34, TRIM5, and TRIM22 from ten Haplorhini primates and one prosimian species were analyzed for transposable element content. In Haplorhini species, TRIM5 displayed an exaggerated interspecies variability, predominantly resulting from changes in the composition of transposable elements in the large first and fourth introns. Multiple lineage-specific endogenous retroviral long terminal repeats (LTRs) were identified in the first intron of TRIM5 and TRIM22. In the prosimian genome, we identified a duplication of TRIM5 with a concomitant loss of TRIM22. The transposable element content of the prosimian TRIM5 genes appears to largely represent the shared Haplorhini/prosimian ancestral state for this gene. Furthermore, we demonstrated that one such differentially fixed LTR provides for species-specific transcriptional regulation of TRIM22 in response to p53 activation. Our results identify a previously unrecognized source of species-specific variation in the antiviral TRIM genes, which can lead to alterations in their transcriptional regulation. These observations suggest that there has existed long-term pressure for exaptation of retroviral LTRs in the non-coding regions of these genes. This likely resulted from serial viral challenges and provided a mechanism for rapid alteration of transcriptional regulation. To our knowledge, this represents the first report of persistent evolutionary pressure for the capture of retroviral LTR insertions.	[Diehl, William E.; Hunter, Eric] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Diehl, William E.; Hunter, Eric] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Johnson, Welkin E.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Emory University; Emory University; Boston College	Hunter, E (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	eric.hunter2@emory.edu		Diehl, William/0000-0001-7943-1214	National Institutes of Health [R01 CA27834, R01 AI095092]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs [OD P51OD11132]; NATIONAL CANCER INSTITUTE [R01CA027834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083118, R01AI095092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; National Institute for Health Research [ACF-2009-07-008] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by research grants R01 CA27834 (EH), R01 AI095092 (WEJ) from the National Institutes of Health. This project was also funded in part by the National Center for Research Resources P51RR165 and is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Cagliani R, 2010, HUM GENET; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Diaz-Griffero F, 2008, VIROLOGY, V378, P233, DOI 10.1016/j.virol.2008.05.008; Diehl WE, 2008, J VIROL, V82, P11140, DOI 10.1128/JVI.00269-08; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388; Hatziioannou T, 2004, J VIROL, V78, P1006, DOI 10.1128/JVI.78.2.1006-1011.2004; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; JUVEN T, 1993, ONCOGENE, V8, P3411; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2002, MOL BIOL EVOL, V19, P1934, DOI 10.1093/oxfordjournals.molbev.a004017; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Leib-Mosch C, 2005, MOL B INT U, P123; LEIBMOSCH C, 1993, GENOMICS, V18, P261, DOI 10.1006/geno.1993.1464; Li X, 2007, VIROLOGY, V360, P419, DOI 10.1016/j.virol.2006.10.035; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Mager DL, 2005, MOL B INT U, P104; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; MURNANE JP, 1995, NUCLEIC ACIDS RES, V23, P2837, DOI 10.1093/nar/23.15.2837; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; Newman RM, 2007, AIDS REV, V9, P114; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Obad S, 2004, ONCOGENE, V23, P4050, DOI 10.1038/sj.onc.1207524; Owens CM, 2004, J VIROL, V78, P5423, DOI 10.1128/JVI.78.10.5423-5437.2004; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Perron MJ, 2006, J VIROL, V80, P5631, DOI 10.1128/JVI.00219-06; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Pi WH, 2010, P NATL ACAD SCI USA, V107, P12992, DOI 10.1073/pnas.1004139107; Rahm N, 2011, J VIROL, V85, P4173, DOI 10.1128/JVI.00075-11; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; Samuelson LC, 1996, MOL BIOL EVOL, V13, P767, DOI 10.1093/oxfordjournals.molbev.a025637; Sanville B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000974; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schaller T, 2007, J VIROL, V81, P11713, DOI 10.1128/JVI.01468-07; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Si ZH, 2006, P NATL ACAD SCI USA, V103, P7454, DOI 10.1073/pnas.0600771103; Singer SS, 2004, J MOL BIOL, V341, P883, DOI 10.1016/j.jmb.2004.06.070; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; STOYE JP, 1988, CELL, V54, P383, DOI 10.1016/0092-8674(88)90201-2; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tareen SU, 2009, VIROLOGY, V385, P473, DOI 10.1016/j.virol.2008.12.018; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; van der Aa LM, 2012, DEV COMP IMMUNOL, V36, P433, DOI 10.1016/j.dci.2011.08.010; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Yap MW, 2008, J VIROL, V82, P5429, DOI 10.1128/JVI.02462-07; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Ylinen LMJ, 2006, J VIROL, V80, P7332, DOI 10.1128/JVI.00516-06; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005	91	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58532	10.1371/journal.pone.0058532	http://dx.doi.org/10.1371/journal.pone.0058532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516500	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400037
J	Du, RF; Mercante, D; Fang, ZD				Du, Ruofei; Mercante, Donald; Fang, Zhide			An Artificial Functional Family Filter in Homolog Searching in Next-generation Sequencing Metagenomics	PLOS ONE			English	Article							COG DATABASE; GENOMICS; ANNOTATION; TOOL	In functional metagenomics, BLAST homology search is a common method to classify metagenomic reads into protein/domain sequence families such as Clusters of Orthologous Groups of proteins (COGs) in order to quantify the abundance of each COG in the community. The resulting functional profile of the community is then used in downstream analysis to correlate the change in abundance to environmental perturbation, clinical variation, and so on. However, the short read length coupled with next-generation sequencing technologies poses a barrier in this approach, essentially because similarity significance cannot be discerned by searching with short reads. Consequently, artificial functional families are produced, in which those with a large number of reads assigned decreases the accuracy of functional profile dramatically. There is no method available to address this problem. We intended to fill this gap in this paper. We revealed that BLAST similarity scores of homologues for short reads from COG protein members coding sequences are distributed differently from the scores of those derived elsewhere. We showed that, by choosing an appropriate score cut-off, we are able to filter out most artificial families and simultaneously to preserve sufficient information in order to build the functional profile. We also showed that, by incorporated application of BLAST and RPS-BLAST, some artificial families with large read counts can be further identified after the score cutoff filtration. Evaluated on three experimental metagenomic datasets with different coverages, we found that the proposed method is robust against read coverage and consistently outperforms the other E-value cutoff methods currently used in literatures.	[Du, Ruofei; Mercante, Donald; Fang, Zhide] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fang, ZD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA.	zfang@lsuhsc.edu	Du, Ruofei/Q-6245-2017	Du, Ruofei/0000-0002-4006-7416	National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; Louisiana Clinical and Translational Science Center of Pennington Biomedical Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louisiana Clinical and Translational Science Center of Pennington Biomedical Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center of Pennington Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 2001, NUCLEIC ACIDS RES, V29, P351, DOI 10.1093/nar/29.2.351; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Dalevi D, 2008, BIOINFORMATICS, V24, pI7, DOI 10.1093/bioinformatics/btn276; Dembo A., 1994, ANN PROBAB, V22, P2022; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hastie T., 2009, UNSUPERVISED LEARNIN; Kaufmann M, 2006, CURR BIOINFORM, V1, P291, DOI 10.2174/157489306777828017; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Korf I., 2003, BLAST ESSENTIAL GUID; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Zhang Q, 2012, BIOCOMPUT-PAC SYM, P259; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zhou J., 2004, MICROBIAL FUNCTIONAL	27	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58669	10.1371/journal.pone.0058669	http://dx.doi.org/10.1371/journal.pone.0058669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516532	Green Submitted, gold, Green Published			2022-12-25	WOS:000316407400046
J	Macedo, TA; Pedrosa, RP; Costa-Hong, V; Kajita, LJ; Morais, GR; De Lima, JJG; Drager, LF; Bortolotto, LA				Macedo, Thiago A.; Pedrosa, Rodrigo P.; Costa-Hong, Valeria; Kajita, Luiz J.; Morais, Gustavo R.; De Lima, Jose J. G.; Drager, Luciano F.; Bortolotto, Luiz A.			Renal Artery Stenosis Predicts Coronary Artery Disease in Patients with Hypertension	PLOS ONE			English	Article							CARDIAC-CATHETERIZATION; VASCULAR-DISEASE; TASK-FORCE; ANGIOGRAPHY; RISK; CARDIOLOGY; PREVALENCE; GUIDELINES; DIAGNOSIS	In hypertensive patients with indication of renal arteriography to investigate renal artery stenosis (RAS) there are no recommendations regarding when to investigate coronary artery disease (CAD). Moreover, the predictors of CAD in patients with RAS are not clear. We aimed to evaluate the frequency and the determinants of CAD in hypertensive patients referred to renal angiography. Eighty-two consecutive patients with high clinical risk suggesting the presence of RAS systematically underwent renal angiography and coronary angiography during the same procedure. Significant arterial stenosis was defined by an obstruction >= 70% to both renal and coronary territories. Significant CAD was present in 32/82 (39%) and significant RAS in 32/82 (39%) patients. Both CAD and RAS were present in 25.6% from the 82 patients. Patients with severe CAD were older (63 +/- 12 vs. 56 +/- 13 years; p = 0.03) and had more angina (41 vs. 16%; p = 0.013) compared to patients without severe CAD. Significant RAS was associated with an increased frequency of severe CAD compared to patients without significant RAS (66% vs. 22%, respectively; p<0.001). Myocardial scintigraphy showed ischemia in 21.8% of the patients with CAD. Binary logistic regression analysis showed that RAS >= 70% was independently associated with CAD >= 70% (OR: 11.48; 95% CI 3.2-40.2; p<0.001), even in patients without angina (OR: 13.48; 95% CI 2.6-12.1; p<0.001). Even considering a small number of patients with significant RAS, we conclude that in hypertensive patients referred to renal angiography, RAS >= 70% may be a strong predictor of severe CAD, independently of angina, and dual investigation should be considered.	[Macedo, Thiago A.; Pedrosa, Rodrigo P.; Costa-Hong, Valeria; De Lima, Jose J. G.; Drager, Luciano F.; Bortolotto, Luiz A.] Univ Sao Paulo, Fac Med, Hosp Clin, Hypertens Unit,Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil; [Kajita, Luiz J.; Morais, Gustavo R.] Univ Sao Paulo, Fac Med, Hosp Clin, Hemodynam Lab,Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Macedo, TA (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Hypertens Unit,Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil.	thiago.cardio@gmail.com	Drager, Luciano F/A-1535-2014; Bortolotto, Luiz A/S-1940-2017; Hong, Valeria A C/S-9645-2017; Pedrosa, Rodrigo P/G-4593-2013	Bortolotto, Luiz A/0000-0002-4865-6442; Hong, Valeria A C/0000-0003-1639-8095; Kajita, Luiz Junya/0000-0002-4448-4911	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao Zerbini	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Zerbini	The authors declare that this work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Fundacao Zerbini. There is no relationship with the pharmaceutical industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqel RA, 2003, J HYPERTENS, V21, P1157, DOI 10.1097/00004872-200306000-00016; Chrysochou C, 2010, J RENAL CARE, V36, P146, DOI 10.1111/j.1755-6686.2010.00161.x; Colyer WR, 2009, PROG CARDIOVASC DIS, V52, P238, DOI 10.1016/j.pcad.2009.09.004; Conlon PJ, 1998, J AM SOC NEPHROL, V9, P252; de Carvalho FC, 2006, AM J HYPERTENS, V19, P1125, DOI 10.1016/j.amjhyper.2006.04.011; De Lima JJG, 2003, HYPERTENSION, V42, P263, DOI 10.1161/01.HYP.0000087889.60760.87; Drager LF, 2004, NEPHROL DIAL TRANSPL, V19, P1803, DOI 10.1093/ndt/gfh261; Dzielinska Z, 2007, J HYPERTENS, V25, P663, DOI 10.1097/HJH.0b013e328011dc6c; GottsaunerWolf M, 1996, EUR HEART J, V17, P1167; Iglesias JI, 2000, AM J MED, V109, P642, DOI 10.1016/S0002-9343(00)00605-7; Kuroda S, 2000, STROKE, V31, P61, DOI 10.1161/01.STR.31.1.61; Liang F, 2012, Indian J Nephrol, V22, P13, DOI 10.4103/0971-4065.91181; Przewlocki T, 2008, KARDIOL POL, V66, P856; Rihal CS, 2002, MAYO CLIN PROC, V77, P309, DOI 10.4065/77.4.309; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Ruilope LM, 2007, J HYPERTENS, V25, P1473, DOI 10.1097/HJH.0b013e328133246c; Shamkhalova MS, 2010, TERAPEVT ARKH, V82, P15; Soulez G, 2000, RADIOGRAPHICS, V20, P1355, DOI 10.1148/radiographics.20.5.g00se131355; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; White CJ, 2006, CIRCULATION, V114, P1892, DOI 10.1161/CIRCULATIONAHA.106.178777	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58635	10.1371/journal.pone.0058635	http://dx.doi.org/10.1371/journal.pone.0058635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516521	gold, Green Published			2022-12-25	WOS:000316407400043
J	Pruett, JR; Hoertel, S; Constantino, JN; Moll, AL; McVey, K; Squire, E; Feczko, E; Povinelli, DJ; Petersen, SE				Pruett, John R., Jr.; Hoertel, Sarah; Constantino, John N.; Moll, Angela LaMacchia; McVey, Kelly; Squire, Emma; Feczko, Eric; Povinelli, Daniel J.; Petersen, Steven E.			Impaired Eye Region Search Accuracy in Children with Autistic Spectrum Disorders	PLOS ONE			English	Article							SUPERIOR VISUAL-SEARCH; FACE RECOGNITION; WILLIAMS-SYNDROME; ATTENTION; GAZE; INDIVIDUALS; PERCEPTION; SYSTEM; POPULATION; FEATURES	To explore mechanisms underlying reduced fixation of eyes in autism, children with Autistic Spectrum Disorders (ASD) and typically developing children were tested in five visual search experiments: simple color feature; color-shape conjunction; face in non-face objects; mouth region; and eye region. No group differences were found for reaction time profile shapes in any of the five experiments, suggesting intact basic search mechanics in children with ASD. Contrary to early reports in the literature, but consistent with other more recent findings, we observed no superiority for conjunction search in children with ASD. Importantly, children with ASD did show reduced accuracy for eye region search (p=.005), suggesting that eyes contribute less to high-level face representations in ASD or that there is an eye region-specific disruption to attentional processes engaged by search in ASD.	[Pruett, John R., Jr.; Hoertel, Sarah; Constantino, John N.; Moll, Angela LaMacchia; Squire, Emma; Feczko, Eric] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Constantino, John N.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [McVey, Kelly; Petersen, Steven E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Povinelli, Daniel J.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Petersen, Steven E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Sch Med, Dept Psychol, St Louis, MO USA; [Petersen, Steven E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Louisiana Lafayette; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pruett, JR (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	pruettj@psychiatry.wustl.edu	Petersen, Steve/ABF-1368-2020		National Institute of Mental Health [R21 MH079958]; National Eye Institute [K12 EY16336]; Autism Speaks Foundation; NATIONAL EYE INSTITUTE [K12EY016336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH079958] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Autism Speaks Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research funding included National Institute of Mental Health R21 MH079958 and National Eye Institute K12 EY16336 (John Pruett). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all of the families who generously participated in this study. We thank Sridhar Kandala for study coordination, Teddi Gray for help with recruiting, Fran Miezin for computer engineering, and Patricia LaVesser and Anna Abbacchi for clinical assessments. Subjects were recruited with the assistance of the Interactive Autism Network (IAN) Research Database at the Kennedy Krieger Institute and Johns Hopkins Medicine-Baltimore, sponsored by the Autism Speaks Foundation. We thank the Washington University School of Medicine Volunteers for Health (VFH) program; Autism Speaks; Missouri Families for Effective Autism Treatment (MO-FEAT); the Illinois Center for Autism; and other local research laboratories, clinics, schools, and community doctors' offices for their help in advertising the studies.	Achenbach T, 2001, CBLC 6 18 PROFILE BO; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwin C, 2006, BRAIN COGNITION, V61, P78, DOI 10.1016/j.bandc.2005.12.008; Baldassi S, 2009, VISION RES, V49, P2151, DOI 10.1016/j.visres.2009.06.007; BARONCOHEN S, 1996, BRIT J PSYCHIAT, V168, P158, DOI DOI 10.1192/BJP.168.2.158; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Constantino JN., 2002, SOCIAL RESPONSIVENES; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hershler O, 2006, VISION RES; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Howlin P, 2009, AJIDD-AM J INTELLECT, V114, P23, DOI 10.1352/2009.114:23;nd41; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kingstone A, 2004, BRAIN COGNITION, V55, P269, DOI 10.1016/j.bandc.2004.02.037; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Lewis MB, 2005, VIS COGN, V12, P1309, DOI 10.1080/13506280444000535; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Mottron L, 2004, J AUTISM DEV DISORD, V34, P19, DOI 10.1023/B:JADD.0000018070.88380.83; Nation K, 2008, DEV PSYCHOPATHOL, V20, P79, DOI 10.1017/S0954579408000047; O'Riordan M, 2001, Q J EXP PSYCHOL-A, V54, P961, DOI 10.1080/02724980042000543; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozonoff S, 2010, J AM ACAD CHILD PSY, V49, P256, DOI 10.1016/j.jaac.2009.11.009; Pellicano E, 2009, PSYCHON B REV, V16, P1094, DOI 10.3758/PBR.16.6.1094; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pruett JR, 2011, J AUTISM DEV DISORD, V41, P715, DOI 10.1007/s10803-010-1090-z; Remington A, 2009, PSYCHOL SCI, V20, P1388, DOI 10.1111/j.1467-9280.2009.02454.x; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Riby DM, 2009, J AUTISM DEV DISORD, V39, P421, DOI 10.1007/s10803-008-0641-z; Rouse H, 2004, J CHILD PSYCHOL PSYC, V45, P1246, DOI 10.1111/j.1469-7610.2004.00317.x; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Senju A, 2008, BRAIN COGNITION, V67, P127, DOI 10.1016/j.bandc.2007.12.001; Swettenham J, 2003, PHILOS T R SOC B, V358, P325, DOI 10.1098/rstb.2002.1203; Tanaka JW, 2010, J CHILD PSYCHOL PSYC, V51, P944, DOI 10.1111/j.1469-7610.2010.02258.x; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; VanRullen R., 2005, VISION RES; Wechsler D, 1974, WECHSLER INTELLIGENC; WENT LN, 1985, HUM GENET, V69, P255, DOI 10.1007/BF00293036; Wolf JM, 2008, AUTISM RES, V1, P329, DOI 10.1002/aur.56; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	59	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58167	10.1371/journal.pone.0058167	http://dx.doi.org/10.1371/journal.pone.0058167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516446	gold, Green Published			2022-12-25	WOS:000316407400020
J	Yuan, ZJ; Shen, YJ				Yuan, Zaijian; Shen, Yanjun			Estimation of Agricultural Water Consumption from Meteorological and Yield Data: A Case Study of Hebei, North China	PLOS ONE			English	Article							WINTER-WHEAT; USE EFFICIENCY; EVAPOTRANSPIRATION; FIELD	Over-exploitation of groundwater resources for irrigated grain production in Hebei province threatens national grain food security. The objective of this study was to quantify agricultural water consumption (AWC) and irrigation water consumption in this region. A methodology to estimate AWC was developed based on Penman-Monteith method using meteorological station data (1984-2008) and existing actual ET (2002-2008) data which estimated from MODIS satellite data through a remote sensing ET model. The validation of the model using the experimental plots (50 m(2)) data observed from the Luancheng Agro-ecosystem Experimental Station, Chinese Academy of Sciences, showed the average deviation of the model was 23.7% for non-rainfed plots. The total AWC and irrigation water (mainly groundwater) consumption for Hebei province from 1984-2008 were then estimated as 864 km(3) and 139 km(3), respectively. In addition, we found the AWC has significantly increased during the past 25 years except for a few counties located in mountainous regions. Estimations of net groundwater consumption for grain food production within the plain area of Hebei province in the past 25 years accounted for 113 km(3) which could cause average groundwater decrease of 7. m over the plain. The integration of meteorological and satellite data allows us to extend estimation of actual ET beyond the record available from satellite data, and the approach could be applicable in other regions globally where similar data are available.	[Yuan, Zaijian] Hebei Univ Sci & Technol, Sch Econ & Management, Shijiazhuang, Peoples R China; [Yuan, Zaijian; Shen, Yanjun] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China	Hebei University of Science & Technology; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Shen, YJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China.	yjshen@sjziam.ac.cn	Shen, Yanjun/A-4630-2013; Shen, Yanjun/K-3323-2019	Shen, Yanjun/0000-0002-2251-2889; Shen, Yanjun/0000-0002-2251-2889	Natural Science Foundation of China (NSFC); Chinese Academy of Sciences (CAS) [40901130, 40871021, KSCX2-EW-J-5]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	The Natural Science Foundation of China (NSFC) and Chinese Academy of Sciences (CAS) supported this work through grants 40901130, 40871021, and KSCX2-EW-J-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Cao GL, 2011, THESIS U ALABAMA TUS; Chen W, 1999, GROUNDWATER HEBEI PR; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; HEILIG GK, 1999, CHINA FOOD CAN CHINA; Ji ZH, 2010, S TO N WATER TRANSFE, V8, P79; [季志恒 JI Zhi-heng], 2010, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V8, P73; Li HJ, 2008, AGR WATER MANAGE, V95, P1271, DOI 10.1016/j.agwat.2008.05.003; Liu XiaoYing, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P155; Long D, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016542; Shen YJ, 2002, HYDROL PROCESS, V16, P2173, DOI 10.1002/hyp.1149; [孙才志 SUN Caizhi], 2010, [生态学报, Acta Ecologica Sinica], V30, P1312; Sun HY, 2010, AGR WATER MANAGE, V97, P1139, DOI 10.1016/j.agwat.2009.06.004; Wu BF, 2012, J HYDROL, V436, P67, DOI 10.1016/j.jhydrol.2012.02.043; Yang H, 2003, AGR WATER MANAGE, V61, P143, DOI 10.1016/S0378-3774(02)00164-6; Yang YM, 2010, AGR WATER MANAGE, V97, P1711, DOI 10.1016/j.agwat.2010.06.002; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069; Zhang YC, 2011, J HYDROL, V408, P203, DOI 10.1016/j.jhydrol.2011.07.036	18	88	109	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58685	10.1371/journal.pone.0058685	http://dx.doi.org/10.1371/journal.pone.0058685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516537	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400050
J	Biernacka, JM; Geske, JR; Schneekloth, TD; Frye, MA; Cunningham, JM; Choi, DS; Tapp, CL; Lewis, BR; Drews, MS; Pietrzak, TL; Colby, CL; Hall-Flavin, DK; Loukianova, LL; Heit, JA; Mrazek, DA; Karpyak, VM				Biernacka, Joanna M.; Geske, Jennifer R.; Schneekloth, Terry D.; Frye, Mark A.; Cunningham, Julie M.; Choi, Doo-Sup; Tapp, Courtney L.; Lewis, Bradley R.; Drews, Maureen S.; Pietrzak, Tracy L.; Colby, Colin L.; Hall-Flavin, Daniel K.; Loukianova, Larissa L.; Heit, John A.; Mrazek, David A.; Karpyak, Victor M.			Replication of Genome Wide Association Studies of Alcohol Dependence: Support for Association with Variation in ADH1C	PLOS ONE			English	Article							DEHYDROGENASE; GENETICS; POLYMORPHISMS; GENES	a Genome-wide association studies (GWAS) have revealed many single nucleotide polymorphisms (SNPs) associated with complex traits. Although these studies frequently fail to identify statistically significant associations, the top association signals from GWAS may be enriched for true associations. We therefore investigated the association of alcohol dependence with 43 SNPs selected from association signals in the first two published GWAS of alcoholism. Our analysis of 808 alcohol-dependent cases and 1,248 controls provided evidence of association of alcohol dependence with SNP rs1614972 in the ADH1C gene (unadjusted p = 0.0017). Because the GWAS study that originally reported association of alcohol dependence with this SNP [1] included only men, we also performed analyses in sex-specific strata. The results suggest that this SNP has a similar effect in both sexes (men: OR (95%CI) = 0.80 (0.66, 0.95); women: OR (95%CI) = 0.83 (0.66, 1.03)). We also observed marginal evidence of association of the rs1614972 minor allele with lower alcohol consumption in the non-alcoholic controls (p = 0.081), and independently in the alcohol-dependent cases (p = 0.046). Despite a number of potential differences between the samples investigated by the prior GWAS and the current study, data presented here provide additional support for the association of SNP rs1614972 in ADH1C with alcohol dependence and extend this finding by demonstrating association with consumption levels in both non-alcoholic and alcohol-dependent populations. Further studies should investigate the association of other polymorphisms in this gene with alcohol dependence and related alcohol-use phenotypes.	[Biernacka, Joanna M.; Schneekloth, Terry D.; Frye, Mark A.; Choi, Doo-Sup; Tapp, Courtney L.; Hall-Flavin, Daniel K.; Loukianova, Larissa L.; Mrazek, David A.; Karpyak, Victor M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Biernacka, Joanna M.; Geske, Jennifer R.; Lewis, Bradley R.; Colby, Colin L.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Drews, Maureen S.; Pietrzak, Tracy L.] Mayo Clin, Dept Informat Technol, Rochester, MN USA; [Heit, John A.] Mayo Clin, Dept Internal Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Biernacka, JM (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA.	biernacka.joanna@mayo.edu	Choi, Doo-Sup/G-9474-2012; Karpyak, Victor M./AGJ-2595-2022	Choi, Doo-Sup/0000-0002-6796-9938; Karpyak, Victor M./0000-0002-9552-6130	S.C. Johnson Program in Genomics of Addiction (Mayo Clinic); NIAAA [P20 AA17830Z]; United States National Institutes of Health (NIH) GEI [U01HG004438]; NIDA; NIH [HHSN268200782096C];  [HG04735]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017830] Funding Source: NIH RePORTER	S.C. Johnson Program in Genomics of Addiction (Mayo Clinic); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); United States National Institutes of Health (NIH) GEI; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by S.C. Johnson Program in Genomics of Addiction (Mayo Clinic) and NIAAA (P20 AA17830Z, PI D.A. Mrazek). Controls were recruited and genotyped as part of the GWAS of Venous Thrombosis study (grant HG04735, PI J.A. Heit). Genotyping for SAGE was funded by United States National Institutes of Health (NIH) GEI (U01HG004438), NIAAA, NIDA, and the NIH contract HHSN268200782096C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Esserlind AL, 2013, EUR J NEURO IN PRESS; Frank J, 2012, ADDICT BIOL, V17, P171, DOI 10.1111/j.1369-1600.2011.00395.x; Gizer IR, 2011, ALCOHOL CLIN EXP RES, V35, P2008, DOI 10.1111/j.1530-0277.2011.01552.x; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Heit JA, 2011, J THROMB HAEMOST, V9, P1133, DOI 10.1111/j.1538-7836.2011.04272.x; Johnson RA, 2002, APPL MULTIVARIATE ST, p[xviii, 767]; Karpyak VM, 2010, ADDICT BIOL, V15, P23, DOI 10.1111/j.1369-1600.2009.00183.x; Karpyak VM, 2009, ALCOHOL CLIN EXP RES, V33, P712, DOI 10.1111/j.1530-0277.2008.00888.x; Karpyak VM, 2012, ADDICT BIOL IN PRESS; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kuo PH, 2008, ALCOHOL CLIN EXP RES, V32, P785, DOI 10.1111/j.1530-0277.2008.00642.x; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Manolio TA, 2009, PHARMACOGENOMICS, V10, P235, DOI 10.2217/14622416.10.2.235; Martinez C, 2010, HEPATOLOGY, V51, P491, DOI 10.1002/hep.23341; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tolstrup JS, 2008, PHARMACOGENOMICS J, V8, P220, DOI 10.1038/sj.tpj.6500471; Treutlein J, 2011, CURR PSYCHIAT REP, V13, P147, DOI 10.1007/s11920-011-0176-4; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Wang HS, 2010, HUM GENET, V128, P165, DOI 10.1007/s00439-010-0841-4; Zuo LJ, 2012, NEUROPSYCHOPHARMACOL, V37, P557, DOI 10.1038/npp.2011.229	30	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58798	10.1371/journal.pone.0058798	http://dx.doi.org/10.1371/journal.pone.0058798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516558	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200115
J	de Melo, IS; Jimenez-Nunez, MD; Iglesias, C; Campos-Caro, A; Moreno-Sanchez, D; Ruiz, FA; Bolivar, J				de Melo, Ivan S.; Jimenez-Nunez, Maria D.; Iglesias, Concepcion; Campos-Caro, Antonio; Moreno-Sanchez, David; Ruiz, Felix A.; Bolivar, Jorge			NOA36 Protein Contains a Highly Conserved Nucleolar Localization Signal Capable of Directing Functional Proteins to the Nucleolus, in Mammalian Cells	PLOS ONE			English	Article							SEQUENCE REQUIREMENTS; TARGETING SIGNAL; DNA-DAMAGE; NUCLEAR; IDENTIFICATION; RNA; POLYPHOSPHATE; COMPLEX; DOMAIN; GENE	NOA36/ZNF330 is an evolutionarily well-preserved protein present in the nucleolus and mitochondria of mammalian cells. We have previously reported that the pro-apoptotic activity of this protein is mediated by a characteristic cysteine-rich domain. We now demonstrate that the nucleolar localization of NOA36 is due to a highly-conserved nucleolar localization signal (NoLS) present in residues 1-33. This NoLS is a sequence containing three clusters of two or three basic amino acids. We fused the amino terminal of NOA36 to eGFP in order to characterize this putative NoLS. We show that a cluster of three lysine residues at positions 3 to 5 within this sequence is critical for the nucleolar localization. We also demonstrate that the sequence as found in human is capable of directing eGFP to the nucleolus in several mammal, fish and insect cells. Moreover, this NoLS is capable of specifically directing the cytosolic yeast enzyme polyphosphatase to the target of the nucleolus of HeLa cells, wherein its enzymatic activity was detected. This NoLS could therefore serve as a very useful tool as a nucleolar marker and for directing particular proteins to the nucleolus in distant animal species.	[de Melo, Ivan S.; Iglesias, Concepcion; Bolivar, Jorge] Univ Cadiz, Fac Ciencias, Dept Biomed Biotecnol & Salud Publ, Cadiz, Spain; [Jimenez-Nunez, Maria D.; Campos-Caro, Antonio; Moreno-Sanchez, David; Ruiz, Felix A.] Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain; [Jimenez-Nunez, Maria D.; Campos-Caro, Antonio; Moreno-Sanchez, David; Ruiz, Felix A.] Univ Cadiz, Fac Med, Dept Biomed Biotecnol & Salud Publ, Cadiz, Spain	Universidad de Cadiz; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz	Bolivar, J (corresponding author), Univ Cadiz, Fac Ciencias, Dept Biomed Biotecnol & Salud Publ, Cadiz, Spain.	jorge.bolivar@uca.es	BOLIVAR, JORGE/G-4322-2015; Campos-Caro, Antonio/T-2807-2019; Ruiz, Felix A./B-1032-2008	BOLIVAR, JORGE/0000-0002-2645-9528; Campos-Caro, Antonio/0000-0001-8532-2153; Ruiz, Felix A./0000-0003-0748-5015	EU-FEDER; Spanish Ministry of Economy and Competitiveness [SAF2003-06398, BFU2009-09074, FIS/PI10/01222]; "Consejeria de Economia, Innovacion y Ciencia'' of the Junta de Andalucia [PAIDI CTS 569, P07-CTS-02765]	EU-FEDER(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); "Consejeria de Economia, Innovacion y Ciencia'' of the Junta de Andalucia	This work was supported by grants from EU-FEDER and the Spanish Ministry of Economy and Competitiveness (SAF2003-06398 and BFU2009-09074 to JB and FIS/PI10/01222 to FAR), and by a grant from the "Consejeria de Economia, Innovacion y Ciencia" of the Junta de Andalucia (PAIDI CTS 569 to JB and P07-CTS-02765 to FAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Bolivar J, 1999, CELL MOL BIOL, V45, P277; Bolivar J, 2001, CYTOGENET CELL GENET, V93, P234, DOI 10.1159/000056989; Bolivar J, 1999, J BIOL CHEM, V274, P36456, DOI 10.1074/jbc.274.51.36456; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; de Melo IS, 2009, BBA-MOL CELL RES, V1793, P1876, DOI 10.1016/j.bbamcr.2009.10.011; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; FRYER JL, 1965, ANN NY ACAD SCI, V126, P566, DOI 10.1111/j.1749-6632.1965.tb14303.x; Goatley LC, 1999, J GEN VIROL, V80, P525, DOI 10.1099/0022-1317-80-3-525; Guo H, 2009, VIRUS RES, V145, P312, DOI 10.1016/j.virusres.2009.07.024; Guo YX, 2003, VIROLOGY, V306, P225, DOI 10.1016/S0042-6822(02)00081-8; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; HATANAKA M, 1990, BIOESSAYS, V12, P143, DOI 10.1002/bies.950120310; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Jimenez-Nunez MD, 2012, HAEMATOLOGICA; Kubota S, 1996, J VIROL, V70, P1282, DOI 10.1128/JVI.70.2.1282-1287.1996; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liu JL, 1997, J VIROL, V71, P3188, DOI 10.1128/JVI.71.4.3188-3196.1997; Liu JY, 2006, FEBS LETT, V580, P1405, DOI 10.1016/j.febslet.2006.01.064; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; MAEDA Y, 1992, EMBO J, V11, P3695, DOI 10.1002/j.1460-2075.1992.tb05454.x; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pellar GJ, 2003, CHROMOSOMA, V111, P461, DOI 10.1007/s00412-003-0231-y; Piston DW, 1999, METHOD CELL BIOL, V58, P31; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Reed ML, 2007, J VIROL, V81, P4298, DOI 10.1128/JVI.02239-06; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Scott M, 2001, NUCLEIC ACIDS RES, V29, P2052, DOI 10.1093/nar/29.10.2052; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; SIOMI H, 1988, CELL, V55, P197, DOI 10.1016/0092-8674(88)90043-8; SIOMI H, 1990, J VIROL, V64, P1803, DOI 10.1128/JVI.64.4.1803-1807.1990; Song ZY, 2005, ONCOGENE, V24, P2723, DOI 10.1038/sj.onc.1208097; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Tan DSW, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-17; Ueki N, 1998, BIOCHEM BIOPH RES CO, V252, P97, DOI 10.1006/bbrc.1998.9606; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Yoshitome S, 2012, BIOCHEM BIOPH RES CO, V422, P770, DOI 10.1016/j.bbrc.2012.05.080	55	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59065	10.1371/journal.pone.0059065	http://dx.doi.org/10.1371/journal.pone.0059065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516598	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200131
J	Moody, RM; Cebrian, J; Heck, KL				Moody, Ryan M.; Cebrian, Just; Heck, Kenneth L., Jr.			Interannual Recruitment Dynamics for Resident and Transient Marsh Species: Evidence for a Lack of Impact by the Macondo Oil Spill	PLOS ONE			English	Article							SALT MARSHES; BIODEGRADATION; HABITATS; NEKTON; FISH; BAY	The emulsification of oil at the Deepwater Horizon (DWH) well head relegated a large proportion of resultant hydrocarbon plumes to the deep sea, facilitated the incorporation of oil droplets into microbial and planktonic food web, and limited the severity of direct, wetland oiling to coastal Louisiana. Nevertheless, many transient fish and invertebrate species rely on offshore surface waters for egg and larval transport before settling in coastal habitats, thereby potentially impacting the recruitment of transient species to coastal nursery habitats quite distant from the well site. We compared the utilization of salt-marsh habitats by transient and resident nekton before and after the DWH accident using data obtained from an oyster reef restoration project in coastal Alabama. Our sampling activities began in the summer preceding the DWH spill and continued almost two years following the accident. Overall, we did not find significant differences in the recruitment of marsh-associated resident and transient nekton in coastal Alabama following the DWH accident. Our results, therefore, provide little evidence for severe acute or persistent oil-induced impacts on organisms that complete their life cycle within the estuary and those that spent portions of their life history in potentially contaminated offshore surface waters prior to their recruitment to nearshore habitats. Our negative findings are consistent with other assessments of nekton in coastal vegetated habitats and bolster the notion that, despite the presence of localized hydrocarbon enrichments in coastal habitats outside of Louisiana the most severe oil impacts were relegated to coastal Louisiana and the deep sea. Analyzing all the information learned from this accident will undoubtedly provide a synthesis of what has or has not been affected in the Northern Gulf of Mexico, which when put in context with oil spill studies elsewhere should improve our ability to avert and manage the negative consequences of such accidents.	[Moody, Ryan M.; Cebrian, Just; Heck, Kenneth L., Jr.] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Cebrian, Just; Heck, Kenneth L., Jr.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Dauphin Island Sea Lab; University of South Alabama	Moody, RM (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA.	rmoody@disl.org			NOAA Fisheries Emergency Disaster Relief Program (EDRP) Funds; BP/The Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; BP	NOAA Fisheries Emergency Disaster Relief Program (EDRP) Funds; BP/The Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; BP	This work was supported by funding provided by NOAA Fisheries Emergency Disaster Relief Program (EDRP) Funds, administered through the Alabama Department of Conservation and Natural Resources; BP grants made to the Marine Environmental Science Consortium and the Northern Gulf Institute; and in part by a grant from BP/The Gulf of Mexico Research Initiative through the Florida Institute of Oceanography to the Florida Institute of Technology. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript, nor does this alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; Just Cebrian is currently on the PLOS One editorial board. This work was partly supported by BP grants made to the Marine Environmental Science Consortium and the Northern Gulf Institute. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.	AKIN S, 2003, ESTUAR COAST SHELF S, V56, P1; [Anonymous], 2012, ENV RESPONSE MANAGEM; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carmichael RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041155; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heck KL, 2001, MAR ECOL PROG SER, V222, P163, DOI 10.3354/meps222163; HETTLER WF, 1989, MAR ECOL PROG SER, V56, P111, DOI 10.3354/meps056111; Kocan RM, 1996, CAN J FISH AQUAT SCI, V53, P2366, DOI 10.1139/cjfas-53-10-2366; McCall BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032735; Miller BS, 2009, EARLY LIFE HISTORY OF MARINE FISHES, P1, DOI 10.1525/california/9780520249721.001.0001; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Oil Spill Commission, 2011, DEEP WAT GULF OIL DI; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; ROGERS BD, 1993, ESTUAR COAST SHELF S, V36, P377, DOI 10.1006/ecss.1993.1023; Roth AMF, 2009, ESTUAR COAST, V32, P565, DOI 10.1007/s12237-009-9135-2; Rozas LP, 2000, MAR POLLUT BULL, V40, P1148, DOI 10.1016/S0025-326X(00)00075-8; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Shervette VR, 2008, ESTUAR COAST, V31, P584, DOI 10.1007/s12237-008-9049-4; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108	27	39	39	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58376	10.1371/journal.pone.0058376	http://dx.doi.org/10.1371/journal.pone.0058376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516467	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200059
J	Ruttiger, L; Singer, W; Panford-Walsh, R; Matsumoto, M; Lee, SC; Zuccotti, A; Zimmermann, U; Jaumann, M; Rohbock, K; Xiong, H; Knipper, M				Ruettiger, Lukas; Singer, Wibke; Panford-Walsh, Rama; Matsumoto, Masahiro; Lee, Sze Chim; Zuccotti, Annalisa; Zimmermann, Ulrike; Jaumann, Mirko; Rohbock, Karin; Xiong, Hao; Knipper, Marlies			The Reduced Cochlear Output and the Failure to Adapt the Central Auditory Response Causes Tinnitus in Noise Exposed Rats	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; ARC MESSENGER-RNA; HOMEOSTATIC SYNAPTIC PLASTICITY; NORMAL-HEARING PATIENTS; NEUROTROPHIC FACTOR; NEURAL ACTIVITY; BRAIN-STEM; PHYSIOLOGICAL EVIDENCE; ACOUSTIC TRAUMA; TONOTOPIC AXIS	Tinnitus is proposed to be caused by decreased central input from the cochlea, followed by increased spontaneous and evoked subcortical activity that is interpreted as compensation for increased responsiveness of central auditory circuits. We compared equally noise exposed rats separated into groups with and without tinnitus for differences in brain responsiveness relative to the degree of deafferentation in the periphery. We analyzed (1) the number of CtBP2/RIBEYE-positive particles in ribbon synapses of the inner hair cell (IHC) as a measure for deafferentation; (2) the fine structure of the amplitudes of auditory brainstem responses (ABR) reflecting differences in sound responses following decreased auditory nerve activity and (3) the expression of the activity-regulated gene Arc in the auditory cortex (AC) to identify long-lasting central activity following sensory deprivation. Following moderate trauma, 30% of animals exhibited tinnitus, similar to the tinnitus prevalence among hearing impaired humans. Although both tinnitus and no-tinnitus animals exhibited a reduced ABR wave I amplitude (generated by primary auditory nerve fibers), IHCs ribbon loss and high-frequency hearing impairment was more severe in tinnitus animals, associated with significantly reduced amplitudes of the more centrally generated wave IV and V and less intense staining of Arc mRNA and protein in the AC. The observed severe IHCs ribbon loss, the minimal restoration of ABR wave size, and reduced cortical Arc expression suggest that tinnitus is linked to a failure to adapt central circuits to reduced cochlear input.	[Ruettiger, Lukas; Singer, Wibke; Panford-Walsh, Rama; Matsumoto, Masahiro; Lee, Sze Chim; Zuccotti, Annalisa; Zimmermann, Ulrike; Jaumann, Mirko; Rohbock, Karin; Xiong, Hao; Knipper, Marlies] Univ Tubingen, Hearing Res Ctr Tubingen, Dept Otolaryngol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Knipper, M (corresponding author), Univ Tubingen, Hearing Res Ctr Tubingen, Dept Otolaryngol, Tubingen, Germany.	marlies.knipper@uni-tuebingen.de		Lee, Sze Chim/0000-0001-5822-6633	Marie Curie Research Training Network CavNET [MRTN-CT-2006-035367]; Deutsche Forschungsgemeinschaft [DFG-Kni-316-4-1]; Hahn Stiftung (Index AG); Open Access Publishing Fund of Tuebingen University	Marie Curie Research Training Network CavNET(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hahn Stiftung (Index AG); Open Access Publishing Fund of Tuebingen University	This work was supported by the Marie Curie Research Training Network CavNET MRTN-CT-2006-035367, the Deutsche Forschungsgemeinschaft DFG-Kni-316-4-1 and Hahn Stiftung (Index AG). The authors acknowledge support by Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHERLEY GR, 1968, J ACOUST SOC AM, V44, P1503, DOI 10.1121/1.1911288; Bauer CA, 2007, J NEUROSCI RES, V85, P1489, DOI 10.1002/jnr.21259; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Cai SQ, 2009, JARO-J ASSOC RES OTO, V10, P5, DOI 10.1007/s10162-008-0142-y; Daberkow DP, 2007, EUR J NEUROSCI, V26, P228, DOI 10.1111/j.1460-9568.2007.05630.x; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; Dominguez M, 2006, NEURAL COMPUT, V18, P2942, DOI 10.1162/neco.2006.18.12.2942; DON M, 1978, J ACOUST SOC AM, V63, P1084, DOI 10.1121/1.381816; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Geven LI, 2011, OTOL NEUROTOL, V32, P315, DOI 10.1097/MAO.0b013e3181fcf180; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Jastreboff PJ, 2007, PROG BRAIN RES, V166, P415, DOI 10.1016/S0079-6123(07)66040-3; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Kaltenbach JA, 2007, PROG BRAIN RES, V166, P89, DOI 10.1016/S0079-6123(07)66009-9; Kehrle HM, 2008, ARCH OTOLARYNGOL, V134, P647, DOI 10.1001/archotol.134.6.647; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kim DK, 2011, ANN OTO RHINOL LARYN, V120, P523, DOI 10.1177/000348941112000806; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Knipper M, 2012, SPRINGER HDB AUDIDOR, P49; Knipper M, 2010, HEARING RES, V266, P60, DOI 10.1016/j.heares.2009.07.013; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Kozlovsky N, 2008, EUR NEUROPSYCHOPHARM, V18, P107, DOI 10.1016/j.euroneuro.2007.04.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; LOEB M, 1967, J ACOUST SOC AM, V42, P453, DOI 10.1121/1.1910600; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; McFeely WJ, 1999, OTOLARYNG HEAD NECK, V121, P367, DOI 10.1016/S0194-5998(99)70222-6; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; Meltser I, 2009, J NEUROTRAUM, V26, P1835, DOI 10.1089/neu.2008.0874; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Moga DE, 2006, HIPPOCAMPUS, V16, P990, DOI 10.1002/hipo.20227; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Mrena R, 2004, ACTA OTO-LARYNGOL, V124, P946, DOI 10.1080/00016480310017045; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Nottet JB, 2006, LARYNGOSCOPE, V116, P970, DOI 10.1097/01.MLG.0000216823.77995.13; Ochi K, 1997, HEARING RES, V105, P105, DOI 10.1016/S0378-5955(96)00201-8; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Ons S, 2010, EUR J NEUROSCI, V31, P2043, DOI 10.1111/j.1460-9568.2010.07242.x; Panford-Walsh R, 2008, MOL PHARMACOL, V74, P595, DOI 10.1124/mol.108.046375; Parra LC, 2007, J ACOUST SOC AM, V121, P1632, DOI 10.1121/1.2431346; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; PENNER MJ, 1986, J SPEECH HEAR RES, V29, P400, DOI 10.1044/jshr.2903.400; PETTIGREW AM, 1984, ANN OTO RHINOL LARYN, V93, P83, DOI 10.1177/00034894840930S416; Pinaud R, 2001, MOL BRAIN RES, V91, P50, DOI 10.1016/S0169-328X(01)00121-8; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Puel JL, 2007, PROG BRAIN RES, V166, P141, DOI 10.1016/S0079-6123(07)66012-9; Qiu CX, 2000, HEARING RES, V139, P153, DOI 10.1016/S0378-5955(99)00171-9; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schaette R, 2009, J NEUROPHYSIOL, V101, P3042, DOI 10.1152/jn.91256.2008; Schecklmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034878; Schimmang T, 2003, DEVELOPMENT, V130, P4741, DOI 10.1242/dev.00676; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Singer W, 2012, MOL NEUROBIOL; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Szczepaniak WS, 1996, EVOKED POTENTIAL, V100, P158, DOI 10.1016/0013-4694(95)00234-0; Tan J, 2007, NEUROSCIENCE, V145, P715, DOI 10.1016/j.neuroscience.2006.11.067; Turner JG, 2007, PROG BRAIN RES, V166, P147, DOI 10.1016/S0079-6123(07)66013-0; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Wang Y, 2002, HEARING RES, V165, P96, DOI 10.1016/S0378-5955(02)00289-7; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; YATES GK, 1990, HEARING RES, V45, P203, DOI 10.1016/0378-5955(90)90121-5; Yilmaz-Rastoder E, 2011, HIPPOCAMPUS, V21, P1290, DOI 10.1002/hipo.20838; Zeng FG, 2012, HEAR RES; Zenner HP, 2006, OTOL NEUROTOL, V27, P1054, DOI 10.1097/01.mao.0000231604.64079.77; Zuccotti A, 2012, J NEUROSCI, V32, P8545, DOI 10.1523/JNEUROSCI.1247-12.2012	97	109	114	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57247	10.1371/journal.pone.0057247	http://dx.doi.org/10.1371/journal.pone.0057247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516401	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200007
J	Tsukahara, T; Haniu, H; Matsuda, Y				Tsukahara, Tamotsu; Haniu, Hisao; Matsuda, Yoshikazu			PTB-Associated Splicing Factor (PSF) Is a PPAR gamma-Binding Protein and Growth Regulator of Colon Cancer Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PROLIFERATION; RNA; DIFFERENTIATION; TRANSCRIPTION; MITOCHONDRIA; SUPERFAMILY; EXPRESSION; PROMOTES; DOMAIN	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor that plays an essential role in cell proliferation, apoptosis, and inflammation. It is over-expressed in many types of cancer, including colon, stomach, breast, and lung cancer, suggesting that regulation of PPAR gamma might affect cancer pathogenesis. Here, using a proteomic approach, we identify PTB-associated splicing factor (PSF) as a novel PPAR gamma-interacting protein and demonstrate that PSF is involved in several important regulatory steps of colon cancer cell proliferation. To investigate the relationship between PSF and PPAR gamma in colon cancer, we evaluated the effects of PSF expression in DLD-1 and HT-29 colon cancer cell lines, which express low and high levels of PPAR gamma, respectively PSF affected the ability of PPAR gamma to bind, and expression of PSF siRNA significantly suppressed the proliferation of colon cancer cells. Furthermore, PSF knockdown induced apoptosis via activation of caspase-3. Interestingly, DLD-1 cells were more susceptible to PSF knockdown-induced cell death than HT-29 cells. Our data suggest that PSF is an important regulator of cell death that plays critical roles in the survival and growth of colon cancer cells. The PSF-PPAR gamma axis may play a role in the control of colorectal carcinogenesis. Taken together, this study is the first to describe the effects of PSF on cell proliferation, tumor growth, and cell signaling associated with PPAR gamma.	[Tsukahara, Tamotsu] Shinshu Univ, Sch Med, Dept Integrat Physiol & Biosyst Control, Asahi Ku, Matsumoto, Nagano 390, Japan; [Haniu, Hisao] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Asahi Ku, Matsumoto, Nagano 390, Japan; [Matsuda, Yoshikazu] Nihon Pharmaceut Univ, Clin Pharmacol Educ Ctr, Ina, Saitama, Japan	Shinshu University; Shinshu University	Tsukahara, T (corresponding author), Shinshu Univ, Sch Med, Dept Integrat Physiol & Biosyst Control, Asahi Ku, Matsumoto, Nagano 390, Japan.	ttamotsu@shinshu-u.ac.jp	Tsukahara, Tamotsu/ABB-3631-2021	Tsukahara, Tamotsu/0000-0001-6469-920X	Japan Society for the Promotion of Science [22591482]; Takeda Science Foundation; Astellas foundation for research on metabolic disorders	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas foundation for research on metabolic disorders	This work was supported by Grants-in-Aid for Scientific Research (C) 22591482 (to Tamotsu Tsukahara) from the Japan Society for the Promotion of Science, and Grants-in-Aid from Takeda Science Foundation (to Tamotsu Tsukahara) and Astellas foundation for research on metabolic disorders (to Tamotsu Tsukahara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett DK, 1996, DEV DYNAM, V205, P64, DOI 10.1002/(SICI)1097-0177(199601)205:1<64::AID-AJA6>3.0.CO;2-3; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Bull AW, 2003, ARCH PATHOL LAB MED, V127, P1121; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choi IK, 2008, INVEST NEW DRUG, V26, P283, DOI 10.1007/s10637-007-9108-x; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Goldberg RM, 2006, ONCOLOGIST, V11, P981, DOI 10.1634/theoncologist.11-9-981; Gupta RA, 2001, J BIOL CHEM, V276, P29681, DOI 10.1074/jbc.M103779200; Haddad AJ, 2011, INT J SURG ONCOL, V2011, DOI 10.1155/2011/285840; Haniu H, 2006, PROTEOMICS, V6, P3251, DOI 10.1002/pmic.200500813; Henics T, 1999, BIOL CELL, V91, P485, DOI 10.1016/S0248-4900(00)88205-2; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kitamura S, 1999, JPN J CANCER RES, V90, P75, DOI 10.1111/j.1349-7006.1999.tb00668.x; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Liu DC, 2004, ACTA PHARMACOL SIN, V25, P1312; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Plotz M, 2012, CELL DEATH DIFFER; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Radhakrishnan SK, 2005, CELL CYCLE, V4, P582, DOI 10.4161/cc.4.4.1583; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sato H, 2000, BRIT J CANCER, V83, P1394, DOI 10.1054/bjoc.2000.1457; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song X, 2005, P NATL ACAD SCI USA, V102, P12189, DOI 10.1073/pnas.0505179102; Song X, 2004, P NATL ACAD SCI USA, V101, P621, DOI 10.1073/pnas.0307794100; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Tsukahara T, 2012, BIOCHEM BIOPH RES CO, V424, P524, DOI 10.1016/j.bbrc.2012.06.149; Tsukahara T, 2010, PROSTAG OTH LIPID M, V93, P126, DOI 10.1016/j.prostaglandins.2010.09.002; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Urban RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE794, DOI 10.1152/ajpendo.00174.2002; Wang G, 2009, P NATL ACAD SCI USA, V106, P16794, DOI 10.1073/pnas.0909022106; Yuqi Liu, 2009, BMC Med Genet, V10, P114, DOI 10.1186/1471-2350-10-114	43	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58749	10.1371/journal.pone.0058749	http://dx.doi.org/10.1371/journal.pone.0058749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516550	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200109
J	von Hoermann, C; Steiger, S; Muller, JK; Ayasse, M				von Hoermann, Christian; Steiger, Sandra; Mueller, Josef K.; Ayasse, Manfred			Too Fresh Is Unattractive! The Attraction of Newly Emerged Nicrophorus vespilloides Females to Odour Bouquets of Large Cadavers at Various Stages of Decomposition	PLOS ONE			English	Article							CARRION BEETLES COLEOPTERA; COLORADO POTATO BEETLE; SILPHIDAE; ORIENTATION; STRATEGIES; INSECTS; DISTANT	The necrophagous burying beetle Nicrophorus vespilloides reproduces on small carcasses that are buried underground to serve as food for their offspring. Cadavers that are too large to bury have previously been postulated to be important food sources for newly emerged beetles; however, the attractiveness of distinct successive stages of decomposition were not further specified. Therefore, we investigated the potential preference of newly emerged N. vespilloides females for odour bouquets of piglet cadavers at specific stages of decomposition. Analyses of walking tracks on a Kramer sphere revealed a significantly higher mean walking speed and, consequently, a higher mean total track length when beetles were confronted with odour plumes of the decomposition stages 'post-bloating', 'advanced decay' or 'dry remains' in comparison with the solvent control. Such a change of the walking speed of newly emerged N. vespilloides females indicates a higher motivation to locate such food sources. In contrast to less discriminating individuals this behaviour provides the advantage of not wasting time at unsuitable food sources. Furthermore, in the advanced decay stage, we registered a significantly higher preference of beetles for upwind directions to its specific odour plume when compared with the solvent control. Such a change to upwind walking behaviour increases the likelihood that a large cadaver will be quickly located. Our findings are of general importance for applied forensic entomology: newly emerged N. vespilloides females on large cadavers can and should be regarded as potential indicators of prolonged post mortem intervals as our results clearly show that they prefer emitted odour bouquets of later decomposition stages.	[von Hoermann, Christian; Steiger, Sandra; Ayasse, Manfred] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Mueller, Josef K.] Univ Freiburg, Dept Evolutionary Biol & Ecol, D-79106 Freiburg, Germany	Ulm University; University of Freiburg	von Hoermann, C (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	christian.hoermann-von-und@uni-ulm.de			Evangelisches Studienwerk Villigst (Protestant Academic Foundation); Robert Bosch foundation	Evangelisches Studienwerk Villigst (Protestant Academic Foundation); Robert Bosch foundation	CvH was supported by the Evangelisches Studienwerk Villigst (Protestant Academic Foundation) and SS was supported by the Robert Bosch foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce AN, 2012, J EVOLUTION BIOL, V25, P930, DOI 10.1111/j.1420-9101.2012.02486.x; Baker TC, 1996, PHYSIOL ENTOMOL, V21, P20, DOI 10.1111/j.1365-3032.1996.tb00831.x; Barata EN, 2001, PHYSIOL ENTOMOL, V26, P26, DOI 10.1046/j.1365-3032.2001.00213.x; Bohm H., 1988, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V6, P91; Bolter CJ, 1997, J CHEM ECOL, V23, P1003, DOI 10.1023/B:JOEC.0000006385.70652.5e; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Degenkolb T, 2011, J CHEM ECOL, V37, P724, DOI 10.1007/s10886-011-9978-4; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Dekeirsschieter J, 2011, BIOTECHNOL AGRON SOC, V15, P435; Dobler S, 2000, MOL PHYLOGENET EVOL, V15, P390, DOI 10.1006/mpev.1999.0765; Eggert Anne-Katrin, 1997, P216; FARKAS SR, 1972, SCIENCE, V178, P67, DOI 10.1126/science.178.4056.67; Goff ML, 2009, EXP APPL ACAROL, V49, P21, DOI 10.1007/s10493-009-9284-9; Grebennikov VV, 2009, EUR J ENTOMOL, V106, P275, DOI 10.14411/eje.2009.035; HANGART.W, 1967, Z VERGL PHYSIOL, V57, P103, DOI 10.1007/BF00303068; Hanski I., 1987, P837; HEINZEL HG, 1989, J COMP PHYSIOL A, V164, P775, DOI 10.1007/BF00616749; HEYMONS R., 1932, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V24, P259, DOI 10.1007/BF00491793; HEYMONS R., 1928, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V10, P330, DOI 10.1007/BF00410270; HEYMONS R., 1927, ZEITSCHR WISS BIOL ABT A MORPHOL U OKOL TIERE, V9, P271, DOI 10.1007/BF00424725; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; KENTNER E, 1990, PEDOBIOLOGIA, V34, P347; Kocarek P, 2001, BIOL RHYTHM RES, V32, P431, DOI 10.1076/brhm.32.4.431.1333; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Matuszewski S, 2008, FORENSIC SCI INT, V180, P61, DOI 10.1016/j.forsciint.2008.06.015; Matuszewski S, 2010, FORENSIC SCI INT, V195, P42, DOI 10.1016/j.forsciint.2009.11.007; Milne Lorus J., 1944, JOUR NEW YORK ENT SOC, V52, P311; MULLER JK, 1990, ANIM BEHAV, V40, P491, DOI 10.1016/S0003-3472(05)80529-9; MULLER JK, 1987, ETHOLOGY, V76, P297; Okada J, 2006, J COMP PHYSIOL A, V192, P715, DOI 10.1007/s00359-006-0106-9; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; PESCHKE K, 1987, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V114, P241; Petruska, 1975, ACTA U PALACKIANAE O, V51, P155; PUKOWSKI ERNA, 1933, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V27, P518, DOI 10.1007/BF00403155; REED H. B., 1958, AMER MIDLAND NAT, V59, P213, DOI 10.2307/2422385; REITER C, 1982, Z RECHTSMED, V89, P197, DOI 10.1007/BF01873802; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; Steenvoorde P, 2004, J Tissue Viability, V14, P97; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; Takken W, 2010, ECOL CONT VECTOR-BOR, V2, P1, DOI 10.3920/978-90-8686-698-4; THIERY D, 1987, J CHEM ECOL, V13, P1139, DOI 10.1007/BF01020544; TRUMBO ST, 1994, AM MIDL NAT, V131, P169, DOI 10.2307/2426619; von Hoermann C, 2011, FORENSIC SCI INT, V212, P173, DOI 10.1016/j.forsciint.2011.06.009; von Hoermann C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-18; WILSON DS, 1984, ANN ENTOMOL SOC AM, V77, P165, DOI 10.1093/aesa/77.2.165	47	21	22	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58524	10.1371/journal.pone.0058524	http://dx.doi.org/10.1371/journal.pone.0058524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516497	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200078
J	Lagrain, B; Brunnbauer, M; Rombouts, I; Koehler, P				Lagrain, Bert; Brunnbauer, Markus; Rombouts, Ine; Koehler, Peter			Identification of Intact High Molecular Weight Glutenin Subunits from the Wheat Proteome Using Combined Liquid Chromatography-Electrospray Ionization Mass Spectrometry	PLOS ONE			English	Article							TOP-DOWN PROTEOMICS; SIGNAL SUPPRESSION; STORAGE PROTEINS; QUALITY; RESOLUTION; VARIETIES	The present paper describes a method for the identification of intact high molecular weight glutenin subunits (HMW-GS), the quality determining proteins from the wheat storage proteome. The method includes isolation of HMW-GS from wheat flour, further separation of HMW-GS by reversed-phase high-performance liquid chromatography (RP-HPLC), and their subsequent molecular identification with electrospray ionization mass spectrometry using a quadrupole-time-of-flight mass analyzer. For HMW-GS isolation, wheat proteins were reduced and extracted from flour with 50% 1-propanol containing 1% dithiothreitol. HMW-GS were then selectively precipitated from the protein mixture by adjusting the 1-propanol concentration to 60%. The composition of the precipitated proteins was first evaluated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with Coomassie staining and RP-HPLC with ultraviolet detection. Besides HMW-GS (>= 65%), the isolated proteins mainly contained omega 5-gliadins. Secondly, the isolated protein fraction was analyzed by liquid chromatography-mass spectrometry. Optimal chromatographic separation of HMW-GS from the other proteins in the isolated fraction was obtained when the mobile phase contained 0.1% trifluoroacetic acid as ion-pairing agent. Individual HMW-GS were then identified by determining their molecular masses from the high-resolution mass spectra and comparing these with theoretical masses calculated from amino acid sequences. Using formic acid instead of trifluoroacetic acid in the mobile phase increased protein peak intensities in the base peak mass chromatogram. This allowed the detection of even traces of other wheat proteins than HMW-GS in the isolated fraction, but the chromatographic separation was inferior with a major overlap between the elution ranges of HMW-GS and omega-gliadins. Overall, the described method allows a rapid assessment of wheat quality through the direct determination of the HMW-GS composition and offers a basis for further top-down proteomics of individual HMW-GS and the entire wheat glutenin fraction.	[Lagrain, Bert; Brunnbauer, Markus; Rombouts, Ine; Koehler, Peter] German Res Ctr Food Chem, Freising Weihenstephan, Germany; [Lagrain, Bert; Rombouts, Ine] Katholieke Univ Leuven, Lab Food Chem & Biochem, Louvain, Belgium; [Lagrain, Bert; Rombouts, Ine] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Louvain, Belgium	Leibniz-Institute for Food Systems Biology at the Technical University of Munich; KU Leuven; KU Leuven	Lagrain, B (corresponding author), German Res Ctr Food Chem, Freising Weihenstephan, Germany.	bert.lagrain@biw.kuleuven.be	Rombouts, Ine/GRS-4802-2022	Rombouts, Ine/0000-0002-4145-5832; Lagrain, Bert/0000-0002-9707-1977	FWO	FWO(FWO)	BL wishes to acknowledge the Research Foundation - Flanders (FWO, Brussels, Belgium; www.fwo.be) for his position as postdoctoral fellow. IR wishes to acknowledge the Special Research Fund (KU Leuven, Leuven, Belgium; www.kuleuven.be) for a position as postdoctoral fellow. IR and BL both wish to acknowledge the FWO for financial support during a research stay at the German Research Center for Food Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; AOAC, 1995, OFFICIAL METHODS ANA, V16th; APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Bean SR, 2000, J CHROMATOGR A, V881, P23, DOI 10.1016/S0021-9673(99)01270-4; Bollecker SSJ, 1998, J AGR FOOD CHEM, V46, P4814, DOI 10.1021/jf980280q; Capriotti AL, 2011, J CHROMATOGR A, V1218, P8760, DOI 10.1016/j.chroma.2011.05.094; Cunsolo V, 2004, J MASS SPECTROM, V39, P66, DOI 10.1002/jms.558; Cunsolo V, 2003, RAPID COMMUN MASS SP, V17, P442, DOI 10.1002/rcm.938; Delcour JA, 2012, ANNU REV FOOD SCI T, V3, P469, DOI 10.1146/annurev-food-022811-101303; Di Stefano V, 2012, J CHROMATOGR A, V1259, P74, DOI 10.1016/j.chroma.2012.04.023; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; FERRIGE AG, 1991, RAPID COMMUN MASS SP, V5, P374, DOI 10.1002/rcm.1290050810; Gao LY, 2010, J AGR FOOD CHEM, V58, P2777, DOI 10.1021/jf903363z; Gustavsson SA, 2001, J CHROMATOGR A, V937, P41, DOI 10.1016/S0021-9673(01)01328-0; HICKMAN DR, 1995, J CEREAL SCI, V22, P99, DOI 10.1016/0733-5210(95)90038-1; HUEBNER FR, 1985, J CHROMATOGR, V327, P333, DOI 10.1016/S0021-9673(01)81662-9; Kasarda DD, 1998, CEREAL CHEM, V75, P70, DOI 10.1094/CCHEM.1998.75.1.70; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; Lagrain B, 2012, J CEREAL SCI, V56, P726, DOI 10.1016/j.jcs.2012.08.003; Liu L, 2009, J CEREAL SCI, V50, P295, DOI 10.1016/j.jcs.2009.05.006; Lutz E, 2012, J AGR FOOD CHEM, V60, P3708, DOI 10.1021/jf204973u; Mamone G, 2000, RAPID COMMUN MASS SP, V14, P897, DOI 10.1002/(SICI)1097-0231(20000530)14:10<897::AID-RCM962>3.0.CO;2-Z; Mamone G, 2009, J CHROMATOGR A, V1216, P7130, DOI 10.1016/j.chroma.2009.07.052; MARCHYLO BA, 1989, J CEREAL SCI, V9, P113, DOI 10.1006/jcrs.1998.0225; McLafferty FW, 2011, ANNU REV ANAL CHEM, V4, P1, DOI 10.1146/annurev-anchem-061010-114018; Muccilli V, 2005, PROTEOMICS, V5, P719, DOI 10.1002/pmic.200401029; PAYNE PI, 1981, THEOR APPL GENET, V60, P229, DOI 10.1007/BF02342544; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Qian YW, 2008, J AM SOC MASS SPECTR, V19, P1542, DOI 10.1016/j.jasms.2008.06.008; Roels SP, 1996, J CEREAL SCI, V24, P227, DOI 10.1006/jcrs.1996.0055; Stephenson JL, 2002, CURR OPIN BIOTECH, V13, P57, DOI 10.1016/S0958-1669(02)00285-9; van Eckert R, 2006, J CEREAL SCI, V43, P331, DOI 10.1016/j.jcs.2005.12.009; Wang K, 2012, HEREDITAS, V149, P41, DOI 10.1111/j.1601-5223.2011.02215.x; Wang YJ, 2005, J CHROMATOGR A, V1073, P35, DOI 10.1016/j.chroma.2004.08.140; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wieser H, 2009, EUR FOOD RES TECHNOL, V229, P523, DOI 10.1007/s00217-009-1081-5; Zhang Q, 2008, J CEREAL SCI, V47, P252, DOI 10.1016/j.jcs.2007.04.013	38	23	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58682	10.1371/journal.pone.0058682	http://dx.doi.org/10.1371/journal.pone.0058682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520527	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900087
J	Puppo, A; Bello, A; Manfredi, A; Cesi, G; Marrocco, E; Della Corte, M; Rossi, S; Giunti, M; Bacci, ML; Simonelli, F; Surace, EM; Kobinger, GP; Auricchio, A				Puppo, Agostina; Bello, Alexander; Manfredi, Anna; Cesi, Giulia; Marrocco, Elena; Della Corte, Michele; Rossi, Settimio; Giunti, Massimo; Bacci, Maria Laura; Simonelli, Francesca; Surace, Enrico Maria; Kobinger, Gary P.; Auricchio, Alberto			Recombinant Vectors Based on Porcine Adeno-Associated Viral Serotypes Transduce the Murine and Pig Retina	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; LONG-TERM PRESERVATION; MEDIATED GENE-TRANSFER; RPE65 MUTATIONS; VISUAL FUNCTION; MOUSE MODEL; SIALIC-ACID; THERAPY; EXPRESSION; ROD	Recombinant adeno-associated viral (AAV) vectors are known to safely and efficiently transduce the retina. Among the various AAV serotypes available, AAV2/5 and 2/8 are the most effective for gene transfer to photoreceptors (PR), which are the most relevant targets for gene therapy of inherited retinal degenerations. However, the search for novel AAV serotypes with improved PR transduction is ongoing. In this work we tested vectors derived from five AAV serotypes isolated from porcine tissues (referred to as porcine AAVs, four of which are newly identified) for their ability to transduce both the murine and the cone-enriched pig retina. Porcine AAV vectors expressing EGFP under the control of the CMV promoter were injected subretinally either in C57BL/6 mice or Large White pigs. The resulting retinal tropism was analyzed one month later on histological sections, while levels of PR transduction were assessed by Western blot. Our results show that all porcine AAV transduce murine and porcine retinal pigment epithelium and PR upon subretinal administration. AAV2/po1 and 2/po5 are the most efficient porcine AAVs for murine PR transduction and exhibit the strongest tropism for pig cone PR. The levels of PR transduction obtained with AAV2/po1 and 2/po5 are similar, albeit not superior, to those obtained with AAV2/5 and AAV2/8, which evinces AAV2/po1 and 2/po5 to be promising vectors for retinal gene therapy.	[Puppo, Agostina; Manfredi, Anna; Cesi, Giulia; Marrocco, Elena; Surace, Enrico Maria; Auricchio, Alberto] Telethon Inst Genet & Med, Naples, Italy; [Auricchio, Alberto] Univ Naples Federico II, Dept Med Translat Sci, Naples, Italy; [Bello, Alexander; Kobinger, Gary P.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada; [Bello, Alexander; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Della Corte, Michele; Rossi, Settimio; Simonelli, Francesca] Univ Naples 2, Dept Ophthalmol, Naples, Italy; [Giunti, Massimo; Bacci, Maria Laura] Univ Bologna, Dept Vet Med Sci, Bologna, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Public Health Agency of Canada; University of Manitoba; Universita della Campania Vanvitelli; University of Bologna	Auricchio, A (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	auricchio@tigem.it	Simonelli, Francesca/AHE-7571-2022; Rossi, Settimio/AHI-1119-2022; AURICCHIO, Alberto/AHE-7979-2022; Manfredi, Anna/ABC-8588-2021	Simonelli, Francesca/0000-0001-8520-6769; AURICCHIO, Alberto/0000-0002-0832-2472; Bacci, Maria Laura/0000-0001-6702-5868; DELLA CORTE, MICHELE/0000-0003-1320-1883; Surace, Enrico Maria/0000-0002-2975-942X	European Community's Seventh Framework Programme [FP7] [242013]; Fondazione Telethon Project [TGM11MT1]	European Community's Seventh Framework Programme [FP7](European Commission); Fondazione Telethon Project(Fondazione Telethon)	The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no 242013 [TREATRUSH] and from Fondazione Telethon Project no TGM11MT1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Allocca M, 2011, INVEST OPHTH VIS SCI, V52, P5713, DOI 10.1167/iovs.10-6269; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Auricchio A, 2002, MOL THER, V6, P238, DOI 10.1006/mthe.2002.0660; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Auricchio A, 2011, HUM GENE THER, V22, P1169, DOI 10.1089/hum.2011.2521; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bello A, 2009, GENE THER, V16, P1320, DOI 10.1038/gt.2009.82; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Boye SL, 2011, INVEST OPHTH VIS SCI, V52, P7098, DOI 10.1167/iovs.11-7867; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2012, HUM GENE THER, V23, P796, DOI 10.1089/hum.2012.123; Daiger SP SL, 2011, RETNET RETINAL INFOR; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Drittanti L, 2000, GENE THER, V7, P924, DOI 10.1038/sj.gt.3301191; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Harris, 2001, RETINA, P2068; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hendrickson A, 2002, EXP EYE RES, V74, P435, DOI 10.1006/exer.2002.1181; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Li AM, 2002, INVEST OPHTH VIS SCI, V43, P1375; Liang FQ, 2001, METH MOLEC MED, V47, P125, DOI 10.1385/1-59259-085-3:125; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Mieziewska K, 1996, MICROSC RES TECHNIQ, V35, P463; Mihelec M, 2011, HUM GENE THER, V22, P1179, DOI 10.1089/hum.2011.069; Min SH, 2005, MOL THER, V12, P644, DOI 10.1016/j.ymthe.2005.06.002; Mohand-Said S, 2001, PROG RETIN EYE RES, V20, P451, DOI 10.1016/S1350-9462(01)00006-4; Mussolino C, 2011, GENE THER, V18, P637, DOI 10.1038/gt.2011.3; Mussolino C, 2011, EMBO MOL MED, V3, P118, DOI 10.1002/emmm.201000119; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Noel JM, 2012, EXP EYE RES, V97, P137, DOI 10.1016/j.exer.2011.12.018; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Perabo L, 2008, COMB CHEM HIGH T SCR, V11, P118; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Smith AJ, 2003, MOL THER, V8, P188, DOI 10.1016/S1525-0016(03)00144-8; Sommer JR, 2011, BRIT J OPHTHALMOL, V95, P1749, DOI 10.1136/bjophthalmol-2011-300417; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Vandenberghe L.H., 2011, SCI TRANSL MED, V3; VESTRE WA, 1984, VET CLIN N AM-LARGE, V6, P667; Walters RW, 2004, J VIROL, V78, P3361, DOI 10.1128/JVI.78.7.3361-3371.2004; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Yang PZ, 2002, INVEST OPHTH VIS SCI, V43, P1488; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59025	10.1371/journal.pone.0059025	http://dx.doi.org/10.1371/journal.pone.0059025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520549	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900109
J	Xiong, YS; Yu, J; Li, C; Zhu, L; Wu, LJ; Zhong, RQ				Xiong, Yi-song; Yu, Juan; Li, Chang; Zhu, Lin; Wu, Li-juan; Zhong, Ren-qian			The Role of Siglec-1 and SR-BI Interaction in the Phagocytosis of Oxidized Low Density Lipoprotein by Macrophages	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; FOAM-CELL-FORMATION; RECEPTOR; SIALOADHESIN; LDL; EXPRESSION; BINDS; ATHEROSCLEROSIS; ACCUMULATION; MONOCYTES	Background: Macrophages play a proatherosclerotic role in atherosclerosis via oxLDL uptake. As an adhesion molecular of I-type lectins, Siglec-1 is highly expressed on circulating monocytes and plaque macrophages of atherosclerotic patients, but the exact role of Siglec-1 has not been elucidated. Methods: In this study, oxLDL was used to stimulate Siglec-1 and some oxLDL receptors (SR-BI, CD64, CD32B, LOX-1 and TLR-4) expression on bone marrow-derived macrophages, whereas small interfering RNA was used to down-regulate Siglec-1. Meanwhile, an ELISA-based assay for Siglec-1-oxLDL interaction was performed, and co-immunoprecipitation (co-IP) and laser scanning confocal microscopy (LSCM) were used to determine the role of Siglec-1 in oxLDL uptake by macrophages. Results: We found that oxLDL could up-regulate the expression of various potential oxLDL receptors, including Siglec-1, in a dose-dependent manner. Moreover, down-regulation of Siglec-1 could attenuate oxLDL uptake by Oil red O staining. LSCM revealed that Siglec-1 and CD64/SR-BI may colocalize on oxLDL-stimulated macrophage surface, whereas co-IP showed that Siglec-1 and SR-BI can be immunoprecipitated by each other. However, no direct interaction between Siglec-1 and oxLDL was found in the in vitro protein interaction system. Conclusions: Thus, Siglec-1 can interact with SR-BI in the phagocytosis of oxLDL by macrophages, rather than act as an independent receptor for oxLDL.	[Xiong, Yi-song; Wu, Li-juan] Chengdu Mil Gen Hosp, Dept Lab Med, Chengdu, Peoples R China; [Yu, Juan; Li, Chang; Zhong, Ren-qian] Second Mil Med Univ, Changzheng Hosp, Dept Lab Med, Shanghai, Peoples R China; [Yu, Juan; Li, Chang; Zhong, Ren-qian] Clin Immunol Ctr PLA, Shanghai, Peoples R China; [Zhu, Lin] Second Mil Med Univ, Changzheng Hosp, Dept Cardiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wu, LJ (corresponding author), Chengdu Mil Gen Hosp, Dept Lab Med, Chengdu, Peoples R China.	lijuanwu1126@126.com; rqzhong@yahoo.com			Hi-Tech research and development program of China (863 Program) [2006AA02Z496]; Funds for Excellent Department Leader, Science and Technology Commission of Shanghai Municipality [07XD14013]; National Natural Science Foundation of China [81072479, 81170263]	Hi-Tech research and development program of China (863 Program)(National High Technology Research and Development Program of China); Funds for Excellent Department Leader, Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hi-Tech research and development program of China (863 Program) (2006AA02Z496), Funds for Excellent Department Leader, Science and Technology Commission of Shanghai Municipality (07XD14013), and The National Natural Science Foundation of China (81072479, 81170263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes YC, 1999, BLOOD, V93, P1245, DOI 10.1182/blood.V93.4.1245.404k09_1245_1252; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1995, J CLIN INVEST, V95, P635, DOI 10.1172/JCI117708; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; Feng JW, 2000, J LIPID RES, V41, P688; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; Fujita Y, 2009, CLIN CHEM, V55, P285, DOI 10.1373/clinchem.2008.119750; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Kataoka H, 2001, ARTERIOSCL THROM VAS, V21, P955, DOI 10.1161/01.ATV.21.6.955; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Laukkanen J, 2000, CIRCULATION, V101, P1091, DOI 10.1161/01.CIR.101.10.1091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuura E, 2006, LUPUS, V15, P478, DOI 10.1191/0961203306lu2337oa; Nicolaou G, 2010, CURR OPIN LIPIDOL, V21, P427, DOI 10.1097/MOL.0b013e32833cacd5; Paul SP, 2000, BLOOD, V96, P483; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schiopu A, 2007, J AM COLL CARDIOL, V50, P2313, DOI 10.1016/j.jacc.2007.07.081; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; STANTON LW, 1992, J BIOL CHEM, V267, P22446; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Van Gorp H, 2009, ARCH VIROL, V154, P1939, DOI 10.1007/s00705-009-0527-1; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Xiong YS, 2009, CLIN BIOCHEM, V42, P1057, DOI 10.1016/j.clinbiochem.2009.02.026; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zou ZC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024559	35	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58831	10.1371/journal.pone.0058831	http://dx.doi.org/10.1371/journal.pone.0058831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520536	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900096
J	Riedel, T; Gomez-Consarnau, L; Tomasch, J; Martin, M; Jarek, M; Gonzalez, JM; Spring, S; Rohlfs, M; Brinkhoff, T; Cypionka, H; Goker, M; Fiebig, A; Klein, J; Goesmann, A; Fuhrman, JA; Wagner-Dobler, I				Riedel, Thomas; Gomez-Consarnau, Laura; Tomasch, Juergen; Martin, Madeleine; Jarek, Michael; Gonzalez, Jose M.; Spring, Stefan; Rohlfs, Meike; Brinkhoff, Thorsten; Cypionka, Heribert; Goeker, Markus; Fiebig, Anne; Klein, Johannes; Goesmann, Alexander; Fuhrman, Jed A.; Wagner-Doebler, Irene			Genomics and Physiology of a Marine Flavobacterium Encoding a Proteorhodopsin and a Xanthorhodopsin-Like Protein	PLOS ONE			English	Article							DRIVEN PROTON TRANSLOCATION; FRESH-WATER; LIGHT; SEQUENCE; BACTERIAL; RHODOPSIN; GENETICS; SYSTEM; PUMP; CELL	Proteorhodopsin (PR) photoheterotrophy in the marine flavobacterium Dokdonia sp. PRO95 has previously been investigated, showing no growth stimulation in the light at intermediate carbon concentrations. Here we report the genome sequence of strain PRO95 and compare it to two other PR encoding Dokdonia genomes: that of strain 4H-3-7-5 which shows the most similar genome, and that of strain MED134 which grows better in the light under oligotrophic conditions. Our genome analysis revealed that the PRO95 genome as well as the 4H-3-7-5 genome encode a protein related to xanthorhodopsins. The genomic environment and phylogenetic distribution of this gene suggest that it may have frequently been recruited by lateral gene transfer. Expression analyses by RT-PCR and direct mRNA-sequencing showed that both rhodopsins and the complete beta-carotene pathway necessary for retinal production are transcribed in PRO95. Proton translocation measurements showed enhanced proton pump activity in response to light, supporting that one or both rhodopsins are functional. Genomic information and carbon source respiration data were used to develop a defined cultivation medium for PRO95, but reproducible growth always required small amounts of yeast extract. Although PRO95 contains and expresses two rhodopsin genes, light did not stimulate its growth as determined by cell numbers in a nutrient poor seawater medium that mimics its natural environment, confirming previous experiments at intermediate carbon concentrations. Starvation or stress conditions might be needed to observe the physiological effect of light induced energy acquisition.	[Riedel, Thomas; Tomasch, Juergen; Martin, Madeleine; Jarek, Michael; Rohlfs, Meike; Wagner-Doebler, Irene] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Gomez-Consarnau, Laura; Fuhrman, Jed A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Gonzalez, Jose M.] Univ La Laguna, Dept Microbiol, Tenerife, Spain; [Spring, Stefan; Goeker, Markus; Fiebig, Anne] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany; [Brinkhoff, Thorsten; Cypionka, Heribert] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany; [Klein, Johannes] Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, D-38106 Braunschweig, Germany; [Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Southern California; Universidad de la Laguna; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Carl von Ossietzky Universitat Oldenburg; Braunschweig University of Technology; University of Bielefeld	Riedel, T (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	Thomas.Riedel@helmholtz-hzi.de	Spring, Stefan/N-6933-2013; Fuhrman, Jed A/C-6461-2013; Gomez-Consarnau, Laura/AAM-1319-2021; Gonzalez, Jose M./C-3333-2013; Göker, Markus/AAX-6258-2021; Wagner-Döbler, Irene/Y-1685-2019	Spring, Stefan/0000-0001-6247-0938; Fuhrman, Jed A/0000-0002-2361-1985; Gonzalez, Jose M./0000-0002-9926-3323; Göker, Markus/0000-0002-5144-6200; Wagner-Dobler, Irene/0000-0001-5883-2502; Tomasch, Jurgen/0000-0002-3914-2781; Goesmann, Alexander/0000-0002-7086-2568	DFG [Transregio-SFB 51 Roseobacter]; Swedish Research Council [623-2009-7258]	DFG(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	TR, JT, HC, TB, MG, AF, IWD gratefully acknowledge funding by the DFG Transregio-SFB 51 Roseobacter, and LGC by the Swedish Research Council (Project 623-2009-7258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque L, 2005, FEMS MICROBIOL LETT, V247, P161, DOI 10.1016/j.femsle.2005.05.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong GA, 1997, ANNU REV MICROBIOL, V51, P629, DOI 10.1146/annurev.micro.51.1.629; Atamna-Ismaeel N, 2008, ISME J, V2, P656, DOI 10.1038/ismej.2008.27; Balashov SP, 2007, CELL MOL LIFE SCI, V64, P2323, DOI 10.1007/s00018-007-7167-y; Balashov SP, 2008, BIOPHYS J, V95, P2402, DOI 10.1529/biophysj.108.132175; Balashov SP, 2010, BIOCHEMISTRY-US, V49, P9792, DOI 10.1021/bi1014166; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Becq J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009989; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bohlin J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-104; Borthwick AD, 2012, CHEM REV, V112, P3641, DOI 10.1021/cr200398y; Cottrell MT, 2009, APPL ENVIRON MICROB, V75, P4958, DOI 10.1128/AEM.00117-09; de Carvalho MP, 2012, CURR MED CHEM, V19, P3564; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; FITZ RM, 1989, ARCH MICROBIOL, V152, P369, DOI 10.1007/BF00425175; FITZ RM, 1991, ARCH MICROBIOL, V155, P444, DOI 10.1007/BF00244959; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Giovannoni SJ, 2012, ISME J; Giovannoni SJ, 2012, P NATL ACAD SCI USA, V109, P13888, DOI 10.1073/pnas.1211722109; Gomez E, 2012, GENE, V497, P263, DOI 10.1016/j.gene.2012.01.069; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Gonzalez JM, 2011, APPL ENVIRON MICROB, V77, P8676, DOI 10.1128/AEM.06152-11; Holert J, 2011, ENV MICROBIOL REP, V3, P136, DOI 10.1111/j.1758-2229.2010.00199.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Ivanova N, 2011, STAND GENOMIC SCI, V4, P91, DOI 10.4056/sigs.1563919; Jiao NZ, 2010, J BACTERIOL, V192, P1169, DOI 10.1128/JB.01504-09; Kang I, 2010, J BACTERIOL, V192, P4798, DOI 10.1128/JB.00761-10; KIM SK, 1992, ANNU REV MICROBIOL, V46, P117, DOI 10.1146/annurev.mi.46.100192.001001; Kimura H, 2011, ISME J, V5, P1641, DOI 10.1038/ismej.2011.36; Klippel B, 2011, J BACTERIOL, V193, P4545, DOI 10.1128/JB.05518-11; Koh EY, 2010, APPL ENVIRON MICROB, V76, P5918, DOI 10.1128/AEM.00562-10; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Oh TK, 2011, INT J SYST EVOL MICR; Riedel T, 2012, STAND GENOMIC SCI, V7, P107, DOI 10.4056/sigs.3216895; Riedel T, 2010, APPL ENVIRON MICROB, V76, P3187, DOI 10.1128/AEM.02971-09; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Sabehi G, 2007, ISME J, V1, P48, DOI 10.1038/ismej.2007.10; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI USA, V109, P14041, DOI 10.1073/pnas.1208755109; Scholes P, 1971, J Bioenerg, V1, P309; Shanker U, 2012, ORIGINS LIFE EVOL B, V42, P31, DOI 10.1007/s11084-012-9266-5; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Staden R, 2000, Methods Mol Biol, V132, P115; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Su HS, 2001, MICROBIOL-UK, V147, P581, DOI 10.1099/00221287-147-3-581; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Trappen S, 2004, INT J SYST EVOL MICR, V54, P445, DOI 10.1099/ijs.0.02922-0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038749; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yoshitsugu M, 2009, BIOCHEMISTRY-US, V48, P4324, DOI 10.1021/bi900228a; Yoshizawa S, 2012, ENVIRON MICROBIOL, V14, P1240, DOI 10.1111/j.1462-2920.2012.02702.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng QA, 2011, J BACTERIOL, V193, P2074, DOI 10.1128/JB.00121-11	82	33	37	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57487	10.1371/journal.pone.0057487	http://dx.doi.org/10.1371/journal.pone.0057487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23526944	gold, Green Published, Green Submitted			2022-12-25	WOS:000315634900024
J	Karabencheva-Christova, TG; Carlsson, U; Balali-Mood, K; Black, GW; Christov, CZ				Karabencheva-Christova, Tatyana G.; Carlsson, Uno; Balali-Mood, Kia; Black, Gary W.; Christov, Christo Z.			Conformational Effects on the Circular Dichroism of Human Carbonic Anhydrase II: A Multilevel Computational Study	PLOS ONE			English	Article							TEM-1 BETA-LACTAMASE; MOLECULAR-DYNAMICS; ROTATIONAL STRENGTHS; SIDE-CHAINS; CHIROPTICAL PROPERTIES; LINEAR DICHROISM; NEAR-ULTRAVIOLET; FAR-ULTRAVIOLET; GAS-PHASE; CLASS-A	Circular Dichroism (CD) spectroscopy is a powerful method for investigating conformational changes in proteins and therefore has numerous applications in structural and molecular biology. Here a computational investigation of the CD spectrum of the Human Carbonic Anhydrase II (HCAII), with main focus on the near-UV CD spectra of the wild-type enzyme and it seven tryptophan mutant forms, is presented and compared to experimental studies. Multilevel computational methods (Molecular Dynamics, Semiempirical Quantum Mechanics, Time-Dependent Density Functional Theory) were applied in order to gain insight into the mechanisms of interaction between the aromatic chromophores within the protein environment and understand how the conformational flexibility of the protein influences these mechanisms. The analysis suggests that combining CD semi empirical calculations, crystal structures and molecular dynamics (MD) could help in achieving a better agreement between the computed and experimental protein spectra and provide some unique insight into the dynamic nature of the mechanisms of chromophore interactions.	[Karabencheva-Christova, Tatyana G.; Black, Gary W.; Christov, Christo Z.] Northumbria Univ, Sch Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Carlsson, Uno] Linkoping Univ, IFM Dept Chem, Linkoping, Sweden; [Balali-Mood, Kia] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Northumbria University; Linkoping University; University of Oxford	Christov, CZ (corresponding author), Northumbria Univ, Sch Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	christo.christov@northumbria.ac.uk		Black, Gary/0000-0003-3697-0714	UK National Service for Computational Chemistry Software; UK National Supercomputer Service Hector; Marie Curie Fellowships (FP7 of EU); Engineering and Physical Sciences Research Council [EP/J003921/1] Funding Source: researchfish; EPSRC [EP/J003921/1] Funding Source: UKRI	UK National Service for Computational Chemistry Software; UK National Supercomputer Service Hector; Marie Curie Fellowships (FP7 of EU); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study is done using support from UK National Service for Computational Chemistry Software, UK National Supercomputer Service Hector and Marie Curie Fellowships (FP7 of EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Andrew CD, 2002, J AM CHEM SOC, V124, P12706, DOI 10.1021/ja027629h; BAYLEY PM, 1969, J PHYS CHEM-US, V73, P228, DOI 10.1021/j100721a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berova N, 2007, CHEM SOC REV, V36, P914, DOI 10.1039/b515476f; Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Bulheller BM, 2007, PHYS CHEM CHEM PHYS, V9, P2020, DOI 10.1039/b615870f; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Casida ME, 2012, ANNU REV PHYS CHEM, V63, P287, DOI [10.1146/annurev-physchem-032511-143803, 10.1146/annurev-physchem-032511-443803]; Christov C, 2006, J MOL MODEL, V12, P411, DOI 10.1007/s00894-005-0061-3; Christov C, 2004, CHEM PHYS LETT, V400, P524, DOI 10.1016/j.cplett.2004.11.008; Christov C, 2004, CHEM PHYS LETT, V396, P282, DOI 10.1016/j.cplett.2004.08.035; Christov C, 2008, CHEM PHYS LETT, V456, P89, DOI 10.1016/j.cplett.2008.03.012; Christov C, 2011, THEOR CHEM ACC, V128, P25, DOI 10.1007/s00214-010-0744-4; Christov CZ, 2008, COMPUT BIOL CHEM, V32, P167, DOI 10.1016/j.compbiolchem.2008.02.003; Dennington R., 2016, GAUSSVIEW; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Furche F., 2005, ANN REPORTS COMPUTAT, V1, P19, DOI [10.1016/s1574-1400(05)01002-9, DOI 10.1016/S1574-1400(05)01002-9]; GOUX WJ, 1980, J AM CHEM SOC, V102, P7080, DOI 10.1021/ja00543a033; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hudecova J, 2012, CHEMPHYSCHEM, V13, P2748, DOI 10.1002/cphc.201200201; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karabencheva T, 2010, ADV PROTEIN CHEM STR, V80, P85, DOI [10.1016/S1876-1623(10)80003-3, 10.1016/B978-0-12-381264-3.00003-5]; Karabencheva T, 2010, BIOPHYS CHEM, V151, P39, DOI 10.1016/j.bpc.2010.05.003; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Li M, 2006, BIOCHEMISTRY-US, V45, P4775, DOI 10.1021/bi051847g; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; MCCAMMON JA, 1999, SIMPLICITY COMPLEXIT; Robinson D, 2009, J PHYS CHEM B, V113, P14521, DOI 10.1021/jp9071108; Robinson D, 2009, J PHYS CHEM B, V113, P2535, DOI 10.1021/jp808943d; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Rogers DM, 2003, J PHYS CHEM A, V107, P11191, DOI 10.1021/jp036081d; Rogers DM, 2004, BIOCHEMISTRY-US, V43, P11092, DOI 10.1021/bi049031n; Rosenfeld L, 1929, Z PHYS, V52, P161, DOI 10.1007/BF01342393; Roy A, 2009, CHIRALITY, V21, pE163, DOI 10.1002/chir.20792; Woody R.W., 1996, CIRCULAR DICHROISM C, P25, DOI DOI 10.1007/978-1-4757-2508-7_2; Woody R.W., 2007, METHODS PROTEIN STRU, P291; Woody RW, 1999, J CHEM PHYS, V111, P2844, DOI 10.1063/1.479562; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Woody RW, 1996, CIRCULAR DICHROISM C, P109; [No title captured]	46	17	17	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56874	10.1371/journal.pone.0056874	http://dx.doi.org/10.1371/journal.pone.0056874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23526922	Green Accepted, Green Published, gold			2022-12-25	WOS:000316849500038
J	Huang, JY; Simcox, J; Mitchell, TC; Jones, D; Cox, J; Luo, B; Cooksey, RC; Boros, LG; McClain, DA				Huang, Jingyu; Simcox, Judith; Mitchell, T. Creighton; Jones, Deborah; Cox, James; Luo, Bai; Cooksey, Robert C.; Boros, Laszlo G.; McClain, Donald A.			Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice	FASEB JOURNAL			English	Article						AMPK; insulin signaling; acetylation	HEREDITARY HEMOCHROMATOSIS; MOUSE MODEL; INSULIN-RESISTANCE; OXIDATIVE STRESS; CELL APOPTOSIS; METABOLISM; ACETYLATION; HEPCIDIN; P53; DEACETYLATION	Excess iron is associated with hepatic damage and diabetes in humans, although the detailed molecular mechanisms are not known. To investigate how iron regulates glucose homeostasis, we fed C57BL/6J male mice with high-iron (HI) diets (2 or 20 g Fe/kg chow). Mice fed an HI diet exhibited elevated AMP-activated protein kinase (AMPK) activity and impaired insulin signaling in skeletal muscle and liver. Consistent with the increased AMPK activity, glucose uptake was enhanced in mice fed an HI diet. The effects of improved glucose tolerance induced by HI feeding were abolished in transgenic mice with expression of muscle specific dominant-negative AMPK. Glucose output was suppressed in the liver of wild-type mice fed an HI diet, due to decreased expression of gluconeogenic genes and decreased substrate (lactate) from peripheral glycolysis. Iron activated AMPK by increasing deacetylase and decreasing LKB1 acetylation, in turn stimulating the phosphorylation of LKB1 and AMPK. The effects of HI diet were abrogated by treatment of the mice with N-acetyl cysteine, suggesting a redox-dependent mechanism for increasing deacetylase activity. In addition, tissue from iron-fed mice exhibited an elevated AMP/ATP ratio, further contributing to AMPK activation. In summary, a diet high in iron improves glucose tolerance by activating AMPK through mechanisms that include deacetylation.Huang J., Simcox, J., Mitchell, T. C., Jones, D., Cox, J., Luo, B., Cooksey, R. C., Boros, L. G., McClain, D. A. Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice.	[Huang, Jingyu; Simcox, Judith; Mitchell, T. Creighton; Jones, Deborah; Cox, James; Luo, Bai; Cooksey, Robert C.; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Huang, Jingyu; Simcox, Judith; Mitchell, T. Creighton; Jones, Deborah; Cox, James; Luo, Bai; Cooksey, Robert C.; McClain, Donald A.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Cooksey, Robert C.; McClain, Donald A.] Vet Affairs Med Ctr, Res Serv, Salt Lake City, UT 84148 USA; [Boros, Laszlo G.] Sidmap LLC, Los Angeles, CA USA; [Boros, Laszlo G.] Harbor UCLA Med Ctr, Dept Pediat, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	McClain, DA (corresponding author), Div Endocrinol, 30 N 2030 East, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359; Simcox, Judith/0000-0001-7350-6342	U.S. National Institutes of Health [RO1DK081842, 1T32DK091317]; Research Service of the U.S. Department of Veterans Affairs; Marilyn Jane Robinson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081842, T32DK091317] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001140] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Marilyn Jane Robinson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Morris Birnbaum (University of Pennsylvania, Philadelphia, PA, USA) for the AMPK-DN mice. This work was supported by the U.S. National Institutes of Health (RO1DK081842, D.M.; 1T32DK091317, J.S.), the Research Service of the U.S. Department of Veterans Affairs, and the Marilyn Jane Robinson Foundation.	Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Fryer LGD, 2002, FEBS LETT, V531, P189, DOI 10.1016/S0014-5793(02)03501-9; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Hatunic M, 2010, METABOLISM, V59, P380, DOI 10.1016/j.metabol.2009.08.006; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang JH, 2007, J BIOL CHEM, V282, P37501, DOI 10.1074/jbc.M703625200; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Huberman A, 2002, ANAL BIOCHEM, V307, P375, DOI 10.1016/S0003-2697(02)00047-7; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Joitihan HA, 2008, MOL MED, V14, P98, DOI 10.2119/2007-00114.Jouihan; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lebeau A, 2002, EUR J CLIN INVEST, V32, P603, DOI 10.1046/j.1365-2362.2002.01026.x; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; McClain DA, 2006, DIABETOLOGIA, V49, P1661, DOI 10.1007/s00125-006-0200-0; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; QUAIL EA, 1995, FEBS LETT, V359, P126, DOI 10.1016/0014-5793(95)00023-3; Rajpathak SN, 2009, DIABETES OBES METAB, V11, P472, DOI 10.1111/j.1463-1326.2008.00985.x; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; Sullivan JL, 2007, EXP BIOL MED, V232, P1014, DOI 10.3181/0703-MR-54; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	38	43	45	2	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2845	2854		10.1096/fj.12-216929	http://dx.doi.org/10.1096/fj.12-216929			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23515442	Green Published			2022-12-25	WOS:000328841000032
J	Puljung, MC; Zagotta, WN				Puljung, Michael C.; Zagotta, William N.			A Secondary Structural Transition in the C-helix Promotes Gating of Cyclic Nucleotide-regulated Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; LIGAND-BINDING; HCN CHANNELS; ACTIVATED CHANNELS; TERMINAL REGION; GATED CHANNELS; CAMP-BINDING; PROTEIN; MODULATION; MOVEMENT	Cyclic nucleotide-regulated ion channels bind second messengers like cAMP to a C-terminal domain, consisting of a beta-roll, followed by two alpha-helices (B- and C-helices). We monitored the cAMP-dependent changes in the structure of the C-helix of a C-terminal fragment of HCN2 channels using transition metal ion FRET between fluorophores on the C-helix and metal ions bound between histidine pairs on the same helix. cAMP induced a change in the dimensions of the C-helix and an increase in the metal binding affinity of the histidine pair. cAMP also caused an increase in the distance between a fluorophore on the C-helix and metal ions bound to the B-helix. Stabilizing the C-helix of intact CNGA1 channels by metal binding to a pair of histidines promoted channel opening. These data suggest that ordering of the C-helix is part of the gating conformational change in cyclic nucleotide-regulated channels.	[Puljung, Michael C.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu		Puljung, Michael/0000-0002-9335-0936	National Institutes of Health [R01 EY010329, F32EY018981]; NATIONAL EYE INSTITUTE [F32EY018981, R01EY010329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY010329 (to W.N.Z.) and F32EY018981 (to M.C.P.).	Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; ARNOLD FH, 1991, SCIENCE, V252, P1796, DOI 10.1126/science.1648261; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Glaaser IW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1717; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; GORDON SE, 1995, NEURON, V14, P177; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Mazzolini M, 2002, BIOPHYS J, V83, P3283, DOI 10.1016/S0006-3495(02)75329-0; Molokanova E, 1997, J NEUROSCI, V17, P9068; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Puljung MC, 2011, BIOPHYS J, V100, P2513, DOI 10.1016/j.bpj.2011.03.063; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; SUH SS, 1991, PROTEIN ENG, V4, P301, DOI 10.1093/protein/4.3.301; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; Taraska JW, 2009, P NATL ACAD SCI USA, V106, P16227, DOI 10.1073/pnas.0905207106; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Yu XZ, 2013, STRUCTURE, V21, P9, DOI 10.1016/j.str.2012.11.013; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	46	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12944	12956		10.1074/jbc.M113.464123	http://dx.doi.org/10.1074/jbc.M113.464123			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525108	hybrid, Green Published			2022-12-25	WOS:000318555100048
J	Zhu, XJ; Zhao, P; Liu, YD; Zhang, XY; Fu, J; Yu, HMI; Qiu, MS; Chen, YP; Hsu, W; Zhang, ZY				Zhu, XiaoJing; Zhao, Pan; Liu, YuDong; Zhang, XiaoYun; Fu, Jiang; Yu, H. -M. Ivy; Qiu, Mengsheng; Chen, YiPing; Hsu, Wei; Zhang, Zunyi			Intra-epithelial Requirement of Canonical Wnt Signaling for Tooth Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; HAIR FOLLICLE DEVELOPMENT; EMBRYONIC AXIS FORMATION; MAMMALIAN TOOTH; TRANSMEMBRANE PROTEIN; DENTAL MESENCHYME; REGULATES GROWTH; MOUSE TOOTH; ENAMEL KNOT; PATHWAY	Multiple Wnt ligands are expressed in the developing tooth and play important and redundant functions during odontogenesis. However, the source of Wnt ligands and their targeting cells and action mechanism in tooth organogenesis remain largely elusive. Here we show that epithelial inactivation of Gpr177, the mouse Wntless (Wls) whose product regulates Wnt sorting and secretion, leads to arrest of tooth development at the early cap stage and abrogates tooth-forming capability of the dental epithelium. Gpr177 in the epithelium is necessary for the activation of canonical Wnt signaling in the dental epithelium and formation of a functional enamel knot. Epithelial deletion of Gpr177 results in defective gene expression and cellular behavior in the dental epithelium but does not alter odontogenic program in the mesenchyme. Furthermore, deletion of Axin2, a negative intracellular regulator of canonical Wnt signaling, rescues the tooth defects in mice carrying Gpr177 mutation in the dental epithelium. Together with the fact that active Wnt canonical signaling is present predominantly in the dental epithelium during tooth development, our results demonstrate that Gpr177-mediated Wnt ligands in the dental epithelium act primarily in an intra-epithelial context to regulate enamel knot formation and subsequent tooth development.	[Zhu, XiaoJing; Zhao, Pan; Liu, YuDong; Zhang, XiaoYun; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Hangzhou 310036, Zhejiang, Peoples R China; [Fu, Jiang; Yu, H. -M. Ivy; Hsu, Wei] Univ Rochester, Med Ctr, Dept Biomed Genet, Ctr Oral Biol,James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Hangzhou Normal University; University of Rochester; Tulane University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, 16 Xuelin St, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org	Hsu, Wei/ABG-6856-2021	Hsu, Wei/0000-0001-6738-6030	National Science Foundation of Zhejiang Province [Z12C120004, LY12C12002]; National Key Basic Research Program of China [2012CB910402]; National Nature Science Foundation of China [31100845, 31201090]; Hangzhou Normal University; National Institutes of Health [DE015654, CA 10638, DE 14044, DE 17792]; NATIONAL CANCER INSTITUTE [R01CA106308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015654, R01DE017792, R01DE014044] Funding Source: NIH RePORTER	National Science Foundation of Zhejiang Province; National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Science Foundation of Zhejiang Province (Z12C120004 and LY12C12002), the National Key Basic Research Program of China (2012CB910402), and the National Nature Science Foundation of China (31100845 and 31201090). This work was also supported in part by start funding from Hangzhou Normal University (to Z. Y. Z), National Institutes of Health Grants DE015654 and CA 10638 (to W. H.) and DE 14044 and DE 17792 (to Y. P. C).	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Fu JA, 2011, DEV DYNAM, V240, P365, DOI 10.1002/dvdy.22541; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Ishida K, 2011, BIOCHEM BIOPH RES CO, V405, P455, DOI 10.1016/j.bbrc.2011.01.052; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; JERNVALL J, 1994, INT J DEV BIOL, V38, P463; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kettunen P, 2005, DEVELOPMENT, V132, P323, DOI 10.1242/dev.01541; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Kratochwil K, 1996, GENE DEV, V10, P1; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lin MK, 2011, DEV DYNAM, V240, P432, DOI 10.1002/dvdy.22550; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohi M, 2010, DEV DYNAM, V239, P160, DOI 10.1002/dvdy.22047; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Song YQ, 2006, DEV DYNAM, V235, P1334, DOI 10.1002/dvdy.20706; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Thesleff I, 2001, Adv Dent Res, V15, P14; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang YD, 2003, DEV DYNAM, V226, P713, DOI 10.1002/dvdy.10274; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhu XJ, 2010, J BIOL CHEM, V285, P29903, DOI 10.1074/jbc.M110.105494	51	39	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12080	12089		10.1074/jbc.M113.462473	http://dx.doi.org/10.1074/jbc.M113.462473			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23525146	Green Published, hybrid			2022-12-25	WOS:000318157600041
J	Lee, Y; Collier, TC; Sanford, MR; Marsden, CD; Fofana, A; Cornel, AJ; Lanzaro, GC				Lee, Yoosook; Collier, Travis C.; Sanford, Michelle R.; Marsden, Clare D.; Fofana, Abdrahamane; Cornel, Anthony J.; Lanzaro, Gregory C.			Chromosome Inversions, Genomic Differentiation and Speciation in the African Malaria Mosquito Anopheles gambiae	PLOS ONE			English	Article							MOLECULAR-FORMS; GENETIC DIFFERENTIATION; NUCLEOTIDE VARIABILITY; REPRODUCTIVE ISOLATION; WEST-AFRICA; S-FORMS; DROSOPHILA; DIVERGENCE; EVOLUTION; COMPLEX	The African malaria vector, Anopheles gambiae, is characterized by multiple polymorphic chromosomal inversions and has become widely studied as a system for exploring models of speciation. Near complete reproductive isolation between different inversion types, known as chromosomal forms, has led to the suggestion that A. gambiae is in early stages of speciation, with divergence evolving in the face of considerable gene flow. We compared the standard chromosomal arrangement (Savanna form) with genomes homozygous for j, b, c, and u inversions (Bamako form) in order to identify regions of genomic divergence with respect to inversion polymorphism. We found levels of divergence between the two sub-taxa within some of these inversions (2Rj and 2Rb), but at a level lower than expected and confined near the inversion breakpoints, consistent with a gene flux model. Unexpectedly, we found that the majority of diverged regions were located on the X chromosome, which contained half of all significantly diverged regions, with much of this divergence located within exons. This is surprising given that the Bamako and Savanna chromosomal forms are both within the S molecular form that is defined by a locus near centromere of X chromosome. Two X-linked genes (a heat shock protein and P450 encoding genes) involved in reproductive isolation between the M and S molecular forms of A. gambiae were also significantly diverged between the two chromosomal forms. These results suggest that genes mediating reproductive isolation are likely located on the X chromosome, as is thought to be the case for the M and S molecular forms. We conclude that genes located on the sex chromosome may be the major force driving speciation between these chromosomal forms of A. gambiae.	[Lee, Yoosook; Collier, Travis C.; Sanford, Michelle R.; Marsden, Clare D.; Lanzaro, Gregory C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Vector Genet Lab, Davis, CA 95616 USA; [Cornel, Anthony J.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Fofana, Abdrahamane] Univ Mali, Fac Med, Malaria Res & Training Ctr, Bamako, Mali	University of California System; University of California Davis; University of California System; University of California Davis; University of Bamako	Lee, Y (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Vector Genet Lab, Davis, CA 95616 USA.	yoslee@ucdavis.edu	Sanford, Michelle/C-9575-2011	Sanford, Michelle/0000-0001-6212-4023; Lee, Yoosook/0000-0002-1392-7177	National Institutes of Health [R01 AI40308, D43 TW007390, T32AI074550]; University of California Malaria Research and Control Program (MRCG); FOGARTY INTERNATIONAL CENTER [D43TW007390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074550, R01AI040308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Malaria Research and Control Program (MRCG); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this paper was supported by grants from the National Institutes of Health to GCL (R01 AI40308, D43 TW007390, and T32AI074550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the University of California Malaria Research and Control Program (MRCG) which procured funding for the custom-designed A. gambiae WGTM used in this study. We thank Matt Rolston who performed microarry hybridization at the UC Davis School of Medicine Microarray Core Facility. We thank Drs. Yury Goltsev (Stanford University), Ki-Hong Jung (Kyung-Hee University, Korea) and Matteo Pellegrini (University of California-Los Angeles) for advice on the microarray data analysis.	Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Ashburner M., 1989, DROSOPHILA; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cheng CD, 2012, GENETICS, V190, P1417, DOI 10.1534/genetics.111.137794; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; CHOVNICK A, 1973, GENETICS, V75, P123; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Coyne JA, 2004, SPECIATION, pxiii; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; di Deco M.A., 1980, Parassitologia (Rome), V22, P304; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; DOBZHANSKY T, 1947, GENETICS, V32, P142; Dobzhansky T., 1949, HEREDITAS, V35, P210, DOI 10.1111/j.1601-5223.1949.tb03334.x; Dulai KS, 1999, GENOME RES, V9, P629; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; HUNT R H, 1973, Parassitologia (Rome), V15, P137; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Lanzaro GC, 1998, P NATL ACAD SCI USA, V95, P14260, DOI 10.1073/pnas.95.24.14260; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lee Y, 2004, AN INDIVIDUAL LEVEL; Lee Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-75; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r24; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; Navarro A, 1997, GENETICS, V147, P931; Navarro A, 1997, GENETICS, V146, P695; Navarro A, 2000, GENETICS, V155, P685; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; OHNO S., 1970, Evolution by gene duplication.; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Persiani A, 1986, Ann Ist Super Sanita, V22, P221; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Reinhold K, 1998, BEHAV ECOL SOCIOBIOL, V44, P1, DOI 10.1007/s002650050508; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Roberts PA, 1976, THE GENETIC AND BIOL, P67; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027920; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; SINGER B, 1986, NEW DEV STAT PSYCHOL, P129; Slotman MA, 2006, GENETICS, V174, P2081, DOI 10.1534/genetics.106.059949; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STROBECK C, 1983, GENETICS, V103, P545; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; STURTEVANT A. H., 1926, BIOL ZENTRALBL, V46, P697; Taylor C, 2001, GENETICS, V157, P743; Ting CT, 2004, P NATL ACAD SCI USA, V101, P12232, DOI 10.1073/pnas.0401975101; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Wang R, 2001, P NATL ACAD SCI USA, V98, P10769, DOI 10.1073/pnas.191003598; Wang-Sattler R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001249; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	73	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57887	10.1371/journal.pone.0057887	http://dx.doi.org/10.1371/journal.pone.0057887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526957	gold, Green Submitted, Green Published			2022-12-25	WOS:000317562600010
J	Xiao, XZ; Yuan, J; Haik, S; Cali, I; Zhan, YA; Moudjou, M; Li, BY; Laplanche, JL; Laude, H; Langeveld, J; Gambetti, P; Kitamoto, T; Kong, QZ; Brandel, JP; Cobb, BA; Petersen, RB; Zou, WQ				Xiao, Xiangzhu; Yuan, Jue; Haik, Stephane; Cali, Ignazio; Zhan, Yian; Moudjou, Mohammed; Li, Baiya; Laplanche, Jean-Louis; Laude, Hubert; Langeveld, Jan; Gambetti, Pierluigi; Kitamoto, Tetsuyuki; Kong, Qingzhong; Brandel, Jean-Philippe; Cobb, Brian A.; Petersen, Robert B.; Zou, Wen-Quan			Glycoform-Selective Prion Formation in Sporadic and Familial Forms of Prion Disease	PLOS ONE			English	Article							PROTEASE-SENSITIVE PRIONOPATHY; SCRAPIE; PRP; MUTATION; SUSCEPTIBILITY; ASSOCIATION; CONFORMERS; FRAGMENT; ANTIBODY	The four glycoforms of the cellular prion protein (PrPC) variably glycosylated at the two N-linked glycosylation sites are converted into their pathological forms (PrPSc) in most cases of sporadic prion diseases. However, a prominent molecular characteristic of PrPSc in the recently identified variably protease-sensitive prionopathy (VPSPr) is the absence of a diglycosylated form, also notable in familial Creutzfeldt-Jakob disease (fCJD), which is linked to mutations in PrP either from Val to Ile at residue 180 (fCJD(V180I)) or from Thr to Ala at residue 183 (fCJD(T183A)). Here we report that fCJD(V180I), but not fCJD(T183A), exhibits a proteinase K (PK)-resistant PrP (PrPres) that is markedly similar to that observed in VPSPr, which exhibits a five-step ladder-like electrophoretic profile, a molecular hallmark of VPSPr. Remarkably, the absence of the diglycosylated PrPres species in both fCJD(V180I) and VPSPr is likewise attributable to the absence of PrPres glycosylated at the first N-linked glycosylation site at residue 181, as in fCJD(T183A). In contrast to fCJD(T183A), both VPSPr and fCJD(V180I) exhibit glycosylation at residue 181 on di- and monoglycosylated (mono181) PrP prior to PK-treatment. Furthermore, PrPV180I with a typical glycoform profile from cultured cells generates detectable PrPres that also contains the diglycosylated PrP in addition to mono-and unglycosylated forms upon PK-treatment. Taken together, our current in vivo and in vitro studies indicate that sporadic VPSPr and familial CJD(V180I) share a unique glycoform-selective prion formation pathway in which the conversion of diglycosylated and mono181 PrPC to PrPSc is inhibited, probably by a dominant-negative effect, or by other co-factors.	[Xiao, Xiangzhu; Yuan, Jue; Cali, Ignazio; Zhan, Yian; Li, Baiya; Gambetti, Pierluigi; Kong, Qingzhong; Cobb, Brian A.; Petersen, Robert B.; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Haik, Stephane; Brandel, Jean-Philippe] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, UMRS 975,Equipe Malad Prions Maladie Alzheimer, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] INSERM, U975, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] CNRS, UMR 7225, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] Hop La Pitie Salpetriere, AP HP, Paris, France; [Moudjou, Mohammed; Laude, Hubert] INRA, UR892, Jouy En Josas, France; [Laplanche, Jean-Louis] Hop Lariboisiere, UF Genet Mol, F-75475 Paris, France; [Langeveld, Jan] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Gambetti, Pierluigi; Kong, Qingzhong; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH USA; [Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Div CJD Sci & Technol, Dept Prion Res,Ctr Translat & Adv Anim Res Human, Sendai, Miyagi 980, Japan; [Petersen, Robert B.; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Zhan, Yian; Zou, Wen-Quan] Nanchang Univ, Affiliated Hosp 1, Dept Crit Care Med, Nanchang, Jiangxi, Peoples R China; [Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Natl Ctr Regenerat Med, Cleveland, OH USA; [Zou, Wen-Quan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Case Western Reserve University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Wageningen University & Research; Case Western Reserve University; Tohoku University; Case Western Reserve University; Case Western Reserve University; Nanchang University; Case Western Reserve University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zou, WQ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	wenquan.zou@case.edu	xiao, xiangzhu/B-9300-2014; LAPLANCHE, Jean-Louis/S-8707-2016; cali, ignazio/AAS-1127-2020; Zou, Wenquan/GWQ-3489-2022; Cali, Ignazio/AAH-6093-2020; Haik, Stephane/M-7247-2018; Zou, Wenquan/ABF-2875-2020	xiao, xiangzhu/0000-0002-8013-9074; cali, ignazio/0000-0001-5770-3848; LAPLANCHE, Jean-Louis/0000-0003-2836-2903	Chinese National Key Clinical Department Project; National Institutes of Health (NIH) [R01NS062787]; CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; President's Discretionary Fund (Case Western Reserve University); NIH [AG-08012, AG-14359]; Centers for Disease Control and Prevention [UR8/CCU515004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359, P50AG008012] Funding Source: NIH RePORTER	Chinese National Key Clinical Department Project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; President's Discretionary Fund (Case Western Reserve University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YAZ was supported by a grant from the Chinese National Key Clinical Department Project. This study was supported by grants to WQZ from the National Institutes of Health (NIH) R01NS062787, the CJD Foundation, Alliance BioSecure, the University Center on Aging and Health with the support of the McGregor Foundation and the President's Discretionary Fund (Case Western Reserve University) as well as to PG from NIH AG-08012, AG-14359 and the Centers for Disease Control and Prevention Contract UR8/CCU515004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capellari Sabina, 2000, Journal of Alzheimer's Disease, V2, P27; Chasseigneaux S, 2006, NEUROSCI LETT, V408, P165, DOI 10.1016/j.neulet.2006.08.008; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cong XJ, 2013, J BIOMOL STRUCT DYN, V31, P829, DOI 10.1080/07391102.2012.712477; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gambetti P, 2011, PRION, V5, P14; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Giaccone G, 2007, J NEUROL NEUROSUR PS, V78, P1379, DOI 10.1136/jnnp.2007.115444; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Nixon R, 2000, BRAIN PATHOL, V10, P670; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Salamat MK, 2011, J VIROL, V85, P3077, DOI 10.1128/JVI.02257-10; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Xanthopoulos K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005633; Xiao XZ, 2011, PRION, V5, P98; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zanusso G, 2007, ARCH NEUROL-CHICAGO, V64, P595, DOI 10.1001/archneur.64.4.595; Zou RS, 2011, AGING-US, V3, P968, DOI 10.18632/aging.100370; Zou WQ, 2011, PRION, V5, P172, DOI 10.4161/pri.5.3.16894; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	40	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58786	10.1371/journal.pone.0058786	http://dx.doi.org/10.1371/journal.pone.0058786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527023	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562100041
J	Latina, A; Gullo, D; Trimarchi, F; Benvenga, S				Latina, Adele; Gullo, Damiano; Trimarchi, Francesco; Benvenga, Salvatore			Hashimoto's Thyroiditis: Similar and Dissimilar Characteristics in Neighboring Areas. Possible Implications for the Epidemiology of Thyroid Cancer	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC THYROIDITIS	Context: Medical centers worldwide report an increased frequency of Hashimoto's thyroiditis (HT) and thyroid cancer (TC), two environmentally influenced diseases. In Sicily, data on HT are available for the province of Messina (1975-2005); data on TC are available for the whole island (2002-2004), with the volcanic province of Catania having the highest incidence. Objective: To replicate in Catania, on comparable years, the HT data of Messina. Design, Methods, Setting: Review of the clinical records of patients in years 1995-2005 to compare presentation and yearly changes of HT. During 1995-2005, records were computer stored in the Endocrine Divisions of the University Hospitals of Catania and Messina, two tertiary referral centers. Results: Catania is outnumbered by Messina (742 vs. 3,409 HT patients). Similar were the linear increase in the yearly number of HT patients, rates of thyroid dysfunctions though with different proportions of subclinical and overt hypothyroidism, and rates of positiveness for TgAb or TPOAb. Different were age and its yearly trend; gender distribution and rates of the sonography variants, though yearly trends were similar. Conclusion: The HT epidemics is smaller in Catania, with changes in presentation overlapping partially those in Messina. Whatever environmental factors might be involved, they (and/or their intensity) were not necessarily the same in these provinces. Intriguingly, the expected number of TC in HT patients with thyroid nodules in Catania is congruent with that of the general population of this province, but it is far less than in the Messina province. Thus, TC and HT incidences could be influenced by distinct environmental factors.	[Latina, Adele; Gullo, Damiano] Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrinol Div,Dept Clin & Mol Biomed, Catania, Italy; [Trimarchi, Francesco; Benvenga, Salvatore] Univ Messina, Endocrinol Sect, Expt Clin Dept Med & Pharmacol, Messina, Italy; [Benvenga, Salvatore] Univ Messina, Master Program Childhood Adolescent & Womens Endo, Messina, Italy	Presidio Ospedaliero Garibaldi-Nesima; University of Catania; University of Messina; University of Messina	Gullo, D (corresponding author), Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrinol Div,Dept Clin & Mol Biomed, Catania, Italy.	segmeint@unict.it	Gullo, Damiano/GNP-5649-2022	Gullo, Damiano/0000-0002-4034-6378	Italian MIUR PRIN project [2008SYHYKS_003]	Italian MIUR PRIN project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was partially supported by the Italian MIUR PRIN project 2008SYHYKS_003 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anil C, 2010, THYROID, V20, P601, DOI 10.1089/thy.2009.0450; Benvenga S., 2004, CURRENT OPINION ENDO, V11, P209, DOI [10.1097/01.med.0000137759.57791.f8, DOI 10.1097/01.MED.0000137759.57791.F8]; Benvenga S, 2008, THYROID, V18, P429, DOI 10.1089/thy.2007.0234; Erdogan M, 2009, ENDOCRINE, V36, P486, DOI 10.1007/s12020-009-9258-z; Feldt-Rasmussen U, 2010, HORM-INT J ENDOCRINO, V9, P109, DOI 10.14310/horm.2002.1261; Guarneri Fabrizio, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P398, DOI 10.1097/MED.0b013e3282ef1c48; Kebebew E, 2001, WORLD J SURG, V25, P632, DOI 10.1007/s002680020165; Kim EY, 2009, CLIN ENDOCRINOL, V71, P581, DOI 10.1111/j.1365-2265.2009.03537.x; Koch CA, 2001, J ENDOCRINOL INVEST, V24, P659, DOI 10.1007/BF03343911; Pellegriti G, 2009, JNCI-J NATL CANCER I, V101, P1575, DOI 10.1093/jnci/djp354; Rizzo M, 2010, ANN ENDOCRINOL-PARIS, V71, P525, DOI 10.1016/j.ando.2010.06.006; Spencer CA, 2007, J CLIN ENDOCR METAB, V92, P4236, DOI 10.1210/jc.2007-0287; Wartofsky L, 2010, HORM-INT J ENDOCRINO, V9, P103, DOI 10.14310/horm.2002.1260	13	39	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e55450	10.1371/journal.pone.0055450	http://dx.doi.org/10.1371/journal.pone.0055450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526929	gold, Green Submitted, Green Published			2022-12-25	WOS:000316411600002
J	Alanazi, MS; Parine, NR; Shaik, JP; Alabdulkarim, HA; Ajaj, SA; Khan, Z				Alanazi, Mohammad Saud; Parine, Narasimha Reddy; Shaik, Jilani Purusottapatnam; Alabdulkarim, Huda A.; Ajaj, Sana Abdulla; Khan, Zahid			Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients	PLOS ONE			English	Article							BETA-CATENIN; COLORECTAL-CANCER; SUPPRESSOR GENE; TCF7L2 VARIANT; APC GENE; RISK; EXPRESSION; SUSCEPTIBILITY; LUNG; AXIN	Breast cancer is a complex heterogeneous disease involving genetic and epigenetic alterations in genes encoding proteins that are components of various signaling pathways. Candidate gene approach have identified association of genetic variants in the Wnt signaling pathway genes and increased susceptibility to several diseases including breast cancer. Due to the rarity of somatic mutations in key genes of Wnt pathway, we investigated the association of genetic variants in these genes with predisposition to breast cancers. We performed a case-control study to identify risk variants by examining 15 SNPs located in 8 genes associated with Wnt signaling. Genotypic analysis of individual locus showed statistically significant association of five SNPs located in beta-catenin, AXIN2, DKK3, SFRP3 and TCF7L2 with breast cancers. Increased risk was observed only with the SNP in b-catenin while the other four SNPs conferred protection against breast cancers. Majority of these associations persisted after stratification of the cases based on estrogen receptor status and age of on-set of breast cancer. The rs7775 SNP in exon 6 of SFRP3 gene that codes for either arginine or glycine exhibited very strong association with breast cancer, even after Bonferroni's correction. Apart from these five variants, rs3923086 in AXIN2 and rs3763511 in DKK4 that did not show any association in the overall population were significantly associated with early on-set and estrogen receptor negative breast cancers, respectively. This is the first study to utilize pathway based approach to identify association of risk variants in the Wnt signaling pathway genes with breast cancers. Confirmation of our findings in larger populations of different ethnicities would provide evidence for the role of Wnt pathway as well as screening markers for early detection of breast carcinomas.	[Alanazi, Mohammad Saud; Parine, Narasimha Reddy; Shaik, Jilani Purusottapatnam; Khan, Zahid] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Alabdulkarim, Huda A.] Comprehens Canc Ctr King Fahad Med City, Riyadh, Saudi Arabia; [Ajaj, Sana Abdulla] King Saud Univ, Coll Med, Dept Family Med, Riyadh 11461, Saudi Arabia	King Saud University; King Fahad Medical City; King Saud University	Khan, Z (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	zahidatkhan@yahoo.com	Parine, Narasimha Reddy/B-7975-2011	Parine, Narasimha Reddy/0000-0002-0765-9022	National Science, Technology and Innovation Plan strategic technologies program [10BIO897-2]	National Science, Technology and Innovation Plan strategic technologies program	This study was financially supported by a grant from National Science, Technology and Innovation Plan strategic technologies program number 10BIO897-2 in the Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, MODERN PATHOL, V20, P711, DOI 10.1038/modpathol.3800822; Anderson WF, 2006, BREAST CANCER RES TR, V100, P121, DOI 10.1007/s10549-006-9231-y; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Connor AE, 2012, BREAST CANCER RES TR, V136, P593, DOI 10.1007/s10549-012-2299-7; Cuilliere-Dartigues P, 2006, ONCOGENE, V25, P4441, DOI 10.1038/sj.onc.1209471; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferlay J, 2010, IARC CANCERBASE; Fernandez-Rozadilla C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012673; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goode EL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-312; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Hazra A, 2008, CANCER CAUSE CONTROL, V19, P975, DOI 10.1007/s10552-008-9164-3; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jin Z, 2001, BRIT J CANCER, V85, P69, DOI 10.1054/bjoc.2001.1853; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kanzaki H, 2006, INT J MOL MED, V18, P279; Klarmann GJ, 2008, EPIGENETICS-US, V3, P59, DOI 10.4161/epi.3.2.5899; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Naidu R, 2012, MED ONCOL, V29, P411, DOI 10.1007/s12032-011-9837-8; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Saudi National Cancer Registry, 2011, CANC INC SURV REP SA; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Tseng RC, 2008, ONCOGENE, V27, P4488, DOI 10.1038/onc.2008.83; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Wang SZ, 2012, MUTAGENESIS, V27, P623, DOI 10.1093/mutage/ges027; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449	45	40	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059555	10.1371/journal.pone.0059555	http://dx.doi.org/10.1371/journal.pone.0059555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516639	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400115
J	Ngo, D; Cheng, Q; O'Connor, AE; DeBoer, KD; Lo, CY; Beaulieu, E; De Seram, M; Hobbs, RM; O'Bryan, MK; Morand, EF				Ngo, Devi; Cheng, Qiang; O'Connor, Anne E.; DeBoer, Kathleen D.; Lo, Camden Y.; Beaulieu, Elaine; De Seram, Mia; Hobbs, Robin M.; O'Bryan, Moira K.; Morand, Eric F.			Glucocorticoid-Induced Leucine Zipper (GILZ) Regulates Testicular FOXO1 Activity and Spermatogonial Stem Cell (SSC) Function	PLOS ONE			English	Article							MALE-FERTILITY; ARTHRITIS; MOUSE; SPERMATOGENESIS; EXPRESSION; PATHWAY; GENE; MICE	Spermatogonia stem cell (SSC) self-renewal and differentiation are tightly regulated processes that ensure a continued production of mature sperm throughout male adulthood. In the present study, we investigated the role of glucocorticoid-induced leucine zipper (GILZ) in maintenance of the male germline and spermatogenesis. GILZ was detectable in germ cells of wild type mice on the day of birth, suggesting a role for GILZ in prospermatogonia and SSC pool formation. Gilz KO mice were generated and adult males were azoospermic and sterile. During the first wave of spermatogenesis in Gilz KO mice, spermatogenesis arrested part way through pachytene of meiosis I. Subsequent waves resulted in a progressive depletion of germ cells through apoptosis to ultimately produce a Sertoli cell-only phenotype. Further, in contrast to wild type littermates, PLZF(+) cells were detected in the peri-luminal region of Gilz KO mice at day 6 post-natal, suggesting a defect in prospermatogonia migration in the absence of GILZ. At age 30 days, transient accumulation of PLZF(+) cells in a subset of tubules and severely compromised spermatogenesis were observed in Gilz KO mice, consistent with defective SSC differentiation. GILZ deficiency was associated with an increase in FOXO1 transcriptional activity, which leads to activation of a selective set of FOXO1 target genes, including a pro-apoptotic protein, BIM. On the other hand, no evidence of a heightened immune response was observed. Together, these results suggest that GILZ suppresses FOXO1 nuclear translocation, promotes SSC differentiation over self-renewal, and favours germ cell survival through inhibition of BIM-dependent pro-apoptotic signals. These findings provide a mechanism for the effects of GILZ on spermatogenesis and strengthen the case for GILZ being a critical molecule in the regulation of male fertility.	[Ngo, Devi; Cheng, Qiang; Beaulieu, Elaine; Morand, Eric F.] Monash Univ, Monash Med Ctr, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [O'Connor, Anne E.; DeBoer, Kathleen D.; De Seram, Mia; Hobbs, Robin M.; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Lo, Camden Y.] Monash Univ, Monash Micro Imaging, Clayton, Vic, Australia; [De Seram, Mia; Hobbs, Robin M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	Monash University; Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University	Cheng, Q (corresponding author), Monash Univ, Monash Med Ctr, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia.	colin.cheng@monash.edu; eric.morand@monash.edu	Ngo, Devi/P-2594-2015; O'Connor, Anne/AAI-6479-2020; Morand, Eric F/I-4718-2013; O'Bryan, Moira K/F-8256-2012; Morand, Eric/AAT-3259-2021; Hobbs, Robin/I-2577-2014	O'Connor, Anne/0000-0001-9334-4256; Morand, Eric F/0000-0002-9507-3338; O'Bryan, Moira K/0000-0001-7298-4940; Morand, Eric/0000-0002-9507-3338; Beaulieu, Elaine/0000-0002-9529-9943; Hobbs, Robin/0000-0002-3853-2614	National Health and Medical Research Council (NHMRC) of Australia [APP1011670]; NHMRC fellowship [545805]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the National Health and Medical Research Council (NHMRC)(http://www.nhmrc.gov.au/) of Australia (Grant number: APP1011670). Moira K. O'Bryan is the recipient of a NHMRC fellowship (# 545805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Beaulieu E, 2011, NAT REV RHEUMATOL, V7, P340, DOI 10.1038/nrrheum.2011.59; Beaulieu E, 2010, ARTHRITIS RHEUM-US, V62, P2651, DOI 10.1002/art.27566; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Cheng QA, 2010, J IMMUNOL, V185, P1238, DOI 10.4049/jimmunol.0904104; de Late PL, 2010, J BIOL CHEM, V285, P5594, DOI 10.1074/jbc.M109.068346; Fallahi M, 2010, GENES-BASEL, V1, P469, DOI 10.3390/genes1030469; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Joha S, 2012, ONCOGENE, V31, P1419, DOI 10.1038/onc.2011.328; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Meng J, 2011, BIOL REPROD, V85, P254, DOI 10.1095/biolreprod.110.090621; Ngo D, ARTHRITIS RHEUM; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Reinholdt LG, 2009, CHROMOSOMA, V118, P723, DOI 10.1007/s00412-009-0230-8; Romero Y, 2012, SEX DEV, V6, P169, DOI 10.1159/000338415; Russell LD, 2008, INT J ANDROL, V16, P83; Suarez PE, 2012, MOL ENDOCRINOL, V26, P1000, DOI 10.1210/me.2011-1249; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	29	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59149	10.1371/journal.pone.0059149	http://dx.doi.org/10.1371/journal.pone.0059149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516608	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400095
J	Peng, H; Li, WC; Seth, DM; Nair, AR; Francis, J; Feng, YM				Peng, Hua; Li, Wencheng; Seth, Dale M.; Nair, Anand R.; Francis, Joseph; Feng, Yumei			(Pro)renin Receptor Mediates Both Angiotensin II-Dependent and -Independent Oxidative Stress in Neuronal Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RENIN/PRORENIN-RECEPTOR; GENE-EXPRESSION; NADPH OXIDASES; RENIN RELEASE; PRORENIN; HYPERTENSION; RESPONSES; BRAIN	The binding of renin or prorenin to the (pro) renin receptor (PRR) promotes angiotensin (Ang) II formation and mediates Ang II-independent signaling pathways. In the central nervous system (CNS), Ang II regulates blood pressure via inducing oxidative stress; however, the role of PRR-mediated Ang II-independent signaling pathways in oxidative stress in the CNS remains undefined. To address this question, Neuro-2A cells were infected with control virus or an adeno-associated virus encoding the human PRR. Human PRR over-expression alone increased ROS levels, NADPH oxidase activity, as well as NADPH oxidase (NOX) isoforms 2 and 4 mRNA expression levels and these effects were not blocked by losartan. Moreover, the increase in NOX 2 and NOX 4 mRNA levels, NADPH oxidase activity, and ROS levels induced by PRR over-expression was prevented by mitogen activated protein kinase/extracellular signal-regulated kinase 1 and 2 (MAPK/ERK1/2) inhibition, and phosphoinositide 3 kinase/Akt (IP3/Akt) inhibition, indicating that PRR regulates NOX activity and ROS formation in neuro-2A cells through Ang II-independent ERK1/2 and IP3/Akt activation. Interestingly, at a concentration of 2 nM or higher, prorenin promoted Ang II formation, and thus further increased the ROS levels in cultured Neuro-2A cells via PRR. In conclusion, human PRR over-expression induced ROS production through both angiotensin II-dependent and -independent mechanisms. We showed that PRR-mediated angiotensin II-independent ROS formation is associated with activation of the MAPK/ERK1/2 and PI3/Akt signaling pathways and up-regulation of mRNA level of NOX 2 and NOX4 isoforms in neuronal cells.	[Peng, Hua; Li, Wencheng; Seth, Dale M.; Feng, Yumei] Tulane Univ, Sch Med, Dept Physiol, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Nair, Anand R.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Tulane University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Feng, YM (corresponding author), Tulane Univ, Sch Med, Dept Physiol, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA.	yfeng1@tulane.edu			American Heart Association National Center [11SDG4880005]; NHLBI [1P30HL101285-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	American Heart Association National Center(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the American Heart Association National Center (11SDG4880005) to Y. Feng and the NHLBI (1P30HL101285-01) L.G. Navar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Biswas Kazal Boron, 2010, Front Biosci (Elite Ed), V2, P1234; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Clavreul N, 2011, AM J PHYSIOL-RENAL, V300, pF1310, DOI 10.1152/ajprenal.00119.2010; Danser AHJ, 2005, J RENIN-ANGIO-ALDO S, V6, P163, DOI 10.3317/jraas.2005.025; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; Feng YM, 2008, CIRC RES, V102, P729, DOI 10.1161/CIRCRESAHA.107.169110; GENAIN CP, 1985, J CLIN INVEST, V76, P1939, DOI 10.1172/JCI112191; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Hoffmann A, 2003, J RECEPT SIG TRANSD, V23, P111, DOI 10.1081/RRS-120018764; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; KURTZ A, 1986, P NATL ACAD SCI USA, V83, P4769, DOI 10.1073/pnas.83.13.4769; Kurtz A, 2011, ANNU REV PHYSIOL, V73, P377, DOI 10.1146/annurev-physiol-012110-142238; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Li WC, 2012, HYPERTENSION, V59, P1188, DOI 10.1161/HYPERTENSIONAHA.111.190108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Nguyen G, 2004, CURR HYPERTENS REP, V6, P129, DOI 10.1007/s11906-004-0088-3; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2008, CURR OPIN PHARMACOL, V8, P127, DOI 10.1016/j.coph.2007.12.009; Nguyen G, 2011, CLIN SCI, V120, P169, DOI 10.1042/CS20100432; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; OKAMURA T, 1981, P NATL ACAD SCI-BIOL, V78, P6940, DOI 10.1073/pnas.78.11.6940; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; SPECK G, 1981, BRAIN RES, V219, P371, DOI 10.1016/0006-8993(81)90300-0; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Zhuo JL, 2011, AM J PHYSIOL-RENAL, V301, pF1193, DOI 10.1152/ajprenal.00555.2011; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4; Zimmerman MC, 2004, PROG BIOPHYS MOL BIO, V84, P125, DOI 10.1016/j.pbiomolbio.2003.11.009	37	51	53	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58339	10.1371/journal.pone.0058339	http://dx.doi.org/10.1371/journal.pone.0058339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516464	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400023
J	Suidan, GL; Duerschmied, D; Dillon, GM; Vanderhorst, V; Hampton, TG; Wong, SL; Voorhees, JR; Wagner, DD				Suidan, Georgette L.; Duerschmied, Daniel; Dillon, Gregory M.; Vanderhorst, Veronique; Hampton, Thomas G.; Wong, Siu Ling; Voorhees, Jaymie R.; Wagner, Denisa D.			Lack of Tryptophan Hydroxylase-1 in Mice Results in Gait Abnormalities	PLOS ONE			English	Article							SEROTONIN; DYNAMICS; BEHAVIOR; ANXIETY; ATTENTION; INFLAMMATION; DISRUPTION; EXPRESSION; MODEL; TPH1	The role of peripheral serotonin in nervous system development is poorly understood. Tryptophan hydroxylase-1 (TPH1) is expressed by non-neuronal cells including enterochromaffin cells of the gut, mast cells and the pineal gland and is the rate-limiting enzyme involved in the biosynthesis of peripheral serotonin. Serotonin released into circulation is taken up by platelets via the serotonin transporter and stored in dense granules. It has been previously reported that mouse embryos removed from Tph1-deficient mothers present abnormal nervous system morphology. The goal of this study was to assess whether Tph1-deficiency results in behavioral abnormalities. We did not find any differences between Tph1-deficient and wild-type mice in general motor behavior as tested by rotarod, grip-strength test, open field and beam walk. However, here we report that Tph1 (-/-) mice display altered gait dynamics and deficits in rearing behavior compared to wild-type (WT) suggesting that tryptophan hydroxylase-1 expression has an impact on the nervous system.	[Suidan, Georgette L.; Duerschmied, Daniel; Wong, Siu Ling; Voorhees, Jaymie R.; Wagner, Denisa D.] Immune Dis Inst, Boston, MA USA; [Suidan, Georgette L.; Duerschmied, Daniel; Wong, Siu Ling; Voorhees, Jaymie R.; Wagner, Denisa D.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Wagner, Denisa D.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Suidan, Georgette L.; Duerschmied, Daniel; Wong, Siu Ling; Wagner, Denisa D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Duerschmied, Daniel] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 1, Freiburg, Germany; [Dillon, Gregory M.] Harvard NeuroDiscovery Ctr, Neurobehav Lab, Boston, MA USA; [Dillon, Gregory M.; Vanderhorst, Veronique] Harvard Univ, Sch Med, Boston, MA USA; [Vanderhorst, Veronique] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Hampton, Thomas G.] Neurosci Discovery Core, Framingham, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Freiburg; Harvard University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Wagner, DD (corresponding author), Immune Dis Inst, Boston, MA USA.	Denisa.Wagner@childrens.harvard.edu	Duerschmied, D./K-8182-2015; Duerschmied, D./AAB-5139-2021; Wong, Siu Ling Christine/A-9895-2019	Duerschmied, D./0000-0001-5249-4012; Duerschmied, D./0000-0001-5249-4012; 	National Heart, Lung and Blood Institute of the National Institutes of Health [R01 HL041002]; National Research Service Award from the National Institutes of Neurological Disease and Stroke of the National Institutes of Health [1F32NS073245]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079623, F32NS073245] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award from the National Institutes of Neurological Disease and Stroke of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was generously supported by National Heart, Lung and Blood Institute of the National Institutes of Health grant R01 HL041002 (to DDW) and a National Research Service Award from the National Institutes of Neurological Disease and Stroke of the National Institutes of Health grant 1F32NS073245 (to GLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Berryman ER, 2009, J MUSCULOSKEL NEURON, V9, P89; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Carter MD, 2011, AUTISM RES, V4, P57, DOI 10.1002/aur.180; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Christensen HD, 2000, NEUROTOXICOL TERATOL, V22, P733, DOI 10.1016/S0892-0362(00)00099-4; Chu V, 2002, MUSCLE NERVE, V26, P513, DOI 10.1002/mus.10223; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Crawley J., 2007, WHATS WRONG MY MOUSE, V2nd; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; Dillon GM, 2009, BEHAV BRAIN RES, V204, P67, DOI 10.1016/j.bbr.2009.04.036; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Dunbar MJ, 2010, J PHYSIOL-LONDON, V588, P139, DOI 10.1113/jphysiol.2009.177378; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Goldberg NRS, 2011, J NEUROSCI RES, V89, P1698, DOI 10.1002/jnr.22699; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Halmoy A, 2010, ARCH GEN PSYCHIAT, V67, P1033, DOI 10.1001/archgenpsychiatry.2010.124; Hampton TG, 2004, PHYSIOL BEHAV, V82, P381, DOI 10.1016/j.physbeh.2004.04.006; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Kale A, 2004, ALCOHOL CLIN EXP RES, V28, P1839, DOI 10.1097/01.ALC.0000148103.09378.81; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Morelli E, 2011, J NEUROSCI, V31, P15742, DOI 10.1523/JNEUROSCI.2989-11.2011; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakamura K, 2006, J NEUROSCI, V26, P530, DOI 10.1523/JNEUROSCI.1835-05.2006; Nantel-Vivier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020304; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Piesla MJ, 2009, BRAIN RES, V1295, P89, DOI 10.1016/j.brainres.2009.07.091; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; VILENSKY JA, 1981, ARCH NEUROL-CHICAGO, V38, P646, DOI 10.1001/archneur.1981.00510100074013; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; Zill P, 2009, NEUROSCIENCE, V159, P1274, DOI 10.1016/j.neuroscience.2009.01.006	45	14	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59032	10.1371/journal.pone.0059032	http://dx.doi.org/10.1371/journal.pone.0059032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516593	Green Published, gold			2022-12-25	WOS:000316407400088
J	Newell, DA; Goldingay, RL; Brooks, LO				Newell, David Alan; Goldingay, Ross Lindsay; Brooks, Lyndon Owen			Population Recovery following Decline in an Endangered Stream-Breeding Frog (Mixophyes fleayi) from Subtropical Australia	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; CHYTRIDIOMYCOSIS; DYNAMICS; SURVIVAL; MORTALITY; DISEASE; SENSITIVITY; PERSISTENCE; EXTINCTION; INFECTION	Amphibians have undergone dramatic declines and extinctions worldwide. Prominent among these have been the stream-breeding frogs in the rainforests of eastern Australia. The amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) has been postulated as the primary cause of these declines. We conducted a capture-mark-recapture study over a 7-year period on the endangered Fleay's barred frog (Mixophyes fleayi) at two independent streams (30 km apart) in order to assess the stability of these populations. This species had undergone a severe decline across its narrow geographic range. Mark-recapture modelling showed that the number of individuals increased 3-10 fold along stream transects over this period. Frog detection probabilities were frequently above 50% but declined as the populations increased. Adult survival was important to overall population persistence in light of low recruitment events, suggesting that longevity may be a key factor in this recovery. One male and female were present in the capture record for >6 years. This study provides an unambiguous example of population recovery in the presence of Bd.	[Newell, David Alan; Goldingay, Ross Lindsay] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Brooks, Lyndon Owen] So Cross Univ, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia	Southern Cross University; Southern Cross University	Newell, DA (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	david.newell@scu.edu.au	Newell, David A/E-7790-2011	Newell, David A/0000-0003-0419-057X; Goldingay, Ross/0000-0002-6684-9299	NSW Department of Environment Climate Change; Co-operative Research Centre for Sustainable Tourism; Declining Frog Working Group of the NSW National Parks and Wildlife Service (NPWS); Northern Rivers Catchment Management Authority via the Commonwealth governments Natural Heritage Trust	NSW Department of Environment Climate Change; Co-operative Research Centre for Sustainable Tourism(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Declining Frog Working Group of the NSW National Parks and Wildlife Service (NPWS); Northern Rivers Catchment Management Authority via the Commonwealth governments Natural Heritage Trust	The work was supported by the NSW Department of Environment & Climate Change, the Co-operative Research Centre for Sustainable Tourism and the Declining Frog Working Group of the NSW National Parks and Wildlife Service (NPWS). The Northern Rivers Catchment Management Authority provided funding via the Commonwealth governments Natural Heritage Trust for the final 2 years of data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham K. P., 1987, AM FISHERIES SOC MON, V5, P437; Conroy SDS, 2003, POPUL ECOL, V45, P105, DOI 10.1007/s10144-003-0145-9; Daskin JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026215; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Goldingay R., 1999, DECLINES DISAPPEARAN, P64; Grafe TU, 2004, OECOLOGIA, V141, P40, DOI 10.1007/s00442-004-1639-7; Hero Jean-Marc, 2006, Pacific Conservation Biology, V12, P313; Hines H, 1999, DECLINES DISAPPEARAN, P44; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Lampo M, 2012, BIOTROPICA, V44, P420, DOI 10.1111/j.1744-7429.2011.00830.x; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lewis BD, 2005, AUST J ZOOL, V53, P185, DOI 10.1071/ZO03063; McDonald K, 1999, DECLINES DISAPPEARAN, P14; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; Murray K., 2010, Ecology, V91, P1557, DOI 10.1890/09-1608.1; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2011, J APPL ECOL, V48, P873, DOI 10.1111/j.1365-2664.2011.02005.x; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richards SJ, 2005, AUST J ZOOL, V53, P229, DOI 10.1071/ZO03036; Richards Stephen J., 1993, Pacific Conservation Biology, V1, P66; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rowley JJL, 2007, WILDLIFE RES, V34, P371, DOI 10.1071/WR07014; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Schmidt BR, 2004, HERPETOL J, V14, P167; Schmidt BR, 2005, CONSERV BIOL, V19, P1149, DOI 10.1111/j.1523-1739.2005.00164.x; Schmidt BR, 2003, CR BIOL, V326, pS119, DOI 10.1016/S1631-0691(03)00048-9; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shirose LJ, 1995, CAN J ZOOL, V73, P1878, DOI 10.1139/z95-220; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stockwell MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036942; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2010, DIVERS DISTRIB, V16, P703, DOI 10.1111/j.1472-4642.2010.00666.x	50	41	43	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58559	10.1371/journal.pone.0058559	http://dx.doi.org/10.1371/journal.pone.0058559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516509	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200088
J	Smithers, LG; Golley, RK; Mittinty, MN; Brazionis, L; Northstone, K; Emmett, P; Lynch, JW				Smithers, Lisa G.; Golley, Rebecca K.; Mittinty, Murthy N.; Brazionis, Laima; Northstone, Kate; Emmett, Pauline; Lynch, John W.			Do Dietary Trajectories between Infancy and Toddlerhood Influence IQ in Childhood and Adolescence? Results from a Prospective Birth Cohort Study	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; PATTERNS; ASSOCIATIONS; INTELLIGENCE; PARAMETERS; CHILDREN; MODEL; AGE	Objective: We examined whether trajectories of dietary patterns from 6 to 24 months of age are associated with intelligence quotient (IQ) in childhood and adolescence. Methods: Participants were children enrolled in a prospective UK birth cohort (n = 7652) who had IQ measured at age 8 and/or 15 years. Dietary patterns were previously extracted from questionnaires when children were aged 6, 15 and 24 months using principal component analysis. Dietary trajectories were generated by combining scores on similar dietary patterns across each age, using multilevel mixed models. Associations between dietary trajectories and IQ were examined in generalized linear models with adjustment for potential confounders. Results: Four dietary pattern trajectories were constructed from 6 to 24 months of age and were named according to foods that made the strongest contribution to trajectory scores; Healthy (characterised by breastfeeding at 6 months, raw fruit and vegetables, cheese and herbs at 15 and 24 months); Discretionary (biscuits, chocolate, crisps at all ages), Traditional (meat, cooked vegetables and puddings at all ages) and, Ready-to-eat (use of ready-prepared baby foods at 6 and 15 months, biscuits, bread and breakfast cereals at 24 months). In fully-adjusted models, a 1 SD change in the Healthy trajectory was weakly associated with higher IQ at age 8 (1.07 (95%CI 0.17, 1.97)) but not 15 years (0.49 (-0.28, 1.26)). Associations between the Discretionary and Traditional trajectories with IQ at 8 and 15 years were as follows; Discretionary; 8 years -0.35(-1.03, 0.33), 15 years -0.73(-1.33, -0.14) Traditional; 8 years -0.19(-0.71, 0.33) 15 years -0.41(-0.77, -0.04)). The Ready-to-eat trajectory had no association with IQ at either age (8 years 0.32(-4.31, 4.95), 15 years 1.11(-3.10, 5.33). Conclusions: The Discretionary and Traditional dietary pattern trajectories from 6 to 24 months of age, over the period when food patterns begin to emerge, are weakly associated with IQ in adolescence.	[Smithers, Lisa G.; Mittinty, Murthy N.; Brazionis, Laima; Lynch, John W.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Golley, Rebecca K.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Northstone, Kate; Emmett, Pauline; Lynch, John W.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Adelaide; University of South Australia; University of Bristol	Smithers, LG (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia.	lisa.smithers@adelaide.edu.au	Emmett, Pauline/AAL-6815-2021; Smithers, Lisa/D-1605-2009; Lynch, John W/A-4797-2008; Golley, Rebecca K/D-1606-2009; Northstone, Kate/A-8165-2011	Smithers, Lisa/0000-0002-6585-7836; Lynch, John W/0000-0003-2781-7902; Northstone, Kate/0000-0002-0602-1983; Golley, Rebecca/0000-0001-5197-7987; Emmett, Pauline/0000-0003-1076-4779	UK Medical Research Council [74882]; Wellcome Trust [076467]; Australia Fellowship [570120]; National Health and Medical Research Council of Australia [478115]; European Community [245012]; Danone; Pfizer; Plum Baby; Medical Research Council [G9815508] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Australia Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); European Community(European Commission); Danone(Danone Nutricia); Pfizer(Pfizer); Plum Baby; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (grant number 74882, http:\\www.mrc.ac.uk), the Wellcome Trust (grant number 076467, http:\\www.wellcome.ac.uk) and the University of Bristol provide core support for the ALSPAC study (http:\\www.bris.ac.uk). JWL is supported by an Australia Fellowship (570120) and RKG with a Postdoctoral Training Fellowship (478115) from the National Health and Medical Research Council of Australia (http:\\www.nhmrc.gov.au). LGS, LB and MNM are supported by funds from the Australia Fellowship awarded to JWL. KN and PE are partly supported by European Community's Seventh Framework Programme (245012, http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. KN and PE have received support from Danone and PE has received support from Pfizer and Plum Baby, who might have an interest in the submitted work. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bryan J, 2004, NUTR REV, V62, P295, DOI [10.1301/nr.2004.aug.295-306, 10.1111/j.1753-4887.2004.tb00055.x]; Caldwell B.M., 1979, HOME OBSERVATION MEA; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Gale CR, 2009, J CHILD PSYCHOL PSYC, V50, P816, DOI 10.1111/j.1469-7610.2008.02029.x; Hoefer C, 1929, J AMER MED ASSOC, V92, P615, DOI 10.1001/jama.1929.02700340015006; Jones G, 2006, J ECON GROWTH, V11, P71, DOI 10.1007/s10887-006-7407-2; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kussmann M, 2010, NUTR REV, V68, pS38, DOI 10.1111/j.1753-4887.2010.00326.x; Li EN, 2004, BIOMETRICS, V60, P1, DOI 10.1111/j.0006-341X.2004.00170.x; Little R.J., 2002, STAT ANAL MISSING DA; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Mikkilae V, 2007, BRIT J NUTR, V98, P218, DOI 10.1017/S0007114507691831; Mishra GD, 2006, BRIT J NUTR, V96, P735, DOI 10.1079/BJN20061871; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Noble S, 2006, J HUM NUTR DIET, V19, P303, DOI 10.1111/j.1365-277X.2006.00708.x; North K, 2000, EUR J CLIN NUTR, V54, P73, DOI 10.1038/sj.ejcn.1600896; Northstone K, 2011, J EPIDEMIOL COMMUNIT, DOI [10. 1111/j.1740-8709.2012.00399.x, DOI 10.1111/J.1740-8709.2012.00399.X]; Northstone K, 2008, BRIT J NUTR, V99, P1099, DOI 10.1017/S0007114507842802; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS; Pachucki MA, 2012, INT J OBESITY, V36, P686, DOI 10.1038/ijo.2011.133; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Smithers LG, 2012, EUR J CLIN NUTR, V66, P658, DOI 10.1038/ejcn.2011.219; Smithers LG, 2012, NUTRIENTS, V4, P935, DOI 10.3390/nu4080935; Smithers LG, 2012, EUR J EPIDEMIOL, V27, P525, DOI 10.1007/s10654-012-9715-5; Smithers LG, 2011, NUTR REV, V69, P449, DOI 10.1111/j.1753-4887.2011.00407.x; Wang CY, 2000, BIOMETRICS, V56, P487, DOI 10.1111/j.0006-341X.2000.00487.x; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1992, WECHSLER INTELLIGENC; Williams J, 1999, BMJ-BRIT MED J, V318, P396	31	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58904	10.1371/journal.pone.0058904	http://dx.doi.org/10.1371/journal.pone.0058904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516574	Green Published, gold, Green Accepted			2022-12-25	WOS:000316849200120
J	Wang, IK; Lin, CL; Lin, PC; Liang, CC; Liu, YL; Chang, CT; Yen, TH; Morisky, DE; Huang, CC; Sung, FC				Wang, I-Kuan; Lin, Cheng-Li; Lin, Po-Chang; Liang, Chih-Chia; Liu, Yao-Lung; Chang, Chiz-Tzung; Yen, Tzung-Hai; Morisky, Donald E.; Huang, Chiu-Ching; Sung, Fung-Chang			Effectiveness of Influenza Vaccination in Patients with End-Stage Renal Disease Receiving Hemodialysis: A Population-Based Study	PLOS ONE			English	Article							RISK MEDICAL CONDITIONS; PNEUMOCOCCAL VACCINATION; ANTIBODY-RESPONSE; DIALYSIS PATIENTS; HEALTH-CARE; MORTALITY; IMMUNIZATION; HOSPITALIZATIONS; INFLAMMATION; ASSOCIATION	Background: Little is known on the effectiveness of influenza vaccine in ESRD patients. This study compared the incidence of hospitalization, morbidity, and mortality in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) between cohorts with and without influenza vaccination. Methods: We used the insurance claims data from 1998 to 2009 in Taiwan to determine the incidence of these events within one year after influenza vaccination in the vaccine (N = 831) and the non-vaccine (N = 3187) cohorts. The vaccine cohort to the non-vaccine cohort incidence rate ratio and hazard ratio (HR) of morbidities and mortality were measured. Results: The age-specific analysis showed that the elderly in the vaccine cohort had lower hospitalization rate (100.8 vs. 133.9 per 100 person-years), contributing to an overall HR of 0.81 (95% confidence interval (CI) 0.72-0.90). The vaccine cohort also had an adjusted HR of 0.85 [95% CI 0.75-0.96] for heart disease. The corresponding incidence of pneumonia and influenza was 22.4 versus 17.2 per 100 person-years, but with an adjusted HR of 0.80 (95% CI 0.64-1.02). The vaccine cohort had lowered risks than the non-vaccine cohort for intensive care unit (ICU) admission (adjusted HR 0.20, 95% CI 0.12-0.33) and mortality (adjusted HR 0.50, 95% CI 0.41-0.60). The time-dependent Cox model revealed an overall adjusted HR for mortality of 0.30 (95% CI 0.26-0.35) after counting vaccination for multi-years. Conclusions: ESRD patients with HD receiving the influenza vaccination could have reduced risks of pneumonia/influenza and other morbidities, ICU stay, hospitalization and death, particularly for the elderly.	[Wang, I-Kuan] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, I-Kuan; Liang, Chih-Chia; Liu, Yao-Lung; Chang, Chiz-Tzung; Huang, Chiu-Ching] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Wang, I-Kuan] China Med Univ, Coll Med, Dept Internal Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lin, Po-Chang] China Med Univ Hosp, Div Infect, Taichung, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; [Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Morisky, Donald E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; University of California System; University of California Los Angeles	Huang, CC (corresponding author), China Med Univ Hosp, Div Nephrol, Taichung, Taiwan.	cch@mail.cmuh.org.tw; fcsung1008@yahoo.com	Yen, Tzung-Hai/AAQ-4525-2020; Morisky, Donald/AAU-4679-2021	Yen, Tzung-Hai/0000-0002-0907-1505; 	Executive Yuan National Science Council [NSC 100-2621-M-039 -001]; Department of Health [DOH101-TD-B- 111-004, DOH101-TD-C-111-005]; China Medical University Hospital [1MS1]	Executive Yuan National Science Council; Department of Health; China Medical University Hospital	Executive Yuan National Science Council (grant number NSC 100-2621-M-039 -001), the Department of Health (grant numbers DOH101-TD-B- 111-004 and DOH101-TD-C-111-005) and the China Medical University Hospital (grant number 1MS1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonen JA, 2000, NEPHRON, V86, P56, DOI 10.1159/000045713; Bond TC, 2012, AM J KIDNEY DIS, V60, P959, DOI 10.1053/j.ajkd.2012.04.018; Brydak LB, 2000, VACCINE, V18, P3280, DOI 10.1016/S0264-410X(00)00126-2; Cavdar C, 2003, SCAND J UROL NEPHROL, V37, P71, DOI 10.1080/00365590310008749; Collins AJ, 2010, AM J KIDNEY DIS, V55, p[1, A426], DOI DOI 10.1053/J.AJKD.2009.10.009; Descamps-Latscha B, 1993, Curr Opin Nephrol Hypertens, V2, P883, DOI 10.1097/00041552-199311000-00005; Engstrom G, 2003, DIABETES, V52, P442, DOI 10.2337/diabetes.52.2.442; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gilbertson DT, 2011, NEPHROL DIAL TRANSPL, V26, P2934, DOI 10.1093/ndt/gfq853; Gilbertson DT, 2003, KIDNEY INT, V63, P738, DOI 10.1046/j.1523-1755.2003.00787.x; Hak E, 2005, ARCH INTERN MED, V165, P274, DOI 10.1001/archinte.165.3.274; Hak E, 2002, CLIN INFECT DIS, V35, P370, DOI 10.1086/341403; JOHNSON DW, 1992, CLIN PHARMACOKINET, V22, P434, DOI 10.2165/00003088-199222060-00003; Kausz A, 2004, SEMIN DIALYSIS, V17, P9, DOI 10.1111/j.1525-139X.2004.17104.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; McGrath LJ, 2012, AM J KIDNEY DIS, V60, P890, DOI 10.1053/j.ajkd.2012.09.001; McGrath LJ, 2012, ARCH INTERN MED, V172, P548, DOI 10.1001/archinternmed.2011.2238; Naqvi SB, 2006, ADV CHRONIC KIDNEY D, V13, P199, DOI 10.1053/j.ackd.2006.04.004; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Sarnak MJ, 2001, CHEST, V120, P1883, DOI 10.1378/chest.120.6.1883; Scharpe J, 2009, AM J KIDNEY DIS, V54, P77, DOI 10.1053/j.ajkd.2008.11.032; Snyder JJ, 2009, J AM SOC NEPHROL, V20, P1614, DOI 10.1681/ASN.2008090954; Song JY, 2006, AM J NEPHROL, V26, P206, DOI 10.1159/000093306; Tanzi E, 2007, J MED VIROL, V79, P1176, DOI 10.1002/jmv.20936; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vanholder R, 2002, BLOOD PURIFICAT, V20, P477, DOI 10.1159/000063556; Vogtlander NPJ, 2004, VACCINE, V22, P2199, DOI 10.1016/j.vaccine.2003.11.046	30	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58317	10.1371/journal.pone.0058317	http://dx.doi.org/10.1371/journal.pone.0058317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516462	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200055
J	Bergwitz, C; Wee, MJ; Sinha, S; Huang, JN; DeRobertis, C; Mensah, LB; Cohen, J; Friedman, A; Kulkarni, M; Hu, YH; Vinayagam, A; Schnall-Levin, M; Berger, B; Perkins, LA; Mohr, SE; Perrimon, N				Bergwitz, Clemens; Wee, Mark J.; Sinha, Sumi; Huang, Joanne; DeRobertis, Charles; Mensah, Lawrence B.; Cohen, Jonathan; Friedman, Adam; Kulkarni, Meghana; Hu, Yanhui; Vinayagam, Arunachalam; Schnall-Levin, Michael; Berger, Bonnie; Perkins, Lizabeth A.; Mohr, Stephanie E.; Perrimon, Norbert			Genetic Determinants of Phosphate Response in Drosophila	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; VASCULAR CALCIFICATION; INORGANIC-PHOSPHATE; IN-VITRO; PROTEIN; EXPRESSION; BONE; REGULATOR; DATABASE; CALCIUM	Phosphate is required for many important cellular processes and having too little phosphate or too much can cause disease and reduce life span in humans. However, the mechanisms underlying homeostatic control of extracellular phosphate levels and cellular effects of phosphate are poorly understood. Here, we establish Drosophila melanogaster as a model system for the study of phosphate effects. We found that Drosophila larval development depends on the availability of phosphate in the medium. Conversely, life span is reduced when adult flies are cultured on high phosphate medium or when hemolymph phosphate is increased in flies with impaired Malpighian tubules. In addition, RNAi-mediated inhibition of MAPK-signaling by knockdown of Ras85D, phl/D-Raf or Dsor1/MEK affects larval development, adult life span and hemolymph phosphate, suggesting that some in vivo effects involve activation of this signaling pathway by phosphate. To identify novel genetic determinants of phosphate responses, we used Drosophila hemocyte-like cultured cells (S2R+) to perform a genome-wide RNAi screen using MAPK activation as the readout. We identified a number of candidate genes potentially important for the cellular response to phosphate. Evaluation of 51 genes in live flies revealed some that affect larval development, adult life span and hemolymph phosphate levels.	[Bergwitz, Clemens; Wee, Mark J.; Sinha, Sumi; Huang, Joanne; DeRobertis, Charles; Mensah, Lawrence B.; Cohen, Jonathan] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Friedman, Adam; Kulkarni, Meghana; Hu, Yanhui; Vinayagam, Arunachalam; Perkins, Lizabeth A.; Mohr, Stephanie E.; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA USA; [Schnall-Levin, Michael; Berger, Bonnie] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; [Schnall-Levin, Michael; Berger, Bonnie] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bergwitz, C (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	cwhb2002@yahoo.com		Hu, Yanhui/0000-0003-1494-1402; arunachalam, vinayagam/0000-0003-0091-4497; Perrimon, Norbert/0000-0001-7542-472X; Mohr, Stephanie/0000-0001-9639-7708	Harvard Catalyst; NIDDK [1K08 DK08361]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947, R01GM067761] Funding Source: NIH RePORTER	Harvard Catalyst; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CB received funding for this project by the Harvard Catalyst and NIDDK 1K08 DK08361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Bergwitz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031730; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Bevington A, 1992, CLIN CHEM ENZYMOL CO, V4, P235; Bringhurst FR, 2006, ENDOCRINOLOGY, V5, P805; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chertow GM, 1999, CLIN NEPHROL, V51, P18; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Dinur M, 2006, MOL ENDOCRINOL, V20, P1652, DOI 10.1210/me.2005-0333; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Hou SC, 2009, FEBS LETT, V583, P2765, DOI 10.1016/j.febslet.2009.07.025; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Ito E, 2010, INT J HEMATOL, V92, P413, DOI 10.1007/s12185-010-0693-7; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; KILAV R, 1995, J CLIN INVEST, V96, P327, DOI 10.1172/JCI118038; KRAUS ME, 1994, MOL CELL BIOL, V14, P5360, DOI 10.1128/MCB.14.8.5360; Laplantine E, 2002, J CELL BIOL, V158, P741, DOI 10.1083/jcb.200205025; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lopez-Mejia IC, 2011, HUM MOL GENET, V20, P4540, DOI 10.1093/hmg/ddr385; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Mason DA, 2009, SEMIN CELL DEV BIOL, V20, P582, DOI 10.1016/j.semcdb.2009.02.006; McGee-Lawrence ME, 2012, BONE; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Moallem E, 1998, J BIOL CHEM, V273, P5253, DOI 10.1074/jbc.273.9.5253; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Nair D, 1997, J BIOL CHEM, V272, P18920, DOI 10.1074/jbc.272.30.18920; Nechama M, 2008, FASEB J, V22, P3458, DOI 10.1096/fj.08-107250; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018; Perez VI, 2011, J GERONTOL A-BIOL, V66, P1286, DOI 10.1093/gerona/glr125; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Razzaque MS, 2009, NEPHROL DIAL TRANSPL, V24, P4, DOI 10.1093/ndt/gfn620; Roberts D. B., 1998, PRACTICAL APPROACH S; Rossi F, 2002, DEV BIOL, V247, P271, DOI 10.1006/dbio.2002.0691; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Smith RK, 2002, DEVELOPMENT, V129, P71; Sprecher E, 2010, J INVEST DERMATOL, V130, P652, DOI 10.1038/jid.2009.337; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; TENENHOUSE HS, 1989, BIOCHIM BIOPHYS ACTA, V984, P207, DOI 10.1016/0005-2736(89)90218-6; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zhang MYH, 2012, ENDOCRINOLOGY, V153, P1806, DOI 10.1210/en.2011-1831; Zhao HW, 2011, PLACENTA, V32, pS104, DOI 10.1016/j.placenta.2010.11.017	73	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56753	10.1371/journal.pone.0056753	http://dx.doi.org/10.1371/journal.pone.0056753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520455	Green Published, gold			2022-12-25	WOS:000318679900014
J	Kanari, Y; Sato, Y; Aoyama, S; Muta, T				Kanari, Yasuyoshi; Sato, Yuki; Aoyama, Satoru; Muta, Tatsushi			Thioredoxin-Interacting Protein Gene Expression via MondoA Is Rapidly and Transiently Suppressed during Inflammatory Responses	PLOS ONE			English	Article							UP-REGULATED PROTEIN-1; TXNIP; GLUCOSE; BINDING; LOCALIZATION; METABOLISM; DIFFERENTIATION; GROWTH; VDUP1	Whereas accumulating evidence indicates that a number of inflammatory genes are induced by activation of nuclear factor-kappa B and other transcription factors, less is known about genes that are suppressed by proinflammatory stimuli. Here we show that expression of thioredoxin-interacting protein (Txnip) is dramatically suppressed both in mRNA and protein levels upon stimulation with lipopolysaccharide in mouse and human macrophages. In addition to lipopolysaccharide, a Toll-like receptor 4 ligand, stimulation with other Toll-like receptor ligands such as CpG DNA also suppressed Txnip expression. Not only the Toll-like receptor ligands, but also other proinflammatory stimulators, such as interleukin-1 beta and tumor necrosis factor-alpha elicited the similar response in fibroblasts. Suppression of Txnip by lipopolysaccharide is accompanied by a decrease of the glucose sensing transcription factor MondoA in the nuclei and dissociation of the MondoA:Mlx complex that bound to the carbohydrate-response elements in the Txnip promoter in unstimulated cells. Lipopolysaccharide-mediated decrease of nuclear MondoA was inhibited in the presence of 2-deoxyglucose. Furthermore, blockage of glyceraldehyde-3-phosphate dehydrogenase by iodoacetate alleviated the suppression of Txnip mRNA by lipopolysaccharide, suggesting the involvement of glucose-metabolites in the regulation. Since Txnip is implicated in the regulation of glucose metabolism, this observation links between inflammatory responses and metabolic regulation.	[Kanari, Yasuyoshi; Muta, Tatsushi] Tohoku Univ, Lab Cell Recognit & Response, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Kanari, Yasuyoshi; Muta, Tatsushi] Ctr Ecosyst Management Adapting Global Change, Global Ctr Excellence Program, Sendai, Miyagi, Japan; [Sato, Yuki; Aoyama, Satoru; Muta, Tatsushi] Tohoku Univ, Fac Sci, Dept Biol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Muta, T (corresponding author), Tohoku Univ, Lab Cell Recognit & Response, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	tmuta@biology.tohoku.ac.jp	Sato, Yuki/GWZ-1382-2022	Sato, Yuki/0000-0002-3758-3452	Ministry of Education, Culture, Sports, Science and Technology of Japan [21117004]; Japan Society for the Promotion of Science [21390088]; Takeda Science Foundation; Naito Foundation; Asahi Grass Foundation; Suzuken Memorial Foundation; Novartis Foundation for the Promotion of Science; Japan Foundation for Applied Enzymology; Global COE Program "Center for ecosystem management adapting to global change" of the Ministry of Education, Culture, Sports, Science and Technology of Japan [J03];  [22590345]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Asahi Grass Foundation; Suzuken Memorial Foundation; Novartis Foundation for the Promotion of Science; Japan Foundation for Applied Enzymology; Global COE Program "Center for ecosystem management adapting to global change" of the Ministry of Education, Culture, Sports, Science and Technology of Japan; 	This work was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas (21117004) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TM, Grant-in-Aid for Scientific Research (B) (21390088) from the Japan Society for the Promotion of Science to TM, and Grant-in-Aid for Scientific Research (C) (22590345) to YK, and grants to TM from Takeda Science Foundation, the Naito Foundation, the Asahi Grass Foundation, Suzuken Memorial Foundation, the Novartis Foundation for the Promotion of Science, and the Japan Foundation for Applied Enzymology, and by the Global COE Program "Center for ecosystem management adapting to global change"(J03) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; Elgort Marc G, 2010, Genes Cancer, V1, P893, DOI 10.1177/1947601910389604; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mousa SA, 2009, AGING-US, V1, P412, DOI 10.18632/aging.100035; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Shao WJ, 2010, CELL SIGNAL, V22, P1240, DOI 10.1016/j.cellsig.2010.04.001; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Yu FX, 2010, J BIOL CHEM, V285, P25822, DOI 10.1074/jbc.M110.108290; Yu FX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008397; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59026	10.1371/journal.pone.0059026	http://dx.doi.org/10.1371/journal.pone.0059026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520550	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900110
J	Marques-Pita, M; Rocha, LM				Marques-Pita, Manuel; Rocha, Luis M.			Canalization and Control in Automata Networks: Body Segmentation in Drosophila melanogaster	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; BOOLEAN NETWORK; COMPLEX-SYSTEMS; CELL-CYCLE; MODELS; ROBUSTNESS; EVOLUTION; EMERGENT; POLARITY; DYNAMICS	We present schema redescription as a methodology to characterize canalization in automata networks used to model biochemical regulation and signalling. In our formulation, canalization becomes synonymous with redundancy present in the logic of automata. This results in straightforward measures to quantify canalization in an automaton (micro-level), which is in turn integrated into a highly scalable framework to characterize the collective dynamics of large-scale automata networks (macro-level). This way, our approach provides a method to link micro-to macro-level dynamics - a crux of complexity. Several new results ensue from this methodology: uncovering of dynamical modularity (modules in the dynamics rather than in the structure of networks), identification of minimal conditions and critical nodes to control the convergence to attractors, simulation of dynamical behaviour from incomplete information about initial conditions, and measures of macro-level canalization and robustness to perturbations. We exemplify our methodology with a well-known model of the intra-and inter cellular genetic regulation of body segmentation in Drosophila melanogaster. We use this model to show that our analysis does not contradict any previous findings. But we also obtain new knowledge about its behaviour: a better understanding of the size of its wild-type attractor basin (larger than previously thought), the identification of novel minimal conditions and critical nodes that control wild-type behaviour, and the resilience of these to stochastic interventions. Our methodology is applicable to any complex network that can be modelled using automata, but we focus on biochemical regulation and signalling, towards a better understanding of the (decentralized) control that orchestrates cellular activity - with the ultimate goal of explaining how do cells and tissues 'compute'.	[Marques-Pita, Manuel; Rocha, Luis M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Marques-Pita, Manuel; Rocha, Luis M.] Indiana Univ, Bloomington, IN USA	Instituto Gulbenkian de Ciencia; Indiana University System; Indiana University Bloomington	Marques-Pita, M (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	marquesm@indiana.edu; rocha@indiana.edu	Marques-Pita, Manuel/AAI-2583-2021	Marques-Pita, Manuel/0000-0003-2180-6823; Rocha, Luis/0000-0001-9402-887X	Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/EIA-CCO/114108/2009]; Fundação para a Ciência e a Tecnologia [PTDC/EIA-CCO/114108/2009] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	Funding provided by Fundacao para a Ciencia e a Tecnologia (Portugal) grant PTDC/EIA-CCO/114108/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts B., 2003, MOL BIOL CELL; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alexander RP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe44; Alvarez-Buylla ER, 2008, PLOS ONE, V3; [Anonymous], 2004, P WORKSH TUT 9 INT C; Assmann SM, 2009, METHODS MOL BIOL, V553, P207, DOI 10.1007/978-1-60327-563-7_10; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bjorklund A, 2006, ANN IEEE SYMP FOUND, P575; Blake A, 1938, CANONICAL EXPRESSION; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; CHANDRA AK, 1978, DISCRETE MATH, V24, P7, DOI 10.1016/0012-365X(78)90168-1; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; CONRAD M, 1990, BIOSYSTEMS, V24, P61, DOI 10.1016/0303-2647(90)90030-5; CRUTCHFIELD JP, 1995, P NATL ACAD SCI USA, V92, P10742, DOI 10.1073/pnas.92.23.10742; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Gat-Viks I, 2003, BIOINFORMATICS, V19, pi108, DOI 10.1093/bioinformatics/btg1014; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Grefenstette J, 2006, BIOSYSTEMS; Harris Stephen E., 2002, Complexity, V7, P23, DOI 10.1002/cplx.10022; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Hooper J.E., 1992, Results and Problems in Cell Differentiation, V18, P1; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, GENETIC NETWORKS CAN; KAUFFMAN SA, 1984, PHYSICA D, V10, P145, DOI 10.1016/0167-2789(84)90257-4; Klir G., 2002, ARCHITECTURE SYSTEMS, V2nd; Kolchinsky A., 2011, ADV ARTIFICIAL LIFE, P423; Kravets VN, 2000, ICCAD - 2000 : IEEE/ACM INTERNATIONAL CONFERENCE ON COMPUTER AIDED DESIGN, P526, DOI 10.1109/ICCAD.2000.896526; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Lu XM, 2010, CELL CYCLE, V9, P2908; Marques-Pita M., 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P233, DOI 10.1109/ALIFE.2011.5954670; Masel J, 2007, GENETICS, V175, P453, DOI 10.1534/genetics.106.065201; MCCLUSKEY EJ, 1956, BELL SYST TECH J, V35, P1445, DOI 10.1002/j.1538-7305.1956.tb03836.x; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Mitchell, 1996, INTRO GENETIC ALGORI; Mitchell M, 2006, ARTIF INTELL, V170, P1194, DOI 10.1016/j.artint.2006.10.002; Peak D, 2004, P NATL ACAD SCI USA, V101, P918, DOI 10.1073/pnas.0307811100; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Quine W.V., 2018, AM MATH MON, V62, P627, DOI [10.1080/00029890.1955.11988710, DOI 10.1080/00029890.1955.11988710]; Raeymaekers L, 2002, J THEOR BIOL, V218, P331, DOI 10.1006/jtbi.2002.3081; Reichhardt CJO, 2007, J PHYS A-MATH THEOR, V40, P4339, DOI 10.1088/1751-8113/40/16/006; Rocha LM, 2005, ARTIF LIFE, V11, P189, DOI 10.1162/1064546053278964; Samaga R, 2010, J COMPUT BIOL, V17, P39, DOI 10.1089/cmb.2009.0121; Shannon C., 1938, T AIEE, V57, P713, DOI [10.1109/EE.1938.6431064, DOI 10.1109/EE.1938.6431064]; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Singh Gurinder, 2014, J MENT HEALTH, V22, P522, DOI [10.3109/10717544.2014.885616, DOI 10.3109/09638237.2014.954693, 10.3109/08039481003777484]; ten Tusscher KHWJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-159; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Valiant L. G., 1984, COMMUNICATIONS ACM; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Von Dassow G, 2002, J EXP ZOOL, V294, P179, DOI 10.1002/jez.10144; Waddington C H, 1957, STRATEGY GENES DISCU; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wallace D., 1998, GROUPS RINGS FIELDS; Willadsen K, 2007, J THEOR BIOL, V249, P749, DOI 10.1016/j.jtbi.2007.09.004; Wolpert L., 1998, PRINCIPLES DEV; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	64	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55946	10.1371/journal.pone.0055946	http://dx.doi.org/10.1371/journal.pone.0055946			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520449	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900008
J	Odoi, KA; Huang, Y; Rezenom, YH; Liu, WR				Odoi, Keturah A.; Huang, Ying; Rezenom, Yohannes H.; Liu, Wenshe R.			Nonsense and Sense Suppression Abilities of Original and Derivative Methanosarcina mazei Pyrrolysyl-tRNA Synthetase-tRNA(Pyl) Pairs in the Escherichia coli BL21(DE3) Cell Strain	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; GENETIC-CODE; L-PHENYLALANINE; FACILE SYSTEM; PROTEIN; LYSINE; ANALOG; UAG	Systematic studies of nonsense and sense suppression of the original and three derivative Methanosarcina mazei PylRS-tRNA(Pyl) pairs and cross recognition between nonsense codons and various tRNA(Pyl) anticodons in the Escherichia coli BL21(DE3) cell strain are reported. tRNA(CUA)(Pyl) is orthogonal in E. coli and able to induce strong amber suppression when it is co-expressed with pyrrolysyl-tRNA synthetase (PylRS) and charged with a PylRS substrate, N-8-tert-butoxycarbonyl-L- lysine (BocK). Similar totRNA(CUA)(Pyl), tRNA(UUA)(Pyl) is also orthogonal in E. coli and can be coupled with PylRS to genetically incorporate BocK at an ochre mutation site. Although tRNA(UUA)(Pyl) is expected to recognize a UAG codon based on the wobble hypothesis, the PylRS-tRNA(UUA)(Pyl) pair does not give rise to amber suppression that surpasses the basal amber suppression level in E. coli. E. coli itself displays a relatively high opal suppression level and tryptophan (Trp) is incorporated at an opal mutation site. Although the PylRS-tRNA(UCA)(Pyl) pair can be used to encode BocK at an opal codon, the pair fails to suppress the incorporation of Trp at the same site. tRNA(CCU)(Pyl) fails to deliver BocK at an AGG codon when co-expressed with PylRS in E. coli.	[Odoi, Keturah A.; Huang, Ying; Rezenom, Yohannes H.; Liu, Wenshe R.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Liu, WR (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	wliu@chem.tamu.edu	Liu, wenshe/O-4425-2014	Liu, wenshe/0000-0002-7078-6534	National Institute of Health [1R01CA161158]; Welch Foundation [A-1715]; NATIONAL CANCER INSTITUTE [R01CA161158] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health (grant 1R01CA161158) and the Welch Foundation (grant A-1715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Ai HW, 2010, CHEM COMMUN, V46, P5506, DOI 10.1039/c0cc00108b; Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; BARON C, 1991, J BIOL CHEM, V266, P20375; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Fekner T, 2009, ANGEW CHEM INT EDIT, V48, P1633, DOI 10.1002/anie.200805420; Fukunaga J, 2006, NUCLEIC ACIDS RES, V34, P3181, DOI 10.1093/nar/gkl414; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; GRIBSKOV M, 1984, NUCLEIC ACIDS RES, V12, P539, DOI 10.1093/nar/12.1Part2.539; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Huang Y, 2010, BIOORG MED CHEM LETT, V20, P878, DOI 10.1016/j.bmcl.2009.12.077; Li X, 2009, ANGEW CHEM INT EDIT, V48, P9184, DOI 10.1002/anie.200904472; Liu WSR, 2011, MOL BIOSYST, V7, P38, DOI 10.1039/c0mb00216j; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; SCHWYZER R, 1971, HELV CHIM ACTA, V54, P1395, DOI 10.1002/hlca.19710540521; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; SWANSON R, 1988, SCIENCE, V242, P1548, DOI 10.1126/science.3144042; Takimoto JK, 2011, ACS CHEM BIOL, V6, P733, DOI 10.1021/cb200057a; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; VOLD BS, 1982, NUCLEIC ACIDS RES, V10, P3125, DOI 10.1093/nar/10.10.3125; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang YS, 2012, J AM CHEM SOC, V134, P2950, DOI 10.1021/ja211972x; Wang YS, 2011, MOL BIOSYST, V7, P714, DOI 10.1039/c0mb00217h; Wang YS, 2010, MOL BIOSYST, V6, P1575, DOI 10.1039/c002155e; Wu B, 2012, CHEMBIOCHEM, V13, P1405, DOI 10.1002/cbic.201200281; Xie JM, 2004, NAT BIOTECHNOL, V22, P1297, DOI 10.1038/nbt1013; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yuan J, 2010, FEBS LETT, V584, P342, DOI 10.1016/j.febslet.2009.11.005; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	41	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57035	10.1371/journal.pone.0057035	http://dx.doi.org/10.1371/journal.pone.0057035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520461	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900020
J	Yoo, M; Khaled, M; Gibbs, KM; Kim, J; Kowalewski, B; Dierks, T; Schachner, M				Yoo, Myungsik; Khaled, Muntasir; Gibbs, Kurt M.; Kim, Jonghun; Kowalewski, Bjoern; Dierks, Thomas; Schachner, Melitta			Arylsulfatase B Improves Locomotor Function after Mouse Spinal Cord Injury	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; ENZYME-REPLACEMENT THERAPY; GLIAL SCAR; UP-REGULATION; CNS INJURY; BINDING PEPTIDES; HEPARAN-SULFATE; AXONAL REGROWTH; RECOVERY; GROWTH	Bacterial chondroitinase ABC (ChaseABC) has been used to remove the inhibitory chondroitin sulfate chains from chondroitin sulfate proteoglycans to improve regeneration after rodent spinal cord injury. We hypothesized that the mammalian enzyme arylsulfatase B (ARSB) would also enhance recovery after mouse spinal cord injury. Application of the mammalian enzyme would be an attractive alternative to ChaseABC because of its more robust chemical stability and reduced immunogenicity. A one-time injection of human ARSB into injured mouse spinal cord eliminated immunoreactivity for chondroitin sulfates within five days, and up to 9 weeks after injury. After a moderate spinal cord injury, we observed improvements of locomotor recovery assessed by the Basso Mouse Scale (BMS) in ARSB treated mice, compared to the buffer-treated control group, at 6 weeks after injection. After a severe spinal cord injury, mice injected with equivalent units of ARSB or ChaseABC improved similarly and both groups achieved significantly more locomotor recovery than the buffer-treated control mice. Serotonin and tyrosine hydroxylase immunoreactive axons were more extensively present in mouse spinal cords treated with ARSB and ChaseABC, and the immunoreactive axons penetrated further beyond the injury site in ARSB or ChaseABC treated mice than in control mice. These results indicate that mammalian ARSB improves functional recovery after CNS injury. The structural/molecular mechanisms underlying the observed functional improvement remain to be elucidated.	[Yoo, Myungsik; Khaled, Muntasir; Gibbs, Kurt M.; Kim, Jonghun; Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Yoo, Myungsik; Khaled, Muntasir; Gibbs, Kurt M.; Kim, Jonghun; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Kowalewski, Bjoern; Dierks, Thomas] Univ Bielefeld, Dept Chem, Bielefeld, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Guangdong, Peoples R China	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Bielefeld; Shantou University	Schachner, M (corresponding author), Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA.	schachner@stu.edu.cn	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Kim, Jonghun/0000-0002-9154-5529	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the New Jersey Commission for Spinal Cord Research and in part from Deutsche Forschungsgemeinschaft. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; Asher RA, 2000, J NEUROSCI, V20, P2427; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BOVOLENTA P, 1991, RESTOR NEUROL NEUROS, V2, P221, DOI 10.3233/RNN-1991-245609; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Butterfield KC, 2010, NEUROSCI LETT, V478, P82, DOI 10.1016/j.neulet.2010.04.070; Butterfield KC, 2010, BIOCHEMISTRY-US, V49, P1549, DOI 10.1021/bi9021044; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; Cavalcante LA, 2003, BRAZ J MED BIOL RES, V36, P993, DOI 10.1590/S0100-879X2003000800005; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fehlings MG, 2008, J NEUROSURG-SPINE, V8, P205, DOI 10.3171/SPI/2008/8/3/205; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GORHAM SD, 1978, H-S Z PHYSIOL CHEM, V359, P1811; Hamai A, 1997, J BIOL CHEM, V272, P9123; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; HUANG PP, 1994, J NEUROTRAUM, V11, P547, DOI 10.1089/neu.1994.11.547; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Iseda T, 2008, J NEUROTRAUM, V25, P334, DOI 10.1089/neu.2007.0289; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim BG, 2006, J COMP NEUROL, V497, P182, DOI 10.1002/cne.20980; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Koshiishi I, 1998, ANAL BIOCHEM, V265, P49, DOI 10.1006/abio.1998.2883; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Liu J, 2006, J CELL SCI, V119, P933, DOI 10.1242/jcs.02796; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Munoz-Rojas MV, 2010, MOL GENET METAB, V99, P346, DOI 10.1016/j.ymgme.2009.11.008; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; Prabhakar V, 2009, J BIOL CHEM, V284, P974, DOI 10.1074/jbc.M806630200; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; Skidmore MA, 2010, NAT PROTOC, V5, P1983, DOI 10.1038/nprot.2010.145; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; WASSERMAN SI, 1976, J CLIN INVEST, V57, P738, DOI 10.1172/JCI108332; Wilson MT, 2000, J COMP NEUROL, V424, P532, DOI 10.1002/1096-9861(20000828)424:3<532::AID-CNE10>3.0.CO;2-Z; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3	75	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57415	10.1371/journal.pone.0057415	http://dx.doi.org/10.1371/journal.pone.0057415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520469	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900028
J	Huang, X; Gong, R; Li, XY; Virtue, A; Yang, F; Yang, IH; Tran, AH; Yang, XF; Wang, H				Huang, Xiao; Gong, Ren; Li, Xinyuan; Virtue, Anthony; Yang, Fan; Yang, Irene H.; Tran, Anh H.; Yang, Xiao-Feng; Wang, Hong			Identification of Novel Pretranslational Regulatory Mechanisms for NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNAS; PATHWAY	NF-kappa B-controlled transcriptional regulation plays a central role in inflammatory and immune responses. Currently, understanding about NF-kappa B activation mechanism emphasizes I kappa B-tethered complex inactivation in the cytoplasm. In the case of NF-kappa B activation, I kappa B phosphorylation leads to its degradation, followed by NF-kappa B relocation to the nucleus and trans-activation of NF-kappa B-targeted genes. Pretranslational mechanism mediated NF-kappa B activation remains poorly understood. In this study, we investigated NF-kappa B pretranslational regulation by performing a series of database mining analyses and using six large national experimental databases (National Center of Biotechnology Information UniGene expressed sequence tag profile database, Gene Expression Omnibus database, Transcription Element Search System database, AceView database, and Epigenomics database) and TargetScan software. We reported the following findings: 1) NF-kappa B-signaling genes are differentially expressed in human and mouse tissues; 2) heart and vessels are the inflammation-privileged tissues and less easy to be inflamed because lacking in key NF-kappa B-signaling molecular expression; 3) NF-kappa B-signaling genes are induced by cardiovascular disease risk factors oxidized phospholipids and proinflammatory cytokines in endothelial cells; 4) transcription factors CCAAT/enhancer-binding proteins and NF-kappa B have higher binding site frequencies in the promoters of proinflammatory cyto-kine-induced NF-kappa B genes; 5) most NF-kappa B-signaling genes have multiple alternative promoters and alternatively spliced isoforms; 6) NF-kappa B family genes can be regulated by DNA methylation; and 7) 27 of 38 NF-kappa B-signaling genes can be regulated by microRNAs. Our findings provide important insight into the mechanism of NF-kappa B activation, which may contribute to cardiovascular disease, inflammatory diseases, and immunological disorders.	[Huang, Xiao; Gong, Ren; Li, Xinyuan; Virtue, Anthony; Tran, Anh H.; Yang, Xiao-Feng; Wang, Hong] Temple Univ, Sch Med, Cardiovasc Res Ctr, Thrombosis Res Ctr,Dept Pharmacol, Philadelphia, PA 19140 USA; [Huang, Xiao] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang 330006, Jiangxi, Peoples R China; [Gong, Ren] Jiangxi Prov Peoples Hosp, Dept Cardiol, Nanchang 330006, Jiangxi, Peoples R China; [Yang, Fan] Griffin Hosp, Dept Med, Derby, CT 06418 USA; [Yang, Irene H.] Yale Univ, New Haven Hosp, Dept Neurol, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nanchang University; Yale University	Yang, XF (corresponding author), Temple Univ, Sch Med, Cardiovasc Res Ctr, 3500 N Broad St,MERB 1059, Philadelphia, PA 19140 USA.	xfyang@temple.edu; hongw@temple.edu	Li, Xinyuan/Z-6299-2019; Li, Xinyuan/B-1139-2015	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367	National Institutes of Health [HL67033, HL77288, HL82774, HL110764, HL117654, HL094451, HL108910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067033, R01HL082774, R01HL108910, R01HL110764, R01HL077288, R01HL117654, R01HL094451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67033, HL77288 HL82774, HL110764, and HL117654 (to H. W.) and HL094451 and HL108910 (to X. F. Y.).	Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holloway Dustin T, 2005, Genome Inform, V16, P83; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Lopez-Pedrera C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/974648; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Ng B, 2004, J ALLERGY CLIN IMMUN, V114, P1463, DOI 10.1016/j.jaci.2004.09.006; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Virtue A, 2011, FRONT BIOSCI-LANDMRK, V16, P3133, DOI 10.2741/3901; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yang F, 2006, CLIN IMMUNOL, V121, P121, DOI 10.1016/j.clim.2006.06.007; Yang Xiao-Feng, 2008, Drug Discov Today Ther Strateg, V5, P125, DOI 10.1016/j.ddstr.2008.11.003; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211	29	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15628	15640		10.1074/jbc.M113.460626	http://dx.doi.org/10.1074/jbc.M113.460626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23515310	Green Published, hybrid			2022-12-25	WOS:000319822300020
J	Cowper-Smith, CD; Harris, J; Eskes, GA; Westwood, DA				Cowper-Smith, Christopher D.; Harris, Jonathan; Eskes, Gail A.; Westwood, David A.			Spatial Interactions between Successive Eye and Arm Movements: Signal Type Matters	PLOS ONE			English	Article							MOTOR CORTEX; SUPERIOR COLLICULUS; TARGET SELECTION; INHIBITION; RETURN; ORGANIZATION; STIMULATION; LOCATIONS; VOLUNTARY; DIRECTION	Spatial interactions between consecutive movements are often attributed to inhibition of return (IOR), a phenomenon in which responses to previously signalled locations are slower than responses to unsignalled locations. In two experiments using peripheral target signals offset by 0 degrees, 90 degrees, or 180 degrees, we show that consecutive saccadic (Experiment 1) and reaching (Experiment 3) responses exhibit a monotonic pattern of reaction times consistent with the currently established spatial distribution of IOR. In contrast, in two experiments with central target signals (i.e., arrowheads pointing at target locations), we find a non-monotonic pattern of reaction times for saccades (Experiment 2) and reaching movements (Experiment 4). The difference in the patterns of results observed demonstrates different behavioral effects that depend on signal type. The pattern of results observed for central stimuli are consistent with a model in which neural adaptation is occurring within motor networks encoding movement direction in a distributed manner.	[Cowper-Smith, Christopher D.; Eskes, Gail A.; Westwood, David A.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Harris, Jonathan; Westwood, David A.] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada; [Eskes, Gail A.] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Westwood, DA (corresponding author), Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada.	David.Westwood@DAL.CA		Westwood, David/0000-0003-3317-0447; Eskes, Gail/0000-0001-5867-9616	Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS); Dalhousie Faculty of Medicine Clinical Research Scholar Award; CIHR New Investigator Award; NSERC Discovery Grant	Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS)(Canadian Institutes of Health Research (CIHR)); Dalhousie Faculty of Medicine Clinical Research Scholar Award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	CCS was supported by studentships from the Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS). GA was supported by a Dalhousie Faculty of Medicine Clinical Research Scholar Award, and DAW was supported by a CIHR New Investigator Award and an NSERC Discovery Grant; these grants also supported the research itself. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Bennett PJ, 2001, PSYCHOL SCI, V12, P76, DOI 10.1111/1467-9280.00313; Berlucchi G, 2006, COGN NEUROPSYCHOL, V23, P1065, DOI 10.1080/02643290600588426; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Cowper-Smith CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013330; Crapse TB, 2009, J NEUROSCI, V29, P5308, DOI 10.1523/JNEUROSCI.4906-08.2009; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Eisenberg M, 2010, J NEUROSCI, V30, P8897, DOI 10.1523/JNEUROSCI.0007-10.2010; Fecteau JH, 2005, J COGNITIVE NEUROSCI, V17, P1714, DOI 10.1162/089892905774589235; Fischer MH, 2003, PERCEPT PSYCHOPHYS, V65, P379, DOI 10.3758/BF03194569; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; Machado L, 2004, Q J EXP PSYCHOL-A, V57, P789, DOI 10.1080/02724980343000486; Macinnes Joseph W, 2003, ScientificWorldJournal, V3, P75; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; MAYLOR EA, 1985, J EXP PSYCHOL HUMAN, V11, P777, DOI 10.1037/0096-1523.11.6.777; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3231, DOI 10.1152/jn.00487.2006; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; PRATT J, 1995, J EXP PSYCHOL HUMAN, V21, P1343, DOI 10.1037/0096-1523.21.6.1343; Pratt J, 1998, CAN J EXP PSYCHOL, V52, P213, DOI 10.1037/h0087294; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; RAFAL R, 1994, CAN J EXP PSYCHOL, V48, P284, DOI 10.1037/1196-1961.48.2.284; RAFAL RD, 1989, J EXP PSYCHOL HUMAN, V15, P673, DOI 10.1037/0096-1523.15.4.673; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Satel J, 2012, EXP BRAIN RES, V223, P469, DOI 10.1007/s00221-012-3274-6; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; Schneider WX, 1995, VISUAL SELECTIVE ATTENTION, P331, DOI 10.1080/13506289508401737; Snyder JJ, 2001, J EXP PSYCHOL HUMAN, V27, P1420, DOI 10.1037//0096-1523.27.6.1420; Spalek TM, 2005, PSYCHOL SCI, V16, P15, DOI 10.1111/j.0956-7976.2005.00774.x; Taylor TL, 1998, PSYCHON B REV, V5, P625, DOI 10.3758/BF03208839; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; Tipper SP, 1996, J EXP PSYCHOL HUMAN, V22, P1289, DOI 10.1037//0096-1523.22.5.1289; Wang ZG, 2012, EXP BRAIN RES, V218, P441, DOI 10.1007/s00221-012-3033-8	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58850	10.1371/journal.pone.0058850	http://dx.doi.org/10.1371/journal.pone.0058850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527038	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100051
J	Liu, XQ; Liu, Y; Zhang, YJ; Chen, ZH; Tang, ZW; Xu, QQ; Wang, Y; Zhao, P; Qi, ZT				Liu, Xiaoqing; Liu, Yuan; Zhang, Yanjun; Chen, Zhihui; Tang, Ziwei; Xu, Qingqiang; Wang, Yue; Zhao, Ping; Qi, Zhongtian			Pre-Existing Immunity with High Neutralizing Activity to 2009 Pandemic H1N1 Influenza Virus in Shanghai Population	PLOS ONE			English	Article							MATCHING PATTERNS; HEMAGGLUTININ; NEURAMINIDASE; TRANSMISSION; INFECTION; VACCINES; H5N1	Pre-existing immunity is an important factor countering the pandemic potential of an emerging influenza virus strain. Thus, studying of pre-existing immunity to the 2009 pandemic H1N1 virus (2009 H1N1) will advance our understanding of the pathogenesis and epidemiology of this emerging pathogen. In the present study, sera were collected from 486 individuals in a hospital in Shanghai, China, before the 2009 H1N1 influenza pandemic. The serum anti-hemagglutinins (HA) antibody, hemagglutination inhibition (HI) antibody and neutralizing antibody against the 2009 H1N1 were assayed. Among this population, 84.2%, 14.61% and 26.5% subjects possessed anti-HA antibody, HI antibody and neutralizing antibody, respectively. Although neutralizing antibody only existed in those sera with detectable anti-HA antibody, there was no obvious correlation between the titers of anti-HA and neutralizing antibody. However, the titers of anti-HA and neutralizing antibody against seasonal H1N1 virus were highly correlated. In the same population, there was no correlation between titers of neutralizing antibody against 2009 H1N1 and seasonal H1N1. DNA immunization performed on mice demonstrated that antibodies to the HA of 2009 pandemic and seasonal H1N1 influenza viruses were strain-specific and had no cross-neutralizing activity. In addition, the predicted conserved epitope in the HA of 2009 H1N1 and recently circulating seasonal H1N1 virus, GLFGAIAGFIE, was not an immunologically valid B-cell epitope. The data in this report are valuable for advancing our understanding of 2009 H1N1 influenza virus infection.	[Liu, Xiaoqing; Liu, Yuan; Zhang, Yanjun; Tang, Ziwei; Xu, Qingqiang; Zhao, Ping; Qi, Zhongtian] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China; [Chen, Zhihui] Second Mil Med Univ, Dept Infect Dis, Changhai Hosp, Shanghai, Peoples R China; [Wang, Yue] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	euy-tokyo@umin.ac.jp; pnzhao@163.com; qizt@smmu.edu.cn			Natural Science Foundation of China [81071364, 31170150]; Shanghai Leading Academic Discipline Project [B901]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by research grants from Natural Science Foundation of China (81071364, 31170150) and Shanghai Leading Academic Discipline Project (B901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Cao JY, 2009, HEPATOL INT, V3, P356, DOI 10.1007/s12072-008-9116-8; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; DOWDLE WR, 1977, J INFECT DIS, V136, pS386, DOI 10.1093/infdis/136.Supplement_3.S386; Du N, 2010, J VIROL, V84, P7822, DOI 10.1128/JVI.00069-10; Fang J, 2011, J VIROL METHODS, V173, P314, DOI 10.1016/j.jviromet.2011.03.001; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kwan-Gett TS, 2009, DISASTER MED PUBLIC, V3, pS109, DOI 10.1097/DMP.0b013e3181c6b818; Lemaitre M, 2011, CLIN MICROBIOL INFEC, V17, P732, DOI 10.1111/j.1469-0691.2010.03352.x; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V390, P1305, DOI 10.1016/j.bbrc.2009.10.142; Liu YA, 2010, VACCINE, V29, P183, DOI 10.1016/j.vaccine.2010.10.059; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mathews JD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-128; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Subbarao K, 1999, ADV VIRUS RES, V54, P349, DOI 10.1016/S0065-3527(08)60371-1; Tang JW, 2010, EMERG INFECT DIS, V16, P874, DOI 10.3201/eid1605.091678; Taubenberger JK, 2007, ANTIVIR THER, V12, P581; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015825; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040	43	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58810	10.1371/journal.pone.0058810	http://dx.doi.org/10.1371/journal.pone.0058810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527030	gold, Green Submitted, Green Published			2022-12-25	WOS:000317562100045
J	Cohen, N; Kravchenko-Balasha, N; Klein, S; Levitzki, A				Cohen, Noam; Kravchenko-Balasha, Nataly; Klein, Shoshana; Levitzki, Alexander			Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development-The Same Tumor by Different Means	PLOS ONE			English	Article							TYROSINE KINASE; CANCER; ARCHITECTURE; INFLAMMATION; PROGRESSION	Transformation is a complex process, involving many changes in the cell. In this work, we investigated the transcriptional changes that arose during the development of squamous cell carcinoma (SCC) in mice. Using microarray analysis, we looked at gene expression during different stages in cancer progression in 31 mice. By analyzing tumor progression in each mouse separately, we were able to define the global changes that were common to all 31 mice, as well as significant changes that occurred in fewer individuals. We found that different genes can contribute to the tumorigenic process in different mice, and that there are many ways to acquire the malignant properties defined by Hanahan and Weinberg as "hallmarks of cancer''. Eventually, however, all these changes lead to a very similar cancerous phenotype. The finding that gene expression is strongly heterogeneous in tumors that were induced by a standardized protocol in closely related mice underscores the need for molecular characterization of human tumors and personalized therapy.	[Cohen, Noam; Kravchenko-Balasha, Nataly; Klein, Shoshana; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel.	alex.levitzki@mail.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479	European Research Council under the European Union [249898]	European Research Council under the European Union(European Research Council (ERC))	Funding provided by a grant from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 249898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2009, CANCER-AM CANCER SOC, V115, P5421, DOI 10.1002/cncr.24616; Awada A, 2012, CURR OPIN ONCOL, V24, P297, DOI 10.1097/CCO.0b013e3283521349; Blay JY, 2012, LANCET ONCOL, V13, P448, DOI 10.1016/S1470-2045(12)70156-0; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Croteau W, 2013, J CELL PHYSIOL, V228, P773, DOI 10.1002/jcp.24225; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Fujii H, 2000, CANCER RES, V60, P114; Gagnon-Bartsch J, 2011, BIOSTATISTICS; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Klein S, 2007, ADV CANCER RES, V97, P295, DOI 10.1016/S0065-230X(06)97013-4; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levitzki A, 2010, MOL ASPECTS MED, V31, P287, DOI 10.1016/j.mam.2010.04.001; McDermott U, 2009, J CLIN ONCOL, V27, P5650, DOI 10.1200/JCO.2009.22.9054; Nistico P, 2012, COLD SPRING HARB PER, V4; PAPADAKIS E, 1992, INT J ONCOL, V1, P403; Popken-Harris P, 2006, VIRUS RES, V119, P177, DOI 10.1016/j.virusres.2006.01.006; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; Quigley DA, 2009, NATURE, V458, P505, DOI 10.1038/nature07683; Shi YZ, 2000, CLIN CANCER RES, V6, P4096; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Ton CC, 2011, BREAST CANCER RES TR, V125, P879, DOI 10.1007/s10549-010-1159-6; Veyrieras JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030629; Wu TD, 2001, J PATHOL, V195, P53, DOI 10.1002/1096-9896(200109)195:1<53::AID-PATH891>3.0.CO;2-H; Yauch RL, 2012, CURR OPIN GENET DEV, V22, P45, DOI 10.1016/j.gde.2012.01.003	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e57748	10.1371/journal.pone.0057748	http://dx.doi.org/10.1371/journal.pone.0057748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526950	gold, Green Published, Green Submitted			2022-12-25	WOS:000316411600005
J	Coudrain, V; Herzog, F; Entling, MH				Coudrain, Valerie; Herzog, Felix; Entling, Martin H.			Effects of Habitat Fragmentation on Abundance, Larval Food and Parasitism of a Spider-Hunting Wasp	PLOS ONE			English	Article							HYMENOPTERA CRABRONIDAE; STRUCTURAL CONNECTIVITY; POPULATION-DENSITY; INVESTMENT RATIOS; NATURAL ENEMIES; SEX-ALLOCATION; PREY SELECTION; LANDSCAPE; TRYPOXYLON; SPHECIDAE	Habitat fragmentation strongly affects species distribution and abundance. However, mechanisms underlying fragmentation effects often remain unresolved. Potential mechanisms are (1) reduced dispersal of a species or (2) altered species interactions in fragmented landscapes. We studied if abundance of the spider-hunting and cavity-nesting wasp Trypoxylon figulus Linnaeus (Hymenoptera: Crabronidae) is affected by fragmentation, and then tested for any effect of larval food (bottom up regulation) and parasitism (top down regulation). Trap nests of T. figulus were studied in 30 agricultural landscapes of the Swiss Plateau. The sites varied in the level of isolation from forest (adjacent, in the open landscape but connected, isolated) and in the amount of woody habitat (from 4 % to 74 %). We recorded wasp abundance (number of occupied reed tubes), determined parasitism of brood cells and analysed the diversity and abundance of spiders that were deposited as larval food. Abundances of T. figulus were negatively related to forest cover in the landscape. In addition, T. figulus abundances were highest at forest edges, reduced by 33.1% in connected sites and by 79.4% in isolated sites. The mean number of spiders per brood cell was lowest in isolated sites. Nevertheless, structural equation modelling revealed that this did not directly determine wasp abundance. Parasitism was neither related to the amount of woody habitat nor to isolation and did not change with host density. Therefore, our study showed that the abundance of T. figulus cannot be fully explained by the studied trophic interactions. Further factors, such as dispersal and habitat preference, seem to play a role in the population dynamics of this widespread secondary carnivore in agricultural landscapes.	[Coudrain, Valerie; Herzog, Felix] Res Stn Agroscope Reckenholz Tanikon ART, Zurich, Switzerland; [Coudrain, Valerie] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Coudrain, Valerie; Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Landau Pfalz, Germany	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; University of Bern; University of Koblenz & Landau	Coudrain, V (corresponding author), Res Stn Agroscope Reckenholz Tanikon ART, Zurich, Switzerland.	valerie.coudrain@art.admin.ch	Herzog, Felix/B-1911-2009; Entling, Martin H/C-6953-2008	Herzog, Felix/0000-0001-9472-4891; 	Swiss National Science Foundation [3100A0-114058]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation under grant number 3100A0-114058. http://www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2007, J ANIM ECOL, V76, P1015, DOI 10.1111/j.1365-2656.2007.01264.x; Arbuckle J. L., 2003, AMOS 5 0 1; ASIS JD, 1994, J KANSAS ENTOMOL SOC, V67, P199; Bailey D, 2010, J APPL ECOL, V47, P1003, DOI 10.1111/j.1365-2664.2010.01858.x; Barthel J, 1995, P 15 EUR C AR, P11; Bellmann H, 1995, BIENEN WESPEN AMEISE; Blackledge TA, 2003, ECOL LETT, V6, P13, DOI 10.1046/j.1461-0248.2003.00384.x; Boccaccio L, 2009, BIOCONTROL, V54, P607, DOI 10.1007/s10526-009-9214-0; Bogya S., 1999, Acta Phytopathologica et Entomologica Hungarica, V34, P99; Bonte D, 2008, ECOGRAPHY, V31, P646, DOI 10.1111/j.0906-7590.2008.05508.x; Bruckmann SV, 2011, J INSECT CONSERV, V15, P707, DOI 10.1007/s10841-010-9370-7; Bucher R, 2011, ECOL ENTOMOL, V36, P680, DOI 10.1111/j.1365-2311.2011.01317.x; Cooper JK, 2012, ECOLOGY LETT; COVILLE RE, 1983, J KANSAS ENTOMOL SOC, V56, P205; Cronin JT, 2005, P ROY SOC B-BIOL SCI, V272, P2225, DOI 10.1098/rspb.2005.3286; DANFORTH BN, 1990, BEHAV ECOL SOCIOBIOL, V27, P159, DOI 10.1007/BF00180299; Elgar MA, 1999, BEHAVIOUR, V136, P147, DOI 10.1163/156853999501252; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farwig N, 2009, LANDSCAPE ECOL, V24, P919, DOI 10.1007/s10980-009-9376-2; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Gonzalez JM, 2004, CARIBB J SCI, V40, P52; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Grace JB., 2015, STRUCTURAL EQUATION; Hanggi A., 1995, MISC FAUNIST HELV; Herrmann JD, 2012, COMMUNITY ECOL, V13, P82, DOI 10.1556/ComEc.13.2012.1.10; Holt RD, 2003, ECOL STU AN, V162, P201; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Holzschuh A, 2009, ECOL APPL, V19, P123, DOI 10.1890/08-0384.1; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Ivanov S. P., 2006, ENTOMOLOGICAL REV, V86, P524, DOI DOI 10.1134/S0013873806050046; Kruess A, 2000, OECOLOGIA, V122, P129, DOI 10.1007/PL00008829; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Loyola RD, 2008, BASIC APPL ECOL, V9, P735, DOI 10.1016/j.baae.2007.06.016; Matthews RW, 2009, ANNU REV ENTOMOL, V54, P251, DOI 10.1146/annurev.ento.54.110807.090440; MEDLER JT, 1967, AM MIDL NAT, V78, P344, DOI 10.2307/2485235; Molumby A, 1997, BEHAV ECOL, V8, P279, DOI 10.1093/beheco/8.3.279; Mortelliti A, 2011, J APPL ECOL, V48, P153, DOI 10.1111/j.1365-2664.2010.01918.x; Mortelliti A, 2010, DIVERS DISTRIB, V16, P941, DOI 10.1111/j.1472-4642.2010.00701.x; Murray TE, 2009, APIDOLOGIE, V40, P211, DOI 10.1051/apido/2009015; O'Neill KM, 2007, ECOL ENTOMOL, V32, P123, DOI 10.1111/j.1365-2311.2006.00851.x; Olberg G, 1959, VERHALTEN SOLITAREN; Otto Stefan, 2007, Fragmenta Faunistica (Warsaw), V50, P57; Pekar S, 2000, EUR J ENTOMOL, V97, P47, DOI 10.14411/eje.2000.012; Polidori C, 2007, ANIM BIOL, V57, P11, DOI 10.1163/157075607780002005; Polidori C, 2009, J NAT HIST, V43, P2985, DOI 10.1080/00222930903383511; R Core Team, 2011, R LANG ENV STAT COMP; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Roth D, 2006, OIKOS, V115, P277, DOI 10.1111/j.2006.0030-1299.15252; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Seidelmann K, 2010, BEHAV ECOL SOCIOBIOL, V64, P337, DOI 10.1007/s00265-009-0850-2; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sobek S, 2009, FOREST ECOL MANAG, V258, P609, DOI 10.1016/j.foreco.2009.04.026; Stamp NE, 2001, ECOL ENTOMOL, V26, P292, DOI 10.1046/j.1365-2311.2001.00325.x; Steffan-Dewenter I, 2002, ECOL ENTOMOL, V27, P631, DOI 10.1046/j.1365-2311.2002.00437.x; Stenchly K, 2007, CANOPY TEMPERATE FLO, P72; Strohm E, 1997, P ROY SOC B-BIOL SCI, V264, P423, DOI 10.1098/rspb.1997.0060; Tischendorf L, 2005, ECOL SOC, V10; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Buschini MLT, 2010, ZOOL STUD, V49, P169; Ulbrich Karin, 2001, Web Ecology, V2, P57; Uma DB, 2010, ETHOLOGY, V116, P85, DOI 10.1111/j.1439-0310.2009.01715.x; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; WITT R, 1998, WESPEN BEOBACHTEN BE; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	70	28	29	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59286	10.1371/journal.pone.0059286	http://dx.doi.org/10.1371/journal.pone.0059286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516622	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400106
J	Huang, KL; Lin, KJ; Hsiao, IT; Kuo, HC; Hsu, WC; Chuang, WL; Kung, MP; Wey, SP; Hsieh, CJ; Wai, YY; Yen, TC; Huang, CC				Huang, Kuo-Lun; Lin, Kun-Ju; Hsiao, Ing-Tsung; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Wai, Yau-Yau; Yen, Tzu-Chen; Huang, Chin-Chang			Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [F-18]AV-45 Positron Emission Tomography in Chinese Population	PLOS ONE			English	Article							F 18; PET; BETA; DEMENTIA; BRAIN; RADIOLIGAND; PLAQUES; DERIVATIVES; BIOMARKERS; DIAGNOSIS	Background: To compare the neocortical amyloid loads among cognitively normal (CN), amnestic mild cognitive impairment (aMCI), and Alzheimer's disease (AD) subjects with [F-18]AV-45 positron emission tomography (PET). Materials and Methods: [F-18]AV-45 PET was performed in 11 CN, 13 aMCI, and 12 AD subjects to compare the cerebral cortex-to-whole cerebellum standard uptake value ratios (SUVRs) of global and individual volumes of interest (VOIs) cerebral cortex. The correlation between global cortical [F-18]AV-45 SUVRs and Mini-Mental State Examination (MMSE) scores was analyzed. Results: The global cortical [F-18]AV-45 SUVRs were significantly different among the CN (1.08 +/- 0.08), aMCI (1.27 +/- 0.06), and AD groups (1.34 +/- 0.13) (p = 0.0003) with amyloidosis positivity rates of 9%, 62%, and 92% in the three groups respectively. Compared to CN subjects, AD subjects had higher SUVRs in the global cortical, precuneus, frontal, parietal, occipital, temporal, and posterior cingulate areas; while aMCI subjects had higher values in the global cortical, precuneus, frontal, occipital and posterior cingulate areas. There were negative correlations of MMSE scores with SUVRs in the global cortical, precuneus, frontal, parietal, occipital, temporal, posterior cingulate and anterior cingulate areas on a combined subject pool of the three groups after age and education attainment adjustment. Conclusions: Amyloid deposition occurs relatively early in precuneus, frontal and posterior cingulate in aMCI subjects. Higher [F-18]AV-45 accumulation is present in parietal, occipital and temporal gyri in AD subjects compared to the aMCI group. Significant correlation between MMSE scores and [F-18]AV-45 SUVRs can be observed among CN, aMCI and AD subjects.	[Huang, Kuo-Lun; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Huang, Chin-Chang] Chang Gung Mem Hosp, Dept Neurol, Tao Yuan, Taiwan; [Huang, Kuo-Lun; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Huang, Chin-Chang] Chang Gung Mem Hosp, Dementia Ctr, Tao Yuan, Taiwan; [Huang, Kuo-Lun; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Huang, Chin-Chang] Chang Gung Univ, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Yen, Tzu-Chen] Chang Gung Univ, Mol Imaging Ctr, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Yen, Tzu-Chen] Chang Gung Univ, Dept Nucl Med, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Yen, Tzu-Chen] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Wey, Shiaw-Pyng; Hsieh, Chia-Ju] Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Wey, Shiaw-Pyng; Hsieh, Chia-Ju] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Kung, Mei-Ping] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Wai, Yau-Yau] Chang Gung Mem Hosp, Dept Radiol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; University of Pennsylvania; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Univ, Mol Imaging Ctr, Tao Yuan, Taiwan.	yentc1110@gmail.com; cch0537@adm.cgmh.org.tw	Lin, Kun-Ju/H-3120-2015	Lin, Kun-Ju/0000-0003-1933-4564; Hsiao, Ing-Tsung/0000-0002-5255-7498; Hsieh, Chia-Ju/0000-0002-2833-7727	National Science Council, Taiwan [NSC-97-2314-B-182A-050, NSC-98-2314-B-182-056, NSC-100-2314-B-182-003, NSC-100-2314-B-182A-091-MY3, NSC-101-2314-B-182A-061-MY2]; Chang Gung Memorial Hospital [CMRPG300071, CMRPG390793, CMRPD1A0312]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was carried out with financial support from the National Science Council, Taiwan (Grant NSC-97-2314-B-182A-050, NSC-98-2314-B-182-056, NSC-100-2314-B-182-003, NSC-100-2314-B-182A-091-MY3, and NSC-101-2314-B-182A-061-MY2), and Chang Gung Memorial Hospital (Grant CMRPG300071, CMRPG390793, and CMRPD1A0312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barthel H, 2010, J NUCL MED, V51; Barthel H, 2011, EUR J NUCL MED MOL I, V38, P1702, DOI 10.1007/s00259-011-1821-1; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Hatashita S, 2010, J ALZHEIMERS DIS, V21, P995, DOI 10.3233/JAD-2010-100222; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Hsieh CJ, 2011, J NUCL MED, V52; Huang KL, 2012, J NEUROL SCI, V319, P124, DOI 10.1016/j.jns.2012.04.014; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jobst K A, 1998, Int Psychogeriatr, V10, P271, DOI 10.1017/S1041610298005389; Juh R, 2004, EUR J RADIOL, V51, P223, DOI 10.1016/S0720-048X(03)00214-6; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Klunk WE, 2001, LIFE SCI, V69, P1471, DOI 10.1016/S0024-3205(01)01232-2; Koole M, 2009, J NUCL MED, V50, P818, DOI 10.2967/jnumed.108.060756; Kudo Y, 2007, J NUCL MED, V48, P553, DOI 10.2967/jnumed.106.037556; LeVine H, 2010, NEUROBIOL AGING, V31, P542, DOI 10.1016/j.neurobiolaging.2008.05.026; Lin KJ, 2010, NUCL MED BIOL, V37, P497, DOI 10.1016/j.nucmedbio.2010.02.003; Lockhart A, 2007, BRAIN, V130, P2607, DOI 10.1093/brain/awm191; Lopponen M, 2003, AGE AGEING, V32, P606, DOI 10.1093/ageing/afg097; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Ono M, 2011, J MED CHEM, V54, P2971, DOI 10.1021/jm200057u; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Ranginwala NA, 2008, AM J GERIAT PSYCHIAT, V16, P384, DOI 10.1097/JGP.0b013e3181629971; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Senda M, 2010, J NUCL MED, V51; Seneca N, 2007, NUCL MED BIOL, V34, P681, DOI 10.1016/j.nucmedbio.2007.06.002; Shoghi-Jadid K, 2005, NUCL MED BIOL, V32, P337, DOI 10.1016/j.nucmedbio.2005.02.003; Small GW, 2006, J GERIATR PSYCH NEUR, V19, P180, DOI 10.1177/0891988706291089; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Teipel SJ, 2013, J ALZHEIMERS DIS, V33, pS329, DOI 10.3233/JAD-2012-129030; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang PN, 2011, J NEUROL NEUROSUR PS, V82, P165, DOI 10.1136/jnnp.2010.209122; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Yao CH, 2010, APPL RADIAT ISOTOPES, V68, P2293, DOI 10.1016/j.apradiso.2010.07.001	48	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58974	10.1371/journal.pone.0058974	http://dx.doi.org/10.1371/journal.pone.0058974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516589	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400085
J	Ndo, C; Simard, F; Kengne, P; Awono-Ambene, P; Morlais, I; Sharakhov, I; Fontenille, D; Antonio-Nkondjio, C				Ndo, Cyrille; Simard, Frederic; Kengne, Pierre; Awono-Ambene, Parfait; Morlais, Isabelle; Sharakhov, Igor; Fontenille, Didier; Antonio-Nkondjio, Christophe			Cryptic Genetic Diversity within the Anopheles nili group of Malaria Vectors in the Equatorial Forest Area of Cameroon (Central Africa)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; NATURAL-POPULATIONS; F-STATISTICS; GAMBIAE; TRANSMISSION; DIPTERA; DIFFERENTIATION; CULICIDAE; SOFTWARE	Background: The Anopheles nili group of mosquitoes includes important vectors of human malaria in equatorial forest and humid savannah regions of sub-Saharan Africa. However, it remains largely understudied, and data on its populations' bionomics and genetic structure are crucially lacking. Here, we used a combination of nuclear (i.e. microsatellite and ribosomal DNA) and mitochondrial DNA markers to explore and compare the level of genetic polymorphism and divergence among populations and species of the group in the savannah and forested areas of Cameroon, Central Africa. Principal Findings: All the markers provided support for the current classification within the An. nili group. However, they revealed high genetic heterogeneity within An. nili s.s. in deep equatorial forest environment. Nuclear markers showed the species to be composed of five highly divergent genetic lineages that differed by 1.8 to 12.9% of their Internal Transcribed Spacer 2 (ITS2) sequences, implying approximate divergence time of 0.82 to 5.86 million years. However, mitochondrial data only detected three major subdivisions, suggesting different evolutionary histories of the markers. Conclusions/Significance: This study enlightened additional cryptic genetic diversity within An. nili s.s. in the deep equatorial forest environment of South Cameroon, reflecting a complex demographic history for this major vector of malaria in this environment. These preliminary results should be complemented by further studies which will shed light on the distribution, epidemiological importance and evolutionary history of this species group in the African rainforest, providing opportunities for in-depth comparative studies of local adaptation and speciation in major African malaria vectors.	[Ndo, Cyrille; Kengne, Pierre; Awono-Ambene, Parfait; Morlais, Isabelle; Antonio-Nkondjio, Christophe] Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Ndo, Cyrille; Simard, Frederic; Kengne, Pierre; Morlais, Isabelle; Fontenille, Didier] Inst Rech Dev, Unite Rech Mixte Malad Infect & Vecteurs Ecol Gen, Montpellier, France; [Ndo, Cyrille] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Sharakhov, Igor] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Antonio-Nkondjio, Christophe] Univ Bamenda, Fac Hlth Sci, Bambili, Cameroon	Institut de Recherche pour le Developpement (IRD); Virginia Polytechnic Institute & State University	Ndo, C (corresponding author), Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon.	cyrndo@yahoo.fr	SIMARD, Frederic/J-9489-2016; Sharakhov, Igor/B-1972-2008; FONTENILLE, didier/G-4091-2013; Frederic, SIMARD/AFV-5001-2022; Morlais, Isabelle/F-5078-2014; Morlais, Isabelle/Q-2171-2019	SIMARD, Frederic/0000-0002-2871-5329; Sharakhov, Igor/0000-0003-0752-3747; Frederic, SIMARD/0000-0002-2871-5329; Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670; Antonio Nkondjio, Christophe/0000-0003-0073-1578; KENGNE, Pierre/0000-0002-3069-3202; FONTENILLE, didier/0000-0002-0544-3885	UNICEF/United Nations Development Programme/World Bank/World Health Organization/TDR/Molecular Entomology [A60347]; National Institutes of Health [R21 AI079350]; French Institut de Recherche pour le Developpement (IRD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079350] Funding Source: NIH RePORTER	UNICEF/United Nations Development Programme/World Bank/World Health Organization/TDR/Molecular Entomology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Institut de Recherche pour le Developpement (IRD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a UNICEF/United Nations Development Programme/World Bank/World Health Organization/TDR/Molecular Entomology grant A60347 to CAN and a National Institutes of Health grant R21 AI079350 to IS. CN was supported by a student fellowship grant from the French Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adja AM, 2011, ANN TROP MED PARASIT, V105, P13, DOI 10.1179/136485910X12851868780388; Adja A M, 2006, Med Trop (Mars), V66, P449; [Anonymous], 1968, ANOPHELINAE AFR S SA; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Antonio-Nkondjio C, 2009, ACTA TROP, V112, P270, DOI 10.1016/j.actatropica.2009.08.009; Antonio-Nkondjio C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-120; Awono-Ambene HP, 2006, AM J TROP MED HYG, V75, P656, DOI 10.4269/ajtmh.2006.75.656; Awono-Ambene HP, 2004, J MED ENTOMOL, V41, P561, DOI 10.1603/0022-2585-41.4.561; Awono-Ambene P, 2009, SCI MED AFR, V1, P13; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Berthomieu A, 2003, MOL ECOL NOTES, V3, P394, DOI 10.1046/j.1471-8286.2003.00462.x; Brunhes J, 1999, J AM MOSQUITO CONTR, V15, P552; CARNEVALE P, 1992, MED VET ENTOMOL, V6, P135, DOI 10.1111/j.1365-2915.1992.tb00590.x; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; Cornuet JM, 1996, GENETICS, V144, P2001; Deitz KC, 2012, J HERED, V103, P585, DOI 10.1093/jhered/ess025; DESALLE R, 1987, GENETICS, V116, P215; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Gillies MT, 1987, ANOPHELINAE AFRICA S, P143; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; HAMON J, 1961, Med Trop (Mars), V21(Special), P643; HOLM S, 1979, SCAND J STAT, V6, P65; Kamau L, 1998, HEREDITY, V80, P675, DOI 10.1046/j.1365-2540.1998.00327.x; Kengne P, 2007, MED VET ENTOMOL, V21, P177, DOI 10.1111/j.1365-2915.2007.00681.x; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LeGoff G, 1997, PARASITE, V4, P187, DOI 10.1051/parasite/1997042187; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Manonmani AM, 2007, ACTA TROP, V104, P72, DOI 10.1016/j.actatropica.2007.07.002; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Ndo C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-161; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; PASKEWITZ SM, 1993, J MED ENTOMOL, V30, P953, DOI 10.1093/jmedent/30.5.953; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Peery A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-202; Primmer CR, 1996, MOL ECOL, V5, P365, DOI 10.1046/j.1365-294X.1996.00092.x; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ridl FC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-194; RIVOLA E., 1957, BULL SOC PATHOL EXOT, V50, P382; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHLOTTERER C, 1994, MOL BIOL EVOL, V11, P513; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharakhova MV, 2011, INFECT GENET EVOL, V11, P746, DOI 10.1016/j.meegid.2010.06.015; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Simard F, 1999, AM J TROP MED HYG, V60, P1000, DOI 10.4269/ajtmh.1999.60.1000; SLATKIN M, 1995, GENETICS, V139, P457; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walton C, 1998, J AM MOSQUITO CONTR, V14, P266; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wright S., 1978, EVOLUTION GENETICS P, V4	66	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58862	10.1371/journal.pone.0058862	http://dx.doi.org/10.1371/journal.pone.0058862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516565	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400069
J	Zhao, JB; Zhang, MJ; Li, W; Su, XF; Zhu, L; Hang, CH				Zhao, Jinbing; Zhang, Meijuan; Li, Wei; Su, Xingfen; Zhu, Lin; Hang, Chunhua			Suppression of JAK2/STAT3 Signaling Reduces End-to-End Arterial Anastomosis Induced Cell Proliferation in Common Carotid Arteries of Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NEOINTIMA FORMATION; MICROVASCULAR ANASTOMOSIS; VASCULAR INJURY; MOUSE MODEL; IN-VIVO; JAK/STAT PATHWAY; BALLOON INJURY; ANGIOTENSIN-II; ACTIVATION	Background: JAK2/STAT3 pathway was reported to play an essential role in the neointima formation after vascular intima injury. However, little is known regarding this pathway to the whole layer injury after end-to-end arterial anastomosis (AA). Here, we investigated the role of JAK2/STAT3 pathway in common carotid arterial (CCA) anastomosis-induced cell proliferation, phenotypic change of vascular smooth muscle cells (VSMCs) and re-endothelialization. Methods: CCAs of adult male Wistar rats were resected at 3, 7, 14, and 30 days after end-to-end CCA anastomosis. Activation of JAK2/STAT3 pathway was detected by Western blotting and Immunofluorescence, and expression of proliferating cell nuclear antigen (PCNA) was detected by Q-PCR and Western blotting. Under the treatment with AG490 (a JAK2 inhibitor), protein levels of JAK2, STAT3 and PCNA, morphological changes of artery, phenotypic change of VSMCs, and re-endothelialization were measured by Western blotting, H&E, Q-PCR, and Evans blue staining respectively. Results: The protein levels of p-JAK2, p-STAT3, and PCNA were up-regulated, peaked on the 7th day in the vessel wall after AA. AG490 down-regulated the levels of p-JAK2, p-STAT3, and PCNA on the 7th-day-group, resulting in reduced vessel wall proliferation on the 7th and 14th day after AA. Besides, AG490 switched the phenotypic change of VSMCs after AA representing inhibited mRNA levels of synthetic phase markers (osteopoitin and SMemb) and up-regulated contractile phase markers (ASMA, SM2 and SM22 alpha). Furthermore, AG490 did not affect the re-endothelialization process on all indicated time points after AA (the 3rd, 7th, 14th, and 30th day). Conclusion: Our study indicated that JAK2/STAT3 signaling pathway played an important role on cell proliferation of the injured vessel wall, and probably a promising target for the exploration of drugs increasing the patency or reducing the vascular narrowness after AA.	[Zhao, Jinbing; Li, Wei; Su, Xingfen; Zhu, Lin; Hang, Chunhua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Jinbing] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Zhang, Meijuan] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing University	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	hang_neurosurgery@163.com	Li, Wei/ABE-4301-2021		National Natural Science Foundation, China [81171170, 81200897]; Nature Science Foundation of Jiangsu Province, China [BK2010459]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This study was supported by grants from National Natural Science Foundation, China (81171170, 81200897) and Nature Science Foundation of Jiangsu Province, China (BK2010459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATH P, 1990, AM J CARDIOL, V65, P297, DOI 10.1016/0002-9149(90)90291-8; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; CLOWES AW, 1983, LAB INVEST, V49, P208; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dotson RJN, 1998, MICROSURG, V18, P125, DOI 10.1002/(SICI)1098-2752(1998)18:2<125::AID-MICR11>3.0.CO;2-#; Dudley AC, 2005, BIOCHEM J, V390, P427, DOI 10.1042/BJ20050351; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kirabo A, 2011, CARDIOVASC RES; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Lee DL, 2006, AM J PHYSIOL-HEART C, V290, pH935, DOI 10.1152/ajpheart.00708.2005; LIDMAN D, 1981, SCAND J PLAST RECONS, V15, P103, DOI 10.3109/02844318109103422; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald JD, 2005, SKULL BASE-INTERD AP, V15, P229, DOI 10.1055/s-2005-872598; Maeng M, 2003, SCAND CARDIOVASC J, V37, P34, DOI 10.1080/14017430310007018; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Neria F, 2007, AM J PHYSIOL-CELL PH, V292, pC1123, DOI 10.1152/ajpcell.00548.2005; Ni CW, 2004, AM J PHYSIOL-CELL PH, V287, pC771, DOI 10.1152/ajpcell.00532.2003; Okamoto E, 1996, LAB INVEST, V74, P120; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Radad K, 2007, J VET SCI, V8, P269, DOI 10.4142/jvs.2007.8.3.269; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Sekhar LN, 2008, NEUROSURGERY, V62, P1373, DOI [10.1227/01.NEU.0000315873.41953.74, 10.1227/01.neu.0000333803.97703.c6]; Seki Y, 2000, CIRC RES, V87, P12, DOI 10.1161/01.RES.87.1.12; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Singh P, 2011, J OTOLARYNGOL-HEAD N, V40, pS59, DOI 10.2310/7070.2010.100092; Siow RCM, 2003, CARDIOVASC RES, V59, P212, DOI 10.1016/S0008-6363(03)00292-X; STEMERMAN MB, 1977, AM J PATHOL, V87, P125; Takase S, 2000, ANN VASC SURG, V14, P427, DOI 10.1007/s100169910092; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; WALL RT, 1980, THROMB RES, V18, P113, DOI 10.1016/0049-3848(80)90175-9; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Watanabe S, 2004, AM J NEPHROL, V24, P387, DOI 10.1159/000079706; Weissberg P L, 1995, Blood Press Suppl, V2, P68; WIESLANDER JB, 1984, SCAND J PLAST RECONS, V18, P193, DOI 10.3109/02844318409052837	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58730	10.1371/journal.pone.0058730	http://dx.doi.org/10.1371/journal.pone.0058730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516544	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400056
J	Kang, EH; Kim, JA; Oh, HW; Park, HM				Kang, Eun-Hye; Kim, Ji-ae; Oh, Hyun-Woo; Park, Hee-Moon			LAMMER Kinase LkhA Plays Multiple Roles in the Vegetative Growth and Asexual and Sexual Development of Aspergillus nidulans	PLOS ONE			English	Article							CELL-CYCLE REGULATORS; SR SPLICING FACTORS; PROTEIN-KINASE; TRANSCRIPTION FACTOR; SCHIZOSACCHAROMYCES-POMBE; COP9 SIGNALOSOME; CONIDIOPHORE DEVELOPMENT; OXIDATIVE STRESS; GENE-EXPRESSION; FISSION YEAST	LAMMER kinase plays pivotal roles in various physiological processes in eukaryotes; however, its function in filamentous fungi is not known. We performed molecular studies on the function of the Aspergillus nidulans LAMMER kinase, LkhA, and report its involvement in multiple developmental processes. The gene for LkhA was highly expressed during reproductive organ development, such as that of conidiophores and cleistothecia. During vegetative growth, the patterns of germ tube emergence and hyphal polarity were changed and septation was increased by lkhA deletion. Northern analyses showed that lkhA regulated the transcription of brlA, csnD, and ppoA, which supported the detrimental effect of lkhA-deletion on asexual and sexual differentiation. LkhA also affected expression of cyclin-dependent kinase NimX(cdc2), a multiple cell cycle regulator, and StuA, an APSES family of fungal transcription factors that play pivotal roles in multiple differentiation processes. Here, for the first time, we present molecular evidence showing that LAMMER kinase is involved in A. nidulans development by modulating the expression of key regulators of developmental processes.	[Kang, Eun-Hye; Park, Hee-Moon] Chungnam Natl Univ, Coll Biosci & Biotechnol, Dept Microbiol & Mol Biol, Taejon, South Korea; [Kim, Ji-ae; Oh, Hyun-Woo] Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, Taejon, South Korea	Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Park, HM (corresponding author), Chungnam Natl Univ, Coll Biosci & Biotechnol, Dept Microbiol & Mol Biol, Taejon, South Korea.	hmpark@cnu.ac.kr	Heemoon, Park/F-5783-2013	Heemoon, Park/0000-0001-6780-9283	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0012791]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0012791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; Braus GH, 2010, CURR OPIN MICROBIOL, V13, P672, DOI 10.1016/j.mib.2010.09.011; Busby TM, 1996, GENETICS, V143, P155; Busch S, 2003, MOL MICROBIOL, V49, P717, DOI 10.1046/j.1365-2958.2003.03612.x; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Chamovitz DA, 2002, CURR BIOL, V12, pR232, DOI 10.1016/S0960-9822(02)00775-3; Cho Soo-Jin, 2010, Mycobiology, V38, P108, DOI 10.4489/MYCO.2010.38.2.108; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; Garcia-Pedrajas MD, 2010, MOL PLANT MICROBE IN, V23, P211, DOI 10.1094/MPMI-23-2-0211; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Han S, 2001, MOL GENET GENOMICS, V266, P260, DOI 10.1007/s004380100552; Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3; HARRIS SD, 1994, GENETICS, V136, P517; Ipcho SVS, 2010, EUKARYOT CELL, V9, P1100, DOI 10.1128/EC.00064-10; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kang WH, 2007, FEBS LETT, V581, P3473, DOI 10.1016/j.febslet.2007.06.053; Kang WH, 2010, J BIOL CHEM, V285, P13797, DOI 10.1074/jbc.M110.113555; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kim HR, 2009, GENETICS, V182, P771, DOI 10.1534/genetics.109.101667; Kim KH, 2001, BIOCHEM BIOPH RES CO, V289, P1237, DOI 10.1006/bbrc.2001.6128; Kpebe A, 2008, GENETICS, V179, P1973, DOI 10.1534/genetics.108.087858; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Matia-Gonzalez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030067; MILLER KY, 1992, GENE DEV, V6, P1770, DOI 10.1101/gad.6.9.1770; Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279; Moser BA, 2000, CURR OPIN MICROBIOL, V3, P631, DOI 10.1016/S1369-5274(00)00152-1; Nahlik K, 2010, MOL MICROBIOL, V78, P964, DOI 10.1111/j.1365-2958.2010.07384.x; Nikolakaki E, 2002, BIOCHEMISTRY-US, V41, P2055, DOI 10.1021/bi011521h; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohara T, 2004, EUKARYOT CELL, V3, P1412, DOI 10.1128/EC.3.6.1412-1422.2004; OSMANI AH, 1994, J CELL SCI, V107, P1519; Osmani SA, 1996, BIOCHEM J, V317, P633, DOI 10.1042/bj3170633; PRADE RA, 1993, EMBO J, V12, P2439, DOI 10.1002/j.1460-2075.1993.tb05898.x; Rabinow L, 2010, J GENET, V89, P271, DOI 10.1007/s12041-010-0038-6; Sambrook J., 2002, MOL CLONING LAB MANU; Savaldi-Goldstein S, 2000, PLANT J, V21, P91, DOI 10.1046/j.1365-313x.2000.00657.x; Schier N, 2001, MOL CELL BIOL, V21, P4075, DOI 10.1128/MCB.21.12.4075-4088.2001; Sessa G, 1996, PLANT CELL, V8, P2223, DOI 10.1105/tpc.8.12.2223; Sohn K. T., 2002, Mycobiology, V30, P117; Tang ZH, 2003, EXP CELL RES, V283, P101, DOI 10.1016/S0014-4827(02)00022-8; Tang ZH, 2011, EXP CELL RES, V317, P2308, DOI 10.1016/j.yexcr.2011.06.014; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; Tong XZ, 2007, MOL PLANT MICROBE IN, V20, P1102, DOI 10.1094/MPMI-20-9-1102; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Wei HJ, 2001, FUNGAL GENET BIOL, V34, P217, DOI 10.1006/fgbi.2001.1303; Wolkow TD, 1996, J CELL SCI, V109, P2179; Wu JG, 1997, MOL CELL BIOL, V17, P6191, DOI 10.1128/MCB.17.10.6191; Ye XS, 1996, EMBO J, V15, P3599, DOI 10.1002/j.1460-2075.1996.tb00729.x; Ye XS, 1999, EMBO J, V18, P6994, DOI 10.1093/emboj/18.24.6994; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yun B, 2000, GENETICS, V156, P749; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160	63	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58762	10.1371/journal.pone.0058762	http://dx.doi.org/10.1371/journal.pone.0058762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516554	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200112
J	Salama, AKS; de Rosa, N; Scheri, RP; Pruitt, SK; Herndon, JE; Marcello, J; Tyler, DS; Abernethy, AP				Salama, April K. S.; de Rosa, Nicole; Scheri, Randall P.; Pruitt, Scott K.; Herndon, James E., II; Marcello, Jennifer; Tyler, Douglas S.; Abernethy, Amy P.			Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance Strategy	PLOS ONE			English	Article							LYMPH-NODE BIOPSY; FOLLOW-UP; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; SURVIVAL; RELAPSE	Background: While curable at early stages, few treatment options exist for advanced melanoma. Currently, no consensus exists regarding the optimal surveillance strategy for patients after resection. The objectives of this study were to identify patterns of metastatic recurrence, to determine the influence of metastatic site on survival, and to identify high-risk periods for recurrence. Methods: A retrospective review of the Duke Melanoma Database from 1970 to 2004 was conducted that focused on patients who were initially diagnosed without metastatic disease. The time to first recurrence was computed from the date of diagnosis, and the associated hazard function was examined to determine the peak risk period of recurrence. Metastatic sites were coded by the American Joint Committee on Cancer (AJCC) system including local skin, distant skin and nodes (M1a), lung (M1b), and other distant (M1c). Results: Of 11,615 patients initially diagnosed without metastatic disease, 4616 (40%) had at least one recurrence. Overall the risk of initial recurrence peaked at 12 months. The risk of initial recurrence at the local skin, distant skin, and nodes peaked at 8 months, and the risk at lung and other distant sites peaked at 24 months. Patients with a cutaneous or nodal recurrence had improved survival compared to other recurrence types. Conclusions: The risk of developing recurrent melanoma peaked at one year, and the site of first recurrence had a significant impact on survival. Defining the timing and expected patterns of recurrence will be important in creating an optimized surveillance strategy for this patient population.	[Salama, April K. S.; Abernethy, Amy P.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Salama, April K. S.; de Rosa, Nicole; Scheri, Randall P.; Pruitt, Scott K.; Herndon, James E., II; Tyler, Douglas S.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [de Rosa, Nicole; Scheri, Randall P.; Pruitt, Scott K.; Tyler, Douglas S.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Herndon, James E., II; Marcello, Jennifer] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Abernethy, AP (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	amy.abernethy@duke.edu		Salama, April/0000-0002-8105-5374; Abernethy, Amy/0000-0001-6930-8722	Pfizer, Inc.	Pfizer, Inc.(Pfizer)	This study was funded through an Outcomes Research service agreement with Pfizer, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; CALLAWAY MP, 1989, BRIT J PLAST SURG, V42, P46, DOI 10.1016/0007-1226(89)90111-2; Carlson GW, 2008, ANN SURG, V248, P378, DOI 10.1097/SLA.0b013e3181855718; CROWLEY NJ, 1990, ANN SURG, V212, P173, DOI 10.1097/00000658-199008000-00010; Dalal KM, 2007, ANN SURG ONCOL, V14, P1934, DOI 10.1245/s10434-007-9357-0; Francken AB, 2007, ANN SURG ONCOL, V14, P1924, DOI 10.1245/s10434-007-9347-2; Gershenwald JE, 1998, J CLIN ONCOL, V16, P2253, DOI 10.1200/JCO.1998.16.6.2253; Hansel G, 2010, J EUR ACAD DERMATOL, V24, P833, DOI 10.1111/j.1468-3083.2009.03536.x; Howlader N., 2016, SEER CANC STAT REV; KOH HK, 1984, JAMA-J AM MED ASSOC, V251, P1859, DOI 10.1001/jama.251.14.1859; MCCARTHY WH, 1988, SURG GYNECOL OBSTET, V166, P497; Morton RL, 2009, ANN SURG ONCOL, V16, P571, DOI 10.1245/s10434-008-0207-5; Nieweg OE, 2006, SURG ONCOL CLIN N AM, V15, P319, DOI 10.1016/j.soc.2005.12.005; Petersen RP, 2007, J THORAC CARDIOV SUR, V133, P104, DOI 10.1016/j.jtcvs.2006.08.065; REINTGEN DS, 1992, ANN PLAS SURG, V28, P45, DOI 10.1097/00000637-199201000-00013; Romano E, 2010, J CLIN ONCOL, V28, P3042, DOI 10.1200/JCO.2009.26.2063; SHAW HM, 1985, ARCH SURG-CHICAGO, V120, P1155; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Tejera-Vaquerizo A, 2007, ACTAS DERMO-SIFILOGR, V98, P531, DOI 10.1016/S0001-7310(07)70128-X; Turner RM, 2011, J CLIN ONCOL; WEISS M, 1995, JAMA-J AM MED ASSOC, V274, P1703, DOI 10.1001/jama.274.21.1703; Xing Y, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq455; Zogakis TG, 2007, ANN SURG ONCOL, V14, P1604, DOI 10.1245/s10434-006-9267-6	25	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57665	10.1371/journal.pone.0057665	http://dx.doi.org/10.1371/journal.pone.0057665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516415	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200017
J	Yurgel, SN; Rice, J; Kahn, ML				Yurgel, Svetlana N.; Rice, Jennifer; Kahn, Michael L.			Transcriptome Analysis of the Role of GlnD/GlnBK in Nitrogen Stress Adaptation by Sinorhizobium meliloti Rm1021	PLOS ONE			English	Article							LEGUMINOSARUM BV VICIAE; AMINO-ACID PERMEASE; RHIZOBIUM-LEGUMINOSARUM; GLUTAMINE-SYNTHETASE; ESCHERICHIA-COLI; GENE-CLUSTER; SUCCINOGLYCAN BIOSYNTHESIS; ENVIRONMENTAL SIGNALS; TRANSPORT-SYSTEM; EXOYFQ OPERON	Transcriptional changes in the nitrogen stress response (NSR) of wild type S. meliloti Rm1021, and isogenic strains missing both PII proteins, GlnB and GlnK, or carrying a Delta glnD-sm2 mutation were analyzed using whole-genome microarrays. This approach allowed us to identify a number of new genes involved in the NSR and showed that the response of these bacteria to nitrogen stress overlaps with other stress responses, including induction of the fixK2 transcriptional activator and genes that are part of the phosphate stress response. Our data also show that GlnD and GlnBK proteins may regulate many genes that are not part of the NSR. Analysis of transcriptome profiles of the Rm1021 Delta glnD-sm2 strain allowed us to identify several genes that appear to be regulated by GlnD without the participation of the PII proteins.	[Yurgel, Svetlana N.; Rice, Jennifer; Kahn, Michael L.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Kahn, Michael L.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University; Washington State University	Yurgel, SN (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	syurgel@wsu.edu		Yurgel, Svetlana/0000-0002-6979-1619; Kahn, Michael/0000-0002-5204-561X	Agricultural Research Center at Washington State University; Energy Biosciences Program at the United States Department of Energy [DE-FG03-96ER20225]	Agricultural Research Center at Washington State University; Energy Biosciences Program at the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Agricultural Research Center at Washington State University and grant DE-FG03-96ER20225 from the Energy Biosciences Program at the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AMAR M, 1994, MOL MICROBIOL, V11, P685, DOI 10.1111/j.1365-2958.1994.tb00346.x; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barnett MJ, 1998, GENETICS, V148, P19; Bartels FW, 2003, J STRUCT BIOL, V143, P145, DOI 10.1016/S1047-8477(03)00127-8; BATUT J, 1994, ANTON LEEUW INT J G, V66, P129, DOI 10.1007/BF00871636; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; Becker A, 1997, J BACTERIOL, V179, P1375, DOI 10.1128/jb.179.4.1375-1384.1997; BECKER A, 1993, MOL GEN GENET, V241, P367, DOI 10.1007/BF00284690; Bobik C, 2006, J BACTERIOL, V188, P4890, DOI 10.1128/JB.00251-06; Carter RA, 2002, MOL PLANT MICROBE IN, V15, P69, DOI 10.1094/MPMI.2002.15.1.69; Cheng HP, 2004, FEMS MICROBIOL LETT, V231, P131, DOI 10.1016/S0378-1097(03)00952-2; Davalos M, 2004, FEMS MICROBIOL LETT, V241, P33, DOI 10.1016/j.femsle.2004.09.041; de Bruijn FJ, 2006, ENVIRON MICROBIOL, V8, P1371, DOI 10.1111/j.1462-2920.2006.01030.x; DEBRUIJN FJ, 1989, J BACTERIOL, V171, P1673, DOI 10.1128/jb.171.3.1673-1682.1989; DOHERTY D, 1988, J BACTERIOL, V170, P4249, DOI 10.1128/jb.170.9.4249-4256.1988; DUSHA I, 1993, MOL GEN GENET, V240, P435, DOI 10.1007/BF00280398; Ferrieres L, 2004, MICROBIOL-SGM, V150, P2335, DOI 10.1099/mic.0.27081-0; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; HUCK S, 1984, J NEUROSCI, V4, P2650; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Jamet A, 2005, J BACTERIOL, V187, P376, DOI 10.1128/JB.187.1.376-381.2005; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Lodwig E, 2004, J BACTERIOL, V186, P842, DOI 10.1128/JB.186.3.842-849.2004; Marroqui S, 2001, J BACTERIOL, V183, P854, DOI 10.1128/JB.183.3.854-864.2001; Moreira LM, 2000, MICROBIOL-UK, V146, P2237, DOI 10.1099/00221287-146-9-2237; MULLER P, 1993, MOL PLANT MICROBE IN, V6, P55, DOI 10.1094/MPMI-6-055; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Napolitani C, 2004, FEBS LETT, V558, P45, DOI 10.1016/S0014-5793(03)01511-4; Nellen-Anthamatten D, 1998, J BACTERIOL, V180, P5251, DOI 10.1128/JB.180.19.5251-5255.1998; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Patriarca EJ, 2002, MICROBIOL MOL BIOL R, V66, P203, DOI 10.1128/MMBR.66.2.203-222.2002; Pickering BS, 2008, J BACTERIOL, V190, P6409, DOI 10.1128/JB.00757-08; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Quester I, 2004, J MOL MICROB BIOTECH, V7, P115, DOI 10.1159/000078655; REED JW, 1991, J BACTERIOL, V173, P3776, DOI 10.1128/JB.173.12.3776-3788.1991; Ruberg S, 2003, J BIOTECHNOL, V106, P255, DOI 10.1016/j.jbiotec.2003.08.005; Rudnick PA, 2001, J BACTERIOL, V183, P2682, DOI 10.1128/JB.183.8.2682-2685.2001; Schluter A, 2000, MICROBIOL-SGM, V146, P2987, DOI 10.1099/00221287-146-11-2987; Schmitz RA, 2002, J MOL MICROB BIOTECH, V4, P235; SHATTERS RG, 1993, J BIOL CHEM, V268, P469; SOMERVILLE JE, 1983, J BACTERIOL, V156, P168, DOI 10.1128/JB.156.1.168-176.1983; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; Wei XM, 1998, APPL ENVIRON MICROB, V64, P1708; White JP, 2009, J BACTERIOL, V191, P1547, DOI 10.1128/JB.00926-08; York GM, 1997, MOL MICROBIOL, V25, P117, DOI 10.1046/j.1365-2958.1997.4481804.x; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Yurgel SN, 2011, MOL PLANT MICROBE IN; Yurgel SN, 2010, J BACTERIOL, V192, P2473, DOI 10.1128/JB.01657-09; Yurgel SN, 2008, P NATL ACAD SCI USA, V105, P18958, DOI 10.1073/pnas.0808048105; Zaheer R, 2009, ENVIRON MICROBIOL, V11, P1572, DOI 10.1111/j.1462-2920.2009.01885.x	62	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58028	10.1371/journal.pone.0058028	http://dx.doi.org/10.1371/journal.pone.0058028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516427	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849200027
J	Gao, Y; Zhang, H; Gao, Q; Wang, LL; Zhang, FC; Siva, VS; Zhou, Z; Song, LS; Zhang, SC				Gao, Yang; Zhang, Huan; Gao, Qiang; Wang, Lingling; Zhang, Fuchong; Siva, Vinu S.; Zhou, Zhi; Song, Linsheng; Zhang, Shicui			Transcriptome Analysis of Artificial Hybrid Pufferfish Jiyan-1and Its Parental Species: Implications for Pufferfish Heterosis	PLOS ONE			English	Article							GENE-EXPRESSION; INSECTICIDE RESISTANCE; METABOLIC-ACTIVITY; CYTOCHROMES P450; RICE; DOMINANCE; REVEALS; GENOME; MAIZE; FUGU	Jiyan-1 puffer, the F1 hybrid of Takifugu rubripes and Takifugu flavidus, displays obvious heterosis in the growth performance, flavor and stress tolerance. In the present study, comparative analysis for the transcriptomes of T. rubripes, T. flavidus and Jiyan-1 was performed aiming to reveal the possible mechanisms of heterosis in pufferfish. Whole transcriptomes were sequenced using the SOLiD4 platform, and a total of 44,305 transcripts corresponding to 18,164 genes were identified collectively. A total of 14,148 transcripts were differentially expressed. By comparing the gene expression patterns of the three samples, the coexistence of overdominance, dominance, underdominance and additivity was observed in the gene action modes of Jiyan-1. There were 2,237 transcripts in the intersection of the differentially expressed transcripts from Jiyan-1 versus T. rubripes and Jiyan-1 versus T. flavidus, among which 213 transcripts were also in the T. rubripes versus T. flavidus. The potential functions of the remaining 2,024 transcripts were mainly associated with metabolic process, nucleotide binding and catalytic activity. The enrichment results indicated metabolism was the most activated biological function in the heterosis. In addition, 35 KEGG pathways were retrieved as affiliated with more than three differentially expressed transcripts and 8,579 potentially novel transcript isoforms were identified for Jiyan-1. The present study revealed the coexistence of multiple gene actions in the hybrid puffer, indicated the importance of metabolism, ion binding function and kinase activity, as well as provided a list of candidate genes and pathways for heterosis. It could be helpful for the better understanding of the determination and regulation mechanisms of heterosis.	[Gao, Yang; Zhang, Huan; Gao, Qiang; Wang, Lingling; Siva, Vinu S.; Zhou, Zhi; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Gao, Yang; Siva, Vinu S.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Fuchong] Ocean & Fishery Sci Res Inst Hebei Prov, Qinhuangdao, Peoples R China; [Zhang, Shicui] Ocean Univ China, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ocean University of China	Zhang, FC (corresponding author), Ocean & Fishery Sci Res Inst Hebei Prov, Qinhuangdao, Peoples R China.	fuchongz@yahoo.com.cn; lshsong@qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China (973 program) [2012CB114404]; Scientific and Technological Support Projects in Hebei Province [08240503D]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Scientific and Technological Support Projects in Hebei Province	This work was supported by National Basic Research Program of China (973 program, No. 2012CB114404 to SZ) and Scientific and Technological Support Projects in Hebei Province (No. 08240503D to FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D CB, 1908, SCIENCE, V28, P455; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; EBATO H, 1983, J NEUROCHEM, V40, P440, DOI 10.1111/j.1471-4159.1983.tb11302.x; Fan W, 2011, J FISHERIES CHINA, V7, P1065; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huan P, 2011, MAR BIOTECHNOL, V14, P1; Huang Y, 2006, PLANT MOL BIOL, V62, P579, DOI 10.1007/s11103-006-9040-z; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Lariepe A, 2012, GENETICS, V190, P795, DOI 10.1534/genetics.111.133447; Lau WC, 2004, CIRCULATION, V109, P166, DOI 10.1161/01.CIR.0000112378.09325.F9; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; LI SL, 1969, THEOR APPL GENET, V39, P68, DOI 10.1007/BF00307719; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu XP, 2008, ANN NY ACAD SCI, V1148, P1, DOI 10.1196/annals.1410.082; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; Malau-Aduli AEO, 2000, J ANIM PHYSIOL AN N, V83, P113, DOI 10.1046/j.1439-0396.2000.00255.x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MCDANIEL RG, 1969, CROP SCI, V9, P823, DOI 10.2135/cropsci1969.0011183X000900060048x; MCDANIEL RG, 1968, GENETICS, V59, P465; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer RC, 2012, PLANT J, V71, P669, DOI 10.1111/j.1365-313X.2012.05021.x; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Pihlajamaki J, 2011, CELL METAB, V14, P208, DOI 10.1016/j.cmet.2011.06.007; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahman MA, 2005, AQUACULTURE, V245, P121, DOI 10.1016/j.aquaculture.2004.11.049; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Song LS, 2001, MAR BIOTECHNOL, V3, P398, DOI 10.1007/s10126-001-0006-5; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Sun QX, 2004, PLANT SCI, V166, P651, DOI 10.1016/j.plantsci.2003.10.033; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; XIAO JH, 1995, GENETICS, V140, P745; YAMASHITA H, 1968, MAR BIOL, V1, P277, DOI 10.1007/BF00360776; Yao YY, 2005, PLANT MOL BIOL, V58, P367, DOI 10.1007/s11103-005-5102-x; Zhang GY, 2010, AQUACULTURE, V302, P71, DOI 10.1016/j.aquaculture.2010.02.005; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	64	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58453	10.1371/journal.pone.0058453	http://dx.doi.org/10.1371/journal.pone.0058453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520511	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900070
J	Sakimoto, S; Kidoya, H; Kamei, M; Naito, H; Yamakawa, D; Sakaguchi, H; Wakabayashi, T; Nishida, K; Takakura, N				Sakimoto, Susumu; Kidoya, Hiroyasu; Kamei, Motohiro; Naito, Hisamichi; Yamakawa, Daishi; Sakaguchi, Hirokazu; Wakabayashi, Taku; Nishida, Kohji; Takakura, Nobuyuki			An Angiogenic Role for Adrenomedullin in Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; CELLS; HYPOXIA; MICE; MACROPHAGES; INDUCTION; ISCHEMIA; PEPTIDE; MODEL	Purpose: Adrenomedullin (ADM) has been shown to take part in physiological and pathological angiogenesis. The purpose of this study was to investigate whether ADM signaling is involved in choroidal neovascularization (CNV) using a mouse model. Methods and Results: CNV was induced by laser photocoagulation in 8-week-old C57BL/6 mice. ADM mRNA expression significantly increased following treatment, peaking 4 days thereafter. The expression of ADM receptor (ADM-R) components (CRLR, RAMP2 and RAMP 3) was higher in CD31(+) CD45(-) endothelial cells (ECs) than CD31(-) CD45(-) non-ECs. Inflammatory stimulation upregulated the expression of ADM not only in cell lines but also in cells in primary cultures of the choroid/retinal pigment epithelium complex. Supernatants from TNF alpha-treated macrophage cell lines potentiated the proliferation of ECs and this was partially suppressed by an ADM antagonist, ADM (22-52). Intravitreous injection of ADM (22-52) or ADM neutralizing monoclonal antibody (mAb) after laser treatment significantly reduced the size of CNV compared with vehicle-treated controls (p<0.01). Conclusions: ADM signaling is involved in laser-induced CNV formation, because both an ADM antagonist and ADM mAb significantly inhibited it. Suppression of ADM signaling might be a valuable alternative treatment for CNV associated with age-related macular degeneration.	[Sakimoto, Susumu; Kidoya, Hiroyasu; Naito, Hisamichi; Yamakawa, Daishi; Wakabayashi, Taku; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Sakimoto, Susumu; Kamei, Motohiro; Sakaguchi, Hirokazu; Wakabayashi, Taku; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Takakura, Nobuyuki] JST Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan.	ntakaku@biken.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610; Naito, Hisamichi/0000-0002-0750-1743	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish.	Abe M, 2006, CLIN SCI, V111, P381, DOI 10.1042/CS20060137; Boguslawski G, 2004, J BIOL CHEM, V279, P5716, DOI 10.1074/jbc.M308625200; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Chen L, 2012, MOL CELL BIOCHEM, V365, P263, DOI 10.1007/s11010-012-1267-1; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Eto T, 2001, PEPTIDES, V22, P1693, DOI 10.1016/S0196-9781(01)00513-7; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hague S, 2000, CLIN CANCER RES, V6, P2808; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Huang W, 2004, INVEST OPHTH VIS SCI, V45, P1507, DOI 10.1167/iovs.03-0731; Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; ISHIYAMA Y, 1993, EUR J PHARMACOL, V241, P271, DOI 10.1016/0014-2999(93)90214-3; Iwase T, 2005, CIRCULATION, V111, P356, DOI 10.1161/01.CIR.0000153352.29335.B9; Kaafarani I, 2009, FASEB J, V23, P3424, DOI 10.1096/fj.08-127852; Kim W, 2003, FASEB J, V17, P1937, DOI 10.1096/fj.02-1209fje; Kong XQ, 2008, CLIN INVEST MED, V31, pE117; Kubo A, 1998, J BIOL CHEM, V273, P16730, DOI 10.1074/jbc.273.27.16730; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Ogita T, 2001, J HYPERTENS, V19, P603, DOI 10.1097/00004872-200103001-00013; Ouafik L, 2002, AM J PATHOL, V160, P1279, DOI 10.1016/S0002-9440(10)62555-2; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rademaker MT, 1997, CIRCULATION, V96, P1983, DOI 10.1161/01.CIR.96.6.1983; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Saita M, 1998, AM J PHYSIOL-REG I, V274, pR979, DOI 10.1152/ajpregu.1998.274.4.R979; Sakimoto S, 2012, DEVELOPMENT, V139, P1327, DOI 10.1242/dev.072330; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; Udono T, 2000, INVEST OPHTH VIS SCI, V41, P1962; Udono T, 2001, INVEST OPHTH VIS SCI, V42, P1080; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5	39	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58096	10.1371/journal.pone.0058096	http://dx.doi.org/10.1371/journal.pone.0058096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520487	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900046
J	Talwar, S; Lynch, JW; Gilbert, DF				Talwar, Sahil; Lynch, Joseph W.; Gilbert, Daniel F.			Fluorescence-Based High-Throughput Functional Profiling of Ligand-Gated Ion Channels at the Level of Single Cells	PLOS ONE			English	Article							RECEPTOR CHLORIDE CHANNELS; GLYCINE RECEPTOR; GABA(A) RECEPTORS; DRUG DISCOVERY; BETA-SUBUNIT; PHARMACOLOGY; PHYSIOLOGY; TECHNOLOGY; EXPRESSION; MUTATIONS	Ion channels are involved in many physiological processes and are attractive targets for therapeutic intervention. Their functional properties vary according to their subunit composition, which in turn varies in a developmental and tissue-specific manner and as a consequence of pathophysiological events. Understanding this diversity requires functional analysis of ion channel properties in large numbers of individual cells. Functional characterisation of ligand-gated channels involves quantitating agonist and drug dose-response relationships using electrophysiological or fluorescence-based techniques. Electrophysiology is limited by low throughput and high-throughput fluorescence-based functional evaluation generally does not enable the characterization of the functional properties of each individual cell. Here we describe a fluorescence-based assay that characterizes functional channel properties at single cell resolution in high throughput mode. It is based on progressive receptor activation and iterative fluorescence imaging and delivers >100 dose-responses in a single well of a 384-well plate, using alpha 1-3 homomeric and alpha beta heteromeric glycine receptor (GlyR) chloride channels as a model system. We applied this assay with transiently transfected HEK293 cells co-expressing halide-sensitive yellow fluorescent protein and different GlyR subunit combinations. Glycine EC50 values of different GlyR isoforms were highly correlated with published electrophysiological data and confirm previously reported pharmacological profiles for the GlyR inhibitors, picrotoxin, strychnine and lindane. We show that inter and intra well variability is low and that clustering of functional phenotypes permits identification of drugs with subunit-specific pharmacological profiles. As this method dramatically improves the efficiency with which ion channel populations can be characterized in the context of cellular heterogeneity, it should facilitate systems-level analysis of ion channel properties in health and disease and the discovery of therapeutics to reverse pathological alterations.	[Talwar, Sahil; Lynch, Joseph W.; Gilbert, Daniel F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Gilbert, Daniel F.] Univ Erlangen Nurnberg, Inst Med Biotechnol, D-91054 Erlangen, Germany	University of Queensland; University of Queensland; University of Erlangen Nuremberg	Gilbert, DF (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	daniel.gilbert@mbt.uni-erlangen.de	Gilbert, Daniel F./F-8714-2011	/0000-0003-4431-4741	National Health and Medical Research Council; Australian Research Council; Central Office for International Affairs at FAU Erlangen, Germany	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Central Office for International Affairs at FAU Erlangen, Germany	The project was funded by the National Health and Medical Research Council and the Australian Research Council. Exchange between laboratories was supported by funds from the Central Office for International Affairs at FAU Erlangen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Chen CY, 2012, LAB CHIP, V12, P794, DOI 10.1039/c1lc20548j; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Eichler SA, 2008, J CELL MOL MED; Eichler SA, 2009, EUR J NEUROSCI, V30, P1077, DOI 10.1111/j.1460-9568.2009.06903.x; Erdmann G, 2012, BIOTECHNOL J, V7, P768, DOI 10.1002/biot.201200117; Esmaeili A, 2011, SPINAL CORD, V49, P280, DOI 10.1038/sc.2010.109; Fan LJ, 2009, BIOORG MED CHEM LETT, V19, P3932, DOI 10.1016/j.bmcl.2009.03.065; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Giddings AM, 2010, J BIOMOL SCREEN, V15, P1204, DOI 10.1177/1087057110384612; Gilbert D, 2007, CHEMBIOCHEM, V8, P89, DOI 10.1002/cbic.200600437; Gilbert D, 2009, J BIOMOL SCREEN, V14, P86, DOI 10.1177/1087057108328017; Gilbert DF, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.017.2009; Gilbert DF, 2009, J BIOMOL SCREEN, V14, P944, DOI 10.1177/1087057109339523; Gilbert DF, 2009, CYTOMETRY A; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Grigoriadis DE, 2009, NEUROPSYCHOPHARMACOL, V34, P106, DOI 10.1038/npp.2008.149; Hall M., 2009, SIGKDD EXPLORATIONS, V11; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hoggatt J, 2012, J CLIN INVEST, V122, P3029, DOI 10.1172/JCI60238; Islam R, 2012, BRIT J PHARMACOL, V165, P2707, DOI 10.1111/j.1476-5381.2011.01722.x; Kim MJ, 2011, LAB CHIP, V11, P104, DOI [10.1039/c0lc00110d, 10.1039/c01c00110d]; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; Kummel A, 2011, J BIOMOL SCREEN, V16, P338, DOI 10.1177/1087057110395390; Legendre P, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.023.2009; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; McManus OB, 2004, ASSAY GUIDANCE MANUA; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Neuzil P, 2012, NAT REV DRUG DISCOV, V11, P620, DOI 10.1038/nrd3799; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Quinlan JR., 1993, C45 PROGRAMS MACHINE; Raiteri M, 2006, PHARMACOL REV, V58, P162, DOI 10.1124/pr.58.2.5; Robinson JP, 2012, J LAB AUTOM; Sambrook J., 2006, CSH PROTOC; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Spencer CI, 2012, ASSAY DRUG DEV TECHN, V10, P313, DOI 10.1089/adt.2011.414; Stoelzle S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00076; Terstappen GC, 2010, FUTURE MED CHEM, V2, P715, DOI 10.4155/FMC.10.180; van Thriel C, 2012, NEUROTOXICOLOGY, V33, P911, DOI 10.1016/j.neuro.2011.10.002; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Weltzien F, 2012, J COMP NEUROL, V520, P3962, DOI 10.1002/cne.23139; Wickenden A, 2012, FUTURE MED CHEM, V4, P661, DOI [10.4155/FMC.12.4, 10.4155/fmc.12.4]; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x	53	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58479	10.1371/journal.pone.0058479	http://dx.doi.org/10.1371/journal.pone.0058479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520514	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900073
J	Chen, KY; Williams, KJ				Chen, Keyang; Williams, Kevin Jon			Molecular Mediators for Raft-dependent Endocytosis of Syndecan-1, a Highly Conserved, Multifunctional Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CLATHRIN-INDEPENDENT ENDOCYTOSIS; IMMUNODEFICIENCY-VIRUS TYPE-1; SELECTIVE INSULIN-RESISTANCE; KINASE SIGNALING PATHWAY; REMNANT LIPOPROTEINS; CYTOPLASMIC DOMAINS; MEMBRANE; PROTEIN; CAVEOLAE	Endocytosis via rafts has attracted considerable recent interest, but the molecular mediators remain incompletely characterized. Here, we focused on the syndecan-1 heparan sulfate proteoglycan, a highly conserved, multifunctional receptor that we previously showed to undergo raft-dependent endocytosis upon clustering. Alanine scanning mutagenesis of three to five consecutive cytoplasmic residues at a time revealed that a conserved juxtamembrane motif, MKKK, was the only region required for efficient endocytosis after clustering. Endocytosis of clustered syndecan-1 occurs in two phases, each requiring a kinase and a corresponding cytoskeletal partner. In the initial phase, ligands trigger rapid MKKK-dependent activation of ERK and the localization of syndecan-1 into rafts. Activation of ERK drives the dissociation of syndecan-1 from alpha-tubulin, a molecule that may act as an anchor for syndecan-1 at the plasma membrane in the basal state. In the second phase, Src family kinases phosphorylate tyrosyl residues within the transmembrane and cytoplasmic regions of syndecan-1, a process that also requires MKKK. Tyrosine phosphorylation of syndecan-1 triggers the robust recruitment of cortactin, which we found to be an essential mediator of efficient actin-dependent endocytosis. These findings represent the first detailed characterization of the molecular events that drive endocytosis of a raft-dependent receptor and identify a novel endocytic motif, MKKK. Moreover, the results provide new tools to study syndecan function and regulation during uptake of its biologically and medically important ligands, such as HIV-1, atherogenic postprandial remnant lipoproteins, and molecules implicated in Alzheimer disease.	[Chen, Keyang; Williams, Kevin Jon] Temple Univ, Sch Med, Dept Med, Div Endocrinol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Williams, KJ (corresponding author), Temple Univ, Sch Med, Sect Endocrinol Diabet & Metab, 3322 North Broad St,Med Off Bldg,Rm 205, Philadelphia, PA 19140 USA.	kjwilliams@temple.edu		Williams, Kevin Jon/0000-0002-0000-2159	National Institutes of Health [HL73898, HL94277]; Temple University School of Medicine; Ruth and Yonatan Ben-Avraham Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073898, R01HL094277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple University School of Medicine; Ruth and Yonatan Ben-Avraham Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73898 and HL94277. This work was also supported by generous recruitment funds from the Temple University School of Medicine and the Ruth and Yonatan Ben-Avraham Fund.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boyanovsky BB, 2009, J LIPID RES, V50, P641, DOI 10.1194/jlr.M800450-JLR200; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chen K, 2011, CIRCULATION, V124; Chen KY, 2010, HEPATOLOGY, V52, P1957, DOI 10.1002/hep.23916; Chen K, 2008, CIRCULATION, V118, pS453; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; de Parseval A, 2005, J BIOL CHEM, V280, P39493, DOI 10.1074/jbc.M504233200; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Granes F, 2003, FEBS LETT, V547, P212, DOI 10.1016/S0014-5793(03)00712-9; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hassing HC, 2012, HEPATOLOGY, V55, P1746, DOI 10.1002/hep.25580; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Li XB, 2006, J CELL BIOCHEM, V99, P936, DOI 10.1002/jcb.20881; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Michaely P, 2007, EMBO J, V26, P3273, DOI 10.1038/sj.emboj.7601769; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; ROSKAMS T, 1995, HEPATOLOGY, V21, P950, DOI 10.1016/0270-9139(95)90239-2; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Williams K J, 2001, Methods Mol Biol, V171, P457; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Williams KJ, 2010, CURR OPIN LIPIDOL, V21, P218, DOI 10.1097/MOL.0b013e328338cabc; Williams KJ, 2005, DIABETES, V54, P1116, DOI 10.2337/diabetes.54.4.1116; Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253; Wittrup A, 2010, P NATL ACAD SCI USA, V107, P13342, DOI 10.1073/pnas.1002622107; Wittrup A, 2009, J BIOL CHEM, V284, P32959, DOI 10.1074/jbc.M109.036129; Wu XD, 2012, CURR OPIN LIPIDOL, V23, P334, DOI 10.1097/MOL.0b013e3283544424; Wu XD, 2012, ARTERIOSCL THROM VAS, V32, P1236, DOI 10.1161/ATVBAHA.111.244525; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 1999, FASEB J, V13, pS91	58	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13988	13999		10.1074/jbc.M112.444737	http://dx.doi.org/10.1074/jbc.M112.444737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23525115	Green Published, hybrid			2022-12-25	WOS:000319253500006
J	Jaru-Ampornpan, P; Liang, FC; Nisthal, A; Nguyen, TX; Wang, PC; Shen, K; Mayo, SL; Shan, SO				Jaru-Ampornpan, Peera; Liang, Fu-Cheng; Nisthal, Alex; Nguyen, Thang X.; Wang, Pengcheng; Shen, Kuang; Mayo, Steven L.; Shan, Shu-ou			Mechanism of an ATP-independent Protein Disaggregase II. DISTINCT MOLECULAR INTERACTIONS DRIVE MULTIPLE STEPS DURING AGGREGATE DISASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; SUBSTRATE RECOGNITION; CHAPERONE; HSP104; DEGRADATION; BINDING; CYTOSOL; DOMAIN; HSP70	The ability of molecular chaperones to overcome the misfolding and aggregation of proteins is essential for the maintenance of proper protein homeostasis in all cells. Thus far, the best studied disaggregase systems are the Clp/Hsp100 family of "ATPases associated with various cellular activities" (AAA(+)) ATPases, which use mechanical forces powered by ATP hydrolysis to remodel protein aggregates. An alternative system to disassemble large protein aggregates is provided by the 38-kDa subunit of the chloroplast signal recognition particle (cpSRP43), which uses binding energy with its substrate proteins to drive disaggregation. The mechanism of this novel chaperone remains unclear. Here, molecular genetics and structure-activity analyses show that the action of cpSRP43 can be dissected into two steps with distinct molecular requirements: (i) initial recognition, during which cpSRP43 binds specifically to a recognition motif displayed on the surface of the aggregate; and (ii) aggregate remodeling, during which highly adaptable binding interactions of cpSRP43 with hydrophobic transmembrane domains of the substrate protein compete with the packing interactions within the aggregate. This establishes a useful framework to understand the molecular mechanism by which binding interactions from a molecular chaperone can be used to overcome protein aggregates in the absence of external energy input from ATP.	[Jaru-Ampornpan, Peera; Liang, Fu-Cheng; Nguyen, Thang X.; Wang, Pengcheng; Shen, Kuang; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Nisthal, Alex; Mayo, Steven L.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Shen, Kuang/H-9441-2016		Department of Defense, National Security Science and Engineering Faculty Fellowship; David and Lucile Packard Fellowship in science and engineering; Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research	Department of Defense, National Security Science and Engineering Faculty Fellowship; David and Lucile Packard Fellowship in science and engineering(The David & Lucile Packard Foundation); Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research	Supported by the Department of Defense, National Security Science and Engineering Faculty Fellowship.; Supported by the David and Lucile Packard Fellowship in science and engineering, the Henry Dreyfus Teacher-Scholar Award, and the Break-throughs in Gerontology award from the American Federation for Aging Research. To whom correspondence should be addressed: Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125. Tel.: 626-395-3879; Fax: 626-568-9430; E-mail: sshan@caltech.edu.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bieschke J, 2009, PROTEIN SCI, V18, P2231, DOI 10.1002/pro.234; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Chakraborty A, 2002, J BIOL CHEM, V277, P47451, DOI 10.1074/jbc.M204827200; Chang Hung-Chun, 2007, Cell, V128, P212; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FERSHT A, 1998, STRUCTURE MECH PROTE, P508; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Murray AN, 2010, PROTEIN SCI, V19, P836, DOI 10.1002/pro.363; Nguyen TX, 2013, J BIOL CHEM, V288, P13420, DOI 10.1074/jbc.M113.462812; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Tang Yun-Chi, 2007, Cell, V128, P412; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027	34	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13431	13445		10.1074/jbc.M113.462861	http://dx.doi.org/10.1074/jbc.M113.462861			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23519468	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000318850300028
J	Liu, XS; Chopp, M; Wang, XL; Zhang, L; Hozeska-Solgot, A; Tang, T; Kassis, H; Zhang, RL; Chen, C; Xu, J; Zhang, ZG				Liu, Xian Shuang; Chopp, Michael; Wang, Xin Li; Zhang, Li; Hozeska-Solgot, Ann; Tang, Tao; Kassis, Haifa; Zhang, Rui Lan; Chen, Charles; Xu, Jennifer; Zhang, Zheng Gang			MicroRNA-17-92 Cluster Mediates the Proliferation and Survival of Neural Progenitor Cells after Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG PATHWAY; SUBVENTRICULAR ZONE; EPIGENETIC REGULATION; MIR-17-92 CLUSTER; NEWBORN NEURONS; ADULT-RAT; N-MYC; DIFFERENTIATION; PTEN; NEUROGENESIS	The role of microRNAs (miRNAs) in mediating adult neurogenesis after stroke has not been extensively studied. The present study investigated the function of the miR17-92 cluster in adult neural progenitor cells after experimental stroke. We found that stroke substantially up-regulated miR17-92 cluster expression in neural progenitor cells of the adult mouse. Overexpression of the miR17-92 cluster either in cultured ischemic neural progenitor cells or in the subventricular zone (SVZ) of ischemic animals significantly increased cell proliferation, whereas inhibition of individual members of the miR17-92 cluster, miR-18a and miR-19a, suppressed cell proliferation and increased cell death. The miR17-92 cluster mediated PTEN (phosphatase and tensin homolog) expression, which is a predicted target of the miR17-92 cluster. Addition of Sonic hedgehog (Shh) protein up-regulated miR17-92 expression and elevated c-Myc protein in ischemic neural progenitor cells, whereas blockade of the Shh signaling pathway down-regulated miR17-92 cluster expression and reduced c-Myc levels. Overexpression of c-Myc up-regulated miR17-92 cluster expression. Intraventricular infusion of Shh and a Shh receptor inhibitor, cyclopamine, to ischemic animals further elevated and suppressed, respectively, miR17-92 cluster expression in the SVZ. These data indicate that the miR17-92 cluster plays an important role in mediating neural progenitor cell function and that the Shh signaling pathway is involved in up-regulating miR17-92 cluster expression.	[Liu, Xian Shuang; Chopp, Michael; Wang, Xin Li; Zhang, Li; Hozeska-Solgot, Ann; Tang, Tao; Kassis, Haifa; Zhang, Rui Lan; Chen, Charles; Xu, Jennifer; Zhang, Zheng Gang] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Liu, XS (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	xsliu@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	Kassis, Haifa/0000-0003-3546-2590	National Institutes of Health [RO1 AG037506, RO1 NS075156]; American Heart Association [10SDG2790012]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants RO1 AG037506 (to M. C.) and RO1 NS075156 (to Z. G. Z.) and American Heart Association Scientist Development Grant 10SDG2790012 (to X. S. L.).	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Budde H, 2010, DEVELOPMENT, V137, P2127, DOI 10.1242/dev.050633; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Denli AM, 2009, NAT STRUCT MOL BIOL, V16, P346, DOI 10.1038/nsmb0409-346; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Li L, 2003, J CELL BIOCHEM, V88, P24, DOI 10.1002/jcb.10312; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237; Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081, DOI 10.1097/00004647-199710000-00010; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu GF, 1999, DEV BIOL, V215, P118, DOI 10.1006/dbio.1999.9431	52	103	114	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12478	12488		10.1074/jbc.M112.449025	http://dx.doi.org/10.1074/jbc.M112.449025			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511639	hybrid, Green Published			2022-12-25	WOS:000318555100007
J	Pronker, ES; Weenen, TC; Commandeur, H; Claassen, EHJHM; Osterhaus, ADME				Pronker, Esther S.; Weenen, Tamar C.; Commandeur, Harry; Claassen, Eric H. J. H. M.; Osterhaus, Albertus D. M. E.			Risk in Vaccine Research and Development Quantified	PLOS ONE			English	Article							DEVELOPMENT SUCCESS RATES; INFLUENZA VACCINES; TRANSITION; TRENDS; DRUG	To date, vaccination is the most cost-effective strategy to combat infectious diseases. Recently, a productivity gap affects the pharmaceutical industry. The productivity gap describes the situation whereby the invested resources within an industry do not match the expected product turn-over. While risk profiles (combining research and development timelines and transition rates) have been published for new chemical entities (NCE), little is documented on vaccine development. The objective is to calculate risk profiles for vaccines targeting human infectious diseases. A database was actively compiled to include all vaccine projects in development from 1998 to 2009 in the pre-clinical development phase, clinical trials phase I, II and III up to Market Registration. The average vaccine, taken from the preclinical phase, requires a development timeline of 10.71 years and has a market entry probability of 6%. Stratification by disease area reveals pandemic influenza vaccine targets as lucrative. Furthermore, vaccines targeting acute infectious diseases and prophylactic vaccines have shown to have a lower risk profile when compared to vaccines targeting chronic infections and therapeutic applications. In conclusion; these statistics apply to vaccines targeting human infectious diseases. Vaccines targeting cancer, allergy and autoimmune diseases require further analysis. Additionally, this paper does not address orphan vaccines targeting unmet medical needs, whether projects are in-licensed or self-originated and firm size and experience. Therefore, it remains to be investigated how these - and other - variables influence the vaccine risk profile. Although we find huge differences between the risk profiles for vaccine and NCE; vaccines outperform NCE when it comes to development timelines.	[Pronker, Esther S.] Vacceleron, Utrecht, Netherlands; [Pronker, Esther S.; Weenen, Tamar C.; Commandeur, Harry] Erasmus Univ, Fac Econ, Rotterdam, Netherlands; [Claassen, Eric H. J. H. M.] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Claassen, Eric H. J. H. M.; Osterhaus, Albertus D. M. E.] Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Pronker, ES (corresponding author), Vacceleron, Utrecht, Netherlands.	e.s.pronker@gmail.com			NGI; Dutch NGI	NGI; Dutch NGI	Research is supported by NGI 2009 Valorisation Award fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; Esther S. Pronker is completing her PhD program using funds from the Dutch NGI Valorisation award from 2009. A. D. M. E. Osterhaus wishes to declare, for the avoidance of any misunderstanding on competing interests, that he co-founded and is chief scientific officer of Viroclinics Biosciences BV a spin out of Erasmus MC. However, for clarification, no materials or support were received from the company, and no agreements were in place concerning the execution or publication of this work. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andre F E, 2002, Dev Biol (Basel), V110, P25; Andre FE, 2001, VACCINE, V19, P2206, DOI 10.1016/S0264-410X(00)00546-6; [Anonymous], 2009, DMHC2582; Archibugi D, 2004, RES POLICY, V33, P1657, DOI 10.1016/j.respol.2004.10.003; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Berthold DR, 2009, J CLIN ONCOL, V27, P1150, DOI 10.1200/JCO.2008.21.1938; Bunnage ME, 2011, NAT CHEM BIOL, V7, P335, DOI 10.1038/nchembio.581; Carney S, 2005, DRUG DISCOV TODAY, V10, P1011, DOI 10.1016/S1359-6446(05)03533-6; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Cunha BA, 2002, CLIN MICROBIOL INFEC, V8, P489, DOI 10.1046/j.1469-0691.2002.00496.x; Danzon PM, 2005, J HEALTH ECON, V24, P317, DOI 10.1016/j.jhealeco.2004.09.006; Data Monitor Business Intelligence, 2009, DMHC2516; Davis MM, 2011, VACCINE, V29, P9414, DOI 10.1016/j.vaccine.2011.09.128; Davis MM, 2010, VACCINE, V28, P1353, DOI 10.1016/j.vaccine.2009.11.007; Dimasi J, 2003, J HLTH EC, V22, P185; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; European Commission, 2009, COMM STAFF WORK DOC; European Commission, 2011, JOINT PROC AGR PROC; Jacobs P, 2010, VACCINE, V28, P2841, DOI 10.1016/j.vaccine.2010.01.056; Jennings LC, 2008, LANCET INFECT DIS, V8, P650, DOI 10.1016/S1473-3099(08)70232-9; Kieny MP, 2005, VACCINE, V23, P5705, DOI 10.1016/j.vaccine.2005.07.077; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Light DW, 2009, VACCINE, V27, P6627, DOI 10.1016/j.vaccine.2009.07.077; Lou K, 2006, NAT REV DRUG DISCOV, V5, P451, DOI 10.1038/nrd2063; Pronker ES, 2012, VACCINE, V30, P7344, DOI 10.1016/j.vaccine.2012.09.071; Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051; Riley S, 2008, RBHC0214; Sahoo A, 2008, BI00027012; Struck MM, 1996, NAT BIOTECHNOL, V14, P591, DOI 10.1038/nbt0596-591; U.S Department of Health and Human Services Food and Drug Administration, 2004, CHALL OPP CRIT PATH; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261	34	117	117	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57755	10.1371/journal.pone.0057755	http://dx.doi.org/10.1371/journal.pone.0057755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526951	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600008
J	Bullinaria, JA; Levy, JP				Bullinaria, John A.; Levy, Joseph P.			Limiting Factors for Mapping Corpus-Based Semantic Representations to Brain Activity	PLOS ONE			English	Article							WORD COOCCURRENCE STATISTICS; CONCRETE CONCEPTS; FMRI; METAANALYSIS; SIMILARITY; OBJECTS	To help understand how semantic information is represented in the human brain, a number of previous studies have explored how a linear mapping from corpus derived semantic representations to corresponding patterns of fMRI brain activations can be learned. They have demonstrated that such a mapping for concrete nouns is able to predict brain activations with accuracy levels significantly above chance, but the more recent elaborations have achieved relatively little performance improvement over the original study. In fact, the absolute accuracies of all these models are still currently rather limited, and it is not clear which aspects of the approach need improving in order to achieve performance levels that might lead to better accounts of human capabilities. This paper presents a systematic series of computational experiments designed to identify the limiting factors of the approach. Two distinct series of artificial brain activation vectors with varying levels of noise are introduced to characterize how the brain activation data restricts performance, and improved corpus based semantic vectors are developed to determine how the word set and model inputs affect the results. These experiments lead to the conclusion that the current state-of-the-art input semantic representations are already operating nearly perfectly (at least for non-ambiguous concrete nouns), and that it is primarily the quality of the fMRI data that is limiting what can be achieved with this approach. The results allow the study to end with empirically informed suggestions about the best directions for future research in this area.	[Bullinaria, John A.] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England; [Levy, Joseph P.] Univ Roehampton, Dept Psychol, London, England	University of Birmingham; Roehampton University	Bullinaria, JA (corresponding author), Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England.	j.a.bullinaria@cs.bham.ac.uk						Baroni M, 2009, LANG RESOUR EVAL, V43, P209, DOI 10.1007/s10579-009-9081-4; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Brants T., 2006, WEB 1T 5 GRAM VERSIO; Bullinaria J. A., 2008, P ESSLLI WORKSH DIST, P1; Bullinaria JA, 2007, BEHAV RES METHODS, V39, P510, DOI 10.3758/BF03193020; Bullinaria JA, 2012, BEHAV RES METHODS, V44, P890, DOI 10.3758/s13428-011-0183-8; Caron J, 2001, COMPUTATIONAL INFORMATION RETRIEVAL, P157; Chen X., 2012, P 2012 SIAM INT C DA, P212, DOI [10.1137/1.9781611972825.19, DOI 10.1137/1.9781611972825.19]; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Devereux Barry, 2010, P NAACL WORKSH COMP, P70; Erk Katrin, 2010, P 2010 WORKSH GEOM M, P17; French R. M., 2002, P 24 ANN C COGN SCI, P316; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Jelodar Ahmad Babaeian, 2010, P NAACL HLT 2010 1 W, P18; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Karypis G, 2003, 02017 U MINN DEP COM; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Levy JP, 2012, PROG NEURAL PROCESS, V20, P292; Liu H., 2009, P 26 ANN INT C MACHI, P649, DOI DOI 10.1145/1553374.1553458; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Mahon BZ, 2010, NEUROSCIENCE, V169, P279, DOI 10.1016/j.neuroscience.2010.04.029; Manning C.D., 1999, FDN STAT NATURAL LAN; Martin A, 2003, COGN NEUROPSYCHOL, V20, P195, DOI 10.1080/02643290342000050; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Murphy Brian, 2012, P 1 JOINT C LEX COMP, P114; Palatucci M., 2009, ADV NEURAL INFORM PR, V22, P1410, DOI DOI 10.1007/116694874; Patel M, 1997, PERSP NEURAL COMP, P199; Pereira F.B., 2010, P 2010 IEEE C EV COM, P1, DOI DOI 10.1109/ICCCN.2010.5560019; Pereira F, 2013, ARTIF INTELL, V194, P240, DOI 10.1016/j.artint.2012.06.005; Raizada RDS, 2012, J COGNITIVE NEUROSCI, V24, P868, DOI 10.1162/jocn_a_00189; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Tyler LK, 2003, NEUROIMAGE, V18, P542, DOI 10.1016/S1053-8119(02)00047-2; Wang J, 2012, HUMAN BRAIN IN PRESS, V33; Wang J, 2010, HUM BRAIN MAPP, V31, P1459, DOI 10.1002/hbm.20950; Zhao Y, 2001, 01040 TR U MINN DEP	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57191	10.1371/journal.pone.0057191	http://dx.doi.org/10.1371/journal.pone.0057191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23526937	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100008
J	Berger, A; Frelin, C; Shah, DK; Benveniste, P; Herrington, R; Gerard, NP; Zuniga-Pflucker, JC; Iscove, NN; Paige, CJ				Berger, Alexandra; Frelin, Catherine; Shah, Divya K.; Benveniste, Patricia; Herrington, Robert; Gerard, Norma P.; Zuniga-Pfluecker, Juan-Carlos; Iscove, Norman N.; Paige, Christopher J.			Neurokinin-1 Receptor Signalling Impacts Bone Marrow Repopulation Efficiency	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; SUBSTANCE-P; PROLIFERATION; INDUCTION; GENE	Tachykinins are a large group of neuropeptides with both central and peripheral activity. Despite the increasing number of studies reporting a growth supportive effect of tachykinin peptides in various in vitro stem cell systems, it remains unclear whether these findings are applicable in vivo. To determine how neurokinin-1 receptor (NK-1R) deficient hematopoietic stem cells would behave in a normal in vivo environment, we tested their reconstitution efficiency using competitive bone marrow repopulation assays. We show here that bone marrow taken from NK-1R deficient mice (Tacr1(-/-)) showed lineage specific B and T cell engraftment deficits compared to wild-type competitor bone marrow cells, providing evidence for an involvement of NK-1R signalling in adult hematopoiesis. Tachykinin knockout mice lacking the peptides SP and/or HK-1 (Tac1(-/-), Tac4(-/-) and Tac1(-/-)/Tac4(-/-) mice) repopulated a lethally irradiated wild-type host with similar efficiency as competing wild-type bone marrow. The difference between peptide and receptor deficient mice indicates a paracrine and/or endocrine mechanism of action rather than autocrine signalling, as tachykinin peptides are supplied by the host environment.	[Berger, Alexandra; Frelin, Catherine; Herrington, Robert; Iscove, Norman N.; Paige, Christopher J.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Frelin, Catherine; Herrington, Robert; Iscove, Norman N.; Paige, Christopher J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Shah, Divya K.; Benveniste, Patricia; Zuniga-Pfluecker, Juan-Carlos; Iscove, Norman N.; Paige, Christopher J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Shah, Divya K.; Benveniste, Patricia; Zuniga-Pfluecker, Juan-Carlos] Sunnybrook Res Inst, Toronto, ON, Canada; [Gerard, Norma P.] Harvard Univ, Childrens Hosp, Sch Med, Ina Sue Perlmutter Lab, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Boston Children's Hospital; Harvard Medical School	Paige, CJ (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	paige@uhnres.utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Benveniste, Patricia/0000-0002-5673-0542	National Cancer Institute of Canada [015005]; Canadian Institute of Health Research [9862]; CIHR Fellowship; Canada Research Chair in Developmental Immunology	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Fellowship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Developmental Immunology(Canada Research Chairs)	This study was supported by a Terry Fox Program Project Grant from the National Cancer Institute of Canada (grant #015005) and by funds from the Canadian Institute of Health Research (grant #9862). DKS was supported by a CIHR Fellowship award. JCZP is a recipient of the Canada Research Chair in Developmental Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YS, 2011, J CELL PHYSIOL, V226, P1204, DOI 10.1002/jcp.22447; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Berger A, 2005, J NEUROIMMUNOL, V164, P48, DOI 10.1016/j.jneuroim.2005.03.016; Berger A, 2012, GENES BRAIN BEHAV, V11, P568, DOI 10.1111/j.1601-183X.2012.00787.x; Berger A, 2010, BLOOD, V116, P3792, DOI 10.1182/blood-2010-06-291062; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909; Li Y, 2000, J HEMATOTH STEM CELL, V9, P445, DOI 10.1089/152581600419107; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Morteau O, 2001, NAT IMMUNOL, V2, P1088, DOI 10.1038/ni1201-1088; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Patacchini R, 2001, EUR J PHARMACOL, V429, P13, DOI 10.1016/S0014-2999(01)01301-2; Rameshwar P, 1996, BLOOD, V88, P98; Rameshwar P, 1997, J IMMUNOL, V158, P3417; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shahrokhi S, 2010, GROWTH FACTORS, V28, P66, DOI 10.3109/08977190903369404; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; Tarasov KV, 2002, NEUROPEPTIDES, V36, P239, DOI 10.1016/S0143-4179(02)00050-1	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58787	10.1371/journal.pone.0058787	http://dx.doi.org/10.1371/journal.pone.0058787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516556	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400063
J	Ferreira, AK; Freitas, VM; Levy, D; Ruiz, JLM; Bydlowski, SP; Rici, REG; Filho, OMR; Chierice, GO; Maria, DA				Ferreira, Adilson Kleber; Freitas, Vanessa Morais; Levy, Debora; Maria Ruiz, Jorge Luiz; Bydlowski, Sergio Paulo; Grassi Rici, Rose Eli; Filho, Otaviano Mendonca R.; Chierice, Gilberto Orivaldo; Maria, Durvanei Augusto			Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine	PLOS ONE			English	Article							CELLS; TUMOR; REORGANIZATION; INHIBITORS; MIGRATION; ACTIN; K-562; VEGF	Background: Renal cell carcinoma (RCC) is the most common type of kidney cancer, and represents the third most common urological malignancy. Despite the advent of targeted therapies for RCC and the improvement of the lifespan of patients, its cost-effectiveness restricted the therapeutic efficacy. In a recent report, we showed that synthetic phosphoethanolamine (Pho-s) has a broad antitumor activity on a variety of tumor cells and showed potent inhibitor effects on tumor progress in vivo. Methodology/Principal Findings: We show that murine renal carcinoma (Renca) is more sensitive to Pho-s when compared to normal immortalized rat proximal tubule cells (IRPTC) and human umbilical vein endothelial cells (HUVEC). In vitro anti-angiogenic activity assays show that Pho-s inhibits endothelial cell proliferation, migration and tube formation. In addition, Pho-s has anti-proliferative effects on HUVEC by inducing a cell cycle arrest at the G2/M phase. It causes a decrease in cyclin D1 mRNA, VEGFR1 gene transcription and VEGFR1 receptor expression. Pho-s also induces nuclear fragmentation and affects the organization of the cytoskeleton through the disruption of actin filaments. Additionally, Pho-s induces apoptosis through the mitochondrial pathway. The putative therapeutic potential of Pho-s was validated in a renal carcinoma model, on which our remarkable in vivo results show that Pho-s potentially inhibits lung metastasis in nude mice, with a superior efficacy when compared to Sunitinib. Conclusions/Significance: Taken together, our findings provide evidence that Pho-s is a compound that potently inhibits lung metastasis, suggesting that it is a promising novel candidate drug for future developments.	[Ferreira, Adilson Kleber; Maria, Durvanei Augusto] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil; [Ferreira, Adilson Kleber; Maria, Durvanei Augusto] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [Freitas, Vanessa Morais] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Levy, Debora; Maria Ruiz, Jorge Luiz; Bydlowski, Sergio Paulo] Univ Sao Paulo, Fac Med, Lab Genet & Mol Hematol LIM 31, Sao Paulo, Brazil; [Chierice, Gilberto Orivaldo] Univ Sao Paulo, Dept Chem & Polymers Technol, Sao Carlos, SP, Brazil; [Filho, Otaviano Mendonca R.] Univ Uberaba, Uberaba, MG, Brazil; [Grassi Rici, Rose Eli] Univ Sao Paulo, Dept Surg, Fac Vet Med & Zootecny, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Uberaba (Uniube); Universidade de Sao Paulo	Maria, DA (corresponding author), Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil.	durvanei@usp.br	Ruiz, Jorge Luis Maria/U-4468-2019; Bydlowski, Sérgio Paulo/D-5171-2013; Freitas, Vanessa M/D-7897-2012; Ferreira, Adilson/K-1991-2013; Levy, Debora/G-8208-2014; Ruiz, Jorge L.M./D-4093-2013; Ferreira, Adilson/AAS-6996-2021	Bydlowski, Sérgio Paulo/0000-0002-7582-5942; Freitas, Vanessa M/0000-0001-9613-8626; Ferreira, Adilson/0000-0002-2605-1899; Levy, Debora/0000-0001-7492-997X; Ruiz, Jorge L.M./0000-0002-7131-2162; Ferreira, Adilson/0000-0002-6160-9798	Sao Paulo Research Foundation (FAPESP) [2007/50571-3, 2008/56089-1, 2010/50220-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a Sao Paulo Research Foundation (FAPESP) - grant (2007/50571-3; Doctorate and Master Fellowship 2008/56089-1; 2010/50220-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Bukowski RM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00013; Carraro-Lacroix LR, 2010, CELL PHYSIOL BIOCHEM, V26, P563, DOI 10.1159/000322324; Das M, 2012, EXPERT OPIN THER TAR, V16, P395, DOI 10.1517/14728222.2012.669752; Rocha FGD, 2011, J GENE MED, V13, P148, DOI 10.1002/jgm.1547; ELLISON DW, 1987, BRAIN RES, V417, P389, DOI 10.1016/0006-8993(87)90471-9; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Ferreira AK, 2012, ANTICANCER RES, V32, P95; Ferreira AK, 2012, BIOMED PHARMACOTHER, V17, P38; Ferreira AK, 2011, J CANC SCI THER, V3, P053; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Foehring D, 2012, CELLS TISSUES ORGANS, V196, P195, DOI 10.1159/000334600; Freitas VM, 2008, J CELL PHYSIOL, V216, P583, DOI 10.1002/jcp.21432; Gagne Paul, 2004, Expert Rev Anticancer Ther, V4, P129, DOI 10.1586/14737140.4.1.129; Ganesamoni R, 2012, J UROLOGY, V187, P1172, DOI 10.1016/j.juro.2011.11.105; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Graeven U, 1999, J CANCER RES CLIN, V125, P621, DOI 10.1007/s004320050325; Grzanka A, 2006, NEOPLASMA, V53, P56; Grzanka A, 2003, BIOCHEM PHARMACOL, V66, P1611, DOI 10.1016/S0006-2952(03)00532-X; Hyoudou K, 2006, FREE RADICAL BIO MED, V41, P1449, DOI 10.1016/j.freeradbiomed.2006.08.004; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Nacev BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024793; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; SEER Star Database, 2003, SEER STAR DAT INC SE; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Sharma A, 2007, BRIT J BIOMED SCI, V64, P23, DOI 10.1080/09674845.2007.11732751; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Sotgia F, 2011, BMC MED, V23, P9; Vaziri SAJ, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00051; Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Weinstein S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043343	37	31	32	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57937	10.1371/journal.pone.0057937	http://dx.doi.org/10.1371/journal.pone.0057937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516420	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400014
J	Yoshida, C; Tsuji, AB; Sudo, H; Sugyo, A; Kikuchi, T; Koizumi, M; Arano, Y; Saga, T				Yoshida, Chisato; Tsuji, Atsushi B.; Sudo, Hitomi; Sugyo, Aya; Kikuchi, Tatsuya; Koizumi, Mitsuru; Arano, Yasushi; Saga, Tsuneo			Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer	PLOS ONE			English	Article							MESYLATE LACKS ACTIVITY; IMATINIB MESYLATE; PHASE-II; GROWTH; PROTEIN; INHIBITION; EXPRESSION; MUTATIONS; SURVIVAL; SCLC	Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains poor. Therefore, the development of more effective therapy is needed. We previously reported that high levels of an anti-c-kit antibody (12A8) accumulated in SCLC xenografts. In the present study, we evaluated the efficacy of two antibodies (12A8 and 67A2) for radioimmunotherapy (RIT) of an SCLC mouse model by labeling with the Y-90 isotope. Methods: In-111- or I-125-labeled antibodies were evaluated in vitro by cell binding, competitive inhibition and cellular internalization assays in c-kit-expressing SY cells and in vivo by biodistribution in SY-bearing mice. Therapeutic efficacy of Y-90-labeled antibodies was evaluated in SY-bearing mice upto day 28 and histological analysis was conducted at day 7. Results: [In-111]12A8 and [In-111]67A2 specifically bound to SY cells with high affinity (8.0 and 1.9 nM, respectively). 67A2 was internalized similar to 12A8. High levels of [In-111]12A8 and [In-111]67A2 accumulated in tumors, but not in major organs. [In-111]67A2 uptake by the tumor was 1.7 times higher than for [In-111]12A8. [Y-90]12A8, but not [Y-90]67A2, suppressed tumor growth in a dose-dependent manner. Tumors treated with 3.7 MBq of [Y-90]12A8, and 1.85 and 3.7 MBq of [Y-90]67A2 (absorbed doses were 21.0, 18.0 and 35.9 Gy, respectively) almost completely disappeared approximately 2 weeks after injection, and regrowth was not observed except for in one mouse treated with 1.85 MBq [Y-90]67A2. The area of necrosis and fibrosis increased depending on the RIT effect. Apoptotic cell numbers increased with increased doses of [Y-90]12A8, whereas no dose-dependent increase was observed following [Y-90]67A2 treatment. Body weight was temporarily reduced but all mice tolerated the RIT experiments well. Conclusion: Treatment with [Y-90]12A8 and [Y-90]67A2 achieved a complete therapeutic response when SY tumors received an absorbed dose greater than 18 Gy and thus are promising RIT agents for metastatic SCLC cells at distant sites.	[Yoshida, Chisato; Tsuji, Atsushi B.; Sudo, Hitomi; Sugyo, Aya; Koizumi, Mitsuru; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Chiba 260, Japan; [Yoshida, Chisato; Arano, Yasushi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chiba, Japan; [Kikuchi, Tatsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Chiba 260, Japan	National Institutes for Quantum Science & Technology; Chiba University; National Institutes for Quantum Science & Technology	Tsuji, AB (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Chiba 260, Japan.	a_tsuji@nirs.go.jp	TSUJI, Atsushi B/I-9922-2019	TSUJI, Atsushi B/0000-0003-2726-288X; Kikuchi, Tatsuya/0000-0003-2966-3126	National Institute of Radiological Sciences	National Institute of Radiological Sciences	This study was funded by National Institute of Radiological Sciences to TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altundag O, 2005, CANCER, V104, P2033, DOI 10.1002/cncr.21407; Blackhall FH, 2007, CURR OPIN ONCOL, V19, P103, DOI 10.1097/CCO.0b013e328011bec3; Burger H, 2003, EUR J CANCER, V39, P793, DOI 10.1016/S0959-8049(03)00026-1; Cheson BD, 2003, BLOOD, V101, P391, DOI 10.1182/blood-2002-06-1793; Chute JP, 1997, MAYO CLIN PROC, V72, P901; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Eckerman EF, 2010, MIRD RADIONUCLIDE DA; El Maalouf Ghassan, 2007, Lung Cancer, V57 Suppl 2, pS30, DOI 10.1016/S0169-5002(07)70425-7; Elias AD, 1997, CHEST, V112, pS251, DOI 10.1378/chest.112.4_Supplement.251S; Fischer B, 2007, CANCER TREAT REV, V33, P391, DOI 10.1016/j.ctrv.2007.01.006; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; HIBI K, 1991, ONCOGENE, V6, P2291; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson BE, 2003, CLIN CANCER RES, V9, P5880; Kassis AI, 2008, SEMIN NUCL MED, V38, P358, DOI 10.1053/j.semnuclmed.2008.05.002; Kitamura Y, 2004, CELL MOL LIFE SCI, V61, P2924, DOI 10.1007/s00018-004-4273-y; Krug LM, 2005, CANCER, V103, P2128, DOI 10.1002/cncr.21000; Krystal GW, 2000, CLIN CANCER RES, V6, P3319; Lebitasy MP, 2001, BRIT J CANCER, V85, P808, DOI 10.1054/bjoc.2001.1955; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Lloyd Katherine P, 2002, Clin Lung Cancer, V3, P213, DOI 10.3816/CLC.2002.n.005; Loke KS, 2012, WORLD J NUCL MED, V10, P122; PACKER AI, 1995, MOL REPROD DEV, V42, P303, DOI 10.1002/mrd.1080420307; Pouget JP, 2011, NAT REV CLIN ONCOL, V8, P720, DOI 10.1038/nrclinonc.2011.160; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; SAGA T, 1991, CANCER RES, V51, P990; Saga T, 1997, JPN J CANCER RES, V88, P1171, DOI 10.1111/j.1349-7006.1997.tb00346.x; SEIFTER EJ, 1988, SEMIN ONCOL, V15, P278; SEKIDO Y, 1991, CANCER RES, V51, P2416; Sharkey RM, 2011, IMMUNOTHERAPY-UK, V3, P349, DOI 10.2217/IMT.10.114; Sihto H, 2005, J CLIN ONCOL, V23, P49, DOI 10.1200/JCO.2005.02.093; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Sogawa C, 2010, NUCL MED BIOL, V37, P179, DOI 10.1016/j.nucmedbio.2009.10.008; Sudo H, 2012, CANCER SCI, V103, P203, DOI 10.1111/j.1349-7006.2011.02126.x; Tolvanen T, 2010, EUR J NUCL MED MOL I, V37, P874, DOI 10.1007/s00259-009-1346-z; Wang WL, 2000, ONCOGENE, V19, P3521, DOI 10.1038/sj.onc.1203698; Yoshida C, 2011, NUCL MED BIOL, V38, P331, DOI 10.1016/j.nucmedbio.2010.10.005; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	39	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59248	10.1371/journal.pone.0059248	http://dx.doi.org/10.1371/journal.pone.0059248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516616	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400101
J	Drummond, ES; Muhling, J; Martins, RN; Wijaya, LK; Ehlert, EM; Harvey, AR				Drummond, Eleanor S.; Muhling, Jill; Martins, Ralph N.; Wijaya, Linda K.; Ehlert, Erich M.; Harvey, Alan R.			Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; NEUROFIBRILLARY TANGLE FORMATION; ALZHEIMERS-DISEASE; A-BETA; APOLIPOPROTEIN-E; PROTEIN-PRECURSOR; TRANSGENIC MICE; TAU PHOSPHORYLATION; GLIAL ACTIVATION; SENILE PLAQUES	Accumulation of beta amyloid (A beta) in the brain is a primary feature of Alzheimer's disease (AD) but the exact molecular mechanisms by which A beta exerts its toxic actions are not yet entirely clear. We documented pathological changes 3 and 6 months after localised injection of recombinant, bi-cistronic adeno-associated viral vectors (rAAV2) expressing human A beta 40-GFP, A beta 42-GFP, C100-GFP or C100(V717F)-GFP into the hippocampus and cerebellum of 8 week old male mice. Injection of all rAAV2 vectors resulted in wide-spread transduction within the hippocampus and cerebellum, as shown by expression of transgene mRNA and GFP protein. Despite the lack of accumulation of A beta protein after injection with AAV vectors, injection of rAAV2-A beta 42-GFP and rAAV2- C100(V717F)-GFP into the hippocampus resulted in significantly increased microgliosis and altered permeability of the blood brain barrier, the latter revealed by high levels of immunoglobulin G (IgG) around the injection site and the presence of IgG positive cells. In comparison, injection of rAAV2-A beta 40-GFP and rAAV2-C100-GFP into the hippocampus resulted in substantially less neuropathology. Injection of rAAV2 vectors into the cerebellum resulted in similar types of pathological changes, but to a lesser degree. The use of viral vectors to express different types of A beta and C100 is a powerful technique with which to examine the direct in vivo consequences of A beta expression in different regions of the mature nervous system and will allow experimentation and analysis of pathological AD-like changes in a broader range of species other than mouse.	[Drummond, Eleanor S.; Muhling, Jill; Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Drummond, Eleanor S.; Martins, Ralph N.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Nedlands, WA 6009, Australia; [Martins, Ralph N.; Wijaya, Linda K.] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Sch Exercise Biomed & Hlth Sci, Churchlands, WA 6018, Australia; [Ehlert, Erich M.] Royal Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands	University of Western Australia; University of Western Australia; Edith Cowan University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Drummond, ES (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia.	E.Drummond@murdoch.edu.au	Ehlert, Erich M/A-4054-2012; Wijaya, Linda/CAF-1162-2022; Drummond, Eleanor/AAB-9731-2021	Wijaya, Linda/0000-0003-2603-7074; Martins, Ralph/0000-0002-4828-9363; Drummond, Eleanor/0000-0002-5466-4609; , Alan/0000-0002-2590-831X	School of Anatomy, Physiology and Human Biology, The University of Western Australia; Australian Postgraduate Award; Jean Rogerson Postgraduate Scholarship	School of Anatomy, Physiology and Human Biology, The University of Western Australia; Australian Postgraduate Award(Australian Government); Jean Rogerson Postgraduate Scholarship	This study was supported by funding from the School of Anatomy, Physiology and Human Biology, The University of Western Australia. ESD was supported by an Australian Postgraduate Award and Jean Rogerson Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2000, EXP NEUROL, V165, P221, DOI 10.1006/exnr.2000.7474; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Borghi R, 2010, J ALZHEIMERS DIS, V22, P771, DOI 10.3233/JAD-2010-100729; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; CANNING DR, 1993, EXP NEUROL, V124, P289, DOI 10.1006/exnr.1993.1199; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Causevic M, 2010, NEUROSCI LETT, V485, P162, DOI 10.1016/j.neulet.2010.08.088; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Cribbs DH, 1996, AM J PATHOL, V148, P1797; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dewachter I, 2002, J NEUROSCI, V22, P3445; Donahue JE, 2008, J NEUROPATH EXP NEUR, V67, P261, DOI 10.1097/NEN.0b013e31816a0dc8; Du J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005530; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farkas IG, 2003, ACTA HISTOCHEM, V105, P115, DOI 10.1078/0065-1281-00696; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Hashimoto M, 2010, ACTA NEUROPATHOL, V119, P543, DOI 10.1007/s00401-010-0661-6; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Ishibashi KI, 2006, J NEUROSCI RES, V84, P632, DOI 10.1002/jnr.20952; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jancso G, 1998, NEUROSCI LETT, V253, P139, DOI 10.1016/S0304-3940(98)00622-3; Jantaratnotai N, 2003, NEUROREPORT, V14, P1429, DOI 10.1097/00001756-200308060-00005; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; JOACHIM CL, 1989, AM J PATHOL, V135, P309; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kalaria RN, 1997, ANN NY ACAD SCI, V826, P263, DOI 10.1111/j.1749-6632.1997.tb48478.x; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; MARUYAMA K, 1995, BIOCHEM BIOPH RES CO, V207, P971, DOI 10.1006/bbrc.1995.1280; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MITA S, 1989, AM J PATHOL, V134, P1253; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Passini MA, 2006, J NEUROSCI, V26, P1334, DOI 10.1523/JNEUROSCI.2676-05.2006; Passos GF, 2010, BRAIN BEHAV IMMUN, V24, P493, DOI 10.1016/j.bbi.2009.12.003; Pihlaja R, 2008, GLIA, V56, P154, DOI 10.1002/glia.20599; PIKE CJ, 1994, NEUROSCIENCE, V63, P517, DOI 10.1016/0306-4522(94)90547-9; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rebeck GW, 2010, J BIOL CHEM, V285, P7440, DOI 10.1074/jbc.M109.083915; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmidt Stephen D., 2004, V299, P279; SEITZ RJ, 1985, ACTA NEUROPATHOL, V68, P15, DOI 10.1007/BF00688950; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Siemers ER, 2010, CLIN NEUROPHARMACOL, V33, P67, DOI 10.1097/WNF.0b013e3181cb577a; Su GC, 1999, BRAIN RES, V818, P105, DOI 10.1016/S0006-8993(98)01143-3; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Weldon DT, 1998, J NEUROSCI, V18, P2161; Yamagata K, 2001, DEMENT GERIATR COGN, V12, P57, DOI 10.1159/000051236; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	80	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59166	10.1371/journal.pone.0059166	http://dx.doi.org/10.1371/journal.pone.0059166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516609	Green Published, gold			2022-12-25	WOS:000316849200135
J	Han, YF; Pu, R; Han, X; Zhao, J; Zhang, YW; Zhang, Q; Yin, JH; Xie, JX; Shen, QX; Deng, Y; Ding, YB; Li, WP; Li, JH; Zhang, HW; Cao, GW				Han, Yifang; Pu, Rui; Han, Xue; Zhao, Jun; Zhang, Yuwei; Zhang, Qi; Yin, Jianhua; Xie, Jiaxin; Shen, Qiuxia; Deng, Yang; Ding, Yibo; Li, Weiping; Li, Juhong; Zhang, Hongwei; Cao, Guangwen			Associations of pri-miR-34b/c and pre-miR-196a2 Polymorphisms and Their Multiplicative Interactions with Hepatitis B Virus Mutations with Hepatocellular Carcinoma Risk	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; ESTROGEN-RECEPTOR; PROMOTER REGION; DOWN-REGULATION; FRAGILE SITES; CANCER; SUSCEPTIBILITY; MICRORNA-34B/C; EXPRESSION; GENOTYPES	Background: Genetic polymorphisms of pri-miR-34b/c and pre-miR-196a2 have been reported to be associated with the susceptibility to cancers. However, the effect of these polymorphisms and their interactions with hepatitis B virus (HBV) mutations on the development of hepatocellular carcinoma (HCC) remains largely unknown. We hypothesized that these polymorphisms might interact with the HBV mutations and play a role in hepatocarcinogenesis. Methods: Pri-miR-34b/c rs4938723 (T>C) and pre-miR-196a2 rs11614913 (T>C) were genotyped in 3,325 subjects including 1,021 HBV-HCC patients using quantitative PCR. HBV mutations were determined by direct sequencing. Contributions of the polymorphisms and their multiplicative interactions with gender or HCC-related HBV mutations to HCC risk were assessed using multivariate regression analyses. Results: rs4938723 CC genotype was significantly associated with HCC risk compared to HBV natural clearance subjects, adjusted for age and gender (adjusted odds ratio [AOR] = 2.01, 95% confidence interval [CI] = 1.16-3.49). rs4938723 variant genotypes in dominant model significantly increased HCC risk in women, compared to female healthy controls (AOR = 1.85, 95% CI = 1.20-2.84) or female HCC-free subjects (AOR = 1.62, 95% CI = 1.14-2.31). rs4938723 CC genotype and rs11614913 TC genotype were significantly associated with increased frequencies of the HCC-related HBV mutations T1674C/G and G1896A, respectively. rs11614913 was not significantly associated with HCC risk, but its CC genotype significantly enhanced the effect of rs4938723 in women. In multivariate regression analyses, rs4938723 in dominant model increased HCC risk (AOR = 1.62, 95% CI = 1.05-2.49), whereas its multiplicative interaction with C1730G, a HBV mutation inversely associated with HCC risk, reduced HCC risk (AOR = 0.34, 95% CI = 0.15-0.81); rs11614913 strengthened the G1896A effect but attenuated the A3120G/T effect on HCC risk. Conclusions: rs4938723 might be a genetic risk factor of HCC but its effect on HCC is significantly affected by the HBV mutations. rs11614913 might not be a HCC susceptible factor but it might affect the effects of the HBV mutations or rs4938723 on HCC risk.	[Han, Yifang; Pu, Rui; Zhang, Yuwei; Zhang, Qi; Yin, Jianhua; Xie, Jiaxin; Shen, Qiuxia; Deng, Yang; Ding, Yibo; Zhang, Hongwei; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Han, Xue] Ctr Dis Control & Prevent Yangpu Dist, Div Chron Dis, Shanghai, Peoples R China; [Zhao, Jun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China; [Li, Weiping] Second Mil Med Univ, Dept Ultrasonog, Changhai Hosp, Shanghai, Peoples R China; [Li, Juhong] Second Mil Med Univ, Hlth Examinat Ctr, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Shanghai Center for Disease Control & Prevention; Naval Medical University; Naval Medical University; Naval Medical University	Cao, GW (corresponding author), Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China.	gcao@smmu.edu.cn		Cao, Guangwen/0000-0002-8094-1278	National Natural Science Foundation of China [81025015, 91129301, 30901272, 81221061]; National Major S&T Project for Controlling Infection-Related Diseases in China [2012ZX10002-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major S&T Project for Controlling Infection-Related Diseases in China	This study was supported by grants from the National Natural Science Foundation of China (81025015, 91129301, 30901272, and 81221061) and the National Major S&T Project for Controlling Infection-Related Diseases in China (2012ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen JS, 2007, J CLIN VIROL, V38, P238, DOI 10.1016/j.jcv.2006.12.007; Chen XD, 2012, INT J CANCER, V130, P1607, DOI 10.1002/ijc.26171; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Hoch RV, 1999, INT J CANCER, V84, P122; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Huang YT, 2011, J CLIN ONCOL, V29, P3643, DOI 10.1200/JCO.2011.36.2335; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jain AK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002859; Jee SH, 2004, JNCI-J NATL CANCER I, V96, P1851, DOI 10.1093/jnci/djh334; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jian Guo, 2012, International Journal of Mechatronics and Automation, V2, P15, DOI 10.1504/IJMA.2012.046583; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Keng VW, 2013, HEPATOLOGY, V57, P120, DOI 10.1002/hep.26004; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Kubo T, 2011, CLIN CANCER RES, V17, P4965, DOI 10.1158/1078-0432.CCR-10-3040; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liu CJ, 2013, ANN SURG ONCOL, V20, pS406, DOI 10.1245/s10434-012-2618-6; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Mazar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024922; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Wang Z., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0040039.PUBMED:22768213; Xie J, 2013, HEPATOLOGY IN PRESS; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yin JH, 2010, J GASTROENTEROL, V45, P1063, DOI 10.1007/s00535-010-0253-1; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Yu MW, 2001, J NATL CANCER I, V93, P1644, DOI 10.1093/jnci/93.21.1644; Zhang HW, 2008, GUT, V57, P1713, DOI 10.1136/gut.2008.157149; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhang Q, 2012, CANCER LETT, V321, P1, DOI 10.1016/j.canlet.2012.03.011; Zhang Q, 2011, HEPAT MON, V11, P86	49	57	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58564	10.1371/journal.pone.0058564	http://dx.doi.org/10.1371/journal.pone.0058564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516510	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200089
J	Yan, FR; Huang, Y; Liu, JL; Lu, T; Lin, JG				Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao; Lin, Jin-Guan			Bayesian Inference for Generalized Linear Mixed Model Based on the Multivariate t Distribution in Population Pharmacokinetic Study	PLOS ONE			English	Article							INDIVIDUALIZATION	This article provides a fully Bayesian approach for modeling of single-dose and complete pharmacokinetic data in a population pharmacokinetic (PK) model. To overcome the impact of outliers and the difficulty of computation, a generalized linear model is chosen with the hypothesis that the errors follow a multivariate Student t distribution which is a heavy-tailed distribution. The aim of this study is to investigate and implement the performance of the multivariate t distribution to analyze population pharmacokinetic data. Bayesian predictive inferences and the Metropolis-Hastings algorithm schemes are used to process the intractable posterior integration. The precision and accuracy of the proposed model are illustrated by the simulating data and a real example of theophylline data.	[Yan, Fang-Rong; Lin, Jin-Guan] Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China; [Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao] China Pharmaceut Univ, Dept Math, Nanjing, Jiangsu, Peoples R China; [Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Lu, Tao] China Pharmaceut Univ, Lab Mol Design & Drug Discovery, Nanjing, Jiangsu, Peoples R China	Southeast University - China; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University	Yan, FR (corresponding author), Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China.	f.r.yan@163.com; lut163@163.com; jglin@seu.edu.cn	Wang, Yue/AAS-5975-2020; WANG, YUE/GWQ-9256-2022		NSFC [81130068, 1117165]; NSFCJS [BK2011058]; Fundamental Research Funds for the Central Universities [JKQ2011032]	NSFC(National Natural Science Foundation of China (NSFC)); NSFCJS; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work of Fang-Rong Yan, Yuan Huang, Jun-Lin Liu and Tao Lu was funded by NSFC (Program No.81130068) and the Fundamental Research Funds for the Central Universities (Program No.JKQ2011032). Jin-Guan Lin's work was supported by NSFC (Program No.1117165) and NSFCJS (Program No.BK2011058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chib S, 1999, STAT COMPUT, V9, P17, DOI 10.1023/A:1008853808677; Davidian M, 1995, STAT MED, V15, P1462; Ette EI, 2004, ANN PHARMACOTHER, V38, P2136, DOI 10.1345/aph.1E260; Ette EI, 2004, ANN PHARMACOTHER, V38, P1907, DOI 10.1345/aph.1E259; Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053; Geweke J, 1993, J APPL ECONOMET, V8, P19; Gimenez O, 2010, ECOLOGY, V91, P951, DOI 10.1890/09-1903.1; Gomez E, 1998, COMMUN STAT-THEOR M, V27, P589, DOI 10.1080/03610929808832115; James WT, 2009, COMPUT METH PROG BIO, V96, P49; Kundu D, 1998, J STAT PLAN INFER, V70, P317, DOI 10.1016/S0378-3758(97)00190-0; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Liu I, 2009, STAT MED, V28, P412, DOI 10.1002/sim.3386; Natarajan R, 2000, J AM STAT ASSOC, V95, P227, DOI 10.2307/2669540; Robert V., 1994, International Journal of Bio-Medical Computing, V36, P153, DOI 10.1016/0020-7101(94)90109-0; Salway R, 2008, BIOMETRICS, V64, P620, DOI 10.1111/j.1541-0420.2007.00897.x; Samson A, 2006, COMPUT STAT DATA AN, V51, P1562, DOI 10.1016/j.csda.2006.05.007; SHEINER LB, 1982, J PHARM SCI, V71, P1344, DOI 10.1002/jps.2600711209; UPTON RA, 1982, J PHARMACOKINET BIOP, V10, P123, DOI 10.1007/BF01062330; VONESH EF, 1992, STAT MED, V11, P1929, DOI 10.1002/sim.4780111413; WADE JR, 1993, J PHARMACOKINET BIOP, V21, P209, DOI 10.1007/BF01059771; Wakefield J, 1996, J PHARMACOKINET BIOP, V24, P103, DOI 10.1007/BF02353512; Wakefield J, 2004, NONLINEAR REGRESSION, P119; Wakefield J, 1991, J R STAT SOC C, V43, P201; Wang JX, 2005, PHARM STAT, V4, P59, DOI 10.1002/pst.154; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	25	1	1	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58369	10.1371/journal.pone.0058369	http://dx.doi.org/10.1371/journal.pone.0058369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520504	Green Submitted, gold, Green Published			2022-12-25	WOS:000318679900063
J	Xiao, Q; Zhong, Y; Lu, DL; Gao, WJ; Jiao, Q; Lu, GM; Su, LY				Xiao, Qian; Zhong, Yuan; Lu, Dali; Gao, Weijia; Jiao, Qing; Lu, Guangming; Su, Linyan			Altered Regional Homogeneity in Pediatric Bipolar Disorder during Manic State: A Resting-State fMRI Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; VENTRAL PREFRONTAL CORTEX; MAJOR DEPRESSIVE DISORDER; WORKING-MEMORY TASK; FUNCTIONAL CONNECTIVITY; NEURAL CIRCUITRY; PSYCHIATRIC-DISORDERS; ORBITOFRONTAL CORTEX; NEURONAL ACTIVATION; FACIAL EXPRESSIONS	Pediatric bipolar disorder (PBD) is a severely debilitating illness, which is characterized by episodes of mania and depression separated by periods of remission. Previous fMRI studies investigating PBD were mainly task-related. However, little is known about the abnormalities in PBD, especially during resting state. Resting state brain activity measured by fMRI might help to explore neurobiological biomarkers of the disorder. Methods: Regional homogeneity (ReHo) was examined with resting-state fMRI (RS-fMRI) on 15 patients with PBD in manic state, with 15 age-and sex-matched healthy youth subjects as controls. Results: Compared with the healthy controls, the patients with PBD showed altered ReHo in the cortical and subcortical structures. The ReHo measurement of the PBD group was negatively correlated with the score of Young Mania Rating Scale (YMRS) in the superior frontal gyrus. Positive correlations between the ReHo measurement and the score of YMRS were found in the hippocampus and the anterior cingulate cortex in the PBD group. Conclusions: Altered regional brain activity is present in patients with PBD during manic state. This study presents new evidence for abnormal ventral-affective and dorsal-cognitive circuits in PBD during resting state and may add fresh insights into the pathophysiological mechanisms underlying PBD.	[Xiao, Qian; Lu, Dali; Gao, Weijia; Su, Linyan] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Jiao, Qing; Lu, Guangming] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Zhong, Yuan] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China	Central South University; Nanjing University; Nanjing Normal University	Su, LY (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China.	xiaoqian851112@hotmail.com	Lu, Dali/GSE-4800-2022		Natural Science Foundation of China [81171291, 81201077]; Key Program for Guangming Lu [BWS11J063, 10z026]; Humanity and Social Science Youth foundation of Ministry of Education [11YJC190039]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Guangming Lu; Humanity and Social Science Youth foundation of Ministry of Education	Natural Science Foundation of China: No. 81171291, 81201077. Key Program for Guangming Lu (Grant No BWS11J063, and No 10z026). Humanity and Social Science Youth foundation of Ministry of Education: No. 11YJC190039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2005, BIPOLAR DISORD, V7, P577, DOI 10.1111/j.1399-5618.2005.00257.x; Adler CM, 2004, BIPOLAR DISORD, V6, P540, DOI 10.1111/j.1399-5618.2004.00117.x; Altshuler LL, 2005, BIOL PSYCHIAT, V58, P763, DOI 10.1016/j.biopsych.2005.09.012; [Anonymous], 2007, J AM ACAD CHILD PSY, V46, P107, DOI 10.1097/01.chi.0000242240.69678.c4; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumberg HP, 2006, BIOL PSYCHIAT, V59, P611, DOI 10.1016/j.biopsych.2005.08.031; Blumberg HP, 2005, BIPOLAR DISORD, V7, P570, DOI 10.1111/j.1399-5618.2005.00264.x; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P601, DOI 10.1001/archpsyc.60.6.601; Blumberg HP, 2003, AM J PSYCHIAT, V160, P1345, DOI 10.1176/appi.ajp.160.7.1345; Blumberg HP, 2000, BIOL PSYCHIAT, V48, P1045, DOI 10.1016/S0006-3223(00)00962-8; Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; BORUCHOW IB, 1991, ANN THORAC SURG, V51, P317, DOI 10.1016/0003-4975(91)90815-8; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chang K, 2005, J AM ACAD CHILD PSY, V44, P565, DOI 10.1097/01.chi.0000159948.75136.0d; Chang K, 2004, ARCH GEN PSYCHIAT, V61, P781, DOI 10.1001/archpsyc.61.8.781; Chen BK, 2004, BIOL PSYCHIAT, V56, P399, DOI 10.1016/j.biopsych.2004.06.024; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Chen CH, 2010, BIPOLAR DISORD, V12, P344, DOI 10.1111/j.1399-5618.2010.00801.x; Chen HH, 2004, NEUROSCI LETT, V363, P65, DOI 10.1016/j.neulet.2004.03.042; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Dickstein DP, 2007, BIPOLAR DISORD, V9, P679, DOI 10.1111/j.1399-5618.2007.00418.x; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Dickstein DP, 2005, J CHILD ADOL PSYCHOP, V15, P534, DOI 10.1089/cap.2005.15.534; Dickstein DP, 2005, ARCH GEN PSYCHIAT, V62, P734, DOI 10.1001/archpsyc.62.7.734; Elliott R, 2004, BIOL PSYCHIAT, V55, P1163, DOI 10.1016/j.biopsych.2004.03.007; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fountoulakis KN, 2008, BRAIN RES REV, V59, P9, DOI 10.1016/j.brainresrev.2008.04.005; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Glahn DC, 2010, HUM BRAIN MAPP, V31, P1041, DOI 10.1002/hbm.20918; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Johnson JG, 2000, AM J PSYCHIAT, V157, P1679, DOI 10.1176/appi.ajp.157.10.1679; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaur S, 2005, AM J PSYCHIAT, V162, P1637, DOI 10.1176/appi.ajp.162.9.1637; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kronhaus DM, 2006, BIPOLAR DISORD, V8, P28, DOI 10.1111/j.1399-5618.2006.00282.x; Lai CH, 2012, J AFFECT DISORDERS, V136, P453, DOI 10.1016/j.jad.2011.11.004; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Leibenluft E, 2007, AM J PSYCHIAT, V164, P52, DOI 10.1176/appi.ajp.164.1.52; [李海军 LI Hai-jun], 2009, [中华精神科杂志, Chinese Journal of Psychiatry], V42, P193; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Malhi GS, 2007, BIPOLAR DISORD, V9, P345, DOI 10.1111/j.1399-5618.2007.00485.x; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x; Nelson EE, 2007, BIPOLAR DISORD, V9, P810, DOI 10.1111/j.1399-5618.2007.00419.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passarotti AM, 2010, J AM ACAD CHILD PSY, V49, P1064, DOI 10.1016/j.jaac.2010.07.009; Passarotti AM, 2010, J INT NEUROPSYCH SOC, V16, P106, DOI 10.1017/S1355617709991019; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Pavuluri MN, 2008, J AM ACAD CHILD PSY, V47, P1273, DOI 10.1097/CHI.0b013e318185d2d1; Pavuluri MN, 2008, PSYCHIAT RES-NEUROIM, V162, P244, DOI 10.1016/j.pscychresns.2007.10.003; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Pavuluri MN, 2006, AM J PSYCHIAT, V163, P286, DOI 10.1176/appi.ajp.163.2.286; Pfeifer JC, 2008, J AM ACAD CHILD PSY, V47, P1289, DOI 10.1097/CHI.0b013e318185d299; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phillips ML, 2008, AM J PSYCHIAT, V165, P313, DOI 10.1176/appi.ajp.2007.07071066; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singh MK, 2010, J CHILD ADOL PSYCHOP, V20, P15, DOI 10.1089/cap.2009.0004; Surguladze SA, 2010, NEUROIMAGE, V53, P58, DOI 10.1016/j.neuroimage.2010.05.069; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002; [王丽 WANG Li], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P271; Wechsler D., 1999, WECHSLER ABBREVIATED; Wessa M, 2007, AM J PSYCHIAT, V164, P638, DOI 10.1176/appi.ajp.164.4.638; Wessa M, 2009, INT REV PSYCHIATR, V21, P357, DOI 10.1080/09540260902962156; WOOD A, 1995, J CHILD PSYCHOL PSYC, V36, P327, DOI 10.1111/j.1469-7610.1995.tb01828.x; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007	85	33	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57978	10.1371/journal.pone.0057978	http://dx.doi.org/10.1371/journal.pone.0057978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23526961	Green Submitted, gold, Green Published			2022-12-25	WOS:000316936100062
J	Rothwell, PJ; Allen, WJ; Sisamakis, E; Kalinin, S; Felekyan, S; Widengren, J; Waksman, G; Seidel, CAM				Rothwell, Paul J.; Allen, William J.; Sisamakis, Evangelos; Kalinin, Stanislav; Felekyan, Suren; Widengren, Jerker; Waksman, Gabriel; Seidel, Claus A. M.			dNTP-dependent Conformational Transitions in the Fingers Subdomain of Klentaq1 DNA Polymerase INSIGHTS INTO THE ROLE OF THE "NUCLEOTIDE-BINDING" STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE FRET; ENERGY-TRANSFER; CRYSTAL-STRUCTURES; LARGE FRAGMENT; INDUCED FIT; KINETIC MECHANISM; STRUCTURAL BASIS; FLUORESCENCE; FIDELITY; SELECTION	DNA polymerases are responsible for the accurate replication of DNA. Kinetic, single-molecule, and x-ray studies show that multiple conformational states are important for DNA polymerase fidelity. Using high precision FRET measurements, we show that Klentaq1 (the Klenow fragment of Thermus aquaticus DNA polymerase 1) is in equilibrium between three structurally distinct states. In the absence of nucleotide, the enzyme is mostly open, whereas in the presence of DNA and a correctly base-pairing dNTP, it re-equilibrates to a closed state. In the presence of a dNTP alone, with DNA and an incorrect dNTP, or in elevated MgCl2 concentrations, an intermediate state termed the "nucleotide-binding" state predominates. Photon distribution and hidden Markov modeling revealed fast dynamic and slow conformational processes occurring between all three states in a complex energy landscape suggesting a mechanism in which dNTP delivery is mediated by the nucleotide-binding state. After nucleotide binding, correct dNTPs are transported to the closed state, whereas incorrect dNTPs are delivered to the open state.	[Seidel, Claus A. M.] Univ Dusseldorf, Chair Mol Phys Chem, D-40225 Dusseldorf, Germany; [Allen, William J.; Waksman, Gabriel] Birkbeck & Univ Coll London, Inst Struct & Mol Biol, London WC1E 7HX, England; [Sisamakis, Evangelos; Widengren, Jerker] Royal Inst Technol, Albanova Univ Ctr, Dept Appl Phys, SE-10691 Stockholm, Sweden; [Allen, William J.; Waksman, Gabriel] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England	Heinrich Heine University Dusseldorf; University of London; Birkbeck University London; Royal Institute of Technology; University of London; Birkbeck University London; University College London		p.rothwell@mail.cryst.bbk.ac.uk; g.waksman@mail.cryst.bbk.ac.uk; cseidel@hhu.de	Seidel, Claus A.M./A-3682-2012	Seidel, Claus A.M./0000-0002-5171-149X; Widengren, Jerker/0000-0003-3200-0374	European Union Marie Curie Actions Research Training Network "DNA Enzymes"; Volkswagen Foundation [I/78 837]; Biological and Biotechnological Science Research Council; Swedish Foundation for International Cooperation in Research and Higher Education [IG2004-2032]	European Union Marie Curie Actions Research Training Network "DNA Enzymes"; Volkswagen Foundation(Volkswagen); Biological and Biotechnological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Foundation for International Cooperation in Research and Higher Education	Supported by the European Union Marie Curie Actions Research Training Network "DNA Enzymes" and Volkswagen Foundation Grant I/78 837.; Supported by a studentship from the Biological and Biotechnological Science Research Council.; Supported by the Swedish Foundation for International Cooperation in Research and Higher Education Stipend IG2004-2032.	Allen WJ, 2008, PROTEIN SCI, V17, P401, DOI 10.1110/ps.073309208; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Berezhna SY, 2012, J AM CHEM SOC, V134, P11261, DOI 10.1021/ja3038273; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Boukobza E, 2001, J PHYS CHEM B, V105, P12165, DOI 10.1021/jp012016x; Bucher D, 2011, BIOCHEMISTRY-US, V50, P10530, DOI 10.1021/bi201481a; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Eggeling C, 2006, J PHYS CHEM A, V110, P2979, DOI 10.1021/jp054581w; Eggeling C, 2001, J BIOTECHNOL, V86, P163, DOI 10.1016/S0168-1656(00)00412-0; Felekyan S, 2012, CHEMPHYSCHEM, V13, P1036, DOI 10.1002/cphc.201100897; Fries JR, 1998, J PHYS CHEM A, V102, P6601, DOI 10.1021/jp980965t; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Holzberger B, 2012, CHEMBIOCHEM, V13, P635, DOI 10.1002/cbic.201100802; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Kalinin S, 2008, J PHYS CHEM B, V112, P8361, DOI 10.1021/jp711942q; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/NMETH.2222, 10.1038/nmeth.2222]; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kim SJ, 2003, J BIOL CHEM, V278, P5072, DOI 10.1074/jbc.M208472200; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; Liu Y, 2010, J PHYS CHEM B, V114, P5386, DOI 10.1021/jp9057669; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; O'Connor D. V., 1984, TIME CORRELATED SING; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rasnik I, 2005, ACCOUNTS CHEM RES, V38, P542, DOI 10.1021/ar040138c; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Selvin P., 2008, SINGLE MOL TECHNIQUE; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shah AM, 2003, BIOCHEMISTRY-US, V42, P10709, DOI 10.1021/bi034885d; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Sindbert S, 2011, J AM CHEM SOC, V133, P2463, DOI 10.1021/ja105725e; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Torella JP, 2011, BIOPHYS J, V100, P1568, DOI 10.1016/j.bpj.2011.01.066; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; van der Meer B W, 2002, J Biotechnol, V82, P181, DOI 10.1016/S1389-0352(01)00037-X; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	61	20	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13575	13591		10.1074/jbc.M112.432690	http://dx.doi.org/10.1074/jbc.M112.432690			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525110	Green Published, hybrid			2022-12-25	WOS:000318850300040
J	Incicco, JJ; Gebhard, LG; Gonzalez-Lebrero, RM; Gamarnik, AV; Kaufman, SB				Jeremias Incicco, J.; Gebhard, Leopoldo G.; Gonzalez-Lebrero, Rodolfo M.; Gamarnik, Andrea V.; Kaufman, Sergio B.			Steady-State NTPase Activity of Dengue Virus NS3: Number of Catalytic Sites, Nucleotide Specificity and Activation by ssRNA	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; HEPATITIS-C VIRUS; TYPE-2 NONSTRUCTURAL PROTEIN-3; ATPASE ACTIVITY; KINETIC-ANALYSIS; HELICASE DOMAIN; PCRA HELICASE; RNA HELICASES; BINDING; ENZYME	Dengue virus nonstructural protein 3 (NS3) unwinds double stranded RNA driven by the free energy derived from the hydrolysis of nucleoside triphosphates. This paper presents the first systematic and quantitative characterization of the steady-state NTPase activity of DENV NS3 and their interaction with ssRNA. Substrate curves for ATP, GTP, CTP and UTP were obtained, and the specificity order for these nucleotides - evaluated as the ratio (k(cat)/K-M)- was GTP approximate to ATP approximate to CTP v UTP, which showed that NS3 have poor ability to discriminate between different NTPs. Competition experiments between the four substrates indicated that all of them are hydrolyzed in one and the same catalytic site of the enzyme. The effect of ssRNA on the ATPase activity of NS3 was studied using poly(A) and poly(C). Both RNA molecules produced a 10 fold increase in the turnover rate constant (k(cat)) and a 100 fold decrease in the apparent affinity (K-M) for ATP. When the ratio [RNA bases]/[NS3] was between 0 and similar to 20 the ATPase activity was inhibited by increasing both poly(A) and poly(C). Using the theory of binding of large ligands (NS3) to a one-dimensional homogeneous lattice of infinite length (RNA) we tested the hypothesis that inhibition is the result of crowding of NS3 molecules along the RNA lattices. Finally, we discuss why this hypothesis is consistent with the idea that the ATPase catalytic cycle is tightly coupled to the movement of NS3 helicase along the RNA.	[Jeremias Incicco, J.; Gonzalez-Lebrero, Rodolfo M.; Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Jeremias Incicco, J.; Gonzalez-Lebrero, Rodolfo M.; Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Gebhard, Leopoldo G.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Kaufman, SB (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina.	sbkauf@qb.ffyb.uba.ar		Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270; Kaufman, Sergio Benjamin/0000-0002-8763-4086	Universidad de Buenos Aires [UBACYT 20020110200182]; National Institutes of Health [1R01AI095175-01]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2010-2092]; Consejo Nacional de Investigaciones Cienticas y Tecnicas (CON-ICET) [PIP 112 201101 00655/12]; Universidad de Buenos Aires; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095175] Funding Source: NIH RePORTER	Universidad de Buenos Aires(University of Buenos Aires); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cienticas y Tecnicas (CON-ICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to SBK from Universidad de Buenos Aires (UBACYT 20020110200182); to AVG from National Institutes of Health (1R01AI095175-01) and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2010-2092); and to RMGL from Consejo Nacional de Investigaciones Cienticas y Tecnicas (CON-ICET)(PIP 112 201101 00655/12). RMGL, AVG and LGG are members of the CONICET. JJI was funded 11 by a doctoral fellowship from Universidad de Buenos Aires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; BOTTS J, 1958, T FARADAY SOC, V54, P593, DOI 10.1039/tf9585400593; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEVILLARD C, 1993, BIOCHEM J, V289, P599, DOI 10.1042/bj2890599; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fucito S, 2008, THESIS U BUENOS AIRE; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; KELETI T, 1987, EUR J BIOCHEM, V170, P179, DOI 10.1111/j.1432-1033.1987.tb13684.x; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; LAIDLER KJ, 1988, J CHEM EDUC, V65, P250, DOI 10.1021/ed065p250; LAIDLER KJ, 1958, CHEM KINETICS ENZYME; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Liao JC, 2011, J BIOMOL STRUCT DYN, V29, P497, DOI 10.1080/07391102.2011.10507401; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; LONDON WP, 1968, B MATH BIOPHYS, V30, P253, DOI 10.1007/BF02476694; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Porter DJT, 1998, J BIOL CHEM, V273, P14247, DOI 10.1074/jbc.273.23.14247; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Rad B, 2012, BIOCHEMISTRY-US, V51, P2921, DOI 10.1021/bi3000676; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; WOLFE AR, 1992, J MOL BIOL, V223, P1063, DOI 10.1016/0022-2836(92)90262-I; Wong I, 1996, BIOCHEMISTRY-US, V35, P5726, DOI 10.1021/bi952959i; World Health Organization, 2009, DENGUE GUIDELINES DI; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; YOUNG MC, 1994, J MOL BIOL, V235, P1436, DOI 10.1006/jmbi.1994.1099; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	54	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58508	10.1371/journal.pone.0058508	http://dx.doi.org/10.1371/journal.pone.0058508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526990	Green Published, gold			2022-12-25	WOS:000317562100027
J	Voskarides, K; Demosthenous, P; Papazachariou, L; Arsali, M; Athanasiou, Y; Zavros, M; Stylianou, K; Xydakis, D; Daphnis, E; Gale, DP; Maxwell, PH; Elia, A; Pattaro, C; Pierides, A; Deltas, C				Voskarides, Konstantinos; Demosthenous, Panayiota; Papazachariou, Louiza; Arsali, Maria; Athanasiou, Yiannis; Zavros, Michalis; Stylianou, Kostas; Xydakis, Dimitris; Daphnis, Eugenios; Gale, Daniel P.; Maxwell, Patrick H.; Elia, Avraam; Pattaro, Cristian; Pierides, Alkis; Deltas, Constantinos			Epistatic Role of the MYH9/APOL1 Region on Familial Hematuria Genes	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BASEMENT-MEMBRANE NEPHROPATHY; CHRONIC KIDNEY-DISEASE; COL4A5 COLLAGEN GENE; ALPORT-SYNDROME; RENAL-FAILURE; EUROPEAN-AMERICANS; AFRICAN-AMERICANS; HEARING-LOSS; MUTATIONS	Familial hematuria (FH) is explained by at least four different genes (see below). About 50% of patients develop late proteinuria and chronic kidney disease (CKD). We hypothesized that MYH9/APOL1, two closely linked genes associated with CKD, may be associated with adverse progression in FH. Our study included 102 thin basement membrane nephropathy (TBMN) patients with three known COL4A3/COL4A4 mutations (cohort A), 83 CFHR5/C3 glomerulopathy patients (cohort B) with a single CFHR5 mutation and 15 Alport syndrome patients (cohort C) with two known COL4A5 mild mutations, who were categorized as "Mild'' (controls) or "Severe'' (cases), based on renal manifestations. E1 and S1 MYH9 haplotypes and variant rs11089788 were analyzed for association with disease phenotype. Evidence for association with "Severe'' progression in CFHR5 nephropathy was found with MYH9 variant rs11089788 and was confirmed in an independent FH cohort, D (cumulative p value = 0.001, odds ratio = 3.06, recessive model). No association was found with APOL1 gene. Quantitative Real time PCR did not reveal any functional significance for the rs11089788 risk allele. Our results derive additional evidence supporting previous reports according to which MYH9 is an important gene per se, predisposing to CKD, suggesting its usefulness as a prognostic marker for young hematuric patients.	[Voskarides, Konstantinos; Demosthenous, Panayiota; Papazachariou, Louiza; Deltas, Constantinos] Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus; [Voskarides, Konstantinos; Demosthenous, Panayiota; Papazachariou, Louiza; Deltas, Constantinos] Univ Cyprus, Lab Mol & Med Genet, Dept Biol Sci, Nicosia, Cyprus; [Arsali, Maria; Athanasiou, Yiannis; Zavros, Michalis] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Stylianou, Kostas; Xydakis, Dimitris; Daphnis, Eugenios] Univ Crete, Dept Nephrol, Iraklion, Greece; [Gale, Daniel P.] UCL, Ctr Nephrol, London, England; [Maxwell, Patrick H.] UCL, Div Med, London, England; [Elia, Avraam] Archbishop Makarios III Hosp, Dept Pediat, Nicosia, Cyprus; [Pattaro, Cristian] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Pattaro, Cristian] Med Univ Lubeck, D-23538 Lubeck, Germany; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus	University of Cyprus; University of Cyprus; University of Crete; University of London; University College London; University of London; University College London; European Academy of Bozen-Bolzano; University of Lubeck; Hippocrateon Private Hospital	Deltas, C (corresponding author), Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus.	Deltas@ucy.ac.cy	Gale, Daniel/D-5594-2013; Stylianou, Konstantinos/H-2806-2019; Voskarides, Konstantinos/A-4669-2013; Deltas, Constantinos/J-9345-2013; Maxwell, Patrick H/C-5557-2008; Deltas, Constantinos/A-4936-2013; Stylianou, Konstantinos/C-5868-2009	Gale, Daniel/0000-0002-9170-1579; Stylianou, Konstantinos/0000-0003-3678-9421; Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; Maxwell, Patrick H/0000-0002-0338-2679; Deltas, Constantinos/0000-0001-5549-9169; Stylianou, Konstantinos/0000-0003-3678-9421; Pattaro, Cristian/0000-0002-4119-0109	Cyprus Research Promotion Foundation [PiENEK ENISigmaX/0505/02, PENEK/ENISigmaX/0308/08, NEW INFRASTRUCTURE/STRATEGIC/0308/24]; EU; University of Cyprus [3/311, 3/346]; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish	Cyprus Research Promotion Foundation; EU(European Commission); University of Cyprus; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported from the Cyprus Research Promotion Foundation grants: Pi ENEK ENI Sigma X/0505/02, PENEK/ENI Sigma X/0308/08, NEW INFRASTRUCTURE/STRATEGIC/0308/24 (co-funding by the EU Structural Funds) and from the University of Cyprus articles 3/311 and 3/346, to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KL, 2002, AM J PATHOL, V160, P721, DOI 10.1016/S0002-9440(10)64892-4; Athanasiou Y, 2011, CLIN J AM SOC NEPHRO, V6, P1436, DOI 10.2215/CJN.09541010; Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248; Barker DF, 1996, AM J HUM GENET, V58, P1157; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Beirowski B, 2006, J AM SOC NEPHROL, V17, P1986, DOI 10.1681/ASN.2005101044; Buzza M, 2001, KIDNEY INT, V60, P480, DOI 10.1046/j.1523-1755.2001.060002480.x; Chen Y, 2001, Zhonghua Nei Ke Za Zhi, V40, P239; Cheng WR, 2011, NEPHROL DIAL TRANSPL, V26, P2544, DOI 10.1093/ndt/gfq768; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; Deltas C, 2012, PEDIATR NEPHROL, V27, P1221, DOI 10.1007/s00467-011-1935-5; Demosthenous P, 2012, CLIN GENET, V81, P240, DOI 10.1111/j.1399-0004.2011.01647.x; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kashtan CE, 2005, PEDIATR NEPHROL, V20, P1027, DOI 10.1007/s00467-005-1859-z; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Martin P, 1998, J AM SOC NEPHROL, V9, P2291; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; O'Seaghdha CM, 2011, HUM MOL GENET, V20, P2450, DOI 10.1093/hmg/ddr118; Papagregoriou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031021; Pattaro C, 2009, KIDNEY INT, V76, P297, DOI 10.1038/ki.2009.135; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Slajpah M, 2007, KIDNEY INT, V71, P1287, DOI 10.1038/sj.ki.5002221; Tonna S, 2008, PEDIATR NEPHROL, V23, P2201, DOI 10.1007/s00467-008-0934-7; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Voskarides K, 2008, CONNECT TISSUE RES, V49, P283, DOI 10.1080/03008200802148280; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Voskarides K, 2012, PEDIATR NEPHROL, V27, P675, DOI 10.1007/s00467-011-2084-6; Wilson JC, 2007, NEPHROL DIAL TRANSPL, V22, P1338, DOI 10.1093/ndt/gfl793	33	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57925	10.1371/journal.pone.0057925	http://dx.doi.org/10.1371/journal.pone.0057925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516419	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400013
J	Andreo, U; Guo, L; Chirieac, DV; Tuyama, AC; Montenont, E; Brodsky, JL; Fisher, EA				Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Brodsky, Jeffrey L.; Fisher, Edward A.			Insulin-Stimulated Degradation of Apolipoprotein B100: Roles of Class II Phosphatidylinositol-3-Kinase and Autophagy	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; APO-B; QUALITY-CONTROL; MESSENGER-RNA; APOPROTEIN-B; FATTY-ACIDS; SECRETION; LIPOPROTEIN; INHIBITION; TRANSPORT	Both in humans and animal models, an acute increase in plasma insulin levels, typically following meals, leads to transient depression of hepatic secretion of very low density lipoproteins (VLDL). One contributing mechanism for the decrease in VLDL secretion is enhanced degradation of apolipoprotein B100 (apoB100), which is required for VLDL formation. Unlike the degradation of nascent apoB100, which occurs in the endoplasmic reticulum (ER), insulin-stimulated apoB100 degradation occurs post-ER and is inhibited by pan-phosphatidylinositol (PI)3-kinase inhibitors. It is unclear, however, which of the three classes of PI3-kinases is required for insulin-stimulated apoB100 degradation, as well as the proteolytic machinery underlying this response. Class III PI3-kinase is not activated by insulin, but the other two classes are. By using a class I-specific inhibitor and siRNA to the major class II isoform in liver, we now show that it is class II PI3-kinase that is required for insulin-stimulated apoB100 degradation in primary mouse hepatocytes. Because the insulin-stimulated process resembles other examples of apoB100 post-ER proteolysis mediated by autophagy, we hypothesized that the effects of insulin in autophagy-deficient mouse primary hepatocytes would be attenuated. Indeed, apoB100 degradation in response to insulin was significantly impaired in two types of autophagy-deficient hepatocytes. Together, our data demonstrate that insulin-stimulated apoB100 degradation in the liver requires both class II PI3-kinase activity and autophagy.	[Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Fisher, Edward A.] NYU, Sch Med, Dept Med Cardiol, New York, NY 10003 USA; [Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Fisher, Edward A.] NYU, Sch Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA; [Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Fisher, Edward A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Tuyama, Ana C.] Rockefeller Univ, Lab Biochem Genet & Metab, New York, NY 10021 USA; [Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	New York University; New York University; New York University; Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fisher, EA (corresponding author), NYU, Sch Med, Dept Med Cardiol, New York, NY 10003 USA.	edward.fisher@nyumc.org	Fisher, Edward/ABE-7469-2020	Guo, Liang/0000-0003-1633-1544; Fisher, Edward/0000-0001-9802-143X	NIH grant [HL58541]; American Heart Association post-doctoral fellowship [0825883D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association post-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH grant HL58541 and American Heart Association post-doctoral fellowship 0825883D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au CS, 2004, METABOLISM, V53, P228, DOI 10.1016/j.metabol.2003.09.011; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; Brodsky JL, 2008, TRENDS ENDOCRIN MET, V19, P254, DOI 10.1016/j.tem.2008.07.002; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Brown AM, 2001, ARTERIOSCL THROM VAS, V21, P1656, DOI 10.1161/hq1001.096640; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Chan DC, 2004, CLIN SCI, V107, P233, DOI 10.1042/CS20040109; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; Chirieac DV, 2000, AM J PHYSIOL-ENDOC M, V279, pE1003, DOI 10.1152/ajpendo.2000.279.5.E1003; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine DM, 1997, CLIN CHEM, V43, P669; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; LEWIS GF, 1993, DIABETES, V42, P833, DOI 10.2337/diabetes.42.6.833; Misawa H, 1998, BIOCHEM BIOPH RES CO, V244, P531, DOI 10.1006/bbrc.1998.8294; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Phung TL, 1997, J BIOL CHEM, V272, P30693, DOI 10.1074/jbc.272.49.30693; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Qiu W, 2011, HEPATOLOGY, V53, P1515, DOI 10.1002/hep.24269; Rozycka M, 1998, GENOMICS, V54, P569, DOI 10.1006/geno.1998.5621; Sparks JD, 1996, BIOCHEM J, V313, P567, DOI 10.1042/bj3130567; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; St-Pierre AC, 2006, AM J CARDIOL, V97, P997, DOI 10.1016/j.amjcard.2005.10.060; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; WANG HX, 1993, J CLIN INVEST, V91, P1380, DOI 10.1172/JCI116340; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhong SM, 2010, J BIOL CHEM, V285, P6453, DOI 10.1074/jbc.M109.060467	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57590	10.1371/journal.pone.0057590	http://dx.doi.org/10.1371/journal.pone.0057590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516411	Green Accepted, Green Published, gold			2022-12-25	WOS:000316849200013
J	Liu, CH; Jiang, D; Cheng, YJ; Deng, XX; Chen, F; Fang, L; Ma, ZC; Xu, J				Liu, Cuihua; Jiang, Dong; Cheng, Yunjiang; Deng, Xiuxin; Chen, Feng; Fang, Liu; Ma, Zhaocheng; Xu, Juan			Chemotaxonomic Study of Citrus, Poncirus and Fortunella Genotypes Based on Peel Oil Volatile Compounds - Deciphering the Genetic Origin of Mangshanyegan (Citrus nobilis Lauriro)	PLOS ONE			English	Article							DIFFERENTIAL ANALYSIS; DIVERSITY; METABOLOMICS; MANDARINS; MARKERS; NUCLEAR	Volatile profiles yielded from gas chromatography-mass spectrometry (GC-MS) analysis provide abundant information not only for metabolism-related research, but also for chemotaxonomy. To study the chemotaxonomy of Mangshanyegan, its volatile profiles of fruit and leaf and those of 29 other genotypes of Citrus, Poncirus, and Fortunella were subjected to phylogenetic analyses. Results showed that 145 identified (including 64 tentatively identified) and 15 unidentified volatile compounds were detected from their peel oils. The phylogenetic analysis of peel oils based on hierarchical cluster analysis (HCA) demonstrated a good agreement with the Swingle taxonomy system, in which the three genera of Citrus, Poncirus, and Fortunella were almost completely separated. As to Citrus, HCA indicated that Citrophorum, Cephalocitrus, and Sinocitrus fell into three subgroups, respectively. Also, it revealed that Mangshanyegan contain volatile compounds similar to those from pummelo, though it is genetically believed to be a mandarin. These results were further supported by the principal component analysis of the peel oils and the HCA results of volatile profiles of leaves in the study.	[Liu, Cuihua; Cheng, Yunjiang; Deng, Xiuxin; Fang, Liu; Ma, Zhaocheng; Xu, Juan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Key Lab Hort Plant Biol, Minist Educ,Coll Hort & Forestry, Wuhan, Peoples R China; [Jiang, Dong] Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China; [Chen, Feng] Clemson Univ, Dept Food Nutr & Packaging Sci, Clemson, SC USA	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Clemson University	Xu, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Key Lab Hort Plant Biol, Minist Educ,Coll Hort & Forestry, Wuhan, Peoples R China.	xujuan@mail.hzau.edu.cn	cheng, yunjiang/B-1199-2015; cheng, yj/G-4049-2011	cheng, yunjiang/0000-0002-9159-9455; cheng, yj/0000-0002-9159-9455; Xiuxin, Deng/0000-0003-4490-4514	National Basic Research Program of China [2011CB100600]; National Natural Science Foundation of China [31272122]; Fundamental Research Funds for the Central Universities [2012MBDX006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financially supported by the National Basic Research Program of China (grant 2011CB100600), the National Natural Science Foundation of China (grant 31272122), and The Fundamental Research Funds for the Central Universities (grant 2012MBDX006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis KA, 2011, METABOLOMICS; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Biswas MK, 2012, MOL BIOL REP, V39, P5373, DOI 10.1007/s11033-011-1338-5; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; Chen ML, 1987, P NAT C FRUIT CROP R; Cheng YJ, 2005, TREE PHYSIOL, V25, P661, DOI 10.1093/treephys/25.6.661; Deng XX, 2000, ACTA HORTIC, P99, DOI 10.17660/ActaHortic.2000.535.10; Fang DQ, 1998, J AM SOC HORTIC SCI, V123, P612, DOI 10.21273/JASHS.123.4.612; Fowler C, 2004, ANNU REV ENV RESOUR, V29, P143, DOI 10.1146/annurev.energy.29.062403.102203; Fraga BM, 2012, PHYTOCHEMISTRY, V76, P7, DOI 10.1016/j.phytochem.2012.01.018; GREEN RM, 1986, THEOR APPL GENET, V72, P170, DOI 10.1007/BF00266989; HANDA T, 1986, JPN J GENET, V61, P15, DOI 10.1266/jjg.61.15; Herrero R, 1996, THEOR APPL GENET, V93, P1327, DOI 10.1007/BF00223466; HIRAI M, 1987, JPN J BREED, V37, P377; Hou YS, 2011, FRONT ENVIRON SCI EN, V5, P84, DOI 10.1007/s11783-010-0283-1; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; KESTERSON J. W., 1964, PROC AMER SOC HORT SCI, V84, P199; Li R.T., 2009, GUANGDONG AGR SCI, V8, P11; Li RC, 2012, PLANT SYST EVOL, V298, P731, DOI 10.1007/s00606-011-0584-2; Li RT, 2000, HUNAN AGR SCI, V5, P30; Li WB, 1993, HUNAN AGR SCI, V3, P3; Li WB, 1992, P INT SOC CITRICULTU, V1, P217; Li YZ, 2006, J HORTIC SCI BIOTECH, V81, P371, DOI 10.1080/14620316.2006.11512075; LIN Z-K, 1992, Acta Botanica Sinica, V34, P133; Liu CH, 2012, FOOD SCI BIOTECHNOL, V21, P531, DOI 10.1007/s10068-012-0068-3; Liu CH, 2012, J AGR FOOD CHEM, V60, P2617, DOI 10.1021/jf2039197; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Luro F, 2012, PHYTOCHEMISTRY, V77, P186, DOI 10.1016/j.phytochem.2011.12.013; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Merle H, 2004, BIOCHEM SYST ECOL, V32, P491, DOI 10.1016/j.bse.2003.09.010; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Pang Xiao-Ming, 2003, Acta Genetica Sinica, V30, P81; PIERINGER A. P., 1964, PROC AMER SOC HORT SCI, V84, P204; Radulovic N, 2012, CHEM BIODIVERS, V9, P106, DOI 10.1002/cbdv.201100204; Schmidt MR, 2006, RISK ANAL, V26, P455, DOI 10.1111/j.1539-6924.2006.00744.x; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Skogerson K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-321; Swingle WT., 1943, CITRUS IND, P128; Tanaka T., 1977, STUD CITROG, V14, P1; Tanaka T, 1954, REV AURANTIACEARUM, P1; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Wayman KA, 2010, PHYTOCHEMISTRY, V71, P766, DOI 10.1016/j.phytochem.2010.01.017; Yamamoto M, 2003, EUPHYTICA, V129, P267, DOI 10.1023/A:1022284908424	50	25	25	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58411	10.1371/journal.pone.0058411	http://dx.doi.org/10.1371/journal.pone.0058411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516475	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200066
J	Otero-Millan, J; Schneider, R; Leigh, RJ; Macknik, SL; Martinez-Conde, S				Otero-Millan, Jorge; Schneider, Rosalyn; Leigh, R. John; Macknik, Stephen L.; Martinez-Conde, Susana			Saccades during Attempted Fixation in Parkinsonian Disorders and Recessive Ataxia: From Microsaccades to Square-Wave Jerks	PLOS ONE			English	Article							CAUDAL FASTIGIAL NUCLEUS; SUPERIOR COLLICULUS; OMNIPAUSE NEURONS; EYE-MOVEMENTS; MUSCIMOL INACTIVATION; GAZE SHIFTS; ABNORMALITIES; INTRUSIONS; GENERATION; PALLIDOTOMY	During attempted visual fixation, saccades of a range of sizes occur. These "fixational saccades'' include microsaccades, which are not apparent in regular clinical tests, and "saccadic intrusions'', predominantly horizontal saccades that interrupt accurate fixation. Square-wave jerks (SWJs), the most common type of saccadic intrusion, consist of an initial saccade away from the target followed, after a short delay, by a "return saccade'' that brings the eye back onto target. SWJs are present in most human subjects, but are prominent by their increased frequency and size in certain parkinsonian disorders and in recessive, hereditary spinocerebellar ataxias. Here we asked whether fixational saccades showed distinctive features in various parkinsonian disorders and in recessive ataxia. Although some saccadic properties differed between patient groups, in all conditions larger saccades were more likely to form SWJs, and the intervals between the first and second saccade of SWJs were similar. These findings support the proposal of a common oculomotor mechanism that generates all fixational saccades, including microsaccades and SWJs. The same mechanism also explains how the return saccade in SWJs is triggered by the position error that occurs when the first saccadic component is large, both in the healthy brain and in neurological disease.	[Otero-Millan, Jorge; Macknik, Stephen L.; Martinez-Conde, Susana] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Otero-Millan, Jorge] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Spain; [Schneider, Rosalyn; Leigh, R. John] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Macknik, Stephen L.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA	Barrow Neurological Institute; Universidade de Vigo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Barrow Neurological Institute	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA.	smart@neuralcorrelate.com	Otero-Millan, Jorge/A-4193-2014; Macknik, Stephen L./H-7704-2019; Otero-Millan, Jorge/A-9863-2010	Otero-Millan, Jorge/0000-0002-9789-8392; Macknik, Stephen L./0000-0002-3143-9230; 	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Science Foundation [0643306, 0852636, 1153786]; NIH [EY06717]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs; Evenor Armington Fund; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Evenor Armington Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the following funding agencies: Barrow Neurological Foundation (to SLM and SMC), Arizona Biomedical Research Commission (to SMC), National Science Foundation (awards 0643306, 0852636 and 1153786 to SMC), NIH (grant EY06717 to RJL), the Office of Research and Development, Medical Research Service, Department of Veterans Affairs (to RJL), and the Evenor Armington Fund (to RJL). Jorge Otero-Millan was a Fellow of the Pedro Barrie de la Maza Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Averbuch-Heller L, 1999, NEUROLOGY, V52, P185, DOI 10.1212/WNL.52.1.185; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Bergeron A, 2001, PROG BRAIN RES, V134, P97; Bhidayasiri R, 2001, NEUROLOGY, V57, P2070, DOI 10.1212/WNL.57.11.2070; Boeve BF, 1999, NEUROLOGY, V53, P795, DOI 10.1212/WNL.53.4.795; Boxer AL, 2012, ARCH NEUROL-CHICAGO, V69, P509, DOI 10.1001/archneurol.2011.1021; Buttner-Ennever JA, 1999, J COMP NEUROL, V413, P55, DOI 10.1002/(SICI)1096-9861(19991011)413:1<55::AID-CNE3>3.0.CO;2-K; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Chen Athena L, 2010, Front Neurol, V1, P147, DOI 10.3389/fneur.2010.00147; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; Cui J, 2009, VISION RES, V49, P228, DOI 10.1016/j.visres.2008.10.015; Cullen KE, 1997, J NEUROPHYSIOL, V78, P3259, DOI 10.1152/jn.1997.78.6.3259; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; EVINGER C, 1982, J NEUROPHYSIOL, V47, P827, DOI 10.1152/jn.1982.47.5.827; EVINGER C, 1991, INVEST OPHTH VIS SCI, V32, P387; Fahey MC, 2008, BRAIN, V131, P1035, DOI 10.1093/brain/awm323; Gandhi NJ, 1997, J NEUROPHYSIOL, V78, P2221, DOI 10.1152/jn.1997.78.4.2221; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Goffart L, 2004, J NEUROPHYSIOL, V92, P3351, DOI 10.1152/jn.01199.2003; Goffart L, 1998, J NEUROPHYSIOL, V79, P1942, DOI 10.1152/jn.1998.79.4.1942; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2007, SCI AM, V297, P56, DOI 10.1038/scientificamerican0807-56; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; McLachlan GJ, 2005, DISCRIMINANT ANAL ST, pi; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Moschovakis AK, 1998, J NEUROSCI, V18, P10219; O'Sullivan JD, 2003, J CLIN NEUROSCI, V10, P181, DOI 10.1016/S0967-5868(02)00125-X; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Pinkhardt EH, 2011, PARKINSONISM RELAT D, V17, P223, DOI 10.1016/j.parkreldis.2010.08.004; Pinnock RA, 2010, J NEUROL, V257, P533, DOI 10.1007/s00415-009-5356-3; Ramat S, 1999, INVEST OPHTH VIS SCI, V40, P1681; RASCOL O, 1991, J NEUROL NEUROSUR PS, V54, P599, DOI 10.1136/jnnp.54.7.599; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Serra A, 2008, NEUROLOGY, V70, P810, DOI 10.1212/01.wnl.0000286952.01476.eb; Shinoda Y, 2011, ANN NY ACAD SCI, V1233, P100, DOI 10.1111/j.1749-6632.2011.06171.x; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; Swartz BE, 2003, ANN NEUROL, V54, P824, DOI 10.1002/ana.10758; Troncoso XG, 2005, PERCEPTION, V34, P409, DOI 10.1068/p5383; Troncoso XG, 2008, P NATL ACAD SCI USA, V105, P16033, DOI 10.1073/pnas.0709389105; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; WEBER H, 1989, J HIRNFORSCH, V30, P603	61	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58535	10.1371/journal.pone.0058535	http://dx.doi.org/10.1371/journal.pone.0058535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516502	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200082
J	Trellet, M; Melquiond, ASJ; Bonvin, AMJJ				Trellet, Mikael; Melquiond, Adrien S. J.; Bonvin, Alexandre M. J. J.			A Unified Conformational Selection and Induced Fit Approach to Protein-Peptide Docking	PLOS ONE			English	Article							WEB SERVER; ALLOSTERIC TRANSITIONS; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; SPECIFICITY; HADDOCK; CAPRI; DETERMINANTS; RECOGNITION; PREDICTION	Protein-peptide interactions are vital for the cell. They mediate, inhibit or serve as structural components in nearly 40% of all macromolecular interactions, and are often associated with diseases, making them interesting leads for protein drug design. In recent years, large-scale technologies have enabled exhaustive studies on the peptide recognition preferences for a number of peptide-binding domain families. Yet, the paucity of data regarding their molecular binding mechanisms together with their inherent flexibility makes the structural prediction of protein-peptide interactions very challenging. This leaves flexible docking as one of the few amenable computational techniques to model these complexes. We present here an ensemble, flexible protein-peptide docking protocol that combines conformational selection and induced fit mechanisms. Starting from an ensemble of three peptide conformations (extended, a-helix, polyproline-II), flexible docking with HADDOCK generates 79.4% of high quality models for bound/unbound and 69.4% for unbound/unbound docking when tested against the largest protein-peptide complexes benchmark dataset available to date. Conformational selection at the rigid-body docking stage successfully recovers the most relevant conformation for a given protein-peptide complex and the subsequent flexible refinement further improves the interface by up to 4.5 angstrom interface RMSD. Cluster-based scoring of the models results in a selection of near-native solutions in the top three for similar to 75% of the successfully predicted cases. This unified conformational selection and induced fit approach to protein-peptide docking should open the route to the modeling of challenging systems such as disorder-order transitions taking place upon binding, significantly expanding the applicability limit of biomolecular interaction modeling by docking.	[Trellet, Mikael; Melquiond, Adrien S. J.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci Chem, Bijvoet Ctr Biomol Res, Computat Struct Biol Grp, Utrecht, Netherlands	Utrecht University	Melquiond, ASJ (corresponding author), Univ Utrecht, Fac Sci Chem, Bijvoet Ctr Biomol Res, Computat Struct Biol Grp, Utrecht, Netherlands.	a.s.j.melquiond@uu.nl; a.m.j.j.bonvin@uu.nl	Bonvin, Alexandre M.J.J./A-5420-2009; Trellet, Mikael/A-9370-2017	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Trellet, Mikael/0000-0001-6337-581X; Melquiond, Adrien/0000-0002-0167-3771	Netherlands Organization for Scientific Research [700.56.442]; WeNMR project (European FP7 e-Infrastructure grant) [261572]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); WeNMR project (European FP7 e-Infrastructure grant)	This work was supported by the Netherlands Organization for Scientific Research (www.nwo.nl) (VICI grant 700.56.442 to A.M.J.J.B.) and the WeNMR project (European FP7 e-Infrastructure grant, contract no. 261572, www.wenmr.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Ben-Shimon A, 2010, J MOL BIOL, V402, P259, DOI 10.1016/j.jmb.2010.07.021; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Casares S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-22; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dagliyan O, 2011, STRUCTURE, V19, P1837, DOI 10.1016/j.str.2011.09.014; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fischer E, 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Frydman-Marom A, 2011, AMYLOID, V18, P119, DOI 10.3109/13506129.2011.582902; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Hahn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032804; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hubbard S. J., 1993, NACCESS; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Karaca E, 2011, STRUCTURE, V19, P555, DOI 10.1016/j.str.2011.01.014; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Madine J, 2008, J AM CHEM SOC, V130, P7873, DOI 10.1021/ja075356q; Maes M, 2012, FEBS J, V279, P2795, DOI 10.1111/j.1742-4658.2012.08680.x; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Musi V, 2006, PROTEIN SCI, V15, P795, DOI 10.1110/ps.051785506; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Niv MY, 2005, J AM CHEM SOC, V127, P14072, DOI 10.1021/ja054195s; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Pons C, 2010, J MOL BIOL, V403, P217, DOI 10.1016/j.jmb.2010.08.029; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schrodinger L., 2020, PYMOL; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stigler RD, 1999, STRUCTURE, V7, P663, DOI 10.1016/S0969-2126(99)80087-2; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Trabuco LG, 2012, NUCLEIC ACIDS RES, V40, pW423, DOI 10.1093/nar/gks398; Tzakos AG, 2004, EUR J BIOCHEM, V271, P3399, DOI 10.1111/j.1432-1033.2004.04274.x; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Wassenaar TA, 2011, CEUR; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Yamin G, 2009, BIOCHEMISTRY-US, V48, P11329, DOI 10.1021/bi901325g; Zhou YY, 1998, FOLD DES, V3, P513, DOI 10.1016/S1359-0278(98)00067-4	59	132	133	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58769	10.1371/journal.pone.0058769	http://dx.doi.org/10.1371/journal.pone.0058769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516555	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200113
J	Castro-Sesquen, YE; Gilman, RH; Yauri, V; Cok, J; Angulo, N; Escalante, H; Bern, C				Castro-Sesquen, Yagahira E.; Gilman, Robert H.; Yauri, Veronica; Cok, Jaime; Angulo, Noelia; Escalante, Hermes; Bern, Caryn			Detection of Soluble Antigen and DNA of Trypanosoma cruzi in Urine Is Independent of Renal Injury in the Guinea Pig Model	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHRONIC CHAGAS-DISEASE; EXPERIMENTAL-INFECTION; PULMONARY TUBERCULOSIS; TRANSRENAL DNA; MICE; PCR; TRANSMISSION; DIAGNOSIS; SPECIMENS	The diagnosis of Chagas disease in humans is generally limited to the detection of specific antibodies. Detection of T. cruzi antigens in urine has been reported previously, but is not used in the diagnosis. In this study, soluble T. cruzi antigens and DNA were detected in urine samples and were associated with kidney injury and systemic detection of the parasite. We used 72 guinea pigs infected with T. cruzi Y strain and 18 non-infected guinea pigs. Blood, kidney, heart and urine samples were collected during the acute phase and chronic phase. Urine samples were concentrated by ultrafiltration. Antigens were detected by Western Blot using a polyclonal antibody against trypomastigote excretory-secretory antigen (TESA). T. cruzi DNA was detected by PCR using primers 121/122 and TcZ1/TcZ2. Levels of T. cruzi DNA in blood, heart and kidney were determined by quantitative PCR. T. cruzi antigens (75 kDa, 80 kDa, 120 kDa, 150 kDa) were detected in the acute phase (67.5%) and the chronic phase (45%). Parasite DNA in urine was detected only in the acute phase (45%). Kidney injury was characterized by high levels of proteinuria, kidney injury molecule-1 (KIM-1) and urea, and some histopathological changes such as inflammation, necrosis, fibrosis and scarce parasites. The detection of antigens and DNA in urine was associated with the presence of parasite DNA in blood and heart and with high levels of parasite DNA in blood, but not with the presence of parasite in kidney or kidney injury. These results suggest that the detection of T. cruzi in urine could be improved to be a valuable method for the diagnosis of Chagas disease, particularly in congenital Chagas disease and in immunocompromised patients.	[Castro-Sesquen, Yagahira E.; Angulo, Noelia] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Yauri, Veronica] Univ Nacl Mayor San Marcos, Fac Med Vet, Lima 14, Peru; [Cok, Jaime] Hosp Nacl Cayetano Heredia, Dept Pathol, Lima, Peru; [Escalante, Hermes] Univ Nacl Trujillo, Fac Ciencias Biol, Trujillo, Peru; [Escalante, Hermes] Ctr Anal & Invest Escalabs, Dept Invest & Prod, Trujillo, Peru; [Bern, Caryn] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Nacional Mayor de San Marcos; Universidad Nacional de Trujillo; University of California System; University of California San Francisco	Gilman, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	rgilman@jhsph.edu		Castro-Sesquen, Yagahira E./0000-0001-6824-9206; Bern, Caryn/0000-0001-8195-7303	Fogarty International Center [5 R24 TW007988, D43 TW006581]; National Institute of Allergy and Infectious Diseases at the National Institute of Health [R01 AI087776]; Centro de Analisis e Investigacion escalabs e.i.rl; MRC [MR/K007467/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [D43TW006581, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087776] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centro de Analisis e Investigacion escalabs e.i.rl; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Fogarty International Center (5 R24 TW007988, D43 TW006581) and National Institute of Allergy and Infectious Diseases (R01 AI087776) at the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Hermes Escalante has been working in Centro de Analisis e Investigacion escalabs e.i.rl. Part of this research was funded by this company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; Bern C, 2009, CLIN INFECT DIS, V49, P1667, DOI 10.1086/648070; Bertot GM, 1998, J PARASITOL, V84, P608, DOI 10.2307/3284731; Boczko J, 2005, J UROLOGY, V173, P1784, DOI 10.1097/01.ju.0000154170.87947.b8; Brinkman JW, 2007, NEPHROL DIAL TRANSPL, V22, P3670, DOI 10.1093/ndt/gfl803; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; Carvalho Maria Fernanda C., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P223, DOI 10.1590/S0036-46651997000400008; Castro-Sesquen YE, 2011, AM J PATHOL, V179, P281, DOI 10.1016/j.ajpath.2011.03.043; Corral RS, 1996, J CLIN MICROBIOL, V34, P1957, DOI 10.1128/JCM.34.8.1957-1962.1996; CORRAL RS, 1995, PARASITE, V2, P339; CORRAL RS, 1989, J CLIN MICROBIOL, V27, P145, DOI 10.1128/JCM.27.1.145-151.1989; COSTA RS, 1991, CLIN IMMUNOL IMMUNOP, V58, P102, DOI 10.1016/0090-1229(91)90152-Z; Cruz Dinna N, 2010, Congest Heart Fail, V16 Suppl 1, pS25, DOI 10.1111/j.1751-7133.2010.00163.x; de Oliveira GM, 2009, PARASITOL RES, V106, P111, DOI 10.1007/s00436-009-1637-0; Debrabant A, 2003, INT J PARASITOL, V33, P257, DOI 10.1016/S0020-7519(03)00008-0; ERMAN A, 1988, CLIN CHIM ACTA, V174, P255, DOI 10.1016/0009-8981(88)90051-4; Fitzwater S, 2008, AM J TROP MED HYG, V79, P768, DOI 10.4269/ajtmh.2008.79.768; FREILIJ HL, 1987, J CLIN MICROBIOL, V25, P133, DOI 10.1128/JCM.25.1.133-137.1987; Gonzalez G, 1996, SCAND J IMMUNOL, V44, P122, DOI 10.1046/j.1365-3083.1996.d01-290.x; Herrera L, 2001, MEM I OSWALDO CRUZ, V96, P713, DOI 10.1590/S0074-02762001000500024; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; ITO K, 1984, J BIOCHEM, V95, P1399, DOI 10.1093/oxfordjournals.jbchem.a134747; JAZIN EE, 1991, INFECT IMMUN, V59, P2189; Junqueira ACV, 1996, T ROY SOC TROP MED H, V90, P129, DOI 10.1016/S0035-9203(96)90111-X; Kashino SS, 2008, CLIN EXP IMMUNOL, V153, P56, DOI 10.1111/j.1365-2249.2008.03672.x; KATZIN A, 1989, T ROY SOC TROP MED H, V83, P341, DOI 10.1016/0035-9203(89)90497-5; KATZIN AM, 1989, EXP PARASITOL, V68, P208, DOI 10.1016/0014-4894(89)90099-4; KOIZUMI T, 1995, EXP ANIM TOKYO, V44, P181, DOI 10.1538/expanim.44.181; Lichtenstein AV, 2001, ANN NY ACAD SCI, V945, P239; Oliveira I, 2010, EXPERT REV ANTI-INFE, V8, P945, DOI 10.1586/ERI.10.74; *ORG PAN SAL, 2006, OPSHDMCD42506; Pinto Ana Yecê das Neves, 2004, Braz J Infect Dis, V8, P454, DOI 10.1590/S1413-86702004000600010; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Pizarro Juan Carlos, 2007, Kinetoplastid Biol Dis, V6, P1, DOI 10.1186/1475-9292-6-1; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; Shane HL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000951; Su YH, 2004, ANN NY ACAD SCI, V1022, P81, DOI 10.1196/annals.1318.014; Toye B, 1998, J CLIN MICROBIOL, V36, P2356, DOI 10.1128/JCM.36.8.2356-2358.1998; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143, DOI 10.1128/JCM.34.9.2143-2147.1996; UMEZAWA ES, 1993, EXP PARASITOL, V76, P352, DOI 10.1006/expr.1993.1043; Veland N, 2011, AM J TROP MED HYG, V84, P556, DOI 10.4269/ajtmh.2011.10-0556; Veloso VM, 2008, MEM I OSWALDO CRUZ, V103, P528, DOI 10.1590/S0074-02762008000600003; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; WINCKER P, 1994, FEMS MICROBIOL LETT, V124, P419, DOI 10.1111/j.1574-6968.1994.tb07318.x; Wincker P, 1997, PARASITOLOGY, V114, P367, DOI 10.1017/S0031182096008554	49	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58480	10.1371/journal.pone.0058480	http://dx.doi.org/10.1371/journal.pone.0058480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520515	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900074
J	Iwata, M; Madtes, DK; Abrams, K; Lamm, WJE; Glenny, RW; Nash, RA; Ramakrishnan, A; Torok-Storb, B				Iwata, Mineo; Madtes, David K.; Abrams, Kraig; Lamm, Wayne J. E.; Glenny, Robb W.; Nash, Richard A.; Ramakrishnan, Aravind; Torok-Storb, Beverly			Late Infusion of Cloned Marrow Fibroblasts Stimulates Endogenous Recovery from Radiation-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; TOTAL-BODY IRRADIATION; ARTERIAL INJURY; TRANSPLANTATION; REGENERATION; ENGRAFTMENT; REPAIR; IDENTIFICATION; HEMANGIOBLAST	In the current study, we used a canine model of radiation-induced lung injury to test the effect of a single i.v. infusion of 10x10(6)/kg of marrow fibroblasts on the progression of damage following 15 Gy exposure to the right lung. The fibroblasts, designated DS1 cells, are a cloned population of immortalized cells isolated from a primary culture of marrow stromal cells. DS1 cells were infused at week 5 post-irradiation when lung damage was evident by imaging with high-resolution computed tomography (CT). At 13 weeks post-irradiation we found that 4 out of 5 dogs receiving DS1 cells had significantly improved pulmonary function compared to 0 out of 5 control dogs (p = 0.047, Fisher's Exact). Pulmonary function was measured as the single breath diffusion capacity-hematocrit (DLCO-Hct), the total inspiratory capacity (IC), and the total lung capacity (TLC), which differed significantly between control and DS1-treated dogs; p = 0.002, p = 0.005, and p = 0.004, respectively. The DS1-treated dogs also had less pneumonitis detected by CT imaging and an increased number of TTF-1 (thyroid transcription factor 1, NKX2-1) positive cells in the bronchioli and alveoli compared to control dogs. Endothelial-like progenitor cells (ELC) of host origin, detected by colony assays, were found in peripheral blood after DS1 cell infusion. ELC numbers peaked one day after infusion, and were not detectable by 7 days. These data suggest that infusion of marrow fibroblasts stimulates mobilization of ELC, which is associated with a reduction in otherwise progressive radiation-induced lung injury. We hypothesize that these two observations are related, specifically that circulating ELC contribute to increased angiogenesis, which facilitates endogenous lung repair.	[Iwata, Mineo; Madtes, David K.; Abrams, Kraig; Nash, Richard A.; Ramakrishnan, Aravind; Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Madtes, David K.; Lamm, Wayne J. E.; Glenny, Robb W.; Nash, Richard A.; Ramakrishnan, Aravind] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Glenny, Robb W.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Torok-Storb, B (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	btorokst@fhcrc.org			National Institutes of Health, Bethesda, Maryland [P30DK056465, U01HL099993]; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland [RC1 AI081298]; Synergy Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL094374, U01HL099993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI081298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Synergy Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful for research funding from the National Institutes of Health, Bethesda, Maryland, grants P30DK056465, and U01HL099993 to BTS, from the National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, grant RC1 AI081298 to RN, and the Synergy Fund to AR and DM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health nor its subsidiary Institutes and Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; BANNISTER LH, 1999, GRAYS ANATOMY, P1666; Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; Burroughs L, 2005, BLOOD, V106, P4002, DOI 10.1182/blood-2005-05-1937; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Georges GE, 2000, BLOOD, V95, P3262, DOI 10.1182/blood.V95.10.3262.010k28_3262_3269; Ghosh SN, 2009, INT J RADIAT ONCOL, V74, P192, DOI 10.1016/j.ijrobp.2009.01.006; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hilgendorf I, 2005, VET RES COMMUN, V29, P103, DOI 10.1023/B:VERC.0000047486.01458.c5; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2008, CURR OPIN LIPIDOL, V19, P491, DOI 10.1097/MOL.0b013e32830dfe33; Hristov M, 2007, THROMB HAEMOSTASIS, V98, P274, DOI 10.1160/TH07-03-0181; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kotton DN, 2008, CELL TISSUE RES, V331, P145, DOI 10.1007/s00441-007-0479-2; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Levis J, 2008, AM J RESP CELL MOL, V38, P16, DOI 10.1165/rcmb.2007-0249OC; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; Mielcarek M, 2011, BIOL BLOOD MARROW TR, V17, P214, DOI 10.1016/j.bbmt.2010.08.015; Nash RA, 2009, AM J TRANSPLANT, V9, P1037, DOI 10.1111/j.1600-6143.2009.02619.x; NASH RA, 1994, BLOOD, V83, P1963; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; SCHARF SJ, 1995, BLOOD, V85, P1954, DOI 10.1182/blood.V85.7.1954.bloodjournal8571954; STORB R, 1985, IMMUNOL REV, V88, P215, DOI 10.1111/j.1600-065X.1985.tb01160.x; STORB R, 1994, BLOOD, V83, P3384; Thomas E.D., 1999, HEMATOPOIETIC CELL T, P1; Tilki D, 2009, TRENDS MOL MED, V15, P501, DOI 10.1016/j.molmed.2009.09.004; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Yan X, 2007, EXP HEMATOL, V35, P1466, DOI 10.1016/j.exphem.2007.05.012	40	2	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57179	10.1371/journal.pone.0057179	http://dx.doi.org/10.1371/journal.pone.0057179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520463	gold, Green Published, Green Submitted			2022-12-25	WOS:000318679900022
J	Sikora, M; Cieplak, M				Sikora, Mateusz; Cieplak, Marek			Formation of Cystine Slipknots in Dimeric Proteins	PLOS ONE			English	Article							MOLECULE FORCE SPECTROSCOPY; CRYSTAL-STRUCTURE; KNOT; TITIN; SUPERFAMILY; INHIBITION; STABILITY; STRENGTH; MODELS; BOND	We consider mechanical stability of dimeric and monomeric proteins with the cystine knot motif. A structure based dynamical model is used to demonstrate that all dimeric and some monomeric proteins of this kind should have considerable resistance to stretching that is significantly larger than that of titin. The mechanisms of the large mechanostability are elucidated. In most cases, it originates from the induced formation of one or two cystine slipknots. Since there are four termini in a dimer, there are several ways of selecting two of them to pull by. We show that in the cystine knot systems, there is strong anisotropy in mechanostability and force patterns related to the selection. We show that the thermodynamic stability of the dimers is enhanced compared to the constituting monomers whereas machanostability is either lower or higher.	[Sikora, Mateusz; Cieplak, Marek] Polish Acad Sci, Inst Phys, Warsaw, Poland	Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Cieplak, M (corresponding author), Polish Acad Sci, Inst Phys, Warsaw, Poland.	mc@ifpan.edu.pl			European Regional Development Fund under the Operational Programme Innovative Economy NanoFun [POIG.02.02.00-00-025/09]; Polish National Science Centre [2011/01/B/ST3/02190, 2011/01/N/ST3/02475]	European Regional Development Fund under the Operational Programme Innovative Economy NanoFun; Polish National Science Centre	The computer resources were financed by the European Regional Development Fund under the Operational Programme Innovative Economy NanoFun POIG.02.02.00-00-025/09. This research has been supported by the Polish National Science Centre Grants No. 2011/01/B/ST3/02190 (MC) and 2011/01/N/ST3/02475 (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bell SL, 2001, BIOCHEM J, V357, P203, DOI 10.1042/0264-6021:3570203; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertz M, 2009, P NATL ACAD SCI USA, V106, P13307, DOI 10.1073/pnas.0902312106; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Bruinzeel W, 2012, PROTEIN EXPRES PURIF, V81, P25, DOI 10.1016/j.pep.2011.08.028; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Carrion-Vazquez M, 2009, ENCY COMPLEXITY SYST, P7026; Cieplak M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2046609; Cieplak M, 2004, PROTEINS, V56, P285, DOI 10.1002/prot.20081; Cieplak M, 2006, BBA-BIOMEMBRANES, V1758, P537, DOI 10.1016/j.bbamem.2006.03.028; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Crampton N, 2010, CURR OPIN STRUC BIOL, V20, P508, DOI 10.1016/j.sbi.2010.05.005; de Young LR, 1999, PROTEIN SCI, V8, P2513; DeYoung LR, 1996, PROTEIN SCI, V5, P1554, DOI 10.1002/pro.5560050811; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Galera-Prat A, 2010, CURR OPIN STRUC BIOL, V20, P63, DOI 10.1016/j.sbi.2010.01.003; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; He CZ, 2012, J AM CHEM SOC, V134, P10428, DOI 10.1021/ja3003205; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Miles LA, 2002, J BIOL CHEM, V277, P43033, DOI 10.1074/jbc.M206690200; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Muller YA, 2002, J BIOL CHEM, V277, P43410, DOI 10.1074/jbc.M206438200; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; NARHI LO, 1993, INT J PEPT PROT RES, V41, P8; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Peplowski L, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3553801; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Prestrelski SJ, 2009, INT J PEPT PROT RES, V44, P357; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schmidt SW, 2008, J AM CHEM SOC, V130, P3664, DOI 10.1021/ja710642a; Sikora M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208101; Sikora M, 2011, PROTEINS, V79, P1786, DOI 10.1002/prot.23001; Sikora M, 2011, NUCLEIC ACIDS RES, V39, pD443, DOI 10.1093/nar/gkq851; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; SOCCI ND, 1994, J CHEM PHYS, V101, P1519, DOI 10.1063/1.467775; Sulkowska JI, 2008, BIOPHYS J, V95, P3174, DOI 10.1529/biophysj.107.127233; Sulkowska JI, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/283201; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57443	10.1371/journal.pone.0057443	http://dx.doi.org/10.1371/journal.pone.0057443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520470	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900029
J	Carbe, C; Garg, A; Cai, ZG; Li, HG; Powers, A; Zhang, X				Carbe, Christian; Garg, Ankur; Cai, Zhigang; Li, Hongge; Powers, Andrea; Zhang, Xin			An Allelic Series at the Paired Box Gene 6 (Pax6) Locus Reveals the Functional Specificity of Pax Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACRIMAL GLAND DEVELOPMENT; RETINAL PROGENITOR CELLS; EYE DEVELOPMENT; BRAIN-DEVELOPMENT; DEVELOPING CORTEX; LENS DEVELOPMENT; DROSOPHILA EYE; MOUSE; DIFFERENTIATION; ANIRIDIA	The advent of the ocular and nervous system in metazoan evolution coincides with the diversification of a single ancestral paired box (Pax) gene into Pax6, Pax6(5a), and Pax2. To investigate the role of these Pax genes in neural development, we have generated an allelic series of knock-in models at the Pax6 locus. We showed that although Pax6(5a) and Pax2 could not replace Pax6 for its autoregulation in lens induction or for neural differentiation in retina, Pax6(5a) was sufficient for corneal-lenticular detachment. In brain development, cell proliferation in the cerebral cortex and dorsoventral patterning of the telencephalon and neural tube were partially rescued in either knock-in mutant. Contrary to the previous belief, our genetic studies showed that the Pax6 isoform Pax6(5a) could potentially play a role in neuronal differentiation in brain development. Importantly, Pax2 showed greater rescue efficiency than Pax6(5a) in the telencephalon even though the latter was identical to Pax6 outside the paired domain. In studying Ngn2, a Pax6 direct target gene in telencephalon, we showed that the level of Ngn2 expression correlated with the in vitro binding of Pax2, Pax6, and Pax6(5a) paired domain on its enhancer. Our results show that Pax6 is uniquely required for eye development, but in brain development, Pax6 can be functionally substituted by related Pax family genes that share a similar paired domain binding specificity.	[Zhang, Xin] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, X (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	xz4@iu.edu	Li, Hongge/G-7594-2015		National Institutes of Health [EY017061, EY018868]; NATIONAL EYE INSTITUTE [R01EY017061, R01EY018868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY017061 and EY018868 (to X. Z.).	Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Berger J, 2007, DEVELOPMENT, V134, P1311, DOI 10.1242/dev.02809; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Bouchard M, 2000, DEVELOPMENT, V127, P3703; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brownell I, 2000, GENESIS, V27, P81, DOI 10.1002/1526-968X(200006)27:2<81::AID-GENE50>3.0.CO;2-N; Carbe C, 2012, DEV BIOL, V363, P320, DOI 10.1016/j.ydbio.2011.12.038; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Donner AL, 2007, GENE EXPR PATTERNS, V7, P606, DOI 10.1016/j.modgep.2007.01.001; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Favor J, 2001, GENETICS, V159, P1689; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mikkola I, 2001, J BIOL CHEM, V276, P4109, DOI 10.1074/jbc.M008882200; Nomura T, 2004, DEVELOPMENT, V131, P787, DOI 10.1242/dev.00984; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pan Y, 2010, DEVELOPMENT, V137, P1085, DOI 10.1242/dev.042820; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030	54	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12130	12141		10.1074/jbc.M112.436865	http://dx.doi.org/10.1074/jbc.M112.436865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23515312	Green Published, hybrid			2022-12-25	WOS:000318157600045
J	Lee, DS; Chen, LJ; Li, CY; Liu, YS; Tan, XL; Lu, BR; Li, J; Gan, SX; Kang, SG; Suh, HS; Zhu, YY				Lee, Dong Sun; Chen, Li Juan; Li, Cheng Yun; Liu, Yongsheng; Tan, Xue Lin; Lu, Bao-Rong; Li, Juan; Gan, Shu Xian; Kang, Sang Gu; Suh, Hak Soo; Zhu, Youyong			The B-sister MADS Gene FST Determines Ovule Patterning and Development of the Zygotic Embryo and Endosperm	PLOS ONE			English	Article							FEMALE GAMETOPHYTE DEVELOPMENT; FLORAL ORGAN IDENTITY; GAMETIC CELL FATE; BOX GENES; SEED DEVELOPMENT; DOMAIN PROTEIN; RICE; ARABIDOPSIS; EXPRESSION; POLARITY	Many homeotic MADS-box genes have been identified as controllers of the floral transition and floral development. However, information regarding B-sister (B-s)-function genes in monocots is still limited. Here, we describe the functional characterization of a B-s-group MADS-box gene FEMALE-STERILE (FST), whose frame-shift mutation (fst) results in abnormal ovules and the complete abortion of zygotic embryos and endosperms in rice. Anatomical analysis showed that the defective development in the fst mutant exclusively occurred in sporophytic tissues including integuments, fertilized proembryos and endosperms. Analyses of the spatio-temporal expression pattern revealed that the prominent FST gene products accumulated in the inner integument, nucellar cell of the micropylar side, apical and base of the proembryos and free endosperm nuclei. Microarray and gene ontology analysis unraveled substantial changes in the expression level of many genes in the fst mutant ovules and seeds, with a subset of genes involved in several developmental and hormonal pathways appearing to be down-regulated. Using both forward and reverse genetics approaches, we demonstrated that rice FST plays indispensable roles and multiple functions during ovule and early seed development. These findings support a novel function for the B-s-group MADS-box genes in plants.	[Lee, Dong Sun; Li, Cheng Yun; Zhu, Youyong] Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist, Kunming, Peoples R China; [Lee, Dong Sun; Chen, Li Juan; Tan, Xue Lin; Li, Juan; Gan, Shu Xian] Yunnan Agr Univ, Rice Res Inst, Kunming, Peoples R China; [Chen, Li Juan; Tan, Xue Lin; Li, Juan; Gan, Shu Xian] Yunnan Agr Univ, Key Lab Mol Breeding Dian Type Japonica Hybrid Ri, Yunnan Educ Dept, Kunming, Peoples R China; [Liu, Yongsheng] Sichuan Univ, Minist Educ, Key Lab Bioresource & Ecoenvironm, Coll Life Sci,State Key Lab Hydraul & Mt River En, Chengdu 610064, Peoples R China; [Lu, Bao-Rong] Fudan Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Kang, Sang Gu] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Suh, Hak Soo] Yeungnam Univ, Sch Biol Resources, Gyongsan, South Korea	Yunnan Agricultural University; Yunnan Agricultural University; Yunnan Agricultural University; Sichuan University; Fudan University; Yeungnam University; Yeungnam University	Zhu, YY (corresponding author), Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist, Kunming, Peoples R China.	yyzhu@ynau.edu.cn	Lee, Dong Sun/HGV-2436-2022; Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390	National Natural Science Foundation of China and Yunnan Province [U1136604]; Ministry of Science and Technology of China [2011CB100401]; Department of Science and Technology of Yunnan Province [2006C0006Z]	National Natural Science Foundation of China and Yunnan Province(Natural Science Foundation of Yunnan Province); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Department of Science and Technology of Yunnan Province	This study is supported by a grant from National Natural Science Foundation of China and Yunnan Province (U1136604), a grant from Ministry of Science and Technology of China (2011CB100401), and a grant from Department of Science and Technology of Yunnan Province (2006C0006Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Becker A, 2002, MOL GENET GENOMICS, V266, P942, DOI 10.1007/s00438-001-0615-8; Bencivenga S, 2011, SEX PLANT REPROD, V24, P113, DOI 10.1007/s00497-011-0162-3; Bowles DJ, 1991, MOL PLANT PATHOLOGY; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe Pankaj, 2009, Commun Integr Biol, V2, P184; Engstrom EM, 2004, PLANT PHYSIOL, V135, P685, DOI 10.1104/pp.104.040394; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; Fujiwara Toru, 2002, Arabidopsis Book, V1, pe0020, DOI 10.1199/tab.0020; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hauser BA, 1998, GENETICS, V150, P411; Hu LF, 2011, PLANT CELL, V23, P515, DOI 10.1105/tpc.110.074369; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kelley DR, 2009, PLANT J, V57, P1054, DOI 10.1111/j.1365-313X.2008.03752.x; KIM WT, 1988, PLANT PHYSIOL, V88, P649, DOI 10.1104/pp.88.3.649; Lee D. S., 2002, International Rice Research Notes, V27, P22; Lee DS, 2003, THESIS LIB YEUNGNAM; Lee S, 2003, PLANT CELL PHYSIOL, V44, P1403, DOI 10.1093/pcp/pcg156; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Li SC, 2006, J INTEGR PLANT BIOL, V48, P307, DOI 10.1111/j.1744-7909.2006.00228.x; Liu YS, 2001, THEOR APPL GENET, V102, P1243, DOI 10.1007/s001220000520; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; Matias-Hernandez L, 2010, PLANT CELL, V22, P1702, DOI 10.1105/tpc.109.068627; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Moll C, 2008, PLANT J, V56, P913, DOI 10.1111/j.1365-313X.2008.03650.x; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nowack MK, 2010, BIOCHEM SOC T, V38, P604, DOI 10.1042/BST0380604; Nuccio ML, 1999, PLANT MOL BIOL, V39, P1153, DOI 10.1023/A:1006101404867; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Prasad K, 2010, PLANT J, V62, P203, DOI 10.1111/j.1365-313X.2010.04139.x; Raffaella B, 2008, PLANT BIOSYST, V142, P643, DOI 10.1080/11263500802411098; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sang XC, 2012, PLANT PHYSIOL, V160, P788, DOI 10.1104/pp.112.200980; Souter M, 2000, J EXP BOT, V51, P971, DOI 10.1093/jexbot/51.347.971; Springer NM, 2002, PLANT PHYSIOL, V128, P1332, DOI 10.1104/pp.010742; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Vignols F, 1997, GENE, V195, P177, DOI 10.1016/S0378-1119(97)00137-6; Wang F, 2010, J INTEGRATIVE PLANT; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; XU DP, 1995, PLANT MOL BIOL, V28, P455, DOI 10.1007/BF00020394; YAMAGATA H, 1982, PLANT PHYSIOL, V70, P1094, DOI 10.1104/pp.70.4.1094; Yamaguchi T, 2006, TSW DEV EMBRYOL, V1, P99; Yang WC, 2010, ANNU REV PLANT BIOL, V61, P89, DOI 10.1146/annurev-arplant-042809-112203; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854	56	30	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58748	10.1371/journal.pone.0058748	http://dx.doi.org/10.1371/journal.pone.0058748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527017	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562100038
J	Walters, D; Stringer, S; Rolls, E				Walters, Daniel; Stringer, Simon; Rolls, Edmund			Path Integration of Head Direction: Updating a Packet of Neural Activity at the Correct Speed Using Axonal Conduction Delays	PLOS ONE			English	Article							SPATIAL VIEW CELLS; FREELY MOVING RATS; DORSAL TEGMENTAL NUCLEUS; CONTINUOUS ATTRACTOR; PRIMATE HIPPOCAMPUS; ENTORHINAL CORTEX; ANTERIOR THALAMUS; FIRING PROPERTIES; VESTIBULAR INPUT; PLACE CELLS	The head direction cell system is capable of accurately updating its current representation of head direction in the absence of visual input. This is known as the path integration of head direction. An important question is how the head direction cell system learns to perform accurate path integration of head direction. In this paper we propose a model of velocity path integration of head direction in which the natural time delay of axonal transmission between a linked continuous attractor network and competitive network acts as a timing mechanism to facilitate the correct speed of path integration. The model effectively learns a "look-up" table for the correct speed of path integration. In simulation, we show that the model is able to successfully learn two different speeds of path integration across two different axonal conduction delays, and without the need to alter any other model parameters. An implication of this model is that, by learning look-up tables for each speed of path integration, the model should exhibit a degree of robustness to damage. In simulations, we show that the speed of path integration is not significantly affected by degrading the network through removing a proportion of the cells that signal rotational velocity.	[Walters, Daniel; Stringer, Simon] Univ Oxford, Dept Expt Psychol, Oxford Ctr Theoret Neurosci & Artificial Intellig, Oxford OX1 2JD, England; [Rolls, Edmund] Oxford Ctr Computat Neurosci, Oxford, England	University of Oxford; University of Oxford	Walters, D (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford Ctr Theoret Neurosci & Artificial Intellig, Oxford OX1 2JD, England.	daniel.walters@psy.ox.ac.uk		Rolls, Edmund/0000-0003-3025-1292	Economic and Social Research Council (ESRC); Wellcome Trust	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Economic and Social Research Council (ESRC) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; [Anonymous], 1998, NEURAL NETWORKS BRAI; Bassett JP, 2001, J NEUROSCI, V21, P5740, DOI 10.1523/JNEUROSCI.21-15-05740.2001; Bassett JP, 2005, HEAD DIRECTION CELLS, P83; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blair HT, 1998, NEURON, V21, P1387, DOI 10.1016/S0896-6273(00)80657-1; BLAIR HT, 1995, J NEUROSCI, V15, P6260; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; CARR CE, 1990, J NEUROSCI, V10, P3227; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; GOODRIDGE JP, 1995, BEHAV NEUROSCI, V109, P49, DOI 10.1037/0735-7044.109.1.49; Goodridge JP, 1997, J NEUROSCI, V17, P9315; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahnloser RHR, 2003, NEUROSCIENCE, V120, P877, DOI 10.1016/S0306-4522(03)00201-X; Hertz JA, 2018, INTRO THEORY NEURAL; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Levine D. S., 1991, INTRO NEURAL COGNITI; MILES FA, 1979, ANNU REV PSYCHOL, V30, P327, DOI 10.1146/annurev.ps.30.020179.001551; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ranck Jr J.B., 1985, ELECT ACTIVITY ARCHI; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Robertson RG, 1998, J NEUROPHYSIOL, V79, P1145, DOI 10.1152/jn.1998.79.3.1145; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.0.CO;2-H; Rolls ET, 2006, REV NEUROSCIENCE, V17, P175; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Rolls ET, 2002, COMPUTATIONAL NEUROS; RUMELHART DE, 1985, COGNITIVE SCI, V9, P75, DOI 10.1207/s15516709cog0901_5; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sharp PE, 2001, BEHAV NEUROSCI, V115, P571, DOI 10.1037/0735-7044.115.3.571; Sharp PE, 2005, HEAD DIRECTION CELLS; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; Stackman RW, 1997, J NEUROSCI, V17, P4349; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Stackman RW, 1998, J NEUROSCI, V18, P9020; Stratton P, 2010, J COMPUT NEUROSCI, V28, P527, DOI 10.1007/s10827-010-0234-7; Stringer SM, 2006, NETWORK-COMP NEURAL, V17, P419, DOI 10.1080/09548980601004032; Stringer SM, 2005, NEUROBIOL LEARN MEM, V83, P79, DOI 10.1016/j.nlm.2004.08.003; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Stringer SN, 2002, NETWORK-COMP NEURAL, V13, P429, DOI 10.1088/0954-898X/13/4/301; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; TAUBE JS, 1990, J NEUROSCI, V10, P436; Taylor JG, 1999, BIOL CYBERN, V80, P393, DOI 10.1007/s004220050534; Walters DM, 2010, BIOL CYBERN, V103, P21, DOI 10.1007/s00422-009-0355-0	53	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58330	10.1371/journal.pone.0058330	http://dx.doi.org/10.1371/journal.pone.0058330			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526976	gold, Green Published			2022-12-25	WOS:000317562100023
J	Chaudhary, S; Polaino, S; Shakya, VPS; Idnurm, A				Chaudhary, Suman; Polaino, Silvia; Shakya, Viplendra P. S.; Idnurm, Alexander			A New Genetic Linkage Map of the Zygomycete Fungus Phycomyces blakesleeanus	PLOS ONE			English	Article							ABNORMAL PHOTOTROPISM; CAROTENE BIOSYNTHESIS; MUTANTS; SEX; RECOMBINATION; EVOLUTION; CHROMOSOMES; MEIOSIS; LIGHT; PHOTORECEPTOR	Phycomyces blakesleeanus is a member of the subphylum Mucoromycotina. A genetic map was constructed from 121 progeny of a cross between two wild type isolates of P. blakesleeanus with 134 markers. The markers were mostly PCR-RFLPs. Markers were located on 46 scaffolds of the genome sequence, covering more than 97% of the genome. Analysis of the alleles in the progeny revealed nine or 12 linkage groups, depending on the log of the odds (LOD) score, across 1583.4 cM at LOD 5. The linkage groups were overlaid on previous mapping data from crosses between mutants, aided by new identification of the mutations in primary metabolism mutant strains. The molecular marker map, the phenotype map and the genome sequence are overall congruent, with some exceptions. The new genetic map provides a genome-wide estimate for recombination, with the average of 33.2 kb per cM. This frequency is one piece of evidence for meiosis during zygospore development in Mucoromycotina species. At the same time as meiosis, transmission of non-recombinant chromosomes is also evident in the mating process in Phycomyces. The new map provides scaffold ordering for the genome sequence and a platform upon which to identify the genes in mutants that are affected in traits of interest, such as carotene biosynthesis, phototropism or gravitropism, using positional cloning.	[Chaudhary, Suman; Polaino, Silvia; Shakya, Viplendra P. S.; Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, KS USA	University of Missouri System; University of Missouri Kansas City	Idnurm, A (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, KS USA.	idnurma@umkc.edu	Shakya, Viplendra P.S/N-7755-2017; Idnurm, Alexander/GPX-9055-2022; Idnurm, Alexander/K-8558-2013; Idnurm, Alexander/AAC-9614-2019	Shakya, Viplendra P.S/0000-0001-6429-8692; Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040; 	University of Missouri - Kansas City Women's Council; UMKC Faculty research grant; National Science Foundation [MCB-0920581]	University of Missouri - Kansas City Women's Council; UMKC Faculty research grant; National Science Foundation(National Science Foundation (NSF))	This research was funded by University of Missouri - Kansas City Women's Council fellowships, a UMKC Faculty research grant and a National Science Foundation grant (MCB-0920581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH GC, 1976, INTRO HIST MYCOLOGY; ALVAREZ MI, 1983, MOL GEN GENET, V191, P507, DOI 10.1007/BF00425770; ALVAREZ MI, 1983, GENETICS, V105, P873; ALVAREZ MI, 1980, MOL GEN GENET, V179, P447, DOI 10.1007/BF00425475; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; BERGMAN K, 1969, BACTERIOL REV, V33, P99, DOI 10.1128/MMBR.33.1.99-157.1969; BERGMAN K, 1973, MOL GEN GENET, V123, P1, DOI 10.1007/BF00282984; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blakeslee A. F., 1906, ANN MYCOL, V4, P1; Blakeslee AF, 1904, P AM ACAD ARTS SCI, V40, P205, DOI DOI 10.2307/20021962; Burgeff H, 1924, BOT ABH, V4, P5; Burgeff H, 1928, Z VEREBUNGSL, V49, P26; CAMPUZANO V, 1995, CURR GENET, V27, P524, DOI 10.1007/BF00314442; CAMPUZANO V, 1993, CURR GENET, V24, P515, DOI 10.1007/BF00351715; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Cerda-Olmedo E, 2001, FEMS MICROBIOL REV, V25, P503; Cerda -Olmedo E, 1987, PHYCOMYCES; CERDAOLMEDO E, 1975, GENET RES, V25, P285, DOI 10.1017/S0016672300015718; CORROCHANO LM, 1992, TRENDS GENET, V8, P268, DOI 10.1016/0168-9525(92)90252-Y; DIAZMINGUEZ JM, 1990, MOL GEN GENET, V224, P269, DOI 10.1007/BF00271561; Ehrenberg CG, 1820, VERHANDL GES NATURF, VI, P98; Eslava A.P., 1996, FUNGAL GENETICS PRIN, P385; ESLAVA AP, 1976, MOL GEN GENET, V147, P235, DOI 10.1007/BF00582874; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; GAUGER W, 1980, EXP MYCOL, V4, P56; GAUGER WL, 1977, J GEN MICROBIOL, V101, P211, DOI 10.1099/00221287-101-2-211; Gola S, 2003, CURR GENET, V42, P276, DOI 10.1007/s00294-002-0353-4; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Idnurm A, 2011, EUKARYOT CELL, V10, P1485, DOI 10.1128/EC.05149-11; JAMES FR, 1982, MYCOLOGIA, V74, P744, DOI 10.2307/3792860; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; KIRK PM, 2001, DICT FUNGI; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; Larson EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011605; Lee J, 2008, APPL ENVIRON MICROB, V74, P2349, DOI 10.1128/AEM.01866-07; LIPSON ED, 1980, MOL GEN GENET, V179, P155, DOI 10.1007/BF00268458; LOPEZDIAZ I, 1983, MOL GEN GENET, V190, P318, DOI 10.1007/BF00330658; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Medina HR, 2011, MOL MICROBIOL, V82, P199, DOI 10.1111/j.1365-2958.2011.07805.x; Mehta BJ, 2001, GENETICS, V158, P635; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; Ooijen JW, 2001, JOINMAP 3 0 SOFTWARE; Ootaki T, 1993, GENETIC NOMENCLATURE; OREJAS M, 1987, MOL GEN GENET, V210, P69, DOI 10.1007/BF00337760; Pomraning KR, 2011, EUKARYOT CELL, V10, P724, DOI 10.1128/EC.00016-11; REVUELTA JL, 1983, MOL GEN GENET, V192, P225, DOI 10.1007/BF00327670; RONCERO MIG, 1982, CURR GENET, V5, P5, DOI 10.1007/BF00445733; Sanz C, 2002, EUR J BIOCHEM, V269, P902, DOI 10.1046/j.0014-2956.2001.02724.x; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; Schimek C, 2009, PHYTOCHEMISTRY, V70, P1867, DOI 10.1016/j.phytochem.2009.07.014; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Tagua VG, 2012, FUNGAL GENET BIOL, V49, P398, DOI 10.1016/j.fgb.2012.03.002; WILLER M, 1995, MOL CELL BIOL, V15, P4964	60	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58931	10.1371/journal.pone.0058931	http://dx.doi.org/10.1371/journal.pone.0058931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516579	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400078
J	Samaranayake, D; Atencio, D; Morse, R; Wade, JT; Chaturvedi, V; Hanes, SD				Samaranayake, Dhanushki; Atencio, David; Morse, Randall; Wade, Joseph T.; Chaturvedi, Vishnu; Hanes, Steven D.			Role of Ess1 in Growth, Morphogenetic Switching, and RNA Polymerase II Transcription in Candida albicans	PLOS ONE			English	Article							COMBINATION ANTIFUNGAL THERAPY; BLOOD-STREAM INFECTIONS; SELECTABLE MARKER URA3; PROLYL-ISOMERASE; FUNGAL-INFECTIONS; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; NONCODING RNAS; AMPHOTERICIN-B; GUIDE SNORNAS	Candida albicans is a fungal pathogen that causes potentially fatal infections among immune-compromised individuals. The emergence of drug resistant C. albicans strains makes it important to identify new antifungal drug targets. Among potential targets are enzymes known as peptidyl-prolyl cis/trans isomerases (PPIases) that catalyze isomerization of peptide bonds preceding proline. We are investigating a PPIase called Ess1, which is conserved in all major human pathogenic fungi. Previously, we reported that C. albicans Ess1 is essential for growth and morphogenetic switching. In the present study, we re-evaluated these findings using more rigorous genetic analyses, including the use of additional CaESS1 mutant alleles, distinct marker genes, and the engineering of suitably-matched isogenic control strains. The results confirm that CaEss1 is essential for growth in C. albicans, but show that reduction of CaESS1 gene dosage by half (delta/+) does not interfere with morphogenetic switching. However, further reduction of CaEss1 levels using a conditional allele does reduce morphogenetic switching. We also examine the role of the linker alpha-helix that distinguishes C. albicans Ess1 from the human Pin1 enzyme, and present results of a genome-wide transcriptome analysis. The latter analysis indicates that CaEss1 has a conserved role in regulation of RNA polymerase II function, and is required for efficient termination of small nucleolar RNAs and repression of cryptic transcription in C. albicans.	[Samaranayake, Dhanushki; Morse, Randall; Wade, Joseph T.; Chaturvedi, Vishnu; Hanes, Steven D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA; [Samaranayake, Dhanushki; Morse, Randall; Wade, Joseph T.] NY State Dept Hlth, Div Genet, Wadsworth Ctr, Albany, NY USA; [Chaturvedi, Vishnu] NY State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY USA; [Hanes, Steven D.] NY State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Atencio, David; Hanes, Steven D.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; Wadsworth Center; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Hanes, SD (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.	haness@upstate.edu		Chaturvedi, Vishnu/0000-0002-3922-9676; Wade, Joseph/0000-0002-9779-3160; Morse, Randall/0000-0003-0000-8718	NIH [R01-GM55108-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by an NIH grant (R01-GM55108-13) to S.D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00115; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Bastidas RJ, 2008, CURR OPIN INVEST DR, V9, P856; Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Casalinuovo I A, 2004, Eur Rev Med Pharmacol Sci, V8, P69; Cassone A, 2012, AIDS, V26, P1457, DOI 10.1097/QAD.0b013e3283536ba8; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; Cruz MC, 1999, MOL CELL BIOL, V19, P4101; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; De Rosa FG, 2009, MINERVA ANESTESIOL, V75, P453; Del Pozo JL, 2011, INT J ARTIF ORGANS, V34, P766, DOI 10.5301/ijao.5000023; Derkx PMF, 2001, MOL GENET GENOMICS, V266, P527, DOI 10.1007/s004380100586; Devasahayam G, 2002, GENETICS, V160, P37; Edlich E, 2006, HANDB EXP PHARM, V172, P359; Epstein JB, 2003, ORAL SURG ORAL MED O, V96, P154, DOI 10.1016/S1079-2104(03)00296-8; FONZI WA, 1993, GENETICS, V134, P717; Fridkin SK, 2006, PEDIATRICS, V117, P1680, DOI 10.1542/peds.2005-1996; Garbati MA, 2012, INT J INFECT DIS, V16, pE76, DOI 10.1016/j.ijid.2011.10.004; Gemmill TR, 2005, J BIOL CHEM, V280, P15510, DOI 10.1074/jbc.M412172200; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; HANI J, 1995, FEBS LETT, V365, P198, DOI 10.1016/0014-5793(95)00471-K; Huang M, 2012, FEMS MICRO LET; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jain A, 2010, J PHARM BIOALLIED SC, V2, P314, DOI 10.4103/0975-7406.72131; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Joseph JD, 2004, J BIOL CHEM, V279, P32373, DOI 10.1074/jbc.M405415200; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Klinke T, 2008, FEMS YEAST RES, V8, P858, DOI 10.1111/j.1567-1364.2008.00411.x; Kontoyiannis DP, 2004, BRIT J HAEMATOL, V126, P165, DOI 10.1111/j.1365-2141.2004.05007.x; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2005, BIOCHEMISTRY-US, V44, P6180, DOI 10.1021/bi050115l; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; LLOYD AT, 1992, NUCLEIC ACIDS RES, V20, P5289, DOI 10.1093/nar/20.20.5289; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lu KP, 1996, NATURE, V380, P544; Ma Z, 2012, MOL CELL BIOL, V32, P3594, DOI 10.1128/MCB.00672-12; Magee PT, 2003, INFECT IMMUN, V71, P2299, DOI 10.1128/IAI.71.5.2299-2309.2003; Mahboubi M, 2010, PHYTOMEDICINE, V17, P771, DOI 10.1016/j.phymed.2010.01.016; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; McNaughton L, 2010, BBA-PROTEINS PROTEOM, V1804, P1537, DOI 10.1016/j.bbapap.2010.03.005; Mean M, 2008, CRIT CARE, V12, DOI 10.1186/cc6212; Mitrovich QM, 2010, SCIENCE, V330, P838, DOI 10.1126/science.1194554; Moreno I, 2010, YEAST, V27, P77, DOI 10.1002/yea.1733; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; Muller FMC, 1999, EUR J PEDIATR, V158, P187, DOI 10.1007/PL00014357; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; ODDS FC, 1994, J MED VET MYCOL, V32, P1; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Pitman SK, 2011, EXPERT OPIN EMERGING; Porta A, 1999, J BACTERIOL, V181, P7516, DOI 10.1128/JB.181.24.7516-7523.1999; Ramon AM, 2003, EUKARYOT CELL, V2, P718, DOI 10.1128/EC.2.4.718-728.2003; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ren P, 2005, MICROBIOL-SGM, V151, P1593, DOI 10.1099/mic.0.27786-0; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; Schattner P, 2004, NUCLEIC ACIDS RES, V32, P4281, DOI 10.1093/nar/gkh768; Schelenz S, 2011, J ORAL PATHOL MED, V40, P83, DOI 10.1111/j.1600-0714.2010.00937.x; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Schiene-Fischer C, 2012, TOPICS CURR CHE 0520; Schmid J, 2011, J CLIN MICROBIOL, V49, P3250, DOI 10.1128/JCM.00941-11; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; SHERMAN F, 1991, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh N, 2004, TRANSPLANTATION, V77, P795, DOI 10.1097/01.TP.0000117252.75651.D6; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Sundstrom P, 2002, INFECT IMMUN, V70, P3281, DOI 10.1128/IAI.70.6.3281-3283.2002; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; Vazquez JA, 2003, MED MYCOL, V41, P355, DOI 10.1080/13693780310001616528; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wellington M, 2005, YEAST, V22, P57, DOI 10.1002/yea.1191; Wilcox CB, 2004, GENETICS, V167, P93, DOI 10.1534/genetics.167.1.93; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yang YL, 2011, MED MYCOL, V49, P103, DOI 10.3109/13693786.2010.487076; Yu CL, 2006, J BIOL CHEM, V281, P9755, DOI 10.1074/jbc.M513178200	88	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59094	10.1371/journal.pone.0059094	http://dx.doi.org/10.1371/journal.pone.0059094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516603	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400092
J	Duan, J; Jiang, W; Cheng, ZY; Heikkila, JJ; Glick, BR				Duan, Jin; Jiang, Wei; Cheng, Zhenyu; Heikkila, John J.; Glick, Bernard R.			The Complete Genome Sequence of the Plant Growth-Promoting Bacterium Pseudomonas sp UW4	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; III SECRETION SYSTEM; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DEAMINASE; CHROMATE RESISTANCE DETERMINANT; ACC DEAMINASE; TRANSGENIC CANOLA; ESCHERICHIA-COLI; COMB-NOV; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE	The plant growth-promoting bacterium (PGPB) Pseudomonas sp. UW4, previously isolated from the rhizosphere of common reeds growing on the campus of the University of Waterloo, promotes plant growth in the presence of different environmental stresses, such as flooding, high concentrations of salt, cold, heavy metals, drought and phytopathogens. In this work, the genome sequence of UW4 was obtained by pyrosequencing and the gaps between the contigs were closed by directed PCR. The P. sp. UW4 genome contains a single circular chromosome that is 6,183,388 bp with a 60.05% G+C content. The bacterial genome contains 5,423 predicted protein-coding sequences that occupy 87.2% of the genome. Nineteen genomic islands (GIs) were predicted and thirty one complete putative insertion sequences were identified. Genes potentially involved in plant growth promotion such as indole-3-acetic acid (IAA) biosynthesis, trehalose production, siderophore production, acetoin synthesis, and phosphate solubilization were determined. Moreover, genes that contribute to the environmental fitness of UW4 were also observed including genes responsible for heavy metal resistance such as nickel, copper, cadmium, zinc, molybdate, cobalt, arsenate, and chromate. Whole-genome comparison with other completely sequenced Pseudomonas strains and phylogeny of four concatenated "housekeeping" genes (16S rRNA, gyrB, rpoB and rpoD) of 128 Pseudomonas strains revealed that UW4 belongs to the fluorescens group, jessenii subgroup.	[Duan, Jin; Jiang, Wei; Cheng, Zhenyu; Heikkila, John J.; Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Duan, J (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	jduan@uwaterloo.ca		Cheng, Zhenyu/0000-0002-7240-9126	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adaikkalam V, 2005, CAN J MICROBIOL, V51, P209, DOI 10.1139/W04-135; Adaikkalam V, 2002, MICROBIOL-SGM, V148, P2857, DOI 10.1099/00221287-148-9-2857; Alvarez AH, 1999, J BACTERIOL, V181, P7398, DOI 10.1128/JB.181.23.7398-7400.1999; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Brown GR, 2001, INT J SYST EVOL MICR, V51, P67, DOI 10.1099/00207713-51-1-67; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Caballero A, 2005, J BACTERIOL, V187, P396, DOI 10.1128/JB.187.1.396-399.2005; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canovas D, 2003, ENVIRON MICROBIOL, V5, P1242, DOI 10.1046/j.1462-2920.2003.00463.x; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; CERVANTES C, 1990, J BACTERIOL, V172, P287, DOI 10.1128/JB.172.1.287-291.1990; CHAMBERS LA, 1971, ARCH MIKROBIOL, V77, P165, DOI 10.1007/BF00408609; Cheng ZY, 2008, CAN J MICROBIOL, V54, P128, DOI 10.1139/w07-128; Cheng ZY, 2007, CAN J MICROBIOL, V53, P912, DOI 10.1139/W07-050; Cheng ZY, 2012, APPL SOIL ECOL, V61, P255, DOI 10.1016/j.apsoil.2011.10.006; Cheng ZY, 2009, PROTEOMICS, V9, P4271, DOI 10.1002/pmic.200900142; Cheng ZY, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-18; Cheng ZY, 2009, MOL PLANT MICROBE IN, V22, P686, DOI 10.1094/MPMI-22-6-0686; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Coenye T, 2001, INT J SYST EVOL MICR, V51, P183, DOI 10.1099/00207713-51-1-183; Cusano AM, 2011, ENV MICROBIOL REP, V3, P203, DOI 10.1111/j.1758-2229.2010.00209.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Denner EBM, 1999, INT J SYST BACTERIOL, V49, P1103, DOI 10.1099/00207713-49-3-1103; Drummond A., 2011, GENEIOUS V5 5; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Dutta D, 2007, INT J SYST EVOL MICR, V57, P353, DOI 10.1099/ijs.0.64638-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farwell AJ, 2007, ENVIRON POLLUT, V147, P540, DOI 10.1016/j.envpol.2006.10.014; Farwell AJ, 2006, PLANT SOIL, V288, P309, DOI 10.1007/s11104-006-9119-y; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; FUJITA MQ, 1989, MOL GEN GENET, V215, P381, DOI 10.1007/BF00427033; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gebhard S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-254; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICK BR, 1995, CAN J MICROBIOL, V41, P533, DOI 10.1139/m95-070; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P11, DOI 10.1016/S0981-9428(00)01212-2; Grichko VP, 2000, J BIOTECHNOL, V81, P45, DOI 10.1016/S0168-1656(00)00270-4; Grichko VP, 2000, CAN J MICROBIOL, V46, P1159, DOI 10.1139/cjm-46-12-1159; Grimes DJ, 1997, INT J SYST BACTERIOL, V47, P19, DOI 10.1099/00207713-47-1-19; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo WB, 2011, J BACTERIOL, V193, P3413, DOI 10.1128/JB.05068-11; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; GUTIERREZ JC, 1995, MOL MICROBIOL, V18, P579, DOI 10.1111/j.1365-2958.1995.mmi_18030579.x; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hao XL, 2012, J BACTERIOL, V194, P736, DOI 10.1128/JB.06475-11; Hao YU, 2007, CAN J MICROBIOL, V53, P1291, DOI 10.1139/W07-099; He MY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-221; Hemmerich C, 2010, BIOINFORMATICS, V26, P1122, DOI 10.1093/bioinformatics/btq090; Hilario E, 2004, ANTON LEEUW INT J G, V86, P51, DOI 10.1023/B:ANTO.0000024910.57117.16; Holt J., 1994, BERGEYS MANUAL DETER; Hontzeas N, 2005, APPL ENVIRON MICROB, V71, P7556, DOI 10.1128/AEM.71.11.7556-7558.2005; HRYNIEWICZ MM, 1991, J BACTERIOL, V173, P5876, DOI 10.1128/jb.173.18.5876-5886.1991; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jimenez JI, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P425; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; JOHNSON JL, 1989, INT J SYST BACTERIOL, V39, P230, DOI 10.1099/00207713-39-3-230; JUKES T H, 1969, P21; Kampfer P, 2008, INT J SYST EVOL MICR, V58, P136, DOI 10.1099/ijs.0.65450-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kertesz MA, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P323; Kimbrel JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-522; Kloda A, 2008, INT J BIOCHEM CELL B, V40, P164, DOI 10.1016/j.biocel.2007.02.003; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lamont IL, 2006, J BACTERIOL, V188, P3149, DOI 10.1128/JB.188.8.3149-3152.2006; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li JP, 2001, CAN J MICROBIOL, V47, P359, DOI 10.1139/cjm-47-4-359; Li JP, 2000, CURR MICROBIOL, V41, P101, DOI 10.1007/s002840010101; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin Y, 2011, J BIOL CHEM, V286, P27225, DOI 10.1074/jbc.M111.265116; Matilla MA, 2011, J BACTERIOL, V193, P1290, DOI 10.1128/JB.01281-10; Mavrodi DV, 2011, J BACTERIOL, V193, P177, DOI 10.1128/JB.00895-10; Mazurier S, 2004, FEMS MICROBIOL ECOL, V49, P455, DOI 10.1016/j.femsec.2004.04.019; McMorran BJ, 2001, MICROBIOL-SGM, V147, P1517, DOI 10.1099/00221287-147-6-1517; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Molina MA, 2006, ENVIRON MICROBIOL, V8, P639, DOI 10.1111/j.1462-2920.2005.00940.x; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nie L, 2002, PLANT PHYSIOL BIOCH, V40, P355, DOI 10.1016/S0981-9428(02)01375-X; NIES A, 1990, J BIOL CHEM, V265, P5648; Ortet P, 2011, J BACTERIOL, V193, P3146, DOI 10.1128/JB.00411-11; OSTROWSKI J, 1990, J BACTERIOL, V172, P779, DOI 10.1128/jb.172.2.779-785.1990; OSTROWSKI J, 1989, J BACTERIOL, V171, P130, DOI 10.1128/jb.171.1.130-140.1989; OUZOUNIS C, 1991, FEBS LETT, V279, P73, DOI 10.1016/0014-5793(91)80254-Z; PALLERONI NJ, 1993, INT J SYST BACTERIOL, V43, P606, DOI 10.1099/00207713-43-3-606; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Peconek J, 2006, INT J SYST EVOL MICR, V56, P1953, DOI 10.1099/ijs.0.64355-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Peix A, 2007, INT J SYST EVOL MICR, V57, P1286, DOI 10.1099/ijs.0.64621-0; Peix A, 2009, INFECT GENET EVOL, V9, P1132, DOI 10.1016/j.meegid.2009.08.001; Pilsyk S, 2009, ACTA BIOCHIM POL, V56, P375; Pimentel BE, 2002, FEMS MICROBIOL LETT, V212, P249, DOI 10.1111/j.1574-6968.2002.tb11274.x; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Preston GM, 2001, MOL MICROBIOL, V41, P999, DOI 10.1046/j.1365-2958.2001.02560.x; Prieto M, 2007, PSEUDOMONAS MODEL SY, P397, DOI [10.1007/978-1-4020-6097-7_14, DOI 10.1007/978-1-4020-6097-7_14]; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Quadroni M, 1999, EUR J BIOCHEM, V266, P986, DOI 10.1046/j.1432-1327.1999.00941.x; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Rezzonico F, 2005, MOL PLANT MICROBE IN, V18, P991, DOI 10.1094/MPMI-18-0991; Rezzonico F, 2004, APPL ENVIRON MICROB, V70, P5119, DOI 10.1128/AEM.70.9.5119-5131.2004; Rivas R, 2007, INT J SYST EVOL MICR, V57, P1331, DOI 10.1099/ijs.0.64912-0; Robison MM, 2001, MOL PLANT PATHOL, V2, P135, DOI 10.1046/j.1364-3703.2001.00060.x; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rodriguez-Salazar J, 2009, FEMS MICROBIOL LETT, V296, P52, DOI 10.1111/j.1574-6968.2009.01614.x; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Saleh SS, 2001, CAN J MICROBIOL, V47, P698, DOI 10.1139/cjm-47-8-698; Satomi M, 2002, INT J SYST EVOL MICR, V52, P739, DOI [10.1099/ijs.0.01427-0, 10.1099/00207713-52-3-739]; SEGERS P, 1994, INT J SYST BACTERIOL, V44, P499, DOI 10.1099/00207713-44-3-499; Self WT, 2001, RES MICROBIOL, V152, P311, DOI 10.1016/S0923-2508(01)01202-5; Shah S, 1998, CAN J MICROBIOL, V44, P833, DOI 10.1139/cjm-44-9-833; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; Stearns JC, 2005, PLANT PHYSIOL BIOCH, V43, P701, DOI 10.1016/j.plaphy.2005.05.010; Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Tate R, 1997, J BACTERIOL, V179, P7343, DOI 10.1128/jb.179.23.7343-7350.1997; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THIARA AS, 1988, EMBO J, V7, P2255, DOI 10.1002/j.1460-2075.1988.tb03065.x; THIARA AS, 1993, MOL MICROBIOL, V8, P495, DOI 10.1111/j.1365-2958.1993.tb01593.x; THIARA AS, 1989, GENE, V81, P65, DOI 10.1016/0378-1119(89)90337-5; Toklikishvili N, 2010, PLANT PATHOL, V59, P1023, DOI 10.1111/j.1365-3059.2010.02326.x; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Valverde A, 2006, INT J SYST EVOL MICR, V56, P2631, DOI 10.1099/ijs.0.64402-0; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Viollet A, 2011, FEMS MICROBIOL ECOL, V75, P457, DOI 10.1111/j.1574-6941.2010.01021.x; Viti C, 2009, MICROBIOL-SGM, V155, P95, DOI 10.1099/mic.0.021873-0; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang CX, 2000, CAN J MICROBIOL, V46, P898, DOI 10.1139/cjm-46-10-898; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wilhelm S, 2007, J BACTERIOL, V189, P6695, DOI 10.1128/JB.00023-07; WILLEMS A, 1992, INT J SYST BACTERIOL, V42, P107, DOI 10.1099/00207713-42-1-107; WILLEMS A, 1990, INT J SYST BACTERIOL, V40, P384, DOI 10.1099/00207713-40-4-384; Wink J, 2003, INT J SYST EVOL MICR, V53, P721, DOI 10.1099/ijs.0.02286-0; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039; YEE TW, 1990, P NATL ACAD SCI USA, V87, P1278, DOI 10.1073/pnas.87.4.1278; Yeramian E, 1999, RES MICROBIOL, V150, P745, DOI 10.1016/S0923-2508(99)00118-7; Yu H, 2011, J BACTERIOL, V193, P5541, DOI 10.1128/JB.05663-11; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zurdo-Pineiro JL, 2007, INT J SYST EVOL MICR, V57, P784, DOI 10.1099/ijs.0.64613-0; ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940	179	239	245	4	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58640	10.1371/journal.pone.0058640	http://dx.doi.org/10.1371/journal.pone.0058640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516524	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200099
J	Golle, J; Lisibach, S; Mast, FW; Lobmaier, JS				Golle, Jessika; Lisibach, Stephanie; Mast, Fred W.; Lobmaier, Janek S.			Sweet Puppies and Cute Babies: Perceptual Adaptation to Babyfacedness Transfers across Species	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; INFANT ATTRACTIVENESS; PERCEIVED CUTENESS; FACE ADAPTATION; EXPRESSION; LOOKING; ADULT; LEVEL; SHAPE; ME	Infant faces are very salient stimuli. The Kindchenschema describes specific features that characterize a cute infant face. In this study we used a visual adaptation paradigm to investigate the universality of the perceptual properties of the Kindchenschema. In Experiment 1, twenty-four participants adapted to cute and less cute human infant faces and in Experiment 2, twenty-four new participants adapted to cute and less cute faces of puppy dogs. In both experiments the task was to assess the cuteness of subsequently presented human infant faces. The results revealed cuteness after-effects for human infant faces in both adaptation conditions, suggesting a common mechanism coding cuteness in human and non-human faces. This study provides experimental evidence for the universality of the well-described concept of the Kindchenschema.	[Golle, Jessika; Lisibach, Stephanie; Mast, Fred W.; Lobmaier, Janek S.] Univ Bern, Dept Psychol, Bern, Switzerland; [Golle, Jessika; Mast, Fred W.; Lobmaier, Janek S.] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland	University of Bern; University of Bern	Lobmaier, JS (corresponding author), Univ Bern, Dept Psychol, Bern, Switzerland.	janek.lobmaier@psy.unibe.ch	Golle, Jessika/AAO-3924-2020; Mast, Fred/B-5058-2013	Mast, Fred/0000-0002-0665-4457; Lobmaier, Janek/0000-0001-8025-1616; Golle, Jessika/0000-0002-8507-7079	Pro*Doc program of the Swiss National Science Foundation [PDFMP1_127238]; Swiss National Science Foundation [PZ00P1_121622/1]	Pro*Doc program of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Jessika Golle was supported by a grant from the Pro*Doc program of the Swiss National Science Foundation awarded to Fred W. Mast (PDFMP1_127238). Janek S. Lobmaier was supported by the Swiss National Science Foundation (grant number PZ00P1_121622/1, www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; BERRY DS, 1985, J PERS SOC PSYCHOL, V48, P312, DOI 10.1037/0022-3514.48.2.312; BROOKS V., 1960, PERCEPT AND MOT SKILLS, V11, P205; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; HILDEBRANDT KA, 1979, INFANT BEHAV DEV, V2, P329, DOI 10.1016/S0163-6383(79)80043-0; Hrdy SB., 1999, ANIM BEHAV, DOI DOI 10.1006/ANBE.1999.1378; Huckstedt B, 1965, Z EXP ANGEW PSYCHOL, V12, P421; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Jenkins R, 2006, PSYCHOL SCI, V17, P506, DOI 10.1111/j.1467-9280.2006.01736.x; Kloth N, 2008, J VISION, V8, DOI 10.1167/8.11.4; LANGLOIS JH, 1995, DEV PSYCHOL, V31, P464, DOI 10.1037/0012-1649.31.3.464; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Little AC, 2008, COGNITION, V106, P1537, DOI 10.1016/j.cognition.2007.06.008; Little AC, 2012, ETHOLOGY, V118, P775, DOI 10.1111/j.1439-0310.2012.02068.x; Lorenz K, 1943, Z TIERPSYCHOL, V5, P94; MCKELVIE SJ, 1993, J SOC BEHAV PERS, V8, P297; Nittono H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046362; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G, 2005, FITTING MIND WORLD A; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038387; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2007, NEUROREPORT, V18, P693, DOI 10.1097/WNR.0b013e3280c1e2d2; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wade N., 2005, FITTING MIND WORLD A, P83; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	33	33	35	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58248	10.1371/journal.pone.0058248	http://dx.doi.org/10.1371/journal.pone.0058248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516453	Green Published, gold			2022-12-25	WOS:000316849200046
J	Kidane, YH; Lawrence, C; Murali, TM				Kidane, Yared H.; Lawrence, Christopher; Murali, T. M.			The Landscape of Host Transcriptional Response Programs Commonly Perturbed by Bacterial Pathogens: Towards Host-Oriented Broad-Spectrum Drug Targets	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; EHRLICHIA-CHAFFEENSIS; ANAPLASMA-PHAGOCYTOPHILUM; YERSINIA-ENTEROCOLITICA; CHOLESTEROL; INFECTION; PROFILES; THERAPY; CANCER	Background: The emergence of drug-resistant pathogen strains and new infectious agents pose major challenges to public health. A promising approach to combat these problems is to target the host's genes or proteins, especially to discover targets that are effective against multiple pathogens, i.e., host-oriented broad-spectrum (HOBS) drug targets. An important first step in the discovery of such drug targets is the identification of host responses that are commonly perturbed by multiple pathogens. Results: In this paper, we present a methodology to identify common host responses elicited by multiple pathogens. First, we identified host responses perturbed by each pathogen using a gene set enrichment analysis of publicly available genome-wide transcriptional datasets. Then, we used biclustering to identify groups of host pathways and biological processes that were perturbed only by a subset of the analyzed pathogens. Finally, we tested the enrichment of each bicluster in human genes that are known drug targets, on the basis of which we elicited putative HOBS targets for specific groups of bacterial pathogens. We identified 84 up-regulated and three down-regulated statistically significant biclusters. Each bicluster contained a group of pathogens that commonly dysregulated a group of biological processes. We validated our approach by checking whether these biclusters correspond to known hallmarks of bacterial infection. Indeed, these biclusters contained biological process such as inflammation, activation of dendritic cells, pro- and anti- apoptotic responses and other innate immune responses. Next, we identified biclusters containing pathogens that infected the same tissue. After a literature-based analysis of the drug targets contained in these biclusters, we suggested new uses of the drugs Anakinra, Etanercept, and Infliximab for gastrointestinal pathogens Yersinia enterocolitica, Helicobacter pylori kx2 strain, and enterohemorrhagic Escherichia coli and the drug Simvastatin for hematopoietic pathogen Ehrlichia chaffeensis. Conclusions: Using a combination of automated analysis of host-response gene expression data and manual study of the literature, we have been able to suggest host-oriented treatments for specific bacterial infections. The analyses and suggestions made in this study may be utilized to generate concrete hypothesis on which gene sets to probe further in the quest for HOBS drug targets for bacterial infections. All our results are available at the following supplementary website: http://bioinformatics.cs.vt.edu/ murali/supplements/2013-kidane-plos-one	[Kidane, Yared H.] Virginia Tech, Genet Bioinformat & Computat Biol PhD Program, Blacksburg, VA USA; [Lawrence, Christopher] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Lawrence, Christopher] Virginia Tech, Dept Biol, Blacksburg, VA USA; [Murali, T. M.] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24060 USA; [Murali, T. M.] Virginia Tech, ICTAS Ctr Syst Biol Engn Tissues, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Murali, TM (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24060 USA.	murali@cs.vt.edu			Initiative to Maximize Students Development program at Virginia Polytechnic Institute and State University; Genetics, Bioinformatics and Computational Biology program at Virginia Polytechnic Institute and State University; Southern Regional Education Board dissertation fellowship program	Initiative to Maximize Students Development program at Virginia Polytechnic Institute and State University; Genetics, Bioinformatics and Computational Biology program at Virginia Polytechnic Institute and State University; Southern Regional Education Board dissertation fellowship program	The work presented in this paper was supported by Initiative to Maximize Students Development program, Genetics, Bioinformatics and Computational Biology program at Virginia Polytechnic Institute and State University, and Southern Regional Education Board dissertation fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERCOVIER H, 1980, CURR MICROBIOL, V4, P201, DOI 10.1007/BF02605857; Berriz GF, 2008, BIOINFORMATICS, V24, P2272, DOI 10.1093/bioinformatics/btn424; Bodey GP, 1983, REV INFECT DIS, V5; Boya P, 2001, EMBO J, V20, P4325, DOI 10.1093/emboj/20.16.4325; CAMPOS LC, 1994, INFECT IMMUN, V62, P3282, DOI 10.1128/IAI.62.8.3282-3288.1994; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fauci A. S., 2005, International Journal of Risk & Safety in Medicine, V17, P157; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Gionis A, 2007, ACM T KNOWL DISCOV D, V1, p14+; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Lindstedt M, 2002, INT IMMUNOL, V14, P1203, DOI 10.1093/intimm/dxf082; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Perusse L, 2005, OBES RES, V13, P381, DOI 10.1038/oby.2005.50; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pucadyil TJ, 2007, TRENDS PARASITOL, V23, P49, DOI 10.1016/j.pt.2006.12.003; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rawlins MD, 2004, NAT REV DRUG DISCOV, V3, P360, DOI 10.1038/nrd1347; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Ritchie JM, 2003, INFECT IMMUN, V71, P7129, DOI 10.1128/IAI.71.12.7129-7139.2003; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; SAEBO A, 1994, INT J TISSUE REACT, V16, P51; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Subramanian A., 2005, P NATL ACAD SCI US; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Teshima CW, 2009, CAN J GASTROENTEROL, V23, P348, DOI 10.1155/2009/180840; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Zhang YX, 2008, CANCER RES, V68, P9519, DOI 10.1158/0008-5472.CAN-08-1549; Zhu YL, 2008, BIOINFORMATICS, V24, P2798, DOI 10.1093/bioinformatics/btn520	65	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58553	10.1371/journal.pone.0058553	http://dx.doi.org/10.1371/journal.pone.0058553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516507	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200086
J	Nivison-Smith, L; Collin, SP; Zhu, Y; Ready, S; Acosta, ML; Hunt, DM; Potter, IC; Kalloniatis, M				Nivison-Smith, Lisa; Collin, Shaun P.; Zhu, Yuan; Ready, Sarah; Acosta, Monica L.; Hunt, David M.; Potter, Ian C.; Kalloniatis, Michael			Retinal Amino Acid Neurochemistry of the Southern Hemisphere Lamprey, Geotria australis	PLOS ONE			English	Article							GABA-LIKE IMMUNOREACTIVITY; LARVAL SEA LAMPREY; TRANSPORTER KNOCKOUT MOUSE; GAMMA-AMINOBUTYRIC-ACID; MACAQUE MONKEY RETINA; GOLDFISH RETINA; BIPOLAR CELLS; GANGLION-CELLS; CAT RETINA; LAMPETRA-FLUVIATILIS	Lampreys are one of the two surviving groups of the agnathan (jawless) stages in vertebrate evolution and are thus ideal candidates for elucidating the evolution of visual systems. This study investigated the retinal amino acid neurochemistry of the southern hemisphere lamprey Geotria australis during the downstream migration of the young, recently-metamorphosed juveniles to the sea and during the upstream migration of the fully-grown and sexually-maturing adults to their spawning areas. Glutamate and taurine were distributed throughout the retina, whilst GABA and glycine were confined to neurons of the inner retina matching patterns seen in most other vertebrates. Glutamine and aspartate immunoreactivity was closely matched to Muller cell morphology. Between the migratory phases, few differences were observed in the distribution of major neurotransmitters i.e. glutamate, GABA and glycine, but changes in amino acids associated with retinal metabolism i.e. glutamine and aspartate, were evident. Taurine immunoreactivity was mostly conserved between migrant stages, consistent with its role in primary cell functions such as osmoregulation. Further investigation of glutamate signalling using the probe agmatine (AGB) to map cation channel permeability revealed entry of AGB into photoreceptors and horizontal cells followed by accumulation in inner retinal neurons. Similarities in AGB profiles between upstream and downstream migrant of G. australis confirmed the conservation of glutamate neurotransmission. Finally, calcium binding proteins, calbindin and calretinin were localized to the inner retina whilst recoverin was localized to photoreceptors. Overall, conservation of major amino acid neurotransmitters and calcium-associated proteins in the lamprey retina confirms these elements as essential features of the vertebrate visual system. On the other hand, metabolic elements of the retina such as neurotransmitter precursor amino acids and Muller cells are more sensitive to environmental changes associated with migration.	[Nivison-Smith, Lisa; Zhu, Yuan; Kalloniatis, Michael] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Collin, Shaun P.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Collin, Shaun P.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Ready, Sarah; Acosta, Monica L.; Kalloniatis, Michael] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand; [Potter, Ian C.] Murdoch Univ, Sch Biol Sci & Biotechnol, Murdoch, WA 6150, Australia; [Kalloniatis, Michael] Univ New S Wales, Ctr Eye Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; University of Western Australia; University of Western Australia; University of Queensland; University of Queensland; University of Auckland; Murdoch University; University of New South Wales Sydney	Kalloniatis, M (corresponding author), Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	m.kalloniatis@unsw.edu.au	Hunt, David M/K-6024-2012; Acosta, Monica/H-2700-2019; Collin, Shaun/K-8827-2012	Hunt, David M/0000-0002-9264-3948; Acosta, Monica/0000-0002-5018-339X; Collin, Shaun/0000-0001-6236-0771; Kalloniatis, Michael/0000-0002-5264-4639; Nivison-Smith, Lisa/0000-0001-6677-1949	National Health and Medical Research Council of Australia [1009342]; Australian Research Council; WA State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); WA State Government	This work was supported in part by research grants from the National Health and Medical Research Council of Australia National Health and Medical Research Council of Australia (number 1009342), the Australian Research Council and The WA State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDH E, 1987, HISTOCHEMISTRY, V86, P485, DOI 10.1007/BF00500621; CARLISLE DB, 1959, J MAR BIOL ASSOC UK, V38, P97, DOI 10.1017/S0025315400015629; Chen C-KJ, 2003, RECOVERIN RHODOPSIN, P101; Collin Shaun P, 2004, Clin Exp Optom, V87, P217; Collin SP, 2004, VISUAL NEUROSCI, V21, P765, DOI 10.1017/S0952523804215103; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Collin SP, 2003, VISUAL NEUROSCI, V20, P119, DOI 10.1017/S0952523803202030; Collin SP, 1999, BRAIN BEHAV EVOLUT, V54, P96, DOI 10.1159/000006616; COLLIN SP, 1993, CAN J ZOOL, V71, P34, DOI 10.1139/z93-006; Collin SP, 2000, BRAIN BEHAV EVOLUT, V55, P120, DOI 10.1159/000006647; CRESCITELLI F, 1956, J GEN PHYSIOL, V39, P423, DOI 10.1085/jgp.39.3.423; CROOKS J, 1992, J COMP NEUROL, V315, P287, DOI 10.1002/cne.903150305; DALIL N, 1990, CR ACAD SCI III-VIE, V311, P403; Dalil-Thiney N, 1998, NEUROSCI LETT, V247, P163, DOI 10.1016/S0304-3940(98)00301-2; DALILTHINEY N, 1994, J COMP NEUROL, V340, P140, DOI 10.1002/cne.903400110; DalilThiney N, 1996, NEUROSCI LETT, V207, P159, DOI 10.1016/0304-3940(96)12511-8; DAVANGER S, 1991, J COMP NEUROL, V311, P483, DOI 10.1002/cne.903110404; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Davies WL, 2007, FASEB J, V21, P2713, DOI 10.1096/fj.06-8057com; Davies WL, 2009, MOL BIOL EVOL, V26, P1803, DOI 10.1093/molbev/msp089; Dickson D.H., 1981, P43; DOWLING JE, 1978, PROC R SOC SER B-BIO, V201, P7, DOI 10.1098/rspb.1978.0030; Duke-Elder SS., 1985, SYSTEM OPHTHALMOLOGY, P453; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EHINGER B, 1988, P NATL ACAD SCI USA, V85, P8321, DOI 10.1073/pnas.85.21.8321; Einarson L, 1932, AM J PATHOL, V8, P295; Fletcher EL, 1997, J COMP NEUROL, V380, P449, DOI 10.1002/(SICI)1096-9861(19970421)380:4<449::AID-CNE3>3.0.CO;2-1; Fletcher EL, 1996, J COMP NEUROL, V376, P343; FRITZSCH B, 1990, VISUAL NEUROSCI, V4, P533, DOI 10.1017/S0952523800005745; Gill HS, 2003, PHYLOGENY LIVING PAR; GRUNERT U, 1990, J COMP NEUROL, V297, P509, DOI 10.1002/cne.902970405; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; Hardisty M. W., 1982, BIOL LAMPREYS B, V4B, P165; HAROSI FI, 1993, VISUAL NEUROSCI, V10, P711, DOI 10.1017/S0952523800005411; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; HENDRICKSON AE, 1988, J COMP NEUROL, V273, P473, DOI 10.1002/cne.902730404; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; HOLMBERG K, 1978, VISION RES, V18, P1313, DOI 10.1016/0042-6989(78)90221-3; Jiang Z, 2010, J NEUROPHYSIOL, V103, P924, DOI 10.1152/jn.00876.2009; KALLONIATIS M, 1994, VISUAL NEUROSCI, V11, P793, DOI 10.1017/S0952523800003096; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; KALLONIATIS M, 1993, J COMP NEUROL, V336, P174, DOI 10.1002/cne.903360203; Kalloniatis M, 2002, VISUAL NEUROSCI, V19, P61, DOI 10.1017/S0952523801191066; KALLONIATIS M, 1990, J COMP NEUROL, V297, P340, DOI 10.1002/cne.902970303; Kalloniatis M, 2013, CLIN EXP OPTOM, V96, P310, DOI 10.1111/cxo.12015; Kalloniatis Michael, 2002, Clin Exp Optom, V85, P27; Kao YH, 2004, J COMP NEUROL, V478, P207, DOI 10.1002/cne.20221; KOLB H, 1977, J NEUROCYTOL, V6, P155, DOI 10.1007/BF01261503; KURIYAMA K, 1990, PROG CLIN BIOL RES, V351, P29; LOMBARDINI JB, 1991, BRAIN RES REV, V16, P151, DOI 10.1016/0165-0173(91)90003-Q; LUGOGARCIA N, 1991, BRAIN RES, V564, P19, DOI 10.1016/0006-8993(91)91346-3; Marc R.E., 1985, P119; MARC RE, 1982, VISION RES, V22, P589, DOI 10.1016/0042-6989(82)90117-1; Marc RE, 1998, INVEST OPHTH VIS SCI, V39, P1694; Marc RE, 1998, INVEST OPHTH VIS SCI, V39, P1685; Marc RE, 2005, VISION RES, V45, P3454, DOI 10.1016/j.visres.2005.07.025; MARC RE, 1990, J NEUROSCI, V10, P4006, DOI 10.1523/JNEUROSCI.10-12-04006.1990; MARC RE, 1981, P NATL ACAD SCI-BIOL, V78, P7185, DOI 10.1073/pnas.78.11.7185; MARC RE, 1992, PROG BRAIN RES, V90, P61; MARC RE, 1985, J COMP NEUROL, V232, P241, DOI 10.1002/cne.902320209; MARC RE, 1995, J NEUROSCI, V15, P5106; MARC RE, 1984, NATURE, V312, P266, DOI 10.1038/312266a0; Marc RE, 1999, J COMP NEUROL, V407, P47, DOI 10.1002/(SICI)1096-9861(19990428)407:1<47::AID-CNE4>3.0.CO;2-0; Marc RE, 1999, J COMP NEUROL, V407, P65; Marc RE, 2002, J NEUROSCI, V22, P413, DOI 10.1523/JNEUROSCI.22-02-00413.2002; MARC RE, 1986, VISION RES, V26, P223, DOI 10.1016/0042-6989(86)90017-9; Marc RE, 1989, PROGR RETINAL RES, P67; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; MARTIN PR, 1992, J COMP NEUROL, V323, P269, DOI 10.1002/cne.903230210; MOSINGER JL, 1986, EXP EYE RES, V42, P631, DOI 10.1016/0014-4835(86)90052-7; Muradov H, 2008, VISION RES, V48, P2302, DOI 10.1016/j.visres.2008.07.006; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; OSBORNE NN, 1986, CELL TISSUE RES, V243, P117; PASTEELS B, 1990, VISUAL NEUROSCI, V5, P1, DOI 10.1017/S0952523800000031; PICCO C, 1993, J PHYSIOL-LONDON, V460, P741, DOI 10.1113/jphysiol.1993.sp019497; Pombal MA, 2003, BRAIN RES, V993, P154, DOI 10.1016/j.brainres.2003.09.005; POTTER I C, 1968, Proceedings of the Linnean Society of London, V179, P229; POTTER I C, 1979, Environmental Biology of Fishes, V4, P65, DOI 10.1007/BF00005929; POTTER IC, 1983, J ZOOL, V200, P1; POTTER IC, 1980, CAN J FISH AQUAT SCI, V37, P1595, DOI 10.1139/f80-207; POURCHO RG, 1987, J NEUROSCI, V7, P1189; POURCHO RG, 1985, BRAIN RES, V348, P339, DOI 10.1016/0006-8993(85)90453-6; POURCHO RG, 1989, VISUAL NEUROSCI, V2, P425, DOI 10.1017/S0952523800012323; POURCHO RG, 1985, J COMP NEUROL, V233, P473, DOI 10.1002/cne.902330406; POW DV, 1994, VISUAL NEUROSCI, V11, P1115, DOI 10.1017/S0952523800006933; Renaud CB, 1997, J APPL ICHTHYOL, V13, P143, DOI 10.1111/j.1439-0426.1997.tb00114.x; RUBINSON K, 1989, VISUAL NEUROSCI, V3, P241, DOI 10.1017/S0952523800009998; RUBINSON K, 1990, J NEUROBIOL, V21, P1123, DOI 10.1002/neu.480210715; SHERRY DM, 1992, VISUAL NEUROSCI, V9, P313, DOI 10.1017/S0952523800010725; Sun D, 2006, J COMP NEUROL, V494, P686, DOI 10.1002/cne.20813; Sun D, 2003, J COMP NEUROL, V465, P38, DOI 10.1002/cne.10830; Sun D, 2007, J COMP NEUROL, V505, P92, DOI 10.1002/cne.21478; Trexler EB, 2001, J COMP NEUROL, V437, P408, DOI 10.1002/cne.1292; Vaney DI, 1998, J NEUROSCI, V18, P10594; VERSAUXBOTTERI C, 1991, VISUAL NEUROSCI, V7, P171; Villar-Cervino V, 2006, J COMP NEUROL, V499, P810, DOI 10.1002/cne.21136; Villar-Cheda B, 2006, BRAIN RES, V1068, P118, DOI 10.1016/j.brainres.2005.11.014; VOADEN MJ, 1978, J NEUROCHEM, V31, P1069, DOI 10.1111/j.1471-4159.1978.tb00149.x; WALD G, 1946, BIOL BULL, V91, P239; WALD G, 1957, J GEN PHYSIOL, V40, P901, DOI 10.1085/jgp.40.6.901; Warskulat U, 2007, ARCH BIOCHEM BIOPHYS, V462, P202, DOI 10.1016/j.abb.2007.03.022; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; WASOWICZ M, 1993, CR ACAD SCI III-VIE, V316, P455; WASSLE H, 1989, J COMP NEUROL, V279, P43, DOI 10.1002/cne.902790105; Yan XX, 1997, ANAT EMBRYOL, V195, P51; Yang CY, 1998, VISION RES, V38, P2521, DOI 10.1016/S0042-6989(98)00100-X; YANG CY, 1994, VISUAL NEUROSCI, V11, P1193, DOI 10.1017/S0952523800006994; YAQUB A, 1991, J COMP NEUROL, V312, P584, DOI 10.1002/cne.903120409; YAZULLA S, 1990, VISUAL NEUROSCI, V4, P299, DOI 10.1017/S0952523800003424	110	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58406	10.1371/journal.pone.0058406	http://dx.doi.org/10.1371/journal.pone.0058406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516473	Green Published, gold			2022-12-25	WOS:000316849200064
J	Nguyen, TX; Jaru-Ampornpan, P; Lam, VQ; Cao, PG; Piszkiewicz, S; Hess, S; Shan, SO				Nguyen, Thang X.; Jaru-Ampornpan, Peera; Lam, Vinh Q.; Cao, Peigen; Piszkiewicz, Samantha; Hess, Sonja; Shan, Shu-ou			Mechanism of an ATP-independent Protein Disaggregase I. STRUCTURE OF A MEMBRANE PROTEIN AGGREGATE REVEALS A MECHANISM OF RECOGNITION BY ITS CHAPERONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE; CHAPERONE; BINDING; HSP104; SUBSTRATE; PROTEOSTASIS; INSIGHTS; CYTOSOL; BODIES; HSP70	Protein aggregation is detrimental to the maintenance of proper protein homeostasis in all cells. To overcome this problem, cells have evolved a network of molecular chaperones to prevent protein aggregation and even reverse existing protein aggregates. The most extensively studied disaggregase systems are ATP-driven macromolecular machines. Recently, we reported an alternative disaggregase system in which the 38-kDa subunit of chloroplast signal recognition particle (cpSRP43) efficiently reverses the aggregation of its substrates, the light-harvesting chlorophyll a/b-binding (LHC) proteins, in the absence of external energy input. To understand the molecular mechanism of this novel activity, here we used biophysical and biochemical methods to characterize the structure and nature of LHC protein aggregates. We show that LHC proteins form micellar, disc-shaped aggregates that are kinetically stable and detergent-resistant. Despite the nonamyloidal nature, the LHC aggregates have a defined global organization, displaying the chaperone recognition motif on its solvent-accessible surface. These findings suggest an attractive mechanism for recognition of the LHC aggregate by cpSRP43 and provide important constraints to define the capability of this chaperone.	[Nguyen, Thang X.; Jaru-Ampornpan, Peera; Lam, Vinh Q.; Cao, Peigen; Piszkiewicz, Samantha; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hess, Sonja] CALTECH, Beckman Inst, Div Biol, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Hess, Sonja/K-4842-2013; Cao, Peigen/F-5958-2012	Hess, Sonja/0000-0002-5904-9816; Piszkiewicz, Samantha/0000-0003-4391-776X	Betty and Gordon Moore Foundation; David and Lucile Packard Fellowship in science and engineering; Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research; Beckman Institute; United States Department of Energy [DE-FG03-01ER46175]	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Fellowship in science and engineering(The David & Lucile Packard Foundation); Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research; Beckman Institute; United States Department of Energy(United States Department of Energy (DOE))	Supported by a grant from the Betty and Gordon Moore Foundation.; Supported by the David and Lucile Packard Fellowship in science and engineering, the Henry Dreyfus Teacher-Scholar Award, and the Break-throughs in Gerontology award from the American Federation for Aging Research. To whom correspondence should be addressed: Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125. Tel.: 626-395-3879; Fax: 626-568-9430; E-mail: sshan@caltech.edu.; We thank A. N. Murray and Dr. J. W. Kelly for recrystallized ThT and fibrilized A beta<INF>1-40</INF>, A. McDowall for EM analyses, members of the Proteome Exploration Laboratory for mass spectrometry assistance, and members of the Shan group for helpful comments on the manuscript. The Proteome Exploration Laboratory is supported by the Betty and Gordon Moore Foundation and the Beckman Institute. AFM studies were supported by United States Department of Energy Grant DE-FG03-01ER46175 (to J. Heath).	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BREMS DN, 1988, P NATL ACAD SCI USA, V85, P3367, DOI 10.1073/pnas.85.10.3367; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Henry RL, 2010, NAT STRUCT MOL BIOL, V17, P676, DOI 10.1038/nsmb0610-676; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jaru-Ampornpan P, 2013, J BIOL CHEM, V288, P13431, DOI 10.1074/jbc.M113.462861; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Luheshi LM, 2009, FEBS LETT, V583, P2581, DOI 10.1016/j.febslet.2009.06.030; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; MITRAKI A, 1987, EUR J BIOCHEM, V163, P29, DOI 10.1111/j.1432-1033.1987.tb10732.x; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; ZETTLMEISSL G, 1979, BIOCHEMISTRY-US, V18, P5567, DOI 10.1021/bi00592a007	45	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13420	13430		10.1074/jbc.M113.462812	http://dx.doi.org/10.1074/jbc.M113.462812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525109	Green Published, hybrid			2022-12-25	WOS:000318850300027
J	Wald, NJ; Bestwick, JP				Wald, Nicholas J.; Bestwick, Jonathan P.			Incorporating DNA Sequencing into Current Prenatal Screening Practice for Down's Syndrome	PLOS ONE			English	Article							RISK	Background: Prenatal screening for Down's syndrome is performed using biochemical and ultrasound markers measured in early pregnancy such as the Integrated test using first and second trimester markers. Recently, DNA sequencing methods have been introduced on free DNA in maternal plasma, yielding a high screening performance. These methods are expensive and there is a test failure rate. We determined the screening performance of merging the Integrated test with the newer DNA techniques in a protocol that substantially reduces the cost compared with universal DNA testing and still achieves high screening performance with no test failures. Methods: Published data were used to model screening performance of a protocol in which all women receive the first stage of the Integrated test at about 11 weeks of pregnancy. On the basis of this higher risk women have reflex DNA testing and lower risk women as well as those with a failed DNA test complete the Integrated test at about 15 weeks. Results: The overall detection rate was 95% with a 0.1% false-positive rate if 20% of women were selected to receive DNA testing. If all women had DNA testing the detection rate would be 3 to 4 percentage points higher with a false-positive rate 30 times greater if women with failed tests were treated as positive and offered a diagnostic amniocentesis, or 3 times greater if they had a second trimester screening test (Quadruple test) and treated as positive only if this were positive. The cost per women screened would be about one-fifth, compared with universal DNA testing, if the DNA test were 20 times the cost of the Integrated test. Conclusion: The proposed screening protocol achieves a high screening performance without programme test failures and at a substantially lower cost than offering all women DNA testing.	[Wald, Nicholas J.; Bestwick, Jonathan P.] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021					Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Morris J, 2005, J MED SCREEN, V12, P202, DOI 10.1258/096914105775220679; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; Morris JK, 2003, PRENATAL DIAG, V23, P252, DOI 10.1002/pd.568; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Office for National Statistics, 2008, BIRTH STAT ENGL WAL; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Wald NJ, 2013, J MED SCREE IN PRESS; Wright C, 2011, NAT MED, V17, P250, DOI 10.1038/nm0311-250; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993	15	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58732	10.1371/journal.pone.0058732	http://dx.doi.org/10.1371/journal.pone.0058732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527014	gold, Green Published			2022-12-25	WOS:000317562600036
J	Wu, HJ; Sun, HY; Wu, W; Zhang, YH; Qin, GW; Li, GR				Wu, Hui-Jun; Sun, Hai-Ying; Wu, Wei; Zhang, Yan-Hui; Qin, Guo-Wei; Li, Gui-Rong			Properties and Molecular Determinants of the Natural Flavone Acacetin for Blocking hKv4.3 Channels	PLOS ONE			English	Article							OUTWARD POTASSIUM CURRENT; KV4.3 K+ CHANNEL; J WAVE SYNDROMES; VENTRICULAR MYOCYTES; BRUGADA-SYNDROME; CHLORIDE CURRENT; ATRIAL MYOCYTES; CELLULAR BASIS; I-TO; MECHANISMS	The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I-to) in human atrial myocytes. However, the molecular determinants of acacetin for blocking I-to are unknown. The present study was designed to investigate the properties and molecular determinants of this compound for blocking hKv4.3 channels (coding I-to) stably expressed in HEK 293 cells using the approaches of whole-cell patch voltage-clamp technique and mutagenesis. It was found that acacetin inhibited hKv4.3 current by binding to both the closed and open channels, and decreased the recovery from inactivation. The blockade of hKv4.3 channels by acacetin was use- and frequency-dependent, and IC(50)s of acacetin for inhibiting hKv4.3 were 7.9, 6.1, 3.9, and 3.2 mu M, respectively, at 0.2, 0.5, 1, and 3.3 Hz. The mutagenesis study revealed that the hKv4.3 mutants T366A and T367A in the P-loop helix, and V392A, I395A and V399A in the S6-segment had a reduced channel blocking efficacy of acacetin (IC50, 44.5 mu M for T366A, 25.8 mu M for T367A, 17.6 mu M for V392A, 16.2 mu M for I395A, and 19.1 mu M for V399A). These results demonstrate the novel information that acacetin may inhibit the closed channels and block the open state of the channels by binding to their P-loop filter helix and S6 domain. The use-and rate-dependent blocking of hKv4.3 by acacetin is likely beneficial for managing atrial fibrillation.	[Wu, Hui-Jun; Sun, Hai-Ying; Wu, Wei; Zhang, Yan-Hui; Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept & Med, Pokfulam, Hong Kong, Peoples R China; [Qin, Guo-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Hong Kong	Li, GR (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept & Med, Pokfulam, Hong Kong, Peoples R China.	grli@hkucc.hk	Li, Gui-Rong/C-4341-2009; , 李贵荣（沧海一粟）/AAZ-4335-2020; Zhang, Yanhui/L-5680-2017	, 李贵荣（沧海一粟）/0000-0002-9437-2280; Zhang, Yanhui/0000-0002-2179-2065	Sun Cheh Yeh Heart Foundation of Hong Kong; Innovation and Technology Commission of the Hong Kong SAR Government [ITS/339/09]; University of Hong Kong	Sun Cheh Yeh Heart Foundation of Hong Kong; Innovation and Technology Commission of the Hong Kong SAR Government; University of Hong Kong(University of Hong Kong)	The study was supported in part by Sun Cheh Yeh Heart Foundation of Hong Kong and a grant (ITS/339/09) from Innovation and Technology Commission of the Hong Kong SAR Government. Hui-Jun Wu, Wei Wu, and Yan-Hui Zhang were supported by a postgraduate scholarship from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2004, AM J PHYSIOL-HEART C, V286, pH602, DOI 10.1152/ajpheart.00673.2003; Antzelevitch C, 2012, CIRC J, V76, P1054, DOI 10.1253/circj.CJ-12-0284; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Ashino S, 2011, CIRC J, V75, P2080, DOI 10.1253/circj.CJ-11-0227; Belhassen B, 2004, CIRCULATION, V110, P1731, DOI 10.1161/01.CIR.0000143159.30585.90; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P603, DOI 10.1085/jgp.101.4.603; Di Diego JM, 2002, CIRCULATION, V106, P2004, DOI 10.1161/01.CIR.0000032002.22105.7A; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Giudicessi JR, 2012, HUM MUTAT, V33, P989, DOI 10.1002/humu.22058; Himmel HM, 1999, AM J PHYSIOL-HEART C, V277, pH107, DOI 10.1152/ajpheart.1999.277.1.H107; Jeong I, 2011, BRIT J PHARMACOL, V163, P510, DOI 10.1111/j.1476-5381.2011.01210.x; Li G. R., 2010, USE ACACETIN RELATED; Li GR, 2000, AM J PHYSIOL-HEART C, V279, pH130, DOI 10.1152/ajpheart.2000.279.1.H130; LI GR, 1995, AM J PHYSIOL-HEART C, V269, pH463, DOI 10.1152/ajpheart.1995.269.2.H463; Li GR, 2004, J MOL CELL CARDIOL, V36, P495, DOI 10.1016/j.yjmcc.2004.01.005; Li GR, 2003, CARDIOVASC RES, V58, P89, DOI 10.1016/S0008-6363(02)00859-3; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li GR, 2008, CIRCULATION, V117, P2449, DOI 10.1161/CIRCULATIONAHA.108.769554; LIU DW, 1993, CIRC RES, V72, P671, DOI 10.1161/01.RES.72.3.671; Lukas A, 1996, CARDIOVASC RES, V32, P593, DOI 10.1016/0008-6363(96)00115-0; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nenov NI, 1998, CIRC RES, V83, P1224, DOI 10.1161/01.RES.83.12.1224; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; SCHACKOW TE, 1995, AM J PHYSIOL-CELL PH, V268, pC1002, DOI 10.1152/ajpcell.1995.268.4.C1002; Schweizer PA, 2010, CLIN RES CARDIOL, V99, P467, DOI 10.1007/s00392-010-0145-7; Tseng GN, 1996, J PHARMACOL EXP THER, V279, P865; Varro A, 2004, CURR MED CHEM, V11, P1, DOI 10.2174/0929867043456296; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Wu HJ, 2011, J MOL CELL CARDIOL, V51, P966, DOI 10.1016/j.yjmcc.2011.08.022; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051550; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; Yang F, 2009, AM J MED, V122, P317, DOI 10.1016/j.amjmed.2008.11.019; Zhang YH, 2012, CARDIOVASC RES, V93, P424, DOI 10.1093/cvr/cvr347; Zhao ZH, 2012, CARDIOVASC RES, V95, P308, DOI 10.1093/cvr/cvs183	38	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57864	10.1371/journal.pone.0057864	http://dx.doi.org/10.1371/journal.pone.0057864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526953	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562600009
J	Roffler-Tarlov, S; Liu, JH; Naumova, EN; Bernal-Ayala, MM; Mason, CA				Roffler-Tarlov, Suzanne; Liu, Jin Hong; Naumova, Elena N.; Bernal-Ayala, Maria Margarita; Mason, Carol A.			L-Dopa and the Albino Riddle: Content of L-Dopa in the Developing Retina of Pigmented and Albino Mice	PLOS ONE			English	Article							TYROSINASE GENE; EMBRYONIC-DEVELOPMENT; TRANSGENIC MICE; CELL PRODUCTION; OPTIC CHIASM; MOUSE RETINA; EXPRESSION; HYDROXYLASE; PATTERNS; MELANIN	Background: The absence or deficiency of melanin as in albinos, has detrimental effects on retinal development that include aberrant axonal projections from eye to brain and impaired vision. In pigmented retinal pigment epithelium (RPE), dihydroxyphenalanine (L-Dopa), an intermediate in the synthetic path for melanin, has been hypothesized to regulate the tempo of neurogenesis. The time course of expression of retinal L-Dopa, whether it is harbored exclusively in the RPE, the extent of deficiency in albinos compared to isogenic controls, and whether L-Dopa can be restored if exogenously delivered to the albino have been unknown. Methodology/Principal Findings: L-Dopa and catecholamines including dopamine extracted from retinas of pigmented (C57BL/6J) and congenic albino (C57BL/6J-tyr(c2j)) mice, were measured throughout development beginning at E10.5 and at maturity. L-Dopa, but not dopamine nor any other catecholamine, appears in pigmented retina as soon as tyrosinase is expressed in RPE at E10.5. In pigmented retina, L-Dopa content increases throughout pre-and postnatal development until the end of the first postnatal month after which it declines sharply. This time course reflects the onset and completion of retinal development. L-Dopa is absent from embryonic albino retina and is greatly reduced in postnatal albino retina compared to pigmented retina. Dopamine is undetectable in both albino and pigmented retinas until after the postnatal expression of the neuronal enzyme tyrosine hydroxylase. If provided to pregnant albino mothers, L-Dopa accumulates in the RPE of the fetuses. Conclusions: L-Dopa in pigmented RPE is most abundant during development after which content declines. This L-Dopa is not converted to dopamine. L-Dopa is absent or at low levels in albino retina and can be restored to the RPE by administration in utero. These findings further implicate L-Dopa as a factor in the RPE that could influence development, and demonstrate that administration of L-Dopa could be a means to rescue developmental abnormalities characteristic of albinos.	[Roffler-Tarlov, Suzanne] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Roffler-Tarlov, Suzanne; Liu, Jin Hong; Bernal-Ayala, Maria Margarita] Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; [Naumova, Elena N.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA USA; [Mason, Carol A.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Mason, Carol A.] Columbia Univ Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Mason, Carol A.] Columbia Univ Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA	Tufts University; Tufts University; Tufts University; Columbia University; Columbia University; Columbia University	Roffler-Tarlov, S (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Suzanne.Tarlov@tufts.edu	Naumova, Elena/AAP-3395-2020	Naumova, Elena/0000-0002-9562-4734	Vision of Children Foundation;  [EY015290]; NATIONAL EYE INSTITUTE [R01EY015290, R01EY012736] Funding Source: NIH RePORTER	Vision of Children Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded by The Vision of Children Foundation and EY015290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beermann F, 2004, MAMM GENOME, V15, P749, DOI 10.1007/s00335-004-4002-8; BEERMANN F, 1992, P NATL ACAD SCI USA, V89, P2809, DOI 10.1073/pnas.89.7.2809; CREEL DJ, 1990, OPHTHALMIC PAED GEN, V11, P193, DOI 10.3109/13816819009020979; Cronin CA, 2003, J NEUROSCI, V23, P11692; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Eisenhofer G, 2003, FASEB J, V17, P1248, DOI 10.1096/fj.02-0736com; Garcia-Frigola C, 2010, EMBO J, V29, P3170, DOI 10.1038/emboj.2010.172; Gimenez E, 2004, PIGM CELL RES, V17, P363, DOI 10.1111/j.1600-0749.2004.00158.x; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; GUILLERY RW, 1990, OPHTHALMIC PAED GEN, V11, P177, DOI 10.3109/13816819009020977; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Ilia M, 2000, J COMP NEUROL, V420, P437; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; Jeffery G, 2001, PHYSIOL REV, V81, P1393, DOI 10.1152/physrev.2001.81.4.1393; Jeffery G, 1997, DEV BRAIN RES, V99, P95, DOI 10.1016/S0165-3806(96)00211-8; Kaas JH, 2005, ILAR J, V46, P357, DOI 10.1093/ilar.46.4.357; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; Kraij-Hans I, 2006, J NEUROBIOL, V66, P47, DOI 10.1002/neu.20200; Kubrusly RCC, 2003, J NEUROCHEM, V86, P45, DOI 10.1046/j.1471-4159.2003.01813.x; Lavado A, 2006, J NEUROCHEM, V96, P1201, DOI 10.1111/j.1471-4159.2006.03657.x; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; NGUYENLEGROS J, 1994, INVEST OPHTH VIS SCI, V35, P2906; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; Rachel RA, 2002, J NEUROSCI, V22, P4249, DOI 10.1523/JNEUROSCI.22-11-04249.2002; Rebsam A, 2012, J NEUROSCI, V32, P4821, DOI 10.1523/JNEUROSCI.5050-11.2012; Reis RA, 2007, BRAIN RES BRAIN RES; Riley PA, 1999, CELL MOL BIOL, V45, P951; Rios M, 1999, J NEUROSCI, V19, P3519; Slotkin T A, 1988, Adv Exp Med Biol, V245, P283; Tian H, 2000, J NEUROSCI, V20, P7362; Tibber MS, 2007, J COMP NEUROL, V503, P128, DOI 10.1002/cne.21388; Tibber MS, 2006, J COMP NEUROL, V496, P369, DOI 10.1002/cne.20920; Witkovsky P, 2005, J COMP NEUROL, V481, P352, DOI 10.1002/cne.20389; Witkovsky P, 2008, J COMP NEUROL, V510, P158, DOI 10.1002/cne.21784; WULLE I, 1989, DEV BRAIN RES, V48, P59, DOI 10.1016/0165-3806(89)90093-X	38	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57184	10.1371/journal.pone.0057184	http://dx.doi.org/10.1371/journal.pone.0057184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526936	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100007
J	Zheng, H; Ma, HP; Wang, J; Ma, M				Zheng, Hong; Ma, Hai-Ping; Wang, Jiang; Ma, Ming			Preoperative HO-1 Levels as Prognostic Factor for Adverse Cardiac Events in Elder Patients Undergoing Non-Cardiac Surgery	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; HEME OXYGENASE-1; HYPOXIA; EXPRESSION; APOPTOSIS; ISCHEMIA	Background: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) and heme oxygenase-1(HO-1) are involved in the tissue hypoxic response. Hypothesis: HIF-1 alpha and HO-1 levels may predict cardiac ischemia and adverse cardiac events during non-cardiac surgery. Methods: HIF-1 alpha and HO-1 levels were determined in elderly patients undergoing non-cardiac surgery preoperatively and at 30 minutes, 48 and 72 hours postoperatively. Results were analyzed with respect to the occurrence of adverse cardiac events. Results: A total of 380 patients with a mean age of 65.3 years were included, and 54 (14.2%) who had adverse cardiac events during or after the surgery. HIF-1 alpha and HO-1 levels in the adverse cardiac event group were significantly higher than in the group without adverse cardiac events at each time point (all, P<0.05). In multivariates regression analysis, the odds of an adverse cardiac event was increased by every 1-year increase in age (odd ratio [OR] 1.39, P<0.001), abnormal ECG at baseline (OR 2.27, P = 0.048), myocardial infarction history (OR 3.18, P = 0.015), and positive baseline cTnI level were associated with an increased likelihood of an adverse cardiac event (OR 8.78, P = 0.019), and for every 1 unit increase of HO-1, the odds of an adverse cardiac event increased by 1.30 (P = 0.002). Conclusion: Determination of preoperative HO-1 levels may aid in identifying patients at risk of developing ischemic cardiac events.	[Zheng, Hong; Ma, Hai-Ping; Wang, Jiang; Ma, Ming] Xinjiang Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Urumqi, Peoples R China	Xinjiang Medical University	Wang, J (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Urumqi, Peoples R China.	wangjiang@sina.cn						Abbate A, 2005, EUR HEART J, V26, P2039, DOI 10.1093/eurheartj/ehi419; Abbate A, 2002, J CELL PHYSIOL, V193, P145, DOI 10.1002/jcp.10174; Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1445, DOI 10.1001/jama.287.11.1445; Cardiovascular Diseases Branch of Chinese Medical Association, 2001, CHINESE J CARDIOLOGY, V29, P710; *CRIT COMM NY HEAR, 1964, DIS HEART BLOOD VESS; Durante W, 2003, J CELL PHYSIOL, V195, P373, DOI 10.1002/jcp.10274; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Goei D, 2010, FUTUR CARDIOL, V6, P603, DOI [10.2217/fca.10.78, 10.2217/FCA.10.78]; Holscher M, 2012, CARDIOVASC RES, V94, P77, DOI 10.1093/cvr/cvs014; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kim SE, 2011, KOREAN CIRC J, V41, P11, DOI 10.4070/kcj.2011.41.1.11; Larsen K, 2010, TRENDS CARDIOVAS MED, V20, P58, DOI 10.1016/j.tcm.2010.04.001; Li YG, 2006, ACTA CARDIOL, V61, P295, DOI 10.2143/AC.61.3.2014831; Mercantini P, 2012, WORLD J SURG, V36, P24, DOI 10.1007/s00268-011-1354-6; Novo G, 2011, INT ANGIOL, V30, P242; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Romero L, 2001, ARCH SURG-CHICAGO, V136, P1370, DOI 10.1001/archsurg.136.12.1370; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314	24	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58567	10.1371/journal.pone.0058567	http://dx.doi.org/10.1371/journal.pone.0058567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526997	Green Submitted, gold, Green Published			2022-12-25	WOS:000317562100031
J	Fahim, MA; Howarth, FC; Nemmar, A; Qureshi, MA; Shafiullah, M; Jayaprakash, P; Hasan, MY				Fahim, Mohamed Abdelmonem; Howarth, Frank Christopher; Nemmar, Abderrahim; Qureshi, Mohamed Anwar; Shafiullah, Mohamed; Jayaprakash, Petrilla; Hasan, Mohamed Yousif			Vitamin E Ameliorates the Decremental Effect of Paraquat on Cardiomyocyte Contractility in Rats	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; OXYGEN FREE-RADICALS; PARKINSONS-DISEASE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CARDIAC MYOCYTES; COMPLEX-I; HEART; CALCIUM; ATHEROSCLEROSIS	Background: Exposure to pesticides and industrial toxins are implicated in cardiovascular disease. Paraquat (PAR) is a toxic chemical widely used as an herbicide in developing countries and described as a major suicide agent. The hypothesis tested here is that PAR induced myocardial dysfunction may be attributed to altered mechanisms of Ca2+ transport which are in turn possibly linked to oxidative stress. The mechanisms of PAR induced myocardial dysfunction and the impact of antioxidant protection was investigated in rat ventricular myocytes. Methodology: Forty adult male Wistar rats were divided into 4 groups receiving the following daily intraperitoneal injections for 3 weeks: Group 1 PAR (10 mg/kg), Control Group 2 saline, Group 3 vitamin E (100 mg/kg) and Group 4 PAR (10 mg/kg) and vitamin E (100 mg/kg). Ventricular action potentials were measured in isolated perfused heart, shortening and intracellular Ca2+ in electrically stimulated ventricular myocytes by video edge detection and fluorescence photometry techniques, and superoxide dismutase (SOD) and catalase (CAT) levels in heart tissue. Principal Findings: Spontaneous heart rate, resting cell length, time to peak (TPK) and time to half (THALF) relaxation of myocyte shortening were unaltered. Amplitude of shortening was significantly reduced in PAR treated rats (4.99 +/- 0.26%) and was normalized by vitamin E (7.46 +/- 0.44%) compared to controls (7.87 +/- 0.52%). PAR significantly increased myocytes resting intracellular Ca2+ whilst TPK and THALF decay and amplitude of the Ca2+ transient were unaltered. The fura-2-cell length trajectory during the relaxation of the twitch contraction was significantly altered in myocytes from PAR treated rats compared to controls suggesting altered myofilament sensitivity to Ca2+ as it was normalized by vitamin E treatment. A significant increase in SOD and CAT activities was observed in both PAR and vitamin E plus PAR groups. Conclusions: PAR exposure compromised rats heart function and ameliorated by vitamin E treatment.	[Fahim, Mohamed Abdelmonem; Howarth, Frank Christopher; Nemmar, Abderrahim; Qureshi, Mohamed Anwar; Jayaprakash, Petrilla] United Arab Emirates Univ, Fac Med, Dept Physiol, Al Ain, U Arab Emirates; [Shafiullah, Mohamed; Hasan, Mohamed Yousif] United Arab Emirates Univ, Fac Med, Dept Pharmacol, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Fahim, MA (corresponding author), United Arab Emirates Univ, Fac Med, Dept Physiol, Al Ain, U Arab Emirates.	m.fahim@uaeu.ac.ae		Jayaprakash, Petrilla/0000-0001-5433-6587	Research Affairs at the UAE University [02-04-8-11/04]	Research Affairs at the UAE University	This work was financially supported by the Research Affairs at the UAE University under a contract no. 02-04-8-11/04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHANASELIS S, 1983, J TOXICOL-CUTAN OCUL, V2, P3, DOI 10.3109/15569528309088518; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BLAUSTEIN AS, 1986, AM J PHYSIOL, V250, pH595, DOI 10.1152/ajpheart.1986.250.4.H595; Ceaser EK, 2003, AM J PHYSIOL-HEART C, V285, pH2298, DOI 10.1152/ajpheart.00508.2003; Chan YC, 2007, TOXICOL IN VITRO, V21, P595, DOI 10.1016/j.tiv.2006.12.007; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cristovao AC, 2009, ANTIOXID REDOX SIGN, V11, P2105, DOI [10.1089/ars.2009.2459, 10.1089/ARS.2009.2459]; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Fahim MA, 2013, PHYSIOL RES, V62, P313, DOI 10.33549/physiolres.932386; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Howarth FC, 2007, EXP PHYSIOL, V92, P1029, DOI 10.1113/expphysiol.2007.038703; Howarth FC, 2008, MOL CELL BIOCHEM, V315, P69, DOI 10.1007/s11010-008-9790-9; Ikuo H, 2003, KAWASAKI IGAKKAISHI, V29, P231; KANEKO M, 1989, AM J PHYSIOL, V257, pH804, DOI 10.1152/ajpheart.1989.257.3.H804; KANEKO M, 1989, AM J PHYSIOL, V256, pH368, DOI 10.1152/ajpheart.1989.256.2.H368; Kaneko M, 1991, Bratisl Lek Listy, V92, P48; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; KOPPEL C, 1994, J TOXICOL-CLIN TOXIC, V32, P205, DOI 10.3109/15563659409000452; Lee HL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-7; Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Martinet W, 2001, CIRC RES, V88, P733, DOI 10.1161/hh0701.088684; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Nemmar A, 2009, TOXICOLOGY, V263, P84, DOI 10.1016/j.tox.2009.06.017; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; Raza H, 2000, J BIOCHEM MOL TOXIC, V14, P131, DOI 10.1002/(SICI)1099-0461(2000)14:3<131::AID-JBT2>3.0.CO;2-Q; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; SAUNDERS N R, 1985, Journal of Thoracic and Cardiovascular Surgery, V89, P734; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; SPURGEON HA, 1992, J PHYSIOL-LONDON, V447, P83, DOI 10.1113/jphysiol.1992.sp018992; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tabata N, 1999, FORENSIC SCI INT, V100, P117, DOI 10.1016/S0379-0738(98)00190-X; Valenca SS, 2008, ENVIRON RES, V108, P199, DOI 10.1016/j.envres.2008.07.001; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; WATANABE N, 1986, BIOCHIM BIOPHYS ACTA, V883, P420, DOI 10.1016/0304-4165(86)90279-5	44	7	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e57651	10.1371/journal.pone.0057651	http://dx.doi.org/10.1371/journal.pone.0057651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526948	gold, Green Published, Green Submitted			2022-12-25	WOS:000316411600004
J	Coburn, JM; Bernstein, N; Bhattacharya, R; Aich, U; Yarema, KJ; Elisseeff, JH				Coburn, Jeannine M.; Bernstein, Nicholas; Bhattacharya, Rahul; Aich, Udayanath; Yarema, Kevin J.; Elisseeff, Jennifer H.			Differential Response of Chondrocytes and Chondrogenic-Induced Mesenchymal Stem Cells to C1-OH Tributanoylated N-Acetylhexosamines	PLOS ONE			English	Article							DISCOIDIN-DOMAIN RECEPTOR-2; ARTICULAR-CARTILAGE; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; EXTRACELLULAR-MATRIX; FEMORAL CONDYLE; CULTURE-SYSTEM; OSTEOARTHRITIS; ACID; SOX9	Articular cartilage has a limited ability to self-repair because of its avascular nature and the low mitotic activity of the residing chondrocytes. There remains a significant need to develop therapeutic strategies to increase the regenerative capacity of cells that could repair cartilage. Multiple cell types, including chondrocytes and mesenchymal stem cells, have roles in articular cartilage regeneration. In this study, we evaluated a platform technology of multiple functionalized hexosamines, namely 3,4,6-O-tributanoylated-N-acetylgalactosamine (3,4,6-O-Bu(3)GalNAc), 3,4,6-O-tributanoylated-N-acetylmannosamine (3,4,6-O-Bu(3)ManNAc) and 3,4,6-O-Bu(3)GlcNAc, with the potential ability to reduce NF kappa B activity. Exposure of IL-1 beta-stimulated chondrocytes to the hexosamine analogs resulted in increased expression of ECM molecules and a corresponding improvement in cartilage-specific ECM accumulation. The greatest ECM accumulation was observed with 3,4,6-O-Bu(3)GalNAc. In contrast, mesenchymal stem cells (MSCs) exposed to 3,4,6-O-Bu(3)GalNAc exhibited a dose dependent decrease in chondrogenic differentation as indicated by decreased ECM accumulation. These studies established the disease modification potential of a hexosamine analog platform on IL-1 beta-stimulated chondrocytes. We determined that the modified hexosamine with the greatest potential for disease modification is 3,4,6-O-Bu(3)GalNAc. This effect was distinctly different with 3,4,6-O-Bu(3)GalNAc exposure to chondrogenic-induced MSCs, where a decrease in ECM accumulation and differentiation was observed. Furthermore, these studies suggest that NF kappa B pathway plays a complex role cartilage repair.	[Coburn, Jeannine M.; Bernstein, Nicholas; Bhattacharya, Rahul; Aich, Udayanath; Yarema, Kevin J.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA; [Coburn, Jeannine M.; Bernstein, Nicholas; Bhattacharya, Rahul; Aich, Udayanath; Yarema, Kevin J.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Coburn, Jeannine M.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Yarema, KJ (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA.	kyarema1@jhu.edu; jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996; Coburn, Jeannine M./0000-0001-6354-5436	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH) [R01AR054005]; Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship [NIA/NIH F31AG033999]; NATIONAL CANCER INSTITUTE [R01CA112314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG033999] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH); Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH) R01AR054005. JMC was supported in part by a Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship NIA/NIH F31AG033999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich U, 2008, ACS CHEM BIOL, V3, P230, DOI 10.1021/cb7002708; Aigner T, 2005, CYTOKINE, V31, P227, DOI 10.1016/j.cyto.2005.04.009; Buckwalter JA, 2003, J ORTHOP SPORT PHYS, V33, P578, DOI 10.2519/jospt.2003.33.10.578; Cameron M L, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P38, DOI 10.1007/BF01552652; Campbell CT, 2008, J MED CHEM, V51, P8135, DOI 10.1021/jm800873k; Catterall JB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3216; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W; Elmouelhi N, 2009, J MED CHEM, V52, P2515, DOI 10.1021/jm801661m; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fitzgerald GK, 2004, ARTHRIT RHEUM-ARTHR, V51, P941, DOI 10.1002/art.20825; Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242; Fujita T, 2004, J CELL BIOCHEM, V93, P374, DOI 10.1002/jcb.20192; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; GOLDRING MB, 1994, J CELL BIOCHEM, V54, P85, DOI 10.1002/jcb.240540110; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Kalson NS, 2010, INT J CLIN PRACT, V64, P1444, DOI 10.1111/j.1742-1241.2010.02420.x; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457; Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008; Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Owen HC, 2007, MOL CELL ENDOCRINOL, V264, P164, DOI 10.1016/j.mce.2006.11.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sakai A, 1999, ARCH ORTHOP TRAUM SU, V119, P121, DOI 10.1007/s004020050374; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Vonk LA, 2011, RHEUMATOLOGY, V50, P463, DOI 10.1093/rheumatology/keq305; Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wu S, 2011, J BIOL CHEM; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655; ZIMMERMANN B, 1993, ANAT EMBRYOL, V187, P67	48	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58899	10.1371/journal.pone.0058899	http://dx.doi.org/10.1371/journal.pone.0058899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516573	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400075
J	Fei, J; Tamski, H; Cook, C; Santanam, N				Fei, Jia; Tamski, Holly; Cook, Carla; Santanam, Nalini			MicroRNA Regulation of Adipose Derived Stem Cells in Aging Rats	PLOS ONE			English	Article							STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DEPOT ORIGIN; FAT TISSUE; IN-VITRO; ADIPOGENESIS; OBESITY	Background: Perturbations in abdominal fat secreted adipokines play a key role in metabolic syndrome. This process is further altered during the aging process, probably due to alterations in the preadipocytes (aka. stromal vascular fraction cells-SVF cells or adipose derived stem cells-ASCs) composition and/or function. Since microRNAs regulate genes involved both in development and aging processes, we hypothesized that the impaired adipose function with aging is due to altered microRNA regulation of adipogenic pathways in SVF cells. Methodology and Principal Findings: Alterations in mRNA and proteins associated with adipogenic differentiation (ERK5 and PPARg) but not osteogenic (RUNX2) pathways were observed in SVF cells isolated from visceral adipose tissue with aging (6 to 30 mo) in female Fischer 344 x Brown Norway Hybrid (FBN) rats. The impaired differentiation capacity with aging correlated with altered levels of miRNAs involved in adipocyte differentiation (miRNA-143) and osteogenic pathways (miRNA-204). Gain and loss of function studies using premir or antagomir-143 validated the age associated adipocyte dysfunction. Conclusions and Significance: Our studies for the first time indicate a role for miRNA mediated regulation of SVF cells with aging. This discovery is important in the light of the findings that dysfunctional adipose derived stem cells contribute to age related chronic diseases.	[Fei, Jia; Tamski, Holly; Cook, Carla; Santanam, Nalini] Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA	Marshall University	Santanam, N (corresponding author), Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	santanam@marshall.edu		Santanam, Nalini/0000-0003-3343-6081	 [NIH5P20RR016477]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER	; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by NIH5P20RR016477. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bays HE, 2011, J AM COLL CARDIOL, V57, P2461, DOI 10.1016/j.jacc.2011.02.038; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cartwright MJ, 2010, J GERONTOL A-BIOL, V65, P242, DOI 10.1093/gerona/glp213; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fei J, 2010, ATHEROSCLEROSIS, V212, P488, DOI 10.1016/j.atherosclerosis.2010.06.044; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Gualillo O, 2007, TRENDS CARDIOVAS MED, V17, P275, DOI 10.1016/j.tcm.2007.09.005; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guo W, 2007, AM J PHYSIOL-ENDOC M, V292, pE1041, DOI 10.1152/ajpendo.00557.2006; Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690; Hong L, 2007, TISSUE ENG, V13, P1197, DOI 10.1089/ten.2006.0317; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Karagiannides I, 2006, J BIOL CHEM, V281, P23025, DOI 10.1074/jbc.M513187200; KIRKLAND JL, 1984, J AM GERIATR SOC, V32, P219, DOI 10.1111/j.1532-5415.1984.tb02006.x; Kirkland JL, 1997, J AM GERIATR SOC, V45, P959, DOI 10.1111/j.1532-5415.1997.tb02967.x; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Larkin LM, 2001, J GERONTOL A-BIOL, V56, pB486, DOI 10.1093/gerona/56.11.B486; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lin YF, 2008, CELL PROLIFERAT, V41, P803, DOI 10.1111/j.1365-2184.2008.00542.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; McGregor RA, 2011, CURR MOL MED, V11, P304; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Sharma AM, 2003, GROWTH HORM IGF RES, V13, pS10, DOI 10.1016/S1096-6374(03)00047-9; Sharma G, 2005, MOL CELL ENDOCRINOL, V245, P93, DOI 10.1016/j.mce.2005.10.027; Shi YY, 2005, PLAST RECONSTR SURG, V116, P1686, DOI 10.1097/01.prs.0000185606.03222.a9; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Xu YF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-21; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zou CH, 2008, J NUTR BIOCHEM, V19, P277, DOI 10.1016/j.jnutbio.2007.06.006; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	53	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59238	10.1371/journal.pone.0059238	http://dx.doi.org/10.1371/journal.pone.0059238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516615	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400100
J	Figley, SA; Chen, YH; Maeda, A; Conroy, L; McMullen, JD; Silver, JI; Stapleton, S; Vitkin, A; Lindsay, P; Burrell, K; Zadeh, G; Fehlings, MG; DaCosta, RS				Figley, Sarah A.; Chen, Yonghong; Maeda, Azusa; Conroy, Leigh; McMullen, Jesse D.; Silver, Jason I.; Stapleton, Shawn; Vitkin, Alex; Lindsay, Patricia; Burrell, Kelly; Zadeh, Gelareh; Fehlings, Michael G.; DaCosta, Ralph S.			A Spinal Cord Window Chamber Model for In Vivo Longitudinal Multimodal Optical and Acoustic Imaging in a Murine Model	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; INJURY; TOMOGRAPHY; MICROSCOPY; REGENERATION; INFLAMMATION; PATHOLOGY; PROTEIN; BRAIN	In vivo and direct imaging of the murine spinal cord and its vasculature using multimodal (optical and acoustic) imaging techniques could significantly advance preclinical studies of the spinal cord. Such intrinsically high resolution and complementary imaging technologies could provide a powerful means of quantitatively monitoring changes in anatomy, structure, physiology and function of the living cord over time after traumatic injury, onset of disease, or therapeutic intervention. However, longitudinal in vivo imaging of the intact spinal cord in rodent models has been challenging, requiring repeated surgeries to expose the cord for imaging or sacrifice of animals at various time points for ex vivo tissue analysis. To address these limitations, we have developed an implantable spinal cord window chamber (SCWC) device and procedures in mice for repeated multimodal intravital microscopic imaging of the cord and its vasculature in situ. We present methodology for using our SCWC to achieve spatially co-registered optical-acoustic imaging performed serially for up to four weeks, without damaging the cord or induction of locomotor deficits in implanted animals. To demonstrate the feasibility, we used the SCWC model to study the response of the normal spinal cord vasculature to ionizing radiation over time using white light and fluorescence microscopy combined with optical coherence tomography (OCT) in vivo. In vivo power Doppler ultrasound and photoacoustics were used to directly visualize the cord and vascular structures and to measure hemoglobin oxygen saturation through the complete spinal cord, respectively. The model was also used for intravital imaging of spinal micrometastases resulting from primary brain tumor using fluorescence and bioluminescence imaging. Our SCWC model overcomes previous in vivo imaging challenges, and our data provide evidence of the broader utility of hybridized optical-acoustic imaging methods for obtaining multiparametric and rich imaging data sets, including over extended periods, for preclinical in vivo spinal cord research.	[Figley, Sarah A.; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Figley, Sarah A.; Burrell, Kelly; Zadeh, Gelareh; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Res Inst, Krembil Neurosci Program, Toronto, ON, Canada; [Chen, Yonghong; McMullen, Jesse D.; Silver, Jason I.; Vitkin, Alex; DaCosta, Ralph S.] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Maeda, Azusa; Conroy, Leigh; Stapleton, Shawn; Vitkin, Alex; DaCosta, Ralph S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Vitkin, Alex; Lindsay, Patricia; DaCosta, Ralph S.] Princess Margaret Hosp, Dept Radiat Oncol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada	University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	DaCosta, RS (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada.	rdacosta@uhnres.utoronto.ca	Vitkin, Alex/C-8123-2016; Vitkin, Alex/I-8166-2012	Vitkin, Alex/0000-0001-5495-8888; Conroy, Leigh/0000-0003-0055-3660; Fehlings, Michael/0000-0002-5722-6364	Cancer Care Ontario; Canadian Institutes of Health Research [93578]; Ontario Ministry of Health and Long Term care	Cancer Care Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term care(Ministry of Health and Long-Term Care, Ontario)	This research was funded in part by Cancer Care Ontario (DaCosta holds a CCO Research Chair in Cancer Imaging; https://www.cancercare.on.ca/), the Canadian Institutes of Health Research (awarded to Dr. DaCosta, reference number 93578; http://www.cihr-irsc.gc.ca/e/193.html) and the Ontario Ministry of Health and Long Term Care (http://www.health.gov.on.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P115; Bhavna Y, 2009, CURR BIOL, V19, P930; Bilgen M., 2006, NEUROANATOMY, V5, P12; BRAUN IF, 1983, RADIOLOGY, V147, P459, DOI 10.1148/radiology.147.2.6340159; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Cadotte DW, 2012, BIOMED OPT EXPRESS, V3, P911, DOI 10.1364/BOE.3.000911; Clarkson R, 2011, MED PHYS, V38, P845, DOI 10.1118/1.3533947; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; DOMMISSE GF, 1974, J BONE JOINT SURG BR, VB 56, P225, DOI 10.1302/0301-620X.56B2.225; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Farrar MJ, 2012, NATURE METHODS ADV; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Fenrich KK, 2012, J PHYSIOL-LONDON, V590, P3665, DOI 10.1113/jphysiol.2012.230532; HORNSEY S, 1990, INT J RADIAT ONCOL, V18, P1437, DOI 10.1016/0360-3016(90)90319-F; Hsu W, 2012, NEUROSURGERY, DOI [10.1227/NEU.1220-b1013e3182532e3182571, DOI 10.1227/NEU.1220-B1013E3182532E3182571]; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Johannssen HC, 2010, J PHYSIOL-LONDON, V588, P3397, DOI 10.1113/jphysiol.2010.191833; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kim JV, 2010, J IMMUNOL METHODS, V352, P89, DOI 10.1016/j.jim.2009.09.007; Kirkpatrick JP, 2010, INT J RADIAT ONCOL, V76, pS42, DOI 10.1016/j.ijrobp.2009.04.095; Lassmann H, 2005, BRAIN PATHOL, V15, P217; Liu TW, 2011, BIOCONJUGATE CHEM, V22, P1021, DOI 10.1021/bc200169x; Madi S, 2001, AM J NEURORADIOL, V22, P1768; MARCUS ML, 1977, CIRC RES, V41, P128, DOI 10.1161/01.RES.41.1.128; MCAFEE PC, 1986, SPINE, V11, P295, DOI 10.1097/00007632-198605000-00001; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; NIX W, 1976, STROKE, V7, P560, DOI 10.1161/01.STR.7.6.560; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; POWERS BE, 1992, INT J RADIAT ONCOL, V23, P539, DOI 10.1016/0360-3016(92)90009-7; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sahgal A, 2011, J NEUROSURG-SPINE, V14, P151, DOI 10.3171/2010.9.SPINE091005; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; SIEGAL T, 1995, INT J RADIAT ONCOL, V31, P57, DOI 10.1016/0360-3016(94)E0305-4; Sinescu Crina, 2010, J Med Life, V3, P254; Stroman PW, 2005, CLIN MED RES, V3, P146, DOI 10.3121/cmr.3.3.146; Tench CR, 2005, J NEUROIMAGING, V15, p94S, DOI 10.1177/1051228405283292; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; VANDERKOGEL AJ, 1993, RADIOTHER ONCOL, V29, P105, DOI 10.1016/0167-8140(93)90234-Y; Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3	46	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58081	10.1371/journal.pone.0058081	http://dx.doi.org/10.1371/journal.pone.0058081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516432	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400015
J	Hammami, I; Nuel, G; Garcia, A				Hammami, Imen; Nuel, Gregory; Garcia, Andre			Statistical Properties of Parasite Density Estimators in Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; THICK BLOOD FILMS; RELIABILITY; DIAGNOSIS; CHILDREN; TRANSMISSION; MICROSCOPY; INFECTION; QBC(R); TESTS	Malaria is a global health problem responsible for nearly one million deaths every year around 85% of which concern children younger than five years old in Sub-Saharan Africa. In addition, around 300 million clinical cases are declared every year. The level of infection, expressed as parasite density, is classically defined as the number of asexual parasites relative to a microliter of blood. Microscopy of Giemsa-stained thick blood films is the gold standard for parasite enumeration. Parasite density estimation methods usually involve threshold values; either the number of white blood cells counted or the number of high power fields read. However, the statistical properties of parasite density estimators generated by these methods have largely been overlooked. Here, we studied the statistical properties (mean error, coefficient of variation, false negative rates) of parasite density estimators of commonly used threshold-based counting techniques depending on variable threshold values. We also assessed the influence of the thresholds on the cost-effectiveness of parasite density estimation methods. In addition, we gave more insights on the behavior of measurement errors according to varying threshold values, and on what should be the optimal threshold values that minimize this variability.	[Hammami, Imen; Nuel, Gregory] Paris Descartes Univ, Dept Appl Math MAPS, UMR CNRS 8145, Paris, France; [Garcia, Andre] Inst Rech Dev, Dept Mother & Child Relat Trop Infect, UMR 216, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Hammami, I (corresponding author), Paris Descartes Univ, Dept Appl Math MAPS, UMR CNRS 8145, Paris, France.	imen.hammami@parisdescartes.fr	Garcia, Andre/ABA-1820-2020; Garcia, Andre/S-2959-2016	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X	Centre National de la Recherche Scientifique (National Center for Scientific Research) (CNRS)	Centre National de la Recherche Scientifique (National Center for Scientific Research) (CNRS)	The authors are funded by Centre National de la Recherche Scientifique (National Center for Scientific Research) (CNRS) PhD Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-4; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRAUNMUNZINGER RA, 1992, TROP MED PARASITOL, V43, P149; Chippaux JP, 1991, ETUDES THESES, P55; Christophers R, 1951, BRIT MED J, V1, P75; CLENDENNEN TE, 1995, T ROY SOC TROP MED H, V89, P183, DOI 10.1016/0035-9203(95)90486-7; Colbourne M J, 1971, Trop Doct, V1, P161; COLLIER JAB, 1983, ANN TROP MED PARASIT, V77, P113, DOI 10.1080/00034983.1983.11811683; DOWLING MAC, 1966, B WORLD HEALTH ORGAN, V34, P249; DRAPER CC, 1971, BRIT MED J, V2, P93, DOI 10.1136/bmj.2.5753.93; Dubey ML, 1999, INDIAN J MED RES, V109, P20; Earle WC, 1931, J LAB CLIN MED, V17, P1124; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Garcia A, 2004, MICROBES INFECT, V6, P68, DOI 10.1016/j.micinf.2003.09.021; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Kilian AHD, 2000, TROP MED INT HEALTH, V5, P3, DOI 10.1046/j.1365-3156.2000.00509.x; KIRKWOOD BR, 2001, ESSENTIALS MED STAT; KREMSNER PG, 1988, J INFECT DIS, V158, P1368, DOI 10.1093/infdis/158.6.1368; Le Port A, 2011, AM J TROP MED HYG, V84, P270, DOI 10.4269/ajtmh.2011.10-0319; Milet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011616; Molineaux L, 1980, THE GARKI PROJECT; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mulder B, 1998, T ROY SOC TROP MED H, V92, P395, DOI 10.1016/S0035-9203(98)91061-6; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; O'Meara WP, 2005, AM J TROP MED HYG, V73, P593, DOI 10.4269/ajtmh.2005.73.593; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Petersen E, 1996, AM J TROP MED HYG, V55, P485, DOI 10.4269/ajtmh.1996.55.485; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; ROGIER C, 1993, T ROY SOC TROP MED H, V87, P245, DOI 10.1016/0035-9203(93)90110-C; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Sakuntabhai A, 2008, MICROBES INFECT, V3, P2000; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; Scott WA, 1955, PUBLIC OPIN QUART, V19, P321, DOI 10.1086/266577; Small DS, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1201; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; WHO, 2000, B WHO; WHO, 2010, BAS MAL MICR 1; WHO, 1961, WHORA126261; ZUROVAC D, 2006, TROP MED INT HEALTH, V11, P1	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e51987	10.1371/journal.pone.0051987	http://dx.doi.org/10.1371/journal.pone.0051987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516389	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400002
J	Schroder, MS; Stellmacher, A; Romorini, S; Marini, C; Montenegro-Venegas, C; Altrock, WD; Gundelfinger, ED; Fejtova, A				Schroeder, Markus S.; Stellmacher, Anne; Romorini, Stefano; Marini, Claudia; Montenegro-Venegas, Carolina; Altrock, Wilko D.; Gundelfinger, Eckart D.; Fejtova, Anna			Regulation of Presynaptic Anchoring of the Scaffold Protein Bassoon by Phosphorylation-Dependent Interaction with 14-3-3 Adaptor Proteins	PLOS ONE			English	Article							ZONE PRECURSOR VESICLES; LONG-TERM POTENTIATION; COFFIN-LOWRY SYNDROME; RIM-BINDING PROTEINS; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; SYNAPTIC PLASTICITY; FIBER SYNAPSES; RIM1-ALPHA; FAMILY	The proper organization of the presynaptic cytomatrix at the active zone is essential for reliable neurotransmitter release from neurons. Despite of the virtual stability of this tightly interconnected proteinaceous network it becomes increasingly clear that regulated dynamic changes of its composition play an important role in the processes of synaptic plasticity. Bassoon, a core component of the presynaptic cytomatrix, is a key player in structural organization and functional regulation of presynaptic release sites. It is one of the most highly phosphorylated synaptic proteins. Nevertheless, to date our knowledge about functions mediated by any one of the identified phosphorylation sites of Bassoon is sparse. In this study, we have identified an interaction of Bassoon with the small adaptor protein 14-3-3, which depends on phosphorylation of the 14-3-3 binding motif of Bassoon. In vitro phosphorylation assays indicate that phosphorylation of the critical Ser-2845 residue of Bassoon can be mediated by a member of the 90-kDa ribosomal S6 protein kinase family. Elimination of Ser-2845 from the 14-3-3 binding motif results in a significant decrease of Bassoon's molecular exchange rates at synapses of living rat neurons. We propose that the phosphorylation-induced 14-3-3 binding to Bassoon modulates its anchoring to the presynaptic cytomatrix. This regulation mechanism might participate in molecular and structural presynaptic remodeling during synaptic plasticity.	[Schroeder, Markus S.; Stellmacher, Anne; Romorini, Stefano; Marini, Claudia; Montenegro-Venegas, Carolina; Altrock, Wilko D.; Gundelfinger, Eckart D.; Fejtova, Anna] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Altrock, Wilko D.; Gundelfinger, Eckart D.] Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN)	Gundelfinger, ED (corresponding author), Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany.	eckart.gundelfinger@lin-magdeburg.de; Anna.Fejtova@lin-magdeburg.de	Fejtova, Anna/AAZ-1024-2020; Fejtova, Anna/E-6343-2015	Fejtova, Anna/0000-0002-1815-4409	DFG-SFB [779]; EC [222918]; European Regional Development Fonds and the Land Saxony-Anhalt [EFRE/LSA 2007-2013]	DFG-SFB(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fonds and the Land Saxony-Anhalt	This study was supported by DFG-SFB 779, the EC contract number 222918 (REPLACES) FP7 - Thematic priority HEALTH to EDG and the European Regional Development Fonds and the Land Saxony-Anhalt (EFRE/LSA 2007-2013) to EDG and AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Fejtova Anna, 2006, V43, P49, DOI 10.1007/012; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Finlin BS, 1999, ARCH BIOCHEM BIOPHYS, V368, P401, DOI 10.1006/abbi.1999.1316; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; ISOBE T, 1991, J MOL BIOL, V217, P125, DOI 10.1016/0022-2836(91)90616-E; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; Kaeser PS, 2009, NEURON, V64, P227, DOI 10.1016/j.neuron.2009.09.019; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Lanore F, 2010, J PHYSIOL-LONDON, V588, P2133, DOI 10.1113/jphysiol.2009.184929; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Maas C, 2012, J NEUROSCI, V32, P11095, DOI 10.1523/JNEUROSCI.0195-12.2012; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Matz J, 2010, P NATL ACAD SCI USA, V107, P8836, DOI 10.1073/pnas.0906087107; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Sgobio C, 2010, BIOL PSYCHIAT, V67, P567, DOI 10.1016/j.biopsych.2009.11.008; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; TRINIDAD JC, 2006, MOL CELL PROTEOMICS; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; Wang XW, 2009, J NEUROSCI, V29, P12584, DOI 10.1523/JNEUROSCI.1255-09.2009; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Weyhersmuller A, 2011, J NEUROSCI, V31, P6041, DOI 10.1523/JNEUROSCI.6698-10.2011; Wu M, 2006, ANAL BIOCHEM, V349, P186, DOI 10.1016/j.ab.2005.11.030; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang Y, 2010, J NEUROSCI, V30, P2542, DOI 10.1523/JNEUROSCI.4285-09.2010; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	65	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58814	10.1371/journal.pone.0058814	http://dx.doi.org/10.1371/journal.pone.0058814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516560	Green Submitted, gold, Green Published			2022-12-25	WOS:000316407400065
J	Thakur, PB; Vaughn-Diaz, VL; Greenwald, JW; Gross, DC				Thakur, Poulami Basu; Vaughn-Diaz, Vanessa L.; Greenwald, Jessica W.; Gross, Dennis C.			Characterization of Five ECF Sigma Factors in the Genome of Pseudomonas syringae pv. syringae B728a	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; TOMATO DC3000; ESCHERICHIA-COLI; LEAF SURFACES; PHASEOLICOLA 1448A; ALGINATE SYNTHESIS; CHROMOSOMAL GENES; HRPL REGULON; AERUGINOSA; IDENTIFICATION	Pseudomonas syringae pv. syringae B728a, a bacterial pathogen of bean, utilizes large surface populations and extracellular signaling to initiate a fundamental change from an epiphytic to a pathogenic lifestyle. Extracytoplasmic function (ECF) sigma (s) factors serve as important regulatory factors in responding to various environmental signals. Bioinformatic analysis of the B728a genome revealed 10 ECF sigma factors. This study analyzed deletion mutants of five previously uncharacterized ECF sigma factor genes in B728a, including three FecI-type ECF sigma factors (ECF5, ECF6, and ECF7) and two ECF sigma factors placed in groups ECF11 and ECF18. Transcriptional profiling by qRT-PCR analysis of ECF sigma factor mutants was used to measure expression of their associated anti-sigma and outer membrane receptor proteins, and expression of genes associated with production of extracellular polysaccharides, fimbriae, glycine betaine and syringomycin. Notably, the B728aDecf7 mutant displayed reduced swarming and had decreased expression of CupC fimbrial genes. Growth and pathogenicity assays, using a susceptible bean host, revealed that none of the tested sigma factor genes are required for in planta growth and lesion formation.	[Thakur, Poulami Basu; Vaughn-Diaz, Vanessa L.; Greenwald, Jessica W.; Gross, Dennis C.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gross, DC (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	d-gross@tamu.edu			Texas A&M University AgriLife Research project [H-8832]	Texas A&M University AgriLife Research project	This work was supported by Texas A&M University AgriLife Research project no. H-8832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Brinkman FSL, 1999, J BACTERIOL, V181, P4746, DOI 10.1128/JB.181.16.4746-4754.1999; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Burch AY, 2012, J BACTERIOL, V194, P1287, DOI 10.1128/JB.06058-11; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Chatterjee A, 2007, APPL ENVIRON MICROB, V73, P3684, DOI 10.1128/AEM.02445-06; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Duque E, 2007, J BACTERIOL, V189, P207, DOI 10.1128/JB.00950-06; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Firoved AM, 2002, J BACTERIOL, V184, P1057, DOI 10.1128/jb.184.4.1057-1064.2002; Greenwald JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034804; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; House BL, 2004, APPL ENVIRON MICROB, V70, P2806, DOI 10.1128/AEM.70.5.2806-2815.2004; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jones AM, 2011, J BACTERIOL, V193, P2767, DOI 10.1128/JB.00069-10; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; KIDAMBI SP, 1995, APPL ENVIRON MICROB, V61, P2172, DOI 10.1128/AEM.61.6.2172-2179.1995; KING EO, 1954, J LAB CLIN MED, V44, P301; Kinscherf TG, 1999, J BACTERIOL, V181, P4133, DOI 10.1128/JB.181.13.4133-4136.1999; Kitten T, 1998, MOL MICROBIOL, V28, P917, DOI 10.1046/j.1365-2958.1998.00842.x; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Laue H, 2006, MICROBIOL-SGM, V152, P2909, DOI 10.1099/mic.0.28875-0; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Loper JE, 2007, PHYTOPATHOLOGY, V97, P233, DOI 10.1094/PHYTO-97-2-0233; Marco ML, 2005, ENVIRON MICROBIOL, V7, P1379, DOI 10.1111/j.1462-2920.2005.00825.x; Markel E, 2013, APPL ENVIRON MICROB, V79, P725, DOI 10.1128/AEM.02801-12; Martinez-Bueno MA, 2002, ENVIRON MICROBIOL, V4, P842, DOI 10.1046/j.1462-2920.2002.00371.x; Matsumoto A, 2009, APPL ENVIRON MICROB, V75, P1679, DOI 10.1128/AEM.00024-09; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Monier JM, 2005, MICROB ECOL, V49, P343, DOI 10.1007/s00248-004-0007-9; Oguiza JA, 2005, TRENDS MICROBIOL, V13, P565, DOI 10.1016/j.tim.2005.10.005; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; PenalozaVazquez A, 1997, J BACTERIOL, V179, P4464, DOI 10.1128/jb.179.14.4464-4472.1997; Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Records AR, 2010, J BACTERIOL, V192, P3584, DOI 10.1128/JB.00114-10; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; SAWAHEL W, 1993, BIOTECHNOL TECH, V7, P261, DOI 10.1007/BF00150895; Schenk A, 2008, MICROBIOL-SGM, V154, P413, DOI 10.1099/mic.0.2007/012864-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Scholz-Schroeder BK, 2001, MOL PLANT MICROBE IN, V14, P336, DOI 10.1094/MPMI.2001.14.3.336; Staron A, 2010, MICROBE, V5, P164; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; VIDAVER AK, 1967, APPL MICROBIOL, V15, P1523, DOI 10.1128/AEM.15.6.1523-1524.1967; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Wang N, 2006, MOL PLANT MICROBE IN, V19, P257, DOI 10.1094/MPMI-19-0257; Wang N, 2006, J BACTERIOL, V188, P160, DOI 10.1128/JB.188.1.160-168.2006; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yamamoto S, 2009, GENE, V438, P57, DOI 10.1016/j.gene.2009.02.015; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	73	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58846	10.1371/journal.pone.0058846	http://dx.doi.org/10.1371/journal.pone.0058846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516563	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400067
J	Adem, A; Al Haj, M; Benedict, S; Yasin, J; Nagelkerke, N; Nyberg, F; Yandle, TG; Frampton, CM; Lewis, LK; Nicholls, MG; Kazzam, E				Adem, Abdu; Al Haj, Mahmoud; Benedict, Sheela; Yasin, Javed; Nagelkerke, Nicolas; Nyberg, Fred; Yandle, Tim G.; Frampton, Chris M.; Lewis, Lynley K.; Nicholls, M. Gary; Kazzam, Elsadig			ANP and BNP Responses to Dehydration in the One-Humped Camel and Effects of Blocking the Renin-Angiotensin System	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; PLASMA; WATER; HEART	The objectives of this study were to investigate and compare the responses of atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) in the circulation of hydrated, dehydrated, and dehydrated losartan - treated camels; and to document the cardiac storage form of B-type natriuretic peptide in the camel heart. Eighteen male camels were used in the study: control or hydrated camels (n = 6), dehydrated camels (n = 6) and dehydrated losartan-treated camels (n = 6) which were dehydrated and received the angiotensin II (Ang II) AT-1 receptor blocker, losartan, at a dose of 5 mg/kg body weight intravenously for 20 days. Control animals were supplied with feed and water ad-libitum while both dehydrated and dehydrated-losartan treated groups were supplied with feed ad-libitum but no water for 20 days. Compared with time-matched controls, dehydrated camels exhibited a significant decrease in plasma levels of both ANP and BNP. Losartan-treated camels also exhibited a significant decline in ANP and BNP levels across 20 days of dehydration but the changes were not different from those seen with dehydration alone. Size exclusion high performance liquid chromatography of extracts of camel heart indicated that proB-type natriuretic peptide is the storage form of the peptide. We conclude first, that dehydration in the camel induces vigorous decrements in circulating levels of ANP and BNP; second, blockade of the renin-angiotensin system has little or no modulatory effect on the ANP and BNP responses to dehydration; third, proB-type natriuretic peptide is the storage form of this hormone in the heart of the one-humped camel.	[Adem, Abdu; Al Haj, Mahmoud] UAE Univ, Fac Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Benedict, Sheela; Yasin, Javed; Nagelkerke, Nicolas; Kazzam, Elsadig] UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Al Haj, Mahmoud; Nyberg, Fred] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Yandle, Tim G.; Frampton, Chris M.; Lewis, Lynley K.; Nicholls, M. Gary] Univ Otago, Dept Med, Christchurch Hosp, Christchurch, New Zealand	United Arab Emirates University; United Arab Emirates University; Uppsala University; Christchurch Hospital New Zealand; University of Otago	Kazzam, E (corresponding author), UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	kazzam@uaeu.ac.ae	Adem, Abdu/AAN-8271-2021; PATHAN, JAVED YASIN/GOE-4396-2022	Adem, Abdu/0000-0002-9289-5301; PATHAN, JAVED YASIN/0000-0002-5867-2833	Sheikh Hamdan Bin Rashid Al Maktoum Award; Faculty of Medicine and Health Sciences; United Arab University	Sheikh Hamdan Bin Rashid Al Maktoum Award; Faculty of Medicine and Health Sciences; United Arab University	This study was supported by a grant from Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and grants from the Faculty of Medicine and Health Sciences and the United Arab University. The authors are grateful to Merck (United States of America) for the gift of losartan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037299; BENGOUMI M, 1993, GEN COMP ENDOCR, V89, P378, DOI 10.1006/gcen.1993.1045; DAVIS CL, 1987, AM J PHYSIOL, V252, pF146, DOI 10.1152/ajprenal.1987.252.1.F146; FLORKOWSKI CM, 1994, AM J PHYSIOL, V266, pR1244, DOI 10.1152/ajpregu.1994.266.4.R1244; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; MACFARLANE WV, 1963, NATURE, V197, P270, DOI 10.1038/197270a0; Omland Torbjorn, 2009, Heart Fail Clin, V5, P471, DOI 10.1016/j.hfc.2009.04.005; Osman AHK, 2004, COMP BIOCHEM PHYS A, V139, P417, DOI 10.1016/j.cbpb.2004.05.009; Pemberton CJ, 1997, J ENDOCRINOL, V155, P541, DOI 10.1677/joe.0.1550541; Richards AM, 1996, CLIN SCI, V91, P3, DOI 10.1042/cs0910003; Rosenstrom U, 2004, J MED CHEM, V47, P859, DOI 10.1021/jm030921v; Ruskoaho H, 1997, J MOL MED, V75, P876, DOI 10.1007/s001090050179; SOSA RE, 1986, AM J PHYSIOL, V250, pF520, DOI 10.1152/ajprenal.1986.250.3.F520	13	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57806	10.1371/journal.pone.0057806	http://dx.doi.org/10.1371/journal.pone.0057806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516417	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200019
J	Chou, CH; Doong, ML; Fuh, JL; Wu, JC; Wang, SJ				Chou, Chi-Hsiang; Doong, Ming-Luen; Fuh, Jong-Ling; Wu, Jaw-Ching; Wang, Shuu-Jiun			Queckenstedt's Test Affects More than Jugular Venous Congestion in Rat	PLOS ONE			English	Article							DRAINAGE	Jugular venous compression by the Queckenstedt's test (Q-test) increases the intracranial pressure, but the effects of isolated jugular venous congestion are not well known. Intraventricular pressure (IVP) was compared during direct obstruction of the common jugular veins (bilateral CJV clipping) and during external compression of bilateral CJV flows (Q-test) in a rat model. Intracerebroventricular catheters were inserted into the right lateral ventricle of nine male Sprague-Dawley rats (371.1 +/- 44.8 g, 82.2 +/- 12.0 days old). The initial mean IVP, arterial pressure (MAP), and pulse rate were 2.8 +/- 1.3 mmHg, 88.8 +/- 12.7 mmHg, and 348.3 +/- 69.1 beats/min, respectively. The mean IVP increment and MAP decrement were 6.5 +/- 2.5 and 13.5 +/- 5.7 mmHg, respectively, during the Q-test, compared to 2.3 +/- 1.5 and 7.3 +/- 3.8 mmHg, respectively, during bilateral CJV clipping (all p = 0.008). The IVP increment and MAP decrement were greater during the Q-test than during bilateral CJV clipping (p = 0.008 and p = 0.038). Although the Q-test and bilateral CJV clipping showed similar effects, the response with the Q-test was greater. Thus, the Q-test appears to obstruct other collateral cerebral veins in addition to bilateral CJV flows. Since this model revealed significant differences between the manual Q-test and bilateral CJV clipping, the finding should be taken into account in future studies on the Q-test in SD rats.	[Chou, Chi-Hsiang] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Chou, Chi-Hsiang] Taipei Vet Gen Hosp, Dept Neurol, Su Ao & Yuanshan Branch, Yi Lan, Taiwan; [Chou, Chi-Hsiang] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei 112, Taiwan; [Doong, Ming-Luen] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Natl Yang Ming Univ, Sch Med, Dept Neurol, Inst Brain Sci, Taipei 112, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Natl Yang Ming Univ, Sch Med, Brain Res Ctr, Taipei 112, Taiwan; [Wu, Jaw-Ching] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Wu, Jaw-Ching] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Doong, ML (corresponding author), Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan.	doong@ym.edu.tw; sjwang@vghtpe.gov.tw		zhou, qi xiang/0000-0001-6829-2538; Fuh, Jong-Ling/0000-0001-9135-3351; Wang, Shuu-Jiun/0000-0001-5179-5358	Taipei Veterans General Hospital Su-Ao and Yuanshan Branch, Taiwan National Science Council [98-2314-B-010-019-MY2]; Taipei Veterans General Hospital [VGHUST100-G7-1-1, V100C-087]; NSC support for Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 99-2911-I-008-100]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	Taipei Veterans General Hospital Su-Ao and Yuanshan Branch, Taiwan National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); NSC support for Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported in part by grants from Taipei Veterans General Hospital Su-Ao and Yuanshan Branch, Taiwan National Science Council (98-2314-B-010-019-MY2), Taipei Veterans General Hospital (VGHUST100-G7-1-1, V100C-087), NSC support for Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 99-2911-I-008-100) and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayling John, 2002, Emerg Med Serv, V31, P42; Chou CH, 2009, CEPHALALGIA, V29, P373, DOI 10.1111/j.1468-2982.2008.01746.x; Chou CH, 2004, CEPHALALGIA, V24, P973, DOI 10.1111/j.1468-2982.2004.00781.x; Chou CH, 2011, ULTRASOUND MED BIOL, V37, P23, DOI 10.1016/j.ultrasmedbio.2010.10.018; Doepp F, 2003, HEADACHE, V43, P96, DOI 10.1046/j.1526-4610.2003.03024.x; Goldman J, 2007, AM J PHYSIOL-HEART C, V292, pH928, DOI 10.1152/ajpheart.00821.2006; Haerer AF, 1992, DEJONGS NEUROLOGIC E, P763; KOSTER M., 1961, ACTA PSYCHIAT ET NEUROL SCAND, V36, P347, DOI 10.1111/j.1600-0447.1961.tb01050.x; MILLER J D, 1987, Neurological Research, V9, P198; MILLER J D, 1987, Neurological Research, V9, P193; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pearce JMS, 2006, J NEUROL NEUROSUR PS, V77, P728, DOI 10.1136/jnnp.2005.083618; Queckenstedt, 1916, DEUTSCH Z NERVENHEIL, V55, P325, DOI [10.1007/BF01733057, DOI 10.1007/BF01733057]; Schreiber SJ, 2003, J APPL PHYSIOL, V94, P1802, DOI 10.1152/japplphysiol.00782.2002; Su DS, 2005, ACTA ANAESTH SCAND, V49, P1172, DOI 10.1111/j.1399-6576.2005.00747.x; SZABO K, 1995, ANN ANAT, V177, P313, DOI 10.1016/S0940-9602(11)80371-7	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59409	10.1371/journal.pone.0059409	http://dx.doi.org/10.1371/journal.pone.0059409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516633	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200147
J	Nyffeler, M; Knornschild, M				Nyffeler, Martin; Knoernschild, Mirjam			Bat Predation by Spiders	PLOS ONE			English	Article							ORB-WEAVING SPIDERS; SEXUAL SIZE DIMORPHISM; DARWINS BARK SPIDER; GOLDEN-TIPPED BAT; PIPISTRELLUS-ABRAMUS; MYOTIS-EMARGINATUS; INSECTIVOROUS BATS; FORAGING BEHAVIOR; KERIVOULA-PAPUENSIS; POMONA CHIROPTERA	In this paper more than 50 incidences of bats being captured by spiders are reviewed. Bat-catching spiders have been reported from virtually every continent with the exception of Antarctica (similar to 90% of the incidences occurring in the warmer areas of the globe between latitude 30 degrees N and 30 degrees S). Most reports refer to the Neotropics (42% of observed incidences), Asia (28.8%), and Australia-Papua New Guinea (13.5%). Bat-catching spiders belong to the mygalomorph family Theraphosidae and the araneomorph families Nephilidae, Araneidae, and Sparassidae. In addition to this, an attack attempt by a large araneomorph hunting spider of the family Pisauridae on an immature bat was witnessed. Eighty-eight percent of the reported incidences of bat catches were attributable to web-building spiders and 12% to hunting spiders. Large tropical orb-weavers of the genera Nephila and Eriophora in particular have been observed catching bats in their huge, strong orb-webs (of up to 1.5 m diameter). The majority of identifiable captured bats were small aerial insectivorous bats, belonging to the families Vespertilionidae (64%) and Emballonuridae (22%) and usually being among the most common bat species in their respective geographic area. While in some instances bats entangled in spider webs may have died of exhaustion, starvation, dehydration, and/or hyperthermia (i.e., non-predation death), there were numerous other instances where spiders were seen actively attacking, killing, and eating the captured bats (i.e., predation). This evidence suggests that spider predation on flying vertebrates is more widespread than previously assumed.	[Nyffeler, Martin] Univ Basel, Dept Environm Sci, Sect Conservat Biol NLU, Basel, Switzerland; [Knoernschild, Mirjam] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany	University of Basel; Ulm University	Nyffeler, M (corresponding author), Univ Basel, Dept Environm Sci, Sect Conservat Biol NLU, Basel, Switzerland.	martin.nyffeler@unibas.ch	Knörnschild, Mirjam/C-9401-2011	Knornschild, Mirjam/0000-0003-0448-9600				Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Aguiar LMS, 2008, REV BRAS ZOOL, V25, P28, DOI 10.1590/S0101-81752008000100005; Allen GM., 2004, BATS BIOL BEHAV FOLK; Altringham JD, 1996, BATS BIOL BEHAV; [Anonymous], AUK; Baerg W. J., 1963, Journal of the New York Entomological Society, V71, P233; Banfield EJ, 1918, TROPIC DAYS; Barlow KE, 1997, J ZOOL, V243, P597, DOI 10.1111/j.1469-7998.1997.tb02804.x; BAUEROVA Z, 1986, FOLIA ZOOL, V35, P305; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; BHAT HR, 1980, MAMMALIA, V44, P343, DOI 10.1515/mamm.1980.44.3.343; BHATTACHARYA G. C., 1941, CURRENT SCI, V10, P183; Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5; Blackledge TA, 2011, J ARACHNOL, V39, P205, DOI 10.1636/Chi10-52.1; Brown Rafe M., 1996, Herpetological Natural History, V4, P1; Burles DW, 2008, CAN J ZOOL, V86, P1367, DOI 10.1139/Z08-125; Cantor T., 1842, J NAT HIST, V9, P481, DOI 10.1080/03745484209445368; Ceballos L, 2005, J ARACHNOL, V33, P509, DOI 10.1636/04-74.1; Churchill S, 2008, AUSTR BATS, V2nd; Conniff R, 1996, NATL GEOGR, V190, P99; Cox James A., 2007, Florida Field Naturalist, V35, P46; CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x; Das Karumampoyil Sakthidas Anoop, 2012, Tropical Natural History, V12, P257; Deans A, 2011, SPIDER CAPTURES BIRD; Diniz Suzana, 2011, Herpetology Notes, V4, P357; Douangboubpha B, 2010, ACTA CHIROPTEROL, V12, P415, DOI 10.3161/150811010X537990; Duca C, 2007, REV BRAS ORNITOL, V15, P615; Ebenstein DM, 2006, J MATER RES, V21, P2035, DOI 10.1557/JMR.2006.0246; Edwards GB, 2009, EENY160 U FLOR I FOO, V160; EISNER T, 1964, SCIENCE, V146, P1058, DOI 10.1126/science.146.3647.1058; EISNER T, 1976, P NATL ACAD SCI USA, V73, P1365, DOI 10.1073/pnas.73.4.1365; EISNER T, 1983, SCIENCE, V219, P185, DOI 10.1126/science.219.4581.185; FENTON MB, 1981, J MAMMAL, V62, P233, DOI 10.2307/1380701; Fitzinger LJFJ, 1870, SITZUNGSBERICHTE MN, V61, P123; FORMANOWICZ DR, 1981, HERPETOLOGICA, V37, P125; FULLARD JH, 1991, AUST J ZOOL, V39, P427, DOI 10.1071/ZO9910427; Funakoshi Kimitake, 1998, Mammal Study, V23, P49, DOI 10.3106/mammalstudy.23.49; Funakoshi K, 2010, MAMM STUDY, V35, P65, DOI 10.3106/041.035.0105; Garcia Rivera L., 2009, B SOC ENTOMOLOGICA A, V45, P505; Gertsch W.J., 1979, AM SPIDERS; Gillette DD, 1970, BATS, P262; Goiti U, 2011, FOLIA ZOOL, V60, P17; GOULD EDWIN, 1955, JOUR MAMMAL, V36, P399, DOI 10.2307/1375682; Graham DL, 1997, J FIELD ORNITHOL, V68, P98; Gregoric M, 2011, J ARACHNOL, V39, P287, DOI 10.1636/CB10-95.1; Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847; Griffin DR, 1958, LISTENING DARK; Grundwald J-E, 2004, THESIS LMU MUNICH GE; GUPPY A, 1988, J COMP PHYSIOL A, V162, P653, DOI 10.1007/BF01342641; Hamidy Amir, 2010, Herpetological Review, V41, P66; HAPPOLD DCD, 1987, MAMMALIA, V51, P337, DOI 10.1515/mamm.1987.51.3.337; Harries DB, 2008, J CAVE KARST STUD, V70, P163; Harvey MS, 2007, INVERTEBR SYST, V21, P407, DOI 10.1071/IS05016; Hermanson JW, 2008, CELLS TISSUES ORGANS, V187, P24, DOI 10.1159/000109961; HERMANSON JW, 1986, J MAMMAL, V67, P751, DOI 10.2307/1381140; Higgins L, 2002, OIKOS, V99, P377, DOI 10.1034/j.1600-0706.2002.990220.x; HIGGINS LE, 1987, J ARACHNOL, V15, P401; Higgins L, 2011, J ARACHNOL, V39, P399, DOI 10.1636/B11-18.1; Higgins L, 2011, EVOL ECOL, V25, P1289, DOI 10.1007/s10682-011-9475-9; Hill DS, 1982, INSECTS HONG KONG; Hill J., 1984, BATS NATURAL HIST; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Huang CY, 2000, THESIS NATL SUN YAT; Jaeger Peter, 2001, Zoosystema, V23, P461; Jager P, 2005, REV SUISSE ZOOL, V112, P87; James D., 2007, CHRISTMAS ISLAND BIO; JONES G, 1993, P ROY SOC B-BIOL SCI, V251, P119, DOI 10.1098/rspb.1993.0017; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; KASTON BJ, 1965, AM MIDL NAT, V73, P336, DOI 10.2307/2423458; Kershaw JCW, 1905, T ROY ENT SOC LONDON, V53, P5; Kilgore CH, 2008, THESIS AUBURN U AUBU; KOH JKH, 2000, GUIDE COMMON SINGAPO; KRULL D, 1991, BEHAV ECOL SOCIOBIOL, V28, P247; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1; Kuntner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007516; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Laduc Travis J., 1993, Bat Research News, V34, P58; Lausen Cori L., 2005, Mammalian Species, P1; LAVAL RK, 1977, J MAMMAL, V58, P403, DOI 10.2307/1379339; Le Souef D., 1915, Emu Melbourne, V14; Lee YF, 2005, ZOOL STUD, V44, P95; Leen N, 1969, WORLD BATS; LEVI H W, 1980, Bulletin of the Museum of Comparative Zoology, V149, P1; Levi Herbert W., 2004, Bulletin of the Museum of Comparative Zoology, V158, P47, DOI 10.3099/0027-4100(2004)158[47:CANRFT]2.0.CO;2; Levi HW, 1970, PSYCHE, V77, P280; Liat L. B., 1964, Malayan Nature Journal, V18, P20; Lin AQ, 2011, ZOOLOGY, V114, P69, DOI 10.1016/j.zool.2010.11.006; Ma J, 2010, ACTA THERIOL, V55, P315, DOI 10.4098/j.at.0001-7051.064.2009; MANCHI S., 2009, INDIAN BIRDS, V5, P118; Manville R. H., 1963, Mammalia, V27, P361, DOI 10.1515/mamm.1963.27.3.361; Marshall SD, 2001, TARANTULAS OTHER ARA; MASTERS WM, 1990, J INSECT BEHAV, V3, P143, DOI 10.1007/BF01417908; McKeown KC, 1952, AUSTR SPIDERS; MEDWAY, 1972, ZOOL J LINN SOC-LOND, V51, P33; Menkhorst, 2001, FIELD GUIDE MAMMALS, V110; Molinari J, 2005, CARIBB J SCI, V41, P340; Moya-Larano J, 2009, J EVOLUTION BIOL, V22, P954, DOI 10.1111/j.1420-9101.2009.01707.x; Neet C.R., 1990, Bulletin of the British Arachnological Society, V8, P161; Nicholas AC, 2011, J ARACHNOL, V39, P22, DOI 10.1636/Hi09-17.1; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; NYFFELER M, 1987, ENTOMOPHAGA, V32, P367, DOI 10.1007/BF02372445; Ochoa G. Jose, 1994, Trianea, V5, P411; Parker DI, 1996, CAN FIELD NAT, V110, P611; Parker DI, 1997, ARCTIC, V50, P256; Pavey CR, 2000, WILDLIFE RES, V27, P283, DOI 10.1071/WR99054; Peloso PL, 2007, REV BRAS ORNITOL, V15, P461; Platnick N.I., 2013, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001]; RICE DALE W., 1957, JOUR MAMMAL, V38, P15, DOI 10.2307/1376471; Robinson M. H, 1971, Revista Peruana de Entomologia Agricola, V14, P304; Robinson M.H., 1973, Smithsonian Contributions to Zoology, VNo. 149, P1; ROBINSON M H, 1971, Psyche (Cambridge), V78, P123, DOI 10.1155/1971/57182; ROBINSON M H, 1970, Zoological Journal of the Linnean Society, V49, P345, DOI 10.1111/j.1096-3642.1970.tb00746.x; Rosevear D., 1965, BATS W AFRICA; RYPSTRA AL, 1985, J ARACHNOL, V13, P71; Sakai WH, 2007, ORNITOL NEOTROP, V18, P117; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Schuck-Paim C, 2000, BEHAVIOUR, V137, P1331, DOI 10.1163/156853900501953; Schulz M, 1997, J ZOOL, V243, P653, DOI 10.1111/j.1469-7998.1997.tb01967.x; Schulz M, 2000, J MAMMAL, V81, P948, DOI 10.1644/1545-1542(2000)081<0948:DAFBOT>2.0.CO;2; Selden PA, 2011, BIOL LETTERS, V7, P775, DOI 10.1098/rsbl.2011.0228; SHERRIFFS W. RAE, 1934, HONG KONG NATURALIST, V5, P85; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; Simmons Nancy B., 1998, American Museum Novitates, V3239, P1; Sirinivasulu C., 2006, Zoos Print Journal, V21, P2241; SPEAKMAN JR, 1991, MAMMAL REV, V21, P123, DOI 10.1111/j.1365-2907.1991.tb00114.x; Steck CE, 2006, ACTA CHIROPTEROL, V8, P445, DOI 10.3161/1733-5329(2006)8[445:TTNOTG]2.0.CO;2; STEWART MM, 1985, J HERPETOL, V19, P391, DOI 10.2307/1564267; STOWE M K, 1986, P101; Sumer S, 2009, J COMP PHYSIOL A, V195, P463, DOI 10.1007/s00359-009-0424-9; Suter RB, 2000, J ARACHNOL, V28, P300, DOI 10.1636/0161-8202(2000)028[0300:SSALOT]2.0.CO;2; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; Teixeira Dante Martins, 1991, Ararajuba, V2, P69; Threlfall C, 2011, THESIS U NEW S WALES; Timm RM, 2007, CARIBB J SCI, V43, P282; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Weems HV, 2011, GOLDEN SILK SPIDER N; WHITAKER J.O., 1998, MAMMALS E US; WHITAKER JO, 1992, J MAMMAL, V73, P646, DOI 10.2307/1382037; Whitaker JO, 2009, ACTA CHIROPTEROL, V11, P393, DOI 10.3161/150811009X485611; Wilhide J.D., 1998, Journal of the Arkansas Academy of Science, V52, P113; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WILSON DE, 1971, J ZOOL, V163, P1; Woodman N, 2003, CARIBB J SCI, V39, P399; World Association of Zoos and Aquariums (WAZA), 2011, BRAZ SALM PINK LAS P; Zhang L, 2007, J ZOOL, V271, P344, DOI 10.1111/j.1469-7998.2006.00210.x; Zhao HH, 2003, J ZOOL, V259, P189, DOI 10.1017/S0952836902003199; ZUBAID A, 1988, MAMMALIA, V52, P134; [No title captured]	154	57	65	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58120	10.1371/journal.pone.0058120	http://dx.doi.org/10.1371/journal.pone.0058120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516436	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200033
J	Yuan, XW; Zhang, SZ; Liu, SY; Yu, ML; Su, HY; Shu, HR; Li, XZ				Yuan, Xiaowei; Zhang, Shizhong; Liu, Shiyang; Yu, Mingli; Su, Hongyan; Shu, Huairui; Li, Xinzheng			Global Analysis of Ankyrin Repeat Domain C3HC4-Type RING Finger Gene Family in Plants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CELL-CYCLE CONTROL; E3 LIGASE; ABSCISIC-ACID; REGULATORY NETWORKS; FUNCTIONAL-ANALYSIS; STRESS RESPONSES; PROTEIN; DROUGHT; XBAT32	Ankyrin repeat (ANK) C3HC4-type RING finger (RF) genes comprise a large family in plants and play important roles in various physiological processes of plant life. In this study, we identified 187 ANK C3HC4-type RF proteins from 29 species with complete genomes and named the ANK C3HC4-type RF proteins the XB3-like proteins because they are structurally related to the rice (Oryza sativa) XB3. A phylogenetic relationship analysis suggested that the XB3-like genes originated from ferns, and the encoded proteins fell into 3 major groups. Among these groups, we found that the spacing between the metal ligand position 6 and 7, and the conserved residues, which was in addition to the metal ligand amino acids, in the C3HC4-type RF were different. Using a wide range of protein structural analyses, protein models were established, and all XB3-like proteins were found to contain two to seven ANKs and a C3HC4-type RF. The microarray data for the XB3-like genes of Arabidopsis, Oryza sative, Zea mays and Glycine max revealed that the expression of XB3-like genes was in different tissues and during different life stages. The preferential expression of XB3-like genes in specified tissues and the response to phytohormone and abiotic stress treatments of Arabidopsis and Zea mays not only confirmed the microarray analysis data but also demonstrated that the XB3-like proteins play roles in plant growth and development as well as in stress responses. Our data provide a very useful reference for the identification and functional analysis of members of this gene family and also provide a new method for the genome-wide analysis of gene families.	[Yuan, Xiaowei; Zhang, Shizhong; Liu, Shiyang; Yu, Mingli; Shu, Huairui; Li, Xinzheng] Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Shizhong; Shu, Huairui] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China; [Su, Hongyan] Ludong Univ, Yantai, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Ludong University	Li, XZ (corresponding author), Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	lxz@sdau.edu.cn			Natural Science Foundation of China [31110103917, 31170233]; National Basic Research Program of China [2011CB100706]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China (31110103917), Natural Science Foundation of China (31170233) and National Basic Research Program of China (2011CB100706). The funders had roles in study design, data collection and analysis and decision to publish.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Carvalho SD, 2012, MOL PLANT, V5, P1295, DOI 10.1093/mp/sss048; Cerana M, 2006, PLANT BIOLOGY, V8, P572, DOI 10.1055/s-2006-924111; CHAO S, 1984, NUCLEIC ACIDS RES, V12, P6629, DOI 10.1093/nar/12.16.6629; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding Y, 2011, PLANT J, V66, P735, DOI 10.1111/j.1365-313X.2011.04534.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gechev TS, 2012, CELLULAR MOL LIFE SC, P1; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Hatfield PM, 1997, PLANT J, V11, P213, DOI 10.1046/j.1365-313X.1997.11020213.x; Huang JY, 2009, PLANT MOL BIOL, V71, P207, DOI 10.1007/s11103-009-9518-6; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KAULEN H, 1991, MOL CELL BIOL, V11, P412, DOI 10.1128/MCB.11.1.412; Kempa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003935; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035682; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Lyzenga WJ, 2012, PLANT J, V71, P23, DOI 10.1111/j.1365-313X.2012.04965.x; Ma K, 2009, GENE, V444, P33, DOI 10.1016/j.gene.2009.05.018; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mistry Jaina, 2007, V396, P43; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nodzon LA, 2004, PLANT J, V40, P996, DOI 10.1111/j.1365-313X.2004.02266.x; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Prasad ME, 2010, PLANT SIGNAL BEHAV, V5, P1425, DOI [10.4161/psb.5.11.13294, 10.1104/pp.110.156976]; Prasad ME, 2010, PLANT PHYSIOL, V153, P1587, DOI 10.1104/pp.110.156976; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Seiler C, 2011, J EXP BOT, V62, P2615, DOI 10.1093/jxb/erq446; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todaka D, 2012, RICE, V5, DOI 10.1186/1939-8433-5-6; Unver T, 2012, PLANT MOL BIOL REP, P1; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Vanstraelen M, 2012, ANN REV CELL DEV BIO, P28; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Wu Xiaoming, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P455; Xu XJ, 2007, J EXP BOT, V58, P3623, DOI 10.1093/jxb/erm212; Yang XH, 2008, J BIOSCIENCES, V33, P103, DOI 10.1007/s12038-008-0026-7; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	62	17	20	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58003	10.1371/journal.pone.0058003	http://dx.doi.org/10.1371/journal.pone.0058003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516424	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200024
J	Deng, JY; Su, SC; Lin, XD; Hassett, DJ; Lu, LJ				Deng, Jingyuan; Su, Shengchang; Lin, Xiaodong; Hassett, Daniel J.; Lu, Long Jason			A Statistical Framework for Improving Genomic Annotations of Prokaryotic Essential Genes	PLOS ONE			English	Article							PREDICTING ESSENTIAL GENES; TRANSPOSON MUTANT LIBRARY; FLUX-BALANCE ANALYSIS; PSEUDOMONAS-AERUGINOSA; IDENTIFICATION; MUTAGENESIS; DELETION; RECONSTRUCTION; VIRULENCE; INSERTION	Large-scale systematic analysis of gene essentiality is an important step closer toward unraveling the complex relationship between genotypes and phenotypes. Such analysis cannot be accomplished without unbiased and accurate annotations of essential genes. In current genomic databases, most of the essential gene annotations are derived from whole-genome transposon mutagenesis (TM), the most frequently used experimental approach for determining essential genes in microorganisms under defined conditions. However, there are substantial systematic biases associated with TM experiments. In this study, we developed a novel Poisson model-based statistical framework to simulate the TM insertion process and subsequently correct the experimental biases. We first quantitatively assessed the effects of major factors that potentially influence the accuracy of TM and subsequently incorporated relevant factors into the framework. Through iteratively optimizing parameters, we inferred the actual insertion events occurred and described each gene's essentiality on probability measure. Evaluated by the definite mapping of essential gene profile in Escherichia coli, our model significantly improved the accuracy of original TM datasets, resulting in more accurate annotations of essential genes. Our method also showed encouraging results in improving subsaturation level TM datasets. To test our model's broad applicability to other bacteria, we applied it to Pseudomonas aeruginosa PAO1 and Francisella tularensis novicida TM datasets. We validated our predictions by literature as well as allelic exchange experiments in PAO1. Our model was correct on six of the seven tested genes. Remarkably, among all three cases that our predictions contradicted the TM assignments, experimental validations supported our predictions. In summary, our method will be a promising tool in improving genomic annotations of essential genes and enabling large-scale explorations of gene essentiality. Our contribution is timely considering the rapidly increasing essential gene sets. A Webserver has been set up to provide convenient access to this tool. All results and source codes are available for download upon publication at http://research.cchmc.org/essentialgene/.	[Deng, Jingyuan; Lu, Long Jason] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH USA; [Deng, Jingyuan; Lu, Long Jason] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Su, Shengchang; Hassett, Daniel J.] Univ Cincinnati, Dept Biochem & Mol Genet, Cincinnati, OH USA; [Lu, Long Jason] Univ Cincinnati, Dept Comp Sci, Cincinnati, OH 45221 USA; [Lin, Xiaodong] Rutgers State Univ, Dept Management Sci & Informat Syst, Piscataway, NJ USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Rutgers State University New Brunswick	Lu, LJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH USA.	long.lu@cchmc.org	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022		CCHMC Trustee Award; Cystic Fibrosis Foundation [HASSETT07G0, R457-CR01]	CCHMC Trustee Award; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by the CCHMC Trustee Award to LJL; and Cystic Fibrosis Foundation grants HASSETT07G0 and R457-CR01 to DJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Balakrishnan N, 2000, ADV STOCHASTIC SIMUL, Vxxvi; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Berg DE, 1989, MOBILE DNA, Vxii; Blades NJ, 2002, MS0220 J HOPK U DEP; Bruccoleri RE, 1998, NUCLEIC ACIDS RES, V26, P4482, DOI 10.1093/nar/26.19.4482; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Deng JY, 2012, BIOMOLECULES, V2, P1, DOI 10.3390/biom2010001; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; GOOD IJ, 1986, STAT SCI, V1, P157, DOI 10.1214/ss/1177013690; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hamer L, 2001, CURR OPIN CHEM BIOL, V5, P67, DOI 10.1016/S1367-5931(00)00162-9; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Imam S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-116; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Joyce Andrew R., 2008, V416, P433, DOI 10.1007/978-1-59745-321-9_30; Judson N, 2000, TRENDS MICROBIOL, V8, P521, DOI 10.1016/S0966-842X(00)01865-5; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lamichhane G, 2011, MBIO, V2, DOI 10.1128/mBio.00301-10; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lehmann EL, 1998, THEORY POINT ESTIMAT, Vxxvi; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mendum TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r127; Molina-Henares MA, 2010, ENVIRON MICROBIOL; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Mushegian A, 1999, CURR OPIN GENET DEV, V9, P709, DOI 10.1016/S0959-437X(99)00023-4; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Ross SM, 1996, STOCHASTIC PROCESSES, Vxv; Saha S, 2006, GENET MOL RES, V5, P224; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Soemphol W, 2011, BIOSCI BIOTECH BIOCH, V75, P1921, DOI 10.1271/bbb.110310; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Stahl M, 2011, FUNCT INTEGR GENOMIC, V11, P241, DOI 10.1007/s10142-011-0214-7; Sundin C, 2004, MICROB PATHOGENESIS, V37, P313, DOI 10.1016/j.micpath.2004.10.005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zolman J., 1993, BIOSTATISTICS EXPT D	54	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58178	10.1371/journal.pone.0058178	http://dx.doi.org/10.1371/journal.pone.0058178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520492	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900051
J	Jhas, B; Sriskanthadevan, S; Skrtic, M; Sukhai, MA; Voisin, V; Jitkova, Y; Gronda, M; Hurren, R; Laister, RC; Bader, GD; Minden, MD; Schimmer, AD				Jhas, Bozhena; Sriskanthadevan, Shrivani; Skrtic, Marko; Sukhai, Mahadeo A.; Voisin, Veronique; Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Laister, Rob C.; Bader, Gary D.; Minden, Mark D.; Schimmer, Aaron D.			Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CYTOTOXICITY ASSAY; ANTICANCER-DRUG; LACTIC-ACIDOSIS; COMPLEX-III; FACTOR-I; DNA; TRANSLATION; TISSUES; MECHANISM	Recently, we demonstrated that the anti-bacterial agent tigecycline preferentially induces death in leukemia cells through the inhibition of mitochondrial protein synthesis. Here, we sought to understand mechanisms of resistance to tigecycline by establishing a leukemia cell line resistant to the drug. TEX leukemia cells were treated with increasing concentrations of tigecycline over 4 months and a population of cells resistant to tigecycline (RTEX+TIG) was selected. Compared to wild type cells, RTEX+TIG cells had undetectable levels of mitochondrially translated proteins Cox-1 and Cox-2, reduced oxygen consumption and increased rates of glycolysis. Moreover, RTEX+TIG cells were more sensitive to inhibitors of glycolysis and more resistant to hypoxia. By electron microscopy, RTEX+TIG cells had abnormally swollen mitochondria with irregular cristae structures. RNA sequencing demonstrated a significant over-representation of genes with binding sites for the HIF1 alpha:HIF1 beta transcription factor complex in their promoters. Upregulation of HIF1a mRNA and protein in RTEX+TIG cells was confirmed by Q-RTPCR and immunoblotting. Strikingly, upon removal of tigecycline from RTEX+TIG cells, the cells reestablished aerobic metabolism. Levels of Cox-1 and Cox-2, oxygen consumption, glycolysis, mitochondrial mass and mitochondrial membrane potential returned to wild type levels, but HIF1a remained elevated. However, upon re-treatment with tigecycline for 72 hours, the glycolytic phenotype was re-established. Thus, we have generated cells with a reversible metabolic phenotype by chronic treatment with an inhibitor of mitochondrial protein synthesis. These cells will provide insight into cellular adaptations used to cope with metabolic stress.	[Jhas, Bozhena; Sriskanthadevan, Shrivani; Skrtic, Marko; Sukhai, Mahadeo A.; Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Laister, Rob C.; Minden, Mark D.; Schimmer, Aaron D.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Jhas, Bozhena; Sriskanthadevan, Shrivani; Skrtic, Marko; Sukhai, Mahadeo A.; Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Laister, Rob C.; Minden, Mark D.; Schimmer, Aaron D.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Voisin, Veronique; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Schimmer, AD (corresponding author), Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada.	aaron.schimmer@utoronto.ca	Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861; Schimmer, Aaron/0000-0003-4023-3899; Pirahas, Shrivani/0000-0002-6361-4769	Canadian Stem Cell Network; Leukemia and Lymphoma Society; National Institutes of Health [NCI 1R01CA157456]; Ontario Ministry of Research and Innovation; Princess Margaret Hospital Foundation; Ministry of Long Term Health; U.S. National Institutes of Health [U.S. National Institutes of Health grant GM103504]; Ontario Graduate Scholarship; Canadian Institutes of Health Research Post-Doctoral Fellow; Leukemia and Lymphoma Society Scholar in clinical research; NATIONAL CANCER INSTITUTE [R01CA157456, R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	Canadian Stem Cell Network; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Princess Margaret Hospital Foundation; Ministry of Long Term Health; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research Post-Doctoral Fellow; Leukemia and Lymphoma Society Scholar in clinical research(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Stem Cell Network, the Leukemia and Lymphoma Society, the National Institutes of Health (NCI 1R01CA157456), the Ontario Institute of Cancer Research with funding provided by the Ontario Ministry of Research and Innovation, the Princess Margaret Hospital Foundation, and the Ministry of Long Term Health and Planning in the Province of Ontario and U.S. National Institutes of Health grant GM103504 (GDB). B.J. is supported by Ontario Graduate Scholarship. M.A.S. is a Canadian Institutes of Health Research Post-Doctoral Fellow. A.D.S. is a Leukemia and Lymphoma Society Scholar in clinical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025; Chen R, 2011, ONCOGENE, V30, P2570, DOI 10.1038/onc.2010.623; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jung C, 2000, ANAL BIOCHEM, V286, P214, DOI 10.1006/abio.2000.4813; Kaplan NO, 1955, METHODS ENZYMOOGY; Kim HM, 1996, J PHARMACOL TOXICOL, V36, P163; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4; Lo S, 2005, INT J ONCOL, V27, P337; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Olson MW, 2006, ANTIMICROB AGENTS CH, V50, P2156, DOI 10.1128/AAC.01499-05; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290; Schimmer AD, 2006, CANCER RES, V66, P2367, DOI 10.1158/0008-5472.CAN-05-1061; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; ZHENG X, 1989, NEUROLOGY, V39, P1203, DOI 10.1212/WNL.39.9.1203	37	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58367	10.1371/journal.pone.0058367	http://dx.doi.org/10.1371/journal.pone.0058367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520503	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900062
J	Miyauchi, C; Kitazawa, D; Ando, I; Hayashi, D; Inoue, YH				Miyauchi, Chie; Kitazawa, Daishi; Ando, Itaru; Hayashi, Daisuke; Inoue, Yoshihiro H.			Orbit/CLASP Is Required for Germline Cyst Formation through Its Developmental Control of Fusomes and Ring Canals in Drosophila Males	PLOS ONE			English	Article							ASYMMETRIC STEM-CELL; OOCYTE DIFFERENTIATION; MICROTUBULE NETWORK; MITOTIC SPINDLES; CONTRACTILE RING; PROTEINS; ORIENTATION; DIVISIONS; SPECTRIN; SPECIFICATION	Orbit, a Drosophila ortholog of microtubule plus-end enriched protein CLASP, plays an important role in many developmental processes involved in microtubule dynamics. Previous studies have shown that Orbit is required for asymmetric stem cell division and cystocyte divisions in germline cysts and for the development of microtubule networks that interconnect oocyte and nurse cells during oogenesis. Here, we examined the cellular localization of Orbit and its role in cyst formation during spermatogenesis. In male germline stem cells, distinct localization of Orbit was first observed on the spectrosome, which is a spherical precursor of the germline-specific cytoskeleton known as the fusome. In dividing stem cells and spermatogonia, Orbit was localized around centrosomes and on kinetochores and spindle microtubules. After cytokinesis, Orbit remained localized on ring canals, which are cytoplasmic bridges between the cells. Thereafter, it was found along fusomes, extending through the ring canal toward all spermatogonia in a cyst. Fusome localization of Orbit was not affected by microtubule depolymerization. Instead, our fluorescence resonance energy transfer experiments suggested that Orbit is closely associated with F-actin, which is abundantly found in fusomes. Surprisingly, F-actin depolymerization influenced neither fusome organization nor Orbit localization on the germline-specific cytoskeleton. We revealed that two conserved regions of Orbit are required for fusome localization. Using orbit hypomorphic mutants, we showed that the protein is required for ring canal formation and for fusome elongation mediated by the interaction of newly generated fusome plugs with the pre-existing fusome. The orbit mutation also disrupted ring canal clustering, which is essential for folding of the spermatogonia after cytokinesis. Orbit accumulates around centrosomes at the onset of spermatogonial mitosis and is required for the capture of one of the duplicated centrosomes onto the fusome. Moreover, Orbit is involved in the proper orientation of spindles towards fusomes during synchronous mitosis of spermatogonial cysts.	[Miyauchi, Chie; Kitazawa, Daishi; Ando, Itaru; Hayashi, Daisuke; Inoue, Yoshihiro H.] Kyoto Inst Technol, Grad Sch Sci & Technol, Insect Biomed Res Ctr, Kyoto 606, Japan	Kyoto Institute of Technology	Inoue, YH (corresponding author), Kyoto Inst Technol, Grad Sch Sci & Technol, Insect Biomed Res Ctr, Kyoto 606, Japan.	yhinoue@kit.ac.jp			 [2301301501];  [2357000400]	; 	This work was supported by Grants-in-Aid for Scientific Research on Priority Area in Japan to YHI (2301301501) and for Scientific Research (C) to YHI (2357000400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Aonuma M, 2005, CELL STRUCT FUNCT, V30, P7, DOI 10.1247/csf.30.7; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; deCuevas M, 1996, DEVELOPMENT, V122, P3959; DENG HY, 1995, J CELL BIOL, V128, P71, DOI 10.1083/jcb.128.1.71; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fuller Margaret T., 1993, P71; Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hime GR, 1996, J CELL SCI, V109, P2779; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Inoue YH, 2004, J CELL BIOL, V166, P49, DOI 10.1083/jcb.200402052; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Inoue YH, 2012, INTECH; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kitazawa D, 2012, J CELL SCI, V125, P3649, DOI 10.1242/jcs.103317; Lee KS, 2010, INSECT MOL BIOL, V19, P131, DOI 10.1111/j.1365-2583.2009.00955.x; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu Z, 1999, DEVELOPMENT, V126, P4477; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Mathe E, 2003, DEVELOPMENT, V130, P901, DOI 10.1242/dev.00315; McGrail M, 1997, DEVELOPMENT, V124, P2409; Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; Roper K, 2004, CURR BIOL, V14, P99, DOI 10.1016/j.cub.2003.12.056; Roper K, 2007, J CELL SCI, V120, P1081, DOI 10.1242/jcs.03407; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Spradling Allan C., 1993, P1; Tates AD, 1971, THESIS RIJKSUNIVERSI; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Wilson PG, 1999, CURR BIOL, V9, P923, DOI 10.1016/S0960-9822(99)80400-X; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313; Yuan HB, 2012, DEV BIOL, V361, P57, DOI 10.1016/j.ydbio.2011.10.010; YUE L, 1992, GENE DEV, V6, P2443, DOI 10.1101/gad.6.12b.2443	53	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58220	10.1371/journal.pone.0058220	http://dx.doi.org/10.1371/journal.pone.0058220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520495	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900054
J	Kahali, B; Gramling, SJB; Marquez, SB; Thompson, K; Lu, L; Reisman, D				Kahali, B.; Gramling, S. J. B.; Marquez, S. B.; Thompson, K.; Lu, L.; Reisman, D.			Identifying targets for the restoration and reactivation of BRM	ONCOGENE			English	Article						epigenetic; histone transferase; SWI/SNF; histone deacetylase complex; tumor suppressor; brahma	HUMAN LUNG-CANCER; CHROMATIN-REMODELING FACTOR; II HISTONE DEACETYLASES; SWI/SNF COMPLEX; GENE-EXPRESSION; BREAST-CANCER; CELL-LINES; TRANSCRIPTIONAL ACTIVITY; RAS MUTATIONS; DNA-BINDING	Brahma (BRM) is a novel anticancer gene, which is frequently inactivated in a variety of tumor types. Unlike many anticancer genes, BRM is not mutated, but rather epigenetically silenced. In addition, histone deacetylase complex (HDAC) inhibitors are known to reverse BRM silencing, but they also inactivate it via acetylation of its C-terminus. High-throughput screening has uncovered many compounds that are effective at pharmacologically restoring BRM and thereby inhibit cancer cell growth. As we do not know which specific proteins, if any, regulate BRM, we sought to identify the proteins, which underlie the epigenetic suppression of BRM. By selectively knocking down each HDAC, we found that HDAC3 and HDAC9 regulate BRM expression, whereas HDAC2 controls its acetylation. Similarly, we ectopically overexpressed 21 different histone acetyltransferases and found that KAT6A, KAT6B and KAT7 induce BRM expression, whereas KAT2B and KAT8 induce its acetylation. We also investigated the role of two transcription factors (TFs) linked to either BRM (GATA3) or HDAC9 (MEF2D) expression. Knockdown of either GATA3 and/or MEF2D downregulated HDAC9 and induced BRM. As targets for molecular biotherapy are typically uniquely, or simply differentially expressed in cancer cells, we also determined if any of these proteins are dysregulated. However, by sequencing, no mutations were found in any of these BRM-regulating HDACs, HATs or TFs. We selectively knocked down GATA3, MEF2D, HDAC3 and HDAC9, and found that each gene-specific knockdown induced growth inhibition. We observed that both GATA3 and HDAC9 were greatly overexpressed only in BRM-negative cell lines indicating that HDAC9 may be a good target for therapy. We also found that the mitogen-activated protein (MAP) kinase pathway regulates both BRM acetylation and BRM silencing as MAP kinase pathway inhibitors both induced BRM as well as caused BRM deacetylation. Together, these data identify a cadre of key proteins, which underlie the epigenetic regulation of BRM.	[Kahali, B.; Gramling, S. J. B.; Marquez, S. B.; Thompson, K.; Reisman, D.] Univ Florida, Dept Med, Dept Hematol Oncol, Gainesville, FL 32610 USA; [Lu, L.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Reisman, D (corresponding author), Univ Florida, Dept Med, Dept Hematol Oncol, Gainesville, FL 32610 USA.	dnreisman@ufl.edu	Kahali, Bhaskar/N-6398-2018	Kahali, Bhaskar/0000-0003-4160-7979	 [5R01CA136683-03]; NATIONAL CANCER INSTITUTE [R01CA136683] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Rachel Dresbeck for her time and effort in editing the manuscript. This research was supported by 5R01CA136683-03 Identifying Agents which Restored BRM expression.	Albergaria A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2327; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Avvakumov Nikita, 2007, Subcell Biochem, V41, P295; Balch C, 2005, FRONT BIOSCI-LANDMRK, V10, P1897, DOI 10.2741/1668; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Bock VL, 2011, BRIT J DERMATOL, V164, P1221, DOI 10.1111/j.1365-2133.2011.10267.x; Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621; Brose MS, 2002, CANCER RES, V62, P6997; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Califano R, 2012, DRUGS, V72, P28, DOI 10.2165/1163012-S0-000000000-00000; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de Castro-Carpeno J, 2008, CLIN TRANSL ONCOL, V10, P6, DOI 10.1007/s12094-008-0147-3; DelBove J, 2011, EPIGENETICS-US, V6, P1444, DOI 10.4161/epi.6.12.18492; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Dwarakanath BS, 2008, INDIAN J MED RES, V128, P13; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gervais C, 2008, LEUKEMIA, V22, P1567, DOI 10.1038/leu.2008.128; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gordon VS, 2010, ONCOL REV, V4, P89, DOI 10.1007/s12156-010-0040-5; Gramling S, 2011, ONCOGENE, V30, P3289, DOI 10.1038/onc.2011.80; Gramling S, 2011, LETT DRUG DES DISCOV, V8, P93, DOI 10.2174/157018011793663840; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Hess-Stumpp H, 2005, EUR J CELL BIOL, V84, P109, DOI 10.1016/j.ejcb.2004.12.010; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; Itoh T, 2008, BIOCHEM BIOPH RES CO, V366, P827, DOI 10.1016/j.bbrc.2007.12.026; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Konofaos P, 2006, SURG ONCOL, V15, P257, DOI 10.1016/j.suronc.2007.03.004; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; LAURENT BC, 1993, COLD SPRING HARB SYM, V58, P257, DOI 10.1101/SQB.1993.058.01.030; Lee JH, 2005, MOL CELLS, V19, P289; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Marijon H, 2011, B CANCER, V98, P1011, DOI 10.1684/bdc.2011.1379; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Medina PP, 2004, GENE CHROMOSOME CANC, V41, P170, DOI 10.1002/gcc.20068; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Mizutani T, 2002, J BIOL CHEM, V277, P15859, DOI 10.1074/jbc.M112421200; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; Moreno DA, 2010, BRIT J HAEMATOL, V150, P665, DOI 10.1111/j.1365-2141.2010.08301.x; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Nakada S, 2001, ANTICANCER RES, V21, P167; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Ozawa Y, 2001, BLOOD, V98, P2116, DOI 10.1182/blood.V98.7.2116; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reisman DN, 2003, CANCER RES, V63, P560; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Rodriguez-Nieto S, 2011, HUM MUTAT, V32, pE1999, DOI 10.1002/humu.21415; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Skov V, 2012, LEUKEMIA LYMPHOMA, V53, P123, DOI 10.3109/10428194.2011.597905; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Strobeck MW, 2001, J BIOL CHEM, V276, P9273, DOI 10.1074/jbc.M009747200; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Tagliabue E, 2010, EXPERT OPIN BIOL TH, V10, P711, DOI 10.1517/14712591003689972; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	85	38	40	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					653	664		10.1038/onc.2012.613	http://dx.doi.org/10.1038/onc.2012.613			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23524580				2022-12-25	WOS:000331125100013
J	Alvares, K; Stern, PH; Veis, A				Alvares, Keith; Stern, Paula H.; Veis, Arthur			Dentin Phosphoprotein Binds Annexin 2 and Is Involved in Calcium Transport in Rat Kidney Ureteric Bud Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; BONE SIALOPROTEIN; SIBLING PROTEINS; INCISOR DENTIN; II TETRAMER; EXPRESSION; PHOSPHOPHORYN; SIALOPHOSPHOPROTEIN; COMPLEX; MINERALIZATION	Dentin phosphoprotein (DPP) is the most abundant noncollagenous protein in the dentin, where it plays a major role in the mineralization of dentin. However, we and others have shown that in addition to being present in the dentin, DPP is also present in nonmineralizing tissues like the kidney, lung, and salivary glands, where it conceivably has other functions such as in calcium transport. Because annexins have been implicated as calcium transporters, we examined the relationships between DPP and annexins. In this report, we show that DPP binds to annexin 2 and 6 present in a rat ureteric bud cell line (RUB1). Immunofluorescence studies show that annexin 2 and DPP colocalize in these cells. In addition, DPP and annexin 2 colocalize in the ureteric bud branches of embryonic metanephric kidney. In the RUB1 cells and ureteric bud branches of embryonic kidney, colocalization was restricted to the cell membrane. Studies on calcium influx into RUB cells show that in the presence of anti-DPP, there was a 40% reduction of calcium influx into these cells. We postulate that DPP has different functions in the kidney as compared with the odontoblasts. In the odontoblasts, its primary function is in the extracellular mineralization of dentin, whereas in the kidney it may participate in calcium transport.	[Alvares, Keith; Veis, Arthur] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Stern, Paula H.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Alvares, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	k-alvares@northwestern.edu		Alvares, Keith/0000-0003-3710-4367	National Institutes of Health [DE001374]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE001374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE001374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE001374 (to A.V.).	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Burn SF, 2011, DEV BIOL, V352, P288, DOI 10.1016/j.ydbio.2011.01.033; Butler WT, 2002, CONNECT TISSUE RES, V43, P301, DOI 10.1080/03008200290000682; Chaplet M, 2006, INT J CANCER, V118, P850, DOI 10.1002/ijc.21442; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; DIMUZIO MT, 1978, CALC TISS RES, V25, P169, DOI 10.1007/BF02010765; DIMUZIO MT, 1978, J BIOL CHEM, V253, P6845; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Fitzpatrick SL, 2000, BIOCHEMISTRY-US, V39, P1021, DOI 10.1021/bi991411z; George A, 1999, CONNECT TISSUE RES, V40, P49, DOI 10.3109/03008209909005277; Gilbert T, 2011, BIOCHIMIE, V93, P2126, DOI 10.1016/j.biochi.2011.07.007; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Hao JJ, 2009, J HISTOCHEM CYTOCHEM, V57, P227, DOI 10.1369/jhc.2008.952119; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026; Lewit-Bentley A, 2000, CELL BIOL INT, V24, P799, DOI 10.1006/cbir.2000.0629; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; MACDOUGALL M, 1985, BIOCHEM J, V232, P493, DOI 10.1042/bj2320493; Mai JX, 2000, BBA-PROTEIN STRUCT M, V1477, P215, DOI 10.1016/S0167-4838(99)00274-5; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; RAHIMA M, 1988, CALCIFIED TISSUE INT, V42, P104, DOI 10.1007/BF02556342; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Riminucci M, 2003, CALCIFIED TISSUE INT, V73, P281, DOI 10.1007/s00223-002-2134-y; Ritchie HH, 2000, BBA-GENE STRUCT EXPR, V1493, P27, DOI 10.1016/S0167-4781(00)00150-0; Saito T, 2004, ARCH ORAL BIOL, V49, P239, DOI 10.1016/j.archoralbio.2003.08.003; STETLERSTEVENSON WG, 1983, BIOCHEMISTRY-US, V22, P4326, DOI 10.1021/bi00287a025; THIEL C, 1992, J CELL SCI, V103, P733; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; VEIS A, 1988, CIBA F SYMP, V136, P161; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; Veis A., 1982, BIOMINERALIZATION BI, P273; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; ZENG FY, 1993, INT J BIOCHEM, V25, P1019, DOI 10.1016/0020-711X(93)90116-V	48	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13036	13045		10.1074/jbc.M112.389627	http://dx.doi.org/10.1074/jbc.M112.389627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525114	hybrid, Green Published			2022-12-25	WOS:000318555100055
J	Wu, M; Beckham, GT; Larsson, AM; Ishida, T; Kim, S; Payne, CM; Himmel, ME; Crowley, MF; Horn, SJ; Westereng, B; Igarashi, K; Samejima, M; Stahlberg, J; Eijsink, VGH; Sandgren, M				Wu, Miao; Beckham, Gregg T.; Larsson, Anna M.; Ishida, Takuya; Kim, Seonah; Payne, Christina M.; Himmel, Michael E.; Crowley, Michael F.; Horn, Svein J.; Westereng, Bjorge; Igarashi, Kiyohiko; Samejima, Masahiro; Stahlberg, Jerry; Eijsink, Vincent G. H.; Sandgren, Mats			Crystal Structure and Computational Characterization of the Lytic Polysaccharide Monooxygenase GH61D from the Basidiomycota Fungus Phanerochaete chrysosporium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; GLYCOSIDE HYDROLASE FAMILY; CELLOBIOSE DEHYDROGENASE; LIGNOCELLULOSIC BIOMASS; SERRATIA-MARCESCENS; CELLULOSE; ENZYMES; DEGRADATION; RESOLUTION; SEQUENCE	Carbohydrate structures are modified and degraded in the biosphere by a myriad of mostly hydrolytic enzymes. Recently, lytic polysaccharide mono-oxygenases (LPMOs) were discovered as a new class of enzymes for cleavage of recalcitrant polysaccharides that instead employ an oxidative mechanism. LPMOs employ copper as the catalytic metal and are dependent on oxygen and reducing agents for activity. LPMOs are found in many fungi and bacteria, but to date no basidiomycete LPMO has been structurally characterized. Here we present the three-dimensional crystal structure of the basidiomycete Phanerochaete chrysosporium GH61D LPMO, and, for the first time, measure the product distribution ofLPMOaction on a lignocellulosic substrate. The structure reveals a copper-bound active site common to LPMOs, a collection of aromatic and polar residues near the binding surface that may be responsible for regioselectivity, and substantial differences in loop structures near the binding face compared with other LPMO structures. The activity assays indicate that this LPMO primarily produces aldonic acids. Last, molecular simulations reveal conformational changes, including the binding of several regions to the cellulose surface, leading to alignment of three tyrosine residues on the binding face of the enzyme with individual cellulose chains, similar to what has been observed for family 1 carbohydrate-binding modules. A calculated potential energy surface for surface translation indicates that P. chrysosporium GH61D exhibits energy wells whose spacing seems adapted to the spacing of cellobiose units along a cellulose chain.	[Wu, Miao; Larsson, Anna M.; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, SE-75007 Uppsala, Sweden; [Beckham, Gregg T.; Kim, Seonah] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; [Horn, Svein J.; Westereng, Bjorge] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; University of Tokyo; University of Kentucky; Norwegian University of Life Sciences	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; mats.sandgren@slu.se	Horn, Svein Jarle/C-6258-2008; Payne, Christina M/C-7338-2011; crowley, michael F/A-4852-2013; Payne, Christina/ABE-8330-2020; Igarashi, Kiyohiko/E-6799-2016; Westereng, Bjørge/A-1688-2013; Stahlberg, Jerry/D-4163-2013	Horn, Svein Jarle/0000-0002-1590-9001; Payne, Christina M/0000-0001-5264-0964; crowley, michael F/0000-0001-5163-9398; Payne, Christina/0000-0001-5264-0964; Igarashi, Kiyohiko/0000-0001-5152-7177; Westereng, Bjørge/0000-0002-5141-7231; Stahlberg, Jerry/0000-0003-4059-8580; Sandgren, Mats/0000-0002-2358-4534	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program MicroDrivE; Japan Society for the Promotion of Science (JSPS); Department of Energy Office of the Biomass Program; Norwegian Research Council [218425, 193817, 196885, 214613]; Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program MicroDrivE; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program MicroDrivE and by the Japan Society for the Promotion of Science (JSPS) through a fellowship (to T.I.).; Supported by the Department of Energy Office of the Biomass Program.; Supported by Norwegian Research Council Grant 218425.; Supported in part by Norwegian Research Council Grants 193817, 196885, and 214613.; Supported by the Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adav SS, 2012, J PROTEOMICS, V75, P1493, DOI 10.1016/j.jprot.2011.11.020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bey M., 2012, APPL ENVIRON MICROB, V287, P3147; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dimarogona M, 2012, BIORESOURCE TECHNOL, V110, P480, DOI 10.1016/j.biortech.2012.01.116; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Habu N, 1997, BIOTECHNOL APPL BIOC, V26, P97; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Henriksson G, 1999, EUR J BIOCHEM, V259, P88, DOI 10.1046/j.1432-1327.1999.00011.x; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hori C, 2011, FEMS MICROBIOL LETT, V321, P14, DOI 10.1111/j.1574-6968.2011.02307.x; Horn SJ, 2011, BIOMASS BIOENERG, V35, P4879, DOI 10.1016/j.biombioe.2011.10.013; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawai R, 2006, BIOTECHNOL LETT, V28, P365, DOI 10.1007/s10529-005-6179-7; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Matthews JF, 2012, J CHEM THEORY COMPUT, V8, P735, DOI 10.1021/ct2007692; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCCRACKEN J, 1987, J AM CHEM SOC, V109, P4064, DOI 10.1021/ja00247a037; MURSHUDOV G, 1996, REFINEMENT PROTEIN S; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Tsukada T, 2006, APPL MICROBIOL BIOT, V73, P807, DOI 10.1007/s00253-006-0526-z; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353	73	131	137	4	131	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12828	12839		10.1074/jbc.M113.459396	http://dx.doi.org/10.1074/jbc.M113.459396			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525113	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000318555100038
J	Neumann, H; Gunther, C; Vieth, M; Grauer, M; Wittkopf, N; Mudter, J; Becker, C; Schoerner, C; Atreya, R; Neurath, MF				Neumann, Helmut; Guenther, Claudia; Vieth, Michael; Grauer, Martin; Wittkopf, Nadine; Mudter, Jonas; Becker, Christoph; Schoerner, Christoph; Atreya, Raja; Neurath, Markus F.			Confocal Laser Endomicroscopy for In Vivo Diagnosis of Clostridium difficile Associated Colitis - A Pilot Study	PLOS ONE			English	Article							EPITHELIAL GAPS; IDENTIFICATION; CLASSIFICATION	Background: Clostridium difficile infection (CDI) is one of the most dreaded causes of hospital-acquired diarrhea. Main objective was to investigate whether confocal laser endomicroscopy (CLE) has the capability for in vivo diagnosis of C. difficile associated histological changes. Second objective was to prove the presence of intramucosal bacteria using CLE. Methods: 80 patients were prospectively included, 10 patients were diagnosed with CDI based on toxigenic culture. To validate the presence of intramucosal bacteria ex vivo, CLE was performed in pure C. difficile culture; additionally fluorescence in situ hybridization (FISH) was performed. Finally, CLE with fluorescence labelled oligonucleotide probe specific for C. difficile was performed ex vivo in order to prove the presence of bacteria. Results: CLE identified CDI-associated histological changes in vivo (sensitivity and accuracy of 88.9% and 96.3%). In addition, intramucosal bacteria were visualized. The presence of these bacteria could be proven by CLE with labeled, specific molecular C. difficile probe and FISH-technique. Based on comparison between CLE and FISH analyses, sensitivity and specificity for the presence of intramucosal bacteria were 100%. Conclusion: CLE has the potential for in vivo diagnosis of CDI associated colitis. In addition, CLE allowed the detection of intramucosal bacteria in vivo.	[Neumann, Helmut; Guenther, Claudia; Grauer, Martin; Wittkopf, Nadine; Mudter, Jonas; Becker, Christoph; Atreya, Raja; Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany; [Vieth, Michael] Klinikum Bayreuth, Inst Pathol, Bayreuth, Germany; [Schoerner, Christoph] Univ Erlangen Nurnberg, Inst Microbiol Immunol & Hyg, Erlangen, Germany	University of Erlangen Nuremberg; Klinikum Bayreuth; University of Erlangen Nuremberg	Neumann, H (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany.	helmut.neumann@uk-erlangen.de	Becker, Christoph/L-2996-2016; Becker, Christoph/A-6694-2008	Becker, Christoph/0000-0002-1388-1041				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bloedt K, 2009, J MED MICROBIOL, V58, P874, DOI 10.1099/jmm.0.009811-0; Buchner AM, 2010, GASTROENTEROLOGY, V138, pS95, DOI 10.1053/j.gastro.2009.10.053; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Gunther U, 2008, GUT, V57, P1331; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kiesslich R, 2005, GASTROENTEROLOGY, V128, P2119, DOI 10.1053/j.gastro.2004.12.035; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kiesslich R, 2007, GASTROENTEROLOGY, V133, P1769, DOI 10.1053/j.gastro.2007.09.011; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leong RWL, 2008, GASTROENTEROLOGY, V135, P1870, DOI 10.1053/j.gastro.2008.08.054; Liu JJ, 2011, GASTROINTEST ENDOSC, V73, P1174, DOI 10.1016/j.gie.2011.01.018; Monkemuller K, 2006, ENDOSCOPY, V38, P546, DOI 10.1055/s-2006-925343; Monaghan T, 2008, GUT, V57, P850, DOI 10.1136/gut.2007.128157; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264; Neumann H, 2013, GUT, V62, P333, DOI 10.1136/gutjnl-2012-303121; Neumann H, 2012, INFLAMM BOWEL DIS, V18, P2261, DOI 10.1002/ibd.22907; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; Wallace M, 2011, ENDOSCOPY, V43, P882, DOI 10.1055/s-0030-1256632	26	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58753	10.1371/journal.pone.0058753	http://dx.doi.org/10.1371/journal.pone.0058753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527018	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562100039
J	Chang, AJ; Sohn, R; Lu, ZH; Arbeit, JM; Lapi, SE				Chang, Albert J.; Sohn, Rebecca; Lu, Zhi Hong; Arbeit, Jeffrey M.; Lapi, Suzanne E.			Detection of Rapalog-Mediated Therapeutic Response in Renal Cancer Xenografts Using Cu-64-bevacizumab ImmunoPET	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; MTOR INHIBITOR EVEROLIMUS; MAMMALIAN TARGET; CELL CARCINOMA; RAPAMYCIN; VEGF; PET; ANGIOGENESIS; METABOLISM	The importance of neovascularization for primary and metastatic tumor growth fostered numerous clinical trials of angiogenesis inhibitors either alone or in combination with conventional antineoplastic therapies. One challenge with the use of molecularly targeted agents has been the disconnection between size reduction and tumor biologic behavior, either when the drug is efficacious or when tumor resistance emerges. Here, we report the synthesis and characterization of Cu-64-NOTA-bevacizumab as a PET imaging agent for imaging intratumoral VEGF content in vivo. Cu-64-NOTA-bevacizumab avidly accumulated in 786-O renal carcinoma xenografts with lower levels in host organs. RAD001 (everolimus) markedly attenuated Cu-64-NOTA-bevacizumab accumulation within 786-O renal carcinoma xenografts. Tumor tissue and cellular molecular analysis validated PET imaging, demonstrating decreases in total and secreted VEGF content and VEGFR2 activation. Notably, Cu-64-NOTA-bevacizumab PET imaging was concordant with the growth arrest of RAD001 tumors. These data suggest that immunoPET targeting of angiogenic factors such as VEGF could be a new class of surrogate markers complementing the RECIST criteria in patients receiving molecularly targeted therapies.	[Chang, Albert J.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA; [Chang, Albert J.; Lapi, Suzanne E.] Washington Univ, Dept Radiol, St Louis, MO USA; [Sohn, Rebecca; Lu, Zhi Hong; Arbeit, Jeffrey M.] Washington Univ, Dept Surg, Div Urol, St Louis, MO 63130 USA; [Arbeit, Jeffrey M.; Lapi, Suzanne E.] Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center	Arbeit, JM (corresponding author), Washington Univ, Dept Surg, Div Urol, St Louis, MO 63130 USA.	arbeitj@wustl.edu; lapis@mir.wustl.edu	Arbeit, Jeffrey/K-6920-2019	Lapi, Suzanne/0000-0003-0090-0191	NCI [R01CA159959]; Beatrice Roe Urology Research Fund; Mallinckrodt Department of Radiology; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA159959] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beatrice Roe Urology Research Fund; Mallinckrodt Department of Radiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI R01CA159959, the Beatrice Roe Urology Research Fund, and Mallinckrodt Department of Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Mohand S, 2011, BIOCONJUGATE CHEM, V22, P1729, DOI 10.1021/bc2002665; Amato RJ, 2009, CANCER-AM CANCER SOC, V115, P2438, DOI 10.1002/cncr.24280; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Barlow AD, 2012, DIABETOLOGIA; Barwick T, 2009, NUCL MED COMMUN, V30, P908, DOI 10.1097/MNM.0b013e32832ee93b; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chowdhury S, 2011, HEMATOL ONCOL CLIN N, V25, P853, DOI 10.1016/j.hoc.2011.05.003; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Honer M, 2010, TRANSL ONCOL, V3, P264, DOI 10.1593/tlo.10127; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Huo YL, 2011, BIOCHEM SOC T, V39, P446, DOI 10.1042/BST0390446; Ikotun OF, 2011, FUTURE MED CHEM, V3, P599, DOI [10.4155/fmc.11.14, 10.4155/FMC.11.14]; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jain RK, 2008, NAT REV CANCER, V8, P309, DOI 10.1038/nrc2346; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Lowery A, 2012, FRONT BIOSCI, V17, P1996; Majhail NS, 2003, J CLIN ONCOL, V21, P3995, DOI 10.1200/JCO.2003.04.073; McCabe KE, 2010, CANCER BIOTHER RADIO, V25, P253, DOI 10.1089/cbr.2010.0776; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; McCubrey JA, 2011, J CELL PHYSIOL, V226, P2762, DOI 10.1002/jcp.22647; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Nagengast WB, 2011, CANCER RES, V71, P143, DOI 10.1158/0008-5472.CAN-10-1088; Nayak TK, 2011, INT J CANCER, V128, P920, DOI 10.1002/ijc.25409; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; Oladipupo S, 2011, P NATL ACAD SCI USA, V108, P13264, DOI 10.1073/pnas.1101321108; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paudyal B, 2011, CANCER SCI, V102, P117, DOI 10.1111/j.1349-7006.2010.01763.x; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sadri K, 2011, NUCL MED COMMUN, V32, P563, DOI 10.1097/MNM.0b013e3283419523; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; van der Veldt AAM, 2010, TARGET ONCOL, V5, P95, DOI 10.1007/s11523-010-0146-5; Vercellino L, 2009, CANCER BIOTHER RADIO, V24, P137, DOI 10.1089/cbr.2008.0527; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Xouri G, 2010, SEMIN CELL DEV BIOL, V21, P40, DOI 10.1016/j.semcdb.2009.11.017; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zhang Y, 2012, AM J NUCL MED MOLEC, V2, P1	50	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58949	10.1371/journal.pone.0058949	http://dx.doi.org/10.1371/journal.pone.0058949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516584	Green Published, Green Submitted, gold			2022-12-25	WOS:000316407400081
J	Kanninen, KM; Grubman, A; Meyerowitz, J; Duncan, C; Tan, JL; Parker, SJ; Crouch, PJ; Paterson, BM; Hickey, JL; Donnelly, PS; Volitakis, I; Tammen, I; Palmer, DN; White, AR				Kanninen, Katja M.; Grubman, Alexandra; Meyerowitz, Jodi; Duncan, Clare; Tan, Jiang-Li; Parker, Sarah J.; Crouch, Peter J.; Paterson, Brett M.; Hickey, James L.; Donnelly, Paul S.; Volitakis, Irene; Tammen, Imke; Palmer, David N.; White, Anthony R.			Increased Zinc and Manganese in Parallel with Neurodegeneration, Synaptic Protein Changes and Activation of Akt/GSK3 Signaling in Ovine CLN6 Neuronal Ceroid Lipofuscinosis	PLOS ONE			English	Article							MITOCHONDRIAL ATP SYNTHASE; SOUTH HAMPSHIRE SHEEP; OXIDATIVE STRESS; BATTENS DISEASE; SUBUNIT-C; BRAIN; PARKINSONISM; ATP13A2; METALLOTHIONEIN; MUTATIONS	Mutations in the CLN6 gene cause a variant late infantile form of neuronal ceroid lipofuscinosis (NCL; Batten disease). CLN6 loss leads to disease clinically characterized by vision impairment, motor and cognitive dysfunction, and seizures. Accumulating evidence suggests that alterations in metal homeostasis and cellular signaling pathways are implicated in several neurodegenerative and developmental disorders, yet little is known about their role in the NCLs. To explore the disease mechanisms of CLN6 NCL, metal concentrations and expression of proteins implicated in cellular signaling pathways were assessed in brain tissue from South Hampshire and Merino CLN6 sheep. Analyses revealed increased zinc and manganese concentrations in affected sheep brain in those regions where neuroinflammation and neurodegeneration first occur. Synaptic proteins, the metal-binding protein metallothionein, and the Akt/GSK3 and ERK/MAPK cellular signaling pathways were also altered. These results demonstrate that altered metal concentrations, synaptic protein changes, and aberrant modulation of cellular signaling pathways are characteristic features in the CLN6 ovine form of NCL.	[Kanninen, Katja M.; Grubman, Alexandra; Meyerowitz, Jodi; Duncan, Clare; Tan, Jiang-Li; Parker, Sarah J.; Crouch, Peter J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Paterson, Brett M.; Hickey, James L.; Donnelly, Paul S.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Paterson, Brett M.; Hickey, James L.; Donnelly, Paul S.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Volitakis, Irene] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Tammen, Imke] Univ Sydney, Fac Vet Sci, ReproGen, Camden, NSW, Australia; [Palmer, David N.] Lincoln Univ, Fac Agr & Life Sci, Canterbury, New Zealand	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; Lincoln University - New Zealand	Kanninen, KM (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	katja.kanninen@uef.fi	Tammen, Imke/AFF-7998-2022; Grubman, Alexandra/AAD-3109-2019; Paterson, Brett M/A-2402-2016; White, Anthony/P-5596-2016	Tammen, Imke/0000-0002-5520-6597; Grubman, Alexandra/0000-0003-4408-4499; Paterson, Brett M/0000-0002-7768-811X; Volitakis, Irene/0000-0003-0766-817X; White, Anthony/0000-0003-1802-9891; Crouch, Peter/0000-0002-7777-4747	Sigrid Juselius Foundation; Academy of Finland; Paulo Foundation; Maud Kuistila Memorial Foundation; Australian Research Council ARC Future Fellowship; National Health and Medical Research Council of Australia; Neurological Foundation of New Zealand; Batten Disease Support and Research Association	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Paulo Foundation; Maud Kuistila Memorial Foundation; Australian Research Council ARC Future Fellowship(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Neurological Foundation of New Zealand; Batten Disease Support and Research Association	KMK was supported by the Sigrid Juselius Foundation, the Academy of Finland, the Paulo Foundation and the Maud Kuistila Memorial Foundation. ARW was supported by an Australian Research Council ARC Future Fellowship. This work was supported by funding from the National Health and Medical Research Council of Australia. The work at Lincoln University was supported in part by the Neurological Foundation of New Zealand and the Batten Disease Support and Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bakirdere S, 2011, BIOL TRACE ELEM RES, V142, P492, DOI 10.1007/s12011-010-8804-0; Benedict JW, 2009, J NEUROSCI RES, V87, P2157, DOI 10.1002/jnr.22032; Bolognin S, 2009, NEUROMOL MED, V11, P223, DOI 10.1007/s12017-009-8102-1; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; Dimri U, 2010, VET PARASITOL, V168, P318, DOI 10.1016/j.vetpar.2009.11.013; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009; Frugier T, 2008, NEUROBIOL DIS, V29, P306, DOI 10.1016/j.nbd.2007.09.006; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Heine C, 2003, BIOCHEM J, V376, P369, DOI 10.1042/BJ20030598; Heiskala H, 1988, Am J Med Genet Suppl, V5, P193; Hesketh S, 2007, J ANIM SCI, V85, P1596, DOI 10.2527/jas.2006-714; Himeno S, 2009, BIOCHIMIE, V91, P1218, DOI 10.1016/j.biochi.2009.04.002; Iguchi K, 2002, J ANDROL, V23, P819; JOHANSSON E, 1990, J TRACE ELEM ELECT H, V4, P139; JOLLY RD, 1989, NEUROPATH APPL NEURO, V15, P371, DOI 10.1111/j.1365-2990.1989.tb01236.x; Kay GW, 2006, BRAIN PATHOL, V16, P110, DOI 10.1111/j.1750-3639.2006.00002.x; Kay GW, 2011, NEUROBIOL DIS, V41, P614, DOI 10.1016/j.nbd.2010.11.008; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kurian MA, 2011, DEV MED CHILD NEUROL, V53, P394, DOI 10.1111/j.1469-8749.2011.03955.x; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Lei Peng, 2011, Int J Alzheimers Dis, V2011, P189246, DOI 10.4061/2011/189246; Lin CL, 2011, CELL DEATH DIFFER, V18, P1651, DOI 10.1038/cdd.2011.80; MAYHEW IG, 1985, NEUROPATH APPL NEURO, V11, P273, DOI 10.1111/j.1365-2990.1985.tb00025.x; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Mole SE, 2011, NEURONAL CEROID LIOP; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Nuttall JR, 2012, NEUROTOX RES, V21, P128, DOI 10.1007/s12640-011-9291-6; Obrenovich ME, 2011, BIOL TRACE ELEM RES, V144, P475, DOI 10.1007/s12011-011-9146-2; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oppermann B, 2001, INVEST OPHTH VIS SCI, V42, P188; Oswald MJ, 2008, NEUROBIOL DIS, V32, P50, DOI 10.1016/j.nbd.2008.06.004; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Palmer D N, 1988, Am J Med Genet Suppl, V5, P141, DOI 10.1002/ajmg.1320310618; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Podhajska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039942; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; SAMUELSON DA, 1990, NEUROBIOL AGING, V11, P663, DOI 10.1016/0197-4580(90)90034-W; Santavuori P, 1988, Am J Med Genet Suppl, V5, P265; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; TEMPLETON DM, 1984, BIOCHEM J, V221, P569, DOI 10.1042/bj2210569; Toth K, 2011, ANNU REV NUTR, V31, P139, DOI 10.1146/annurev-nutr-072610-145218; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Wang X, 2012, J PHYSIOL BIOCHEM, V68, P563, DOI 10.1007/s13105-012-0174-y; Wohlke A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002304; Zangger K, 2001, BIOCHEM J, V359, P353, DOI 10.1042/0264-6021:3590353	63	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58644	10.1371/journal.pone.0058644	http://dx.doi.org/10.1371/journal.pone.0058644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516525	Green Published, gold			2022-12-25	WOS:000316407400044
J	Li, XK; Yuan, CF; Wang, JL; Zhang, YQ; Zhang, ZY; Guo, Z				Li, Xiao-Kang; Yuan, Chao-Fan; Wang, Jun-Lin; Zhang, Yong-Quan; Zhang, Zhi-Yong; Guo, Zheng			The Treatment Effect of Porous Titanium Alloy Rod on the Early Stage Talar Osteonecrosis of Sheep	PLOS ONE			English	Article							FEMORAL-HEAD; AVASCULAR NECROSIS; ANIMAL-MODEL; ATRAUMATIC OSTEONECROSIS; FOLLOW-UP; IMPLANTS; TALUS; BONE; BISPHOSPHONATE; PATHOGENESIS	Osteonecrosis of the talus (ONT) may severely affect the function of the ankle joint. Most orthopedists believe that ONT should be treated at an early stage, but a concise and effective surgical treatment is lacking. In this study, porous titanium alloy rods were prepared and implanted into the tali of sheep with early-stage ONT (IM group). The curative effect of the rods was compared to treatment by core decompression (DC group). No significant differences in bone reconstruction were observed between the two groups at 1 month after intervention. After 3 months, the macroscopic view of gross specimens of the IM group showed ordinary contours, but the specimens of the DC group showed obvious partial bone defects and cartilage degeneration. Quantitative analysis of the reconstructed trabeculae by micro-CT and histological study suggested that the curative effect of the IM group was superior to that of the DC group at 3 months after intervention. These favorable short-term results of the implantation of porous titanium alloy rods into the tali of sheep with early-stage ONT may provide insight into an innovative surgical treatment for ONT.	[Li, Xiao-Kang; Yuan, Chao-Fan; Zhang, Yong-Quan; Guo, Zheng] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Wang, Jun-Lin] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Zhang, Zhi-Yong] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Zhi-Yong] Natl Tissue Engn Ctr China, Shanghai, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Sch Med, Shanghai 200030, Peoples R China.	mr.zhiyong@gmail.com; guozheng@fmmu.edu.cn	zhang, zhiyong/G-3227-2010	zhang, zhiyong/0000-0001-7903-1544	National Natural Science Foundation of China [81171773, SJZT10Z09, 81101353]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No: 81171773) to Guo Zheng and Xijing Zhutui Project (SJZT10Z09) and National Natural Science Foundation of China (81101353) to Zhang Zhi-Yong. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Bagaria V, 2011, EUR J RADIOL, V80, P814, DOI 10.1016/j.ejrad.2010.10.007; Bekler Halil, 2007, Acta Orthop Traumatol Turc, V41, P58; Bertollo N, 2012, J ARTHROPLASTY; Comesana R, 2011, ACTA BIOMATER, V7, P3476, DOI 10.1016/j.actbio.2011.05.023; Delanois RE, 1998, J BONE JOINT SURG AM, V80A, P529, DOI 10.2106/00004623-199804000-00009; Floerkemeier T, 2011, INT ORTHOP, V35, P489, DOI 10.1007/s00264-009-0940-9; Grice John, 2011, Foot Ankle Surg, V17, P317, DOI 10.1016/j.fas.2009.10.005; Guest M., 1999, FOOT, V9, P44; Hasegawa Y, 1997, ARCH ORTHOP TRAUM SU, V116, P251; Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013; Jureus J, 2012, ACTA ORTHOP, V83, P511, DOI 10.3109/17453674.2012.729184; Kim SY, 2005, J BONE JOINT SURG AM, V87A, P2012, DOI 10.2106/JBJS.D.02593; Kitaoka HB, 1998, J BONE JOINT SURG AM, V80A, P370, DOI 10.2106/00004623-199803000-00010; Li YL, 2009, INT ORTHOP, V33, P573, DOI 10.1007/s00264-008-0672-2; Manggold J, 2002, LAB ANIM-UK, V36, P173, DOI 10.1258/0023677021912460; Marulanda GA, 2010, J FOOT ANKLE SURG, V49, P20, DOI 10.1053/j.jfas.2009.07.004; Mont MA, 1996, J BONE JOINT SURG BR, V78B, P827, DOI 10.1302/0301-620X.78B5.0780827; Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010; Nadeau Melissa, 2007, Mcgill J Med, V10, P4; Norimatsu H, 1997, OSTEOPOROSIS INT, V7, P57, DOI 10.1007/BF03194344; Palmquist A., 2011, J BIOMATER APPL; Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006; Pearce DH, 2005, RADIOGRAPHICS, V25, P399, DOI 10.1148/rg.252045709; Petcu EB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-78; Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032; Rieger UM, 2009, MICROSURG, V29, P667, DOI 10.1002/micr.20676; Saini A, 2004, CLIN RADIOL, V59, P1079, DOI 10.1016/j.crad.2004.04.014; Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007; Tanzer M, 2008, J BONE JOINT SURG AM, V90A, P1282, DOI 10.2106/JBJS.F.00847; Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538; Velez R, 2011, ARCH ORTHOP TRAUM SU, V131, P5, DOI 10.1007/s00402-010-1084-5; Wan L, 2006, OSTEOARTHR CARTILAGE, V14, P1294, DOI 10.1016/j.joca.2006.05.012; Yu Xiao-guang, 2010, Zhonghua Yi Xue Za Zhi, V90, P1035; Yuan CF, 2012, INT J MED SCI, V9, P816, DOI 10.7150/ijms.4882; Zhang P, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-15	36	13	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58459	10.1371/journal.pone.0058459	http://dx.doi.org/10.1371/journal.pone.0058459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516485	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400031
J	Yoneda, M; Georges-Courbot, MC; Ikeda, F; Ishii, M; Nagata, N; Jacquot, F; Raoul, H; Sato, H; Kai, C				Yoneda, Misako; Georges-Courbot, Marie-Claude; Ikeda, Fusako; Ishii, Miho; Nagata, Noriyo; Jacquot, Frederic; Raoul, Herve; Sato, Hiroki; Kai, Chieko			Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects against Lethal Nipah Virus Challenge	PLOS ONE			English	Article							ENCEPHALITIS OUTBREAK; PIG-FARMERS; INFECTION; PATHOGENESIS; PATHOLOGY; RESCUE; MODEL	Nipah virus (NiV) is a member of the genus Henipavirus, which emerged in Malaysia in 1998. In pigs, infection resulted in a predominantly non-lethal respiratory disease; however, infection in humans resulted in over 100 deaths. Nipah virus has continued to re-emerge in Bangladesh and India, and person-to-person transmission appeared in the outbreak. Although a number of NiV vaccine studies have been reported, there are currently no vaccines or treatments licensed for human use. In this study, we have developed a recombinant measles virus (rMV) vaccine expressing NiV envelope glycoproteins (rMV-HL-G and rMV-Ed-G). Vaccinated hamsters were completely protected against NiV challenge, while the mortality of unvaccinated control hamsters was 90%. We trialed our vaccine in a non-human primate model, African green monkeys. Upon intraperitoneal infection with NiV, monkeys showed several clinical signs of disease including severe depression, reduced ability to move and decreased food ingestion and died at 7 days post infection (dpi). Intranasal and oral inoculation induced similar clinical illness in monkeys, evident around 9 dpi, and resulted in a moribund stage around 14 dpi. Two monkeys immunized subcutaneously with rMV-Ed-G showed no clinical illness prior to euthanasia after challenge with NiV. Viral RNA was not detected in any organ samples collected from vaccinated monkeys, and no pathological changes were found upon histopathological examination. From our findings, we propose that rMV-NiV-G is an appropriate NiV vaccine candidate for use in humans.	[Yoneda, Misako; Ikeda, Fusako; Ishii, Miho; Sato, Hiroki; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 108, Japan; [Kai, Chieko] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Minato Ku, Tokyo, Japan; [Georges-Courbot, Marie-Claude; Jacquot, Frederic; Raoul, Herve] INSERM, Lab INSERM Jean Merieux P4, F-69008 Lyon, France; [Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	University of Tokyo; University of Tokyo; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institute of Infectious Diseases (NIID)	Yoneda, M (corresponding author), Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 108, Japan.	yone@ims.u-tokyo.ac.jp; ckai@ims.u-tokyo.ac.jp	raoul, herve/G-3403-2013		Ministry of Education, Science, Culture and Sports of Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants in aid from the Ministry of Education, Science, Culture and Sports of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, FIELDS VIROLOGY; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chattopadhyay A, 2011, J VIROL, V85, P2004, DOI 10.1128/JVI.01852-10; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2001, J INFECTION, V42, P40, DOI 10.1053/jinf.2000.0782; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Guerbois M, 2009, VIROLOGY, V388, P191, DOI 10.1016/j.virol.2009.02.047; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Hilleman MR, 2001, VACCINE, V20, P651, DOI 10.1016/S0264-410X(01)00384-X; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Kai C, 2011, J DISASTER IN PRESS; Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8; Lo MK, 2008, J CLIN VIROL, V43, P396, DOI 10.1016/j.jcv.2008.08.007; Lorin C, 2004, J VIROL, V78, P146, DOI 10.1128/JVI.78.1.146-157.2004; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Ovsyannikova IG, 2003, CLIN DIAGN LAB IMMUN, V10, P411, DOI 10.1128/CDLI.10.3.411-416.2003; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Tan CT, 2003, ANN ACAD MED SINGAP, V32, P112; Terao-Muto Y, 2008, ANTIVIR RES, V80, P370, DOI 10.1016/j.antiviral.2008.08.006; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yoneda M, 2006, P NATL ACAD SCI USA, V103, P16508, DOI 10.1073/pnas.0606972103; 2004, HLTH SCI B, V2, P5	32	49	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58414	10.1371/journal.pone.0058414	http://dx.doi.org/10.1371/journal.pone.0058414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516477	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400026
J	Chen, L; Liu, HO; Liu, J; Zhu, Y; Xu, L; He, HY; Zhang, H; Wang, SS; Wu, Q; Liu, WS; Liu, YD; Pan, D; Ren, SF; Xu, JJ; Gu, JX				Chen, Lin; Liu, Haiou; Liu, Jing; Zhu, Yu; Xu, Le; He, Hongyong; Zhang, Heng; Wang, Shanshan; Wu, Qian; Liu, Weisi; Liu, Yidong; Pan, Deng; Ren, Shifang; Xu, Jiejie; Gu, Jianxin			Klotho Endows Hepatoma Cells with Resistance to Anoikis via VEGFR2/PAK1 Activation in Hepatocellular Carcinoma	PLOS ONE			English	Article							OXIDATIVE STRESS; GROWTH; EXPRESSION; CANCER; MOUSE; P21-ACTIVATED-KINASE-1; ASSOCIATION; SUPPRESSOR; RECEPTOR; CA2+	Klotho was originally characterized as an aging suppressor gene that predisposed Klotho-deficient mice to premature aging-like syndrome. Although Klotho was recently reported to exhibit tumor suppressive properties during various malignant transformations, the functional role and molecular mechanism of Klotho in hepatocarcinogenesis remains poorly understood. In our present study, immunohistochemical Klotho staining levels in a clinical follow-up of 52 hepatoma patients were significantly associated with liver cirrhosis, tumor multiplicity and venous invasion. The overall survival rate of hepatoma patients with high Klotho expression was significantly lower than those patients with low Klotho expression. Moreover, Klotho overexpression increased cellular migration, anchorage-independent growth, and anoikis resistance in hepatoma cells. Klotho overexpression elevated p21-activated kinase 1 (PAK1) expression and shRNA-mediated PAK1 knockdown and kinase activity inhibition with kinase dead mutant PAK1 K299R coexpression or allosteric inhibitor IPA3 treatment reversed anoikis resistance in Klotho-overexpressed hepatoma cells. More importantly, the pivotal significance of upregulated VEGFR2 protein levels mediated by Klotho expression was confirmed by VEGFR2 inhibitor Axitinib and blocking antibody treatment in hepatoma cells. Axitinib treatment sensitized anoikis was reversed by constitutive active mutant PAK1 T423E coexpression in Klotho-overexpressed hepatoma cells. Conversely, knockdown of Klotho reduced VEGFR2/PAK1 dependent anoikis resistance, which could be reversed by PAK1 T423E. These results revealed a novel oncogenic function of Klotho in promoting anoikis resistance via activating VEGFR2/PAK1 signaling, thus facilitating tumor migration and invasion during hepatoma progression, which could provide a putative molecular mechanism for tumor metastasis.	[Chen, Lin; Liu, Haiou; Wang, Shanshan; Wu, Qian; Liu, Weisi; Liu, Yidong; Pan, Deng; Ren, Shifang; Xu, Jiejie; Gu, Jianxin] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Zhu, Yu; Xu, Le] Fudan Univ, Shanghai Med Coll, Dept Urol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [He, Hongyong; Zhang, Heng] Fudan Univ, Shanghai Med Coll, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Liu, Jing] Nantong Univ, Sch Med, Nantong, Peoples R China	Fudan University; Fudan University; Fudan University; Nantong University	Xu, JJ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	jjxufdu@fudan.edu.cn	Liu, Haiou/AFS-2886-2022; Xu, Le/HDN-9623-2022	Liu, Haiou/0000-0003-0200-8981; liu, weisi/0000-0002-4730-5448	National Basic Research Program of China 973 Program [2012CB822104, 2010CB912104]; State Key Project Specialized for Infectious Diseases of China [2012ZX10002-008, 2012ZX10002-012]; National High-Tech RD 863 Program [2012AA020203]; National Natural Science Fund [30930025, 31010103906, 31170766, 31100629, 31270863]	National Basic Research Program of China 973 Program(National Basic Research Program of China); State Key Project Specialized for Infectious Diseases of China; National High-Tech RD 863 Program(National High Technology Research and Development Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China 973 Program (2012CB822104, 2010CB912104) and State Key Project Specialized for Infectious Diseases of China (2012ZX10002-008, 2012ZX10002-012), National High-Tech R&D 863 Program (2012AA020203), and National Natural Science Fund (30930025, 31010103906, 31170766, 31100629, 31270863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99; Chen S, 2003, J BIOL CHEM, V278, P20029, DOI 10.1074/jbc.M300818200; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fukino K, 2002, BIOCHEM BIOPH RES CO, V293, P332, DOI 10.1016/S0006-291X(02)00216-4; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; He H, 2012, CANC SCI; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Liu H, 2012, CANC SCI; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lu L, 2008, CANCER INVEST, V26, P185, DOI 10.1080/07357900701638343; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Woolfolk EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1286, DOI 10.1152/ajpcell.00448.2004; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Xu L, 2012, CANC SCI; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	39	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58413	10.1371/journal.pone.0058413	http://dx.doi.org/10.1371/journal.pone.0058413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516476	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200067
J	Deuba, K; Ekstrom, AM; Shrestha, R; Ionita, G; Bhatta, L; Karki, DK				Deuba, Keshab; Ekstrom, Anna Mia; Shrestha, Rachana; Ionita, George; Bhatta, Laxmi; Karki, Deepak Kumar			Psychosocial Health Problems Associated with Increased HIV Risk Behavior among Men Who Have Sex with Men in Nepal: A Cross-Sectional Survey	PLOS ONE			English	Article							SOCIAL SUPPORT; BISEXUAL ADULTS; SUBSTANCE USE; URBAN MEN; GAY; DISCRIMINATION; DISORDERS; INFECTION; VIOLENCE; CHENNAI	Background: Men who have sex with men (MSM) are marginalized, hidden, underserved and at high risk for HIV in Nepal. We examined the association between MSM sub-populations, psychosocial health problems and support, access to prevention and non-use of condoms. Methods: Between September-November of 2010, a cross-sectional survey on HIV-related risk behavior was performed across Nepal through snowball sampling facilitated by non-governmental organizations, recruiting 339 MSM, age 15 or older. The primary outcomes were: (a) non-use of condoms at least once in last three anal sex encounters with men and (b) non-use of condoms with women in the last encounter. The secondary outcome was participation in HIV prevention interventions in the past year. Results: Among the 339 MSM interviewed, 78% did not use condoms at their last anal sex with another man, 35% did not use condoms in their last sex with a woman, 70% had experienced violence in the last 12 months, 61% were experiencing depression and 47% had thought of committing suicide. After adjustment for age, religion, marital status, and MSM subpopulations (bisexual, ta, meti, gay), non-use of condoms at last anal sex with a man was significantly associated with non-participation in HIV interventions, experience of physical and sexual violence, depression, repeated suicidal thoughts, small social support network and being dissatisfied with social support. Depression was marginally associated with non-use of condoms with women. The findings suggest that among MSM who reported non-use of condoms at last anal sex, the ta subgroup and those lacking family acceptance were the least likely to have participated in any preventive interventions. Conclusions: MSM in Nepal have a prevalence of psychosocial health problems in turn associated with high risk behavior for HIV. Future HIV prevention efforts targeting MSM in Nepal should cover all MSM subpopulations and prioritize psychosocial health interventions.	[Deuba, Keshab] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Shrestha, Rachana; Bhatta, Laxmi] Pokhara Univ, Nobel Coll, Kathmandu, Nepal; [Ionita, George] UNDP, Kathmandu, Nepal; [Karki, Deepak Kumar] Natl Ctr AIDS & STD Control, Kathmandu, Nepal	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Deuba, K (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	deuba4k@gmail.com	Ekström, Anna Mia/H-6901-2013	Deuba, Keshab/0000-0002-9933-2210; Karki, Deepak Kumar/0000-0002-0392-6592; Bhatta, Laxmi/0000-0002-8166-1470	Netherlands Development Organization (SNV) through the Social Inclusion Research Fund (SIRF), Nepal	Netherlands Development Organization (SNV) through the Social Inclusion Research Fund (SIRF), Nepal	The Netherlands Development Organization (SNV) provided financial support through the Social Inclusion Research Fund (SIRF), Nepal for this work. The SNV had no role in study design or protocol development, data collection or analysis, report writing or the decision to publish this research data in a peer-reviewed article.	ALTMAN DG, 1994, BRIT MED J, V309, P996, DOI 10.1136/bmj.309.6960.996; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; BARTHOLOW BN, 1994, CHILD ABUSE NEGLECT, V18, P747; Chu Sandra Ka Hon, 2008, HIV AIDS Policy Law Rev, V13, P62; Collins S, 2006, LANCET, V368, P907, DOI 10.1016/S0140-6736(06)69353-7; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Darbes LA, 2005, HEALTH PSYCHOL, V24, P617, DOI 10.1037/0278-6133.24.6.617; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Deuba K, 2014, ASIA-PAC J PUBLIC HE, V26, P126, DOI 10.1177/1010539512441491; Devkota B, 2009, ASIA-PAC J PUBLIC HE, V21, P377, DOI 10.1177/1010539509342434; Dilley JW, 1998, AIDS EDUC PREV, V10, P317; FOLKMAN S, 1992, HEALTH PSYCHOL, V11, P218, DOI 10.1037/0278-6133.11.4.218; Heintz AJ, 2006, J INTERPERS VIOLENCE, V21, P193, DOI 10.1177/0886260505282104; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; HIV/AIDS and STD Control Board, 2007, NEP NAT AIDS SPEND A; IV/AIDS and STD Control Board, 2010, UNGASS COUNTR PROGR; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Lu L, 1997, J SOC PSYCHOL, V137, P618, DOI 10.1080/00224549709595483; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McCabe SE, 2010, AM J PUBLIC HEALTH, V100, P1946, DOI 10.2105/AJPH.2009.163147; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; National Institute on Alcohol Abuse and Alcoholism, 2006, ALC US ALC US DIS US; NCASC, 2012, NAT EST HIV INF NEP; NCASC FHI New ERA, 2009, INT BIOB SURV IBBS M; NCASC FHI New ERA, 2007, INT BIOB SURV IBBS M; New ERA/SACTS, 2006, INT BIOB SURV FEM SE; OBRIEN K, 1993, SOC SCI MED, V36, P1161, DOI 10.1016/0277-9536(93)90236-W; Pant Sunil, 2006, HIV AIDS Policy Law Rev, V11, P87; RADLOFF LS, 1977, J APPL PSYCHOL MEASU, V1, P385, DOI DOI 10.1177/014662167700100306; Relf MV, 2004, J ASSOC NURSE AIDS C, V15, P14, DOI 10.1177/1055329003261965; Remafedi G, 1998, AM J PUBLIC HEALTH, V88, P57, DOI 10.2105/AJPH.88.1.57; RET Asia amfAR, 2006, MSM HIV AIDS RISK AS; Ruan WJ, 2008, DRUG ALCOHOL DEPEN, V92, P27, DOI 10.1016/j.drugalcdep.2007.06.001; Saavedra Jorge, 2008, J Int AIDS Soc, V11, P9, DOI 10.1186/1758-2652-11-9; Safren SA, 2010, JAIDS-J ACQ IMM DEF, V55, pS74, DOI 10.1097/QAI.0b013e3181fbc939; Safren SA, 2009, PSYCHOL HEALTH MED, V14, P705, DOI 10.1080/13548500903334754; Samet Sharon, 2007, Addict Sci Clin Pract, V4, P19; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Simoni JM, 2006, AM J PUBLIC HEALTH, V96, P2240, DOI 10.2105/AJPH.2004.054056; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Sivasubramanian M, 2011, PSYCHOL HEALTH MED, V16, P450, DOI 10.1080/13548506.2011.554645; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Strathdee SA, 1998, J ACQ IMMUN DEF SYND, V19, P61, DOI 10.1097/00042560-199809010-00010; Thomas B, 2009, AIDS PATIENT CARE ST, V23, P981, DOI 10.1089/apc.2009.0092; Thomas B, 2009, AIDS EDUC PREV, V21, P372, DOI 10.1521/aeap.2009.21.4.372; Wilson E, 2011, CULT HEALTH SEX, V13, P253, DOI 10.1080/13691058.2010.524247	49	42	45	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58099	10.1371/journal.pone.0058099	http://dx.doi.org/10.1371/journal.pone.0058099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516434	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849200032
J	Dixit, SS; Wang, TN; Manzano, EJQ; Yoo, S; Lee, J; Chiang, DY; Ryan, N; Respress, JL; Yechoor, VK; Wehrens, XHT				Dixit, Sayali S.; Wang, Tiannan; Manzano, Eiffel John Q.; Yoo, Shin; Lee, Jeongkyung; Chiang, David Y.; Ryan, Nicole; Respress, Jonathan L.; Yechoor, Vijay K.; Wehrens, Xander H. T.			Effects of CaMKII-Mediated Phosphorylation of Ryanodine Receptor Type 2 on Islet Calcium Handling, Insulin Secretion, and Glucose Tolerance	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM STRESS; PROTEIN-KINASE-II; INTRACELLULAR CA2+ STORES; HEART-FAILURE; MOUSE ISLETS; APOPTOSIS; CHANNELS; RESISTANCE; EXPRESSION	Altered insulin secretion contributes to the pathogenesis of type 2 diabetes. This alteration is correlated with altered intracellular Ca2+-handling in pancreatic beta cells. Insulin secretion is triggered by elevation in cytoplasmic Ca2+ concentration ([Ca2+](cyt)) of beta cells. This elevation in [Ca2+](cyt) leads to activation of Ca2+/calmodulin-dependent protein kinase II (CAMKII), which, in turn, controls multiple aspects of insulin secretion. CaMKII is known to phosphorylate ryanodine receptor 2 (RyR2), an intracellular Ca2+-release channel implicated in Ca2+-dependent steps of insulin secretion. Our data show that RyR2 is CaMKII phosphorylated in a pancreatic beta-cell line in a glucose-sensitive manner. However, it is not clear whether any change in CaMKII-mediated phosphorylation underlies abnormal RyR2 function in beta cells and whether such a change contributes to alterations in insulin secretion. Therefore, knock-in mice with a mutation in RyR2 that mimics its constitutive CaMKII phosphorylation, RyR2-S2814D, were studied. This mutation led to a gain-of-function defect in RyR2 indicated by increased basal RyR2-mediated Ca2+ leak in islets of these mice. This chronic in vivo defect in RyR2 resulted in basal hyperinsulinemia. In addition, S2814D mice also developed glucose intolerance, impaired glucose-stimulated insulin secretion and lowered [Ca2+](cyt) transients, which are hallmarks of pre-diabetes. The glucose-sensitive Ca2+ pool in islets from S2814D mice was also reduced. These observations were supported by immunohistochemical analyses of islets in diabetic human and mouse pancreata that revealed significantly enhanced CaMKII phosphorylation of RyR2 in type 2 diabetes. Together, these studies implicate that the chronic gain-of-function defect in RyR2 due to CaMKII hyperphosphorylation is a novel mechanism that contributes to pathogenesis of type 2 diabetes.	[Dixit, Sayali S.; Wang, Tiannan; Manzano, Eiffel John Q.; Yoo, Shin; Chiang, David Y.; Ryan, Nicole; Respress, Jonathan L.; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Lee, Jeongkyung; Yechoor, Vijay K.] Baylor Coll Med, Diabet & Endocrinol Res Ctr, Houston, TX 77030 USA; [Lee, Jeongkyung; Yechoor, Vijay K.] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Med, Div Cardiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wehrens, XHT (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	wehrens@bcm.edu	Wehrens, Xander/AAQ-9574-2020; Yechoor, Vijay/AAX-3244-2021	Wehrens, Xander/0000-0001-5044-672X; Chiang, David/0000-0002-5883-6383	Muscular Dystrophy Association; National Institutes of Health (NIH) [HL089598, HL091947]; Diabetes and Endocrinology Research Center grant at Baylor College of Medicine [P30-079638]; Ruth L. Kirschstein National Research Service Award (NRSA); NIH grant [T32-HL07676-20]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089598, R01HL117641, T32HL007676, R01HL091947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center grant at Baylor College of Medicine; Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	XHTW is a W. M. Keck Foundation Distinguished Young Scholar in Medical Research, Established Investigator of the American Heart Association (AHA), and is supported by the Muscular Dystrophy Association and National Institutes of Health (NIH) grants HL089598 and HL091947. This work was supported in part by the Diabetes and Endocrinology Research Center grant (P30-079638) at Baylor College of Medicine. SSD was a recipient of the Ruth L. Kirschstein National Research Service Award (NRSA) supported by NIH grant T32-HL07676-20. DYC is supported by AHA predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Chen Z, 2010, FASEB J, V24, P357, DOI 10.1096/fj.09-138446; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH2409, DOI 10.1152/ajpheart.00562.2007; Denda S, 2012, J INVEST DERMATOL, V132, P69, DOI 10.1038/jid.2011.256; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Dukes ID, 1996, DIABETES, V45, P845, DOI 10.2337/diabetes.45.7.845; Dyachok O, 2001, J CELL SCI, V114, P2179; Easom RA, 1997, ENDOCRINOLOGY, V138, P2359, DOI 10.1210/en.138.6.2359; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Garcia-Perez C, 2008, J BIOL CHEM, V283, P32771, DOI 10.1074/jbc.M803385200; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Huang W, 2011, EXP EYE RES, V93, P700, DOI 10.1016/j.exer.2011.09.001; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Jahanshahi P, 2009, ENDOCRINOLOGY, V150, P607, DOI 10.1210/en.2008-0773; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; Kato I, 2008, DIABETES-METAB RES, V24, P486, DOI 10.1002/dmrr.864; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Miura Y, 1997, J PHYSIOL-LONDON, V503, P387, DOI 10.1111/j.1469-7793.1997.387bh.x; Noguchi N, 2008, BIOCHEM BIOPH RES CO, V371, P735, DOI 10.1016/j.bbrc.2008.04.142; Okamoto H, 2002, DIABETES, V51, pS462, DOI 10.2337/diabetes.51.2007.S462; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; POLONSKY KS, 1995, DIABETES, V44, P705, DOI 10.2337/diabetes.44.6.705; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; ROE MW, 1994, J BIOL CHEM, V269, P18279; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Takasawa S, 2010, BIOCHEM BIOPH RES CO, V397, P140, DOI 10.1016/j.bbrc.2010.05.051; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wehrens XHT, 2011, HEART RHYTHM, V8, P323, DOI 10.1016/j.hrthm.2010.09.079; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2004, NAT REV DRUG DISCOV, V3, P565, DOI 10.1038/nrd1440; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 2000, DIABETES, V49, P2094, DOI 10.2337/diabetes.49.12.2094; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245	60	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58655	10.1371/journal.pone.0058655	http://dx.doi.org/10.1371/journal.pone.0058655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516528	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200102
J	Huang, JF; Lv, CJ; Hu, MY; Zhong, GH				Huang, Jingfei; Lv, Chaojun; Hu, Meiying; Zhong, Guohua			The Mitochondria-Mediate Apoptosis of Lepidopteran Cells Induced by Azadirachtin	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; NEEM LIMONOIDS AZADIRACHTIN; CASPASE ACTIVATION; CYCLOSPORINE-A; CAMPTOTHECIN; SF9; RESPONSES; DEATH; PROLIFERATION	Mitochondria have been shown to play an important role in apoptosis using mammalian cell lines. However, this seems not to be the case in Drosophila, an insect model organism; thus more in-depth studies of insect cell apoptosis are necessary. In the present study, mitochondrial involvement during azadirachtin- and camptothecin-induced apoptosis in Spodoptera frugiperda Sf9 cells (isolated from Spodoptera frugiperda pupal ovarian tissue) was investigated. The results showed that both azadirachtin and camptothecin could induce apoptosis in Sf9 cells. Reactive oxygen species (ROS) generation, activation of mitochondrial permeability transition pores (MPTPs) and loss of mitochondrial membrane potential (MMP) were observed very early during apoptosis and were followed subsequently by the release of cytochrome-c from the mitochondria. Furthermore, the results also revealed that the opening of MPTPs and the loss of MMP induced by azadirachtin could be significantly inhibited by the permeability transition pore (PTP) inhibitor cyclosporin A (CsA), which was used to identify the key role of mitochondria in the apoptosis of Sf9 cells. However, in camptothecin-treated Sf9 cells, CsA could not suppress the opening of MPTPs and the loss of MMP when apoptosis was induced. The data from caspase-3 and caspase-9 activity assays and detection of apoptosis by morphological observation and flow cytometry also uncovered the different effect of CsA on the two botanical apoptosis inducers. Although different mechanisms of apoptosis induction exist, our study revealed that mitochondria play a crucial role in insect cell line apoptosis.	[Huang, Jingfei; Lv, Chaojun; Hu, Meiying; Zhong, Guohua] South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China; [Lv, Chaojun] Chinese Acad Trop Agr Sci, Inst Coconut, Wenchang, Hainan Province, Peoples R China	South China Agricultural University; Chinese Academy of Tropical Agricultural Sciences	Zhong, GH (corresponding author), South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China.	guohuazhong@scau.edu.cn			China National Nature Science Foundation [30971944]	China National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from China National Nature Science Foundation (No. 30971944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2011, BIOCHIM BIOPHYS ACTA, V181, P3597; Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Anuradha A, 2007, INSECT BIOCHEM MOLEC, V37, P627, DOI 10.1016/j.ibmb.2007.03.009; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; BENNETT WM, 1986, ANNU REV MED, V37, P215; Bredholt T, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-101; Challa M, 2007, EMBO J, V26, P3144, DOI 10.1038/sj.emboj.7601745; Chandna S, 2004, INT J RADIAT BIOL, V80, P301, DOI [10.1080/09553000440001679794, 10.1080/09553000410001679794]; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Colombini M, 2007, METHOD CELL BIOL, V80, P241, DOI 10.1016/S0091-679X(06)80012-9; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dorstyn L, 2002, J CELL BIOL, V156, P1089, DOI 10.1083/jcb.200111107; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; Dorstyn L, 2006, CELL DEATH DIFFER, V13, P1049, DOI 10.1038/sj.cdd.4401918; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Huang JF, 2011, PESTIC BIOCHEM PHYS, V100, P256, DOI 10.1016/j.pestbp.2011.04.010; Huang JF, 2011, PESTIC BIOCHEM PHYS, V99, P16, DOI 10.1016/j.pestbp.2010.08.002; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Kumar RP, 2007, INSECT BIOCHEM MOLEC, V37, P635, DOI 10.1016/j.ibmb.2007.03.010; Kumarswamy R, 2009, INT J BIOCHEM CELL B, V41, P1430, DOI 10.1016/j.biocel.2008.12.009; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee An-Chin, 1997, Methods in Cell Science, V19, P71, DOI 10.1023/A:1009761922055; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu KY, 2012, INSECT SCI, V19, P30, DOI 10.1111/j.1744-7917.2011.01431.x; Liu LJ, 2007, CELL BIOL INT, V31, P996, DOI 10.1016/j.cellbi.2007.03.011; Liu TX, 2006, PEST MANAG SCI, V62, P38, DOI 10.1002/ps.1123; LOWERY DT, 1994, ENTOMOL EXP APPL, V72, P77, DOI 10.1007/BF02382417; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Mendes CS, 2006, EMBO REP, V7, P933, DOI 10.1038/sj.embor.7400773; Mitchell MJ, 1997, ARCH INSECT BIOCHEM, V35, P199, DOI 10.1002/(SICI)1520-6327(1997)35:1/2<199::AID-ARCH18>3.3.CO;2-7; Mohan M, 2003, CELL BIOL INT, V27, P483, DOI 10.1016/S1065-6995(03)00071-4; MORDUE AJ, 1993, J INSECT PHYSIOL, V39, P903, DOI 10.1016/0022-1910(93)90001-8; MOREIRA MF, 1994, ARCH INSECT BIOCHEM, V27, P287, DOI 10.1002/arch.940270405; Nathan SS, 2006, CHEMOSPHERE, V64, P1650, DOI 10.1016/j.chemosphere.2006.01.037; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Palmeira CM, 1996, J PHARMACOL TOX MET, V35, P35, DOI 10.1016/1056-8719(95)00131-X; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pfau W, 2009, TOXICOL LETT, V189, P214; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Priyadarsini RV, 2010, FREE RADICAL RES, V44, P624, DOI 10.3109/10715761003692503; Priyadarsini RV, 2009, FREE RADICAL RES, V43, P492, DOI 10.1080/10715760902870637; REMBOLD H, 1993, Z NATURFORSCH C, V48, P495; Rhee WJ, 2002, BIOCHEM BIOPH RES CO, V295, P779, DOI 10.1016/S0006-291X(02)00746-5; Robertson SL, 2007, ARCH INSECT BIOCHEM, V64, P200, DOI 10.1002/arch.20171; Ruiz-Meana M, 2006, CARDIOVASC RES, V71, P715, DOI 10.1016/j.cardiores.2006.06.019; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; Salehzadeh A, 2003, INSECT BIOCHEM MOLEC, V33, P681, DOI 10.1016/S0965-1748(03)00057-2; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thoh M, 2010, J BIOL CHEM, V285, P5888, DOI 10.1074/jbc.M109.065847; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004; Vande VC, 2000, MOL CELL BIOL, V20; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Wang XD, 2001, GENE DEV, V15, P2922; Xiu MH, 2005, CHINESE SCI BULL, V50, P1191, DOI 10.1360/04WC0275; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	74	48	52	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58499	10.1371/journal.pone.0058499	http://dx.doi.org/10.1371/journal.pone.0058499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516491	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200073
J	Korup, S; Rietscher, J; Calvignac-Spencer, S; Trusch, F; Hofmann, J; Moens, U; Sauer, I; Voigt, S; Schmuck, R; Ehlers, B				Korup, Sarah; Rietscher, Janita; Calvignac-Spencer, Sebastien; Trusch, Franziska; Hofmann, Joerg; Moens, Ugo; Sauer, Igor; Voigt, Sebastian; Schmuck, Rosa; Ehlers, Bernhard			Identification of a Novel Human Polyomavirus in Organs of the Gastrointestinal Tract	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; JC VIRUS; CROSS-REACTIVITY; WU POLYOMAVIRUS; BK VIRUS; STOOL; SEROEPIDEMIOLOGY; SEROPREVALENCE; INFECTION; SEQUENCES	Polyomaviruses are small, non-enveloped viruses with a circular double-stranded DNA genome. Using a generic polyomavirus PCR targeting the VP1 major structural protein gene, a novel polyomavirus was initially identified in resected human liver tissue and provisionally named Human Polyomavirus 12 (HPyV12). Its 5033 bp genome is predicted to encode large and small T antigens and the 3 structural proteins VP1, VP2 and VP3. Phylogenetic analyses did not reveal a close relationship to any known human or animal polyomavirus. Investigation of organs, body fluids and excretions of diseased individuals and healthy subjects with both HPyV12-specific nested PCR and quantitative real-time PCR revealed additional virus-positive samples of resected liver, cecum and rectum tissues and a positive fecal sample. A capsomer-based IgG ELISA was established using the major capsid protein VP1 of HPyV12. Seroprevalences of 23% and 17%, respectively, were determined in sera from healthy adults and adolescents and a pediatric group of children. These data indicate that the virus naturally infects humans and that primary infection may already occur in childhood.	[Korup, Sarah; Rietscher, Janita; Trusch, Franziska; Voigt, Sebastian; Ehlers, Bernhard] Robert Koch Inst, Div Viral Infect, Berlin, Germany; [Calvignac-Spencer, Sebastien] Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany; [Hofmann, Joerg] Charite, Inst Virol, D-13353 Berlin, Germany; [Moens, Ugo] Univ Tromso, Dept Med Biol, Tromso, Norway; [Sauer, Igor; Schmuck, Rosa] Charite, Charite Campus Virchow, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UiT The Arctic University of Tromso; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ehlers, B (corresponding author), Robert Koch Inst, Div Viral Infect, Berlin, Germany.	EhlersB@rki.de	Sauer, Igor/AAM-4217-2021; Calvignac-Spencer, Sebastien/D-2313-2010; Voigt, Sebastian/W-8594-2019	Calvignac-Spencer, Sebastien/0000-0003-4834-0509; Voigt, Sebastian/0000-0003-1544-9903; Sauer, Igor/0000-0001-9355-937X; Hofmann, Joerg/0000-0003-3966-515X				Abend JR, 2009, SEMIN CANCER BIOL, V19, P252, DOI 10.1016/j.semcancer.2009.02.004; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babakir-Mina M, 2009, J MED VIROL, V81, P1668, DOI 10.1002/jmv.21559; Bergallo M, 2009, J VIROL METHODS, V162, P69, DOI 10.1016/j.jviromet.2009.07.016; Bialasiewicz S, 2009, J CLIN VIROL, V45, P249, DOI 10.1016/j.jcv.2009.05.002; Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001; Buck CB, 2012, J VIROL, V86, P10887, DOI 10.1128/JVI.01690-12; Chen TT, 2011, J INFECT DIS, V204, P1523, DOI 10.1093/infdis/jir614; Donepudi S, 2012, SEMIN ONCOL, V39, P163, DOI 10.1053/j.seminoncol.2012.01.003; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gerits N, 2012, VIROLOGY, V432, P316, DOI 10.1016/j.virol.2012.05.024; Imperiale M.J., 2007, FIELDS VIROLOGY, V2, P2263; Imperiale MJ, 2000, VIROLOGY, V267, P1, DOI 10.1006/viro.1999.0092; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Leendertz FH, 2011, J VIROL, V85, P916, DOI 10.1128/JVI.01585-10; Lim ES, 2012, VIROLOGY; Loyo M, 2010, INT J CANCER, V126, P2991, DOI 10.1002/ijc.24737; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Moens U, 2011, PATHOLOG RES INT, V2011; Moens U, 2008, J DTSCH DERMATOL GES, V6, P704, DOI 10.1111/j.1610-0387.2008.06810.x; Neske F, 2009, J CLIN VIROL, V44, P115, DOI 10.1016/j.jcv.2008.12.004; Ren LL, 2009, EMERG INFECT DIS, V15, P134, DOI 10.3201/eid1501.080693; Ricciardiello L, 2000, GASTROENTEROLOGY, V119, P1228, DOI 10.1053/gast.2000.19269; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Toracchio S, 2010, EMERG INFECT DIS, V16, P1702, DOI 10.3201/eid1611.100628; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; Trusch F, 2012, J GEN VIROL, V93, P698, DOI 10.1099/vir.0.039156-0; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Van Ghelue M, 2012, REV MED VIROL, V22, P354, DOI 10.1002/rmv.1711; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Viscidi RP, 2006, ADV EXP MED BIOL, V577, P73; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449	48	119	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58021	10.1371/journal.pone.0058021	http://dx.doi.org/10.1371/journal.pone.0058021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516426	Green Published, gold			2022-12-25	WOS:000316849200026
J	Basco, D; Blaauw, B; Pisani, F; Sparaneo, A; Nicchia, GP; Mola, MG; Reggiani, C; Svelto, M; Frigeri, A				Basco, Davide; Blaauw, Bert; Pisani, Francesco; Sparaneo, Angelo; Nicchia, Grazia Paola; Mola, Maria Grazia; Reggiani, Carlo; Svelto, Maria; Frigeri, Antonio			AQP4-Dependent Water Transport Plays a Functional Role in Exercise-Induced Skeletal Muscle Adaptations	PLOS ONE			English	Article							AQUAPORIN-4 EXPRESSION; MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; LOADING CONTROL; BRAIN; VOLUME; ORGANIZATION; ISOFORMS; ACTIN	In this study we assess the functional role of Aquaporin-4 (AQP4) in the skeletal muscle by analyzing whether physical activity modulates AQP4 expression and whether the absence of AQP4 has an effect on osmotic behavior, muscle contractile properties, and physical activity. To this purpose, rats and mice were trained on the treadmill for 10 (D10) and 30 (D30) days and tested with exercise to exhaustion, and muscles were used for immunoblotting, RT-PCR, and fiber-type distribution analysis. Taking advantage of the AQP4 KO murine model, functional analysis of AQP4 was performed on dissected muscle fibers and sarcolemma vesicles. Moreover, WT and AQP4 KO mice were subjected to both voluntary and forced activity. Rat fast-twitch muscles showed a twofold increase in AQP4 protein in D10 and D30 rats compared to sedentary rats. Such increase positively correlated with the animal performance, since highest level of AQP4 protein was found in high runner rats. Interestingly, no shift in muscle fiber composition nor an increase in AQP4-positive fibers was found. Furthermore, no changes in AQP4 mRNA after exercise were detected, suggesting that post-translational events are likely to be responsible for AQP4 modulation. Experiments performed on AQP4 KO mice revealed a strong impairment in osmotic responses as well as in forced and voluntary activities compared to WT mice, even though force development amplitude and contractile properties were unvaried. Our findings definitively demonstrate the physiological role of AQP4 in supporting muscle contractile activity and metabolic changes that occur in fast-twitch skeletal muscle during prolonged exercise.	[Basco, Davide; Pisani, Francesco; Sparaneo, Angelo; Nicchia, Grazia Paola; Mola, Maria Grazia; Svelto, Maria; Frigeri, Antonio] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Basco, Davide; Pisani, Francesco; Sparaneo, Angelo; Nicchia, Grazia Paola; Mola, Maria Grazia; Svelto, Maria; Frigeri, Antonio] Univ Bari, Ctr Excellence Comparat Genom CEGBA, Bari, Italy; [Blaauw, Bert] Venetian Inst Mol Med, Padua, Italy; [Blaauw, Bert; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Reggiani, Carlo] CNR, Inst Neurosci, Padua, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Veneto Institute Molecular Medicine; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Frigeri, A (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	a.frigeri@biologia.uniba.it	Mola, Maria Grazia/I-3507-2019; PISANI, Francesco/AAC-1749-2019; frigeri, Antonio/AAC-6336-2022; Sparaneo, Angelo/B-4689-2017; blaauw, bert/A-7614-2014; Svelto, Maria/P-6186-2014	Mola, Maria Grazia/0000-0002-4421-9237; PISANI, Francesco/0000-0001-8511-117X; blaauw, bert/0000-0002-3893-1463; BLAAUW, BERT/0000-0002-4167-5106; Svelto, Maria/0000-0002-5584-9541; Basco, Davide/0000-0002-7984-5676; Frigeri, Antonio/0000-0002-5284-2934; Sparaneo, Angelo/0000-0002-3211-3072	Association Francaise Contre les Myopathies [14336]; FIRB - Rete Nazionale di Proteomica [RBRN07BMCT_009]	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); FIRB - Rete Nazionale di Proteomica	Funding was provided by the Association Francaise Contre les Myopathies (project no. 14336 to AF) and FIRB - Rete Nazionale di Proteomica (RBRN07BMCT_009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Assereto S, 2008, CELL CYCLE, V7, P2199, DOI 10.4161/cc.7.14.6272; Basco D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019225; Basco D, 2010, EUR J APPL PHYSIOL, V110, P1215, DOI 10.1007/s00421-010-1592-6; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; CRENSHAW AG, 1994, ACTA PHYSIOL SCAND, V152, P265, DOI 10.1111/j.1748-1716.1994.tb09806.x; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Fan Y, 2005, J NEUROSCI RES, V82, P458, DOI 10.1002/jnr.20664; Fathi R, 2010, REGUL PEPTIDES, V165, P133, DOI 10.1016/j.regpep.2010.05.013; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Frigeri A, 2004, FASEB J, V18, P905, DOI 10.1096/fj.03-0987fje; Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545; Frigeri A, 2002, FASEB J, V16, P1120, DOI 10.1096/fj.01-0797fje; FRIGERI A, 1995, J CELL SCI, V108, P2993; Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com; Frigeri A, 2001, FASEB J, V15, P1282, DOI 10.1096/fj.00-0525fje; GREENLEAF JE, 1979, AM J PHYSIOL, V236, pR206, DOI 10.1152/ajpregu.1979.236.3.R206; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kaakinen M, 2007, CELL TISSUE RES, V329, P529, DOI 10.1007/s00441-007-0442-2; LINDINGER MI, 1994, AM J PHYSIOL, V266, pR1896, DOI 10.1152/ajpregu.1994.266.6.R1896; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Nicchia GP, 2010, NEUROSCIENCE, V168, P903, DOI 10.1016/j.neuroscience.2010.02.008; Pisani F, 2011, GLIA, V59, P1923, DOI 10.1002/glia.21234; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SCHOTLAND DL, 1981, ACTA NEUROPATHOL, V54, P189, DOI 10.1007/BF00687741; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Usher-Smith JA, 2009, BIOL REV, V84, P143, DOI 10.1111/j.1469-185X.2008.00066.x; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wakayama Y, 2002, ARCH NEUROL-CHICAGO, V59, P431, DOI 10.1001/archneur.59.3.431; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Yang BX, 2000, AM J PHYSIOL-CELL PH, V278, pC1108, DOI 10.1152/ajpcell.2000.278.6.C1108	37	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58712	10.1371/journal.pone.0058712	http://dx.doi.org/10.1371/journal.pone.0058712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520529	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900089
J	Luo, Q; Hamer, R; Reinert, G; Deane, CM				Luo, Qiang; Hamer, Rebecca; Reinert, Gesine; Deane, Charlotte M.			Local Network Patterns in Protein-Protein Interfaces	PLOS ONE			English	Article							STRUCTURALLY CONSERVED RESIDUES; HOT-SPOTS; BINDING; PREDICTION; MOTIFS; SITES; PRINCIPLES; MODEL	Protein-protein interfaces hold the key to understanding protein-protein interactions. In this paper we investigated local interaction network patterns beyond pair-wise contact sites by considering interfaces as contact networks among residues. A contact site was defined as any residue on the surface of one protein which was in contact with a residue on the surface of another protein. We labeled the sub-graphs of these contact networks by their amino acid types. The observed distributions of these labeled sub-graphs were compared with the corresponding background distributions and the results suggested that there were preferred chemical patterns of closely packed residues at the interface. These preferred patterns point to biological constraints on physical proximity between those residues on one protein which were involved in binding to residues which were close on the interacting partner. Interaction interfaces were far from random and contain information beyond pairs and triangles. To illustrate the possible application of the local network patterns observed, we introduced a signature method, called iScore, based on these local patterns to assess interface predictions. On our data sets iScore achieved 83.6% specificity with 82% sensitivity.	[Luo, Qiang] Natl Univ Def Technol, Coll Informat Syst & Management, Dept Management, Changsha, Hunan, Peoples R China; [Hamer, Rebecca; Reinert, Gesine; Deane, Charlotte M.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Hamer, Rebecca; Reinert, Gesine; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	National University of Defense Technology - China; University of Oxford; University of Oxford	Luo, Q (corresponding author), Natl Univ Def Technol, Coll Informat Syst & Management, Dept Management, Changsha, Hunan, Peoples R China.	mrqiangluo@gmail.com	Luo, Qiang/ADI-7405-2022	Luo, Qiang/0000-0002-0426-6039; Reinert, Gesine/0000-0002-0363-9470; Deane, Charlotte/0000-0003-1388-2252	BBSRC; EPSRC through OCISB; National Natural Sciences Foundation of China [11101429]; Research Fund for the Doctoral Program of Higher Education of China [20114307120019]; EPSRC [EP/K032402/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K032402/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC through OCISB(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by BBSRC (www.bbsrc.ac.uk) and EPSRC (www.epsrc.ac.uk) through OCISB (www.sysbio.ox.ac.uk). QL is partially supported by National Natural Sciences Foundation of China (Grant No. 11101429) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20114307120019). Part of this work was completed while GR was visiting the Institute for Mathematical Sciences in Singapore, and the support is gratefully acknowledged. Part of this work was completed while QL was visiting the Centre for Computational Systems Biology in Fudan University, and the support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; BUCKLAND M, 1994, J AM SOC INFORM SCI, V45, P12, DOI 10.1002/(SICI)1097-4571(199401)45:1<12::AID-ASI2>3.0.CO;2-L; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Eisenhaber F, 1996, PROTEIN ENG, V9, P1121, DOI 10.1093/protein/9.12.1121; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009; Hamer R, 2010, PROTEINS, V78, P2781, DOI 10.1002/prot.22792; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Liu SY, 2008, BIOINFORMATICS, V24, P2634, DOI 10.1093/bioinformatics/btn497; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nussinov R, 2005, PHYS BIOL, V2; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Rahat O, 2008, PROTEINS, V71, P621, DOI 10.1002/prot.21749; Rahat O, 2009, BIOINFORMATICS, V25, P2921, DOI 10.1093/bioinformatics/btp541; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Snedecor G.W., 1989, AMES IOWA STATE U PR; Torrance JW, 2007, J MOL BIOL, V369, P1140, DOI 10.1016/j.jmb.2007.03.055; Tsai CJ, 1997, PROTEIN SCI, V6, P1793, DOI 10.1002/pro.5560060901; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105	32	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57031	10.1371/journal.pone.0057031	http://dx.doi.org/10.1371/journal.pone.0057031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520460	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900019
J	Sanjuan-Jimenez, R; Colmenero, JD; Bermudez, P; Alonso, A; Morata, P				Sanjuan-Jimenez, Rocio; Colmenero, Juan D.; Bermudez, Pilar; Alonso, Antonio; Morata, Pilar			Amplicon DNA Melting Analysis for the Simultaneous Detection of Brucella spp and Mycobacterium tuberculosis Complex. Potential Use in Rapid Differential Diagnosis between Extrapulmonary Tuberculosis and Focal Complications of Brucellosis	PLOS ONE			English	Article							TIME MULTIPLEX PCR; SYBR-GREEN-I; ASSAY; ABORTUS; IDENTIFICATION	Some sites of extrapulmonary tuberculosis and focal complications of brucellosis are very difficult to differentiate clinically, radiologically, and even histopathologically. Conventional microbiological methods for the diagnosis of extrapulmonary tuberculosis and complicated brucellosis not only lack adequate sensitivity, they are also time consuming, which could lead to an unfavourable prognosis. The aim of this work was to develop a multiplex real-time PCR assay based on SYBR Green I to simultaneously detect Brucella spp and Mycobacterium tuberculosis complex and evaluate the efficacy of the technique with different candidate genes. The IS711, bcsp31 and omp2a genes were used for the identification of Brucella spp and the IS6110, senX3-regX3 and cfp31 genes were targeted for the detection of the M. tuberculosis complex. As a result of the different combinations of primers, nine different reactions were evaluated. A test was defined as positive only when the gene combinations were capable of co-amplifying both pathogens in a single reaction tube and showed distinguishable melting temperatures for each microorganism. According to the melting analysis, only three combinations of amplicons (senX3-regX3+bcsp31, senX3-regX3+IS711 and IS6110+IS711) were visible. Detection limits of senX3-regX3+bcsp31 and senX3-regX3+IS711 were of 2 and 3 genome equivalents for M. tuberculosis complex and Brucella while for IS6110+IS711 they were of 200 and 300 genome equivalents, respectively. The three assays correctly identified all the samples, showing negative results for the control patients. The presence of multicopy elements and GC content were the components most influencing the efficiency of the test; this should be taken into account when designing a multiplex-based SYBR Green I assay. In conclusion, multiplex real time PCR assays based on the targets senX3-regX3+bcsp31 and senX3-regX3+IS711 using SYBR Green I are highly sensitive and reproducible. This may therefore be a practical approach for the rapid differential diagnosis between extrapulmonary tuberculosis and complicated brucellosis.	[Sanjuan-Jimenez, Rocio; Alonso, Antonio; Morata, Pilar] Univ Malaga, Fac Med, Biochem Mol Biol & Immunol Dept, E-29071 Malaga, Spain; [Colmenero, Juan D.] Carlos Haya Univ Hosp, Infect Dis Serv, Malaga, Spain; [Bermudez, Pilar] Carlos Haya Univ Hosp, Microbiol Serv, Malaga, Spain	Universidad de Malaga; Hospital Carlos Haya; Hospital Carlos Haya	Morata, P (corresponding author), Univ Malaga, Fac Med, Biochem Mol Biol & Immunol Dept, E-29071 Malaga, Spain.	morata@uma.es		Morata Losa, Maria Pilar/0000-0002-2423-6347; Sanjuan-Jimenez, Rocio/0000-0002-6591-0289	Consejeria de Innovacion Ciencia y Empresa of the Junta de Andalucia (Spain) [CTS-276, P-08-CTS-3969]	Consejeria de Innovacion Ciencia y Empresa of the Junta de Andalucia (Spain)(Junta de Andalucia)	This work received financial support from the Consejeria de Innovacion Ciencia y Empresa (grant CTS-276 and P-08-CTS-3969) both of the Junta de Andalucia (Spain). Rocio Sanjuan-Jimenez is a fellow attached to the project P-08-CTS-3969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bogdanovich T, 2004, J CLIN MICROBIOL, V42, P2261, DOI 10.1128/JCM.42.5.2261-2263.2004; Broccolo F, 2003, J CLIN MICROBIOL, V41, P4565, DOI 10.1128/JCM.41.10.4565-4572.2003; Colmenero JD, 2010, SPINE, V35, pE1392, DOI 10.1097/BRS.0b013e3181e8eeaf; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Queipo-Ortuno MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004526; Liu J, 2012, J CLIN MICROBIOL, V50, P98, DOI 10.1128/JCM.05416-11; Markoulatos P, 2000, J VIROL METHODS, V84, P161, DOI 10.1016/S0166-0934(99)00141-X; Morata P, 1998, J CLIN MICROBIOL, V36, P2443, DOI 10.1128/JCM.36.9.2443-2446.1998; Nakajima C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-118; Newby DT, 2003, APPL ENVIRON MICROB, V69, P4753, DOI 10.1128/AEM.69.8.4753-4759.2003; Pappas G, 2006, LANCET INFECT DIS, V3, P213; Probert WS, 2004, J CLIN MICROBIOL, V42, P1290, DOI 10.1128/JCM.42.3.1290-1293.2004; Queipo-Ortuno MI, 2005, CLIN MICROBIOL INFEC, V11, P713, DOI 10.1111/j.1469-0691.2005.01202.x; Redkar R, 2001, MOL CELL PROBE, V15, P43, DOI 10.1006/mcpr.2000.0338; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Smith K, 2004, J MED MICROBIOL, V53, P115, DOI 10.1099/jmm.0.05416-0; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	20	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58353	10.1371/journal.pone.0058353	http://dx.doi.org/10.1371/journal.pone.0058353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520501	gold, Green Published, Green Submitted			2022-12-25	WOS:000318679900060
J	Wang, SH; An, TT; Duan, JC; Zhang, LJ; Wu, MN; Zhou, QH; Chen, JF; Zhuo, ML; Yang, L; Wang, YY; Bai, H; Wang, J				Wang, Shuhang; An, Tongtong; Duan, Jianchun; Zhang, Lijian; Wu, Meina; Zhou, Qinghua; Chen, Jinfeng; Zhuo, Minglei; Yang, Lu; Wang, Yuyan; Bai, Hua; Wang, Jie			Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; MET AMPLIFICATION; GEFITINIB; SENSITIVITY; RESISTANCE; ERLOTINIB; TUMORS	Introduction: Genetic aberrancies within epidermal growth factor receptor (EGFR) pathway are associated with therapeutic outcomes of EGFR-tyrosine kinase inhibitors (TKIs) in advanced non-small cell lung cancer (NSCLC). However, the impact of chemotherapy on EGFR-related genes alterations has not been defined in NSCLC. Our study aims to investigate the impact of neoadjuvant chemotherapy (Neoadj-Chemo) on EGFR activating mutations and associated EGFR-TKIs resistance-related genes. Patients and Methods: Matched tumor samples were obtained retrospectively from 66 NSCLC patients (stages IIb-IIIb) corresponding to pre-and post-Neoadj-Chemo. EGFR mutations were detected by denaturing high performance liquid chromatography (DHPLC) and confirmed by Amplification Refractory Mutation System technology (ARMS), KRAS mutations, T790M mutation and c-MET amplification were identified using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP), ARMS, and real-time PCR, respectively. Results: Before Neoadj-Chemo, EGFR mutations were identified in 33.3% (22/66) of NSCLC patients. Only 18.2% (12/66) of patients carried EGFR mutations after Neoadj-Chemo (p = 0.013). The median peak value of EGFR 19 exon mutations decreased non-significantly after Neoadj-Chemo. KRAS mutation rate decreased from 4.6% (3/66) to 3.0% (2/66) with Neoadj-Chemo. Although the overall percentage of patients exhibiting c-MET amplifications (6.1% [4/66]) did not change with Neoadj-Chemo, two patients transitioned from negative to positive c-MET amplification, and two patients reversed these changes post-Neoadj-Chemo. T790M mutations were absent from all samples. Conclusion: Neoadjuvant chemotherapy tends to decrease the mutation frequency of EGFR mutation and downstream genes, which suggests that real-time samples analysis for genetic aberrancies within EGFR pathways have important value to delineate specific patient populations and facilitate individualized treatment.	[Wang, Shuhang; An, Tongtong; Duan, Jianchun; Wu, Meina; Zhuo, Minglei; Yang, Lu; Wang, Yuyan; Bai, Hua; Wang, Jie] Peking Univ, Sch Oncol, Dept Thorac Med Oncol,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zhang, Lijian; Chen, Jinfeng] Peking Univ, Sch Oncol, Dept Thorac Surg,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zhou, Qinghua] Tianjin Med Univ Gen Hosp, Dept Thorac Surg, Tianjin, Peoples R China	Peking University; Peking University; Tianjin Medical University	Bai, H (corresponding author), Peking Univ, Sch Oncol, Dept Thorac Med Oncol,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	baihuahb@sina.com; wangjie_cc@yahoo.com	Duan, Jianchun/AAM-5765-2020	zhuo, minglei/0000-0003-2489-7791	National Natural Sciences Foundation Distinguished Young Scholars [81025012]; National Natural Sciences Foundation General Program [81172235]; Capital Development Foundation [2007-1023]; Beijing Health Systems Academic Leader [2011-2-22]; Science and Technology Project of Beijing [Z090507017709015]; National Natural Sciences Foundation China Youth Science Foundation [81101726]	National Natural Sciences Foundation Distinguished Young Scholars; National Natural Sciences Foundation General Program; Capital Development Foundation; Beijing Health Systems Academic Leader; Science and Technology Project of Beijing; National Natural Sciences Foundation China Youth Science Foundation	Supported by grants from National Natural Sciences Foundation Distinguished Young Scholars (81025012), National Natural Sciences Foundation General Program (81172235), the Capital Development Foundation (2007-1023), Beijing Health Systems Academic Leader (2011-2-22) and Science and Technology Project of Beijing (Z090507017709015), National Natural Sciences Foundation China Youth Science Foundation (81101726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Chin TM, 2008, CLIN CANCER RES, V14, P6867, DOI 10.1158/1078-0432.CCR-08-0093; Dong Qiang-gang, 2006, Zhonghua Zhongliu Zazhi, V28, P686; Duan Jian-chun, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P323; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Lee JS, 2009, J THORAC ONCOL, V4, pS283; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mu XL, 2005, CLIN CANCER RES, V11, P4289, DOI 10.1158/1078-0432.CCR-04-2506; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	34	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e51021	10.1371/journal.pone.0051021	http://dx.doi.org/10.1371/journal.pone.0051021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520442	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900001
J	Roberts, BM; Ahn, B; Smuder, AJ; Al-Rajhi, M; Gill, LC; Beharry, AW; Powers, SK; Fuller, DD; Ferreira, LF; Judge, AR				Roberts, Brandon M.; Ahn, Bumsoo; Smuder, Ashley J.; Al-Rajhi, Monsour; Gill, Luther C.; Beharry, Adam W.; Powers, Scott K.; Fuller, David D.; Ferreira, Leonardo F.; Judge, Andrew R.			Diaphragm and ventilatory dysfunction during cancer cachexia	FASEB JOURNAL			English	Article						C-26; respiratory muscles; muscle function; single fiber; limb muscle	MYOSIN HEAVY-CHAIN; SKELETAL-MUSCLE ATROPHY; MOTOR UNIT RECRUITMENT; KAPPA-B; SHORTENING VELOCITY; FORCE; ACTIVATION; EXPRESSION; PROTEIN; CONTRACTION	Cancer cachexia is characterized by a continuous loss of locomotor skeletal muscle mass, which causes profound muscle weakness. If this atrophy and weakness also occurs in diaphragm muscle, it could lead to respiratory failure, which is a major cause of death in patients with cancer. Thus, the purpose of the current study was to determine whether colon-26 (C-26) cancer cachexia causes diaphragm muscle fiber atrophy and weakness and compromises ventilation. All diaphragm muscle fiber types were significantly atrophied in C-26 mice compared to controls, and the atrophy-related genes, atrogin-1 and MuRF1, significantly increased. Maximum isometric specific force of diaphragm strips, absolute maximal calcium activated force, and maximal specific calcium-activated force of permeabilized diaphragm fibers were all significantly decreased in C-26 mice compared to controls. Further, isotonic contractile properties of the diaphragm were affected to an even greater extent than isometric function. Ventilation measurements demonstrated that C-26 mice have a significantly lower tidal volume compared to controls under basal conditions and, unlike control mice, an inability to increase breathing frequency, tidal volume, and, thus, minute ventilation in response to a respiratory challenge. These data demonstrate that C-26 cancer cachexia causes profound respiratory muscle atrophy and weakness and ventilatory dysfunction.Roberts, B. M., Ahn, B., Smuder, A. J., Al-Rajhi, M., Gill, L. C., Beharry, A. W., Powers, S. K., Fuller, D. D., Ferreira, L. F., Judge, A. R. Diaphragm and ventilatory dysfunction during cancer cachexia.	[Roberts, Brandon M.; Gill, Luther C.; Beharry, Adam W.; Fuller, David D.; Judge, Andrew R.] Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA; [Ahn, Bumsoo; Smuder, Ashley J.; Al-Rajhi, Monsour; Powers, Scott K.; Ferreira, Leonardo F.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Judge, AR (corresponding author), Univ Florida, Dept Phys Therapy, 1275 Ctr Dr,HPNP Bldg 1142, Gainesville, FL 32611 USA.	arjudge@phhp.ufl.edu	Roberts, Brandon M/AAG-4266-2021; Ahn, Bumsoo/GNP-7749-2022; Roberts, Brandon/H-4504-2019; Ahn, Bumsoo/AAK-3818-2021	Roberts, Brandon M/0000-0003-0395-6967; Ahn, Bumsoo/0000-0002-2743-7099; Ferreira, Leonardo/0000-0001-6581-5882	Bankhead Coley Cancer Research Program [09BN-09]; U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR060209]; U.S. National Institute of Neurological Disorders and Stroke [R01 NS080180]; U.S. National Heart, Lung, and Blood Institute [R01HL087839, R00HL098453]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087839, T32HL105355, R00HL098453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Bankhead Coley Cancer Research Program; U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Bankhead Coley Cancer Research Program grant 09BN-09 and U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01AR060209 (to A.R.J.); U.S. National Institute of Neurological Disorders and Stroke grant R01 NS080180 (to D. D. F.); and U.S. National Heart, Lung, and Blood Institute grants R01HL087839 (to S. K. P.) and R00HL098453 (to L.F.F.).	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; BROOKS SV, 1990, J APPL PHYSIOL, V68, P1282, DOI 10.1152/jappl.1990.68.3.1282; Bullimore SR, 2010, CAN J PHYSIOL PHARM, V88, P937, DOI [10.1139/y10-068, 10.1139/Y10-068]; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Campbell K, 1997, BIOPHYS J, V72, P254, DOI 10.1016/S0006-3495(97)78664-8; Campbell KS, 2003, AM J PHYSIOL-HEART C, V285, pH2857, DOI 10.1152/ajpheart.00295.2003; Campbell KS, 2002, BIOPHYS J, V82, P929, DOI 10.1016/S0006-3495(02)75454-4; CLAFLIN DR, 1985, J PHYSIOL-LONDON, V359, P357, DOI 10.1113/jphysiol.1985.sp015589; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cosper PF, 2012, INT J CANCER, V130, P2722, DOI 10.1002/ijc.26298; Costelli P, 2001, BRIT J CANCER, V84, P946, DOI 10.1054/bjoc.2001.1696; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; Edman K A, 1988, Adv Exp Med Biol, V226, P643; Eley HL, 2008, BRIT J CANCER, V98, P443, DOI 10.1038/sj.bjc.6604150; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Feathers LSB, 2003, J PAIN SYMPTOM MANAG, V25, P305, DOI 10.1016/S0885-3924(03)00048-4; Ferreira LF, 2012, J APPL PHYSIOL, V112, P1538, DOI 10.1152/japplphysiol.01269.2011; Ferreira LF, 2011, MED SCI SPORT EXER, V43, P1025, DOI 10.1249/MSS.0b013e3182019a78; Ferreira LF, 2010, AM J PHYSIOL-CELL PH, V299, pC552, DOI 10.1152/ajpcell.00065.2010; Fouladiun M, 2007, CLIN CANCER RES, V13, P6379, DOI 10.1158/1078-0432.CCR-07-1147; Frimel TN, 2005, MUSCLE NERVE, V32, P605, DOI 10.1002/mus.20398; Fuller DD, 2008, EXP NEUROL, V211, P97, DOI 10.1016/j.expneurol.2008.01.013; Gilliver SF, 2011, EXP PHYSIOL, V96, P171, DOI 10.1113/expphysiol.2010.054239; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; Johannigman JA, 1997, SURGERY, V122, P737, DOI 10.1016/S0039-6060(97)90081-7; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kravitz RM, 2009, PEDIATRICS, V123, pS231, DOI 10.1542/peds.2008-2952G; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mantilla CB, 2011, RESP PHYSIOL NEUROBI, V179, P57, DOI 10.1016/j.resp.2011.06.028; Miller SE, 1997, SURGERY, V122, P740; Mintzopoulos D., 2011, P INT SOC MAG RESON, V19, P1138; Moreno-Gonzalez A, 2007, J PHYSIOL-LONDON, V579, P313, DOI 10.1113/jphysiol.2006.124164; Moss RL, 2010, J GEN PHYSIOL, V136, P21, DOI 10.1085/jgp.201010471; MOSS RL, 1982, J MUSCLE RES CELL M, V3, P295, DOI 10.1007/BF00713039; Murphy KT, 2012, DIS MODEL MECH, V5, P533, DOI 10.1242/dmm.008839; Murphy KT, 2011, AM J PHYSIOL-REG I, V301, pR716, DOI 10.1152/ajpregu.00121.2011; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; Qiu K, 2012, MOL THER, V20, P21, DOI 10.1038/mt.2011.214; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Ripamonti C, 2002, SUPPORT CARE CANCER, V10, P204, DOI 10.1007/s005200100296; Sandhu MS, 2009, RESP PHYSIOL NEUROBI, V169, P94, DOI 10.1016/j.resp.2009.06.014; Schmitt TL, 2007, J MOL MED, V85, P647, DOI 10.1007/s00109-007-0177-2; SEGAL SS, 1986, AM J PHYSIOL, V250, pC474, DOI 10.1152/ajpcell.1986.250.3.C474; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Sieck GC, 1997, EUR RESPIR J, V10, P2147, DOI 10.1183/09031936.97.10092147; SIECK GC, 1989, J APPL PHYSIOL, V66, P2539, DOI 10.1152/jappl.1989.66.6.2539; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; TESSITORE L, 1993, ARCH BIOCHEM BIOPHYS, V306, P52, DOI 10.1006/abbi.1993.1479; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	60	61	64	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2013	27	7					2600	2610		10.1096/fj.12-222844	http://dx.doi.org/10.1096/fj.12-222844			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277TA	23515443	Green Published			2022-12-25	WOS:000328841000009
J	Huang, WQ; Bei, L; Eklund, EA				Huang, Weiqi; Bei, Ling; Eklund, Elizabeth A.			Fas-associated Phosphatase 1 (Fap1) Influences beta Catenin Activity in Myeloid Progenitor Cells Expressing the Bcr-abl Oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; TYROSINE-PHOSPHATASE; CONSTITUTIVE ACTIVATION; PTPN13 GENE; PDZ DOMAIN; ICSBP; GP91(PHOX); PU.1; MICE; TRANSCRIPTION	Increased beta catenin activity correlates with leukemia stem cell expansion and disease progression in chronic myeloid leukemia (CML). We found previously that expression of the CML-related Bcr-abl oncoprotein in myeloid progenitor cells increases expression of Fas-associated phosphatase 1 (Fap1). This resulted in Fap1-dependent resistance to Fas-induced apoptosis in these cells. Fap1 also interacts with the adenomatous polyposis coli (Apc) protein, but the functional significance of this interaction is unknown. Apc participates in a complex that includes glycogen synthase kinase beta (Gsk3 beta) and beta catenin. Assembly of this complex results in phosphorylation of beta catenin by Gsk3 beta, which facilitates beta catenin ubiquitination and degradation by the proteasome. In this study, we found increased association of Fap1 with the Apc complex in Bcr-abl(+) myeloid progenitor cells. We also found Fap1-dependent inactivation of Gsk3 beta and consequent stabilization of beta catenin in these cells. Consistent with this, Bcr-abl(+) cells exhibited a Fap1-dependent increase in beta catenin activity. Our studies identified Fap1-dependent Gsk3 beta inactivation as a molecular mechanism for increased beta catenin activity in CML.	[Huang, Weiqi; Bei, Ling; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Huang, Weiqi; Bei, Ling; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Eklund, Elizabeth A.] Jesse Brown Vet Hlth Adm Hosp, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch, Dept Med, 303 E Chicago Ave, Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu			NATIONAL CANCER INSTITUTE [R01CA174205] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002067] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA174205] Funding Source: Medline; BLRD VA [I01 BX002067] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BLRD VA		Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Barker N, 2000, ADV CANCER RES, V77, P1; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2013, LEUKEMIA LYMPHOMA, V54, P619, DOI 10.3109/10428194.2012.720979; Huang WQ, 2012, J BIOL CHEM, V287, P8110, DOI 10.1074/jbc.M111.294884; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kozlov G, 2002, J MOL BIOL, V320, P813, DOI 10.1016/S0022-2836(02)00544-2; LARRICK JW, 1980, J IMMUNOL, V125, P6; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Saras J, 1997, J BIOL CHEM, V272, P20979, DOI 10.1074/jbc.272.34.20979; SARAS J, 1994, J BIOL CHEM, V269, P24082; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9280, DOI 10.1021/bi101131f; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	28	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12766	12776		10.1074/jbc.M112.429696	http://dx.doi.org/10.1074/jbc.M112.429696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519466	Green Published, hybrid			2022-12-25	WOS:000318555100033
J	Distefano, G; Ferrari, RJ; Weiss, C; Deasy, BM; Boninger, ML; Fitzgerald, GK; Huard, J; Ambrosio, F				Distefano, Giovanna; Ferrari, Ricardo Jose; Weiss, Christopher; Deasy, Bridget M.; Boninger, Michael L.; Fitzgerald, G. Kelley; Huard, Johnny; Ambrosio, Fabrisia			Neuromuscular Electrical Stimulation as a Method to Maximize the Beneficial Effects of Muscle Stem Cells Transplanted into Dystrophic Skeletal Muscle	PLOS ONE			English	Article							MDX MICE; MYOBLAST TRANSPLANTATION; REPAIR; ADULT; REGENERATION; EXPRESSION; IMPROVES	Cellular therapy is a potential approach to improve the regenerative capacity of damaged or diseased skeletal muscle. However, its clinical use has often been limited by impaired donor cell survival, proliferation and differentiation following transplantation. Additionally, functional improvements after transplantation are all-too-often negligible. Because the host microenvironment plays an important role in the fate of transplanted cells, methods to modulate the microenvironment and guide donor cell behavior are warranted. The purpose of this study was to investigate whether the use of neuromuscular electrical stimulation (NMES) for 1 or 4 weeks following muscle-derived stem cell (MDSC) transplantation into dystrophic skeletal muscle can modulate the fate of donor cells and enhance their contribution to muscle regeneration and functional improvements. Animals submitted to 4 weeks of NMES after transplantation demonstrated a 2-fold increase in the number of dystrophin+ myofibers as compared to control transplanted muscles. These findings were concomitant with an increased vascularity in the MDSC+NMES group when compared to non-stimulated counterparts. Additionally, animals subjected to NMES (with or without MDSC transplantation) presented an increased maximal specific tetanic force when compared to controls. Although cell transplantation and/or the use of NMES resulted in no changes in fatigue resistance, the combination of both MDSC transplantation and NMES resulted in a faster recovery from fatigue, when compared to non-injected and non-stimulated counterparts. We conclude that NMES is a viable method to improve MDSC engraftment, enhance dystrophic muscle strength, and, in combination with MDSC transplantation, improve recovery from fatigue. These findings suggest that NMES may be a clinically-relevant adjunct approach for cell transplantation into skeletal muscle.	[Distefano, Giovanna; Ferrari, Ricardo Jose; Weiss, Christopher; Boninger, Michael L.; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Distefano, Giovanna; Ferrari, Ricardo Jose; Fitzgerald, G. Kelley; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Huard, Johnny; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Huard, Johnny; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Deasy, Bridget M.; Boninger, Michael L.; Huard, Johnny; Ambrosio, Fabrisia] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ambrosio, F (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	ambrosiof@upmc.edu	Distefano, Giovanna/AAB-9914-2022	Distefano, Giovanna/0000-0003-1208-5008; Boninger, Michael/0000-0001-6966-919X; Weiss, Christopher/0000-0003-4704-9533; Fitzgerald, G Kelley/0000-0001-6293-3103	Foundation for Physical Therapy; NIH K12 for Physical and Occupational Therapists-Comprehensive Opportunities in Rehabilitation Research Training [K12 HD055931]; Competitive Medical Research Fund of the University of Pittsburgh; Department of Physical Medicine & Rehabilitation at the University of Pittsburgh; Cook MyoSite Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, K01AG039477] Funding Source: NIH RePORTER	Foundation for Physical Therapy; NIH K12 for Physical and Occupational Therapists-Comprehensive Opportunities in Rehabilitation Research Training; Competitive Medical Research Fund of the University of Pittsburgh(University of Pittsburgh); Department of Physical Medicine & Rehabilitation at the University of Pittsburgh; Cook MyoSite Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Source: - Foundation for Physical Therapy (http://foundation4pt.org/) - NIH K12 for Physical and Occupational Therapists-Comprehensive Opportunities in Rehabilitation Research Training (K12 HD055931, FA) (http://www.corrt.pitt.edu/) - Competitive Medical Research Fund of the University of Pittsburgh (http://www.oorhs.pitt.edu/funding/cmrf.aspx) Department of Physical Medicine & Rehabilitation at the University of Pittsburgh (http://www.rehabmedicine.pitt.edu/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: One of the co-authors, Johnny Huard, has a potential financial conflict of interest because he has received remuneration as a consultant with Cook MyoSite Incorporated during the performance period of this project. None of the other authors has a financial or other relationship that might lead to conflict of interest concerning the publication of this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ambrosio F, 2010, TISSUE ENG PT A, V16, P839, DOI [10.1089/ten.tea.2009.0113, 10.1089/ten.TEA.2009.0113]; Ambrosio F, 2012, JOVE-J VIS EXP, DOI 10.3791/3914; Ambrosio F, 2009, ARCH PHYS MED REHAB, V90, P66, DOI 10.1016/j.apmr.2008.06.035; Annex BH, 1998, AM J PHYSIOL-HEART C, V274, pH860, DOI 10.1152/ajpheart.1998.274.3.H860; Auda-Boucher G, 2007, EXP CELL RES, V313, P997, DOI 10.1016/j.yexcr.2006.12.021; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bouchentouf M, 2006, NEUROMUSCULAR DISORD, V16, P518, DOI 10.1016/j.nmd.2006.06.003; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Brutsaert Tom D, 2002, BMC Physiol, V2, P8, DOI 10.1186/1472-6793-2-8; de Juan-Pardo EM, 2006, INT J NANOMED, V1, P203, DOI 10.2147/nano.2006.1.2.203; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Goudemant JF, 1998, NEUROMUSCULAR DISORD, V8, P371, DOI 10.1016/S0960-8966(98)00049-2; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; HANG J, 1995, AM J PHYSIOL-HEART C, V269, pH1827, DOI 10.1152/ajpheart.1995.269.5.H1827; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Mueller GM, 2002, HUM GENE THER, V13, P1081, DOI 10.1089/104303402753812485; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Payne TR, 2007, J AM COLL CARDIOL, V50, P1677, DOI 10.1016/j.jacc.2007.04.100; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404	25	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e54922	10.1371/journal.pone.0054922	http://dx.doi.org/10.1371/journal.pone.0054922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526927	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000317562100003
J	Yang, LQ; Lin, FC; Zhou, Y; Xu, JR; Yu, CS; Pan, WJ; Lei, H				Yang, Liqin; Lin, Fuchun; Zhou, Yan; Xu, Jianrong; Yu, Chunshui; Pan, Wen-Ju; Lei, Hao			Iterative Cross-Correlation Analysis of Resting State Functional Magnetic Resonance Imaging Data	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; HUMAN BRAIN; MAJOR DEPRESSION; BLIND SEPARATION; CONNECTIVITY; CORTEX; MRI	Seed-based cross-correlation analysis (sCCA) and independent component analysis have been widely employed to extract functional networks from the resting state functional magnetic resonance imaging data. However, the results of sCCA, in terms of both connectivity strength and network topology, can be sensitive to seed selection variations. ICA avoids the potential problems due to seed selection, but choosing which component(s) to represent the network of interest could be subjective and problematic. In this study, we proposed a seed-based iterative cross-correlation analysis (siCCA) method for resting state brain network analysis. The method was applied to extract default mode network (DMN) and stable task control network (STCN) in two independent datasets acquired from normal adults. Compared with the networks obtained by traditional sCCA and ICA, the resting state networks produced by siCCA were found to be highly stable and independent on seed selection. siCCA was used to analyze DMN in first-episode major depressive disorder (MDD) patients. It was found that, in the MDD patients, the volume of DMN negatively correlated with the patients' social disability screening schedule scores.	[Yang, Liqin; Lin, Fuchun; Pan, Wen-Ju; Lei, Hao] Chinese Acad Sci, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Zhou, Yan; Xu, Jianrong] Jiao Tong Univ, Sch Med, RenJi Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yu, Chunshui] Capital Med Univ, XuanWu Hosp, Dept Radiol, Beijing, Peoples R China; [Yang, Liqin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Shanghai Jiao Tong University; Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pan, WJ (corresponding author), Chinese Acad Sci, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China.	wpan5@emory.edu; leihao@wipm.ac.cn	, 雷皓/H-8147-2019; Lei, Hao/A-7004-2008; Lin, Fuchun/M-2789-2019; Lin, Fuchun/D-2371-2012	, 雷皓/0000-0003-3412-1241; Lei, Hao/0000-0003-3412-1241; Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474; Yu, Chunshui/0000-0001-5648-5199; Yang, Liqin/0000-0003-1823-4756	973 program of the Ministry of Science and Technology of China [2011CB707802]; National Natural Science Foundation of China [81171302, 20921004, 81171325, 30970901]; Shanghai Science and Technology Committee Medical Guide Project [114119a0900]; Shanghai Leading Academic Discipline Project [S30203]	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Medical Guide Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 program of the Ministry of Science and Technology of China (2011CB707802), National Natural Science Foundation of China (No. 81171302, 20921004, 81171325 and 30970901), Shanghai Science and Technology Committee Medical Guide Project (No. 114119a0900), and Shanghai Leading Academic Discipline Project (No. S30203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P547, DOI DOI 10.5169/SEALS-266450; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Press W. H., 1992, ART SCI COMPUTING; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Shen YW, 1985, HDB EPIDEMIOLOGICAL; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293	31	3	3	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58653	10.1371/journal.pone.0058653	http://dx.doi.org/10.1371/journal.pone.0058653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527002	Green Published, gold, Green Submitted			2022-12-25	WOS:000316411600009
J	Blasche, S; Mortl, M; Steuber, H; Siszler, G; Nisa, S; Schwarz, F; Lavrik, I; Gronewold, TMA; Maskos, K; Donnenberg, MS; Ullmann, D; Uetz, P; Koegl, M				Blasche, Sonja; Moertl, Mario; Steuber, Holger; Siszler, Gabriella; Nisa, Shahista; Schwarz, Frank; Lavrik, Inna; Gronewold, Thomas M. A.; Maskos, Klaus; Donnenberg, Michael S.; Ullmann, Dirk; Uetz, Peter; Koegl, Manfred			The E. coli Effector Protein NleF Is a Caspase Inhibitor	PLOS ONE			English	Article							BLOCK APOPTOSIS; ACTIVATION; SPECIFICITY; SELECTION; INTERACT; SYSTEM; GENES; ESPF	Enterohemorrhagic and enteropathogenic E. coli (EHEC and EPEC) can cause severe and potentially life-threatening infections. Their pathogenicity is mediated by at least 40 effector proteins which they inject into their host cells by a type-III secretion system leading to the subversion of several cellular pathways. However, the molecular function of several effectors remains unknown, even though they contribute to virulence. Here we show that one of them, NleF, binds to caspase-4, -8, and -9 in yeast two-hybrid, LUMIER, and direct interaction assays. NleF inhibits the catalytic activity of the caspases in vitro and in cell lysate and prevents apoptosis in HeLa and Caco-2 cells. We have solved the crystal structure of the caspase-9/NleF complex which shows that NleF uses a novel mode of caspase inhibition, involving the insertion of the carboxy-terminus of NleF into the active site of the protease. In conformance with our structural model, mutagenized NleF with truncated or elongated carboxy-termini revealed a complete loss in caspase binding and apoptosis inhibition. Evasion of apoptosis helps pathogenic E. coli and other pathogens to take over the host cell by counteracting the cell's ability to self-destruct upon infection. Recently, two other effector proteins, namely NleD and NleH, were shown to interfere with apoptosis. Even though NleF is not the only effector protein capable of apoptosis inhibition, direct inhibition of caspases by bacterial effectors has not been reported to date. Also unique so far is its mode of inhibition that resembles the one obtained for synthetic peptide-type inhibitors and as such deviates substantially from previously reported caspase-9 inhibitors such as the BIR3 domain of XIAP.	[Blasche, Sonja; Siszler, Gabriella; Schwarz, Frank; Koegl, Manfred] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Moertl, Mario; Steuber, Holger; Maskos, Klaus; Ullmann, Dirk] Proteros Biostruct GmbH, Martinsried, Germany; [Nisa, Shahista; Donnenberg, Michael S.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Lavrik, Inna] German Canc Res Ctr, Div Immunogenet, Heidelberg, Germany; [Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [Gronewold, Thomas M. A.] SAW Instruments GmbH, Bonn, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University System of Maryland; University of Maryland Baltimore; Helmholtz Association; German Cancer Research Center (DKFZ); Virginia Commonwealth University	Uetz, P (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA.	uetz@vcu.edu	Lavrik, Inna N/C-1700-2009; Uetz, Peter/A-7119-2012; Schwarz, Frank/AGV-7773-2022	Lavrik, Inna N/0000-0002-9324-309X; Uetz, Peter/0000-0001-6194-4927; Donnenberg, Michael/0000-0002-8818-3184	European Union (EU) [HEALTH-F3-2009-223101]; National Institute of Allergy and Infectious Diseases [1U19AI090873]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090873] Funding Source: NIH RePORTER	European Union (EU)(CGIAREuropean Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Seventh Research Framework Programme of the European Union (AntiPathoGN; EU grant HEALTH-F3-2009-223101). SN and MSD were supported by award number 1U19AI090873 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1045; Charatan F, 2006, BRIT MED J, V333, P673, DOI 10.1136/bmj.333.7570.673-c; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Echtenkamp F, 2008, FEMS MICROBIOL LETT, V281, P98, DOI 10.1111/j.1574-6968.2008.01088.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foster DB, 2000, INFECT IMMUN, V68, P3108, DOI 10.1128/IAI.68.6.3108-3115.2000; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Heczko U, 2001, INFECT IMMUN, V69, P4580, DOI 10.1128/IAI.69.7.4580-4589.2001; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LEVINE MM, 1978, LANCET, V1, P1119; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nougayrede JP, 2007, CELL MICROBIOL, V9, P680, DOI 10.1111/j.1462-5822.2006.00820.x; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Ozoren N, 2002, NEOPLASIA, V4, P551, DOI 10.1038/sj.neo.7900270; Papatheodorou P, 2006, CELL MICROBIOL, V8, P677, DOI 10.1111/j.1462-5822.2005.00660.x; Perpeet M, 2006, ANAL LETT, V39, P1747, DOI 10.1080/000327106006714063; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Tahoun A, 2011, INFECT IMMUN; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Xu GZ, 2003, J BIOL CHEM, V278, P5455, DOI 10.1074/jbc.M211607200; Yamada T, 2011, INT J PARASITOL, V41, P595, DOI 10.1016/j.ijpara.2010.11.012; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	46	72	79	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58937	10.1371/journal.pone.0058937	http://dx.doi.org/10.1371/journal.pone.0058937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516580	gold, Green Submitted, Green Published			2022-12-25	WOS:000316407400079
J	Chakraborty, S				Chakraborty, Sandeep			A Quantitative Measure of Electrostatic Perturbation in Holo and Apo Enzymes Induced by Structural Changes	PLOS ONE			English	Article							TOXIN REPRESSOR DTXR; ULTRAHIGH-RESOLUTION STRUCTURE; ZN SUPEROXIDE-DISMUTASE; FREE-ENERGY COUPLINGS; BETA-LACTAMASE; PK(A) VALUES; ENZYMATIC-REACTIONS; CRYSTAL-STRUCTURES; TRANSITION-STATE; LIGAND-BINDING	Biological pathways are subject to subtle manipulations that achieve a wide range of functional variation in differing physiological niches. In many instances, changes in the structure of an enzyme on ligand binding germinate electrostatic perturbations that form the basis of its changed catalytic or transcriptional efficiency. Computational methods that seek to gain insights into the electrostatic changes in enzymes require expertise to setup and computing prowess. In the current work, we present a fast, easy and reliable methodology to compute electrostatic perturbations induced by ligand binding (MEPP). The theoretical foundation of MEPP is the conserved electrostatic potential difference (EPD) in cognate pairs of active site residues in proteins with the same functionality. Previously, this invariance has been used to unravel promiscuous serine protease and metallo-b-lactamase scaffolds in alkaline phosphatases. Given that a similarity in EPD is significant, we expect differences in the EPD to be significant too. MEPP identifies residues or domains that undergo significant electrostatic perturbations, and also enumerates residue pairs that undergo significant polarity change. The gain in a certain polarity of a residue with respect to neighboring residues, or the reversal of polarity between two residues might indicate a change in the preferred ligand. The methodology of MEPP has been demonstrated on several enzymes that employ varying mechanisms to perform their roles. For example, we have attributed the change in polarity in residue pairs to be responsible for the loss of metal ion binding in fructose 1,6-bisphosphatases, and corroborated the pre-organized state of the active site of the enzyme with respect to functionally relevant changes in electric fields in ketosteroid isomerases.	Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sanchak@gmail.com			Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award Grant)	Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award Grant)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy) and the Department of Science and Technology (JC Bose Award Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov E, 2011, PROTEINS, V79, P3260, DOI 10.1002/prot.23189; Atkins P., 2006, PHYS CHEM; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bate P, 2004, J MOL BIOL, V340, P263, DOI 10.1016/j.jmb.2004.04.070; Chakraborty S, 2012, FEBS LETT, V586, P3710, DOI 10.1016/j.febslet.2012.08.030; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039577; Chakraborty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028470; Chen P, 2004, J AM CHEM SOC, V126, P4991, DOI 10.1021/ja031564g; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eisberg R. M., 1985, QUANTUM PHYS ATOMS M; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Fafarman AT, 2012, P NATL ACAD SCI USA, V109, pE299, DOI 10.1073/pnas.1111566109; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Fuhrmann CN, 2006, J AM CHEM SOC, V128, P9086, DOI 10.1021/ja057721o; Gao JL, 2006, CHEM REV, V106, P3188, DOI 10.1021/cr050293k; Grochowski P, 2008, BIOPOLYMERS, V89, P93, DOI 10.1002/bip.20877; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jha SK, 2011, P NATL ACAD SCI USA, V108, P16612, DOI 10.1073/pnas.1113874108; JOHNSON ML, 1986, BIOCHEMISTRY-US, V25, P791, DOI 10.1021/bi00352a009; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Kamerlin SCL, 2010, P NATL ACAD SCI USA, V107, P4075, DOI 10.1073/pnas.0914579107; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; Khare SD, 2003, J MOL BIOL, V334, P515, DOI 10.1016/j.jmb.2003.09.069; Kraut DA, 2006, PLOS BIOL, V4, P501, DOI 10.1371/journal.pbio.0040099; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; Love JF, 2004, P NATL ACAD SCI USA, V101, P2506, DOI 10.1073/pnas.0303794101; Love JF, 2003, J BACTERIOL, V185, P2251, DOI 10.1128/JB.185.7.2251-2258.2003; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Pohl E, 1998, J BIOL CHEM, V273, P22420, DOI 10.1074/jbc.273.35.22420; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Ren Z, 2012, P NATL ACAD SCI USA, V109, P107, DOI 10.1073/pnas.1109213108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROYER WE, 1994, J MOL BIOL, V235, P657, DOI 10.1006/jmbi.1994.1019; Schmidlin T, 2009, BIOPHYS J, V97, P1709, DOI 10.1016/j.bpj.2009.06.043; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Tomanicek SJ, 2011, FEBS LETT, V585, P364, DOI 10.1016/j.febslet.2010.12.017; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tuzmen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016474; van Gunsteren W. F., 1987, GRONINGEN MOL SIMULA; Vonderach M, 2011, PHYS CHEM CHEM PHYS, V13, P15554, DOI 10.1039/c1cp21528k; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1981, BIOCHEMISTRY-US, V20, P3167, DOI 10.1021/bi00514a028; Warshel A, 1981, Ann N Y Acad Sci, V367, P370, DOI 10.1111/j.1749-6632.1981.tb50579.x; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; Warshel A, 2007, BIOCHEMISTRY-US, V46, P1466, DOI 10.1021/bi061752u; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; WEBER G, 1987, BIOCHEMISTRY-US, V26, P331, DOI 10.1021/bi00375a046; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	63	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59352	10.1371/journal.pone.0059352	http://dx.doi.org/10.1371/journal.pone.0059352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516628	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400107
J	Koizumi, A; Kitagawa, N; Kondo, HM; Kitamura, MS; Sato, T; Kashino, M				Koizumi, Ai; Kitagawa, Norimichi; Kondo, Hirohito M.; Kitamura, Miho S.; Sato, Takao; Kashino, Makio			Serotonin Transporter Gene-Linked Polymorphism Affects Detection of Facial Expressions	PLOS ONE			English	Article							REGION 5-HTTLPR POLYMORPHISM; REGULATORY REGION; AMYGDALA ACTIVITY; DEPRESSION; STIMULI; ANXIETY; RECOGNITION; ASSOCIATION; INTENSITY; ATTENTION	Previous studies have demonstrated that the serotonin transporter gene-linked polymorphic region (5-HTTLPR) affects the recognition of facial expressions and attention to them. However, the relationship between 5-HTTLPR and the perceptual detection of others' facial expressions, the process which takes place prior to emotional labeling (i.e., recognition), is not clear. To examine whether the perceptual detection of emotional facial expressions is influenced by the allelic variation (short/long) of 5-HTTLPR, happy and sad facial expressions were presented at weak and mid intensities (25% and 50%). Ninety-eight participants, genotyped for 5-HTTLPR, judged whether emotion in images of faces was present. Participants with short alleles showed higher sensitivity (d') to happy than to sad expressions, while participants with long allele(s) showed no such positivity advantage. This effect of 5-HTTLPR was found at different facial expression intensities among males and females. The results suggest that at the perceptual stage, a short allele enhances the processing of positive facial expressions rather than that of negative facial expressions.	[Kitagawa, Norimichi; Kondo, Hirohito M.; Kitamura, Miho S.; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Kanagawa, Japan; [Koizumi, Ai; Sato, Takao] Univ Tokyo, Dept Psychol, Tokyo, Japan; [Koizumi, Ai; Kashino, Makio] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kanagawa, Japan; [Kitamura, Miho S.] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Tokyo Institute of Technology	Koizumi, A (corresponding author), NTT Corp, NTT Commun Sci Labs, Kanagawa, Japan.	bellkoizumi@gmail.com	Kitamura, Miho/Q-2405-2019; Kondo, Hirohito/H-3646-2011	Kondo, Hirohito/0000-0002-7444-4996	Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists [20-11352, 18-4848]; Grants-in-Aid for Scientific Research [24650130] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AK and MSK were supported by the Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (20-11352 and 18-4848; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antypa N, 2011, NEUROSCIENCE, V172, P303, DOI 10.1016/j.neuroscience.2010.10.042; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Becker DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026551; Beevers CG, 2011, J ABNORM PSYCHOL, V120, P187, DOI 10.1037/a0022125; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Ekman P, 1978, FACIAL ACTION CODING; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Friedel E, 2009, PSYCHOPHARMACOLOGY, V205, P261, DOI 10.1007/s00213-009-1536-1; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Gorea A, 2000, P NATL ACAD SCI USA, V97, P12380, DOI 10.1073/pnas.97.22.12380; Green DM, 1966, SIGNAL DETECTION THE; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Koizumi A, 2010, NEUROREPORT, V21, P422, DOI 10.1097/WNR.0b013e32833833f0; Lee BT, 2008, GENES BRAIN BEHAV, V7, P899, DOI 10.1111/j.1601-183X.2008.00429.x; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036513; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Macmillan N. A., 1993, HDB DATA ANAL BEHAV, P21; Murakami F, 1999, J HUM GENET, V44, P15, DOI 10.1007/s100380050098; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Thomason ME, 2010, BIOL PSYCHOL, V85, P38, DOI 10.1016/j.biopsycho.2010.04.009; Yoon KL, 2009, J ABNORM PSYCHOL, V118, P223, DOI 10.1037/a0014658	35	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59074	10.1371/journal.pone.0059074	http://dx.doi.org/10.1371/journal.pone.0059074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516600	gold, Green Submitted, Green Published			2022-12-25	WOS:000316407400090
J	Kouskoura, T; Kozlova, A; Alexiou, M; Blumer, S; Zouvelou, V; Katsaros, C; Chiquet, M; Mitsiadis, TA; Graf, D				Kouskoura, Thaleia; Kozlova, Anastasiia; Alexiou, Maria; Blumer, Susanne; Zouvelou, Vasiliki; Katsaros, Christos; Chiquet, Matthias; Mitsiadis, Thimios A.; Graf, Daniel			The Etiology of Cleft Palate Formation in BMP7-Deficient Mice	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; MOUSE SECONDARY PALATE; MUTANT MICE; EPITHELIAL DIFFERENTIATION; MATRIX METALLOPROTEINASES; CRANIOFACIAL DEVELOPMENT; NEURAL CREST; BMP; PALATOGENESIS; EXPRESSION	Palatogenesis is a complex process implying growth, elevation and fusion of the two lateral palatal shelves during embryogenesis. This process is tightly controlled by genetic and mechanistic cues that also coordinate the growth of other orofacial structures. Failure at any of these steps can result in cleft palate, which is a frequent craniofacial malformation in humans. To understand the etiology of cleft palate linked to the BMP signaling pathway, we studied palatogenesis in Bmp7-deficient mouse embryos. Bmp7 expression was found in several orofacial structures including the edges of the palatal shelves prior and during their fusion. Bmp7 deletion resulted in a general alteration of oral cavity morphology, unpaired palatal shelf elevation, delayed shelf approximation, and subsequent lack of fusion. Cell proliferation and expression of specific genes involved in palatogenesis were not altered in Bmp7-deficient embryos. Conditional ablation of Bmp7 with Keratin14-Cre or Wnt1-Cre revealed that neither epithelial nor neural crest-specific loss of Bmp7 alone could recapitulate the cleft palate phenotype. Palatal shelves from mutant embryos were able to fuse when cultured in vitro as isolated shelves in proximity, but not when cultured as whole upper jaw explants. Thus, deformations in the oral cavity of Bmp7-deficient embryos such as the shorter and wider mandible were not solely responsible for cleft palate formation. These findings indicate a requirement for Bmp7 for the coordination of both developmental and mechanistic aspects of palatogenesis.	[Kouskoura, Thaleia; Kozlova, Anastasiia; Alexiou, Maria; Mitsiadis, Thimios A.; Graf, Daniel] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Kouskoura, Thaleia; Blumer, Susanne; Katsaros, Christos; Chiquet, Matthias] Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Zouvelou, Vasiliki] Univ Athens, Sch Med, Dept Histol & Embryol, Athens 11528, Greece	University of Zurich; University of Bern; Athens Medical School; National & Kapodistrian University of Athens	Graf, D (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	daniel.graf@zzm.uzh.ch	Mitsiadis, Thimios/B-5564-2016	Mitsiadis, Thimios/0000-0002-9812-9982; Graf, Daniel/0000-0003-1163-8117; Katsaros, Christos/0000-0001-5545-6740; Chiquet, Matthias/0000-0001-7812-4853	University of Zurich; Swiss National Science Foundation (SNSF) [31003A-135530]; Swiss Dental Association (SSO) [234-07, 255/10]	University of Zurich; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Dental Association (SSO)	This work was supported by funds from the University of Zurich, the Swiss National Science Foundation (SNSF) (grant 31003A-135530 to D.G.and T.A.M.), and the Swiss Dental Association (SSO) for the Projects 234-07 (T.A.M.) and 255/10 (T.K.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Bloch-Zupan A, 2011, AM J HUM GENET, V89, P773, DOI 10.1016/j.ajhg.2011.11.002; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; BRINKLEY LL, 1987, DEVELOPMENT, V100, P629; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chou MJ, 2004, ANAT EMBRYOL, V208, P19, DOI 10.1007/s00429-004-0379-0; d'Amaro R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00377; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DIEWERT VM, 1981, TERATOLOGY, V24, P43, DOI 10.1002/tera.1420240106; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Gkantidis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047762; Godin RE, 1998, DEVELOPMENT, V125, P3473; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jin JZ, 2008, CELL TISSUE RES, V333, P29, DOI 10.1007/s00441-008-0612-x; Jin JZ, 2010, DEV DYNAM, V239, P2110, DOI 10.1002/dvdy.22339; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kouskoura Thaleia, 2011, Schweiz Monatsschr Zahnmed, V121, P636; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lavrin IO, 2001, ARCH ORAL BIOL, V46, P865, DOI 10.1016/S0003-9969(01)00044-9; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Li IWS, 1996, J CELL PHYSIOL, V169, P115, DOI 10.1002/(SICI)1097-4652(199610)169:1<115::AID-JCP12>3.0.CO;2-C; Li L, 2011, DEV BIOL, V349, P451, DOI 10.1016/j.ydbio.2010.10.023; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Lu HB, 2000, ARCH ORAL BIOL, V45, P133, DOI 10.1016/S0003-9969(99)00118-1; Maddox BK, 1998, J CRAN GENET DEV BIO, V18, P195; Martinez-Sanz E, 2008, DIFFERENTIATION, V76, P417, DOI 10.1111/j.1432-0436.2007.00226.x; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Morris-Wiman J, 1999, J CRAN GENET DEV BIO, V19, P201; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Prows C A, 1999, Neonatal Netw, V18, P13; Ricks JE, 2002, TERATOLOGY, V65, P116, DOI 10.1002/tera.10022; Sani FV, 2010, EUR J ORAL SCI, V118, P221, DOI 10.1111/j.1600-0722.2010.00732.x; SEEGMILLER RE, 1977, J EMBRYOL EXP MORPH, V38, P227; SHIOTA K, 1990, ACTA ANAT, V137, P59; SHULER CF, 1995, CRIT REV ORAL BIOL M, V6, P202, DOI 10.1177/10454411950060030301; Snead MP, 1999, J MED GENET, V36, P353; Tsunekawa N, 2005, EUR J NEUROSCI, V21, P173, DOI 10.1111/j.1460-9568.2004.03860.x; Vieira AR, 2008, J DENT RES, V87, P119, DOI 10.1177/154405910808700202; Wang YH, 1999, DEV DYNAM, V216, P320, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<320::AID-DVDY2>3.0.CO;2-H; Wyatt AW, 2010, HUM MUTAT, V31, P781, DOI 10.1002/humu.21280; Yu K, 2011, DEV DYNAM, V240, P1737, DOI 10.1002/dvdy.22670; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262	61	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059463	10.1371/journal.pone.0059463	http://dx.doi.org/10.1371/journal.pone.0059463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516636	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400112
J	Liu, J; Liu, FY; Tong, ZQ; Li, ZH; Chen, W; Luo, WH; Li, H; Luo, HJ; Tang, Y; Tang, JM; Cai, J; Liao, FF; Wan, Y				Liu, Jia; Liu, Feng-Yu; Tong, Zhi-Qian; Li, Zhi-Hua; Chen, Wen; Luo, Wen-Hong; Li, Hui; Luo, Hong-Jun; Tang, Yan; Tang, Jun-Min; Cai, Jie; Liao, Fei-Fei; Wan, You			Lysine-Specific Demethylase 1 in Breast Cancer Cells Contributes to the Production of Endogenous Formaldehyde in the Metastatic Bone Cancer Pain Model of Rats	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE ALDH; DYNAMIC-RANGE NEURONS; ROOT GANGLION NEURONS; SPINAL DORSAL-HORN; SERINE HYDROXYMETHYLTRANSFERASE; DIMETHYLGLYCINE DEHYDROGENASE; INFLAMMATORY NOCICEPTION; DIFFERENT INTENSITIES; ECTOPIC DISCHARGES; NEUROPATHIC PAIN	Background: Bone cancer pain seriously affects the quality of life of cancer patients. Our previous study found that endogenous formaldehyde was produced by cancer cells metastasized into bone marrows and played an important role in bone cancer pain. However, the mechanism of production of this endogenous formaldehyde by metastatic cancer cells was unknown in bone cancer pain rats. Lysine-specific demethylase 1 (LSD1) is one of the major enzymes catalyzing the production of formaldehyde. The expression of LSD1 and the concentration of formaldehyde were up-regulated in many high-risk tumors. Objective: This study aimed to investigate whether LSD1 in metastasized MRMT-1 breast cancer cells in bone marrows participated in the production of endogenous formaldehyde in bone cancer pain rats. Methodology/Principal Findings: Concentration of the endogenous formaldehyde was measured by high performance liquid chromatography (HPLC). Endogenous formaldehyde dramatically increased in cultured MRMT-1 breast cancer cells in vitro, in bone marrows and sera of bone cancer pain rats, in tumor tissues and sera of MRMT-1 subcutaneous vaccination model rats in vivo. Formaldehyde at a concentration as low as the above measured (3 mM) induced pain behaviors in normal rats. The expression of LSD1 which mainly located in nuclei of cancer cells significantly increased in bone marrows of bone cancer pain rats from 14 d to 21 d after inoculation. Furthermore, inhibition of LSD1 decreased the production of formaldehyde in MRMT-1 cells in vitro. Intraperitoneal injection of LSD1 inhibitor pargyline from 3 d to 14 d after inoculation of MRMT-1 cancer cells reduced bone cancer pain behaviors. Conclusion: Our data in the present study, combing our previous report, suggested that in the endogenous formaldehyde-induced pain in bone cancer pain rats, LSD1 in metastasized cancer cells contributed to the production of the endogenous formaldehyde.	[Liu, Jia; Liu, Feng-Yu; Tong, Zhi-Qian; Li, Zhi-Hua; Chen, Wen; Cai, Jie; Liao, Fei-Fei; Wan, You] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Liu, Jia; Liu, Feng-Yu; Tong, Zhi-Qian; Li, Zhi-Hua; Chen, Wen; Cai, Jie; Liao, Fei-Fei; Wan, You] Peking Univ, Dept Neurobiol, Beijing 100871, Peoples R China; [Tong, Zhi-Qian] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Li, Zhi-Hua] Zhengzhou Univ, Basic Med Coll, Dept Anat, Zhengzhou, Peoples R China; [Luo, Wen-Hong; Li, Hui; Luo, Hong-Jun] Shantou Univ, Coll Med, Cent Lab, Shantou, Peoples R China; [Tang, Yan; Tang, Jun-Min] Peking Univ, Sch Basic Med Sci, Dept Anat & Histol, Beijing 100871, Peoples R China; [Wan, You] Minist Hlth, Minist Educ, Key Lab Neurosci, Beijing, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Zhengzhou University; Shantou University; Peking University	Wan, Y (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	ywan@hsc.pku.edu.cn	cai, jie/HHS-0606-2022; Wan, You/M-5279-2019	Wan, You/0000-0001-6110-7192	National Natural Science Foundation of China [81171042, 81070893]; Specialized Research Fund for Doctoral Program of Higher Education [20110001110058]; Key Project of Chinese Ministry of Education [109003]; Beijing Municipal Commission of Education "Special Grants for Outstanding Ph.D. Program Tutors"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Beijing Municipal Commission of Education "Special Grants for Outstanding Ph.D. Program Tutors"	This research was supported by grants from the National Natural Science Foundation of China (81171042, 81070893), Specialized Research Fund for Doctoral Program of Higher Education (20110001110058), the Key Project of Chinese Ministry of Education (109003) and Beijing Municipal Commission of Education "Special Grants for Outstanding Ph.D. Program Tutors". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J MOL MICROB BIOTECH, V6, P67, DOI 10.1159/000076737; ALOISI AM, 1995, BRAIN RES, V699, P242, DOI 10.1016/0006-8993(95)00912-A; ALOISI AM, 1995, PHYSIOL BEHAV, V58, P603, DOI 10.1016/0031-9384(95)00099-5; Binzak BA, 2001, AM J HUM GENET, V68, P839, DOI 10.1086/319520; Chi YN, 2012, NEUROSCI BULL, V28, P715, DOI 10.1007/s12264-012-1284-9; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Ebeler SE, 1997, J CHROMATOGR B, V702, P211, DOI 10.1016/S0378-4347(97)00369-1; Grant S, 2009, CLIN CANCER RES, V15, P7111, DOI 10.1158/1078-0432.CCR-09-2399; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Han Y, 2012, NEUROSCI BULL, V28, P165, DOI 10.1007/s12264-012-1211-0; HARADA Y, 1976, CANCER RES, V36, P18; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Ho YC, 2007, J BIOMED MATER RES B, V83B, P340, DOI 10.1002/jbm.b.30801; Huang Y, 2012, BREAST CANCER RES TR, V131, P777, DOI 10.1007/s10549-011-1480-8; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Jelski W, 2008, CLIN CHIM ACTA, V395, P1, DOI 10.1016/j.cca.2008.05.001; Jelski W, 2006, J CLIN LAB ANAL, V20, P105, DOI 10.1002/jcla.20109; Jiang YQ, 2008, PAIN, V137, P495, DOI 10.1016/j.pain.2007.10.011; Kalasz H, 2003, MINI-REV MED CHEM, V3, P175, DOI 10.2174/1389557033488187; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Liu FY, 2007, J PHARMACOL EXP THER, V321, P1046, DOI 10.1124/jpet.106.115204; Liu FY, 2012, BRAIN RES, V1427, P65, DOI 10.1016/j.brainres.2011.10.016; Liu FY, 2011, NEUROSCI BULL, V27, P1, DOI 10.1007/s12264-011-1039-z; Liu FY, 2010, BRAIN RES, V1330, P45, DOI 10.1016/j.brainres.2010.03.010; Lu Y, 2008, BRAIN RES, V1200, P19, DOI 10.1016/j.brainres.2008.01.012; Luo WH, 2001, J CHROMATOGR B, V753, P253, DOI 10.1016/S0378-4347(00)00552-1; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Lyles GA, 1996, INT J BIOCHEM CELL B, V28, P259, DOI 10.1016/1357-2725(95)00130-1; MacAllister SL, 2011, CHEM-BIOL INTERACT, V191, P308, DOI 10.1016/j.cbi.2011.01.017; MACKENZIE CG, 1956, J BIOL CHEM, V222, P145; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nagae M, 2007, J BONE MINER METAB, V25, P99, DOI 10.1007/s00774-006-0734-8; Peters CM, 2004, NEUROSCIENCE, V126, P1043, DOI 10.1016/j.neuroscience.2004.04.027; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Pradhan AAA, 2010, EUR J PAIN, V14, P503, DOI 10.1016/j.ejpain.2009.08.010; QUADRI SK, 1973, P SOC EXP BIOL MED, V142, P22; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Sabino M. C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P561; SCHIRCH V, 1986, EUR J BIOCHEM, V161, P45, DOI 10.1111/j.1432-1033.1986.tb10122.x; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Sevcik MA, 2005, PAIN, V115, P128, DOI 10.1016/j.pain.2005.02.022; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; Su YL, 2010, NEUROSCI BULL, V26, P429, DOI 10.1007/s12264-010-0932-1; Sun Q, 2005, BRAIN RES, V1032, P63, DOI 10.1016/j.brainres.2004.10.033; Sun Q, 2005, EXP NEUROL, V191, P128, DOI 10.1016/j.expneurol.2004.09.008; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Terry MB, 2006, CARCINOGENESIS, V27, P840, DOI 10.1093/carcin/bgi285; THORNDIKE J, 1977, CANCER RES, V37, P1125; Tong ZQ, 2013, AGE, V35, P583, DOI 10.1007/s11357-012-9388-8; Tong ZQ, 2011, NEUROBIOL AGING, V32, P31, DOI 10.1016/j.neurobiolaging.2009.07.013; Tong ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010234; Wang JW, 2012, NEUROCHEM RES, V37, P2125, DOI 10.1007/s11064-012-0834-x; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Willmann D, 2012, INT J CANCER, V131, P2704, DOI 10.1002/ijc.27555; Xing GG, 2007, EXP NEUROL, V208, P323, DOI 10.1016/j.expneurol.2007.09.004; Yi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-61; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	23	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58957	10.1371/journal.pone.0058957	http://dx.doi.org/10.1371/journal.pone.0058957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516587	Green Submitted, Green Published, gold			2022-12-25	WOS:000316407400084
J	Shin, JR; Lim, KJ; Kim, DJ; Cho, JH; Kim, SC				Shin, Ju Ri; Lim, Ki Jung; Kim, Da Jung; Cho, Ju Hyun; Kim, Sun Chang			Display of Multimeric Antimicrobial Peptides on the Escherichia coli Cell Surface and Its Application as Whole-Cell Antibiotics	PLOS ONE			English	Article							RESISTANCE; GROWTH; HISTORY; AGENTS	Concerns over the increasing emergence of antibiotic-resistant pathogenic microorganisms due to the overuse of antibiotics and the lack of effective antibiotics for livestock have prompted efforts to develop alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) with a broad-spectrum activity and rapid killing, along with little opportunity for the development of resistance, represent one of the promising novel alternatives. Their high production cost and cytotoxicity, however, limit the use of AMPs as effective antibiotic agents to livestock. To overcome these problems, we developed potent antimicrobial Escherichia coli displaying multimeric AMPs on the cell surface so that the AMP multimers can be converted into active AMP monomers by the pepsin in the stomach of livestock. Buf IIIb, a strong AMP without cytotoxicity, was expressed on the surface of E. coli as Lpp-OmpA-fused tandem multimers with a pepsin substrate residue, leucine, at the C-terminus of each monomer. The AMP multimers were successfully converted into active AMPs upon pepsin cleavage, and the liberated Buf IIIb-L monomers inhibited the growth of two major oral infectious pathogens of livestock, Salmonella enteritidis and Listeria monocytogenes. Live antimicrobial microorganisms developed in this study may represent the most effective means of providing potent AMPs to livestock, and have a great impact on controlling over pathogenic microorganisms in the livestock production.	[Shin, Ju Ri; Lim, Ki Jung; Kim, Da Jung; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Cho, Ju Hyun] Gyeongsang Natl Univ, Dept Biol, Life Sci Res Inst, Jinju, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Gyeongsang National University	Cho, JH (corresponding author), Gyeongsang Natl Univ, Dept Biol, Life Sci Res Inst, Jinju, South Korea.	juhyun.cho@gnu.ac.kr; sunkim@kaist.ac.kr	Kim, Sun Chang/C-2026-2011; Kim, Sun/GSN-4867-2022		Next-Generation BioGreen 21 Program (SSAC) [PJ008110]; Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology [2011-0031955]	Next-Generation BioGreen 21 Program (SSAC)(Rural Development Administration (RDA), Republic of Korea); Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Next-Generation BioGreen 21 Program (SSAC; PJ008110), the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Burdock GA, 2004, TOXICOL LETT, V150, P3, DOI 10.1016/j.toxlet.2003.07.004; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Conly J, 2002, CAN MED ASSOC J, V167, P885; FRANCISCO JA, 1992, P NATL ACAD SCI USA, V89, P2713, DOI 10.1073/pnas.89.7.2713; Funk JA, 2006, MICROB DRUG RESIST, V12, P210, DOI 10.1089/mdr.2006.12.210; Ingham AB, 2007, BIOTECHNOL APPL BIOC, V47, P1, DOI 10.1043/BA20060207; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P3872, DOI 10.1128/AEM.71.7.3872-3881.2005; Jang SA, 2012, PEPTIDES, V34, P283, DOI 10.1016/j.peptides.2012.01.015; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129; Kim JM, 2008, APPL MICROBIOL BIOT, V78, P123, DOI 10.1007/s00253-007-1273-5; Lee SH, 2004, APPL ENVIRON MICROB, V70, P5074, DOI 10.1128/AEM.70.9.5074-5080.2004; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Lloyd DH, 2012, VET DERMATOL, V23, P299, DOI 10.1111/j.1365-3164.2012.01042.x; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Melton-Witt JA, 2012, INFECT IMMUN, V80, P720, DOI 10.1128/IAI.05958-11; Merrell DS, 2002, CURR OPIN MICROBIOL, V5, P51, DOI 10.1016/S1369-5274(02)00285-0; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; MOORE PR, 1946, J BIOL CHEM, V165, P437; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Park IY, 2004, J BIOL CHEM, V279, P13896, DOI 10.1074/jbc.M311418200; Sambrook J, 2001, MOL CLONING LAB MANU; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Stathopoulos C, 1996, APPL MICROBIOL BIOT, V45, P112, DOI 10.1007/s002530050657; Strandberg KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049588; Wang AJA, 2002, APPL ENVIRON MICROB, V68, P1684, DOI 10.1128/AEM.68.4.1684-1689.2002; Yan F, 2004, CURR OPIN GASTROEN, V20, P565, DOI 10.1097/00001574-200411000-00011	30	14	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58997	10.1371/journal.pone.0058997	http://dx.doi.org/10.1371/journal.pone.0058997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516591	gold, Green Published, Green Submitted			2022-12-25	WOS:000316407400087
J	Amran, MY; Fujii, J; Suzuki, SO; Kolling, GL; Villanueva, SYAM; Kainuma, M; Kobayashi, H; Kameyama, H; Yoshida, S				Amran, Muhammad Yunus; Fujii, Jun; Suzuki, Satoshi O.; Kolling, Glynis L.; Villanueva, Sharon Y. A. M.; Kainuma, Mosaburo; Kobayashi, Hideyuki; Kameyama, Hideko; Yoshida, Shin-ichi			Investigation of Encephalopathy Caused by Shiga Toxin 2c-Producing Escherichia coli Infection in Mice	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; CENTRAL-NERVOUS-SYSTEM; GB3/CD77 SYNTHASE GENE; CELLS IN-VITRO; ENDOTHELIAL-CELLS; O104/H4 OUTBREAK; BRAIN; MODEL; AQUAPORIN-4; SCLEROSIS	A large outbreak of Shiga toxin (Stx)-producing enteroaggregative Escherichia coli (EAEC) O104:H4 occurred in northern Germany. From this outbreak, at least 900 patients developed hemolytic uremic syndrome (HUS), resulting in more than 50 deaths. Thirty percent of the HUS patients showed encephalopathy. We previously established a mouse model with encephalopathy associated with blood brain barrier (BBB) damage after oral infection with the Shiga toxin (Stx) 2c-producing Escherichia coli O157:H- strain E32511 (E32511). In this model, we detected high expression of the Stx receptor synthase enzyme, glycosphingolipid globotriaosylceramide (Gb3) synthase, in endothelial cells (ECs) and neurons in the reticular formation of the medulla oblongata by in situ hybridization. Caspase-3 was activated in neurons in the reticular formation of the medulla oblongata and the anterior horn of the spinal cord. Astrocytes (ASTs) were activated in the medulla oblongata and spinal cord, and a decrease in aquaporin 4 around the ECs suggested that BBB integrity was compromised directly by Stx2c or through the activation of ASTs. We also report the effectiveness of azithromycin (AZM) in our model. Moreover, AZM strongly inhibited the release of Stx2c from E32511 in vitro.	[Amran, Muhammad Yunus; Fujii, Jun; Villanueva, Sharon Y. A. M.; Kameyama, Hideko; Yoshida, Shin-ichi] Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 812, Japan; [Suzuki, Satoshi O.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 812, Japan; [Kolling, Glynis L.] Univ Virginia, Ctr Global Hlth, Charlottesville, VA USA; [Kainuma, Mosaburo] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 812, Japan; [Kobayashi, Hideyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Chem, Kitakyushu, Fukuoka 807, Japan; [Amran, Muhammad Yunus] Hasanuddin Univ, Fac Med, Hasanuddin Univ Hosp, Dept Neurol, Makassar, South Sulawesi, Indonesia	Kyushu University; Kyushu University; University of Virginia; Kyushu University; University of Occupational & Environmental Health - Japan; Universitas Hasanuddin	Amran, MY (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 812, Japan.	yunus09@bact.med.kyushu-u.ac.jp	Suzuki, Satoshi O/H-8367-2019	Suzuki, Satoshi O/0000-0002-0742-5680; Villanueva, Sharon Yvette Angelina/0000-0001-6958-4110	Health and Labor Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan [851114300001]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23500479, 22590256]	Health and Labor Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by funds from the 851114300001 Health and Labor Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan and grant 23500479 and 22590256 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Bauwens A, 2011, THROMB HAEMOSTASIS, V105, P515, DOI 10.1160/TH10-02-0140; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; FORSYTH KD, 1989, LANCET, V2, P411; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Fujii J, 2003, INFECT IMMUN, V71, P2724, DOI 10.1128/IAI.71.5.2724-2735.2003; FUJII J, 1994, INFECT IMMUN, V62, P3447, DOI 10.1128/IAI.62.8.3447-3453.1994; Fujii J, 1996, INFECT IMMUN, V64, P5053, DOI 10.1128/IAI.64.12.5053-5060.1996; Fujii J, 2008, INFECT IMMUN, V76, P3679, DOI 10.1128/IAI.01581-07; Fujii J, 2009, MICROB PATHOGENESIS, V46, P179, DOI 10.1016/j.micpath.2009.01.005; Furukawa K, 2002, J BIOL CHEM, V277, P11247, DOI 10.1074/jbc.M109519200; Goldstein J, 2007, BRAIN RES, V1161, P106, DOI 10.1016/j.brainres.2007.05.067; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Hamm S, 2004, CELL TISSUE RES, V315, P157, DOI 10.1007/s00441-003-0825-y; Ikeda K, 1999, CLIN NEPHROL, V52, P357; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Landoni VI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002632; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; LOUISE CB, 1992, INFECT IMMUN, V60, P1536, DOI 10.1128/IAI.60.4.1536-1543.1992; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Matano S, 2012, J INFECT CHEMOTHER, V18, P558, DOI 10.1007/s10156-011-0336-9; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Nitschke M, 2012, JAMA-J AM MED ASSOC, V307, P1046, DOI 10.1001/jama.2012.264; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; Ohara T, 2002, ANTIMICROB AGENTS CH, V46, P3478, DOI 10.1128/AAC.46.11.3478-3483.2002; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rooney J C, 1971, Aust Paediatr J, V7, P28; Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Smith M C, 1993, MLO Med Lab Obs, V25, P67; Lucero MS, 2012, MICROB PATHOGENESIS, V53, P87, DOI 10.1016/j.micpath.2012.05.005; Steinborn M, 2004, PEDIATR RADIOL, V34, P805, DOI 10.1007/s00247-004-1289-2; STROCKBINE NA, 1988, J BACTERIOL, V170, P1116, DOI 10.1128/jb.170.3.1116-1122.1988; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; UPADHYAYA K, 1980, PEDIATRICS, V65, P115; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; WIELS J, 1981, P NATL ACAD SCI-BIOL, V78, P6485, DOI 10.1073/pnas.78.10.6485; Wong CS, 2012, CLIN INFECT DIS, V55, P33, DOI 10.1093/cid/cis299; Yamada Y, 1999, ANN NEUROL, V45, P716; Yoshimura K, 1999, FEMS IMMUNOL MED MIC, V26, P101, DOI 10.1016/S0928-8244(99)00119-4; Zhang QS, 2009, J INFECT DIS, V199, P486, DOI 10.1086/596509	49	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58959	10.1371/journal.pone.0058959	http://dx.doi.org/10.1371/journal.pone.0058959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516588	Green Published, gold			2022-12-25	WOS:000316849200125
J	Artamonov, M; Momotani, K; Utepbergenov, D; Franke, A; Khromov, A; Derewenda, ZS; Somlyo, AV				Artamonov, Mykhaylo; Momotani, Ko; Utepbergenov, Darkhan; Franke, Aaron; Khromov, Alexander; Derewenda, Zygmunt S.; Somlyo, Avril V.			The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; PROTEIN PHOSPHATASE; CA2+ SENSITIZATION; SMALL-SUBUNIT; MAP KINASES; PHOSPHORYLATION; ACTIVATION; GROWTH; CELLS; DIPHOSPHORYLATION	In the canonical model of smooth muscle (SM) contraction, the contractile force is generated by phosphorylation of the myosin regulatory light chain (RLC20) by the myosin light chain kinase (MLCK). Moreover, phosphorylation of the myosin targeting subunit (MYPT1) of the RLC20 phosphatase (MLCP) by the RhoA-dependent ROCK kinase, inhibits the phosphatase activity and consequently inhibits dephosphorylation of RLC20 with concomitant increase in contractile force, at constant intracellular [Ca2+]. This pathway is referred to as Ca2+-sensitization. There is, however, emerging evidence suggesting that additional Ser/Thr kinases may contribute to the regulatory pathways in SM. Here, we report data implicating the p90 ribosomal S6 kinase (RSK) in SM contractility. During both Ca2+- and agonist (U46619) induced SM contraction, RSK inhibition by the highly selective compound BI-D1870 (which has no effect on MLCK or ROCK) resulted in significant suppression of contractile force. Furthermore, phosphorylation levels of RLC20 and MYPT1 were both significantly decreased. Experiments involving the irreversible MLCP inhibitor microcystin-LR, in the absence of Ca2+, revealed that the decrease in phosphorylation levels of RLC20 upon RSK inhibition are not due solely to the increase in the phosphatase activity, but reflect direct or indirect phosphorylation of RLC20 by RSK. Finally, we show that agonist (U46619) stimulation of SM leads to activation of extracellular signal-regulated kinases ERK1/2 and PDK1, consistent with a canonical activation cascade for RSK. Thus, we demonstrate a novel and important physiological function of the p90 ribosomal S6 kinase, which to date has been typically associated with the regulation of gene expression.	[Artamonov, Mykhaylo; Momotani, Ko; Utepbergenov, Darkhan; Franke, Aaron; Khromov, Alexander; Derewenda, Zygmunt S.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA	University of Virginia	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA.	avs5u@virginia.edu	Utepbergenov, Darkhan/N-9881-2014; Utepbergenov, Darkhan/AAA-1249-2021; Artamonov, Mykhaylo/AAD-3488-2021	Utepbergenov, Darkhan/0000-0002-9005-4103; Utepbergenov, Darkhan/0000-0002-9005-4103; Artamonov, Mykhaylo/0000-0002-0848-2054	University of Virginia Cancer Center through the NCI Cancer Center Support Grant [P30CA44579]; National Institutes of Health [R01GM86457, R01DK088905]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	University of Virginia Cancer Center through the NCI Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the University of Virginia Cancer Center through the NCI Cancer Center Support Grant (P30CA44579) and in part by the National Institutes of Health (R01GM86457 to ZSD and AVS, and R01DK088905 to AVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Chao A, 2012, J PROTEOMICS, V75, P3342, DOI 10.1016/j.jprot.2012.03.043; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; HORIUTI K, 1988, J PHYSIOL-LONDON, V398, P131, DOI 10.1113/jphysiol.1988.sp017034; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kawai M, 2007, J MUSCLE RES CELL M, V28, P371, DOI 10.1007/s10974-008-9131-3; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; Kuemmerle JF, 2003, AM J PHYSIOL-GASTR L, V284, pG411, DOI 10.1152/ajpgi.00310.2002; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Miggin SM, 2001, BBA-MOL CELL RES, V1539, P147, DOI 10.1016/S0167-4889(01)00103-3; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Morrison DL, 1996, BIOCHEM CELL BIOL, V74, P549, DOI 10.1139/o96-459; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rocic P, 2001, AM J PHYSIOL-CELL PH, V280, pC90, DOI 10.1152/ajpcell.2001.280.1.C90; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith JA, 2005, CANCER RES, V65, P1027; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; SOMLYO AV, 1988, J GEN PHYSIOL, V91, P165, DOI 10.1085/jgp.91.2.165; Suizu F, 2000, J BIOCHEM-TOKYO, V128, P435, DOI 10.1093/oxfordjournals.jbchem.a022771; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takizawa N, 2003, AM J PHYSIOL-CELL PH, V284, pC250, DOI 10.1152/ajpcell.00153.2002; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Xiao DL, 2002, AM J PHYSIOL-HEART C, V282, pH292, DOI 10.1152/ajpheart.2002.282.1.H292; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Zhou YB, 1999, BIOCHEM BIOPH RES CO, V254, P158, DOI 10.1006/bbrc.1998.9915	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58703	10.1371/journal.pone.0058703	http://dx.doi.org/10.1371/journal.pone.0058703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516539	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849200107
J	Cooper, CA; Klobas, LCG; Maga, EA; Murray, JD				Cooper, Caitlin A.; Klobas, Lydia C. Garas; Maga, Elizabeth A.; Murray, James D.			Consuming Transgenic Goats' Milk Containing the Antimicrobial Protein Lysozyme Helps Resolve Diarrhea in Young Pigs	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; EXPRESSING HUMAN LYSOZYME; MAMMARY-GLAND; BROILER-CHICKENS; BARRIER FUNCTION; DAIRY GOATS; GROWTH; MODULATION; CONSUMPTION; LACTOFERRIN	Childhood diarrhea is a significant problem in many developing countries and E. coli is a main causative agent of diarrhea in young children. Lysozyme is an antimicrobial protein highly expressed in human milk, but not ruminant milk, and is thought to help protect breastfeeding children against diarrheal diseases. We hypothesized that consumption of milk from transgenic goats which produce human lysozyme (hLZ-milk) in their milk would accelerate recovery from bacterial-induced diarrhea. Young pigs were used as a model for children and infected with enterotoxigenic E. coli. Once clinical signs of diarrhea developed, pigs were fed hLZ-milk or non-transgenic control goat milk three times a day for two days. Clinical observations and complete blood counts (CBC) were performed. Animals were euthanized and samples collected to assess differences in histology, cytokine expression and bacterial translocation into the mesenteric lymph node. Pigs consuming hLZ-milk recovered from clinical signs of infection faster than pigs consuming control milk, with significantly improved fecal consistency (p = 0.0190) and activity level (p = 0.0350). The CBC analysis showed circulating monocytes (p = 0.0413), neutrophils (p = 0.0219), and lymphocytes (p = 0.0222) returned faster to pre-infection proportions in hLZ-milk fed pigs, while control-fed pigs had significantly higher hematocrit (p = 0.027), indicating continuing dehydration. In the ileum, pigs fed hLZ-milk had significantly lower expression of pro-inflammatory cytokine IL-8 (p = 0.0271), longer intestinal villi (p<0.0001), deeper crypts (p = 0.0053), and a thinner lamina propria (p = 0.0004). These data demonstrate that consumption of hLZ-milk helped pigs recover from infection faster, making hLZ-milk an effective treatment of E. coli-induced diarrhea.	[Cooper, Caitlin A.; Klobas, Lydia C. Garas; Maga, Elizabeth A.; Murray, James D.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Murray, James D.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Murray, JD (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	Jdmurray@ucdavis.edu			Jastro-Shields grant from the University of California, Davis [CAC-1112]	Jastro-Shields grant from the University of California, Davis	This work was supported by a Jastro-Shields grant (CAC-1112) from the University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actor JK, 2009, CURR PHARM DESIGN, V15, P1956, DOI 10.2174/138161209788453202; Awad WA, 2009, POULTRY SCI, V88, P49, DOI 10.3382/ps.2008-00244; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brundige DR, 2008, J NUTR, V138, P921, DOI 10.1093/jn/138.5.921; Brundige DR, 2010, TRANSGENIC RES, V19, P563, DOI 10.1007/s11248-009-9334-4; Cooper CA, 2011, TRANSGENIC RES, V20, P1235, DOI 10.1007/s11248-011-9489-7; Dwinell MB, 2003, SURGERY, V133, P601, DOI 10.1067/msy.2003.143; GORDON LI, 1979, J CLIN INVEST, V64, P226, DOI 10.1172/JCI109443; Hettinga K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019433; Jackson KA, 2010, TRANSGENIC RES, V19, P977, DOI 10.1007/s11248-010-9371-z; Jensen GM, 2006, VET MICROBIOL, V115, P243, DOI 10.1016/j.vetmic.2006.01.002; JIMENEZFLORES R, 1988, J DAIRY SCI, V71, P2640, DOI 10.3168/jds.S0022-0302(88)79857-4; Koppelmann T, 2012, BR J NUTR, V28, P1; Lessard M, 2009, J ANIM SCI, V87, P922, DOI 10.2527/jas.2008-0919; Liao YL, 2012, BIOCHEM CELL BIOL, V90, P476, DOI [10.1139/o11-075, 10.1139/O11-075]; Liu D, 2010, AVIAN PATHOL, V39, P17, DOI 10.1080/03079450903447404; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; MAGA EA, 1995, BIO-TECHNOL, V13, P1452, DOI 10.1038/nbt1295-1452; Maga EA, 2003, TRANSGENIC RES, V12, P485, DOI 10.1023/A:1024257906647; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Maga EA, 2006, TRANSGENIC RES, V15, P515, DOI 10.1007/s11248-006-0014-3; Maga EA, 2012, APPL ENVIRON MICROB, V78, P6153, DOI 10.1128/AEM.00956-12; Matkowskyj KA, 2000, NAT MED, V6, P1048, DOI 10.1038/79563; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Nyachoti CM, 2012, J ANIM SCI, V90, P252, DOI 10.2527/jas.2010-3596; Ogundele MO, 1998, MEDIAT INFLAMM, V7, P363, DOI 10.1080/09629359890893; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Rockova S, 2011, ANAEROBE, V17, P223, DOI 10.1016/j.anaerobe.2011.07.009; Savkovic SD, 1996, INFECT IMMUN, V64, P4480, DOI 10.1128/IAI.64.11.4480-4487.1996; SCHULZE F, 1980, ARCH EXP VET MED, V34, P317; Sharma R, 2010, PEDIATR SURG INT, V26, P11, DOI 10.1007/s00383-009-2536-2; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Yang B, 2011, PLOS ONE, V16; Yuhan R, 1997, GASTROENTEROLOGY, V113, P1873, DOI 10.1016/S0016-5085(97)70006-4	37	70	75	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58409	10.1371/journal.pone.0058409	http://dx.doi.org/10.1371/journal.pone.0058409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516474	Green Published, gold			2022-12-25	WOS:000316849200065
J	Nguyen, CQ; Ogunniyi, AO; Karabiyik, A; Love, JC				Nguyen, Cuong Q.; Ogunniyi, Adebola O.; Karabiyik, Afife; Love, J. Christopher			Single-Cell Analysis Reveals Isotype-Specific Autoreactive B Cell Repertoires in Sjogren's Syndrome	PLOS ONE			English	Article							THYROID-STIMULATING IMMUNOGLOBULINS; CLASSIFICATION CRITERIA; ANTINUCLEAR ANTIBODIES; GRAVES-DISEASE; AUTOANTIBODIES; PATHOGENESIS; PREVALENCE; SELECTION; MOUSE	Microengraving is a novel technology that uses an array of microfabricated subnanoliter wells to isolate and characterize secreted proteins from larger number of single cells. This printing technique permits the capture and characterization of secreted antibodies on glass slides. Here, we profiled the antigenic repertoires of B cells reacting against salivary gland tissues in Sjogren's syndrome (SjS), an autoimmune disease targeting the exocrine glands. Single-cell suspensions of spleen and cervical lymph node cells prepared from normal C57BL/6 and SjS-susceptible (SjS(s)) C57BL/6.NOD-AecAec2 mice were dispersed into subnanoliter wells (nanowells). Capture slides preincubated with mouse immunoglobulins were used for printing. Detection antibodies included fluorescence conjugated anti-IgG1, salivary gland lysates of C57BL/6 and SjS(s) mice. Results indicate an increase in the frequency of IgG1-secreting cells in the spleen of SjS(s) mice compared to C57BL/6 mice. Cells from the lymph node of SjS(s) mice yield higher instances of IgG1 reactive against salivary gland antigens than cells from the lymph nodes of C57BL/6 mice. These data demonstrate the isotype-specific reactivity of antibodies during the autoimmune process, and further reveals significant differences in the non-autoimmune and autoimmune antibody repertoires. These results support the generation of self-reactive B cell repertoires during the autoimmune process, at the same time, verifying that microengraving of single cells might allow for identification of novel biomarkers in SjS.	[Nguyen, Cuong Q.; Karabiyik, Afife] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32605 USA; [Nguyen, Cuong Q.] Univ Florida, Coll Dent, Ctr Orphan Autoimmune Disorders, Gainesville, FL USA; [Ogunniyi, Adebola O.; Love, J. Christopher] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Love, J. Christopher] Koch Inst Integrat Canc Res, Cambridge, MA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Massachusetts Institute of Technology (MIT)	Nguyen, CQ (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32605 USA.	nguyenc@ufl.edu			Sjogren's Syndrome Foundation; PHS Grant from the NIDCR [R00 DE018958]; NIH/NIAID [RC1AI086152]; UNCF/Merck Graduate Research Dissertation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE018958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097681] Funding Source: NIH RePORTER	Sjogren's Syndrome Foundation; PHS Grant from the NIDCR; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNCF/Merck Graduate Research Dissertation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Sjogren's Syndrome Foundation (CQN) and PHS Grant R00 DE018958 grant (CQN) from the NIDCR. This research was also supported in part by the NIH/NIAID (RC1AI086152). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy And Infectious Diseases or the National Institutes of Health. A.O.O. was supported by UNCF/Merck Graduate Research Dissertation Fellowship. J.C.L. is a Camille Dreyfus Teacher-Scholar and Latham Family Career Development Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Cha SH, 2006, J RHEUMATOL, V33, P296; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; DWYER DS, 1983, NATURE, V301, P611, DOI 10.1038/301611a0; FOX RI, 1992, RHEUM DIS CLIN N AM, V18, P517; Gao JH, 2006, J AUTOIMMUN, V26, P90, DOI 10.1016/j.jaut.2005.11.004; Gao JH, 2004, ARTHRITIS RHEUM-US, V50, P2615, DOI 10.1002/art.20371; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gordon TP, 2001, AUTOIMMUNITY, V34, P123, DOI 10.3109/08916930109001960; HARDIN JA, 1985, CLIN RHEUM DIS, V11, P485; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Jonsson R, 2000, SCAND J RHEUMATOL, V29, P341; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lernmark A, 2001, J CLIN INVEST, V108, P1091, DOI 10.1172/JCI200114234; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Nguyen CQ, 2007, J IMMUNOL, V179, P382, DOI 10.4049/jimmunol.179.1.382; Nguyen CQ, 2009, OCUL SURF, V7, P11, DOI 10.1016/S1542-0124(12)70289-6; Nguyen CQ, 2007, FRONT BIOSCI-LANDMRK, V12, P1767, DOI 10.2741/2187; Novljan MP, 2006, SCAND J RHEUMATOL, V35, P463, DOI 10.1080/03009740600759860; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Ronan JL, 2009, J IMMUNOL METHODS, V340, P164, DOI 10.1016/j.jim.2008.10.018; Routsias JG, 2007, CLIN REV ALLERG IMMU, V32, P238, DOI 10.1007/s12016-007-8003-8; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; SMITH BR, 1974, LANCET, V2, P427; Story CM, 2008, P NATL ACAD SCI USA, V105, P17902, DOI 10.1073/pnas.0805470105; Sugai Susumu, 2004, Autoimmun Rev, V3 Suppl 1, pS67; TENG CS, 1977, CLIN ENDOCRINOL, V6, P207, DOI 10.1111/j.1365-2265.1977.tb03316.x; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	33	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58127	10.1371/journal.pone.0058127	http://dx.doi.org/10.1371/journal.pone.0058127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516437	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849200034
J	Nagel, ZD; Cun, SJ; Klinman, JP				Nagel, Zachary D.; Cun, Shujian; Klinman, Judith P.			Identification of a Long-range Protein Network That Modulates Active Site Dynamics in Extremophilic Alcohol Dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL FLEXIBILITY; DIHYDROFOLATE-REDUCTASE; ENZYME DYNAMICS; TEMPERATURE; ADAPTATION; CATALYSIS; FLUCTUATIONS; PARAMETERS; STABILITY; COMPLEX	A tetrameric thermophilic alcohol dehydrogenase from Bacillus stearothermophilus (ht-ADH) has been mutated at an aromatic side chain in the active site (Trp-87). The ht-W87A mutation results in a loss of the Arrhenius break seen at 30 degrees C for the wild-type enzyme and an increase in cold lability that is attributed to destabilization of the active tetrameric form. Kinetic isotope effects (KIEs) are nearly temperature-independent over the experimental temperature range, and similar in magnitude to those measured above 30 degrees C for the wild-type enzyme. This suggests that the rigidification in the wild-type enzyme below 30 degrees C does not occur for ht-W87A. A mutation at the dimer-dimer interface in a thermolabile psychrophilic homologue of ht-ADH, ps-A25Y, leads to a more thermostable enzyme and a change in the rate-determining step at low temperature. The reciprocal mutation in ht-ADH, ht-Y25A, results in kinetic behavior similar to that of W87A. Collectively, the results indicate that flexibility at the active site is intimately connected to a subunit interaction 20 angstrom away. The convex Arrhenius curves previously reported for ht-ADH (Kohen, A., Cannio, R., Bartolucci, S., and Klinman, J. P. (1999) Nature 399, 496499) are proposed to arise, at least in part, from a change in subunit interactions that rigidifies the substrate-binding domain below 30 degrees C, and impedes the ability of the enzyme to sample the catalytically relevant conformational landscape. These results implicate an evolutionarily conserved, long-range network of dynamical communication that controls C-H activation in the prokaryotic alcohol dehydrogenases.	[Nagel, Zachary D.; Cun, Shujian; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cun, Shujian; Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu			National Institutes of Health [GM025765, GM008295]; National Science Foundation [MCB0446395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025765, R01GM025765, T32GM008295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM025765 (to J. P. K.) and GM008295 (to Z. D. N.) and the National Science Foundation Grant MCB0446395 (to J. P. K.).	Anandarajah K, 2008, Z PHYS CHEM, V222, P1333, DOI 10.1524/zpch.2008.5391; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Ceccarelli C, 2004, BIOCHEMISTRY-US, V43, P5266, DOI 10.1021/bi049736p; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Fan F, 2007, BIOCHEMISTRY-US, V46, P6402, DOI 10.1021/bi700255v; Feller G, 2007, EXTREMOPHILES, V11, P211, DOI 10.1007/s00792-006-0050-1; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Forst, 1973, THEORY UNIMOLECULAR; Glowacki DR, 2012, NAT CHEM, V4, P169, DOI [10.1038/NCHEM.1244, 10.1038/nchem.1244]; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Heyes DJ, 2011, J BIOL CHEM, V286, P11849, DOI 10.1074/jbc.M111.219626; Klinman JP, 2009, CHEM PHYS LETT, V471, P179, DOI 10.1016/j.cplett.2009.01.038; Kohen A, 2000, J AM CHEM SOC, V122, P10738, DOI 10.1021/ja002229k; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Liang ZX, 2004, BIOCHEMISTRY-US, V43, P14676, DOI 10.1021/bi049004x; Liang ZX, 2004, J AM CHEM SOC, V126, P9500, DOI 10.1021/ja047087z; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Limbach HH, 2006, PHILOS T R SOC B, V361, P1399, DOI 10.1098/rstb.2006.1872; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Loveridge EJ, 2009, BIOCHEMISTRY-US, V48, P5922, DOI 10.1021/bi900411a; MASSEY V, 1966, J BIOL CHEM, V241, P2347; Merkley ED, 2010, PROTEIN ENG DES SEL, V23, P327, DOI 10.1093/protein/gzp090; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Nagel ZD, 2012, BIOCHEMISTRY-US, V51, P4147, DOI 10.1021/bi3001352; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Nanda V, 2000, PROTEINS, V40, P112, DOI 10.1002/(SICI)1097-0134(20000701)40:1<112::AID-PROT130>3.0.CO;2-C; Oyeyemi OA, 2011, BIOCHEMISTRY-US, V50, P8251, DOI 10.1021/bi200640s; Pudney CR, 2009, J AM CHEM SOC, V131, P17072, DOI 10.1021/ja908469m; Schramm VL, 2011, ANNU REV BIOCHEM, V80, P703, DOI 10.1146/annurev-biochem-061809-100742; SOMERO GN, 1978, ANNU REV ECOL SYST, V9, P1, DOI 10.1146/annurev.es.09.110178.000245; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Stojkovic V, 2012, J AM CHEM SOC, V134, P1738, DOI 10.1021/ja209425w; Tang KES, 1998, J BIOMOL STRUCT DYN, V16, P397, DOI 10.1080/07391102.1998.10508256; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; Tsigos I, 1998, EUR J BIOCHEM, V254, P356, DOI 10.1046/j.1432-1327.1998.2540356.x; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; VARLEY PG, 1991, J MOL BIOL, V220, P531, DOI 10.1016/0022-2836(91)90028-5; VIHINEN M, 1987, PROTEIN ENG, V1, P477, DOI 10.1093/protein/1.6.477; WEBER G, 1995, J PHYS CHEM-US, V99, P1052, DOI 10.1021/j100003a031; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	48	36	36	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14087	14097		10.1074/jbc.M113.453951	http://dx.doi.org/10.1074/jbc.M113.453951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23525111	hybrid, Green Published			2022-12-25	WOS:000319253500014
J	Ali, SS; Whitney, JC; Stevenson, J; Robinson, H; Howell, PL; Navarre, WW				Ali, Sabrina S.; Whitney, John C.; Stevenson, James; Robinson, Howard; Howell, P. Lynne; Navarre, William Wiley			Structural Insights into the Regulation of Foreign Genes in Salmonella by the Hha/H-NS Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORIZONTALLY ACQUIRED GENES; PROTEIN H-NS; ESCHERICHIA-COLI; NUCLEOID-PROTEIN; DIMERIZATION DOMAIN; BACTERIAL GENOMES; CRYSTAL-STRUCTURE; DNA; BINDING; OLIGOMERIZATION	The bacterial nucleoid-associated proteins Hha and H-NS jointly repress horizontally acquired genes in Salmonella, including essential virulence loci encoded within Salmonella pathogenicity islands. Hha is known to interact with the N-terminal dimerization domain of H-NS; however, the manner in which this interaction enhances transcriptional silencing is not understood. To further understand this process, we solved the x-ray crystal structure of Hha in complex with the N-terminal dimerization domain of H-NS (H-NS(1-46)) to 3.2 angstrom resolution. Two monomers of Hha bind to symmetrical sites on either side of the H-NS(1-46) dimer. Disruption of the Hha/H-NS interaction by the H-NS site-specific mutation I11A results in increased expression of the Hha/H-NS co-regulated gene hilA without affecting the expression levels of proV, a target gene repressed by H-NS in an Hha-independent fashion. Examination of the structure revealed a cluster of conserved basic amino acids that protrude from the surface of Hha on the opposite side of the Hha/H-NS(1-46) interface. Hha mutants with a diminished positively charged surface maintain the ability to interact with H-NS but can no longer regulate hilA. Increased expression of the hilA locus did not correspond to significant depletion of H-NS at the promoter region in chromatin immunoprecipitation assays. However, in vitro, we find Hha improves H-NS binding to target DNA fragments. Taken together, our results show for the first time how Hha and H-NS interact to direct transcriptional repression and reveal that a positively charged surface of Hha enhances the silencing activity of H-NS nucleoprotein filaments.	[Ali, Sabrina S.; Stevenson, James; Navarre, William Wiley] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Whitney, John C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Whitney, John C.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Energy (DOE); Brookhaven National Laboratory	Navarre, WW (corresponding author), Univ Toronto, Fac Med, Dept Mol Genet, Rm 4379,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	william.navarre@utoronto.ca		Navarre, William/0000-0002-9293-9220	Canada Institutes for Health Research (CIHR) [MOP-86683, MSH-87729]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; CIHR [13337]; Natural Science and Engineering Research Council of Canada; Cystic Fibrosis Canada; Ontario Graduate Scholarship Program; Ontario Student Opportunities Trust Fund; Hospital for Sick Children Foundation Student Scholarship Program	Canada Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada; Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Ontario Student Opportunities Trust Fund; Hospital for Sick Children Foundation Student Scholarship Program	The Navarre laboratory is supported by an Operating Grant and New Investigator Award from the Canada Institutes for Health Research (CIHR) (MOP-86683 and MSH-87729) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 386286-10). This work was also supported by CIHR Grant 13337 (to P. L. H.). The National Synchrotron Light Source Beam line X29 is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institutes of Health National Center for Research Resources.; Supported in part by graduate scholarships from the Natural Science and Engineering Research Council of Canada, Cystic Fibrosis Canada, the Ontario Graduate Scholarship Program, the Ontario Student Opportunities Trust Fund, and the Hospital for Sick Children Foundation Student Scholarship Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali SS, 2011, J BACTERIOL, V193, P4881, DOI 10.1128/JB.05198-11; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Badaut C, 2002, J BIOL CHEM, V277, P41657, DOI 10.1074/jbc.M206037200; Bae SH, 2008, BIOCHEMISTRY-US, V47, P1993, DOI 10.1021/bi701914t; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Cerdan R, 2003, J MOL BIOL, V334, P179, DOI 10.1016/j.jmb.2003.09.051; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Dame RT, 2008, BIOCHEM SOC T, V36, P732, DOI 10.1042/BST0360732; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Dame RT, 2001, BIOCHIMIE, V83, P231; Daubin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r57; Ekhnovich IN, 2007, J BACTERIOL, V189, P6882, DOI 10.1128/JB.00905-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fahlen TF, 2001, J BACTERIOL, V183, P6620, DOI 10.1128/JB.183.22.6620-6629.2001; de Alba CF, 2011, FEBS LETT, V585, P1765, DOI 10.1016/j.febslet.2011.05.024; Garcia J, 2005, BIOCHEM J, V388, P755, DOI 10.1042/BJ20050002; Garcia J, 2006, J MOL BIOL, V359, P679, DOI 10.1016/j.jmb.2006.03.059; Garcia J, 2009, FEBS LETT, V583, P2911, DOI 10.1016/j.febslet.2009.07.054; Gordon BRG, 2008, J BACTERIOL, V190, P7052, DOI 10.1128/JB.00733-08; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; Nieto JM, 2002, J BACTERIOL, V184, P629, DOI 10.1128/JB.184.3.629-635.2002; Olekhnovich IN, 2006, J MOL BIOL, V357, P373, DOI 10.1016/j.jmb.2006.01.007; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paytubi S, 2004, MOL MICROBIOL, V54, P251, DOI 10.1111/j.1365-2958.2004.04268.x; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pons JI, 2004, PROTEIN EXPRES PURIF, V35, P293, DOI 10.1016/j.pep.2004.02.018; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takagi S, 2009, BRIT J HAEMATOL, V147, P543, DOI 10.1111/j.1365-2141.2009.07863.x; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; UEGUCHI C, 1993, MOL GEN GENET, V236, P171, DOI 10.1007/BF00277109; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Yun SH, 2012, MOL CELLS, V33, P211, DOI 10.1007/s10059-012-0006-5; Zhou YN, 2006, J BACTERIOL, V188, P7022, DOI 10.1128/JB.00687-06	62	50	53	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13356	13369		10.1074/jbc.M113.455378	http://dx.doi.org/10.1074/jbc.M113.455378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23515315	Green Published, hybrid			2022-12-25	WOS:000318850300021
J	Schwartz, C; Hampton, M; Andrews, MT				Schwartz, Christine; Hampton, Marshall; Andrews, Matthew T.			Seasonal and Regional Differences in Gene Expression in the Brain of a Hibernating Mammal	PLOS ONE			English	Article							GROUND-SQUIRRELS; PROTEIN RBM3; AROUSAL; RECEPTOR; HAMSTERS; SURVIVAL; TEMPERATURE; METABOLISM; ACTIVATION; PLASTICITY	Mammalian hibernation presents a unique opportunity to study naturally occurring neuroprotection. Hibernating ground squirrels undergo rapid and extreme physiological changes in body temperature, oxygen consumption, and heart rate without suffering neurological damage from ischemia and reperfusion injury. Different brain regions show markedly different activity during the torpor/arousal cycle: the cerebral cortex shows activity only during the periodic returns to normothermia, while the hypothalamus is active over the entire temperature range. Therefore, region-specific neuroprotective strategies must exist to permit this compartmentalized spectrum of activity. In this study, we use the Illumina HiSeq platform to compare the transcriptomes of these two brain regions at four collection points across the hibernation season: April Active, October Active, Torpor, and IBA. In the cerebral cortex, 1,085 genes were found to be differentially expressed across collection points, while 1,063 genes were differentially expressed in the hypothalamus. Comparison of these transcripts indicates that the cerebral cortex and hypothalamus implement very different strategies during hibernation, showing less than 20% of these differentially expressed genes in common. The cerebral cortex transcriptome shows evidence of remodeling and plasticity during hibernation, including transcripts for the presynaptic cytomatrix proteins bassoon and piccolo, and extracellular matrix components, including laminins and collagens. Conversely, the hypothalamic transcriptome displays upregulation of transcripts involved in damage response signaling and protein turnover during hibernation, including the DNA damage repair gene RAD50 and ubiquitin E3 ligases UBR1 and UBR5. Additionally, the hypothalamus transcriptome also provides evidence of potential mechanisms underlying the hibernation phenotype, including feeding and satiety signaling, seasonal timing mechanisms, and fuel utilization. This study provides insight into potential neuroprotective strategies and hibernation control mechanisms, and also specifically shows that the hibernator brain exhibits both seasonal and regional differences in mRNA expression.	[Schwartz, Christine; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Hampton, Marshall] Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Andrews, MT (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.	mandrews@d.umn.edu		Hampton, Marshall/0000-0002-9725-3316	National Institutes of Health [1RC2HL101625-01, 1F32NS077643-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health (1RC2HL101625-01 to M. T. A). C. S. was supported by NIH fellowship 1F32NS077643-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bratincsak A, 2007, J COMP NEUROL, V505, P443, DOI 10.1002/cne.21507; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Chiu Kin, 2007, J Vis Exp, P269, DOI 10.3791/269; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; DAAN S, 1991, NEUROSCI LETT, V128, P265, DOI 10.1016/0304-3940(91)90276-Y; DAVIS DE, 1976, Q REV BIOL, V51, P477, DOI 10.1086/409594; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Drew KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7; Epperson LE, 2010, J COMP PHYSIOL B, V180, P599, DOI 10.1007/s00360-009-0422-9; Franklin K., 2007, MOUSE BRAIN STEREOTA; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gundelfinger ED, 2010, EUR J NEUROSCI, V31, P2156, DOI 10.1111/j.1460-9568.2010.07253.x; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Han S, 2010, J NEUROSCI, V30, P15102, DOI 10.1523/JNEUROSCI.3128-10.2010; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HELLER HC, 1979, ANNU REV PHYSIOL, V41, P305, DOI 10.1146/annurev.ph.41.030179.001513; HELLER HC, 1972, COMP BIOCHEM PHYSIOL, V41, P349, DOI 10.1016/0300-9629(72)90066-7; HERMES MLHJ, 1993, BRAIN RES, V631, P313, DOI 10.1016/0006-8993(93)91550-C; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jethwa PH, 2008, NEUROENDOCRINOLOGY, V88, P80, DOI 10.1159/000127319; Jinka TR, 2011, J NEUROSCI, V31, P10752, DOI 10.1523/JNEUROSCI.1240-11.2011; Kasukawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023228; KILDUFF TS, 1990, J NEUROSCI, V10, P2463; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Martens K, 2010, FEBS LETT, V584, P1054, DOI 10.1016/j.febslet.2010.01.061; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McCroskery S, 2009, NEUROSCIENCE, V163, P168, DOI 10.1016/j.neuroscience.2009.06.012; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Morawski M, 2012, INT J BIOCHEM CELL B, V44, P690, DOI 10.1016/j.biocel.2012.01.010; MROSOVSK.N, 1974, PHYSIOL BEHAV, V12, P265, DOI 10.1016/0031-9384(74)90181-4; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Novak U, 2004, J CLIN NEUROSCI, V11, P227, DOI 10.1016/j.jocn.2003.10.006; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okamoto I, 2006, COMP BIOCHEM PHYS C, V144, P47, DOI 10.1016/j.cbpc.2006.05.003; Osborne PG, 2006, BEHAV BRAIN RES, V168, P208, DOI 10.1016/j.bbr.2005.11.007; Otaki JM, 2010, DEV NEUROBIOL, V70, P424, DOI 10.1002/dneu.20786; PENGELLEY E, 1961, CAN J ZOOLOG, V39, P105, DOI 10.1139/z61-013; Revel FG, 2007, P NATL ACAD SCI USA, V104, P13816, DOI 10.1073/pnas.0704699104; Ruby NF, 1996, P NATL ACAD SCI USA, V93, P9864, DOI 10.1073/pnas.93.18.9864; Russell RL, 2010, J COMP PHYSIOL B, V180, P1165, DOI 10.1007/s00360-010-0484-8; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; STANTON TL, 1982, REGUL PEPTIDES, V3, P135, DOI 10.1016/0167-0115(82)90090-8; TORKE KG, 1977, J MAMMAL, V58, P385, DOI 10.2307/1379337; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; van Breukelen F, 2002, J COMP PHYSIOL B, V172, P355, DOI 10.1007/s00360-002-0256-1; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; von der Ohe CG, 2006, J NEUROSCI, V26, P10590, DOI 10.1523/JNEUROSCI.2874-06.2006; Wardman JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028152; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; Yan J, 2006, PHYSIOL GENOMICS, V25, P346, DOI 10.1152/physiolgenomics.00260.2005; Yan J, 2008, PHYSIOL GENOMICS, V32, P170, DOI 10.1152/physiolgenomics.00075.2007; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	74	77	79	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58427	10.1371/journal.pone.0058427	http://dx.doi.org/10.1371/journal.pone.0058427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526982	Green Submitted, Green Published, gold			2022-12-25	WOS:000317562600021
J	Bao, DP; Gong, M; Zheng, HJ; Chen, MJ; Zhang, L; Wang, H; Jiang, JP; Wu, L; Zhu, YQ; Zhu, G; Zhou, Y; Li, CH; Wang, SY; Zhao, Y; Zhao, GP; Tan, Q				Bao, Dapeng; Gong, Ming; Zheng, Huajun; Chen, Mingjie; Zhang, Liang; Wang, Hong; Jiang, Jianping; Wu, Lin; Zhu, Yongqiang; Zhu, Gang; Zhou, Yan; Li, Chuanhua; Wang, Shengyue; Zhao, Yan; Zhao, Guoping; Tan, Qi			Sequencing and Comparative Analysis of the Straw Mushroom (Volvariella volvacea) Genome	PLOS ONE			English	Article							AFLATOXIN BIOSYNTHESIS; COPRINOPSIS-CINEREA; GENE IDENTIFICATION; NUCLEAR BEHAVIOR; MATING-TYPE; ENZYMES; FAMILY; BASIDIOMYCETE; EXPRESSION; LACCASE	Volvariella volvacea, the edible straw mushroom, is a highly nutritious food source that is widely cultivated on a commercial scale in many parts of Asia using agricultural wastes (rice straw, cotton wastes) as growth substrates. However, developments in V. volvacea cultivation have been limited due to a low biological efficiency (i.e. conversion of growth substrate to mushroom fruit bodies), sensitivity to low temperatures, and an unclear sexuality pattern that has restricted the breeding of improved strains. We have now sequenced the genome of V. volvacea and assembled it into 62 scaffolds with a total genome size of 35.7 megabases (Mb), containing 11,084 predicted gene models. Comparative analyses were performed with the model species in basidiomycete on mating type system, carbohydrate active enzymes, and fungal oxidative lignin enzymes. We also studied transcriptional regulation of the response to low temperature (4 degrees C). We found that the genome of V. volvacea has many genes that code for enzymes, which are involved in the degradation of cellulose, hemicellulose, and pectin. The molecular genetics of the mating type system in V. volvacea was also found to be similar to the bipolar system in basidiomycetes, suggesting that it is secondary homothallism. Sensitivity to low temperatures could be due to the lack of the initiation of the biosynthesis of unsaturated fatty acids, trehalose and glycogen biosyntheses in this mushroom. Genome sequencing of V. volvacea has improved our understanding of the biological characteristics related to the degradation of the cultivating compost consisting of agricultural waste, the sexual reproduction mechanism, and the sensitivity to low temperatures at the molecular level which in turn will enable us to increase the industrial production of this mushroom.	[Bao, Dapeng; Gong, Ming; Chen, Mingjie; Wang, Hong; Wu, Lin; Zhu, Gang; Li, Chuanhua; Zhao, Yan; Tan, Qi] Minist Sci & Technol MOST, Natl Engn Res Ctr Edible Fungi, Shanghai, Peoples R China; [Bao, Dapeng; Gong, Ming; Chen, Mingjie; Wang, Hong; Wu, Lin; Zhu, Gang; Li, Chuanhua; Zhao, Yan; Tan, Qi] Minist Agr, Key Lab Edible Fungi Resources & Utilizat South, Shanghai, Peoples R China; [Bao, Dapeng; Gong, Ming; Chen, Mingjie; Wang, Hong; Wu, Lin; Zhu, Gang; Li, Chuanhua; Zhao, Yan; Tan, Qi] Shanghai Acad Agr Sci, Inst Edible Fungi, Shanghai, Peoples R China; [Zheng, Huajun; Zhang, Liang; Jiang, Jianping; Zhu, Yongqiang; Zhou, Yan; Wang, Shengyue; Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Academy of Agricultural Sciences	Bao, DP (corresponding author), Minist Sci & Technol MOST, Natl Engn Res Ctr Edible Fungi, Shanghai, Peoples R China.	baodp@hotmail.com; syj0@saas.sh.cn		Zhao, Guo-Ping/0000-0002-7621-6620	Shanghai Committee of Science and Technology, P. R. China [10dz2212400]	Shanghai Committee of Science and Technology, P. R. China	This work was supported by the Shanghai Committee of Science and Technology, P. R. China (Grant No. 10dz2212400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; Aimi T, 2005, CURR GENET, V48, P184, DOI 10.1007/s00294-005-0012-7; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bhatnagar D, 2003, APPL MICROBIOL BIOT, V61, P83, DOI 10.1007/s00253-002-1199-x; Briza P, 1996, EUR J BIOCHEM, V239, P124, DOI 10.1111/j.1432-1033.1996.0124u.x; BRIZA P, 1994, P NATL ACAD SCI USA, V91, P4524, DOI 10.1073/pnas.91.10.4524; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; Buswell JA, 1996, WORLD J MICROB BIOT, V12, P537, DOI 10.1007/BF00419469; CAI YJ, 1994, MYCOL RES, V98, P1019, DOI 10.1016/S0953-7562(09)80428-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang S.-T., 1974, Mushroom Journal, P350; Chang S.T., 1978, BIOL CULTIVATION EDI, P573, DOI DOI 10.1016/B978-0-12-168050-3.50033-5; CHANG SC, 1982, APPL ENVIRON MICROB, V43, P440, DOI 10.1128/AEM.43.2.440-446.1982; CHANG ST, 1971, AM J BOT, V58, P552, DOI 10.2307/2441038; CHANG ST, 1966, NATURE, V212, P528, DOI 10.1038/212528b0; CHANG ST, 1977, ECON BOT, V31, P374, DOI 10.1007/BF02866890; CHANG ST, 1969, CYTOLOGIA, V34, P293, DOI 10.1508/cytologia.34.293; CHANG ST, 1969, BOT MAG TOKYO, V82, P102; CHANG ST, 1970, AM J BOT, V57, P165, DOI 10.2307/2440509; Chang ST, 1996, WORLD J MICROB BIOT, V12, P473, DOI 10.1007/BF00419460; Chang ST, 1965, CHUNG CHI J, V5, P91; Chang ST, 1996, MUSHROOM BIOL MUSHRO, V2, P1; Chang ST, 1980, MUSHROOM NEWSLETTER, V1, P5; Chen SC, 2004, FEMS MICROBIOL LETT, V230, P171, DOI 10.1016/S0378-1097(03)00878-4; Chen SC, 2003, FEMS MICROBIOL LETT, V218, P143, DOI 10.1111/j.1574-6968.2003.tb11510.x; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Dunaevskii IaE, 2008, RUSSIAN J BIOORGANIC, V34, P317; Ehrlich KC, 2004, APPL ENVIRON MICROB, V70, P6518, DOI 10.1128/AEM.70.11.6518-6524.2004; Elliot TJ, 1982, TROPICAL MUSHROOMS B, P11; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; Iwahashi H, 1998, APPL ENVIRON MICROB, V64, P4614; James TY, 2006, GENETICS, V172, P1877, DOI 10.1534/genetics.105.051128; Joh JH, 2004, FEMS MICROBIOL LETT, V239, P57, DOI 10.1016/j.femsle.2004.08.020; Kandror O, 2004, MOL CELL, V13, P771, DOI 10.1016/S1097-2765(04)00148-0; Kerrigan R. W., 2011, Mushroom biology and mushroom products. Proceedings of the 7th International Conference on Mushroom Biology and Mushroom Products, Arcachon, France, 4-7 October, 2011. Volume 1. Oral presentations, P1; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Kitazume T, 2002, EUR J BIOCHEM, V269, P2075, DOI 10.1046/j.1432-1033.2002.02855.x; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kudryavtseva OA, 2008, MICROBIOLOGY+, V77, P643, DOI 10.1134/S0026261708060015; Kues U, 2011, MYCOTA, V14, P97; LI Y, 1992, WORLD J MICROB BIOT, V8, P621, DOI 10.1007/BF01238801; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Melo NR, 2008, CYP56 DIT2P CANDIDA; Ming-Hua S, 2007, J MICROBIOL BIOTECHN, V17, P1271; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murata Y, 2006, EXTREMOPHILES, V10, P117, DOI 10.1007/s00792-005-0480-1; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; Natarajan K, 2007, PLOS BIOL, V5, pe17; Nelson David R., 2009, Human Genomics, V4, P59; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ramirez L, 2011, INT MICROBIOL, V14, P111, DOI 10.2436/20.1501.01.141; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; ROYSE DJ, 1987, EXP MYCOL, V11, P11, DOI 10.1016/0147-5975(87)90031-4; Saier Jr MH, 2006, TCDB TRANSPORTER CLA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Santiago CM, 1983, PHILIPPINES J SCI, V114, P53; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sweeney MD, 2012, CATALYSTS, V2, P244, DOI 10.3390/catal2020244; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wen Y, 2005, APPL ENVIRON MICROB, V71, P3192, DOI 10.1128/AEM.71.6.3192-3198.2005; Xie B. G., 2010, ANN M MYC SOC CHIN, P2; Ya R, 2009, MYCOL RES, V113, P240, DOI 10.1016/j.mycres.2008.11.002; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [张红 ZHANG Hong], 2006, [上海大学学报. 自然科学版, Journal of Shanghai University. Natural Science], V12, P547; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	90	110	154	5	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58294	10.1371/journal.pone.0058294	http://dx.doi.org/10.1371/journal.pone.0058294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526973	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100021
J	Ikezaki, K; Komori, T; Yanagida, T				Ikezaki, Keigo; Komori, Tomotaka; Yanagida, Toshio			Spontaneous Detachment of the Leading Head Contributes to Myosin VI Backward Steps	PLOS ONE			English	Article							HAND-OVER-HAND; LEVER ARM; MECHANISM	Myosin VI is an ATP driven molecular motor that normally takes forward and processive steps on actin filaments, but also on occasion stochastic backward steps. While a number of models have attempted to explain the backwards steps, none offer an acceptable mechanism for their existence. We therefore performed single molecule imaging of myosin VI and calculated the stepping rates of forward and backward steps at the single molecule level. The forward stepping rate was proportional to the ATP concentration, whereas the backward stepping rate was independent. Using these data, we proposed that spontaneous detachment of the leading head is uncoupled from ATP binding and is responsible for the backward steps of myosin VI.	[Ikezaki, Keigo; Komori, Tomotaka; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Ikezaki, Keigo; Komori, Tomotaka; Yanagida, Toshio] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Yanagida, Toshio] Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan; [Yanagida, Toshio] Osaka Univ, Immunol Frontier Res Ctr IFReC, Suita, Osaka, Japan	Osaka University; RIKEN; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Komori, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	komotomo@fbs.osaka-u.ac.jp; yanagida@fbs.osaka-u.ac.jp			MEXT, Japan [24-2619]; RIKEN QBiC, Japan; MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN QBiC, Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for JSPS Fellows 24-2619 (to KI) from MEXT, Japan and funding from RIKEN QBiC, Japan and the Global COE program 'System Dynamics of Biological Function' also from MEXT, Japan. The funders had no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dunn AR, 2010, P NATL ACAD SCI USA, V107, P7746, DOI 10.1073/pnas.1002430107; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Ikezaki K, 2012, SMALL, V8, P3035, DOI 10.1002/smll.201200765; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Peiying C, 2011, J MOL BIOL, V405, P105; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Shiroguchi K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001031; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	20	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58912	10.1371/journal.pone.0058912	http://dx.doi.org/10.1371/journal.pone.0058912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527046	Green Published, Green Submitted, gold			2022-12-25	WOS:000316411600016
J	Korn, L; Gonen, E; Shaked, Y; Golan, M				Korn, Liat; Gonen, Ester; Shaked, Yael; Golan, Moria			Health Perceptions, Self and Body Image, Physical Activity and Nutrition among Undergraduate Students in Israel	PLOS ONE			English	Article							FRESHMAN WEIGHT-GAIN; COLLEGE-STUDENTS; UNITED-STATES; UNIVERSITY-STUDENTS; GENDER-DIFFERENCES; BEHAVIORS; OBESITY; OVERWEIGHT; EXERCISE; STRESS	Purpose: This study examines health perceptions, self and body image, physical exercise and nutrition among undergraduate students. Methods: A structured, self-reported questionnaire was administered to more than 1500 students at a large academic institute in Israel. The study population was heterogenic in both gender and fields of academic study. Results: High correlations between health perceptions, appropriate nutrition, and positive self and body image were found. The relationships between these variables differed between the subpopulation in the sample and the different genders. Engagement in physical exercise contributed to positive body image and positive health perceptions more than engagement in healthy nutrition. Nutrition students reported higher frequencies of positive health perceptions, positive self and body image and higher engagement in physical exercise in comparison to all other students in the sample. Conclusions: This study suggests, as have many before, that successful health promotion policy should reflect a collectivist rather than an individualist ethos by providing health prerequisites through a public policy of health-promotion, where the academic settings support a healthy lifestyle policy, by increasing availability of a healthy, nutritious and varied menu in the cafeterias, and offering students various activities that enhance healthy eating and exercise. Implications and contribution: This study examined health perceptions, self-image, physical exercise and nutrition among undergraduate students and found high correlations between these topics. Nutrition students reported higher frequencies of positive health perceptions, and positive self and body image and engaged more in physical exercise when compared with all other students in the sample.	[Korn, Liat; Shaked, Yael] Ariel Univ Ctr Samaria, Sch Hlth Sci, Dept Hlth Management, Ariel, Israel; [Gonen, Ester] Ariel Univ Ctr Samaria, Sch Hlth Sci, Dept Nutr, Ariel, Israel; [Gonen, Ester; Golan, Moria] Tel Hai Acad Coll, Dept Nutr, Upper Galilee, Israel	Ariel University; Ariel University; Tel Hai Academy College	Korn, L (corresponding author), Ariel Univ Ctr Samaria, Sch Hlth Sci, Dept Hlth Management, Ariel, Israel.	kornli@zahav.net.il	Korn, Liat/L-1907-2019	Korn, Liat/0000-0001-5688-8983	AUC (Ariel University Center); Tel Hai Academic College, Upper Galilee	AUC (Ariel University Center); Tel Hai Academic College, Upper Galilee	This study was funded by the AUC (Ariel University Center) and Tel Hai Academic College, Upper Galilee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruguete MS, 2009, EAT BEHAV, V10, P143, DOI 10.1016/j.eatbeh.2009.03.004; Austin SB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-313; Berg KC, 2009, EAT BEHAV, V10, P137, DOI 10.1016/j.eatbeh.2009.03.003; Biro FM, 2006, J ADOLESCENT HEALTH, V39, P501, DOI 10.1016/j.jadohealth.2006.03.010; Center for Disease Control and Prevention- CDC, 2010, VIT SIGNS STAT SPEC; Clarke PJ, 2009, AM J PUBLIC HEALTH, V99, P1893, DOI 10.2105/AJPH.2008.141317; Cluskey M, 2009, J AM DIET ASSOC, V109, P325, DOI 10.1016/j.jada.2008.10.045; COMPAS BE, 1986, AM J COMMUN PSYCHOL, V14, P241, DOI 10.1007/BF00911173; Dahlqvist V, 2008, NURS EDUC TODAY, V28, P476, DOI 10.1016/j.nedt.2007.07.010; DREWNOWSKI A, 1987, PSYCHOSOM MED, V49, P626, DOI 10.1097/00006842-198711000-00008; Greaney ML, 2009, J NUTR EDUC BEHAV, V41, P281, DOI 10.1016/j.jneb.2008.04.354; Grogen S, 1999, BODY IMAGE UNDERSTAN; Jessor R., 2003, SURVEY PERSONAL SOCI; Jessor R, 2010, J RES ADOLESCENCE, V20, P707, DOI 10.1111/j.1532-7795.2010.00656.x; Kicklighter JR, 2010, J AM COLL HEALTH, V59, P98, DOI 10.1080/07448481.2010.483709; Lee RLT, 2005, PUBLIC HEALTH NURS, V22, P209, DOI 10.1111/j.0737-1209.2005.220304.x; Leiker M, 2010, DISS ABSTR INT A, V71, P1239; Levitsky DA, 2004, INT J OBESITY, V28, P1435, DOI 10.1038/sj.ijo.0802776; Liu CH, 2007, PHYSIOL BEHAV, V92, P748, DOI 10.1016/j.physbeh.2007.05.068; Maglione JL, 2009, RES NURS HEALTH, V32, P634, DOI 10.1002/nur.20353; Mareno N., 2010, DISS ABSTR INT B, V70, P4089; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nigg CR, 2010, J OCCUP ENVIRON MED, V52, pS4, DOI 10.1097/JOM.0b013e3181c78a3a; O'Dea JA, 2001, J NUTR EDUC, V33, P332, DOI 10.1016/S1499-4046(06)60355-2; Omigbodun OO, 2006, SOC PSYCH PSYCH EPID, V41, P415, DOI 10.1007/s00127-006-0037-3; Ozier AD, 2008, J AM DIET ASSOC, V108, P49, DOI 10.1016/j.jada.2007.10.011; Pliner P, 2008, PHYSIOL BEHAV, V93, P76, DOI 10.1016/j.physbeh.2007.07.017; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; RYAN RM, 1995, J PERS, V63, P397, DOI 10.1111/j.1467-6494.1995.tb00501.x; Schmalz DL, 2007, J ADOLESCENT HEALTH, V41, P559, DOI 10.1016/j.jadohealth.2007.07.001; Smith BL, 1998, PERCEPT MOTOR SKILL, V86, P723, DOI 10.2466/pms.1998.86.2.723; SONSTROEM RJ, 1989, MED SCI SPORT EXER, V21, P329; Stock C, 2001, HEALTH PROMOT INT, V16, P145, DOI 10.1093/heapro/16.2.145; STRIEGELMOORE RH, 1986, AM PSYCHOL, V41, P246, DOI 10.1037/0003-066X.41.3.246; TIGGEMANN M, 1988, SEX ROLES, V18, P75, DOI 10.1007/BF00288018; Vohs KD, 2001, INT J EAT DISORDER, V29, P280, DOI 10.1002/eat.1019; von Bothmer Margareta I K, 2005, Nurs Health Sci, V7, P107, DOI 10.1111/j.1442-2018.2005.00227.x; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; World Health Organization, 2000, WHO TECHN REP SER, V894	39	43	43	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58543	10.1371/journal.pone.0058543	http://dx.doi.org/10.1371/journal.pone.0058543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516503	Green Published, gold, Green Submitted			2022-12-25	WOS:000316407400038
J	Liu, XH; Yue, LF; Wang, DW; Li, N; Cong, L				Liu, Xiao Hui; Yue, Ling Fen; Wang, Da Wei; Li, Ning; Cong, Lin			Inbreeding Avoidance Drives Consistent Variation of Fine-Scale Genetic Structure Caused by Dispersal in the Seasonal Mating System of Brandt's Voles	PLOS ONE			English	Article							MATE CHOICE; POLYANDRY; EVOLUTION; FEMALES; SUCCESS; RELATEDNESS; PHILOPATRY; PATERNITY; PARENTAGE; SOFTWARE	Inbreeding depression is a major evolutionary and ecological force influencing population dynamics and the evolution of inbreeding-avoidance traits such as mating systems and dispersal. Mating systems and dispersal are fundamental determinants of population genetic structure. Resolving the relationships among genetic structure, seasonal breeding-related mating systems and dispersal will facilitate our understanding of the evolution of inbreeding avoidance. The goals of this study were as follows: (i) to determine whether females actively avoided mating with relatives in a group-living rodent species, Brandt's voles (Lasiopodomys brandtii), by combined analysis of their mating system, dispersal and genetic structure; and (ii) to analyze the relationships among the variation in fine-genetic structure, inbreeding avoidance, season-dependent mating strategies and individual dispersal. Using both individual-and population-level analyses, we found that the majority of Brandt's vole groups consisted of close relatives. However, both group-specific FISs, an inbreeding coefficient that expresses the expected percentage rate of homozygosity arising from a given breeding system, and relatedness of mates showed no sign of inbreeding. Using group pedigrees and paternity analysis, we show that the mating system of Brandt's voles consists of a type of polygyny for males and extra-group polyandry for females, which may decrease inbreeding by increasing the frequency of mating among distantly-related individuals. The consistent variation in within-group relatedness, among-group relatedness and fine-scale genetic structures was mostly due to dispersal, which primarily occurred during the breeding season. Biologically relevant variation in the fine-scale genetic structure suggests that dispersal during the mating season may be a strategy to avoid inbreeding and drive the polygynous and extra-group polyandrous mating system of this species.	[Liu, Xiao Hui; Yue, Ling Fen; Wang, Da Wei; Li, Ning] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Xiao Hui; Wang, Da Wei; Li, Ning] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Weed & Rodent Biol & Management, Beijing 100193, Peoples R China; [Cong, Lin] Heilongjiang Acad Agr Sci, Inst Plant Protect, Harbin, Heilongjiang Pr, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Heilongjiang Academy of Agricultural Sciences	Liu, XH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	lxiaohui2000@163.com		Liu, Xiao-Hui/0000-0002-8674-1787	National Basic Research Program of China [2007CB109104]	National Basic Research Program of China(National Basic Research Program of China)	This research was funded by the National Basic Research Program of China (project no. 2007CB109104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen Guokang, 2003, Acta Theriologica Sinica, V23, P220; Cheptou PO, 2011, NEW PHYTOL, V189, P395, DOI 10.1111/j.1469-8137.2010.03541.x; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Duffie CV, 2009, MOL ECOL, V18, P2103, DOI 10.1111/j.1365-294X.2009.04179.x; Evans JP, 2005, EVOLUTION, V59, P106; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faulkes CG, 2001, TRENDS ECOL EVOL, V16, P184, DOI 10.1016/S0169-5347(01)02116-4; Firman RC, 2008, EVOLUTION, V62, P603, DOI 10.1111/j.1558-5646.2007.00307.x; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Honer OP, 2007, NATURE, V448, P798, DOI 10.1038/nature06040; Huo YJ, 2010, BEHAV PROCESS, V84, P745, DOI 10.1016/j.beproc.2010.05.002; Ivy TM, 2005, EVOLUTION, V59, P152, DOI 10.1111/j.0014-3820.2005.tb00902.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lebigre C, 2010, MOL ECOL, V19, P1929, DOI 10.1111/j.1365-294X.2010.04614.x; Lee JW, 2009, MOL ECOL, V18, P2728, DOI 10.1111/j.1365-294X.2009.04228.x; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Moore J, 2007, MOL ECOL, V16, P4421, DOI 10.1111/j.1365-294X.2007.03560.x; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Russell DW, 2001, MOL CLONING LAB MANU; Schweizer M, 2007, MOL ECOL, V16, P2463, DOI 10.1111/j.1365-294X.2007.03284.x; SCRIBNER KT, 1993, J MAMMAL, V74, P1026, DOI 10.2307/1382442; Shi D, 1998, ACTA AGRESTIA SINICA, V6, P53; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Thuman KA, 2005, ANIM BEHAV, V69, P765, DOI 10.1016/j.anbehav.2004.10.003; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Van de Casteele T, 2006, MOL ECOL, V15, P2557, DOI 10.1111/j.1365-294X.2006.02946.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wan Xin-rong, 2007, Shengtaixue Zazhi, V26, P359; Wan Xinrong, 2002, Acta Theriologica Sinica, V22, P116; Wan Xinrong, 2001, Acta Theriologica Sinica, V21, P67; Wan Xinrong, 2006, Acta Theriologica Sinica, V26, P226; [王大伟 Wang Dawei], 2010, [生态学报, Acta Ecologica Sinica], V21, P3562; Wang D, 2007, MOL ECOL NOTES, V7, P671, DOI 10.1111/j.1471-8286.2006.01673.x; Wang D, 2011, CONSERV GENET, V12, P659, DOI 10.1007/s10592-010-0172-y; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1921, GENETICS, V6, P111; Xie Xiao-Ming, 1994, Acta Zoologica Sinica, V40, P262; Yin Feng, 1998, Acta Theriologica Sinica, V18, P277; Yin Feng, 1998, Acta Zoologica Sinica, V44, P162; Yu XD, 2004, J ETHOL, V22, P17, DOI 10.1007/s10164-003-0097-8; Yue LF, 2009, MOL ECOL RESOUR, V9, P1194, DOI 10.1111/j.1755-0998.2009.02601.x; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zeh JA, 2008, GENETICA, V134, P45, DOI 10.1007/s10709-007-9192-z; ZHANG J, 1979, Acta Zoologica Sinica, V25, P250; Zhang Jian-Jun, 2006, Acta Zoologica Sinica, V52, P224; Zhang Jian-Jun, 2005, Chinese Journal of Zoology, V40, P19; Zhang Jian-jun, 2007, Shengtaixue Zazhi, V26, P219; Zhong W, 2007, J ARID ENVIRON, V68, P398, DOI 10.1016/j.jaridenv.2006.06.008	67	11	12	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58101	10.1371/journal.pone.0058101	http://dx.doi.org/10.1371/journal.pone.0058101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516435	Green Submitted, gold, Green Published			2022-12-25	WOS:000316407400017
J	Millar, K; Lloyd, SM; McLean, JS; Batty, GD; Burns, H; Cavanagh, J; Deans, KA; Ford, I; McConnachie, A; McGinty, A; Mottus, R; Packard, CJ; Sattar, N; Shiels, PG; Velupillai, YN; Tannahill, C				Millar, Keith; Lloyd, Suzanne M.; McLean, Jennifer S.; Batty, G. David; Burns, Harry; Cavanagh, Jonathan; Deans, Kevin A.; Ford, Ian; McConnachie, Alex; McGinty, Agnes; Mottus, Rene; Packard, Chris J.; Sattar, Naveed; Shiels, Paul G.; Velupillai, Yoga N.; Tannahill, Carol			Personality, Socio-Economic Status and Inflammation: Cross-Sectional, Population-Based Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; COGNITIVE-ABILITY; 5-FACTOR MODEL; LIFE-COURSE; HEALTH; MORTALITY; SMOKING; MARKERS; INTELLIGENCE	Background: Associations between socio-economic status (SES), personality and inflammation were examined to determine whether low SES subjects scoring high on neuroticism or hostility might suffer relatively higher levels of inflammation than affluent subjects. Methods: In a cross-sectional design, 666 subjects were recruited from areas of high (most deprived - "MD") and low (least deprived - "LD") deprivation. IL-6, ICAM-1, CRP and fibrinogen were measured along with demographic and health-behaviour variables, and personality traits of neuroticism, extraversion and psychoticism (hostility). Regression models assessed the prediction of inflammation as a function of personality, deprivation and their interaction. Results: Levels of CRP and IL-6 were an increasing function of neuroticism and extraversion only in LD subjects opposite trends were seen in MD subjects. The result was ascribed parsimoniously to an inflammatory ceiling effect or, more speculatively, to SES-related health-behaviour differences. Psychoticism was strongly associated with ICAM-1 in both MD and LD subjects. Conclusions: The association between neuroticism, CRP and IL-6 may be reduced in MD subjects confirming speculation that the association differs across population sub-groups. The association between psychoticism and ICAM-1 supports evidence that hostility has adverse effects upon the endothelium, with consequences for cardiovascular health. Health interventions may be more effective by accounting for personality- related effects upon biological processes.	[Millar, Keith; Cavanagh, Jonathan] Univ Glasgow, Inst Mental Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Lloyd, Suzanne M.; Ford, Ian; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [McLean, Jennifer S.; Tannahill, Carol] Glasgow Ctr Populat Hlth, Glasgow, Lanark, Scotland; [Batty, G. David] MRC Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England; [Burns, Harry] Scottish Govt, Edinburgh, Midlothian, Scotland; [Deans, Kevin A.] Glasgow Royal Infirm, Dept Vasc Biochem, NHS Greater Glasgow & Clyde, Glasgow G4 0SF, Lanark, Scotland; [Deans, Kevin A.] Aberdeen Royal Infirm, Dept Clin Biochem, NHS Grampian, Aberdeen, Scotland; [McGinty, Agnes; Packard, Chris J.] Univ Glasgow, Western Infirm, Glasgow Clin Res Facil, Glasgow G11 6NT, Lanark, Scotland; [Mottus, Rene] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Velupillai, Yoga N.] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland	University of Glasgow; University of Glasgow; University of London; University College London; University of Glasgow; University of Aberdeen; University of Glasgow; University of Edinburgh; University of Glasgow; University of Glasgow; University of Limerick	McLean, JS (corresponding author), Glasgow Ctr Populat Hlth, Glasgow, Lanark, Scotland.	Jennifer.mclean@drs.glasgow.gov.uk	Ford, Ian/ABE-6145-2020; Lloyd, Suzanne/H-7424-2013; Batty, GD/Y-4401-2018	Batty, GD/0000-0003-1822-5753; Shiels, Paul/0000-0002-7577-9843	Glasgow Centre for Population Health; Scottish Government; Medical Research Council [MR/K026992/1] Funding Source: researchfish	Glasgow Centre for Population Health; Scottish Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Glasgow Centre for Population Health which is a partnership between National Health Service (NHS) Greater Glasgow and Clyde, Glasgow City Council and the University of Glasgow, supported by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 1997, ADDICTION, V92, P1023, DOI 10.1111/j.1360-0443.1997.tb02982.x; Batty GD, 2010, EUR J CARDIOV PREV R, V17, P24, DOI 10.1097/HJR.0b013e328321311b; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Berlin I, 2003, ADDICTION, V98, P1575, DOI 10.1046/j.1360-0443.2003.00523.x; Bosma H, 1999, BRIT MED J, V318, P18; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Chapman BP, 2011, BRAIN BEHAV IMMUN, V25, P667, DOI 10.1016/j.bbi.2011.01.003; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Chapman BP, 2009, BRAIN BEHAV IMMUN, V23, P636, DOI 10.1016/j.bbi.2008.12.009; Costa P.T., 1992, NEO FFI PERSONALITY; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; De Moor MHM, 2006, PREV MED, V42, P273, DOI 10.1016/j.ypmed.2005.12.002; Deans KA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4170; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Goldberg D.P., 1978, MANUAL GEN HLTH QUES; Goodman A, 2008, EUR J EPIDEMIOL, V23, P379, DOI 10.1007/s10654-008-9248-0; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Harper S, 2002, INT J EPIDEMIOL, V31, P395, DOI 10.1093/ije/31.2.395; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Henningsson S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-16; Janicki-Deverts D, 2010, BRAIN BEHAV IMMUN, V24, P58, DOI 10.1016/j.bbi.2009.07.009; Jonassaint CR, 2011, INT J BEHAV MED, V18, P13, DOI 10.1007/s12529-009-9069-x; Jousilahti P, 2003, J EPIDEMIOL COMMUN H, V57, P730, DOI 10.1136/jech.57.9.730; Kop WJ, 2003, BRAIN BEHAV IMMUN, V17, P233, DOI 10.1016/S0889-1591(03)00051-5; Korten AE, 1999, J EPIDEMIOL COMMUN H, V53, P83, DOI 10.1136/jech.53.2.83; Kubzansky LD, 1999, ANN BEHAV MED, V21, P330, DOI 10.1007/BF02895966; Lubbock LA, 2005, AM J CARDIOL, V96, P1506, DOI 10.1016/j.amjcard.2005.07.059; Marsland AL, 2008, BRAIN BEHAV IMMUN, V22, P753, DOI 10.1016/j.bbi.2007.11.008; Miller GE, 2003, J BEHAV MED, V26, P501, DOI 10.1023/A:1026273817984; Mottus R, 2013, PSYCHOSOM MED, V75, P11, DOI 10.1097/PSY.0b013e31827576cc; Mroczek DK, 2007, PSYCHOL SCI, V18, P371, DOI 10.1111/j.1467-9280.2007.01907.x; Nabi H, 2008, INT J EPIDEMIOL, V37, P386, DOI 10.1093/ije/dyn013; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; Nelson H., 1991, NATL ADULT READING T; Packard CJ, 2012, J PUBLIC HEALTH-UK, V34, P615, DOI 10.1093/pubmed/fds030; PARKES KR, 1984, PSYCHOL MED, V14, P825, DOI 10.1017/S0033291700019796; Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106; Raynor DA, 2009, J AM COLL HEALTH, V58, P73, DOI 10.3200/JACH.58.1.73-82; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Roberts BW, 2009, PSYCHOL SCI, V20, P553, DOI 10.1111/j.1467-9280.2009.02339.x; Scottish Government, 2004, SCOTT IND MULT DEPR; Shipley BA, 2007, PSYCHOSOM MED, V69, P923, DOI 10.1097/PSY.0b013e31815abf83; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109; Sutin AR, 2010, PSYCHOL MED, V40, P1485, DOI 10.1017/S0033291709992029; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Velupillai YN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-126; Weiss A, 2005, PSYCHOSOM MED, V67, P724, DOI 10.1097/01.psy.0000181272.58103.18; Yeung RR, 1997, PERS INDIV DIFFER, V22, P47, DOI 10.1016/S0191-8869(96)00158-4	49	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58256	10.1371/journal.pone.0058256	http://dx.doi.org/10.1371/journal.pone.0058256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516457	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000316849200051
J	Tian, L; Zhang, Y; Chen, Y; Cai, M; Dong, HL; Xiong, LZ				Tian, Li; Zhang, Yang; Chen, Yu; Cai, Min; Dong, Hailong; Xiong, Lize			EMMPRIN Is an Independent Negative Prognostic Factor for Patients with Astrocytic Glioma	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INCREASES CHEMOSENSITIVITY; CD147 OVEREXPRESSION; TUMOR PROGRESSION; POOR-PROGNOSIS; EXPRESSION; CANCER; INDUCER; CLASSIFICATION; INVASION	Extracellular matrix metalloproteinase inducer (EMMPRIN), also known as CD147, is a member of the immunoglobulin superfamily that is present on the surface of tumor cells and stimulates adjacent fibroblasts to produce matrix metalloproteinases (MMPs). It has been proved to be associated with tumor invasion and metastasis in various human malignancies. In our study, the protein expression level of EMMPRIN in 306 cases of astrocytic glioma is investigated by immunohistochemistry assay. Statistical analysis was utilized to evaluate the association of EMMPRIN with clinicopathological characteristics and prognosis of patients. It was proved that EMMPRIN protein expression was increased in glioma compared with that in normal brain tissue. Moreover, EMMPRIN immunohistochemical staining was correlated with WHO grade and Karnofsky performance score for strong positive EMMPRIN staining is more frequently detected in glioma of advanced grade or low KPS score. It is also demonstrated that EMMPRIN could be an independent negative prognostic factor in glioma for patients with glioma of strong EMMPRIN staining tend to have high risk of death. These results proved that EMMPRIN is associated with prognosis of glioma, which may also suggest the potential role of EMMPRIN in glioma management.	[Tian, Li; Chen, Yu; Cai, Min; Dong, Hailong; Xiong, Lize] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Yang] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, HL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China.	donghl@fmmu.edu.cn; mzkxlz@126.com		Dong, Hailong/0000-0001-8984-9067				Afonso J, 2011, EJSO-EUR J SURG ONC, V37, P811, DOI 10.1016/j.ejso.2011.06.006; Chu TW, 2011, PATHOL ONCOL RES, V17, P705, DOI 10.1007/s12253-011-9373-z; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Ducray F, 2011, EXPERT REV ANTICANC, V11, P781, DOI [10.1586/era.10.202, 10.1586/ERA.10.202]; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Fuller GN, 2007, BRAIN PATHOL, V17, P304, DOI 10.1111/j.1750-3639.2007.00084.x; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Gu J, 2009, EUR J PEDIATR, V168, P705, DOI 10.1007/s00431-008-0828-5; Gupta K, 2012, J CANCER RES CLIN, V138, P1971, DOI 10.1007/s00432-012-1323-y; Huet E, 2008, CONNECT TISSUE RES, V49, P175, DOI 10.1080/03008200802151722; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia L, 2009, ANN HEMATOL, V88, P753, DOI 10.1007/s00277-008-0678-2; Kanekura T, 2010, J DERMATOL SCI, V57, P149, DOI 10.1016/j.jdermsci.2009.12.008; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kuang YH, 2009, CANCER LETT, V276, P189, DOI 10.1016/j.canlet.2008.11.010; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Piao SL, 2012, J CANCER RES CLIN, V138, P627, DOI 10.1007/s00432-011-1142-6; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Sameshima T, 2000, INT J CANCER, V88, P21, DOI 10.1002/1097-0215(20001001)88:1<21::AID-IJC4>3.0.CO;2-S; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stenzinger A, 2012, HUM PATHOL, V43, P1471, DOI 10.1016/j.humpath.2011.10.023; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Tang Y, 2004, MOL CANCER RES, V2, P73; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P157; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zhong X, 2012, ANN SURG ONCOL	34	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58069	10.1371/journal.pone.0058069	http://dx.doi.org/10.1371/journal.pone.0058069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516431	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200031
J	Archetti, M; Richardson, AD; O'Keefe, J; Delpierre, N				Archetti, Marco; Richardson, Andrew D.; O'Keefe, John; Delpierre, Nicolas			Predicting Climate Change Impacts on the Amount and Duration of Autumn Colors in a New England Forest	PLOS ONE			English	Article							GROWING-SEASON; PHENOLOGICAL TRANSITIONS; DECIDUOUS FOREST; FLOWERING TIMES; PRODUCTIVITY; TEMPERATURE; EARLIER	Climate change affects the phenology of many species. As temperature and precipitation are thought to control autumn color change in temperate deciduous trees, it is possible that climate change might also affect the phenology of autumn colors. Using long-term data for eight tree species in a New England hardwood forest, we show that the timing and cumulative amount of autumn color are correlated with variation in temperature and precipitation at specific times of the year. A phenological model driven by accumulated cold degree-days and photoperiod reproduces most of the interspecific and interannual variability in the timing of autumn colors. We use this process-oriented model to predict changes in the phenology of autumn colors to 2099, showing that, while responses vary among species, climate change under standard IPCC projections will lead to an overall increase in the amount of autumn colors for most species.	[Archetti, Marco; Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [O'Keefe, John] Harvard Forest, Petersham, MA USA; [Delpierre, Nicolas] Univ Paris Sud, Lab Ecol Systemat & Evolut, Orsay, France	Harvard University; Harvard University; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Archetti, M (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	m.archetti@uea.ac.uk	Richardson, Andrew/F-5691-2011	Richardson, Andrew/0000-0002-0148-6714; Delpierre, Nicolas/0000-0003-0906-9402	National Foundation's (NSF) LTER program [DEB-0080592]; National Science Foundation [EF-1065029]; Northeastern States Research Cooperative; United States of America National Phenology Network; USGS [G10AP00129]; United States National Park Service Inventory and Monitoring Program; Direct For Biological Sciences [1237491] Funding Source: National Science Foundation; Emerging Frontiers [1065029, 1065734, 1065074] Funding Source: National Science Foundation	National Foundation's (NSF) LTER program; National Science Foundation(National Science Foundation (NSF)); Northeastern States Research Cooperative; United States of America National Phenology Network; USGS(United States Geological Survey); United States National Park Service Inventory and Monitoring Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research at Harvard Forest is partially supported by the National Foundation's (NSF) LTER program (award number DEB-0080592). ADR acknowledges support from the National Science Foundation through the Macrosystems Biology program (award EF-1065029), and the Northeastern States Research Cooperative, in addition to the United States Geological Survey Status (USGS) and Trends Program, the United States National Park Service Inventory and Monitoring Program, and the United States of America National Phenology Network, through grant number G10AP00129 from the USGS. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of either USGS or NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; Archetti M, 2009, ANN BOT-LONDON, V103, P703, DOI 10.1093/aob/mcn259; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Delpierre N, 2009, AGR FOREST METEOROL, V149, P938, DOI 10.1016/j.agrformet.2008.11.014; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Estrella N, 2006, CLIM RES, V32, P253, DOI 10.3354/cr032253; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Fridley JD, 2012, NATURE, V485, P359, DOI 10.1038/nature11056; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Frumhoff PC, 2007, CONFRONTING CLIMATE; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hagen SC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006154; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Jolly WM, 2004, TREE PHYSIOL, V24, P1069, DOI 10.1093/treephys/24.9.1069; Kozlowski TT., 1997, GROWTH CONTROL WOODY; Lebourgeois F, 2010, INT J BIOMETEOROL, V54, P563, DOI 10.1007/s00484-010-0305-5; Matsumoto K, 2003, GLOBAL CHANGE BIOL, V9, P1634, DOI 10.1046/j.1365-2486.2003.00688.x; MAYER DG, 1993, ECOL MODEL, V68, P21, DOI 10.1016/0304-3800(93)90105-2; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Migliavacca M., 2012, BIOGEOSCI DISCUSS, V9, P879, DOI DOI 10.5194/BGD-9-879-2012; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Press W., 1992, NUMERICAL RECIPES FO; Primack D, 2004, AM J BOT, V91, P1260, DOI 10.3732/ajb.91.8.1260; Richardson AD, 2006, GLOBAL CHANGE BIOL, V12, P1174, DOI 10.1111/j.1365-2486.2006.01164.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Richardson Andrew D., 2009, P87, DOI 10.1007/978-1-4419-0026-5_4; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Sparks TH, 2011, INT J BIOMETEOROL, V55, P447, DOI 10.1007/s00484-010-0355-8; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021	42	78	80	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57373	10.1371/journal.pone.0057373	http://dx.doi.org/10.1371/journal.pone.0057373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520468	gold, Green Submitted, Green Published			2022-12-25	WOS:000318679900027
J	Kierdorf, K; Katzmarski, N; Haas, CA; Prinz, M				Kierdorf, Katrin; Katzmarski, Natalie; Haas, Carola A.; Prinz, Marco			Bone Marrow Cell Recruitment to the Brain in the Absence of Irradiation or Parabiosis Bias	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEMATOPOIETIC-CELLS; ALZHEIMERS-DISEASE; AMYLOID DEPOSITION; MYELOID CELLS; STEM-CELLS; MICROGLIA; BLOOD; BARRIER; CNS	The engraftment of bone marrow-derived cells has been described not only during diseases of the central nervous system (CNS) but also under healthy conditions. However, previous studies pointing to an ample bone marrow cell engraftment used irradiation-induced bone marrow chimeras that evoked severe alterations of the CNS micromilieu including disturbances of the blood brain barrier (BBB), damage of endothelial cells and local induction of proinflammatory cytokines. On the other hand, parabiosis experiments using temporarily joined circulatory systems generally yielded low levels of myeloid cell chimerism thereby potentially underestimating bone marrow cell turnover with the CNS. To avoid these drawbacks we established a protocol using the alkylating agent busulfan prior to allogenic bone marrow transplantation from CX(3)CR1(GFP/+) donors. This regimen resulted in a stable and high peripheral myeloid chimerism, significantly reduced cytokine induction and preserved BBB integrity. Importantly, bone marrow cell recruitment to the CNS was strongly diminished under these conditions and only weakly enhanced during local neurodegeneration induced by facial nerve axotomy. These results underscore the requirement of local CNS conditioning for efficient recruitment of bone marrow cells, establish busulfan as an alternative treatment for studying bone marrow chimeras and suggest a critical re-evaluation of earlier chimeric studies involving irradiation or parabiosis regimens.	[Kierdorf, Katrin; Katzmarski, Natalie; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Kierdorf, Katrin; Katzmarski, Natalie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Haas, Carola A.] Univ Freiburg, Dept Neurosurg, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Kierdorf, Katrin/AAO-6288-2021	Kierdorf, Katrin/0000-0002-9272-4780	Deutsche Forschungsgemeinschaft (DFG) research unit (FOR) "From monocytes to brain macrophagesconditions influencing the fate of myeloid cells in the brain" [1336]; BMBF; DFG [SFB 620, PR 577/8-2]; competence network of neurodegenerative disorders (DZNE); centre of chronic immunodeficiency (CCI)	Deutsche Forschungsgemeinschaft (DFG) research unit (FOR) "From monocytes to brain macrophagesconditions influencing the fate of myeloid cells in the brain"(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); competence network of neurodegenerative disorders (DZNE); centre of chronic immunodeficiency (CCI)	MP is supported by the Deutsche Forschungsgemeinschaft (DFG) funded research unit (FOR) 1336 "From monocytes to brain macrophagesconditions influencing the fate of myeloid cells in the brain". MP is further granted by the BMBF-funded competence network of multiple sclerosis (KKNMS), the competence network of neurodegenerative disorders (DZNE), the centre of chronic immunodeficiency (CCI), and the DFG (SFB 620, PR 577/8-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Algotsson A, 2007, ACTA NEUROL SCAND, V115, P403, DOI 10.1111/j.1600-0404.2007.00823.x; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; CHAMPLIN RE, 1985, BLOOD, V65, P1039; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; HADDOW A, 1953, LANCET, V264, P207; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Koistinaho M, 2005, BRAIN RES REV, V48, P240, DOI 10.1016/j.brainresrev.2004.12.014; Lampron A, 2011, CELL TRANSPLANT; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; PUGIN J, 1995, J INFLAMM, V45, P49; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; VASSAL G, 1990, CANCER RES, V50, P6203; Yuan H, 2003, BRAIN RES, V969, P59, DOI 10.1016/S0006-8993(03)02278-9	38	110	110	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58544	10.1371/journal.pone.0058544	http://dx.doi.org/10.1371/journal.pone.0058544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23526995	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900080
J	Lizunov, VA; Stenkula, K; Troy, A; Cushman, SW; Zimmerberg, J				Lizunov, Vladimir A.; Stenkula, Karin; Troy, Aaron; Cushman, Samuel W.; Zimmerberg, Joshua			Insulin Regulates Glut4 Confinement in Plasma Membrane Clusters in Adipose Cells	PLOS ONE			English	Article							GLUCOSE-TRANSPORT; ANCHORED PROTEINS; LIPID RAFTS; TRANSLOCATION; VESICLES; FUSION; RAT; TRAFFICKING; MICROSCOPY; DIFFUSION	Insulin-stimulated delivery of glucose transporter-4 (GLUT4) to the plasma membrane (PM) is the hallmark of glucose metabolism. In this study we examined insulin's effects on GLUT4 organization in PM of adipose cells by direct microscopic observation of single monomers tagged with photoswitchable fluorescent protein. In the basal state, after exocytotic delivery only a fraction of GLUT4 is dispersed into the PM as monomers, while most of the GLUT4 stays at the site of fusion and forms elongated clusters (60-240 nm). GLUT4 monomers outside clusters diffuse freely and do not aggregate with other monomers. In contrast, GLUT4 molecule collision with an existing cluster can lead to immediate confinement and association with that cluster. Insulin has three effects: it shifts the fraction of dispersed GLUT4 upon delivery, it augments the dissociation of GLUT4 monomers from clusters similar to 3-fold and it decreases the rate of endocytic uptake. All together these three effects of insulin shift most of the PM GLUT4 from clustered to dispersed states. GLUT4 confinement in clusters represents a novel kinetic mechanism for insulin regulation of glucose homeostasis.	[Lizunov, Vladimir A.; Troy, Aaron; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Stenkula, Karin; Cushman, Samuel W.] NIDDKD, Expt Diabet Metab & Nutr Sect, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	joshz@mail.nih.gov		Stenkula, Karin/0000-0002-0739-1150; Troy, Aaron/0000-0001-9844-5718	Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055118] Funding Source: NIH RePORTER	Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011919; Al-Hasani H, 1999, FEBS LETT, V460, P338, DOI 10.1016/S0014-5793(99)01369-1; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Deutsch E, 2012, MOL BIOL CELL; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hagiwara A, 2011, CYTOSKELETON, V68, P512, DOI 10.1002/cm.20528; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Kenkre VM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051907; KONO T, 1977, J BIOL CHEM, V252, P2226; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2012, AM J PHYSIOL-ENDOC M, V302, pE950, DOI 10.1152/ajpendo.00466.2011; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Malide D, 2000, J CELL SCI, V113, P4203; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078	44	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57559	10.1371/journal.pone.0057559	http://dx.doi.org/10.1371/journal.pone.0057559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520472	Green Submitted, Green Published, gold			2022-12-25	WOS:000318679900031
J	Qin, SP; Hu, CS; Oenema, O				Qin, Shuping; Hu, Chunsheng; Oenema, Oene			Differentiating Intracellular from Extracellular Alkaline Phosphatase Activity in Soil by Sonication	PLOS ONE			English	Article							ENZYME-ACTIVITIES; ACID-PHOSPHATASE; ORGANIC-MATTER; FUMIGATION; PHOSPHORUS; EXTRACTION; ULTRASOUND; DYNAMICS; ENERGY	Differentiating intracellular from extracellular enzyme activity is important in soil enzymology, but not easy. Here, we report on an adjusted sonication method for the separation of intracellular from extracellular phosphatase activity in soil. Under optimal sonication conditions [soil:water ratio = 1/8 (w/v) and power density = 15 watt ml(-1)], the activity of alkaline phosphomonoesterase (phosphatase) in a Haplic Cambisol soil increased with sonication time in two distinct steps. A first plateau of enzyme activity was reached between 60 and 100 s, and a second higher plateau after 300 s. We also found that sonication for 100 s under optimal conditions activated most (about 80%) of the alkaline phosphatase that was added to an autoclaved soil, while total bacteria number was not affected. Sonication for 300 s reduced the total bacteria number by three orders of magnitude but had no further effects on enzyme activity. Our results indicate that the first plateau of alkaline phosphatase activity was derived from extracellular enzymes attached to soil particles, and the second plateau to the combination of extracellular and intracellular enzymes after cell lysis. We conclude that our adjusted sonication method may be an alternative to the currently used physiological and chloroform-fumigation methods for differentiating intracellular from extracellular phosphatase activity in soil. Further testing is needed to find out whether this holds for other soil types.	[Qin, Shuping; Hu, Chunsheng] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China; [Oenema, Oene] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Oenema, Oene] Alterra, Res, Wageningen, Netherlands	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Wageningen University & Research; Wageningen University & Research	Hu, CS (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China.	cshu@sjziam.ac.cn	Qin, Shuping/B-4451-2010		National Natural Science Foundation of China [31270554, 30970534]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31270554) and 30970534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd S. A., 1990, Soil biochemistry. Volume 6., P1; De Cesare F, 2000, SOIL BIOL BIOCHEM, V32, P825, DOI 10.1016/S0038-0717(99)00212-6; Dilly O, 1998, Z PFLANZ BODENKUNDE, V161, P243, DOI 10.1002/jpln.1998.3581610310; Gianfreda L, 2006, SOIL BIOL, V8, P257; Grierson PF, 2000, SOIL BIOL BIOCHEM, V32, P1817, DOI 10.1016/S0038-0717(00)00155-3; Guenon R, 2013, SOIL BIOL BIOCHEM, V57, P663, DOI 10.1016/j.soilbio.2012.07.006; Klose S, 1999, BIOL FERT SOILS, V29, P46, DOI 10.1007/s003740050523; Klose S, 2002, J PLANT NUTR SOIL SC, V165, P429, DOI 10.1002/1522-2624(200208)165:4<429::AID-JPLN429>3.0.CO;2-S; Kong CH, 2008, SOIL BIOL BIOCHEM, V40, P1862, DOI 10.1016/j.soilbio.2008.03.009; Kramer S, 2000, SOIL BIOL BIOCHEM, V32, P179, DOI 10.1016/S0038-0717(99)00140-6; MAMBA S, 1995, INT J ENVIRON AN CH, V60, P295, DOI 10.1080/03067319508042885; Margon A, 2008, SOIL BIOL BIOCHEM, V40, P2178, DOI 10.1016/j.soilbio.2008.02.006; Murage EW, 2007, SOIL SCI SOC AM J, V71, P1363, DOI 10.2136/sssaj2006.0196; NAKAS JP, 1987, SOIL BIOL BIOCHEM, V19, P13, DOI 10.1016/0038-0717(87)90118-0; Nannipieri P, 2012, BIOL FERT SOILS, V48, P743, DOI 10.1007/s00374-012-0723-0; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Nannipieri P, 2002, BOOK SOIL P, P1; Nannipieri P, 1996, SOIL BIOL BIOCHEM, V28, P107, DOI 10.1016/0038-0717(95)00108-5; Ormeci B, 2005, ENVIRON ENG SCI, V22, P459, DOI 10.1089/ees.2005.22.459; RAMSAY AJ, 1984, SOIL BIOL BIOCHEM, V16, P475, DOI 10.1016/0038-0717(84)90055-5; Renella G, 2002, SOIL BIOL BIOCHEM, V34, P51, DOI 10.1016/S0038-0717(01)00152-3; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Speir T, 1978, SOIL ENZYMES, V203; Stemmer M, 1998, SOIL BIOL BIOCHEM, V30, P9, DOI 10.1016/S0038-0717(97)00093-X; STEVENSON I. L., 1958, Plant and Soil, V10, P1, DOI 10.1007/BF01343733; TARAFDAR JC, 1988, BIOL FERT SOILS, V5, P308, DOI 10.1007/BF00262137; Udawatta RP, 2009, AGR ECOSYST ENVIRON, V131, P98, DOI 10.1016/j.agee.2008.06.001; Vargas LHM, 2004, WORLD J MICROB BIOT, V20, P137, DOI 10.1023/B:WIBI.0000021726.69233.12; Wang JB, 2011, PLANT SOIL ENVIRON, V57, P251, DOI 10.17221/437/2010-PSE; Yachmenev VG, 2004, ULTRASONICS, V42, P87, DOI 10.1016/j.ultras.2004.01.011; Yeates C, 1998, Biol Proced Online, V1, P40, DOI 10.1251/bpo6	31	4	6	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58691	10.1371/journal.pone.0058691	http://dx.doi.org/10.1371/journal.pone.0058691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23527006	Green Submitted, Green Published, gold			2022-12-25	WOS:000318334500114
J	Ahmed, I; Greenwood, R; Costello, BD; Ratcliffe, NM; Probert, CS				Ahmed, Iftikhar; Greenwood, Rosemary; Costello, Ben de lacy; Ratcliffe, Norman M.; Probert, Chris S.			An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome	PLOS ONE			English	Article							ULCERATIVE-COLITIS; METHANE PRODUCTION; CALPROTECTIN; MARKERS; DISEASE; EPIDEMIOLOGY; INFLAMMATION; PERFORMANCE; BIOMARKERS; DIAGNOSIS	Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to invasive investigations in order to rule out other diseases and reassure their patients. Volatile organic metabolites (VOMs) are emitted from feces; understanding changes in the patterns of these VOMs could aid our understanding of the etiology of the disease and the development of biomarkers, which can assist in the diagnosis of IBS. We report the first comprehensive study of the fecal VOMs patterns in patients with diarrhea-predominant IBS (IBS-D), active Crohn's disease (CD), ulcerative colitis (UC) and healthy controls. 30 patients with IBS-D, 62 with CD, 48 with UC and 109 healthy controls were studied. Diagnosis of IBS-D was made using the Manning criteria and all patients with CD and UC met endoscopic, histologic and/or radiologic criteria. Fecal VOMs were extracted by solid phase microextraction (SPME) and analyzed by gas chromatography-mass spectrometry (GC-MS). 240 VOMs were identified. Univariate analysis showed that esters of short chain fatty acids, cyclohexanecarboxylic acid and its ester derivatives were associated with IBS-D (p<0.05), while aldehydes were more abundant in IBD (p<0.05). A predictive model, developed by multivariate analysis, separated IBS-D from active CD, UC and healthy controls with a sensitivity of 94%, 96% and 90%; and a specificity of 82%, 80% and 80% respectively (p<0.05). The understanding of the derivation of these VOMs may cast light on the etiology of IBS-D and IBD. These data show that fecal VOMs analyses could contribute to the diagnosis of IBS-D, for which there is no laboratory test, as well as IBD.	[Ahmed, Iftikhar] Univ Bristol, Bristol Royal Infirm, Dept Gastroenterol, Bristol, Avon, England; [Greenwood, Rosemary] Bristol Royal Infirm & Gen Hosp, Dept Res & Dev, Bristol, Avon, England; [Costello, Ben de lacy; Ratcliffe, Norman M.] Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England; [Probert, Chris S.] Univ Liverpool, Dept Gastroenterol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	Bristol Royal Infirmary; University of Bristol; Bristol Royal Infirmary; University of West England; University of Liverpool	Ratcliffe, NM (corresponding author), Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England.	norman.ratcliffe@uwe.ac.uk	De Lacy Costello, Ben/I-8259-2019; de Lacy Costello, Ben/ABG-2043-2021	de Lacy Costello, Ben/0000-0003-2999-6801; Probert, Christopher/0000-0003-4550-0239; Wu, Feibo/0000-0001-8797-3398	University of Bristol	University of Bristol	Iftikhar Ahmed received research fellowship from University of Bristol. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BP, 2012, GASTROENTEROL CLIN N, V41, P483, DOI 10.1016/j.gtc.2012.01.007; Ahmed I, 2011, THESIS U BRISTOL; Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Chang L, 2004, ALIMENT PHARM THER, V20, P31, DOI 10.1111/j.1365-2036.2004.02183.x; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Costa F, 2005, GUT, V54, P364, DOI 10.1136/gut.2004.043406; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; D'Inca R, 2008, AM J GASTROENTEROL, V103, P2007, DOI 10.1111/j.1572-0241.2008.01870.x; De Preter V, 2011, MOL NUTR FOOD RES, V55, P714, DOI 10.1002/mnfr.201000442; Sanchez MDG, 2006, MED CLIN-BARCELONA, V127, P41; Dixon E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018471; Drossman DA, 2005, GASTROENTEROLOGY, V128, P580, DOI 10.1053/j.gastro.2004.12.006; Drossman Douglas A, 2006, Chin J Dig Dis, V7, P181, DOI 10.1111/j.1443-9573.2006.00265.x; Durant JA, 1997, ANAEROBE, V3, P391, DOI 10.1006/anae.1997.0129; Elia M, 2008, ALIMENT PHARM THER, V27, P120, DOI 10.1111/j.1365-2036.2007.03544.x; Furnari M, 2012, J GASTROINTEST LIVER, V21, P157; Garcia-Sanchez V, 2010, J CROHNS COLITIS, V4, P144, DOI 10.1016/j.crohns.2009.09.008; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Gonlachanvit S, 2004, GUT, V53, P1577, DOI 10.1136/gut.2004.041632; Grundy D, 2006, GASTROENTEROLOGY, V130, P1391, DOI 10.1053/j.gastro.2005.11.060; HARVEY RF, 1980, LANCET, V1, P514; HEGAZI F Z, 1980, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Mikrobiologie der Landwirtschaft der Technologie und des Umweltschutzes, V135, P212; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; Kajander K, 2009, WORLD J GASTROENTERO, V15, P6068, DOI 10.3748/wjg.15.6068; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Maxion-Bergemann S, 2006, PHARMACOECONOMICS, V24, P21, DOI 10.2165/00019053-200624010-00002; Mulak A, 2004, MED SCI MONITOR, V10, pRA55; Ong DK, J GASTROENTEROL HEPA, V25, P1366; Oresic M, 2006, EXPERT REV MOL DIAGN, V6, P575, DOI 10.1586/14737159.6.4.575; Otten CMT, 2008, CLIN CHEM LAB MED, V46, P1275, DOI 10.1515/CCLM.2008.246; Pelli MA, 1999, DIS COLON RECTUM, V42, P71, DOI 10.1007/BF02235186; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Pimentel M, 2003, DIGEST DIS SCI, V48, P86, DOI 10.1023/A:1021738515885; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Probert CSJ, 2004, GUT, V53, P58, DOI 10.1136/gut.53.1.58; Quigley EMM, 2006, DIGEST LIVER DIS, V38, P717, DOI 10.1016/j.dld.2006.05.009; Quigley Eamonn M M, 2005, Chin J Dig Dis, V6, P122, DOI 10.1111/j.1443-9573.2005.00202.x; Reddymasu SC, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-23; SANDLER RS, 1990, GASTROENTEROLOGY, V99, P409, DOI 10.1016/0016-5085(90)91023-Y; Schlotterbeck G, 2006, PHARMACOGENOMICS, V7, P1055, DOI 10.2217/14622416.7.7.1055; Schoepfer AM, 2008, INFLAMM BOWEL DIS, V14, P32, DOI 10.1002/ibd.20275; SEO M, 1995, AM J GASTROENTEROL, V90, P1759; Shen Q, 2011, EUROPEAN J NUTR, P1; Silberer H, 2005, CLIN LAB, V51, P117; Staudacher HM, 2011, J HUM NUTR DIET, V24, P487, DOI 10.1111/j.1365-277X.2011.01162.x; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; Whitehead WE, 2010, AM J GASTROENTEROL, V105, P814, DOI 10.1038/ajg.2010.56; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466; Zumarraga L, 1997, ALIMENT PHARM THERAP, V11, P1067, DOI 10.1046/j.1365-2036.1997.00250.x	57	188	193	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58204	10.1371/journal.pone.0058204	http://dx.doi.org/10.1371/journal.pone.0058204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	24205003	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849200042
J	Zhang, LF; Thomas, JC; Miragaia, M; Bouchami, O; Chaves, F; d'Azevedo, PA; Aanensen, DM; de Lencastre, H; Gray, BM; Robinson, DA				Zhang, Liangfen; Thomas, Jonathan C.; Miragaia, Maria; Bouchami, Ons; Chaves, Fernando; d'Azevedo, Pedro A.; Aanensen, David M.; de Lencastre, Herminia; Gray, Barry M.; Robinson, D. Ashley			Multilocus Sequence Typing and Further Genetic Characterization of the Enigmatic Pathogen, Staphylococcus hominis	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; LEVEL RESISTANCE; BLOOD CULTURES; IDENTIFICATION; NOVOBIOCIN; EMERGENCE; SKIN; INFECTIONS	Staphylococcus hominis is a commensal resident of human skin and an opportunistic pathogen. The species is subdivided into two subspecies, S. hominis subsp. hominis and S. hominis subsp. novobiosepticus, which are difficult to distinguish. To investigate the evolution and epidemiology of S. hominis, a total of 108 isolates collected from 10 countries over 40 years were characterized by classical phenotypic methods and genetic methods. One nonsynonymous mutation in gyrB, scored with a novel SNP typing assay, had a perfect association with the novobiocin-resistant phenotype. A multilocus sequence typing (MLST) scheme was developed from six housekeeping gene fragments, and revealed relatively high levels of genetic diversity and a significant impact of recombination on S. hominis population structure. Among the 40 sequence types (STs) identified by MLST, three STs (ST2, ST16 and ST23) were S. hominis subsp. novobiosepticus, and they distinguished between isolates from different outbreaks, whereas 37 other STs were S. hominis subsp. hominis, one of which was widely disseminated (ST1). A modified PCR assay was developed to detect the presence of ccrAB4 from the SCCmec genetic element. S. hominis subsp. novobiosepticus isolates were oxacillin-resistant and carriers of specific components of SCCmec (mecA class A, ccrAB3, ccrAB4, ccrC), whereas S. hominis subsp. hominis included both oxacillin-sensitive and -resistant isolates and a more diverse array of SCCmec components. Surprisingly, phylogenetic analyses indicated that S. hominis subsp. novobiosepticus may be a polyphyletic and, hence, artificial taxon. In summary, these results revealed the genetic diversity of S. hominis, the identities of outbreak-causing clones, and the evolutionary relationships between subspecies and clones. The pathogenic lifestyle attributed to S. hominis subsp. novobiosepticus may have originated on more than one occasion.	[Zhang, Liangfen; Thomas, Jonathan C.; Robinson, D. Ashley] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Miragaia, Maria; Bouchami, Ons; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Chaves, Fernando] Hosp Univ 12 Octubre, Microbiol Serv, Madrid, Spain; [d'Azevedo, Pedro A.] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [Aanensen, David M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Gray, Barry M.] Univ Illinois, Dept Pediat, Peoria, IL USA	University of Mississippi; University of Mississippi Medical Center; Universidade Nova de Lisboa; Hospital Universitario 12 de Octubre; Universidade Federal de Ciencias da Saude de Porto Alegre; Imperial College London; Rockefeller University; University of Illinois System; University of Illinois Peoria	Robinson, DA (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	darobinson@umc.edu	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	National Institutes of Health [GM080602]; Spanish Network for Research in Infectious Diseases [RD06/0008]; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/BIA-EVF/117507/2010, Pest-OE/EQB/LAO004/2011]; NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Network for Research in Infectious Diseases; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant GM080602 from the National Institutes of Health (to DAR) and grant RD06/0008 from the Spanish Network for Research in Infectious Diseases (to FC). The work performed in Portugal was supported by grants PTDC/BIA-EVF/117507/2010 (to MM) and grant #Pest-OE/EQB/LAO004/2011 (to ITQB) from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Chassain B, 2012, J CLIN MICROBIOL, V50, P3003, DOI 10.1128/JCM.00988-12; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; CLSI, 2007, M100S17 CLSI; Cunha BA, 2007, HEART LUNG, V36, P380, DOI 10.1016/j.hrtlng.2006.11.002; d'Azevedo PA, 2008, J MED MICROBIOL, V57, P256, DOI 10.1099/jmm.0.47345-0; Santos OCDS, 2009, DIAGN MICR INFEC DIS, V64, P1, DOI 10.1016/j.diagmicrobio.2008.12.017; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLENDER RD, 1995, J FOOD PROTECT, V58, P853, DOI 10.4315/0362-028X-58.8.853; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FAGHRI MA, 1984, APPL ENVIRON MICROB, V47, P1054, DOI 10.1128/AEM.47.5.1054-1061.1984; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzgibbon JE, 2001, RES MICROBIOL, V152, P805, DOI 10.1016/S0923-2508(01)01264-5; Fournier B, 1998, ANTIMICROB AGENTS CH, V42, P121, DOI 10.1128/AAC.42.1.121; Fujimoto-Nakamura M, 2005, ANTIMICROB AGENTS CH, V49, P3810, DOI 10.1128/AAC.49.9.3810-3815.2005; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Garza-Gonzalez E, 2011, SCAND J INFECT DIS, V43, P930, DOI 10.3109/00365548.2011.598873; Gilad J, 2007, J CLIN MICROBIOL, V45, P685, DOI 10.1128/JCM.02228-06; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; GUNN BA, 1983, INT J SYST BACTERIOL, V33, P751, DOI 10.1099/00207713-33-4-751; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Iyer MN, 2005, AM J OPHTHALMOL, V139, P930, DOI 10.1016/j.ajo.2004.10.060; Katayama Y, 2003, J BACTERIOL, V185, P2711, DOI 10.1128/JB.185.9.2711-2722.2003; Kim SD, 2000, INFECT CONT HOSP EP, V21, P213, DOI 10.1086/501747; KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82, DOI 10.1128/JCM.1.1.82-88.1975; Kloos WE, 1998, INT J SYST BACTERIOL, V48, P799, DOI 10.1099/00207713-48-3-799; KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; Lebeaux D, 2012, ANTIMICROB AGENTS CH, V56, P315, DOI 10.1128/AAC.00547-11; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Petinaki E, 2005, J ANTIMICROB CHEMOTH, V55, P811, DOI 10.1093/jac/dki072; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Ruhe J, 2004, EUR J CLIN MICROBIOL, V23, P495, DOI 10.1007/s10096-004-1134-4; de Gopegui ER, 2011, ENFERM INFEC MICR CL, V29, P339, DOI 10.1016/j.eimc.2011.02.001; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; SMITH JM, 1994, J EVOLUTION BIOL, V7, P525, DOI 10.1046/j.1420-9101.1994.7050525.x; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Palazzo ICV, 2008, J ANTIMICROB CHEMOTH, V62, P1222, DOI 10.1093/jac/dkn375; Vickers AA, 2007, ANTIMICROB AGENTS CH, V51, P4484, DOI 10.1128/AAC.00708-07; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weinstein MP, 1998, J CLIN MICROBIOL, V36, P2089, DOI 10.1128/JCM.36.7.2089-2092.1998; Wohoush A, 2011, CLIN MICROBIOL INFEC, V17, P569, DOI 10.1111/j.1469-0691.2010.03372.x; Zhang LF, 2012, J MOL EVOL, V75, P43, DOI 10.1007/s00239-012-9520-5	63	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66496	10.1371/journal.pone.0066496	http://dx.doi.org/10.1371/journal.pone.0066496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776678	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400148
J	Li, SH; Zhang, XJ; Sun, Z; Li, FH; Xiang, JH				Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai			Transcriptome Analysis on Chinese Shrimp Fenneropenaeus chinensis during WSSV Acute Infection	PLOS ONE			English	Article							SPOT-SYNDROME-VIRUS; BLACK TIGER SHRIMP; DIFFERENTIALLY EXPRESSED GENES; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; PROPHENOLOXIDASE-ACTIVATING SYSTEM; ANTILIPOPOLYSACCHARIDE FACTOR ALF; RNA INTERFERENCE PATHWAY; PENAEUS-MONODON; MOLECULAR-CLONING; ANTIMICROBIAL ACTIVITY	Previous studies have discovered a lot of immune-related genes responding to white spot syndrome virus (WSSV) infection in crustacean. However, little information is available in relation to underlying mechanisms of host responses during the WSSV acute infection stage in naturally infected shrimp. In this study, we employed next-generation sequencing and bioinformatic techniques to observe the transcriptome differences of the shrimp between latent infection stage and acute infection stage. A total of 64,188,426 Illumina reads, including 31,685,758 reads from the latent infection group and 32,502,668 reads from the acute infection group, were generated and assembled into 46,676 unigenes (mean length: 676 bp; range: 200-15,094 bp). Approximately 24,000 peptides were predicted and classified based on homology searches, gene ontology, clusters of orthologous groups of proteins, and biological pathway mapping. Among which, 805 differentially expressed genes were identified and categorized into 11 groups based on their possible function. Genes in the Toll and IMD pathways, the Ras-activated endocytosis process, the RNA interference pathway, anti-lipopolysaccharide factors and many other genes, were found to be activated in shrimp from latent infection stage to acute infection stage. The anti-bacterially proPO-activating cascade was firstly uncovered to be probably participated in antiviral process. These genes contain not only members playing function in host defense against WSSV, but also genes utilized by WSSV for its rapid proliferation. In addition, the transcriptome data provides detail information for identifying novel genes in absence of the genome database of shrimp.	[Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	fhli@ms.qdio.ac.cn; jhxiang@ms.qdio.ac.cn	zhang, jin/GXV-9154-2022; xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Sun, Zheng/0000-0002-8537-8576; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Major State Basic Research Development Program [2012CB114403]; National High Tech Research and Development Program [2012AA10A404, 2012AA092205]; National Natural Science Foundation Program [31072203]; China Agriculture Research System-47 [CARS-47]; Special Fund for Agro-scientific Research in the Public Interest [201103034]	Major State Basic Research Development Program(National Basic Research Program of China); National High Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation Program(National Natural Science Foundation of China (NSFC)); China Agriculture Research System-47; Special Fund for Agro-scientific Research in the Public Interest	This work was financially supported by the Major State Basic Research Development Program (2012CB114403), National High Tech Research and Development Program (2012AA10A404, 2012AA092205), National Natural Science Foundation Program (31072203), China Agriculture Research System-47 (CARS-47), and Special Fund for Agro-scientific Research in the Public Interest (201103034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Assavalapsakul W, 2009, DIS AQUAT ORGAN, V84, P167, DOI 10.3354/dao02044; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Beale KM, 2008, COMP BIOCHEM PHYS D, V3, P263, DOI 10.1016/j.cbd.2008.07.001; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Chen LL, 2000, DIS AQUAT ORGAN, V40, P157, DOI 10.3354/dao040157; Chen P, 2010, FISH SHELLFISH IMMUN, V28, P106, DOI 10.1016/j.fsi.2009.10.002; Chen WY, 2008, DEV COMP IMMUNOL, V32, P1142, DOI 10.1016/j.dci.2008.03.003; Chen YH, 2012, FISH SHELLFISH IMMUN, V32, P373, DOI 10.1016/j.fsi.2011.11.032; Codran A, 2006, J GEN VIROL, V87, P2583, DOI 10.1099/vir.0.81710-0; Dechklar M, 2008, BIOCHEM BIOPH RES CO, V367, P768, DOI 10.1016/j.bbrc.2008.01.031; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Flegel T.W., 2008, DIS ASIAN AQUACULTUR, V6, P355; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Gai YC, 2008, FISH SHELLFISH IMMUN, V24, P156, DOI 10.1016/j.fsi.2007.08.006; Gao HW, 2009, MOL BIOL REP, V36, P1159, DOI 10.1007/s11033-008-9292-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han F, 2012, GENE, V495, P65, DOI 10.1016/j.gene.2011.11.048; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hossain MS, 2004, VIROLOGY, V325, P106, DOI 10.1016/j.virol.2004.05.005; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jimenez-Vega F, 2007, J SHELLFISH RES, V26, P1169, DOI 10.2983/0730-8000(2007)26[1169:IOLVAA]2.0.CO;2; Jiravanichpaisal P, 2006, FISH SHELLFISH IMMUN, V20, P718, DOI 10.1016/j.fsi.2005.09.002; Jiravanichpaisal P, 2004, FISH SHELLFISH IMMUN, V17, P265, DOI 10.1016/j.fsi.2004.03.010; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khadijah S, 2003, J VIROL, V77, P10162, DOI 10.1128/JVI.77.18.10162-10167.2003; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Ko CF, 2007, DEV COMP IMMUNOL, V31, P12, DOI 10.1016/j.dci.2006.05.002; Krishnan P, 2009, DIS AQUAT ORGAN, V86, P263, DOI 10.3354/dao02126; Lai CY, 2005, FISH SHELLFISH IMMUN, V18, P417, DOI 10.1016/j.fsi.2004.10.004; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Li CH, 2008, DEV COMP IMMUNOL, V32, P784, DOI 10.1016/j.dci.2007.11.008; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Liu B, 2006, AQUACULTURE, V253, P163, DOI 10.1016/j.aquaculture.2005.08.022; Liu CH, 2006, FISH SHELLFISH IMMUN, V21, P60, DOI 10.1016/j.fsi.2005.10.004; Liu FS, 2005, MAR BIOTECHNOL, V7, P600, DOI 10.1007/s10126-005-5006-4; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Magbanua FO, 2000, DIS AQUAT ORGAN, V42, P77, DOI 10.3354/dao042077; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Masuda T, 2012, FISH SHELLFISH IMMUN, V32, P61, DOI 10.1016/j.fsi.2011.10.020; Mekata T, 2011, MOL CELL PROBE, V25, P94, DOI 10.1016/j.mcp.2011.02.001; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005; Roux MM, 2002, J VIROL, V76, P8978, DOI 10.1128/JVI.76.17.8978.2002; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Saksmerprome V, 2009, J VIROL METHODS, V162, P213, DOI 10.1016/j.jviromet.2009.08.010; Sarathi M, 2008, MAR BIOTECHNOL, V10, P198, DOI 10.1007/s10126-007-9052-y; Shekhar MS, 2009, MAR BIOTECHNOL, V11, P1, DOI 10.1007/s10126-008-9155-0; Shi XZ, 2009, FISH SHELLFISH IMMUN, V27, P610, DOI 10.1016/j.fsi.2009.07.005; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Sritunyalucksana K, 1999, DEV COMP IMMUNOL, V23, P179, DOI 10.1016/S0145-305X(99)00005-1; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Su JS, 2008, FISH SHELLFISH IMMUN, V24, P223, DOI 10.1016/j.fsi.2007.11.006; Sun C, 2011, MOL BIOL REP, V38, P5313, DOI 10.1007/s11033-011-0681-x; Sun YM, 2013, AQUACULTURE, V376, P124, DOI 10.1016/j.aquaculture.2012.11.014; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Swift ML, 1997, J CHEM INF COMP SCI, V37, P411, DOI 10.1021/ci960402j; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LT, 2001, J FISH DIS, V24, P315, DOI 10.1046/j.1365-2761.2001.00286.x; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thakur PC, 2002, DIS AQUAT ORGAN, V49, P235, DOI 10.3354/dao049235; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Tirasophon W, 2005, BIOCHEM BIOPH RES CO, V334, P102, DOI 10.1016/j.bbrc.2005.06.063; Tirasophon W, 2007, ANTIVIR RES, V74, P150, DOI 10.1016/j.antiviral.2006.11.002; Tsai MF, 1999, DIS AQUAT ORGAN, V38, P107, DOI 10.3354/dao038107; Unajak S, 2006, COMP BIOCHEM PHYS B, V145, P179, DOI 10.1016/j.cbpb.2006.07.002; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang DD, 2012, CHIN J OCEANOL LIMN, V30, P611, DOI 10.1007/s00343-012-1195-7; Wang LL, 2011, AFR J BIOTECHNOL, V10, P17678, DOI 10.5897/AJB11.2017; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Westenberg M, 2005, VIRUS RES, V114, P133, DOI 10.1016/j.virusres.2005.06.006; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Wu Y, 2007, AQUACULTURE, V271, P21, DOI 10.1016/j.aquaculture.2007.06.029; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Xu JY, 2007, ANTIVIR RES, V73, P126, DOI 10.1016/j.antiviral.2006.08.007; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; You XX, 2010, AQUACULTURE, V305, P133, DOI 10.1016/j.aquaculture.2010.04.024; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; Zhu F, 2012, MAR BIOTECHNOL, V14, P63, DOI 10.1007/s10126-011-9387-2; Zong RR, 2008, FISH SHELLFISH IMMUN, V25, P258, DOI 10.1016/j.fsi.2008.05.006	119	131	138	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58627	10.1371/journal.pone.0058627	http://dx.doi.org/10.1371/journal.pone.0058627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	24098432	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100033
J	Zhang, L; Zhang, DD; Yu, BW; Wang, SB; Liu, YL; Wang, J; Li, X; Shang, XY; Li, HY				Zhang, Ling; Zhang, Dandan; Yu, Baowen; Wang, Shangbo; Liu, Yanlin; Wang, Jian; Li, Xin; Shang, Xiaoyun; Li, Hongyuan			Prevalence of HIV Infection and Associated Risk Factors among Men Who Have Sex with Men (MSM) in Harbin, P. R. China	PLOS ONE			English	Article							EPIDEMIC; BEHAVIOR; HIV/AIDS; SHANGHAI; SYPHILIS	Objective: To assess the prevalence of HIV infection and characteristically risk of factors which associated with HIV infection among MSM in Harbin, China. Methods: A face-to-face questionnaire interview was conducted among 463 Men Who Have Sex with Men (MSM) who were recruited by the snowball sampling in Harbin from April, 2011 to July, 2011. The questionnaire mainly included demographics, AIDS knowledge, homosexual behavior and the status of intervention in MSM. Blood specimens were obtained and tested for the diagnoses of HIV, syphilis and hepatitis C virus (HCV). Associations between above exposed factors and HIV infection were analyzed using a univariate analysis and forward stepwise logistic regression. Results: The prevalence of HIV and syphilis was 9.5 and 14.3%. The awareness rate of AIDS was 86.8%. The rate of unprotected sexual behavior was 57.6% of MSM during the past 6 months. The univariate analysis identified that the age (age >= 35 years old), cohabitation, more than 10 years of homosexual behavior and more than 10 homosexual partners were risk factors which associated with the HIV infection, and that protected sex during the past 6 months was a protective factor for the HIV infection. The multivariate analysis identified that the duration of homosexual behavior and commercial sexual behavior were independent risk factors which associated with the HIV infection, and the protected sex during the past 6 months was a protective factor for the HIV infection. Conclusion: The prevalence of HIV among MSM in Harbin has been rapidly increasing in the past few years. Targeted, tailored, and comprehensive interventions are urgently needed to prevent the HIV infection from MSM.	[Zhang, Ling; Li, Xin; Shang, Xiaoyun; Li, Hongyuan] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China; [Zhang, Dandan] AntiTB Stn, Harbin, Peoples R China; [Yu, Baowen] Sanitat Supervis Stn, Harbin, Peoples R China; [Zhang, Ling; Wang, Shangbo; Liu, Yanlin; Wang, Jian] Ctr Dis Control & Prevent, Harbin, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention	Li, HY (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China.	lihongyuan00@126.com	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adimora AA, 2006, SEX TRANSM DIS, V33, P596, DOI 10.1097/01.olq.0000233666.67788.fc; Center of control and prevention of STD and AIDS of Chinese Center for Disease Control and Prevention, 2007, CTR CONTR PREV STD A; China Ministry of Health, 2011, CHIN EST REP EN; China's Ministry of Health/ WHO / UNAIDS, 2005 UPD HIV AIDS EP; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Feng TJ, 2008, SEX TRANSM DIS, V35, P1022, DOI 10.1097/OLQ.0b013e31818600f4; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; He Q, 2008, AIDS BEHAV, V12, pS93, DOI 10.1007/s10461-008-9388-y; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Li HM, 2011, PLOS ONE, V6; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mi GD, 2007, AIDS, V21, pS67, DOI 10.1097/01.aids.0000304699.85379.32; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Office for AIDS prevention and control committee of the State Council, 2004, JOINT EV REP AIDS PR, P7; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Qiu RZ, 1997, AIDS SEXUAL ETHICS, P121; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Guevara WJU, 2012, J SEX MED, V9, P1634, DOI 10.1111/j.1743-6109.2012.02713.x; USAID, 2007, HLTH POL INT VAL INV; USAID, 2006, VAL INV MSM PROGR AS; WANG J, 2008, CHIN J AIDS STD, V14, P75; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wong FY, 2008, AIDS CARE, V20, P170, DOI 10.1080/09540120701534707; Xu Juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P975; Zhang BC, 2012, CHIN J AIDS STD PREV, V8, P197; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c	33	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58440	10.1371/journal.pone.0058440	http://dx.doi.org/10.1371/journal.pone.0058440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23776678	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200068
J	Zhang, JX; Guo, LY; Feng, L; Jiang, WD; Kuang, SY; Liu, Y; Hu, K; Jiang, J; Li, SH; Tang, L; Zhou, XQ				Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Kuang, Sheng-Yao; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Tang, Ling; Zhou, Xiao-Qiu			Soybean beta-Conglycinin Induces Inflammation and Oxidation and Causes Dysfunction of Intestinal Digestion and Absorption in Fish	PLOS ONE			English	Article							SALMON SALMO-SALAR; TROUT ONCORHYNCHUS-MYKISS; MORHUA FED STANDARD; FED GRADED-LEVELS; JUVENILE JIAN; ENZYME-ACTIVITIES; ATLANTIC SALMON; BODY-COMPOSITION; RAINBOW-TROUT; GLUTAMINE SUPPLEMENTATION	beta-conglycinin has been identified as one of the major feed allergens. However, studies of beta-conglycinin on fish are scarce. This study investigated the effects of b-conglycinin on the growth, digestive and absorptive ability, inflammatory response, oxidative status and gene expression of juvenile Jian carp (Cyprinus carpio var. Jian) in vivo and their enterocytes in vitro. The results indicated that the specific growth rate (SGR), feed intake, and feed efficiency were reduced by beta-conglycinin. In addition, activities of trypsin, chymotrypsin, lipase, creatine kinase, Na+, K+-ATPase and alkaline phosphatase in the intestine showed similar tendencies. The protein content of the hepatopancreas and intestines, and the weight and length of the intestines were all reduced by beta-conglycinin. beta-conglycinin increased lipid and protein oxidation in the detected tissues and cells. However, beta-conglycinin decreased superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione peroxidase (GPx) and glutathione reductase (GR) activities and glutathione (GSH) content in the intestine and enterocytes. Similar antioxidant activity in the hepatopancreas was observed, except for GST. The expression of target of rapamycin (TOR) gene was reduced by beta-conglycinin. Furthermore, mRNA levels of interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta (TGF-beta) genes were increased by beta-conglycinin. However, beta-conglycinin increased CuZnSOD, MnSOD, CAT, and GPx1b gene expression. In conclusion, this study indicates that beta-conglycinin induces inflammation and oxidation, and causes dysfunction of intestinal digestion and absorption in fish, and finally reduces fish growth. The results of this study provide some information to the mechanism of beta-conglycinin-induced negative effects.	[Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhou, XQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	xqzhouqq@tom.com	jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022		National Science Foundation of China [3087192]; National Department Public Benefit Research Foundation (Agriculture) of China [2010003020]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-08-0905]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation (Agriculture) of China; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This study was financially supported by the National Science Foundation of China (3087192), National Department Public Benefit Research Foundation (Agriculture) of China (2010003020) and Project supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-08-0905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHUSSAINI AH, 1949, Q J MICROSC SCI, V90, P323; Bakke-McKellep AM, 2007, J FISH DIS, V30, P65, DOI 10.1111/j.1365-2761.2007.00782.x; Baltacioglu E, 2008, ARCH ORAL BIOL, V53, P716, DOI 10.1016/j.archoralbio.2008.02.002; Baudry N, 1996, FEBS LETT, V396, P223, DOI 10.1016/0014-5793(96)01107-6; Bhor VM, 2004, INT J BIOCHEM CELL B, V36, P89, DOI 10.1016/S1357-2725(03)00142-0; Bicho A, 1999, J EXP BIOL, V202, P39; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttle LG, 2001, VET IMMUNOL IMMUNOP, V80, P237, DOI 10.1016/S0165-2427(01)00269-0; Cao YH, 1998, JPEN-PARENTER ENTER, V22, P224, DOI 10.1177/0148607198022004224; Chen F, 2011, J ANIM SCI, V89, P743, DOI 10.2527/jas.2010-3146; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Chen J, 2009, AQUACULTURE, V288, P285, DOI 10.1016/j.aquaculture.2008.10.053; DALY JG, 1995, FISH SHELLFISH IMMUN, V5, P265, DOI 10.1006/fsim.1995.0026; Feng L, 2009, THESIS SICHUAN AGR U; Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246; Furne M, 2005, AQUACULTURE, V250, P391, DOI 10.1016/j.aquaculture.2005.05.017; Gamboa-Delgado J, 2009, AQUACULTURE, V291, P115, DOI 10.1016/j.aquaculture.2009.03.012; Guillaume J., 2001, NUTR FEEDING FISH CR, P35; Guo PF, 2008, INT ARCH ALLERGY IMM, V145, P102, DOI 10.1159/000108135; Han PF, 2010, ARCH ANIM NUTR, V64, P254, DOI 10.1080/17450391003625003; Hao Y, 2009, ARCH ANIM NUTR, V63, P188, DOI 10.1080/17450390902860026; He W, 2009, AQUACULT NUTR, V15, P402, DOI 10.1111/j.1365-2095.2008.00604.x; Hegazi MM, 2010, AQUAT TOXICOL, V99, P118, DOI 10.1016/j.aquatox.2010.04.007; Huang HH, 2011, AQUACULT NUTR, V17, pE233, DOI 10.1111/j.1365-2095.2010.00756.x; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; ILENCHUK TT, 1982, INSECT BIOCHEM, V12, P675, DOI 10.1016/0020-1790(82)90056-7; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang J., 2005, THESIS SICHUAN AGR U; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Jiang WD, 2009, AQUAC RES, V40, P955, DOI 10.1111/j.1365-2109.2009.02191.x; Johnson AT, 2003, J SURG RES, V115, P242, DOI 10.1016/j.jss.2003.07.003; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; LI DF, 1990, J ANIM SCI, V68, P1790; Li W, 2010, AQUACULT NUTR, V16, P137, DOI 10.1111/j.1365-2095.2008.00645.x; Lilleeng E, 2007, AQUACULTURE, V267, P269, DOI 10.1016/j.aquaculture.2007.01.048; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Lin SM, 2011, ANIM FEED SCI TECH, V168, P80, DOI 10.1016/j.anifeedsci.2011.03.012; Lin Y, 2006, AQUACULTURE, V256, P389, DOI 10.1016/j.aquaculture.2006.02.011; Ling J, 2010, AQUACULT NUTR, V16, P616, DOI 10.1111/j.1365-2095.2009.00699.x; Liu ZQ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1105, DOI 10.1152/ajpendo.00337.2002; Lushchak V I, 2001, Am J Physiol Regul Integr Comp Physiol, V280, pR100; Moellering D, 1999, FEBS LETT, V448, P292, DOI 10.1016/S0014-5793(99)00371-3; Mulier B, 1998, EUR RESPIR J, V11, P384, DOI 10.1183/09031936.98.11020384; National Research Council, 1993, NUTR REQ FISH; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishi T, 2003, J NUTR, V133, P352, DOI 10.1093/jn/133.2.352; Ostaszewska T, 2005, AQUACULTURE, V245, P273, DOI 10.1016/j.aquaculture.2004.12.005; Refstie S, 2006, AQUACULTURE, V261, P269, DOI 10.1016/j.aquaculture.2006.07.011; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Salze G, 2010, AQUACULTURE, V298, P294, DOI 10.1016/j.aquaculture.2009.11.003; Satoh J, 2003, J GASTROEN HEPATOL, V18, P719, DOI 10.1046/j.1440-1746.2003.03042.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sun P, 2008, J NUTR BIOCHEM, V19, P627, DOI 10.1016/j.jnutbio.2007.08.007; Tan LN, 2011, AQUACULT NUTR, V17, P338, DOI 10.1111/j.1365-2095.2010.00793.x; Tang L, 2009, AQUACULT NUTR, V15, P477, DOI 10.1111/j.1365-2095.2008.00613.x; Turan A, 2007, DIGEST DIS SCI, V52, P1840, DOI 10.1007/s10620-006-9633-z; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; Utsumi S., 1997, FOOD PROTEINS THEIR, P257; Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039; Wasa M, 2005, J SURG RES, V123, P75, DOI 10.1016/j.jss.2004.07.018; Wen ZP, 2009, AQUACULT NUTR, V15, P470, DOI 10.1111/j.1365-2095.2008.00612.x; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; WINDMUELLER HG, 1982, ADV ENZYMOL RAMB, V53, P201; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Xiao WW, 2011, AQUACULT NUTR, V17, P408, DOI 10.1111/j.1365-2095.2010.00818.x; Xu J, 2010, J ANIM PLANT SCI, V20, P170; Zhang J-X, 2007, AQUACULT SCI, V2, P315; Zhang J-X, 2003, THESIS SICHUAN AGR U; Zhang XD, 2008, AQUACULTURE, V280, P136, DOI 10.1016/j.aquaculture.2008.05.010; Zhao Y, 2010, FOOD AGR IMMUNOL, V21, P209, DOI 10.1080/09540101003596644; Zhou XQ, 2008, AQUACULT NUTR, V14, P381, DOI 10.1111/j.1365-2095.2007.00535.x; Zhu Q, 2012, J APPL ICHTHYOL, DOI [10.1111/j.1439-0426.2011.011676.x, DOI 10.1111/J.1439-0426.2011.011676.X]	76	265	280	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58115	10.1371/journal.pone.0058115	http://dx.doi.org/10.1371/journal.pone.0058115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	24124552	Green Published, Green Submitted, gold			2022-12-25	WOS:000318679900047
J	Zhang, XL; Ge, XH; Shao, YJ; Sun, GL; Li, ZY				Zhang, Xueli; Ge, Xianhong; Shao, Yujiao; Sun, Genlou; Li, Zaiyun			Genomic Change, Retrotransposon Mobilization and Extensive Cytosine Methylation Alteration in Brassica napus Introgressions from Two Intertribal Hybridizations	PLOS ONE			English	Article							PARTIAL HYBRIDS; CHROMOSOME ELIMINATION; INTERGENERIC HYBRIDS; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; HOMEOLOGOUS RECOMBINATION; ORYCHOPHRAGMUS-VIOLACEUS; HELIANTHUS-ANNUUS; GENE-EXPRESSION; MAJOR ROLE	Hybridization and introgression represent important means for the transfer and/or de novo origination of traits and play an important role in facilitating speciation and plant breeding. Two sets of introgression lines in Brassica napus L. were previously established by its intertribal hybridizations with two wild species and long-term selection. In this study, the methods of amplified fragment length polymorphisms (AFLP), sequence-specific amplification polymorphism (SSAP) and methylation-sensitive amplified polymorphism (MSAP) were used to determine their genomic change, retrotransposon mobilization and cytosine methylation alteration in these lines. The genomic change revealed by the loss or gain of AFLP bands occurred for similar to 10% of the total bands amplified in the two sets of introgressions, while no bands specific for wild species were detected. The new and absent SSAP bands appeared for 9 out of 11 retrotransposons analyzed, with low frequency of new bands and their total percentage of about 5% in both sets. MSAP analysis indicated that methylation changes were common in these lines (33.4-39.8%) and the hypermethylation was more frequent than hypomethylation. Our results suggested that certain extents of genetic and epigenetic alterations were induced by hybridization and alien DNA introgression. The cryptic mechanism of these changes and potential application of these lines in breeding were also discussed.	[Zhang, Xueli; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China; [Shao, Yujiao] Hubei Univ Educ, Coll Chem & Life Sci, Wuhan, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Hubei University Education; Saint Marys University - Canada	Ge, XH (corresponding author), Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China.	gexianhong@gmail.com; lizaiyun@mail.hzau.edu.cn	; Zeng, Qingdong/H-7208-2014	Wu, Jianhui/0000-0001-8154-1199; Zeng, Qingdong/0000-0002-7856-2340; Kang, Zhensheng/0000-0001-5575-0122	Agricultural Ministry of China [201103016]	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs)	The work was supported by the grant from Agricultural Ministry of China (201103016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; ANDERSON E., 1949, Introgressive hybridization.; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen HF, 2007, PLANT CELL REP, V26, P1791, DOI 10.1007/s00299-007-0392-x; Cheng BF, 2002, GENOME, V45, P110, DOI 10.1139/g01-131; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Du XZ, 2008, PLANT CELL REP, V27, P261, DOI 10.1007/s00299-007-0452-2; Faure N, 2002, THEOR APPL GENET, V104, P652, DOI 10.1007/s001220100746; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hua YW, 2006, ANN BOT-LONDON, V97, P993, DOI 10.1093/aob/mcl073; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kashkush K, 2007, GENETICS, V177, P1975, DOI 10.1534/genetics.107.080234; Kidwell Kimberlee K., 1992, P1; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lashermes P, 2000, THEOR APPL GENET, V100, P139, DOI 10.1007/s001220050019; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Li ZY, 2007, PLANT CELL REP, V26, P701, DOI 10.1007/s00299-006-0290-7; Liu B., 1999, Journal of Genetics and Breeding, V53, P279; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Liu H.L., 2000, GENETICS BREEDING RA; Liu M, 2007, GENOME, V50, P985, DOI 10.1139/G07-071; LUO P, 1994, PLANT BREEDING, V113, P83, DOI 10.1111/j.1439-0523.1994.tb00707.x; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Ma N, 2007, EUPHYTICA, V157, P231, DOI 10.1007/s10681-007-9416-4; Ma N, 2006, PLANT CELL REP, V25, P1089, DOI 10.1007/s00299-006-0171-0; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; Okamoto H, 2001, TRENDS PLANT SCI, V6, P527, DOI 10.1016/S1360-1385(01)02105-7; Osborn TC, 2003, GENETICS, V165, P1569; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Tate Jennifer A., 2005, P371, DOI 10.1016/B978-012301463-4/50009-7; Tu YQ, 2009, ANN BOT-LONDON, V103, P1039, DOI 10.1093/aob/mcp045; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhao N, 2011, GENETICS, V188, P499, DOI 10.1534/genetics.111.127688; Zhao ZG, 2007, GENOME, V50, P226, DOI 10.1139/G06-146; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	74	38	46	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56346	10.1371/journal.pone.0056346	http://dx.doi.org/10.1371/journal.pone.0056346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23526955	Green Submitted, Green Published, gold			2022-12-25	WOS:000315524900023
J	Rayhan, RU; Stevens, BW; Timbol, CR; Adewuyi, O; Walitt, B; VanMeter, JW; Baraniuk, JN				Rayhan, Rakib U.; Stevens, Benson W.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Walitt, Brian; VanMeter, John W.; Baraniuk, James N.			Increased Brain White Matter Axial Diffusivity Associated with Fatigue, Pain and Hyperalgesia in Gulf War Illness	PLOS ONE			English	Article							ATTENTION; VETERANS; MOTION; VALIDATION; MECHANISMS; DISTORTION; MIGRAINE; STIMULI; NETWORK; DORSAL	Background: Gulf War exposures in 1990 and 1991 have caused 25% to 30% of deployed personnel to develop a syndrome of chronic fatigue, pain, hyperalgesia, cognitive and affective dysfunction. Methods: Gulf War veterans (n=31) and sedentary veteran and civilian controls (n=20) completed fMRI scans for diffusion tensor imaging. A combination of dolorimetry, subjective reports of pain and fatigue were correlated to white matter diffusivity properties to identify tracts associated with symptom constructs. Results: Gulf War Illness subjects had significantly correlated fatigue, pain, hyperalgesia, and increased axial diffusivity in the right inferior fronto-occipital fasciculus. ROC generated thresholds and subsequent binary regression analysis predicted CMI classification based upon axial diffusivity in the right inferior fronto-occipital fasciculus. These correlates were absent for controls in dichotomous regression analysis. Conclusion: The right inferior fronto-occipital fasciculus may be a potential biomarker for Gulf War Illness. This tract links cortical regions involved in fatigue, pain, emotional and reward processing, and the right ventral attention network in cognition. The axonal neuropathological mechanism(s) explaining increased axial diffusivity may account for the most prominent symptoms of Gulf War Illness.	[Rayhan, Rakib U.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Baraniuk, James N.] Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA; [Stevens, Benson W.; VanMeter, John W.] Georgetown Univ, Med Ctr, Dept Neurol, Ctr Funct & Mol Imaging, Washington, DC 20007 USA; [Walitt, Brian] Washington Hosp Ctr, Div Rheumatol, Washington, DC 20010 USA	Georgetown University; Georgetown University; MedStar Washington Hospital Center	Rayhan, RU (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA.	rur@georgetown.edu	VanMeter, John W/D-2589-2018	VanMeter, John W/0000-0002-7012-5197; Baraniuk, James Nicholas/0000-0002-1866-4177	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award [W81-XWH-09-1-0526]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA) [UL1TR000101, UL1RR031975]	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Sources of funding were provided by the Department of Defense Congressionally Directed Medical Research Program (CDMRP) award W81-XWH-09-1-0526. Research support for the Clinical Research Unit at Georgetown University Medical Center was funded in whole or in part with federal funds (Grant #UL1TR000101, previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Baraniuk JN, 2013, AM J TRANSL RES, V5, P53; Baraniuk JN, 1998, ANN ALLERG ASTHMA IM, V81, P359, DOI 10.1016/S1081-1206(10)63129-8; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burdach K., 1822, BAUE LEBEN GEHIRNS Z, VSecond; Camara E, 2010, J NEUROSCI, V30, P11398, DOI 10.1523/JNEUROSCI.0111-10.2010; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Cook DB, 2004, J RHEUMATOL, V31, P364; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Forkel J, 2012, CORTEX; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Gu L, 2012, J TRAUMA AC IN PRESS; Harrison DM, 2013, J NEUROL, V260, P397, DOI 10.1007/s00415-012-6638-8; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kumar R, 2011, J NEUROL SCI, V307, P106, DOI 10.1016/j.jns.2011.04.028; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lima D, 2008, SCI PAIN, V5, P477; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagae LM, 2012, AM J NEURORADIOL, V33, P1720, DOI 10.3174/ajnr.A3037; Naranch K, 2002, OTOLARYNG HEAD NECK, V127, P387, DOI 10.1067/mhn.2002.129038; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Petrides M., 2002, PRINCIPLES FRONTAL L; Pierpaoli C, 2010, STOCKH SWED ISMRM 18; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Research Advisory Committee on Gulf War Veterans' Illness (RAC-GWVI), 2008, GULF WAR ILLN HLTH G; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Senapati AK, 2005, BRAIN RES, V1036, P173, DOI 10.1016/j.brainres.2004.12.043; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Tillman GD, 2012, NEUROTOXICOLOGY; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wallin MT, 2009, COGN BEHAV NEUROL, V22, P155, DOI 10.1097/WNN.0b013e3181b278e8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserfallen JB, 1997, J ALLERGY CLIN IMMUN, V100, P16, DOI 10.1016/S0091-6749(97)70189-1; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39	75	119	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58493	10.1371/journal.pone.0058493	http://dx.doi.org/10.1371/journal.pone.0058493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23798990	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600025
J	Zhang, Y; Tan, XJ; Cui, AL; Mao, NY; Xu, ST; Zhu, Z; Zhou, JH; Shi, J; Zhao, YP; Wang, XJ; Huang, XY; Zhu, SL; Zhang, Y; Tang, W; Ling, H; Xu, WB				Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Zhou, Jianhui; Shi, Jing; Zhao, Yueping; Wang, Xianjun; Huang, Xueyong; Zhu, Shuangli; Zhang, Yong; Tang, Wei; Ling, Hua; Xu, Wenbo			Complete Genome Analysis of the C4 Subgenotype Strains of Enterovirus 71: Predominant Recombination C4 Viruses Persistently Circulating in China for 14 Years	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; HAND; FOOT; COXSACKIEVIRUS; EMERGENCE; EVOLUTION; INFECTION; OUTBREAK; SINGAPORE	Genetic recombination is a well-known phenomenon for enteroviruses. To investigate the genetic characterization and the potential recombination of enterovirus 71 (EV71) circulating in China, we determined the 16 complete genome sequences of EV71 isolated from Hand Foot Mouth Disease (HFMD) patients during the large scale outbreak and non-outbreak years since 1998 in China. The full length genome sequences of 16 Chinese EV71 in present study were aligned with 186 genome sequences of EV71 available from GenBank, including 104 China mainland and 82 international sequences, covering the time period of 1970-2011. The oldest strains of each subgenotype of EV71 and prototype strains of HEV-A were included to do the phylogenetic and Simplot analysis. Phylogenetic analysis indicated that all Chinese strains were clustered into C4 subgenotype of EV71, except for HuB/CHN/2009 clustered into A and Xiamen/CHN/2009 clustered into B5 subgenotype. Most of C4 EV71 were clustered into 2 predominant evolutionary branches: C4b and C4a evolutionary brunches. Our comprehensive recombination analysis showed the evidence of genome recombination of subgenotype C4 (including C4a and C4b) sequences between structural genes from genotype C EV71 and non-structural genes from the prototype strains of CAV16, 14 and 4, but the evidence of intratypic recombination between C4 strains and B subgenotype was not enough strong. This intertypic recombination C4 viruses were first seen in 1998 and became the predominant endemic viruses circulating in China mainland for at least 14 years. A shift between C4a and C4b evolutionary brunches of C4 recombination viruses were observed, and C4a viruses have been associated with large scale nationwide HFMD outbreak with higher morbidity and mortality since 2007.	[Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Shi, Jing; Zhu, Shuangli; Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhou, Jianhui] Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China; [Shi, Jing] Capital Univ Med Sci, Beijing Children Hosp, Beijing, Peoples R China; [Zhao, Yueping] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wang, Xianjun] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Tang, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Ling, Hua] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Shanghai Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	National Basic Research Program of China (973 Program) [2011CB504902]; National Natural Science Foundation of China [30901259]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]; Science and Technology Development Plan of Shandong Province [2009GG10002055]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of National Ministry of Science; Science and Technology Development Plan of Shandong Province	This study was supported by National Basic Research Program of China (973 Program): (Grant No. 2011CB504902); Projects of the National Natural Science Foundation of China (Grant No. 30901259); Key Technologies R&D Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003); and Science and Technology Development Plan of Shandong Province (2009GG10002055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yamayoshi S, 2012, J VIROL, V86, P5686, DOI 10.1128/JVI.00020-12; Yang F, 2001, SCI CHINA SER C, V44, P178, DOI 10.1007/BF02879323; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034401; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	38	67	107	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56341	10.1371/journal.pone.0056341	http://dx.doi.org/10.1371/journal.pone.0056341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23516601	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200036
J	Li, RM; Xie, W; Wang, SL; Wu, QJ; Yang, NN; Yang, X; Pan, HP; Zhou, XM; Bai, LY; Xu, BY; Zhou, XG; Zhang, YJ				Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Zhou, Xiaomao; Bai, Lianyang; Xu, Baoyun; Zhou, Xuguo; Zhang, Youjun			Reference Gene Selection for qRT-PCR Analysis in the Sweetpotato Whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae)	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; QUANTITATIVE PCR; Q-BIOTYPE; EXPRESSION; RNA; NORMALIZATION; QUANTIFICATION; SUSCEPTIBILITY	Background: Accurate evaluation of gene expression requires normalization relative to the expression of reliable reference genes. Expression levels of "classical" reference genes can differ, however, across experimental conditions. Although quantitative real-time PCR (qRT-PCR) has been used extensively to decipher gene function in the sweetpotato whitefly Bemisia tabaci, a world-wide pest in many agricultural systems, the stability of its reference genes has rarely been validated. Results: In this study, 15 candidate reference genes from B. tabaci were evaluated using two Excel-based algorithms geNorm and Normfinder under a diverse set of biotic and abiotic conditions. At least two reference genes were selected to normalize gene expressions in B. tabaci under experimental conditions. Specifically, for biotic conditions including host plant, acquisition of a plant virus, developmental stage, tissue (body region of the adult), and whitefly biotype, ribosomal protein L29 was the most stable reference gene. In contrast, the expression of elongation factor 1 alpha, peptidylprolyl isomerase A, NADH dehydrogenase, succinate dehydrogenase complex subunit A and heat shock protein 40 were consistently stable across various abiotic conditions including photoperiod, temperature, and insecticide susceptibility. Conclusion: Our finding is the first step toward establishing a standardized quantitative real-time PCR procedure following the MIQE (Minimum Information for publication of Quantitative real time PCR Experiments) guideline in an agriculturally important insect pest, and provides a solid foundation for future RNA interference based functional study in B. tabaci.	[Li, Rumei; Zhou, Xiaomao; Bai, Lianyang] Hunan Agr Univ, Inst Pesticide, Changsha, Hunan, Peoples R China; [Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; zhangyj@mail.caas.net.cn	Zhang, Youjun/AAY-7948-2020; Yang, Xin/AAG-5375-2020	Zhang, Youjun/0000-0003-3508-6695; 	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [30900153]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), and the National Natural Science Foundation of China (No. 30900153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kylee J, 2011, PLOS ONE, V6; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002	53	156	166	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53006	10.1371/journal.pone.0053006	http://dx.doi.org/10.1371/journal.pone.0053006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308130	Green Published, Green Submitted, gold			2022-12-25	WOS:000313429800024
J	Manrique-Poyato, MI; Lopez-Leon, MD; Gomez, R; Perfectti, F; Camacho, JPM				Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Gomez, Ricardo; Perfectti, Francisco; Martinez Camacho, Juan Pedro			Population Genetic Structure of the Grasshopper Eyprepocnemis plorans in the South and East of the Iberian Peninsula	PLOS ONE			English	Article							SEQUENCE REPEAT POLYMORPHISMS; B-CHROMOSOME; ALLELIC DROPOUT; FEMALE FITNESS; RAPD MARKERS; ISSR-PCR; DIVERSITY; IDENTIFICATION; DYNAMICS; GENOME	The grasshopper Eyprepocnemis plorans subsp. plorans harbors a very widespread polymorphism for supernumerary (B) chromosomes which appear to have arisen recently. These chromosomes behave as genomic parasites because they are harmful for the individuals carrying them and show meiotic drive in the initial stages of population invasion. The rapid increase in B chromosome frequency at intrapopulation level is thus granted by meiotic drive, but its spread among populations most likely depends on interpopulation gene flow. We analyze here the population genetic structure in 10 natural populations from two regions (in the south and east) of the Iberian Peninsula. The southern populations were coastal whereas the eastern ones were inland populations located at 260-655 m altitude. The analysis of 97 ISSR markers revealed significant genetic differentiation among populations (average G(ST) = 0.129), and the Structure software and AMOVA indicated a significant genetic differentiation between southern and eastern populations. There was also significant isolation by distance (IBD) between populations. Remarkably, these results were roughly similar to those found when only the markers showing low or no dropout were included, suggesting that allelic dropout had negligible effects on population genetic analysis. We conclude that high gene flow helped this parasitic B chromosome to spread through most of the geographical range of the subspecies E. plorans plorans.	[Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Perfectti, Francisco; Martinez Camacho, Juan Pedro] Univ Granada, Dept Genet, Granada, Spain; [Inmaculada Manrique-Poyato, Maria] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Celulas Troncales, Seville, Spain; [Gomez, Ricardo] Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal, Albacete, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Universidad de Castilla-La Mancha	Camacho, JPM (corresponding author), Univ Granada, Dept Genet, Granada, Spain.	jpmcamac@ugr.es	Perfectti, Francisco/C-5087-2008; López-León, María Dolores/L-9026-2014; Camacho, Juan Pedro M/L-6869-2014; Cabrero, Josefa/L-8899-2014	Perfectti, Francisco/0000-0002-5551-213X; López-León, María Dolores/0000-0003-2337-7313; Camacho, Juan Pedro M/0000-0002-2507-9814; Cabrero, Josefa/0000-0002-5848-6985; Gomez Ladron de Guevara, Ricardo/0000-0003-3430-0346	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11917]; Spanish Ministerio de Ciencia e Innovacion; FEDER funds	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER funds(European Commission)	This study was supported by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-11917), and was partially performed by FEDER funds. MIMP was supported by a fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C., 2004, MOL MARKERS NATURAL; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; Cabrero J, 1997, CHROMOSOME RES, V5, P194, DOI 10.1023/A:1018499015091; Camacho JPM, 1997, AM NAT, V149, P1030, DOI 10.1086/286037; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Cano J, 2005, J DERMATOL SCI, V39, P17, DOI 10.1016/j.jdermsci.2005.01.016; Datwyler SL, 2004, SYST BOT, V29, P165, DOI 10.1600/036364404772974077; de Leon JH, 2005, J INSECT SCI, V5; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dirsh V. M., 1958, Proceedings of the Royal Entomological Society of London (B), V27, P33; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez ME, 2002, THEOR APPL GENET, V104, P845, DOI 10.1007/s00122-001-0848-2; Hernandez F., 1984, Boletin del Servicio de Defensa contra Plagas e Inspeccion Fitopatologica, V10, P245; Herrera JA, 1996, HEREDITY, V76, P633, DOI 10.1038/hdy.1996.90; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; JONES RN, 1991, AM NAT, V137, P430, DOI 10.1086/285175; KANTETY RV, 1995, MOL BREEDING, V1, P365, DOI 10.1007/BF01248414; Kar PK, 2005, GENETICA, V125, P173, DOI 10.1007/s10709-005-7002-z; Kojima T, 1998, THEOR APPL GENET, V96, P37, DOI 10.1007/s001220050706; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lu ZX, 2006, PLANT SCI, V170, P407, DOI 10.1016/j.plantsci.2005.09.009; Munoz E, 1998, P ROY SOC B-BIOL SCI, V265, P1903, DOI 10.1098/rspb.1998.0518; Nagaoka T, 1997, THEOR APPL GENET, V94, P597, DOI 10.1007/s001220050456; PARDO MC, 1995, HEREDITY, V74, P654, DOI 10.1038/hdy.1995.89; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P376, DOI 10.1159/000079315; Phillips CB, 2002, NEW ZEAL J AGR RES, V45, P295, DOI 10.1080/00288233.2002.9513519; Pinedo-Cancino V, 2006, AM J TROP MED HYG, V75, P238, DOI 10.4269/ajtmh.2006.75.238; Pradeep Appukuttan R., 2005, Journal of Applied Genetics, V46, P291; Ratnaparkhe MB, 1998, THEOR APPL GENET, V97, P515, DOI 10.1007/s001220050925; Ren ZM, 2008, GENETICA, V132, P103, DOI 10.1007/s10709-007-9153-6; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Sesarini C, 2008, GENETICA, V133, P295, DOI 10.1007/s10709-007-9213-y; Slatkin Montgomery, 1994, P3; Soulsbury CD, 2007, CONSERV GENET, V8, P733, DOI 10.1007/s10592-006-9194-x; Spiegelhalter DJ, 2002, J R STAT SOC B, V17, P37; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tester DJ, 2006, HEART RHYTHM, V3, P815, DOI 10.1016/j.hrthm.2006.03.016; Tsumura Y, 1996, THEOR APPL GENET, V92, P40, DOI 10.1007/BF00222949; Vandergast AG, 2009, J INSECT CONSERV, V13, P329, DOI 10.1007/s10841-008-9176-z; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vijayan K, 2006, J INSECT SCI, V6, DOI 10.1673/2006_6_30.1; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu W, 2005, BIOCHEM SYST ECOL, V33, P1141, DOI 10.1016/j.bse.2005.02.010; Zhang XP, 2006, BIOCHEM SYST ECOL, V34, P38, DOI 10.1016/j.bse.2005.05.007; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	54	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59041	10.1371/journal.pone.0059041	http://dx.doi.org/10.1371/journal.pone.0059041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520552	Green Published, gold, Green Submitted			2022-12-25	WOS:000318679900112
J	Yu, H; Jin, HW; Sun, LD; Zhang, LR; Sun, G; Wang, ZL; Yu, YC				Yu, Hui; Jin, Hongwei; Sun, Lidan; Zhang, Liangren; Sun, Gang; Wang, Zhanli; Yu, Yongchun			Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies	PLOS ONE			English	Article							TLR7; RECOGNITION; INFECTION; PATTERNS; LIGANDS	Chemical feature based pharmacophore models were generated for Toll-like receptors 7 (TLR7) agonists using HypoGen algorithm, which is implemented in the Discovery Studio software. Several methods tools used in validation of pharmacophore model were presented. The first hypothesis Hypo1 was considered to be the best pharmacophore model, which consists of four features: one hydrogen bond acceptor, one hydrogen bond donor, and two hydrophobic features. In addition, homology modeling and molecular docking studies were employed to probe the intermolecular interactions between TLR7 and its agonists. The results further confirmed the reliability of the pharmacophore model. The obtained pharmacophore model (Hypo1) was then employed as a query to screen the Traditional Chinese Medicine Database (TCMD) for other potential lead compounds. One hit was identified as a potent TLR7 agonist, which has antiviral activity against hepatitis virus in vitro. Therefore, our current work provides confidence for the utility of the selected chemical feature based pharmacophore model to design novel TLR7 agonists with desired biological activity.	[Yu, Hui; Yu, Yongchun] Tongji Univ, Affiliated Peoples Hosp 10, Dept Lab Ctr, Shanghai 200092, Peoples R China; [Jin, Hongwei; Sun, Lidan; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Yu, Hui; Sun, Gang] Second Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China; [Wang, Zhanli] First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China	Tongji University; Peking University; Baotou Medical College; Baotou Medical College	Wang, ZL (corresponding author), First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China.	wang.zhanli@hotmail.com; yyc@tongji.edu.cn	Zhang, Liang/GWM-6088-2022; Patel, Hemal/C-7325-2019	Westenbrink, B. Daan/0000-0002-1362-7019; Patel, Hemal/0000-0001-6722-9625; van Gilst, Wiek/0000-0003-2968-8585	National Natural Science Foundation of China [20902068]; Ministry of Education of China [20090001120049]; Natural Science Foundation of Inner Mongolia Autonomous Region, China [2011BS1201]; State Key Laboratory of Natural and Biomimetic Drugs [K20110103]; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Inner Mongolia Autonomous Region, China; State Key Laboratory of Natural and Biomimetic Drugs; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	This work was supported in part by grants from the National Natural Science Foundation of China (No. 20902068), Doctoral Fund of Ministry of Education of China (No. 20090001120049), Natural Science Foundation of Inner Mongolia Autonomous Region, China (No. 2011BS1201), Project of State Key Laboratory of Natural and Biomimetic Drugs (No. K20110103), and Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2005, TRAD CHIN MED DAT TC; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; CHONG L, 2008, Patent No. 200805555; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; COOK A, 2008, Patent No. 2008004948; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Gong J, 2010, J MOL MODEL, V16, P1283, DOI 10.1007/s00894-009-0640-9; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iavarone C, 2011, J IMMUNOL, V186, P4213, DOI 10.4049/jimmunol.1003585; JONES P, 2006, Patent No. 2006117670; JONES P, 2007, Patent No. 200709301; Jones P, 2011, BIOORG MED CHEM LETT, V21, P5939, DOI 10.1016/j.bmcl.2011.07.076; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kurimoto A, 2010, J MED CHEM, V53, P2964, DOI 10.1021/jm100070n; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Li H, 2000, IUL BIOTECH, V2, P171; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Pryde DC, 2011, MEDCHEMCOMM, V2, P185, DOI 10.1039/c0md00197j; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TD, 2011, BIOORG MED CHEM LETT, V21, P2389, DOI 10.1016/j.bmcl.2011.02.092; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186; Yu H, 2012, CURR MED CHEM, V19, P1365, DOI 10.2174/092986712799462603	34	69	88	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e56514	10.1371/journal.pone.0056514	http://dx.doi.org/10.1371/journal.pone.0056514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526932	gold, Green Submitted, Green Published			2022-12-25	WOS:000317562600005
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600038
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300065
